*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 86 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 250 ALA A 101 ALA^? 11.28 ZN ZN A 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 32.91 0.46 27.63 33.66 0.11 29.56 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 32.09 5.17 22.05 31.25 5.48 23.29 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 86 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 250 ALA A 102 ALA.? 9.34 ZN ZN A 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 32.91 0.46 27.63 33.66 0.11 29.56 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 33.09 1.52 21.68 34.14 1.27 20.64 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 86 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 250 ALA A 101 ALA^? 11.28 ZN ZN A 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 40.70 8.14 28.73 41.06 6.40 29.84 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 37.42 3.90 29.26 38.47 2.36 30.22 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 32.09 5.17 22.05 31.25 5.48 23.29 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 86 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 250 ALA A 102 ALA.? 9.34 ZN ZN A 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 37.80 0.44 25.56 37.02 -1.29 26.44 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 33.09 1.52 21.68 34.14 1.27 20.64 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 86 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 250 ALA A 102 ALA.? 9.34 ZN ZN A 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 32.91 0.46 27.63 33.66 0.11 29.56 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 33.09 1.52 21.68 34.14 1.27 20.64 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 86 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 250 ALA A 161 ALA.? 7.16 O1S EPE C 377 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 24.22 -22.86 5.01 22.88 -23.16 4.38 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 A 49 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 86 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 250 ALA B 101 ALA^? 11.06 ZN ZN B 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -14.73 -2.17 28.75 -13.66 -1.71 29.80 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 A 49 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 86 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 250 ALA B 102 ALA.? 9.36 ZN ZN B 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -13.15 -2.66 25.34 -14.20 -2.84 24.29 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 A 49 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 86 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 250 ALA B 101 ALA^? 11.06 ZN ZN B 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -14.73 -2.17 28.75 -13.66 -1.71 29.80 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 A 49 ASP B 82 ASP.? 10.62 O3S EPE B 376 A 86 HIS B 80 HIS.? 6.72 O2S EPE B 376 A 250 ALA B 78 ALA.? 7.78 O2S EPE B 376 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -22.38 12.66 48.09 -22.95 14.65 48.48 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -14.76 4.18 47.71 -14.60 5.45 48.54 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 A 49 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 86 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 250 ALA B 102 ALA.? 9.36 ZN ZN B 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -13.15 -2.66 25.34 -14.20 -2.84 24.29 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 A 49 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 86 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 250 ALA B 102 ALA.? 9.36 ZN ZN B 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -13.15 -2.66 25.34 -14.20 -2.84 24.29 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 A 49 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 86 HIS B 169 HIS^? 10.86 O3S EPE A 377 A 250 ALA B 161 ALA.? 8.19 O3S EPE A 377 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -4.10 -26.00 8.07 -3.75 -27.17 8.94 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 A 49 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 86 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 250 ALA C 101 ALA^? 11.01 ZN ZN C 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 17.04 -27.71 53.14 16.81 -26.24 53.31 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 15 3 # 15 A 49 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 86 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 250 ALA C 102 ALA.? 9.31 ZN ZN C 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 14.49 -29.28 50.81 14.45 -30.75 50.81 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 16 3 # 16 A 49 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 86 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 250 ALA C 101 ALA^? 11.01 ZN ZN C 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 17.04 -27.71 53.14 16.81 -26.24 53.31 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 17 3 # 17 A 49 ASP C 82 ASP.? 10.22 O3S EPE C 376 A 86 HIS C 80 HIS.? 6.69 O2S EPE C 376 A 250 ALA C 78 ALA.? 7.87 O2S EPE C 376 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 23.03 -14.86 74.18 22.44 -14.42 76.16 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 24.39 -12.24 63.20 23.97 -11.24 64.29 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 18 3 # 18 A 49 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 86 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 250 ALA C 101 ALA^? 11.01 ZN ZN C 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 17.04 -27.71 53.14 16.81 -26.24 53.31 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 19 3 # 19 A 49 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 86 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 250 ALA C 102 ALA.? 9.31 ZN ZN C 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 14.49 -29.28 50.81 14.45 -30.75 50.81 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 20 3 # 20 A 49 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 86 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 250 ALA C 101 ALA^? 11.01 ZN ZN C 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 17.04 -27.71 53.14 16.81 -26.24 53.31 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 21 3 # 21 A 49 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 86 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 250 ALA C 102 ALA.? 9.31 ZN ZN C 375 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 14.49 -29.28 50.81 14.45 -30.75 50.81 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 22 3 # 22 A 49 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 86 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 250 ALA C 161 ALA.? 14.45 O1 TRS A 378 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 14.54 -40.01 25.90 15.56 -39.75 24.83 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 22 hits 2wwt_o00 naa= 3 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 168 SER^? 10.80 O1S EPE C 377 A 524 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 556 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 A 445 SER B 168 SER^? 10.59 O3S EPE A 377 A 524 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 556 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 A 445 SER C 168 SER^? 24.11 O1 TRS A 378 A 524 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 556 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 13.13 -47.52 24.96 14.34 -48.17 26.54 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 3 hits 3o4g_o00 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 168 SER^? 10.80 O1S EPE C 377 A 123 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 172 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 45.74 29.80 42.79 47.58 31.06 41.64 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 44.17 25.61 37.60 45.21 25.56 35.81 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 39.85 24.35 34.94 41.12 25.58 33.83 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 A 98 SER C 168 SER^? 24.11 O1 TRS A 378 A 123 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 172 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 45.74 29.80 42.79 47.58 31.06 41.64 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 44.17 25.61 37.60 45.21 25.56 35.81 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 39.85 24.35 34.94 41.12 25.58 33.83 19.06 -47.14 27.83 18.62 -49.09 27.08 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o00 naa= 3 ULMN 6 1b93_c00 METHYLGLYOXAL SYNTHASE user 1 6 # 1 A 19 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 66 GLY A 291 GLY^? 4.06 ZN ZN A 374 A 71 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 91 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 98 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 101 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 5.70 58.47 82.03 7.42 59.47 82.70 37.42 3.90 29.26 38.47 2.36 30.22 coo 9.36 61.63 75.93 9.60 61.20 75.31 39.29 -3.03 33.06 39.67 -3.69 33.42 coo 10.79 65.44 78.59 9.33 64.03 79.14 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 4.57 56.01 85.24 3.72 54.19 85.89 40.70 8.14 28.73 41.06 6.40 29.84 coo 12.11 59.31 79.49 10.07 58.80 79.56 40.60 0.33 34.12 38.69 0.39 33.24 coo 13.95 63.65 80.11 15.57 62.92 78.98 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 6 1b93_c00 METHYLGLYOXAL SYNTHASE user 2 6 # 2 A 19 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 66 GLY B 291 GLY^? 4.09 ZN ZN B 374 A 71 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 91 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 98 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 101 ASP B 312 ASP.? 7.53 ZN ZN B 374 coo 5.70 58.47 82.03 7.42 59.47 82.70 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 9.36 61.63 75.93 9.60 61.20 75.31 -6.52 8.91 21.71 -6.06 9.31 21.13 coo 10.79 65.44 78.59 9.33 64.03 79.14 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 4.57 56.01 85.24 3.72 54.19 85.89 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 12.11 59.31 79.49 10.07 58.80 79.56 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 13.95 63.65 80.11 15.57 62.92 78.98 -4.08 14.12 24.69 -6.01 13.62 25.36 ULMN 6 1b93_c00 METHYLGLYOXAL SYNTHASE user 3 6 # 3 A 19 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 66 GLY C 291 GLY^? 4.07 ZN ZN C 374 A 71 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 91 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 98 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 101 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 5.70 58.47 82.03 7.42 59.47 82.70 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 9.36 61.63 75.93 9.60 61.20 75.31 1.77 -25.71 54.72 0.95 -25.76 54.56 coo 10.79 65.44 78.59 9.33 64.03 79.14 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 4.57 56.01 85.24 3.72 54.19 85.89 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 12.11 59.31 79.49 10.07 58.80 79.56 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 13.95 63.65 80.11 15.57 62.92 78.98 -0.90 -20.80 57.97 0.71 -21.61 59.03 1b93_c00 source 1b93 METHYLGLYOXAL SYNTHASE : 3 hits 1b93_c00 naa= 6 ULMN 6 1b93_c01 METHYLGLYOXAL SYNTHASE user 1 6 # 1 B 19 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 66 GLY A 291 GLY^? 4.06 ZN ZN A 374 B 71 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 91 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 98 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 101 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 24.23 49.16 79.41 24.71 50.32 81.09 37.42 3.90 29.26 38.47 2.36 30.22 coo 28.91 45.35 84.89 28.68 44.69 85.29 39.29 -3.03 33.06 39.67 -3.69 33.42 coo 30.80 49.64 85.95 29.66 49.27 84.20 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 20.84 50.77 77.36 19.09 50.51 76.22 40.70 8.14 28.73 41.06 6.40 29.84 coo 24.68 48.27 86.40 24.62 47.82 84.35 40.60 0.33 34.12 38.69 0.39 33.24 coo 27.92 50.91 88.49 27.41 49.89 90.27 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 6 1b93_c01 METHYLGLYOXAL SYNTHASE user 2 6 # 2 B 19 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 66 GLY B 291 GLY^? 4.09 ZN ZN B 374 B 71 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 91 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 98 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 101 ASP B 312 ASP.? 7.53 ZN ZN B 374 coo 24.23 49.16 79.41 24.71 50.32 81.09 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 28.91 45.35 84.89 28.68 44.69 85.29 -6.52 8.91 21.71 -6.06 9.31 21.13 coo 30.80 49.64 85.95 29.66 49.27 84.20 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 20.84 50.77 77.36 19.09 50.51 76.22 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 24.68 48.27 86.40 24.62 47.82 84.35 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 27.92 50.91 88.49 27.41 49.89 90.27 -4.08 14.12 24.69 -6.01 13.62 25.36 ULMN 6 1b93_c01 METHYLGLYOXAL SYNTHASE user 3 6 # 3 B 19 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 66 GLY C 291 GLY^? 4.07 ZN ZN C 374 B 71 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 91 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 98 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 101 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 24.23 49.16 79.41 24.71 50.32 81.09 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 28.91 45.35 84.89 28.68 44.69 85.29 1.77 -25.71 54.72 0.95 -25.76 54.56 coo 30.80 49.64 85.95 29.66 49.27 84.20 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 20.84 50.77 77.36 19.09 50.51 76.22 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 24.68 48.27 86.40 24.62 47.82 84.35 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 27.92 50.91 88.49 27.41 49.89 90.27 -0.90 -20.80 57.97 0.71 -21.61 59.03 1b93_c01 source 1b93 METHYLGLYOXAL SYNTHASE : 3 hits 1b93_c01 naa= 6 ULMN 6 1b93_c02 METHYLGLYOXAL SYNTHASE user 1 6 # 1 C 19 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 66 GLY A 291 GLY^? 4.06 ZN ZN A 374 C 71 ASP A 292 ASP^? 8.63 ZN ZN A 374 C 91 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 98 HIS A 333 HIS~? -3.55 ZN ZN A 374s C 101 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 28.70 72.28 84.82 27.09 70.94 84.67 37.42 3.90 29.26 38.47 2.36 30.22 coo 22.05 75.71 82.36 21.71 76.35 82.69 39.29 -3.03 33.06 39.67 -3.69 33.42 coo 20.84 71.59 79.86 22.76 72.01 80.63 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 31.68 70.62 87.34 33.24 70.85 88.75 40.70 8.14 28.73 41.06 6.40 29.84 coo 21.75 72.65 86.11 23.69 73.40 85.84 40.60 0.33 34.12 38.69 0.39 33.24 coo 19.15 70.01 83.12 17.47 70.83 84.11 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 6 1b93_c02 METHYLGLYOXAL SYNTHASE user 2 6 # 2 C 19 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 66 GLY B 291 GLY^? 4.09 ZN ZN B 374 C 71 ASP B 292 ASP^? 8.88 ZN ZN B 374 C 91 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 98 HIS B 333 HIS~? -3.37 ZN ZN B 374s C 101 ASP B 312 ASP.? 7.53 ZN ZN B 374 coo 28.70 72.28 84.82 27.09 70.94 84.67 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 22.05 75.71 82.36 21.71 76.35 82.69 -6.52 8.91 21.71 -6.06 9.31 21.13 coo 20.84 71.59 79.86 22.76 72.01 80.63 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 31.68 70.62 87.34 33.24 70.85 88.75 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 21.75 72.65 86.11 23.69 73.40 85.84 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 19.15 70.01 83.12 17.47 70.83 84.11 -4.08 14.12 24.69 -6.01 13.62 25.36 ULMN 6 1b93_c02 METHYLGLYOXAL SYNTHASE user 3 6 # 3 C 19 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 66 GLY C 291 GLY^? 4.07 ZN ZN C 374 C 71 ASP C 292 ASP^? 8.69 ZN ZN C 374 C 91 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 98 HIS C 333 HIS~? -3.37 ZN ZN C 374s C 101 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 28.70 72.28 84.82 27.09 70.94 84.67 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 22.05 75.71 82.36 21.71 76.35 82.69 1.77 -25.71 54.72 0.95 -25.76 54.56 coo 20.84 71.59 79.86 22.76 72.01 80.63 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 31.68 70.62 87.34 33.24 70.85 88.75 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 21.75 72.65 86.11 23.69 73.40 85.84 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 19.15 70.01 83.12 17.47 70.83 84.11 -0.90 -20.80 57.97 0.71 -21.61 59.03 1b93_c02 source 1b93 METHYLGLYOXAL SYNTHASE : 3 hits 1b93_c02 naa= 6 ULMN 5 2dw7_c02 BLL6730 PROTEIN user 1 5 # 1 C 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 C 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 C 292 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 322 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 45.66 0.76 26.15 51.53 0.58 28.90 coo 0.95 12.72 73.51 1.58 12.72 68.31 44.47 1.55 20.70 47.30 5.10 24.27 coo -0.04 8.61 56.23 -0.37 10.52 55.44 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -0.04 10.31 60.47 1.33 11.89 60.44 32.91 0.46 27.63 33.66 0.11 29.56 coo -4.59 24.28 66.67 -6.26 24.34 67.99 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 5 2dw7_c02 BLL6730 PROTEIN user 2 5 # 2 C 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 C 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 292 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 322 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 0.95 12.72 73.51 1.58 12.72 68.31 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -0.04 8.61 56.23 -0.37 10.52 55.44 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -0.04 10.31 60.47 1.33 11.89 60.44 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 5 2dw7_c02 BLL6730 PROTEIN user 3 5 # 3 C 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 C 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 292 ASP C 27 ASP.? 8.23 ZN ZN C 375 C 322 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 0.95 12.72 73.51 1.58 12.72 68.31 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -0.04 8.61 56.23 -0.37 10.52 55.44 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -0.04 10.31 60.47 1.33 11.89 60.44 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -4.59 24.28 66.67 -6.26 24.34 67.99 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c02 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c02 naa= 5 ULMN 5 2dw7_c03 BLL6730 PROTEIN user 1 5 # 1 D 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 D 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 D 292 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 322 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 45.66 0.76 26.15 51.53 0.58 28.90 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 44.47 1.55 20.70 47.30 5.10 24.27 coo 25.71 -0.96 52.28 27.04 0.47 51.50 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 25.64 -3.22 48.26 25.16 -1.74 46.85 32.91 0.46 27.63 33.66 0.11 29.56 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 5 2dw7_c03 BLL6730 PROTEIN user 2 5 # 2 D 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 D 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 D 292 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 322 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 44.47 1.55 20.70 47.30 5.10 24.27 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 45.66 0.76 26.15 51.53 0.58 28.90 coo 25.71 -0.96 52.28 27.04 0.47 51.50 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 25.64 -3.22 48.26 25.16 -1.74 46.85 32.91 0.46 27.63 33.66 0.11 29.56 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 5 2dw7_c03 BLL6730 PROTEIN user 3 5 # 3 D 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 D 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 292 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 322 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 25.71 -0.96 52.28 27.04 0.47 51.50 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 25.64 -3.22 48.26 25.16 -1.74 46.85 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 5 2dw7_c03 BLL6730 PROTEIN user 4 5 # 4 D 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 D 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 292 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 322 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 25.71 -0.96 52.28 27.04 0.47 51.50 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 25.64 -3.22 48.26 25.16 -1.74 46.85 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c03 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c03 naa= 5 ULMN 5 2dw7_c04 BLL6730 PROTEIN user 1 5 # 1 E 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 E 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 E 292 ASP A 27 ASP.? 8.12 ZN ZN A 375 E 322 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 45.66 0.76 26.15 51.53 0.58 28.90 coo -23.22 55.98 120.74 -18.11 55.31 120.43 44.47 1.55 20.70 47.30 5.10 24.27 coo -5.96 58.02 117.33 -5.22 57.97 119.29 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -10.30 57.72 118.87 -10.29 56.01 120.10 32.91 0.46 27.63 33.66 0.11 29.56 coo -17.15 59.71 133.33 -17.96 61.54 134.01 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 5 2dw7_c04 BLL6730 PROTEIN user 2 5 # 2 E 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 E 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 E 292 ASP A 27 ASP.? 8.12 ZN ZN A 375 E 322 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 44.47 1.55 20.70 47.30 5.10 24.27 coo -23.22 55.98 120.74 -18.11 55.31 120.43 45.66 0.76 26.15 51.53 0.58 28.90 coo -5.96 58.02 117.33 -5.22 57.97 119.29 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -10.30 57.72 118.87 -10.29 56.01 120.10 32.91 0.46 27.63 33.66 0.11 29.56 coo -17.15 59.71 133.33 -17.96 61.54 134.01 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 5 2dw7_c04 BLL6730 PROTEIN user 3 5 # 3 E 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 E 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 E 292 ASP B 27 ASP.? 8.17 ZN ZN B 375 E 322 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -5.96 58.02 117.33 -5.22 57.97 119.29 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -10.30 57.72 118.87 -10.29 56.01 120.10 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 5 2dw7_c04 BLL6730 PROTEIN user 4 5 # 4 E 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 E 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 E 292 ASP C 27 ASP.? 8.23 ZN ZN C 375 E 322 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -23.22 55.98 120.74 -18.11 55.31 120.43 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -5.96 58.02 117.33 -5.22 57.97 119.29 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -10.30 57.72 118.87 -10.29 56.01 120.10 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -17.15 59.71 133.33 -17.96 61.54 134.01 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c04 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c04 naa= 5 ULMN 5 2dw7_c08 BLL6730 PROTEIN user 1 5 # 1 I 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 I 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 I 292 ASP A 27 ASP.? 8.12 ZN ZN A 375 I 322 HIS A 103 HIS~? -4.82 ZN ZN A 375s I 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 45.66 0.76 26.15 51.53 0.58 28.90 coo 54.31 95.46 46.01 55.34 91.59 42.65 44.47 1.55 20.70 47.30 5.10 24.27 coo 56.81 85.09 31.70 58.18 83.71 32.51 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 56.84 87.49 35.57 56.39 86.07 37.05 32.91 0.46 27.63 33.66 0.11 29.56 coo 66.35 87.81 48.53 68.10 89.01 48.77 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 5 2dw7_c08 BLL6730 PROTEIN user 2 5 # 2 I 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 I 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 I 292 ASP B 27 ASP.? 8.17 ZN ZN B 375 I 322 HIS B 103 HIS~? 5.04 ZN ZN B 375 I 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 54.31 95.46 46.01 55.34 91.59 42.65 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 56.81 85.09 31.70 58.18 83.71 32.51 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 56.84 87.49 35.57 56.39 86.07 37.05 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 66.35 87.81 48.53 68.10 89.01 48.77 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 5 2dw7_c08 BLL6730 PROTEIN user 3 5 # 3 I 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 I 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 I 292 ASP C 27 ASP.? 8.23 ZN ZN C 375 I 322 HIS C 103 HIS~? 4.97 ZN ZN C 375 I 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 54.31 95.46 46.01 55.34 91.59 42.65 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 56.81 85.09 31.70 58.18 83.71 32.51 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 56.84 87.49 35.57 56.39 86.07 37.05 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 66.35 87.81 48.53 68.10 89.01 48.77 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c08 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c08 naa= 5 ULMN 5 2dw7_c10 BLL6730 PROTEIN user 1 5 # 1 K 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 K 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 K 292 ASP A 27 ASP.? 8.12 ZN ZN A 375 K 322 HIS A 103 HIS~? -4.82 ZN ZN A 375s K 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 45.66 0.76 26.15 51.53 0.58 28.90 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 44.47 1.55 20.70 47.30 5.10 24.27 coo 40.58 49.95 -18.97 41.43 51.52 -20.08 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 44.56 49.39 -16.82 45.93 49.12 -18.38 32.91 0.46 27.63 33.66 0.11 29.56 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 5 2dw7_c10 BLL6730 PROTEIN user 2 5 # 2 K 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 K 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 K 292 ASP B 27 ASP.? 8.17 ZN ZN B 375 K 322 HIS B 103 HIS~? 5.04 ZN ZN B 375 K 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 40.58 49.95 -18.97 41.43 51.52 -20.08 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 44.56 49.39 -16.82 45.93 49.12 -18.38 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 5 2dw7_c10 BLL6730 PROTEIN user 3 5 # 3 K 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 K 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 K 292 ASP C 27 ASP.? 8.23 ZN ZN C 375 K 322 HIS C 103 HIS~? 4.97 ZN ZN C 375 K 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 40.58 49.95 -18.97 41.43 51.52 -20.08 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 44.56 49.39 -16.82 45.93 49.12 -18.38 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c10 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c10 naa= 5 ULMN 5 2dw7_c14 BLL6730 PROTEIN user 1 5 # 1 O 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 O 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 O 292 ASP A 27 ASP.? 8.12 ZN ZN A 375 O 322 HIS A 103 HIS~? -4.82 ZN ZN A 375s O 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 45.66 0.76 26.15 51.53 0.58 28.90 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 44.47 1.55 20.70 47.30 5.10 24.27 coo 46.80 -43.22 7.31 47.12 -41.38 6.34 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 47.65 -45.38 3.39 46.30 -44.47 2.05 32.91 0.46 27.63 33.66 0.11 29.56 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 5 2dw7_c14 BLL6730 PROTEIN user 2 5 # 2 O 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 O 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 O 292 ASP B 27 ASP.? 8.17 ZN ZN B 375 O 322 HIS B 103 HIS~? 5.04 ZN ZN B 375 O 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 46.80 -43.22 7.31 47.12 -41.38 6.34 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 47.65 -45.38 3.39 46.30 -44.47 2.05 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 5 2dw7_c14 BLL6730 PROTEIN user 3 5 # 3 O 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 O 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 O 292 ASP C 27 ASP.? 8.23 ZN ZN C 375 O 322 HIS C 103 HIS~? 4.97 ZN ZN C 375 O 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 46.80 -43.22 7.31 47.12 -41.38 6.34 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 47.65 -45.38 3.39 46.30 -44.47 2.05 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c14 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c14 naa= 5 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 D 39 ARG A 153 ARG~? 11.00 C6 EPE C 377 D 219 LYS A 139 LYS^? -2.64 O3S EPE C 377s D 376 GLY C 178 GLY^? 3.71 C6 EPE C 377 D 399 GLY A 162 GLY.? 4.48 O1S EPE C 377 coo 0.59 75.69 110.95 1.51 77.84 112.93 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo 1.28 85.37 123.16 0.84 80.41 120.28 17.05 -24.82 10.77 19.64 -29.66 10.35 coo -1.06 80.88 111.45 -0.91 81.65 111.55 23.14 -36.24 3.79 23.36 -36.64 3.06 coo 7.52 81.86 116.81 7.49 81.18 116.34 25.38 -26.08 6.68 25.80 -25.42 6.56 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 2 4 # 2 D 39 ARG B 153 ARG~? 10.73 C6 EPE A 377 D 219 LYS B 139 LYS^? -2.84 O2S EPE A 377s D 376 GLY A 178 GLY^? 3.80 C6 EPE A 377 D 399 GLY B 162 GLY.? 5.31 O3S EPE A 377 coo 0.59 75.69 110.95 1.51 77.84 112.93 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo 1.28 85.37 123.16 0.84 80.41 120.28 4.48 -26.42 12.36 5.89 -27.34 7.19 coo -1.06 80.88 111.45 -0.91 81.65 111.55 3.25 -33.31 -0.46 2.85 -33.92 -0.95 coo 7.52 81.86 116.81 7.49 81.18 116.34 -1.71 -25.67 5.15 -2.30 -25.15 5.24 13pk_c03 source 13pk 3-PHOSPHOGLYCERATE KINASE : 2 hits 13pk_c03 naa= 4 ULMN 4 1a7u_c04 CHLOROPEROXIDASE T user 1 4 # 1 A 140 ALA A 130 ALA^? 13.12 ZN ZN A 375 A 141 PRO A 131 PRO^? 12.44 O3 TRS A 378 A 228 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 257 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo -3.17 33.71 41.15 -2.19 32.81 40.39 32.90 -15.33 31.26 32.77 -14.21 32.26 coo -4.29 30.56 43.91 -3.25 32.54 44.01 30.79 -18.33 29.08 30.83 -16.12 29.03 coo 2.03 38.95 28.44 3.60 38.60 29.83 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 6.85 37.62 29.99 7.50 38.47 31.78 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 4 1a7u_c04 CHLOROPEROXIDASE T user 2 4 # 2 A 140 ALA B 130 ALA^? 12.75 ZN ZN B 375 A 141 PRO B 131 PRO^? 16.14 ZN ZN B 375 A 228 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 257 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo -3.17 33.71 41.15 -2.19 32.81 40.39 3.26 0.96 16.13 3.04 1.82 17.39 coo -4.29 30.56 43.91 -3.25 32.54 44.01 5.18 -2.46 14.29 3.66 -2.13 15.89 coo 2.03 38.95 28.44 3.60 38.60 29.83 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 6.85 37.62 29.99 7.50 38.47 31.78 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 4 1a7u_c04 CHLOROPEROXIDASE T user 3 4 # 3 A 140 ALA C 130 ALA^? 12.95 ZN ZN C 375 A 141 PRO C 131 PRO^? 15.97 ZN ZN C 375 A 228 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 257 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo -3.17 33.71 41.15 -2.19 32.81 40.39 -1.84 -25.01 41.51 -1.61 -23.99 42.63 coo -4.29 30.56 43.91 -3.25 32.54 44.01 -1.50 -25.61 37.38 0.00 -25.37 39.02 coo 2.03 38.95 28.44 3.60 38.60 29.83 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 6.85 37.62 29.99 7.50 38.47 31.78 10.51 -24.81 51.94 8.80 -23.79 52.62 1a7u_c04 source 1a7u CHLOROPEROXIDASE T : 3 hits 1a7u_c04 naa= 4 ULMN 4 1a7u_c05 CHLOROPEROXIDASE T user 1 4 # 1 B 140 ALA A 130 ALA^? 13.12 ZN ZN A 375 B 141 PRO A 131 PRO^? 12.44 O3 TRS A 378 B 228 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 257 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 25.73 54.94 3.35 27.07 55.54 3.80 32.90 -15.33 31.26 32.77 -14.21 32.26 coo 25.81 51.10 5.29 24.88 53.11 5.69 30.79 -18.33 29.08 30.83 -16.12 29.03 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 32.76 68.02 0.70 31.21 68.44 2.05 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 4 1a7u_c05 CHLOROPEROXIDASE T user 2 4 # 2 B 140 ALA B 130 ALA^? 12.75 ZN ZN B 375 B 141 PRO B 131 PRO^? 16.14 ZN ZN B 375 B 228 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 257 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 25.73 54.94 3.35 27.07 55.54 3.80 3.26 0.96 16.13 3.04 1.82 17.39 coo 25.81 51.10 5.29 24.88 53.11 5.69 5.18 -2.46 14.29 3.66 -2.13 15.89 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 32.76 68.02 0.70 31.21 68.44 2.05 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 4 1a7u_c05 CHLOROPEROXIDASE T user 3 4 # 3 B 140 ALA C 130 ALA^? 12.95 ZN ZN C 375 B 141 PRO C 131 PRO^? 15.97 ZN ZN C 375 B 228 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 257 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 25.73 54.94 3.35 27.07 55.54 3.80 -1.84 -25.01 41.51 -1.61 -23.99 42.63 coo 25.81 51.10 5.29 24.88 53.11 5.69 -1.50 -25.61 37.38 0.00 -25.37 39.02 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 32.76 68.02 0.70 31.21 68.44 2.05 10.51 -24.81 51.94 8.80 -23.79 52.62 1a7u_c05 source 1a7u CHLOROPEROXIDASE T : 3 hits 1a7u_c05 naa= 4 ULMN 4 1akm_c03 ORNITHINE TRANSCARBAMYLASE user 1 4 # 1 A 57 ARG B 198 ARG^? 21.95 C2 EPE C 377 A 58 THR B 179 THR^? 20.09 C2 EPE C 377 A 106 ARG C 153 ARG~? 15.97 C2 EPE C 377 A 133 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 37.17 69.43 16.95 39.61 69.29 18.96 11.64 -52.94 14.57 14.19 -52.83 16.31 coo 31.76 68.35 14.99 32.00 68.70 12.89 9.45 -47.49 18.16 11.61 -47.34 18.08 coo 33.87 66.22 9.96 35.73 68.37 10.99 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 35.28 73.60 8.07 35.11 72.84 9.96 13.13 -47.52 24.96 14.34 -48.17 26.54 1akm_c03 source 1akm ORNITHINE TRANSCARBAMYLASE : 1 hits 1akm_c03 naa= 4 ULMN 4 1akm_c04 ORNITHINE TRANSCARBAMYLASE user 1 4 # 1 B 57 ARG B 198 ARG^? 21.95 C2 EPE C 377 B 58 THR B 179 THR^? 20.09 C2 EPE C 377 B 106 ARG C 153 ARG~? 15.97 C2 EPE C 377 B 133 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 31.47 45.08 32.03 31.41 42.08 31.00 11.64 -52.94 14.57 14.19 -52.83 16.31 coo 30.01 50.73 32.15 31.74 51.62 33.16 9.45 -47.49 18.16 11.61 -47.34 18.08 coo 35.62 52.37 31.71 35.46 49.72 33.20 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 36.28 50.33 39.07 34.91 49.66 37.71 13.13 -47.52 24.96 14.34 -48.17 26.54 1akm_c04 source 1akm ORNITHINE TRANSCARBAMYLASE : 1 hits 1akm_c04 naa= 4 ULMN 4 1akm_c05 ORNITHINE TRANSCARBAMYLASE user 1 4 # 1 C 57 ARG B 198 ARG^? 21.95 C2 EPE C 377 C 58 THR B 179 THR^? 20.09 C2 EPE C 377 C 106 ARG C 153 ARG~? 15.97 C2 EPE C 377 C 133 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 22.08 47.45 4.33 23.58 48.95 2.06 11.64 -52.94 14.57 14.19 -52.83 16.31 coo 19.99 47.16 9.87 19.96 45.01 10.26 9.45 -47.49 18.16 11.61 -47.34 18.08 coo 23.22 42.51 11.24 22.66 42.44 8.27 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 18.34 38.49 6.81 18.75 40.50 6.70 13.13 -47.52 24.96 14.34 -48.17 26.54 1akm_c05 source 1akm ORNITHINE TRANSCARBAMYLASE : 1 hits 1akm_c05 naa= 4 ULMN 4 1bcr_c00 SERINE CARBOXYPEPTIDASE II user 1 4 # 1 A 146 SER A 168 SER^? 10.80 O1S EPE C 377 A 147 TYR A 167 TYR^? 7.08 C7 EPE C 377 B 338 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 397 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 66.05 29.20 71.20 67.54 30.99 71.60 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 69.74 28.84 76.21 71.42 27.25 77.79 32.29 -31.90 7.76 33.83 -34.20 8.34 coo 65.80 31.83 62.23 66.99 32.08 63.95 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 65.11 33.35 66.77 66.04 32.32 68.30 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 4 1bcr_c00 SERINE CARBOXYPEPTIDASE II user 2 4 # 2 A 146 SER C 168 SER^? 24.11 O1 TRS A 378 A 147 TYR C 167 TYR^? 26.66 O2S EPE A 377 B 338 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 397 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 66.05 29.20 71.20 67.54 30.99 71.60 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 69.74 28.84 76.21 71.42 27.25 77.79 3.31 -45.81 25.21 0.69 -46.75 24.83 coo 65.80 31.83 62.23 66.99 32.08 63.95 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 65.11 33.35 66.77 66.04 32.32 68.30 13.13 -47.52 24.96 14.34 -48.17 26.54 1bcr_c00 source 1bcr SERINE CARBOXYPEPTIDASE II : 2 hits 1bcr_c00 naa= 4 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 1 4 # 1 A 72 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 141 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 143 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 148 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 86.21 51.78 11.27 86.87 50.27 12.61 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 77.92 48.13 25.32 78.70 49.17 23.61 40.70 8.14 28.73 41.06 6.40 29.84 coo 79.83 48.98 19.95 81.76 49.72 20.33 37.42 3.90 29.26 38.47 2.36 30.22 coo 76.11 54.71 19.44 77.75 55.81 18.59 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 2 4 # 2 A 72 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 141 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 143 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 148 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 86.21 51.78 11.27 86.87 50.27 12.61 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 77.92 48.13 25.32 78.70 49.17 23.61 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 79.83 48.98 19.95 81.76 49.72 20.33 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 76.11 54.71 19.44 77.75 55.81 18.59 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 3 4 # 3 A 72 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 141 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 143 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 148 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 86.21 51.78 11.27 86.87 50.27 12.61 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 77.92 48.13 25.32 78.70 49.17 23.61 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 79.83 48.98 19.95 81.76 49.72 20.33 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 76.11 54.71 19.44 77.75 55.81 18.59 3.38 -29.70 55.34 4.58 -28.10 54.66 1cd5_c00 source 1cd5 GLUCOSAMINE 6-PHOSPHATE DEAMINASE : 3 hits 1cd5_c00 naa= 4 ULMN 4 1cqj_c00 SUCCINYL-COA SYNTHETASE BETA CHAIN user 1 4 # 1 A 208 GLU B 227 GLU.? 24.58 O3S EPE A 377 A 246 HIS B 224 HIS.? 17.79 O2S EPE A 377 B 109 TYR C 133 TYR^? 16.76 ZN ZN C 375 B 197 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 42.05 62.45 76.31 40.18 63.04 75.45 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 37.14 61.56 73.28 37.00 63.65 73.26 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 50.22 35.25 75.17 48.69 37.57 74.89 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 45.03 37.30 75.10 44.89 38.23 76.98 11.24 -30.50 31.64 12.59 -30.76 33.22 1cqj_c00 source 1cqj SUCCINYL-COA SYNTHETASE BETA CHAIN : 1 hits 1cqj_c00 naa= 4 ULMN 4 1cqj_c01 SUCCINYL-COA SYNTHETASE BETA CHAIN user 1 4 # 1 D 208 GLU B 227 GLU.? 24.58 O3S EPE A 377 D 246 HIS B 224 HIS.? 17.79 O2S EPE A 377 E 109 TYR C 133 TYR^? 16.76 ZN ZN C 375 E 197 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo -2.91 18.30 76.21 -1.08 17.82 77.32 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 2.87 18.34 77.03 2.47 16.92 78.50 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo -1.67 35.94 53.83 -0.91 34.37 56.05 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 1.76 35.71 58.20 0.46 36.19 59.80 11.24 -30.50 31.64 12.59 -30.76 33.22 1cqj_c01 source 1cqj SUCCINYL-COA SYNTHETASE BETA CHAIN : 1 hits 1cqj_c01 naa= 4 ULMN 4 1dco_c01 DCOH user 1 4 # 1 B 62 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 63 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 80 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 89 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 30.13 28.91 18.82 29.78 26.89 19.27 37.42 3.90 29.26 38.47 2.36 30.22 coo 30.80 33.19 23.94 30.03 35.03 23.38 32.91 0.46 27.63 33.66 0.11 29.56 coo 25.47 25.21 25.04 27.09 24.88 26.31 40.60 0.33 34.12 38.69 0.39 33.24 coo 32.70 23.27 17.35 31.06 23.48 18.68 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 4 1dco_c01 DCOH user 2 4 # 2 B 62 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 63 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 80 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 89 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 30.13 28.91 18.82 29.78 26.89 19.27 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 30.80 33.19 23.94 30.03 35.03 23.38 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 25.47 25.21 25.04 27.09 24.88 26.31 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 32.70 23.27 17.35 31.06 23.48 18.68 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 4 1dco_c01 DCOH user 3 4 # 3 B 62 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 63 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 80 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 89 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 30.13 28.91 18.82 29.78 26.89 19.27 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 30.80 33.19 23.94 30.03 35.03 23.38 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 25.47 25.21 25.04 27.09 24.88 26.31 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 32.70 23.27 17.35 31.06 23.48 18.68 10.65 -27.85 62.57 8.78 -27.40 61.73 1dco_c01 source 1dco DCOH : 3 hits 1dco_c01 naa= 4 ULMN 4 1dco_c04 DCOH user 1 4 # 1 E 62 HIS A 69 HIS.? -3.40 ZN ZN A 374s E 63 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 80 HIS A 333 HIS~? -3.55 ZN ZN A 374s E 89 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 19.60 57.21 59.85 19.08 56.80 57.88 37.42 3.90 29.26 38.47 2.36 30.22 coo 16.21 54.27 64.44 16.08 55.68 65.97 32.91 0.46 27.63 33.66 0.11 29.56 coo 11.87 56.63 56.75 11.79 54.55 56.99 40.60 0.33 34.12 38.69 0.39 33.24 coo 21.75 55.40 54.53 20.13 56.68 54.67 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 4 1dco_c04 DCOH user 2 4 # 2 E 62 HIS B 69 HIS.? -3.36 ZN ZN B 374s E 63 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 80 HIS B 333 HIS~? -3.37 ZN ZN B 374s E 89 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 19.60 57.21 59.85 19.08 56.80 57.88 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 16.21 54.27 64.44 16.08 55.68 65.97 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 11.87 56.63 56.75 11.79 54.55 56.99 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 21.75 55.40 54.53 20.13 56.68 54.67 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 4 1dco_c04 DCOH user 3 4 # 3 E 62 HIS C 69 HIS.? -3.39 ZN ZN C 374s E 63 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 80 HIS C 333 HIS~? -3.37 ZN ZN C 374s E 89 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 19.60 57.21 59.85 19.08 56.80 57.88 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 16.21 54.27 64.44 16.08 55.68 65.97 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 11.87 56.63 56.75 11.79 54.55 56.99 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 21.75 55.40 54.53 20.13 56.68 54.67 10.65 -27.85 62.57 8.78 -27.40 61.73 1dco_c04 source 1dco DCOH : 3 hits 1dco_c04 naa= 4 ULMN 4 1dco_c07 DCOH user 1 4 # 1 H 62 HIS A 69 HIS.? -3.40 ZN ZN A 374s H 63 HIS A 103 HIS~? -4.82 ZN ZN A 375s H 80 HIS A 333 HIS~? -3.55 ZN ZN A 374s H 89 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 25.41 62.31 81.97 26.41 62.87 83.70 37.42 3.90 29.26 38.47 2.36 30.22 coo 27.91 57.00 79.64 28.08 57.36 77.58 32.91 0.46 27.63 33.66 0.11 29.56 coo 32.94 62.32 86.32 31.68 60.75 86.87 40.60 0.33 34.12 38.69 0.39 33.24 coo 22.93 64.49 87.27 24.97 64.23 86.95 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 4 1dco_c07 DCOH user 2 4 # 2 H 62 HIS B 69 HIS.? -3.36 ZN ZN B 374s H 63 HIS B 103 HIS~? 5.04 ZN ZN B 375 H 80 HIS B 333 HIS~? -3.37 ZN ZN B 374s H 89 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 25.41 62.31 81.97 26.41 62.87 83.70 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 27.91 57.00 79.64 28.08 57.36 77.58 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 32.94 62.32 86.32 31.68 60.75 86.87 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 22.93 64.49 87.27 24.97 64.23 86.95 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 4 1dco_c07 DCOH user 3 4 # 3 H 62 HIS C 69 HIS.? -3.39 ZN ZN C 374s H 63 HIS C 103 HIS~? 4.97 ZN ZN C 375 H 80 HIS C 333 HIS~? -3.37 ZN ZN C 374s H 89 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 25.41 62.31 81.97 26.41 62.87 83.70 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 27.91 57.00 79.64 28.08 57.36 77.58 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 32.94 62.32 86.32 31.68 60.75 86.87 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 22.93 64.49 87.27 24.97 64.23 86.95 10.65 -27.85 62.57 8.78 -27.40 61.73 1dco_c07 source 1dco DCOH : 3 hits 1dco_c07 naa= 4 ULMN 4 1dd8_c00 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 1 4 # 1 A 163 CYH A 170 CYH^? -4.87 C10 EPE C 377s A 298 HIS A 163 HIS.? 11.18 O1S EPE C 377 A 333 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 392 PHE C 180 PHE^? -4.33 O8 EPE C 377s coo 35.40 69.19 64.32 37.60 70.93 64.10 25.74 -30.01 4.94 27.86 -30.22 6.82 coo 33.88 74.99 60.50 35.24 73.95 61.71 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 35.99 74.82 67.51 35.98 73.21 66.18 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 42.33 69.65 62.68 42.99 72.12 63.86 29.90 -34.68 4.21 31.04 -37.24 4.01 ULMN 4 1dd8_c00 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 2 4 # 2 A 163 CYH B 170 CYH^? -5.04 N1 EPE A 377s A 298 HIS B 163 HIS.? 11.54 O3S EPE A 377 A 333 HIS B 169 HIS^? 10.86 O3S EPE A 377 A 392 PHE A 180 PHE^? 4.05 O8 EPE A 377 coo 35.40 69.19 64.32 37.60 70.93 64.10 -0.70 -28.36 2.22 -0.22 -26.07 0.51 coo 33.88 74.99 60.50 35.24 73.95 61.71 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 35.99 74.82 67.51 35.98 73.21 66.18 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 42.33 69.65 62.68 42.99 72.12 63.86 -0.71 -29.06 -4.30 -0.06 -29.96 -6.91 ULMN 4 1dd8_c00 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 3 4 # 3 A 163 CYH C 170 CYH^? 22.19 N TRS A 378 A 298 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 333 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 392 PHE B 180 PHE^? 25.23 O2S EPE A 377 coo 35.40 69.19 64.32 37.60 70.93 64.10 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 33.88 74.99 60.50 35.24 73.95 61.71 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 35.99 74.82 67.51 35.98 73.21 66.18 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 42.33 69.65 62.68 42.99 72.12 63.86 5.49 -47.88 21.09 3.41 -49.53 20.15 ULMN 4 1dd8_c00 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 4 4 # 4 A 163 CYH C 170 CYH^? 22.19 N TRS A 378 A 298 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 333 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 392 PHE B 180 PHE^? 25.23 O2S EPE A 377 coo 35.40 69.19 64.32 37.60 70.93 64.10 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 33.88 74.99 60.50 35.24 73.95 61.71 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 35.99 74.82 67.51 35.98 73.21 66.18 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 42.33 69.65 62.68 42.99 72.12 63.86 5.49 -47.88 21.09 3.41 -49.53 20.15 1dd8_c00 source 1dd8 BETA-KETOACYL [ACYL CARRIER PROTEIN] SYNTHASE : 4 hits 1dd8_c00 naa= 4 ULMN 4 1dd8_c01 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 1 4 # 1 B 163 CYH A 170 CYH^? -4.87 C10 EPE C 377s B 298 HIS A 163 HIS.? 11.18 O1S EPE C 377 B 333 HIS A 169 HIS^? 11.22 O1S EPE C 377 B 392 PHE C 180 PHE^? -4.33 O8 EPE C 377s coo 36.35 45.34 70.21 36.57 44.22 72.81 25.74 -30.01 4.94 27.86 -30.22 6.82 coo 34.44 38.52 70.53 35.24 40.22 71.46 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 41.02 41.23 72.17 39.27 42.32 71.79 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 34.75 46.39 77.04 36.53 44.64 78.31 29.90 -34.68 4.21 31.04 -37.24 4.01 ULMN 4 1dd8_c01 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 2 4 # 2 B 163 CYH B 170 CYH^? -5.04 N1 EPE A 377s B 298 HIS B 163 HIS.? 11.54 O3S EPE A 377 B 333 HIS B 169 HIS^? 10.86 O3S EPE A 377 B 392 PHE A 180 PHE^? 4.05 O8 EPE A 377 coo 36.35 45.34 70.21 36.57 44.22 72.81 -0.70 -28.36 2.22 -0.22 -26.07 0.51 coo 34.44 38.52 70.53 35.24 40.22 71.46 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 41.02 41.23 72.17 39.27 42.32 71.79 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 34.75 46.39 77.04 36.53 44.64 78.31 -0.71 -29.06 -4.30 -0.06 -29.96 -6.91 ULMN 4 1dd8_c01 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 3 4 # 3 B 163 CYH C 170 CYH^? 22.19 N TRS A 378 B 298 HIS C 163 HIS.? 22.24 O1 TRS A 378 B 333 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 392 PHE B 180 PHE^? 25.23 O2S EPE A 377 coo 36.35 45.34 70.21 36.57 44.22 72.81 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 34.44 38.52 70.53 35.24 40.22 71.46 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 41.02 41.23 72.17 39.27 42.32 71.79 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 34.75 46.39 77.04 36.53 44.64 78.31 5.49 -47.88 21.09 3.41 -49.53 20.15 ULMN 4 1dd8_c01 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 4 4 # 4 B 163 CYH C 170 CYH^? 22.19 N TRS A 378 B 298 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 333 HIS C 163 HIS.? 22.24 O1 TRS A 378 B 392 PHE B 180 PHE^? 25.23 O2S EPE A 377 coo 36.35 45.34 70.21 36.57 44.22 72.81 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 34.44 38.52 70.53 35.24 40.22 71.46 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 41.02 41.23 72.17 39.27 42.32 71.79 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 34.75 46.39 77.04 36.53 44.64 78.31 5.49 -47.88 21.09 3.41 -49.53 20.15 1dd8_c01 source 1dd8 BETA-KETOACYL [ACYL CARRIER PROTEIN] SYNTHASE : 4 hits 1dd8_c01 naa= 4 ULMN 4 1dd8_c02 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 1 4 # 1 C 163 CYH A 170 CYH^? -4.87 C10 EPE C 377s C 298 HIS A 163 HIS.? 11.18 O1S EPE C 377 C 333 HIS A 169 HIS^? 11.22 O1S EPE C 377 C 392 PHE C 180 PHE^? -4.33 O8 EPE C 377s coo 56.26 66.80 120.15 56.49 64.08 119.30 25.74 -30.01 4.94 27.86 -30.22 6.82 coo 54.26 62.31 125.28 54.86 62.62 123.29 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 51.27 62.90 118.61 53.04 63.84 119.22 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 60.64 61.97 117.27 58.81 59.95 116.51 29.90 -34.68 4.21 31.04 -37.24 4.01 ULMN 4 1dd8_c02 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 2 4 # 2 C 163 CYH B 170 CYH^? -5.04 N1 EPE A 377s C 298 HIS B 163 HIS.? 11.54 O3S EPE A 377 C 333 HIS B 169 HIS^? 10.86 O3S EPE A 377 C 392 PHE A 180 PHE^? 4.05 O8 EPE A 377 coo 56.26 66.80 120.15 56.49 64.08 119.30 -0.70 -28.36 2.22 -0.22 -26.07 0.51 coo 54.26 62.31 125.28 54.86 62.62 123.29 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 51.27 62.90 118.61 53.04 63.84 119.22 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 60.64 61.97 117.27 58.81 59.95 116.51 -0.71 -29.06 -4.30 -0.06 -29.96 -6.91 ULMN 4 1dd8_c02 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 3 4 # 3 C 163 CYH C 170 CYH^? 22.19 N TRS A 378 C 298 HIS C 163 HIS.? 22.24 O1 TRS A 378 C 333 HIS C 169 HIS^? 22.39 O1 TRS A 378 C 392 PHE B 180 PHE^? 25.23 O2S EPE A 377 coo 56.26 66.80 120.15 56.49 64.08 119.30 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 54.26 62.31 125.28 54.86 62.62 123.29 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 51.27 62.90 118.61 53.04 63.84 119.22 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 60.64 61.97 117.27 58.81 59.95 116.51 5.49 -47.88 21.09 3.41 -49.53 20.15 ULMN 4 1dd8_c02 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 4 4 # 4 C 163 CYH C 170 CYH^? 22.19 N TRS A 378 C 298 HIS C 169 HIS^? 22.39 O1 TRS A 378 C 333 HIS C 163 HIS.? 22.24 O1 TRS A 378 C 392 PHE B 180 PHE^? 25.23 O2S EPE A 377 coo 56.26 66.80 120.15 56.49 64.08 119.30 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 54.26 62.31 125.28 54.86 62.62 123.29 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 51.27 62.90 118.61 53.04 63.84 119.22 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 60.64 61.97 117.27 58.81 59.95 116.51 5.49 -47.88 21.09 3.41 -49.53 20.15 1dd8_c02 source 1dd8 BETA-KETOACYL [ACYL CARRIER PROTEIN] SYNTHASE : 4 hits 1dd8_c02 naa= 4 ULMN 4 1dd8_c03 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 1 4 # 1 D 163 CYH A 170 CYH^? -4.87 C10 EPE C 377s D 298 HIS A 163 HIS.? 11.18 O1S EPE C 377 D 333 HIS A 169 HIS^? 11.22 O1S EPE C 377 D 392 PHE C 180 PHE^? -4.33 O8 EPE C 377s coo 67.34 86.01 109.78 66.48 87.39 107.43 25.74 -30.01 4.94 27.86 -30.22 6.82 coo 70.13 92.51 109.26 69.00 90.99 108.37 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 71.07 86.98 104.57 69.72 87.07 106.17 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 61.70 87.79 105.86 62.91 88.45 103.42 29.90 -34.68 4.21 31.04 -37.24 4.01 ULMN 4 1dd8_c03 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 2 4 # 2 D 163 CYH B 170 CYH^? -5.04 N1 EPE A 377s D 298 HIS B 163 HIS.? 11.54 O3S EPE A 377 D 333 HIS B 169 HIS^? 10.86 O3S EPE A 377 D 392 PHE A 180 PHE^? 4.05 O8 EPE A 377 coo 67.34 86.01 109.78 66.48 87.39 107.43 -0.70 -28.36 2.22 -0.22 -26.07 0.51 coo 70.13 92.51 109.26 69.00 90.99 108.37 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 71.07 86.98 104.57 69.72 87.07 106.17 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 61.70 87.79 105.86 62.91 88.45 103.42 -0.71 -29.06 -4.30 -0.06 -29.96 -6.91 ULMN 4 1dd8_c03 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 3 4 # 3 D 163 CYH C 170 CYH^? 22.19 N TRS A 378 D 298 HIS C 163 HIS.? 22.24 O1 TRS A 378 D 333 HIS C 169 HIS^? 22.39 O1 TRS A 378 D 392 PHE B 180 PHE^? 25.23 O2S EPE A 377 coo 67.34 86.01 109.78 66.48 87.39 107.43 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 70.13 92.51 109.26 69.00 90.99 108.37 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 71.07 86.98 104.57 69.72 87.07 106.17 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 61.70 87.79 105.86 62.91 88.45 103.42 5.49 -47.88 21.09 3.41 -49.53 20.15 ULMN 4 1dd8_c03 BETA-KETOACYL [ACYL CARRIER PROTEIN]user 4 4 # 4 D 163 CYH C 170 CYH^? 22.19 N TRS A 378 D 298 HIS C 169 HIS^? 22.39 O1 TRS A 378 D 333 HIS C 163 HIS.? 22.24 O1 TRS A 378 D 392 PHE B 180 PHE^? 25.23 O2S EPE A 377 coo 67.34 86.01 109.78 66.48 87.39 107.43 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 70.13 92.51 109.26 69.00 90.99 108.37 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 71.07 86.98 104.57 69.72 87.07 106.17 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 61.70 87.79 105.86 62.91 88.45 103.42 5.49 -47.88 21.09 3.41 -49.53 20.15 1dd8_c03 source 1dd8 BETA-KETOACYL [ACYL CARRIER PROTEIN] SYNTHASE : 4 hits 1dd8_c03 naa= 4 ULMN 4 1ddj_c00 PLASMINOGEN user 1 4 # 1 A 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 A 741 ALA A 102 ALA.? 9.34 ZN ZN A 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 37.80 0.44 25.56 37.02 -1.29 26.44 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.37 50.89 2.29 11.05 51.63 2.25 27.68 4.60 19.76 28.15 4.96 20.33 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 33.09 1.52 21.68 34.14 1.27 20.64 ULMN 4 1ddj_c00 PLASMINOGEN user 2 4 # 2 A 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 A 741 ALA B 102 ALA.? 9.36 ZN ZN B 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.37 50.89 2.29 11.05 51.63 2.25 -13.71 -6.55 30.41 -13.82 -5.76 30.60 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -13.15 -2.66 25.34 -14.20 -2.84 24.29 ULMN 4 1ddj_c00 PLASMINOGEN user 3 4 # 3 A 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 A 741 ALA C 102 ALA.? 9.31 ZN ZN C 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.37 50.89 2.29 11.05 51.63 2.25 20.37 -26.80 49.54 20.07 -26.59 50.27 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 14.49 -29.28 50.81 14.45 -30.75 50.81 1ddj_c00 source 1ddj PLASMINOGEN : 3 hits 1ddj_c00 naa= 4 ULMN 4 1ddj_c01 PLASMINOGEN user 1 4 # 1 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 B 741 ALA A 102 ALA.? 9.34 ZN ZN A 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 37.80 0.44 25.56 37.02 -1.29 26.44 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 27.68 4.60 19.76 28.15 4.96 20.33 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 33.09 1.52 21.68 34.14 1.27 20.64 ULMN 4 1ddj_c01 PLASMINOGEN user 2 4 # 2 B 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 B 741 ALA B 102 ALA.? 9.36 ZN ZN B 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -13.71 -6.55 30.41 -13.82 -5.76 30.60 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -13.15 -2.66 25.34 -14.20 -2.84 24.29 ULMN 4 1ddj_c01 PLASMINOGEN user 3 4 # 3 B 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 B 741 ALA C 102 ALA.? 9.31 ZN ZN C 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 20.37 -26.80 49.54 20.07 -26.59 50.27 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 14.49 -29.28 50.81 14.45 -30.75 50.81 1ddj_c01 source 1ddj PLASMINOGEN : 3 hits 1ddj_c01 naa= 4 ULMN 4 1ddj_c02 PLASMINOGEN user 1 4 # 1 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 C 741 ALA A 102 ALA.? 9.34 ZN ZN A 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 37.80 0.44 25.56 37.02 -1.29 26.44 coo 16.06 55.72 54.73 15.97 56.49 56.70 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 9.38 49.29 65.28 9.01 50.03 65.31 27.68 4.60 19.76 28.15 4.96 20.33 coo 13.55 54.01 62.74 13.86 55.50 62.79 33.09 1.52 21.68 34.14 1.27 20.64 ULMN 4 1ddj_c02 PLASMINOGEN user 2 4 # 2 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 C 741 ALA B 102 ALA.? 9.36 ZN ZN B 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 16.06 55.72 54.73 15.97 56.49 56.70 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 9.38 49.29 65.28 9.01 50.03 65.31 -13.71 -6.55 30.41 -13.82 -5.76 30.60 coo 13.55 54.01 62.74 13.86 55.50 62.79 -13.15 -2.66 25.34 -14.20 -2.84 24.29 ULMN 4 1ddj_c02 PLASMINOGEN user 3 4 # 3 C 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 C 741 ALA C 102 ALA.? 9.31 ZN ZN C 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 16.06 55.72 54.73 15.97 56.49 56.70 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 9.38 49.29 65.28 9.01 50.03 65.31 20.37 -26.80 49.54 20.07 -26.59 50.27 coo 13.55 54.01 62.74 13.86 55.50 62.79 14.49 -29.28 50.81 14.45 -30.75 50.81 1ddj_c02 source 1ddj PLASMINOGEN : 3 hits 1ddj_c02 naa= 4 ULMN 4 1ddj_c03 PLASMINOGEN user 1 4 # 1 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 D 741 ALA A 102 ALA.? 9.34 ZN ZN A 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 37.80 0.44 25.56 37.02 -1.29 26.44 coo -25.73 33.05 39.28 -27.50 34.05 39.88 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -27.66 47.32 40.66 -27.81 47.01 41.41 27.68 4.60 19.76 28.15 4.96 20.33 coo -29.58 40.72 40.37 -30.29 39.69 41.25 33.09 1.52 21.68 34.14 1.27 20.64 ULMN 4 1ddj_c03 PLASMINOGEN user 2 4 # 2 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 D 741 ALA B 102 ALA.? 9.36 ZN ZN B 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -13.71 -6.55 30.41 -13.82 -5.76 30.60 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -13.15 -2.66 25.34 -14.20 -2.84 24.29 ULMN 4 1ddj_c03 PLASMINOGEN user 3 4 # 3 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 D 741 ALA C 102 ALA.? 9.31 ZN ZN C 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -25.73 33.05 39.28 -27.50 34.05 39.88 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -27.66 47.32 40.66 -27.81 47.01 41.41 20.37 -26.80 49.54 20.07 -26.59 50.27 coo -29.58 40.72 40.37 -30.29 39.69 41.25 14.49 -29.28 50.81 14.45 -30.75 50.81 1ddj_c03 source 1ddj PLASMINOGEN : 3 hits 1ddj_c03 naa= 4 ULMN 4 1ddj_c04 PLASMINOGEN user 1 4 # 1 A 603 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 646 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 741 ALA A 161 ALA.? 7.16 O1S EPE C 377 A 742 GLY A 160 GLY.? 10.75 O1S EPE C 377 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 24.22 -22.86 5.01 22.88 -23.16 4.38 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 26.87 -20.51 3.59 26.23 -20.86 3.40 ULMN 4 1ddj_c04 PLASMINOGEN user 2 4 # 2 A 603 HIS B 169 HIS^? 10.86 O3S EPE A 377 A 646 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 741 ALA B 161 ALA.? 8.19 O3S EPE A 377 A 742 GLY B 160 GLY.? 11.45 O3S EPE A 377 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -7.67 -24.84 7.30 -7.31 -25.39 7.61 ULMN 4 1ddj_c04 PLASMINOGEN user 3 4 # 3 A 603 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 646 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 741 ALA C 161 ALA.? 14.45 O1 TRS A 378 A 742 GLY C 160 GLY.? 17.10 O1 TRS A 378 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 14.54 -40.01 25.90 15.56 -39.75 24.83 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 15.27 -41.63 29.25 15.56 -41.55 28.55 1ddj_c04 source 1ddj PLASMINOGEN : 3 hits 1ddj_c04 naa= 4 ULMN 4 1ddj_c05 PLASMINOGEN user 1 4 # 1 B 603 HIS A 169 HIS^? 11.22 O1S EPE C 377 B 646 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 741 ALA A 161 ALA.? 7.16 O1S EPE C 377 B 742 GLY A 160 GLY.? 10.75 O1S EPE C 377 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 24.22 -22.86 5.01 22.88 -23.16 4.38 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 26.87 -20.51 3.59 26.23 -20.86 3.40 ULMN 4 1ddj_c05 PLASMINOGEN user 2 4 # 2 B 603 HIS B 169 HIS^? 10.86 O3S EPE A 377 B 646 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 741 ALA B 161 ALA.? 8.19 O3S EPE A 377 B 742 GLY B 160 GLY.? 11.45 O3S EPE A 377 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -7.67 -24.84 7.30 -7.31 -25.39 7.61 ULMN 4 1ddj_c05 PLASMINOGEN user 3 4 # 3 B 603 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 646 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 741 ALA C 161 ALA.? 14.45 O1 TRS A 378 B 742 GLY C 160 GLY.? 17.10 O1 TRS A 378 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 13.13 -47.52 24.96 14.34 -48.17 26.54 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 19.06 -47.14 27.83 18.62 -49.09 27.08 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 14.54 -40.01 25.90 15.56 -39.75 24.83 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 15.27 -41.63 29.25 15.56 -41.55 28.55 1ddj_c05 source 1ddj PLASMINOGEN : 3 hits 1ddj_c05 naa= 4 ULMN 4 1ddj_c06 PLASMINOGEN user 1 4 # 1 C 603 HIS A 169 HIS^? 11.22 O1S EPE C 377 C 646 ASP A 158 ASP~? 15.23 O1S EPE C 377 C 741 ALA A 161 ALA.? 7.16 O1S EPE C 377 C 742 GLY A 160 GLY.? 10.75 O1S EPE C 377 coo 15.33 59.81 59.60 13.98 60.99 60.69 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 16.06 55.72 54.73 15.97 56.49 56.70 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 13.55 54.01 62.74 13.86 55.50 62.79 24.22 -22.86 5.01 22.88 -23.16 4.38 coo 16.36 51.81 61.40 15.69 51.50 61.72 26.87 -20.51 3.59 26.23 -20.86 3.40 ULMN 4 1ddj_c06 PLASMINOGEN user 2 4 # 2 C 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 741 ALA B 101 ALA^? 11.06 ZN ZN B 375 C 742 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 13.55 54.01 62.74 13.86 55.50 62.79 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 16.36 51.81 61.40 15.69 51.50 61.72 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 4 1ddj_c06 PLASMINOGEN user 3 4 # 3 C 603 HIS B 169 HIS^? 10.86 O3S EPE A 377 C 646 ASP B 158 ASP~? 14.93 O3S EPE A 377 C 741 ALA B 161 ALA.? 8.19 O3S EPE A 377 C 742 GLY B 160 GLY.? 11.45 O3S EPE A 377 coo 15.33 59.81 59.60 13.98 60.99 60.69 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 16.06 55.72 54.73 15.97 56.49 56.70 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 13.55 54.01 62.74 13.86 55.50 62.79 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo 16.36 51.81 61.40 15.69 51.50 61.72 -7.67 -24.84 7.30 -7.31 -25.39 7.61 ULMN 4 1ddj_c06 PLASMINOGEN user 4 4 # 4 C 603 HIS C 169 HIS^? 22.39 O1 TRS A 378 C 646 ASP C 158 ASP~? 22.01 O1 TRS A 378 C 741 ALA C 161 ALA.? 14.45 O1 TRS A 378 C 742 GLY C 160 GLY.? 17.10 O1 TRS A 378 coo 15.33 59.81 59.60 13.98 60.99 60.69 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 16.06 55.72 54.73 15.97 56.49 56.70 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 13.55 54.01 62.74 13.86 55.50 62.79 14.54 -40.01 25.90 15.56 -39.75 24.83 coo 16.36 51.81 61.40 15.69 51.50 61.72 15.27 -41.63 29.25 15.56 -41.55 28.55 1ddj_c06 source 1ddj PLASMINOGEN : 4 hits 1ddj_c06 naa= 4 ULMN 4 1ddj_c07 PLASMINOGEN user 1 4 # 1 D 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 741 ALA A 101 ALA^? 11.28 ZN ZN A 375 D 742 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 32.91 0.46 27.63 33.66 0.11 29.56 coo -25.73 33.05 39.28 -27.50 34.05 39.88 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -29.58 40.72 40.37 -30.29 39.69 41.25 32.09 5.17 22.05 31.25 5.48 23.29 coo -29.22 39.61 36.72 -28.92 40.32 37.00 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 4 1ddj_c07 PLASMINOGEN user 2 4 # 2 D 603 HIS A 169 HIS^? 11.22 O1S EPE C 377 D 646 ASP A 158 ASP~? 15.23 O1S EPE C 377 D 741 ALA A 161 ALA.? 7.16 O1S EPE C 377 D 742 GLY A 160 GLY.? 10.75 O1S EPE C 377 coo -30.51 33.83 43.05 -30.50 33.12 45.03 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo -25.73 33.05 39.28 -27.50 34.05 39.88 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -29.58 40.72 40.37 -30.29 39.69 41.25 24.22 -22.86 5.01 22.88 -23.16 4.38 coo -29.22 39.61 36.72 -28.92 40.32 37.00 26.87 -20.51 3.59 26.23 -20.86 3.40 ULMN 4 1ddj_c07 PLASMINOGEN user 3 4 # 3 D 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 741 ALA B 101 ALA^? 11.06 ZN ZN B 375 D 742 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 4 1ddj_c07 PLASMINOGEN user 4 4 # 4 D 603 HIS B 169 HIS^? 10.86 O3S EPE A 377 D 646 ASP B 158 ASP~? 14.93 O3S EPE A 377 D 741 ALA B 161 ALA.? 8.19 O3S EPE A 377 D 742 GLY B 160 GLY.? 11.45 O3S EPE A 377 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -7.67 -24.84 7.30 -7.31 -25.39 7.61 ULMN 4 1ddj_c07 PLASMINOGEN user 5 4 # 5 D 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 741 ALA C 101 ALA^? 11.01 ZN ZN C 375 D 742 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -25.73 33.05 39.28 -27.50 34.05 39.88 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -29.58 40.72 40.37 -30.29 39.69 41.25 17.04 -27.71 53.14 16.81 -26.24 53.31 coo -29.22 39.61 36.72 -28.92 40.32 37.00 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 4 1ddj_c07 PLASMINOGEN user 6 4 # 6 D 603 HIS C 169 HIS^? 22.39 O1 TRS A 378 D 646 ASP C 158 ASP~? 22.01 O1 TRS A 378 D 741 ALA C 161 ALA.? 14.45 O1 TRS A 378 D 742 GLY C 160 GLY.? 17.10 O1 TRS A 378 coo -30.51 33.83 43.05 -30.50 33.12 45.03 13.13 -47.52 24.96 14.34 -48.17 26.54 coo -25.73 33.05 39.28 -27.50 34.05 39.88 19.06 -47.14 27.83 18.62 -49.09 27.08 coo -29.58 40.72 40.37 -30.29 39.69 41.25 14.54 -40.01 25.90 15.56 -39.75 24.83 coo -29.22 39.61 36.72 -28.92 40.32 37.00 15.27 -41.63 29.25 15.56 -41.55 28.55 1ddj_c07 source 1ddj PLASMINOGEN : 6 hits 1ddj_c07 naa= 4 ULMN 4 1doo_c01 HEAT SHOCK LOCUS U user 1 4 # 1 B 1 THR A 171 THR^? -6.32 O1S EPE C 377s B 33 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 48 GLY A 162 GLY.? 4.48 O1S EPE C 377 B 124 SER A 173 SER^? 8.70 C6 EPE C 377 coo 26.69 108.13 78.57 25.70 107.69 80.43 22.07 -30.68 4.19 22.03 -30.09 2.08 coo 30.17 110.91 86.31 27.32 111.03 80.63 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 22.32 108.46 85.29 22.91 108.64 85.71 25.38 -26.08 6.68 25.80 -25.42 6.56 coo 24.65 103.43 76.04 24.59 105.78 75.60 17.10 -34.58 2.20 18.37 -33.49 0.48 ULMN 4 1doo_c01 HEAT SHOCK LOCUS U user 2 4 # 2 B 1 THR B 171 THR^? -5.46 O3S EPE A 377s B 33 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 48 GLY B 162 GLY.? 5.31 O3S EPE A 377 B 124 SER B 173 SER^? 8.63 C9 EPE A 377 coo 26.69 108.13 78.57 25.70 107.69 80.43 0.89 -31.19 4.26 -0.81 -32.58 4.42 coo 30.17 110.91 86.31 27.32 111.03 80.63 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 22.32 108.46 85.29 22.91 108.64 85.71 -1.71 -25.67 5.15 -2.30 -25.15 5.24 coo 24.65 103.43 76.04 24.59 105.78 75.60 4.35 -36.83 4.64 1.88 -36.99 4.49 ULMN 4 1doo_c01 HEAT SHOCK LOCUS U user 3 4 # 3 B 1 THR C 171 THR^? 17.48 C2 EPE C 377 B 33 LYS C 139 LYS^? 16.11 N TRS A 378 B 48 GLY C 162 GLY.? 17.81 N TRS A 378 B 124 SER C 173 SER^? 14.26 C2 EPE C 377 coo 26.69 108.13 78.57 25.70 107.69 80.43 11.53 -42.54 18.55 13.17 -44.02 18.73 coo 30.17 110.91 86.31 27.32 111.03 80.63 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 22.32 108.46 85.29 22.91 108.64 85.71 11.10 -40.67 24.41 11.25 -40.70 25.20 coo 24.65 103.43 76.04 24.59 105.78 75.60 13.37 -42.81 12.12 14.73 -44.10 13.72 1doo_c01 source 1doo HEAT SHOCK LOCUS U : 3 hits 1doo_c01 naa= 4 ULMN 4 1dqa_c01 HMG-COA REDUCTASE user 1 4 # 1 A 559 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 866 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 691 LYS B 247 LYS^? 11.69 ZN ZN B 375 B 767 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -22.81 12.95 20.94 -21.53 11.61 22.00 -10.29 7.50 19.92 -9.48 6.56 21.59 coo -27.22 8.35 20.32 -26.13 9.06 21.96 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -13.84 7.49 25.23 -18.59 10.61 22.36 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo -16.59 12.53 18.44 -17.59 12.51 20.33 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 4 1dqa_c01 HMG-COA REDUCTASE user 2 4 # 2 A 559 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 866 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 691 LYS C 247 LYS^? 13.94 ZN ZN C 375 B 767 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -22.81 12.95 20.94 -21.53 11.61 22.00 3.38 -29.70 55.34 4.58 -28.10 54.66 coo -27.22 8.35 20.32 -26.13 9.06 21.96 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -13.84 7.49 25.23 -18.59 10.61 22.36 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo -16.59 12.53 18.44 -17.59 12.51 20.33 5.80 -28.16 48.27 6.08 -27.64 50.28 1dqa_c01 source 1dqa HMG-COA REDUCTASE : 2 hits 1dqa_c01 naa= 4 ULMN 4 1dqa_c02 HMG-COA REDUCTASE user 1 4 # 1 C 559 GLU B 336 GLU~? 2.48 ZN ZN B 375s C 866 HIS B 333 HIS~? -3.37 ZN ZN B 374s D 691 LYS B 247 LYS^? 11.69 ZN ZN B 375 D 767 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 2.52 -17.06 53.60 1.80 -15.55 52.31 -10.29 7.50 19.92 -9.48 6.56 21.59 coo -0.49 -14.18 58.34 -1.10 -14.75 56.41 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 1.29 -9.73 44.90 2.50 -13.53 49.86 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo 7.27 -14.00 50.03 5.26 -14.61 49.76 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 4 1dqa_c02 HMG-COA REDUCTASE user 2 4 # 2 C 559 GLU C 336 GLU~? 2.53 ZN ZN C 375s C 866 HIS C 333 HIS~? -3.37 ZN ZN C 374s D 691 LYS C 247 LYS^? 13.94 ZN ZN C 375 D 767 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 2.52 -17.06 53.60 1.80 -15.55 52.31 3.38 -29.70 55.34 4.58 -28.10 54.66 coo -0.49 -14.18 58.34 -1.10 -14.75 56.41 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 1.29 -9.73 44.90 2.50 -13.53 49.86 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo 7.27 -14.00 50.03 5.26 -14.61 49.76 5.80 -28.16 48.27 6.08 -27.64 50.28 1dqa_c02 source 1dqa HMG-COA REDUCTASE : 2 hits 1dqa_c02 naa= 4 ULMN 4 1dqa_c03 HMG-COA REDUCTASE user 1 4 # 1 C 691 LYS B 247 LYS^? 11.69 ZN ZN B 375 C 767 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 559 GLU B 336 GLU~? 2.48 ZN ZN B 375s D 866 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 7.67 -13.01 32.62 11.37 -18.19 32.80 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo 8.60 -21.71 34.56 10.21 -20.31 34.42 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 15.10 -21.69 32.68 14.07 -19.90 32.14 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 16.93 -22.04 26.69 16.84 -20.62 28.23 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 4 1dqa_c03 HMG-COA REDUCTASE user 2 4 # 2 C 691 LYS C 247 LYS^? 13.94 ZN ZN C 375 C 767 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 559 GLU C 336 GLU~? 2.53 ZN ZN C 375s D 866 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 7.67 -13.01 32.62 11.37 -18.19 32.80 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo 8.60 -21.71 34.56 10.21 -20.31 34.42 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 15.10 -21.69 32.68 14.07 -19.90 32.14 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 16.93 -22.04 26.69 16.84 -20.62 28.23 2.70 -25.03 58.20 4.12 -24.40 56.79 1dqa_c03 source 1dqa HMG-COA REDUCTASE : 2 hits 1dqa_c03 naa= 4 ULMN 4 1dub_c00 2-ENOYL-COA HYDRATASE user 1 4 # 1 A 98 ALA B 134 ALA^? 19.13 O1S EPE A 377 A 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 A 144 GLU B 241 GLU^? 19.53 O1S EPE A 377 A 164 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 58.27 102.60 178.19 59.43 101.66 178.07 2.44 -10.57 15.47 3.90 -10.65 15.03 coo 59.27 103.88 173.55 59.11 104.69 173.45 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 61.78 103.61 169.93 62.63 102.26 171.29 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 65.46 104.88 175.81 64.47 105.72 174.12 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 4 1dub_c00 2-ENOYL-COA HYDRATASE user 2 4 # 2 A 98 ALA C 134 ALA^? 20.03 ZN ZN C 375 A 141 GLY C 240 GLY^? 19.25 N TRS A 378 A 144 GLU C 241 GLU^? 18.99 ZN ZN C 375 A 164 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 58.27 102.60 178.19 59.43 101.66 178.07 6.08 -27.55 33.44 4.94 -27.08 32.58 coo 59.27 103.88 173.55 59.11 104.69 173.45 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 61.78 103.61 169.93 62.63 102.26 171.29 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 65.46 104.88 175.81 64.47 105.72 174.12 11.24 -30.50 31.64 12.59 -30.76 33.22 1dub_c00 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c00 naa= 4 ULMN 4 1dub_c01 2-ENOYL-COA HYDRATASE user 1 4 # 1 B 98 ALA B 134 ALA^? 19.13 O1S EPE A 377 B 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 B 144 GLU B 241 GLU^? 19.53 O1S EPE A 377 B 164 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 93.67 115.22 150.99 93.63 113.90 150.22 2.44 -10.57 15.47 3.90 -10.65 15.03 coo 88.87 114.43 152.30 88.45 115.15 152.32 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 85.20 111.99 152.05 86.60 110.89 150.91 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 88.14 113.46 145.73 86.79 113.92 147.30 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 4 1dub_c01 2-ENOYL-COA HYDRATASE user 2 4 # 2 B 98 ALA C 134 ALA^? 20.03 ZN ZN C 375 B 141 GLY C 240 GLY^? 19.25 N TRS A 378 B 144 GLU C 241 GLU^? 18.99 ZN ZN C 375 B 164 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 93.67 115.22 150.99 93.63 113.90 150.22 6.08 -27.55 33.44 4.94 -27.08 32.58 coo 88.87 114.43 152.30 88.45 115.15 152.32 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 85.20 111.99 152.05 86.60 110.89 150.91 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 88.14 113.46 145.73 86.79 113.92 147.30 11.24 -30.50 31.64 12.59 -30.76 33.22 1dub_c01 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c01 naa= 4 ULMN 4 1dub_c02 2-ENOYL-COA HYDRATASE user 1 4 # 1 C 98 ALA B 134 ALA^? 19.13 O1S EPE A 377 C 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 C 144 GLU B 241 GLU^? 19.53 O1S EPE A 377 C 164 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 53.00 102.79 132.36 53.08 101.42 133.06 2.44 -10.57 15.47 3.90 -10.65 15.03 coo 56.28 104.55 135.84 56.09 105.34 136.05 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 58.46 103.90 139.48 57.57 102.00 139.16 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 51.71 102.03 140.09 53.02 103.62 140.54 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 4 1dub_c02 2-ENOYL-COA HYDRATASE user 2 4 # 2 C 98 ALA C 134 ALA^? 20.03 ZN ZN C 375 C 141 GLY C 240 GLY^? 19.25 N TRS A 378 C 144 GLU C 241 GLU^? 18.99 ZN ZN C 375 C 164 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 53.00 102.79 132.36 53.08 101.42 133.06 6.08 -27.55 33.44 4.94 -27.08 32.58 coo 56.28 104.55 135.84 56.09 105.34 136.05 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 58.46 103.90 139.48 57.57 102.00 139.16 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 51.71 102.03 140.09 53.02 103.62 140.54 11.24 -30.50 31.64 12.59 -30.76 33.22 1dub_c02 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c02 naa= 4 ULMN 4 1dub_c03 2-ENOYL-COA HYDRATASE user 1 4 # 1 D 98 ALA B 134 ALA^? 19.13 O1S EPE A 377 D 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 D 144 GLU B 241 GLU^? 19.53 O1S EPE A 377 D 164 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 88.91 81.99 128.63 88.96 83.34 129.32 2.44 -10.57 15.47 3.90 -10.65 15.03 coo 86.19 80.64 132.77 86.38 79.85 132.93 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 84.75 81.24 136.88 85.62 83.14 136.43 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 91.47 83.05 136.24 90.35 81.38 136.84 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 4 1dub_c03 2-ENOYL-COA HYDRATASE user 2 4 # 2 D 98 ALA C 134 ALA^? 20.03 ZN ZN C 375 D 141 GLY C 240 GLY^? 19.25 N TRS A 378 D 144 GLU C 241 GLU^? 18.99 ZN ZN C 375 D 164 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 88.91 81.99 128.63 88.96 83.34 129.32 6.08 -27.55 33.44 4.94 -27.08 32.58 coo 86.19 80.64 132.77 86.38 79.85 132.93 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 84.75 81.24 136.88 85.62 83.14 136.43 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 91.47 83.05 136.24 90.35 81.38 136.84 11.24 -30.50 31.64 12.59 -30.76 33.22 1dub_c03 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c03 naa= 4 ULMN 4 1dub_c04 2-ENOYL-COA HYDRATASE user 1 4 # 1 E 98 ALA B 134 ALA^? 19.13 O1S EPE A 377 E 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 E 144 GLU B 241 GLU^? 19.53 O1S EPE A 377 E 164 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 91.93 82.37 174.92 90.77 83.36 175.00 2.44 -10.57 15.47 3.90 -10.65 15.03 coo 90.07 81.07 170.50 90.23 80.26 170.38 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 87.05 81.30 167.53 86.38 82.74 168.94 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 84.40 80.02 173.80 85.08 79.06 172.03 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 4 1dub_c04 2-ENOYL-COA HYDRATASE user 2 4 # 2 E 98 ALA C 134 ALA^? 20.03 ZN ZN C 375 E 141 GLY C 240 GLY^? 19.25 N TRS A 378 E 144 GLU C 241 GLU^? 18.99 ZN ZN C 375 E 164 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 91.93 82.37 174.92 90.77 83.36 175.00 6.08 -27.55 33.44 4.94 -27.08 32.58 coo 90.07 81.07 170.50 90.23 80.26 170.38 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 87.05 81.30 167.53 86.38 82.74 168.94 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 84.40 80.02 173.80 85.08 79.06 172.03 11.24 -30.50 31.64 12.59 -30.76 33.22 1dub_c04 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c04 naa= 4 ULMN 4 1dub_c05 2-ENOYL-COA HYDRATASE user 1 4 # 1 F 98 ALA B 134 ALA^? 19.13 O1S EPE A 377 F 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 F 144 GLU B 241 GLU^? 19.53 O1S EPE A 377 F 164 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 52.21 69.79 154.56 52.11 71.07 153.72 2.44 -10.57 15.47 3.90 -10.65 15.03 coo 57.12 70.68 155.10 57.52 69.95 155.02 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 60.62 73.13 154.21 59.05 74.26 153.35 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 56.75 71.71 148.46 58.44 71.01 149.54 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 4 1dub_c05 2-ENOYL-COA HYDRATASE user 2 4 # 2 F 98 ALA C 134 ALA^? 20.03 ZN ZN C 375 F 141 GLY C 240 GLY^? 19.25 N TRS A 378 F 144 GLU C 241 GLU^? 18.99 ZN ZN C 375 F 164 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 52.21 69.79 154.56 52.11 71.07 153.72 6.08 -27.55 33.44 4.94 -27.08 32.58 coo 57.12 70.68 155.10 57.52 69.95 155.02 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 60.62 73.13 154.21 59.05 74.26 153.35 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 56.75 71.71 148.46 58.44 71.01 149.54 11.24 -30.50 31.64 12.59 -30.76 33.22 1dub_c05 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c05 naa= 4 ULMN 4 1e7l_c00 RECOMBINATION ENDONUCLEASE VII user 1 4 # 1 A 41 HIS A 42 HIS^? 26.23 ZN ZN A 375 A 43 HIS A 361 HIS^? 22.47 ZN ZN A 375 A 65 GLU A 56 GLU~? 18.18 ZN ZN A 374 B 105 HIS A 359 HIS^? 27.14 ZN ZN A 375 coo -8.56 17.41 8.71 -9.21 15.58 9.51 43.48 12.60 9.22 44.86 13.19 7.76 coo -7.86 15.79 13.55 -6.41 15.13 12.19 46.25 9.10 12.92 46.66 10.09 11.12 coo 0.61 18.90 14.14 -0.63 19.28 12.44 47.24 13.21 19.42 47.19 11.28 20.29 coo -9.53 15.99 5.74 -8.28 14.32 5.53 45.80 8.64 6.53 46.53 8.87 4.58 1e7l_c00 source 1e7l RECOMBINATION ENDONUCLEASE VII : 1 hits 1e7l_c00 naa= 4 ULMN 4 1e7l_c02 RECOMBINATION ENDONUCLEASE VII user 1 4 # 1 A 41 HIS A 42 HIS^? 26.23 ZN ZN A 375 A 43 HIS A 361 HIS^? 22.47 ZN ZN A 375 A 65 GLU A 56 GLU~? 18.18 ZN ZN A 374 B 105 HIS A 359 HIS^? 27.14 ZN ZN A 375 coo -8.56 17.41 8.71 -9.21 15.58 9.51 43.48 12.60 9.22 44.86 13.19 7.76 coo -7.86 15.79 13.55 -6.41 15.13 12.19 46.25 9.10 12.92 46.66 10.09 11.12 coo 0.61 18.90 14.14 -0.63 19.28 12.44 47.24 13.21 19.42 47.19 11.28 20.29 coo -9.53 15.99 5.74 -8.28 14.32 5.53 45.80 8.64 6.53 46.53 8.87 4.58 1e7l_c02 source 1e7l RECOMBINATION ENDONUCLEASE VII : 1 hits 1e7l_c02 naa= 4 ULMN 4 1eyp_c00 CHALCONE-FLAVONONE ISOMERASE 1 user 1 4 # 1 A 48 THR B 242 THR^? 18.76 ZN ZN B 375 A 106 TYR B 133 TYR^? 17.24 ZN ZN B 375 A 113 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 190 THR B 104 THR~? 6.79 ZN ZN B 375 coo 22.06 26.20 31.80 23.25 24.42 31.55 1.06 -7.67 12.24 3.05 -6.84 12.40 coo 25.78 19.82 28.38 24.53 18.95 30.74 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo 31.98 16.71 37.61 32.38 18.76 37.14 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 28.27 16.17 41.32 28.66 15.49 39.31 -6.78 -0.91 23.63 -5.15 -0.73 25.06 1eyp_c00 source 1eyp CHALCONE-FLAVONONE ISOMERASE 1 : 1 hits 1eyp_c00 naa= 4 ULMN 4 1eyp_c01 CHALCONE-FLAVONONE ISOMERASE 1 user 1 4 # 1 B 48 THR A 242 THR^? 8.72 O3 TRS A 378 B 106 TYR A 133 TYR^? 12.87 O3 TRS A 378 B 113 ASN A 105 ASN~? 9.65 ZN ZN A 375 B 190 THR A 104 THR~? 6.76 ZN ZN A 375 coo 31.55 -18.10 62.71 31.91 -16.02 63.16 30.60 -18.28 22.38 30.36 -19.25 24.36 coo 31.39 -11.16 66.20 30.18 -10.84 63.67 26.66 -12.84 21.54 25.55 -13.01 18.92 coo 36.52 -5.01 57.74 37.90 -6.60 58.02 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 32.92 -6.00 53.75 33.40 -5.89 55.87 32.17 -3.62 26.15 30.67 -3.61 27.70 ULMN 4 1eyp_c01 CHALCONE-FLAVONONE ISOMERASE 1 user 2 4 # 2 B 48 THR B 242 THR^? 18.76 ZN ZN B 375 B 106 TYR B 133 TYR^? 17.24 ZN ZN B 375 B 113 ASN B 105 ASN~? 9.47 ZN ZN B 375 B 190 THR B 104 THR~? 6.79 ZN ZN B 375 coo 31.55 -18.10 62.71 31.91 -16.02 63.16 1.06 -7.67 12.24 3.05 -6.84 12.40 coo 31.39 -11.16 66.20 30.18 -10.84 63.67 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo 36.52 -5.01 57.74 37.90 -6.60 58.02 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 32.92 -6.00 53.75 33.40 -5.89 55.87 -6.78 -0.91 23.63 -5.15 -0.73 25.06 1eyp_c01 source 1eyp CHALCONE-FLAVONONE ISOMERASE 1 : 2 hits 1eyp_c01 naa= 4 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 1 4 # 1 A 33 ARG B 153 ARG~? 10.73 C6 EPE A 377 A 42 ARG A 198 ARG^? 11.16 C6 EPE A 377 A 197 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 203 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 23.24 19.51 21.94 24.57 16.76 21.61 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo 16.08 17.48 28.78 19.09 16.85 28.49 -1.05 -38.83 -3.85 -3.04 -38.62 -1.48 coo 28.26 9.63 19.68 28.71 10.56 22.55 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 33.62 12.31 23.18 30.84 12.90 24.36 8.58 -36.69 10.51 9.21 -33.68 10.79 1f75_c00 source 1f75 UNDECAPRENYL PYROPHOSPHATE SYNTHETASE : 1 hits 1f75_c00 naa= 4 ULMN 4 1glo_c00 CATHEPSIN S user 1 4 # 1 A 19 GLN B 183 GLN.? 25.94 O1 TRS A 378 A 25 SER C 168 SER^? 24.11 O1 TRS A 378 A 164 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 184 ASN C 166 ASN.? 27.69 ZN ZN C 375 coo -11.53 38.19 18.47 -9.42 38.35 18.87 7.41 -49.44 30.49 8.75 -47.79 30.78 coo -7.21 36.10 21.15 -5.41 37.65 20.61 9.08 -45.42 26.78 10.19 -47.47 27.43 coo -4.08 38.90 17.01 -5.94 38.04 16.53 9.61 -42.49 30.12 8.57 -43.28 31.77 coo -7.20 34.51 12.46 -6.97 36.44 13.40 1.70 -45.88 30.14 0.89 -45.44 32.06 1glo_c00 source 1glo CATHEPSIN S : 1 hits 1glo_c00 naa= 4 ULMN 4 1kas_c00 BETA-KETOACYL ACP SYNTHASE II user 1 4 # 1 163 CYH C 170 CYH^? 22.19 N TRS A 378 303 HIS C 163 HIS.? 22.24 O1 TRS A 378 340 HIS C 169 HIS^? 22.39 O1 TRS A 378 400 PHE B 180 PHE^? 25.23 O2S EPE A 377 coo 16.75 23.75 11.48 16.42 25.83 13.36 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 15.95 21.52 18.00 16.33 23.09 16.67 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 21.34 25.20 15.45 19.58 24.66 14.44 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 14.43 29.45 13.32 16.55 29.76 15.09 5.49 -47.88 21.09 3.41 -49.53 20.15 1kas_c00 source 1kas BETA-KETOACYL ACP SYNTHASE II : 1 hits 1kas_c00 naa= 4 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 4 # 1 166 LYS A 340 LYS~? 12.75 ZN ZN A 374 270 ASP A 292 ASP^? 8.63 ZN ZN A 374 297 HIS A 333 HIS~? -3.55 ZN ZN A 374s 317 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 27.27 1.43 25.09 29.18 5.25 22.89 44.47 1.55 20.70 47.30 5.10 24.27 coo 29.40 9.25 9.79 31.51 9.14 10.05 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 29.05 8.65 14.00 30.25 7.04 14.30 40.60 0.33 34.12 38.69 0.39 33.24 coo 29.25 11.66 19.43 29.42 9.79 18.51 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 4 # 2 166 LYS B 340 LYS~? 12.84 ZN ZN B 374 270 ASP B 292 ASP^? 8.88 ZN ZN B 374 297 HIS B 333 HIS~? -3.37 ZN ZN B 374s 317 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 27.27 1.43 25.09 29.18 5.25 22.89 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 29.40 9.25 9.79 31.51 9.14 10.05 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 29.05 8.65 14.00 30.25 7.04 14.30 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 29.25 11.66 19.43 29.42 9.79 18.51 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 4 # 3 166 LYS C 340 LYS~? 12.92 ZN ZN C 374 270 ASP C 292 ASP^? 8.69 ZN ZN C 374 297 HIS C 333 HIS~? -3.37 ZN ZN C 374s 317 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 27.27 1.43 25.09 29.18 5.25 22.89 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 29.40 9.25 9.79 31.51 9.14 10.05 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 29.05 8.65 14.00 30.25 7.04 14.30 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 29.25 11.66 19.43 29.42 9.79 18.51 3.38 -29.70 55.34 4.58 -28.10 54.66 1mdr_c00 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 3 hits 1mdr_c00 naa= 4 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 A 192 LYS A 138 LYS^? 13.11 N TRS A 378 A 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 302 SER A 174 SER^? 9.43 O3S EPE C 377 A 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 85.01 60.31 56.44 83.15 64.89 56.44 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 71.86 54.60 60.61 70.38 53.71 61.84 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 68.68 62.06 66.08 69.52 59.75 65.97 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 66.34 67.16 63.84 67.47 65.57 63.06 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 A 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 302 SER B 174 SER^? 9.21 O2S EPE A 377 A 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 85.01 60.31 56.44 83.15 64.89 56.44 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 71.86 54.60 60.61 70.38 53.71 61.84 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 68.68 62.06 66.08 69.52 59.75 65.97 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 66.34 67.16 63.84 67.47 65.57 63.06 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 A 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 302 SER B 174 SER^? 9.21 O2S EPE A 377 A 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 85.01 60.31 56.44 83.15 64.89 56.44 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 71.86 54.60 60.61 70.38 53.71 61.84 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 68.68 62.06 66.08 69.52 59.75 65.97 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 66.34 67.16 63.84 67.47 65.57 63.06 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 4 4 # 4 A 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 302 SER C 174 SER^? 11.73 O3S EPE C 377 A 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 85.01 60.31 56.44 83.15 64.89 56.44 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 71.86 54.60 60.61 70.38 53.71 61.84 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 68.68 62.06 66.08 69.52 59.75 65.97 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 66.34 67.16 63.84 67.47 65.57 63.06 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 5 4 # 5 A 192 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 302 SER B 174 SER^? 9.21 O2S EPE A 377 A 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 85.01 60.31 56.44 83.15 64.89 56.44 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 71.86 54.60 60.61 70.38 53.71 61.84 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 68.68 62.06 66.08 69.52 59.75 65.97 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 66.34 67.16 63.84 67.47 65.57 63.06 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 6 4 # 6 A 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 302 SER A 174 SER^? 9.43 O3S EPE C 377 A 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 85.01 60.31 56.44 83.15 64.89 56.44 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 71.86 54.60 60.61 70.38 53.71 61.84 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 68.68 62.06 66.08 69.52 59.75 65.97 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 66.34 67.16 63.84 67.47 65.57 63.06 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 7 4 # 7 A 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 302 SER C 174 SER^? 11.73 O3S EPE C 377 A 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 85.01 60.31 56.44 83.15 64.89 56.44 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 71.86 54.60 60.61 70.38 53.71 61.84 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 68.68 62.06 66.08 69.52 59.75 65.97 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 66.34 67.16 63.84 67.47 65.57 63.06 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 8 4 # 8 A 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 302 SER C 174 SER^? 11.73 O3S EPE C 377 A 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 85.01 60.31 56.44 83.15 64.89 56.44 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 71.86 54.60 60.61 70.38 53.71 61.84 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 68.68 62.06 66.08 69.52 59.75 65.97 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 66.34 67.16 63.84 67.47 65.57 63.06 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 9 4 # 9 A 192 LYS C 138 LYS^? 8.30 N TRS A 378 A 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 302 SER C 174 SER^? 11.73 O3S EPE C 377 A 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 85.01 60.31 56.44 83.15 64.89 56.44 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 71.86 54.60 60.61 70.38 53.71 61.84 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 68.68 62.06 66.08 69.52 59.75 65.97 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 66.34 67.16 63.84 67.47 65.57 63.06 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 10 4 # 10 A 192 LYS C 139 LYS^? 16.11 N TRS A 378 A 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 302 SER A 174 SER^? 9.43 O3S EPE C 377 A 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 85.01 60.31 56.44 83.15 64.89 56.44 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 71.86 54.60 60.61 70.38 53.71 61.84 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 68.68 62.06 66.08 69.52 59.75 65.97 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 66.34 67.16 63.84 67.47 65.57 63.06 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 11 4 # 11 A 192 LYS C 139 LYS^? 16.11 N TRS A 378 A 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 302 SER A 174 SER^? 9.43 O3S EPE C 377 A 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 85.01 60.31 56.44 83.15 64.89 56.44 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 71.86 54.60 60.61 70.38 53.71 61.84 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 68.68 62.06 66.08 69.52 59.75 65.97 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 66.34 67.16 63.84 67.47 65.57 63.06 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 12 4 # 12 A 192 LYS C 139 LYS^? 16.11 N TRS A 378 A 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 302 SER B 174 SER^? 9.21 O2S EPE A 377 A 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 85.01 60.31 56.44 83.15 64.89 56.44 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 71.86 54.60 60.61 70.38 53.71 61.84 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 68.68 62.06 66.08 69.52 59.75 65.97 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 66.34 67.16 63.84 67.47 65.57 63.06 6.08 -43.60 3.61 5.68 -45.21 2.31 1o04_c00 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 12 hits 1o04_c00 naa= 4 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 B 192 LYS A 138 LYS^? 13.11 N TRS A 378 B 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 302 SER A 174 SER^? 9.43 O3S EPE C 377 B 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 54.45 47.08 36.74 56.53 48.29 32.40 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 67.17 40.71 41.61 68.49 39.13 42.13 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 70.41 37.34 33.01 69.41 36.86 35.23 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 73.06 40.82 28.87 71.88 41.23 30.58 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 B 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 302 SER B 174 SER^? 9.21 O2S EPE A 377 B 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 54.45 47.08 36.74 56.53 48.29 32.40 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 67.17 40.71 41.61 68.49 39.13 42.13 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 70.41 37.34 33.01 69.41 36.86 35.23 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 73.06 40.82 28.87 71.88 41.23 30.58 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 B 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 302 SER B 174 SER^? 9.21 O2S EPE A 377 B 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 54.45 47.08 36.74 56.53 48.29 32.40 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 67.17 40.71 41.61 68.49 39.13 42.13 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 70.41 37.34 33.01 69.41 36.86 35.23 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 73.06 40.82 28.87 71.88 41.23 30.58 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 4 4 # 4 B 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 302 SER C 174 SER^? 11.73 O3S EPE C 377 B 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 54.45 47.08 36.74 56.53 48.29 32.40 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 67.17 40.71 41.61 68.49 39.13 42.13 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 70.41 37.34 33.01 69.41 36.86 35.23 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 73.06 40.82 28.87 71.88 41.23 30.58 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 5 4 # 5 B 192 LYS B 138 LYS^? 15.17 O1S EPE A 377 B 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 302 SER B 174 SER^? 9.21 O2S EPE A 377 B 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 54.45 47.08 36.74 56.53 48.29 32.40 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 67.17 40.71 41.61 68.49 39.13 42.13 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 70.41 37.34 33.01 69.41 36.86 35.23 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 73.06 40.82 28.87 71.88 41.23 30.58 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 6 4 # 6 B 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 302 SER A 174 SER^? 9.43 O3S EPE C 377 B 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 54.45 47.08 36.74 56.53 48.29 32.40 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 67.17 40.71 41.61 68.49 39.13 42.13 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 70.41 37.34 33.01 69.41 36.86 35.23 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 73.06 40.82 28.87 71.88 41.23 30.58 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 7 4 # 7 B 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 302 SER C 174 SER^? 11.73 O3S EPE C 377 B 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 54.45 47.08 36.74 56.53 48.29 32.40 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 67.17 40.71 41.61 68.49 39.13 42.13 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 70.41 37.34 33.01 69.41 36.86 35.23 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 73.06 40.82 28.87 71.88 41.23 30.58 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 8 4 # 8 B 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 302 SER C 174 SER^? 11.73 O3S EPE C 377 B 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 54.45 47.08 36.74 56.53 48.29 32.40 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 67.17 40.71 41.61 68.49 39.13 42.13 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 70.41 37.34 33.01 69.41 36.86 35.23 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 73.06 40.82 28.87 71.88 41.23 30.58 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 9 4 # 9 B 192 LYS C 138 LYS^? 8.30 N TRS A 378 B 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 302 SER C 174 SER^? 11.73 O3S EPE C 377 B 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 54.45 47.08 36.74 56.53 48.29 32.40 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 67.17 40.71 41.61 68.49 39.13 42.13 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 70.41 37.34 33.01 69.41 36.86 35.23 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 73.06 40.82 28.87 71.88 41.23 30.58 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 10 4 # 10 B 192 LYS C 139 LYS^? 16.11 N TRS A 378 B 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 302 SER A 174 SER^? 9.43 O3S EPE C 377 B 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 54.45 47.08 36.74 56.53 48.29 32.40 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 67.17 40.71 41.61 68.49 39.13 42.13 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 70.41 37.34 33.01 69.41 36.86 35.23 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 73.06 40.82 28.87 71.88 41.23 30.58 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 11 4 # 11 B 192 LYS C 139 LYS^? 16.11 N TRS A 378 B 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 302 SER A 174 SER^? 9.43 O3S EPE C 377 B 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 54.45 47.08 36.74 56.53 48.29 32.40 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 67.17 40.71 41.61 68.49 39.13 42.13 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 70.41 37.34 33.01 69.41 36.86 35.23 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 73.06 40.82 28.87 71.88 41.23 30.58 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 12 4 # 12 B 192 LYS C 139 LYS^? 16.11 N TRS A 378 B 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 302 SER B 174 SER^? 9.21 O2S EPE A 377 B 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 54.45 47.08 36.74 56.53 48.29 32.40 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 67.17 40.71 41.61 68.49 39.13 42.13 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 70.41 37.34 33.01 69.41 36.86 35.23 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 73.06 40.82 28.87 71.88 41.23 30.58 6.08 -43.60 3.61 5.68 -45.21 2.31 1o04_c01 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 12 hits 1o04_c01 naa= 4 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 C 192 LYS A 138 LYS^? 13.11 N TRS A 378 C 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 C 302 SER A 174 SER^? 9.43 O3S EPE C 377 C 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 83.30 16.28 88.61 85.25 11.75 88.79 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 79.88 15.02 74.11 80.06 15.36 72.02 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 87.46 9.36 71.39 86.33 11.53 71.37 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 87.65 3.44 72.32 86.49 4.99 73.13 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 C 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s C 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 C 302 SER B 174 SER^? 9.21 O2S EPE A 377 C 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 83.30 16.28 88.61 85.25 11.75 88.79 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 79.88 15.02 74.11 80.06 15.36 72.02 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 87.46 9.36 71.39 86.33 11.53 71.37 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 87.65 3.44 72.32 86.49 4.99 73.13 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 C 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s C 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 C 302 SER B 174 SER^? 9.21 O2S EPE A 377 C 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 83.30 16.28 88.61 85.25 11.75 88.79 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 79.88 15.02 74.11 80.06 15.36 72.02 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 87.46 9.36 71.39 86.33 11.53 71.37 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 87.65 3.44 72.32 86.49 4.99 73.13 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 4 4 # 4 C 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s C 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 C 302 SER C 174 SER^? 11.73 O3S EPE C 377 C 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 83.30 16.28 88.61 85.25 11.75 88.79 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 79.88 15.02 74.11 80.06 15.36 72.02 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 87.46 9.36 71.39 86.33 11.53 71.37 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 87.65 3.44 72.32 86.49 4.99 73.13 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 5 4 # 5 C 192 LYS B 138 LYS^? 15.17 O1S EPE A 377 C 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 C 302 SER B 174 SER^? 9.21 O2S EPE A 377 C 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 83.30 16.28 88.61 85.25 11.75 88.79 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 79.88 15.02 74.11 80.06 15.36 72.02 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 87.46 9.36 71.39 86.33 11.53 71.37 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 87.65 3.44 72.32 86.49 4.99 73.13 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 6 4 # 6 C 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s C 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s C 302 SER A 174 SER^? 9.43 O3S EPE C 377 C 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 83.30 16.28 88.61 85.25 11.75 88.79 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 79.88 15.02 74.11 80.06 15.36 72.02 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 87.46 9.36 71.39 86.33 11.53 71.37 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 87.65 3.44 72.32 86.49 4.99 73.13 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 7 4 # 7 C 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s C 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s C 302 SER C 174 SER^? 11.73 O3S EPE C 377 C 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 83.30 16.28 88.61 85.25 11.75 88.79 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 79.88 15.02 74.11 80.06 15.36 72.02 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 87.46 9.36 71.39 86.33 11.53 71.37 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 87.65 3.44 72.32 86.49 4.99 73.13 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 8 4 # 8 C 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s C 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 C 302 SER C 174 SER^? 11.73 O3S EPE C 377 C 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 83.30 16.28 88.61 85.25 11.75 88.79 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 79.88 15.02 74.11 80.06 15.36 72.02 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 87.46 9.36 71.39 86.33 11.53 71.37 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 87.65 3.44 72.32 86.49 4.99 73.13 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 9 4 # 9 C 192 LYS C 138 LYS^? 8.30 N TRS A 378 C 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s C 302 SER C 174 SER^? 11.73 O3S EPE C 377 C 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 83.30 16.28 88.61 85.25 11.75 88.79 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 79.88 15.02 74.11 80.06 15.36 72.02 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 87.46 9.36 71.39 86.33 11.53 71.37 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 87.65 3.44 72.32 86.49 4.99 73.13 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 10 4 # 10 C 192 LYS C 139 LYS^? 16.11 N TRS A 378 C 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s C 302 SER A 174 SER^? 9.43 O3S EPE C 377 C 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 83.30 16.28 88.61 85.25 11.75 88.79 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 79.88 15.02 74.11 80.06 15.36 72.02 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 87.46 9.36 71.39 86.33 11.53 71.37 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 87.65 3.44 72.32 86.49 4.99 73.13 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 11 4 # 11 C 192 LYS C 139 LYS^? 16.11 N TRS A 378 C 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 C 302 SER A 174 SER^? 9.43 O3S EPE C 377 C 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 83.30 16.28 88.61 85.25 11.75 88.79 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 79.88 15.02 74.11 80.06 15.36 72.02 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 87.46 9.36 71.39 86.33 11.53 71.37 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 87.65 3.44 72.32 86.49 4.99 73.13 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 12 4 # 12 C 192 LYS C 139 LYS^? 16.11 N TRS A 378 C 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 C 302 SER B 174 SER^? 9.21 O2S EPE A 377 C 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 83.30 16.28 88.61 85.25 11.75 88.79 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 79.88 15.02 74.11 80.06 15.36 72.02 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 87.46 9.36 71.39 86.33 11.53 71.37 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 87.65 3.44 72.32 86.49 4.99 73.13 6.08 -43.60 3.61 5.68 -45.21 2.31 1o04_c02 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 12 hits 1o04_c02 naa= 4 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 D 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s D 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 D 302 SER B 174 SER^? 9.21 O2S EPE A 377 D 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 51.91 3.68 69.52 49.61 2.30 73.71 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 55.94 16.93 75.09 55.86 19.04 75.37 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 48.09 18.43 80.84 49.40 18.94 78.77 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 47.32 15.81 86.19 48.62 15.41 84.58 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 D 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s D 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 D 302 SER B 174 SER^? 9.21 O2S EPE A 377 D 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 51.91 3.68 69.52 49.61 2.30 73.71 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 55.94 16.93 75.09 55.86 19.04 75.37 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 48.09 18.43 80.84 49.40 18.94 78.77 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 47.32 15.81 86.19 48.62 15.41 84.58 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 D 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s D 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 D 302 SER C 174 SER^? 11.73 O3S EPE C 377 D 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 51.91 3.68 69.52 49.61 2.30 73.71 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 55.94 16.93 75.09 55.86 19.04 75.37 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 48.09 18.43 80.84 49.40 18.94 78.77 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 47.32 15.81 86.19 48.62 15.41 84.58 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 4 4 # 4 D 192 LYS B 138 LYS^? 15.17 O1S EPE A 377 D 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 D 302 SER B 174 SER^? 9.21 O2S EPE A 377 D 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 51.91 3.68 69.52 49.61 2.30 73.71 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 55.94 16.93 75.09 55.86 19.04 75.37 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 48.09 18.43 80.84 49.40 18.94 78.77 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 47.32 15.81 86.19 48.62 15.41 84.58 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 5 4 # 5 D 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s D 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s D 302 SER A 174 SER^? 9.43 O3S EPE C 377 D 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 51.91 3.68 69.52 49.61 2.30 73.71 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 55.94 16.93 75.09 55.86 19.04 75.37 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 48.09 18.43 80.84 49.40 18.94 78.77 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 47.32 15.81 86.19 48.62 15.41 84.58 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 6 4 # 6 D 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s D 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s D 302 SER C 174 SER^? 11.73 O3S EPE C 377 D 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 51.91 3.68 69.52 49.61 2.30 73.71 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 55.94 16.93 75.09 55.86 19.04 75.37 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 48.09 18.43 80.84 49.40 18.94 78.77 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 47.32 15.81 86.19 48.62 15.41 84.58 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 7 4 # 7 D 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s D 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 D 302 SER C 174 SER^? 11.73 O3S EPE C 377 D 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 51.91 3.68 69.52 49.61 2.30 73.71 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 55.94 16.93 75.09 55.86 19.04 75.37 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 48.09 18.43 80.84 49.40 18.94 78.77 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 47.32 15.81 86.19 48.62 15.41 84.58 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 8 4 # 8 D 192 LYS C 138 LYS^? 8.30 N TRS A 378 D 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s D 302 SER C 174 SER^? 11.73 O3S EPE C 377 D 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 51.91 3.68 69.52 49.61 2.30 73.71 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 55.94 16.93 75.09 55.86 19.04 75.37 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 48.09 18.43 80.84 49.40 18.94 78.77 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 47.32 15.81 86.19 48.62 15.41 84.58 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 9 4 # 9 D 192 LYS C 139 LYS^? 16.11 N TRS A 378 D 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 D 302 SER B 174 SER^? 9.21 O2S EPE A 377 D 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 51.91 3.68 69.52 49.61 2.30 73.71 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 55.94 16.93 75.09 55.86 19.04 75.37 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 48.09 18.43 80.84 49.40 18.94 78.77 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 47.32 15.81 86.19 48.62 15.41 84.58 6.08 -43.60 3.61 5.68 -45.21 2.31 1o04_c03 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 9 hits 1o04_c03 naa= 4 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 E 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s E 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 E 302 SER B 174 SER^? 9.21 O2S EPE A 377 E 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 52.46 147.49 107.94 50.14 148.75 103.77 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 57.01 134.41 102.36 57.01 132.29 102.10 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 49.26 132.62 96.59 50.54 132.08 98.67 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 48.52 135.25 91.24 49.73 135.67 92.87 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 E 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s E 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 E 302 SER B 174 SER^? 9.21 O2S EPE A 377 E 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 52.46 147.49 107.94 50.14 148.75 103.77 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 57.01 134.41 102.36 57.01 132.29 102.10 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 49.26 132.62 96.59 50.54 132.08 98.67 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 48.52 135.25 91.24 49.73 135.67 92.87 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 E 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s E 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 E 302 SER C 174 SER^? 11.73 O3S EPE C 377 E 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 52.46 147.49 107.94 50.14 148.75 103.77 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 57.01 134.41 102.36 57.01 132.29 102.10 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 49.26 132.62 96.59 50.54 132.08 98.67 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 48.52 135.25 91.24 49.73 135.67 92.87 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 4 4 # 4 E 192 LYS B 138 LYS^? 15.17 O1S EPE A 377 E 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 E 302 SER B 174 SER^? 9.21 O2S EPE A 377 E 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 52.46 147.49 107.94 50.14 148.75 103.77 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 57.01 134.41 102.36 57.01 132.29 102.10 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 49.26 132.62 96.59 50.54 132.08 98.67 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 48.52 135.25 91.24 49.73 135.67 92.87 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 5 4 # 5 E 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s E 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s E 302 SER A 174 SER^? 9.43 O3S EPE C 377 E 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 52.46 147.49 107.94 50.14 148.75 103.77 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 57.01 134.41 102.36 57.01 132.29 102.10 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 49.26 132.62 96.59 50.54 132.08 98.67 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 48.52 135.25 91.24 49.73 135.67 92.87 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 6 4 # 6 E 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s E 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s E 302 SER C 174 SER^? 11.73 O3S EPE C 377 E 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 52.46 147.49 107.94 50.14 148.75 103.77 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 57.01 134.41 102.36 57.01 132.29 102.10 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 49.26 132.62 96.59 50.54 132.08 98.67 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 48.52 135.25 91.24 49.73 135.67 92.87 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 7 4 # 7 E 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s E 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 E 302 SER C 174 SER^? 11.73 O3S EPE C 377 E 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 52.46 147.49 107.94 50.14 148.75 103.77 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 57.01 134.41 102.36 57.01 132.29 102.10 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 49.26 132.62 96.59 50.54 132.08 98.67 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 48.52 135.25 91.24 49.73 135.67 92.87 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 8 4 # 8 E 192 LYS C 138 LYS^? 8.30 N TRS A 378 E 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s E 302 SER C 174 SER^? 11.73 O3S EPE C 377 E 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 52.46 147.49 107.94 50.14 148.75 103.77 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 57.01 134.41 102.36 57.01 132.29 102.10 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 49.26 132.62 96.59 50.54 132.08 98.67 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 48.52 135.25 91.24 49.73 135.67 92.87 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 9 4 # 9 E 192 LYS C 139 LYS^? 16.11 N TRS A 378 E 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 E 302 SER B 174 SER^? 9.21 O2S EPE A 377 E 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 52.46 147.49 107.94 50.14 148.75 103.77 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 57.01 134.41 102.36 57.01 132.29 102.10 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 49.26 132.62 96.59 50.54 132.08 98.67 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 48.52 135.25 91.24 49.73 135.67 92.87 6.08 -43.60 3.61 5.68 -45.21 2.31 1o04_c04 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 9 hits 1o04_c04 naa= 4 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 F 192 LYS A 138 LYS^? 13.11 N TRS A 378 F 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 F 302 SER A 174 SER^? 9.43 O3S EPE C 377 F 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 84.18 136.24 88.80 85.96 140.90 88.66 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 80.72 137.29 103.27 80.90 136.95 105.39 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 87.99 143.28 106.06 86.95 141.03 106.01 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 87.94 149.19 105.12 86.87 147.57 104.33 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 F 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s F 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 F 302 SER B 174 SER^? 9.21 O2S EPE A 377 F 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 84.18 136.24 88.80 85.96 140.90 88.66 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 80.72 137.29 103.27 80.90 136.95 105.39 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 87.99 143.28 106.06 86.95 141.03 106.01 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 87.94 149.19 105.12 86.87 147.57 104.33 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 F 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s F 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 F 302 SER B 174 SER^? 9.21 O2S EPE A 377 F 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 84.18 136.24 88.80 85.96 140.90 88.66 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 80.72 137.29 103.27 80.90 136.95 105.39 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 87.99 143.28 106.06 86.95 141.03 106.01 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 87.94 149.19 105.12 86.87 147.57 104.33 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 4 4 # 4 F 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s F 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 F 302 SER C 174 SER^? 11.73 O3S EPE C 377 F 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 84.18 136.24 88.80 85.96 140.90 88.66 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 80.72 137.29 103.27 80.90 136.95 105.39 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 87.99 143.28 106.06 86.95 141.03 106.01 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 87.94 149.19 105.12 86.87 147.57 104.33 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 5 4 # 5 F 192 LYS B 138 LYS^? 15.17 O1S EPE A 377 F 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 F 302 SER B 174 SER^? 9.21 O2S EPE A 377 F 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 84.18 136.24 88.80 85.96 140.90 88.66 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 80.72 137.29 103.27 80.90 136.95 105.39 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 87.99 143.28 106.06 86.95 141.03 106.01 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 87.94 149.19 105.12 86.87 147.57 104.33 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 6 4 # 6 F 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s F 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s F 302 SER A 174 SER^? 9.43 O3S EPE C 377 F 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 84.18 136.24 88.80 85.96 140.90 88.66 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 80.72 137.29 103.27 80.90 136.95 105.39 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 87.99 143.28 106.06 86.95 141.03 106.01 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 87.94 149.19 105.12 86.87 147.57 104.33 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 7 4 # 7 F 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s F 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s F 302 SER C 174 SER^? 11.73 O3S EPE C 377 F 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 84.18 136.24 88.80 85.96 140.90 88.66 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 80.72 137.29 103.27 80.90 136.95 105.39 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 87.99 143.28 106.06 86.95 141.03 106.01 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 87.94 149.19 105.12 86.87 147.57 104.33 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 8 4 # 8 F 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s F 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 F 302 SER C 174 SER^? 11.73 O3S EPE C 377 F 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 84.18 136.24 88.80 85.96 140.90 88.66 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 80.72 137.29 103.27 80.90 136.95 105.39 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 87.99 143.28 106.06 86.95 141.03 106.01 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 87.94 149.19 105.12 86.87 147.57 104.33 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 9 4 # 9 F 192 LYS C 138 LYS^? 8.30 N TRS A 378 F 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s F 302 SER C 174 SER^? 11.73 O3S EPE C 377 F 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 84.18 136.24 88.80 85.96 140.90 88.66 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 80.72 137.29 103.27 80.90 136.95 105.39 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 87.99 143.28 106.06 86.95 141.03 106.01 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 87.94 149.19 105.12 86.87 147.57 104.33 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 10 4 # 10 F 192 LYS C 139 LYS^? 16.11 N TRS A 378 F 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s F 302 SER A 174 SER^? 9.43 O3S EPE C 377 F 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 84.18 136.24 88.80 85.96 140.90 88.66 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 80.72 137.29 103.27 80.90 136.95 105.39 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 87.99 143.28 106.06 86.95 141.03 106.01 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 87.94 149.19 105.12 86.87 147.57 104.33 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 11 4 # 11 F 192 LYS C 139 LYS^? 16.11 N TRS A 378 F 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 F 302 SER A 174 SER^? 9.43 O3S EPE C 377 F 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 84.18 136.24 88.80 85.96 140.90 88.66 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 80.72 137.29 103.27 80.90 136.95 105.39 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 87.99 143.28 106.06 86.95 141.03 106.01 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 87.94 149.19 105.12 86.87 147.57 104.33 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 12 4 # 12 F 192 LYS C 139 LYS^? 16.11 N TRS A 378 F 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 F 302 SER B 174 SER^? 9.21 O2S EPE A 377 F 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 84.18 136.24 88.80 85.96 140.90 88.66 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 80.72 137.29 103.27 80.90 136.95 105.39 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 87.99 143.28 106.06 86.95 141.03 106.01 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 87.94 149.19 105.12 86.87 147.57 104.33 6.08 -43.60 3.61 5.68 -45.21 2.31 1o04_c05 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 12 hits 1o04_c05 naa= 4 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 G 192 LYS A 138 LYS^? 13.11 N TRS A 378 G 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 G 302 SER A 174 SER^? 9.43 O3S EPE C 377 G 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 56.79 103.91 140.42 58.85 102.76 144.77 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 69.06 110.82 135.59 70.39 112.47 135.16 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 72.18 114.35 144.24 71.25 114.81 141.99 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 75.14 110.89 148.28 73.91 110.46 146.63 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 G 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s G 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 G 302 SER B 174 SER^? 9.21 O2S EPE A 377 G 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 56.79 103.91 140.42 58.85 102.76 144.77 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 69.06 110.82 135.59 70.39 112.47 135.16 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 72.18 114.35 144.24 71.25 114.81 141.99 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 75.14 110.89 148.28 73.91 110.46 146.63 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 G 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s G 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 G 302 SER B 174 SER^? 9.21 O2S EPE A 377 G 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 56.79 103.91 140.42 58.85 102.76 144.77 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 69.06 110.82 135.59 70.39 112.47 135.16 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 72.18 114.35 144.24 71.25 114.81 141.99 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 75.14 110.89 148.28 73.91 110.46 146.63 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 4 4 # 4 G 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s G 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 G 302 SER C 174 SER^? 11.73 O3S EPE C 377 G 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 56.79 103.91 140.42 58.85 102.76 144.77 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 69.06 110.82 135.59 70.39 112.47 135.16 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 72.18 114.35 144.24 71.25 114.81 141.99 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 75.14 110.89 148.28 73.91 110.46 146.63 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 5 4 # 5 G 192 LYS B 138 LYS^? 15.17 O1S EPE A 377 G 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 G 302 SER B 174 SER^? 9.21 O2S EPE A 377 G 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 56.79 103.91 140.42 58.85 102.76 144.77 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 69.06 110.82 135.59 70.39 112.47 135.16 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 72.18 114.35 144.24 71.25 114.81 141.99 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 75.14 110.89 148.28 73.91 110.46 146.63 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 6 4 # 6 G 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s G 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s G 302 SER C 174 SER^? 11.73 O3S EPE C 377 G 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 56.79 103.91 140.42 58.85 102.76 144.77 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 69.06 110.82 135.59 70.39 112.47 135.16 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 72.18 114.35 144.24 71.25 114.81 141.99 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 75.14 110.89 148.28 73.91 110.46 146.63 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 7 4 # 7 G 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s G 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 G 302 SER C 174 SER^? 11.73 O3S EPE C 377 G 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 56.79 103.91 140.42 58.85 102.76 144.77 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 69.06 110.82 135.59 70.39 112.47 135.16 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 72.18 114.35 144.24 71.25 114.81 141.99 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 75.14 110.89 148.28 73.91 110.46 146.63 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 8 4 # 8 G 192 LYS C 138 LYS^? 8.30 N TRS A 378 G 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s G 302 SER C 174 SER^? 11.73 O3S EPE C 377 G 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 56.79 103.91 140.42 58.85 102.76 144.77 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 69.06 110.82 135.59 70.39 112.47 135.16 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 72.18 114.35 144.24 71.25 114.81 141.99 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 75.14 110.89 148.28 73.91 110.46 146.63 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 9 4 # 9 G 192 LYS C 139 LYS^? 16.11 N TRS A 378 G 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 G 302 SER A 174 SER^? 9.43 O3S EPE C 377 G 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 56.79 103.91 140.42 58.85 102.76 144.77 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 69.06 110.82 135.59 70.39 112.47 135.16 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 72.18 114.35 144.24 71.25 114.81 141.99 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 75.14 110.89 148.28 73.91 110.46 146.63 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 10 4 # 10 G 192 LYS C 139 LYS^? 16.11 N TRS A 378 G 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 G 302 SER B 174 SER^? 9.21 O2S EPE A 377 G 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 56.79 103.91 140.42 58.85 102.76 144.77 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 69.06 110.82 135.59 70.39 112.47 135.16 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 72.18 114.35 144.24 71.25 114.81 141.99 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 75.14 110.89 148.28 73.91 110.46 146.63 6.08 -43.60 3.61 5.68 -45.21 2.31 1o04_c06 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 10 hits 1o04_c06 naa= 4 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 H 192 LYS A 138 LYS^? 13.11 N TRS A 378 H 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 H 302 SER A 174 SER^? 9.43 O3S EPE C 377 H 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 87.99 92.28 120.76 86.42 87.51 120.70 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 74.53 97.35 116.61 73.03 98.14 115.35 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 71.83 89.76 111.02 72.57 92.08 111.26 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 69.74 84.60 113.28 70.77 86.22 114.09 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 H 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s H 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 H 302 SER B 174 SER^? 9.21 O2S EPE A 377 H 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 87.99 92.28 120.76 86.42 87.51 120.70 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 74.53 97.35 116.61 73.03 98.14 115.35 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 71.83 89.76 111.02 72.57 92.08 111.26 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 69.74 84.60 113.28 70.77 86.22 114.09 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 H 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s H 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 H 302 SER B 174 SER^? 9.21 O2S EPE A 377 H 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 87.99 92.28 120.76 86.42 87.51 120.70 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 74.53 97.35 116.61 73.03 98.14 115.35 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 71.83 89.76 111.02 72.57 92.08 111.26 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 69.74 84.60 113.28 70.77 86.22 114.09 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 4 4 # 4 H 192 LYS A 139 LYS^? -2.64 O3S EPE C 377s H 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 H 302 SER C 174 SER^? 11.73 O3S EPE C 377 H 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 87.99 92.28 120.76 86.42 87.51 120.70 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 74.53 97.35 116.61 73.03 98.14 115.35 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 71.83 89.76 111.02 72.57 92.08 111.26 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 69.74 84.60 113.28 70.77 86.22 114.09 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 5 4 # 5 H 192 LYS B 138 LYS^? 15.17 O1S EPE A 377 H 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 H 302 SER B 174 SER^? 9.21 O2S EPE A 377 H 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 87.99 92.28 120.76 86.42 87.51 120.70 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 74.53 97.35 116.61 73.03 98.14 115.35 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 71.83 89.76 111.02 72.57 92.08 111.26 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 69.74 84.60 113.28 70.77 86.22 114.09 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 6 4 # 6 H 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s H 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s H 302 SER A 174 SER^? 9.43 O3S EPE C 377 H 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 87.99 92.28 120.76 86.42 87.51 120.70 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 74.53 97.35 116.61 73.03 98.14 115.35 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 71.83 89.76 111.02 72.57 92.08 111.26 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 69.74 84.60 113.28 70.77 86.22 114.09 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 7 4 # 7 H 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s H 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s H 302 SER C 174 SER^? 11.73 O3S EPE C 377 H 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 87.99 92.28 120.76 86.42 87.51 120.70 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 74.53 97.35 116.61 73.03 98.14 115.35 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 71.83 89.76 111.02 72.57 92.08 111.26 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 69.74 84.60 113.28 70.77 86.22 114.09 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 8 4 # 8 H 192 LYS B 139 LYS^? -2.84 O2S EPE A 377s H 268 GLU C 205 GLU^? 12.89 O3S EPE C 377 H 302 SER C 174 SER^? 11.73 O3S EPE C 377 H 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 87.99 92.28 120.76 86.42 87.51 120.70 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 74.53 97.35 116.61 73.03 98.14 115.35 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 71.83 89.76 111.02 72.57 92.08 111.26 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 69.74 84.60 113.28 70.77 86.22 114.09 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 9 4 # 9 H 192 LYS C 138 LYS^? 8.30 N TRS A 378 H 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s H 302 SER C 174 SER^? 11.73 O3S EPE C 377 H 399 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 87.99 92.28 120.76 86.42 87.51 120.70 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 74.53 97.35 116.61 73.03 98.14 115.35 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 71.83 89.76 111.02 72.57 92.08 111.26 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 69.74 84.60 113.28 70.77 86.22 114.09 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 10 4 # 10 H 192 LYS C 139 LYS^? 16.11 N TRS A 378 H 268 GLU A 205 GLU^? -4.84 O3S EPE C 377s H 302 SER A 174 SER^? 9.43 O3S EPE C 377 H 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 87.99 92.28 120.76 86.42 87.51 120.70 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 74.53 97.35 116.61 73.03 98.14 115.35 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 71.83 89.76 111.02 72.57 92.08 111.26 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 69.74 84.60 113.28 70.77 86.22 114.09 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 11 4 # 11 H 192 LYS C 139 LYS^? 16.11 N TRS A 378 H 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 H 302 SER A 174 SER^? 9.43 O3S EPE C 377 H 399 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 87.99 92.28 120.76 86.42 87.51 120.70 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 74.53 97.35 116.61 73.03 98.14 115.35 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 71.83 89.76 111.02 72.57 92.08 111.26 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 69.74 84.60 113.28 70.77 86.22 114.09 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 12 4 # 12 H 192 LYS C 139 LYS^? 16.11 N TRS A 378 H 268 GLU B 205 GLU^? 4.50 O2S EPE A 377 H 302 SER B 174 SER^? 9.21 O2S EPE A 377 H 399 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 87.99 92.28 120.76 86.42 87.51 120.70 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 74.53 97.35 116.61 73.03 98.14 115.35 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 71.83 89.76 111.02 72.57 92.08 111.26 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 69.74 84.60 113.28 70.77 86.22 114.09 6.08 -43.60 3.61 5.68 -45.21 2.31 1o04_c07 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 12 hits 1o04_c07 naa= 4 ULMN 4 1ohh_c03 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 4 # 1 A 373 ARG A 203 ARG^? 8.58 O3S EPE C 377 E 162 LYS B 139 LYS^? -2.84 O2S EPE A 377s E 188 GLU C 205 GLU^? 12.89 O3S EPE C 377 E 189 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 101.13 34.06 -17.55 103.52 32.17 -17.47 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 99.70 45.17 -13.94 103.86 40.77 -11.97 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 111.54 40.04 -16.26 109.58 40.74 -16.69 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 107.06 33.49 -18.08 106.01 34.28 -15.30 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 4 1ohh_c03 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 4 # 2 A 373 ARG B 203 ARG^? 8.69 O2S EPE A 377 E 162 LYS C 139 LYS^? 16.11 N TRS A 378 E 188 GLU A 205 GLU^? -4.84 O3S EPE C 377s E 189 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 101.13 34.06 -17.55 103.52 32.17 -17.47 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 99.70 45.17 -13.94 103.86 40.77 -11.97 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 111.54 40.04 -16.26 109.58 40.74 -16.69 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 107.06 33.49 -18.08 106.01 34.28 -15.30 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 4 1ohh_c03 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 4 # 3 A 373 ARG C 203 ARG^? 8.27 O3S EPE C 377 E 162 LYS A 139 LYS^? -2.64 O3S EPE C 377s E 188 GLU B 205 GLU^? 4.50 O2S EPE A 377 E 189 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 101.13 34.06 -17.55 103.52 32.17 -17.47 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 99.70 45.17 -13.94 103.86 40.77 -11.97 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 111.54 40.04 -16.26 109.58 40.74 -16.69 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 107.06 33.49 -18.08 106.01 34.28 -15.30 8.58 -36.69 10.51 9.21 -33.68 10.79 1ohh_c03 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 3 hits 1ohh_c03 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL A 108 VAL~? 9.21 ZN ZN A 375 A 194 GLY A 111 GLY.? 12.81 ZN ZN A 375 A 417 ILE B 164 ILE.? -5.50 O1S EPE A 377s A 457 ALA A 230 ALA.? 3.77 C3 EPE A 377 coo 60.43 93.31 8.03 62.16 94.30 8.93 34.04 -9.04 23.95 31.94 -9.50 24.38 coo 59.34 89.99 13.88 59.24 89.18 13.73 40.78 -9.44 18.50 40.17 -9.34 19.07 coo 39.61 128.90 22.54 40.04 128.24 23.80 1.33 -22.12 1.59 2.61 -22.59 2.06 coo 43.27 124.32 20.47 43.79 125.29 21.53 7.28 -23.47 0.64 6.30 -24.70 0.61 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL A 108 VAL~? 9.21 ZN ZN A 375 A 194 GLY A 112 GLY~? 9.06 ZN ZN A 375 A 417 ILE B 328 ILE^? 16.79 ZN ZN B 374 A 457 ALA B 321 ALA~? 19.77 ZN ZN B 374 coo 60.43 93.31 8.03 62.16 94.30 8.93 34.04 -9.04 23.95 31.94 -9.50 24.38 coo 59.34 89.99 13.88 59.24 89.18 13.73 39.28 -7.29 21.25 39.96 -7.72 21.33 coo 39.61 128.90 22.54 40.04 128.24 23.80 0.93 17.58 15.13 1.21 16.93 16.38 coo 43.27 124.32 20.47 43.79 125.29 21.53 7.50 17.37 16.99 6.00 17.39 16.91 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 151 VAL A 108 VAL~? 9.21 ZN ZN A 375 A 194 GLY A 244 GLY^? 11.92 ZN ZN A 375 A 417 ILE B 29 ILE.? 11.17 ZN ZN B 375 A 457 ALA B 23 ALA~? 10.82 ZN ZN B 375 coo 60.43 93.31 8.03 62.16 94.30 8.93 34.04 -9.04 23.95 31.94 -9.50 24.38 coo 59.34 89.99 13.88 59.24 89.18 13.73 32.51 -13.15 26.46 33.13 -12.90 26.03 coo 39.61 128.90 22.54 40.04 128.24 23.80 -10.13 -4.74 28.72 -9.18 -5.11 27.79 coo 43.27 124.32 20.47 43.79 125.29 21.53 -4.97 -5.23 25.00 -5.92 -5.35 26.16 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 151 VAL A 128 VAL^? 14.60 O3 TRS A 378 A 194 GLY A 244 GLY^? 11.92 ZN ZN A 375 A 417 ILE C 45 ILE^? 13.35 ZN ZN C 375 A 457 ALA C 67 ALA^? 10.56 ZN ZN C 374 coo 60.43 93.31 8.03 62.16 94.30 8.93 36.57 -17.31 27.04 34.80 -16.49 26.01 coo 59.34 89.99 13.88 59.24 89.18 13.73 32.51 -13.15 26.46 33.13 -12.90 26.03 coo 39.61 128.90 22.54 40.04 128.24 23.80 13.89 -37.39 57.06 14.44 -37.19 55.73 coo 43.27 124.32 20.47 43.79 125.29 21.53 14.85 -30.74 56.60 15.29 -29.68 57.59 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 151 VAL A 128 VAL^? 14.60 O3 TRS A 378 A 194 GLY A 246 GLY^? 9.76 ZN ZN A 375 A 417 ILE C 45 ILE^? 13.35 ZN ZN C 375 A 457 ALA C 67 ALA^? 10.56 ZN ZN C 374 coo 60.43 93.31 8.03 62.16 94.30 8.93 36.57 -17.31 27.04 34.80 -16.49 26.01 coo 59.34 89.99 13.88 59.24 89.18 13.73 38.31 -12.10 29.42 37.83 -12.45 28.86 coo 39.61 128.90 22.54 40.04 128.24 23.80 13.89 -37.39 57.06 14.44 -37.19 55.73 coo 43.27 124.32 20.47 43.79 125.29 21.53 14.85 -30.74 56.60 15.29 -29.68 57.59 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 A 151 VAL A 216 VAL~? 11.74 O1S EPE C 377 A 194 GLY A 157 GLY~? 9.65 O1S EPE C 377 A 417 ILE A 297 ILE~? 17.21 ZN ZN A 374 A 457 ALA A 300 ALA~? 16.31 ZN ZN A 375 coo 60.43 93.31 8.03 62.16 94.30 8.93 20.56 -17.95 2.37 21.08 -19.60 3.74 coo 59.34 89.99 13.88 59.24 89.18 13.73 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 39.61 128.90 22.54 40.04 128.24 23.80 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 43.27 124.32 20.47 43.79 125.29 21.53 38.46 -17.14 37.26 39.29 -15.90 37.59 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 A 151 VAL A 275 VAL^? 20.43 ZN ZN A 374 A 194 GLY A 258 GLY~? 25.62 ZN ZN A 374 A 417 ILE C 65 ILE^? 15.89 C3 EPE C 376 A 457 ALA C 98 ALA^? 19.12 C3 EPE C 376 coo 60.43 93.31 8.03 62.16 94.30 8.93 50.08 -8.59 43.71 51.74 -9.86 43.03 coo 59.34 89.99 13.88 59.24 89.18 13.73 56.88 -13.16 41.55 56.67 -13.61 40.87 coo 39.61 128.90 22.54 40.04 128.24 23.80 19.44 -32.66 59.78 18.89 -32.45 61.13 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.29 -30.67 58.07 25.77 -31.44 56.87 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 A 151 VAL A 288 VAL^? 11.42 ZN ZN A 375 A 194 GLY A 290 GLY^? 5.60 ZN ZN A 375 A 417 ILE C 65 ILE^? 15.89 C3 EPE C 376 A 457 ALA C 98 ALA^? 19.12 C3 EPE C 376 coo 60.43 93.31 8.03 62.16 94.30 8.93 43.05 -11.94 32.21 44.10 -11.19 30.38 coo 59.34 89.99 13.88 59.24 89.18 13.73 41.03 -5.77 31.09 40.29 -6.09 31.40 coo 39.61 128.90 22.54 40.04 128.24 23.80 19.44 -32.66 59.78 18.89 -32.45 61.13 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.29 -30.67 58.07 25.77 -31.44 56.87 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 9 4 # 9 A 151 VAL A 309 VAL^? 13.46 ZN ZN A 375 A 194 GLY A 290 GLY^? 5.60 ZN ZN A 375 A 417 ILE C 65 ILE^? 15.89 C3 EPE C 376 A 457 ALA C 98 ALA^? 19.12 C3 EPE C 376 coo 60.43 93.31 8.03 62.16 94.30 8.93 45.28 -10.30 35.78 47.06 -9.94 34.57 coo 59.34 89.99 13.88 59.24 89.18 13.73 41.03 -5.77 31.09 40.29 -6.09 31.40 coo 39.61 128.90 22.54 40.04 128.24 23.80 19.44 -32.66 59.78 18.89 -32.45 61.13 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.29 -30.67 58.07 25.77 -31.44 56.87 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 10 4 # 10 A 151 VAL A 309 VAL^? 13.46 ZN ZN A 375 A 194 GLY A 311 GLY^? 8.82 ZN ZN A 374 A 417 ILE C 65 ILE^? 15.89 C3 EPE C 376 A 457 ALA C 98 ALA^? 19.12 C3 EPE C 376 coo 60.43 93.31 8.03 62.16 94.30 8.93 45.28 -10.30 35.78 47.06 -9.94 34.57 coo 59.34 89.99 13.88 59.24 89.18 13.73 42.54 -3.74 37.15 41.89 -4.18 37.32 coo 39.61 128.90 22.54 40.04 128.24 23.80 19.44 -32.66 59.78 18.89 -32.45 61.13 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.29 -30.67 58.07 25.77 -31.44 56.87 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 11 4 # 11 A 151 VAL A 329 VAL^? 17.09 ZN ZN A 374 A 194 GLY A 311 GLY^? 8.82 ZN ZN A 374 A 417 ILE C 65 ILE^? 15.89 C3 EPE C 376 A 457 ALA C 98 ALA^? 19.12 C3 EPE C 376 coo 60.43 93.31 8.03 62.16 94.30 8.93 48.33 -9.29 39.53 50.17 -9.83 38.53 coo 59.34 89.99 13.88 59.24 89.18 13.73 42.54 -3.74 37.15 41.89 -4.18 37.32 coo 39.61 128.90 22.54 40.04 128.24 23.80 19.44 -32.66 59.78 18.89 -32.45 61.13 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.29 -30.67 58.07 25.77 -31.44 56.87 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 12 4 # 12 A 151 VAL A 329 VAL^? 17.09 ZN ZN A 374 A 194 GLY A 311 GLY^? 8.82 ZN ZN A 374 A 417 ILE C 66 ILE^? 13.44 ZN ZN C 375 A 457 ALA C 101 ALA^? 11.01 ZN ZN C 375 coo 60.43 93.31 8.03 62.16 94.30 8.93 48.33 -9.29 39.53 50.17 -9.83 38.53 coo 59.34 89.99 13.88 59.24 89.18 13.73 42.54 -3.74 37.15 41.89 -4.18 37.32 coo 39.61 128.90 22.54 40.04 128.24 23.80 17.25 -34.28 54.52 17.36 -34.75 53.15 coo 43.27 124.32 20.47 43.79 125.29 21.53 17.04 -27.71 53.14 16.81 -26.24 53.31 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 13 4 # 13 A 151 VAL A 343 VAL~? 12.11 ZN ZN A 375 A 194 GLY A 112 GLY~? 9.06 ZN ZN A 375 A 417 ILE B 328 ILE^? 16.79 ZN ZN B 374 A 457 ALA B 321 ALA~? 19.77 ZN ZN B 374 coo 60.43 93.31 8.03 62.16 94.30 8.93 41.83 -1.38 16.72 39.88 -0.62 17.58 coo 59.34 89.99 13.88 59.24 89.18 13.73 39.28 -7.29 21.25 39.96 -7.72 21.33 coo 39.61 128.90 22.54 40.04 128.24 23.80 0.93 17.58 15.13 1.21 16.93 16.38 coo 43.27 124.32 20.47 43.79 125.29 21.53 7.50 17.37 16.99 6.00 17.39 16.91 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 14 4 # 14 A 151 VAL B 108 VAL~? 9.11 ZN ZN B 375 A 194 GLY B 112 GLY~? 9.09 ZN ZN B 375 A 417 ILE C 328 ILE^? 16.72 ZN ZN C 374 A 457 ALA C 321 ALA~? 19.69 ZN ZN C 374 coo 60.43 93.31 8.03 62.16 94.30 8.93 -5.25 -2.64 18.06 -3.55 -3.49 19.20 coo 59.34 89.99 13.88 59.24 89.18 13.73 -10.98 -0.97 15.01 -10.85 -0.63 14.30 coo 39.61 128.90 22.54 40.04 128.24 23.80 -11.34 -23.92 55.01 -10.20 -23.15 54.29 coo 43.27 124.32 20.47 43.79 125.29 21.53 -13.40 -18.49 51.25 -12.60 -19.47 52.03 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 15 4 # 15 A 151 VAL B 108 VAL~? 9.11 ZN ZN B 375 A 194 GLY B 244 GLY^? 11.85 ZN ZN B 375 A 417 ILE C 29 ILE.? 10.95 ZN ZN C 375 A 457 ALA C 23 ALA~? 11.04 ZN ZN C 375 coo 60.43 93.31 8.03 62.16 94.30 8.93 -5.25 -2.64 18.06 -3.55 -3.49 19.20 coo 59.34 89.99 13.88 59.24 89.18 13.73 -0.61 -2.61 16.62 -1.32 -2.49 16.19 coo 39.61 128.90 22.54 40.04 128.24 23.80 16.25 -25.50 48.78 15.31 -25.73 47.74 coo 43.27 124.32 20.47 43.79 125.29 21.53 11.77 -25.07 43.97 13.11 -24.84 44.66 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 16 4 # 16 A 151 VAL B 108 VAL~? 9.11 ZN ZN B 375 A 194 GLY B 244 GLY^? 11.85 ZN ZN B 375 A 417 ILE C 328 ILE^? 16.72 ZN ZN C 374 A 457 ALA C 321 ALA~? 19.69 ZN ZN C 374 coo 60.43 93.31 8.03 62.16 94.30 8.93 -5.25 -2.64 18.06 -3.55 -3.49 19.20 coo 59.34 89.99 13.88 59.24 89.18 13.73 -0.61 -2.61 16.62 -1.32 -2.49 16.19 coo 39.61 128.90 22.54 40.04 128.24 23.80 -11.34 -23.92 55.01 -10.20 -23.15 54.29 coo 43.27 124.32 20.47 43.79 125.29 21.53 -13.40 -18.49 51.25 -12.60 -19.47 52.03 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 17 4 # 17 A 151 VAL B 128 VAL^? 14.57 ZN ZN B 375 A 194 GLY B 244 GLY^? 11.85 ZN ZN B 375 A 417 ILE A 45 ILE^? 13.26 ZN ZN A 375 A 457 ALA A 67 ALA^? 10.32 ZN ZN A 374 coo 60.43 93.31 8.03 62.16 94.30 8.93 0.39 -0.46 11.26 0.17 -2.24 12.58 coo 59.34 89.99 13.88 59.24 89.18 13.73 -0.61 -2.61 16.62 -1.32 -2.49 16.19 coo 39.61 128.90 22.54 40.04 128.24 23.80 42.02 4.24 17.97 40.78 3.59 17.51 coo 43.27 124.32 20.47 43.79 125.29 21.53 37.22 5.65 22.28 37.04 6.85 23.17 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 18 4 # 18 A 151 VAL B 128 VAL^? 14.57 ZN ZN B 375 A 194 GLY B 246 GLY^? 9.61 ZN ZN B 375 A 417 ILE A 45 ILE^? 13.26 ZN ZN A 375 A 457 ALA A 67 ALA^? 10.32 ZN ZN A 374 coo 60.43 93.31 8.03 62.16 94.30 8.93 0.39 -0.46 11.26 0.17 -2.24 12.58 coo 59.34 89.99 13.88 59.24 89.18 13.73 -2.31 3.58 14.78 -2.28 2.80 14.58 coo 39.61 128.90 22.54 40.04 128.24 23.80 42.02 4.24 17.97 40.78 3.59 17.51 coo 43.27 124.32 20.47 43.79 125.29 21.53 37.22 5.65 22.28 37.04 6.85 23.17 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 19 4 # 19 A 151 VAL B 152 VAL~? 13.46 O3S EPE A 377 A 194 GLY B 157 GLY~? 9.55 O3S EPE A 377 A 417 ILE C 297 ILE~? 17.14 ZN ZN C 374 A 457 ALA C 300 ALA~? 16.47 ZN ZN C 375 coo 60.43 93.31 8.03 62.16 94.30 8.93 -5.73 -37.45 8.95 -4.57 -37.92 10.75 coo 59.34 89.99 13.88 59.24 89.18 13.73 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo 39.61 128.90 22.54 40.04 128.24 23.80 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 43.27 124.32 20.47 43.79 125.29 21.53 -9.24 -24.63 44.86 -9.08 -24.63 46.37 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 20 4 # 20 A 151 VAL B 199 VAL^? 22.32 O2S EPE A 377 A 194 GLY B 176 GLY^? 16.19 O2S EPE A 377 A 417 ILE C 29 ILE.? 10.95 ZN ZN C 375 A 457 ALA C 23 ALA~? 11.04 ZN ZN C 375 coo 60.43 93.31 8.03 62.16 94.30 8.93 5.46 -49.70 13.69 3.81 -48.69 14.79 coo 59.34 89.99 13.88 59.24 89.18 13.73 9.40 -43.99 8.52 8.65 -44.36 8.52 coo 39.61 128.90 22.54 40.04 128.24 23.80 16.25 -25.50 48.78 15.31 -25.73 47.74 coo 43.27 124.32 20.47 43.79 125.29 21.53 11.77 -25.07 43.97 13.11 -24.84 44.66 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 21 4 # 21 A 151 VAL B 216 VAL~? 12.75 O3S EPE A 377 A 194 GLY B 160 GLY.? 11.45 O3S EPE A 377 A 417 ILE B 58 ILE~? 20.36 C2 EPE B 376 A 457 ALA B 62 ALA.? 21.54 ZN ZN B 374 coo 60.43 93.31 8.03 62.16 94.30 8.93 -6.83 -28.22 14.05 -5.28 -27.59 12.58 coo 59.34 89.99 13.88 59.24 89.18 13.73 -7.67 -24.84 7.30 -7.31 -25.39 7.61 coo 39.61 128.90 22.54 40.04 128.24 23.80 -31.90 4.20 31.89 -32.05 4.42 33.42 coo 43.27 124.32 20.47 43.79 125.29 21.53 -30.17 -1.37 27.22 -29.17 -0.49 26.46 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 22 4 # 22 A 151 VAL B 275 VAL^? 20.37 ZN ZN B 374 A 194 GLY B 258 GLY~? 25.40 ZN ZN B 374 A 417 ILE A 65 ILE^? 15.75 ZN ZN A 374 A 457 ALA A 98 ALA^? 19.17 C3 EPE A 376 coo 60.43 93.31 8.03 62.16 94.30 8.93 -2.07 22.44 14.13 -2.67 22.68 12.03 coo 59.34 89.99 13.88 59.24 89.18 13.73 -3.80 23.92 6.13 -3.78 23.26 5.65 coo 39.61 128.90 22.54 40.04 128.24 23.80 37.88 10.64 19.11 38.92 11.23 20.01 coo 43.27 124.32 20.47 43.79 125.29 21.53 32.69 13.47 16.67 32.07 12.82 15.47 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 23 4 # 23 A 151 VAL B 329 VAL^? 17.03 ZN ZN B 374 A 194 GLY B 311 GLY^? 8.79 ZN ZN B 374 A 417 ILE A 65 ILE^? 15.75 ZN ZN A 374 A 457 ALA A 98 ALA^? 19.17 C3 EPE A 376 coo 60.43 93.31 8.03 62.16 94.30 8.93 -3.22 18.08 13.56 -4.48 18.53 11.85 coo 59.34 89.99 13.88 59.24 89.18 13.73 -5.28 13.83 20.42 -4.55 13.48 20.52 coo 39.61 128.90 22.54 40.04 128.24 23.80 37.88 10.64 19.11 38.92 11.23 20.01 coo 43.27 124.32 20.47 43.79 125.29 21.53 32.69 13.47 16.67 32.07 12.82 15.47 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 24 4 # 24 A 151 VAL B 329 VAL^? 17.03 ZN ZN B 374 A 194 GLY B 311 GLY^? 8.79 ZN ZN B 374 A 417 ILE A 66 ILE^? 13.44 ZN ZN A 375 A 457 ALA A 101 ALA^? 11.28 ZN ZN A 375 coo 60.43 93.31 8.03 62.16 94.30 8.93 -3.22 18.08 13.56 -4.48 18.53 11.85 coo 59.34 89.99 13.88 59.24 89.18 13.73 -5.28 13.83 20.42 -4.55 13.48 20.52 coo 39.61 128.90 22.54 40.04 128.24 23.80 36.87 5.10 17.60 36.37 4.05 16.75 coo 43.27 124.32 20.47 43.79 125.29 21.53 32.09 5.17 22.05 31.25 5.48 23.29 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 25 4 # 25 A 151 VAL B 343 VAL~? 12.08 ZN ZN B 375 A 194 GLY B 112 GLY~? 9.09 ZN ZN B 375 A 417 ILE C 328 ILE^? 16.72 ZN ZN C 374 A 457 ALA C 321 ALA~? 19.69 ZN ZN C 374 coo 60.43 93.31 8.03 62.16 94.30 8.93 -18.57 -1.46 16.53 -17.55 -1.89 18.48 coo 59.34 89.99 13.88 59.24 89.18 13.73 -10.98 -0.97 15.01 -10.85 -0.63 14.30 coo 39.61 128.90 22.54 40.04 128.24 23.80 -11.34 -23.92 55.01 -10.20 -23.15 54.29 coo 43.27 124.32 20.47 43.79 125.29 21.53 -13.40 -18.49 51.25 -12.60 -19.47 52.03 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 26 4 # 26 A 151 VAL C 106 VAL~? 6.93 ZN ZN C 375 A 194 GLY C 111 GLY.? 12.85 ZN ZN C 375 A 417 ILE A 164 ILE.? 7.03 O2S EPE C 377 A 457 ALA C 230 ALA.? -3.51 C2 EPE C 377s coo 60.43 93.31 8.03 62.16 94.30 8.93 9.38 -31.44 48.18 10.35 -32.52 49.88 coo 59.34 89.99 13.88 59.24 89.18 13.73 5.64 -38.51 45.88 5.60 -37.66 45.90 coo 39.61 128.90 22.54 40.04 128.24 23.80 28.39 -27.14 11.25 27.87 -26.31 12.41 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.50 -33.74 13.85 25.41 -33.57 12.34 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 27 4 # 27 A 151 VAL C 106 VAL~? 6.93 ZN ZN C 375 A 194 GLY C 112 GLY~? 9.08 ZN ZN C 375 A 417 ILE A 164 ILE.? 7.03 O2S EPE C 377 A 457 ALA C 230 ALA.? -3.51 C2 EPE C 377s coo 60.43 93.31 8.03 62.16 94.30 8.93 9.38 -31.44 48.18 10.35 -32.52 49.88 coo 59.34 89.99 13.88 59.24 89.18 13.73 6.12 -35.35 47.97 5.41 -35.71 47.93 coo 39.61 128.90 22.54 40.04 128.24 23.80 28.39 -27.14 11.25 27.87 -26.31 12.41 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.50 -33.74 13.85 25.41 -33.57 12.34 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 28 4 # 28 A 151 VAL C 128 VAL^? 14.35 ZN ZN C 375 A 194 GLY C 244 GLY^? 11.70 ZN ZN C 375 A 417 ILE B 45 ILE^? 13.38 ZN ZN B 375 A 457 ALA B 67 ALA^? 10.44 ZN ZN B 374 coo 60.43 93.31 8.03 62.16 94.30 8.93 -2.00 -30.83 40.65 0.02 -30.12 40.01 coo 59.34 89.99 13.88 59.24 89.18 13.73 2.79 -27.67 41.30 2.83 -28.37 41.63 coo 39.61 128.90 22.54 40.04 128.24 23.80 -21.63 0.89 20.85 -20.94 -0.39 20.98 coo 43.27 124.32 20.47 43.79 125.29 21.53 -17.51 1.20 26.23 -17.65 1.96 27.53 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 29 4 # 29 A 151 VAL C 128 VAL^? 14.35 ZN ZN C 375 A 194 GLY C 246 GLY^? 9.60 ZN ZN C 375 A 417 ILE B 45 ILE^? 13.38 ZN ZN B 375 A 457 ALA B 67 ALA^? 10.44 ZN ZN B 374 coo 60.43 93.31 8.03 62.16 94.30 8.93 -2.00 -30.83 40.65 0.02 -30.12 40.01 coo 59.34 89.99 13.88 59.24 89.18 13.73 -1.22 -29.27 46.37 -0.90 -29.41 45.67 coo 39.61 128.90 22.54 40.04 128.24 23.80 -21.63 0.89 20.85 -20.94 -0.39 20.98 coo 43.27 124.32 20.47 43.79 125.29 21.53 -17.51 1.20 26.23 -17.65 1.96 27.53 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 30 4 # 30 A 151 VAL C 275 VAL^? 20.28 ZN ZN C 374 A 194 GLY C 258 GLY~? 25.44 ZN ZN C 374 A 417 ILE B 65 ILE^? 15.80 ZN ZN B 374 A 457 ALA B 98 ALA^? 18.79 C3 EPE B 376 coo 60.43 93.31 8.03 62.16 94.30 8.93 -13.34 -25.57 60.06 -14.48 -27.44 59.88 coo 59.34 89.99 13.88 59.24 89.18 13.73 -18.33 -32.18 59.97 -18.10 -32.63 59.35 coo 39.61 128.90 22.54 40.04 128.24 23.80 -22.91 0.41 28.48 -23.27 1.78 28.71 coo 43.27 124.32 20.47 43.79 125.29 21.53 -23.64 -3.90 33.07 -23.65 -5.30 32.62 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 31 4 # 31 A 151 VAL C 329 VAL^? 17.04 ZN ZN C 374 A 194 GLY C 311 GLY^? 8.68 ZN ZN C 374 A 417 ILE B 65 ILE^? 15.80 ZN ZN B 374 A 457 ALA B 98 ALA^? 18.79 C3 EPE B 376 coo 60.43 93.31 8.03 62.16 94.30 8.93 -10.48 -27.66 57.23 -11.17 -29.63 57.69 coo 59.34 89.99 13.88 59.24 89.18 13.73 -2.62 -24.75 57.19 -2.77 -24.31 56.55 coo 39.61 128.90 22.54 40.04 128.24 23.80 -22.91 0.41 28.48 -23.27 1.78 28.71 coo 43.27 124.32 20.47 43.79 125.29 21.53 -23.64 -3.90 33.07 -23.65 -5.30 32.62 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 32 4 # 32 A 151 VAL C 329 VAL^? 17.04 ZN ZN C 374 A 194 GLY C 311 GLY^? 8.68 ZN ZN C 374 A 417 ILE B 66 ILE^? 13.53 ZN ZN B 375 A 457 ALA B 101 ALA^? 11.06 ZN ZN B 375 coo 60.43 93.31 8.03 62.16 94.30 8.93 -10.48 -27.66 57.23 -11.17 -29.63 57.69 coo 59.34 89.99 13.88 59.24 89.18 13.73 -2.62 -24.75 57.19 -2.77 -24.31 56.55 coo 39.61 128.90 22.54 40.04 128.24 23.80 -19.81 -2.59 24.51 -19.43 -3.87 23.81 coo 43.27 124.32 20.47 43.79 125.29 21.53 -14.73 -2.17 28.75 -13.66 -1.71 29.80 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 33 4 # 33 A 151 VAL C 343 VAL~? 12.12 ZN ZN C 375 A 194 GLY C 111 GLY.? 12.85 ZN ZN C 375 A 417 ILE A 248 ILE^? 17.37 ZN ZN A 375 A 457 ALA A 300 ALA~? 16.31 ZN ZN A 375 coo 60.43 93.31 8.03 62.16 94.30 8.93 11.23 -39.18 52.40 12.11 -37.19 52.15 coo 59.34 89.99 13.88 59.24 89.18 13.73 5.64 -38.51 45.88 5.60 -37.66 45.90 coo 39.61 128.90 22.54 40.04 128.24 23.80 40.92 -18.65 31.37 40.47 -19.69 32.14 coo 43.27 124.32 20.47 43.79 125.29 21.53 38.46 -17.14 37.26 39.29 -15.90 37.59 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 33 hits 1pix_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL A 113 VAL~? 5.55 ZN ZN A 375 B 194 GLY A 111 GLY.? 12.81 ZN ZN A 375 B 417 ILE B 248 ILE^? 17.17 ZN ZN B 375 B 457 ALA B 130 ALA^? 12.75 ZN ZN B 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 40.86 -5.95 24.42 40.35 -4.20 25.70 coo 50.40 126.23 20.48 50.46 127.00 20.75 40.78 -9.44 18.50 40.17 -9.34 19.07 coo 68.38 85.45 19.33 67.41 85.52 20.41 1.53 5.19 8.85 2.92 5.26 8.57 coo 65.50 91.13 17.77 64.65 89.88 18.00 3.26 0.96 16.13 3.04 1.82 17.39 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 B 151 VAL A 113 VAL~? 5.55 ZN ZN A 375 B 194 GLY A 111 GLY.? 12.81 ZN ZN A 375 B 417 ILE B 248 ILE^? 17.17 ZN ZN B 375 B 457 ALA B 300 ALA~? 16.49 ZN ZN B 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 40.86 -5.95 24.42 40.35 -4.20 25.70 coo 50.40 126.23 20.48 50.46 127.00 20.75 40.78 -9.44 18.50 40.17 -9.34 19.07 coo 68.38 85.45 19.33 67.41 85.52 20.41 1.53 5.19 8.85 2.92 5.26 8.57 coo 65.50 91.13 17.77 64.65 89.88 18.00 5.39 8.45 13.10 4.54 9.60 13.56 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 B 151 VAL A 113 VAL~? 5.55 ZN ZN A 375 B 194 GLY A 246 GLY^? 9.76 ZN ZN A 375 B 417 ILE B 248 ILE^? 17.17 ZN ZN B 375 B 457 ALA B 130 ALA^? 12.75 ZN ZN B 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 40.86 -5.95 24.42 40.35 -4.20 25.70 coo 50.40 126.23 20.48 50.46 127.00 20.75 38.31 -12.10 29.42 37.83 -12.45 28.86 coo 68.38 85.45 19.33 67.41 85.52 20.41 1.53 5.19 8.85 2.92 5.26 8.57 coo 65.50 91.13 17.77 64.65 89.88 18.00 3.26 0.96 16.13 3.04 1.82 17.39 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 B 151 VAL A 113 VAL~? 5.55 ZN ZN A 375 B 194 GLY A 291 GLY^? 4.06 ZN ZN A 374 B 417 ILE B 248 ILE^? 17.17 ZN ZN B 375 B 457 ALA B 130 ALA^? 12.75 ZN ZN B 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 40.86 -5.95 24.42 40.35 -4.20 25.70 coo 50.40 126.23 20.48 50.46 127.00 20.75 39.29 -3.03 33.06 39.67 -3.69 33.42 coo 68.38 85.45 19.33 67.41 85.52 20.41 1.53 5.19 8.85 2.92 5.26 8.57 coo 65.50 91.13 17.77 64.65 89.88 18.00 3.26 0.96 16.13 3.04 1.82 17.39 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 B 151 VAL A 128 VAL^? 14.60 O3 TRS A 378 B 194 GLY A 244 GLY^? 11.92 ZN ZN A 375 B 417 ILE C 45 ILE^? 13.35 ZN ZN C 375 B 457 ALA C 67 ALA^? 10.56 ZN ZN C 374 coo 52.95 126.71 13.21 51.34 125.24 13.19 36.57 -17.31 27.04 34.80 -16.49 26.01 coo 50.40 126.23 20.48 50.46 127.00 20.75 32.51 -13.15 26.46 33.13 -12.90 26.03 coo 68.38 85.45 19.33 67.41 85.52 20.41 13.89 -37.39 57.06 14.44 -37.19 55.73 coo 65.50 91.13 17.77 64.65 89.88 18.00 14.85 -30.74 56.60 15.29 -29.68 57.59 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 B 151 VAL A 128 VAL^? 14.60 O3 TRS A 378 B 194 GLY A 246 GLY^? 9.76 ZN ZN A 375 B 417 ILE B 248 ILE^? 17.17 ZN ZN B 375 B 457 ALA B 130 ALA^? 12.75 ZN ZN B 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 36.57 -17.31 27.04 34.80 -16.49 26.01 coo 50.40 126.23 20.48 50.46 127.00 20.75 38.31 -12.10 29.42 37.83 -12.45 28.86 coo 68.38 85.45 19.33 67.41 85.52 20.41 1.53 5.19 8.85 2.92 5.26 8.57 coo 65.50 91.13 17.77 64.65 89.88 18.00 3.26 0.96 16.13 3.04 1.82 17.39 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 B 151 VAL A 216 VAL~? 11.74 O1S EPE C 377 B 194 GLY A 157 GLY~? 9.65 O1S EPE C 377 B 417 ILE A 297 ILE~? 17.21 ZN ZN A 374 B 457 ALA A 300 ALA~? 16.31 ZN ZN A 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 20.56 -17.95 2.37 21.08 -19.60 3.74 coo 50.40 126.23 20.48 50.46 127.00 20.75 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 68.38 85.45 19.33 67.41 85.52 20.41 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 65.50 91.13 17.77 64.65 89.88 18.00 38.46 -17.14 37.26 39.29 -15.90 37.59 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 B 151 VAL A 216 VAL~? 11.74 O1S EPE C 377 B 194 GLY A 160 GLY.? 10.75 O1S EPE C 377 B 417 ILE A 58 ILE~? 20.76 O2S EPE A 376 B 457 ALA A 62 ALA.? 21.75 ZN ZN A 374 coo 52.95 126.71 13.21 51.34 125.24 13.19 20.56 -17.95 2.37 21.08 -19.60 3.74 coo 50.40 126.23 20.48 50.46 127.00 20.75 26.87 -20.51 3.59 26.23 -20.86 3.40 coo 68.38 85.45 19.33 67.41 85.52 20.41 42.70 19.78 17.31 42.05 20.88 17.88 coo 65.50 91.13 17.77 64.65 89.88 18.00 41.03 13.97 12.85 41.56 12.98 13.85 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 9 4 # 9 B 151 VAL A 307 VAL^? 19.34 ZN ZN A 375 B 194 GLY A 277 GLY.? 24.28 ZN ZN A 374 B 417 ILE C 45 ILE^? 13.35 ZN ZN C 375 B 457 ALA C 67 ALA^? 10.56 ZN ZN C 374 coo 52.95 126.71 13.21 51.34 125.24 13.19 46.44 -16.28 38.69 48.29 -15.22 38.04 coo 50.40 126.23 20.48 50.46 127.00 20.75 49.23 -14.07 46.91 49.73 -13.44 47.06 coo 68.38 85.45 19.33 67.41 85.52 20.41 13.89 -37.39 57.06 14.44 -37.19 55.73 coo 65.50 91.13 17.77 64.65 89.88 18.00 14.85 -30.74 56.60 15.29 -29.68 57.59 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 10 4 # 10 B 151 VAL A 329 VAL^? 17.09 ZN ZN A 374 B 194 GLY A 311 GLY^? 8.82 ZN ZN A 374 B 417 ILE C 66 ILE^? 13.44 ZN ZN C 375 B 457 ALA C 101 ALA^? 11.01 ZN ZN C 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 48.33 -9.29 39.53 50.17 -9.83 38.53 coo 50.40 126.23 20.48 50.46 127.00 20.75 42.54 -3.74 37.15 41.89 -4.18 37.32 coo 68.38 85.45 19.33 67.41 85.52 20.41 17.25 -34.28 54.52 17.36 -34.75 53.15 coo 65.50 91.13 17.77 64.65 89.88 18.00 17.04 -27.71 53.14 16.81 -26.24 53.31 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 11 4 # 11 B 151 VAL B 113 VAL~? 5.59 ZN ZN B 375 B 194 GLY B 246 GLY^? 9.61 ZN ZN B 375 B 417 ILE C 248 ILE^? 17.32 ZN ZN C 375 B 457 ALA C 130 ALA^? 12.95 ZN ZN C 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 -10.54 2.71 15.93 -10.40 3.87 17.78 coo 50.40 126.23 20.48 50.46 127.00 20.75 -2.31 3.58 14.78 -2.28 2.80 14.58 coo 68.38 85.45 19.33 67.41 85.52 20.41 -7.82 -30.82 43.49 -8.77 -30.10 42.68 coo 65.50 91.13 17.77 64.65 89.88 18.00 -1.84 -25.01 41.51 -1.61 -23.99 42.63 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 12 4 # 12 B 151 VAL B 113 VAL~? 5.59 ZN ZN B 375 B 194 GLY B 291 GLY^? 4.09 ZN ZN B 374 B 417 ILE C 248 ILE^? 17.32 ZN ZN C 375 B 457 ALA C 130 ALA^? 12.95 ZN ZN C 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 -10.54 2.71 15.93 -10.40 3.87 17.78 coo 50.40 126.23 20.48 50.46 127.00 20.75 -6.52 8.91 21.71 -6.06 9.31 21.13 coo 68.38 85.45 19.33 67.41 85.52 20.41 -7.82 -30.82 43.49 -8.77 -30.10 42.68 coo 65.50 91.13 17.77 64.65 89.88 18.00 -1.84 -25.01 41.51 -1.61 -23.99 42.63 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 13 4 # 13 B 151 VAL B 128 VAL^? 14.57 ZN ZN B 375 B 194 GLY B 246 GLY^? 9.61 ZN ZN B 375 B 417 ILE C 248 ILE^? 17.32 ZN ZN C 375 B 457 ALA C 130 ALA^? 12.95 ZN ZN C 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 0.39 -0.46 11.26 0.17 -2.24 12.58 coo 50.40 126.23 20.48 50.46 127.00 20.75 -2.31 3.58 14.78 -2.28 2.80 14.58 coo 68.38 85.45 19.33 67.41 85.52 20.41 -7.82 -30.82 43.49 -8.77 -30.10 42.68 coo 65.50 91.13 17.77 64.65 89.88 18.00 -1.84 -25.01 41.51 -1.61 -23.99 42.63 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 14 4 # 14 B 151 VAL B 152 VAL~? 13.46 O3S EPE A 377 B 194 GLY B 157 GLY~? 9.55 O3S EPE A 377 B 417 ILE C 297 ILE~? 17.14 ZN ZN C 374 B 457 ALA C 300 ALA~? 16.47 ZN ZN C 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 -5.73 -37.45 8.95 -4.57 -37.92 10.75 coo 50.40 126.23 20.48 50.46 127.00 20.75 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo 68.38 85.45 19.33 67.41 85.52 20.41 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 65.50 91.13 17.77 64.65 89.88 18.00 -9.24 -24.63 44.86 -9.08 -24.63 46.37 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 15 4 # 15 B 151 VAL B 199 VAL^? 22.32 O2S EPE A 377 B 194 GLY B 176 GLY^? 16.19 O2S EPE A 377 B 417 ILE C 29 ILE.? 10.95 ZN ZN C 375 B 457 ALA C 23 ALA~? 11.04 ZN ZN C 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 5.46 -49.70 13.69 3.81 -48.69 14.79 coo 50.40 126.23 20.48 50.46 127.00 20.75 9.40 -43.99 8.52 8.65 -44.36 8.52 coo 68.38 85.45 19.33 67.41 85.52 20.41 16.25 -25.50 48.78 15.31 -25.73 47.74 coo 65.50 91.13 17.77 64.65 89.88 18.00 11.77 -25.07 43.97 13.11 -24.84 44.66 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 16 4 # 16 B 151 VAL B 202 VAL^? 13.09 O2S EPE A 377 B 194 GLY B 176 GLY^? 16.19 O2S EPE A 377 B 417 ILE C 29 ILE.? 10.95 ZN ZN C 375 B 457 ALA C 23 ALA~? 11.04 ZN ZN C 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 3.82 -41.64 8.59 2.58 -41.50 6.80 coo 50.40 126.23 20.48 50.46 127.00 20.75 9.40 -43.99 8.52 8.65 -44.36 8.52 coo 68.38 85.45 19.33 67.41 85.52 20.41 16.25 -25.50 48.78 15.31 -25.73 47.74 coo 65.50 91.13 17.77 64.65 89.88 18.00 11.77 -25.07 43.97 13.11 -24.84 44.66 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 17 4 # 17 B 151 VAL B 216 VAL~? 12.75 O3S EPE A 377 B 194 GLY B 160 GLY.? 11.45 O3S EPE A 377 B 417 ILE B 58 ILE~? 20.36 C2 EPE B 376 B 457 ALA B 62 ALA.? 21.54 ZN ZN B 374 coo 52.95 126.71 13.21 51.34 125.24 13.19 -6.83 -28.22 14.05 -5.28 -27.59 12.58 coo 50.40 126.23 20.48 50.46 127.00 20.75 -7.67 -24.84 7.30 -7.31 -25.39 7.61 coo 68.38 85.45 19.33 67.41 85.52 20.41 -31.90 4.20 31.89 -32.05 4.42 33.42 coo 65.50 91.13 17.77 64.65 89.88 18.00 -30.17 -1.37 27.22 -29.17 -0.49 26.46 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 18 4 # 18 B 151 VAL B 307 VAL^? 19.39 ZN ZN B 375 B 194 GLY B 277 GLY.? 24.23 ZN ZN B 374 B 417 ILE A 45 ILE^? 13.26 ZN ZN A 375 B 457 ALA A 67 ALA^? 10.32 ZN ZN A 374 coo 52.95 126.71 13.21 51.34 125.24 13.19 1.76 14.81 9.29 -0.23 15.57 8.69 coo 50.40 126.23 20.48 50.46 127.00 20.75 3.65 23.16 11.55 3.12 23.75 11.78 coo 68.38 85.45 19.33 67.41 85.52 20.41 42.02 4.24 17.97 40.78 3.59 17.51 coo 65.50 91.13 17.77 64.65 89.88 18.00 37.22 5.65 22.28 37.04 6.85 23.17 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 19 4 # 19 B 151 VAL C 181 VAL^? 9.67 C5 EPE C 377 B 194 GLY A 157 GLY~? 9.65 O1S EPE C 377 B 417 ILE A 297 ILE~? 17.21 ZN ZN A 374 B 457 ALA A 300 ALA~? 16.31 ZN ZN A 375 coo 52.95 126.71 13.21 51.34 125.24 13.19 32.10 -30.99 1.69 32.13 -29.59 -0.03 coo 50.40 126.23 20.48 50.46 127.00 20.75 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 68.38 85.45 19.33 67.41 85.52 20.41 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 65.50 91.13 17.77 64.65 89.88 18.00 38.46 -17.14 37.26 39.29 -15.90 37.59 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 20 4 # 20 B 151 VAL C 307 VAL^? 19.37 ZN ZN C 375 B 194 GLY C 277 GLY.? 24.27 ZN ZN C 374 B 417 ILE B 45 ILE^? 13.38 ZN ZN B 375 B 457 ALA B 67 ALA^? 10.44 ZN ZN B 374 coo 52.95 126.71 13.21 51.34 125.24 13.19 -13.56 -28.36 50.80 -13.18 -29.95 52.27 coo 50.40 126.23 20.48 50.46 127.00 20.75 -18.35 -23.56 56.48 -18.29 -23.66 57.31 coo 68.38 85.45 19.33 67.41 85.52 20.41 -21.63 0.89 20.85 -20.94 -0.39 20.98 coo 65.50 91.13 17.77 64.65 89.88 18.00 -17.51 1.20 26.23 -17.65 1.96 27.53 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 20 hits 1pix_c01 naa= 4 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 1 4 # 1 A 28 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 114 HIS A 319 HIS~? 24.64 ZN ZN A 374 A 115 HIS A 316 HIS~? 20.33 O8 EPE A 376 A 477 GLU A 51 GLU~? 11.89 O2S EPE A 376 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 41.01 -9.30 52.79 42.52 -8.54 54.04 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 36.36 -5.20 52.06 36.55 -4.24 53.92 coo 5.56 18.52 30.85 3.87 17.54 30.36 41.17 19.74 26.83 40.87 21.56 28.00 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 2 4 # 2 A 28 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 114 HIS B 319 HIS~? 24.73 ZN ZN B 374 A 115 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 477 GLU B 51 GLU~? 11.61 O3S EPE B 376 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 9.35 16.65 21.02 10.22 16.89 22.90 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 8.16 23.53 21.75 7.85 25.60 21.62 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 7.45 20.77 27.47 7.65 22.47 28.71 coo 5.56 18.52 30.85 3.87 17.54 30.36 -25.55 10.19 35.45 -25.80 11.09 37.35 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 3 4 # 3 A 28 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 114 HIS B 319 HIS~? 24.73 ZN ZN B 374 A 115 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 477 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 9.35 16.65 21.02 10.22 16.89 22.90 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 8.16 23.53 21.75 7.85 25.60 21.62 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 7.45 20.77 27.47 7.65 22.47 28.71 coo 5.56 18.52 30.85 3.87 17.54 30.36 -26.20 13.19 30.44 -25.34 14.95 29.81 1pvd_c00 source 1pvd PYRUVATE DECARBOXYLASE (PDC) (E.C.4.1.1.1) : 3 hits 1pvd_c00 naa= 4 ULMN 4 1pvd_c01 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 1 4 # 1 B 28 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 114 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 115 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 477 GLU C 127 GLU^? 21.05 ZN ZN C 375 coo 7.54 16.02 24.50 8.40 15.18 26.23 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 12.56 11.13 24.12 12.84 11.07 26.21 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 8.02 10.56 23.37 8.23 11.43 25.26 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -16.37 -13.88 29.96 -14.84 -12.68 29.83 -6.33 -33.63 38.15 -7.56 -32.26 37.10 1pvd_c01 source 1pvd PYRUVATE DECARBOXYLASE (PDC) (E.C.4.1.1.1) : 1 hits 1pvd_c01 naa= 4 ULMN 4 1qrg_c00 CARBONIC ANHYDRASE user 1 4 # 1 A 62 GLU B 136 GLU^? 17.92 O1S EPE A 377 A 75 GLN C 299 GLN~? 18.18 ZN ZN C 375 A 84 GLU B 135 GLU^? 15.63 O1S EPE A 377 A 202 ASN C 298 ASN~? 20.98 ZN ZN C 375 coo 31.58 50.21 48.39 31.33 50.18 50.48 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 15.01 67.80 50.45 13.17 67.90 51.59 -5.59 -23.33 41.58 -5.78 -22.85 39.46 coo 31.72 45.69 48.66 33.65 44.89 48.92 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 11.82 69.95 45.33 12.39 70.17 47.37 -8.94 -17.91 43.67 -9.93 -16.29 44.63 1qrg_c00 source 1qrg CARBONIC ANHYDRASE : 1 hits 1qrg_c00 naa= 4 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 1 4 # 1 A 170 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 202 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 448 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 473 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 15.19 27.99 11.95 13.02 28.03 12.03 37.80 0.44 25.56 37.02 -1.29 26.44 coo 4.95 34.38 14.49 6.71 33.17 14.61 39.49 -1.24 39.18 39.76 0.49 37.96 coo 6.73 30.70 11.43 8.79 30.60 11.04 40.60 0.33 34.12 38.69 0.39 33.24 coo 16.78 26.00 16.74 15.90 26.28 14.86 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 2 4 # 2 A 170 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 202 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 448 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 473 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 15.19 27.99 11.95 13.02 28.03 12.03 32.91 0.46 27.63 33.66 0.11 29.56 coo 4.95 34.38 14.49 6.71 33.17 14.61 39.49 -1.24 39.18 39.76 0.49 37.96 coo 6.73 30.70 11.43 8.79 30.60 11.04 40.60 0.33 34.12 38.69 0.39 33.24 coo 16.78 26.00 16.74 15.90 26.28 14.86 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 3 4 # 3 A 170 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 202 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 448 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 473 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 15.19 27.99 11.95 13.02 28.03 12.03 40.60 0.33 34.12 38.69 0.39 33.24 coo 4.95 34.38 14.49 6.71 33.17 14.61 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 6.73 30.70 11.43 8.79 30.60 11.04 37.80 0.44 25.56 37.02 -1.29 26.44 coo 16.78 26.00 16.74 15.90 26.28 14.86 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 4 4 # 4 A 170 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 202 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 448 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 473 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 15.19 27.99 11.95 13.02 28.03 12.03 40.60 0.33 34.12 38.69 0.39 33.24 coo 4.95 34.38 14.49 6.71 33.17 14.61 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 6.73 30.70 11.43 8.79 30.60 11.04 32.91 0.46 27.63 33.66 0.11 29.56 coo 16.78 26.00 16.74 15.90 26.28 14.86 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 5 4 # 5 A 170 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 202 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 448 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 473 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 15.19 27.99 11.95 13.02 28.03 12.03 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 4.95 34.38 14.49 6.71 33.17 14.61 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 6.73 30.70 11.43 8.79 30.60 11.04 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 16.78 26.00 16.74 15.90 26.28 14.86 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 6 4 # 6 A 170 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 202 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 448 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 473 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 15.19 27.99 11.95 13.02 28.03 12.03 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 4.95 34.38 14.49 6.71 33.17 14.61 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 6.73 30.70 11.43 8.79 30.60 11.04 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 16.78 26.00 16.74 15.90 26.28 14.86 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 7 4 # 7 A 170 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 202 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 448 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 473 ASP B 312 ASP.? 7.53 ZN ZN B 374 coo 15.19 27.99 11.95 13.02 28.03 12.03 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 4.95 34.38 14.49 6.71 33.17 14.61 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 6.73 30.70 11.43 8.79 30.60 11.04 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 16.78 26.00 16.74 15.90 26.28 14.86 -4.08 14.12 24.69 -6.01 13.62 25.36 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 8 4 # 8 A 170 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 202 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 448 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 473 ASP B 312 ASP.? 7.53 ZN ZN B 374 coo 15.19 27.99 11.95 13.02 28.03 12.03 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 4.95 34.38 14.49 6.71 33.17 14.61 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 6.73 30.70 11.43 8.79 30.60 11.04 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 16.78 26.00 16.74 15.90 26.28 14.86 -4.08 14.12 24.69 -6.01 13.62 25.36 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 9 4 # 9 A 170 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 202 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 448 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 473 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 15.19 27.99 11.95 13.02 28.03 12.03 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 4.95 34.38 14.49 6.71 33.17 14.61 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 6.73 30.70 11.43 8.79 30.60 11.04 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 16.78 26.00 16.74 15.90 26.28 14.86 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 10 4 # 10 A 170 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 202 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 448 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 473 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 15.19 27.99 11.95 13.02 28.03 12.03 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 4.95 34.38 14.49 6.71 33.17 14.61 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 6.73 30.70 11.43 8.79 30.60 11.04 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 16.78 26.00 16.74 15.90 26.28 14.86 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 11 4 # 11 A 170 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 202 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 448 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 473 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 15.19 27.99 11.95 13.02 28.03 12.03 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 4.95 34.38 14.49 6.71 33.17 14.61 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 6.73 30.70 11.43 8.79 30.60 11.04 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 16.78 26.00 16.74 15.90 26.28 14.86 -0.90 -20.80 57.97 0.71 -21.61 59.03 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 12 4 # 12 A 170 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 202 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 448 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 473 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 15.19 27.99 11.95 13.02 28.03 12.03 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 4.95 34.38 14.49 6.71 33.17 14.61 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 6.73 30.70 11.43 8.79 30.60 11.04 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 16.78 26.00 16.74 15.90 26.28 14.86 -0.90 -20.80 57.97 0.71 -21.61 59.03 1v0y_c00 source 1v0y PHOSPHOLIPASE D : 12 hits 1v0y_c00 naa= 4 ULMN 4 1xqw_c01 PROLINE IMINOPEPTIDASE user 1 4 # 1 A 105 ALA A 67 ALA^? 10.32 ZN ZN A 374 A 106 TYR A 100 TYR^? 14.62 ZN ZN A 375 A 244 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 271 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 15.05 3.71 6.93 14.58 4.88 7.78 37.22 5.65 22.28 37.04 6.85 23.17 coo 19.84 3.34 10.90 21.84 1.93 12.24 31.64 5.60 17.48 30.43 3.13 17.07 coo 9.85 8.15 0.76 10.61 7.04 2.39 40.70 8.14 28.73 41.06 6.40 29.84 coo 10.61 7.65 6.01 12.39 6.55 6.23 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 4 1xqw_c01 PROLINE IMINOPEPTIDASE user 2 4 # 2 A 105 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 106 TYR A 100 TYR^? 14.62 ZN ZN A 375 A 244 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 271 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 15.05 3.71 6.93 14.58 4.88 7.78 33.09 1.52 21.68 34.14 1.27 20.64 coo 19.84 3.34 10.90 21.84 1.93 12.24 31.64 5.60 17.48 30.43 3.13 17.07 coo 9.85 8.15 0.76 10.61 7.04 2.39 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 10.61 7.65 6.01 12.39 6.55 6.23 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 4 1xqw_c01 PROLINE IMINOPEPTIDASE user 3 4 # 3 A 105 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 106 TYR A 100 TYR^? 14.62 ZN ZN A 375 A 244 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 271 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 15.05 3.71 6.93 14.58 4.88 7.78 33.09 1.52 21.68 34.14 1.27 20.64 coo 19.84 3.34 10.90 21.84 1.93 12.24 31.64 5.60 17.48 30.43 3.13 17.07 coo 9.85 8.15 0.76 10.61 7.04 2.39 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 10.61 7.65 6.01 12.39 6.55 6.23 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 4 1xqw_c01 PROLINE IMINOPEPTIDASE user 4 4 # 4 A 105 ALA B 67 ALA^? 10.44 ZN ZN B 374 A 106 TYR B 100 TYR^? 14.57 ZN ZN B 375 A 244 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 271 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 15.05 3.71 6.93 14.58 4.88 7.78 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 19.84 3.34 10.90 21.84 1.93 12.24 -17.63 -5.70 28.19 -15.74 -7.29 26.85 coo 9.85 8.15 0.76 10.61 7.04 2.39 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 10.61 7.65 6.01 12.39 6.55 6.23 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 4 1xqw_c01 PROLINE IMINOPEPTIDASE user 5 4 # 5 A 105 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 106 TYR B 100 TYR^? 14.57 ZN ZN B 375 A 244 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 271 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 15.05 3.71 6.93 14.58 4.88 7.78 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 19.84 3.34 10.90 21.84 1.93 12.24 -17.63 -5.70 28.19 -15.74 -7.29 26.85 coo 9.85 8.15 0.76 10.61 7.04 2.39 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 10.61 7.65 6.01 12.39 6.55 6.23 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 4 1xqw_c01 PROLINE IMINOPEPTIDASE user 6 4 # 6 A 105 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 106 TYR B 100 TYR^? 14.57 ZN ZN B 375 A 244 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 271 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 15.05 3.71 6.93 14.58 4.88 7.78 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 19.84 3.34 10.90 21.84 1.93 12.24 -17.63 -5.70 28.19 -15.74 -7.29 26.85 coo 9.85 8.15 0.76 10.61 7.04 2.39 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 10.61 7.65 6.01 12.39 6.55 6.23 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 4 1xqw_c01 PROLINE IMINOPEPTIDASE user 7 4 # 7 A 105 ALA C 67 ALA^? 10.56 ZN ZN C 374 A 106 TYR C 100 TYR^? 14.49 ZN ZN C 375 A 244 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 271 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 15.05 3.71 6.93 14.58 4.88 7.78 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 19.84 3.34 10.90 21.84 1.93 12.24 20.27 -30.73 51.89 19.47 -30.85 49.23 coo 9.85 8.15 0.76 10.61 7.04 2.39 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 10.61 7.65 6.01 12.39 6.55 6.23 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 4 1xqw_c01 PROLINE IMINOPEPTIDASE user 8 4 # 8 A 105 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 106 TYR C 100 TYR^? 14.49 ZN ZN C 375 A 244 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 271 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 15.05 3.71 6.93 14.58 4.88 7.78 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 19.84 3.34 10.90 21.84 1.93 12.24 20.27 -30.73 51.89 19.47 -30.85 49.23 coo 9.85 8.15 0.76 10.61 7.04 2.39 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 10.61 7.65 6.01 12.39 6.55 6.23 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 4 1xqw_c01 PROLINE IMINOPEPTIDASE user 9 4 # 9 A 105 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 106 TYR C 100 TYR^? 14.49 ZN ZN C 375 A 244 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 271 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 15.05 3.71 6.93 14.58 4.88 7.78 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 19.84 3.34 10.90 21.84 1.93 12.24 20.27 -30.73 51.89 19.47 -30.85 49.23 coo 9.85 8.15 0.76 10.61 7.04 2.39 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 10.61 7.65 6.01 12.39 6.55 6.23 10.51 -24.81 51.94 8.80 -23.79 52.62 1xqw_c01 source 1xqw PROLINE IMINOPEPTIDASE : 9 hits 1xqw_c01 naa= 4 ULMN 4 1xtc_c00 CHOLERA TOXIN user 1 4 # 1 A 7 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 61 SER A 174 SER^? 9.43 O3S EPE C 377 A 110 GLU A 200 GLU^? 11.53 C6 EPE A 377 A 112 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 4 1xtc_c00 CHOLERA TOXIN user 2 4 # 2 A 7 ARG B 203 ARG^? 8.69 O2S EPE A 377 A 61 SER B 174 SER^? 9.21 O2S EPE A 377 A 110 GLU B 200 GLU^? 21.89 O2S EPE A 377 A 112 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 4 1xtc_c00 CHOLERA TOXIN user 3 4 # 3 A 7 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 61 SER C 174 SER^? 11.73 O3S EPE C 377 A 110 GLU C 200 GLU^? 10.81 O8 EPE C 377 A 112 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 16.33 -45.08 6.01 16.53 -46.96 5.10 1xtc_c00 source 1xtc CHOLERA TOXIN : 3 hits 1xtc_c00 naa= 4 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 1 4 # 1 A 125 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 151 SER A 174 SER^? 9.43 O3S EPE C 377 A 369 GLY B 176 GLY^? 16.19 O2S EPE A 377 A 450 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 48.89 -0.02 20.42 48.11 2.83 21.18 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 43.71 3.15 18.25 42.31 5.11 18.82 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 46.80 10.26 23.98 47.38 10.43 24.45 9.40 -43.99 8.52 8.65 -44.36 8.52 coo 51.72 4.74 17.91 51.63 5.04 21.04 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 2 4 # 2 A 125 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 151 SER A 174 SER^? 9.43 O3S EPE C 377 A 369 GLY B 176 GLY^? 16.19 O2S EPE A 377 A 450 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 48.89 -0.02 20.42 48.11 2.83 21.18 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 43.71 3.15 18.25 42.31 5.11 18.82 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 46.80 10.26 23.98 47.38 10.43 24.45 9.40 -43.99 8.52 8.65 -44.36 8.52 coo 51.72 4.74 17.91 51.63 5.04 21.04 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 3 4 # 3 A 125 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 151 SER A 174 SER^? 9.43 O3S EPE C 377 A 369 GLY C 178 GLY^? 3.71 C6 EPE C 377 A 450 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 48.89 -0.02 20.42 48.11 2.83 21.18 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 43.71 3.15 18.25 42.31 5.11 18.82 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 46.80 10.26 23.98 47.38 10.43 24.45 23.14 -36.24 3.79 23.36 -36.64 3.06 coo 51.72 4.74 17.91 51.63 5.04 21.04 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 4 4 # 4 A 125 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 151 SER B 173 SER^? 8.63 C9 EPE A 377 A 369 GLY B 176 GLY^? 16.19 O2S EPE A 377 A 450 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 48.89 -0.02 20.42 48.11 2.83 21.18 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 43.71 3.15 18.25 42.31 5.11 18.82 4.35 -36.83 4.64 1.88 -36.99 4.49 coo 46.80 10.26 23.98 47.38 10.43 24.45 9.40 -43.99 8.52 8.65 -44.36 8.52 coo 51.72 4.74 17.91 51.63 5.04 21.04 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 5 4 # 5 A 125 ARG B 203 ARG^? 8.69 O2S EPE A 377 A 151 SER B 174 SER^? 9.21 O2S EPE A 377 A 369 GLY A 178 GLY^? 3.80 C6 EPE A 377 A 450 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 48.89 -0.02 20.42 48.11 2.83 21.18 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 43.71 3.15 18.25 42.31 5.11 18.82 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 46.80 10.26 23.98 47.38 10.43 24.45 3.25 -33.31 -0.46 2.85 -33.92 -0.95 coo 51.72 4.74 17.91 51.63 5.04 21.04 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 6 4 # 6 A 125 ARG B 203 ARG^? 8.69 O2S EPE A 377 A 151 SER B 174 SER^? 9.21 O2S EPE A 377 A 369 GLY C 176 GLY^? 9.30 C6 EPE C 377 A 450 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 48.89 -0.02 20.42 48.11 2.83 21.18 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 43.71 3.15 18.25 42.31 5.11 18.82 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 46.80 10.26 23.98 47.38 10.43 24.45 17.46 -39.97 3.60 18.08 -40.46 3.91 coo 51.72 4.74 17.91 51.63 5.04 21.04 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 7 4 # 7 A 125 ARG B 203 ARG^? 8.69 O2S EPE A 377 A 151 SER C 174 SER^? 11.73 O3S EPE C 377 A 369 GLY A 176 GLY^? 9.59 C9 EPE A 377 A 450 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 48.89 -0.02 20.42 48.11 2.83 21.18 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 43.71 3.15 18.25 42.31 5.11 18.82 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 46.80 10.26 23.98 47.38 10.43 24.45 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 51.72 4.74 17.91 51.63 5.04 21.04 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 8 4 # 8 A 125 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 151 SER A 173 SER^? 8.70 C6 EPE C 377 A 369 GLY A 176 GLY^? 9.59 C9 EPE A 377 A 450 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 48.89 -0.02 20.42 48.11 2.83 21.18 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 43.71 3.15 18.25 42.31 5.11 18.82 17.10 -34.58 2.20 18.37 -33.49 0.48 coo 46.80 10.26 23.98 47.38 10.43 24.45 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 51.72 4.74 17.91 51.63 5.04 21.04 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 9 4 # 9 A 125 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 151 SER A 174 SER^? 9.43 O3S EPE C 377 A 369 GLY B 176 GLY^? 16.19 O2S EPE A 377 A 450 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 48.89 -0.02 20.42 48.11 2.83 21.18 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 43.71 3.15 18.25 42.31 5.11 18.82 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 46.80 10.26 23.98 47.38 10.43 24.45 9.40 -43.99 8.52 8.65 -44.36 8.52 coo 51.72 4.74 17.91 51.63 5.04 21.04 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 10 4 # 10 A 125 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 151 SER C 174 SER^? 11.73 O3S EPE C 377 A 369 GLY A 176 GLY^? 9.59 C9 EPE A 377 A 450 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 48.89 -0.02 20.42 48.11 2.83 21.18 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 43.71 3.15 18.25 42.31 5.11 18.82 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 46.80 10.26 23.98 47.38 10.43 24.45 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 51.72 4.74 17.91 51.63 5.04 21.04 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 11 4 # 11 A 125 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 151 SER C 174 SER^? 11.73 O3S EPE C 377 A 369 GLY A 176 GLY^? 9.59 C9 EPE A 377 A 450 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 48.89 -0.02 20.42 48.11 2.83 21.18 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 43.71 3.15 18.25 42.31 5.11 18.82 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 46.80 10.26 23.98 47.38 10.43 24.45 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 51.72 4.74 17.91 51.63 5.04 21.04 8.58 -36.69 10.51 9.21 -33.68 10.79 2hgs_c00 source 2hgs GLUTATHIONE SYNTHETASE : 11 hits 2hgs_c00 naa= 4 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 100 TYR^? 14.62 ZN ZN A 375 B 190 LYS A 20 LYS~? 16.95 ZN ZN A 375 B 222 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 7.17 16.59 41.26 8.01 19.20 40.73 31.64 5.60 17.48 30.43 3.13 17.07 coo 13.38 20.00 35.06 11.43 22.49 39.53 26.66 -3.22 19.04 24.73 2.41 18.30 coo 9.76 26.58 38.10 11.63 25.78 38.76 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR A 231 TYR^? 10.06 O1S EPE A 377 B 190 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 222 ASP B 237 ASP^? 15.58 N TRS A 378 coo 7.17 16.59 41.26 8.01 19.20 40.73 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 13.38 20.00 35.06 11.43 22.49 39.53 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 9.76 26.58 38.10 11.63 25.78 38.76 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 190 LYS B 138 LYS^? 15.17 O1S EPE A 377 B 222 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 13.38 20.00 35.06 11.43 22.49 39.53 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 9.76 26.58 38.10 11.63 25.78 38.76 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 190 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 222 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 13.38 20.00 35.06 11.43 22.49 39.53 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 9.76 26.58 38.10 11.63 25.78 38.76 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 140 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 190 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 222 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 13.38 20.00 35.06 11.43 22.49 39.53 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 9.76 26.58 38.10 11.63 25.78 38.76 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 140 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 190 LYS C 139 LYS^? 16.11 N TRS A 378 B 222 ASP A 237 ASP^? 6.80 N TRS A 378 coo 7.17 16.59 41.26 8.01 19.20 40.73 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 13.38 20.00 35.06 11.43 22.49 39.53 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 9.76 26.58 38.10 11.63 25.78 38.76 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 7 3 # 7 A 140 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 190 LYS C 139 LYS^? 16.11 N TRS A 378 B 222 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 13.38 20.00 35.06 11.43 22.49 39.53 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 9.76 26.58 38.10 11.63 25.78 38.76 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 8 3 # 8 A 140 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 190 LYS C 139 LYS^? 16.11 N TRS A 378 B 222 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 13.38 20.00 35.06 11.43 22.49 39.53 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 9.76 26.58 38.10 11.63 25.78 38.76 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 9 3 # 9 A 140 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 190 LYS A 295 LYS.? 12.61 ZN ZN A 374 B 222 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 7.17 16.59 41.26 8.01 19.20 40.73 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 13.38 20.00 35.06 11.43 22.49 39.53 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 9.76 26.58 38.10 11.63 25.78 38.76 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 10 3 # 10 A 140 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 190 LYS A 295 LYS.? 12.61 ZN ZN A 374 B 222 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 7.17 16.59 41.26 8.01 19.20 40.73 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 13.38 20.00 35.06 11.43 22.49 39.53 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 9.76 26.58 38.10 11.63 25.78 38.76 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 11 3 # 11 A 140 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 190 LYS A 301 LYS~? 24.94 ZN ZN A 375 B 222 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 7.17 16.59 41.26 8.01 19.20 40.73 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 13.38 20.00 35.06 11.43 22.49 39.53 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 9.76 26.58 38.10 11.63 25.78 38.76 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 12 3 # 12 A 140 TYR A 314 TYR~? 12.17 O8 EPE A 376 B 190 LYS A 295 LYS.? 12.61 ZN ZN A 374 B 222 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 7.17 16.59 41.26 8.01 19.20 40.73 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 13.38 20.00 35.06 11.43 22.49 39.53 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 9.76 26.58 38.10 11.63 25.78 38.76 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 13 3 # 13 A 140 TYR B 18 TYR~? 10.93 ZN ZN B 375 B 190 LYS B 110 LYS.? 16.94 ZN ZN B 375 B 222 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 7.17 16.59 41.26 8.01 19.20 40.73 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 13.38 20.00 35.06 11.43 22.49 39.53 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo 9.76 26.58 38.10 11.63 25.78 38.76 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 14 3 # 14 A 140 TYR B 133 TYR^? 17.24 ZN ZN B 375 B 190 LYS B 110 LYS.? 16.94 ZN ZN B 375 B 222 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 7.17 16.59 41.26 8.01 19.20 40.73 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo 13.38 20.00 35.06 11.43 22.49 39.53 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo 9.76 26.58 38.10 11.63 25.78 38.76 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 15 3 # 15 A 140 TYR B 231 TYR^? 16.39 O2S EPE A 377 B 190 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 222 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 13.38 20.00 35.06 11.43 22.49 39.53 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 9.76 26.58 38.10 11.63 25.78 38.76 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 16 3 # 16 A 140 TYR B 231 TYR^? 16.39 O2S EPE A 377 B 190 LYS C 239 LYS^? 16.29 N TRS A 378 B 222 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 13.38 20.00 35.06 11.43 22.49 39.53 5.15 -29.07 27.87 7.72 -24.69 27.36 coo 9.76 26.58 38.10 11.63 25.78 38.76 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 17 3 # 17 A 140 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 190 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 222 ASP B 237 ASP^? 15.58 N TRS A 378 coo 7.17 16.59 41.26 8.01 19.20 40.73 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 13.38 20.00 35.06 11.43 22.49 39.53 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 9.76 26.58 38.10 11.63 25.78 38.76 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 18 3 # 18 A 140 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 190 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 222 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 13.38 20.00 35.06 11.43 22.49 39.53 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 9.76 26.58 38.10 11.63 25.78 38.76 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 19 3 # 19 A 140 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 190 LYS C 138 LYS^? 8.30 N TRS A 378 B 222 ASP A 237 ASP^? 6.80 N TRS A 378 coo 7.17 16.59 41.26 8.01 19.20 40.73 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 13.38 20.00 35.06 11.43 22.49 39.53 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 9.76 26.58 38.10 11.63 25.78 38.76 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 20 3 # 20 A 140 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 190 LYS C 138 LYS^? 8.30 N TRS A 378 B 222 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 13.38 20.00 35.06 11.43 22.49 39.53 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 9.76 26.58 38.10 11.63 25.78 38.76 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 21 3 # 21 A 140 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 190 LYS C 139 LYS^? 16.11 N TRS A 378 B 222 ASP A 237 ASP^? 6.80 N TRS A 378 coo 7.17 16.59 41.26 8.01 19.20 40.73 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 13.38 20.00 35.06 11.43 22.49 39.53 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 9.76 26.58 38.10 11.63 25.78 38.76 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 22 3 # 22 A 140 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 190 LYS C 139 LYS^? 16.11 N TRS A 378 B 222 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 13.38 20.00 35.06 11.43 22.49 39.53 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 9.76 26.58 38.10 11.63 25.78 38.76 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 23 3 # 23 A 140 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 190 LYS B 295 LYS.? 11.37 ZN ZN B 375 B 222 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 7.17 16.59 41.26 8.01 19.20 40.73 1.32 11.76 14.56 0.84 10.00 16.68 coo 13.38 20.00 35.06 11.43 22.49 39.53 4.57 8.76 22.84 2.39 5.01 24.93 coo 9.76 26.58 38.10 11.63 25.78 38.76 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 24 3 # 24 A 140 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 190 LYS B 295 LYS.? 11.37 ZN ZN B 375 B 222 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 7.17 16.59 41.26 8.01 19.20 40.73 1.32 11.76 14.56 0.84 10.00 16.68 coo 13.38 20.00 35.06 11.43 22.49 39.53 4.57 8.76 22.84 2.39 5.01 24.93 coo 9.76 26.58 38.10 11.63 25.78 38.76 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 25 3 # 25 A 140 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 190 LYS B 301 LYS~? 25.03 ZN ZN B 375 B 222 ASP B 306 ASP.? 24.86 ZN ZN B 375 coo 7.17 16.59 41.26 8.01 19.20 40.73 1.32 11.76 14.56 0.84 10.00 16.68 coo 13.38 20.00 35.06 11.43 22.49 39.53 8.36 10.35 11.75 10.05 14.82 9.04 coo 9.76 26.58 38.10 11.63 25.78 38.76 3.99 14.73 5.36 5.18 14.04 3.76 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 26 3 # 26 A 140 TYR B 314 TYR~? 14.73 O8 EPE B 376 B 190 LYS B 295 LYS.? 11.37 ZN ZN B 375 B 222 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 7.17 16.59 41.26 8.01 19.20 40.73 2.08 17.58 27.10 3.13 18.35 29.60 coo 13.38 20.00 35.06 11.43 22.49 39.53 4.57 8.76 22.84 2.39 5.01 24.93 coo 9.76 26.58 38.10 11.63 25.78 38.76 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 27 3 # 27 A 140 TYR B 314 TYR~? 14.73 O8 EPE B 376 B 190 LYS B 295 LYS.? 11.37 ZN ZN B 375 B 222 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 7.17 16.59 41.26 8.01 19.20 40.73 2.08 17.58 27.10 3.13 18.35 29.60 coo 13.38 20.00 35.06 11.43 22.49 39.53 4.57 8.76 22.84 2.39 5.01 24.93 coo 9.76 26.58 38.10 11.63 25.78 38.76 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 28 3 # 28 A 140 TYR C 18 TYR.? 11.04 ZN ZN C 375 B 190 LYS C 110 LYS.? 19.48 ZN ZN C 375 B 222 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 7.17 16.59 41.26 8.01 19.20 40.73 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 13.38 20.00 35.06 11.43 22.49 39.53 5.59 -36.33 42.73 4.93 -41.69 39.22 coo 9.76 26.58 38.10 11.63 25.78 38.76 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 29 3 # 29 A 140 TYR C 133 TYR^? 16.76 ZN ZN C 375 B 190 LYS C 20 LYS~? 17.53 ZN ZN C 375 B 222 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 7.17 16.59 41.26 8.01 19.20 40.73 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 13.38 20.00 35.06 11.43 22.49 39.53 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 9.76 26.58 38.10 11.63 25.78 38.76 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 30 3 # 30 A 140 TYR C 231 TYR^? -4.25 C2 TRS A 378s B 190 LYS A 239 LYS^? -7.47 O3 TRS A 378s B 222 ASP A 237 ASP^? 6.80 N TRS A 378 coo 7.17 16.59 41.26 8.01 19.20 40.73 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 13.38 20.00 35.06 11.43 22.49 39.53 24.38 -22.19 19.59 20.35 -19.68 21.34 coo 9.76 26.58 38.10 11.63 25.78 38.76 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 31 3 # 31 A 140 TYR C 231 TYR^? -4.25 C2 TRS A 378s B 190 LYS C 139 LYS^? 16.11 N TRS A 378 B 222 ASP A 237 ASP^? 6.80 N TRS A 378 coo 7.17 16.59 41.26 8.01 19.20 40.73 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 13.38 20.00 35.06 11.43 22.49 39.53 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 9.76 26.58 38.10 11.63 25.78 38.76 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 32 3 # 32 A 140 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 190 LYS A 138 LYS^? 13.11 N TRS A 378 B 222 ASP B 237 ASP^? 15.58 N TRS A 378 coo 7.17 16.59 41.26 8.01 19.20 40.73 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 13.38 20.00 35.06 11.43 22.49 39.53 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 9.76 26.58 38.10 11.63 25.78 38.76 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 33 3 # 33 A 140 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 190 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 222 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 13.38 20.00 35.06 11.43 22.49 39.53 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 9.76 26.58 38.10 11.63 25.78 38.76 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 34 3 # 34 A 140 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 190 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 222 ASP B 237 ASP^? 15.58 N TRS A 378 coo 7.17 16.59 41.26 8.01 19.20 40.73 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 13.38 20.00 35.06 11.43 22.49 39.53 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 9.76 26.58 38.10 11.63 25.78 38.76 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 35 3 # 35 A 140 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 190 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 222 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 13.38 20.00 35.06 11.43 22.49 39.53 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 9.76 26.58 38.10 11.63 25.78 38.76 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 36 3 # 36 A 140 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 190 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 222 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 13.38 20.00 35.06 11.43 22.49 39.53 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 9.76 26.58 38.10 11.63 25.78 38.76 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 37 3 # 37 A 140 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 190 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 222 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 7.17 16.59 41.26 8.01 19.20 40.73 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 13.38 20.00 35.06 11.43 22.49 39.53 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 9.76 26.58 38.10 11.63 25.78 38.76 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 38 3 # 38 A 140 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 190 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 222 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 7.17 16.59 41.26 8.01 19.20 40.73 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 13.38 20.00 35.06 11.43 22.49 39.53 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 9.76 26.58 38.10 11.63 25.78 38.76 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 39 3 # 39 A 140 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 190 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 222 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 7.17 16.59 41.26 8.01 19.20 40.73 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 13.38 20.00 35.06 11.43 22.49 39.53 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 9.76 26.58 38.10 11.63 25.78 38.76 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 40 3 # 40 A 140 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 190 LYS C 301 LYS~? 24.63 ZN ZN C 375 B 222 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo 7.17 16.59 41.26 8.01 19.20 40.73 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 13.38 20.00 35.06 11.43 22.49 39.53 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 9.76 26.58 38.10 11.63 25.78 38.76 -16.81 -30.01 48.18 -17.96 -30.59 46.51 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 41 3 # 41 A 140 TYR C 314 TYR~? 12.22 O8 EPE C 376 B 190 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 222 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 7.17 16.59 41.26 8.01 19.20 40.73 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 13.38 20.00 35.06 11.43 22.49 39.53 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 9.76 26.58 38.10 11.63 25.78 38.76 -11.50 -14.47 50.76 -10.89 -12.44 50.87 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 41 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 20 LYS~? 16.95 ZN ZN A 375 A 222 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 140 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 26.66 -3.22 19.04 24.73 2.41 18.30 coo -1.04 26.60 27.37 -2.94 25.93 26.69 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 1.51 16.60 24.17 0.82 19.23 24.79 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS A 138 LYS^? 13.11 N TRS A 378 A 222 ASP B 237 ASP^? 15.58 N TRS A 378 B 140 TYR C 234 TYR^? 9.10 O2S EPE C 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 18.11 -21.79 12.78 16.12 -17.81 15.44 coo -1.04 26.60 27.37 -2.94 25.93 26.69 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 1.51 16.60 24.17 0.82 19.23 24.79 14.09 -28.86 16.23 14.98 -29.39 13.69 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 222 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 140 TYR C 234 TYR^? 9.10 O2S EPE C 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 17.05 -24.82 10.77 19.64 -29.66 10.35 coo -1.04 26.60 27.37 -2.94 25.93 26.69 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 1.51 16.60 24.17 0.82 19.23 24.79 14.09 -28.86 16.23 14.98 -29.39 13.69 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 222 ASP B 237 ASP^? 15.58 N TRS A 378 B 140 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 17.05 -24.82 10.77 19.64 -29.66 10.35 coo -1.04 26.60 27.37 -2.94 25.93 26.69 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 1.51 16.60 24.17 0.82 19.23 24.79 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 190 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 222 ASP B 237 ASP^? 15.58 N TRS A 378 B 140 TYR B 234 TYR^? 11.34 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 17.05 -24.82 10.77 19.64 -29.66 10.35 coo -1.04 26.60 27.37 -2.94 25.93 26.69 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 1.51 16.60 24.17 0.82 19.23 24.79 8.50 -28.26 15.53 9.64 -30.80 15.55 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 190 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 222 ASP B 237 ASP^? 15.58 N TRS A 378 B 140 TYR C 234 TYR^? 9.10 O2S EPE C 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 17.05 -24.82 10.77 19.64 -29.66 10.35 coo -1.04 26.60 27.37 -2.94 25.93 26.69 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 1.51 16.60 24.17 0.82 19.23 24.79 14.09 -28.86 16.23 14.98 -29.39 13.69 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 7 3 # 7 A 190 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 222 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 140 TYR B 234 TYR^? 11.34 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 17.05 -24.82 10.77 19.64 -29.66 10.35 coo -1.04 26.60 27.37 -2.94 25.93 26.69 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 1.51 16.60 24.17 0.82 19.23 24.79 8.50 -28.26 15.53 9.64 -30.80 15.55 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 8 3 # 8 A 190 LYS A 239 LYS^? -7.47 O3 TRS A 378s A 222 ASP A 237 ASP^? 6.80 N TRS A 378 B 140 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo -4.61 20.12 30.34 -2.74 22.65 25.95 24.38 -22.19 19.59 20.35 -19.68 21.34 coo -1.04 26.60 27.37 -2.94 25.93 26.69 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 1.51 16.60 24.17 0.82 19.23 24.79 23.23 -33.44 18.32 24.66 -32.16 20.35 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 9 3 # 9 A 190 LYS A 295 LYS.? 12.61 ZN ZN A 374 A 222 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 140 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 32.96 -9.31 39.54 28.55 -6.00 37.21 coo -1.04 26.60 27.37 -2.94 25.93 26.69 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 1.51 16.60 24.17 0.82 19.23 24.79 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 10 3 # 10 A 190 LYS A 295 LYS.? 12.61 ZN ZN A 374 A 222 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 140 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 32.96 -9.31 39.54 28.55 -6.00 37.21 coo -1.04 26.60 27.37 -2.94 25.93 26.69 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 1.51 16.60 24.17 0.82 19.23 24.79 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 11 3 # 11 A 190 LYS A 295 LYS.? 12.61 ZN ZN A 374 A 222 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 140 TYR A 314 TYR~? 12.17 O8 EPE A 376 coo -4.61 20.12 30.34 -2.74 22.65 25.95 32.96 -9.31 39.54 28.55 -6.00 37.21 coo -1.04 26.60 27.37 -2.94 25.93 26.69 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 1.51 16.60 24.17 0.82 19.23 24.79 36.88 -2.62 44.67 35.35 -1.67 42.53 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 12 3 # 12 A 190 LYS A 301 LYS~? 24.94 ZN ZN A 375 A 222 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 140 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 39.11 -19.59 40.11 42.80 -21.77 43.38 coo -1.04 26.60 27.37 -2.94 25.93 26.69 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 1.51 16.60 24.17 0.82 19.23 24.79 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 13 3 # 13 A 190 LYS B 110 LYS.? 16.94 ZN ZN B 375 A 222 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 140 TYR B 18 TYR~? 10.93 ZN ZN B 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 1.51 16.60 24.17 0.82 19.23 24.79 -12.77 -5.58 18.92 -13.52 -3.89 16.83 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 14 3 # 14 A 190 LYS B 110 LYS.? 16.94 ZN ZN B 375 A 222 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 140 TYR B 133 TYR^? 17.24 ZN ZN B 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 1.51 16.60 24.17 0.82 19.23 24.79 -0.70 -9.54 18.25 -1.85 -12.04 17.66 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 15 3 # 15 A 190 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 222 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 140 TYR A 234 TYR^? 9.43 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 3.52 -23.27 14.19 3.97 -21.31 18.72 coo -1.04 26.60 27.37 -2.94 25.93 26.69 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 1.51 16.60 24.17 0.82 19.23 24.79 12.00 -25.53 12.31 10.15 -27.11 10.97 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 16 3 # 16 A 190 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 222 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 140 TYR C 234 TYR^? 9.10 O2S EPE C 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 4.48 -26.42 12.36 5.89 -27.34 7.19 coo -1.04 26.60 27.37 -2.94 25.93 26.69 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 1.51 16.60 24.17 0.82 19.23 24.79 14.09 -28.86 16.23 14.98 -29.39 13.69 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 17 3 # 17 A 190 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 222 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 140 TYR A 234 TYR^? 9.43 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 4.48 -26.42 12.36 5.89 -27.34 7.19 coo -1.04 26.60 27.37 -2.94 25.93 26.69 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 1.51 16.60 24.17 0.82 19.23 24.79 12.00 -25.53 12.31 10.15 -27.11 10.97 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 18 3 # 18 A 190 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 222 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 140 TYR C 234 TYR^? 9.10 O2S EPE C 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 4.48 -26.42 12.36 5.89 -27.34 7.19 coo -1.04 26.60 27.37 -2.94 25.93 26.69 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 1.51 16.60 24.17 0.82 19.23 24.79 14.09 -28.86 16.23 14.98 -29.39 13.69 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 19 3 # 19 A 190 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 222 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 140 TYR A 234 TYR^? 9.43 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 4.48 -26.42 12.36 5.89 -27.34 7.19 coo -1.04 26.60 27.37 -2.94 25.93 26.69 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 1.51 16.60 24.17 0.82 19.23 24.79 12.00 -25.53 12.31 10.15 -27.11 10.97 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 20 3 # 20 A 190 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 222 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 140 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 4.48 -26.42 12.36 5.89 -27.34 7.19 coo -1.04 26.60 27.37 -2.94 25.93 26.69 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 1.51 16.60 24.17 0.82 19.23 24.79 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 21 3 # 21 A 190 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 222 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 140 TYR C 234 TYR^? 9.10 O2S EPE C 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 4.48 -26.42 12.36 5.89 -27.34 7.19 coo -1.04 26.60 27.37 -2.94 25.93 26.69 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 1.51 16.60 24.17 0.82 19.23 24.79 14.09 -28.86 16.23 14.98 -29.39 13.69 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 22 3 # 22 A 190 LYS B 295 LYS.? 11.37 ZN ZN B 375 A 222 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 140 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 4.57 8.76 22.84 2.39 5.01 24.93 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 1.51 16.60 24.17 0.82 19.23 24.79 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 23 3 # 23 A 190 LYS B 295 LYS.? 11.37 ZN ZN B 375 A 222 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 140 TYR B 314 TYR~? 14.73 O8 EPE B 376 coo -4.61 20.12 30.34 -2.74 22.65 25.95 4.57 8.76 22.84 2.39 5.01 24.93 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 1.51 16.60 24.17 0.82 19.23 24.79 2.08 17.58 27.10 3.13 18.35 29.60 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 24 3 # 24 A 190 LYS B 295 LYS.? 11.37 ZN ZN B 375 A 222 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 140 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 4.57 8.76 22.84 2.39 5.01 24.93 coo -1.04 26.60 27.37 -2.94 25.93 26.69 9.35 16.65 21.02 10.22 16.89 22.90 coo 1.51 16.60 24.17 0.82 19.23 24.79 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 25 3 # 25 A 190 LYS B 295 LYS.? 11.37 ZN ZN B 375 A 222 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 140 TYR B 314 TYR~? 14.73 O8 EPE B 376 coo -4.61 20.12 30.34 -2.74 22.65 25.95 4.57 8.76 22.84 2.39 5.01 24.93 coo -1.04 26.60 27.37 -2.94 25.93 26.69 9.35 16.65 21.02 10.22 16.89 22.90 coo 1.51 16.60 24.17 0.82 19.23 24.79 2.08 17.58 27.10 3.13 18.35 29.60 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 26 3 # 26 A 190 LYS B 301 LYS~? 25.03 ZN ZN B 375 A 222 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 140 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 8.36 10.35 11.75 10.05 14.82 9.04 coo -1.04 26.60 27.37 -2.94 25.93 26.69 3.99 14.73 5.36 5.18 14.04 3.76 coo 1.51 16.60 24.17 0.82 19.23 24.79 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 27 3 # 27 A 190 LYS C 20 LYS~? 17.53 ZN ZN C 375 A 222 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 140 TYR C 133 TYR^? 16.76 ZN ZN C 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 16.25 -27.94 42.71 21.97 -27.95 45.58 coo -1.04 26.60 27.37 -2.94 25.93 26.69 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 1.51 16.60 24.17 0.82 19.23 24.79 8.59 -26.93 36.99 10.82 -27.74 35.52 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 28 3 # 28 A 190 LYS C 110 LYS.? 19.48 ZN ZN C 375 A 222 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 140 TYR C 18 TYR.? 11.04 ZN ZN C 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 5.59 -36.33 42.73 4.93 -41.69 39.22 coo -1.04 26.60 27.37 -2.94 25.93 26.69 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 1.51 16.60 24.17 0.82 19.23 24.79 12.32 -34.51 46.53 10.40 -36.24 47.57 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 29 3 # 29 A 190 LYS C 138 LYS^? 8.30 N TRS A 378 A 222 ASP A 237 ASP^? 6.80 N TRS A 378 B 140 TYR B 234 TYR^? 11.34 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 12.95 -30.51 23.19 15.44 -26.53 25.46 coo -1.04 26.60 27.37 -2.94 25.93 26.69 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 1.51 16.60 24.17 0.82 19.23 24.79 8.50 -28.26 15.53 9.64 -30.80 15.55 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 30 3 # 30 A 190 LYS C 139 LYS^? 16.11 N TRS A 378 A 222 ASP A 237 ASP^? 6.80 N TRS A 378 B 140 TYR A 234 TYR^? 9.43 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 13.08 -32.56 20.05 9.65 -36.55 18.68 coo -1.04 26.60 27.37 -2.94 25.93 26.69 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 1.51 16.60 24.17 0.82 19.23 24.79 12.00 -25.53 12.31 10.15 -27.11 10.97 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 31 3 # 31 A 190 LYS C 139 LYS^? 16.11 N TRS A 378 A 222 ASP A 237 ASP^? 6.80 N TRS A 378 B 140 TYR B 234 TYR^? 11.34 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 13.08 -32.56 20.05 9.65 -36.55 18.68 coo -1.04 26.60 27.37 -2.94 25.93 26.69 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 1.51 16.60 24.17 0.82 19.23 24.79 8.50 -28.26 15.53 9.64 -30.80 15.55 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 32 3 # 32 A 190 LYS C 139 LYS^? 16.11 N TRS A 378 A 222 ASP A 237 ASP^? 6.80 N TRS A 378 B 140 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo -4.61 20.12 30.34 -2.74 22.65 25.95 13.08 -32.56 20.05 9.65 -36.55 18.68 coo -1.04 26.60 27.37 -2.94 25.93 26.69 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 1.51 16.60 24.17 0.82 19.23 24.79 23.23 -33.44 18.32 24.66 -32.16 20.35 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 33 3 # 33 A 190 LYS C 139 LYS^? 16.11 N TRS A 378 A 222 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 140 TYR A 234 TYR^? 9.43 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 13.08 -32.56 20.05 9.65 -36.55 18.68 coo -1.04 26.60 27.37 -2.94 25.93 26.69 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 1.51 16.60 24.17 0.82 19.23 24.79 12.00 -25.53 12.31 10.15 -27.11 10.97 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 34 3 # 34 A 190 LYS C 139 LYS^? 16.11 N TRS A 378 A 222 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 140 TYR A 234 TYR^? 9.43 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 13.08 -32.56 20.05 9.65 -36.55 18.68 coo -1.04 26.60 27.37 -2.94 25.93 26.69 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 1.51 16.60 24.17 0.82 19.23 24.79 12.00 -25.53 12.31 10.15 -27.11 10.97 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 35 3 # 35 A 190 LYS C 139 LYS^? 16.11 N TRS A 378 A 222 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 140 TYR B 234 TYR^? 11.34 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 13.08 -32.56 20.05 9.65 -36.55 18.68 coo -1.04 26.60 27.37 -2.94 25.93 26.69 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 1.51 16.60 24.17 0.82 19.23 24.79 8.50 -28.26 15.53 9.64 -30.80 15.55 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 36 3 # 36 A 190 LYS C 239 LYS^? 16.29 N TRS A 378 A 222 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 140 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo -4.61 20.12 30.34 -2.74 22.65 25.95 5.15 -29.07 27.87 7.72 -24.69 27.36 coo -1.04 26.60 27.37 -2.94 25.93 26.69 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 1.51 16.60 24.17 0.82 19.23 24.79 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 37 3 # 37 A 190 LYS C 295 LYS.? 14.49 ZN ZN C 374 A 222 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 140 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo -1.04 26.60 27.37 -2.94 25.93 26.69 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 1.51 16.60 24.17 0.82 19.23 24.79 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 38 3 # 38 A 190 LYS C 295 LYS.? 14.49 ZN ZN C 374 A 222 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 140 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 1.51 16.60 24.17 0.82 19.23 24.79 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 39 3 # 39 A 190 LYS C 295 LYS.? 14.49 ZN ZN C 374 A 222 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 140 TYR C 314 TYR~? 12.22 O8 EPE C 376 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 1.51 16.60 24.17 0.82 19.23 24.79 -3.69 -15.10 57.54 -1.00 -15.00 58.41 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 40 3 # 40 A 190 LYS C 301 LYS~? 24.63 ZN ZN C 375 A 222 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 140 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 1.51 16.60 24.17 0.82 19.23 24.79 -8.26 -25.36 50.23 -5.59 -24.48 49.71 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 40 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c00 TRYPSIN user 1 3 # 1 A 57 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 102 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 195 SER A 168 SER^? 10.80 O1S EPE C 377 coo 25.57 41.22 61.68 24.18 39.98 62.50 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 22.33 45.48 59.73 23.35 43.67 60.06 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 20.90 36.72 61.65 22.18 37.53 63.52 30.58 -27.33 4.57 31.12 -25.87 2.65 ULMN 3 1a0j_c00 TRYPSIN user 2 3 # 2 A 57 HIS B 169 HIS^? 10.86 O3S EPE A 377 A 102 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 195 SER B 168 SER^? 10.59 O3S EPE A 377 coo 25.57 41.22 61.68 24.18 39.98 62.50 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 22.33 45.48 59.73 23.35 43.67 60.06 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 20.90 36.72 61.65 22.18 37.53 63.52 -4.73 -25.07 0.35 -6.94 -24.95 1.40 ULMN 3 1a0j_c00 TRYPSIN user 3 3 # 3 A 57 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 102 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 195 SER C 168 SER^? 24.11 O1 TRS A 378 coo 25.57 41.22 61.68 24.18 39.98 62.50 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 22.33 45.48 59.73 23.35 43.67 60.06 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 20.90 36.72 61.65 22.18 37.53 63.52 9.08 -45.42 26.78 10.19 -47.47 27.43 1a0j_c00 source 1a0j TRYPSIN : 3 hits 1a0j_c00 naa= 3 ULMN 3 1a0j_c01 TRYPSIN user 1 3 # 1 B 57 HIS A 169 HIS^? 11.22 O1S EPE C 377 B 102 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 195 SER A 168 SER^? 10.80 O1S EPE C 377 coo 44.08 45.58 52.81 45.86 46.55 52.85 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 43.04 44.75 47.18 43.31 45.51 49.13 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 48.11 50.52 52.24 48.62 48.46 53.13 30.58 -27.33 4.57 31.12 -25.87 2.65 ULMN 3 1a0j_c01 TRYPSIN user 2 3 # 2 B 57 HIS B 169 HIS^? 10.86 O3S EPE A 377 B 102 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 195 SER B 168 SER^? 10.59 O3S EPE A 377 coo 44.08 45.58 52.81 45.86 46.55 52.85 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 43.04 44.75 47.18 43.31 45.51 49.13 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 48.11 50.52 52.24 48.62 48.46 53.13 -4.73 -25.07 0.35 -6.94 -24.95 1.40 ULMN 3 1a0j_c01 TRYPSIN user 3 3 # 3 B 57 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 102 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 195 SER C 168 SER^? 24.11 O1 TRS A 378 coo 44.08 45.58 52.81 45.86 46.55 52.85 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 43.04 44.75 47.18 43.31 45.51 49.13 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 48.11 50.52 52.24 48.62 48.46 53.13 9.08 -45.42 26.78 10.19 -47.47 27.43 1a0j_c01 source 1a0j TRYPSIN : 3 hits 1a0j_c01 naa= 3 ULMN 3 1a0j_c02 TRYPSIN user 1 3 # 1 C 57 HIS A 169 HIS^? 11.22 O1S EPE C 377 C 102 ASP A 158 ASP~? 15.23 O1S EPE C 377 C 195 SER A 168 SER^? 10.80 O1S EPE C 377 coo 34.37 41.18 73.21 34.04 43.09 73.87 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 34.89 38.34 78.12 35.11 39.59 76.42 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 36.16 46.87 75.66 34.01 46.43 74.59 30.58 -27.33 4.57 31.12 -25.87 2.65 ULMN 3 1a0j_c02 TRYPSIN user 2 3 # 2 C 57 HIS B 169 HIS^? 10.86 O3S EPE A 377 C 102 ASP B 158 ASP~? 14.93 O3S EPE A 377 C 195 SER B 168 SER^? 10.59 O3S EPE A 377 coo 34.37 41.18 73.21 34.04 43.09 73.87 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 34.89 38.34 78.12 35.11 39.59 76.42 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 36.16 46.87 75.66 34.01 46.43 74.59 -4.73 -25.07 0.35 -6.94 -24.95 1.40 ULMN 3 1a0j_c02 TRYPSIN user 3 3 # 3 C 57 HIS C 169 HIS^? 22.39 O1 TRS A 378 C 102 ASP C 158 ASP~? 22.01 O1 TRS A 378 C 195 SER C 168 SER^? 24.11 O1 TRS A 378 coo 34.37 41.18 73.21 34.04 43.09 73.87 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 34.89 38.34 78.12 35.11 39.59 76.42 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 36.16 46.87 75.66 34.01 46.43 74.59 9.08 -45.42 26.78 10.19 -47.47 27.43 1a0j_c02 source 1a0j TRYPSIN : 3 hits 1a0j_c02 naa= 3 ULMN 3 1a0j_c03 TRYPSIN user 1 3 # 1 D 57 HIS A 169 HIS^? 11.22 O1S EPE C 377 D 102 ASP A 158 ASP~? 15.23 O1S EPE C 377 D 195 SER A 168 SER^? 10.80 O1S EPE C 377 coo 8.19 15.01 95.72 7.78 16.53 97.01 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 13.53 16.28 93.98 11.45 16.21 94.40 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 6.63 21.03 97.42 6.71 19.20 98.95 30.58 -27.33 4.57 31.12 -25.87 2.65 ULMN 3 1a0j_c03 TRYPSIN user 2 3 # 2 D 57 HIS B 169 HIS^? 10.86 O3S EPE A 377 D 102 ASP B 158 ASP~? 14.93 O3S EPE A 377 D 195 SER B 168 SER^? 10.59 O3S EPE A 377 coo 8.19 15.01 95.72 7.78 16.53 97.01 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 13.53 16.28 93.98 11.45 16.21 94.40 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 6.63 21.03 97.42 6.71 19.20 98.95 -4.73 -25.07 0.35 -6.94 -24.95 1.40 ULMN 3 1a0j_c03 TRYPSIN user 3 3 # 3 D 57 HIS C 169 HIS^? 22.39 O1 TRS A 378 D 102 ASP C 158 ASP~? 22.01 O1 TRS A 378 D 195 SER C 168 SER^? 24.11 O1 TRS A 378 coo 8.19 15.01 95.72 7.78 16.53 97.01 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 13.53 16.28 93.98 11.45 16.21 94.40 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 6.63 21.03 97.42 6.71 19.20 98.95 9.08 -45.42 26.78 10.19 -47.47 27.43 1a0j_c03 source 1a0j TRYPSIN : 3 hits 1a0j_c03 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 193 GLY A 342 GLY~? 12.90 ZN ZN A 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 37.80 0.44 25.56 37.02 -1.29 26.44 coo 22.33 45.48 59.73 23.35 43.67 60.06 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 22.57 32.23 64.13 21.98 32.82 64.22 44.89 -3.04 18.23 44.73 -2.27 17.91 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 37.42 3.90 29.26 38.47 2.36 30.22 coo 22.33 45.48 59.73 23.35 43.67 60.06 40.70 8.14 28.73 41.06 6.40 29.84 coo 22.57 32.23 64.13 21.98 32.82 64.22 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1a0j_c12 TRYPSIN user 3 3 # 3 A 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo 25.57 41.22 61.68 24.18 39.98 62.50 37.42 3.90 29.26 38.47 2.36 30.22 coo 22.33 45.48 59.73 23.35 43.67 60.06 40.70 8.14 28.73 41.06 6.40 29.84 coo 22.57 32.23 64.13 21.98 32.82 64.22 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 1a0j_c12 TRYPSIN user 4 3 # 4 A 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 32.91 0.46 27.63 33.66 0.11 29.56 coo 22.33 45.48 59.73 23.35 43.67 60.06 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 22.57 32.23 64.13 21.98 32.82 64.22 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1a0j_c12 TRYPSIN user 5 3 # 5 A 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo 25.57 41.22 61.68 24.18 39.98 62.50 32.91 0.46 27.63 33.66 0.11 29.56 coo 22.33 45.48 59.73 23.35 43.67 60.06 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 22.57 32.23 64.13 21.98 32.82 64.22 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 1a0j_c12 TRYPSIN user 6 3 # 6 A 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 193 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 32.91 0.46 27.63 33.66 0.11 29.56 coo 22.33 45.48 59.73 23.35 43.67 60.06 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 22.57 32.23 64.13 21.98 32.82 64.22 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1a0j_c12 TRYPSIN user 7 3 # 7 A 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 193 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 32.91 0.46 27.63 33.66 0.11 29.56 coo 22.33 45.48 59.73 23.35 43.67 60.06 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 22.57 32.23 64.13 21.98 32.82 64.22 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1a0j_c12 TRYPSIN user 8 3 # 8 A 57 HIS A 319 HIS~? 24.64 ZN ZN A 374 A 102 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 193 GLY A 277 GLY.? 24.28 ZN ZN A 374 coo 25.57 41.22 61.68 24.18 39.98 62.50 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 22.33 45.48 59.73 23.35 43.67 60.06 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 22.57 32.23 64.13 21.98 32.82 64.22 49.23 -14.07 46.91 49.73 -13.44 47.06 ULMN 3 1a0j_c12 TRYPSIN user 9 3 # 9 A 57 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 193 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 22.33 45.48 59.73 23.35 43.67 60.06 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 22.57 32.23 64.13 21.98 32.82 64.22 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1a0j_c12 TRYPSIN user 10 3 # 10 A 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 22.33 45.48 59.73 23.35 43.67 60.06 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 22.57 32.23 64.13 21.98 32.82 64.22 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1a0j_c12 TRYPSIN user 11 3 # 11 A 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo 25.57 41.22 61.68 24.18 39.98 62.50 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 22.33 45.48 59.73 23.35 43.67 60.06 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 22.57 32.23 64.13 21.98 32.82 64.22 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 1a0j_c12 TRYPSIN user 12 3 # 12 A 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 22.57 32.23 64.13 21.98 32.82 64.22 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1a0j_c12 TRYPSIN user 13 3 # 13 A 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo 25.57 41.22 61.68 24.18 39.98 62.50 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 22.57 32.23 64.13 21.98 32.82 64.22 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 1a0j_c12 TRYPSIN user 14 3 # 14 A 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 193 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 22.57 32.23 64.13 21.98 32.82 64.22 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1a0j_c12 TRYPSIN user 15 3 # 15 A 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 193 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 22.57 32.23 64.13 21.98 32.82 64.22 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1a0j_c12 TRYPSIN user 16 3 # 16 A 57 HIS B 319 HIS~? 24.73 ZN ZN B 374 A 102 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 193 GLY B 277 GLY.? 24.23 ZN ZN B 374 coo 25.57 41.22 61.68 24.18 39.98 62.50 8.16 23.53 21.75 7.85 25.60 21.62 coo 22.33 45.48 59.73 23.35 43.67 60.06 9.35 16.65 21.02 10.22 16.89 22.90 coo 22.57 32.23 64.13 21.98 32.82 64.22 3.65 23.16 11.55 3.12 23.75 11.78 ULMN 3 1a0j_c12 TRYPSIN user 17 3 # 17 A 57 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 193 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 22.33 45.48 59.73 23.35 43.67 60.06 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 22.57 32.23 64.13 21.98 32.82 64.22 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 1a0j_c12 TRYPSIN user 18 3 # 18 A 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 22.33 45.48 59.73 23.35 43.67 60.06 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 22.57 32.23 64.13 21.98 32.82 64.22 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1a0j_c12 TRYPSIN user 19 3 # 19 A 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo 25.57 41.22 61.68 24.18 39.98 62.50 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 22.33 45.48 59.73 23.35 43.67 60.06 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 22.57 32.23 64.13 21.98 32.82 64.22 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 1a0j_c12 TRYPSIN user 20 3 # 20 A 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 22.33 45.48 59.73 23.35 43.67 60.06 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 22.57 32.23 64.13 21.98 32.82 64.22 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1a0j_c12 TRYPSIN user 21 3 # 21 A 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo 25.57 41.22 61.68 24.18 39.98 62.50 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 22.33 45.48 59.73 23.35 43.67 60.06 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 22.57 32.23 64.13 21.98 32.82 64.22 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 1a0j_c12 TRYPSIN user 22 3 # 22 A 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 193 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 22.33 45.48 59.73 23.35 43.67 60.06 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 22.57 32.23 64.13 21.98 32.82 64.22 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1a0j_c12 TRYPSIN user 23 3 # 23 A 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 193 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 25.57 41.22 61.68 24.18 39.98 62.50 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 22.33 45.48 59.73 23.35 43.67 60.06 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 22.57 32.23 64.13 21.98 32.82 64.22 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1a0j_c12 TRYPSIN user 24 3 # 24 A 57 HIS C 319 HIS~? 24.70 ZN ZN C 374 A 102 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 193 GLY C 277 GLY.? 24.27 ZN ZN C 374 coo 25.57 41.22 61.68 24.18 39.98 62.50 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 22.33 45.48 59.73 23.35 43.67 60.06 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 22.57 32.23 64.13 21.98 32.82 64.22 -18.35 -23.56 56.48 -18.29 -23.66 57.31 1a0j_c12 source 1a0j TRYPSIN : 24 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 193 GLY A 342 GLY~? 12.90 ZN ZN A 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 37.80 0.44 25.56 37.02 -1.29 26.44 coo 43.04 44.75 47.18 43.31 45.51 49.13 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 50.46 51.91 56.90 50.65 51.62 56.14 44.89 -3.04 18.23 44.73 -2.27 17.91 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 37.42 3.90 29.26 38.47 2.36 30.22 coo 43.04 44.75 47.18 43.31 45.51 49.13 40.70 8.14 28.73 41.06 6.40 29.84 coo 50.46 51.91 56.90 50.65 51.62 56.14 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 193 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 32.91 0.46 27.63 33.66 0.11 29.56 coo 43.04 44.75 47.18 43.31 45.51 49.13 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 50.46 51.91 56.90 50.65 51.62 56.14 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1a0j_c13 TRYPSIN user 4 3 # 4 B 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 32.91 0.46 27.63 33.66 0.11 29.56 coo 43.04 44.75 47.18 43.31 45.51 49.13 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 50.46 51.91 56.90 50.65 51.62 56.14 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1a0j_c13 TRYPSIN user 5 3 # 5 B 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo 44.08 45.58 52.81 45.86 46.55 52.85 32.91 0.46 27.63 33.66 0.11 29.56 coo 43.04 44.75 47.18 43.31 45.51 49.13 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 50.46 51.91 56.90 50.65 51.62 56.14 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 1a0j_c13 TRYPSIN user 6 3 # 6 B 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 193 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 32.91 0.46 27.63 33.66 0.11 29.56 coo 43.04 44.75 47.18 43.31 45.51 49.13 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 50.46 51.91 56.90 50.65 51.62 56.14 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1a0j_c13 TRYPSIN user 7 3 # 7 B 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 193 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 32.91 0.46 27.63 33.66 0.11 29.56 coo 43.04 44.75 47.18 43.31 45.51 49.13 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 50.46 51.91 56.90 50.65 51.62 56.14 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1a0j_c13 TRYPSIN user 8 3 # 8 B 57 HIS A 319 HIS~? 24.64 ZN ZN A 374 B 102 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 193 GLY A 277 GLY.? 24.28 ZN ZN A 374 coo 44.08 45.58 52.81 45.86 46.55 52.85 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 43.04 44.75 47.18 43.31 45.51 49.13 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 50.46 51.91 56.90 50.65 51.62 56.14 49.23 -14.07 46.91 49.73 -13.44 47.06 ULMN 3 1a0j_c13 TRYPSIN user 9 3 # 9 B 57 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 193 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 43.04 44.75 47.18 43.31 45.51 49.13 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 50.46 51.91 56.90 50.65 51.62 56.14 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1a0j_c13 TRYPSIN user 10 3 # 10 B 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 43.04 44.75 47.18 43.31 45.51 49.13 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 50.46 51.91 56.90 50.65 51.62 56.14 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1a0j_c13 TRYPSIN user 11 3 # 11 B 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 50.46 51.91 56.90 50.65 51.62 56.14 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1a0j_c13 TRYPSIN user 12 3 # 12 B 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo 44.08 45.58 52.81 45.86 46.55 52.85 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 50.46 51.91 56.90 50.65 51.62 56.14 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 1a0j_c13 TRYPSIN user 13 3 # 13 B 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 193 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 50.46 51.91 56.90 50.65 51.62 56.14 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1a0j_c13 TRYPSIN user 14 3 # 14 B 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 193 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 50.46 51.91 56.90 50.65 51.62 56.14 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1a0j_c13 TRYPSIN user 15 3 # 15 B 57 HIS B 319 HIS~? 24.73 ZN ZN B 374 B 102 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 193 GLY B 277 GLY.? 24.23 ZN ZN B 374 coo 44.08 45.58 52.81 45.86 46.55 52.85 8.16 23.53 21.75 7.85 25.60 21.62 coo 43.04 44.75 47.18 43.31 45.51 49.13 9.35 16.65 21.02 10.22 16.89 22.90 coo 50.46 51.91 56.90 50.65 51.62 56.14 3.65 23.16 11.55 3.12 23.75 11.78 ULMN 3 1a0j_c13 TRYPSIN user 16 3 # 16 B 57 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 193 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 43.04 44.75 47.18 43.31 45.51 49.13 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 50.46 51.91 56.90 50.65 51.62 56.14 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 1a0j_c13 TRYPSIN user 17 3 # 17 B 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 43.04 44.75 47.18 43.31 45.51 49.13 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 50.46 51.91 56.90 50.65 51.62 56.14 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1a0j_c13 TRYPSIN user 18 3 # 18 B 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 43.04 44.75 47.18 43.31 45.51 49.13 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 50.46 51.91 56.90 50.65 51.62 56.14 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1a0j_c13 TRYPSIN user 19 3 # 19 B 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo 44.08 45.58 52.81 45.86 46.55 52.85 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 43.04 44.75 47.18 43.31 45.51 49.13 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 50.46 51.91 56.90 50.65 51.62 56.14 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 1a0j_c13 TRYPSIN user 20 3 # 20 B 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 193 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 43.04 44.75 47.18 43.31 45.51 49.13 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 50.46 51.91 56.90 50.65 51.62 56.14 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1a0j_c13 TRYPSIN user 21 3 # 21 B 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 193 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 44.08 45.58 52.81 45.86 46.55 52.85 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 43.04 44.75 47.18 43.31 45.51 49.13 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 50.46 51.91 56.90 50.65 51.62 56.14 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1a0j_c13 TRYPSIN user 22 3 # 22 B 57 HIS C 319 HIS~? 24.70 ZN ZN C 374 B 102 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 193 GLY C 277 GLY.? 24.27 ZN ZN C 374 coo 44.08 45.58 52.81 45.86 46.55 52.85 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 43.04 44.75 47.18 43.31 45.51 49.13 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 50.46 51.91 56.90 50.65 51.62 56.14 -18.35 -23.56 56.48 -18.29 -23.66 57.31 1a0j_c13 source 1a0j TRYPSIN : 22 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 193 GLY A 342 GLY~? 12.90 ZN ZN A 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 37.80 0.44 25.56 37.02 -1.29 26.44 coo 34.89 38.34 78.12 35.11 39.59 76.42 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 35.43 51.03 72.12 35.20 50.72 72.87 44.89 -3.04 18.23 44.73 -2.27 17.91 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 37.42 3.90 29.26 38.47 2.36 30.22 coo 34.89 38.34 78.12 35.11 39.59 76.42 40.70 8.14 28.73 41.06 6.40 29.84 coo 35.43 51.03 72.12 35.20 50.72 72.87 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1a0j_c14 TRYPSIN user 3 3 # 3 C 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo 34.37 41.18 73.21 34.04 43.09 73.87 37.42 3.90 29.26 38.47 2.36 30.22 coo 34.89 38.34 78.12 35.11 39.59 76.42 40.70 8.14 28.73 41.06 6.40 29.84 coo 35.43 51.03 72.12 35.20 50.72 72.87 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 1a0j_c14 TRYPSIN user 4 3 # 4 C 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 193 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 32.91 0.46 27.63 33.66 0.11 29.56 coo 34.89 38.34 78.12 35.11 39.59 76.42 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 35.43 51.03 72.12 35.20 50.72 72.87 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1a0j_c14 TRYPSIN user 5 3 # 5 C 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 32.91 0.46 27.63 33.66 0.11 29.56 coo 34.89 38.34 78.12 35.11 39.59 76.42 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 35.43 51.03 72.12 35.20 50.72 72.87 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1a0j_c14 TRYPSIN user 6 3 # 6 C 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo 34.37 41.18 73.21 34.04 43.09 73.87 32.91 0.46 27.63 33.66 0.11 29.56 coo 34.89 38.34 78.12 35.11 39.59 76.42 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 35.43 51.03 72.12 35.20 50.72 72.87 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 1a0j_c14 TRYPSIN user 7 3 # 7 C 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 193 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 32.91 0.46 27.63 33.66 0.11 29.56 coo 34.89 38.34 78.12 35.11 39.59 76.42 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 35.43 51.03 72.12 35.20 50.72 72.87 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1a0j_c14 TRYPSIN user 8 3 # 8 C 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 193 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 32.91 0.46 27.63 33.66 0.11 29.56 coo 34.89 38.34 78.12 35.11 39.59 76.42 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 35.43 51.03 72.12 35.20 50.72 72.87 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1a0j_c14 TRYPSIN user 9 3 # 9 C 57 HIS A 319 HIS~? 24.64 ZN ZN A 374 C 102 ASP A 320 ASP~? -21.81 ZN ZN A 374s C 193 GLY A 277 GLY.? 24.28 ZN ZN A 374 coo 34.37 41.18 73.21 34.04 43.09 73.87 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 34.89 38.34 78.12 35.11 39.59 76.42 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 35.43 51.03 72.12 35.20 50.72 72.87 49.23 -14.07 46.91 49.73 -13.44 47.06 ULMN 3 1a0j_c14 TRYPSIN user 10 3 # 10 C 57 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 193 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 34.89 38.34 78.12 35.11 39.59 76.42 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 35.43 51.03 72.12 35.20 50.72 72.87 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1a0j_c14 TRYPSIN user 11 3 # 11 C 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 34.89 38.34 78.12 35.11 39.59 76.42 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 35.43 51.03 72.12 35.20 50.72 72.87 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1a0j_c14 TRYPSIN user 12 3 # 12 C 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo 34.37 41.18 73.21 34.04 43.09 73.87 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 34.89 38.34 78.12 35.11 39.59 76.42 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 35.43 51.03 72.12 35.20 50.72 72.87 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 1a0j_c14 TRYPSIN user 13 3 # 13 C 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 35.43 51.03 72.12 35.20 50.72 72.87 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1a0j_c14 TRYPSIN user 14 3 # 14 C 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo 34.37 41.18 73.21 34.04 43.09 73.87 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 35.43 51.03 72.12 35.20 50.72 72.87 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 1a0j_c14 TRYPSIN user 15 3 # 15 C 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 193 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 35.43 51.03 72.12 35.20 50.72 72.87 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1a0j_c14 TRYPSIN user 16 3 # 16 C 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 193 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 35.43 51.03 72.12 35.20 50.72 72.87 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1a0j_c14 TRYPSIN user 17 3 # 17 C 57 HIS B 319 HIS~? 24.73 ZN ZN B 374 C 102 ASP B 320 ASP~? -21.78 ZN ZN B 374s C 193 GLY B 277 GLY.? 24.23 ZN ZN B 374 coo 34.37 41.18 73.21 34.04 43.09 73.87 8.16 23.53 21.75 7.85 25.60 21.62 coo 34.89 38.34 78.12 35.11 39.59 76.42 9.35 16.65 21.02 10.22 16.89 22.90 coo 35.43 51.03 72.12 35.20 50.72 72.87 3.65 23.16 11.55 3.12 23.75 11.78 ULMN 3 1a0j_c14 TRYPSIN user 18 3 # 18 C 57 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 193 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 34.89 38.34 78.12 35.11 39.59 76.42 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 35.43 51.03 72.12 35.20 50.72 72.87 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 1a0j_c14 TRYPSIN user 19 3 # 19 C 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 34.89 38.34 78.12 35.11 39.59 76.42 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 35.43 51.03 72.12 35.20 50.72 72.87 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1a0j_c14 TRYPSIN user 20 3 # 20 C 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo 34.37 41.18 73.21 34.04 43.09 73.87 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 34.89 38.34 78.12 35.11 39.59 76.42 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 35.43 51.03 72.12 35.20 50.72 72.87 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 1a0j_c14 TRYPSIN user 21 3 # 21 C 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 C 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 34.89 38.34 78.12 35.11 39.59 76.42 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 35.43 51.03 72.12 35.20 50.72 72.87 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1a0j_c14 TRYPSIN user 22 3 # 22 C 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 C 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo 34.37 41.18 73.21 34.04 43.09 73.87 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 34.89 38.34 78.12 35.11 39.59 76.42 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 35.43 51.03 72.12 35.20 50.72 72.87 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 1a0j_c14 TRYPSIN user 23 3 # 23 C 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 193 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 34.89 38.34 78.12 35.11 39.59 76.42 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 35.43 51.03 72.12 35.20 50.72 72.87 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1a0j_c14 TRYPSIN user 24 3 # 24 C 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 193 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 34.37 41.18 73.21 34.04 43.09 73.87 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 34.89 38.34 78.12 35.11 39.59 76.42 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 35.43 51.03 72.12 35.20 50.72 72.87 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1a0j_c14 TRYPSIN user 25 3 # 25 C 57 HIS C 319 HIS~? 24.70 ZN ZN C 374 C 102 ASP C 320 ASP~? -21.75 ZN ZN C 374s C 193 GLY C 277 GLY.? 24.27 ZN ZN C 374 coo 34.37 41.18 73.21 34.04 43.09 73.87 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 34.89 38.34 78.12 35.11 39.59 76.42 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 35.43 51.03 72.12 35.20 50.72 72.87 -18.35 -23.56 56.48 -18.29 -23.66 57.31 1a0j_c14 source 1a0j TRYPSIN : 25 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 193 GLY A 342 GLY~? 12.90 ZN ZN A 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 37.80 0.44 25.56 37.02 -1.29 26.44 coo 13.53 16.28 93.98 11.45 16.21 94.40 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 1.80 21.25 100.04 2.61 21.42 100.18 44.89 -3.04 18.23 44.73 -2.27 17.91 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 37.42 3.90 29.26 38.47 2.36 30.22 coo 13.53 16.28 93.98 11.45 16.21 94.40 40.70 8.14 28.73 41.06 6.40 29.84 coo 1.80 21.25 100.04 2.61 21.42 100.18 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 193 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 32.91 0.46 27.63 33.66 0.11 29.56 coo 13.53 16.28 93.98 11.45 16.21 94.40 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 1.80 21.25 100.04 2.61 21.42 100.18 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1a0j_c15 TRYPSIN user 4 3 # 4 D 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 32.91 0.46 27.63 33.66 0.11 29.56 coo 13.53 16.28 93.98 11.45 16.21 94.40 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 1.80 21.25 100.04 2.61 21.42 100.18 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1a0j_c15 TRYPSIN user 5 3 # 5 D 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo 8.19 15.01 95.72 7.78 16.53 97.01 32.91 0.46 27.63 33.66 0.11 29.56 coo 13.53 16.28 93.98 11.45 16.21 94.40 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 1.80 21.25 100.04 2.61 21.42 100.18 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 1a0j_c15 TRYPSIN user 6 3 # 6 D 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 193 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 32.91 0.46 27.63 33.66 0.11 29.56 coo 13.53 16.28 93.98 11.45 16.21 94.40 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 1.80 21.25 100.04 2.61 21.42 100.18 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1a0j_c15 TRYPSIN user 7 3 # 7 D 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 193 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 32.91 0.46 27.63 33.66 0.11 29.56 coo 13.53 16.28 93.98 11.45 16.21 94.40 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 1.80 21.25 100.04 2.61 21.42 100.18 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1a0j_c15 TRYPSIN user 8 3 # 8 D 57 HIS A 319 HIS~? 24.64 ZN ZN A 374 D 102 ASP A 320 ASP~? -21.81 ZN ZN A 374s D 193 GLY A 277 GLY.? 24.28 ZN ZN A 374 coo 8.19 15.01 95.72 7.78 16.53 97.01 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 13.53 16.28 93.98 11.45 16.21 94.40 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 1.80 21.25 100.04 2.61 21.42 100.18 49.23 -14.07 46.91 49.73 -13.44 47.06 ULMN 3 1a0j_c15 TRYPSIN user 9 3 # 9 D 57 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 193 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 13.53 16.28 93.98 11.45 16.21 94.40 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 1.80 21.25 100.04 2.61 21.42 100.18 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1a0j_c15 TRYPSIN user 10 3 # 10 D 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 13.53 16.28 93.98 11.45 16.21 94.40 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 1.80 21.25 100.04 2.61 21.42 100.18 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1a0j_c15 TRYPSIN user 11 3 # 11 D 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 1.80 21.25 100.04 2.61 21.42 100.18 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1a0j_c15 TRYPSIN user 12 3 # 12 D 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo 8.19 15.01 95.72 7.78 16.53 97.01 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 1.80 21.25 100.04 2.61 21.42 100.18 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 1a0j_c15 TRYPSIN user 13 3 # 13 D 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 193 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 1.80 21.25 100.04 2.61 21.42 100.18 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1a0j_c15 TRYPSIN user 14 3 # 14 D 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 193 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 1.80 21.25 100.04 2.61 21.42 100.18 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1a0j_c15 TRYPSIN user 15 3 # 15 D 57 HIS B 319 HIS~? 24.73 ZN ZN B 374 D 102 ASP B 320 ASP~? -21.78 ZN ZN B 374s D 193 GLY B 277 GLY.? 24.23 ZN ZN B 374 coo 8.19 15.01 95.72 7.78 16.53 97.01 8.16 23.53 21.75 7.85 25.60 21.62 coo 13.53 16.28 93.98 11.45 16.21 94.40 9.35 16.65 21.02 10.22 16.89 22.90 coo 1.80 21.25 100.04 2.61 21.42 100.18 3.65 23.16 11.55 3.12 23.75 11.78 ULMN 3 1a0j_c15 TRYPSIN user 16 3 # 16 D 57 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 193 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 13.53 16.28 93.98 11.45 16.21 94.40 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 1.80 21.25 100.04 2.61 21.42 100.18 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 1a0j_c15 TRYPSIN user 17 3 # 17 D 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 13.53 16.28 93.98 11.45 16.21 94.40 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 1.80 21.25 100.04 2.61 21.42 100.18 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1a0j_c15 TRYPSIN user 18 3 # 18 D 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 13.53 16.28 93.98 11.45 16.21 94.40 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 1.80 21.25 100.04 2.61 21.42 100.18 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1a0j_c15 TRYPSIN user 19 3 # 19 D 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo 8.19 15.01 95.72 7.78 16.53 97.01 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 13.53 16.28 93.98 11.45 16.21 94.40 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 1.80 21.25 100.04 2.61 21.42 100.18 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 1a0j_c15 TRYPSIN user 20 3 # 20 D 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 193 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 13.53 16.28 93.98 11.45 16.21 94.40 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 1.80 21.25 100.04 2.61 21.42 100.18 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1a0j_c15 TRYPSIN user 21 3 # 21 D 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 193 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 8.19 15.01 95.72 7.78 16.53 97.01 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 13.53 16.28 93.98 11.45 16.21 94.40 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 1.80 21.25 100.04 2.61 21.42 100.18 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1a0j_c15 TRYPSIN user 22 3 # 22 D 57 HIS C 319 HIS~? 24.70 ZN ZN C 374 D 102 ASP C 320 ASP~? -21.75 ZN ZN C 374s D 193 GLY C 277 GLY.? 24.27 ZN ZN C 374 coo 8.19 15.01 95.72 7.78 16.53 97.01 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 13.53 16.28 93.98 11.45 16.21 94.40 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 1.80 21.25 100.04 2.61 21.42 100.18 -18.35 -23.56 56.48 -18.29 -23.66 57.31 1a0j_c15 source 1a0j TRYPSIN : 22 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 41 ARG.? 31.19 ZN ZN A 375 265 HIS A 361 HIS^? 22.47 ZN ZN A 375 274 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo -15.18 55.46 8.55 -14.82 52.98 10.38 42.11 12.31 4.12 44.66 13.27 2.71 coo -14.48 45.59 11.18 -14.02 47.49 10.42 46.25 9.10 12.92 46.66 10.09 11.12 coo 0.94 52.26 9.16 1.95 54.78 9.91 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 153 ARG~? 11.00 C6 EPE C 377 265 HIS A 148 HIS~? 11.43 C8 EPE A 377 274 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo -15.18 55.46 8.55 -14.82 52.98 10.38 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo -14.48 45.59 11.18 -14.02 47.49 10.42 14.41 -28.00 -10.43 13.63 -27.83 -12.37 coo 0.94 52.26 9.16 1.95 54.78 9.91 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG A 153 ARG~? 11.00 C6 EPE C 377 265 HIS A 169 HIS^? 11.22 O1S EPE C 377 274 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo -15.18 55.46 8.55 -14.82 52.98 10.38 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo -14.48 45.59 11.18 -14.02 47.49 10.42 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 0.94 52.26 9.16 1.95 54.78 9.91 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG A 284 ARG^? 28.58 ZN ZN A 375 265 HIS A 263 HIS~? 20.93 ZN ZN A 375 274 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo -15.18 55.46 8.55 -14.82 52.98 10.38 52.06 -24.03 32.92 53.49 -25.85 30.90 coo -14.48 45.59 11.18 -14.02 47.49 10.42 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 0.94 52.26 9.16 1.95 54.78 9.91 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1a41_c01 TOPOISOMERASE I user 5 3 # 5 223 ARG B 153 ARG~? 10.73 C6 EPE A 377 265 HIS B 148 HIS~? 20.83 O3S EPE A 377 274 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -6.64 -44.75 10.12 -7.62 -46.49 10.77 coo 0.94 52.26 9.16 1.95 54.78 9.91 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 1a41_c01 TOPOISOMERASE I user 6 3 # 6 223 ARG B 153 ARG~? 10.73 C6 EPE A 377 265 HIS B 224 HIS.? 17.79 O2S EPE A 377 274 TYR B 234 TYR^? 11.34 O2S EPE A 377 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 0.94 52.26 9.16 1.95 54.78 9.91 8.50 -28.26 15.53 9.64 -30.80 15.55 ULMN 3 1a41_c01 TOPOISOMERASE I user 7 3 # 7 223 ARG B 198 ARG^? 21.95 C2 EPE C 377 265 HIS C 169 HIS^? 22.39 O1 TRS A 378 274 TYR B 226 TYR.? 21.63 O2S EPE A 377 coo -15.18 55.46 8.55 -14.82 52.98 10.38 11.64 -52.94 14.57 14.19 -52.83 16.31 coo -14.48 45.59 11.18 -14.02 47.49 10.42 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 0.94 52.26 9.16 1.95 54.78 9.91 -2.18 -44.73 18.44 0.01 -45.92 17.08 ULMN 3 1a41_c01 TOPOISOMERASE I user 8 3 # 8 223 ARG C 153 ARG~? 15.97 C2 EPE C 377 265 HIS C 148 HIS~? 13.04 O8 EPE C 377 274 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo -15.18 55.46 8.55 -14.82 52.98 10.38 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -14.48 45.59 11.18 -14.02 47.49 10.42 27.13 -47.60 14.36 28.94 -48.66 14.50 coo 0.94 52.26 9.16 1.95 54.78 9.91 23.23 -33.44 18.32 24.66 -32.16 20.35 ULMN 3 1a41_c01 TOPOISOMERASE I user 9 3 # 9 223 ARG C 153 ARG~? 15.97 C2 EPE C 377 265 HIS C 169 HIS^? 22.39 O1 TRS A 378 274 TYR B 226 TYR.? 21.63 O2S EPE A 377 coo -15.18 55.46 8.55 -14.82 52.98 10.38 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -14.48 45.59 11.18 -14.02 47.49 10.42 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 0.94 52.26 9.16 1.95 54.78 9.91 -2.18 -44.73 18.44 0.01 -45.92 17.08 ULMN 3 1a41_c01 TOPOISOMERASE I user 10 3 # 10 223 ARG C 153 ARG~? 15.97 C2 EPE C 377 265 HIS C 169 HIS^? 22.39 O1 TRS A 378 274 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo -15.18 55.46 8.55 -14.82 52.98 10.38 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -14.48 45.59 11.18 -14.02 47.49 10.42 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 0.94 52.26 9.16 1.95 54.78 9.91 23.23 -33.44 18.32 24.66 -32.16 20.35 1a41_c01 source 1a41 TOPOISOMERASE I : 10 hits 1a41_c01 naa= 3 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 40 LYS A 28 LYS.? 12.48 C7 EPE A 376 B 114 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 37.80 0.44 25.56 37.02 -1.29 26.44 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 26.87 3.56 26.76 22.81 3.70 30.35 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 2 3 # 2 B 13 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 40 LYS A 28 LYS.? 12.48 C7 EPE A 376 B 114 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 37.42 3.90 29.26 38.47 2.36 30.22 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 26.87 3.56 26.76 22.81 3.70 30.35 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 3 3 # 3 B 13 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 40 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 114 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 37.42 3.90 29.26 38.47 2.36 30.22 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 44.47 1.55 20.70 47.30 5.10 24.27 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 4 3 # 4 B 13 HIS A 224 HIS~? 7.33 C7 EPE A 377 B 40 LYS A 218 LYS~? 21.49 C3 EPE A 377 B 114 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 5 3 # 5 B 13 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 40 LYS A 337 LYS~? 14.02 ZN ZN A 374 B 114 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 40.60 0.33 34.12 38.69 0.39 33.24 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 45.66 0.76 26.15 51.53 0.58 28.90 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 6 3 # 6 B 13 HIS A 359 HIS^? 27.14 ZN ZN A 375 B 40 LYS A 350 LYS~? 21.83 ZN ZN A 375 B 114 HIS A 361 HIS^? 22.47 ZN ZN A 375 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 45.80 8.64 6.53 46.53 8.87 4.58 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 39.19 -2.77 6.68 35.27 -5.97 7.17 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 46.25 9.10 12.92 46.66 10.09 11.12 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 7 3 # 7 B 13 HIS A 361 HIS^? 22.47 ZN ZN A 375 B 40 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 114 HIS A 359 HIS^? 27.14 ZN ZN A 375 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 46.25 9.10 12.92 46.66 10.09 11.12 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 44.47 1.55 20.70 47.30 5.10 24.27 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 45.80 8.64 6.53 46.53 8.87 4.58 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 8 3 # 8 B 13 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 40 LYS B 28 LYS.? 11.75 C7 EPE B 376 B 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 9 3 # 9 B 13 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 40 LYS B 28 LYS.? 11.75 C7 EPE B 376 B 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 10 3 # 10 B 13 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 40 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 11 3 # 11 B 13 HIS B 224 HIS.? 17.79 O2S EPE A 377 B 40 LYS B 218 LYS~? 23.26 O3S EPE A 377 B 114 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 12 3 # 12 B 13 HIS B 316 HIS~? 20.54 O8 EPE B 376 B 40 LYS B 295 LYS.? 11.37 ZN ZN B 375 B 114 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 7.45 20.77 27.47 7.65 22.47 28.71 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 4.57 8.76 22.84 2.39 5.01 24.93 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 13 3 # 13 B 13 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 40 LYS C 28 LYS.? 13.32 C7 EPE C 376 B 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 15.95 -21.05 50.17 18.02 -16.90 49.10 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 14 3 # 14 B 13 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 40 LYS C 28 LYS.? 13.32 C7 EPE C 376 B 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 15.95 -21.05 50.17 18.02 -16.90 49.10 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 15 3 # 15 B 13 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 40 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 16 3 # 16 B 13 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 40 LYS C 218 LYS~? 12.80 O1 TRS A 378 B 114 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 26.24 -37.78 26.13 29.59 -36.75 30.95 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 27.13 -47.60 14.36 28.94 -48.66 14.50 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 17 3 # 17 B 13 HIS C 316 HIS~? -20.42 O8 EPE C 376s B 40 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 114 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 18 3 # 18 B 13 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 40 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 114 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 10.51 -24.81 51.94 8.80 -23.79 52.62 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 18 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS A 68 HIS.? -3.31 ZN ZN A 375s E 40 LYS A 28 LYS.? 12.48 C7 EPE A 376 E 114 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 37.80 0.44 25.56 37.02 -1.29 26.44 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 26.87 3.56 26.76 22.81 3.70 30.35 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 2 3 # 2 E 13 HIS A 69 HIS.? -3.40 ZN ZN A 374s E 40 LYS A 28 LYS.? 12.48 C7 EPE A 376 E 114 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 37.42 3.90 29.26 38.47 2.36 30.22 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 26.87 3.56 26.76 22.81 3.70 30.35 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 3 3 # 3 E 13 HIS A 69 HIS.? -3.40 ZN ZN A 374s E 40 LYS A 340 LYS~? 12.75 ZN ZN A 374 E 114 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 37.42 3.90 29.26 38.47 2.36 30.22 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 44.47 1.55 20.70 47.30 5.10 24.27 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 4 3 # 4 E 13 HIS A 224 HIS~? 7.33 C7 EPE A 377 E 40 LYS A 218 LYS~? 21.49 C3 EPE A 377 E 114 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 5 3 # 5 E 13 HIS A 333 HIS~? -3.55 ZN ZN A 374s E 40 LYS A 295 LYS.? 12.61 ZN ZN A 374 E 114 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 40.60 0.33 34.12 38.69 0.39 33.24 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 6 3 # 6 E 13 HIS A 359 HIS^? 27.14 ZN ZN A 375 E 40 LYS A 350 LYS~? 21.83 ZN ZN A 375 E 114 HIS A 361 HIS^? 22.47 ZN ZN A 375 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 45.80 8.64 6.53 46.53 8.87 4.58 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 46.25 9.10 12.92 46.66 10.09 11.12 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 7 3 # 7 E 13 HIS A 361 HIS^? 22.47 ZN ZN A 375 E 40 LYS A 340 LYS~? 12.75 ZN ZN A 374 E 114 HIS A 359 HIS^? 27.14 ZN ZN A 375 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 46.25 9.10 12.92 46.66 10.09 11.12 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 44.47 1.55 20.70 47.30 5.10 24.27 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 45.80 8.64 6.53 46.53 8.87 4.58 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 8 3 # 8 E 13 HIS B 68 HIS.? -3.38 ZN ZN B 375s E 40 LYS B 28 LYS.? 11.75 C7 EPE B 376 E 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 9 3 # 9 E 13 HIS B 69 HIS.? -3.36 ZN ZN B 374s E 40 LYS B 28 LYS.? 11.75 C7 EPE B 376 E 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 10 3 # 10 E 13 HIS B 69 HIS.? -3.36 ZN ZN B 374s E 40 LYS B 340 LYS~? 12.84 ZN ZN B 374 E 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 11 3 # 11 E 13 HIS B 224 HIS.? 17.79 O2S EPE A 377 E 40 LYS B 218 LYS~? 23.26 O3S EPE A 377 E 114 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 12 3 # 12 E 13 HIS B 316 HIS~? 20.54 O8 EPE B 376 E 40 LYS B 295 LYS.? 11.37 ZN ZN B 375 E 114 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 7.45 20.77 27.47 7.65 22.47 28.71 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 4.57 8.76 22.84 2.39 5.01 24.93 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 13 3 # 13 E 13 HIS C 68 HIS.? -3.41 ZN ZN C 375s E 40 LYS C 28 LYS.? 13.32 C7 EPE C 376 E 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 14 3 # 14 E 13 HIS C 69 HIS.? -3.39 ZN ZN C 374s E 40 LYS C 28 LYS.? 13.32 C7 EPE C 376 E 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 15 3 # 15 E 13 HIS C 69 HIS.? -3.39 ZN ZN C 374s E 40 LYS C 340 LYS~? 12.92 ZN ZN C 374 E 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 16 3 # 16 E 13 HIS C 224 HIS~? 8.36 C3 EPE C 377 E 40 LYS C 218 LYS~? 12.80 O1 TRS A 378 E 114 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 27.13 -47.60 14.36 28.94 -48.66 14.50 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 17 3 # 17 E 13 HIS C 316 HIS~? -20.42 O8 EPE C 376s E 40 LYS C 295 LYS.? 14.49 ZN ZN C 374 E 114 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 18 3 # 18 E 13 HIS C 333 HIS~? -3.37 ZN ZN C 374s E 40 LYS C 295 LYS.? 14.49 ZN ZN C 374 E 114 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 10.51 -24.81 51.94 8.80 -23.79 52.62 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 18 hits 1a4y_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 15 GLU~? 17.23 ZN ZN A 375 A 60 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 175 TYR A 18 TYR~? 11.08 ZN ZN A 375 coo 46.10 28.27 19.27 45.48 26.99 20.84 29.50 -0.46 14.62 27.65 0.59 14.66 coo 56.42 28.06 12.93 55.01 27.92 14.50 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 45.02 22.04 15.38 46.16 24.00 13.76 34.99 -4.02 17.62 37.68 -4.71 17.89 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 15 GLU~? 17.23 ZN ZN A 375 A 60 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 175 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo 46.10 28.27 19.27 45.48 26.99 20.84 29.50 -0.46 14.62 27.65 0.59 14.66 coo 56.42 28.06 12.93 55.01 27.92 14.50 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 45.02 22.04 15.38 46.16 24.00 13.76 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU A 135 GLU^? 12.87 C3 TRS A 378 A 60 ASP A 237 ASP^? 6.80 N TRS A 378 A 175 TYR A 133 TYR^? 12.87 O3 TRS A 378 coo 46.10 28.27 19.27 45.48 26.99 20.84 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 56.42 28.06 12.93 55.01 27.92 14.50 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 45.02 22.04 15.38 46.16 24.00 13.76 26.66 -12.84 21.54 25.55 -13.01 18.92 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU B 15 GLU~? 17.09 ZN ZN B 375 A 60 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 175 TYR B 18 TYR~? 10.93 ZN ZN B 375 coo 46.10 28.27 19.27 45.48 26.99 20.84 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 56.42 28.06 12.93 55.01 27.92 14.50 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 45.02 22.04 15.38 46.16 24.00 13.76 -12.77 -5.58 18.92 -13.52 -3.89 16.83 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU B 15 GLU~? 17.09 ZN ZN B 375 A 60 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 175 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 46.10 28.27 19.27 45.48 26.99 20.84 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 56.42 28.06 12.93 55.01 27.92 14.50 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 45.02 22.04 15.38 46.16 24.00 13.76 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 6 3 # 6 A 49 GLU B 201 GLU^? 17.83 O2S EPE A 377 A 60 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 175 TYR B 226 TYR.? 21.63 O2S EPE A 377 coo 46.10 28.27 19.27 45.48 26.99 20.84 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 56.42 28.06 12.93 55.01 27.92 14.50 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 45.02 22.04 15.38 46.16 24.00 13.76 -2.18 -44.73 18.44 0.01 -45.92 17.08 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 7 3 # 7 A 49 GLU C 15 GLU~? 17.26 ZN ZN C 375 A 60 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 175 TYR C 18 TYR.? 11.04 ZN ZN C 375 coo 46.10 28.27 19.27 45.48 26.99 20.84 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 56.42 28.06 12.93 55.01 27.92 14.50 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 45.02 22.04 15.38 46.16 24.00 13.76 12.32 -34.51 46.53 10.40 -36.24 47.57 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 8 3 # 8 A 49 GLU C 15 GLU~? 17.26 ZN ZN C 375 A 60 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 175 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo 46.10 28.27 19.27 45.48 26.99 20.84 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 56.42 28.06 12.93 55.01 27.92 14.50 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 45.02 22.04 15.38 46.16 24.00 13.76 20.27 -30.73 51.89 19.47 -30.85 49.23 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 8 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 125 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 156 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 37.80 0.44 25.56 37.02 -1.29 26.44 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR A 85 TYR~? -4.05 C2 EPE A 376s A 125 HIS A 80 HIS.? 6.41 O2S EPE A 376 A 156 LYS A 77 LYS.? 10.13 O1S EPE A 376 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 33.18 16.26 32.13 31.71 14.36 30.75 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 28.52 23.28 34.79 26.69 23.10 35.81 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 22.49 17.50 33.52 21.76 14.55 38.95 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 3 3 # 3 A 115 TYR A 100 TYR^? 14.62 ZN ZN A 375 A 125 HIS A 8 HIS~? 24.55 ZN ZN A 375 A 156 LYS A 38 LYS.? 22.26 C2 EPE A 376 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 31.64 5.60 17.48 30.43 3.13 17.07 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 26.75 7.68 8.85 25.49 8.72 10.18 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 30.55 14.65 7.31 33.02 15.96 12.69 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 4 3 # 4 A 115 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 125 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 156 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 5 3 # 5 A 115 TYR B 85 TYR~? 3.87 C2 EPE B 376 A 125 HIS B 80 HIS.? 6.72 O2S EPE B 376 A 156 LYS B 77 LYS.? 10.81 C10 EPE B 376 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -11.11 3.17 47.04 -5.49 6.11 47.22 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 6 3 # 6 A 115 TYR B 231 TYR^? 16.39 O2S EPE A 377 A 125 HIS B 224 HIS.? 17.79 O2S EPE A 377 A 156 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 7 3 # 7 A 115 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 125 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 156 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 8 3 # 8 A 115 TYR C 85 TYR~? -3.91 C2 EPE C 376s A 125 HIS C 80 HIS.? 6.69 O2S EPE C 376 A 156 LYS C 77 LYS.? 10.79 O2S EPE C 376 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 22.95 -10.74 60.05 19.36 -5.86 59.26 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 8 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 18 TYR~? 11.08 ZN ZN A 375 B 125 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 156 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 37.80 0.44 25.56 37.02 -1.29 26.44 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR A 85 TYR~? -4.05 C2 EPE A 376s B 125 HIS A 80 HIS.? 6.41 O2S EPE A 376 B 156 LYS A 77 LYS.? 10.13 O1S EPE A 376 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 33.18 16.26 32.13 31.71 14.36 30.75 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 28.52 23.28 34.79 26.69 23.10 35.81 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 22.49 17.50 33.52 21.76 14.55 38.95 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 3 3 # 3 B 115 TYR B 18 TYR~? 10.93 ZN ZN B 375 B 125 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 156 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 4 3 # 4 B 115 TYR B 85 TYR~? 3.87 C2 EPE B 376 B 125 HIS B 80 HIS.? 6.72 O2S EPE B 376 B 156 LYS B 77 LYS.? 10.81 C10 EPE B 376 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -11.11 3.17 47.04 -5.49 6.11 47.22 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 5 3 # 5 B 115 TYR B 231 TYR^? 16.39 O2S EPE A 377 B 125 HIS B 224 HIS.? 17.79 O2S EPE A 377 B 156 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 6 3 # 6 B 115 TYR C 18 TYR.? 11.04 ZN ZN C 375 B 125 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 156 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 7 3 # 7 B 115 TYR C 85 TYR~? -3.91 C2 EPE C 376s B 125 HIS C 80 HIS.? 6.69 O2S EPE C 376 B 156 LYS C 77 LYS.? 10.79 O2S EPE C 376 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 22.95 -10.74 60.05 19.36 -5.86 59.26 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 7 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 18 TYR~? 11.08 ZN ZN A 375 C 125 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 156 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 37.80 0.44 25.56 37.02 -1.29 26.44 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR A 85 TYR~? -4.05 C2 EPE A 376s C 125 HIS A 80 HIS.? 6.41 O2S EPE A 376 C 156 LYS A 77 LYS.? 10.13 O1S EPE A 376 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 33.18 16.26 32.13 31.71 14.36 30.75 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 28.52 23.28 34.79 26.69 23.10 35.81 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 22.49 17.50 33.52 21.76 14.55 38.95 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 3 3 # 3 C 115 TYR A 100 TYR^? 14.62 ZN ZN A 375 C 125 HIS A 8 HIS~? 24.55 ZN ZN A 375 C 156 LYS A 38 LYS.? 22.26 C2 EPE A 376 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 31.64 5.60 17.48 30.43 3.13 17.07 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 26.75 7.68 8.85 25.49 8.72 10.18 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 30.55 14.65 7.31 33.02 15.96 12.69 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 4 3 # 4 C 115 TYR B 18 TYR~? 10.93 ZN ZN B 375 C 125 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 156 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 5 3 # 5 C 115 TYR B 85 TYR~? 3.87 C2 EPE B 376 C 125 HIS B 80 HIS.? 6.72 O2S EPE B 376 C 156 LYS B 77 LYS.? 10.81 C10 EPE B 376 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -11.11 3.17 47.04 -5.49 6.11 47.22 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 6 3 # 6 C 115 TYR B 100 TYR^? 14.57 ZN ZN B 375 C 125 HIS B 8 HIS~? 24.51 ZN ZN B 375 C 156 LYS B 38 LYS.? 21.80 C3 EPE B 376 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -17.63 -5.70 28.19 -15.74 -7.29 26.85 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -21.73 -14.76 29.99 -21.14 -14.36 31.97 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -28.97 -12.32 32.11 -27.27 -6.31 33.15 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 7 3 # 7 C 115 TYR B 231 TYR^? 16.39 O2S EPE A 377 C 125 HIS B 224 HIS.? 17.79 O2S EPE A 377 C 156 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 8 3 # 8 C 115 TYR C 18 TYR.? 11.04 ZN ZN C 375 C 125 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 156 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 9 3 # 9 C 115 TYR C 85 TYR~? -3.91 C2 EPE C 376s C 125 HIS C 80 HIS.? 6.69 O2S EPE C 376 C 156 LYS C 77 LYS.? 10.79 O2S EPE C 376 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 22.95 -10.74 60.05 19.36 -5.86 59.26 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 9 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 18 TYR~? 11.08 ZN ZN A 375 D 125 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 156 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 54.10 1.42 85.16 54.14 4.17 85.62 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 61.27 5.43 85.32 62.73 6.38 86.49 37.80 0.44 25.56 37.02 -1.29 26.44 coo 60.28 4.62 76.00 58.35 6.41 80.65 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR A 85 TYR~? -4.05 C2 EPE A 376s D 125 HIS A 80 HIS.? 6.41 O2S EPE A 376 D 156 LYS A 77 LYS.? 10.13 O1S EPE A 376 coo 54.10 1.42 85.16 54.14 4.17 85.62 33.18 16.26 32.13 31.71 14.36 30.75 coo 61.27 5.43 85.32 62.73 6.38 86.49 28.52 23.28 34.79 26.69 23.10 35.81 coo 60.28 4.62 76.00 58.35 6.41 80.65 22.49 17.50 33.52 21.76 14.55 38.95 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 3 3 # 3 D 115 TYR B 18 TYR~? 10.93 ZN ZN B 375 D 125 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 156 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 54.10 1.42 85.16 54.14 4.17 85.62 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 61.27 5.43 85.32 62.73 6.38 86.49 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 60.28 4.62 76.00 58.35 6.41 80.65 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 4 3 # 4 D 115 TYR B 85 TYR~? 3.87 C2 EPE B 376 D 125 HIS B 80 HIS.? 6.72 O2S EPE B 376 D 156 LYS B 77 LYS.? 10.81 C10 EPE B 376 coo 54.10 1.42 85.16 54.14 4.17 85.62 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 61.27 5.43 85.32 62.73 6.38 86.49 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 60.28 4.62 76.00 58.35 6.41 80.65 -11.11 3.17 47.04 -5.49 6.11 47.22 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 5 3 # 5 D 115 TYR B 231 TYR^? 16.39 O2S EPE A 377 D 125 HIS B 224 HIS.? 17.79 O2S EPE A 377 D 156 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 54.10 1.42 85.16 54.14 4.17 85.62 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 61.27 5.43 85.32 62.73 6.38 86.49 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 60.28 4.62 76.00 58.35 6.41 80.65 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 6 3 # 6 D 115 TYR C 18 TYR.? 11.04 ZN ZN C 375 D 125 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 156 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 54.10 1.42 85.16 54.14 4.17 85.62 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 61.27 5.43 85.32 62.73 6.38 86.49 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 60.28 4.62 76.00 58.35 6.41 80.65 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 7 3 # 7 D 115 TYR C 85 TYR~? -3.91 C2 EPE C 376s D 125 HIS C 80 HIS.? 6.69 O2S EPE C 376 D 156 LYS C 77 LYS.? 10.79 O2S EPE C 376 coo 54.10 1.42 85.16 54.14 4.17 85.62 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 61.27 5.43 85.32 62.73 6.38 86.49 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 60.28 4.62 76.00 58.35 6.41 80.65 22.95 -10.74 60.05 19.36 -5.86 59.26 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 7 hits 1a79_c03 naa= 3 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 1 3 # 1 A 98 SER A 168 SER^? 10.80 O1S EPE C 377 A 228 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 257 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 9.47 41.64 34.15 9.10 39.28 33.93 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 2.03 38.95 28.44 3.60 38.60 29.83 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 6.85 37.62 29.99 7.50 38.47 31.78 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 2 3 # 2 A 98 SER B 168 SER^? 10.59 O3S EPE A 377 A 228 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 257 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 9.47 41.64 34.15 9.10 39.28 33.93 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 2.03 38.95 28.44 3.60 38.60 29.83 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 6.85 37.62 29.99 7.50 38.47 31.78 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 3 3 # 3 A 98 SER C 168 SER^? 24.11 O1 TRS A 378 A 228 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 257 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 9.47 41.64 34.15 9.10 39.28 33.93 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 2.03 38.95 28.44 3.60 38.60 29.83 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 6.85 37.62 29.99 7.50 38.47 31.78 13.13 -47.52 24.96 14.34 -48.17 26.54 1a7u_c02 source 1a7u CHLOROPEROXIDASE T : 3 hits 1a7u_c02 naa= 3 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 1 3 # 1 B 98 SER A 168 SER^? 10.80 O1S EPE C 377 B 228 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 257 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 28.35 71.07 3.94 30.08 69.46 4.49 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 32.76 68.02 0.70 31.21 68.44 2.05 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 2 3 # 2 B 98 SER B 168 SER^? 10.59 O3S EPE A 377 B 228 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 257 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 28.35 71.07 3.94 30.08 69.46 4.49 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 32.76 68.02 0.70 31.21 68.44 2.05 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 3 3 # 3 B 98 SER C 168 SER^? 24.11 O1 TRS A 378 B 228 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 257 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 28.35 71.07 3.94 30.08 69.46 4.49 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 32.76 68.02 0.70 31.21 68.44 2.05 13.13 -47.52 24.96 14.34 -48.17 26.54 1a7u_c03 source 1a7u CHLOROPEROXIDASE T : 3 hits 1a7u_c03 naa= 3 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 1 3 # 1 16 ALA A 46 ALA^? 12.15 ZN ZN A 374 19 HIS A 68 HIS.? -3.31 ZN ZN A 375s 22 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 41.72 6.36 22.02 41.31 7.82 22.33 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.80 0.44 25.56 37.02 -1.29 26.44 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 2 3 # 2 16 ALA A 46 ALA^? 12.15 ZN ZN A 374 19 HIS A 69 HIS.? -3.40 ZN ZN A 374s 22 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 41.72 6.36 22.02 41.31 7.82 22.33 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.42 3.90 29.26 38.47 2.36 30.22 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 3 3 # 3 16 ALA A 57 ALA~? 19.05 C2 EPE A 376 19 HIS A 42 HIS^? 26.23 ZN ZN A 375 22 HIS A 361 HIS^? 22.47 ZN ZN A 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 42.98 14.90 17.25 41.58 14.60 17.74 coo 46.88 33.59 48.26 46.24 34.32 46.40 43.48 12.60 9.22 44.86 13.19 7.76 coo 48.05 31.12 44.60 48.20 33.05 43.77 46.25 9.10 12.92 46.66 10.09 11.12 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 4 3 # 4 16 ALA A 57 ALA~? 19.05 C2 EPE A 376 19 HIS A 361 HIS^? 22.47 ZN ZN A 375 22 HIS A 42 HIS^? 26.23 ZN ZN A 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 42.98 14.90 17.25 41.58 14.60 17.74 coo 46.88 33.59 48.26 46.24 34.32 46.40 46.25 9.10 12.92 46.66 10.09 11.12 coo 48.05 31.12 44.60 48.20 33.05 43.77 43.48 12.60 9.22 44.86 13.19 7.76 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 5 3 # 5 16 ALA A 62 ALA.? 21.75 ZN ZN A 374 19 HIS A 359 HIS^? 27.14 ZN ZN A 375 22 HIS A 361 HIS^? 22.47 ZN ZN A 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 41.03 13.97 12.85 41.56 12.98 13.85 coo 46.88 33.59 48.26 46.24 34.32 46.40 45.80 8.64 6.53 46.53 8.87 4.58 coo 48.05 31.12 44.60 48.20 33.05 43.77 46.25 9.10 12.92 46.66 10.09 11.12 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 6 3 # 6 16 ALA A 67 ALA^? 10.32 ZN ZN A 374 19 HIS A 68 HIS.? -3.31 ZN ZN A 375s 22 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 37.22 5.65 22.28 37.04 6.85 23.17 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.80 0.44 25.56 37.02 -1.29 26.44 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 7 3 # 7 16 ALA A 67 ALA^? 10.32 ZN ZN A 374 19 HIS A 68 HIS.? -3.31 ZN ZN A 375s 22 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 37.22 5.65 22.28 37.04 6.85 23.17 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.80 0.44 25.56 37.02 -1.29 26.44 coo 48.05 31.12 44.60 48.20 33.05 43.77 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 8 3 # 8 16 ALA A 67 ALA^? 10.32 ZN ZN A 374 19 HIS A 69 HIS.? -3.40 ZN ZN A 374s 22 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 37.22 5.65 22.28 37.04 6.85 23.17 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.42 3.90 29.26 38.47 2.36 30.22 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 9 3 # 9 16 ALA A 67 ALA^? 10.32 ZN ZN A 374 19 HIS A 69 HIS.? -3.40 ZN ZN A 374s 22 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 37.22 5.65 22.28 37.04 6.85 23.17 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.42 3.90 29.26 38.47 2.36 30.22 coo 48.05 31.12 44.60 48.20 33.05 43.77 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 10 3 # 10 16 ALA A 67 ALA^? 10.32 ZN ZN A 374 19 HIS A 103 HIS~? -4.82 ZN ZN A 375s 22 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 37.22 5.65 22.28 37.04 6.85 23.17 coo 46.88 33.59 48.26 46.24 34.32 46.40 32.91 0.46 27.63 33.66 0.11 29.56 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 11 3 # 11 16 ALA A 67 ALA^? 10.32 ZN ZN A 374 19 HIS A 103 HIS~? -4.82 ZN ZN A 375s 22 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 37.22 5.65 22.28 37.04 6.85 23.17 coo 46.88 33.59 48.26 46.24 34.32 46.40 32.91 0.46 27.63 33.66 0.11 29.56 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 12 3 # 12 16 ALA A 101 ALA^? 11.28 ZN ZN A 375 19 HIS A 68 HIS.? -3.31 ZN ZN A 375s 22 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 32.09 5.17 22.05 31.25 5.48 23.29 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.80 0.44 25.56 37.02 -1.29 26.44 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 13 3 # 13 16 ALA A 101 ALA^? 11.28 ZN ZN A 375 19 HIS A 68 HIS.? -3.31 ZN ZN A 375s 22 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 32.09 5.17 22.05 31.25 5.48 23.29 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.80 0.44 25.56 37.02 -1.29 26.44 coo 48.05 31.12 44.60 48.20 33.05 43.77 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 14 3 # 14 16 ALA A 101 ALA^? 11.28 ZN ZN A 375 19 HIS A 69 HIS.? -3.40 ZN ZN A 374s 22 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 32.09 5.17 22.05 31.25 5.48 23.29 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.42 3.90 29.26 38.47 2.36 30.22 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 15 3 # 15 16 ALA A 101 ALA^? 11.28 ZN ZN A 375 19 HIS A 69 HIS.? -3.40 ZN ZN A 374s 22 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 32.09 5.17 22.05 31.25 5.48 23.29 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.42 3.90 29.26 38.47 2.36 30.22 coo 48.05 31.12 44.60 48.20 33.05 43.77 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 16 3 # 16 16 ALA A 101 ALA^? 11.28 ZN ZN A 375 19 HIS A 103 HIS~? -4.82 ZN ZN A 375s 22 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 32.09 5.17 22.05 31.25 5.48 23.29 coo 46.88 33.59 48.26 46.24 34.32 46.40 32.91 0.46 27.63 33.66 0.11 29.56 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 17 3 # 17 16 ALA A 101 ALA^? 11.28 ZN ZN A 375 19 HIS A 103 HIS~? -4.82 ZN ZN A 375s 22 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 32.09 5.17 22.05 31.25 5.48 23.29 coo 46.88 33.59 48.26 46.24 34.32 46.40 32.91 0.46 27.63 33.66 0.11 29.56 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 18 3 # 18 16 ALA A 102 ALA.? 9.34 ZN ZN A 375 19 HIS A 68 HIS.? -3.31 ZN ZN A 375s 22 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 33.09 1.52 21.68 34.14 1.27 20.64 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.80 0.44 25.56 37.02 -1.29 26.44 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 19 3 # 19 16 ALA A 102 ALA.? 9.34 ZN ZN A 375 19 HIS A 68 HIS.? -3.31 ZN ZN A 375s 22 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 33.09 1.52 21.68 34.14 1.27 20.64 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.80 0.44 25.56 37.02 -1.29 26.44 coo 48.05 31.12 44.60 48.20 33.05 43.77 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 20 3 # 20 16 ALA A 102 ALA.? 9.34 ZN ZN A 375 19 HIS A 69 HIS.? -3.40 ZN ZN A 374s 22 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 33.09 1.52 21.68 34.14 1.27 20.64 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.42 3.90 29.26 38.47 2.36 30.22 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 21 3 # 21 16 ALA A 102 ALA.? 9.34 ZN ZN A 375 19 HIS A 69 HIS.? -3.40 ZN ZN A 374s 22 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 33.09 1.52 21.68 34.14 1.27 20.64 coo 46.88 33.59 48.26 46.24 34.32 46.40 37.42 3.90 29.26 38.47 2.36 30.22 coo 48.05 31.12 44.60 48.20 33.05 43.77 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 22 3 # 22 16 ALA A 102 ALA.? 9.34 ZN ZN A 375 19 HIS A 103 HIS~? -4.82 ZN ZN A 375s 22 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 33.09 1.52 21.68 34.14 1.27 20.64 coo 46.88 33.59 48.26 46.24 34.32 46.40 32.91 0.46 27.63 33.66 0.11 29.56 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 23 3 # 23 16 ALA A 102 ALA.? 9.34 ZN ZN A 375 19 HIS A 103 HIS~? -4.82 ZN ZN A 375s 22 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 33.09 1.52 21.68 34.14 1.27 20.64 coo 46.88 33.59 48.26 46.24 34.32 46.40 32.91 0.46 27.63 33.66 0.11 29.56 coo 48.05 31.12 44.60 48.20 33.05 43.77 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 24 3 # 24 16 ALA A 318 ALA~? 19.12 ZN ZN A 374 19 HIS A 316 HIS~? 20.33 O8 EPE A 376 22 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 53.27 36.51 45.29 51.98 36.45 44.47 41.32 -8.99 47.30 42.41 -8.00 47.53 coo 46.88 33.59 48.26 46.24 34.32 46.40 36.36 -5.20 52.06 36.55 -4.24 53.92 coo 48.05 31.12 44.60 48.20 33.05 43.77 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 25 3 # 25 16 ALA B 46 ALA^? 12.02 ZN ZN B 374 19 HIS B 68 HIS.? -3.38 ZN ZN B 375s 22 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 -20.28 4.12 23.98 -20.70 4.20 25.49 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 26 3 # 26 16 ALA B 46 ALA^? 12.02 ZN ZN B 374 19 HIS B 69 HIS.? -3.36 ZN ZN B 374s 22 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 -20.28 4.12 23.98 -20.70 4.20 25.49 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 27 3 # 27 16 ALA B 57 ALA~? 18.97 C2 EPE B 376 19 HIS B 42 HIS^? 26.13 ZN ZN B 375 22 HIS B 361 HIS^? 22.30 ZN ZN B 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 -29.17 3.22 27.98 -28.03 2.53 28.68 coo 46.88 33.59 48.26 46.24 34.32 46.40 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 48.05 31.12 44.60 48.20 33.05 43.77 -29.54 0.86 20.66 -31.47 0.05 20.77 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 28 3 # 28 16 ALA B 57 ALA~? 18.97 C2 EPE B 376 19 HIS B 361 HIS^? 22.30 ZN ZN B 375 22 HIS B 42 HIS^? 26.13 ZN ZN B 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 -29.17 3.22 27.98 -28.03 2.53 28.68 coo 46.88 33.59 48.26 46.24 34.32 46.40 -29.54 0.86 20.66 -31.47 0.05 20.77 coo 48.05 31.12 44.60 48.20 33.05 43.77 -32.72 -2.76 23.44 -34.69 -2.87 22.69 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 29 3 # 29 16 ALA B 62 ALA.? 21.54 ZN ZN B 374 19 HIS B 359 HIS^? 24.30 ZN ZN B 375 22 HIS B 361 HIS^? 22.30 ZN ZN B 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo 46.88 33.59 48.26 46.24 34.32 46.40 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 48.05 31.12 44.60 48.20 33.05 43.77 -29.54 0.86 20.66 -31.47 0.05 20.77 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 30 3 # 30 16 ALA B 62 ALA.? 21.54 ZN ZN B 374 19 HIS B 361 HIS^? 22.30 ZN ZN B 375 22 HIS B 359 HIS^? 24.30 ZN ZN B 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo 46.88 33.59 48.26 46.24 34.32 46.40 -29.54 0.86 20.66 -31.47 0.05 20.77 coo 48.05 31.12 44.60 48.20 33.05 43.77 -31.70 -2.47 18.00 -31.61 -0.90 16.60 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 31 3 # 31 16 ALA B 67 ALA^? 10.44 ZN ZN B 374 19 HIS B 68 HIS.? -3.38 ZN ZN B 375s 22 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 32 3 # 32 16 ALA B 67 ALA^? 10.44 ZN ZN B 374 19 HIS B 68 HIS.? -3.38 ZN ZN B 375s 22 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 48.05 31.12 44.60 48.20 33.05 43.77 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 33 3 # 33 16 ALA B 67 ALA^? 10.44 ZN ZN B 374 19 HIS B 69 HIS.? -3.36 ZN ZN B 374s 22 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 34 3 # 34 16 ALA B 67 ALA^? 10.44 ZN ZN B 374 19 HIS B 69 HIS.? -3.36 ZN ZN B 374s 22 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 48.05 31.12 44.60 48.20 33.05 43.77 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 35 3 # 35 16 ALA B 67 ALA^? 10.44 ZN ZN B 374 19 HIS B 103 HIS~? 5.04 ZN ZN B 375 22 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 46.88 33.59 48.26 46.24 34.32 46.40 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 36 3 # 36 16 ALA B 67 ALA^? 10.44 ZN ZN B 374 19 HIS B 103 HIS~? 5.04 ZN ZN B 375 22 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 46.88 33.59 48.26 46.24 34.32 46.40 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 37 3 # 37 16 ALA B 101 ALA^? 11.06 ZN ZN B 375 19 HIS B 68 HIS.? -3.38 ZN ZN B 375s 22 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 38 3 # 38 16 ALA B 101 ALA^? 11.06 ZN ZN B 375 19 HIS B 68 HIS.? -3.38 ZN ZN B 375s 22 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 48.05 31.12 44.60 48.20 33.05 43.77 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 39 3 # 39 16 ALA B 101 ALA^? 11.06 ZN ZN B 375 19 HIS B 69 HIS.? -3.36 ZN ZN B 374s 22 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 40 3 # 40 16 ALA B 101 ALA^? 11.06 ZN ZN B 375 19 HIS B 69 HIS.? -3.36 ZN ZN B 374s 22 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 48.05 31.12 44.60 48.20 33.05 43.77 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 41 3 # 41 16 ALA B 101 ALA^? 11.06 ZN ZN B 375 19 HIS B 103 HIS~? 5.04 ZN ZN B 375 22 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 46.88 33.59 48.26 46.24 34.32 46.40 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 42 3 # 42 16 ALA B 101 ALA^? 11.06 ZN ZN B 375 19 HIS B 103 HIS~? 5.04 ZN ZN B 375 22 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 46.88 33.59 48.26 46.24 34.32 46.40 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 43 3 # 43 16 ALA B 102 ALA.? 9.36 ZN ZN B 375 19 HIS B 68 HIS.? -3.38 ZN ZN B 375s 22 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 44 3 # 44 16 ALA B 102 ALA.? 9.36 ZN ZN B 375 19 HIS B 68 HIS.? -3.38 ZN ZN B 375s 22 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 48.05 31.12 44.60 48.20 33.05 43.77 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 45 3 # 45 16 ALA B 102 ALA.? 9.36 ZN ZN B 375 19 HIS B 69 HIS.? -3.36 ZN ZN B 374s 22 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 46 3 # 46 16 ALA B 102 ALA.? 9.36 ZN ZN B 375 19 HIS B 69 HIS.? -3.36 ZN ZN B 374s 22 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 46.88 33.59 48.26 46.24 34.32 46.40 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 48.05 31.12 44.60 48.20 33.05 43.77 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 47 3 # 47 16 ALA B 102 ALA.? 9.36 ZN ZN B 375 19 HIS B 103 HIS~? 5.04 ZN ZN B 375 22 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 46.88 33.59 48.26 46.24 34.32 46.40 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 48 3 # 48 16 ALA B 102 ALA.? 9.36 ZN ZN B 375 19 HIS B 103 HIS~? 5.04 ZN ZN B 375 22 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 46.88 33.59 48.26 46.24 34.32 46.40 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 48.05 31.12 44.60 48.20 33.05 43.77 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 49 3 # 49 16 ALA B 318 ALA~? 19.05 ZN ZN B 374 19 HIS B 316 HIS~? 20.54 O8 EPE B 376 22 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 53.27 36.51 45.29 51.98 36.45 44.47 4.54 19.55 20.17 3.54 20.61 20.36 coo 46.88 33.59 48.26 46.24 34.32 46.40 7.45 20.77 27.47 7.65 22.47 28.71 coo 48.05 31.12 44.60 48.20 33.05 43.77 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 50 3 # 50 16 ALA B 318 ALA~? 19.05 ZN ZN B 374 19 HIS B 319 HIS~? 24.73 ZN ZN B 374 22 HIS B 316 HIS~? 20.54 O8 EPE B 376 coo 53.27 36.51 45.29 51.98 36.45 44.47 4.54 19.55 20.17 3.54 20.61 20.36 coo 46.88 33.59 48.26 46.24 34.32 46.40 8.16 23.53 21.75 7.85 25.60 21.62 coo 48.05 31.12 44.60 48.20 33.05 43.77 7.45 20.77 27.47 7.65 22.47 28.71 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 51 3 # 51 16 ALA B 362 ALA^? 16.08 ZN ZN B 375 19 HIS B 359 HIS^? 24.30 ZN ZN B 375 22 HIS B 361 HIS^? 22.30 ZN ZN B 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 -24.59 3.58 19.16 -24.10 3.96 17.83 coo 46.88 33.59 48.26 46.24 34.32 46.40 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 48.05 31.12 44.60 48.20 33.05 43.77 -29.54 0.86 20.66 -31.47 0.05 20.77 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 52 3 # 52 16 ALA B 362 ALA^? 16.08 ZN ZN B 375 19 HIS B 361 HIS^? 22.30 ZN ZN B 375 22 HIS B 359 HIS^? 24.30 ZN ZN B 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 -24.59 3.58 19.16 -24.10 3.96 17.83 coo 46.88 33.59 48.26 46.24 34.32 46.40 -29.54 0.86 20.66 -31.47 0.05 20.77 coo 48.05 31.12 44.60 48.20 33.05 43.77 -31.70 -2.47 18.00 -31.61 -0.90 16.60 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 53 3 # 53 16 ALA C 46 ALA^? 12.13 ZN ZN C 374 19 HIS C 68 HIS.? -3.41 ZN ZN C 375s 22 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 13.15 -33.59 59.71 14.10 -32.75 60.59 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 54 3 # 54 16 ALA C 46 ALA^? 12.13 ZN ZN C 374 19 HIS C 69 HIS.? -3.39 ZN ZN C 374s 22 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 13.15 -33.59 59.71 14.10 -32.75 60.59 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 55 3 # 55 16 ALA C 57 ALA~? 19.02 C3 EPE C 376 19 HIS C 42 HIS^? 26.23 ZN ZN C 375 22 HIS C 361 HIS^? 22.27 ZN ZN C 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 20.74 -36.43 65.42 20.93 -35.24 64.51 coo 46.88 33.59 48.26 46.24 34.32 46.40 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 48.05 31.12 44.60 48.20 33.05 43.77 17.80 -42.63 61.65 19.35 -43.97 62.12 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 56 3 # 56 16 ALA C 57 ALA~? 19.02 C3 EPE C 376 19 HIS C 361 HIS^? 22.27 ZN ZN C 375 22 HIS C 42 HIS^? 26.23 ZN ZN C 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 20.74 -36.43 65.42 20.93 -35.24 64.51 coo 46.88 33.59 48.26 46.24 34.32 46.40 17.80 -42.63 61.65 19.35 -43.97 62.12 coo 48.05 31.12 44.60 48.20 33.05 43.77 23.45 -43.42 61.49 24.00 -45.25 62.37 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 57 3 # 57 16 ALA C 62 ALA.? 21.65 ZN ZN C 375 19 HIS C 359 HIS^? 24.82 ZN ZN C 375 22 HIS C 361 HIS^? 22.27 ZN ZN C 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 23.65 -38.52 62.14 22.14 -38.28 62.04 coo 46.88 33.59 48.26 46.24 34.32 46.40 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 48.05 31.12 44.60 48.20 33.05 43.77 17.80 -42.63 61.65 19.35 -43.97 62.12 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 58 3 # 58 16 ALA C 62 ALA.? 21.65 ZN ZN C 375 19 HIS C 361 HIS^? 22.27 ZN ZN C 375 22 HIS C 359 HIS^? 24.82 ZN ZN C 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 23.65 -38.52 62.14 22.14 -38.28 62.04 coo 46.88 33.59 48.26 46.24 34.32 46.40 17.80 -42.63 61.65 19.35 -43.97 62.12 coo 48.05 31.12 44.60 48.20 33.05 43.77 19.80 -46.87 59.86 18.04 -47.50 60.82 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 59 3 # 59 16 ALA C 67 ALA^? 10.56 ZN ZN C 374 19 HIS C 68 HIS.? -3.41 ZN ZN C 375s 22 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 60 3 # 60 16 ALA C 67 ALA^? 10.56 ZN ZN C 374 19 HIS C 68 HIS.? -3.41 ZN ZN C 375s 22 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 48.05 31.12 44.60 48.20 33.05 43.77 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 61 3 # 61 16 ALA C 67 ALA^? 10.56 ZN ZN C 374 19 HIS C 69 HIS.? -3.39 ZN ZN C 374s 22 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 62 3 # 62 16 ALA C 67 ALA^? 10.56 ZN ZN C 374 19 HIS C 69 HIS.? -3.39 ZN ZN C 374s 22 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 48.05 31.12 44.60 48.20 33.05 43.77 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 63 3 # 63 16 ALA C 67 ALA^? 10.56 ZN ZN C 374 19 HIS C 103 HIS~? 4.97 ZN ZN C 375 22 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 46.88 33.59 48.26 46.24 34.32 46.40 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 64 3 # 64 16 ALA C 67 ALA^? 10.56 ZN ZN C 374 19 HIS C 103 HIS~? 4.97 ZN ZN C 375 22 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 46.88 33.59 48.26 46.24 34.32 46.40 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 65 3 # 65 16 ALA C 101 ALA^? 11.01 ZN ZN C 375 19 HIS C 68 HIS.? -3.41 ZN ZN C 375s 22 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 66 3 # 66 16 ALA C 101 ALA^? 11.01 ZN ZN C 375 19 HIS C 68 HIS.? -3.41 ZN ZN C 375s 22 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 48.05 31.12 44.60 48.20 33.05 43.77 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 67 3 # 67 16 ALA C 101 ALA^? 11.01 ZN ZN C 375 19 HIS C 69 HIS.? -3.39 ZN ZN C 374s 22 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 68 3 # 68 16 ALA C 101 ALA^? 11.01 ZN ZN C 375 19 HIS C 69 HIS.? -3.39 ZN ZN C 374s 22 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 48.05 31.12 44.60 48.20 33.05 43.77 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 69 3 # 69 16 ALA C 101 ALA^? 11.01 ZN ZN C 375 19 HIS C 103 HIS~? 4.97 ZN ZN C 375 22 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 46.88 33.59 48.26 46.24 34.32 46.40 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 70 3 # 70 16 ALA C 101 ALA^? 11.01 ZN ZN C 375 19 HIS C 103 HIS~? 4.97 ZN ZN C 375 22 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 46.88 33.59 48.26 46.24 34.32 46.40 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 71 3 # 71 16 ALA C 102 ALA.? 9.31 ZN ZN C 375 19 HIS C 68 HIS.? -3.41 ZN ZN C 375s 22 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 72 3 # 72 16 ALA C 102 ALA.? 9.31 ZN ZN C 375 19 HIS C 68 HIS.? -3.41 ZN ZN C 375s 22 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 48.05 31.12 44.60 48.20 33.05 43.77 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 73 3 # 73 16 ALA C 102 ALA.? 9.31 ZN ZN C 375 19 HIS C 69 HIS.? -3.39 ZN ZN C 374s 22 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 74 3 # 74 16 ALA C 102 ALA.? 9.31 ZN ZN C 375 19 HIS C 69 HIS.? -3.39 ZN ZN C 374s 22 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 53.27 36.51 45.29 51.98 36.45 44.47 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 46.88 33.59 48.26 46.24 34.32 46.40 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 48.05 31.12 44.60 48.20 33.05 43.77 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 75 3 # 75 16 ALA C 102 ALA.? 9.31 ZN ZN C 375 19 HIS C 103 HIS~? 4.97 ZN ZN C 375 22 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 53.27 36.51 45.29 51.98 36.45 44.47 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 46.88 33.59 48.26 46.24 34.32 46.40 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 76 3 # 76 16 ALA C 102 ALA.? 9.31 ZN ZN C 375 19 HIS C 103 HIS~? 4.97 ZN ZN C 375 22 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 53.27 36.51 45.29 51.98 36.45 44.47 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 46.88 33.59 48.26 46.24 34.32 46.40 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 48.05 31.12 44.60 48.20 33.05 43.77 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 77 3 # 77 16 ALA C 318 ALA~? 18.85 ZN ZN C 374 19 HIS C 316 HIS~? -20.42 O8 EPE C 376s 22 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 53.27 36.51 45.29 51.98 36.45 44.47 -11.35 -17.41 55.53 -11.30 -17.89 56.96 coo 46.88 33.59 48.26 46.24 34.32 46.40 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 48.05 31.12 44.60 48.20 33.05 43.77 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 78 3 # 78 16 ALA C 318 ALA~? 18.85 ZN ZN C 374 19 HIS C 319 HIS~? 24.70 ZN ZN C 374 22 HIS C 316 HIS~? -20.42 O8 EPE C 376s coo 53.27 36.51 45.29 51.98 36.45 44.47 -11.35 -17.41 55.53 -11.30 -17.89 56.96 coo 46.88 33.59 48.26 46.24 34.32 46.40 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 48.05 31.12 44.60 48.20 33.05 43.77 -9.15 -10.09 56.84 -9.69 -8.65 58.28 1a8h_c02 source 1a8h METHIONYL-TRNA SYNTHETASE : 78 hits 1a8h_c02 naa= 3 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 1 3 # 1 94 SER A 168 SER^? 10.80 O1S EPE C 377 223 ASP A 158 ASP~? 15.23 O1S EPE C 377 252 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 40.95 0.07 3.20 39.54 1.39 4.66 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 41.54 1.64 9.09 40.82 1.05 7.19 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 2 3 # 2 94 SER B 168 SER^? 10.59 O3S EPE A 377 223 ASP B 158 ASP~? 14.93 O3S EPE A 377 252 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 40.95 0.07 3.20 39.54 1.39 4.66 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 41.54 1.64 9.09 40.82 1.05 7.19 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 3 3 # 3 94 SER C 168 SER^? 24.11 O1 TRS A 378 223 ASP C 158 ASP~? 22.01 O1 TRS A 378 252 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 40.95 0.07 3.20 39.54 1.39 4.66 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 41.54 1.64 9.09 40.82 1.05 7.19 13.13 -47.52 24.96 14.34 -48.17 26.54 1a8q_c00 source 1a8q BROMOPEROXIDASE A1 : 3 hits 1a8q_c00 naa= 3 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 1 3 # 1 94 SER A 168 SER^? 10.80 O1S EPE C 377 224 ASP A 158 ASP~? 15.23 O1S EPE C 377 253 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 16.00 80.13 58.60 16.16 82.12 59.96 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 8.47 84.84 62.27 10.52 84.40 62.08 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 13.14 83.03 63.68 14.37 82.62 62.02 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 2 3 # 2 94 SER B 168 SER^? 10.59 O3S EPE A 377 224 ASP B 158 ASP~? 14.93 O3S EPE A 377 253 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 16.00 80.13 58.60 16.16 82.12 59.96 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 8.47 84.84 62.27 10.52 84.40 62.08 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 13.14 83.03 63.68 14.37 82.62 62.02 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 3 3 # 3 94 SER C 168 SER^? 24.11 O1 TRS A 378 224 ASP C 158 ASP~? 22.01 O1 TRS A 378 253 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 16.00 80.13 58.60 16.16 82.12 59.96 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 8.47 84.84 62.27 10.52 84.40 62.08 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 13.14 83.03 63.68 14.37 82.62 62.02 13.13 -47.52 24.96 14.34 -48.17 26.54 1a8s_c00 source 1a8s CHLOROPEROXIDASE F : 3 hits 1a8s_c00 naa= 3 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 1 3 # 1 44 LYS A 91 LYS~? 15.85 O2S EPE A 376 141 HIS A 359 HIS^? 27.14 ZN ZN A 375 333 ARG A 41 ARG.? 31.19 ZN ZN A 375 coo 69.56 26.03 31.04 72.53 30.39 31.84 36.23 21.81 22.32 41.86 22.67 23.70 coo 85.95 39.62 33.57 84.70 40.34 35.09 45.80 8.64 6.53 46.53 8.87 4.58 coo 87.31 36.08 32.89 89.57 36.58 34.95 42.11 12.31 4.12 44.66 13.27 2.71 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 2 3 # 2 44 LYS A 94 LYS~? 16.25 O2S EPE A 376 141 HIS A 359 HIS^? 27.14 ZN ZN A 375 333 ARG A 41 ARG.? 31.19 ZN ZN A 375 coo 69.56 26.03 31.04 72.53 30.39 31.84 33.79 23.90 18.72 34.24 28.62 22.89 coo 85.95 39.62 33.57 84.70 40.34 35.09 45.80 8.64 6.53 46.53 8.87 4.58 coo 87.31 36.08 32.89 89.57 36.58 34.95 42.11 12.31 4.12 44.66 13.27 2.71 1aa6_c01 source 1aa6 FORMATE DEHYDROGENASE H : 2 hits 1aa6_c01 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG C 153 ARG~? 15.97 C2 EPE C 377 78 HIS C 169 HIS^? 22.39 O1 TRS A 378 122 TYR C 133 TYR^? 16.76 ZN ZN C 375 coo 48.32 72.26 30.89 48.69 69.28 31.53 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 53.63 68.24 34.99 53.08 69.10 33.16 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 75.01 61.87 32.93 75.34 59.26 31.96 8.59 -26.93 36.99 10.82 -27.74 35.52 1ab4_c00 source 1ab4 GYRASE A : 1 hits 1ab4_c00 naa= 3 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 1 3 # 1 A 223 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 262 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 312 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 29.33 36.13 69.70 30.07 34.20 70.11 37.80 0.44 25.56 37.02 -1.29 26.44 coo 38.54 36.60 66.38 37.88 34.77 67.15 40.60 0.33 34.12 38.69 0.39 33.24 coo 30.62 37.23 61.07 30.08 35.73 62.49 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 2 3 # 2 A 223 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 262 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 312 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 29.33 36.13 69.70 30.07 34.20 70.11 37.80 0.44 25.56 37.02 -1.29 26.44 coo 38.54 36.60 66.38 37.88 34.77 67.15 40.60 0.33 34.12 38.69 0.39 33.24 coo 30.62 37.23 61.07 30.08 35.73 62.49 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 3 3 # 3 A 223 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 262 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 312 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 29.33 36.13 69.70 30.07 34.20 70.11 32.91 0.46 27.63 33.66 0.11 29.56 coo 38.54 36.60 66.38 37.88 34.77 67.15 40.60 0.33 34.12 38.69 0.39 33.24 coo 30.62 37.23 61.07 30.08 35.73 62.49 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 4 3 # 4 A 223 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 262 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 312 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 29.33 36.13 69.70 30.07 34.20 70.11 40.60 0.33 34.12 38.69 0.39 33.24 coo 38.54 36.60 66.38 37.88 34.77 67.15 37.80 0.44 25.56 37.02 -1.29 26.44 coo 30.62 37.23 61.07 30.08 35.73 62.49 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 5 3 # 5 A 223 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 262 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 312 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 29.33 36.13 69.70 30.07 34.20 70.11 40.60 0.33 34.12 38.69 0.39 33.24 coo 38.54 36.60 66.38 37.88 34.77 67.15 32.91 0.46 27.63 33.66 0.11 29.56 coo 30.62 37.23 61.07 30.08 35.73 62.49 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 6 3 # 6 A 223 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 262 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 312 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 29.33 36.13 69.70 30.07 34.20 70.11 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 38.54 36.60 66.38 37.88 34.77 67.15 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 30.62 37.23 61.07 30.08 35.73 62.49 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 7 3 # 7 A 223 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 262 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 312 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 29.33 36.13 69.70 30.07 34.20 70.11 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 38.54 36.60 66.38 37.88 34.77 67.15 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 30.62 37.23 61.07 30.08 35.73 62.49 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 8 3 # 8 A 223 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 262 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 312 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 29.33 36.13 69.70 30.07 34.20 70.11 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 38.54 36.60 66.38 37.88 34.77 67.15 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 30.62 37.23 61.07 30.08 35.73 62.49 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 9 3 # 9 A 223 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 262 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 312 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 29.33 36.13 69.70 30.07 34.20 70.11 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 38.54 36.60 66.38 37.88 34.77 67.15 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 30.62 37.23 61.07 30.08 35.73 62.49 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 10 3 # 10 A 223 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 262 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 312 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 29.33 36.13 69.70 30.07 34.20 70.11 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 38.54 36.60 66.38 37.88 34.77 67.15 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 30.62 37.23 61.07 30.08 35.73 62.49 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 11 3 # 11 A 223 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 262 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 312 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 29.33 36.13 69.70 30.07 34.20 70.11 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 38.54 36.60 66.38 37.88 34.77 67.15 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 30.62 37.23 61.07 30.08 35.73 62.49 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 12 3 # 12 A 223 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 262 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 312 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 29.33 36.13 69.70 30.07 34.20 70.11 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 38.54 36.60 66.38 37.88 34.77 67.15 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 30.62 37.23 61.07 30.08 35.73 62.49 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 13 3 # 13 A 223 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 262 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 312 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 29.33 36.13 69.70 30.07 34.20 70.11 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 38.54 36.60 66.38 37.88 34.77 67.15 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 30.62 37.23 61.07 30.08 35.73 62.49 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 14 3 # 14 A 223 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 262 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 312 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 29.33 36.13 69.70 30.07 34.20 70.11 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 38.54 36.60 66.38 37.88 34.77 67.15 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 30.62 37.23 61.07 30.08 35.73 62.49 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 15 3 # 15 A 223 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 262 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 312 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 29.33 36.13 69.70 30.07 34.20 70.11 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 38.54 36.60 66.38 37.88 34.77 67.15 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 30.62 37.23 61.07 30.08 35.73 62.49 10.65 -27.85 62.57 8.78 -27.40 61.73 1aj8_c00 source 1aj8 CITRATE SYNTHASE : 15 hits 1aj8_c00 naa= 3 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 1 3 # 1 B 223 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 262 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 312 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 23.86 29.50 91.20 24.12 31.58 91.00 37.80 0.44 25.56 37.02 -1.29 26.44 coo 29.35 31.42 99.15 28.72 33.09 98.04 40.60 0.33 34.12 38.69 0.39 33.24 coo 20.42 28.25 99.26 20.25 29.62 97.63 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 2 3 # 2 B 223 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 262 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 312 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 23.86 29.50 91.20 24.12 31.58 91.00 37.80 0.44 25.56 37.02 -1.29 26.44 coo 29.35 31.42 99.15 28.72 33.09 98.04 40.60 0.33 34.12 38.69 0.39 33.24 coo 20.42 28.25 99.26 20.25 29.62 97.63 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 3 3 # 3 B 223 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 262 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 312 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 23.86 29.50 91.20 24.12 31.58 91.00 40.60 0.33 34.12 38.69 0.39 33.24 coo 29.35 31.42 99.15 28.72 33.09 98.04 37.80 0.44 25.56 37.02 -1.29 26.44 coo 20.42 28.25 99.26 20.25 29.62 97.63 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 4 3 # 4 B 223 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 262 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 312 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 23.86 29.50 91.20 24.12 31.58 91.00 40.60 0.33 34.12 38.69 0.39 33.24 coo 29.35 31.42 99.15 28.72 33.09 98.04 32.91 0.46 27.63 33.66 0.11 29.56 coo 20.42 28.25 99.26 20.25 29.62 97.63 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 5 3 # 5 B 223 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 262 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 312 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 23.86 29.50 91.20 24.12 31.58 91.00 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 29.35 31.42 99.15 28.72 33.09 98.04 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 20.42 28.25 99.26 20.25 29.62 97.63 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 6 3 # 6 B 223 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 262 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 312 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 23.86 29.50 91.20 24.12 31.58 91.00 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 29.35 31.42 99.15 28.72 33.09 98.04 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 20.42 28.25 99.26 20.25 29.62 97.63 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 7 3 # 7 B 223 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 262 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 312 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 23.86 29.50 91.20 24.12 31.58 91.00 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 29.35 31.42 99.15 28.72 33.09 98.04 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 20.42 28.25 99.26 20.25 29.62 97.63 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 8 3 # 8 B 223 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 262 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 312 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 23.86 29.50 91.20 24.12 31.58 91.00 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 29.35 31.42 99.15 28.72 33.09 98.04 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 20.42 28.25 99.26 20.25 29.62 97.63 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 9 3 # 9 B 223 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 262 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 312 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 23.86 29.50 91.20 24.12 31.58 91.00 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 29.35 31.42 99.15 28.72 33.09 98.04 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 20.42 28.25 99.26 20.25 29.62 97.63 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 10 3 # 10 B 223 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 262 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 312 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 23.86 29.50 91.20 24.12 31.58 91.00 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 29.35 31.42 99.15 28.72 33.09 98.04 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 20.42 28.25 99.26 20.25 29.62 97.63 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 11 3 # 11 B 223 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 262 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 312 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 23.86 29.50 91.20 24.12 31.58 91.00 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 29.35 31.42 99.15 28.72 33.09 98.04 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 20.42 28.25 99.26 20.25 29.62 97.63 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 12 3 # 12 B 223 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 262 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 312 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 23.86 29.50 91.20 24.12 31.58 91.00 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 29.35 31.42 99.15 28.72 33.09 98.04 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 20.42 28.25 99.26 20.25 29.62 97.63 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 13 3 # 13 B 223 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 262 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 312 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 23.86 29.50 91.20 24.12 31.58 91.00 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 29.35 31.42 99.15 28.72 33.09 98.04 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 20.42 28.25 99.26 20.25 29.62 97.63 10.65 -27.85 62.57 8.78 -27.40 61.73 1aj8_c01 source 1aj8 CITRATE SYNTHASE : 13 hits 1aj8_c01 naa= 3 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR A 177 THR^? 8.80 C6 EPE A 377 350 PHE A 180 PHE^? 4.05 O8 EPE A 377 357 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo 17.85 20.47 14.62 16.85 19.84 12.80 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo 7.92 21.96 13.27 8.57 20.30 15.42 -0.71 -29.06 -4.30 -0.06 -29.96 -6.91 coo 8.82 20.77 7.90 10.59 19.75 9.80 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 2 3 # 2 252 THR B 177 THR^? 19.16 C2 EPE C 377 350 PHE B 180 PHE^? 25.23 O2S EPE A 377 357 CYH C 170 CYH^? 22.19 N TRS A 378 coo 17.85 20.47 14.62 16.85 19.84 12.80 9.43 -46.41 11.44 10.68 -47.97 10.55 coo 7.92 21.96 13.27 8.57 20.30 15.42 5.49 -47.88 21.09 3.41 -49.53 20.15 coo 8.82 20.77 7.90 10.59 19.75 9.80 9.66 -43.43 21.72 7.18 -43.27 22.99 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 3 3 # 3 252 THR C 177 THR^? 8.04 C8 EPE C 377 350 PHE C 180 PHE^? -4.33 O8 EPE C 377s 357 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo 17.85 20.47 14.62 16.85 19.84 12.80 20.64 -38.60 2.16 21.28 -38.84 0.08 coo 7.92 21.96 13.27 8.57 20.30 15.42 29.90 -34.68 4.21 31.04 -37.24 4.01 coo 8.82 20.77 7.90 10.59 19.75 9.80 25.74 -30.01 4.94 27.86 -30.22 6.82 1akd_c01 source 1akd CYTOCHROME P450CAM : 3 hits 1akd_c01 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS A 68 HIS.? -3.31 ZN ZN A 375s 320 HIS A 333 HIS~? -3.55 ZN ZN A 374s 375 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 37.80 0.44 25.56 37.02 -1.29 26.44 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 40.60 0.33 34.12 38.69 0.39 33.24 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1al6_c00 CITRATE SYNTHASE user 2 3 # 2 274 HIS A 103 HIS~? -4.82 ZN ZN A 375s 320 HIS A 333 HIS~? -3.55 ZN ZN A 374s 375 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 32.91 0.46 27.63 33.66 0.11 29.56 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 40.60 0.33 34.12 38.69 0.39 33.24 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1al6_c00 CITRATE SYNTHASE user 3 3 # 3 274 HIS A 333 HIS~? -3.55 ZN ZN A 374s 320 HIS A 68 HIS.? -3.31 ZN ZN A 375s 375 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 40.60 0.33 34.12 38.69 0.39 33.24 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 37.80 0.44 25.56 37.02 -1.29 26.44 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1al6_c00 CITRATE SYNTHASE user 4 3 # 4 274 HIS A 333 HIS~? -3.55 ZN ZN A 374s 320 HIS A 103 HIS~? -4.82 ZN ZN A 375s 375 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 40.60 0.33 34.12 38.69 0.39 33.24 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 32.91 0.46 27.63 33.66 0.11 29.56 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1al6_c00 CITRATE SYNTHASE user 5 3 # 5 274 HIS B 68 HIS.? -3.38 ZN ZN B 375s 320 HIS B 333 HIS~? -3.37 ZN ZN B 374s 375 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1al6_c00 CITRATE SYNTHASE user 6 3 # 6 274 HIS B 103 HIS~? 5.04 ZN ZN B 375 320 HIS B 333 HIS~? -3.37 ZN ZN B 374s 375 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1al6_c00 CITRATE SYNTHASE user 7 3 # 7 274 HIS B 333 HIS~? -3.37 ZN ZN B 374s 320 HIS B 68 HIS.? -3.38 ZN ZN B 375s 375 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1al6_c00 CITRATE SYNTHASE user 8 3 # 8 274 HIS B 333 HIS~? -3.37 ZN ZN B 374s 320 HIS B 103 HIS~? 5.04 ZN ZN B 375 375 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1al6_c00 CITRATE SYNTHASE user 9 3 # 9 274 HIS C 68 HIS.? -3.41 ZN ZN C 375s 320 HIS C 333 HIS~? -3.37 ZN ZN C 374s 375 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1al6_c00 CITRATE SYNTHASE user 10 3 # 10 274 HIS C 103 HIS~? 4.97 ZN ZN C 375 320 HIS C 333 HIS~? -3.37 ZN ZN C 374s 375 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1al6_c00 CITRATE SYNTHASE user 11 3 # 11 274 HIS C 333 HIS~? -3.37 ZN ZN C 374s 320 HIS C 68 HIS.? -3.41 ZN ZN C 375s 375 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1al6_c00 CITRATE SYNTHASE user 12 3 # 12 274 HIS C 333 HIS~? -3.37 ZN ZN C 374s 320 HIS C 103 HIS~? 4.97 ZN ZN C 375 375 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 10.65 -27.85 62.57 8.78 -27.40 61.73 1al6_c00 source 1al6 CITRATE SYNTHASE : 12 hits 1al6_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 48 ASP.? 7.40 ZN ZN A 374 187 GLU A 51 GLU~? 11.89 O2S EPE A 376 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -52.57 56.60 47.75 -51.52 54.87 46.95 40.70 8.14 28.73 41.06 6.40 29.84 coo -45.08 48.37 46.81 -46.53 49.74 45.96 41.17 19.74 26.83 40.87 21.56 28.00 coo -47.40 44.36 48.48 -50.80 49.18 46.20 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 55 ASP~? 17.36 O2S EPE A 376 187 GLU A 90 GLU~? 12.44 O2S EPE A 376 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -52.57 56.60 47.75 -51.52 54.87 46.95 45.10 18.98 22.18 44.20 20.57 23.21 coo -45.08 48.37 46.81 -46.53 49.74 45.96 33.69 24.77 24.85 34.29 26.39 26.04 coo -47.40 44.36 48.48 -50.80 49.18 46.20 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP A 55 ASP~? 17.36 O2S EPE A 376 187 GLU A 90 GLU~? 12.44 O2S EPE A 376 229 LYS A 94 LYS~? 16.25 O2S EPE A 376 coo -52.57 56.60 47.75 -51.52 54.87 46.95 45.10 18.98 22.18 44.20 20.57 23.21 coo -45.08 48.37 46.81 -46.53 49.74 45.96 33.69 24.77 24.85 34.29 26.39 26.04 coo -47.40 44.36 48.48 -50.80 49.18 46.20 33.79 23.90 18.72 34.24 28.62 22.89 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP A 82 ASP.? 8.88 O2S EPE A 376 187 GLU A 90 GLU~? 12.44 O2S EPE A 376 229 LYS A 91 LYS~? 15.85 O2S EPE A 376 coo -52.57 56.60 47.75 -51.52 54.87 46.95 34.38 27.71 34.24 32.73 27.59 35.53 coo -45.08 48.37 46.81 -46.53 49.74 45.96 33.69 24.77 24.85 34.29 26.39 26.04 coo -47.40 44.36 48.48 -50.80 49.18 46.20 36.23 21.81 22.32 41.86 22.67 23.70 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP A 96 ASP.? 22.36 O2S EPE A 376 187 GLU A 90 GLU~? 12.44 O2S EPE A 376 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -52.57 56.60 47.75 -51.52 54.87 46.95 33.23 19.97 13.69 32.21 21.81 13.47 coo -45.08 48.37 46.81 -46.53 49.74 45.96 33.69 24.77 24.85 34.29 26.39 26.04 coo -47.40 44.36 48.48 -50.80 49.18 46.20 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 6 3 # 6 33 ASP A 115 ASP~? 13.24 ZN ZN A 375 187 GLU A 336 GLU~? 2.52 ZN ZN A 375s 229 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -52.57 56.60 47.75 -51.52 54.87 46.95 41.88 -11.27 21.52 40.65 -12.98 21.39 coo -45.08 48.37 46.81 -46.53 49.74 45.96 41.61 -2.34 29.43 39.56 -1.83 29.49 coo -47.40 44.36 48.48 -50.80 49.18 46.20 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 7 3 # 7 33 ASP A 312 ASP.? 7.50 ZN ZN A 374 187 GLU A 336 GLU~? 2.52 ZN ZN A 375s 229 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -52.57 56.60 47.75 -51.52 54.87 46.95 39.49 -1.24 39.18 39.76 0.49 37.96 coo -45.08 48.37 46.81 -46.53 49.74 45.96 41.61 -2.34 29.43 39.56 -1.83 29.49 coo -47.40 44.36 48.48 -50.80 49.18 46.20 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 8 3 # 8 33 ASP B 48 ASP.? 7.36 ZN ZN B 374 187 GLU B 51 GLU~? 11.61 O3S EPE B 376 229 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -25.55 10.19 35.45 -25.80 11.09 37.35 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 9 3 # 9 33 ASP B 82 ASP.? 10.62 O3S EPE B 376 187 GLU B 90 GLU~? 12.95 O2S EPE B 376 229 LYS B 91 LYS~? 15.73 O3S EPE B 376 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -22.38 12.66 48.09 -22.95 14.65 48.48 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -26.35 5.03 43.39 -26.95 6.71 44.51 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -26.96 4.56 38.63 -29.49 9.20 36.26 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 10 3 # 10 33 ASP B 96 ASP.? 22.64 O2S EPE B 376 187 GLU B 90 GLU~? 12.95 O2S EPE B 376 229 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -29.98 -4.37 36.65 -30.49 -4.93 38.64 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -26.35 5.03 43.39 -26.95 6.71 44.51 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 11 3 # 11 33 ASP B 115 ASP~? 12.98 ZN ZN B 375 187 GLU B 336 GLU~? 2.48 ZN ZN B 375s 229 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -10.29 7.50 19.92 -9.48 6.56 21.59 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 12 3 # 12 33 ASP B 312 ASP.? 7.53 ZN ZN B 374 187 GLU B 336 GLU~? 2.48 ZN ZN B 375s 229 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -10.29 7.50 19.92 -9.48 6.56 21.59 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 13 3 # 13 33 ASP C 48 ASP.? 7.30 ZN ZN C 374 187 GLU C 51 GLU~? 12.03 O3S EPE C 376 229 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo -52.57 56.60 47.75 -51.52 54.87 46.95 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -45.08 48.37 46.81 -46.53 49.74 45.96 19.07 -27.28 70.66 19.78 -25.91 72.07 coo -47.40 44.36 48.48 -50.80 49.18 46.20 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 14 3 # 14 33 ASP C 82 ASP.? 10.22 O3S EPE C 376 187 GLU C 90 GLU~? 12.50 O3S EPE C 376 229 LYS C 91 LYS~? 15.57 O3S EPE C 376 coo -52.57 56.60 47.75 -51.52 54.87 46.95 23.03 -14.86 74.18 22.44 -14.42 76.16 coo -45.08 48.37 46.81 -46.53 49.74 45.96 27.07 -22.98 69.65 26.90 -21.97 71.52 coo -47.40 44.36 48.48 -50.80 49.18 46.20 24.97 -26.94 68.30 21.78 -29.04 72.70 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 15 3 # 15 33 ASP C 115 ASP~? 12.87 ZN ZN C 375 187 GLU C 336 GLU~? 2.53 ZN ZN C 375s 229 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -52.57 56.60 47.75 -51.52 54.87 46.95 1.88 -37.38 46.52 1.77 -36.70 44.54 coo -45.08 48.37 46.81 -46.53 49.74 45.96 3.38 -29.70 55.34 4.58 -28.10 54.66 coo -47.40 44.36 48.48 -50.80 49.18 46.20 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 16 3 # 16 33 ASP C 312 ASP.? 7.48 ZN ZN C 374 187 GLU C 336 GLU~? 2.53 ZN ZN C 375s 229 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -45.08 48.37 46.81 -46.53 49.74 45.96 3.38 -29.70 55.34 4.58 -28.10 54.66 coo -47.40 44.36 48.48 -50.80 49.18 46.20 5.23 -34.02 59.10 0.53 -34.86 62.24 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 16 hits 1ald_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 48 ASP.? 7.40 ZN ZN A 374 214 ASP A 306 ASP.? 24.91 ZN ZN A 375 289 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 40.70 8.14 28.73 41.06 6.40 29.84 coo 26.86 59.76 46.36 25.42 58.23 45.92 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 9.42 68.07 30.27 7.35 68.27 30.10 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 292 ASP^? 8.63 ZN ZN A 374 214 ASP A 237 ASP^? 6.80 N TRS A 378 289 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -0.62 65.95 29.97 0.31 67.47 31.05 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 26.86 59.76 46.36 25.42 58.23 45.92 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 292 ASP^? 8.63 ZN ZN A 374 214 ASP A 352 ASP~? 25.70 ZN ZN A 375 289 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -0.62 65.95 29.97 0.31 67.47 31.05 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 26.86 59.76 46.36 25.42 58.23 45.92 43.66 -0.56 3.32 44.78 0.99 4.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 368 ASP.? 11.85 ZN ZN A 374 214 ASP A 352 ASP~? 25.70 ZN ZN A 375 289 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 48.24 5.16 33.58 47.82 3.96 35.30 coo 26.86 59.76 46.36 25.42 58.23 45.92 43.66 -0.56 3.32 44.78 0.99 4.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 48 ASP.? 7.36 ZN ZN B 374 214 ASP B 306 ASP.? 24.86 ZN ZN B 375 289 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 26.86 59.76 46.36 25.42 58.23 45.92 3.99 14.73 5.36 5.18 14.04 3.76 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 292 ASP^? 8.88 ZN ZN B 374 214 ASP B 352 ASP~? 25.82 ZN ZN B 375 289 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -0.62 65.95 29.97 0.31 67.47 31.05 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 26.86 59.76 46.36 25.42 58.23 45.92 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo 9.42 68.07 30.27 7.35 68.27 30.10 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP B 368 ASP.? 11.70 ZN ZN B 374 214 ASP B 352 ASP~? 25.82 ZN ZN B 375 289 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 26.86 59.76 46.36 25.42 58.23 45.92 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo 9.42 68.07 30.27 7.35 68.27 30.10 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP C 48 ASP.? 7.30 ZN ZN C 374 214 ASP C 306 ASP.? 24.81 ZN ZN C 375 289 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 26.86 59.76 46.36 25.42 58.23 45.92 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 9.42 68.07 30.27 7.35 68.27 30.10 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP C 232 ASP^? 3.77 O2S EPE C 377 214 ASP A 27 ASP.? 8.12 ZN ZN A 375 289 ASP A 237 ASP^? 6.80 N TRS A 378 coo -0.62 65.95 29.97 0.31 67.47 31.05 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 26.86 59.76 46.36 25.42 58.23 45.92 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 9.42 68.07 30.27 7.35 68.27 30.10 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP C 232 ASP^? 3.77 O2S EPE C 377 214 ASP A 107 ASP~? -2.33 ZN ZN A 375s 289 ASP A 237 ASP^? 6.80 N TRS A 378 coo -0.62 65.95 29.97 0.31 67.47 31.05 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 26.86 59.76 46.36 25.42 58.23 45.92 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP C 232 ASP^? 3.77 O2S EPE C 377 214 ASP C 27 ASP.? 8.23 ZN ZN C 375 289 ASP A 237 ASP^? 6.80 N TRS A 378 coo -0.62 65.95 29.97 0.31 67.47 31.05 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 26.86 59.76 46.36 25.42 58.23 45.92 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 9.42 68.07 30.27 7.35 68.27 30.10 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP C 292 ASP^? 8.69 ZN ZN C 374 214 ASP C 237 ASP^? 16.80 O1S EPE A 377 289 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -0.62 65.95 29.97 0.31 67.47 31.05 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 26.86 59.76 46.36 25.42 58.23 45.92 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 9.42 68.07 30.27 7.35 68.27 30.10 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP C 292 ASP^? 8.69 ZN ZN C 374 214 ASP C 352 ASP~? 25.48 ZN ZN C 375 289 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -0.62 65.95 29.97 0.31 67.47 31.05 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 26.86 59.76 46.36 25.42 58.23 45.92 18.63 -50.25 49.90 18.47 -49.69 51.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP C 368 ASP.? 11.74 ZN ZN C 374 214 ASP C 352 ASP~? 25.48 ZN ZN C 375 289 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 26.86 59.76 46.36 25.42 58.23 45.92 18.63 -50.25 49.90 18.47 -49.69 51.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 10.65 -27.85 62.57 8.78 -27.40 61.73 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 14 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 107 ASP~? -2.33 ZN ZN A 375s 204 GLU A 336 GLU~? 2.52 ZN ZN A 375s 289 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 4.34 62.44 32.05 4.22 64.48 32.53 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 9.42 68.07 30.27 7.35 68.27 30.10 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 306 ASP.? 24.91 ZN ZN A 375 204 GLU A 254 GLU^? 30.93 ZN ZN A 375 289 ASP A 281 ASP.? 28.06 ZN ZN A 375 coo -0.62 65.95 29.97 0.31 67.47 31.05 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 4.34 62.44 32.05 4.22 64.48 32.53 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 52.87 -20.75 45.53 51.52 -19.24 45.99 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 107 ASP~? -2.23 ZN ZN B 375s 204 GLU B 336 GLU~? 2.48 ZN ZN B 375s 289 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 4.34 62.44 32.05 4.22 64.48 32.53 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 9.42 68.07 30.27 7.35 68.27 30.10 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP C 107 ASP~? -2.30 ZN ZN C 375s 204 GLU C 336 GLU~? 2.53 ZN ZN C 375s 289 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 4.34 62.44 32.05 4.22 64.48 32.53 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.43 -20.86 54.35 0.32 -19.00 54.12 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 4 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 107 ASP~? -2.33 ZN ZN A 375s 227 GLU A 15 GLU~? 17.23 ZN ZN A 375 289 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -0.62 65.95 29.97 0.31 67.47 31.05 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 3.96 55.76 41.24 4.83 57.69 41.17 29.50 -0.46 14.62 27.65 0.59 14.66 coo 9.42 68.07 30.27 7.35 68.27 30.10 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 107 ASP~? -2.33 ZN ZN A 375s 227 GLU A 25 GLU.? 17.13 ZN ZN A 375 289 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 3.96 55.76 41.24 4.83 57.69 41.17 21.52 -4.56 31.66 21.12 -5.25 33.61 coo 9.42 68.07 30.27 7.35 68.27 30.10 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 237 ASP^? 6.80 N TRS A 378 227 GLU A 241 GLU^? 13.09 O3 TRS A 378 289 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo -0.62 65.95 29.97 0.31 67.47 31.05 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 3.96 55.76 41.24 4.83 57.69 41.17 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 9.42 68.07 30.27 7.35 68.27 30.10 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 281 ASP.? 28.06 ZN ZN A 375 227 GLU A 262 GLU~? 24.15 ZN ZN A 374 289 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo -0.62 65.95 29.97 0.31 67.47 31.05 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 3.96 55.76 41.24 4.83 57.69 41.17 59.50 -9.24 37.85 59.47 -7.16 38.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 368 ASP.? 11.85 ZN ZN A 374 227 GLU A 56 GLU~? 18.18 ZN ZN A 374 289 ASP A 269 ASP.? 18.90 ZN ZN A 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 48.24 5.16 33.58 47.82 3.96 35.30 coo 3.96 55.76 41.24 4.83 57.69 41.17 47.24 13.21 19.42 47.19 11.28 20.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 54.82 -1.21 28.36 56.43 0.27 28.67 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 107 ASP~? -2.23 ZN ZN B 375s 227 GLU B 15 GLU~? 17.09 ZN ZN B 375 289 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo -0.62 65.95 29.97 0.31 67.47 31.05 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 3.96 55.76 41.24 4.83 57.69 41.17 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 9.42 68.07 30.27 7.35 68.27 30.10 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP B 107 ASP~? -2.23 ZN ZN B 375s 227 GLU B 25 GLU.? 18.70 ZN ZN B 375 289 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 3.96 55.76 41.24 4.83 57.69 41.17 1.46 -5.92 31.01 3.44 -6.69 31.23 coo 9.42 68.07 30.27 7.35 68.27 30.10 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP B 368 ASP.? 11.70 ZN ZN B 374 227 GLU B 56 GLU~? 18.10 ZN ZN B 374 289 ASP B 269 ASP.? 18.26 ZN ZN B 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 3.96 55.76 41.24 4.83 57.69 41.17 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 9.42 68.07 30.27 7.35 68.27 30.10 -18.05 15.19 12.20 -19.75 16.35 12.84 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP C 107 ASP~? -2.30 ZN ZN C 375s 227 GLU C 15 GLU~? 17.26 ZN ZN C 375 289 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -0.62 65.95 29.97 0.31 67.47 31.05 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 3.96 55.76 41.24 4.83 57.69 41.17 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP C 107 ASP~? -2.30 ZN ZN C 375s 227 GLU C 25 GLU.? 17.70 ZN ZN C 375 289 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 3.96 55.76 41.24 4.83 57.69 41.17 10.47 -15.76 42.35 12.38 -15.28 41.57 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP C 107 ASP~? -2.30 ZN ZN C 375s 227 GLU C 135 GLU^? 15.12 O1 TRS A 378 289 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -0.62 65.95 29.97 0.31 67.47 31.05 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 3.96 55.76 41.24 4.83 57.69 41.17 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP C 107 ASP~? -2.30 ZN ZN C 375s 227 GLU C 135 GLU^? 15.12 O1 TRS A 378 289 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -0.62 65.95 29.97 0.31 67.47 31.05 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 3.96 55.76 41.24 4.83 57.69 41.17 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP C 368 ASP.? 11.74 ZN ZN C 374 227 GLU C 56 GLU~? 18.45 ZN ZN C 374 289 ASP C 269 ASP~? 18.04 ZN ZN C 374 coo -0.62 65.95 29.97 0.31 67.47 31.05 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 3.96 55.76 41.24 4.83 57.69 41.17 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 9.42 68.07 30.27 7.35 68.27 30.10 -1.79 -38.40 63.28 -1.15 -38.99 65.26 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 13 hits 1amy_c06 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 16 SER~? 19.64 ZN ZN A 375 A 292 ASP B 237 ASP^? 15.58 N TRS A 378 A 322 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 36.34 32.23 39.60 36.43 34.62 39.93 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 19.73 19.18 41.39 21.50 18.65 40.34 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 41.69 45.14 46.60 41.78 47.19 46.18 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 173 SER^? 8.70 C6 EPE C 377 A 292 ASP A 237 ASP^? 6.80 N TRS A 378 A 322 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo 36.34 32.23 39.60 36.43 34.62 39.93 17.10 -34.58 2.20 18.37 -33.49 0.48 coo 19.73 19.18 41.39 21.50 18.65 40.34 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 41.69 45.14 46.60 41.78 47.19 46.18 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 174 SER^? 9.43 O3S EPE C 377 A 292 ASP A 237 ASP^? 6.80 N TRS A 378 A 322 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo 36.34 32.23 39.60 36.43 34.62 39.93 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 19.73 19.18 41.39 21.50 18.65 40.34 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 41.69 45.14 46.60 41.78 47.19 46.18 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER A 363 SER.? 15.15 ZN ZN A 374 A 292 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 322 HIS A 359 HIS^? 27.14 ZN ZN A 375 coo 36.34 32.23 39.60 36.43 34.62 39.93 46.51 8.06 20.34 45.84 9.37 22.25 coo 19.73 19.18 41.39 21.50 18.65 40.34 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 41.69 45.14 46.60 41.78 47.19 46.18 45.80 8.64 6.53 46.53 8.87 4.58 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER A 363 SER.? 15.15 ZN ZN A 374 A 292 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 322 HIS A 359 HIS^? 27.14 ZN ZN A 375 coo 36.34 32.23 39.60 36.43 34.62 39.93 46.51 8.06 20.34 45.84 9.37 22.25 coo 19.73 19.18 41.39 21.50 18.65 40.34 39.49 -1.24 39.18 39.76 0.49 37.96 coo 41.69 45.14 46.60 41.78 47.19 46.18 45.80 8.64 6.53 46.53 8.87 4.58 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER B 16 SER~? 19.34 ZN ZN B 375 A 292 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 322 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 19.73 19.18 41.39 21.50 18.65 40.34 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 41.69 45.14 46.60 41.78 47.19 46.18 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER B 173 SER^? 8.63 C9 EPE A 377 A 292 ASP B 237 ASP^? 15.58 N TRS A 378 A 322 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 36.34 32.23 39.60 36.43 34.62 39.93 4.35 -36.83 4.64 1.88 -36.99 4.49 coo 19.73 19.18 41.39 21.50 18.65 40.34 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 41.69 45.14 46.60 41.78 47.19 46.18 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER B 174 SER^? 9.21 O2S EPE A 377 A 292 ASP B 237 ASP^? 15.58 N TRS A 378 A 322 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 36.34 32.23 39.60 36.43 34.62 39.93 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 19.73 19.18 41.39 21.50 18.65 40.34 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 41.69 45.14 46.60 41.78 47.19 46.18 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 A 194 SER C 16 SER.? 19.22 ZN ZN C 375 A 292 ASP A 237 ASP^? 6.80 N TRS A 378 A 322 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 36.34 32.23 39.60 36.43 34.62 39.93 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 19.73 19.18 41.39 21.50 18.65 40.34 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 41.69 45.14 46.60 41.78 47.19 46.18 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 A 194 SER C 173 SER^? 14.26 C2 EPE C 377 A 292 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 322 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo 36.34 32.23 39.60 36.43 34.62 39.93 13.37 -42.81 12.12 14.73 -44.10 13.72 coo 19.73 19.18 41.39 21.50 18.65 40.34 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 41.69 45.14 46.60 41.78 47.19 46.18 27.13 -47.60 14.36 28.94 -48.66 14.50 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 A 194 SER C 174 SER^? 11.73 O3S EPE C 377 A 292 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 322 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo 36.34 32.23 39.60 36.43 34.62 39.93 13.31 -42.10 8.38 13.05 -39.69 8.34 coo 19.73 19.18 41.39 21.50 18.65 40.34 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 41.69 45.14 46.60 41.78 47.19 46.18 27.13 -47.60 14.36 28.94 -48.66 14.50 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 11 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 16 SER~? 19.64 ZN ZN A 375 B 292 ASP B 237 ASP^? 15.58 N TRS A 378 B 322 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 35.42 71.28 22.94 36.24 69.06 22.37 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 24.74 78.07 5.59 24.32 79.03 7.46 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 48.81 64.16 26.34 49.30 62.16 26.73 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 363 SER.? 15.15 ZN ZN A 374 B 292 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 322 HIS A 359 HIS^? 27.14 ZN ZN A 375 coo 35.42 71.28 22.94 36.24 69.06 22.37 46.51 8.06 20.34 45.84 9.37 22.25 coo 24.74 78.07 5.59 24.32 79.03 7.46 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 48.81 64.16 26.34 49.30 62.16 26.73 45.80 8.64 6.53 46.53 8.87 4.58 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER A 363 SER.? 15.15 ZN ZN A 374 B 292 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 322 HIS A 359 HIS^? 27.14 ZN ZN A 375 coo 35.42 71.28 22.94 36.24 69.06 22.37 46.51 8.06 20.34 45.84 9.37 22.25 coo 24.74 78.07 5.59 24.32 79.03 7.46 39.49 -1.24 39.18 39.76 0.49 37.96 coo 48.81 64.16 26.34 49.30 62.16 26.73 45.80 8.64 6.53 46.53 8.87 4.58 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER B 16 SER~? 19.34 ZN ZN B 375 B 292 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 322 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 24.74 78.07 5.59 24.32 79.03 7.46 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 48.81 64.16 26.34 49.30 62.16 26.73 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER B 173 SER^? 8.63 C9 EPE A 377 B 292 ASP B 237 ASP^? 15.58 N TRS A 378 B 322 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 35.42 71.28 22.94 36.24 69.06 22.37 4.35 -36.83 4.64 1.88 -36.99 4.49 coo 24.74 78.07 5.59 24.32 79.03 7.46 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 48.81 64.16 26.34 49.30 62.16 26.73 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER B 174 SER^? 9.21 O2S EPE A 377 B 292 ASP B 237 ASP^? 15.58 N TRS A 378 B 322 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 35.42 71.28 22.94 36.24 69.06 22.37 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 24.74 78.07 5.59 24.32 79.03 7.46 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 48.81 64.16 26.34 49.30 62.16 26.73 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER C 16 SER.? 19.22 ZN ZN C 375 B 292 ASP A 237 ASP^? 6.80 N TRS A 378 B 322 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 35.42 71.28 22.94 36.24 69.06 22.37 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 24.74 78.07 5.59 24.32 79.03 7.46 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 48.81 64.16 26.34 49.30 62.16 26.73 9.33 -29.64 54.17 7.95 -29.11 52.67 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 7 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 203 ARG^? 8.58 O3S EPE C 377 B 342 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 531 ARG B 153 ARG~? 10.73 C6 EPE A 377 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -1.46 -36.52 4.12 -1.19 -38.78 2.09 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 203 ARG^? 8.58 O3S EPE C 377 B 342 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 531 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG C 203 ARG^? 8.27 O3S EPE C 377 B 342 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 531 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 20.83 -31.38 -1.20 19.50 -33.43 -3.04 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 3 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 342 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 531 ARG B 153 ARG~? 10.73 C6 EPE A 377 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -1.46 -36.52 4.12 -1.19 -38.78 2.09 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 342 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 531 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 342 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 531 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 20.83 -31.38 -1.20 19.50 -33.43 -3.04 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 3 hits 1asy_c01 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 73 PHE.? 6.87 C7 EPE A 376 A 223 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 265 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 39.74 52.86 65.74 41.15 55.14 66.52 29.46 5.70 32.24 28.53 3.17 33.10 coo 30.70 47.50 67.53 29.83 49.47 67.39 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 19.99 54.53 64.11 20.55 58.78 68.33 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 172 PHE^? 6.53 C9 EPE C 377 A 223 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 265 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 39.74 52.86 65.74 41.15 55.14 66.52 18.79 -35.53 6.28 17.39 -37.92 6.30 coo 30.70 47.50 67.53 29.83 49.47 67.39 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 19.99 54.53 64.11 20.55 58.78 68.33 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 172 PHE^? 6.53 C9 EPE C 377 A 223 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 265 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 39.74 52.86 65.74 41.15 55.14 66.52 18.79 -35.53 6.28 17.39 -37.92 6.30 coo 30.70 47.50 67.53 29.83 49.47 67.39 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 19.99 54.53 64.11 20.55 58.78 68.33 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE A 260 PHE~? 19.27 ZN ZN A 375 A 223 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 265 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 39.74 52.86 65.74 41.15 55.14 66.52 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 30.70 47.50 67.53 29.83 49.47 67.39 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 19.99 54.53 64.11 20.55 58.78 68.33 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE A 370 PHE.? 12.81 O8 EPE A 376 A 223 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 265 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 39.74 52.86 65.74 41.15 55.14 66.52 46.70 4.90 39.59 44.12 4.72 40.65 coo 30.70 47.50 67.53 29.83 49.47 67.39 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 19.99 54.53 64.11 20.55 58.78 68.33 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE A 372 PHE.? 17.32 ZN ZN A 374 A 223 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 265 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 39.74 52.86 65.74 41.15 55.14 66.52 52.79 1.59 40.88 50.60 -0.15 40.87 coo 30.70 47.50 67.53 29.83 49.47 67.39 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 19.99 54.53 64.11 20.55 58.78 68.33 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE A 372 PHE.? 17.32 ZN ZN A 374 A 223 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 265 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 39.74 52.86 65.74 41.15 55.14 66.52 52.79 1.59 40.88 50.60 -0.15 40.87 coo 30.70 47.50 67.53 29.83 49.47 67.39 48.24 5.16 33.58 47.82 3.96 35.30 coo 19.99 54.53 64.11 20.55 58.78 68.33 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE B 73 PHE.? 6.98 C7 EPE B 376 A 223 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 265 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 39.74 52.86 65.74 41.15 55.14 66.52 -7.83 3.89 33.63 -5.47 3.39 32.20 coo 30.70 47.50 67.53 29.83 49.47 67.39 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 19.99 54.53 64.11 20.55 58.78 68.33 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE B 172 PHE^? 6.04 C9 EPE A 377 A 223 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 265 LYS A 218 LYS~? 21.49 C3 EPE A 377 coo 39.74 52.86 65.74 41.15 55.14 66.52 6.52 -33.24 3.28 8.59 -34.82 2.34 coo 30.70 47.50 67.53 29.83 49.47 67.39 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 19.99 54.53 64.11 20.55 58.78 68.33 17.38 -15.22 -1.06 17.49 -9.91 -3.23 ULMN 3 1ax4_c04 TRYPTOPHANASE user 10 3 # 10 A 130 PHE B 172 PHE^? 6.04 C9 EPE A 377 A 223 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 265 LYS C 139 LYS^? 16.11 N TRS A 378 coo 39.74 52.86 65.74 41.15 55.14 66.52 6.52 -33.24 3.28 8.59 -34.82 2.34 coo 30.70 47.50 67.53 29.83 49.47 67.39 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 19.99 54.53 64.11 20.55 58.78 68.33 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1ax4_c04 TRYPTOPHANASE user 11 3 # 11 A 130 PHE B 260 PHE~? 19.39 ZN ZN B 375 A 223 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 265 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 39.74 52.86 65.74 41.15 55.14 66.52 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 30.70 47.50 67.53 29.83 49.47 67.39 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 19.99 54.53 64.11 20.55 58.78 68.33 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1ax4_c04 TRYPTOPHANASE user 12 3 # 12 A 130 PHE B 370 PHE.? 12.32 O8 EPE B 376 A 223 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 265 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 39.74 52.86 65.74 41.15 55.14 66.52 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 30.70 47.50 67.53 29.83 49.47 67.39 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 19.99 54.53 64.11 20.55 58.78 68.33 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1ax4_c04 TRYPTOPHANASE user 13 3 # 13 A 130 PHE B 372 PHE.? 17.31 ZN ZN B 374 A 223 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 265 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 39.74 52.86 65.74 41.15 55.14 66.52 -11.64 24.23 19.14 -9.49 22.46 19.29 coo 30.70 47.50 67.53 29.83 49.47 67.39 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 19.99 54.53 64.11 20.55 58.78 68.33 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1ax4_c04 TRYPTOPHANASE user 14 3 # 14 A 130 PHE C 172 PHE^? 14.49 O2S EPE A 377 A 223 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 265 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 39.74 52.86 65.74 41.15 55.14 66.52 9.48 -40.91 13.04 8.71 -41.08 10.37 coo 30.70 47.50 67.53 29.83 49.47 67.39 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 19.99 54.53 64.11 20.55 58.78 68.33 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1ax4_c04 TRYPTOPHANASE user 15 3 # 15 A 130 PHE C 260 PHE~? 19.40 ZN ZN C 375 A 223 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 265 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 39.74 52.86 65.74 41.15 55.14 66.52 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 30.70 47.50 67.53 29.83 49.47 67.39 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 19.99 54.53 64.11 20.55 58.78 68.33 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1ax4_c04 TRYPTOPHANASE user 16 3 # 16 A 130 PHE C 370 PHE.? 12.75 O8 EPE C 376 A 223 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 265 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 39.74 52.86 65.74 41.15 55.14 66.52 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 30.70 47.50 67.53 29.83 49.47 67.39 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 19.99 54.53 64.11 20.55 58.78 68.33 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1ax4_c04 TRYPTOPHANASE user 17 3 # 17 A 130 PHE C 372 PHE.? 17.18 ZN ZN C 374 A 223 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 265 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 39.74 52.86 65.74 41.15 55.14 66.52 -6.66 -27.35 68.48 -6.43 -26.37 65.89 coo 30.70 47.50 67.53 29.83 49.47 67.39 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 19.99 54.53 64.11 20.55 58.78 68.33 -21.60 -25.17 57.51 -24.75 -21.09 54.19 1ax4_c04 source 1ax4 TRYPTOPHANASE : 17 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 73 PHE.? 6.87 C7 EPE A 376 B 223 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 265 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 7.48 54.94 99.62 7.67 52.27 100.42 29.46 5.70 32.24 28.53 3.17 33.10 coo 10.43 61.66 91.81 9.80 60.04 90.61 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 5.43 58.06 80.08 8.57 53.00 79.37 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 172 PHE^? 6.53 C9 EPE C 377 B 223 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 265 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 7.48 54.94 99.62 7.67 52.27 100.42 18.79 -35.53 6.28 17.39 -37.92 6.30 coo 10.43 61.66 91.81 9.80 60.04 90.61 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 5.43 58.06 80.08 8.57 53.00 79.37 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 172 PHE^? 6.53 C9 EPE C 377 B 223 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 265 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 7.48 54.94 99.62 7.67 52.27 100.42 18.79 -35.53 6.28 17.39 -37.92 6.30 coo 10.43 61.66 91.81 9.80 60.04 90.61 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 5.43 58.06 80.08 8.57 53.00 79.37 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE A 260 PHE~? 19.27 ZN ZN A 375 B 223 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 265 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 7.48 54.94 99.62 7.67 52.27 100.42 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 10.43 61.66 91.81 9.80 60.04 90.61 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 5.43 58.06 80.08 8.57 53.00 79.37 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE A 370 PHE.? 12.81 O8 EPE A 376 B 223 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 265 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 7.48 54.94 99.62 7.67 52.27 100.42 46.70 4.90 39.59 44.12 4.72 40.65 coo 10.43 61.66 91.81 9.80 60.04 90.61 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 5.43 58.06 80.08 8.57 53.00 79.37 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE A 372 PHE.? 17.32 ZN ZN A 374 B 223 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 265 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 7.48 54.94 99.62 7.67 52.27 100.42 52.79 1.59 40.88 50.60 -0.15 40.87 coo 10.43 61.66 91.81 9.80 60.04 90.61 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 5.43 58.06 80.08 8.57 53.00 79.37 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE A 372 PHE.? 17.32 ZN ZN A 374 B 223 ASP A 368 ASP.? 11.85 ZN ZN A 374 B 265 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 7.48 54.94 99.62 7.67 52.27 100.42 52.79 1.59 40.88 50.60 -0.15 40.87 coo 10.43 61.66 91.81 9.80 60.04 90.61 48.24 5.16 33.58 47.82 3.96 35.30 coo 5.43 58.06 80.08 8.57 53.00 79.37 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE B 73 PHE.? 6.98 C7 EPE B 376 B 223 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 265 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 7.48 54.94 99.62 7.67 52.27 100.42 -7.83 3.89 33.63 -5.47 3.39 32.20 coo 10.43 61.66 91.81 9.80 60.04 90.61 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 5.43 58.06 80.08 8.57 53.00 79.37 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE B 172 PHE^? 6.04 C9 EPE A 377 B 223 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 265 LYS A 218 LYS~? 21.49 C3 EPE A 377 coo 7.48 54.94 99.62 7.67 52.27 100.42 6.52 -33.24 3.28 8.59 -34.82 2.34 coo 10.43 61.66 91.81 9.80 60.04 90.61 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 5.43 58.06 80.08 8.57 53.00 79.37 17.38 -15.22 -1.06 17.49 -9.91 -3.23 ULMN 3 1ax4_c05 TRYPTOPHANASE user 10 3 # 10 B 130 PHE B 172 PHE^? 6.04 C9 EPE A 377 B 223 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 265 LYS C 139 LYS^? 16.11 N TRS A 378 coo 7.48 54.94 99.62 7.67 52.27 100.42 6.52 -33.24 3.28 8.59 -34.82 2.34 coo 10.43 61.66 91.81 9.80 60.04 90.61 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 5.43 58.06 80.08 8.57 53.00 79.37 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1ax4_c05 TRYPTOPHANASE user 11 3 # 11 B 130 PHE B 260 PHE~? 19.39 ZN ZN B 375 B 223 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 265 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 7.48 54.94 99.62 7.67 52.27 100.42 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 10.43 61.66 91.81 9.80 60.04 90.61 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 5.43 58.06 80.08 8.57 53.00 79.37 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1ax4_c05 TRYPTOPHANASE user 12 3 # 12 B 130 PHE B 370 PHE.? 12.32 O8 EPE B 376 B 223 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 265 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 7.48 54.94 99.62 7.67 52.27 100.42 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 10.43 61.66 91.81 9.80 60.04 90.61 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 5.43 58.06 80.08 8.57 53.00 79.37 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1ax4_c05 TRYPTOPHANASE user 13 3 # 13 B 130 PHE B 372 PHE.? 17.31 ZN ZN B 374 B 223 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 265 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 7.48 54.94 99.62 7.67 52.27 100.42 -11.64 24.23 19.14 -9.49 22.46 19.29 coo 10.43 61.66 91.81 9.80 60.04 90.61 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 5.43 58.06 80.08 8.57 53.00 79.37 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1ax4_c05 TRYPTOPHANASE user 14 3 # 14 B 130 PHE C 172 PHE^? 14.49 O2S EPE A 377 B 223 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 265 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 7.48 54.94 99.62 7.67 52.27 100.42 9.48 -40.91 13.04 8.71 -41.08 10.37 coo 10.43 61.66 91.81 9.80 60.04 90.61 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 5.43 58.06 80.08 8.57 53.00 79.37 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1ax4_c05 TRYPTOPHANASE user 15 3 # 15 B 130 PHE C 260 PHE~? 19.40 ZN ZN C 375 B 223 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 265 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 7.48 54.94 99.62 7.67 52.27 100.42 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 10.43 61.66 91.81 9.80 60.04 90.61 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 5.43 58.06 80.08 8.57 53.00 79.37 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1ax4_c05 TRYPTOPHANASE user 16 3 # 16 B 130 PHE C 370 PHE.? 12.75 O8 EPE C 376 B 223 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 265 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 7.48 54.94 99.62 7.67 52.27 100.42 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 10.43 61.66 91.81 9.80 60.04 90.61 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 5.43 58.06 80.08 8.57 53.00 79.37 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1ax4_c05 TRYPTOPHANASE user 17 3 # 17 B 130 PHE C 372 PHE.? 17.18 ZN ZN C 374 B 223 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 265 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 7.48 54.94 99.62 7.67 52.27 100.42 -6.66 -27.35 68.48 -6.43 -26.37 65.89 coo 10.43 61.66 91.81 9.80 60.04 90.61 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 5.43 58.06 80.08 8.57 53.00 79.37 -21.60 -25.17 57.51 -24.75 -21.09 54.19 1ax4_c05 source 1ax4 TRYPTOPHANASE : 17 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 73 PHE.? 6.87 C7 EPE A 376 C 223 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 265 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -6.55 73.45 23.60 -6.77 71.48 21.66 29.46 5.70 32.24 28.53 3.17 33.10 coo -9.52 75.74 33.62 -8.85 73.74 33.93 40.70 8.14 28.73 41.06 6.40 29.84 coo -4.44 67.20 42.32 -7.50 62.41 40.49 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 73 PHE.? 6.87 C7 EPE A 376 C 223 ASP A 292 ASP^? 8.63 ZN ZN A 374 C 265 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -6.55 73.45 23.60 -6.77 71.48 21.66 29.46 5.70 32.24 28.53 3.17 33.10 coo -9.52 75.74 33.62 -8.85 73.74 33.93 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -4.44 67.20 42.32 -7.50 62.41 40.49 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 172 PHE^? 6.53 C9 EPE C 377 C 223 ASP C 232 ASP^? 3.77 O2S EPE C 377 C 265 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo -6.55 73.45 23.60 -6.77 71.48 21.66 18.79 -35.53 6.28 17.39 -37.92 6.30 coo -9.52 75.74 33.62 -8.85 73.74 33.93 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -4.44 67.20 42.32 -7.50 62.41 40.49 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE A 260 PHE~? 19.27 ZN ZN A 375 C 223 ASP A 330 ASP^? 12.08 ZN ZN A 374 C 265 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -6.55 73.45 23.60 -6.77 71.48 21.66 52.43 -14.27 35.94 50.19 -13.42 34.56 coo -9.52 75.74 33.62 -8.85 73.74 33.93 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -4.44 67.20 42.32 -7.50 62.41 40.49 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE A 370 PHE.? 12.81 O8 EPE A 376 C 223 ASP A 330 ASP^? 12.08 ZN ZN A 374 C 265 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -6.55 73.45 23.60 -6.77 71.48 21.66 46.70 4.90 39.59 44.12 4.72 40.65 coo -9.52 75.74 33.62 -8.85 73.74 33.93 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -4.44 67.20 42.32 -7.50 62.41 40.49 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE A 372 PHE.? 17.32 ZN ZN A 374 C 223 ASP A 330 ASP^? 12.08 ZN ZN A 374 C 265 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo -6.55 73.45 23.60 -6.77 71.48 21.66 52.79 1.59 40.88 50.60 -0.15 40.87 coo -9.52 75.74 33.62 -8.85 73.74 33.93 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -4.44 67.20 42.32 -7.50 62.41 40.49 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE B 73 PHE.? 6.98 C7 EPE B 376 C 223 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 265 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -7.83 3.89 33.63 -5.47 3.39 32.20 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE B 172 PHE^? 6.04 C9 EPE A 377 C 223 ASP A 232 ASP^? 4.68 O1S EPE A 377 C 265 LYS A 218 LYS~? 21.49 C3 EPE A 377 coo -6.55 73.45 23.60 -6.77 71.48 21.66 6.52 -33.24 3.28 8.59 -34.82 2.34 coo -9.52 75.74 33.62 -8.85 73.74 33.93 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -4.44 67.20 42.32 -7.50 62.41 40.49 17.38 -15.22 -1.06 17.49 -9.91 -3.23 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE B 172 PHE^? 6.04 C9 EPE A 377 C 223 ASP A 232 ASP^? 4.68 O1S EPE A 377 C 265 LYS C 139 LYS^? 16.11 N TRS A 378 coo -6.55 73.45 23.60 -6.77 71.48 21.66 6.52 -33.24 3.28 8.59 -34.82 2.34 coo -9.52 75.74 33.62 -8.85 73.74 33.93 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -4.44 67.20 42.32 -7.50 62.41 40.49 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1ax4_c06 TRYPTOPHANASE user 10 3 # 10 C 130 PHE B 260 PHE~? 19.39 ZN ZN B 375 C 223 ASP B 330 ASP^? 11.92 ZN ZN B 374 C 265 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -4.07 16.87 6.20 -4.31 14.59 7.80 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -4.44 67.20 42.32 -7.50 62.41 40.49 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1ax4_c06 TRYPTOPHANASE user 11 3 # 11 C 130 PHE B 370 PHE.? 12.32 O8 EPE B 376 C 223 ASP B 330 ASP^? 11.92 ZN ZN B 374 C 265 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -11.49 20.06 25.00 -9.59 19.04 26.81 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -4.44 67.20 42.32 -7.50 62.41 40.49 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1ax4_c06 TRYPTOPHANASE user 12 3 # 12 C 130 PHE B 372 PHE.? 17.31 ZN ZN B 374 C 223 ASP B 330 ASP^? 11.92 ZN ZN B 374 C 265 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -11.64 24.23 19.14 -9.49 22.46 19.29 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -4.44 67.20 42.32 -7.50 62.41 40.49 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1ax4_c06 TRYPTOPHANASE user 13 3 # 13 C 130 PHE C 73 PHE.? 6.88 C8 EPE C 376 C 223 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 265 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo -6.55 73.45 23.60 -6.77 71.48 21.66 12.87 -18.52 55.06 11.27 -18.17 52.78 coo -9.52 75.74 33.62 -8.85 73.74 33.93 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -4.44 67.20 42.32 -7.50 62.41 40.49 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1ax4_c06 TRYPTOPHANASE user 14 3 # 14 C 130 PHE C 172 PHE^? 14.49 O2S EPE A 377 C 223 ASP B 232 ASP^? 14.54 O2S EPE A 377 C 265 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo -6.55 73.45 23.60 -6.77 71.48 21.66 9.48 -40.91 13.04 8.71 -41.08 10.37 coo -9.52 75.74 33.62 -8.85 73.74 33.93 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -4.44 67.20 42.32 -7.50 62.41 40.49 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1ax4_c06 TRYPTOPHANASE user 15 3 # 15 C 130 PHE C 260 PHE~? 19.40 ZN ZN C 375 C 223 ASP C 330 ASP^? 11.91 ZN ZN C 374 C 265 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1ax4_c06 TRYPTOPHANASE user 16 3 # 16 C 130 PHE C 370 PHE.? 12.75 O8 EPE C 376 C 223 ASP C 330 ASP^? 11.91 ZN ZN C 374 C 265 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1ax4_c06 TRYPTOPHANASE user 17 3 # 17 C 130 PHE C 372 PHE.? 17.18 ZN ZN C 374 C 223 ASP C 330 ASP^? 11.91 ZN ZN C 374 C 265 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -6.66 -27.35 68.48 -6.43 -26.37 65.89 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -21.60 -25.17 57.51 -24.75 -21.09 54.19 1ax4_c06 source 1ax4 TRYPTOPHANASE : 17 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 73 PHE.? 6.87 C7 EPE A 376 D 223 ASP A 292 ASP^? 8.63 ZN ZN A 374 D 265 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -38.60 55.38 52.70 -40.06 57.72 53.04 29.46 5.70 32.24 28.53 3.17 33.10 coo -29.46 51.67 48.51 -28.63 53.31 49.56 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -18.87 56.53 54.79 -19.47 62.22 53.03 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 172 PHE^? 6.53 C9 EPE C 377 D 223 ASP C 232 ASP^? 3.77 O2S EPE C 377 D 265 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo -38.60 55.38 52.70 -40.06 57.72 53.04 18.79 -35.53 6.28 17.39 -37.92 6.30 coo -29.46 51.67 48.51 -28.63 53.31 49.56 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -18.87 56.53 54.79 -19.47 62.22 53.03 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 260 PHE~? 19.27 ZN ZN A 375 D 223 ASP A 330 ASP^? 12.08 ZN ZN A 374 D 265 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -38.60 55.38 52.70 -40.06 57.72 53.04 52.43 -14.27 35.94 50.19 -13.42 34.56 coo -29.46 51.67 48.51 -28.63 53.31 49.56 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -18.87 56.53 54.79 -19.47 62.22 53.03 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE A 370 PHE.? 12.81 O8 EPE A 376 D 223 ASP A 330 ASP^? 12.08 ZN ZN A 374 D 265 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -38.60 55.38 52.70 -40.06 57.72 53.04 46.70 4.90 39.59 44.12 4.72 40.65 coo -29.46 51.67 48.51 -28.63 53.31 49.56 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -18.87 56.53 54.79 -19.47 62.22 53.03 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE A 372 PHE.? 17.32 ZN ZN A 374 D 223 ASP A 330 ASP^? 12.08 ZN ZN A 374 D 265 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo -38.60 55.38 52.70 -40.06 57.72 53.04 52.79 1.59 40.88 50.60 -0.15 40.87 coo -29.46 51.67 48.51 -28.63 53.31 49.56 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -18.87 56.53 54.79 -19.47 62.22 53.03 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE A 372 PHE.? 17.32 ZN ZN A 374 D 223 ASP A 368 ASP.? 11.85 ZN ZN A 374 D 265 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo -38.60 55.38 52.70 -40.06 57.72 53.04 52.79 1.59 40.88 50.60 -0.15 40.87 coo -29.46 51.67 48.51 -28.63 53.31 49.56 48.24 5.16 33.58 47.82 3.96 35.30 coo -18.87 56.53 54.79 -19.47 62.22 53.03 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE B 73 PHE.? 6.98 C7 EPE B 376 D 223 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 265 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -7.83 3.89 33.63 -5.47 3.39 32.20 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE B 172 PHE^? 6.04 C9 EPE A 377 D 223 ASP A 232 ASP^? 4.68 O1S EPE A 377 D 265 LYS A 218 LYS~? 21.49 C3 EPE A 377 coo -38.60 55.38 52.70 -40.06 57.72 53.04 6.52 -33.24 3.28 8.59 -34.82 2.34 coo -29.46 51.67 48.51 -28.63 53.31 49.56 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -18.87 56.53 54.79 -19.47 62.22 53.03 17.38 -15.22 -1.06 17.49 -9.91 -3.23 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE B 172 PHE^? 6.04 C9 EPE A 377 D 223 ASP A 232 ASP^? 4.68 O1S EPE A 377 D 265 LYS C 139 LYS^? 16.11 N TRS A 378 coo -38.60 55.38 52.70 -40.06 57.72 53.04 6.52 -33.24 3.28 8.59 -34.82 2.34 coo -29.46 51.67 48.51 -28.63 53.31 49.56 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -18.87 56.53 54.79 -19.47 62.22 53.03 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1ax4_c07 TRYPTOPHANASE user 10 3 # 10 D 130 PHE B 260 PHE~? 19.39 ZN ZN B 375 D 223 ASP B 330 ASP^? 11.92 ZN ZN B 374 D 265 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -4.07 16.87 6.20 -4.31 14.59 7.80 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -18.87 56.53 54.79 -19.47 62.22 53.03 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1ax4_c07 TRYPTOPHANASE user 11 3 # 11 D 130 PHE B 370 PHE.? 12.32 O8 EPE B 376 D 223 ASP B 330 ASP^? 11.92 ZN ZN B 374 D 265 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -11.49 20.06 25.00 -9.59 19.04 26.81 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -18.87 56.53 54.79 -19.47 62.22 53.03 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1ax4_c07 TRYPTOPHANASE user 12 3 # 12 D 130 PHE B 372 PHE.? 17.31 ZN ZN B 374 D 223 ASP B 330 ASP^? 11.92 ZN ZN B 374 D 265 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -11.64 24.23 19.14 -9.49 22.46 19.29 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -18.87 56.53 54.79 -19.47 62.22 53.03 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1ax4_c07 TRYPTOPHANASE user 13 3 # 13 D 130 PHE C 172 PHE^? 14.49 O2S EPE A 377 D 223 ASP B 232 ASP^? 14.54 O2S EPE A 377 D 265 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo -38.60 55.38 52.70 -40.06 57.72 53.04 9.48 -40.91 13.04 8.71 -41.08 10.37 coo -29.46 51.67 48.51 -28.63 53.31 49.56 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -18.87 56.53 54.79 -19.47 62.22 53.03 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1ax4_c07 TRYPTOPHANASE user 14 3 # 14 D 130 PHE C 260 PHE~? 19.40 ZN ZN C 375 D 223 ASP C 330 ASP^? 11.91 ZN ZN C 374 D 265 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1ax4_c07 TRYPTOPHANASE user 15 3 # 15 D 130 PHE C 370 PHE.? 12.75 O8 EPE C 376 D 223 ASP C 330 ASP^? 11.91 ZN ZN C 374 D 265 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1ax4_c07 TRYPTOPHANASE user 16 3 # 16 D 130 PHE C 372 PHE.? 17.18 ZN ZN C 374 D 223 ASP C 330 ASP^? 11.91 ZN ZN C 374 D 265 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -6.66 -27.35 68.48 -6.43 -26.37 65.89 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -21.60 -25.17 57.51 -24.75 -21.09 54.19 1ax4_c07 source 1ax4 TRYPTOPHANASE : 16 hits 1ax4_c07 naa= 3 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 110 SER A 168 SER^? 10.80 O1S EPE C 377 A 266 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 294 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 32.07 25.76 77.83 34.46 26.05 77.46 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 33.07 35.01 79.81 33.39 33.02 79.13 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 35.53 30.26 79.89 34.62 28.71 78.80 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 110 SER B 168 SER^? 10.59 O3S EPE A 377 A 266 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 294 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 32.07 25.76 77.83 34.46 26.05 77.46 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 33.07 35.01 79.81 33.39 33.02 79.13 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 35.53 30.26 79.89 34.62 28.71 78.80 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 110 SER C 168 SER^? 24.11 O1 TRS A 378 A 266 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 294 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 32.07 25.76 77.83 34.46 26.05 77.46 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 33.07 35.01 79.81 33.39 33.02 79.13 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 35.53 30.26 79.89 34.62 28.71 78.80 13.13 -47.52 24.96 14.34 -48.17 26.54 1azw_c00 source 1azw PROLINE IMINOPEPTIDASE : 3 hits 1azw_c00 naa= 3 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 1 3 # 1 B 110 SER A 168 SER^? 10.80 O1S EPE C 377 B 266 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 294 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 51.18 33.22 36.61 49.29 31.79 37.02 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 44.19 39.32 34.54 45.21 37.66 35.38 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 45.79 34.26 34.63 47.54 33.80 35.70 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 2 3 # 2 B 110 SER B 168 SER^? 10.59 O3S EPE A 377 B 266 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 294 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 51.18 33.22 36.61 49.29 31.79 37.02 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 44.19 39.32 34.54 45.21 37.66 35.38 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 45.79 34.26 34.63 47.54 33.80 35.70 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 3 3 # 3 B 110 SER C 168 SER^? 24.11 O1 TRS A 378 B 266 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 294 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 51.18 33.22 36.61 49.29 31.79 37.02 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 44.19 39.32 34.54 45.21 37.66 35.38 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 45.79 34.26 34.63 47.54 33.80 35.70 13.13 -47.52 24.96 14.34 -48.17 26.54 1azw_c01 source 1azw PROLINE IMINOPEPTIDASE : 3 hits 1azw_c01 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS A 263 HIS~? 20.93 ZN ZN A 375 A 171 ARG A 274 ARG^? 15.42 ZN ZN A 374 A 190 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 22.59 2.26 43.22 21.17 3.47 42.27 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 13.63 3.81 28.83 14.49 2.91 31.59 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 24.97 7.47 37.69 21.24 10.69 35.89 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 2 3 # 2 A 85 HIS B 263 HIS~? 20.98 ZN ZN B 375 A 171 ARG B 274 ARG^? 15.33 ZN ZN B 374 A 190 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 22.59 2.26 43.22 21.17 3.47 42.27 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 13.63 3.81 28.83 14.49 2.91 31.59 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 24.97 7.47 37.69 21.24 10.69 35.89 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 3 3 # 3 A 85 HIS C 263 HIS~? 20.89 ZN ZN C 375 A 171 ARG C 274 ARG^? 15.09 ZN ZN C 374 A 190 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 22.59 2.26 43.22 21.17 3.47 42.27 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 13.63 3.81 28.83 14.49 2.91 31.59 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 24.97 7.47 37.69 21.24 10.69 35.89 -8.06 -35.63 62.23 -11.30 -33.36 66.69 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 3 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS A 263 HIS~? 20.93 ZN ZN A 375 B 171 ARG A 274 ARG^? 15.42 ZN ZN A 374 B 190 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 2.83 4.83 10.84 1.96 4.32 7.97 47.87 -1.95 44.32 44.79 -1.96 44.32 coo -8.96 9.04 2.88 -5.39 12.11 5.08 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 2 3 # 2 B 85 HIS B 263 HIS~? 20.98 ZN ZN B 375 B 171 ARG B 274 ARG^? 15.33 ZN ZN B 374 B 190 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 2.83 4.83 10.84 1.96 4.32 7.97 -4.90 23.06 20.40 -3.60 21.04 22.31 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 3 3 # 3 B 85 HIS C 263 HIS~? 20.89 ZN ZN C 375 B 171 ARG C 274 ARG^? 15.09 ZN ZN C 374 B 190 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 2.83 4.83 10.84 1.96 4.32 7.97 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -8.06 -35.63 62.23 -11.30 -33.36 66.69 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 3 hits 1azy_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 182 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 286 ASN B 238 ASN^? 8.84 O1S EPE A 377 coo 26.03 44.66 108.90 25.67 42.61 108.82 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 18.06 44.02 105.38 18.08 45.37 107.03 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 25.47 38.28 112.06 27.26 39.30 111.54 7.11 -18.54 9.31 8.52 -20.00 8.45 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP A 281 ASP.? 28.06 ZN ZN A 375 A 182 GLU A 254 GLU^? 30.93 ZN ZN A 375 A 286 ASN A 327 ASN^? 23.94 ZN ZN A 375 coo 26.03 44.66 108.90 25.67 42.61 108.82 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 18.06 44.02 105.38 18.08 45.37 107.03 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 25.47 38.28 112.06 27.26 39.30 111.54 47.65 -15.59 42.64 48.42 -17.07 43.94 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 182 GLU A 254 GLU^? 30.93 ZN ZN A 375 A 286 ASN A 327 ASN^? 23.94 ZN ZN A 375 coo 26.03 44.66 108.90 25.67 42.61 108.82 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 18.06 44.02 105.38 18.08 45.37 107.03 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 25.47 38.28 112.06 27.26 39.30 111.54 47.65 -15.59 42.64 48.42 -17.07 43.94 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 182 GLU B 25 GLU.? 18.70 ZN ZN B 375 A 286 ASN B 105 ASN~? 9.47 ZN ZN B 375 coo 26.03 44.66 108.90 25.67 42.61 108.82 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 18.06 44.02 105.38 18.08 45.37 107.03 1.46 -5.92 31.01 3.44 -6.69 31.23 coo 25.47 38.28 112.06 27.26 39.30 111.54 -8.71 -5.38 22.66 -10.29 -4.82 23.98 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 A 109 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 182 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 286 ASN B 105 ASN~? 9.47 ZN ZN B 375 coo 26.03 44.66 108.90 25.67 42.61 108.82 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 18.06 44.02 105.38 18.08 45.37 107.03 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 25.47 38.28 112.06 27.26 39.30 111.54 -8.71 -5.38 22.66 -10.29 -4.82 23.98 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 A 109 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 182 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 286 ASN C 238 ASN^? 16.63 O2S EPE A 377 coo 26.03 44.66 108.90 25.67 42.61 108.82 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 18.06 44.02 105.38 18.08 45.37 107.03 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 25.47 38.28 112.06 27.26 39.30 111.54 5.28 -30.50 23.50 4.52 -30.81 21.55 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 7 3 # 7 A 109 ASP B 237 ASP^? 15.58 N TRS A 378 A 182 GLU B 136 GLU^? 17.92 O1S EPE A 377 A 286 ASN B 238 ASN^? 8.84 O1S EPE A 377 coo 26.03 44.66 108.90 25.67 42.61 108.82 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 18.06 44.02 105.38 18.08 45.37 107.03 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 25.47 38.28 112.06 27.26 39.30 111.54 7.11 -18.54 9.31 8.52 -20.00 8.45 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 8 3 # 8 A 109 ASP B 281 ASP.? 29.04 ZN ZN B 374 A 182 GLU B 254 GLU^? 30.73 ZN ZN B 375 A 286 ASN B 327 ASN^? 24.15 ZN ZN B 374 coo 26.03 44.66 108.90 25.67 42.61 108.82 4.51 22.24 5.26 6.45 23.04 5.71 coo 18.06 44.02 105.38 18.08 45.37 107.03 1.12 17.35 -1.99 2.87 17.99 -2.99 coo 25.47 38.28 112.06 27.26 39.30 111.54 3.03 18.84 10.12 4.53 19.91 9.07 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 9 3 # 9 A 109 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 182 GLU B 254 GLU^? 30.73 ZN ZN B 375 A 286 ASN B 327 ASN^? 24.15 ZN ZN B 374 coo 26.03 44.66 108.90 25.67 42.61 108.82 3.99 14.73 5.36 5.18 14.04 3.76 coo 18.06 44.02 105.38 18.08 45.37 107.03 1.12 17.35 -1.99 2.87 17.99 -2.99 coo 25.47 38.28 112.06 27.26 39.30 111.54 3.03 18.84 10.12 4.53 19.91 9.07 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 10 3 # 10 A 109 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 182 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 286 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo 26.03 44.66 108.90 25.67 42.61 108.82 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 18.06 44.02 105.38 18.08 45.37 107.03 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 25.47 38.28 112.06 27.26 39.30 111.54 12.40 -28.97 45.42 13.67 -29.13 47.17 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 11 3 # 11 A 109 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 182 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 286 ASN A 238 ASN^? -4.13 C2 TRS A 378s coo 26.03 44.66 108.90 25.67 42.61 108.82 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 18.06 44.02 105.38 18.08 45.37 107.03 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 25.47 38.28 112.06 27.26 39.30 111.54 22.25 -25.65 17.52 21.37 -27.55 17.01 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 12 3 # 12 A 109 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 182 GLU C 136 GLU^? 12.99 N TRS A 378 A 286 ASN C 238 ASN^? 16.63 O2S EPE A 377 coo 26.03 44.66 108.90 25.67 42.61 108.82 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 18.06 44.02 105.38 18.08 45.37 107.03 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 25.47 38.28 112.06 27.26 39.30 111.54 5.28 -30.50 23.50 4.52 -30.81 21.55 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 13 3 # 13 A 109 ASP C 281 ASP.? 29.07 ZN ZN C 374 A 182 GLU C 254 GLU^? 30.85 ZN ZN C 375 A 286 ASN C 327 ASN^? 24.03 ZN ZN C 374 coo 26.03 44.66 108.90 25.67 42.61 108.82 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 18.06 44.02 105.38 18.08 45.37 107.03 -21.46 -36.51 49.50 -23.48 -36.16 48.85 coo 25.47 38.28 112.06 27.26 39.30 111.54 -16.01 -26.28 53.09 -18.10 -26.10 52.88 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 14 3 # 14 A 109 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 182 GLU C 254 GLU^? 30.85 ZN ZN C 375 A 286 ASN C 327 ASN^? 24.03 ZN ZN C 374 coo 26.03 44.66 108.90 25.67 42.61 108.82 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 18.06 44.02 105.38 18.08 45.37 107.03 -21.46 -36.51 49.50 -23.48 -36.16 48.85 coo 25.47 38.28 112.06 27.26 39.30 111.54 -16.01 -26.28 53.09 -18.10 -26.10 52.88 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 14 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 182 GLU A 25 GLU.? 17.13 ZN ZN A 375 B 286 ASN A 105 ASN~? 9.65 ZN ZN A 375 coo 13.82 69.26 132.27 11.87 70.14 132.51 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 8.74 63.05 136.42 9.87 62.19 134.79 21.52 -4.56 31.66 21.12 -5.25 33.61 coo 8.26 72.60 129.22 10.14 73.45 129.80 30.92 -4.10 21.33 31.10 -1.93 21.21 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 182 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 286 ASN A 105 ASN~? 9.65 ZN ZN A 375 coo 13.82 69.26 132.27 11.87 70.14 132.51 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 8.74 63.05 136.42 9.87 62.19 134.79 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 8.26 72.60 129.22 10.14 73.45 129.80 30.92 -4.10 21.33 31.10 -1.93 21.21 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 182 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 286 ASN B 238 ASN^? 8.84 O1S EPE A 377 coo 13.82 69.26 132.27 11.87 70.14 132.51 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 8.74 63.05 136.42 9.87 62.19 134.79 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 8.26 72.60 129.22 10.14 73.45 129.80 7.11 -18.54 9.31 8.52 -20.00 8.45 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 B 109 ASP A 281 ASP.? 28.06 ZN ZN A 375 B 182 GLU A 254 GLU^? 30.93 ZN ZN A 375 B 286 ASN A 327 ASN^? 23.94 ZN ZN A 375 coo 13.82 69.26 132.27 11.87 70.14 132.51 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 8.74 63.05 136.42 9.87 62.19 134.79 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 8.26 72.60 129.22 10.14 73.45 129.80 47.65 -15.59 42.64 48.42 -17.07 43.94 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 B 109 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 182 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 286 ASN A 294 ASN.? 12.36 ZN ZN A 374 coo 13.82 69.26 132.27 11.87 70.14 132.51 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 8.74 63.05 136.42 9.87 62.19 134.79 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 8.26 72.60 129.22 10.14 73.45 129.80 35.77 -6.31 41.36 37.34 -5.07 42.10 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 B 109 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 182 GLU A 254 GLU^? 30.93 ZN ZN A 375 B 286 ASN A 327 ASN^? 23.94 ZN ZN A 375 coo 13.82 69.26 132.27 11.87 70.14 132.51 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 8.74 63.05 136.42 9.87 62.19 134.79 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 8.26 72.60 129.22 10.14 73.45 129.80 47.65 -15.59 42.64 48.42 -17.07 43.94 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 7 3 # 7 B 109 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 182 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 286 ASN A 294 ASN.? 12.36 ZN ZN A 374 coo 13.82 69.26 132.27 11.87 70.14 132.51 39.49 -1.24 39.18 39.76 0.49 37.96 coo 8.74 63.05 136.42 9.87 62.19 134.79 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 8.26 72.60 129.22 10.14 73.45 129.80 35.77 -6.31 41.36 37.34 -5.07 42.10 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 8 3 # 8 B 109 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 182 GLU B 25 GLU.? 18.70 ZN ZN B 375 B 286 ASN B 105 ASN~? 9.47 ZN ZN B 375 coo 13.82 69.26 132.27 11.87 70.14 132.51 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 8.74 63.05 136.42 9.87 62.19 134.79 1.46 -5.92 31.01 3.44 -6.69 31.23 coo 8.26 72.60 129.22 10.14 73.45 129.80 -8.71 -5.38 22.66 -10.29 -4.82 23.98 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 9 3 # 9 B 109 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 182 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 286 ASN B 105 ASN~? 9.47 ZN ZN B 375 coo 13.82 69.26 132.27 11.87 70.14 132.51 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 8.74 63.05 136.42 9.87 62.19 134.79 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 8.26 72.60 129.22 10.14 73.45 129.80 -8.71 -5.38 22.66 -10.29 -4.82 23.98 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 10 3 # 10 B 109 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 182 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 286 ASN C 238 ASN^? 16.63 O2S EPE A 377 coo 13.82 69.26 132.27 11.87 70.14 132.51 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 8.74 63.05 136.42 9.87 62.19 134.79 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 8.26 72.60 129.22 10.14 73.45 129.80 5.28 -30.50 23.50 4.52 -30.81 21.55 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 11 3 # 11 B 109 ASP B 281 ASP.? 29.04 ZN ZN B 374 B 182 GLU B 254 GLU^? 30.73 ZN ZN B 375 B 286 ASN B 327 ASN^? 24.15 ZN ZN B 374 coo 13.82 69.26 132.27 11.87 70.14 132.51 4.51 22.24 5.26 6.45 23.04 5.71 coo 8.74 63.05 136.42 9.87 62.19 134.79 1.12 17.35 -1.99 2.87 17.99 -2.99 coo 8.26 72.60 129.22 10.14 73.45 129.80 3.03 18.84 10.12 4.53 19.91 9.07 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 12 3 # 12 B 109 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 182 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 286 ASN B 294 ASN.? 12.27 ZN ZN B 374 coo 13.82 69.26 132.27 11.87 70.14 132.51 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 8.74 63.05 136.42 9.87 62.19 134.79 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 8.26 72.60 129.22 10.14 73.45 129.80 2.18 12.34 23.84 0.88 14.02 24.05 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 13 3 # 13 B 109 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 182 GLU B 254 GLU^? 30.73 ZN ZN B 375 B 286 ASN B 327 ASN^? 24.15 ZN ZN B 374 coo 13.82 69.26 132.27 11.87 70.14 132.51 3.99 14.73 5.36 5.18 14.04 3.76 coo 8.74 63.05 136.42 9.87 62.19 134.79 1.12 17.35 -1.99 2.87 17.99 -2.99 coo 8.26 72.60 129.22 10.14 73.45 129.80 3.03 18.84 10.12 4.53 19.91 9.07 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 14 3 # 14 B 109 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 182 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 286 ASN B 294 ASN.? 12.27 ZN ZN B 374 coo 13.82 69.26 132.27 11.87 70.14 132.51 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 8.74 63.05 136.42 9.87 62.19 134.79 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 8.26 72.60 129.22 10.14 73.45 129.80 2.18 12.34 23.84 0.88 14.02 24.05 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 15 3 # 15 B 109 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 182 GLU C 25 GLU.? 17.70 ZN ZN C 375 B 286 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo 13.82 69.26 132.27 11.87 70.14 132.51 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 8.74 63.05 136.42 9.87 62.19 134.79 10.47 -15.76 42.35 12.38 -15.28 41.57 coo 8.26 72.60 129.22 10.14 73.45 129.80 12.40 -28.97 45.42 13.67 -29.13 47.17 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 16 3 # 16 B 109 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 182 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 286 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo 13.82 69.26 132.27 11.87 70.14 132.51 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 8.74 63.05 136.42 9.87 62.19 134.79 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 8.26 72.60 129.22 10.14 73.45 129.80 12.40 -28.97 45.42 13.67 -29.13 47.17 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 17 3 # 17 B 109 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 182 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 286 ASN A 238 ASN^? -4.13 C2 TRS A 378s coo 13.82 69.26 132.27 11.87 70.14 132.51 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 8.74 63.05 136.42 9.87 62.19 134.79 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 8.26 72.60 129.22 10.14 73.45 129.80 22.25 -25.65 17.52 21.37 -27.55 17.01 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 18 3 # 18 B 109 ASP C 281 ASP.? 29.07 ZN ZN C 374 B 182 GLU C 254 GLU^? 30.85 ZN ZN C 375 B 286 ASN C 327 ASN^? 24.03 ZN ZN C 374 coo 13.82 69.26 132.27 11.87 70.14 132.51 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 8.74 63.05 136.42 9.87 62.19 134.79 -21.46 -36.51 49.50 -23.48 -36.16 48.85 coo 8.26 72.60 129.22 10.14 73.45 129.80 -16.01 -26.28 53.09 -18.10 -26.10 52.88 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 19 3 # 19 B 109 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 182 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 286 ASN C 294 ASN.? 11.92 ZN ZN C 374 coo 13.82 69.26 132.27 11.87 70.14 132.51 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 8.74 63.05 136.42 9.87 62.19 134.79 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 8.26 72.60 129.22 10.14 73.45 129.80 -3.30 -17.98 52.78 -3.53 -18.25 54.87 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 20 3 # 20 B 109 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 182 GLU C 254 GLU^? 30.85 ZN ZN C 375 B 286 ASN C 327 ASN^? 24.03 ZN ZN C 374 coo 13.82 69.26 132.27 11.87 70.14 132.51 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 8.74 63.05 136.42 9.87 62.19 134.79 -21.46 -36.51 49.50 -23.48 -36.16 48.85 coo 8.26 72.60 129.22 10.14 73.45 129.80 -16.01 -26.28 53.09 -18.10 -26.10 52.88 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 21 3 # 21 B 109 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 182 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 286 ASN C 294 ASN.? 11.92 ZN ZN C 374 coo 13.82 69.26 132.27 11.87 70.14 132.51 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 8.74 63.05 136.42 9.87 62.19 134.79 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 8.26 72.60 129.22 10.14 73.45 129.80 -3.30 -17.98 52.78 -3.53 -18.25 54.87 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 21 hits 1b57_c01 naa= 3 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 15 GLU~? 17.23 ZN ZN A 375 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 29.50 -0.46 14.62 27.65 0.59 14.66 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU A 51 GLU~? 11.89 O2S EPE A 376 B 88 ASP B 368 ASP.? 11.70 ZN ZN B 374 B 89 HIS B 366 HIS.? 14.78 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 41.17 19.74 26.83 40.87 21.56 28.00 coo 58.74 13.49 55.78 58.72 14.38 57.67 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 60.89 12.20 60.42 60.43 13.81 61.68 -20.57 16.04 20.92 -18.78 16.88 20.21 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU A 56 GLU~? 18.18 ZN ZN A 374 B 88 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 89 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 47.24 13.21 19.42 47.19 11.28 20.29 coo 58.74 13.49 55.78 58.72 14.38 57.67 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 60.89 12.20 60.42 60.43 13.81 61.68 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU A 127 GLU^? 14.05 O3 TRS A 378 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 39.39 -22.49 26.46 38.47 -23.38 24.73 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 5 3 # 5 A 133 GLU A 150 GLU~? 12.50 C5 EPE C 377 B 88 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 89 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 22.60 -31.63 -7.22 23.33 -32.82 -5.63 coo 58.74 13.49 55.78 58.72 14.38 57.67 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.89 12.20 60.42 60.43 13.81 61.68 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 6 3 # 6 A 133 GLU A 150 GLU~? 12.50 C5 EPE C 377 B 88 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 89 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 22.60 -31.63 -7.22 23.33 -32.82 -5.63 coo 58.74 13.49 55.78 58.72 14.38 57.67 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 7 3 # 7 A 133 GLU A 151 GLU~? 15.60 C7 EPE A 377 B 88 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 89 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 58.74 13.49 55.78 58.72 14.38 57.67 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 60.89 12.20 60.42 60.43 13.81 61.68 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 8 3 # 8 A 133 GLU A 151 GLU~? 15.60 C7 EPE A 377 B 88 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 89 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 58.74 13.49 55.78 58.72 14.38 57.67 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 9 3 # 9 A 133 GLU A 151 GLU~? 15.60 C7 EPE A 377 B 88 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 89 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 58.74 13.49 55.78 58.72 14.38 57.67 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 10 3 # 10 A 133 GLU A 197 GLU^? 9.85 O8 EPE A 377 B 88 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 89 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -4.05 -31.37 -7.20 -4.83 -32.55 -8.76 coo 58.74 13.49 55.78 58.72 14.38 57.67 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 11 3 # 11 A 133 GLU A 197 GLU^? 9.85 O8 EPE A 377 B 88 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 89 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -4.05 -31.37 -7.20 -4.83 -32.55 -8.76 coo 58.74 13.49 55.78 58.72 14.38 57.67 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.89 12.20 60.42 60.43 13.81 61.68 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 12 3 # 12 A 133 GLU A 197 GLU^? 9.85 O8 EPE A 377 B 88 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 89 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -4.05 -31.37 -7.20 -4.83 -32.55 -8.76 coo 58.74 13.49 55.78 58.72 14.38 57.67 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 13 3 # 13 A 133 GLU A 201 GLU^? -3.12 C2 EPE A 377s B 88 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 89 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 44.53 38.98 5.35 43.53 40.60 6.22 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 58.74 13.49 55.78 58.72 14.38 57.67 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 60.89 12.20 60.42 60.43 13.81 61.68 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 14 3 # 14 A 133 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 88 ASP B 368 ASP.? 11.70 ZN ZN B 374 B 89 HIS B 366 HIS.? 14.78 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 58.74 13.49 55.78 58.72 14.38 57.67 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 60.89 12.20 60.42 60.43 13.81 61.68 -20.57 16.04 20.92 -18.78 16.88 20.21 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 15 3 # 15 A 133 GLU A 227 GLU.? 13.15 O8 EPE A 377 B 88 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 89 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 5.87 -17.01 -8.12 5.06 -15.73 -9.55 coo 58.74 13.49 55.78 58.72 14.38 57.67 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 16 3 # 16 A 133 GLU A 228 GLU.? 8.71 C3 EPE A 377 B 88 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 89 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 44.53 38.98 5.35 43.53 40.60 6.22 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 58.74 13.49 55.78 58.72 14.38 57.67 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 60.89 12.20 60.42 60.43 13.81 61.68 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 17 3 # 17 A 133 GLU A 228 GLU.? 8.71 C3 EPE A 377 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 18 3 # 18 A 133 GLU A 262 GLU~? 24.15 ZN ZN A 374 B 88 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 89 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 59.50 -9.24 37.85 59.47 -7.16 38.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.89 12.20 60.42 60.43 13.81 61.68 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 19 3 # 19 A 133 GLU A 262 GLU~? 24.15 ZN ZN A 374 B 88 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 89 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 44.53 38.98 5.35 43.53 40.60 6.22 59.50 -9.24 37.85 59.47 -7.16 38.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 60.89 12.20 60.42 60.43 13.81 61.68 13.13 -47.52 24.96 14.34 -48.17 26.54 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 20 3 # 20 A 133 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 21 3 # 21 A 133 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 88 ASP C 368 ASP.? 11.74 ZN ZN C 374 B 89 HIS C 366 HIS.? 14.85 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 58.74 13.49 55.78 58.72 14.38 57.67 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 60.89 12.20 60.42 60.43 13.81 61.68 4.16 -33.39 68.22 2.28 -32.65 67.64 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 22 3 # 22 A 133 GLU B 15 GLU~? 17.09 ZN ZN B 375 B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 23 3 # 23 A 133 GLU B 51 GLU~? 11.61 O3S EPE B 376 B 88 ASP C 368 ASP.? 11.74 ZN ZN C 374 B 89 HIS C 366 HIS.? 14.85 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -25.55 10.19 35.45 -25.80 11.09 37.35 coo 58.74 13.49 55.78 58.72 14.38 57.67 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 60.89 12.20 60.42 60.43 13.81 61.68 4.16 -33.39 68.22 2.28 -32.65 67.64 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 24 3 # 24 A 133 GLU B 56 GLU~? 18.10 ZN ZN B 374 B 88 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 89 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 58.74 13.49 55.78 58.72 14.38 57.67 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 60.89 12.20 60.42 60.43 13.81 61.68 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 25 3 # 25 A 133 GLU B 90 GLU~? 12.95 O2S EPE B 376 B 88 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 89 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 58.74 13.49 55.78 58.72 14.38 57.67 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 60.89 12.20 60.42 60.43 13.81 61.68 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 26 3 # 26 A 133 GLU B 150 GLU~? 12.97 C6 EPE A 377 B 88 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 89 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 58.74 13.49 55.78 58.72 14.38 57.67 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 60.89 12.20 60.42 60.43 13.81 61.68 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 27 3 # 27 A 133 GLU B 150 GLU~? 12.97 C6 EPE A 377 B 88 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 89 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 58.74 13.49 55.78 58.72 14.38 57.67 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 28 3 # 28 A 133 GLU B 150 GLU~? 12.97 C6 EPE A 377 B 88 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 89 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 58.74 13.49 55.78 58.72 14.38 57.67 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 29 3 # 29 A 133 GLU B 151 GLU~? 19.22 O3S EPE A 377 B 88 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 89 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 58.74 13.49 55.78 58.72 14.38 57.67 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 60.89 12.20 60.42 60.43 13.81 61.68 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 30 3 # 30 A 133 GLU B 151 GLU~? 19.22 O3S EPE A 377 B 88 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 89 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 58.74 13.49 55.78 58.72 14.38 57.67 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 31 3 # 31 A 133 GLU B 151 GLU~? 19.22 O3S EPE A 377 B 88 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 89 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 58.74 13.49 55.78 58.72 14.38 57.67 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 32 3 # 32 A 133 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 33 3 # 33 A 133 GLU B 197 GLU^? 29.51 O2S EPE A 377 B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 6.54 -53.58 20.85 4.69 -53.18 21.76 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 34 3 # 34 A 133 GLU B 200 GLU^? 21.89 O2S EPE A 377 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 35 3 # 35 A 133 GLU B 201 GLU^? 17.83 O2S EPE A 377 B 88 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 89 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 44.53 38.98 5.35 43.53 40.60 6.22 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 60.89 12.20 60.42 60.43 13.81 61.68 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 36 3 # 36 A 133 GLU B 201 GLU^? 17.83 O2S EPE A 377 B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 37 3 # 37 A 133 GLU B 227 GLU.? 24.58 O3S EPE A 377 B 88 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 89 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 58.74 13.49 55.78 58.72 14.38 57.67 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 38 3 # 38 A 133 GLU B 262 GLU~? 24.13 ZN ZN B 374 B 88 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 89 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 44.53 38.98 5.35 43.53 40.60 6.22 -9.48 23.81 6.41 -10.83 24.55 7.88 coo 58.74 13.49 55.78 58.72 14.38 57.67 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 60.89 12.20 60.42 60.43 13.81 61.68 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 39 3 # 39 A 133 GLU B 262 GLU~? 24.13 ZN ZN B 374 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -9.48 23.81 6.41 -10.83 24.55 7.88 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 40 3 # 40 A 133 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 41 3 # 41 A 133 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 88 ASP A 368 ASP.? 11.85 ZN ZN A 374 B 89 HIS A 366 HIS.? 14.86 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 58.74 13.49 55.78 58.72 14.38 57.67 48.24 5.16 33.58 47.82 3.96 35.30 coo 60.89 12.20 60.42 60.43 13.81 61.68 51.10 6.85 29.91 51.20 5.36 31.38 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 42 3 # 42 A 133 GLU C 51 GLU~? 12.03 O3S EPE C 376 B 88 ASP A 368 ASP.? 11.85 ZN ZN A 374 B 89 HIS A 366 HIS.? 14.86 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 19.07 -27.28 70.66 19.78 -25.91 72.07 coo 58.74 13.49 55.78 58.72 14.38 57.67 48.24 5.16 33.58 47.82 3.96 35.30 coo 60.89 12.20 60.42 60.43 13.81 61.68 51.10 6.85 29.91 51.20 5.36 31.38 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 43 3 # 43 A 133 GLU C 56 GLU~? 18.45 ZN ZN C 374 B 88 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 58.74 13.49 55.78 58.72 14.38 57.67 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 44 3 # 44 A 133 GLU C 150 GLU~? 19.96 C2 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 18.79 -51.73 16.88 16.73 -51.34 17.24 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 45 3 # 45 A 133 GLU C 150 GLU~? 19.96 C2 EPE C 377 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 18.79 -51.73 16.88 16.73 -51.34 17.24 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 46 3 # 46 A 133 GLU C 151 GLU~? 17.15 O8 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 47 3 # 47 A 133 GLU C 151 GLU~? 17.15 O8 EPE C 377 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 48 3 # 48 A 133 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 49 3 # 49 A 133 GLU C 184 GLU.? 20.48 N4 EPE C 377 B 88 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 58.74 13.49 55.78 58.72 14.38 57.67 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 50 3 # 50 A 133 GLU C 184 GLU.? 20.48 N4 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 51 3 # 51 A 133 GLU C 184 GLU.? 20.48 N4 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 52 3 # 52 A 133 GLU C 184 GLU.? 20.48 N4 EPE C 377 B 88 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 89 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 58.74 13.49 55.78 58.72 14.38 57.67 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.89 12.20 60.42 60.43 13.81 61.68 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 53 3 # 53 A 133 GLU C 197 GLU^? 9.42 O8 EPE C 377 B 88 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 32.51 -36.09 0.58 33.81 -36.84 -0.90 coo 58.74 13.49 55.78 58.72 14.38 57.67 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 54 3 # 54 A 133 GLU C 197 GLU^? 9.42 O8 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 32.51 -36.09 0.58 33.81 -36.84 -0.90 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 55 3 # 55 A 133 GLU C 197 GLU^? 9.42 O8 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 32.51 -36.09 0.58 33.81 -36.84 -0.90 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 56 3 # 56 A 133 GLU C 200 GLU^? 10.81 O8 EPE C 377 B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 57 3 # 57 A 133 GLU C 200 GLU^? 10.81 O8 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 58 3 # 58 A 133 GLU C 201 GLU^? -3.18 C8 EPE C 377s B 88 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 89 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 44.53 38.98 5.35 43.53 40.60 6.22 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 58.74 13.49 55.78 58.72 14.38 57.67 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 59 3 # 59 A 133 GLU C 227 GLU.? 14.45 C7 EPE C 377 B 88 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 58.74 13.49 55.78 58.72 14.38 57.67 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 60 3 # 60 A 133 GLU C 227 GLU.? 14.45 C7 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 61 3 # 61 A 133 GLU C 227 GLU.? 14.45 C7 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 62 3 # 62 A 133 GLU C 228 GLU.? 9.65 C7 EPE C 377 B 88 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 89 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 44.53 38.98 5.35 43.53 40.60 6.22 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 58.74 13.49 55.78 58.72 14.38 57.67 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 63 3 # 63 A 133 GLU C 228 GLU.? 9.65 C7 EPE C 377 B 88 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 89 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 58.74 13.49 55.78 58.72 14.38 57.67 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.89 12.20 60.42 60.43 13.81 61.68 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 64 3 # 64 A 133 GLU C 241 GLU^? 18.99 ZN ZN C 375 B 88 ASP A 368 ASP.? 11.85 ZN ZN A 374 B 89 HIS A 366 HIS.? 14.86 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 58.74 13.49 55.78 58.72 14.38 57.67 48.24 5.16 33.58 47.82 3.96 35.30 coo 60.89 12.20 60.42 60.43 13.81 61.68 51.10 6.85 29.91 51.20 5.36 31.38 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 65 3 # 65 A 133 GLU C 262 GLU~? 24.05 ZN ZN C 374 B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -15.17 -35.96 63.25 -14.01 -35.31 64.90 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 66 3 # 66 A 133 GLU C 262 GLU~? 24.05 ZN ZN C 374 B 88 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 89 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 44.53 38.98 5.35 43.53 40.60 6.22 -15.17 -35.96 63.25 -14.01 -35.31 64.90 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 67 3 # 67 A 133 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 88 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 89 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 58.74 13.49 55.78 58.72 14.38 57.67 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.89 12.20 60.42 60.43 13.81 61.68 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 68 3 # 68 A 133 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 88 ASP B 368 ASP.? 11.70 ZN ZN B 374 B 89 HIS B 366 HIS.? 14.78 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 58.74 13.49 55.78 58.72 14.38 57.67 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 60.89 12.20 60.42 60.43 13.81 61.68 -20.57 16.04 20.92 -18.78 16.88 20.21 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 69 3 # 69 A 133 GLU C 349 GLU~? 21.43 ZN ZN C 375 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 1b66_c00 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 69 hits 1b66_c00 naa= 3 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 15 GLU~? 17.23 ZN ZN A 375 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 29.50 -0.46 14.62 27.65 0.59 14.66 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU A 51 GLU~? 11.89 O2S EPE A 376 B 88 ASP B 368 ASP.? 11.70 ZN ZN B 374 B 89 HIS B 366 HIS.? 14.78 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 41.17 19.74 26.83 40.87 21.56 28.00 coo 58.74 13.49 55.78 58.72 14.38 57.67 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 60.89 12.20 60.42 60.43 13.81 61.68 -20.57 16.04 20.92 -18.78 16.88 20.21 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU A 56 GLU~? 18.18 ZN ZN A 374 B 88 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 89 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 47.24 13.21 19.42 47.19 11.28 20.29 coo 58.74 13.49 55.78 58.72 14.38 57.67 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 60.89 12.20 60.42 60.43 13.81 61.68 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU A 127 GLU^? 14.05 O3 TRS A 378 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 39.39 -22.49 26.46 38.47 -23.38 24.73 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 5 3 # 5 A 133 GLU A 150 GLU~? 12.50 C5 EPE C 377 B 88 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 89 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 22.60 -31.63 -7.22 23.33 -32.82 -5.63 coo 58.74 13.49 55.78 58.72 14.38 57.67 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.89 12.20 60.42 60.43 13.81 61.68 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 6 3 # 6 A 133 GLU A 150 GLU~? 12.50 C5 EPE C 377 B 88 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 89 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 22.60 -31.63 -7.22 23.33 -32.82 -5.63 coo 58.74 13.49 55.78 58.72 14.38 57.67 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 7 3 # 7 A 133 GLU A 151 GLU~? 15.60 C7 EPE A 377 B 88 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 89 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 58.74 13.49 55.78 58.72 14.38 57.67 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 60.89 12.20 60.42 60.43 13.81 61.68 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 8 3 # 8 A 133 GLU A 151 GLU~? 15.60 C7 EPE A 377 B 88 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 89 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 58.74 13.49 55.78 58.72 14.38 57.67 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 9 3 # 9 A 133 GLU A 151 GLU~? 15.60 C7 EPE A 377 B 88 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 89 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 58.74 13.49 55.78 58.72 14.38 57.67 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 10 3 # 10 A 133 GLU A 197 GLU^? 9.85 O8 EPE A 377 B 88 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 89 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -4.05 -31.37 -7.20 -4.83 -32.55 -8.76 coo 58.74 13.49 55.78 58.72 14.38 57.67 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 11 3 # 11 A 133 GLU A 197 GLU^? 9.85 O8 EPE A 377 B 88 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 89 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -4.05 -31.37 -7.20 -4.83 -32.55 -8.76 coo 58.74 13.49 55.78 58.72 14.38 57.67 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.89 12.20 60.42 60.43 13.81 61.68 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 12 3 # 12 A 133 GLU A 197 GLU^? 9.85 O8 EPE A 377 B 88 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 89 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -4.05 -31.37 -7.20 -4.83 -32.55 -8.76 coo 58.74 13.49 55.78 58.72 14.38 57.67 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 13 3 # 13 A 133 GLU A 201 GLU^? -3.12 C2 EPE A 377s B 88 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 89 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 44.53 38.98 5.35 43.53 40.60 6.22 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 58.74 13.49 55.78 58.72 14.38 57.67 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 60.89 12.20 60.42 60.43 13.81 61.68 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 14 3 # 14 A 133 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 88 ASP B 368 ASP.? 11.70 ZN ZN B 374 B 89 HIS B 366 HIS.? 14.78 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 58.74 13.49 55.78 58.72 14.38 57.67 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 60.89 12.20 60.42 60.43 13.81 61.68 -20.57 16.04 20.92 -18.78 16.88 20.21 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 15 3 # 15 A 133 GLU A 227 GLU.? 13.15 O8 EPE A 377 B 88 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 89 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 5.87 -17.01 -8.12 5.06 -15.73 -9.55 coo 58.74 13.49 55.78 58.72 14.38 57.67 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 60.89 12.20 60.42 60.43 13.81 61.68 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 16 3 # 16 A 133 GLU A 228 GLU.? 8.71 C3 EPE A 377 B 88 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 89 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 44.53 38.98 5.35 43.53 40.60 6.22 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 58.74 13.49 55.78 58.72 14.38 57.67 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 60.89 12.20 60.42 60.43 13.81 61.68 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 17 3 # 17 A 133 GLU A 228 GLU.? 8.71 C3 EPE A 377 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 18 3 # 18 A 133 GLU A 262 GLU~? 24.15 ZN ZN A 374 B 88 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 89 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 59.50 -9.24 37.85 59.47 -7.16 38.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.89 12.20 60.42 60.43 13.81 61.68 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 19 3 # 19 A 133 GLU A 262 GLU~? 24.15 ZN ZN A 374 B 88 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 89 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 44.53 38.98 5.35 43.53 40.60 6.22 59.50 -9.24 37.85 59.47 -7.16 38.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 60.89 12.20 60.42 60.43 13.81 61.68 13.13 -47.52 24.96 14.34 -48.17 26.54 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 20 3 # 20 A 133 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 21 3 # 21 A 133 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 88 ASP C 368 ASP.? 11.74 ZN ZN C 374 B 89 HIS C 366 HIS.? 14.85 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 58.74 13.49 55.78 58.72 14.38 57.67 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 60.89 12.20 60.42 60.43 13.81 61.68 4.16 -33.39 68.22 2.28 -32.65 67.64 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 22 3 # 22 A 133 GLU B 15 GLU~? 17.09 ZN ZN B 375 B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 23 3 # 23 A 133 GLU B 51 GLU~? 11.61 O3S EPE B 376 B 88 ASP C 368 ASP.? 11.74 ZN ZN C 374 B 89 HIS C 366 HIS.? 14.85 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -25.55 10.19 35.45 -25.80 11.09 37.35 coo 58.74 13.49 55.78 58.72 14.38 57.67 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 60.89 12.20 60.42 60.43 13.81 61.68 4.16 -33.39 68.22 2.28 -32.65 67.64 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 24 3 # 24 A 133 GLU B 56 GLU~? 18.10 ZN ZN B 374 B 88 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 89 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 58.74 13.49 55.78 58.72 14.38 57.67 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 60.89 12.20 60.42 60.43 13.81 61.68 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 25 3 # 25 A 133 GLU B 90 GLU~? 12.95 O2S EPE B 376 B 88 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 89 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 58.74 13.49 55.78 58.72 14.38 57.67 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 60.89 12.20 60.42 60.43 13.81 61.68 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 26 3 # 26 A 133 GLU B 150 GLU~? 12.97 C6 EPE A 377 B 88 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 89 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 58.74 13.49 55.78 58.72 14.38 57.67 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 60.89 12.20 60.42 60.43 13.81 61.68 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 27 3 # 27 A 133 GLU B 150 GLU~? 12.97 C6 EPE A 377 B 88 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 89 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 58.74 13.49 55.78 58.72 14.38 57.67 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 28 3 # 28 A 133 GLU B 150 GLU~? 12.97 C6 EPE A 377 B 88 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 89 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 58.74 13.49 55.78 58.72 14.38 57.67 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 29 3 # 29 A 133 GLU B 151 GLU~? 19.22 O3S EPE A 377 B 88 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 89 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 58.74 13.49 55.78 58.72 14.38 57.67 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 60.89 12.20 60.42 60.43 13.81 61.68 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 30 3 # 30 A 133 GLU B 151 GLU~? 19.22 O3S EPE A 377 B 88 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 89 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 58.74 13.49 55.78 58.72 14.38 57.67 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 31 3 # 31 A 133 GLU B 151 GLU~? 19.22 O3S EPE A 377 B 88 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 89 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 58.74 13.49 55.78 58.72 14.38 57.67 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 32 3 # 32 A 133 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 33 3 # 33 A 133 GLU B 197 GLU^? 29.51 O2S EPE A 377 B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 6.54 -53.58 20.85 4.69 -53.18 21.76 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 34 3 # 34 A 133 GLU B 200 GLU^? 21.89 O2S EPE A 377 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 35 3 # 35 A 133 GLU B 201 GLU^? 17.83 O2S EPE A 377 B 88 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 89 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 44.53 38.98 5.35 43.53 40.60 6.22 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 60.89 12.20 60.42 60.43 13.81 61.68 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 36 3 # 36 A 133 GLU B 201 GLU^? 17.83 O2S EPE A 377 B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 37 3 # 37 A 133 GLU B 227 GLU.? 24.58 O3S EPE A 377 B 88 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 89 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 58.74 13.49 55.78 58.72 14.38 57.67 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 38 3 # 38 A 133 GLU B 262 GLU~? 24.13 ZN ZN B 374 B 88 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 89 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 44.53 38.98 5.35 43.53 40.60 6.22 -9.48 23.81 6.41 -10.83 24.55 7.88 coo 58.74 13.49 55.78 58.72 14.38 57.67 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 60.89 12.20 60.42 60.43 13.81 61.68 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 39 3 # 39 A 133 GLU B 262 GLU~? 24.13 ZN ZN B 374 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -9.48 23.81 6.41 -10.83 24.55 7.88 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 40 3 # 40 A 133 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 41 3 # 41 A 133 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 88 ASP A 368 ASP.? 11.85 ZN ZN A 374 B 89 HIS A 366 HIS.? 14.86 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 58.74 13.49 55.78 58.72 14.38 57.67 48.24 5.16 33.58 47.82 3.96 35.30 coo 60.89 12.20 60.42 60.43 13.81 61.68 51.10 6.85 29.91 51.20 5.36 31.38 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 42 3 # 42 A 133 GLU C 51 GLU~? 12.03 O3S EPE C 376 B 88 ASP A 368 ASP.? 11.85 ZN ZN A 374 B 89 HIS A 366 HIS.? 14.86 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 19.07 -27.28 70.66 19.78 -25.91 72.07 coo 58.74 13.49 55.78 58.72 14.38 57.67 48.24 5.16 33.58 47.82 3.96 35.30 coo 60.89 12.20 60.42 60.43 13.81 61.68 51.10 6.85 29.91 51.20 5.36 31.38 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 43 3 # 43 A 133 GLU C 56 GLU~? 18.45 ZN ZN C 374 B 88 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 58.74 13.49 55.78 58.72 14.38 57.67 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 44 3 # 44 A 133 GLU C 150 GLU~? 19.96 C2 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 18.79 -51.73 16.88 16.73 -51.34 17.24 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 45 3 # 45 A 133 GLU C 150 GLU~? 19.96 C2 EPE C 377 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 18.79 -51.73 16.88 16.73 -51.34 17.24 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 46 3 # 46 A 133 GLU C 151 GLU~? 17.15 O8 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 47 3 # 47 A 133 GLU C 151 GLU~? 17.15 O8 EPE C 377 B 88 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 89 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.89 12.20 60.42 60.43 13.81 61.68 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 48 3 # 48 A 133 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 49 3 # 49 A 133 GLU C 184 GLU.? 20.48 N4 EPE C 377 B 88 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 58.74 13.49 55.78 58.72 14.38 57.67 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 50 3 # 50 A 133 GLU C 184 GLU.? 20.48 N4 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 51 3 # 51 A 133 GLU C 184 GLU.? 20.48 N4 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 52 3 # 52 A 133 GLU C 184 GLU.? 20.48 N4 EPE C 377 B 88 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 89 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 58.74 13.49 55.78 58.72 14.38 57.67 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.89 12.20 60.42 60.43 13.81 61.68 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 53 3 # 53 A 133 GLU C 197 GLU^? 9.42 O8 EPE C 377 B 88 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 32.51 -36.09 0.58 33.81 -36.84 -0.90 coo 58.74 13.49 55.78 58.72 14.38 57.67 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 54 3 # 54 A 133 GLU C 197 GLU^? 9.42 O8 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 32.51 -36.09 0.58 33.81 -36.84 -0.90 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 55 3 # 55 A 133 GLU C 197 GLU^? 9.42 O8 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 32.51 -36.09 0.58 33.81 -36.84 -0.90 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 56 3 # 56 A 133 GLU C 200 GLU^? 10.81 O8 EPE C 377 B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 57 3 # 57 A 133 GLU C 200 GLU^? 10.81 O8 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 58 3 # 58 A 133 GLU C 201 GLU^? -3.18 C8 EPE C 377s B 88 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 89 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 44.53 38.98 5.35 43.53 40.60 6.22 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 58.74 13.49 55.78 58.72 14.38 57.67 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 59 3 # 59 A 133 GLU C 227 GLU.? 14.45 C7 EPE C 377 B 88 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 58.74 13.49 55.78 58.72 14.38 57.67 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 60 3 # 60 A 133 GLU C 227 GLU.? 14.45 C7 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 61 3 # 61 A 133 GLU C 227 GLU.? 14.45 C7 EPE C 377 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 44.53 38.98 5.35 43.53 40.60 6.22 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 62 3 # 62 A 133 GLU C 228 GLU.? 9.65 C7 EPE C 377 B 88 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 89 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 44.53 38.98 5.35 43.53 40.60 6.22 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 58.74 13.49 55.78 58.72 14.38 57.67 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 60.89 12.20 60.42 60.43 13.81 61.68 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 63 3 # 63 A 133 GLU C 228 GLU.? 9.65 C7 EPE C 377 B 88 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 89 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 58.74 13.49 55.78 58.72 14.38 57.67 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.89 12.20 60.42 60.43 13.81 61.68 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 64 3 # 64 A 133 GLU C 241 GLU^? 18.99 ZN ZN C 375 B 88 ASP A 368 ASP.? 11.85 ZN ZN A 374 B 89 HIS A 366 HIS.? 14.86 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 58.74 13.49 55.78 58.72 14.38 57.67 48.24 5.16 33.58 47.82 3.96 35.30 coo 60.89 12.20 60.42 60.43 13.81 61.68 51.10 6.85 29.91 51.20 5.36 31.38 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 65 3 # 65 A 133 GLU C 262 GLU~? 24.05 ZN ZN C 374 B 88 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 89 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 -15.17 -35.96 63.25 -14.01 -35.31 64.90 coo 58.74 13.49 55.78 58.72 14.38 57.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.89 12.20 60.42 60.43 13.81 61.68 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 66 3 # 66 A 133 GLU C 262 GLU~? 24.05 ZN ZN C 374 B 88 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 89 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 44.53 38.98 5.35 43.53 40.60 6.22 -15.17 -35.96 63.25 -14.01 -35.31 64.90 coo 58.74 13.49 55.78 58.72 14.38 57.67 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 60.89 12.20 60.42 60.43 13.81 61.68 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 67 3 # 67 A 133 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 88 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 89 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 58.74 13.49 55.78 58.72 14.38 57.67 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.89 12.20 60.42 60.43 13.81 61.68 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 68 3 # 68 A 133 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 88 ASP B 368 ASP.? 11.70 ZN ZN B 374 B 89 HIS B 366 HIS.? 14.78 ZN ZN B 374 coo 44.53 38.98 5.35 43.53 40.60 6.22 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 58.74 13.49 55.78 58.72 14.38 57.67 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 60.89 12.20 60.42 60.43 13.81 61.68 -20.57 16.04 20.92 -18.78 16.88 20.21 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 69 3 # 69 A 133 GLU C 349 GLU~? 21.43 ZN ZN C 375 B 88 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 89 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 44.53 38.98 5.35 43.53 40.60 6.22 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 58.74 13.49 55.78 58.72 14.38 57.67 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 60.89 12.20 60.42 60.43 13.81 61.68 -12.57 2.98 23.02 -10.64 2.83 22.25 1b66_c02 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 69 hits 1b66_c02 naa= 3 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 1 3 # 1 124 ASP A 27 ASP.? 8.12 ZN ZN A 375 260 ASP A 107 ASP~? -2.33 ZN ZN A 375s 289 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 30.43 27.27 28.31 29.04 28.69 29.00 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 34.79 33.03 22.11 33.47 32.83 23.76 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 30.83 30.57 23.91 30.62 30.06 25.92 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 2 3 # 2 124 ASP A 107 ASP~? -2.33 ZN ZN A 375s 260 ASP A 27 ASP.? 8.12 ZN ZN A 375 289 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 30.43 27.27 28.31 29.04 28.69 29.00 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.79 33.03 22.11 33.47 32.83 23.76 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 30.83 30.57 23.91 30.62 30.06 25.92 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 3 3 # 3 124 ASP B 107 ASP~? -2.23 ZN ZN B 375s 260 ASP B 27 ASP.? 8.17 ZN ZN B 375 289 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 30.43 27.27 28.31 29.04 28.69 29.00 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.79 33.03 22.11 33.47 32.83 23.76 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 30.83 30.57 23.91 30.62 30.06 25.92 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 4 3 # 4 124 ASP C 27 ASP.? 8.23 ZN ZN C 375 260 ASP C 107 ASP~? -2.30 ZN ZN C 375s 289 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 30.43 27.27 28.31 29.04 28.69 29.00 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 34.79 33.03 22.11 33.47 32.83 23.76 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 30.83 30.57 23.91 30.62 30.06 25.92 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 5 3 # 5 124 ASP C 107 ASP~? -2.30 ZN ZN C 375s 260 ASP C 27 ASP.? 8.23 ZN ZN C 375 289 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 30.43 27.27 28.31 29.04 28.69 29.00 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.79 33.03 22.11 33.47 32.83 23.76 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 30.83 30.57 23.91 30.62 30.06 25.92 10.51 -24.81 51.94 8.80 -23.79 52.62 1b6g_c00 source 1b6g HALOALKANE DEHALOGENASE : 5 hits 1b6g_c00 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 230 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 273 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 9.23 21.44 106.88 10.18 19.34 105.31 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 1.45 22.80 104.16 2.58 21.02 104.01 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 2.97 11.64 107.87 6.59 15.13 107.03 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR A 231 TYR^? 10.06 O1S EPE A 377 A 230 ASP B 237 ASP^? 15.58 N TRS A 378 A 273 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 9.23 21.44 106.88 10.18 19.34 105.31 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 1.45 22.80 104.16 2.58 21.02 104.01 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 2.97 11.64 107.87 6.59 15.13 107.03 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 A 145 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 230 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 273 LYS C 138 LYS^? 8.30 N TRS A 378 coo 9.23 21.44 106.88 10.18 19.34 105.31 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 1.45 22.80 104.16 2.58 21.02 104.01 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 2.97 11.64 107.87 6.59 15.13 107.03 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 A 145 TYR A 250 TYR^? 23.04 O3 TRS A 378 A 230 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 273 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 9.23 21.44 106.88 10.18 19.34 105.31 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 1.45 22.80 104.16 2.58 21.02 104.01 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 2.97 11.64 107.87 6.59 15.13 107.03 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 A 145 TYR A 250 TYR^? 23.04 O3 TRS A 378 A 230 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 273 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 9.23 21.44 106.88 10.18 19.34 105.31 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 1.45 22.80 104.16 2.58 21.02 104.01 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 2.97 11.64 107.87 6.59 15.13 107.03 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 A 145 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 230 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 273 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 9.23 21.44 106.88 10.18 19.34 105.31 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 1.45 22.80 104.16 2.58 21.02 104.01 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 2.97 11.64 107.87 6.59 15.13 107.03 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 A 145 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 230 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 273 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 9.23 21.44 106.88 10.18 19.34 105.31 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 1.45 22.80 104.16 2.58 21.02 104.01 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 2.97 11.64 107.87 6.59 15.13 107.03 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 A 145 TYR B 231 TYR^? 16.39 O2S EPE A 377 A 230 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 273 LYS C 139 LYS^? 16.11 N TRS A 378 coo 9.23 21.44 106.88 10.18 19.34 105.31 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 1.45 22.80 104.16 2.58 21.02 104.01 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 2.97 11.64 107.87 6.59 15.13 107.03 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 A 145 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 230 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 273 LYS A 138 LYS^? 13.11 N TRS A 378 coo 9.23 21.44 106.88 10.18 19.34 105.31 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 1.45 22.80 104.16 2.58 21.02 104.01 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 2.97 11.64 107.87 6.59 15.13 107.03 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 A 145 TYR B 250 TYR^? 23.22 ZN ZN B 375 A 230 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 273 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 9.23 21.44 106.88 10.18 19.34 105.31 0.70 6.87 1.10 3.12 5.62 1.69 coo 1.45 22.80 104.16 2.58 21.02 104.01 3.99 14.73 5.36 5.18 14.04 3.76 coo 2.97 11.64 107.87 6.59 15.13 107.03 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 A 145 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 230 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 273 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 9.23 21.44 106.88 10.18 19.34 105.31 1.32 11.76 14.56 0.84 10.00 16.68 coo 1.45 22.80 104.16 2.58 21.02 104.01 3.99 14.73 5.36 5.18 14.04 3.76 coo 2.97 11.64 107.87 6.59 15.13 107.03 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 12 3 # 12 A 145 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 230 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 273 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 9.23 21.44 106.88 10.18 19.34 105.31 2.08 17.58 27.10 3.13 18.35 29.60 coo 1.45 22.80 104.16 2.58 21.02 104.01 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 2.97 11.64 107.87 6.59 15.13 107.03 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 13 3 # 13 A 145 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 230 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 273 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 9.23 21.44 106.88 10.18 19.34 105.31 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 1.45 22.80 104.16 2.58 21.02 104.01 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 2.97 11.64 107.87 6.59 15.13 107.03 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 14 3 # 14 A 145 TYR C 231 TYR^? -4.25 C2 TRS A 378s A 230 ASP A 237 ASP^? 6.80 N TRS A 378 A 273 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 9.23 21.44 106.88 10.18 19.34 105.31 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 1.45 22.80 104.16 2.58 21.02 104.01 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 2.97 11.64 107.87 6.59 15.13 107.03 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 15 3 # 15 A 145 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 230 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 273 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 9.23 21.44 106.88 10.18 19.34 105.31 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 1.45 22.80 104.16 2.58 21.02 104.01 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 2.97 11.64 107.87 6.59 15.13 107.03 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 16 3 # 16 A 145 TYR C 250 TYR^? 23.68 ZN ZN C 375 A 230 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 273 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 9.23 21.44 106.88 10.18 19.34 105.31 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 1.45 22.80 104.16 2.58 21.02 104.01 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 2.97 11.64 107.87 6.59 15.13 107.03 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 17 3 # 17 A 145 TYR C 250 TYR^? 23.68 ZN ZN C 375 A 230 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 273 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 9.23 21.44 106.88 10.18 19.34 105.31 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 1.45 22.80 104.16 2.58 21.02 104.01 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 2.97 11.64 107.87 6.59 15.13 107.03 -11.06 -26.43 40.09 -5.81 -27.52 38.93 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 18 3 # 18 A 145 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 230 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 273 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 9.23 21.44 106.88 10.18 19.34 105.31 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 1.45 22.80 104.16 2.58 21.02 104.01 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 2.97 11.64 107.87 6.59 15.13 107.03 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 19 3 # 19 A 145 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 230 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 273 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 9.23 21.44 106.88 10.18 19.34 105.31 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 1.45 22.80 104.16 2.58 21.02 104.01 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 2.97 11.64 107.87 6.59 15.13 107.03 -11.06 -26.43 40.09 -5.81 -27.52 38.93 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 19 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 18 TYR~? 11.08 ZN ZN A 375 B 230 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 273 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 11.81 13.41 73.03 10.00 13.03 75.12 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 19.17 11.01 76.14 17.26 10.42 76.77 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.10 2.31 76.60 10.24 7.24 75.62 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR A 231 TYR^? 10.06 O1S EPE A 377 B 230 ASP B 237 ASP^? 15.58 N TRS A 378 B 273 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 11.81 13.41 73.03 10.00 13.03 75.12 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 19.17 11.01 76.14 17.26 10.42 76.77 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 11.10 2.31 76.60 10.24 7.24 75.62 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 B 145 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 230 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 273 LYS C 138 LYS^? 8.30 N TRS A 378 coo 11.81 13.41 73.03 10.00 13.03 75.12 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 19.17 11.01 76.14 17.26 10.42 76.77 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 11.10 2.31 76.60 10.24 7.24 75.62 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 B 145 TYR A 250 TYR^? 23.04 O3 TRS A 378 B 230 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 273 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 11.81 13.41 73.03 10.00 13.03 75.12 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 19.17 11.01 76.14 17.26 10.42 76.77 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 11.10 2.31 76.60 10.24 7.24 75.62 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 B 145 TYR A 250 TYR^? 23.04 O3 TRS A 378 B 230 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 273 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 11.81 13.41 73.03 10.00 13.03 75.12 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 19.17 11.01 76.14 17.26 10.42 76.77 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 11.10 2.31 76.60 10.24 7.24 75.62 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 B 145 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 230 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 273 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 11.81 13.41 73.03 10.00 13.03 75.12 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 19.17 11.01 76.14 17.26 10.42 76.77 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 11.10 2.31 76.60 10.24 7.24 75.62 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 B 145 TYR B 18 TYR~? 10.93 ZN ZN B 375 B 230 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 273 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 11.81 13.41 73.03 10.00 13.03 75.12 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 19.17 11.01 76.14 17.26 10.42 76.77 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.10 2.31 76.60 10.24 7.24 75.62 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 B 145 TYR B 231 TYR^? 16.39 O2S EPE A 377 B 230 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 273 LYS C 139 LYS^? 16.11 N TRS A 378 coo 11.81 13.41 73.03 10.00 13.03 75.12 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 19.17 11.01 76.14 17.26 10.42 76.77 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 11.10 2.31 76.60 10.24 7.24 75.62 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 B 145 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 230 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 273 LYS A 138 LYS^? 13.11 N TRS A 378 coo 11.81 13.41 73.03 10.00 13.03 75.12 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 19.17 11.01 76.14 17.26 10.42 76.77 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 11.10 2.31 76.60 10.24 7.24 75.62 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 B 145 TYR B 250 TYR^? 23.22 ZN ZN B 375 B 230 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 273 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 11.81 13.41 73.03 10.00 13.03 75.12 0.70 6.87 1.10 3.12 5.62 1.69 coo 19.17 11.01 76.14 17.26 10.42 76.77 3.99 14.73 5.36 5.18 14.04 3.76 coo 11.10 2.31 76.60 10.24 7.24 75.62 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 B 145 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 230 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 273 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 11.81 13.41 73.03 10.00 13.03 75.12 1.32 11.76 14.56 0.84 10.00 16.68 coo 19.17 11.01 76.14 17.26 10.42 76.77 3.99 14.73 5.36 5.18 14.04 3.76 coo 11.10 2.31 76.60 10.24 7.24 75.62 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 12 3 # 12 B 145 TYR B 314 TYR~? 14.73 O8 EPE B 376 B 230 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 273 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 11.81 13.41 73.03 10.00 13.03 75.12 2.08 17.58 27.10 3.13 18.35 29.60 coo 19.17 11.01 76.14 17.26 10.42 76.77 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 11.10 2.31 76.60 10.24 7.24 75.62 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 13 3 # 13 B 145 TYR C 18 TYR.? 11.04 ZN ZN C 375 B 230 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 273 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 11.81 13.41 73.03 10.00 13.03 75.12 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 19.17 11.01 76.14 17.26 10.42 76.77 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.10 2.31 76.60 10.24 7.24 75.62 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 14 3 # 14 B 145 TYR C 231 TYR^? -4.25 C2 TRS A 378s B 230 ASP A 237 ASP^? 6.80 N TRS A 378 B 273 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 11.81 13.41 73.03 10.00 13.03 75.12 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 19.17 11.01 76.14 17.26 10.42 76.77 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 11.10 2.31 76.60 10.24 7.24 75.62 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 15 3 # 15 B 145 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 230 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 273 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 11.81 13.41 73.03 10.00 13.03 75.12 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 19.17 11.01 76.14 17.26 10.42 76.77 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 11.10 2.31 76.60 10.24 7.24 75.62 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 16 3 # 16 B 145 TYR C 250 TYR^? 23.68 ZN ZN C 375 B 230 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 273 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 11.81 13.41 73.03 10.00 13.03 75.12 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 19.17 11.01 76.14 17.26 10.42 76.77 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 11.10 2.31 76.60 10.24 7.24 75.62 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 17 3 # 17 B 145 TYR C 250 TYR^? 23.68 ZN ZN C 375 B 230 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 273 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 11.81 13.41 73.03 10.00 13.03 75.12 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 19.17 11.01 76.14 17.26 10.42 76.77 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 11.10 2.31 76.60 10.24 7.24 75.62 -11.06 -26.43 40.09 -5.81 -27.52 38.93 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 18 3 # 18 B 145 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 230 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 273 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 11.81 13.41 73.03 10.00 13.03 75.12 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 19.17 11.01 76.14 17.26 10.42 76.77 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 11.10 2.31 76.60 10.24 7.24 75.62 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 19 3 # 19 B 145 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 230 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 273 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 11.81 13.41 73.03 10.00 13.03 75.12 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 19.17 11.01 76.14 17.26 10.42 76.77 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 11.10 2.31 76.60 10.24 7.24 75.62 -11.06 -26.43 40.09 -5.81 -27.52 38.93 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 19 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 260 PHE~? 19.27 ZN ZN A 375 A 159 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 188 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 13.91 34.58 14.67 12.95 36.00 12.47 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 20.97 28.40 16.26 20.19 30.15 15.34 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 22.55 41.65 15.60 18.92 37.20 14.63 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 370 PHE.? 12.81 O8 EPE A 376 A 159 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 188 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 13.91 34.58 14.67 12.95 36.00 12.47 46.70 4.90 39.59 44.12 4.72 40.65 coo 20.97 28.40 16.26 20.19 30.15 15.34 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 22.55 41.65 15.60 18.92 37.20 14.63 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 372 PHE.? 17.32 ZN ZN A 374 A 159 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 188 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 13.91 34.58 14.67 12.95 36.00 12.47 52.79 1.59 40.88 50.60 -0.15 40.87 coo 20.97 28.40 16.26 20.19 30.15 15.34 48.24 5.16 33.58 47.82 3.96 35.30 coo 22.55 41.65 15.60 18.92 37.20 14.63 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE B 370 PHE.? 12.32 O8 EPE B 376 A 159 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 188 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 13.91 34.58 14.67 12.95 36.00 12.47 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 20.97 28.40 16.26 20.19 30.15 15.34 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 22.55 41.65 15.60 18.92 37.20 14.63 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE B 372 PHE.? 17.31 ZN ZN B 374 A 159 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 188 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 13.91 34.58 14.67 12.95 36.00 12.47 -11.64 24.23 19.14 -9.49 22.46 19.29 coo 20.97 28.40 16.26 20.19 30.15 15.34 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 22.55 41.65 15.60 18.92 37.20 14.63 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE C 260 PHE~? 19.40 ZN ZN C 375 A 159 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 188 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 13.91 34.58 14.67 12.95 36.00 12.47 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 20.97 28.40 16.26 20.19 30.15 15.34 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 22.55 41.65 15.60 18.92 37.20 14.63 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE C 370 PHE.? 12.75 O8 EPE C 376 A 159 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 188 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 13.91 34.58 14.67 12.95 36.00 12.47 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 20.97 28.40 16.26 20.19 30.15 15.34 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 22.55 41.65 15.60 18.92 37.20 14.63 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE C 372 PHE.? 17.18 ZN ZN C 374 A 159 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 188 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 13.91 34.58 14.67 12.95 36.00 12.47 -6.66 -27.35 68.48 -6.43 -26.37 65.89 coo 20.97 28.40 16.26 20.19 30.15 15.34 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 22.55 41.65 15.60 18.92 37.20 14.63 -8.06 -35.63 62.23 -11.30 -33.36 66.69 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 8 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 153 ARG~? 11.00 C6 EPE C 377 A 141 THR C 177 THR^? 8.04 C8 EPE C 377 A 235 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 6.21 93.81 36.58 4.58 96.33 37.17 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo 6.80 92.87 28.33 4.91 92.74 27.40 20.64 -38.60 2.16 21.28 -38.84 0.08 coo 12.98 90.36 47.57 11.26 89.62 46.62 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 141 THR A 177 THR^? 8.80 C6 EPE A 377 A 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 6.21 93.81 36.58 4.58 96.33 37.17 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 6.80 92.87 28.33 4.91 92.74 27.40 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo 12.98 90.36 47.57 11.26 89.62 46.62 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 141 THR A 177 THR^? 8.80 C6 EPE A 377 A 235 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 6.21 93.81 36.58 4.58 96.33 37.17 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 6.80 92.87 28.33 4.91 92.74 27.40 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo 12.98 90.36 47.57 11.26 89.62 46.62 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 141 THR B 171 THR^? -5.46 O3S EPE A 377s A 235 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 6.21 93.81 36.58 4.58 96.33 37.17 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 6.80 92.87 28.33 4.91 92.74 27.40 0.89 -31.19 4.26 -0.81 -32.58 4.42 coo 12.98 90.36 47.57 11.26 89.62 46.62 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG B 153 ARG~? 10.73 C6 EPE A 377 A 141 THR A 177 THR^? 8.80 C6 EPE A 377 A 235 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 6.21 93.81 36.58 4.58 96.33 37.17 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo 6.80 92.87 28.33 4.91 92.74 27.40 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo 12.98 90.36 47.57 11.26 89.62 46.62 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG B 203 ARG^? 8.69 O2S EPE A 377 A 141 THR B 177 THR^? 19.16 C2 EPE C 377 A 235 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 6.21 93.81 36.58 4.58 96.33 37.17 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 6.80 92.87 28.33 4.91 92.74 27.40 9.43 -46.41 11.44 10.68 -47.97 10.55 coo 12.98 90.36 47.57 11.26 89.62 46.62 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 A 137 ARG C 153 ARG~? 15.97 C2 EPE C 377 A 141 THR B 177 THR^? 19.16 C2 EPE C 377 A 235 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 6.21 93.81 36.58 4.58 96.33 37.17 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 6.80 92.87 28.33 4.91 92.74 27.40 9.43 -46.41 11.44 10.68 -47.97 10.55 coo 12.98 90.36 47.57 11.26 89.62 46.62 19.06 -47.14 27.83 18.62 -49.09 27.08 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 A 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 141 THR A 171 THR^? -6.32 O1S EPE C 377s A 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 6.21 93.81 36.58 4.58 96.33 37.17 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 6.80 92.87 28.33 4.91 92.74 27.40 22.07 -30.68 4.19 22.03 -30.09 2.08 coo 12.98 90.36 47.57 11.26 89.62 46.62 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 A 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 141 THR A 206 THR^? -4.52 O1S EPE C 377s A 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 6.21 93.81 36.58 4.58 96.33 37.17 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 6.80 92.87 28.33 4.91 92.74 27.40 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 12.98 90.36 47.57 11.26 89.62 46.62 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 A 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 141 THR C 177 THR^? 8.04 C8 EPE C 377 A 235 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 6.21 93.81 36.58 4.58 96.33 37.17 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 6.80 92.87 28.33 4.91 92.74 27.40 20.64 -38.60 2.16 21.28 -38.84 0.08 coo 12.98 90.36 47.57 11.26 89.62 46.62 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 A 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 141 THR C 177 THR^? 8.04 C8 EPE C 377 A 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 6.21 93.81 36.58 4.58 96.33 37.17 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 6.80 92.87 28.33 4.91 92.74 27.40 20.64 -38.60 2.16 21.28 -38.84 0.08 coo 12.98 90.36 47.57 11.26 89.62 46.62 6.16 -32.41 17.86 6.89 -34.31 18.36 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 11 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 153 ARG~? 11.00 C6 EPE C 377 D 141 THR C 177 THR^? 8.04 C8 EPE C 377 D 235 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo -8.33 92.80 100.06 -7.71 95.33 98.44 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo -9.24 93.49 108.77 -7.37 94.21 109.61 20.64 -38.60 2.16 21.28 -38.84 0.08 coo -14.64 87.74 89.51 -12.89 87.43 90.65 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 D 141 THR A 177 THR^? 8.80 C6 EPE A 377 D 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo -8.33 92.80 100.06 -7.71 95.33 98.44 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -9.24 93.49 108.77 -7.37 94.21 109.61 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo -14.64 87.74 89.51 -12.89 87.43 90.65 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 D 141 THR A 177 THR^? 8.80 C6 EPE A 377 D 235 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo -8.33 92.80 100.06 -7.71 95.33 98.44 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -9.24 93.49 108.77 -7.37 94.21 109.61 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo -14.64 87.74 89.51 -12.89 87.43 90.65 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 D 141 THR B 171 THR^? -5.46 O3S EPE A 377s D 235 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo -8.33 92.80 100.06 -7.71 95.33 98.44 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -9.24 93.49 108.77 -7.37 94.21 109.61 0.89 -31.19 4.26 -0.81 -32.58 4.42 coo -14.64 87.74 89.51 -12.89 87.43 90.65 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG B 203 ARG^? 8.69 O2S EPE A 377 D 141 THR B 177 THR^? 19.16 C2 EPE C 377 D 235 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo -8.33 92.80 100.06 -7.71 95.33 98.44 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -9.24 93.49 108.77 -7.37 94.21 109.61 9.43 -46.41 11.44 10.68 -47.97 10.55 coo -14.64 87.74 89.51 -12.89 87.43 90.65 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG B 203 ARG^? 8.69 O2S EPE A 377 D 141 THR B 177 THR^? 19.16 C2 EPE C 377 D 235 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo -8.33 92.80 100.06 -7.71 95.33 98.44 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -9.24 93.49 108.77 -7.37 94.21 109.61 9.43 -46.41 11.44 10.68 -47.97 10.55 coo -14.64 87.74 89.51 -12.89 87.43 90.65 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 D 137 ARG B 203 ARG^? 8.69 O2S EPE A 377 D 141 THR C 171 THR^? 17.48 C2 EPE C 377 D 235 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo -8.33 92.80 100.06 -7.71 95.33 98.44 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -9.24 93.49 108.77 -7.37 94.21 109.61 11.53 -42.54 18.55 13.17 -44.02 18.73 coo -14.64 87.74 89.51 -12.89 87.43 90.65 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 D 137 ARG C 153 ARG~? 15.97 C2 EPE C 377 D 141 THR B 177 THR^? 19.16 C2 EPE C 377 D 235 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo -8.33 92.80 100.06 -7.71 95.33 98.44 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -9.24 93.49 108.77 -7.37 94.21 109.61 9.43 -46.41 11.44 10.68 -47.97 10.55 coo -14.64 87.74 89.51 -12.89 87.43 90.65 19.06 -47.14 27.83 18.62 -49.09 27.08 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 D 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 D 141 THR A 171 THR^? -6.32 O1S EPE C 377s D 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo -8.33 92.80 100.06 -7.71 95.33 98.44 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -9.24 93.49 108.77 -7.37 94.21 109.61 22.07 -30.68 4.19 22.03 -30.09 2.08 coo -14.64 87.74 89.51 -12.89 87.43 90.65 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 D 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 D 141 THR C 177 THR^? 8.04 C8 EPE C 377 D 235 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo -8.33 92.80 100.06 -7.71 95.33 98.44 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -9.24 93.49 108.77 -7.37 94.21 109.61 20.64 -38.60 2.16 21.28 -38.84 0.08 coo -14.64 87.74 89.51 -12.89 87.43 90.65 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 D 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 D 141 THR C 177 THR^? 8.04 C8 EPE C 377 D 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo -8.33 92.80 100.06 -7.71 95.33 98.44 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -9.24 93.49 108.77 -7.37 94.21 109.61 20.64 -38.60 2.16 21.28 -38.84 0.08 coo -14.64 87.74 89.51 -12.89 87.43 90.65 6.16 -32.41 17.86 6.89 -34.31 18.36 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 11 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 153 ARG~? 11.00 C6 EPE C 377 C 141 THR C 177 THR^? 8.04 C8 EPE C 377 C 235 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo -6.81 68.31 28.28 -4.82 68.47 27.57 20.64 -38.60 2.16 21.28 -38.84 0.08 coo -13.01 70.96 47.58 -11.44 71.65 46.34 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 C 141 THR A 177 THR^? 8.80 C6 EPE A 377 C 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -6.81 68.31 28.28 -4.82 68.47 27.57 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo -13.01 70.96 47.58 -11.44 71.65 46.34 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 C 141 THR A 177 THR^? 8.80 C6 EPE A 377 C 235 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -6.81 68.31 28.28 -4.82 68.47 27.57 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo -13.01 70.96 47.58 -11.44 71.65 46.34 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 C 141 THR A 206 THR^? -4.52 O1S EPE C 377s C 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -6.81 68.31 28.28 -4.82 68.47 27.57 19.99 -27.38 6.69 21.08 -26.14 5.25 coo -13.01 70.96 47.58 -11.44 71.65 46.34 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 C 141 THR B 171 THR^? -5.46 O3S EPE A 377s C 235 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -6.81 68.31 28.28 -4.82 68.47 27.57 0.89 -31.19 4.26 -0.81 -32.58 4.42 coo -13.01 70.96 47.58 -11.44 71.65 46.34 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 C 141 THR B 206 THR^? 5.63 O3S EPE A 377 C 235 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -6.81 68.31 28.28 -4.82 68.47 27.57 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo -13.01 70.96 47.58 -11.44 71.65 46.34 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 C 137 ARG B 153 ARG~? 10.73 C6 EPE A 377 C 141 THR A 177 THR^? 8.80 C6 EPE A 377 C 235 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo -6.81 68.31 28.28 -4.82 68.47 27.57 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 C 137 ARG B 203 ARG^? 8.69 O2S EPE A 377 C 141 THR B 177 THR^? 19.16 C2 EPE C 377 C 235 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -6.81 68.31 28.28 -4.82 68.47 27.57 9.43 -46.41 11.44 10.68 -47.97 10.55 coo -13.01 70.96 47.58 -11.44 71.65 46.34 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 C 137 ARG B 203 ARG^? 8.69 O2S EPE A 377 C 141 THR C 171 THR^? 17.48 C2 EPE C 377 C 235 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -6.81 68.31 28.28 -4.82 68.47 27.57 11.53 -42.54 18.55 13.17 -44.02 18.73 coo -13.01 70.96 47.58 -11.44 71.65 46.34 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 C 137 ARG B 203 ARG^? 8.69 O2S EPE A 377 C 141 THR C 206 THR^? 14.70 N TRS A 378 C 235 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -6.81 68.31 28.28 -4.82 68.47 27.57 12.97 -38.24 19.88 14.05 -39.36 21.39 coo -13.01 70.96 47.58 -11.44 71.65 46.34 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 C 137 ARG C 153 ARG~? 15.97 C2 EPE C 377 C 141 THR B 177 THR^? 19.16 C2 EPE C 377 C 235 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo -5.79 67.26 36.83 -4.57 64.58 37.74 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -6.81 68.31 28.28 -4.82 68.47 27.57 9.43 -46.41 11.44 10.68 -47.97 10.55 coo -13.01 70.96 47.58 -11.44 71.65 46.34 19.06 -47.14 27.83 18.62 -49.09 27.08 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 C 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 C 141 THR A 171 THR^? -6.32 O1S EPE C 377s C 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -6.81 68.31 28.28 -4.82 68.47 27.57 22.07 -30.68 4.19 22.03 -30.09 2.08 coo -13.01 70.96 47.58 -11.44 71.65 46.34 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 C 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 C 141 THR A 206 THR^? -4.52 O1S EPE C 377s C 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -6.81 68.31 28.28 -4.82 68.47 27.57 19.99 -27.38 6.69 21.08 -26.14 5.25 coo -13.01 70.96 47.58 -11.44 71.65 46.34 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 C 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 C 141 THR C 177 THR^? 8.04 C8 EPE C 377 C 235 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -6.81 68.31 28.28 -4.82 68.47 27.57 20.64 -38.60 2.16 21.28 -38.84 0.08 coo -13.01 70.96 47.58 -11.44 71.65 46.34 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 C 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 C 141 THR C 177 THR^? 8.04 C8 EPE C 377 C 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo -5.79 67.26 36.83 -4.57 64.58 37.74 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -6.81 68.31 28.28 -4.82 68.47 27.57 20.64 -38.60 2.16 21.28 -38.84 0.08 coo -13.01 70.96 47.58 -11.44 71.65 46.34 6.16 -32.41 17.86 6.89 -34.31 18.36 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 15 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 B 141 THR A 177 THR^? 8.80 C6 EPE A 377 B 235 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 8.13 67.41 100.27 7.18 68.35 97.45 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 8.28 67.78 108.81 6.22 67.65 109.43 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo 14.55 73.52 89.47 12.81 73.95 90.56 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 203 ARG^? 8.58 O3S EPE C 377 B 141 THR B 171 THR^? -5.46 O3S EPE A 377s B 235 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 8.13 67.41 100.27 7.18 68.35 97.45 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 8.28 67.78 108.81 6.22 67.65 109.43 0.89 -31.19 4.26 -0.81 -32.58 4.42 coo 14.55 73.52 89.47 12.81 73.95 90.56 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG B 203 ARG^? 8.69 O2S EPE A 377 B 141 THR B 177 THR^? 19.16 C2 EPE C 377 B 235 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 8.13 67.41 100.27 7.18 68.35 97.45 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 8.28 67.78 108.81 6.22 67.65 109.43 9.43 -46.41 11.44 10.68 -47.97 10.55 coo 14.55 73.52 89.47 12.81 73.95 90.56 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG B 203 ARG^? 8.69 O2S EPE A 377 B 141 THR C 171 THR^? 17.48 C2 EPE C 377 B 235 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 8.13 67.41 100.27 7.18 68.35 97.45 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 8.28 67.78 108.81 6.22 67.65 109.43 11.53 -42.54 18.55 13.17 -44.02 18.73 coo 14.55 73.52 89.47 12.81 73.95 90.56 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 B 141 THR A 171 THR^? -6.32 O1S EPE C 377s B 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 8.13 67.41 100.27 7.18 68.35 97.45 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 8.28 67.78 108.81 6.22 67.65 109.43 22.07 -30.68 4.19 22.03 -30.09 2.08 coo 14.55 73.52 89.47 12.81 73.95 90.56 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 B 137 ARG C 203 ARG^? 8.27 O3S EPE C 377 B 141 THR C 177 THR^? 8.04 C8 EPE C 377 B 235 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 8.13 67.41 100.27 7.18 68.35 97.45 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 8.28 67.78 108.81 6.22 67.65 109.43 20.64 -38.60 2.16 21.28 -38.84 0.08 coo 14.55 73.52 89.47 12.81 73.95 90.56 6.16 -32.41 17.86 6.89 -34.31 18.36 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 6 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 27 ASP.? 8.12 ZN ZN A 375 16 HIS A 103 HIS~? -4.82 ZN ZN A 375s 67 GLY A 7 GLY~? 22.99 ZN ZN A 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 32.91 0.46 27.63 33.66 0.11 29.56 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 31.92 8.80 9.28 31.38 8.48 8.65 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 27 ASP.? 8.12 ZN ZN A 375 16 HIS A 103 HIS~? -4.82 ZN ZN A 375s 67 GLY A 86 GLY~? 5.69 O2S EPE A 376 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 32.91 0.46 27.63 33.66 0.11 29.56 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 32.79 20.63 30.29 33.61 20.50 30.22 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP A 48 ASP.? 7.40 ZN ZN A 374 16 HIS A 69 HIS.? -3.40 ZN ZN A 374s 67 GLY A 7 GLY~? 22.99 ZN ZN A 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 40.70 8.14 28.73 41.06 6.40 29.84 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 37.42 3.90 29.26 38.47 2.36 30.22 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 31.92 8.80 9.28 31.38 8.48 8.65 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP A 82 ASP.? 8.88 O2S EPE A 376 16 HIS A 80 HIS.? 6.41 O2S EPE A 376 67 GLY A 34 GLY.? 18.52 C3 EPE A 376 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 34.38 27.71 34.24 32.73 27.59 35.53 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 28.52 23.28 34.79 26.69 23.10 35.81 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 28.75 15.24 16.90 28.17 14.75 17.10 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP A 107 ASP~? -2.33 ZN ZN A 375s 16 HIS A 68 HIS.? -3.31 ZN ZN A 375s 67 GLY A 7 GLY~? 22.99 ZN ZN A 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 37.80 0.44 25.56 37.02 -1.29 26.44 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 31.92 8.80 9.28 31.38 8.48 8.65 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 6 3 # 6 14 ASP A 107 ASP~? -2.33 ZN ZN A 375s 16 HIS A 68 HIS.? -3.31 ZN ZN A 375s 67 GLY A 272 GLY.? 18.36 ZN ZN A 374 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 37.80 0.44 25.56 37.02 -1.29 26.44 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 54.23 -1.17 38.61 53.76 -1.27 37.97 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 7 3 # 7 14 ASP A 107 ASP~? -2.33 ZN ZN A 375s 16 HIS A 103 HIS~? -4.82 ZN ZN A 375s 67 GLY A 7 GLY~? 22.99 ZN ZN A 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 32.91 0.46 27.63 33.66 0.11 29.56 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 31.92 8.80 9.28 31.38 8.48 8.65 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 8 3 # 8 14 ASP A 158 ASP~? 15.23 O1S EPE C 377 16 HIS A 169 HIS^? 11.22 O1S EPE C 377 67 GLY A 240 GLY^? 7.12 C3 TRS A 378 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 27.04 -20.59 17.45 27.05 -20.66 18.34 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 9 3 # 9 14 ASP A 292 ASP^? 8.63 ZN ZN A 374 16 HIS A 333 HIS~? -3.55 ZN ZN A 374s 67 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 40.60 0.33 34.12 38.69 0.39 33.24 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 10 3 # 10 14 ASP A 292 ASP^? 8.63 ZN ZN A 374 16 HIS A 333 HIS~? -3.55 ZN ZN A 374s 67 GLY A 122 GLY.? 19.60 ZN ZN A 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 40.60 0.33 34.12 38.69 0.39 33.24 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 51.97 -15.01 25.49 51.32 -15.01 26.00 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 11 3 # 11 14 ASP A 292 ASP^? 8.63 ZN ZN A 374 16 HIS A 333 HIS~? -3.55 ZN ZN A 374s 67 GLY A 249 GLY^? 18.94 ZN ZN A 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 40.60 0.33 34.12 38.69 0.39 33.24 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 44.87 -19.78 28.98 45.04 -19.55 29.74 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 12 3 # 12 14 ASP A 292 ASP^? 8.63 ZN ZN A 374 16 HIS A 333 HIS~? -3.55 ZN ZN A 374s 67 GLY A 277 GLY.? 24.28 ZN ZN A 374 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 40.60 0.33 34.12 38.69 0.39 33.24 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 49.23 -14.07 46.91 49.73 -13.44 47.06 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 13 3 # 13 14 ASP A 312 ASP.? 7.50 ZN ZN A 374 16 HIS A 333 HIS~? -3.55 ZN ZN A 374s 67 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 39.49 -1.24 39.18 39.76 0.49 37.96 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 40.60 0.33 34.12 38.69 0.39 33.24 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 14 3 # 14 14 ASP A 312 ASP.? 7.50 ZN ZN A 374 16 HIS A 333 HIS~? -3.55 ZN ZN A 374s 67 GLY A 111 GLY.? 12.81 ZN ZN A 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 39.49 -1.24 39.18 39.76 0.49 37.96 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 40.60 0.33 34.12 38.69 0.39 33.24 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 40.78 -9.44 18.50 40.17 -9.34 19.07 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 15 3 # 15 14 ASP A 312 ASP.? 7.50 ZN ZN A 374 16 HIS A 333 HIS~? -3.55 ZN ZN A 374s 67 GLY A 122 GLY.? 19.60 ZN ZN A 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 39.49 -1.24 39.18 39.76 0.49 37.96 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 40.60 0.33 34.12 38.69 0.39 33.24 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 51.97 -15.01 25.49 51.32 -15.01 26.00 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 16 3 # 16 14 ASP A 312 ASP.? 7.50 ZN ZN A 374 16 HIS A 333 HIS~? -3.55 ZN ZN A 374s 67 GLY A 249 GLY^? 18.94 ZN ZN A 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 39.49 -1.24 39.18 39.76 0.49 37.96 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 40.60 0.33 34.12 38.69 0.39 33.24 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 44.87 -19.78 28.98 45.04 -19.55 29.74 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 17 3 # 17 14 ASP A 320 ASP~? -21.81 ZN ZN A 374s 16 HIS A 319 HIS~? 24.64 ZN ZN A 374 67 GLY A 258 GLY~? 25.62 ZN ZN A 374 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 56.88 -13.16 41.55 56.67 -13.61 40.87 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 18 3 # 18 14 ASP A 320 ASP~? -21.81 ZN ZN A 374s 16 HIS A 319 HIS~? 24.64 ZN ZN A 374 67 GLY A 272 GLY.? 18.36 ZN ZN A 374 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 54.23 -1.17 38.61 53.76 -1.27 37.97 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 19 3 # 19 14 ASP B 27 ASP.? 8.17 ZN ZN B 375 16 HIS B 103 HIS~? 5.04 ZN ZN B 375 67 GLY B 7 GLY~? 23.15 ZN ZN B 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -24.83 -11.10 27.95 -24.79 -11.89 27.82 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 20 3 # 20 14 ASP B 27 ASP.? 8.17 ZN ZN B 375 16 HIS B 103 HIS~? 5.04 ZN ZN B 375 67 GLY B 86 GLY~? 6.17 O2S EPE B 376 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -20.10 7.74 42.37 -20.48 8.20 41.79 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 21 3 # 21 14 ASP B 48 ASP.? 7.36 ZN ZN B 374 16 HIS B 69 HIS.? -3.36 ZN ZN B 374s 67 GLY B 7 GLY~? 23.15 ZN ZN B 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -24.83 -11.10 27.95 -24.79 -11.89 27.82 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 22 3 # 22 14 ASP B 82 ASP.? 10.62 O3S EPE B 376 16 HIS B 80 HIS.? 6.72 O2S EPE B 376 67 GLY B 34 GLY.? 18.31 C3 EPE B 376 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -22.38 12.66 48.09 -22.95 14.65 48.48 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -22.85 -5.92 36.81 -22.11 -6.23 36.83 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 23 3 # 23 14 ASP B 107 ASP~? -2.23 ZN ZN B 375s 16 HIS B 68 HIS.? -3.38 ZN ZN B 375s 67 GLY B 7 GLY~? 23.15 ZN ZN B 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -24.83 -11.10 27.95 -24.79 -11.89 27.82 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 24 3 # 24 14 ASP B 107 ASP~? -2.23 ZN ZN B 375s 16 HIS B 68 HIS.? -3.38 ZN ZN B 375s 67 GLY B 272 GLY.? 18.77 ZN ZN B 374 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -11.90 23.22 15.48 -12.02 22.37 15.54 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 25 3 # 25 14 ASP B 107 ASP~? -2.23 ZN ZN B 375s 16 HIS B 103 HIS~? 5.04 ZN ZN B 375 67 GLY B 7 GLY~? 23.15 ZN ZN B 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -24.83 -11.10 27.95 -24.79 -11.89 27.82 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 26 3 # 26 14 ASP B 158 ASP~? 14.93 O3S EPE A 377 16 HIS B 169 HIS^? 10.86 O3S EPE A 377 67 GLY B 240 GLY^? 14.23 O1S EPE A 377 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 1.60 -13.95 10.45 2.15 -13.33 10.77 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 27 3 # 27 14 ASP B 292 ASP^? 8.88 ZN ZN B 374 16 HIS B 333 HIS~? -3.37 ZN ZN B 374s 67 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 28 3 # 28 14 ASP B 292 ASP^? 8.88 ZN ZN B 374 16 HIS B 333 HIS~? -3.37 ZN ZN B 374s 67 GLY B 111 GLY.? 12.91 ZN ZN B 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -11.60 -2.92 11.75 -11.04 -2.69 12.33 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 29 3 # 29 14 ASP B 292 ASP^? 8.88 ZN ZN B 374 16 HIS B 333 HIS~? -3.37 ZN ZN B 374s 67 GLY B 122 GLY~? 19.62 ZN ZN B 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -9.36 8.56 2.89 -8.77 8.49 3.46 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 30 3 # 30 14 ASP B 292 ASP^? 8.88 ZN ZN B 374 16 HIS B 333 HIS~? -3.37 ZN ZN B 374s 67 GLY B 249 GLY^? 18.76 ZN ZN B 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -1.04 5.72 4.91 -0.82 6.46 5.20 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 31 3 # 31 14 ASP B 312 ASP.? 7.53 ZN ZN B 374 16 HIS B 333 HIS~? -3.37 ZN ZN B 374s 67 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 32 3 # 32 14 ASP B 312 ASP.? 7.53 ZN ZN B 374 16 HIS B 333 HIS~? -3.37 ZN ZN B 374s 67 GLY B 111 GLY.? 12.91 ZN ZN B 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -11.60 -2.92 11.75 -11.04 -2.69 12.33 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 33 3 # 33 14 ASP B 312 ASP.? 7.53 ZN ZN B 374 16 HIS B 333 HIS~? -3.37 ZN ZN B 374s 67 GLY B 122 GLY~? 19.62 ZN ZN B 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -9.36 8.56 2.89 -8.77 8.49 3.46 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 34 3 # 34 14 ASP B 312 ASP.? 7.53 ZN ZN B 374 16 HIS B 333 HIS~? -3.37 ZN ZN B 374s 67 GLY B 249 GLY^? 18.76 ZN ZN B 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -1.04 5.72 4.91 -0.82 6.46 5.20 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 35 3 # 35 14 ASP B 320 ASP~? -21.78 ZN ZN B 374s 16 HIS B 319 HIS~? 24.73 ZN ZN B 374 67 GLY B 258 GLY~? 25.40 ZN ZN B 374 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 9.35 16.65 21.02 10.22 16.89 22.90 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 8.16 23.53 21.75 7.85 25.60 21.62 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -3.80 23.92 6.13 -3.78 23.26 5.65 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 36 3 # 36 14 ASP B 320 ASP~? -21.78 ZN ZN B 374s 16 HIS B 319 HIS~? 24.73 ZN ZN B 374 67 GLY B 272 GLY.? 18.77 ZN ZN B 374 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 9.35 16.65 21.02 10.22 16.89 22.90 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 8.16 23.53 21.75 7.85 25.60 21.62 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -11.90 23.22 15.48 -12.02 22.37 15.54 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 37 3 # 37 14 ASP C 27 ASP.? 8.23 ZN ZN C 375 16 HIS C 103 HIS~? 4.97 ZN ZN C 375 67 GLY C 7 GLY~? 23.11 ZN ZN C 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 27.26 -36.33 52.02 27.65 -36.56 51.35 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 38 3 # 38 14 ASP C 27 ASP.? 8.23 ZN ZN C 375 16 HIS C 103 HIS~? 4.97 ZN ZN C 375 67 GLY C 86 GLY~? 5.92 O3S EPE C 376 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 21.73 -19.07 67.60 21.30 -19.69 68.01 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 39 3 # 39 14 ASP C 48 ASP.? 7.30 ZN ZN C 374 16 HIS C 69 HIS.? -3.39 ZN ZN C 374s 67 GLY C 7 GLY~? 23.11 ZN ZN C 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 27.26 -36.33 52.02 27.65 -36.56 51.35 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 40 3 # 40 14 ASP C 82 ASP.? 10.22 O3S EPE C 376 16 HIS C 80 HIS.? 6.69 O2S EPE C 376 67 GLY C 34 GLY.? 18.40 C3 EPE C 376 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 23.03 -14.86 74.18 22.44 -14.42 76.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 28.32 -27.49 57.24 28.16 -27.07 56.58 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 41 3 # 41 14 ASP C 107 ASP~? -2.30 ZN ZN C 375s 16 HIS C 68 HIS.? -3.41 ZN ZN C 375s 67 GLY C 7 GLY~? 23.11 ZN ZN C 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 27.26 -36.33 52.02 27.65 -36.56 51.35 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 42 3 # 42 14 ASP C 107 ASP~? -2.30 ZN ZN C 375s 16 HIS C 68 HIS.? -3.41 ZN ZN C 375s 67 GLY C 272 GLY.? 18.55 ZN ZN C 374 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -7.94 -30.61 66.74 -7.33 -30.77 66.23 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 43 3 # 43 14 ASP C 107 ASP~? -2.30 ZN ZN C 375s 16 HIS C 103 HIS~? 4.97 ZN ZN C 375 67 GLY C 7 GLY~? 23.11 ZN ZN C 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 27.26 -36.33 52.02 27.65 -36.56 51.35 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 44 3 # 44 14 ASP C 292 ASP^? 8.69 ZN ZN C 374 16 HIS C 333 HIS~? -3.37 ZN ZN C 374s 67 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 45 3 # 45 14 ASP C 292 ASP^? 8.69 ZN ZN C 374 16 HIS C 333 HIS~? -3.37 ZN ZN C 374s 67 GLY C 111 GLY.? 12.85 ZN ZN C 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 5.64 -38.51 45.88 5.60 -37.66 45.90 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 46 3 # 46 14 ASP C 292 ASP^? 8.69 ZN ZN C 374 16 HIS C 333 HIS~? -3.37 ZN ZN C 374s 67 GLY C 122 GLY~? 19.71 ZN ZN C 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -7.79 -41.59 50.69 -7.69 -40.80 50.48 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 47 3 # 47 14 ASP C 292 ASP^? 8.69 ZN ZN C 374 16 HIS C 333 HIS~? -3.37 ZN ZN C 374s 67 GLY C 249 GLY^? 18.92 ZN ZN C 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -9.08 -35.38 44.08 -9.51 -34.84 44.55 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 48 3 # 48 14 ASP C 292 ASP^? 8.69 ZN ZN C 374 16 HIS C 333 HIS~? -3.37 ZN ZN C 374s 67 GLY C 277 GLY.? 24.27 ZN ZN C 374 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -18.35 -23.56 56.48 -18.29 -23.66 57.31 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 49 3 # 49 14 ASP C 312 ASP.? 7.48 ZN ZN C 374 16 HIS C 333 HIS~? -3.37 ZN ZN C 374s 67 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 50 3 # 50 14 ASP C 312 ASP.? 7.48 ZN ZN C 374 16 HIS C 333 HIS~? -3.37 ZN ZN C 374s 67 GLY C 111 GLY.? 12.85 ZN ZN C 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 5.64 -38.51 45.88 5.60 -37.66 45.90 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 51 3 # 51 14 ASP C 312 ASP.? 7.48 ZN ZN C 374 16 HIS C 333 HIS~? -3.37 ZN ZN C 374s 67 GLY C 122 GLY~? 19.71 ZN ZN C 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -7.79 -41.59 50.69 -7.69 -40.80 50.48 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 52 3 # 52 14 ASP C 312 ASP.? 7.48 ZN ZN C 374 16 HIS C 333 HIS~? -3.37 ZN ZN C 374s 67 GLY C 249 GLY^? 18.92 ZN ZN C 375 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -9.08 -35.38 44.08 -9.51 -34.84 44.55 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 53 3 # 53 14 ASP C 320 ASP~? -21.75 ZN ZN C 374s 16 HIS C 319 HIS~? 24.70 ZN ZN C 374 67 GLY C 258 GLY~? 25.44 ZN ZN C 374 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -18.33 -32.18 59.97 -18.10 -32.63 59.35 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 54 3 # 54 14 ASP C 320 ASP~? -21.75 ZN ZN C 374s 16 HIS C 319 HIS~? 24.70 ZN ZN C 374 67 GLY C 272 GLY.? 18.55 ZN ZN C 374 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -7.94 -30.61 66.74 -7.33 -30.77 66.23 1be1_c02 source 1be1 GLUTAMATE MUTASE : 54 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 107 ASP~? -2.33 ZN ZN A 375s 435 GLU A 336 GLU~? 2.52 ZN ZN A 375s 510 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 88.62 69.90 41.16 89.05 70.67 43.04 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 89.52 76.11 40.17 89.01 75.16 41.97 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 84.89 77.60 46.67 85.63 75.79 46.03 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP A 306 ASP.? 24.91 ZN ZN A 375 435 GLU A 254 GLU^? 30.93 ZN ZN A 375 510 ASP A 281 ASP.? 28.06 ZN ZN A 375 coo 88.62 69.90 41.16 89.05 70.67 43.04 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 89.52 76.11 40.17 89.01 75.16 41.97 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 84.89 77.60 46.67 85.63 75.79 46.03 52.87 -20.75 45.53 51.52 -19.24 45.99 ULMN 3 1bf2_c00 ISOAMYLASE user 3 3 # 3 375 ASP B 107 ASP~? -2.23 ZN ZN B 375s 435 GLU B 336 GLU~? 2.48 ZN ZN B 375s 510 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 88.62 69.90 41.16 89.05 70.67 43.04 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 89.52 76.11 40.17 89.01 75.16 41.97 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 84.89 77.60 46.67 85.63 75.79 46.03 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1bf2_c00 ISOAMYLASE user 4 3 # 4 375 ASP C 107 ASP~? -2.30 ZN ZN C 375s 435 GLU C 336 GLU~? 2.53 ZN ZN C 375s 510 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 88.62 69.90 41.16 89.05 70.67 43.04 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 89.52 76.11 40.17 89.01 75.16 41.97 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 84.89 77.60 46.67 85.63 75.79 46.03 1.43 -20.86 54.35 0.32 -19.00 54.12 1bf2_c00 source 1bf2 ISOAMYLASE : 4 hits 1bf2_c00 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU A 151 GLU~? 15.60 C7 EPE A 377 70 HIS A 148 HIS~? 11.43 C8 EPE A 377 281 HIS A 21 HIS~? 17.08 ZN ZN A 375 coo 66.09 46.17 155.81 66.77 48.19 155.70 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 69.05 50.55 157.03 68.00 52.29 156.51 14.41 -28.00 -10.43 13.63 -27.83 -12.37 coo 100.93 36.73 156.02 100.47 38.42 157.18 24.93 -8.05 18.54 26.13 -9.04 17.11 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 2 3 # 2 28 GLU A 151 GLU~? 15.60 C7 EPE A 377 70 HIS A 148 HIS~? 11.43 C8 EPE A 377 281 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 66.09 46.17 155.81 66.77 48.19 155.70 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 69.05 50.55 157.03 68.00 52.29 156.51 14.41 -28.00 -10.43 13.63 -27.83 -12.37 coo 100.93 36.73 156.02 100.47 38.42 157.18 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 3 3 # 3 28 GLU A 151 GLU~? 15.60 C7 EPE A 377 70 HIS A 148 HIS~? 11.43 C8 EPE A 377 281 HIS B 224 HIS.? 17.79 O2S EPE A 377 coo 66.09 46.17 155.81 66.77 48.19 155.70 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 69.05 50.55 157.03 68.00 52.29 156.51 14.41 -28.00 -10.43 13.63 -27.83 -12.37 coo 100.93 36.73 156.02 100.47 38.42 157.18 -4.29 -40.29 15.37 -2.45 -41.31 15.36 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 4 3 # 4 28 GLU B 151 GLU~? 19.22 O3S EPE A 377 70 HIS B 148 HIS~? 20.83 O3S EPE A 377 281 HIS C 224 HIS~? 8.36 C3 EPE C 377 coo 66.09 46.17 155.81 66.77 48.19 155.70 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 69.05 50.55 157.03 68.00 52.29 156.51 -6.64 -44.75 10.12 -7.62 -46.49 10.77 coo 100.93 36.73 156.02 100.47 38.42 157.18 26.69 -40.96 16.23 26.39 -40.40 14.23 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 5 3 # 5 28 GLU C 135 GLU^? 15.12 O1 TRS A 378 70 HIS C 21 HIS~? 17.02 O1 TRS A 378 281 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 66.09 46.17 155.81 66.77 48.19 155.70 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 69.05 50.55 157.03 68.00 52.29 156.51 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 100.93 36.73 156.02 100.47 38.42 157.18 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 6 3 # 6 28 GLU C 135 GLU^? 15.12 O1 TRS A 378 70 HIS C 21 HIS~? 17.02 O1 TRS A 378 281 HIS C 263 HIS~? 20.89 ZN ZN C 375 coo 66.09 46.17 155.81 66.77 48.19 155.70 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 69.05 50.55 157.03 68.00 52.29 156.51 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 100.93 36.73 156.02 100.47 38.42 157.18 -11.47 -39.00 56.70 -10.25 -40.03 55.33 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 7 3 # 7 28 GLU C 151 GLU~? 17.15 O8 EPE C 377 70 HIS C 148 HIS~? 13.04 O8 EPE C 377 281 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo 66.09 46.17 155.81 66.77 48.19 155.70 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 69.05 50.55 157.03 68.00 52.29 156.51 27.13 -47.60 14.36 28.94 -48.66 14.50 coo 100.93 36.73 156.02 100.47 38.42 157.18 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 8 3 # 8 28 GLU C 151 GLU~? 17.15 O8 EPE C 377 70 HIS C 148 HIS~? 13.04 O8 EPE C 377 281 HIS A 224 HIS~? 7.33 C7 EPE A 377 coo 66.09 46.17 155.81 66.77 48.19 155.70 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 69.05 50.55 157.03 68.00 52.29 156.51 27.13 -47.60 14.36 28.94 -48.66 14.50 coo 100.93 36.73 156.02 100.47 38.42 157.18 12.08 -23.60 -5.02 10.59 -24.98 -4.54 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 9 3 # 9 28 GLU C 336 GLU~? 2.53 ZN ZN C 375s 70 HIS C 68 HIS.? -3.41 ZN ZN C 375s 281 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 66.09 46.17 155.81 66.77 48.19 155.70 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 69.05 50.55 157.03 68.00 52.29 156.51 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 100.93 36.73 156.02 100.47 38.42 157.18 13.13 -47.52 24.96 14.34 -48.17 26.54 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 9 hits 1bfd_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 227 GLU.? 13.15 O8 EPE A 377 A 503 TYR B 167 TYR^? 5.54 O8 EPE A 377 A 537 GLU A 228 GLU.? 8.71 C3 EPE A 377 coo 24.06 146.21 11.09 22.89 146.18 9.36 5.87 -17.01 -8.12 5.06 -15.73 -9.55 coo 15.91 140.69 8.32 15.71 143.39 9.13 -0.72 -24.00 -3.91 0.54 -23.91 -6.42 coo 16.65 144.44 13.24 18.34 145.22 12.33 3.91 -21.00 -3.12 3.67 -19.15 -2.10 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU A 241 GLU^? 13.09 O3 TRS A 378 A 503 TYR A 133 TYR^? 12.87 O3 TRS A 378 A 537 GLU A 135 GLU^? 12.87 C3 TRS A 378 coo 24.06 146.21 11.09 22.89 146.18 9.36 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 15.91 140.69 8.32 15.71 143.39 9.13 26.66 -12.84 21.54 25.55 -13.01 18.92 coo 16.65 144.44 13.24 18.34 145.22 12.33 24.60 -15.96 15.66 25.54 -15.70 13.79 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU B 241 GLU^? 19.53 O1S EPE A 377 A 503 TYR B 133 TYR^? 17.24 ZN ZN B 375 A 537 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 24.06 146.21 11.09 22.89 146.18 9.36 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 15.91 140.69 8.32 15.71 143.39 9.13 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo 16.65 144.44 13.24 18.34 145.22 12.33 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU C 136 GLU^? 12.99 N TRS A 378 A 503 TYR C 133 TYR^? 16.76 ZN ZN C 375 A 537 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 24.06 146.21 11.09 22.89 146.18 9.36 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 15.91 140.69 8.32 15.71 143.39 9.13 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 16.65 144.44 13.24 18.34 145.22 12.33 11.24 -30.50 31.64 12.59 -30.76 33.22 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 5 3 # 5 A 461 GLU C 241 GLU^? 18.99 ZN ZN C 375 A 503 TYR C 133 TYR^? 16.76 ZN ZN C 375 A 537 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 24.06 146.21 11.09 22.89 146.18 9.36 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 15.91 140.69 8.32 15.71 143.39 9.13 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 16.65 144.44 13.24 18.34 145.22 12.33 11.24 -30.50 31.64 12.59 -30.76 33.22 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 5 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 136 GLU^? 12.15 O3 TRS A 378 A 504 TYR A 133 TYR^? 12.87 O3 TRS A 378 A 540 GLU A 135 GLU^? 12.87 C3 TRS A 378 coo 81.34 87.29 87.22 82.36 86.09 88.61 19.87 -16.93 18.72 17.94 -16.19 18.72 coo 80.85 81.34 94.77 81.70 80.16 92.41 26.66 -12.84 21.54 25.55 -13.01 18.92 coo 79.94 80.46 88.84 81.11 81.36 87.27 24.60 -15.96 15.66 25.54 -15.70 13.79 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU A 227 GLU.? 13.15 O8 EPE A 377 A 504 TYR A 226 TYR.? 5.45 C8 EPE A 377 A 540 GLU A 228 GLU.? 8.71 C3 EPE A 377 coo 81.34 87.29 87.22 82.36 86.09 88.61 5.87 -17.01 -8.12 5.06 -15.73 -9.55 coo 80.85 81.34 94.77 81.70 80.16 92.41 7.72 -24.64 -8.18 7.45 -27.31 -8.97 coo 79.94 80.46 88.84 81.11 81.36 87.27 3.91 -21.00 -3.12 3.67 -19.15 -2.10 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 3 3 # 3 A 451 GLU A 227 GLU.? 13.15 O8 EPE A 377 A 504 TYR B 167 TYR^? 5.54 O8 EPE A 377 A 540 GLU A 228 GLU.? 8.71 C3 EPE A 377 coo 81.34 87.29 87.22 82.36 86.09 88.61 5.87 -17.01 -8.12 5.06 -15.73 -9.55 coo 80.85 81.34 94.77 81.70 80.16 92.41 -0.72 -24.00 -3.91 0.54 -23.91 -6.42 coo 79.94 80.46 88.84 81.11 81.36 87.27 3.91 -21.00 -3.12 3.67 -19.15 -2.10 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 4 3 # 4 A 451 GLU B 136 GLU^? 17.92 O1S EPE A 377 A 504 TYR B 133 TYR^? 17.24 ZN ZN B 375 A 540 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 81.34 87.29 87.22 82.36 86.09 88.61 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 80.85 81.34 94.77 81.70 80.16 92.41 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo 79.94 80.46 88.84 81.11 81.36 87.27 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 5 3 # 5 A 451 GLU B 227 GLU.? 24.58 O3S EPE A 377 A 504 TYR B 226 TYR.? 21.63 O2S EPE A 377 A 540 GLU B 228 GLU.? 26.61 O2S EPE A 377 coo 81.34 87.29 87.22 82.36 86.09 88.61 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 80.85 81.34 94.77 81.70 80.16 92.41 -2.18 -44.73 18.44 0.01 -45.92 17.08 coo 79.94 80.46 88.84 81.11 81.36 87.27 -2.18 -42.16 24.63 -2.03 -43.87 25.91 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 6 3 # 6 A 451 GLU B 241 GLU^? 19.53 O1S EPE A 377 A 504 TYR B 133 TYR^? 17.24 ZN ZN B 375 A 540 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 81.34 87.29 87.22 82.36 86.09 88.61 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 80.85 81.34 94.77 81.70 80.16 92.41 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo 79.94 80.46 88.84 81.11 81.36 87.27 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 7 3 # 7 A 451 GLU C 136 GLU^? 12.99 N TRS A 378 A 504 TYR C 133 TYR^? 16.76 ZN ZN C 375 A 540 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 81.34 87.29 87.22 82.36 86.09 88.61 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 80.85 81.34 94.77 81.70 80.16 92.41 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 79.94 80.46 88.84 81.11 81.36 87.27 11.24 -30.50 31.64 12.59 -30.76 33.22 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 8 3 # 8 A 451 GLU C 241 GLU^? 18.99 ZN ZN C 375 A 504 TYR C 133 TYR^? 16.76 ZN ZN C 375 A 540 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 81.34 87.29 87.22 82.36 86.09 88.61 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 80.85 81.34 94.77 81.70 80.16 92.41 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 79.94 80.46 88.84 81.11 81.36 87.27 11.24 -30.50 31.64 12.59 -30.76 33.22 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 8 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 136 GLU^? 12.15 O3 TRS A 378 B 504 TYR A 133 TYR^? 12.87 O3 TRS A 378 B 540 GLU A 135 GLU^? 12.87 C3 TRS A 378 coo 86.52 35.28 112.74 87.08 36.38 110.99 19.87 -16.93 18.72 17.94 -16.19 18.72 coo 84.93 40.21 105.31 85.72 41.45 107.72 26.66 -12.84 21.54 25.55 -13.01 18.92 coo 83.38 41.19 112.55 85.47 40.59 112.72 24.60 -15.96 15.66 25.54 -15.70 13.79 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU A 227 GLU.? 13.15 O8 EPE A 377 B 504 TYR A 226 TYR.? 5.45 C8 EPE A 377 B 540 GLU A 228 GLU.? 8.71 C3 EPE A 377 coo 86.52 35.28 112.74 87.08 36.38 110.99 5.87 -17.01 -8.12 5.06 -15.73 -9.55 coo 84.93 40.21 105.31 85.72 41.45 107.72 7.72 -24.64 -8.18 7.45 -27.31 -8.97 coo 83.38 41.19 112.55 85.47 40.59 112.72 3.91 -21.00 -3.12 3.67 -19.15 -2.10 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 3 3 # 3 B 451 GLU A 227 GLU.? 13.15 O8 EPE A 377 B 504 TYR B 167 TYR^? 5.54 O8 EPE A 377 B 540 GLU A 228 GLU.? 8.71 C3 EPE A 377 coo 86.52 35.28 112.74 87.08 36.38 110.99 5.87 -17.01 -8.12 5.06 -15.73 -9.55 coo 84.93 40.21 105.31 85.72 41.45 107.72 -0.72 -24.00 -3.91 0.54 -23.91 -6.42 coo 83.38 41.19 112.55 85.47 40.59 112.72 3.91 -21.00 -3.12 3.67 -19.15 -2.10 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 4 3 # 4 B 451 GLU A 228 GLU.? 8.71 C3 EPE A 377 B 504 TYR A 226 TYR.? 5.45 C8 EPE A 377 B 540 GLU A 227 GLU.? 13.15 O8 EPE A 377 coo 86.52 35.28 112.74 87.08 36.38 110.99 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 84.93 40.21 105.31 85.72 41.45 107.72 7.72 -24.64 -8.18 7.45 -27.31 -8.97 coo 83.38 41.19 112.55 85.47 40.59 112.72 5.87 -17.01 -8.12 5.06 -15.73 -9.55 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 5 3 # 5 B 451 GLU B 136 GLU^? 17.92 O1S EPE A 377 B 504 TYR B 133 TYR^? 17.24 ZN ZN B 375 B 540 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 86.52 35.28 112.74 87.08 36.38 110.99 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 84.93 40.21 105.31 85.72 41.45 107.72 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo 83.38 41.19 112.55 85.47 40.59 112.72 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 6 3 # 6 B 451 GLU B 227 GLU.? 24.58 O3S EPE A 377 B 504 TYR B 226 TYR.? 21.63 O2S EPE A 377 B 540 GLU B 228 GLU.? 26.61 O2S EPE A 377 coo 86.52 35.28 112.74 87.08 36.38 110.99 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 84.93 40.21 105.31 85.72 41.45 107.72 -2.18 -44.73 18.44 0.01 -45.92 17.08 coo 83.38 41.19 112.55 85.47 40.59 112.72 -2.18 -42.16 24.63 -2.03 -43.87 25.91 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 7 3 # 7 B 451 GLU C 136 GLU^? 12.99 N TRS A 378 B 504 TYR C 133 TYR^? 16.76 ZN ZN C 375 B 540 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 86.52 35.28 112.74 87.08 36.38 110.99 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 84.93 40.21 105.31 85.72 41.45 107.72 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 83.38 41.19 112.55 85.47 40.59 112.72 11.24 -30.50 31.64 12.59 -30.76 33.22 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 8 3 # 8 B 451 GLU C 241 GLU^? 18.99 ZN ZN C 375 B 504 TYR C 133 TYR^? 16.76 ZN ZN C 375 B 540 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 86.52 35.28 112.74 87.08 36.38 110.99 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 84.93 40.21 105.31 85.72 41.45 107.72 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 83.38 41.19 112.55 85.47 40.59 112.72 11.24 -30.50 31.64 12.59 -30.76 33.22 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 8 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 153 ARG~? 11.00 C6 EPE C 377 A 451 GLU A 151 GLU~? 15.60 C7 EPE A 377 A 540 GLU A 150 GLU~? 12.50 C5 EPE C 377 coo 79.04 80.20 80.81 79.58 81.40 83.63 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo 81.34 87.29 87.22 82.36 86.09 88.61 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 79.94 80.46 88.84 81.11 81.36 87.27 22.60 -31.63 -7.22 23.33 -32.82 -5.63 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG A 198 ARG^? 11.16 C6 EPE A 377 A 451 GLU A 201 GLU^? -3.12 C2 EPE A 377s A 540 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 79.04 80.20 80.81 79.58 81.40 83.63 -1.05 -38.83 -3.85 -3.04 -38.62 -1.48 coo 81.34 87.29 87.22 82.36 86.09 88.61 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 79.94 80.46 88.84 81.11 81.36 87.27 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 451 GLU A 175 GLU^? 13.72 C8 EPE A 377 A 540 GLU A 201 GLU^? -3.12 C2 EPE A 377s coo 79.04 80.20 80.81 79.58 81.40 83.63 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 81.34 87.29 87.22 82.36 86.09 88.61 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 79.94 80.46 88.84 81.11 81.36 87.27 7.01 -32.51 -2.93 6.57 -30.84 -1.85 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 451 GLU A 201 GLU^? -3.12 C2 EPE A 377s A 540 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 79.04 80.20 80.81 79.58 81.40 83.63 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 81.34 87.29 87.22 82.36 86.09 88.61 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 79.94 80.46 88.84 81.11 81.36 87.27 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG B 153 ARG~? 10.73 C6 EPE A 377 A 451 GLU B 151 GLU~? 19.22 O3S EPE A 377 A 540 GLU B 150 GLU~? 12.97 C6 EPE A 377 coo 79.04 80.20 80.81 79.58 81.40 83.63 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo 81.34 87.29 87.22 82.36 86.09 88.61 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 79.94 80.46 88.84 81.11 81.36 87.27 -6.18 -40.46 2.00 -5.62 -38.68 0.95 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 6 3 # 6 A 382 ARG B 198 ARG^? 21.95 C2 EPE C 377 A 451 GLU B 201 GLU^? 17.83 O2S EPE A 377 A 540 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 79.04 80.20 80.81 79.58 81.40 83.63 11.64 -52.94 14.57 14.19 -52.83 16.31 coo 81.34 87.29 87.22 82.36 86.09 88.61 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 79.94 80.46 88.84 81.11 81.36 87.27 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 7 3 # 7 A 382 ARG C 198 ARG^? 10.55 C8 EPE C 377 A 451 GLU C 201 GLU^? -3.18 C8 EPE C 377s A 540 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 79.04 80.20 80.81 79.58 81.40 83.63 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo 81.34 87.29 87.22 82.36 86.09 88.61 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 79.94 80.46 88.84 81.11 81.36 87.27 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 8 3 # 8 A 382 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 451 GLU C 175 GLU^? 13.76 O8 EPE C 377 A 540 GLU C 201 GLU^? -3.18 C8 EPE C 377s coo 79.04 80.20 80.81 79.58 81.40 83.63 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 79.94 80.46 88.84 81.11 81.36 87.27 23.53 -40.20 6.95 23.95 -38.27 7.71 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 9 3 # 9 A 382 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 451 GLU C 201 GLU^? -3.18 C8 EPE C 377s A 540 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo 79.04 80.20 80.81 79.58 81.40 83.63 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 81.34 87.29 87.22 82.36 86.09 88.61 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 79.94 80.46 88.84 81.11 81.36 87.27 16.33 -45.08 6.01 16.53 -46.96 5.10 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 9 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 153 ARG~? 11.00 C6 EPE C 377 B 451 GLU A 151 GLU~? 15.60 C7 EPE A 377 B 540 GLU A 150 GLU~? 12.50 C5 EPE C 377 coo 82.21 41.07 119.14 83.95 40.66 116.59 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo 86.52 35.28 112.74 87.08 36.38 110.99 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 83.38 41.19 112.55 85.47 40.59 112.72 22.60 -31.63 -7.22 23.33 -32.82 -5.63 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 198 ARG^? 11.16 C6 EPE A 377 B 451 GLU A 201 GLU^? -3.12 C2 EPE A 377s B 540 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 82.21 41.07 119.14 83.95 40.66 116.59 -1.05 -38.83 -3.85 -3.04 -38.62 -1.48 coo 86.52 35.28 112.74 87.08 36.38 110.99 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 83.38 41.19 112.55 85.47 40.59 112.72 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG B 153 ARG~? 10.73 C6 EPE A 377 B 451 GLU B 151 GLU~? 19.22 O3S EPE A 377 B 540 GLU B 150 GLU~? 12.97 C6 EPE A 377 coo 82.21 41.07 119.14 83.95 40.66 116.59 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo 86.52 35.28 112.74 87.08 36.38 110.99 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 83.38 41.19 112.55 85.47 40.59 112.72 -6.18 -40.46 2.00 -5.62 -38.68 0.95 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG B 198 ARG^? 21.95 C2 EPE C 377 B 451 GLU B 201 GLU^? 17.83 O2S EPE A 377 B 540 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 82.21 41.07 119.14 83.95 40.66 116.59 11.64 -52.94 14.57 14.19 -52.83 16.31 coo 86.52 35.28 112.74 87.08 36.38 110.99 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 83.38 41.19 112.55 85.47 40.59 112.72 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 5 3 # 5 B 382 ARG C 153 ARG~? 15.97 C2 EPE C 377 B 451 GLU C 151 GLU~? 17.15 O8 EPE C 377 B 540 GLU C 150 GLU~? 19.96 C2 EPE C 377 coo 82.21 41.07 119.14 83.95 40.66 116.59 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 86.52 35.28 112.74 87.08 36.38 110.99 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 83.38 41.19 112.55 85.47 40.59 112.72 18.79 -51.73 16.88 16.73 -51.34 17.24 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 6 3 # 6 B 382 ARG C 198 ARG^? 10.55 C8 EPE C 377 B 451 GLU C 201 GLU^? -3.18 C8 EPE C 377s B 540 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 82.21 41.07 119.14 83.95 40.66 116.59 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo 86.52 35.28 112.74 87.08 36.38 110.99 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 83.38 41.19 112.55 85.47 40.59 112.72 22.01 -43.83 0.76 21.98 -45.84 -0.06 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 6 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG B 214 ARG~? 23.93 O3S EPE A 377 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 317 ARG B 153 ARG~? 10.73 C6 EPE A 377 coo 76.57 109.19 73.41 73.86 110.26 72.16 -7.68 -23.63 22.44 -8.04 -24.96 25.17 coo 82.09 117.51 66.37 80.60 114.32 71.44 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 65.21 120.62 58.76 63.62 123.14 59.66 -1.46 -36.52 4.12 -1.19 -38.78 2.09 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 1 hits 1bib_c00 naa= 3 ULMN 3 1bol_c00 RIBONUCLEASE RH user 1 3 # 1 A 46 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 105 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 109 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 37.80 0.44 25.56 37.02 -1.29 26.44 coo 43.60 31.12 0.44 42.42 31.86 -1.18 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1bol_c00 RIBONUCLEASE RH user 2 3 # 2 A 46 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 105 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 109 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 40.60 0.33 34.12 38.69 0.39 33.24 coo 43.60 31.12 0.44 42.42 31.86 -1.18 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1bol_c00 RIBONUCLEASE RH user 3 3 # 3 A 46 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 105 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 109 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1bol_c00 RIBONUCLEASE RH user 4 3 # 4 A 46 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 105 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 109 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1bol_c00 RIBONUCLEASE RH user 5 3 # 5 A 46 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 105 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 109 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 43.60 31.12 0.44 42.42 31.86 -1.18 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1bol_c00 RIBONUCLEASE RH user 6 3 # 6 A 46 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 105 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 109 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 43.60 31.12 0.44 42.42 31.86 -1.18 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 9.33 -29.64 54.17 7.95 -29.11 52.67 1bol_c00 source 1bol RIBONUCLEASE RH : 6 hits 1bol_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 26 GLY.? 13.89 ZN ZN A 375 48 HIS A 103 HIS~? -4.82 ZN ZN A 375s 99 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 12.38 5.55 24.25 13.27 5.59 24.39 23.61 -0.70 30.49 24.31 -1.07 30.25 coo 18.80 12.68 24.53 17.69 13.54 26.08 32.91 0.46 27.63 33.66 0.11 29.56 coo 17.07 18.51 26.62 16.67 17.07 28.09 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY A 30 GLY^? 14.83 ZN ZN A 375 48 HIS A 103 HIS~? -4.82 ZN ZN A 375s 99 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 12.38 5.55 24.25 13.27 5.59 24.39 27.68 4.60 19.76 28.15 4.96 20.33 coo 18.80 12.68 24.53 17.69 13.54 26.08 32.91 0.46 27.63 33.66 0.11 29.56 coo 17.07 18.51 26.62 16.67 17.07 28.09 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY A 277 GLY.? 24.28 ZN ZN A 374 48 HIS A 319 HIS~? 24.64 ZN ZN A 374 99 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 12.38 5.55 24.25 13.27 5.59 24.39 49.23 -14.07 46.91 49.73 -13.44 47.06 coo 18.80 12.68 24.53 17.69 13.54 26.08 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 17.07 18.51 26.62 16.67 17.07 28.09 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 4 3 # 4 30 GLY A 290 GLY^? 5.60 ZN ZN A 375 48 HIS A 69 HIS.? -3.40 ZN ZN A 374s 99 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 12.38 5.55 24.25 13.27 5.59 24.39 41.03 -5.77 31.09 40.29 -6.09 31.40 coo 18.80 12.68 24.53 17.69 13.54 26.08 37.42 3.90 29.26 38.47 2.36 30.22 coo 17.07 18.51 26.62 16.67 17.07 28.09 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 5 3 # 5 30 GLY A 290 GLY^? 5.60 ZN ZN A 375 48 HIS A 103 HIS~? -4.82 ZN ZN A 375s 99 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 12.38 5.55 24.25 13.27 5.59 24.39 41.03 -5.77 31.09 40.29 -6.09 31.40 coo 18.80 12.68 24.53 17.69 13.54 26.08 32.91 0.46 27.63 33.66 0.11 29.56 coo 17.07 18.51 26.62 16.67 17.07 28.09 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 6 3 # 6 30 GLY A 291 GLY^? 4.06 ZN ZN A 374 48 HIS A 69 HIS.? -3.40 ZN ZN A 374s 99 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 12.38 5.55 24.25 13.27 5.59 24.39 39.29 -3.03 33.06 39.67 -3.69 33.42 coo 18.80 12.68 24.53 17.69 13.54 26.08 37.42 3.90 29.26 38.47 2.36 30.22 coo 17.07 18.51 26.62 16.67 17.07 28.09 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 7 3 # 7 30 GLY A 291 GLY^? 4.06 ZN ZN A 374 48 HIS A 103 HIS~? -4.82 ZN ZN A 375s 99 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 12.38 5.55 24.25 13.27 5.59 24.39 39.29 -3.03 33.06 39.67 -3.69 33.42 coo 18.80 12.68 24.53 17.69 13.54 26.08 32.91 0.46 27.63 33.66 0.11 29.56 coo 17.07 18.51 26.62 16.67 17.07 28.09 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 8 3 # 8 30 GLY A 342 GLY~? 12.90 ZN ZN A 375 48 HIS A 68 HIS.? -3.31 ZN ZN A 375s 99 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 12.38 5.55 24.25 13.27 5.59 24.39 44.89 -3.04 18.23 44.73 -2.27 17.91 coo 18.80 12.68 24.53 17.69 13.54 26.08 37.80 0.44 25.56 37.02 -1.29 26.44 coo 17.07 18.51 26.62 16.67 17.07 28.09 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 9 3 # 9 30 GLY B 26 GLY.? 14.28 ZN ZN B 375 48 HIS B 103 HIS~? 5.04 ZN ZN B 375 99 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 12.38 5.55 24.25 13.27 5.59 24.39 -1.82 -2.93 32.32 -2.26 -3.11 31.69 coo 18.80 12.68 24.53 17.69 13.54 26.08 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 10 3 # 10 30 GLY B 30 GLY^? 14.63 ZN ZN B 375 48 HIS B 103 HIS~? 5.04 ZN ZN B 375 99 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 12.38 5.55 24.25 13.27 5.59 24.39 -13.71 -6.55 30.41 -13.82 -5.76 30.60 coo 18.80 12.68 24.53 17.69 13.54 26.08 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 11 3 # 11 30 GLY B 277 GLY.? 24.23 ZN ZN B 374 48 HIS B 319 HIS~? 24.73 ZN ZN B 374 99 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 12.38 5.55 24.25 13.27 5.59 24.39 3.65 23.16 11.55 3.12 23.75 11.78 coo 18.80 12.68 24.53 17.69 13.54 26.08 8.16 23.53 21.75 7.85 25.60 21.62 coo 17.07 18.51 26.62 16.67 17.07 28.09 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 12 3 # 12 30 GLY B 290 GLY^? 5.66 ZN ZN B 375 48 HIS B 69 HIS.? -3.36 ZN ZN B 374s 99 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 12.38 5.55 24.25 13.27 5.59 24.39 -6.82 7.95 18.08 -6.13 7.62 18.39 coo 18.80 12.68 24.53 17.69 13.54 26.08 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 17.07 18.51 26.62 16.67 17.07 28.09 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 13 3 # 13 30 GLY B 290 GLY^? 5.66 ZN ZN B 375 48 HIS B 103 HIS~? 5.04 ZN ZN B 375 99 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 12.38 5.55 24.25 13.27 5.59 24.39 -6.82 7.95 18.08 -6.13 7.62 18.39 coo 18.80 12.68 24.53 17.69 13.54 26.08 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 14 3 # 14 30 GLY B 291 GLY^? 4.09 ZN ZN B 374 48 HIS B 69 HIS.? -3.36 ZN ZN B 374s 99 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 12.38 5.55 24.25 13.27 5.59 24.39 -6.52 8.91 21.71 -6.06 9.31 21.13 coo 18.80 12.68 24.53 17.69 13.54 26.08 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 17.07 18.51 26.62 16.67 17.07 28.09 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 15 3 # 15 30 GLY B 291 GLY^? 4.09 ZN ZN B 374 48 HIS B 103 HIS~? 5.04 ZN ZN B 375 99 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 12.38 5.55 24.25 13.27 5.59 24.39 -6.52 8.91 21.71 -6.06 9.31 21.13 coo 18.80 12.68 24.53 17.69 13.54 26.08 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 16 3 # 16 30 GLY B 342 GLY~? 13.01 ZN ZN B 375 48 HIS B 68 HIS.? -3.38 ZN ZN B 375s 99 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 12.38 5.55 24.25 13.27 5.59 24.39 -18.10 1.14 13.74 -18.67 1.02 14.34 coo 18.80 12.68 24.53 17.69 13.54 26.08 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 17.07 18.51 26.62 16.67 17.07 28.09 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 17 3 # 17 30 GLY C 26 GLY.? 14.31 ZN ZN C 375 48 HIS C 103 HIS~? 4.97 ZN ZN C 375 99 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 12.38 5.55 24.25 13.27 5.59 24.39 12.94 -16.92 46.05 12.77 -17.67 45.98 coo 18.80 12.68 24.53 17.69 13.54 26.08 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 17.07 18.51 26.62 16.67 17.07 28.09 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 18 3 # 18 30 GLY C 30 GLY^? 14.80 ZN ZN C 375 48 HIS C 103 HIS~? 4.97 ZN ZN C 375 99 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 12.38 5.55 24.25 13.27 5.59 24.39 20.37 -26.80 49.54 20.07 -26.59 50.27 coo 18.80 12.68 24.53 17.69 13.54 26.08 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 17.07 18.51 26.62 16.67 17.07 28.09 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 19 3 # 19 30 GLY C 277 GLY.? 24.27 ZN ZN C 374 48 HIS C 319 HIS~? 24.70 ZN ZN C 374 99 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 12.38 5.55 24.25 13.27 5.59 24.39 -18.35 -23.56 56.48 -18.29 -23.66 57.31 coo 18.80 12.68 24.53 17.69 13.54 26.08 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 17.07 18.51 26.62 16.67 17.07 28.09 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 20 3 # 20 30 GLY C 290 GLY^? 5.72 ZN ZN C 375 48 HIS C 69 HIS.? -3.39 ZN ZN C 374s 99 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 12.38 5.55 24.25 13.27 5.59 24.39 0.35 -28.86 53.11 0.38 -28.21 52.55 coo 18.80 12.68 24.53 17.69 13.54 26.08 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 17.07 18.51 26.62 16.67 17.07 28.09 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 21 3 # 21 30 GLY C 290 GLY^? 5.72 ZN ZN C 375 48 HIS C 103 HIS~? 4.97 ZN ZN C 375 99 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 12.38 5.55 24.25 13.27 5.59 24.39 0.35 -28.86 53.11 0.38 -28.21 52.55 coo 18.80 12.68 24.53 17.69 13.54 26.08 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 17.07 18.51 26.62 16.67 17.07 28.09 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 22 3 # 22 30 GLY C 291 GLY^? 4.07 ZN ZN C 374 48 HIS C 69 HIS.? -3.39 ZN ZN C 374s 99 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 12.38 5.55 24.25 13.27 5.59 24.39 1.77 -25.71 54.72 0.95 -25.76 54.56 coo 18.80 12.68 24.53 17.69 13.54 26.08 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 17.07 18.51 26.62 16.67 17.07 28.09 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 23 3 # 23 30 GLY C 291 GLY^? 4.07 ZN ZN C 374 48 HIS C 103 HIS~? 4.97 ZN ZN C 375 99 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 12.38 5.55 24.25 13.27 5.59 24.39 1.77 -25.71 54.72 0.95 -25.76 54.56 coo 18.80 12.68 24.53 17.69 13.54 26.08 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 17.07 18.51 26.62 16.67 17.07 28.09 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 24 3 # 24 30 GLY C 342 GLY~? 13.18 ZN ZN C 375 48 HIS C 68 HIS.? -3.41 ZN ZN C 375s 99 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 12.38 5.55 24.25 13.27 5.59 24.39 7.81 -40.56 53.34 8.53 -40.45 53.72 coo 18.80 12.68 24.53 17.69 13.54 26.08 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 17.07 18.51 26.62 16.67 17.07 28.09 5.80 -28.16 48.27 6.08 -27.64 50.28 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 24 hits 1bp2_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 153 ARG~? 11.00 C6 EPE C 377 A 128 GLU A 151 GLU~? 15.60 C7 EPE A 377 A 225 GLU A 150 GLU~? 12.50 C5 EPE C 377 coo 38.56 19.11 14.83 37.12 21.00 16.76 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo 36.48 24.43 22.02 36.86 26.34 21.13 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 40.16 23.71 17.01 38.52 24.96 17.40 22.60 -31.63 -7.22 23.33 -32.82 -5.63 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG B 153 ARG~? 10.73 C6 EPE A 377 A 128 GLU B 151 GLU~? 19.22 O3S EPE A 377 A 225 GLU B 150 GLU~? 12.97 C6 EPE A 377 coo 38.56 19.11 14.83 37.12 21.00 16.76 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo 36.48 24.43 22.02 36.86 26.34 21.13 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 40.16 23.71 17.01 38.52 24.96 17.40 -6.18 -40.46 2.00 -5.62 -38.68 0.95 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG B 284 ARG^? 30.04 ZN ZN B 375 A 128 GLU B 253 GLU^? 31.12 ZN ZN B 375 A 225 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 38.56 19.11 14.83 37.12 21.00 16.76 1.85 12.86 -2.25 0.88 12.89 -5.16 coo 36.48 24.43 22.02 36.86 26.34 21.13 -5.44 14.03 -5.56 -4.22 13.73 -7.31 coo 40.16 23.71 17.01 38.52 24.96 17.40 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1bqc_c01 BETA-MANNANASE user 4 3 # 4 A 50 ARG C 153 ARG~? 15.97 C2 EPE C 377 A 128 GLU C 151 GLU~? 17.15 O8 EPE C 377 A 225 GLU C 150 GLU~? 19.96 C2 EPE C 377 coo 38.56 19.11 14.83 37.12 21.00 16.76 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 36.48 24.43 22.02 36.86 26.34 21.13 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 40.16 23.71 17.01 38.52 24.96 17.40 18.79 -51.73 16.88 16.73 -51.34 17.24 ULMN 3 1bqc_c01 BETA-MANNANASE user 5 3 # 5 A 50 ARG C 198 ARG^? 10.55 C8 EPE C 377 A 128 GLU C 201 GLU^? -3.18 C8 EPE C 377s A 225 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 38.56 19.11 14.83 37.12 21.00 16.76 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo 36.48 24.43 22.02 36.86 26.34 21.13 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 40.16 23.71 17.01 38.52 24.96 17.40 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 1bqc_c01 BETA-MANNANASE user 6 3 # 6 A 50 ARG C 284 ARG^? 27.80 ZN ZN C 375 A 128 GLU C 253 GLU^? 31.42 ZN ZN C 375 A 225 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 38.56 19.11 14.83 37.12 21.00 16.76 -17.70 -37.64 45.94 -17.45 -40.51 44.86 coo 36.48 24.43 22.02 36.86 26.34 21.13 -18.88 -44.02 49.77 -19.94 -45.34 51.07 coo 40.16 23.71 17.01 38.52 24.96 17.40 -21.46 -36.51 49.50 -23.48 -36.16 48.85 1bqc_c01 source 1bqc BETA-MANNANASE : 6 hits 1bqc_c01 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS A 8 HIS~? 24.55 ZN ZN A 375 A 168 ARG A 41 ARG.? 31.19 ZN ZN A 375 A 187 LYS A 38 LYS.? 22.26 C2 EPE A 376 coo 62.47 12.00 59.65 61.76 10.14 60.31 26.75 7.68 8.85 25.49 8.72 10.18 coo 55.10 8.37 73.00 55.48 9.59 70.20 42.11 12.31 4.12 44.66 13.27 2.71 coo 66.76 10.09 66.23 61.80 8.06 65.82 30.55 14.65 7.31 33.02 15.96 12.69 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 A 82 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 168 ARG A 274 ARG^? 15.42 ZN ZN A 374 A 187 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 62.47 12.00 59.65 61.76 10.14 60.31 51.10 6.85 29.91 51.20 5.36 31.38 coo 55.10 8.37 73.00 55.48 9.59 70.20 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 66.76 10.09 66.23 61.80 8.06 65.82 56.12 0.48 35.73 59.67 4.01 35.99 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 2 hits 1brw_c00 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS A 169 HIS^? 11.22 O1S EPE C 377 B1168 ARG C 198 ARG^? 10.55 C8 EPE C 377 B1187 LYS A 154 LYS~? 18.09 O1S EPE C 377 coo 35.03 5.72 103.61 36.82 5.00 102.79 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 41.91 5.48 91.85 40.59 6.81 94.28 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo 32.93 -0.12 99.60 37.71 2.39 99.23 24.03 -26.17 -4.04 26.99 -24.22 -8.52 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 B1082 HIS B 169 HIS^? 10.86 O3S EPE A 377 B1168 ARG A 198 ARG^? 11.16 C6 EPE A 377 B1187 LYS B 154 LYS~? 18.23 O3S EPE A 377 coo 35.03 5.72 103.61 36.82 5.00 102.79 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 41.91 5.48 91.85 40.59 6.81 94.28 -1.05 -38.83 -3.85 -3.04 -38.62 -1.48 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -7.89 -34.48 4.91 -13.85 -35.95 3.01 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 B1082 HIS C 169 HIS^? 22.39 O1 TRS A 378 B1168 ARG B 198 ARG^? 21.95 C2 EPE C 377 B1187 LYS C 154 LYS~? 23.94 C1 TRS A 378 coo 35.03 5.72 103.61 36.82 5.00 102.79 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 41.91 5.48 91.85 40.59 6.81 94.28 11.64 -52.94 14.57 14.19 -52.83 16.31 coo 32.93 -0.12 99.60 37.71 2.39 99.23 18.67 -47.92 22.36 20.33 -51.69 25.99 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 3 hits 1brw_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 14 PHE~? 13.00 ZN ZN A 375 A 205 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 236 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 4.14 2.10 36.34 6.69 3.08 36.92 34.51 0.34 14.77 34.92 -0.05 17.51 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 14 PHE~? 13.00 ZN ZN A 375 A 205 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 236 LYS A 110 LYS.? 16.46 O3 TRS A 378 coo 4.14 2.10 36.34 6.69 3.08 36.92 34.51 0.34 14.77 34.92 -0.05 17.51 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 37.52 -11.39 18.62 36.00 -16.08 14.56 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 143 PHE^? -3.89 C10 EPE A 377s A 205 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 236 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 4.14 2.10 36.34 6.69 3.08 36.92 8.68 -28.97 1.51 8.47 -29.44 4.22 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE A 143 PHE^? -3.89 C10 EPE A 377s A 205 ASP B 237 ASP^? 15.58 N TRS A 378 A 236 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 4.14 2.10 36.34 6.69 3.08 36.92 8.68 -28.97 1.51 8.47 -29.44 4.22 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE A 143 PHE^? -3.89 C10 EPE A 377s A 205 ASP B 237 ASP^? 15.58 N TRS A 378 A 236 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 4.14 2.10 36.34 6.69 3.08 36.92 8.68 -28.97 1.51 8.47 -29.44 4.22 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE A 172 PHE^? 6.53 C9 EPE C 377 A 205 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 236 LYS A 138 LYS^? 13.11 N TRS A 378 coo 4.14 2.10 36.34 6.69 3.08 36.92 18.79 -35.53 6.28 17.39 -37.92 6.30 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE A 302 PHE~? 17.86 O1 TRS A 378 A 205 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 236 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 4.14 2.10 36.34 6.69 3.08 36.92 34.13 -22.97 38.46 32.71 -25.28 37.80 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE A 370 PHE.? 12.81 O8 EPE A 376 A 205 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 236 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 4.14 2.10 36.34 6.69 3.08 36.92 46.70 4.90 39.59 44.12 4.72 40.65 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 54.82 -1.21 28.36 56.43 0.27 28.67 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 9 3 # 9 A 109 PHE B 14 PHE~? 12.83 ZN ZN B 375 A 205 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 236 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 4.14 2.10 36.34 6.69 3.08 36.92 -17.27 -6.95 21.62 -15.57 -4.76 21.74 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 10 3 # 10 A 109 PHE B 14 PHE~? 12.83 ZN ZN B 375 A 205 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 236 LYS B 110 LYS.? 16.94 ZN ZN B 375 coo 4.14 2.10 36.34 6.69 3.08 36.92 -17.27 -6.95 21.62 -15.57 -4.76 21.74 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -8.36 -4.86 12.39 -7.58 -9.04 11.62 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 11 3 # 11 A 109 PHE B 14 PHE~? 12.83 ZN ZN B 375 A 205 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 236 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 4.14 2.10 36.34 6.69 3.08 36.92 -17.27 -6.95 21.62 -15.57 -4.76 21.74 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 12 3 # 12 A 109 PHE B 143 PHE^? 13.71 O2S EPE A 377 A 205 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 236 LYS C 138 LYS^? 8.30 N TRS A 378 coo 4.14 2.10 36.34 6.69 3.08 36.92 4.74 -39.41 14.59 7.03 -37.80 14.65 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 13 3 # 13 A 109 PHE B 143 PHE^? 13.71 O2S EPE A 377 A 205 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 236 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 4.14 2.10 36.34 6.69 3.08 36.92 4.74 -39.41 14.59 7.03 -37.80 14.65 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 14 3 # 14 A 109 PHE B 143 PHE^? 13.71 O2S EPE A 377 A 205 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 236 LYS C 138 LYS^? 8.30 N TRS A 378 coo 4.14 2.10 36.34 6.69 3.08 36.92 4.74 -39.41 14.59 7.03 -37.80 14.65 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 15 3 # 15 A 109 PHE B 143 PHE^? 13.71 O2S EPE A 377 A 205 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 236 LYS C 139 LYS^? 16.11 N TRS A 378 coo 4.14 2.10 36.34 6.69 3.08 36.92 4.74 -39.41 14.59 7.03 -37.80 14.65 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 16 3 # 16 A 109 PHE B 172 PHE^? 6.04 C9 EPE A 377 A 205 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 236 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 4.14 2.10 36.34 6.69 3.08 36.92 6.52 -33.24 3.28 8.59 -34.82 2.34 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 17 3 # 17 A 109 PHE B 302 PHE~? 23.76 ZN ZN B 375 A 205 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 236 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 4.14 2.10 36.34 6.69 3.08 36.92 11.95 5.09 12.05 13.66 2.98 11.30 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 9.35 16.65 21.02 10.22 16.89 22.90 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 18 3 # 18 A 109 PHE B 370 PHE.? 12.32 O8 EPE B 376 A 205 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 236 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 4.14 2.10 36.34 6.69 3.08 36.92 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 19 3 # 19 A 109 PHE C 14 PHE~? 12.81 ZN ZN C 375 A 205 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 236 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 4.14 2.10 36.34 6.69 3.08 36.92 17.06 -35.49 48.83 14.82 -33.96 49.59 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 20 3 # 20 A 109 PHE C 14 PHE~? 12.81 ZN ZN C 375 A 205 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 236 LYS C 110 LYS.? 19.48 ZN ZN C 375 coo 4.14 2.10 36.34 6.69 3.08 36.92 17.06 -35.49 48.83 14.82 -33.96 49.59 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 5.59 -36.33 42.73 4.93 -41.69 39.22 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 21 3 # 21 A 109 PHE C 14 PHE~? 12.81 ZN ZN C 375 A 205 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 236 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 4.14 2.10 36.34 6.69 3.08 36.92 17.06 -35.49 48.83 14.82 -33.96 49.59 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 22 3 # 22 A 109 PHE C 73 PHE.? 6.88 C8 EPE C 376 A 205 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 236 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 4.14 2.10 36.34 6.69 3.08 36.92 12.87 -18.52 55.06 11.27 -18.17 52.78 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 23 3 # 23 A 109 PHE C 143 PHE^? 4.11 C9 EPE C 377 A 205 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 236 LYS A 138 LYS^? 13.11 N TRS A 378 coo 4.14 2.10 36.34 6.69 3.08 36.92 21.21 -36.18 10.80 19.31 -34.15 10.67 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 24 3 # 24 A 109 PHE C 143 PHE^? 4.11 C9 EPE C 377 A 205 ASP A 237 ASP^? 6.80 N TRS A 378 A 236 LYS A 138 LYS^? 13.11 N TRS A 378 coo 4.14 2.10 36.34 6.69 3.08 36.92 21.21 -36.18 10.80 19.31 -34.15 10.67 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 25 3 # 25 A 109 PHE C 143 PHE^? 4.11 C9 EPE C 377 A 205 ASP A 237 ASP^? 6.80 N TRS A 378 A 236 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 4.14 2.10 36.34 6.69 3.08 36.92 21.21 -36.18 10.80 19.31 -34.15 10.67 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 26 3 # 26 A 109 PHE C 172 PHE^? 14.49 O2S EPE A 377 A 205 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 236 LYS C 138 LYS^? 8.30 N TRS A 378 coo 4.14 2.10 36.34 6.69 3.08 36.92 9.48 -40.91 13.04 8.71 -41.08 10.37 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 27 3 # 27 A 109 PHE C 302 PHE~? 23.56 ZN ZN C 375 A 205 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 236 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 4.14 2.10 36.34 6.69 3.08 36.92 -10.84 -22.04 38.19 -10.68 -22.30 35.40 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 28 3 # 28 A 109 PHE C 370 PHE.? 12.75 O8 EPE C 376 A 205 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 236 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 4.14 2.10 36.34 6.69 3.08 36.92 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 5.23 -34.02 59.10 0.53 -34.86 62.24 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 28 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 259 GLN~? 28.90 ZN ZN A 375 A 91 LEU A 257 LEU~? 23.88 ZN ZN A 374 A 133 GLU A 254 GLU^? 30.93 ZN ZN A 375 coo 43.58 43.67 66.73 42.32 42.78 68.15 58.90 -16.16 37.51 60.42 -17.61 36.90 coo 38.58 45.09 70.44 38.28 45.21 72.59 53.11 -15.70 42.27 51.31 -14.45 42.42 coo 44.05 36.87 70.65 43.15 38.64 69.97 55.35 -23.67 37.01 55.67 -25.35 38.24 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 259 GLN~? 28.90 ZN ZN A 375 A 91 LEU A 257 LEU~? 23.88 ZN ZN A 374 A 133 GLU A 262 GLU~? 24.15 ZN ZN A 374 coo 43.58 43.67 66.73 42.32 42.78 68.15 58.90 -16.16 37.51 60.42 -17.61 36.90 coo 38.58 45.09 70.44 38.28 45.21 72.59 53.11 -15.70 42.27 51.31 -14.45 42.42 coo 44.05 36.87 70.65 43.15 38.64 69.97 59.50 -9.24 37.85 59.47 -7.16 38.33 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 344 GLN~? 19.01 ZN ZN A 375 A 91 LEU A 347 LEU~? 17.28 ZN ZN A 375 A 133 GLU A 349 GLU~? 21.94 ZN ZN A 375 coo 43.58 43.67 66.73 42.32 42.78 68.15 45.67 2.52 13.85 47.64 2.01 13.33 coo 38.58 45.09 70.44 38.28 45.21 72.59 39.84 0.41 12.10 38.14 1.65 11.48 coo 44.05 36.87 70.65 43.15 38.64 69.97 44.64 -4.62 8.34 45.23 -6.64 8.63 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN A 346 GLN~? 13.26 ZN ZN A 375 A 91 LEU A 347 LEU~? 17.28 ZN ZN A 375 A 133 GLU A 349 GLU~? 21.94 ZN ZN A 375 coo 43.58 43.67 66.73 42.32 42.78 68.15 42.03 -5.48 14.40 41.20 -5.67 16.38 coo 38.58 45.09 70.44 38.28 45.21 72.59 39.84 0.41 12.10 38.14 1.65 11.48 coo 44.05 36.87 70.65 43.15 38.64 69.97 44.64 -4.62 8.34 45.23 -6.64 8.63 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN A 348 GLN~? 22.76 ZN ZN A 375 A 91 LEU A 347 LEU~? 17.28 ZN ZN A 375 A 133 GLU A 349 GLU~? 21.94 ZN ZN A 375 coo 43.58 43.67 66.73 42.32 42.78 68.15 45.30 1.40 7.97 44.85 3.48 7.99 coo 38.58 45.09 70.44 38.28 45.21 72.59 39.84 0.41 12.10 38.14 1.65 11.48 coo 44.05 36.87 70.65 43.15 38.64 69.97 44.64 -4.62 8.34 45.23 -6.64 8.63 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 213 GLN~? 15.99 O1S EPE A 377 A 91 LEU B 212 LEU~? 13.91 O3S EPE A 377 A 133 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 43.58 43.67 66.73 42.32 42.78 68.15 -2.28 -25.33 18.62 -0.54 -24.65 19.67 coo 38.58 45.09 70.44 38.28 45.21 72.59 -5.99 -22.60 13.08 -7.30 -21.84 11.49 coo 44.05 36.87 70.65 43.15 38.64 69.97 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN B 259 GLN~? 29.53 ZN ZN B 375 A 91 LEU B 257 LEU~? 23.76 ZN ZN B 374 A 133 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 43.58 43.67 66.73 42.32 42.78 68.15 -5.41 23.11 1.24 -4.67 22.70 -0.73 coo 38.58 45.09 70.44 38.28 45.21 72.59 0.14 21.76 6.81 0.31 20.97 8.83 coo 44.05 36.87 70.65 43.15 38.64 69.97 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN B 259 GLN~? 29.53 ZN ZN B 375 A 91 LEU B 257 LEU~? 23.76 ZN ZN B 374 A 133 GLU B 262 GLU~? 24.13 ZN ZN B 374 coo 43.58 43.67 66.73 42.32 42.78 68.15 -5.41 23.11 1.24 -4.67 22.70 -0.73 coo 38.58 45.09 70.44 38.28 45.21 72.59 0.14 21.76 6.81 0.31 20.97 8.83 coo 44.05 36.87 70.65 43.15 38.64 69.97 -9.48 23.81 6.41 -10.83 24.55 7.88 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN B 346 GLN~? 13.15 ZN ZN B 375 A 91 LEU B 347 LEU~? 17.24 ZN ZN B 375 A 133 GLU B 349 GLU~? 21.77 ZN ZN B 375 coo 43.58 43.67 66.73 42.32 42.78 68.15 -17.50 -3.97 12.92 -15.77 -3.25 13.99 coo 38.58 45.09 70.44 38.28 45.21 72.59 -21.69 -5.65 17.63 -21.81 -6.90 19.46 coo 44.05 36.87 70.65 43.15 38.64 69.97 -22.55 -8.05 9.47 -20.93 -7.23 8.30 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN B 348 GLN~? 22.96 ZN ZN B 375 A 91 LEU B 347 LEU~? 17.24 ZN ZN B 375 A 133 GLU B 349 GLU~? 21.77 ZN ZN B 375 coo 43.58 43.67 66.73 42.32 42.78 68.15 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 38.58 45.09 70.44 38.28 45.21 72.59 -21.69 -5.65 17.63 -21.81 -6.90 19.46 coo 44.05 36.87 70.65 43.15 38.64 69.97 -22.55 -8.05 9.47 -20.93 -7.23 8.30 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 11 3 # 11 A 50 GLN C 124 GLN^? 24.57 ZN ZN C 375 A 91 LEU C 123 LEU.? 17.43 ZN ZN C 375 A 133 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 43.58 43.67 66.73 42.32 42.78 68.15 -9.48 -42.79 45.16 -11.30 -43.67 45.70 coo 38.58 45.09 70.44 38.28 45.21 72.59 -7.65 -37.78 47.66 -8.55 -36.07 48.64 coo 44.05 36.87 70.65 43.15 38.64 69.97 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 12 3 # 12 A 50 GLN C 259 GLN~? 29.09 ZN ZN C 375 A 91 LEU C 257 LEU~? 23.47 ZN ZN C 374 A 133 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 43.58 43.67 66.73 42.32 42.78 68.15 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 38.58 45.09 70.44 38.28 45.21 72.59 -18.18 -29.71 56.20 -16.65 -28.20 55.97 coo 44.05 36.87 70.65 43.15 38.64 69.97 -21.46 -36.51 49.50 -23.48 -36.16 48.85 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 13 3 # 13 A 50 GLN C 259 GLN~? 29.09 ZN ZN C 375 A 91 LEU C 257 LEU~? 23.47 ZN ZN C 374 A 133 GLU C 262 GLU~? 24.05 ZN ZN C 374 coo 43.58 43.67 66.73 42.32 42.78 68.15 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 38.58 45.09 70.44 38.28 45.21 72.59 -18.18 -29.71 56.20 -16.65 -28.20 55.97 coo 44.05 36.87 70.65 43.15 38.64 69.97 -15.17 -35.96 63.25 -14.01 -35.31 64.90 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 14 3 # 14 A 50 GLN C 259 GLN~? 29.09 ZN ZN C 375 A 91 LEU C 279 LEU.? 26.42 ZN ZN C 374 A 133 GLU C 262 GLU~? 24.05 ZN ZN C 374 coo 43.58 43.67 66.73 42.32 42.78 68.15 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 38.58 45.09 70.44 38.28 45.21 72.59 -20.60 -28.88 60.53 -19.01 -28.02 61.74 coo 44.05 36.87 70.65 43.15 38.64 69.97 -15.17 -35.96 63.25 -14.01 -35.31 64.90 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 15 3 # 15 A 50 GLN C 346 GLN~? 13.37 ZN ZN C 375 A 91 LEU C 347 LEU~? 17.24 ZN ZN C 375 A 133 GLU C 349 GLU~? 21.43 ZN ZN C 375 coo 43.58 43.67 66.73 42.32 42.78 68.15 10.15 -41.70 48.35 9.41 -39.67 48.22 coo 38.58 45.09 70.44 38.28 45.21 72.59 16.14 -41.10 51.17 18.03 -40.00 50.85 coo 44.05 36.87 70.65 43.15 38.64 69.97 13.16 -47.99 47.44 11.07 -47.60 47.14 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 16 3 # 16 A 50 GLN C 348 GLN~? 22.89 ZN ZN C 375 A 91 LEU C 347 LEU~? 17.24 ZN ZN C 375 A 133 GLU C 349 GLU~? 21.43 ZN ZN C 375 coo 43.58 43.67 66.73 42.32 42.78 68.15 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 38.58 45.09 70.44 38.28 45.21 72.59 16.14 -41.10 51.17 18.03 -40.00 50.85 coo 44.05 36.87 70.65 43.15 38.64 69.97 13.16 -47.99 47.44 11.07 -47.60 47.14 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 16 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 259 GLN~? 28.90 ZN ZN A 375 B 591 LEU A 257 LEU~? 23.88 ZN ZN A 374 B 633 GLU A 254 GLU^? 30.93 ZN ZN A 375 coo 88.06 44.34 57.19 89.06 45.53 55.74 58.90 -16.16 37.51 60.42 -17.61 36.90 coo 86.70 48.66 52.61 87.15 48.69 50.51 53.11 -15.70 42.27 51.31 -14.45 42.42 coo 95.42 44.52 54.43 93.46 45.31 54.70 55.35 -23.67 37.01 55.67 -25.35 38.24 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 259 GLN~? 28.90 ZN ZN A 375 B 591 LEU A 257 LEU~? 23.88 ZN ZN A 374 B 633 GLU A 262 GLU~? 24.15 ZN ZN A 374 coo 88.06 44.34 57.19 89.06 45.53 55.74 58.90 -16.16 37.51 60.42 -17.61 36.90 coo 86.70 48.66 52.61 87.15 48.69 50.51 53.11 -15.70 42.27 51.31 -14.45 42.42 coo 95.42 44.52 54.43 93.46 45.31 54.70 59.50 -9.24 37.85 59.47 -7.16 38.33 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN A 344 GLN~? 19.01 ZN ZN A 375 B 591 LEU A 347 LEU~? 17.28 ZN ZN A 375 B 633 GLU A 349 GLU~? 21.94 ZN ZN A 375 coo 88.06 44.34 57.19 89.06 45.53 55.74 45.67 2.52 13.85 47.64 2.01 13.33 coo 86.70 48.66 52.61 87.15 48.69 50.51 39.84 0.41 12.10 38.14 1.65 11.48 coo 95.42 44.52 54.43 93.46 45.31 54.70 44.64 -4.62 8.34 45.23 -6.64 8.63 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN A 346 GLN~? 13.26 ZN ZN A 375 B 591 LEU A 347 LEU~? 17.28 ZN ZN A 375 B 633 GLU A 349 GLU~? 21.94 ZN ZN A 375 coo 88.06 44.34 57.19 89.06 45.53 55.74 42.03 -5.48 14.40 41.20 -5.67 16.38 coo 86.70 48.66 52.61 87.15 48.69 50.51 39.84 0.41 12.10 38.14 1.65 11.48 coo 95.42 44.52 54.43 93.46 45.31 54.70 44.64 -4.62 8.34 45.23 -6.64 8.63 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN A 348 GLN~? 22.76 ZN ZN A 375 B 591 LEU A 347 LEU~? 17.28 ZN ZN A 375 B 633 GLU A 349 GLU~? 21.94 ZN ZN A 375 coo 88.06 44.34 57.19 89.06 45.53 55.74 45.30 1.40 7.97 44.85 3.48 7.99 coo 86.70 48.66 52.61 87.15 48.69 50.51 39.84 0.41 12.10 38.14 1.65 11.48 coo 95.42 44.52 54.43 93.46 45.31 54.70 44.64 -4.62 8.34 45.23 -6.64 8.63 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 6 3 # 6 B 550 GLN B 213 GLN~? 15.99 O1S EPE A 377 B 591 LEU B 212 LEU~? 13.91 O3S EPE A 377 B 633 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 88.06 44.34 57.19 89.06 45.53 55.74 -2.28 -25.33 18.62 -0.54 -24.65 19.67 coo 86.70 48.66 52.61 87.15 48.69 50.51 -5.99 -22.60 13.08 -7.30 -21.84 11.49 coo 95.42 44.52 54.43 93.46 45.31 54.70 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 7 3 # 7 B 550 GLN B 259 GLN~? 29.53 ZN ZN B 375 B 591 LEU B 257 LEU~? 23.76 ZN ZN B 374 B 633 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 88.06 44.34 57.19 89.06 45.53 55.74 -5.41 23.11 1.24 -4.67 22.70 -0.73 coo 86.70 48.66 52.61 87.15 48.69 50.51 0.14 21.76 6.81 0.31 20.97 8.83 coo 95.42 44.52 54.43 93.46 45.31 54.70 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 8 3 # 8 B 550 GLN B 259 GLN~? 29.53 ZN ZN B 375 B 591 LEU B 257 LEU~? 23.76 ZN ZN B 374 B 633 GLU B 262 GLU~? 24.13 ZN ZN B 374 coo 88.06 44.34 57.19 89.06 45.53 55.74 -5.41 23.11 1.24 -4.67 22.70 -0.73 coo 86.70 48.66 52.61 87.15 48.69 50.51 0.14 21.76 6.81 0.31 20.97 8.83 coo 95.42 44.52 54.43 93.46 45.31 54.70 -9.48 23.81 6.41 -10.83 24.55 7.88 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 9 3 # 9 B 550 GLN B 346 GLN~? 13.15 ZN ZN B 375 B 591 LEU B 347 LEU~? 17.24 ZN ZN B 375 B 633 GLU B 349 GLU~? 21.77 ZN ZN B 375 coo 88.06 44.34 57.19 89.06 45.53 55.74 -17.50 -3.97 12.92 -15.77 -3.25 13.99 coo 86.70 48.66 52.61 87.15 48.69 50.51 -21.69 -5.65 17.63 -21.81 -6.90 19.46 coo 95.42 44.52 54.43 93.46 45.31 54.70 -22.55 -8.05 9.47 -20.93 -7.23 8.30 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 10 3 # 10 B 550 GLN B 348 GLN~? 22.96 ZN ZN B 375 B 591 LEU B 347 LEU~? 17.24 ZN ZN B 375 B 633 GLU B 349 GLU~? 21.77 ZN ZN B 375 coo 88.06 44.34 57.19 89.06 45.53 55.74 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 86.70 48.66 52.61 87.15 48.69 50.51 -21.69 -5.65 17.63 -21.81 -6.90 19.46 coo 95.42 44.52 54.43 93.46 45.31 54.70 -22.55 -8.05 9.47 -20.93 -7.23 8.30 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 11 3 # 11 B 550 GLN C 124 GLN^? 24.57 ZN ZN C 375 B 591 LEU C 123 LEU.? 17.43 ZN ZN C 375 B 633 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 88.06 44.34 57.19 89.06 45.53 55.74 -9.48 -42.79 45.16 -11.30 -43.67 45.70 coo 86.70 48.66 52.61 87.15 48.69 50.51 -7.65 -37.78 47.66 -8.55 -36.07 48.64 coo 95.42 44.52 54.43 93.46 45.31 54.70 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 12 3 # 12 B 550 GLN C 259 GLN~? 29.09 ZN ZN C 375 B 591 LEU C 257 LEU~? 23.47 ZN ZN C 374 B 633 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 88.06 44.34 57.19 89.06 45.53 55.74 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 86.70 48.66 52.61 87.15 48.69 50.51 -18.18 -29.71 56.20 -16.65 -28.20 55.97 coo 95.42 44.52 54.43 93.46 45.31 54.70 -21.46 -36.51 49.50 -23.48 -36.16 48.85 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 13 3 # 13 B 550 GLN C 259 GLN~? 29.09 ZN ZN C 375 B 591 LEU C 257 LEU~? 23.47 ZN ZN C 374 B 633 GLU C 262 GLU~? 24.05 ZN ZN C 374 coo 88.06 44.34 57.19 89.06 45.53 55.74 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 86.70 48.66 52.61 87.15 48.69 50.51 -18.18 -29.71 56.20 -16.65 -28.20 55.97 coo 95.42 44.52 54.43 93.46 45.31 54.70 -15.17 -35.96 63.25 -14.01 -35.31 64.90 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 14 3 # 14 B 550 GLN C 259 GLN~? 29.09 ZN ZN C 375 B 591 LEU C 279 LEU.? 26.42 ZN ZN C 374 B 633 GLU C 262 GLU~? 24.05 ZN ZN C 374 coo 88.06 44.34 57.19 89.06 45.53 55.74 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 86.70 48.66 52.61 87.15 48.69 50.51 -20.60 -28.88 60.53 -19.01 -28.02 61.74 coo 95.42 44.52 54.43 93.46 45.31 54.70 -15.17 -35.96 63.25 -14.01 -35.31 64.90 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 15 3 # 15 B 550 GLN C 346 GLN~? 13.37 ZN ZN C 375 B 591 LEU C 347 LEU~? 17.24 ZN ZN C 375 B 633 GLU C 349 GLU~? 21.43 ZN ZN C 375 coo 88.06 44.34 57.19 89.06 45.53 55.74 10.15 -41.70 48.35 9.41 -39.67 48.22 coo 86.70 48.66 52.61 87.15 48.69 50.51 16.14 -41.10 51.17 18.03 -40.00 50.85 coo 95.42 44.52 54.43 93.46 45.31 54.70 13.16 -47.99 47.44 11.07 -47.60 47.14 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 16 3 # 16 B 550 GLN C 348 GLN~? 22.89 ZN ZN C 375 B 591 LEU C 347 LEU~? 17.24 ZN ZN C 375 B 633 GLU C 349 GLU~? 21.43 ZN ZN C 375 coo 88.06 44.34 57.19 89.06 45.53 55.74 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 86.70 48.66 52.61 87.15 48.69 50.51 16.14 -41.10 51.17 18.03 -40.00 50.85 coo 95.42 44.52 54.43 93.46 45.31 54.70 13.16 -47.99 47.44 11.07 -47.60 47.14 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 16 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 259 GLN~? 28.90 ZN ZN A 375 C1091 LEU A 257 LEU~? 23.88 ZN ZN A 374 C1133 GLU A 254 GLU^? 30.93 ZN ZN A 375 coo 68.29 34.44 43.03 66.67 34.74 44.37 58.90 -16.16 37.51 60.42 -17.61 36.90 coo 65.83 38.95 47.05 65.46 38.90 49.20 53.11 -15.70 42.27 51.31 -14.45 42.42 coo 63.14 29.39 46.25 63.84 31.31 45.74 55.35 -23.67 37.01 55.67 -25.35 38.24 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 259 GLN~? 28.90 ZN ZN A 375 C1091 LEU A 257 LEU~? 23.88 ZN ZN A 374 C1133 GLU A 262 GLU~? 24.15 ZN ZN A 374 coo 68.29 34.44 43.03 66.67 34.74 44.37 58.90 -16.16 37.51 60.42 -17.61 36.90 coo 65.83 38.95 47.05 65.46 38.90 49.20 53.11 -15.70 42.27 51.31 -14.45 42.42 coo 63.14 29.39 46.25 63.84 31.31 45.74 59.50 -9.24 37.85 59.47 -7.16 38.33 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN B 213 GLN~? 15.99 O1S EPE A 377 C1091 LEU B 212 LEU~? 13.91 O3S EPE A 377 C1133 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 68.29 34.44 43.03 66.67 34.74 44.37 -2.28 -25.33 18.62 -0.54 -24.65 19.67 coo 65.83 38.95 47.05 65.46 38.90 49.20 -5.99 -22.60 13.08 -7.30 -21.84 11.49 coo 63.14 29.39 46.25 63.84 31.31 45.74 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 259 GLN~? 29.53 ZN ZN B 375 C1091 LEU B 257 LEU~? 23.76 ZN ZN B 374 C1133 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 68.29 34.44 43.03 66.67 34.74 44.37 -5.41 23.11 1.24 -4.67 22.70 -0.73 coo 65.83 38.95 47.05 65.46 38.90 49.20 0.14 21.76 6.81 0.31 20.97 8.83 coo 63.14 29.39 46.25 63.84 31.31 45.74 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN B 259 GLN~? 29.53 ZN ZN B 375 C1091 LEU B 257 LEU~? 23.76 ZN ZN B 374 C1133 GLU B 262 GLU~? 24.13 ZN ZN B 374 coo 68.29 34.44 43.03 66.67 34.74 44.37 -5.41 23.11 1.24 -4.67 22.70 -0.73 coo 65.83 38.95 47.05 65.46 38.90 49.20 0.14 21.76 6.81 0.31 20.97 8.83 coo 63.14 29.39 46.25 63.84 31.31 45.74 -9.48 23.81 6.41 -10.83 24.55 7.88 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN B 259 GLN~? 29.53 ZN ZN B 375 C1091 LEU B 279 LEU.? 26.56 ZN ZN B 374 C1133 GLU B 262 GLU~? 24.13 ZN ZN B 374 coo 68.29 34.44 43.03 66.67 34.74 44.37 -5.41 23.11 1.24 -4.67 22.70 -0.73 coo 65.83 38.95 47.05 65.46 38.90 49.20 -0.89 26.78 7.31 -2.14 26.58 9.09 coo 63.14 29.39 46.25 63.84 31.31 45.74 -9.48 23.81 6.41 -10.83 24.55 7.88 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 7 3 # 7 C1050 GLN B 346 GLN~? 13.15 ZN ZN B 375 C1091 LEU B 347 LEU~? 17.24 ZN ZN B 375 C1133 GLU B 349 GLU~? 21.77 ZN ZN B 375 coo 68.29 34.44 43.03 66.67 34.74 44.37 -17.50 -3.97 12.92 -15.77 -3.25 13.99 coo 65.83 38.95 47.05 65.46 38.90 49.20 -21.69 -5.65 17.63 -21.81 -6.90 19.46 coo 63.14 29.39 46.25 63.84 31.31 45.74 -22.55 -8.05 9.47 -20.93 -7.23 8.30 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 8 3 # 8 C1050 GLN B 348 GLN~? 22.96 ZN ZN B 375 C1091 LEU B 347 LEU~? 17.24 ZN ZN B 375 C1133 GLU B 349 GLU~? 21.77 ZN ZN B 375 coo 68.29 34.44 43.03 66.67 34.74 44.37 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 65.83 38.95 47.05 65.46 38.90 49.20 -21.69 -5.65 17.63 -21.81 -6.90 19.46 coo 63.14 29.39 46.25 63.84 31.31 45.74 -22.55 -8.05 9.47 -20.93 -7.23 8.30 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 9 3 # 9 C1050 GLN C 259 GLN~? 29.09 ZN ZN C 375 C1091 LEU C 257 LEU~? 23.47 ZN ZN C 374 C1133 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 68.29 34.44 43.03 66.67 34.74 44.37 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 65.83 38.95 47.05 65.46 38.90 49.20 -18.18 -29.71 56.20 -16.65 -28.20 55.97 coo 63.14 29.39 46.25 63.84 31.31 45.74 -21.46 -36.51 49.50 -23.48 -36.16 48.85 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 10 3 # 10 C1050 GLN C 259 GLN~? 29.09 ZN ZN C 375 C1091 LEU C 257 LEU~? 23.47 ZN ZN C 374 C1133 GLU C 262 GLU~? 24.05 ZN ZN C 374 coo 68.29 34.44 43.03 66.67 34.74 44.37 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 65.83 38.95 47.05 65.46 38.90 49.20 -18.18 -29.71 56.20 -16.65 -28.20 55.97 coo 63.14 29.39 46.25 63.84 31.31 45.74 -15.17 -35.96 63.25 -14.01 -35.31 64.90 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 11 3 # 11 C1050 GLN C 259 GLN~? 29.09 ZN ZN C 375 C1091 LEU C 279 LEU.? 26.42 ZN ZN C 374 C1133 GLU C 262 GLU~? 24.05 ZN ZN C 374 coo 68.29 34.44 43.03 66.67 34.74 44.37 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 65.83 38.95 47.05 65.46 38.90 49.20 -20.60 -28.88 60.53 -19.01 -28.02 61.74 coo 63.14 29.39 46.25 63.84 31.31 45.74 -15.17 -35.96 63.25 -14.01 -35.31 64.90 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 12 3 # 12 C1050 GLN C 346 GLN~? 13.37 ZN ZN C 375 C1091 LEU C 347 LEU~? 17.24 ZN ZN C 375 C1133 GLU C 349 GLU~? 21.43 ZN ZN C 375 coo 68.29 34.44 43.03 66.67 34.74 44.37 10.15 -41.70 48.35 9.41 -39.67 48.22 coo 65.83 38.95 47.05 65.46 38.90 49.20 16.14 -41.10 51.17 18.03 -40.00 50.85 coo 63.14 29.39 46.25 63.84 31.31 45.74 13.16 -47.99 47.44 11.07 -47.60 47.14 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 13 3 # 13 C1050 GLN C 348 GLN~? 22.89 ZN ZN C 375 C1091 LEU C 347 LEU~? 17.24 ZN ZN C 375 C1133 GLU C 349 GLU~? 21.43 ZN ZN C 375 coo 68.29 34.44 43.03 66.67 34.74 44.37 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 65.83 38.95 47.05 65.46 38.90 49.20 16.14 -41.10 51.17 18.03 -40.00 50.85 coo 63.14 29.39 46.25 63.84 31.31 45.74 13.16 -47.99 47.44 11.07 -47.60 47.14 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 13 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 259 GLN~? 28.90 ZN ZN A 375 A 91 LEU A 257 LEU~? 23.88 ZN ZN A 374 A 133 GLU A 254 GLU^? 30.93 ZN ZN A 375 coo 38.23 53.34 67.59 38.84 53.87 69.56 58.90 -16.16 37.51 60.42 -17.61 36.90 coo 35.40 53.22 73.30 35.37 54.87 74.74 53.11 -15.70 42.27 51.31 -14.45 42.42 coo 45.08 56.04 70.60 43.15 55.19 70.77 55.35 -23.67 37.01 55.67 -25.35 38.24 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 259 GLN~? 28.90 ZN ZN A 375 A 91 LEU A 257 LEU~? 23.88 ZN ZN A 374 A 133 GLU A 262 GLU~? 24.15 ZN ZN A 374 coo 38.23 53.34 67.59 38.84 53.87 69.56 58.90 -16.16 37.51 60.42 -17.61 36.90 coo 35.40 53.22 73.30 35.37 54.87 74.74 53.11 -15.70 42.27 51.31 -14.45 42.42 coo 45.08 56.04 70.60 43.15 55.19 70.77 59.50 -9.24 37.85 59.47 -7.16 38.33 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 213 GLN~? 15.99 O1S EPE A 377 A 91 LEU B 212 LEU~? 13.91 O3S EPE A 377 A 133 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 38.23 53.34 67.59 38.84 53.87 69.56 -2.28 -25.33 18.62 -0.54 -24.65 19.67 coo 35.40 53.22 73.30 35.37 54.87 74.74 -5.99 -22.60 13.08 -7.30 -21.84 11.49 coo 45.08 56.04 70.60 43.15 55.19 70.77 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 259 GLN~? 29.53 ZN ZN B 375 A 91 LEU B 257 LEU~? 23.76 ZN ZN B 374 A 133 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 38.23 53.34 67.59 38.84 53.87 69.56 -5.41 23.11 1.24 -4.67 22.70 -0.73 coo 35.40 53.22 73.30 35.37 54.87 74.74 0.14 21.76 6.81 0.31 20.97 8.83 coo 45.08 56.04 70.60 43.15 55.19 70.77 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 259 GLN~? 29.53 ZN ZN B 375 A 91 LEU B 257 LEU~? 23.76 ZN ZN B 374 A 133 GLU B 262 GLU~? 24.13 ZN ZN B 374 coo 38.23 53.34 67.59 38.84 53.87 69.56 -5.41 23.11 1.24 -4.67 22.70 -0.73 coo 35.40 53.22 73.30 35.37 54.87 74.74 0.14 21.76 6.81 0.31 20.97 8.83 coo 45.08 56.04 70.60 43.15 55.19 70.77 -9.48 23.81 6.41 -10.83 24.55 7.88 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 346 GLN~? 13.15 ZN ZN B 375 A 91 LEU B 347 LEU~? 17.24 ZN ZN B 375 A 133 GLU B 349 GLU~? 21.77 ZN ZN B 375 coo 38.23 53.34 67.59 38.84 53.87 69.56 -17.50 -3.97 12.92 -15.77 -3.25 13.99 coo 35.40 53.22 73.30 35.37 54.87 74.74 -21.69 -5.65 17.63 -21.81 -6.90 19.46 coo 45.08 56.04 70.60 43.15 55.19 70.77 -22.55 -8.05 9.47 -20.93 -7.23 8.30 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN B 348 GLN~? 22.96 ZN ZN B 375 A 91 LEU B 347 LEU~? 17.24 ZN ZN B 375 A 133 GLU B 349 GLU~? 21.77 ZN ZN B 375 coo 38.23 53.34 67.59 38.84 53.87 69.56 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 35.40 53.22 73.30 35.37 54.87 74.74 -21.69 -5.65 17.63 -21.81 -6.90 19.46 coo 45.08 56.04 70.60 43.15 55.19 70.77 -22.55 -8.05 9.47 -20.93 -7.23 8.30 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN C 259 GLN~? 29.09 ZN ZN C 375 A 91 LEU C 257 LEU~? 23.47 ZN ZN C 374 A 133 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 38.23 53.34 67.59 38.84 53.87 69.56 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 35.40 53.22 73.30 35.37 54.87 74.74 -18.18 -29.71 56.20 -16.65 -28.20 55.97 coo 45.08 56.04 70.60 43.15 55.19 70.77 -21.46 -36.51 49.50 -23.48 -36.16 48.85 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN C 259 GLN~? 29.09 ZN ZN C 375 A 91 LEU C 257 LEU~? 23.47 ZN ZN C 374 A 133 GLU C 262 GLU~? 24.05 ZN ZN C 374 coo 38.23 53.34 67.59 38.84 53.87 69.56 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 35.40 53.22 73.30 35.37 54.87 74.74 -18.18 -29.71 56.20 -16.65 -28.20 55.97 coo 45.08 56.04 70.60 43.15 55.19 70.77 -15.17 -35.96 63.25 -14.01 -35.31 64.90 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN C 259 GLN~? 29.09 ZN ZN C 375 A 91 LEU C 279 LEU.? 26.42 ZN ZN C 374 A 133 GLU C 262 GLU~? 24.05 ZN ZN C 374 coo 38.23 53.34 67.59 38.84 53.87 69.56 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 35.40 53.22 73.30 35.37 54.87 74.74 -20.60 -28.88 60.53 -19.01 -28.02 61.74 coo 45.08 56.04 70.60 43.15 55.19 70.77 -15.17 -35.96 63.25 -14.01 -35.31 64.90 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 10 hits 1bsj_c00 naa= 3 ULMN 3 1bu7_c02 CYTOCHROME P450 user 1 3 # 1 A 268 THR A 177 THR^? 8.80 C6 EPE A 377 A 393 PHE A 180 PHE^? 4.05 O8 EPE A 377 A 400 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo 45.81 71.19 43.26 47.70 70.19 43.25 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo 48.54 63.17 48.16 46.74 64.99 49.22 -0.71 -29.06 -4.30 -0.06 -29.96 -6.91 coo 53.76 64.39 46.87 52.06 66.55 47.33 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1bu7_c02 CYTOCHROME P450 user 2 3 # 2 A 268 THR B 177 THR^? 19.16 C2 EPE C 377 A 393 PHE B 180 PHE^? 25.23 O2S EPE A 377 A 400 CYH C 170 CYH^? 22.19 N TRS A 378 coo 45.81 71.19 43.26 47.70 70.19 43.25 9.43 -46.41 11.44 10.68 -47.97 10.55 coo 48.54 63.17 48.16 46.74 64.99 49.22 5.49 -47.88 21.09 3.41 -49.53 20.15 coo 53.76 64.39 46.87 52.06 66.55 47.33 9.66 -43.43 21.72 7.18 -43.27 22.99 ULMN 3 1bu7_c02 CYTOCHROME P450 user 3 3 # 3 A 268 THR C 177 THR^? 8.04 C8 EPE C 377 A 393 PHE C 180 PHE^? -4.33 O8 EPE C 377s A 400 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo 45.81 71.19 43.26 47.70 70.19 43.25 20.64 -38.60 2.16 21.28 -38.84 0.08 coo 48.54 63.17 48.16 46.74 64.99 49.22 29.90 -34.68 4.21 31.04 -37.24 4.01 coo 53.76 64.39 46.87 52.06 66.55 47.33 25.74 -30.01 4.94 27.86 -30.22 6.82 1bu7_c02 source 1bu7 CYTOCHROME P450 : 3 hits 1bu7_c02 naa= 3 ULMN 3 1bu7_c03 CYTOCHROME P450 user 1 3 # 1 B 268 THR A 177 THR^? 8.80 C6 EPE A 377 B 393 PHE A 180 PHE^? 4.05 O8 EPE A 377 B 400 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo 37.20 116.32 52.00 35.18 117.07 52.13 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo 33.81 121.65 59.26 35.49 119.55 59.81 -0.71 -29.06 -4.30 -0.06 -29.96 -6.91 coo 28.79 121.15 57.00 30.51 118.99 56.70 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1bu7_c03 CYTOCHROME P450 user 2 3 # 2 B 268 THR B 177 THR^? 19.16 C2 EPE C 377 B 393 PHE B 180 PHE^? 25.23 O2S EPE A 377 B 400 CYH C 170 CYH^? 22.19 N TRS A 378 coo 37.20 116.32 52.00 35.18 117.07 52.13 9.43 -46.41 11.44 10.68 -47.97 10.55 coo 33.81 121.65 59.26 35.49 119.55 59.81 5.49 -47.88 21.09 3.41 -49.53 20.15 coo 28.79 121.15 57.00 30.51 118.99 56.70 9.66 -43.43 21.72 7.18 -43.27 22.99 ULMN 3 1bu7_c03 CYTOCHROME P450 user 3 3 # 3 B 268 THR C 177 THR^? 8.04 C8 EPE C 377 B 393 PHE C 180 PHE^? -4.33 O8 EPE C 377s B 400 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo 37.20 116.32 52.00 35.18 117.07 52.13 20.64 -38.60 2.16 21.28 -38.84 0.08 coo 33.81 121.65 59.26 35.49 119.55 59.81 29.90 -34.68 4.21 31.04 -37.24 4.01 coo 28.79 121.15 57.00 30.51 118.99 56.70 25.74 -30.01 4.94 27.86 -30.22 6.82 1bu7_c03 source 1bu7 CYTOCHROME P450 : 3 hits 1bu7_c03 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 55 ASP~? 17.36 O2S EPE A 376 A 354 GLU A 52 GLU~? 13.77 C2 EPE A 376 A 421 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 31.05 49.37 64.51 31.97 51.11 63.85 45.10 18.98 22.18 44.20 20.57 23.21 coo 29.07 50.42 58.36 29.02 52.18 59.49 46.63 16.37 27.65 45.50 16.12 29.45 coo 30.82 59.76 58.47 31.12 59.02 60.40 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 354 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 421 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 31.05 49.37 64.51 31.97 51.11 63.85 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 29.07 50.42 58.36 29.02 52.18 59.49 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 30.82 59.76 58.47 31.12 59.02 60.40 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 354 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 421 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 31.05 49.37 64.51 31.97 51.11 63.85 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 29.07 50.42 58.36 29.02 52.18 59.49 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 30.82 59.76 58.47 31.12 59.02 60.40 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 354 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 421 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 31.05 49.37 64.51 31.97 51.11 63.85 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 29.07 50.42 58.36 29.02 52.18 59.49 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 30.82 59.76 58.47 31.12 59.02 60.40 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP B 55 ASP~? 16.89 O3S EPE B 376 A 354 GLU B 52 GLU~? 15.59 C2 EPE B 376 A 421 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 31.05 49.37 64.51 31.97 51.11 63.85 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 29.07 50.42 58.36 29.02 52.18 59.49 -26.20 13.19 30.44 -25.34 14.95 29.81 coo 30.82 59.76 58.47 31.12 59.02 60.40 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 6 3 # 6 A 325 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 354 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 421 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 31.05 49.37 64.51 31.97 51.11 63.85 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 29.07 50.42 58.36 29.02 52.18 59.49 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 30.82 59.76 58.47 31.12 59.02 60.40 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 7 3 # 7 A 325 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 354 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 421 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 31.05 49.37 64.51 31.97 51.11 63.85 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 29.07 50.42 58.36 29.02 52.18 59.49 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 30.82 59.76 58.47 31.12 59.02 60.40 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 8 3 # 8 A 325 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 354 GLU B 254 GLU^? 30.73 ZN ZN B 375 A 421 ASP B 280 ASP.? 32.17 ZN ZN B 374 coo 31.05 49.37 64.51 31.97 51.11 63.85 3.99 14.73 5.36 5.18 14.04 3.76 coo 29.07 50.42 58.36 29.02 52.18 59.49 1.12 17.35 -1.99 2.87 17.99 -2.99 coo 30.82 59.76 58.47 31.12 59.02 60.40 2.63 27.37 3.18 1.41 29.12 3.45 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 9 3 # 9 A 325 ASP C 55 ASP~? 17.38 O3S EPE C 376 A 354 GLU C 52 GLU~? 13.90 C2 EPE C 376 A 421 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 31.05 49.37 64.51 31.97 51.11 63.85 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 29.07 50.42 58.36 29.02 52.18 59.49 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 30.82 59.76 58.47 31.12 59.02 60.40 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 10 3 # 10 A 325 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 354 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 421 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 31.05 49.37 64.51 31.97 51.11 63.85 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 29.07 50.42 58.36 29.02 52.18 59.49 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 30.82 59.76 58.47 31.12 59.02 60.40 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 11 3 # 11 A 325 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 354 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 421 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 31.05 49.37 64.51 31.97 51.11 63.85 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 29.07 50.42 58.36 29.02 52.18 59.49 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 30.82 59.76 58.47 31.12 59.02 60.40 -0.90 -20.80 57.97 0.71 -21.61 59.03 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 12 3 # 12 A 325 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 354 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 421 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 31.05 49.37 64.51 31.97 51.11 63.85 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 29.07 50.42 58.36 29.02 52.18 59.49 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 30.82 59.76 58.47 31.12 59.02 60.40 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 13 3 # 13 A 325 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 354 GLU C 254 GLU^? 30.85 ZN ZN C 375 A 421 ASP C 280 ASP.? 31.92 ZN ZN C 374 coo 31.05 49.37 64.51 31.97 51.11 63.85 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 29.07 50.42 58.36 29.02 52.18 59.49 -21.46 -36.51 49.50 -23.48 -36.16 48.85 coo 30.82 59.76 58.47 31.12 59.02 60.40 -25.13 -30.20 58.02 -25.85 -28.27 58.51 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 13 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 55 ASP~? 17.36 O2S EPE A 376 B 354 GLU A 51 GLU~? 11.89 O2S EPE A 376 B 421 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 45.10 18.98 22.18 44.20 20.57 23.21 coo 27.87 10.66 47.95 27.82 8.60 48.27 41.17 19.74 26.83 40.87 21.56 28.00 coo 26.02 1.87 43.38 25.90 1.97 45.49 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 55 ASP~? 17.36 O2S EPE A 376 B 354 GLU A 52 GLU~? 13.77 C2 EPE A 376 B 421 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 45.10 18.98 22.18 44.20 20.57 23.21 coo 27.87 10.66 47.95 27.82 8.60 48.27 46.63 16.37 27.65 45.50 16.12 29.45 coo 26.02 1.87 43.38 25.90 1.97 45.49 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 354 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 421 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 27.87 10.66 47.95 27.82 8.60 48.27 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 26.02 1.87 43.38 25.90 1.97 45.49 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 354 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 421 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 27.87 10.66 47.95 27.82 8.60 48.27 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 26.02 1.87 43.38 25.90 1.97 45.49 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 354 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 421 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 25.90 8.19 53.87 25.36 6.97 52.29 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 27.87 10.66 47.95 27.82 8.60 48.27 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 26.02 1.87 43.38 25.90 1.97 45.49 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 6 3 # 6 B 325 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 354 GLU A 254 GLU^? 30.93 ZN ZN A 375 B 421 ASP A 280 ASP.? 32.54 ZN ZN A 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 27.87 10.66 47.95 27.82 8.60 48.27 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 26.02 1.87 43.38 25.90 1.97 45.49 57.62 -18.45 47.11 59.50 -17.52 47.44 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 7 3 # 7 B 325 ASP B 55 ASP~? 16.89 O3S EPE B 376 B 354 GLU B 51 GLU~? 11.61 O3S EPE B 376 B 421 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 27.87 10.66 47.95 27.82 8.60 48.27 -25.55 10.19 35.45 -25.80 11.09 37.35 coo 26.02 1.87 43.38 25.90 1.97 45.49 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 8 3 # 8 B 325 ASP B 55 ASP~? 16.89 O3S EPE B 376 B 354 GLU B 52 GLU~? 15.59 C2 EPE B 376 B 421 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 27.87 10.66 47.95 27.82 8.60 48.27 -26.20 13.19 30.44 -25.34 14.95 29.81 coo 26.02 1.87 43.38 25.90 1.97 45.49 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 9 3 # 9 B 325 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 354 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 421 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 27.87 10.66 47.95 27.82 8.60 48.27 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 26.02 1.87 43.38 25.90 1.97 45.49 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 10 3 # 10 B 325 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 354 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 421 ASP B 312 ASP.? 7.53 ZN ZN B 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 27.87 10.66 47.95 27.82 8.60 48.27 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 26.02 1.87 43.38 25.90 1.97 45.49 -4.08 14.12 24.69 -6.01 13.62 25.36 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 11 3 # 11 B 325 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 354 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 421 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 25.90 8.19 53.87 25.36 6.97 52.29 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 27.87 10.66 47.95 27.82 8.60 48.27 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 26.02 1.87 43.38 25.90 1.97 45.49 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 12 3 # 12 B 325 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 354 GLU B 254 GLU^? 30.73 ZN ZN B 375 B 421 ASP B 280 ASP.? 32.17 ZN ZN B 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 3.99 14.73 5.36 5.18 14.04 3.76 coo 27.87 10.66 47.95 27.82 8.60 48.27 1.12 17.35 -1.99 2.87 17.99 -2.99 coo 26.02 1.87 43.38 25.90 1.97 45.49 2.63 27.37 3.18 1.41 29.12 3.45 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 13 3 # 13 B 325 ASP C 55 ASP~? 17.38 O3S EPE C 376 B 354 GLU C 51 GLU~? 12.03 O3S EPE C 376 B 421 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 27.87 10.66 47.95 27.82 8.60 48.27 19.07 -27.28 70.66 19.78 -25.91 72.07 coo 26.02 1.87 43.38 25.90 1.97 45.49 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 14 3 # 14 B 325 ASP C 55 ASP~? 17.38 O3S EPE C 376 B 354 GLU C 52 GLU~? 13.90 C2 EPE C 376 B 421 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 27.87 10.66 47.95 27.82 8.60 48.27 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 26.02 1.87 43.38 25.90 1.97 45.49 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 15 3 # 15 B 325 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 354 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 421 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 27.87 10.66 47.95 27.82 8.60 48.27 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 26.02 1.87 43.38 25.90 1.97 45.49 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 16 3 # 16 B 325 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 354 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 421 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 27.87 10.66 47.95 27.82 8.60 48.27 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 26.02 1.87 43.38 25.90 1.97 45.49 -0.90 -20.80 57.97 0.71 -21.61 59.03 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 17 3 # 17 B 325 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 354 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 421 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 25.90 8.19 53.87 25.36 6.97 52.29 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 27.87 10.66 47.95 27.82 8.60 48.27 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 26.02 1.87 43.38 25.90 1.97 45.49 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 18 3 # 18 B 325 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 354 GLU C 254 GLU^? 30.85 ZN ZN C 375 B 421 ASP C 280 ASP.? 31.92 ZN ZN C 374 coo 25.90 8.19 53.87 25.36 6.97 52.29 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 27.87 10.66 47.95 27.82 8.60 48.27 -21.46 -36.51 49.50 -23.48 -36.16 48.85 coo 26.02 1.87 43.38 25.90 1.97 45.49 -25.13 -30.20 58.02 -25.85 -28.27 58.51 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 18 hits 1bvz_c09 naa= 3 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 1 3 # 1 A 179 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 227 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 332 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo 123.98 30.59 1.90 124.68 28.67 1.28 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 119.16 28.51 2.63 120.67 28.31 1.13 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 25.74 -30.01 4.94 27.86 -30.22 6.82 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 2 3 # 2 A 179 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 227 HIS B 169 HIS^? 10.86 O3S EPE A 377 A 332 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo 123.98 30.59 1.90 124.68 28.67 1.28 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 119.16 28.51 2.63 120.67 28.31 1.13 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1bwd_c02 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 3 3 # 3 A 179 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 227 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 332 CYH C 170 CYH^? 22.19 N TRS A 378 coo 123.98 30.59 1.90 124.68 28.67 1.28 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 119.16 28.51 2.63 120.67 28.31 1.13 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 114.70 31.13 -3.42 115.96 29.28 -1.69 9.66 -43.43 21.72 7.18 -43.27 22.99 1bwd_c02 source 1bwd INOSAMINE-PHOSPHATE AMIDINOTRANSFERASE : 3 hits 1bwd_c02 naa= 3 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 1 3 # 1 B 179 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 227 HIS A 169 HIS^? 11.22 O1S EPE C 377 B 332 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo 94.18 76.57 24.23 93.74 77.97 22.66 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 89.34 74.44 23.40 90.11 76.41 23.55 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 85.03 76.39 29.77 85.85 76.14 27.06 25.74 -30.01 4.94 27.86 -30.22 6.82 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 2 3 # 2 B 179 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 227 HIS B 169 HIS^? 10.86 O3S EPE A 377 B 332 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo 94.18 76.57 24.23 93.74 77.97 22.66 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 89.34 74.44 23.40 90.11 76.41 23.55 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 85.03 76.39 29.77 85.85 76.14 27.06 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1bwd_c03 INOSAMINE-PHOSPHATE AMIDINOTRANSFERAuser 3 3 # 3 B 179 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 227 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 332 CYH C 170 CYH^? 22.19 N TRS A 378 coo 94.18 76.57 24.23 93.74 77.97 22.66 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 89.34 74.44 23.40 90.11 76.41 23.55 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 85.03 76.39 29.77 85.85 76.14 27.06 9.66 -43.43 21.72 7.18 -43.27 22.99 1bwd_c03 source 1bwd INOSAMINE-PHOSPHATE AMIDINOTRANSFERASE : 3 hits 1bwd_c03 naa= 3 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 1 3 # 1 191 ASN B 166 ASN.? 12.55 O8 EPE A 377 194 HIS B 163 HIS.? 11.54 O3S EPE A 377 196 TYR B 167 TYR^? 5.54 O8 EPE A 377 coo 40.94 71.26 25.74 40.29 70.59 23.82 -2.65 -19.38 -5.26 -2.77 -17.28 -5.58 coo 38.86 67.47 19.31 37.78 65.73 19.79 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 41.10 73.64 20.13 38.52 73.39 19.02 -0.72 -24.00 -3.91 0.54 -23.91 -6.42 1bwl_c01 source 1bwl NADPH DEHYDROGENASE 1 : 1 hits 1bwl_c01 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN A 334 ASN~? 9.69 ZN ZN A 374 192 ASP A 107 ASP~? -2.33 ZN ZN A 375s 195 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 45.98 2.64 32.26 46.53 3.77 30.56 coo 56.18 0.19 32.76 56.16 -1.23 31.19 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN B 334 ASN~? 9.65 ZN ZN B 374 192 ASP B 107 ASP~? -2.23 ZN ZN B 375s 195 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -13.83 13.67 21.41 -15.89 13.09 21.50 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 3 3 # 3 104 ASN C 334 ASN~? 9.79 ZN ZN C 374 192 ASP C 107 ASP~? -2.30 ZN ZN C 375s 195 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 2.44 -29.45 62.54 3.79 -30.90 63.32 coo 56.18 0.19 32.76 56.16 -1.23 31.19 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 9.33 -29.64 54.17 7.95 -29.11 52.67 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 3 hits 1bwp_c01 naa= 3 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 105 ASN~? 9.65 ZN ZN A 375 A 108 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 144 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 16.88 2.43 18.09 16.20 3.65 19.72 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 16.00 9.54 19.61 16.53 10.80 21.20 32.91 0.46 27.63 33.66 0.11 29.56 coo 20.15 8.89 19.42 18.82 8.12 20.82 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN A 334 ASN~? 9.69 ZN ZN A 374 A 108 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 144 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 16.88 2.43 18.09 16.20 3.65 19.72 45.98 2.64 32.26 46.53 3.77 30.56 coo 16.00 9.54 19.61 16.53 10.80 21.20 37.42 3.90 29.26 38.47 2.36 30.22 coo 20.15 8.89 19.42 18.82 8.12 20.82 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 A 106 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 108 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 144 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 16.88 2.43 18.09 16.20 3.65 19.72 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 16.00 9.54 19.61 16.53 10.80 21.20 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 20.15 8.89 19.42 18.82 8.12 20.82 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 A 106 ASN B 334 ASN~? 9.65 ZN ZN B 374 A 108 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 144 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 16.88 2.43 18.09 16.20 3.65 19.72 -13.83 13.67 21.41 -15.89 13.09 21.50 coo 16.00 9.54 19.61 16.53 10.80 21.20 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 20.15 8.89 19.42 18.82 8.12 20.82 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 A 106 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 108 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 144 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 16.88 2.43 18.09 16.20 3.65 19.72 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 16.00 9.54 19.61 16.53 10.80 21.20 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 20.15 8.89 19.42 18.82 8.12 20.82 12.27 -21.58 47.53 11.82 -22.95 49.16 1c2t_c02 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 5 hits 1c2t_c02 naa= 3 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 105 ASN~? 9.65 ZN ZN A 375 B 108 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 144 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 32.91 0.46 27.63 33.66 0.11 29.56 coo 35.12 16.22 2.69 37.05 17.04 2.40 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN A 334 ASN~? 9.69 ZN ZN A 374 B 108 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 144 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 45.98 2.64 32.26 46.53 3.77 30.56 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 37.42 3.90 29.26 38.47 2.36 30.22 coo 35.12 16.22 2.69 37.05 17.04 2.40 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN B 105 ASN~? 9.47 ZN ZN B 375 B 108 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 144 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 35.12 16.22 2.69 37.05 17.04 2.40 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN B 334 ASN~? 9.65 ZN ZN B 374 B 108 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 144 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -13.83 13.67 21.41 -15.89 13.09 21.50 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 35.12 16.22 2.69 37.05 17.04 2.40 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 B 106 ASN C 105 ASN~? 9.60 ZN ZN C 375 B 108 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 144 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 35.12 16.22 2.69 37.05 17.04 2.40 12.27 -21.58 47.53 11.82 -22.95 49.16 1c2t_c03 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 5 hits 1c2t_c03 naa= 3 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 1 3 # 1 A 110 SER A 168 SER^? 10.80 O1S EPE C 377 A 235 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 263 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 30.32 56.27 16.76 31.62 57.99 17.94 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 31.33 62.80 9.68 31.68 62.04 11.62 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 30.23 62.32 14.77 30.86 60.47 15.53 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 2 3 # 2 A 110 SER B 168 SER^? 10.59 O3S EPE A 377 A 235 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 263 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 30.32 56.27 16.76 31.62 57.99 17.94 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 31.33 62.80 9.68 31.68 62.04 11.62 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 30.23 62.32 14.77 30.86 60.47 15.53 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 3 3 # 3 A 110 SER C 168 SER^? 24.11 O1 TRS A 378 A 235 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 263 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 30.32 56.27 16.76 31.62 57.99 17.94 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 31.33 62.80 9.68 31.68 62.04 11.62 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 30.23 62.32 14.77 30.86 60.47 15.53 13.13 -47.52 24.96 14.34 -48.17 26.54 1c4x_c00 source 1c4x 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDR: 3 hits 1c4x_c00 naa= 3 ULMN 3 1c82_c00 HYALURONATE LYASE user 1 3 # 1 A 349 ASN B 294 ASN.? 12.27 ZN ZN B 374 A 399 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 408 TYR B 314 TYR~? 14.73 O8 EPE B 376 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 2.18 12.34 23.84 0.88 14.02 24.05 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 7.45 20.77 27.47 7.65 22.47 28.71 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 2.08 17.58 27.10 3.13 18.35 29.60 1c82_c00 source 1c82 HYALURONATE LYASE : 1 hits 1c82_c00 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 148 HIS~? 11.43 C8 EPE A 377 A 408 TYR A 226 TYR.? 5.45 C8 EPE A 377 A 480 ARG A 198 ARG^? 11.16 C6 EPE A 377 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 14.41 -28.00 -10.43 13.63 -27.83 -12.37 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 7.72 -24.64 -8.18 7.45 -27.31 -8.97 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -1.05 -38.83 -3.85 -3.04 -38.62 -1.48 ULMN 3 1c82_c02 HYALURONATE LYASE user 2 3 # 2 A 399 HIS A 224 HIS~? 7.33 C7 EPE A 377 A 408 TYR A 226 TYR.? 5.45 C8 EPE A 377 A 480 ARG A 198 ARG^? 11.16 C6 EPE A 377 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 7.72 -24.64 -8.18 7.45 -27.31 -8.97 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -1.05 -38.83 -3.85 -3.04 -38.62 -1.48 ULMN 3 1c82_c02 HYALURONATE LYASE user 3 3 # 3 A 399 HIS B 224 HIS.? 17.79 O2S EPE A 377 A 408 TYR B 226 TYR.? 21.63 O2S EPE A 377 A 480 ARG B 198 ARG^? 21.95 C2 EPE C 377 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -2.18 -44.73 18.44 0.01 -45.92 17.08 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 11.64 -52.94 14.57 14.19 -52.83 16.31 1c82_c02 source 1c82 HYALURONATE LYASE : 3 hits 1c82_c02 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 16 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 67 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 32.91 0.46 27.63 33.66 0.11 29.56 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 16 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 67 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 37.80 0.44 25.56 37.02 -1.29 26.44 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 16 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 67 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 32.91 0.46 27.63 33.66 0.11 29.56 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 16 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 67 GLY A 244 GLY^? 11.92 ZN ZN A 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 32.91 0.46 27.63 33.66 0.11 29.56 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 32.51 -13.15 26.46 33.13 -12.90 26.03 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 5 3 # 5 A 14 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 16 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 67 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 32.91 0.46 27.63 33.66 0.11 29.56 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 6 3 # 6 A 14 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 16 HIS A 319 HIS~? 24.64 ZN ZN A 374 A 67 GLY A 325 GLY~? 25.53 ZN ZN A 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 43.05 -19.34 46.86 42.56 -18.83 46.33 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 7 3 # 7 A 14 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 16 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 67 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 48.24 5.16 33.58 47.82 3.96 35.30 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 51.10 6.85 29.91 51.20 5.36 31.38 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 8 3 # 8 A 14 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 16 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 67 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 9 3 # 9 A 14 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 16 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 67 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 10 3 # 10 A 14 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 16 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 67 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 11 3 # 11 A 14 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 16 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 67 GLY B 244 GLY^? 11.85 ZN ZN B 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -0.61 -2.61 16.62 -1.32 -2.49 16.19 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 12 3 # 12 A 14 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 16 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 67 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 13 3 # 13 A 14 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 16 HIS B 319 HIS~? 24.73 ZN ZN B 374 A 67 GLY B 325 GLY~? 25.63 ZN ZN B 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 9.35 16.65 21.02 10.22 16.89 22.90 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 8.16 23.53 21.75 7.85 25.60 21.62 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 10.15 18.18 11.38 9.73 17.62 11.87 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 14 3 # 14 A 14 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 16 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 67 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 15 3 # 15 A 14 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 16 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 67 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 16 3 # 16 A 14 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 16 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 67 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 17 3 # 17 A 14 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 16 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 67 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 18 3 # 18 A 14 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 16 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 67 GLY C 244 GLY^? 11.70 ZN ZN C 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 2.79 -27.67 41.30 2.83 -28.37 41.63 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 19 3 # 19 A 14 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 16 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 67 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 20 3 # 20 A 14 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 16 HIS C 319 HIS~? 24.70 ZN ZN C 374 A 67 GLY C 325 GLY~? 25.60 ZN ZN C 375 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -18.52 -20.89 48.72 -17.66 -20.90 48.73 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 21 3 # 21 A 14 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 16 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 67 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -2.36 -27.10 61.01 -2.45 -27.52 60.29 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 21 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 16 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 67 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 6.38 39.80 88.71 6.88 38.89 86.87 32.91 0.46 27.63 33.66 0.11 29.56 coo 17.63 42.50 89.25 18.11 42.29 88.64 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 16 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 67 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 6.38 39.80 88.71 6.88 38.89 86.87 37.80 0.44 25.56 37.02 -1.29 26.44 coo 17.63 42.50 89.25 18.11 42.29 88.64 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 3 3 # 3 C 14 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 16 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 67 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 6.38 39.80 88.71 6.88 38.89 86.87 32.91 0.46 27.63 33.66 0.11 29.56 coo 17.63 42.50 89.25 18.11 42.29 88.64 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 4 3 # 4 C 14 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 16 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 67 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 6.38 39.80 88.71 6.88 38.89 86.87 32.91 0.46 27.63 33.66 0.11 29.56 coo 17.63 42.50 89.25 18.11 42.29 88.64 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 5 3 # 5 C 14 ASP A 320 ASP~? -21.81 ZN ZN A 374s C 16 HIS A 319 HIS~? 24.64 ZN ZN A 374 C 67 GLY A 325 GLY~? 25.53 ZN ZN A 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 6.38 39.80 88.71 6.88 38.89 86.87 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 17.63 42.50 89.25 18.11 42.29 88.64 43.05 -19.34 46.86 42.56 -18.83 46.33 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 6 3 # 6 C 14 ASP A 368 ASP.? 11.85 ZN ZN A 374 C 16 HIS A 366 HIS.? 14.86 ZN ZN A 374 C 67 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo 10.04 44.27 88.44 9.47 42.32 89.03 48.24 5.16 33.58 47.82 3.96 35.30 coo 6.38 39.80 88.71 6.88 38.89 86.87 51.10 6.85 29.91 51.20 5.36 31.38 coo 17.63 42.50 89.25 18.11 42.29 88.64 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 7 3 # 7 C 14 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 16 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 67 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 6.38 39.80 88.71 6.88 38.89 86.87 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 8 3 # 8 C 14 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 16 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 67 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 6.38 39.80 88.71 6.88 38.89 86.87 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 17.63 42.50 89.25 18.11 42.29 88.64 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 9 3 # 9 C 14 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 16 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 67 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 6.38 39.80 88.71 6.88 38.89 86.87 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 10 3 # 10 C 14 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 16 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 67 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 6.38 39.80 88.71 6.88 38.89 86.87 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 11 3 # 11 C 14 ASP B 320 ASP~? -21.78 ZN ZN B 374s C 16 HIS B 319 HIS~? 24.73 ZN ZN B 374 C 67 GLY B 325 GLY~? 25.63 ZN ZN B 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 9.35 16.65 21.02 10.22 16.89 22.90 coo 6.38 39.80 88.71 6.88 38.89 86.87 8.16 23.53 21.75 7.85 25.60 21.62 coo 17.63 42.50 89.25 18.11 42.29 88.64 10.15 18.18 11.38 9.73 17.62 11.87 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 12 3 # 12 C 14 ASP B 368 ASP.? 11.70 ZN ZN B 374 C 16 HIS B 366 HIS.? 14.78 ZN ZN B 374 C 67 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo 10.04 44.27 88.44 9.47 42.32 89.03 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 6.38 39.80 88.71 6.88 38.89 86.87 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 17.63 42.50 89.25 18.11 42.29 88.64 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 13 3 # 13 C 14 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 16 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 67 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 6.38 39.80 88.71 6.88 38.89 86.87 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 17.63 42.50 89.25 18.11 42.29 88.64 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 14 3 # 14 C 14 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 16 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 67 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 6.38 39.80 88.71 6.88 38.89 86.87 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 17.63 42.50 89.25 18.11 42.29 88.64 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 15 3 # 15 C 14 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 16 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 67 GLY C 244 GLY^? 11.70 ZN ZN C 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 6.38 39.80 88.71 6.88 38.89 86.87 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 17.63 42.50 89.25 18.11 42.29 88.64 2.79 -27.67 41.30 2.83 -28.37 41.63 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 16 3 # 16 C 14 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 16 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 67 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 6.38 39.80 88.71 6.88 38.89 86.87 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 17.63 42.50 89.25 18.11 42.29 88.64 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 17 3 # 17 C 14 ASP C 320 ASP~? -21.75 ZN ZN C 374s C 16 HIS C 319 HIS~? 24.70 ZN ZN C 374 C 67 GLY C 325 GLY~? 25.60 ZN ZN C 375 coo 10.04 44.27 88.44 9.47 42.32 89.03 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 6.38 39.80 88.71 6.88 38.89 86.87 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 17.63 42.50 89.25 18.11 42.29 88.64 -18.52 -20.89 48.72 -17.66 -20.90 48.73 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 18 3 # 18 C 14 ASP C 368 ASP.? 11.74 ZN ZN C 374 C 16 HIS C 366 HIS.? 14.85 ZN ZN C 374 C 67 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo 10.04 44.27 88.44 9.47 42.32 89.03 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 6.38 39.80 88.71 6.88 38.89 86.87 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 17.63 42.50 89.25 18.11 42.29 88.64 -2.36 -27.10 61.01 -2.45 -27.52 60.29 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 18 hits 1cb7_c07 naa= 3 ULMN 3 1cb8_c00 CHONDROITINASE AC user 1 3 # 1 A 175 ASN B 294 ASN.? 12.27 ZN ZN B 374 A 225 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 234 TYR B 314 TYR~? 14.73 O8 EPE B 376 coo 26.32 35.76 46.63 26.28 33.63 46.67 2.18 12.34 23.84 0.88 14.02 24.05 coo 27.04 28.61 41.75 26.86 28.65 43.84 7.45 20.77 27.47 7.65 22.47 28.71 coo 21.80 30.48 43.67 23.70 29.06 45.12 2.08 17.58 27.10 3.13 18.35 29.60 ULMN 3 1cb8_c00 CHONDROITINASE AC user 2 3 # 2 A 175 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 225 HIS C 21 HIS~? 17.02 O1 TRS A 378 A 234 TYR C 133 TYR^? 16.76 ZN ZN C 375 coo 26.32 35.76 46.63 26.28 33.63 46.67 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 27.04 28.61 41.75 26.86 28.65 43.84 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 21.80 30.48 43.67 23.70 29.06 45.12 8.59 -26.93 36.99 10.82 -27.74 35.52 1cb8_c00 source 1cb8 CHONDROITINASE AC : 2 hits 1cb8_c00 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 203 ARG^? 8.58 O3S EPE C 377 127 ARG B 203 ARG^? 8.69 O2S EPE A 377 270 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo -0.83 25.63 1.57 0.97 28.05 0.90 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 203 ARG^? 8.58 O3S EPE C 377 127 ARG C 203 ARG^? 8.27 O3S EPE C 377 270 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo -0.83 25.63 1.57 0.97 28.05 0.90 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG B 203 ARG^? 8.69 O2S EPE A 377 127 ARG A 203 ARG^? 8.58 O3S EPE C 377 270 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo -0.83 25.63 1.57 0.97 28.05 0.90 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG B 203 ARG^? 8.69 O2S EPE A 377 127 ARG C 203 ARG^? 8.27 O3S EPE C 377 270 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo -0.83 25.63 1.57 0.97 28.05 0.90 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 5 3 # 5 71 ARG C 203 ARG^? 8.27 O3S EPE C 377 127 ARG A 203 ARG^? 8.58 O3S EPE C 377 270 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo -0.83 25.63 1.57 0.97 28.05 0.90 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 6 3 # 6 71 ARG C 203 ARG^? 8.27 O3S EPE C 377 127 ARG B 203 ARG^? 8.69 O2S EPE A 377 270 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo -0.83 25.63 1.57 0.97 28.05 0.90 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 12.76 -38.43 -2.33 12.71 -39.82 -3.96 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 6 hits 1cbx_c01 naa= 3 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN A 105 ASN~? 9.65 ZN ZN A 375 108 HIS A 103 HIS~? -4.82 ZN ZN A 375s 144 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 32.91 0.46 27.63 33.66 0.11 29.56 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 3 # 2 106 ASN A 334 ASN~? 9.69 ZN ZN A 374 108 HIS A 69 HIS.? -3.40 ZN ZN A 374s 144 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 45.98 2.64 32.26 46.53 3.77 30.56 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 37.42 3.90 29.26 38.47 2.36 30.22 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 3 # 3 106 ASN B 105 ASN~? 9.47 ZN ZN B 375 108 HIS B 103 HIS~? 5.04 ZN ZN B 375 144 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 4 3 # 4 106 ASN C 105 ASN~? 9.60 ZN ZN C 375 108 HIS C 103 HIS~? 4.97 ZN ZN C 375 144 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 12.27 -21.58 47.53 11.82 -22.95 49.16 1cde_c04 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 4 hits 1cde_c04 naa= 3 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN A 105 ASN~? 9.65 ZN ZN A 375 108 HIS A 103 HIS~? -4.82 ZN ZN A 375s 144 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 32.91 0.46 27.63 33.66 0.11 29.56 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 3 # 2 106 ASN A 334 ASN~? 9.69 ZN ZN A 374 108 HIS A 69 HIS.? -3.40 ZN ZN A 374s 144 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 45.98 2.64 32.26 46.53 3.77 30.56 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 37.42 3.90 29.26 38.47 2.36 30.22 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 3 # 3 106 ASN B 105 ASN~? 9.47 ZN ZN B 375 108 HIS B 103 HIS~? 5.04 ZN ZN B 375 144 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 4 3 # 4 106 ASN C 105 ASN~? 9.60 ZN ZN C 375 108 HIS C 103 HIS~? 4.97 ZN ZN C 375 144 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 12.27 -21.58 47.53 11.82 -22.95 49.16 1cde_c05 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 4 hits 1cde_c05 naa= 3 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN A 105 ASN~? 9.65 ZN ZN A 375 108 HIS A 103 HIS~? -4.82 ZN ZN A 375s 144 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 32.91 0.46 27.63 33.66 0.11 29.56 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 3 # 2 106 ASN A 334 ASN~? 9.69 ZN ZN A 374 108 HIS A 69 HIS.? -3.40 ZN ZN A 374s 144 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 45.98 2.64 32.26 46.53 3.77 30.56 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 37.42 3.90 29.26 38.47 2.36 30.22 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 3 # 3 106 ASN B 105 ASN~? 9.47 ZN ZN B 375 108 HIS B 103 HIS~? 5.04 ZN ZN B 375 144 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 4 3 # 4 106 ASN C 105 ASN~? 9.60 ZN ZN C 375 108 HIS C 103 HIS~? 4.97 ZN ZN C 375 144 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 12.27 -21.58 47.53 11.82 -22.95 49.16 1cde_c06 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 4 hits 1cde_c06 naa= 3 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN A 105 ASN~? 9.65 ZN ZN A 375 108 HIS A 103 HIS~? -4.82 ZN ZN A 375s 144 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 32.91 0.46 27.63 33.66 0.11 29.56 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 3 # 2 106 ASN A 334 ASN~? 9.69 ZN ZN A 374 108 HIS A 69 HIS.? -3.40 ZN ZN A 374s 144 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 45.98 2.64 32.26 46.53 3.77 30.56 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 37.42 3.90 29.26 38.47 2.36 30.22 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 3 # 3 106 ASN B 105 ASN~? 9.47 ZN ZN B 375 108 HIS B 103 HIS~? 5.04 ZN ZN B 375 144 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 4 3 # 4 106 ASN C 105 ASN~? 9.60 ZN ZN C 375 108 HIS C 103 HIS~? 4.97 ZN ZN C 375 144 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 12.27 -21.58 47.53 11.82 -22.95 49.16 1cde_c07 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 4 hits 1cde_c07 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 27 ASP.? 8.12 ZN ZN A 375 264 GLU A 241 GLU^? 13.09 O3 TRS A 378 328 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 45.62 80.42 43.69 45.65 82.01 45.07 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 59.69 92.71 39.85 58.53 92.03 41.47 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 45.39 90.72 40.63 45.07 89.14 41.90 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 107 ASP~? -2.33 ZN ZN A 375s 264 GLU A 127 GLU^? 14.05 O3 TRS A 378 328 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 45.62 80.42 43.69 45.65 82.01 45.07 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 59.69 92.71 39.85 58.53 92.03 41.47 39.39 -22.49 26.46 38.47 -23.38 24.73 coo 45.39 90.72 40.63 45.07 89.14 41.90 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 107 ASP~? -2.33 ZN ZN A 375s 264 GLU A 349 GLU~? 21.94 ZN ZN A 375 328 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 45.62 80.42 43.69 45.65 82.01 45.07 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 59.69 92.71 39.85 58.53 92.03 41.47 44.64 -4.62 8.34 45.23 -6.64 8.63 coo 45.39 90.72 40.63 45.07 89.14 41.90 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 115 ASP~? 13.24 ZN ZN A 375 264 GLU A 15 GLU~? 17.23 ZN ZN A 375 328 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 45.62 80.42 43.69 45.65 82.01 45.07 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 59.69 92.71 39.85 58.53 92.03 41.47 29.50 -0.46 14.62 27.65 0.59 14.66 coo 45.39 90.72 40.63 45.07 89.14 41.90 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP A 269 ASP.? 18.90 ZN ZN A 374 264 GLU A 52 GLU~? 13.77 C2 EPE A 376 328 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 54.82 -1.21 28.36 56.43 0.27 28.67 coo 59.69 92.71 39.85 58.53 92.03 41.47 46.63 16.37 27.65 45.50 16.12 29.45 coo 45.39 90.72 40.63 45.07 89.14 41.90 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP A 269 ASP.? 18.90 ZN ZN A 374 264 GLU A 56 GLU~? 18.18 ZN ZN A 374 328 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 54.82 -1.21 28.36 56.43 0.27 28.67 coo 59.69 92.71 39.85 58.53 92.03 41.47 47.24 13.21 19.42 47.19 11.28 20.29 coo 45.39 90.72 40.63 45.07 89.14 41.90 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP A 292 ASP^? 8.63 ZN ZN A 374 264 GLU A 119 GLU~? 15.23 ZN ZN A 375 328 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 45.62 80.42 43.69 45.65 82.01 45.07 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 59.69 92.71 39.85 58.53 92.03 41.47 47.50 -11.03 21.23 45.94 -11.22 19.71 coo 45.39 90.72 40.63 45.07 89.14 41.90 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP A 368 ASP.? 11.85 ZN ZN A 374 264 GLU A 119 GLU~? 15.23 ZN ZN A 375 328 ASP A 269 ASP.? 18.90 ZN ZN A 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 48.24 5.16 33.58 47.82 3.96 35.30 coo 59.69 92.71 39.85 58.53 92.03 41.47 47.50 -11.03 21.23 45.94 -11.22 19.71 coo 45.39 90.72 40.63 45.07 89.14 41.90 54.82 -1.21 28.36 56.43 0.27 28.67 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP A 368 ASP.? 11.85 ZN ZN A 374 264 GLU A 262 GLU~? 24.15 ZN ZN A 374 328 ASP A 269 ASP.? 18.90 ZN ZN A 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 48.24 5.16 33.58 47.82 3.96 35.30 coo 59.69 92.71 39.85 58.53 92.03 41.47 59.50 -9.24 37.85 59.47 -7.16 38.33 coo 45.39 90.72 40.63 45.07 89.14 41.90 54.82 -1.21 28.36 56.43 0.27 28.67 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP A 368 ASP.? 11.85 ZN ZN A 374 264 GLU A 262 GLU~? 24.15 ZN ZN A 374 328 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 48.24 5.16 33.58 47.82 3.96 35.30 coo 59.69 92.71 39.85 58.53 92.03 41.47 59.50 -9.24 37.85 59.47 -7.16 38.33 coo 45.39 90.72 40.63 45.07 89.14 41.90 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 11 3 # 11 229 ASP B 107 ASP~? -2.23 ZN ZN B 375s 264 GLU B 241 GLU^? 19.53 O1S EPE A 377 328 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 45.62 80.42 43.69 45.65 82.01 45.07 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 59.69 92.71 39.85 58.53 92.03 41.47 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 45.39 90.72 40.63 45.07 89.14 41.90 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 12 3 # 12 229 ASP B 115 ASP~? 12.98 ZN ZN B 375 264 GLU B 15 GLU~? 17.09 ZN ZN B 375 328 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 45.62 80.42 43.69 45.65 82.01 45.07 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 59.69 92.71 39.85 58.53 92.03 41.47 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 45.39 90.72 40.63 45.07 89.14 41.90 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 13 3 # 13 229 ASP B 269 ASP.? 18.26 ZN ZN B 374 264 GLU B 52 GLU~? 15.59 C2 EPE B 376 328 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 59.69 92.71 39.85 58.53 92.03 41.47 -26.20 13.19 30.44 -25.34 14.95 29.81 coo 45.39 90.72 40.63 45.07 89.14 41.90 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 14 3 # 14 229 ASP B 269 ASP.? 18.26 ZN ZN B 374 264 GLU B 56 GLU~? 18.10 ZN ZN B 374 328 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 59.69 92.71 39.85 58.53 92.03 41.47 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 45.39 90.72 40.63 45.07 89.14 41.90 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 15 3 # 15 229 ASP B 292 ASP^? 8.88 ZN ZN B 374 264 GLU B 25 GLU.? 18.70 ZN ZN B 375 328 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 45.62 80.42 43.69 45.65 82.01 45.07 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 59.69 92.71 39.85 58.53 92.03 41.47 1.46 -5.92 31.01 3.44 -6.69 31.23 coo 45.39 90.72 40.63 45.07 89.14 41.90 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 16 3 # 16 229 ASP B 368 ASP.? 11.70 ZN ZN B 374 264 GLU B 262 GLU~? 24.13 ZN ZN B 374 328 ASP B 269 ASP.? 18.26 ZN ZN B 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 59.69 92.71 39.85 58.53 92.03 41.47 -9.48 23.81 6.41 -10.83 24.55 7.88 coo 45.39 90.72 40.63 45.07 89.14 41.90 -18.05 15.19 12.20 -19.75 16.35 12.84 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 17 3 # 17 229 ASP B 368 ASP.? 11.70 ZN ZN B 374 264 GLU B 262 GLU~? 24.13 ZN ZN B 374 328 ASP B 330 ASP^? 11.92 ZN ZN B 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 59.69 92.71 39.85 58.53 92.03 41.47 -9.48 23.81 6.41 -10.83 24.55 7.88 coo 45.39 90.72 40.63 45.07 89.14 41.90 -4.33 18.16 18.13 -5.04 17.21 19.90 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 18 3 # 18 229 ASP C 27 ASP.? 8.23 ZN ZN C 375 264 GLU C 241 GLU^? 18.99 ZN ZN C 375 328 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 45.62 80.42 43.69 45.65 82.01 45.07 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 59.69 92.71 39.85 58.53 92.03 41.47 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 45.39 90.72 40.63 45.07 89.14 41.90 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 19 3 # 19 229 ASP C 115 ASP~? 12.87 ZN ZN C 375 264 GLU C 15 GLU~? 17.26 ZN ZN C 375 328 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 45.62 80.42 43.69 45.65 82.01 45.07 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 59.69 92.71 39.85 58.53 92.03 41.47 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 45.39 90.72 40.63 45.07 89.14 41.90 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 20 3 # 20 229 ASP C 269 ASP~? 18.04 ZN ZN C 374 264 GLU C 52 GLU~? 13.90 C2 EPE C 376 328 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 59.69 92.71 39.85 58.53 92.03 41.47 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 45.39 90.72 40.63 45.07 89.14 41.90 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 21 3 # 21 229 ASP C 269 ASP~? 18.04 ZN ZN C 374 264 GLU C 56 GLU~? 18.45 ZN ZN C 374 328 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 59.69 92.71 39.85 58.53 92.03 41.47 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 45.39 90.72 40.63 45.07 89.14 41.90 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 22 3 # 22 229 ASP C 368 ASP.? 11.74 ZN ZN C 374 264 GLU C 262 GLU~? 24.05 ZN ZN C 374 328 ASP C 269 ASP~? 18.04 ZN ZN C 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 59.69 92.71 39.85 58.53 92.03 41.47 -15.17 -35.96 63.25 -14.01 -35.31 64.90 coo 45.39 90.72 40.63 45.07 89.14 41.90 -1.79 -38.40 63.28 -1.15 -38.99 65.26 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 23 3 # 23 229 ASP C 368 ASP.? 11.74 ZN ZN C 374 264 GLU C 262 GLU~? 24.05 ZN ZN C 374 328 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 45.62 80.42 43.69 45.65 82.01 45.07 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 59.69 92.71 39.85 58.53 92.03 41.47 -15.17 -35.96 63.25 -14.01 -35.31 64.90 coo 45.39 90.72 40.63 45.07 89.14 41.90 -7.16 -24.94 59.28 -5.20 -24.20 59.64 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 23 hits 1cdg_c00 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS A 21 HIS~? 17.08 ZN ZN A 375 A 262 GLU A 135 GLU^? 12.87 C3 TRS A 378 A 358 GLU A 136 GLU^? 12.15 O3 TRS A 378 coo 26.19 60.87 43.98 27.48 59.27 43.30 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 27.13 54.07 50.45 26.96 54.19 48.35 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 27.06 50.43 44.36 27.99 52.27 44.74 19.87 -16.93 18.72 17.94 -16.19 18.72 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS A 224 HIS~? 7.33 C7 EPE A 377 A 262 GLU A 227 GLU.? 13.15 O8 EPE A 377 A 358 GLU A 228 GLU.? 8.71 C3 EPE A 377 coo 26.19 60.87 43.98 27.48 59.27 43.30 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 27.13 54.07 50.45 26.96 54.19 48.35 5.87 -17.01 -8.12 5.06 -15.73 -9.55 coo 27.06 50.43 44.36 27.99 52.27 44.74 3.91 -21.00 -3.12 3.67 -19.15 -2.10 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 A 232 HIS A 224 HIS~? 7.33 C7 EPE A 377 A 262 GLU A 228 GLU.? 8.71 C3 EPE A 377 A 358 GLU A 227 GLU.? 13.15 O8 EPE A 377 coo 26.19 60.87 43.98 27.48 59.27 43.30 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 27.13 54.07 50.45 26.96 54.19 48.35 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 27.06 50.43 44.36 27.99 52.27 44.74 5.87 -17.01 -8.12 5.06 -15.73 -9.55 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 A 232 HIS A 263 HIS~? 20.93 ZN ZN A 375 A 262 GLU A 253 GLU^? 31.48 ZN ZN A 375 A 358 GLU A 254 GLU^? 30.93 ZN ZN A 375 coo 26.19 60.87 43.98 27.48 59.27 43.30 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 27.13 54.07 50.45 26.96 54.19 48.35 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 27.06 50.43 44.36 27.99 52.27 44.74 55.35 -23.67 37.01 55.67 -25.35 38.24 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 A 232 HIS B 21 HIS~? 17.19 ZN ZN B 375 A 262 GLU B 135 GLU^? 15.63 O1S EPE A 377 A 358 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 26.19 60.87 43.98 27.48 59.27 43.30 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 27.13 54.07 50.45 26.96 54.19 48.35 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 27.06 50.43 44.36 27.99 52.27 44.74 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 A 232 HIS B 21 HIS~? 17.19 ZN ZN B 375 A 262 GLU B 136 GLU^? 17.92 O1S EPE A 377 A 358 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 26.19 60.87 43.98 27.48 59.27 43.30 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 27.13 54.07 50.45 26.96 54.19 48.35 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 27.06 50.43 44.36 27.99 52.27 44.74 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 7 3 # 7 A 232 HIS B 263 HIS~? 20.98 ZN ZN B 375 A 262 GLU B 253 GLU^? 31.12 ZN ZN B 375 A 358 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 26.19 60.87 43.98 27.48 59.27 43.30 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 27.13 54.07 50.45 26.96 54.19 48.35 -5.44 14.03 -5.56 -4.22 13.73 -7.31 coo 27.06 50.43 44.36 27.99 52.27 44.74 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 8 3 # 8 A 232 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 262 GLU C 241 GLU^? 18.99 ZN ZN C 375 A 358 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 26.19 60.87 43.98 27.48 59.27 43.30 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 27.13 54.07 50.45 26.96 54.19 48.35 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 27.06 50.43 44.36 27.99 52.27 44.74 11.24 -30.50 31.64 12.59 -30.76 33.22 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 9 3 # 9 A 232 HIS C 224 HIS~? 8.36 C3 EPE C 377 A 262 GLU C 227 GLU.? 14.45 C7 EPE C 377 A 358 GLU C 228 GLU.? 9.65 C7 EPE C 377 coo 26.19 60.87 43.98 27.48 59.27 43.30 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 27.13 54.07 50.45 26.96 54.19 48.35 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 27.06 50.43 44.36 27.99 52.27 44.74 33.17 -34.88 12.75 35.01 -35.99 12.68 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 10 3 # 10 A 232 HIS C 224 HIS~? 8.36 C3 EPE C 377 A 262 GLU C 228 GLU.? 9.65 C7 EPE C 377 A 358 GLU C 227 GLU.? 14.45 C7 EPE C 377 coo 26.19 60.87 43.98 27.48 59.27 43.30 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 27.13 54.07 50.45 26.96 54.19 48.35 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 27.06 50.43 44.36 27.99 52.27 44.74 35.69 -39.75 16.92 37.70 -40.13 16.40 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 10 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 21 HIS~? 17.08 ZN ZN A 375 B 262 GLU A 135 GLU^? 12.87 C3 TRS A 378 B 358 GLU A 136 GLU^? 12.15 O3 TRS A 378 coo 44.98 77.01 48.39 44.42 78.67 47.18 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 41.60 83.57 54.16 42.46 83.24 52.25 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 44.05 87.61 48.73 43.15 85.67 48.52 19.87 -16.93 18.72 17.94 -16.19 18.72 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS A 224 HIS~? 7.33 C7 EPE A 377 B 262 GLU A 227 GLU.? 13.15 O8 EPE A 377 B 358 GLU A 228 GLU.? 8.71 C3 EPE A 377 coo 44.98 77.01 48.39 44.42 78.67 47.18 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 41.60 83.57 54.16 42.46 83.24 52.25 5.87 -17.01 -8.12 5.06 -15.73 -9.55 coo 44.05 87.61 48.73 43.15 85.67 48.52 3.91 -21.00 -3.12 3.67 -19.15 -2.10 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 B 232 HIS A 224 HIS~? 7.33 C7 EPE A 377 B 262 GLU A 228 GLU.? 8.71 C3 EPE A 377 B 358 GLU A 227 GLU.? 13.15 O8 EPE A 377 coo 44.98 77.01 48.39 44.42 78.67 47.18 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 41.60 83.57 54.16 42.46 83.24 52.25 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 44.05 87.61 48.73 43.15 85.67 48.52 5.87 -17.01 -8.12 5.06 -15.73 -9.55 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 B 232 HIS A 263 HIS~? 20.93 ZN ZN A 375 B 262 GLU A 253 GLU^? 31.48 ZN ZN A 375 B 358 GLU A 254 GLU^? 30.93 ZN ZN A 375 coo 44.98 77.01 48.39 44.42 78.67 47.18 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 41.60 83.57 54.16 42.46 83.24 52.25 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 44.05 87.61 48.73 43.15 85.67 48.52 55.35 -23.67 37.01 55.67 -25.35 38.24 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 B 232 HIS B 21 HIS~? 17.19 ZN ZN B 375 B 262 GLU B 135 GLU^? 15.63 O1S EPE A 377 B 358 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 44.98 77.01 48.39 44.42 78.67 47.18 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 41.60 83.57 54.16 42.46 83.24 52.25 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 44.05 87.61 48.73 43.15 85.67 48.52 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 B 232 HIS B 21 HIS~? 17.19 ZN ZN B 375 B 262 GLU B 136 GLU^? 17.92 O1S EPE A 377 B 358 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 44.98 77.01 48.39 44.42 78.67 47.18 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 41.60 83.57 54.16 42.46 83.24 52.25 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 44.05 87.61 48.73 43.15 85.67 48.52 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 7 3 # 7 B 232 HIS B 263 HIS~? 20.98 ZN ZN B 375 B 262 GLU B 253 GLU^? 31.12 ZN ZN B 375 B 358 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 44.98 77.01 48.39 44.42 78.67 47.18 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 41.60 83.57 54.16 42.46 83.24 52.25 -5.44 14.03 -5.56 -4.22 13.73 -7.31 coo 44.05 87.61 48.73 43.15 85.67 48.52 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 8 3 # 8 B 232 HIS C 163 HIS.? 22.24 O1 TRS A 378 B 262 GLU C 241 GLU^? 18.99 ZN ZN C 375 B 358 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 44.98 77.01 48.39 44.42 78.67 47.18 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 41.60 83.57 54.16 42.46 83.24 52.25 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 44.05 87.61 48.73 43.15 85.67 48.52 11.24 -30.50 31.64 12.59 -30.76 33.22 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 9 3 # 9 B 232 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 262 GLU C 227 GLU.? 14.45 C7 EPE C 377 B 358 GLU C 228 GLU.? 9.65 C7 EPE C 377 coo 44.98 77.01 48.39 44.42 78.67 47.18 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 41.60 83.57 54.16 42.46 83.24 52.25 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 44.05 87.61 48.73 43.15 85.67 48.52 33.17 -34.88 12.75 35.01 -35.99 12.68 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 10 3 # 10 B 232 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 262 GLU C 228 GLU.? 9.65 C7 EPE C 377 B 358 GLU C 227 GLU.? 14.45 C7 EPE C 377 coo 44.98 77.01 48.39 44.42 78.67 47.18 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 41.60 83.57 54.16 42.46 83.24 52.25 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 44.05 87.61 48.73 43.15 85.67 48.52 35.69 -39.75 16.92 37.70 -40.13 16.40 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 11 3 # 11 B 232 HIS C 263 HIS~? 20.89 ZN ZN C 375 B 262 GLU C 253 GLU^? 31.42 ZN ZN C 375 B 358 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 44.98 77.01 48.39 44.42 78.67 47.18 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 41.60 83.57 54.16 42.46 83.24 52.25 -18.88 -44.02 49.77 -19.94 -45.34 51.07 coo 44.05 87.61 48.73 43.15 85.67 48.52 -21.46 -36.51 49.50 -23.48 -36.16 48.85 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 11 hits 1chm_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 175 GLU^? 13.72 C8 EPE A 377 A 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 120 SER B 173 SER^? 8.63 C9 EPE A 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo -31.18 6.91 75.60 -32.39 8.51 74.91 6.08 -43.60 3.61 5.68 -45.21 2.31 coo -34.73 8.57 68.21 -33.63 9.08 70.28 4.35 -36.83 4.64 1.88 -36.99 4.49 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 175 GLU^? 13.72 C8 EPE A 377 A 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 120 SER C 174 SER^? 11.73 O3S EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo -31.18 6.91 75.60 -32.39 8.51 74.91 6.08 -43.60 3.61 5.68 -45.21 2.31 coo -34.73 8.57 68.21 -33.63 9.08 70.28 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 200 GLU^? 11.53 C6 EPE A 377 A 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 120 SER B 173 SER^? 8.63 C9 EPE A 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo -31.18 6.91 75.60 -32.39 8.51 74.91 6.08 -43.60 3.61 5.68 -45.21 2.31 coo -34.73 8.57 68.21 -33.63 9.08 70.28 4.35 -36.83 4.64 1.88 -36.99 4.49 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU A 201 GLU^? -3.12 C2 EPE A 377s A 89 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo -31.18 6.91 75.60 -32.39 8.51 74.91 5.77 -31.61 7.46 7.86 -31.06 7.53 coo -34.73 8.57 68.21 -33.63 9.08 70.28 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 89 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 120 SER C 174 SER^? 11.73 O3S EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 16.97 -31.31 7.38 16.25 -32.10 9.22 coo -31.18 6.91 75.60 -32.39 8.51 74.91 11.89 -37.55 15.12 10.61 -36.09 14.30 coo -34.73 8.57 68.21 -33.63 9.08 70.28 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU B 150 GLU~? 12.97 C6 EPE A 377 A 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 120 SER B 173 SER^? 8.63 C9 EPE A 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo -31.18 6.91 75.60 -32.39 8.51 74.91 6.08 -43.60 3.61 5.68 -45.21 2.31 coo -34.73 8.57 68.21 -33.63 9.08 70.28 4.35 -36.83 4.64 1.88 -36.99 4.49 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 89 GLU B 201 GLU^? 17.83 O2S EPE A 377 A 120 SER C 173 SER^? 14.26 C2 EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 6.08 -43.60 3.61 5.68 -45.21 2.31 coo -31.18 6.91 75.60 -32.39 8.51 74.91 3.89 -44.87 12.99 4.21 -43.80 14.75 coo -34.73 8.57 68.21 -33.63 9.08 70.28 13.37 -42.81 12.12 14.73 -44.10 13.72 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 89 GLU C 175 GLU^? 13.76 O8 EPE C 377 A 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 6.08 -43.60 3.61 5.68 -45.21 2.31 coo -31.18 6.91 75.60 -32.39 8.51 74.91 16.33 -45.08 6.01 16.53 -46.96 5.10 coo -34.73 8.57 68.21 -33.63 9.08 70.28 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c00 CHITINASE user 9 3 # 9 A 67 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 89 GLU C 175 GLU^? 13.76 O8 EPE C 377 A 120 SER C 173 SER^? 14.26 C2 EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 6.08 -43.60 3.61 5.68 -45.21 2.31 coo -31.18 6.91 75.60 -32.39 8.51 74.91 16.33 -45.08 6.01 16.53 -46.96 5.10 coo -34.73 8.57 68.21 -33.63 9.08 70.28 13.37 -42.81 12.12 14.73 -44.10 13.72 ULMN 3 1cns_c00 CHITINASE user 10 3 # 10 A 67 GLU B 200 GLU^? 21.89 O2S EPE A 377 A 89 GLU C 175 GLU^? 13.76 O8 EPE C 377 A 120 SER C 173 SER^? 14.26 C2 EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 6.58 -49.91 8.32 6.28 -50.66 6.33 coo -31.18 6.91 75.60 -32.39 8.51 74.91 16.33 -45.08 6.01 16.53 -46.96 5.10 coo -34.73 8.57 68.21 -33.63 9.08 70.28 13.37 -42.81 12.12 14.73 -44.10 13.72 ULMN 3 1cns_c00 CHITINASE user 11 3 # 11 A 67 GLU B 201 GLU^? 17.83 O2S EPE A 377 A 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 120 SER B 173 SER^? 8.63 C9 EPE A 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 3.89 -44.87 12.99 4.21 -43.80 14.75 coo -31.18 6.91 75.60 -32.39 8.51 74.91 6.08 -43.60 3.61 5.68 -45.21 2.31 coo -34.73 8.57 68.21 -33.63 9.08 70.28 4.35 -36.83 4.64 1.88 -36.99 4.49 ULMN 3 1cns_c00 CHITINASE user 12 3 # 12 A 67 GLU B 201 GLU^? 17.83 O2S EPE A 377 A 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 120 SER C 174 SER^? 11.73 O3S EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 3.89 -44.87 12.99 4.21 -43.80 14.75 coo -31.18 6.91 75.60 -32.39 8.51 74.91 6.08 -43.60 3.61 5.68 -45.21 2.31 coo -34.73 8.57 68.21 -33.63 9.08 70.28 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1cns_c00 CHITINASE user 13 3 # 13 A 67 GLU B 201 GLU^? 17.83 O2S EPE A 377 A 89 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 120 SER C 174 SER^? 11.73 O3S EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 3.89 -44.87 12.99 4.21 -43.80 14.75 coo -31.18 6.91 75.60 -32.39 8.51 74.91 11.89 -37.55 15.12 10.61 -36.09 14.30 coo -34.73 8.57 68.21 -33.63 9.08 70.28 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1cns_c00 CHITINASE user 14 3 # 14 A 67 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 89 GLU A 201 GLU^? -3.12 C2 EPE A 377s A 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 5.77 -31.61 7.46 7.86 -31.06 7.53 coo -31.18 6.91 75.60 -32.39 8.51 74.91 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo -34.73 8.57 68.21 -33.63 9.08 70.28 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c00 CHITINASE user 15 3 # 15 A 67 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 89 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 5.77 -31.61 7.46 7.86 -31.06 7.53 coo -31.18 6.91 75.60 -32.39 8.51 74.91 16.97 -31.31 7.38 16.25 -32.10 9.22 coo -34.73 8.57 68.21 -33.63 9.08 70.28 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c00 CHITINASE user 16 3 # 16 A 67 GLU C 175 GLU^? 13.76 O8 EPE C 377 A 89 GLU A 175 GLU^? 13.72 C8 EPE A 377 A 120 SER A 173 SER^? 8.70 C6 EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 16.33 -45.08 6.01 16.53 -46.96 5.10 coo -31.18 6.91 75.60 -32.39 8.51 74.91 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo -34.73 8.57 68.21 -33.63 9.08 70.28 17.10 -34.58 2.20 18.37 -33.49 0.48 ULMN 3 1cns_c00 CHITINASE user 17 3 # 17 A 67 GLU C 175 GLU^? 13.76 O8 EPE C 377 A 89 GLU A 175 GLU^? 13.72 C8 EPE A 377 A 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 16.33 -45.08 6.01 16.53 -46.96 5.10 coo -31.18 6.91 75.60 -32.39 8.51 74.91 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo -34.73 8.57 68.21 -33.63 9.08 70.28 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c00 CHITINASE user 18 3 # 18 A 67 GLU C 200 GLU^? 10.81 O8 EPE C 377 A 89 GLU A 175 GLU^? 13.72 C8 EPE A 377 A 120 SER A 173 SER^? 8.70 C6 EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo -31.18 6.91 75.60 -32.39 8.51 74.91 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo -34.73 8.57 68.21 -33.63 9.08 70.28 17.10 -34.58 2.20 18.37 -33.49 0.48 ULMN 3 1cns_c00 CHITINASE user 19 3 # 19 A 67 GLU C 201 GLU^? -3.18 C8 EPE C 377s A 89 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 23.53 -40.20 6.95 23.95 -38.27 7.71 coo -31.18 6.91 75.60 -32.39 8.51 74.91 16.97 -31.31 7.38 16.25 -32.10 9.22 coo -34.73 8.57 68.21 -33.63 9.08 70.28 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c00 CHITINASE user 20 3 # 20 A 67 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 89 GLU B 201 GLU^? 17.83 O2S EPE A 377 A 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 11.89 -37.55 15.12 10.61 -36.09 14.30 coo -31.18 6.91 75.60 -32.39 8.51 74.91 3.89 -44.87 12.99 4.21 -43.80 14.75 coo -34.73 8.57 68.21 -33.63 9.08 70.28 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c00 CHITINASE user 21 3 # 21 A 67 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 89 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 11.89 -37.55 15.12 10.61 -36.09 14.30 coo -31.18 6.91 75.60 -32.39 8.51 74.91 5.77 -31.61 7.46 7.86 -31.06 7.53 coo -34.73 8.57 68.21 -33.63 9.08 70.28 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c00 CHITINASE user 22 3 # 22 A 67 GLU C 228 GLU.? 9.65 C7 EPE C 377 A 89 GLU C 197 GLU^? 9.42 O8 EPE C 377 A 120 SER A 168 SER^? 10.80 O1S EPE C 377 coo -24.35 9.53 67.64 -25.07 11.29 68.60 33.17 -34.88 12.75 35.01 -35.99 12.68 coo -31.18 6.91 75.60 -32.39 8.51 74.91 32.51 -36.09 0.58 33.81 -36.84 -0.90 coo -34.73 8.57 68.21 -33.63 9.08 70.28 30.58 -27.33 4.57 31.12 -25.87 2.65 1cns_c00 source 1cns CHITINASE : 22 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 150 GLU~? 12.50 C5 EPE C 377 B 89 GLU A 175 GLU^? 13.72 C8 EPE A 377 B 120 SER A 173 SER^? 8.70 C6 EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 22.60 -31.63 -7.22 23.33 -32.82 -5.63 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 17.10 -34.58 2.20 18.37 -33.49 0.48 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 175 GLU^? 13.72 C8 EPE A 377 B 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 120 SER B 173 SER^? 8.63 C9 EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 4.35 -36.83 4.64 1.88 -36.99 4.49 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU A 175 GLU^? 13.72 C8 EPE A 377 B 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 120 SER C 174 SER^? 11.73 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU A 175 GLU^? 13.72 C8 EPE A 377 B 89 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU A 197 GLU^? 9.85 O8 EPE A 377 B 89 GLU A 228 GLU.? 8.71 C3 EPE A 377 B 120 SER B 168 SER^? 10.59 O3S EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -4.05 -31.37 -7.20 -4.83 -32.55 -8.76 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -4.73 -25.07 0.35 -6.94 -24.95 1.40 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU A 200 GLU^? 11.53 C6 EPE A 377 B 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU A 200 GLU^? 11.53 C6 EPE A 377 B 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 120 SER B 173 SER^? 8.63 C9 EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 4.35 -36.83 4.64 1.88 -36.99 4.49 ULMN 3 1cns_c01 CHITINASE user 8 3 # 8 B 67 GLU A 201 GLU^? -3.12 C2 EPE A 377s B 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c01 CHITINASE user 9 3 # 9 B 67 GLU A 201 GLU^? -3.12 C2 EPE A 377s B 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 120 SER B 173 SER^? 8.63 C9 EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 4.35 -36.83 4.64 1.88 -36.99 4.49 ULMN 3 1cns_c01 CHITINASE user 10 3 # 10 B 67 GLU A 201 GLU^? -3.12 C2 EPE A 377s B 89 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c01 CHITINASE user 11 3 # 11 B 67 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 89 GLU A 175 GLU^? 13.72 C8 EPE A 377 B 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c01 CHITINASE user 12 3 # 12 B 67 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 89 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c01 CHITINASE user 13 3 # 13 B 67 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 89 GLU C 201 GLU^? -3.18 C8 EPE C 377s B 120 SER C 174 SER^? 11.73 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1cns_c01 CHITINASE user 14 3 # 14 B 67 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 89 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 120 SER C 174 SER^? 11.73 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1cns_c01 CHITINASE user 15 3 # 15 B 67 GLU A 228 GLU.? 8.71 C3 EPE A 377 B 89 GLU A 197 GLU^? 9.85 O8 EPE A 377 B 120 SER B 168 SER^? 10.59 O3S EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -4.05 -31.37 -7.20 -4.83 -32.55 -8.76 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -4.73 -25.07 0.35 -6.94 -24.95 1.40 ULMN 3 1cns_c01 CHITINASE user 16 3 # 16 B 67 GLU B 150 GLU~? 12.97 C6 EPE A 377 B 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 120 SER B 173 SER^? 8.63 C9 EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 4.35 -36.83 4.64 1.88 -36.99 4.49 ULMN 3 1cns_c01 CHITINASE user 17 3 # 17 B 67 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 89 GLU A 201 GLU^? -3.12 C2 EPE A 377s B 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c01 CHITINASE user 18 3 # 18 B 67 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 89 GLU B 201 GLU^? 17.83 O2S EPE A 377 B 120 SER C 173 SER^? 14.26 C2 EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.37 -42.81 12.12 14.73 -44.10 13.72 ULMN 3 1cns_c01 CHITINASE user 19 3 # 19 B 67 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 89 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c01 CHITINASE user 20 3 # 20 B 67 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 89 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 120 SER C 173 SER^? 14.26 C2 EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.37 -42.81 12.12 14.73 -44.10 13.72 ULMN 3 1cns_c01 CHITINASE user 21 3 # 21 B 67 GLU B 200 GLU^? 21.89 O2S EPE A 377 B 89 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c01 CHITINASE user 22 3 # 22 B 67 GLU B 200 GLU^? 21.89 O2S EPE A 377 B 89 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 120 SER C 173 SER^? 14.26 C2 EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.37 -42.81 12.12 14.73 -44.10 13.72 ULMN 3 1cns_c01 CHITINASE user 23 3 # 23 B 67 GLU B 201 GLU^? 17.83 O2S EPE A 377 B 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 120 SER B 173 SER^? 8.63 C9 EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 4.35 -36.83 4.64 1.88 -36.99 4.49 ULMN 3 1cns_c01 CHITINASE user 24 3 # 24 B 67 GLU B 201 GLU^? 17.83 O2S EPE A 377 B 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 120 SER C 174 SER^? 11.73 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1cns_c01 CHITINASE user 25 3 # 25 B 67 GLU B 201 GLU^? 17.83 O2S EPE A 377 B 89 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 120 SER C 174 SER^? 11.73 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1cns_c01 CHITINASE user 26 3 # 26 B 67 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 89 GLU A 201 GLU^? -3.12 C2 EPE A 377s B 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c01 CHITINASE user 27 3 # 27 B 67 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 89 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c01 CHITINASE user 28 3 # 28 B 67 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c01 CHITINASE user 29 3 # 29 B 67 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 120 SER C 174 SER^? 11.73 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1cns_c01 CHITINASE user 30 3 # 30 B 67 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 89 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 120 SER C 174 SER^? 11.73 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1cns_c01 CHITINASE user 31 3 # 31 B 67 GLU B 241 GLU^? 19.53 O1S EPE A 377 B 89 GLU B 136 GLU^? 17.92 O1S EPE A 377 B 120 SER B 211 SER.? 16.40 O1S EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -5.21 -19.23 16.51 -5.80 -18.14 14.41 ULMN 3 1cns_c01 CHITINASE user 32 3 # 32 B 67 GLU C 150 GLU~? 19.96 C2 EPE C 377 B 89 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 120 SER C 173 SER^? 14.26 C2 EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 18.79 -51.73 16.88 16.73 -51.34 17.24 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.37 -42.81 12.12 14.73 -44.10 13.72 ULMN 3 1cns_c01 CHITINASE user 33 3 # 33 B 67 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 89 GLU A 175 GLU^? 13.72 C8 EPE A 377 B 120 SER A 173 SER^? 8.70 C6 EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 17.10 -34.58 2.20 18.37 -33.49 0.48 ULMN 3 1cns_c01 CHITINASE user 34 3 # 34 B 67 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 89 GLU A 175 GLU^? 13.72 C8 EPE A 377 B 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c01 CHITINASE user 35 3 # 35 B 67 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 89 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c01 CHITINASE user 36 3 # 36 B 67 GLU C 200 GLU^? 10.81 O8 EPE C 377 B 89 GLU A 175 GLU^? 13.72 C8 EPE A 377 B 120 SER A 173 SER^? 8.70 C6 EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 17.10 -34.58 2.20 18.37 -33.49 0.48 ULMN 3 1cns_c01 CHITINASE user 37 3 # 37 B 67 GLU C 201 GLU^? -3.18 C8 EPE C 377s B 89 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c01 CHITINASE user 38 3 # 38 B 67 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 89 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c01 CHITINASE user 39 3 # 39 B 67 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 89 GLU B 201 GLU^? 17.83 O2S EPE A 377 B 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c01 CHITINASE user 40 3 # 40 B 67 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 89 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c01 CHITINASE user 41 3 # 41 B 67 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 89 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 120 SER A 174 SER^? 9.43 O3S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1cns_c01 CHITINASE user 42 3 # 42 B 67 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 89 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 120 SER B 174 SER^? 9.21 O2S EPE A 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1cns_c01 CHITINASE user 43 3 # 43 B 67 GLU C 228 GLU.? 9.65 C7 EPE C 377 B 89 GLU C 197 GLU^? 9.42 O8 EPE C 377 B 120 SER A 168 SER^? 10.80 O1S EPE C 377 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 32.51 -36.09 0.58 33.81 -36.84 -0.90 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 30.58 -27.33 4.57 31.12 -25.87 2.65 ULMN 3 1cns_c01 CHITINASE user 44 3 # 44 B 67 GLU C 241 GLU^? 18.99 ZN ZN C 375 B 89 GLU C 136 GLU^? 12.99 N TRS A 378 B 120 SER C 211 SER.? 14.21 O1 TRS A 378 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 16.63 -31.54 32.35 15.08 -33.00 33.51 1cns_c01 source 1cns CHITINASE : 44 hits 1cns_c01 naa= 3 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 1 3 # 1 361 GLU A 15 GLU~? 17.23 ZN ZN A 375 447 HIS A 21 HIS~? 17.08 ZN ZN A 375 485 ASN A 105 ASN~? 9.65 ZN ZN A 375 coo -7.99 19.51 30.67 -8.74 17.98 29.42 29.50 -0.46 14.62 27.65 0.59 14.66 coo -15.81 17.12 25.99 -13.91 16.92 26.88 24.93 -8.05 18.54 26.13 -9.04 17.11 coo -13.17 13.85 30.36 -11.76 15.41 30.53 30.92 -4.10 21.33 31.10 -1.93 21.21 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 2 3 # 2 361 GLU B 15 GLU~? 17.09 ZN ZN B 375 447 HIS B 21 HIS~? 17.19 ZN ZN B 375 485 ASN B 105 ASN~? 9.47 ZN ZN B 375 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -8.71 -5.38 22.66 -10.29 -4.82 23.98 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 3 3 # 3 361 GLU C 15 GLU~? 17.26 ZN ZN C 375 447 HIS C 21 HIS~? 17.02 O1 TRS A 378 485 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo -7.99 19.51 30.67 -8.74 17.98 29.42 19.30 -32.62 45.28 21.00 -31.37 45.17 coo -15.81 17.12 25.99 -13.91 16.92 26.88 14.59 -28.36 37.80 14.05 -30.33 37.30 coo -13.17 13.85 30.36 -11.76 15.41 30.53 12.40 -28.97 45.42 13.67 -29.13 47.17 1coy_c00 source 1coy CHOLESTEROL OXIDASE (E.C.1.1.3.6) COMPLEX WITH: 3 hits 1coy_c00 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 173 ASP C 232 ASP^? 3.77 O2S EPE C 377 C 48 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 24.35 4.55 25.11 25.94 3.23 25.53 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR A 314 TYR~? 12.17 O8 EPE A 376 A 173 ASP A 292 ASP^? 8.63 ZN ZN A 374 C 48 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 24.35 4.55 25.11 25.94 3.23 25.53 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 173 ASP A 232 ASP^? 4.68 O1S EPE A 377 C 48 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 24.35 4.55 25.11 25.94 3.23 25.53 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 173 ASP B 292 ASP^? 8.88 ZN ZN B 374 C 48 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 2.08 17.58 27.10 3.13 18.35 29.60 coo 24.35 4.55 25.11 25.94 3.23 25.53 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 101 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 173 ASP B 320 ASP~? -21.78 ZN ZN B 374s C 48 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 2.08 17.58 27.10 3.13 18.35 29.60 coo 24.35 4.55 25.11 25.94 3.23 25.53 9.35 16.65 21.02 10.22 16.89 22.90 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 101 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 173 ASP B 232 ASP^? 14.54 O2S EPE A 377 C 48 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 24.35 4.55 25.11 25.94 3.23 25.53 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 101 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 173 ASP C 292 ASP^? 8.69 ZN ZN C 374 C 48 ARG C 274 ARG^? 15.09 ZN ZN C 374 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 24.35 4.55 25.11 25.94 3.23 25.53 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -8.42 -22.35 63.85 -6.68 -20.58 62.11 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 203 ARG^? 8.58 O3S EPE C 377 C 101 TYR A 234 TYR^? 9.43 O2S EPE A 377 C 173 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 32.27 5.62 48.15 31.93 6.48 51.06 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 29.64 3.64 57.39 31.22 5.14 55.65 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG A 203 ARG^? 8.58 O3S EPE C 377 C 101 TYR C 234 TYR^? 9.10 O2S EPE C 377 C 173 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 32.27 5.62 48.15 31.93 6.48 51.06 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 29.64 3.64 57.39 31.22 5.14 55.65 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG A 274 ARG^? 15.42 ZN ZN A 374 C 101 TYR A 314 TYR~? 12.17 O8 EPE A 376 C 173 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 32.27 5.62 48.15 31.93 6.48 51.06 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 29.64 3.64 57.39 31.22 5.14 55.65 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG B 203 ARG^? 8.69 O2S EPE A 377 C 101 TYR B 234 TYR^? 11.34 O2S EPE A 377 C 173 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 32.27 5.62 48.15 31.93 6.48 51.06 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 29.64 3.64 57.39 31.22 5.14 55.65 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG B 274 ARG^? 15.33 ZN ZN B 374 C 101 TYR B 314 TYR~? 14.73 O8 EPE B 376 C 173 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 32.27 5.62 48.15 31.93 6.48 51.06 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 29.64 3.64 57.39 31.22 5.14 55.65 2.08 17.58 27.10 3.13 18.35 29.60 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 48 ARG C 203 ARG^? 8.27 O3S EPE C 377 C 101 TYR C 234 TYR^? 9.10 O2S EPE C 377 C 173 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 32.27 5.62 48.15 31.93 6.48 51.06 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 29.64 3.64 57.39 31.22 5.14 55.65 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 48 ARG C 274 ARG^? 15.09 ZN ZN C 374 C 101 TYR C 314 TYR~? 12.22 O8 EPE C 376 C 173 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 32.27 5.62 48.15 31.93 6.48 51.06 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 29.64 3.64 57.39 31.22 5.14 55.65 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 1.43 -20.86 54.35 0.32 -19.00 54.12 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 203 ARG^? 8.58 O3S EPE C 377 D 101 TYR A 234 TYR^? 9.43 O2S EPE A 377 D 173 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 69.08 8.58 32.60 69.70 10.81 30.58 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 71.77 11.86 24.26 70.23 12.22 26.56 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 71.60 6.14 19.25 70.26 6.87 20.69 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG A 274 ARG^? 15.42 ZN ZN A 374 D 101 TYR A 314 TYR~? 12.17 O8 EPE A 376 D 173 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 69.08 8.58 32.60 69.70 10.81 30.58 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 71.77 11.86 24.26 70.23 12.22 26.56 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 71.60 6.14 19.25 70.26 6.87 20.69 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG B 203 ARG^? 8.69 O2S EPE A 377 D 101 TYR B 234 TYR^? 11.34 O2S EPE A 377 D 173 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 69.08 8.58 32.60 69.70 10.81 30.58 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 71.77 11.86 24.26 70.23 12.22 26.56 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 71.60 6.14 19.25 70.26 6.87 20.69 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG B 274 ARG^? 15.33 ZN ZN B 374 D 101 TYR B 314 TYR~? 14.73 O8 EPE B 376 D 173 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 69.08 8.58 32.60 69.70 10.81 30.58 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 71.77 11.86 24.26 70.23 12.22 26.56 2.08 17.58 27.10 3.13 18.35 29.60 coo 71.60 6.14 19.25 70.26 6.87 20.69 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG B 274 ARG^? 15.33 ZN ZN B 374 D 101 TYR B 314 TYR~? 14.73 O8 EPE B 376 D 173 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 69.08 8.58 32.60 69.70 10.81 30.58 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 71.77 11.86 24.26 70.23 12.22 26.56 2.08 17.58 27.10 3.13 18.35 29.60 coo 71.60 6.14 19.25 70.26 6.87 20.69 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 48 ARG C 203 ARG^? 8.27 O3S EPE C 377 D 101 TYR C 234 TYR^? 9.10 O2S EPE C 377 D 173 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 69.08 8.58 32.60 69.70 10.81 30.58 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 71.77 11.86 24.26 70.23 12.22 26.56 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 71.60 6.14 19.25 70.26 6.87 20.69 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 48 ARG C 274 ARG^? 15.09 ZN ZN C 374 D 101 TYR C 314 TYR~? 12.22 O8 EPE C 376 D 173 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 69.08 8.58 32.60 69.70 10.81 30.58 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 71.77 11.86 24.26 70.23 12.22 26.56 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 71.60 6.14 19.25 70.26 6.87 20.69 1.43 -20.86 54.35 0.32 -19.00 54.12 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 173 ASP C 232 ASP^? 3.77 O2S EPE C 377 D 48 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 173 ASP C 232 ASP^? 3.77 O2S EPE C 377 D 48 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR A 314 TYR~? 12.17 O8 EPE A 376 B 173 ASP A 292 ASP^? 8.63 ZN ZN A 374 D 48 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 173 ASP A 232 ASP^? 4.68 O1S EPE A 377 D 48 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 173 ASP A 232 ASP^? 4.68 O1S EPE A 377 D 48 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 101 TYR B 314 TYR~? 14.73 O8 EPE B 376 B 173 ASP B 292 ASP^? 8.88 ZN ZN B 374 D 48 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 2.08 17.58 27.10 3.13 18.35 29.60 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 101 TYR B 314 TYR~? 14.73 O8 EPE B 376 B 173 ASP B 320 ASP~? -21.78 ZN ZN B 374s D 48 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 2.08 17.58 27.10 3.13 18.35 29.60 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 9.35 16.65 21.02 10.22 16.89 22.90 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 101 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 173 ASP B 232 ASP^? 14.54 O2S EPE A 377 D 48 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 101 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 173 ASP B 232 ASP^? 14.54 O2S EPE A 377 D 48 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 101 TYR C 314 TYR~? 12.22 O8 EPE C 376 B 173 ASP C 292 ASP^? 8.69 ZN ZN C 374 D 48 ARG C 274 ARG^? 15.09 ZN ZN C 374 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -8.42 -22.35 63.85 -6.68 -20.58 62.11 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA B 118 ALA~? 13.77 ZN ZN B 375 A 74 ASN B 114 ASN~? 6.61 ZN ZN B 375 A 75 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -7.92 6.00 8.46 -6.87 4.90 8.37 coo 1.20 66.40 122.20 2.03 64.53 121.46 -6.09 3.05 14.26 -5.63 4.05 16.11 coo 4.68 65.84 125.52 4.11 65.60 126.05 -2.31 3.58 14.78 -2.28 2.80 14.58 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c04 naa= 3 ULMN 3 1cz0_c00 INTRON-ENCODED HOMING ENDONUCLEASE Iuser 1 3 # 1 A 61 ARG B 198 ARG^? 21.95 C2 EPE C 377 A 98 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 105 CYH C 170 CYH^? 22.19 N TRS A 378 coo 7.07 33.61 23.71 5.33 32.14 25.75 11.64 -52.94 14.57 14.19 -52.83 16.31 coo 3.48 23.70 23.03 2.52 25.46 22.40 13.13 -47.52 24.96 14.34 -48.17 26.54 coo -0.29 24.99 18.39 -1.39 22.52 19.08 9.66 -43.43 21.72 7.18 -43.27 22.99 ULMN 3 1cz0_c00 INTRON-ENCODED HOMING ENDONUCLEASE Iuser 2 3 # 2 A 61 ARG C 198 ARG^? 10.55 C8 EPE C 377 A 98 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 105 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo 7.07 33.61 23.71 5.33 32.14 25.75 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo 3.48 23.70 23.03 2.52 25.46 22.40 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo -0.29 24.99 18.39 -1.39 22.52 19.08 25.74 -30.01 4.94 27.86 -30.22 6.82 1cz0_c00 source 1cz0 INTRON-ENCODED HOMING ENDONUCLEASE I-PPOI : 2 hits 1cz0_c00 naa= 3 ULMN 3 1cz0_c01 INTRON-ENCODED HOMING ENDONUCLEASE Iuser 1 3 # 1 B 261 ARG B 198 ARG^? 21.95 C2 EPE C 377 B 298 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 305 CYH C 170 CYH^? 22.19 N TRS A 378 coo 29.33 30.70 34.35 30.40 28.94 32.09 11.64 -52.94 14.57 14.19 -52.83 16.31 coo 30.19 20.41 34.76 31.59 21.88 35.30 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 34.39 20.58 39.40 34.78 17.92 38.61 9.66 -43.43 21.72 7.18 -43.27 22.99 1cz0_c01 source 1cz0 INTRON-ENCODED HOMING ENDONUCLEASE I-PPOI : 1 hits 1cz0_c01 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 56 ILE A 88 ILE~? 8.69 C2 EPE A 376 A 82 TYR A 85 TYR~? -4.05 C2 EPE A 376s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 40.70 8.14 28.73 41.06 6.40 29.84 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 36.65 17.14 27.57 37.35 15.91 27.94 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 33.18 16.26 32.13 31.71 14.36 30.75 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 82 ASP.? 8.88 O2S EPE A 376 A 56 ILE A 88 ILE~? 8.69 C2 EPE A 376 A 82 TYR A 85 TYR~? -4.05 C2 EPE A 376s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 34.38 27.71 34.24 32.73 27.59 35.53 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 36.65 17.14 27.57 37.35 15.91 27.94 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 33.18 16.26 32.13 31.71 14.36 30.75 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP A 82 ASP.? 8.88 O2S EPE A 376 A 56 ILE A 89 ILE~? 8.96 O2S EPE A 376 A 82 TYR A 85 TYR~? -4.05 C2 EPE A 376s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 34.38 27.71 34.24 32.73 27.59 35.53 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 31.76 18.45 26.55 30.57 17.75 26.92 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 33.18 16.26 32.13 31.71 14.36 30.75 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP A 237 ASP^? 6.80 N TRS A 378 A 56 ILE C 217 ILE~? 6.28 C1 TRS A 378 A 82 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 23.52 -34.57 24.36 23.07 -34.24 23.11 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 23.23 -33.44 18.32 24.66 -32.16 20.35 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 56 ILE A 297 ILE~? 17.21 ZN ZN A 374 A 82 TYR A 296 TYR~? 11.37 ZN ZN A 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 34.09 -11.35 35.81 31.97 -10.07 34.54 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 56 ILE A 297 ILE~? 17.21 ZN ZN A 374 A 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 7 3 # 7 A 37 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 56 ILE A 328 ILE^? 16.66 ZN ZN A 374 A 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 45.06 -10.60 42.14 43.79 -10.64 41.43 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 8 3 # 8 A 37 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 56 ILE A 297 ILE~? 17.21 ZN ZN A 374 A 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 9 3 # 9 A 37 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 56 ILE A 328 ILE^? 16.66 ZN ZN A 374 A 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 45.06 -10.60 42.14 43.79 -10.64 41.43 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 10 3 # 10 A 37 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 56 ILE A 297 ILE~? 17.21 ZN ZN A 374 A 82 TYR A 296 TYR~? 11.37 ZN ZN A 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 39.49 -1.24 39.18 39.76 0.49 37.96 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 34.09 -11.35 35.81 31.97 -10.07 34.54 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 11 3 # 11 A 37 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 56 ILE A 297 ILE~? 17.21 ZN ZN A 374 A 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 39.49 -1.24 39.18 39.76 0.49 37.96 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 12 3 # 12 A 37 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 56 ILE A 328 ILE^? 16.66 ZN ZN A 374 A 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 39.49 -1.24 39.18 39.76 0.49 37.96 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 45.06 -10.60 42.14 43.79 -10.64 41.43 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 13 3 # 13 A 37 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 56 ILE A 328 ILE^? 16.66 ZN ZN A 374 A 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 45.06 -10.60 42.14 43.79 -10.64 41.43 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 14 3 # 14 A 37 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 56 ILE A 297 ILE~? 17.21 ZN ZN A 374 A 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 15 3 # 15 A 37 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 56 ILE B 88 ILE~? 8.50 C2 EPE B 376 A 82 TYR B 85 TYR~? 3.87 C2 EPE B 376 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -21.46 7.42 36.75 -20.79 7.94 35.59 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -16.40 8.45 39.29 -15.27 6.03 38.43 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 16 3 # 16 A 37 ASP B 82 ASP.? 10.62 O3S EPE B 376 A 56 ILE B 88 ILE~? 8.50 C2 EPE B 376 A 82 TYR B 85 TYR~? 3.87 C2 EPE B 376 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -22.38 12.66 48.09 -22.95 14.65 48.48 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -21.46 7.42 36.75 -20.79 7.94 35.59 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -16.40 8.45 39.29 -15.27 6.03 38.43 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 17 3 # 17 A 37 ASP B 82 ASP.? 10.62 O3S EPE B 376 A 56 ILE B 89 ILE~? 9.23 O2S EPE B 376 A 82 TYR B 85 TYR~? 3.87 C2 EPE B 376 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -22.38 12.66 48.09 -22.95 14.65 48.48 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -20.50 3.71 40.39 -19.35 3.27 40.76 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -16.40 8.45 39.29 -15.27 6.03 38.43 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 18 3 # 18 A 37 ASP B 237 ASP^? 15.58 N TRS A 378 A 56 ILE A 217 ILE~? 14.44 O1S EPE A 377 A 82 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 15.72 -16.98 2.77 14.88 -18.16 3.10 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 19 3 # 19 A 37 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 56 ILE B 297 ILE~? 17.30 ZN ZN B 374 A 82 TYR B 296 TYR~? 11.48 ZN ZN B 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 5.95 12.58 17.93 6.10 13.55 18.88 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 3.06 5.94 19.61 2.50 3.84 21.38 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 20 3 # 20 A 37 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 56 ILE B 297 ILE~? 17.30 ZN ZN B 374 A 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 5.95 12.58 17.93 6.10 13.55 18.88 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 21 3 # 21 A 37 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 56 ILE B 328 ILE^? 16.79 ZN ZN B 374 A 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 0.93 17.58 15.13 1.21 16.93 16.38 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 22 3 # 22 A 37 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 56 ILE B 248 ILE^? 17.17 ZN ZN B 375 A 82 TYR B 250 TYR^? 23.22 ZN ZN B 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 3.99 14.73 5.36 5.18 14.04 3.76 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 1.53 5.19 8.85 2.92 5.26 8.57 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 0.70 6.87 1.10 3.12 5.62 1.69 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 23 3 # 23 A 37 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 56 ILE B 297 ILE~? 17.30 ZN ZN B 374 A 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 3.99 14.73 5.36 5.18 14.04 3.76 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 5.95 12.58 17.93 6.10 13.55 18.88 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 24 3 # 24 A 37 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 56 ILE B 328 ILE^? 16.79 ZN ZN B 374 A 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 3.99 14.73 5.36 5.18 14.04 3.76 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 0.93 17.58 15.13 1.21 16.93 16.38 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 25 3 # 25 A 37 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 56 ILE B 297 ILE~? 17.30 ZN ZN B 374 A 82 TYR B 296 TYR~? 11.48 ZN ZN B 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 5.95 12.58 17.93 6.10 13.55 18.88 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 3.06 5.94 19.61 2.50 3.84 21.38 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 26 3 # 26 A 37 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 56 ILE B 297 ILE~? 17.30 ZN ZN B 374 A 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 5.95 12.58 17.93 6.10 13.55 18.88 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 27 3 # 27 A 37 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 56 ILE B 328 ILE^? 16.79 ZN ZN B 374 A 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 0.93 17.58 15.13 1.21 16.93 16.38 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 28 3 # 28 A 37 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 56 ILE B 328 ILE^? 16.79 ZN ZN B 374 A 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 9.35 16.65 21.02 10.22 16.89 22.90 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 0.93 17.58 15.13 1.21 16.93 16.38 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 29 3 # 29 A 37 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 56 ILE B 297 ILE~? 17.30 ZN ZN B 374 A 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 5.95 12.58 17.93 6.10 13.55 18.88 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 30 3 # 30 A 37 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 56 ILE C 88 ILE~? 8.70 C2 EPE C 376 A 82 TYR C 85 TYR~? -3.91 C2 EPE C 376s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 19.39 -24.24 66.47 18.05 -24.67 66.14 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 17.64 -18.79 65.22 18.00 -19.09 62.48 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 31 3 # 31 A 37 ASP C 82 ASP.? 10.22 O3S EPE C 376 A 56 ILE C 88 ILE~? 8.70 C2 EPE C 376 A 82 TYR C 85 TYR~? -3.91 C2 EPE C 376s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 23.03 -14.86 74.18 22.44 -14.42 76.16 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 19.39 -24.24 66.47 18.05 -24.67 66.14 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 17.64 -18.79 65.22 18.00 -19.09 62.48 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 32 3 # 32 A 37 ASP C 82 ASP.? 10.22 O3S EPE C 376 A 56 ILE C 89 ILE~? 9.29 O3S EPE C 376 A 82 TYR C 85 TYR~? -3.91 C2 EPE C 376s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 23.03 -14.86 74.18 22.44 -14.42 76.16 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 23.32 -21.71 64.14 23.21 -20.73 63.10 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 17.64 -18.79 65.22 18.00 -19.09 62.48 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 33 3 # 33 A 37 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 56 ILE B 217 ILE~? 16.43 O3S EPE A 377 A 82 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -4.71 -29.77 18.11 -4.22 -29.62 19.49 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 34 3 # 34 A 37 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 56 ILE C 297 ILE~? 17.14 ZN ZN C 374 A 82 TYR C 296 TYR~? 11.54 ZN ZN C 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -2.51 -21.77 46.19 0.10 -20.95 45.58 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 35 3 # 35 A 37 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 56 ILE C 297 ILE~? 17.14 ZN ZN C 374 A 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 36 3 # 36 A 37 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 56 ILE C 328 ILE^? 16.72 ZN ZN C 374 A 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -11.34 -23.92 55.01 -10.20 -23.15 54.29 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 37 3 # 37 A 37 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 56 ILE C 297 ILE~? 17.14 ZN ZN C 374 A 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 38 3 # 38 A 37 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 56 ILE C 328 ILE^? 16.72 ZN ZN C 374 A 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -11.34 -23.92 55.01 -10.20 -23.15 54.29 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 39 3 # 39 A 37 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 56 ILE C 297 ILE~? 17.14 ZN ZN C 374 A 82 TYR C 296 TYR~? 11.54 ZN ZN C 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -2.51 -21.77 46.19 0.10 -20.95 45.58 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 40 3 # 40 A 37 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 56 ILE C 297 ILE~? 17.14 ZN ZN C 374 A 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 41 3 # 41 A 37 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 56 ILE C 328 ILE^? 16.72 ZN ZN C 374 A 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -11.34 -23.92 55.01 -10.20 -23.15 54.29 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 42 3 # 42 A 37 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 56 ILE C 328 ILE^? 16.72 ZN ZN C 374 A 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -11.34 -23.92 55.01 -10.20 -23.15 54.29 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 43 3 # 43 A 37 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 56 ILE C 297 ILE~? 17.14 ZN ZN C 374 A 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -8.26 -25.36 50.23 -5.59 -24.48 49.71 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 43 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 56 ILE A 88 ILE~? 8.69 C2 EPE A 376 B 82 TYR A 85 TYR~? -4.05 C2 EPE A 376s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 40.70 8.14 28.73 41.06 6.40 29.84 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 36.65 17.14 27.57 37.35 15.91 27.94 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 33.18 16.26 32.13 31.71 14.36 30.75 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 82 ASP.? 8.88 O2S EPE A 376 B 56 ILE A 88 ILE~? 8.69 C2 EPE A 376 B 82 TYR A 85 TYR~? -4.05 C2 EPE A 376s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 34.38 27.71 34.24 32.73 27.59 35.53 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 36.65 17.14 27.57 37.35 15.91 27.94 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 33.18 16.26 32.13 31.71 14.36 30.75 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP A 82 ASP.? 8.88 O2S EPE A 376 B 56 ILE A 89 ILE~? 8.96 O2S EPE A 376 B 82 TYR A 85 TYR~? -4.05 C2 EPE A 376s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 34.38 27.71 34.24 32.73 27.59 35.53 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 31.76 18.45 26.55 30.57 17.75 26.92 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 33.18 16.26 32.13 31.71 14.36 30.75 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP A 237 ASP^? 6.80 N TRS A 378 B 56 ILE C 217 ILE~? 6.28 C1 TRS A 378 B 82 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 23.52 -34.57 24.36 23.07 -34.24 23.11 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 23.23 -33.44 18.32 24.66 -32.16 20.35 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 56 ILE A 297 ILE~? 17.21 ZN ZN A 374 B 82 TYR A 296 TYR~? 11.37 ZN ZN A 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 34.09 -11.35 35.81 31.97 -10.07 34.54 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 56 ILE A 297 ILE~? 17.21 ZN ZN A 374 B 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 7 3 # 7 B 37 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 56 ILE A 328 ILE^? 16.66 ZN ZN A 374 B 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 45.06 -10.60 42.14 43.79 -10.64 41.43 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 8 3 # 8 B 37 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 56 ILE A 297 ILE~? 17.21 ZN ZN A 374 B 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 9 3 # 9 B 37 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 56 ILE A 328 ILE^? 16.66 ZN ZN A 374 B 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 45.06 -10.60 42.14 43.79 -10.64 41.43 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 10 3 # 10 B 37 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 56 ILE A 297 ILE~? 17.21 ZN ZN A 374 B 82 TYR A 296 TYR~? 11.37 ZN ZN A 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 39.49 -1.24 39.18 39.76 0.49 37.96 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 34.09 -11.35 35.81 31.97 -10.07 34.54 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 11 3 # 11 B 37 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 56 ILE A 297 ILE~? 17.21 ZN ZN A 374 B 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 39.49 -1.24 39.18 39.76 0.49 37.96 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 12 3 # 12 B 37 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 56 ILE A 328 ILE^? 16.66 ZN ZN A 374 B 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 39.49 -1.24 39.18 39.76 0.49 37.96 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 45.06 -10.60 42.14 43.79 -10.64 41.43 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 13 3 # 13 B 37 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 56 ILE A 328 ILE^? 16.66 ZN ZN A 374 B 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 45.06 -10.60 42.14 43.79 -10.64 41.43 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 14 3 # 14 B 37 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 56 ILE A 297 ILE~? 17.21 ZN ZN A 374 B 82 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 37.67 -13.06 42.03 37.68 -12.21 43.11 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 15 3 # 15 B 37 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 56 ILE B 88 ILE~? 8.50 C2 EPE B 376 B 82 TYR B 85 TYR~? 3.87 C2 EPE B 376 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -21.46 7.42 36.75 -20.79 7.94 35.59 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -16.40 8.45 39.29 -15.27 6.03 38.43 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 16 3 # 16 B 37 ASP B 82 ASP.? 10.62 O3S EPE B 376 B 56 ILE B 88 ILE~? 8.50 C2 EPE B 376 B 82 TYR B 85 TYR~? 3.87 C2 EPE B 376 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -22.38 12.66 48.09 -22.95 14.65 48.48 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -21.46 7.42 36.75 -20.79 7.94 35.59 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -16.40 8.45 39.29 -15.27 6.03 38.43 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 17 3 # 17 B 37 ASP B 82 ASP.? 10.62 O3S EPE B 376 B 56 ILE B 89 ILE~? 9.23 O2S EPE B 376 B 82 TYR B 85 TYR~? 3.87 C2 EPE B 376 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -22.38 12.66 48.09 -22.95 14.65 48.48 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -20.50 3.71 40.39 -19.35 3.27 40.76 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -16.40 8.45 39.29 -15.27 6.03 38.43 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 18 3 # 18 B 37 ASP B 237 ASP^? 15.58 N TRS A 378 B 56 ILE A 217 ILE~? 14.44 O1S EPE A 377 B 82 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 15.72 -16.98 2.77 14.88 -18.16 3.10 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 19 3 # 19 B 37 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 56 ILE B 297 ILE~? 17.30 ZN ZN B 374 B 82 TYR B 296 TYR~? 11.48 ZN ZN B 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 5.95 12.58 17.93 6.10 13.55 18.88 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 3.06 5.94 19.61 2.50 3.84 21.38 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 20 3 # 20 B 37 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 56 ILE B 297 ILE~? 17.30 ZN ZN B 374 B 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 5.95 12.58 17.93 6.10 13.55 18.88 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 21 3 # 21 B 37 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 56 ILE B 328 ILE^? 16.79 ZN ZN B 374 B 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 0.93 17.58 15.13 1.21 16.93 16.38 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 22 3 # 22 B 37 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 56 ILE B 248 ILE^? 17.17 ZN ZN B 375 B 82 TYR B 250 TYR^? 23.22 ZN ZN B 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 3.99 14.73 5.36 5.18 14.04 3.76 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 1.53 5.19 8.85 2.92 5.26 8.57 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 0.70 6.87 1.10 3.12 5.62 1.69 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 23 3 # 23 B 37 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 56 ILE B 297 ILE~? 17.30 ZN ZN B 374 B 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 3.99 14.73 5.36 5.18 14.04 3.76 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 5.95 12.58 17.93 6.10 13.55 18.88 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 24 3 # 24 B 37 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 56 ILE B 328 ILE^? 16.79 ZN ZN B 374 B 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 3.99 14.73 5.36 5.18 14.04 3.76 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 0.93 17.58 15.13 1.21 16.93 16.38 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 25 3 # 25 B 37 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 56 ILE B 297 ILE~? 17.30 ZN ZN B 374 B 82 TYR B 296 TYR~? 11.48 ZN ZN B 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 5.95 12.58 17.93 6.10 13.55 18.88 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 3.06 5.94 19.61 2.50 3.84 21.38 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 26 3 # 26 B 37 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 56 ILE B 297 ILE~? 17.30 ZN ZN B 374 B 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 5.95 12.58 17.93 6.10 13.55 18.88 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 27 3 # 27 B 37 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 56 ILE B 328 ILE^? 16.79 ZN ZN B 374 B 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 0.93 17.58 15.13 1.21 16.93 16.38 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 28 3 # 28 B 37 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 56 ILE B 328 ILE^? 16.79 ZN ZN B 374 B 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 9.35 16.65 21.02 10.22 16.89 22.90 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 0.93 17.58 15.13 1.21 16.93 16.38 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 29 3 # 29 B 37 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 56 ILE B 297 ILE~? 17.30 ZN ZN B 374 B 82 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 5.95 12.58 17.93 6.10 13.55 18.88 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 30 3 # 30 B 37 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 56 ILE C 88 ILE~? 8.70 C2 EPE C 376 B 82 TYR C 85 TYR~? -3.91 C2 EPE C 376s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 19.39 -24.24 66.47 18.05 -24.67 66.14 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 17.64 -18.79 65.22 18.00 -19.09 62.48 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 31 3 # 31 B 37 ASP C 82 ASP.? 10.22 O3S EPE C 376 B 56 ILE C 88 ILE~? 8.70 C2 EPE C 376 B 82 TYR C 85 TYR~? -3.91 C2 EPE C 376s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 23.03 -14.86 74.18 22.44 -14.42 76.16 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 19.39 -24.24 66.47 18.05 -24.67 66.14 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 17.64 -18.79 65.22 18.00 -19.09 62.48 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 32 3 # 32 B 37 ASP C 82 ASP.? 10.22 O3S EPE C 376 B 56 ILE C 89 ILE~? 9.29 O3S EPE C 376 B 82 TYR C 85 TYR~? -3.91 C2 EPE C 376s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 23.03 -14.86 74.18 22.44 -14.42 76.16 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 23.32 -21.71 64.14 23.21 -20.73 63.10 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 17.64 -18.79 65.22 18.00 -19.09 62.48 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 33 3 # 33 B 37 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 56 ILE B 217 ILE~? 16.43 O3S EPE A 377 B 82 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -4.71 -29.77 18.11 -4.22 -29.62 19.49 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 34 3 # 34 B 37 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 56 ILE C 297 ILE~? 17.14 ZN ZN C 374 B 82 TYR C 296 TYR~? 11.54 ZN ZN C 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -2.51 -21.77 46.19 0.10 -20.95 45.58 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 35 3 # 35 B 37 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 56 ILE C 297 ILE~? 17.14 ZN ZN C 374 B 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 36 3 # 36 B 37 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 56 ILE C 328 ILE^? 16.72 ZN ZN C 374 B 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -11.34 -23.92 55.01 -10.20 -23.15 54.29 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 37 3 # 37 B 37 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 56 ILE C 297 ILE~? 17.14 ZN ZN C 374 B 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 38 3 # 38 B 37 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 56 ILE C 328 ILE^? 16.72 ZN ZN C 374 B 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -11.34 -23.92 55.01 -10.20 -23.15 54.29 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 39 3 # 39 B 37 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 56 ILE C 297 ILE~? 17.14 ZN ZN C 374 B 82 TYR C 296 TYR~? 11.54 ZN ZN C 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -2.51 -21.77 46.19 0.10 -20.95 45.58 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 40 3 # 40 B 37 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 56 ILE C 297 ILE~? 17.14 ZN ZN C 374 B 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 41 3 # 41 B 37 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 56 ILE C 328 ILE^? 16.72 ZN ZN C 374 B 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -11.34 -23.92 55.01 -10.20 -23.15 54.29 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 42 3 # 42 B 37 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 56 ILE C 328 ILE^? 16.72 ZN ZN C 374 B 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -11.34 -23.92 55.01 -10.20 -23.15 54.29 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 43 3 # 43 B 37 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 56 ILE C 297 ILE~? 17.14 ZN ZN C 374 B 82 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -8.93 -19.74 48.91 -8.97 -18.72 49.85 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -8.26 -25.36 50.23 -5.59 -24.48 49.71 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 43 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 243 ASP A 96 ASP.? 22.36 O2S EPE A 376 A 272 LYS A 91 LYS~? 15.85 O2S EPE A 376 coo 2.03 68.31 21.46 0.66 68.36 23.90 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 16.93 55.67 9.65 17.16 54.23 11.19 33.23 19.97 13.69 32.21 21.81 13.47 coo 14.13 45.79 13.40 14.25 49.41 18.30 36.23 21.81 22.32 41.86 22.67 23.70 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 243 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 272 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 16.93 55.67 9.65 17.16 54.23 11.19 48.24 5.16 33.58 47.82 3.96 35.30 coo 14.13 45.79 13.40 14.25 49.41 18.30 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 243 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 272 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 16.93 55.67 9.65 17.16 54.23 11.19 48.24 5.16 33.58 47.82 3.96 35.30 coo 14.13 45.79 13.40 14.25 49.41 18.30 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 100 TYR^? 14.62 ZN ZN A 375 A 243 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 272 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 31.64 5.60 17.48 30.43 3.13 17.07 coo 16.93 55.67 9.65 17.16 54.23 11.19 39.49 -1.24 39.18 39.76 0.49 37.96 coo 14.13 45.79 13.40 14.25 49.41 18.30 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR A 250 TYR^? 23.04 O3 TRS A 378 A 243 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 272 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 16.93 55.67 9.65 17.16 54.23 11.19 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 14.13 45.79 13.40 14.25 49.41 18.30 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR A 296 TYR~? 11.37 ZN ZN A 375 A 243 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 272 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 34.09 -11.35 35.81 31.97 -10.07 34.54 coo 16.93 55.67 9.65 17.16 54.23 11.19 48.24 5.16 33.58 47.82 3.96 35.30 coo 14.13 45.79 13.40 14.25 49.41 18.30 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 243 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 272 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 2.03 68.31 21.46 0.66 68.36 23.90 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 16.93 55.67 9.65 17.16 54.23 11.19 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 14.13 45.79 13.40 14.25 49.41 18.30 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR A 315 TYR~? 21.30 O8 EPE A 376 A 243 ASP A 281 ASP.? 28.06 ZN ZN A 375 A 272 LYS A 285 LYS^? 20.00 O3 TRS A 378 coo 2.03 68.31 21.46 0.66 68.36 23.90 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 16.93 55.67 9.65 17.16 54.23 11.19 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 14.13 45.79 13.40 14.25 49.41 18.30 47.09 -21.09 34.01 41.69 -24.22 32.75 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR A 315 TYR~? 21.30 O8 EPE A 376 A 243 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 272 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 16.93 55.67 9.65 17.16 54.23 11.19 48.24 5.16 33.58 47.82 3.96 35.30 coo 14.13 45.79 13.40 14.25 49.41 18.30 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 243 ASP B 96 ASP.? 22.64 O2S EPE B 376 A 272 LYS B 91 LYS~? 15.73 O3S EPE B 376 coo 2.03 68.31 21.46 0.66 68.36 23.90 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 16.93 55.67 9.65 17.16 54.23 11.19 -29.98 -4.37 36.65 -30.49 -4.93 38.64 coo 14.13 45.79 13.40 14.25 49.41 18.30 -26.96 4.56 38.63 -29.49 9.20 36.26 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 243 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 272 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 16.93 55.67 9.65 17.16 54.23 11.19 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 14.13 45.79 13.40 14.25 49.41 18.30 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 243 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 272 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 16.93 55.67 9.65 17.16 54.23 11.19 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 14.13 45.79 13.40 14.25 49.41 18.30 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 173 TYR B 100 TYR^? 14.57 ZN ZN B 375 A 243 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 272 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 2.03 68.31 21.46 0.66 68.36 23.90 -17.63 -5.70 28.19 -15.74 -7.29 26.85 coo 16.93 55.67 9.65 17.16 54.23 11.19 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 14.13 45.79 13.40 14.25 49.41 18.30 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 14 3 # 14 A 173 TYR B 226 TYR.? 21.63 O2S EPE A 377 A 243 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 272 LYS C 215 LYS~? 17.39 O1 TRS A 378 coo 2.03 68.31 21.46 0.66 68.36 23.90 -2.18 -44.73 18.44 0.01 -45.92 17.08 coo 16.93 55.67 9.65 17.16 54.23 11.19 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 14.13 45.79 13.40 14.25 49.41 18.30 22.70 -37.10 29.95 20.60 -41.87 33.53 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 15 3 # 15 A 173 TYR B 231 TYR^? 16.39 O2S EPE A 377 A 243 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 272 LYS C 215 LYS~? 17.39 O1 TRS A 378 coo 2.03 68.31 21.46 0.66 68.36 23.90 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 16.93 55.67 9.65 17.16 54.23 11.19 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 14.13 45.79 13.40 14.25 49.41 18.30 22.70 -37.10 29.95 20.60 -41.87 33.53 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 16 3 # 16 A 173 TYR B 231 TYR^? 16.39 O2S EPE A 377 A 243 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 272 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 2.03 68.31 21.46 0.66 68.36 23.90 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 16.93 55.67 9.65 17.16 54.23 11.19 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 14.13 45.79 13.40 14.25 49.41 18.30 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 17 3 # 17 A 173 TYR B 250 TYR^? 23.22 ZN ZN B 375 A 243 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 272 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 0.70 6.87 1.10 3.12 5.62 1.69 coo 16.93 55.67 9.65 17.16 54.23 11.19 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 14.13 45.79 13.40 14.25 49.41 18.30 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 18 3 # 18 A 173 TYR B 296 TYR~? 11.48 ZN ZN B 375 A 243 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 272 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 3.06 5.94 19.61 2.50 3.84 21.38 coo 16.93 55.67 9.65 17.16 54.23 11.19 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 14.13 45.79 13.40 14.25 49.41 18.30 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 19 3 # 19 A 173 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 243 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 272 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 2.03 68.31 21.46 0.66 68.36 23.90 1.32 11.76 14.56 0.84 10.00 16.68 coo 16.93 55.67 9.65 17.16 54.23 11.19 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 14.13 45.79 13.40 14.25 49.41 18.30 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 20 3 # 20 A 173 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 243 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 272 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 2.08 17.58 27.10 3.13 18.35 29.60 coo 16.93 55.67 9.65 17.16 54.23 11.19 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 14.13 45.79 13.40 14.25 49.41 18.30 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 21 3 # 21 A 173 TYR B 315 TYR~? 21.53 O8 EPE B 376 A 243 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 272 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 4.11 23.72 25.55 5.20 26.22 24.94 coo 16.93 55.67 9.65 17.16 54.23 11.19 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 14.13 45.79 13.40 14.25 49.41 18.30 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 22 3 # 22 A 173 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 243 ASP C 96 ASP.? 22.89 O3S EPE C 376 A 272 LYS C 91 LYS~? 15.57 O3S EPE C 376 coo 2.03 68.31 21.46 0.66 68.36 23.90 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 16.93 55.67 9.65 17.16 54.23 11.19 31.06 -32.15 62.51 32.92 -31.34 63.13 coo 14.13 45.79 13.40 14.25 49.41 18.30 24.97 -26.94 68.30 21.78 -29.04 72.70 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 23 3 # 23 A 173 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 243 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 272 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 2.03 68.31 21.46 0.66 68.36 23.90 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 16.93 55.67 9.65 17.16 54.23 11.19 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 14.13 45.79 13.40 14.25 49.41 18.30 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 24 3 # 24 A 173 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 243 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 272 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 16.93 55.67 9.65 17.16 54.23 11.19 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 14.13 45.79 13.40 14.25 49.41 18.30 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 25 3 # 25 A 173 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 243 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 272 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 16.93 55.67 9.65 17.16 54.23 11.19 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 14.13 45.79 13.40 14.25 49.41 18.30 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 26 3 # 26 A 173 TYR C 100 TYR^? 14.49 ZN ZN C 375 A 243 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 272 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 20.27 -30.73 51.89 19.47 -30.85 49.23 coo 16.93 55.67 9.65 17.16 54.23 11.19 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 14.13 45.79 13.40 14.25 49.41 18.30 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 27 3 # 27 A 173 TYR C 133 TYR^? 16.76 ZN ZN C 375 A 243 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 272 LYS A 138 LYS^? 13.11 N TRS A 378 coo 2.03 68.31 21.46 0.66 68.36 23.90 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 16.93 55.67 9.65 17.16 54.23 11.19 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 14.13 45.79 13.40 14.25 49.41 18.30 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 28 3 # 28 A 173 TYR C 250 TYR^? 23.68 ZN ZN C 375 A 243 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 272 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 16.93 55.67 9.65 17.16 54.23 11.19 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 14.13 45.79 13.40 14.25 49.41 18.30 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 29 3 # 29 A 173 TYR C 296 TYR~? 11.54 ZN ZN C 375 A 243 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 272 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo 16.93 55.67 9.65 17.16 54.23 11.19 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 14.13 45.79 13.40 14.25 49.41 18.30 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 30 3 # 30 A 173 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 243 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 272 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 2.03 68.31 21.46 0.66 68.36 23.90 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 16.93 55.67 9.65 17.16 54.23 11.19 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 14.13 45.79 13.40 14.25 49.41 18.30 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 31 3 # 31 A 173 TYR C 315 TYR~? 21.59 O8 EPE C 376 A 243 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 272 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 2.03 68.31 21.46 0.66 68.36 23.90 -10.50 -13.02 60.73 -13.04 -12.15 61.66 coo 16.93 55.67 9.65 17.16 54.23 11.19 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 14.13 45.79 13.40 14.25 49.41 18.30 5.23 -34.02 59.10 0.53 -34.86 62.24 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 31 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 285 LYS^? 20.00 O3 TRS A 378 A 177 GLU A 253 GLU^? 31.48 ZN ZN A 375 A 201 LEU A 251 LEU^? 22.24 ZN ZN A 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 47.09 -21.09 34.01 41.69 -24.22 32.75 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 52.57 -19.38 31.15 52.41 -17.39 31.96 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 285 LYS^? 20.00 O3 TRS A 378 A 177 GLU A 254 GLU^? 30.93 ZN ZN A 375 A 201 LEU A 251 LEU^? 22.24 ZN ZN A 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 47.09 -21.09 34.01 41.69 -24.22 32.75 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 52.57 -19.38 31.15 52.41 -17.39 31.96 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 177 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 201 LEU A 47 LEU.? 6.92 ZN ZN A 374 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 44.47 1.55 20.70 47.30 5.10 24.27 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 42.30 4.26 26.28 42.13 2.67 27.73 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS A 350 LYS~? 21.83 ZN ZN A 375 A 177 GLU A 9 GLU~? 28.50 ZN ZN A 375 A 201 LEU A 13 LEU~? 21.91 ZN ZN A 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 31.54 5.84 4.26 31.09 6.26 2.19 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 34.43 -0.50 8.07 34.57 -0.43 5.89 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS A 350 LYS~? 21.83 ZN ZN A 375 A 177 GLU A 15 GLU~? 17.23 ZN ZN A 375 A 201 LEU A 13 LEU~? 21.91 ZN ZN A 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 29.50 -0.46 14.62 27.65 0.59 14.66 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 34.43 -0.50 8.07 34.57 -0.43 5.89 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS A 354 LYS~? 27.90 ZN ZN A 375 A 177 GLU A 9 GLU~? 28.50 ZN ZN A 375 A 201 LEU A 13 LEU~? 21.91 ZN ZN A 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 31.54 5.84 4.26 31.09 6.26 2.19 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 34.43 -0.50 8.07 34.57 -0.43 5.89 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS A 354 LYS~? 27.90 ZN ZN A 375 A 177 GLU A 9 GLU~? 28.50 ZN ZN A 375 A 201 LEU A 356 LEU.? 27.14 ZN ZN A 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 31.54 5.84 4.26 31.09 6.26 2.19 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 38.06 4.19 2.32 35.93 3.79 2.19 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 A 145 LYS A 355 LYS.? 33.47 ZN ZN A 375 A 177 GLU A 9 GLU~? 28.50 ZN ZN A 375 A 201 LEU A 356 LEU.? 27.14 ZN ZN A 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 39.94 1.41 -1.05 41.91 -2.04 -4.52 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 31.54 5.84 4.26 31.09 6.26 2.19 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 38.06 4.19 2.32 35.93 3.79 2.19 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 A 145 LYS B 3 LYS.? 34.82 ZN ZN B 375 A 177 GLU B 9 GLU~? 28.41 ZN ZN B 375 A 201 LEU B 356 LEU.? 26.83 ZN ZN B 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -28.77 -13.23 18.96 -27.30 -14.74 19.63 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 A 145 LYS B 110 LYS.? 16.94 ZN ZN B 375 A 177 GLU B 241 GLU^? 19.53 O1S EPE A 377 A 201 LEU B 243 LEU^? 14.34 ZN ZN B 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -2.34 -6.48 15.24 -4.14 -7.33 14.39 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 11 3 # 11 A 145 LYS B 247 LYS^? 11.69 ZN ZN B 375 A 177 GLU B 119 GLU~? 15.38 ZN ZN B 375 A 201 LEU B 123 LEU.? 17.38 ZN ZN B 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -11.67 2.61 5.82 -11.38 1.03 7.26 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -5.20 6.91 4.85 -4.58 8.66 5.96 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 12 3 # 12 A 145 LYS B 285 LYS^? 22.19 ZN ZN B 375 A 177 GLU B 253 GLU^? 31.12 ZN ZN B 375 A 201 LEU B 251 LEU^? 22.61 ZN ZN B 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 1.97 10.60 4.02 5.48 5.38 4.89 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -5.44 14.03 -5.56 -4.22 13.73 -7.31 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -3.28 12.31 0.94 -3.84 13.59 2.55 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 13 3 # 13 A 145 LYS B 285 LYS^? 22.19 ZN ZN B 375 A 177 GLU B 254 GLU^? 30.73 ZN ZN B 375 A 201 LEU B 251 LEU^? 22.61 ZN ZN B 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 1.97 10.60 4.02 5.48 5.38 4.89 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 1.12 17.35 -1.99 2.87 17.99 -2.99 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -3.28 12.31 0.94 -3.84 13.59 2.55 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 14 3 # 14 A 145 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 177 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 201 LEU B 47 LEU.? 6.75 ZN ZN B 374 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -16.64 7.19 23.14 -14.64 7.83 22.57 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 15 3 # 15 A 145 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 177 GLU B 15 GLU~? 17.09 ZN ZN B 375 A 201 LEU B 13 LEU~? 21.73 ZN ZN B 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -20.65 -12.23 18.98 -21.90 -13.76 18.06 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 16 3 # 16 A 145 LYS B 354 LYS~? 28.15 ZN ZN B 375 A 177 GLU B 9 GLU~? 28.41 ZN ZN B 375 A 201 LEU B 356 LEU.? 26.83 ZN ZN B 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -28.77 -13.23 18.96 -27.30 -14.74 19.63 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 17 3 # 17 A 145 LYS B 355 LYS.? 33.64 ZN ZN B 375 A 177 GLU B 9 GLU~? 28.41 ZN ZN B 375 A 201 LEU B 356 LEU.? 26.83 ZN ZN B 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -28.77 -13.23 18.96 -27.30 -14.74 19.63 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 18 3 # 18 A 145 LYS C 3 LYS.? 28.91 O1 TRS A 378 A 177 GLU C 9 GLU~? 28.11 O1 TRS A 378 A 201 LEU C 356 LEU.? 26.94 ZN ZN C 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 30.63 -48.52 50.80 31.26 -43.98 46.49 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 28.74 -39.91 47.06 29.82 -41.70 47.37 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 24.98 -46.32 49.97 26.09 -45.05 48.63 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 19 3 # 19 A 145 LYS C 247 LYS^? 13.94 ZN ZN C 375 A 177 GLU C 119 GLU~? 15.59 ZN ZN C 375 A 201 LEU C 123 LEU.? 17.43 ZN ZN C 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -0.72 -41.44 48.78 1.35 -42.03 49.11 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -7.65 -37.78 47.66 -8.55 -36.07 48.64 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 20 3 # 20 A 145 LYS C 285 LYS^? 22.29 ZN ZN C 375 A 177 GLU C 253 GLU^? 31.42 ZN ZN C 375 A 201 LEU C 251 LEU^? 22.30 ZN ZN C 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -14.01 -33.36 45.98 -12.46 -31.50 40.58 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -18.88 -44.02 49.77 -19.94 -45.34 51.07 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -14.08 -38.44 49.58 -13.43 -37.26 51.32 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 21 3 # 21 A 145 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 177 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 201 LEU C 47 LEU.? 6.79 ZN ZN C 374 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 8.91 -31.30 59.57 7.16 -30.19 58.83 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 22 3 # 22 A 145 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 177 GLU C 9 GLU~? 28.11 O1 TRS A 378 A 201 LEU C 13 LEU~? 21.97 ZN ZN C 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 28.74 -39.91 47.06 29.82 -41.70 47.37 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 20.87 -40.58 45.98 21.86 -42.31 45.08 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 23 3 # 23 A 145 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 177 GLU C 15 GLU~? 17.26 ZN ZN C 375 A 201 LEU C 13 LEU~? 21.97 ZN ZN C 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 20.87 -40.58 45.98 21.86 -42.31 45.08 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 24 3 # 24 A 145 LYS C 354 LYS~? 23.72 O1 TRS A 378 A 177 GLU C 9 GLU~? 28.11 O1 TRS A 378 A 201 LEU C 356 LEU.? 26.94 ZN ZN C 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 28.74 -39.91 47.06 29.82 -41.70 47.37 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 24.98 -46.32 49.97 26.09 -45.05 48.63 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 25 3 # 25 A 145 LYS C 355 LYS.? 32.67 ZN ZN C 375 A 177 GLU C 9 GLU~? 28.11 O1 TRS A 378 A 201 LEU C 356 LEU.? 26.94 ZN ZN C 375 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 24.80 -50.74 47.95 22.71 -54.81 46.20 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 28.74 -39.91 47.06 29.82 -41.70 47.37 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 24.98 -46.32 49.97 26.09 -45.05 48.63 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 25 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 110 LYS.? 16.46 O3 TRS A 378 B 177 GLU A 241 GLU^? 13.09 O3 TRS A 378 B 201 LEU A 243 LEU^? 14.05 O3 TRS A 378 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 37.52 -11.39 18.62 36.00 -16.08 14.56 coo 27.00 6.35 51.01 26.30 4.53 50.18 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 23.74 1.68 49.50 22.87 -0.24 49.97 31.75 -13.70 22.02 32.50 -13.55 19.95 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 285 LYS^? 20.00 O3 TRS A 378 B 177 GLU A 253 GLU^? 31.48 ZN ZN A 375 B 201 LEU A 251 LEU^? 22.24 ZN ZN A 375 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 47.09 -21.09 34.01 41.69 -24.22 32.75 coo 27.00 6.35 51.01 26.30 4.53 50.18 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 23.74 1.68 49.50 22.87 -0.24 49.97 52.57 -19.38 31.15 52.41 -17.39 31.96 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS A 285 LYS^? 20.00 O3 TRS A 378 B 177 GLU A 254 GLU^? 30.93 ZN ZN A 375 B 201 LEU A 251 LEU^? 22.24 ZN ZN A 375 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 47.09 -21.09 34.01 41.69 -24.22 32.75 coo 27.00 6.35 51.01 26.30 4.53 50.18 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 23.74 1.68 49.50 22.87 -0.24 49.97 52.57 -19.38 31.15 52.41 -17.39 31.96 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 177 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 201 LEU A 47 LEU.? 6.92 ZN ZN A 374 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 44.47 1.55 20.70 47.30 5.10 24.27 coo 27.00 6.35 51.01 26.30 4.53 50.18 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 23.74 1.68 49.50 22.87 -0.24 49.97 42.30 4.26 26.28 42.13 2.67 27.73 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS A 354 LYS~? 27.90 ZN ZN A 375 B 177 GLU A 9 GLU~? 28.50 ZN ZN A 375 B 201 LEU A 356 LEU.? 27.14 ZN ZN A 375 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 27.00 6.35 51.01 26.30 4.53 50.18 31.54 5.84 4.26 31.09 6.26 2.19 coo 23.74 1.68 49.50 22.87 -0.24 49.97 38.06 4.19 2.32 35.93 3.79 2.19 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS A 355 LYS.? 33.47 ZN ZN A 375 B 177 GLU A 9 GLU~? 28.50 ZN ZN A 375 B 201 LEU A 356 LEU.? 27.14 ZN ZN A 375 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 39.94 1.41 -1.05 41.91 -2.04 -4.52 coo 27.00 6.35 51.01 26.30 4.53 50.18 31.54 5.84 4.26 31.09 6.26 2.19 coo 23.74 1.68 49.50 22.87 -0.24 49.97 38.06 4.19 2.32 35.93 3.79 2.19 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 B 145 LYS B 3 LYS.? 34.82 ZN ZN B 375 B 177 GLU B 9 GLU~? 28.41 ZN ZN B 375 B 201 LEU B 356 LEU.? 26.83 ZN ZN B 375 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo 27.00 6.35 51.01 26.30 4.53 50.18 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -28.77 -13.23 18.96 -27.30 -14.74 19.63 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 B 145 LYS B 247 LYS^? 11.69 ZN ZN B 375 B 177 GLU B 119 GLU~? 15.38 ZN ZN B 375 B 201 LEU B 123 LEU.? 17.38 ZN ZN B 375 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo 27.00 6.35 51.01 26.30 4.53 50.18 -11.67 2.61 5.82 -11.38 1.03 7.26 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -5.20 6.91 4.85 -4.58 8.66 5.96 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 B 145 LYS B 285 LYS^? 22.19 ZN ZN B 375 B 177 GLU B 253 GLU^? 31.12 ZN ZN B 375 B 201 LEU B 251 LEU^? 22.61 ZN ZN B 375 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 1.97 10.60 4.02 5.48 5.38 4.89 coo 27.00 6.35 51.01 26.30 4.53 50.18 -5.44 14.03 -5.56 -4.22 13.73 -7.31 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -3.28 12.31 0.94 -3.84 13.59 2.55 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 B 145 LYS B 285 LYS^? 22.19 ZN ZN B 375 B 177 GLU B 254 GLU^? 30.73 ZN ZN B 375 B 201 LEU B 251 LEU^? 22.61 ZN ZN B 375 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 1.97 10.60 4.02 5.48 5.38 4.89 coo 27.00 6.35 51.01 26.30 4.53 50.18 1.12 17.35 -1.99 2.87 17.99 -2.99 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -3.28 12.31 0.94 -3.84 13.59 2.55 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 11 3 # 11 B 145 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 177 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 201 LEU B 47 LEU.? 6.75 ZN ZN B 374 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 27.00 6.35 51.01 26.30 4.53 50.18 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -16.64 7.19 23.14 -14.64 7.83 22.57 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 12 3 # 12 B 145 LYS B 354 LYS~? 28.15 ZN ZN B 375 B 177 GLU B 9 GLU~? 28.41 ZN ZN B 375 B 201 LEU B 356 LEU.? 26.83 ZN ZN B 375 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 27.00 6.35 51.01 26.30 4.53 50.18 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -28.77 -13.23 18.96 -27.30 -14.74 19.63 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 13 3 # 13 B 145 LYS B 355 LYS.? 33.64 ZN ZN B 375 B 177 GLU B 9 GLU~? 28.41 ZN ZN B 375 B 201 LEU B 356 LEU.? 26.83 ZN ZN B 375 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo 27.00 6.35 51.01 26.30 4.53 50.18 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -28.77 -13.23 18.96 -27.30 -14.74 19.63 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 14 3 # 14 B 145 LYS C 285 LYS^? 22.29 ZN ZN C 375 B 177 GLU C 253 GLU^? 31.42 ZN ZN C 375 B 201 LEU C 251 LEU^? 22.30 ZN ZN C 375 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -14.01 -33.36 45.98 -12.46 -31.50 40.58 coo 27.00 6.35 51.01 26.30 4.53 50.18 -18.88 -44.02 49.77 -19.94 -45.34 51.07 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -14.08 -38.44 49.58 -13.43 -37.26 51.32 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 15 3 # 15 B 145 LYS C 285 LYS^? 22.29 ZN ZN C 375 B 177 GLU C 254 GLU^? 30.85 ZN ZN C 375 B 201 LEU C 251 LEU^? 22.30 ZN ZN C 375 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -14.01 -33.36 45.98 -12.46 -31.50 40.58 coo 27.00 6.35 51.01 26.30 4.53 50.18 -21.46 -36.51 49.50 -23.48 -36.16 48.85 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -14.08 -38.44 49.58 -13.43 -37.26 51.32 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 16 3 # 16 B 145 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 177 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 201 LEU C 47 LEU.? 6.79 ZN ZN C 374 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 27.00 6.35 51.01 26.30 4.53 50.18 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 23.74 1.68 49.50 22.87 -0.24 49.97 8.91 -31.30 59.57 7.16 -30.19 58.83 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 16 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 104 THR~? 6.76 ZN ZN A 375 A 156 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 160 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 10.50 56.87 17.73 11.24 57.93 19.43 32.17 -3.62 26.15 30.67 -3.61 27.70 coo 11.64 63.07 23.95 11.76 62.47 21.20 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 5.78 61.30 21.65 8.04 62.89 17.54 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR A 206 THR^? -4.52 O1S EPE C 377s A 156 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 160 LYS A 138 LYS^? 13.11 N TRS A 378 coo 10.50 56.87 17.73 11.24 57.93 19.43 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 11.64 63.07 23.95 11.76 62.47 21.20 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 5.78 61.30 21.65 8.04 62.89 17.54 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 3 3 # 3 A 132 THR A 206 THR^? -4.52 O1S EPE C 377s A 156 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 160 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 10.50 56.87 17.73 11.24 57.93 19.43 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 11.64 63.07 23.95 11.76 62.47 21.20 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 5.78 61.30 21.65 8.04 62.89 17.54 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 4 3 # 4 A 132 THR B 104 THR~? 6.79 ZN ZN B 375 A 156 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 160 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 10.50 56.87 17.73 11.24 57.93 19.43 -6.78 -0.91 23.63 -5.15 -0.73 25.06 coo 11.64 63.07 23.95 11.76 62.47 21.20 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 5.78 61.30 21.65 8.04 62.89 17.54 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 5 3 # 5 A 132 THR B 206 THR^? 5.63 O3S EPE A 377 A 156 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 160 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 10.50 56.87 17.73 11.24 57.93 19.43 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo 11.64 63.07 23.95 11.76 62.47 21.20 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 5.78 61.30 21.65 8.04 62.89 17.54 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 6 3 # 6 A 132 THR C 206 THR^? 14.70 N TRS A 378 A 156 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 160 LYS C 138 LYS^? 8.30 N TRS A 378 coo 10.50 56.87 17.73 11.24 57.93 19.43 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 11.64 63.07 23.95 11.76 62.47 21.20 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 5.78 61.30 21.65 8.04 62.89 17.54 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 7 3 # 7 A 132 THR C 206 THR^? 14.70 N TRS A 378 A 156 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 160 LYS C 139 LYS^? 16.11 N TRS A 378 coo 10.50 56.87 17.73 11.24 57.93 19.43 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 11.64 63.07 23.95 11.76 62.47 21.20 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 5.78 61.30 21.65 8.04 62.89 17.54 13.08 -32.56 20.05 9.65 -36.55 18.68 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 7 hits 1db3_c01 naa= 3 ULMN 3 1dco_c00 DCOH user 1 3 # 1 A 62 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 63 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 89 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 49.66 36.74 42.37 48.88 35.30 43.64 37.80 0.44 25.56 37.02 -1.29 26.44 coo 49.93 35.76 35.94 51.58 36.96 35.47 37.42 3.90 29.26 38.47 2.36 30.22 coo 46.15 35.33 47.12 47.46 33.99 46.29 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1dco_c00 DCOH user 2 3 # 2 A 62 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 63 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 89 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 49.66 36.74 42.37 48.88 35.30 43.64 37.42 3.90 29.26 38.47 2.36 30.22 coo 49.93 35.76 35.94 51.58 36.96 35.47 32.91 0.46 27.63 33.66 0.11 29.56 coo 46.15 35.33 47.12 47.46 33.99 46.29 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1dco_c00 DCOH user 3 3 # 3 A 62 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 63 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 89 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 49.66 36.74 42.37 48.88 35.30 43.64 32.91 0.46 27.63 33.66 0.11 29.56 coo 49.93 35.76 35.94 51.58 36.96 35.47 37.80 0.44 25.56 37.02 -1.29 26.44 coo 46.15 35.33 47.12 47.46 33.99 46.29 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1dco_c00 DCOH user 4 3 # 4 A 62 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 63 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 89 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 49.66 36.74 42.37 48.88 35.30 43.64 32.91 0.46 27.63 33.66 0.11 29.56 coo 49.93 35.76 35.94 51.58 36.96 35.47 37.42 3.90 29.26 38.47 2.36 30.22 coo 46.15 35.33 47.12 47.46 33.99 46.29 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1dco_c00 DCOH user 5 3 # 5 A 62 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 63 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 89 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 49.66 36.74 42.37 48.88 35.30 43.64 32.91 0.46 27.63 33.66 0.11 29.56 coo 49.93 35.76 35.94 51.58 36.96 35.47 37.42 3.90 29.26 38.47 2.36 30.22 coo 46.15 35.33 47.12 47.46 33.99 46.29 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1dco_c00 DCOH user 6 3 # 6 A 62 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 63 HIS A 163 HIS.? 11.18 O1S EPE C 377 A 89 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 49.66 36.74 42.37 48.88 35.30 43.64 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 49.93 35.76 35.94 51.58 36.96 35.47 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 46.15 35.33 47.12 47.46 33.99 46.29 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1dco_c00 DCOH user 7 3 # 7 A 62 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 63 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 89 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 49.66 36.74 42.37 48.88 35.30 43.64 40.60 0.33 34.12 38.69 0.39 33.24 coo 49.93 35.76 35.94 51.58 36.96 35.47 37.42 3.90 29.26 38.47 2.36 30.22 coo 46.15 35.33 47.12 47.46 33.99 46.29 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1dco_c00 DCOH user 8 3 # 8 A 62 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 63 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 89 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 49.66 36.74 42.37 48.88 35.30 43.64 40.60 0.33 34.12 38.69 0.39 33.24 coo 49.93 35.76 35.94 51.58 36.96 35.47 37.42 3.90 29.26 38.47 2.36 30.22 coo 46.15 35.33 47.12 47.46 33.99 46.29 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 3 1dco_c00 DCOH user 9 3 # 9 A 62 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 63 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 89 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 49.66 36.74 42.37 48.88 35.30 43.64 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 49.93 35.76 35.94 51.58 36.96 35.47 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 46.15 35.33 47.12 47.46 33.99 46.29 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1dco_c00 DCOH user 10 3 # 10 A 62 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 63 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 89 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 49.66 36.74 42.37 48.88 35.30 43.64 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 49.93 35.76 35.94 51.58 36.96 35.47 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 46.15 35.33 47.12 47.46 33.99 46.29 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1dco_c00 DCOH user 11 3 # 11 A 62 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 63 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 89 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 49.66 36.74 42.37 48.88 35.30 43.64 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 49.93 35.76 35.94 51.58 36.96 35.47 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 46.15 35.33 47.12 47.46 33.99 46.29 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1dco_c00 DCOH user 12 3 # 12 A 62 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 63 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 89 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 49.66 36.74 42.37 48.88 35.30 43.64 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 49.93 35.76 35.94 51.58 36.96 35.47 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 46.15 35.33 47.12 47.46 33.99 46.29 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1dco_c00 DCOH user 13 3 # 13 A 62 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 63 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 89 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 49.66 36.74 42.37 48.88 35.30 43.64 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 49.93 35.76 35.94 51.58 36.96 35.47 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 46.15 35.33 47.12 47.46 33.99 46.29 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1dco_c00 DCOH user 14 3 # 14 A 62 HIS B 169 HIS^? 10.86 O3S EPE A 377 A 63 HIS B 163 HIS.? 11.54 O3S EPE A 377 A 89 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 49.66 36.74 42.37 48.88 35.30 43.64 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 49.93 35.76 35.94 51.58 36.96 35.47 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 46.15 35.33 47.12 47.46 33.99 46.29 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1dco_c00 DCOH user 15 3 # 15 A 62 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 63 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 89 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 49.66 36.74 42.37 48.88 35.30 43.64 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 49.93 35.76 35.94 51.58 36.96 35.47 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 46.15 35.33 47.12 47.46 33.99 46.29 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1dco_c00 DCOH user 16 3 # 16 A 62 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 63 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 89 ASP B 312 ASP.? 7.53 ZN ZN B 374 coo 49.66 36.74 42.37 48.88 35.30 43.64 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 49.93 35.76 35.94 51.58 36.96 35.47 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 46.15 35.33 47.12 47.46 33.99 46.29 -4.08 14.12 24.69 -6.01 13.62 25.36 ULMN 3 1dco_c00 DCOH user 17 3 # 17 A 62 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 63 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 89 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 49.66 36.74 42.37 48.88 35.30 43.64 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 49.93 35.76 35.94 51.58 36.96 35.47 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 46.15 35.33 47.12 47.46 33.99 46.29 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1dco_c00 DCOH user 18 3 # 18 A 62 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 63 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 89 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 49.66 36.74 42.37 48.88 35.30 43.64 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 49.93 35.76 35.94 51.58 36.96 35.47 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 46.15 35.33 47.12 47.46 33.99 46.29 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1dco_c00 DCOH user 19 3 # 19 A 62 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 63 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 89 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 49.66 36.74 42.37 48.88 35.30 43.64 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 49.93 35.76 35.94 51.58 36.96 35.47 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 46.15 35.33 47.12 47.46 33.99 46.29 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1dco_c00 DCOH user 20 3 # 20 A 62 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 63 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 89 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 49.66 36.74 42.37 48.88 35.30 43.64 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 49.93 35.76 35.94 51.58 36.96 35.47 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 46.15 35.33 47.12 47.46 33.99 46.29 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1dco_c00 DCOH user 21 3 # 21 A 62 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 63 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 89 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 49.66 36.74 42.37 48.88 35.30 43.64 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 49.93 35.76 35.94 51.58 36.96 35.47 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 46.15 35.33 47.12 47.46 33.99 46.29 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1dco_c00 DCOH user 22 3 # 22 A 62 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 63 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 89 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 49.66 36.74 42.37 48.88 35.30 43.64 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 49.93 35.76 35.94 51.58 36.96 35.47 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 46.15 35.33 47.12 47.46 33.99 46.29 19.06 -47.14 27.83 18.62 -49.09 27.08 ULMN 3 1dco_c00 DCOH user 23 3 # 23 A 62 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 63 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 89 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 49.66 36.74 42.37 48.88 35.30 43.64 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 49.93 35.76 35.94 51.58 36.96 35.47 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 46.15 35.33 47.12 47.46 33.99 46.29 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1dco_c00 DCOH user 24 3 # 24 A 62 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 63 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 89 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 49.66 36.74 42.37 48.88 35.30 43.64 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 49.93 35.76 35.94 51.58 36.96 35.47 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 46.15 35.33 47.12 47.46 33.99 46.29 -0.90 -20.80 57.97 0.71 -21.61 59.03 1dco_c00 source 1dco DCOH : 24 hits 1dco_c00 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 37.80 0.44 25.56 37.02 -1.29 26.44 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.37 50.89 2.29 11.05 51.63 2.25 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 37.80 0.44 25.56 37.02 -1.29 26.44 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.37 50.89 2.29 11.05 51.63 2.25 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 37.80 0.44 25.56 37.02 -1.29 26.44 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.37 50.89 2.29 11.05 51.63 2.25 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 37.42 3.90 29.26 38.47 2.36 30.22 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 40.70 8.14 28.73 41.06 6.40 29.84 coo 11.37 50.89 2.29 11.05 51.63 2.25 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ddj_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 37.42 3.90 29.26 38.47 2.36 30.22 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 40.70 8.14 28.73 41.06 6.40 29.84 coo 11.37 50.89 2.29 11.05 51.63 2.25 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1ddj_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 32.91 0.46 27.63 33.66 0.11 29.56 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 11.37 50.89 2.29 11.05 51.63 2.25 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1ddj_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 739 GLY A 244 GLY^? 11.92 ZN ZN A 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 32.91 0.46 27.63 33.66 0.11 29.56 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 11.37 50.89 2.29 11.05 51.63 2.25 32.51 -13.15 26.46 33.13 -12.90 26.03 ULMN 3 1ddj_c12 PLASMINOGEN user 8 3 # 8 A 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 32.91 0.46 27.63 33.66 0.11 29.56 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 11.37 50.89 2.29 11.05 51.63 2.25 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1ddj_c12 PLASMINOGEN user 9 3 # 9 A 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 32.91 0.46 27.63 33.66 0.11 29.56 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 11.37 50.89 2.29 11.05 51.63 2.25 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1ddj_c12 PLASMINOGEN user 10 3 # 10 A 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 32.91 0.46 27.63 33.66 0.11 29.56 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.37 50.89 2.29 11.05 51.63 2.25 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ddj_c12 PLASMINOGEN user 11 3 # 11 A 603 HIS A 319 HIS~? 24.64 ZN ZN A 374 A 646 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 739 GLY A 277 GLY.? 24.28 ZN ZN A 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 11.37 50.89 2.29 11.05 51.63 2.25 49.23 -14.07 46.91 49.73 -13.44 47.06 ULMN 3 1ddj_c12 PLASMINOGEN user 12 3 # 12 A 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 40.60 0.33 34.12 38.69 0.39 33.24 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 11.37 50.89 2.29 11.05 51.63 2.25 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1ddj_c12 PLASMINOGEN user 13 3 # 13 A 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 646 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 40.60 0.33 34.12 38.69 0.39 33.24 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 39.49 -1.24 39.18 39.76 0.49 37.96 coo 11.37 50.89 2.29 11.05 51.63 2.25 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1ddj_c12 PLASMINOGEN user 14 3 # 14 A 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 646 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 739 GLY A 272 GLY.? 18.36 ZN ZN A 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 40.60 0.33 34.12 38.69 0.39 33.24 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 39.49 -1.24 39.18 39.76 0.49 37.96 coo 11.37 50.89 2.29 11.05 51.63 2.25 54.23 -1.17 38.61 53.76 -1.27 37.97 ULMN 3 1ddj_c12 PLASMINOGEN user 15 3 # 15 A 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.37 50.89 2.29 11.05 51.63 2.25 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1ddj_c12 PLASMINOGEN user 16 3 # 16 A 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.37 50.89 2.29 11.05 51.63 2.25 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ddj_c12 PLASMINOGEN user 17 3 # 17 A 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.37 50.89 2.29 11.05 51.63 2.25 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1ddj_c12 PLASMINOGEN user 18 3 # 18 A 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 11.37 50.89 2.29 11.05 51.63 2.25 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ddj_c12 PLASMINOGEN user 19 3 # 19 A 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 11.37 50.89 2.29 11.05 51.63 2.25 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1ddj_c12 PLASMINOGEN user 20 3 # 20 A 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 11.37 50.89 2.29 11.05 51.63 2.25 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1ddj_c12 PLASMINOGEN user 21 3 # 21 A 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 739 GLY B 244 GLY^? 11.85 ZN ZN B 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 11.37 50.89 2.29 11.05 51.63 2.25 -0.61 -2.61 16.62 -1.32 -2.49 16.19 ULMN 3 1ddj_c12 PLASMINOGEN user 22 3 # 22 A 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 11.37 50.89 2.29 11.05 51.63 2.25 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1ddj_c12 PLASMINOGEN user 23 3 # 23 A 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 739 GLY B 293 GLY.? 9.60 ZN ZN B 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 11.37 50.89 2.29 11.05 51.63 2.25 -0.50 9.63 20.82 -0.36 10.23 21.34 ULMN 3 1ddj_c12 PLASMINOGEN user 24 3 # 24 A 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.37 50.89 2.29 11.05 51.63 2.25 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ddj_c12 PLASMINOGEN user 25 3 # 25 A 603 HIS B 319 HIS~? 24.73 ZN ZN B 374 A 646 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 739 GLY B 277 GLY.? 24.23 ZN ZN B 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 8.16 23.53 21.75 7.85 25.60 21.62 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 9.35 16.65 21.02 10.22 16.89 22.90 coo 11.37 50.89 2.29 11.05 51.63 2.25 3.65 23.16 11.55 3.12 23.75 11.78 ULMN 3 1ddj_c12 PLASMINOGEN user 26 3 # 26 A 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 11.37 50.89 2.29 11.05 51.63 2.25 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1ddj_c12 PLASMINOGEN user 27 3 # 27 A 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 646 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 11.37 50.89 2.29 11.05 51.63 2.25 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1ddj_c12 PLASMINOGEN user 28 3 # 28 A 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 646 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 739 GLY B 272 GLY.? 18.77 ZN ZN B 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 11.37 50.89 2.29 11.05 51.63 2.25 -11.90 23.22 15.48 -12.02 22.37 15.54 ULMN 3 1ddj_c12 PLASMINOGEN user 29 3 # 29 A 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.37 50.89 2.29 11.05 51.63 2.25 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1ddj_c12 PLASMINOGEN user 30 3 # 30 A 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.37 50.89 2.29 11.05 51.63 2.25 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ddj_c12 PLASMINOGEN user 31 3 # 31 A 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.37 50.89 2.29 11.05 51.63 2.25 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1ddj_c12 PLASMINOGEN user 32 3 # 32 A 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 739 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.37 50.89 2.29 11.05 51.63 2.25 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 1ddj_c12 PLASMINOGEN user 33 3 # 33 A 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 11.37 50.89 2.29 11.05 51.63 2.25 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ddj_c12 PLASMINOGEN user 34 3 # 34 A 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 11.37 50.89 2.29 11.05 51.63 2.25 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1ddj_c12 PLASMINOGEN user 35 3 # 35 A 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 11.37 50.89 2.29 11.05 51.63 2.25 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1ddj_c12 PLASMINOGEN user 36 3 # 36 A 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 739 GLY C 244 GLY^? 11.70 ZN ZN C 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 11.37 50.89 2.29 11.05 51.63 2.25 2.79 -27.67 41.30 2.83 -28.37 41.63 ULMN 3 1ddj_c12 PLASMINOGEN user 37 3 # 37 A 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 11.37 50.89 2.29 11.05 51.63 2.25 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1ddj_c12 PLASMINOGEN user 38 3 # 38 A 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 739 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 11.37 50.89 2.29 11.05 51.63 2.25 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1ddj_c12 PLASMINOGEN user 39 3 # 39 A 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.37 50.89 2.29 11.05 51.63 2.25 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ddj_c12 PLASMINOGEN user 40 3 # 40 A 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 646 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 11.37 50.89 2.29 11.05 51.63 2.25 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1ddj_c12 PLASMINOGEN user 41 3 # 41 A 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 646 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 739 GLY C 272 GLY.? 18.55 ZN ZN C 374 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 11.37 50.89 2.29 11.05 51.63 2.25 -7.94 -30.61 66.74 -7.33 -30.77 66.23 1ddj_c12 source 1ddj PLASMINOGEN : 41 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 739 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 37.80 0.44 25.56 37.02 -1.29 26.44 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 37.80 0.44 25.56 37.02 -1.29 26.44 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 37.80 0.44 25.56 37.02 -1.29 26.44 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 37.80 0.44 25.56 37.02 -1.29 26.44 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1ddj_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 37.42 3.90 29.26 38.47 2.36 30.22 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 40.70 8.14 28.73 41.06 6.40 29.84 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1ddj_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 37.42 3.90 29.26 38.47 2.36 30.22 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 40.70 8.14 28.73 41.06 6.40 29.84 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ddj_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 37.42 3.90 29.26 38.47 2.36 30.22 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 40.70 8.14 28.73 41.06 6.40 29.84 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1ddj_c13 PLASMINOGEN user 8 3 # 8 B 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 739 GLY A 342 GLY~? 12.90 ZN ZN A 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 37.42 3.90 29.26 38.47 2.36 30.22 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 40.70 8.14 28.73 41.06 6.40 29.84 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 44.89 -3.04 18.23 44.73 -2.27 17.91 ULMN 3 1ddj_c13 PLASMINOGEN user 9 3 # 9 B 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 32.91 0.46 27.63 33.66 0.11 29.56 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1ddj_c13 PLASMINOGEN user 10 3 # 10 B 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 739 GLY A 244 GLY^? 11.92 ZN ZN A 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 32.91 0.46 27.63 33.66 0.11 29.56 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 32.51 -13.15 26.46 33.13 -12.90 26.03 ULMN 3 1ddj_c13 PLASMINOGEN user 11 3 # 11 B 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 32.91 0.46 27.63 33.66 0.11 29.56 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1ddj_c13 PLASMINOGEN user 12 3 # 12 B 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 32.91 0.46 27.63 33.66 0.11 29.56 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1ddj_c13 PLASMINOGEN user 13 3 # 13 B 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 32.91 0.46 27.63 33.66 0.11 29.56 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ddj_c13 PLASMINOGEN user 14 3 # 14 B 603 HIS A 319 HIS~? 24.64 ZN ZN A 374 B 646 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 739 GLY A 277 GLY.? 24.28 ZN ZN A 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 41.01 -9.30 52.79 42.52 -8.54 54.04 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 49.23 -14.07 46.91 49.73 -13.44 47.06 ULMN 3 1ddj_c13 PLASMINOGEN user 15 3 # 15 B 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 40.60 0.33 34.12 38.69 0.39 33.24 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1ddj_c13 PLASMINOGEN user 16 3 # 16 B 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 646 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 40.60 0.33 34.12 38.69 0.39 33.24 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 39.49 -1.24 39.18 39.76 0.49 37.96 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1ddj_c13 PLASMINOGEN user 17 3 # 17 B 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 646 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 739 GLY A 272 GLY.? 18.36 ZN ZN A 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 40.60 0.33 34.12 38.69 0.39 33.24 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 39.49 -1.24 39.18 39.76 0.49 37.96 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 54.23 -1.17 38.61 53.76 -1.27 37.97 ULMN 3 1ddj_c13 PLASMINOGEN user 18 3 # 18 B 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1ddj_c13 PLASMINOGEN user 19 3 # 19 B 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ddj_c13 PLASMINOGEN user 20 3 # 20 B 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1ddj_c13 PLASMINOGEN user 21 3 # 21 B 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1ddj_c13 PLASMINOGEN user 22 3 # 22 B 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ddj_c13 PLASMINOGEN user 23 3 # 23 B 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1ddj_c13 PLASMINOGEN user 24 3 # 24 B 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 739 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1ddj_c13 PLASMINOGEN user 25 3 # 25 B 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1ddj_c13 PLASMINOGEN user 26 3 # 26 B 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 739 GLY B 244 GLY^? 11.85 ZN ZN B 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -0.61 -2.61 16.62 -1.32 -2.49 16.19 ULMN 3 1ddj_c13 PLASMINOGEN user 27 3 # 27 B 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1ddj_c13 PLASMINOGEN user 28 3 # 28 B 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 739 GLY B 293 GLY.? 9.60 ZN ZN B 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -0.50 9.63 20.82 -0.36 10.23 21.34 ULMN 3 1ddj_c13 PLASMINOGEN user 29 3 # 29 B 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ddj_c13 PLASMINOGEN user 30 3 # 30 B 603 HIS B 169 HIS^? 10.86 O3S EPE A 377 B 646 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 739 GLY A 178 GLY^? 3.80 C6 EPE A 377 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 3.25 -33.31 -0.46 2.85 -33.92 -0.95 ULMN 3 1ddj_c13 PLASMINOGEN user 31 3 # 31 B 603 HIS B 319 HIS~? 24.73 ZN ZN B 374 B 646 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 739 GLY B 277 GLY.? 24.23 ZN ZN B 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 8.16 23.53 21.75 7.85 25.60 21.62 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 9.35 16.65 21.02 10.22 16.89 22.90 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 3.65 23.16 11.55 3.12 23.75 11.78 ULMN 3 1ddj_c13 PLASMINOGEN user 32 3 # 32 B 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 646 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1ddj_c13 PLASMINOGEN user 33 3 # 33 B 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 646 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 739 GLY B 272 GLY.? 18.77 ZN ZN B 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -11.90 23.22 15.48 -12.02 22.37 15.54 ULMN 3 1ddj_c13 PLASMINOGEN user 34 3 # 34 B 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1ddj_c13 PLASMINOGEN user 35 3 # 35 B 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ddj_c13 PLASMINOGEN user 36 3 # 36 B 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1ddj_c13 PLASMINOGEN user 37 3 # 37 B 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1ddj_c13 PLASMINOGEN user 38 3 # 38 B 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ddj_c13 PLASMINOGEN user 39 3 # 39 B 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1ddj_c13 PLASMINOGEN user 40 3 # 40 B 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1ddj_c13 PLASMINOGEN user 41 3 # 41 B 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 739 GLY C 244 GLY^? 11.70 ZN ZN C 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 2.79 -27.67 41.30 2.83 -28.37 41.63 ULMN 3 1ddj_c13 PLASMINOGEN user 42 3 # 42 B 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1ddj_c13 PLASMINOGEN user 43 3 # 43 B 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 739 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1ddj_c13 PLASMINOGEN user 44 3 # 44 B 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ddj_c13 PLASMINOGEN user 45 3 # 45 B 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 646 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1ddj_c13 PLASMINOGEN user 46 3 # 46 B 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 646 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 739 GLY C 272 GLY.? 18.55 ZN ZN C 374 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -7.94 -30.61 66.74 -7.33 -30.77 66.23 1ddj_c13 source 1ddj PLASMINOGEN : 46 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 739 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 37.80 0.44 25.56 37.02 -1.29 26.44 coo 16.06 55.72 54.73 15.97 56.49 56.70 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 9.38 49.29 65.28 9.01 50.03 65.31 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 37.80 0.44 25.56 37.02 -1.29 26.44 coo 16.06 55.72 54.73 15.97 56.49 56.70 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 9.38 49.29 65.28 9.01 50.03 65.31 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 37.80 0.44 25.56 37.02 -1.29 26.44 coo 16.06 55.72 54.73 15.97 56.49 56.70 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 9.38 49.29 65.28 9.01 50.03 65.31 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 37.80 0.44 25.56 37.02 -1.29 26.44 coo 16.06 55.72 54.73 15.97 56.49 56.70 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 9.38 49.29 65.28 9.01 50.03 65.31 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 37.42 3.90 29.26 38.47 2.36 30.22 coo 16.06 55.72 54.73 15.97 56.49 56.70 40.70 8.14 28.73 41.06 6.40 29.84 coo 9.38 49.29 65.28 9.01 50.03 65.31 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ddj_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 37.42 3.90 29.26 38.47 2.36 30.22 coo 16.06 55.72 54.73 15.97 56.49 56.70 40.70 8.14 28.73 41.06 6.40 29.84 coo 9.38 49.29 65.28 9.01 50.03 65.31 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1ddj_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 739 GLY A 342 GLY~? 12.90 ZN ZN A 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 37.42 3.90 29.26 38.47 2.36 30.22 coo 16.06 55.72 54.73 15.97 56.49 56.70 40.70 8.14 28.73 41.06 6.40 29.84 coo 9.38 49.29 65.28 9.01 50.03 65.31 44.89 -3.04 18.23 44.73 -2.27 17.91 ULMN 3 1ddj_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 32.91 0.46 27.63 33.66 0.11 29.56 coo 16.06 55.72 54.73 15.97 56.49 56.70 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 9.38 49.29 65.28 9.01 50.03 65.31 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1ddj_c14 PLASMINOGEN user 9 3 # 9 C 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 739 GLY A 244 GLY^? 11.92 ZN ZN A 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 32.91 0.46 27.63 33.66 0.11 29.56 coo 16.06 55.72 54.73 15.97 56.49 56.70 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 9.38 49.29 65.28 9.01 50.03 65.31 32.51 -13.15 26.46 33.13 -12.90 26.03 ULMN 3 1ddj_c14 PLASMINOGEN user 10 3 # 10 C 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 32.91 0.46 27.63 33.66 0.11 29.56 coo 16.06 55.72 54.73 15.97 56.49 56.70 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 9.38 49.29 65.28 9.01 50.03 65.31 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1ddj_c14 PLASMINOGEN user 11 3 # 11 C 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 32.91 0.46 27.63 33.66 0.11 29.56 coo 16.06 55.72 54.73 15.97 56.49 56.70 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 9.38 49.29 65.28 9.01 50.03 65.31 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1ddj_c14 PLASMINOGEN user 12 3 # 12 C 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 32.91 0.46 27.63 33.66 0.11 29.56 coo 16.06 55.72 54.73 15.97 56.49 56.70 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 9.38 49.29 65.28 9.01 50.03 65.31 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ddj_c14 PLASMINOGEN user 13 3 # 13 C 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s C 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 C 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 40.60 0.33 34.12 38.69 0.39 33.24 coo 16.06 55.72 54.73 15.97 56.49 56.70 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 9.38 49.29 65.28 9.01 50.03 65.31 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1ddj_c14 PLASMINOGEN user 14 3 # 14 C 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s C 646 ASP A 312 ASP.? 7.50 ZN ZN A 374 C 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 40.60 0.33 34.12 38.69 0.39 33.24 coo 16.06 55.72 54.73 15.97 56.49 56.70 39.49 -1.24 39.18 39.76 0.49 37.96 coo 9.38 49.29 65.28 9.01 50.03 65.31 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1ddj_c14 PLASMINOGEN user 15 3 # 15 C 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s C 646 ASP A 312 ASP.? 7.50 ZN ZN A 374 C 739 GLY A 272 GLY.? 18.36 ZN ZN A 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 40.60 0.33 34.12 38.69 0.39 33.24 coo 16.06 55.72 54.73 15.97 56.49 56.70 39.49 -1.24 39.18 39.76 0.49 37.96 coo 9.38 49.29 65.28 9.01 50.03 65.31 54.23 -1.17 38.61 53.76 -1.27 37.97 ULMN 3 1ddj_c14 PLASMINOGEN user 16 3 # 16 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 739 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 16.06 55.72 54.73 15.97 56.49 56.70 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 9.38 49.29 65.28 9.01 50.03 65.31 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1ddj_c14 PLASMINOGEN user 17 3 # 17 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 16.06 55.72 54.73 15.97 56.49 56.70 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 9.38 49.29 65.28 9.01 50.03 65.31 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1ddj_c14 PLASMINOGEN user 18 3 # 18 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 16.06 55.72 54.73 15.97 56.49 56.70 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 9.38 49.29 65.28 9.01 50.03 65.31 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ddj_c14 PLASMINOGEN user 19 3 # 19 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 16.06 55.72 54.73 15.97 56.49 56.70 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 9.38 49.29 65.28 9.01 50.03 65.31 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1ddj_c14 PLASMINOGEN user 20 3 # 20 C 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 16.06 55.72 54.73 15.97 56.49 56.70 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 9.38 49.29 65.28 9.01 50.03 65.31 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1ddj_c14 PLASMINOGEN user 21 3 # 21 C 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 16.06 55.72 54.73 15.97 56.49 56.70 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 9.38 49.29 65.28 9.01 50.03 65.31 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ddj_c14 PLASMINOGEN user 22 3 # 22 C 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 16.06 55.72 54.73 15.97 56.49 56.70 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 9.38 49.29 65.28 9.01 50.03 65.31 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1ddj_c14 PLASMINOGEN user 23 3 # 23 C 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 739 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 16.06 55.72 54.73 15.97 56.49 56.70 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 9.38 49.29 65.28 9.01 50.03 65.31 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1ddj_c14 PLASMINOGEN user 24 3 # 24 C 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 9.38 49.29 65.28 9.01 50.03 65.31 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1ddj_c14 PLASMINOGEN user 25 3 # 25 C 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 739 GLY B 244 GLY^? 11.85 ZN ZN B 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 9.38 49.29 65.28 9.01 50.03 65.31 -0.61 -2.61 16.62 -1.32 -2.49 16.19 ULMN 3 1ddj_c14 PLASMINOGEN user 26 3 # 26 C 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 9.38 49.29 65.28 9.01 50.03 65.31 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1ddj_c14 PLASMINOGEN user 27 3 # 27 C 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 739 GLY B 293 GLY.? 9.60 ZN ZN B 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 9.38 49.29 65.28 9.01 50.03 65.31 -0.50 9.63 20.82 -0.36 10.23 21.34 ULMN 3 1ddj_c14 PLASMINOGEN user 28 3 # 28 C 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 9.38 49.29 65.28 9.01 50.03 65.31 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ddj_c14 PLASMINOGEN user 29 3 # 29 C 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s C 646 ASP B 312 ASP.? 7.53 ZN ZN B 374 C 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 16.06 55.72 54.73 15.97 56.49 56.70 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 9.38 49.29 65.28 9.01 50.03 65.31 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1ddj_c14 PLASMINOGEN user 30 3 # 30 C 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s C 646 ASP B 312 ASP.? 7.53 ZN ZN B 374 C 739 GLY B 272 GLY.? 18.77 ZN ZN B 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 16.06 55.72 54.73 15.97 56.49 56.70 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 9.38 49.29 65.28 9.01 50.03 65.31 -11.90 23.22 15.48 -12.02 22.37 15.54 ULMN 3 1ddj_c14 PLASMINOGEN user 31 3 # 31 C 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 16.06 55.72 54.73 15.97 56.49 56.70 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 9.38 49.29 65.28 9.01 50.03 65.31 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1ddj_c14 PLASMINOGEN user 32 3 # 32 C 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 16.06 55.72 54.73 15.97 56.49 56.70 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 9.38 49.29 65.28 9.01 50.03 65.31 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ddj_c14 PLASMINOGEN user 33 3 # 33 C 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 16.06 55.72 54.73 15.97 56.49 56.70 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 9.38 49.29 65.28 9.01 50.03 65.31 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1ddj_c14 PLASMINOGEN user 34 3 # 34 C 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 16.06 55.72 54.73 15.97 56.49 56.70 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 9.38 49.29 65.28 9.01 50.03 65.31 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ddj_c14 PLASMINOGEN user 35 3 # 35 C 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 16.06 55.72 54.73 15.97 56.49 56.70 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 9.38 49.29 65.28 9.01 50.03 65.31 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1ddj_c14 PLASMINOGEN user 36 3 # 36 C 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 739 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 16.06 55.72 54.73 15.97 56.49 56.70 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 9.38 49.29 65.28 9.01 50.03 65.31 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 1ddj_c14 PLASMINOGEN user 37 3 # 37 C 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 C 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 16.06 55.72 54.73 15.97 56.49 56.70 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 9.38 49.29 65.28 9.01 50.03 65.31 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1ddj_c14 PLASMINOGEN user 38 3 # 38 C 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 C 739 GLY C 244 GLY^? 11.70 ZN ZN C 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 16.06 55.72 54.73 15.97 56.49 56.70 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 9.38 49.29 65.28 9.01 50.03 65.31 2.79 -27.67 41.30 2.83 -28.37 41.63 ULMN 3 1ddj_c14 PLASMINOGEN user 39 3 # 39 C 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 C 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 16.06 55.72 54.73 15.97 56.49 56.70 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 9.38 49.29 65.28 9.01 50.03 65.31 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1ddj_c14 PLASMINOGEN user 40 3 # 40 C 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 C 739 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 16.06 55.72 54.73 15.97 56.49 56.70 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 9.38 49.29 65.28 9.01 50.03 65.31 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1ddj_c14 PLASMINOGEN user 41 3 # 41 C 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 16.06 55.72 54.73 15.97 56.49 56.70 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 9.38 49.29 65.28 9.01 50.03 65.31 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ddj_c14 PLASMINOGEN user 42 3 # 42 C 603 HIS C 316 HIS~? -20.42 O8 EPE C 376s C 646 ASP C 320 ASP~? -21.75 ZN ZN C 374s C 739 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 16.06 55.72 54.73 15.97 56.49 56.70 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 9.38 49.29 65.28 9.01 50.03 65.31 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1ddj_c14 PLASMINOGEN user 43 3 # 43 C 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s C 646 ASP C 312 ASP.? 7.48 ZN ZN C 374 C 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo 15.33 59.81 59.60 13.98 60.99 60.69 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 16.06 55.72 54.73 15.97 56.49 56.70 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 9.38 49.29 65.28 9.01 50.03 65.31 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1ddj_c14 PLASMINOGEN user 44 3 # 44 C 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s C 646 ASP C 312 ASP.? 7.48 ZN ZN C 374 C 739 GLY C 272 GLY.? 18.55 ZN ZN C 374 coo 15.33 59.81 59.60 13.98 60.99 60.69 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 16.06 55.72 54.73 15.97 56.49 56.70 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 9.38 49.29 65.28 9.01 50.03 65.31 -7.94 -30.61 66.74 -7.33 -30.77 66.23 1ddj_c14 source 1ddj PLASMINOGEN : 44 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 739 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 37.80 0.44 25.56 37.02 -1.29 26.44 coo -25.73 33.05 39.28 -27.50 34.05 39.88 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -27.66 47.32 40.66 -27.81 47.01 41.41 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 37.80 0.44 25.56 37.02 -1.29 26.44 coo -25.73 33.05 39.28 -27.50 34.05 39.88 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -27.66 47.32 40.66 -27.81 47.01 41.41 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 37.80 0.44 25.56 37.02 -1.29 26.44 coo -25.73 33.05 39.28 -27.50 34.05 39.88 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -27.66 47.32 40.66 -27.81 47.01 41.41 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 37.80 0.44 25.56 37.02 -1.29 26.44 coo -25.73 33.05 39.28 -27.50 34.05 39.88 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -27.66 47.32 40.66 -27.81 47.01 41.41 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1ddj_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 37.42 3.90 29.26 38.47 2.36 30.22 coo -25.73 33.05 39.28 -27.50 34.05 39.88 40.70 8.14 28.73 41.06 6.40 29.84 coo -27.66 47.32 40.66 -27.81 47.01 41.41 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1ddj_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 37.42 3.90 29.26 38.47 2.36 30.22 coo -25.73 33.05 39.28 -27.50 34.05 39.88 40.70 8.14 28.73 41.06 6.40 29.84 coo -27.66 47.32 40.66 -27.81 47.01 41.41 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ddj_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 37.42 3.90 29.26 38.47 2.36 30.22 coo -25.73 33.05 39.28 -27.50 34.05 39.88 40.70 8.14 28.73 41.06 6.40 29.84 coo -27.66 47.32 40.66 -27.81 47.01 41.41 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1ddj_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 739 GLY A 342 GLY~? 12.90 ZN ZN A 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 37.42 3.90 29.26 38.47 2.36 30.22 coo -25.73 33.05 39.28 -27.50 34.05 39.88 40.70 8.14 28.73 41.06 6.40 29.84 coo -27.66 47.32 40.66 -27.81 47.01 41.41 44.89 -3.04 18.23 44.73 -2.27 17.91 ULMN 3 1ddj_c15 PLASMINOGEN user 9 3 # 9 D 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 739 GLY A 244 GLY^? 11.92 ZN ZN A 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 32.91 0.46 27.63 33.66 0.11 29.56 coo -25.73 33.05 39.28 -27.50 34.05 39.88 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -27.66 47.32 40.66 -27.81 47.01 41.41 32.51 -13.15 26.46 33.13 -12.90 26.03 ULMN 3 1ddj_c15 PLASMINOGEN user 10 3 # 10 D 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 32.91 0.46 27.63 33.66 0.11 29.56 coo -25.73 33.05 39.28 -27.50 34.05 39.88 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -27.66 47.32 40.66 -27.81 47.01 41.41 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1ddj_c15 PLASMINOGEN user 11 3 # 11 D 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 32.91 0.46 27.63 33.66 0.11 29.56 coo -25.73 33.05 39.28 -27.50 34.05 39.88 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -27.66 47.32 40.66 -27.81 47.01 41.41 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1ddj_c15 PLASMINOGEN user 12 3 # 12 D 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 32.91 0.46 27.63 33.66 0.11 29.56 coo -25.73 33.05 39.28 -27.50 34.05 39.88 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -27.66 47.32 40.66 -27.81 47.01 41.41 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ddj_c15 PLASMINOGEN user 13 3 # 13 D 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 32.91 0.46 27.63 33.66 0.11 29.56 coo -25.73 33.05 39.28 -27.50 34.05 39.88 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -27.66 47.32 40.66 -27.81 47.01 41.41 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1ddj_c15 PLASMINOGEN user 14 3 # 14 D 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 739 GLY A 342 GLY~? 12.90 ZN ZN A 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 32.91 0.46 27.63 33.66 0.11 29.56 coo -25.73 33.05 39.28 -27.50 34.05 39.88 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -27.66 47.32 40.66 -27.81 47.01 41.41 44.89 -3.04 18.23 44.73 -2.27 17.91 ULMN 3 1ddj_c15 PLASMINOGEN user 15 3 # 15 D 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s D 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 D 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 40.60 0.33 34.12 38.69 0.39 33.24 coo -25.73 33.05 39.28 -27.50 34.05 39.88 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -27.66 47.32 40.66 -27.81 47.01 41.41 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1ddj_c15 PLASMINOGEN user 16 3 # 16 D 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s D 646 ASP A 312 ASP.? 7.50 ZN ZN A 374 D 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 40.60 0.33 34.12 38.69 0.39 33.24 coo -25.73 33.05 39.28 -27.50 34.05 39.88 39.49 -1.24 39.18 39.76 0.49 37.96 coo -27.66 47.32 40.66 -27.81 47.01 41.41 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1ddj_c15 PLASMINOGEN user 17 3 # 17 D 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s D 646 ASP A 312 ASP.? 7.50 ZN ZN A 374 D 739 GLY A 272 GLY.? 18.36 ZN ZN A 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 40.60 0.33 34.12 38.69 0.39 33.24 coo -25.73 33.05 39.28 -27.50 34.05 39.88 39.49 -1.24 39.18 39.76 0.49 37.96 coo -27.66 47.32 40.66 -27.81 47.01 41.41 54.23 -1.17 38.61 53.76 -1.27 37.97 ULMN 3 1ddj_c15 PLASMINOGEN user 18 3 # 18 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 739 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1ddj_c15 PLASMINOGEN user 19 3 # 19 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1ddj_c15 PLASMINOGEN user 20 3 # 20 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ddj_c15 PLASMINOGEN user 21 3 # 21 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1ddj_c15 PLASMINOGEN user 22 3 # 22 D 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1ddj_c15 PLASMINOGEN user 23 3 # 23 D 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ddj_c15 PLASMINOGEN user 24 3 # 24 D 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1ddj_c15 PLASMINOGEN user 25 3 # 25 D 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 739 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1ddj_c15 PLASMINOGEN user 26 3 # 26 D 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1ddj_c15 PLASMINOGEN user 27 3 # 27 D 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 739 GLY B 244 GLY^? 11.85 ZN ZN B 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -0.61 -2.61 16.62 -1.32 -2.49 16.19 ULMN 3 1ddj_c15 PLASMINOGEN user 28 3 # 28 D 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1ddj_c15 PLASMINOGEN user 29 3 # 29 D 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 739 GLY B 293 GLY.? 9.60 ZN ZN B 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -0.50 9.63 20.82 -0.36 10.23 21.34 ULMN 3 1ddj_c15 PLASMINOGEN user 30 3 # 30 D 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ddj_c15 PLASMINOGEN user 31 3 # 31 D 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1ddj_c15 PLASMINOGEN user 32 3 # 32 D 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 739 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1ddj_c15 PLASMINOGEN user 33 3 # 33 D 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s D 646 ASP B 312 ASP.? 7.53 ZN ZN B 374 D 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1ddj_c15 PLASMINOGEN user 34 3 # 34 D 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s D 646 ASP B 312 ASP.? 7.53 ZN ZN B 374 D 739 GLY B 272 GLY.? 18.77 ZN ZN B 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -11.90 23.22 15.48 -12.02 22.37 15.54 ULMN 3 1ddj_c15 PLASMINOGEN user 35 3 # 35 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 739 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -25.73 33.05 39.28 -27.50 34.05 39.88 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -27.66 47.32 40.66 -27.81 47.01 41.41 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1ddj_c15 PLASMINOGEN user 36 3 # 36 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -25.73 33.05 39.28 -27.50 34.05 39.88 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -27.66 47.32 40.66 -27.81 47.01 41.41 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1ddj_c15 PLASMINOGEN user 37 3 # 37 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -25.73 33.05 39.28 -27.50 34.05 39.88 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ddj_c15 PLASMINOGEN user 38 3 # 38 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -25.73 33.05 39.28 -27.50 34.05 39.88 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1ddj_c15 PLASMINOGEN user 39 3 # 39 D 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -25.73 33.05 39.28 -27.50 34.05 39.88 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -27.66 47.32 40.66 -27.81 47.01 41.41 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1ddj_c15 PLASMINOGEN user 40 3 # 40 D 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -25.73 33.05 39.28 -27.50 34.05 39.88 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ddj_c15 PLASMINOGEN user 41 3 # 41 D 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -25.73 33.05 39.28 -27.50 34.05 39.88 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1ddj_c15 PLASMINOGEN user 42 3 # 42 D 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 739 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -25.73 33.05 39.28 -27.50 34.05 39.88 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -27.66 47.32 40.66 -27.81 47.01 41.41 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 1ddj_c15 PLASMINOGEN user 43 3 # 43 D 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -25.73 33.05 39.28 -27.50 34.05 39.88 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -27.66 47.32 40.66 -27.81 47.01 41.41 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1ddj_c15 PLASMINOGEN user 44 3 # 44 D 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 739 GLY C 244 GLY^? 11.70 ZN ZN C 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -25.73 33.05 39.28 -27.50 34.05 39.88 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -27.66 47.32 40.66 -27.81 47.01 41.41 2.79 -27.67 41.30 2.83 -28.37 41.63 ULMN 3 1ddj_c15 PLASMINOGEN user 45 3 # 45 D 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -25.73 33.05 39.28 -27.50 34.05 39.88 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1ddj_c15 PLASMINOGEN user 46 3 # 46 D 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 739 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -25.73 33.05 39.28 -27.50 34.05 39.88 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1ddj_c15 PLASMINOGEN user 47 3 # 47 D 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -25.73 33.05 39.28 -27.50 34.05 39.88 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ddj_c15 PLASMINOGEN user 48 3 # 48 D 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -25.73 33.05 39.28 -27.50 34.05 39.88 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1ddj_c15 PLASMINOGEN user 49 3 # 49 D 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s D 646 ASP C 312 ASP.? 7.48 ZN ZN C 374 D 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo -30.51 33.83 43.05 -30.50 33.12 45.03 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1ddj_c15 PLASMINOGEN user 50 3 # 50 D 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s D 646 ASP C 312 ASP.? 7.48 ZN ZN C 374 D 739 GLY C 272 GLY.? 18.55 ZN ZN C 374 coo -30.51 33.83 43.05 -30.50 33.12 45.03 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -7.94 -30.61 66.74 -7.33 -30.77 66.23 1ddj_c15 source 1ddj PLASMINOGEN : 50 hits 1ddj_c15 naa= 3 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 1 3 # 1 A 50 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 96 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 137 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 1.83 2.95 4.76 1.26 0.98 4.81 40.60 0.33 34.12 38.69 0.39 33.24 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 41.61 -2.34 29.43 39.56 -1.83 29.49 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 2 3 # 2 A 50 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 96 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 137 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 1.83 2.95 4.76 1.26 0.98 4.81 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -10.29 7.50 19.92 -9.48 6.56 21.59 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 3 3 # 3 A 50 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 96 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 137 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 1.83 2.95 4.76 1.26 0.98 4.81 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 3.38 -29.70 55.34 4.58 -28.10 54.66 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 10.51 -24.81 51.94 8.80 -23.79 52.62 1de3_c00 source 1de3 RIBONUCLEASE ALPHA-SARCIN : 3 hits 1de3_c00 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 90 GLU~? 12.44 O2S EPE A 376 A 226 THR A 367 THR.? 11.13 ZN ZN A 374 A 229 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 9.66 102.78 70.07 9.79 101.18 71.42 33.69 24.77 24.85 34.29 26.39 26.04 coo 7.24 97.46 49.60 8.11 95.69 48.80 46.41 8.27 30.19 44.93 8.03 28.58 coo 10.53 97.56 43.71 9.33 93.71 47.17 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 175 GLU^? 13.72 C8 EPE A 377 A 226 THR C 206 THR^? 14.70 N TRS A 378 A 229 LYS C 138 LYS^? 8.30 N TRS A 378 coo 9.66 102.78 70.07 9.79 101.18 71.42 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 7.24 97.46 49.60 8.11 95.69 48.80 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU A 200 GLU^? 11.53 C6 EPE A 377 A 226 THR A 206 THR^? -4.52 O1S EPE C 377s A 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 9.66 102.78 70.07 9.79 101.18 71.42 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 7.24 97.46 49.60 8.11 95.69 48.80 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 10.53 97.56 43.71 9.33 93.71 47.17 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 226 THR A 242 THR^? 8.72 O3 TRS A 378 A 229 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo 9.66 102.78 70.07 9.79 101.18 71.42 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 7.24 97.46 49.60 8.11 95.69 48.80 30.60 -18.28 22.38 30.36 -19.25 24.36 coo 10.53 97.56 43.71 9.33 93.71 47.17 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU B 90 GLU~? 12.95 O2S EPE B 376 A 226 THR B 367 THR.? 10.99 ZN ZN B 374 A 229 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 9.66 102.78 70.07 9.79 101.18 71.42 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 7.24 97.46 49.60 8.11 95.69 48.80 -18.95 13.55 24.81 -19.03 11.36 25.00 coo 10.53 97.56 43.71 9.33 93.71 47.17 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 226 THR A 206 THR^? -4.52 O1S EPE C 377s A 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 9.66 102.78 70.07 9.79 101.18 71.42 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 7.24 97.46 49.60 8.11 95.69 48.80 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 10.53 97.56 43.71 9.33 93.71 47.17 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU B 200 GLU^? 21.89 O2S EPE A 377 A 226 THR B 206 THR^? 5.63 O3S EPE A 377 A 229 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 9.66 102.78 70.07 9.79 101.18 71.42 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 7.24 97.46 49.60 8.11 95.69 48.80 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo 10.53 97.56 43.71 9.33 93.71 47.17 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 57 GLU B 200 GLU^? 21.89 O2S EPE A 377 A 226 THR B 222 THR~? 21.64 O3S EPE A 377 A 229 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 9.66 102.78 70.07 9.79 101.18 71.42 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 7.24 97.46 49.60 8.11 95.69 48.80 -10.58 -37.08 17.00 -12.43 -36.02 17.53 coo 10.53 97.56 43.71 9.33 93.71 47.17 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 57 GLU B 227 GLU.? 24.58 O3S EPE A 377 A 226 THR C 126 THR^? 16.85 ZN ZN C 375 A 229 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 9.66 102.78 70.07 9.79 101.18 71.42 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 7.24 97.46 49.60 8.11 95.69 48.80 -5.70 -36.58 41.92 -4.55 -37.27 43.63 coo 10.53 97.56 43.71 9.33 93.71 47.17 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 57 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 226 THR B 242 THR^? 18.76 ZN ZN B 375 A 229 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 9.66 102.78 70.07 9.79 101.18 71.42 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 7.24 97.46 49.60 8.11 95.69 48.80 1.06 -7.67 12.24 3.05 -6.84 12.40 coo 10.53 97.56 43.71 9.33 93.71 47.17 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 57 GLU C 90 GLU~? 12.50 O3S EPE C 376 A 226 THR C 367 THR.? 11.10 ZN ZN C 374 A 229 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 9.66 102.78 70.07 9.79 101.18 71.42 27.07 -22.98 69.65 26.90 -21.97 71.52 coo 7.24 97.46 49.60 8.11 95.69 48.80 7.09 -30.04 66.37 8.69 -30.35 64.94 coo 10.53 97.56 43.71 9.33 93.71 47.17 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 57 GLU C 127 GLU^? 21.05 ZN ZN C 375 A 226 THR C 104 THR~? 6.99 ZN ZN C 375 A 229 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 9.66 102.78 70.07 9.79 101.18 71.42 -6.33 -33.63 38.15 -7.56 -32.26 37.10 coo 7.24 97.46 49.60 8.11 95.69 48.80 9.25 -26.14 47.92 9.13 -24.05 47.44 coo 10.53 97.56 43.71 9.33 93.71 47.17 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 57 GLU C 175 GLU^? 13.76 O8 EPE C 377 A 226 THR B 206 THR^? 5.63 O3S EPE A 377 A 229 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 9.66 102.78 70.07 9.79 101.18 71.42 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 7.24 97.46 49.60 8.11 95.69 48.80 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo 10.53 97.56 43.71 9.33 93.71 47.17 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 A 57 GLU C 184 GLU.? 20.48 N4 EPE C 377 A 226 THR A 126 THR^? 16.96 ZN ZN A 375 A 229 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 9.66 102.78 70.07 9.79 101.18 71.42 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 7.24 97.46 49.60 8.11 95.69 48.80 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 10.53 97.56 43.71 9.33 93.71 47.17 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 A 57 GLU C 184 GLU.? 20.48 N4 EPE C 377 A 226 THR A 206 THR^? -4.52 O1S EPE C 377s A 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 9.66 102.78 70.07 9.79 101.18 71.42 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 7.24 97.46 49.60 8.11 95.69 48.80 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 10.53 97.56 43.71 9.33 93.71 47.17 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 A 57 GLU C 184 GLU.? 20.48 N4 EPE C 377 A 226 THR A 206 THR^? -4.52 O1S EPE C 377s A 229 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 9.66 102.78 70.07 9.79 101.18 71.42 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 7.24 97.46 49.60 8.11 95.69 48.80 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 10.53 97.56 43.71 9.33 93.71 47.17 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 A 57 GLU C 200 GLU^? 10.81 O8 EPE C 377 A 226 THR C 206 THR^? 14.70 N TRS A 378 A 229 LYS C 138 LYS^? 8.30 N TRS A 378 coo 9.66 102.78 70.07 9.79 101.18 71.42 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 7.24 97.46 49.60 8.11 95.69 48.80 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 A 57 GLU C 227 GLU.? 14.45 C7 EPE C 377 A 226 THR A 126 THR^? 16.96 ZN ZN A 375 A 229 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 9.66 102.78 70.07 9.79 101.18 71.42 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 7.24 97.46 49.60 8.11 95.69 48.80 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 10.53 97.56 43.71 9.33 93.71 47.17 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 A 57 GLU C 227 GLU.? 14.45 C7 EPE C 377 A 226 THR A 206 THR^? -4.52 O1S EPE C 377s A 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 9.66 102.78 70.07 9.79 101.18 71.42 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 7.24 97.46 49.60 8.11 95.69 48.80 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 10.53 97.56 43.71 9.33 93.71 47.17 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 A 57 GLU C 227 GLU.? 14.45 C7 EPE C 377 A 226 THR C 206 THR^? 14.70 N TRS A 378 A 229 LYS C 138 LYS^? 8.30 N TRS A 378 coo 9.66 102.78 70.07 9.79 101.18 71.42 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 7.24 97.46 49.60 8.11 95.69 48.80 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 A 57 GLU C 228 GLU.? 9.65 C7 EPE C 377 A 226 THR A 126 THR^? 16.96 ZN ZN A 375 A 229 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 9.66 102.78 70.07 9.79 101.18 71.42 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 7.24 97.46 49.60 8.11 95.69 48.80 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 10.53 97.56 43.71 9.33 93.71 47.17 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 A 57 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 226 THR C 242 THR^? 18.64 ZN ZN C 375 A 229 LYS C 239 LYS^? 16.29 N TRS A 378 coo 9.66 102.78 70.07 9.79 101.18 71.42 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 7.24 97.46 49.60 8.11 95.69 48.80 2.56 -30.12 34.96 0.88 -28.79 34.66 coo 10.53 97.56 43.71 9.33 93.71 47.17 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 A 57 GLU C 349 GLU~? 21.43 ZN ZN C 375 A 226 THR C 104 THR~? 6.99 ZN ZN C 375 A 229 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 9.66 102.78 70.07 9.79 101.18 71.42 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 7.24 97.46 49.60 8.11 95.69 48.80 9.25 -26.14 47.92 9.13 -24.05 47.44 coo 10.53 97.56 43.71 9.33 93.71 47.17 15.95 -21.05 50.17 18.02 -16.90 49.10 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 23 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 90 GLU~? 12.44 O2S EPE A 376 B 226 THR A 367 THR.? 11.13 ZN ZN A 374 B 229 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 15.90 87.61 49.61 13.92 86.96 49.36 33.69 24.77 24.85 34.29 26.39 26.04 coo 20.74 95.78 68.68 19.29 96.84 69.83 46.41 8.27 30.19 44.93 8.03 28.58 coo 22.32 101.61 71.64 17.89 98.63 71.55 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 175 GLU^? 13.72 C8 EPE A 377 B 226 THR C 206 THR^? 14.70 N TRS A 378 B 229 LYS C 138 LYS^? 8.30 N TRS A 378 coo 15.90 87.61 49.61 13.92 86.96 49.36 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 20.74 95.78 68.68 19.29 96.84 69.83 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU A 200 GLU^? 11.53 C6 EPE A 377 B 226 THR A 206 THR^? -4.52 O1S EPE C 377s B 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 15.90 87.61 49.61 13.92 86.96 49.36 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 20.74 95.78 68.68 19.29 96.84 69.83 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 22.32 101.61 71.64 17.89 98.63 71.55 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 226 THR A 242 THR^? 8.72 O3 TRS A 378 B 229 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo 15.90 87.61 49.61 13.92 86.96 49.36 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 20.74 95.78 68.68 19.29 96.84 69.83 30.60 -18.28 22.38 30.36 -19.25 24.36 coo 22.32 101.61 71.64 17.89 98.63 71.55 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU B 90 GLU~? 12.95 O2S EPE B 376 B 226 THR B 367 THR.? 10.99 ZN ZN B 374 B 229 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 15.90 87.61 49.61 13.92 86.96 49.36 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 20.74 95.78 68.68 19.29 96.84 69.83 -18.95 13.55 24.81 -19.03 11.36 25.00 coo 22.32 101.61 71.64 17.89 98.63 71.55 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 226 THR A 206 THR^? -4.52 O1S EPE C 377s B 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 15.90 87.61 49.61 13.92 86.96 49.36 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 20.74 95.78 68.68 19.29 96.84 69.83 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 22.32 101.61 71.64 17.89 98.63 71.55 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU B 200 GLU^? 21.89 O2S EPE A 377 B 226 THR B 206 THR^? 5.63 O3S EPE A 377 B 229 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 15.90 87.61 49.61 13.92 86.96 49.36 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 20.74 95.78 68.68 19.29 96.84 69.83 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo 22.32 101.61 71.64 17.89 98.63 71.55 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 57 GLU B 200 GLU^? 21.89 O2S EPE A 377 B 226 THR B 222 THR~? 21.64 O3S EPE A 377 B 229 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 15.90 87.61 49.61 13.92 86.96 49.36 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 20.74 95.78 68.68 19.29 96.84 69.83 -10.58 -37.08 17.00 -12.43 -36.02 17.53 coo 22.32 101.61 71.64 17.89 98.63 71.55 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 57 GLU B 227 GLU.? 24.58 O3S EPE A 377 B 226 THR C 126 THR^? 16.85 ZN ZN C 375 B 229 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 15.90 87.61 49.61 13.92 86.96 49.36 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 20.74 95.78 68.68 19.29 96.84 69.83 -5.70 -36.58 41.92 -4.55 -37.27 43.63 coo 22.32 101.61 71.64 17.89 98.63 71.55 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 57 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 226 THR B 242 THR^? 18.76 ZN ZN B 375 B 229 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 15.90 87.61 49.61 13.92 86.96 49.36 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 20.74 95.78 68.68 19.29 96.84 69.83 1.06 -7.67 12.24 3.05 -6.84 12.40 coo 22.32 101.61 71.64 17.89 98.63 71.55 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 57 GLU C 90 GLU~? 12.50 O3S EPE C 376 B 226 THR C 367 THR.? 11.10 ZN ZN C 374 B 229 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 15.90 87.61 49.61 13.92 86.96 49.36 27.07 -22.98 69.65 26.90 -21.97 71.52 coo 20.74 95.78 68.68 19.29 96.84 69.83 7.09 -30.04 66.37 8.69 -30.35 64.94 coo 22.32 101.61 71.64 17.89 98.63 71.55 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 57 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 226 THR B 206 THR^? 5.63 O3S EPE A 377 B 229 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 15.90 87.61 49.61 13.92 86.96 49.36 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 20.74 95.78 68.68 19.29 96.84 69.83 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo 22.32 101.61 71.64 17.89 98.63 71.55 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 B 57 GLU C 184 GLU.? 20.48 N4 EPE C 377 B 226 THR A 126 THR^? 16.96 ZN ZN A 375 B 229 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 15.90 87.61 49.61 13.92 86.96 49.36 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 20.74 95.78 68.68 19.29 96.84 69.83 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 22.32 101.61 71.64 17.89 98.63 71.55 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 B 57 GLU C 184 GLU.? 20.48 N4 EPE C 377 B 226 THR A 206 THR^? -4.52 O1S EPE C 377s B 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 15.90 87.61 49.61 13.92 86.96 49.36 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 20.74 95.78 68.68 19.29 96.84 69.83 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 22.32 101.61 71.64 17.89 98.63 71.55 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 B 57 GLU C 184 GLU.? 20.48 N4 EPE C 377 B 226 THR A 206 THR^? -4.52 O1S EPE C 377s B 229 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 15.90 87.61 49.61 13.92 86.96 49.36 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 20.74 95.78 68.68 19.29 96.84 69.83 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 22.32 101.61 71.64 17.89 98.63 71.55 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 B 57 GLU C 200 GLU^? 10.81 O8 EPE C 377 B 226 THR C 206 THR^? 14.70 N TRS A 378 B 229 LYS C 138 LYS^? 8.30 N TRS A 378 coo 15.90 87.61 49.61 13.92 86.96 49.36 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 20.74 95.78 68.68 19.29 96.84 69.83 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 B 57 GLU C 227 GLU.? 14.45 C7 EPE C 377 B 226 THR A 126 THR^? 16.96 ZN ZN A 375 B 229 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 15.90 87.61 49.61 13.92 86.96 49.36 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 20.74 95.78 68.68 19.29 96.84 69.83 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 22.32 101.61 71.64 17.89 98.63 71.55 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 B 57 GLU C 227 GLU.? 14.45 C7 EPE C 377 B 226 THR A 206 THR^? -4.52 O1S EPE C 377s B 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 15.90 87.61 49.61 13.92 86.96 49.36 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 20.74 95.78 68.68 19.29 96.84 69.83 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 22.32 101.61 71.64 17.89 98.63 71.55 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 B 57 GLU C 227 GLU.? 14.45 C7 EPE C 377 B 226 THR C 206 THR^? 14.70 N TRS A 378 B 229 LYS C 138 LYS^? 8.30 N TRS A 378 coo 15.90 87.61 49.61 13.92 86.96 49.36 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 20.74 95.78 68.68 19.29 96.84 69.83 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 B 57 GLU C 228 GLU.? 9.65 C7 EPE C 377 B 226 THR A 126 THR^? 16.96 ZN ZN A 375 B 229 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 15.90 87.61 49.61 13.92 86.96 49.36 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 20.74 95.78 68.68 19.29 96.84 69.83 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 22.32 101.61 71.64 17.89 98.63 71.55 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 B 57 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 226 THR C 242 THR^? 18.64 ZN ZN C 375 B 229 LYS C 239 LYS^? 16.29 N TRS A 378 coo 15.90 87.61 49.61 13.92 86.96 49.36 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 20.74 95.78 68.68 19.29 96.84 69.83 2.56 -30.12 34.96 0.88 -28.79 34.66 coo 22.32 101.61 71.64 17.89 98.63 71.55 5.15 -29.07 27.87 7.72 -24.69 27.36 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 21 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 90 GLU~? 12.44 O2S EPE A 376 C 226 THR A 367 THR.? 11.13 ZN ZN A 374 C 229 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 5.43 40.40 61.63 4.27 41.99 60.90 33.69 24.77 24.85 34.29 26.39 26.04 coo 22.16 45.88 73.63 23.23 47.70 73.25 46.41 8.27 30.19 44.93 8.03 28.58 coo 28.90 45.91 73.55 25.22 49.72 72.97 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 175 GLU^? 13.72 C8 EPE A 377 C 226 THR C 206 THR^? 14.70 N TRS A 378 C 229 LYS C 138 LYS^? 8.30 N TRS A 378 coo 5.43 40.40 61.63 4.27 41.99 60.90 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 22.16 45.88 73.63 23.23 47.70 73.25 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU A 200 GLU^? 11.53 C6 EPE A 377 C 226 THR A 206 THR^? -4.52 O1S EPE C 377s C 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 5.43 40.40 61.63 4.27 41.99 60.90 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 22.16 45.88 73.63 23.23 47.70 73.25 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 28.90 45.91 73.55 25.22 49.72 72.97 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU A 336 GLU~? 2.52 ZN ZN A 375s C 226 THR A 242 THR^? 8.72 O3 TRS A 378 C 229 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo 5.43 40.40 61.63 4.27 41.99 60.90 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 22.16 45.88 73.63 23.23 47.70 73.25 30.60 -18.28 22.38 30.36 -19.25 24.36 coo 28.90 45.91 73.55 25.22 49.72 72.97 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU B 90 GLU~? 12.95 O2S EPE B 376 C 226 THR B 367 THR.? 10.99 ZN ZN B 374 C 229 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 5.43 40.40 61.63 4.27 41.99 60.90 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 22.16 45.88 73.63 23.23 47.70 73.25 -18.95 13.55 24.81 -19.03 11.36 25.00 coo 28.90 45.91 73.55 25.22 49.72 72.97 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU B 175 GLU^? 16.09 C9 EPE A 377 C 226 THR A 206 THR^? -4.52 O1S EPE C 377s C 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 5.43 40.40 61.63 4.27 41.99 60.90 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 22.16 45.88 73.63 23.23 47.70 73.25 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 28.90 45.91 73.55 25.22 49.72 72.97 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU B 200 GLU^? 21.89 O2S EPE A 377 C 226 THR B 206 THR^? 5.63 O3S EPE A 377 C 229 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 5.43 40.40 61.63 4.27 41.99 60.90 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 22.16 45.88 73.63 23.23 47.70 73.25 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo 28.90 45.91 73.55 25.22 49.72 72.97 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 57 GLU B 200 GLU^? 21.89 O2S EPE A 377 C 226 THR B 222 THR~? 21.64 O3S EPE A 377 C 229 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 5.43 40.40 61.63 4.27 41.99 60.90 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 22.16 45.88 73.63 23.23 47.70 73.25 -10.58 -37.08 17.00 -12.43 -36.02 17.53 coo 28.90 45.91 73.55 25.22 49.72 72.97 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 57 GLU B 227 GLU.? 24.58 O3S EPE A 377 C 226 THR C 126 THR^? 16.85 ZN ZN C 375 C 229 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 5.43 40.40 61.63 4.27 41.99 60.90 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 22.16 45.88 73.63 23.23 47.70 73.25 -5.70 -36.58 41.92 -4.55 -37.27 43.63 coo 28.90 45.91 73.55 25.22 49.72 72.97 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 57 GLU B 336 GLU~? 2.48 ZN ZN B 375s C 226 THR B 242 THR^? 18.76 ZN ZN B 375 C 229 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 5.43 40.40 61.63 4.27 41.99 60.90 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 22.16 45.88 73.63 23.23 47.70 73.25 1.06 -7.67 12.24 3.05 -6.84 12.40 coo 28.90 45.91 73.55 25.22 49.72 72.97 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 57 GLU C 90 GLU~? 12.50 O3S EPE C 376 C 226 THR C 367 THR.? 11.10 ZN ZN C 374 C 229 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 5.43 40.40 61.63 4.27 41.99 60.90 27.07 -22.98 69.65 26.90 -21.97 71.52 coo 22.16 45.88 73.63 23.23 47.70 73.25 7.09 -30.04 66.37 8.69 -30.35 64.94 coo 28.90 45.91 73.55 25.22 49.72 72.97 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 57 GLU C 175 GLU^? 13.76 O8 EPE C 377 C 226 THR B 206 THR^? 5.63 O3S EPE A 377 C 229 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 5.43 40.40 61.63 4.27 41.99 60.90 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 22.16 45.88 73.63 23.23 47.70 73.25 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo 28.90 45.91 73.55 25.22 49.72 72.97 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 C 57 GLU C 184 GLU.? 20.48 N4 EPE C 377 C 226 THR A 126 THR^? 16.96 ZN ZN A 375 C 229 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 5.43 40.40 61.63 4.27 41.99 60.90 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 22.16 45.88 73.63 23.23 47.70 73.25 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 28.90 45.91 73.55 25.22 49.72 72.97 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 C 57 GLU C 184 GLU.? 20.48 N4 EPE C 377 C 226 THR A 206 THR^? -4.52 O1S EPE C 377s C 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 5.43 40.40 61.63 4.27 41.99 60.90 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 22.16 45.88 73.63 23.23 47.70 73.25 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 28.90 45.91 73.55 25.22 49.72 72.97 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 C 57 GLU C 184 GLU.? 20.48 N4 EPE C 377 C 226 THR A 206 THR^? -4.52 O1S EPE C 377s C 229 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 5.43 40.40 61.63 4.27 41.99 60.90 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 22.16 45.88 73.63 23.23 47.70 73.25 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 28.90 45.91 73.55 25.22 49.72 72.97 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 C 57 GLU C 200 GLU^? 10.81 O8 EPE C 377 C 226 THR C 206 THR^? 14.70 N TRS A 378 C 229 LYS C 138 LYS^? 8.30 N TRS A 378 coo 5.43 40.40 61.63 4.27 41.99 60.90 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 22.16 45.88 73.63 23.23 47.70 73.25 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 C 57 GLU C 227 GLU.? 14.45 C7 EPE C 377 C 226 THR A 126 THR^? 16.96 ZN ZN A 375 C 229 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 5.43 40.40 61.63 4.27 41.99 60.90 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 22.16 45.88 73.63 23.23 47.70 73.25 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 28.90 45.91 73.55 25.22 49.72 72.97 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 C 57 GLU C 227 GLU.? 14.45 C7 EPE C 377 C 226 THR A 206 THR^? -4.52 O1S EPE C 377s C 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 5.43 40.40 61.63 4.27 41.99 60.90 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 22.16 45.88 73.63 23.23 47.70 73.25 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 28.90 45.91 73.55 25.22 49.72 72.97 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 C 57 GLU C 227 GLU.? 14.45 C7 EPE C 377 C 226 THR C 206 THR^? 14.70 N TRS A 378 C 229 LYS C 138 LYS^? 8.30 N TRS A 378 coo 5.43 40.40 61.63 4.27 41.99 60.90 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 22.16 45.88 73.63 23.23 47.70 73.25 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 C 57 GLU C 228 GLU.? 9.65 C7 EPE C 377 C 226 THR A 126 THR^? 16.96 ZN ZN A 375 C 229 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 5.43 40.40 61.63 4.27 41.99 60.90 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 22.16 45.88 73.63 23.23 47.70 73.25 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 28.90 45.91 73.55 25.22 49.72 72.97 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 C 57 GLU C 336 GLU~? 2.53 ZN ZN C 375s C 226 THR C 242 THR^? 18.64 ZN ZN C 375 C 229 LYS C 239 LYS^? 16.29 N TRS A 378 coo 5.43 40.40 61.63 4.27 41.99 60.90 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 22.16 45.88 73.63 23.23 47.70 73.25 2.56 -30.12 34.96 0.88 -28.79 34.66 coo 28.90 45.91 73.55 25.22 49.72 72.97 5.15 -29.07 27.87 7.72 -24.69 27.36 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 21 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 90 GLU~? 12.44 O2S EPE A 376 D 226 THR A 367 THR.? 11.13 ZN ZN A 374 D 229 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 26.07 55.89 66.14 25.33 56.50 68.01 33.69 24.77 24.85 34.29 26.39 26.04 coo 11.79 47.62 52.67 10.10 46.51 53.39 46.41 8.27 30.19 44.93 8.03 28.58 coo 10.05 41.79 49.80 7.94 44.71 53.76 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 175 GLU^? 13.72 C8 EPE A 377 D 226 THR C 206 THR^? 14.70 N TRS A 378 D 229 LYS C 138 LYS^? 8.30 N TRS A 378 coo 26.07 55.89 66.14 25.33 56.50 68.01 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 11.79 47.62 52.67 10.10 46.51 53.39 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU A 200 GLU^? 11.53 C6 EPE A 377 D 226 THR A 206 THR^? -4.52 O1S EPE C 377s D 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 26.07 55.89 66.14 25.33 56.50 68.01 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 11.79 47.62 52.67 10.10 46.51 53.39 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 10.05 41.79 49.80 7.94 44.71 53.76 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU A 336 GLU~? 2.52 ZN ZN A 375s D 226 THR A 242 THR^? 8.72 O3 TRS A 378 D 229 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo 26.07 55.89 66.14 25.33 56.50 68.01 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 11.79 47.62 52.67 10.10 46.51 53.39 30.60 -18.28 22.38 30.36 -19.25 24.36 coo 10.05 41.79 49.80 7.94 44.71 53.76 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU B 90 GLU~? 12.95 O2S EPE B 376 D 226 THR B 367 THR.? 10.99 ZN ZN B 374 D 229 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 26.07 55.89 66.14 25.33 56.50 68.01 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 11.79 47.62 52.67 10.10 46.51 53.39 -18.95 13.55 24.81 -19.03 11.36 25.00 coo 10.05 41.79 49.80 7.94 44.71 53.76 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU B 175 GLU^? 16.09 C9 EPE A 377 D 226 THR A 206 THR^? -4.52 O1S EPE C 377s D 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 26.07 55.89 66.14 25.33 56.50 68.01 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 11.79 47.62 52.67 10.10 46.51 53.39 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 10.05 41.79 49.80 7.94 44.71 53.76 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU B 200 GLU^? 21.89 O2S EPE A 377 D 226 THR B 206 THR^? 5.63 O3S EPE A 377 D 229 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 26.07 55.89 66.14 25.33 56.50 68.01 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 11.79 47.62 52.67 10.10 46.51 53.39 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo 10.05 41.79 49.80 7.94 44.71 53.76 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 57 GLU B 200 GLU^? 21.89 O2S EPE A 377 D 226 THR B 222 THR~? 21.64 O3S EPE A 377 D 229 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 26.07 55.89 66.14 25.33 56.50 68.01 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 11.79 47.62 52.67 10.10 46.51 53.39 -10.58 -37.08 17.00 -12.43 -36.02 17.53 coo 10.05 41.79 49.80 7.94 44.71 53.76 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 57 GLU B 227 GLU.? 24.58 O3S EPE A 377 D 226 THR C 126 THR^? 16.85 ZN ZN C 375 D 229 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 26.07 55.89 66.14 25.33 56.50 68.01 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 11.79 47.62 52.67 10.10 46.51 53.39 -5.70 -36.58 41.92 -4.55 -37.27 43.63 coo 10.05 41.79 49.80 7.94 44.71 53.76 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 57 GLU B 336 GLU~? 2.48 ZN ZN B 375s D 226 THR B 242 THR^? 18.76 ZN ZN B 375 D 229 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 26.07 55.89 66.14 25.33 56.50 68.01 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 11.79 47.62 52.67 10.10 46.51 53.39 1.06 -7.67 12.24 3.05 -6.84 12.40 coo 10.05 41.79 49.80 7.94 44.71 53.76 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 57 GLU C 90 GLU~? 12.50 O3S EPE C 376 D 226 THR C 367 THR.? 11.10 ZN ZN C 374 D 229 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 26.07 55.89 66.14 25.33 56.50 68.01 27.07 -22.98 69.65 26.90 -21.97 71.52 coo 11.79 47.62 52.67 10.10 46.51 53.39 7.09 -30.04 66.37 8.69 -30.35 64.94 coo 10.05 41.79 49.80 7.94 44.71 53.76 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 57 GLU C 175 GLU^? 13.76 O8 EPE C 377 D 226 THR B 206 THR^? 5.63 O3S EPE A 377 D 229 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 26.07 55.89 66.14 25.33 56.50 68.01 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 11.79 47.62 52.67 10.10 46.51 53.39 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo 10.05 41.79 49.80 7.94 44.71 53.76 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 D 57 GLU C 184 GLU.? 20.48 N4 EPE C 377 D 226 THR A 126 THR^? 16.96 ZN ZN A 375 D 229 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 26.07 55.89 66.14 25.33 56.50 68.01 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 11.79 47.62 52.67 10.10 46.51 53.39 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 10.05 41.79 49.80 7.94 44.71 53.76 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 D 57 GLU C 184 GLU.? 20.48 N4 EPE C 377 D 226 THR A 206 THR^? -4.52 O1S EPE C 377s D 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 26.07 55.89 66.14 25.33 56.50 68.01 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 11.79 47.62 52.67 10.10 46.51 53.39 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 10.05 41.79 49.80 7.94 44.71 53.76 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 D 57 GLU C 184 GLU.? 20.48 N4 EPE C 377 D 226 THR A 206 THR^? -4.52 O1S EPE C 377s D 229 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 26.07 55.89 66.14 25.33 56.50 68.01 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 11.79 47.62 52.67 10.10 46.51 53.39 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 10.05 41.79 49.80 7.94 44.71 53.76 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 D 57 GLU C 200 GLU^? 10.81 O8 EPE C 377 D 226 THR C 206 THR^? 14.70 N TRS A 378 D 229 LYS C 138 LYS^? 8.30 N TRS A 378 coo 26.07 55.89 66.14 25.33 56.50 68.01 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 11.79 47.62 52.67 10.10 46.51 53.39 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 D 57 GLU C 227 GLU.? 14.45 C7 EPE C 377 D 226 THR A 126 THR^? 16.96 ZN ZN A 375 D 229 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 26.07 55.89 66.14 25.33 56.50 68.01 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 11.79 47.62 52.67 10.10 46.51 53.39 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 10.05 41.79 49.80 7.94 44.71 53.76 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 D 57 GLU C 227 GLU.? 14.45 C7 EPE C 377 D 226 THR A 206 THR^? -4.52 O1S EPE C 377s D 229 LYS A 138 LYS^? 13.11 N TRS A 378 coo 26.07 55.89 66.14 25.33 56.50 68.01 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 11.79 47.62 52.67 10.10 46.51 53.39 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 10.05 41.79 49.80 7.94 44.71 53.76 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 D 57 GLU C 227 GLU.? 14.45 C7 EPE C 377 D 226 THR C 206 THR^? 14.70 N TRS A 378 D 229 LYS C 138 LYS^? 8.30 N TRS A 378 coo 26.07 55.89 66.14 25.33 56.50 68.01 35.69 -39.75 16.92 37.70 -40.13 16.40 coo 11.79 47.62 52.67 10.10 46.51 53.39 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 D 57 GLU C 228 GLU.? 9.65 C7 EPE C 377 D 226 THR A 126 THR^? 16.96 ZN ZN A 375 D 229 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 26.07 55.89 66.14 25.33 56.50 68.01 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 11.79 47.62 52.67 10.10 46.51 53.39 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 10.05 41.79 49.80 7.94 44.71 53.76 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 D 57 GLU C 336 GLU~? 2.53 ZN ZN C 375s D 226 THR C 242 THR^? 18.64 ZN ZN C 375 D 229 LYS C 239 LYS^? 16.29 N TRS A 378 coo 26.07 55.89 66.14 25.33 56.50 68.01 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 11.79 47.62 52.67 10.10 46.51 53.39 2.56 -30.12 34.96 0.88 -28.79 34.66 coo 10.05 41.79 49.80 7.94 44.71 53.76 5.15 -29.07 27.87 7.72 -24.69 27.36 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 21 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 21 HIS~? 17.08 ZN ZN A 375 A 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 229 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 0.84 91.24 49.01 2.91 91.61 49.23 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS A 21 HIS~? 17.08 ZN ZN A 375 A 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 229 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 0.84 91.24 49.01 2.91 91.61 49.23 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 123 HIS A 21 HIS~? 17.08 ZN ZN A 375 A 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 229 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 1.13 77.49 40.64 0.62 75.57 39.98 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 0.84 91.24 49.01 2.91 91.61 49.23 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 123 HIS A 42 HIS^? 26.23 ZN ZN A 375 A 200 ASP A 55 ASP~? 17.36 O2S EPE A 376 A 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 1.13 77.49 40.64 0.62 75.57 39.98 43.48 12.60 9.22 44.86 13.19 7.76 coo 0.84 91.24 49.01 2.91 91.61 49.23 45.10 18.98 22.18 44.20 20.57 23.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 123 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 229 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 37.80 0.44 25.56 37.02 -1.29 26.44 coo 0.84 91.24 49.01 2.91 91.61 49.23 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 10.53 97.56 43.71 9.33 93.71 47.17 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 123 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 229 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 37.42 3.90 29.26 38.47 2.36 30.22 coo 0.84 91.24 49.01 2.91 91.61 49.23 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 10.53 97.56 43.71 9.33 93.71 47.17 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 123 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 200 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 229 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 32.91 0.46 27.63 33.66 0.11 29.56 coo 0.84 91.24 49.01 2.91 91.61 49.23 48.24 5.16 33.58 47.82 3.96 35.30 coo 10.53 97.56 43.71 9.33 93.71 47.17 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 123 HIS A 263 HIS~? 20.93 ZN ZN A 375 A 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 229 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 0.84 91.24 49.01 2.91 91.61 49.23 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 123 HIS A 263 HIS~? 20.93 ZN ZN A 375 A 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 229 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 1.13 77.49 40.64 0.62 75.57 39.98 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 0.84 91.24 49.01 2.91 91.61 49.23 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 123 HIS A 263 HIS~? 20.93 ZN ZN A 375 A 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 229 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 0.84 91.24 49.01 2.91 91.61 49.23 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 10.53 97.56 43.71 9.33 93.71 47.17 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 123 HIS A 319 HIS~? 24.64 ZN ZN A 374 A 200 ASP A 281 ASP.? 28.06 ZN ZN A 375 A 229 LYS A 285 LYS^? 20.00 O3 TRS A 378 coo 1.13 77.49 40.64 0.62 75.57 39.98 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 0.84 91.24 49.01 2.91 91.61 49.23 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 10.53 97.56 43.71 9.33 93.71 47.17 47.09 -21.09 34.01 41.69 -24.22 32.75 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 123 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 229 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 1.13 77.49 40.64 0.62 75.57 39.98 40.60 0.33 34.12 38.69 0.39 33.24 coo 0.84 91.24 49.01 2.91 91.61 49.23 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 123 HIS A 361 HIS^? 22.47 ZN ZN A 375 A 200 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 1.13 77.49 40.64 0.62 75.57 39.98 46.25 9.10 12.92 46.66 10.09 11.12 coo 0.84 91.24 49.01 2.91 91.61 49.23 40.70 8.14 28.73 41.06 6.40 29.84 coo 10.53 97.56 43.71 9.33 93.71 47.17 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 A 123 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 200 ASP A 55 ASP~? 17.36 O2S EPE A 376 A 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 1.13 77.49 40.64 0.62 75.57 39.98 51.10 6.85 29.91 51.20 5.36 31.38 coo 0.84 91.24 49.01 2.91 91.61 49.23 45.10 18.98 22.18 44.20 20.57 23.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 A 123 HIS B 21 HIS~? 17.19 ZN ZN B 375 A 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 229 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 0.84 91.24 49.01 2.91 91.61 49.23 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 10.53 97.56 43.71 9.33 93.71 47.17 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 A 123 HIS B 21 HIS~? 17.19 ZN ZN B 375 A 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 229 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 0.84 91.24 49.01 2.91 91.61 49.23 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 10.53 97.56 43.71 9.33 93.71 47.17 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 A 123 HIS B 21 HIS~? 17.19 ZN ZN B 375 A 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 229 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 1.13 77.49 40.64 0.62 75.57 39.98 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 0.84 91.24 49.01 2.91 91.61 49.23 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 10.53 97.56 43.71 9.33 93.71 47.17 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 A 123 HIS B 42 HIS^? 26.13 ZN ZN B 375 A 200 ASP B 55 ASP~? 16.89 O3S EPE B 376 A 229 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 1.13 77.49 40.64 0.62 75.57 39.98 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 0.84 91.24 49.01 2.91 91.61 49.23 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 10.53 97.56 43.71 9.33 93.71 47.17 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 A 123 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 229 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 0.84 91.24 49.01 2.91 91.61 49.23 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 10.53 97.56 43.71 9.33 93.71 47.17 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 A 123 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 229 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 0.84 91.24 49.01 2.91 91.61 49.23 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 10.53 97.56 43.71 9.33 93.71 47.17 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 A 123 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 200 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 229 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 0.84 91.24 49.01 2.91 91.61 49.23 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 A 123 HIS B 263 HIS~? 20.98 ZN ZN B 375 A 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 229 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 0.84 91.24 49.01 2.91 91.61 49.23 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 10.53 97.56 43.71 9.33 93.71 47.17 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 A 123 HIS B 263 HIS~? 20.98 ZN ZN B 375 A 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 229 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 1.13 77.49 40.64 0.62 75.57 39.98 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 0.84 91.24 49.01 2.91 91.61 49.23 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 10.53 97.56 43.71 9.33 93.71 47.17 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 A 123 HIS B 263 HIS~? 20.98 ZN ZN B 375 A 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 229 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 1.13 77.49 40.64 0.62 75.57 39.98 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 0.84 91.24 49.01 2.91 91.61 49.23 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 10.53 97.56 43.71 9.33 93.71 47.17 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 A 123 HIS B 319 HIS~? 24.73 ZN ZN B 374 A 200 ASP B 281 ASP.? 29.04 ZN ZN B 374 A 229 LYS B 285 LYS^? 22.19 ZN ZN B 375 coo 1.13 77.49 40.64 0.62 75.57 39.98 8.16 23.53 21.75 7.85 25.60 21.62 coo 0.84 91.24 49.01 2.91 91.61 49.23 4.51 22.24 5.26 6.45 23.04 5.71 coo 10.53 97.56 43.71 9.33 93.71 47.17 1.97 10.60 4.02 5.48 5.38 4.89 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 A 123 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 229 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 1.13 77.49 40.64 0.62 75.57 39.98 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 0.84 91.24 49.01 2.91 91.61 49.23 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 10.53 97.56 43.71 9.33 93.71 47.17 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 27 3 # 27 A 123 HIS B 359 HIS^? 24.30 ZN ZN B 375 A 200 ASP B 55 ASP~? 16.89 O3S EPE B 376 A 229 LYS B 94 LYS~? 17.44 O2S EPE B 376 coo 1.13 77.49 40.64 0.62 75.57 39.98 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 0.84 91.24 49.01 2.91 91.61 49.23 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 10.53 97.56 43.71 9.33 93.71 47.17 -29.53 0.46 40.71 -30.43 3.58 45.55 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 28 3 # 28 A 123 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 200 ASP B 55 ASP~? 16.89 O3S EPE B 376 A 229 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 1.13 77.49 40.64 0.62 75.57 39.98 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 0.84 91.24 49.01 2.91 91.61 49.23 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 10.53 97.56 43.71 9.33 93.71 47.17 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 29 3 # 29 A 123 HIS C 21 HIS~? 17.02 O1 TRS A 378 A 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 229 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 0.84 91.24 49.01 2.91 91.61 49.23 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 30 3 # 30 A 123 HIS C 21 HIS~? 17.02 O1 TRS A 378 A 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 229 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 0.84 91.24 49.01 2.91 91.61 49.23 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 31 3 # 31 A 123 HIS C 21 HIS~? 17.02 O1 TRS A 378 A 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 229 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 1.13 77.49 40.64 0.62 75.57 39.98 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 0.84 91.24 49.01 2.91 91.61 49.23 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 32 3 # 32 A 123 HIS C 42 HIS^? 26.23 ZN ZN C 375 A 200 ASP C 55 ASP~? 17.38 O3S EPE C 376 A 229 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 1.13 77.49 40.64 0.62 75.57 39.98 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 0.84 91.24 49.01 2.91 91.61 49.23 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 10.53 97.56 43.71 9.33 93.71 47.17 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 33 3 # 33 A 123 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 229 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 0.84 91.24 49.01 2.91 91.61 49.23 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 10.53 97.56 43.71 9.33 93.71 47.17 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 34 3 # 34 A 123 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 229 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 0.84 91.24 49.01 2.91 91.61 49.23 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 10.53 97.56 43.71 9.33 93.71 47.17 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 35 3 # 35 A 123 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 200 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 229 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 0.84 91.24 49.01 2.91 91.61 49.23 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 36 3 # 36 A 123 HIS C 263 HIS~? 20.89 ZN ZN C 375 A 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 229 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 0.84 91.24 49.01 2.91 91.61 49.23 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 37 3 # 37 A 123 HIS C 263 HIS~? 20.89 ZN ZN C 375 A 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 229 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 1.13 77.49 40.64 0.62 75.57 39.98 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 0.84 91.24 49.01 2.91 91.61 49.23 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 38 3 # 38 A 123 HIS C 263 HIS~? 20.89 ZN ZN C 375 A 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 229 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 0.84 91.24 49.01 2.91 91.61 49.23 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 10.53 97.56 43.71 9.33 93.71 47.17 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 39 3 # 39 A 123 HIS C 319 HIS~? 24.70 ZN ZN C 374 A 200 ASP C 281 ASP.? 29.07 ZN ZN C 374 A 229 LYS C 285 LYS^? 22.29 ZN ZN C 375 coo 1.13 77.49 40.64 0.62 75.57 39.98 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 0.84 91.24 49.01 2.91 91.61 49.23 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 -14.01 -33.36 45.98 -12.46 -31.50 40.58 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 40 3 # 40 A 123 HIS C 319 HIS~? 24.70 ZN ZN C 374 A 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 229 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 1.13 77.49 40.64 0.62 75.57 39.98 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 0.84 91.24 49.01 2.91 91.61 49.23 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 10.53 97.56 43.71 9.33 93.71 47.17 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 41 3 # 41 A 123 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 229 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 1.13 77.49 40.64 0.62 75.57 39.98 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 0.84 91.24 49.01 2.91 91.61 49.23 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 42 3 # 42 A 123 HIS C 359 HIS^? 24.82 ZN ZN C 375 A 200 ASP C 55 ASP~? 17.38 O3S EPE C 376 A 229 LYS C 94 LYS~? 16.71 O3S EPE C 376 coo 1.13 77.49 40.64 0.62 75.57 39.98 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 0.84 91.24 49.01 2.91 91.61 49.23 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 10.53 97.56 43.71 9.33 93.71 47.17 30.11 -27.61 67.14 30.55 -24.06 72.29 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 43 3 # 43 A 123 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 200 ASP C 55 ASP~? 17.38 O3S EPE C 376 A 229 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 1.13 77.49 40.64 0.62 75.57 39.98 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 0.84 91.24 49.01 2.91 91.61 49.23 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 10.53 97.56 43.71 9.33 93.71 47.17 22.12 -22.06 69.94 21.88 -19.84 74.70 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 43 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 21 HIS~? 17.08 ZN ZN A 375 B 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 B 229 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 17.54 90.31 75.01 17.17 92.01 73.80 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS A 21 HIS~? 17.08 ZN ZN A 375 B 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 B 229 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 17.54 90.31 75.01 17.17 92.01 73.80 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 123 HIS A 21 HIS~? 17.08 ZN ZN A 375 B 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 B 229 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 9.24 94.26 88.22 8.02 94.07 89.92 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 17.54 90.31 75.01 17.17 92.01 73.80 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 123 HIS A 42 HIS^? 26.23 ZN ZN A 375 B 200 ASP A 55 ASP~? 17.36 O2S EPE A 376 B 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 9.24 94.26 88.22 8.02 94.07 89.92 43.48 12.60 9.22 44.86 13.19 7.76 coo 17.54 90.31 75.01 17.17 92.01 73.80 45.10 18.98 22.18 44.20 20.57 23.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 123 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 229 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 37.80 0.44 25.56 37.02 -1.29 26.44 coo 17.54 90.31 75.01 17.17 92.01 73.80 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 22.32 101.61 71.64 17.89 98.63 71.55 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 123 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 229 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 37.42 3.90 29.26 38.47 2.36 30.22 coo 17.54 90.31 75.01 17.17 92.01 73.80 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 22.32 101.61 71.64 17.89 98.63 71.55 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 123 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 200 ASP A 368 ASP.? 11.85 ZN ZN A 374 B 229 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 32.91 0.46 27.63 33.66 0.11 29.56 coo 17.54 90.31 75.01 17.17 92.01 73.80 48.24 5.16 33.58 47.82 3.96 35.30 coo 22.32 101.61 71.64 17.89 98.63 71.55 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 123 HIS A 263 HIS~? 20.93 ZN ZN A 375 B 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 B 229 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 17.54 90.31 75.01 17.17 92.01 73.80 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 123 HIS A 263 HIS~? 20.93 ZN ZN A 375 B 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 B 229 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 9.24 94.26 88.22 8.02 94.07 89.92 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 17.54 90.31 75.01 17.17 92.01 73.80 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 123 HIS A 263 HIS~? 20.93 ZN ZN A 375 B 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 229 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 17.54 90.31 75.01 17.17 92.01 73.80 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 22.32 101.61 71.64 17.89 98.63 71.55 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 123 HIS A 319 HIS~? 24.64 ZN ZN A 374 B 200 ASP A 281 ASP.? 28.06 ZN ZN A 375 B 229 LYS A 285 LYS^? 20.00 O3 TRS A 378 coo 9.24 94.26 88.22 8.02 94.07 89.92 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 17.54 90.31 75.01 17.17 92.01 73.80 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 22.32 101.61 71.64 17.89 98.63 71.55 47.09 -21.09 34.01 41.69 -24.22 32.75 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 123 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 B 229 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 9.24 94.26 88.22 8.02 94.07 89.92 40.60 0.33 34.12 38.69 0.39 33.24 coo 17.54 90.31 75.01 17.17 92.01 73.80 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 B 123 HIS A 361 HIS^? 22.47 ZN ZN A 375 B 200 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 9.24 94.26 88.22 8.02 94.07 89.92 46.25 9.10 12.92 46.66 10.09 11.12 coo 17.54 90.31 75.01 17.17 92.01 73.80 40.70 8.14 28.73 41.06 6.40 29.84 coo 22.32 101.61 71.64 17.89 98.63 71.55 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 B 123 HIS A 366 HIS.? 14.86 ZN ZN A 374 B 200 ASP A 55 ASP~? 17.36 O2S EPE A 376 B 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 9.24 94.26 88.22 8.02 94.07 89.92 51.10 6.85 29.91 51.20 5.36 31.38 coo 17.54 90.31 75.01 17.17 92.01 73.80 45.10 18.98 22.18 44.20 20.57 23.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 B 123 HIS B 21 HIS~? 17.19 ZN ZN B 375 B 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 B 229 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 17.54 90.31 75.01 17.17 92.01 73.80 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 22.32 101.61 71.64 17.89 98.63 71.55 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 B 123 HIS B 21 HIS~? 17.19 ZN ZN B 375 B 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 B 229 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 17.54 90.31 75.01 17.17 92.01 73.80 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 22.32 101.61 71.64 17.89 98.63 71.55 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 B 123 HIS B 21 HIS~? 17.19 ZN ZN B 375 B 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 B 229 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 9.24 94.26 88.22 8.02 94.07 89.92 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 17.54 90.31 75.01 17.17 92.01 73.80 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 22.32 101.61 71.64 17.89 98.63 71.55 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 B 123 HIS B 42 HIS^? 26.13 ZN ZN B 375 B 200 ASP B 55 ASP~? 16.89 O3S EPE B 376 B 229 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 9.24 94.26 88.22 8.02 94.07 89.92 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 17.54 90.31 75.01 17.17 92.01 73.80 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 22.32 101.61 71.64 17.89 98.63 71.55 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 B 123 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 229 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 17.54 90.31 75.01 17.17 92.01 73.80 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 22.32 101.61 71.64 17.89 98.63 71.55 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 B 123 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 229 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 17.54 90.31 75.01 17.17 92.01 73.80 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 22.32 101.61 71.64 17.89 98.63 71.55 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 B 123 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 200 ASP B 368 ASP.? 11.70 ZN ZN B 374 B 229 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 17.54 90.31 75.01 17.17 92.01 73.80 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 B 123 HIS B 263 HIS~? 20.98 ZN ZN B 375 B 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 B 229 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 17.54 90.31 75.01 17.17 92.01 73.80 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 22.32 101.61 71.64 17.89 98.63 71.55 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 B 123 HIS B 263 HIS~? 20.98 ZN ZN B 375 B 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 B 229 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 9.24 94.26 88.22 8.02 94.07 89.92 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 17.54 90.31 75.01 17.17 92.01 73.80 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 22.32 101.61 71.64 17.89 98.63 71.55 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 B 123 HIS B 263 HIS~? 20.98 ZN ZN B 375 B 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 229 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 9.24 94.26 88.22 8.02 94.07 89.92 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 17.54 90.31 75.01 17.17 92.01 73.80 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 22.32 101.61 71.64 17.89 98.63 71.55 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 B 123 HIS B 319 HIS~? 24.73 ZN ZN B 374 B 200 ASP B 281 ASP.? 29.04 ZN ZN B 374 B 229 LYS B 285 LYS^? 22.19 ZN ZN B 375 coo 9.24 94.26 88.22 8.02 94.07 89.92 8.16 23.53 21.75 7.85 25.60 21.62 coo 17.54 90.31 75.01 17.17 92.01 73.80 4.51 22.24 5.26 6.45 23.04 5.71 coo 22.32 101.61 71.64 17.89 98.63 71.55 1.97 10.60 4.02 5.48 5.38 4.89 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 B 123 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 B 229 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 9.24 94.26 88.22 8.02 94.07 89.92 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 17.54 90.31 75.01 17.17 92.01 73.80 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 22.32 101.61 71.64 17.89 98.63 71.55 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 27 3 # 27 B 123 HIS B 359 HIS^? 24.30 ZN ZN B 375 B 200 ASP B 55 ASP~? 16.89 O3S EPE B 376 B 229 LYS B 94 LYS~? 17.44 O2S EPE B 376 coo 9.24 94.26 88.22 8.02 94.07 89.92 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 17.54 90.31 75.01 17.17 92.01 73.80 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 22.32 101.61 71.64 17.89 98.63 71.55 -29.53 0.46 40.71 -30.43 3.58 45.55 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 28 3 # 28 B 123 HIS B 366 HIS.? 14.78 ZN ZN B 374 B 200 ASP B 55 ASP~? 16.89 O3S EPE B 376 B 229 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 9.24 94.26 88.22 8.02 94.07 89.92 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 17.54 90.31 75.01 17.17 92.01 73.80 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 22.32 101.61 71.64 17.89 98.63 71.55 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 29 3 # 29 B 123 HIS C 21 HIS~? 17.02 O1 TRS A 378 B 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 B 229 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 17.54 90.31 75.01 17.17 92.01 73.80 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 30 3 # 30 B 123 HIS C 21 HIS~? 17.02 O1 TRS A 378 B 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 B 229 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 17.54 90.31 75.01 17.17 92.01 73.80 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 31 3 # 31 B 123 HIS C 21 HIS~? 17.02 O1 TRS A 378 B 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 B 229 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 9.24 94.26 88.22 8.02 94.07 89.92 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 17.54 90.31 75.01 17.17 92.01 73.80 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 32 3 # 32 B 123 HIS C 42 HIS^? 26.23 ZN ZN C 375 B 200 ASP C 55 ASP~? 17.38 O3S EPE C 376 B 229 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 9.24 94.26 88.22 8.02 94.07 89.92 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 17.54 90.31 75.01 17.17 92.01 73.80 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 22.32 101.61 71.64 17.89 98.63 71.55 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 33 3 # 33 B 123 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 229 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 17.54 90.31 75.01 17.17 92.01 73.80 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 22.32 101.61 71.64 17.89 98.63 71.55 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 34 3 # 34 B 123 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 229 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 17.54 90.31 75.01 17.17 92.01 73.80 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 22.32 101.61 71.64 17.89 98.63 71.55 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 35 3 # 35 B 123 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 200 ASP C 368 ASP.? 11.74 ZN ZN C 374 B 229 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 17.54 90.31 75.01 17.17 92.01 73.80 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 22.32 101.61 71.64 17.89 98.63 71.55 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 36 3 # 36 B 123 HIS C 263 HIS~? 20.89 ZN ZN C 375 B 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 B 229 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 17.54 90.31 75.01 17.17 92.01 73.80 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 37 3 # 37 B 123 HIS C 263 HIS~? 20.89 ZN ZN C 375 B 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 B 229 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 9.24 94.26 88.22 8.02 94.07 89.92 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 17.54 90.31 75.01 17.17 92.01 73.80 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 38 3 # 38 B 123 HIS C 263 HIS~? 20.89 ZN ZN C 375 B 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 229 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 17.54 90.31 75.01 17.17 92.01 73.80 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 22.32 101.61 71.64 17.89 98.63 71.55 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 39 3 # 39 B 123 HIS C 319 HIS~? 24.70 ZN ZN C 374 B 200 ASP C 281 ASP.? 29.07 ZN ZN C 374 B 229 LYS C 285 LYS^? 22.29 ZN ZN C 375 coo 9.24 94.26 88.22 8.02 94.07 89.92 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 17.54 90.31 75.01 17.17 92.01 73.80 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 -14.01 -33.36 45.98 -12.46 -31.50 40.58 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 40 3 # 40 B 123 HIS C 319 HIS~? 24.70 ZN ZN C 374 B 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 229 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 9.24 94.26 88.22 8.02 94.07 89.92 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 17.54 90.31 75.01 17.17 92.01 73.80 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 22.32 101.61 71.64 17.89 98.63 71.55 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 41 3 # 41 B 123 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 B 229 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 9.24 94.26 88.22 8.02 94.07 89.92 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 17.54 90.31 75.01 17.17 92.01 73.80 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 42 3 # 42 B 123 HIS C 359 HIS^? 24.82 ZN ZN C 375 B 200 ASP C 55 ASP~? 17.38 O3S EPE C 376 B 229 LYS C 94 LYS~? 16.71 O3S EPE C 376 coo 9.24 94.26 88.22 8.02 94.07 89.92 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 17.54 90.31 75.01 17.17 92.01 73.80 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 22.32 101.61 71.64 17.89 98.63 71.55 30.11 -27.61 67.14 30.55 -24.06 72.29 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 43 3 # 43 B 123 HIS C 366 HIS.? 14.85 ZN ZN C 374 B 200 ASP C 55 ASP~? 17.38 O3S EPE C 376 B 229 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 9.24 94.26 88.22 8.02 94.07 89.92 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 17.54 90.31 75.01 17.17 92.01 73.80 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 22.32 101.61 71.64 17.89 98.63 71.55 22.12 -22.06 69.94 21.88 -19.84 74.70 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 43 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 21 HIS~? 17.08 ZN ZN A 375 C 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 C 229 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 19.52 52.01 79.59 20.28 51.65 77.65 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS A 21 HIS~? 17.08 ZN ZN A 375 C 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 C 229 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 19.52 52.01 79.59 20.28 51.65 77.65 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 123 HIS A 21 HIS~? 17.08 ZN ZN A 375 C 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 C 229 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 26.77 65.84 83.49 27.06 67.76 84.27 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 19.52 52.01 79.59 20.28 51.65 77.65 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 123 HIS A 42 HIS^? 26.23 ZN ZN A 375 C 200 ASP A 55 ASP~? 17.36 O2S EPE A 376 C 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 26.77 65.84 83.49 27.06 67.76 84.27 43.48 12.60 9.22 44.86 13.19 7.76 coo 19.52 52.01 79.59 20.28 51.65 77.65 45.10 18.98 22.18 44.20 20.57 23.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 123 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 C 229 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 37.80 0.44 25.56 37.02 -1.29 26.44 coo 19.52 52.01 79.59 20.28 51.65 77.65 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 28.90 45.91 73.55 25.22 49.72 72.97 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 123 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 C 229 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 37.42 3.90 29.26 38.47 2.36 30.22 coo 19.52 52.01 79.59 20.28 51.65 77.65 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 28.90 45.91 73.55 25.22 49.72 72.97 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 123 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 200 ASP A 368 ASP.? 11.85 ZN ZN A 374 C 229 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.52 52.01 79.59 20.28 51.65 77.65 48.24 5.16 33.58 47.82 3.96 35.30 coo 28.90 45.91 73.55 25.22 49.72 72.97 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 123 HIS A 263 HIS~? 20.93 ZN ZN A 375 C 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 C 229 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 19.52 52.01 79.59 20.28 51.65 77.65 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 123 HIS A 263 HIS~? 20.93 ZN ZN A 375 C 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 C 229 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 26.77 65.84 83.49 27.06 67.76 84.27 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 19.52 52.01 79.59 20.28 51.65 77.65 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 123 HIS A 263 HIS~? 20.93 ZN ZN A 375 C 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 C 229 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 19.52 52.01 79.59 20.28 51.65 77.65 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 28.90 45.91 73.55 25.22 49.72 72.97 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 123 HIS A 319 HIS~? 24.64 ZN ZN A 374 C 200 ASP A 281 ASP.? 28.06 ZN ZN A 375 C 229 LYS A 285 LYS^? 20.00 O3 TRS A 378 coo 26.77 65.84 83.49 27.06 67.76 84.27 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 19.52 52.01 79.59 20.28 51.65 77.65 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 28.90 45.91 73.55 25.22 49.72 72.97 47.09 -21.09 34.01 41.69 -24.22 32.75 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 123 HIS A 333 HIS~? -3.55 ZN ZN A 374s C 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 C 229 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 26.77 65.84 83.49 27.06 67.76 84.27 40.60 0.33 34.12 38.69 0.39 33.24 coo 19.52 52.01 79.59 20.28 51.65 77.65 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 C 123 HIS A 361 HIS^? 22.47 ZN ZN A 375 C 200 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 26.77 65.84 83.49 27.06 67.76 84.27 46.25 9.10 12.92 46.66 10.09 11.12 coo 19.52 52.01 79.59 20.28 51.65 77.65 40.70 8.14 28.73 41.06 6.40 29.84 coo 28.90 45.91 73.55 25.22 49.72 72.97 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 C 123 HIS A 366 HIS.? 14.86 ZN ZN A 374 C 200 ASP A 55 ASP~? 17.36 O2S EPE A 376 C 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 26.77 65.84 83.49 27.06 67.76 84.27 51.10 6.85 29.91 51.20 5.36 31.38 coo 19.52 52.01 79.59 20.28 51.65 77.65 45.10 18.98 22.18 44.20 20.57 23.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 C 123 HIS B 21 HIS~? 17.19 ZN ZN B 375 C 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 C 229 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 19.52 52.01 79.59 20.28 51.65 77.65 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 28.90 45.91 73.55 25.22 49.72 72.97 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 C 123 HIS B 21 HIS~? 17.19 ZN ZN B 375 C 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 C 229 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 19.52 52.01 79.59 20.28 51.65 77.65 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 28.90 45.91 73.55 25.22 49.72 72.97 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 C 123 HIS B 21 HIS~? 17.19 ZN ZN B 375 C 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 C 229 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 26.77 65.84 83.49 27.06 67.76 84.27 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 19.52 52.01 79.59 20.28 51.65 77.65 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 28.90 45.91 73.55 25.22 49.72 72.97 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 C 123 HIS B 42 HIS^? 26.13 ZN ZN B 375 C 200 ASP B 55 ASP~? 16.89 O3S EPE B 376 C 229 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 26.77 65.84 83.49 27.06 67.76 84.27 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 19.52 52.01 79.59 20.28 51.65 77.65 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 28.90 45.91 73.55 25.22 49.72 72.97 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 C 123 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 C 229 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 19.52 52.01 79.59 20.28 51.65 77.65 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 28.90 45.91 73.55 25.22 49.72 72.97 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 C 123 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 C 229 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 19.52 52.01 79.59 20.28 51.65 77.65 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 28.90 45.91 73.55 25.22 49.72 72.97 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 C 123 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 200 ASP B 368 ASP.? 11.70 ZN ZN B 374 C 229 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.52 52.01 79.59 20.28 51.65 77.65 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 C 123 HIS B 263 HIS~? 20.98 ZN ZN B 375 C 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 C 229 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 19.52 52.01 79.59 20.28 51.65 77.65 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 28.90 45.91 73.55 25.22 49.72 72.97 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 C 123 HIS B 263 HIS~? 20.98 ZN ZN B 375 C 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 C 229 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 26.77 65.84 83.49 27.06 67.76 84.27 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 19.52 52.01 79.59 20.28 51.65 77.65 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 28.90 45.91 73.55 25.22 49.72 72.97 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 C 123 HIS B 263 HIS~? 20.98 ZN ZN B 375 C 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 C 229 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 26.77 65.84 83.49 27.06 67.76 84.27 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 19.52 52.01 79.59 20.28 51.65 77.65 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 28.90 45.91 73.55 25.22 49.72 72.97 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 C 123 HIS B 319 HIS~? 24.73 ZN ZN B 374 C 200 ASP B 281 ASP.? 29.04 ZN ZN B 374 C 229 LYS B 285 LYS^? 22.19 ZN ZN B 375 coo 26.77 65.84 83.49 27.06 67.76 84.27 8.16 23.53 21.75 7.85 25.60 21.62 coo 19.52 52.01 79.59 20.28 51.65 77.65 4.51 22.24 5.26 6.45 23.04 5.71 coo 28.90 45.91 73.55 25.22 49.72 72.97 1.97 10.60 4.02 5.48 5.38 4.89 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 C 123 HIS B 333 HIS~? -3.37 ZN ZN B 374s C 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 C 229 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 26.77 65.84 83.49 27.06 67.76 84.27 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 19.52 52.01 79.59 20.28 51.65 77.65 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 28.90 45.91 73.55 25.22 49.72 72.97 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 27 3 # 27 C 123 HIS B 359 HIS^? 24.30 ZN ZN B 375 C 200 ASP B 55 ASP~? 16.89 O3S EPE B 376 C 229 LYS B 94 LYS~? 17.44 O2S EPE B 376 coo 26.77 65.84 83.49 27.06 67.76 84.27 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 19.52 52.01 79.59 20.28 51.65 77.65 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 28.90 45.91 73.55 25.22 49.72 72.97 -29.53 0.46 40.71 -30.43 3.58 45.55 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 28 3 # 28 C 123 HIS B 366 HIS.? 14.78 ZN ZN B 374 C 200 ASP B 55 ASP~? 16.89 O3S EPE B 376 C 229 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 26.77 65.84 83.49 27.06 67.76 84.27 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 19.52 52.01 79.59 20.28 51.65 77.65 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 28.90 45.91 73.55 25.22 49.72 72.97 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 29 3 # 29 C 123 HIS C 21 HIS~? 17.02 O1 TRS A 378 C 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 C 229 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 19.52 52.01 79.59 20.28 51.65 77.65 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 30 3 # 30 C 123 HIS C 21 HIS~? 17.02 O1 TRS A 378 C 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 C 229 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 19.52 52.01 79.59 20.28 51.65 77.65 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 31 3 # 31 C 123 HIS C 21 HIS~? 17.02 O1 TRS A 378 C 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 C 229 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 26.77 65.84 83.49 27.06 67.76 84.27 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 19.52 52.01 79.59 20.28 51.65 77.65 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 32 3 # 32 C 123 HIS C 42 HIS^? 26.23 ZN ZN C 375 C 200 ASP C 55 ASP~? 17.38 O3S EPE C 376 C 229 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 26.77 65.84 83.49 27.06 67.76 84.27 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 19.52 52.01 79.59 20.28 51.65 77.65 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 28.90 45.91 73.55 25.22 49.72 72.97 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 33 3 # 33 C 123 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 C 229 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 19.52 52.01 79.59 20.28 51.65 77.65 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 28.90 45.91 73.55 25.22 49.72 72.97 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 34 3 # 34 C 123 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 C 229 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 19.52 52.01 79.59 20.28 51.65 77.65 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 28.90 45.91 73.55 25.22 49.72 72.97 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 35 3 # 35 C 123 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 200 ASP C 368 ASP.? 11.74 ZN ZN C 374 C 229 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.52 52.01 79.59 20.28 51.65 77.65 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 28.90 45.91 73.55 25.22 49.72 72.97 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 36 3 # 36 C 123 HIS C 263 HIS~? 20.89 ZN ZN C 375 C 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 C 229 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 19.52 52.01 79.59 20.28 51.65 77.65 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 37 3 # 37 C 123 HIS C 263 HIS~? 20.89 ZN ZN C 375 C 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 C 229 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 26.77 65.84 83.49 27.06 67.76 84.27 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 19.52 52.01 79.59 20.28 51.65 77.65 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 38 3 # 38 C 123 HIS C 263 HIS~? 20.89 ZN ZN C 375 C 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 C 229 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 19.52 52.01 79.59 20.28 51.65 77.65 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 28.90 45.91 73.55 25.22 49.72 72.97 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 39 3 # 39 C 123 HIS C 319 HIS~? 24.70 ZN ZN C 374 C 200 ASP C 281 ASP.? 29.07 ZN ZN C 374 C 229 LYS C 285 LYS^? 22.29 ZN ZN C 375 coo 26.77 65.84 83.49 27.06 67.76 84.27 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 19.52 52.01 79.59 20.28 51.65 77.65 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 -14.01 -33.36 45.98 -12.46 -31.50 40.58 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 40 3 # 40 C 123 HIS C 319 HIS~? 24.70 ZN ZN C 374 C 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 C 229 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 26.77 65.84 83.49 27.06 67.76 84.27 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 19.52 52.01 79.59 20.28 51.65 77.65 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 28.90 45.91 73.55 25.22 49.72 72.97 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 41 3 # 41 C 123 HIS C 333 HIS~? -3.37 ZN ZN C 374s C 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 C 229 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 26.77 65.84 83.49 27.06 67.76 84.27 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 19.52 52.01 79.59 20.28 51.65 77.65 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 42 3 # 42 C 123 HIS C 359 HIS^? 24.82 ZN ZN C 375 C 200 ASP C 55 ASP~? 17.38 O3S EPE C 376 C 229 LYS C 94 LYS~? 16.71 O3S EPE C 376 coo 26.77 65.84 83.49 27.06 67.76 84.27 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 19.52 52.01 79.59 20.28 51.65 77.65 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 28.90 45.91 73.55 25.22 49.72 72.97 30.11 -27.61 67.14 30.55 -24.06 72.29 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 43 3 # 43 C 123 HIS C 366 HIS.? 14.85 ZN ZN C 374 C 200 ASP C 55 ASP~? 17.38 O3S EPE C 376 C 229 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 26.77 65.84 83.49 27.06 67.76 84.27 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 19.52 52.01 79.59 20.28 51.65 77.65 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 28.90 45.91 73.55 25.22 49.72 72.97 22.12 -22.06 69.94 21.88 -19.84 74.70 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 43 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 21 HIS~? 17.08 ZN ZN A 375 D 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 D 229 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 4.60 52.95 52.50 5.57 51.29 53.40 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS A 21 HIS~? 17.08 ZN ZN A 375 D 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 D 229 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 4.60 52.95 52.50 5.57 51.29 53.40 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 123 HIS A 21 HIS~? 17.08 ZN ZN A 375 D 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 D 229 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo -10.90 48.74 53.41 -12.98 48.90 53.67 24.93 -8.05 18.54 26.13 -9.04 17.11 coo 4.60 52.95 52.50 5.57 51.29 53.40 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 123 HIS A 42 HIS^? 26.23 ZN ZN A 375 D 200 ASP A 55 ASP~? 17.36 O2S EPE A 376 D 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -10.90 48.74 53.41 -12.98 48.90 53.67 43.48 12.60 9.22 44.86 13.19 7.76 coo 4.60 52.95 52.50 5.57 51.29 53.40 45.10 18.98 22.18 44.20 20.57 23.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 123 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 D 229 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 37.80 0.44 25.56 37.02 -1.29 26.44 coo 4.60 52.95 52.50 5.57 51.29 53.40 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 10.05 41.79 49.80 7.94 44.71 53.76 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 123 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 D 229 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 37.42 3.90 29.26 38.47 2.36 30.22 coo 4.60 52.95 52.50 5.57 51.29 53.40 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 10.05 41.79 49.80 7.94 44.71 53.76 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 123 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 200 ASP A 368 ASP.? 11.85 ZN ZN A 374 D 229 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 32.91 0.46 27.63 33.66 0.11 29.56 coo 4.60 52.95 52.50 5.57 51.29 53.40 48.24 5.16 33.58 47.82 3.96 35.30 coo 10.05 41.79 49.80 7.94 44.71 53.76 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 123 HIS A 263 HIS~? 20.93 ZN ZN A 375 D 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 D 229 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 4.60 52.95 52.50 5.57 51.29 53.40 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 123 HIS A 263 HIS~? 20.93 ZN ZN A 375 D 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 D 229 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo -10.90 48.74 53.41 -12.98 48.90 53.67 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 4.60 52.95 52.50 5.57 51.29 53.40 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 123 HIS A 263 HIS~? 20.93 ZN ZN A 375 D 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 D 229 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 4.60 52.95 52.50 5.57 51.29 53.40 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 10.05 41.79 49.80 7.94 44.71 53.76 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 123 HIS A 319 HIS~? 24.64 ZN ZN A 374 D 200 ASP A 281 ASP.? 28.06 ZN ZN A 375 D 229 LYS A 285 LYS^? 20.00 O3 TRS A 378 coo -10.90 48.74 53.41 -12.98 48.90 53.67 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 4.60 52.95 52.50 5.57 51.29 53.40 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 10.05 41.79 49.80 7.94 44.71 53.76 47.09 -21.09 34.01 41.69 -24.22 32.75 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 123 HIS A 333 HIS~? -3.55 ZN ZN A 374s D 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 D 229 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo -10.90 48.74 53.41 -12.98 48.90 53.67 40.60 0.33 34.12 38.69 0.39 33.24 coo 4.60 52.95 52.50 5.57 51.29 53.40 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 D 123 HIS A 361 HIS^? 22.47 ZN ZN A 375 D 200 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -10.90 48.74 53.41 -12.98 48.90 53.67 46.25 9.10 12.92 46.66 10.09 11.12 coo 4.60 52.95 52.50 5.57 51.29 53.40 40.70 8.14 28.73 41.06 6.40 29.84 coo 10.05 41.79 49.80 7.94 44.71 53.76 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 D 123 HIS A 366 HIS.? 14.86 ZN ZN A 374 D 200 ASP A 55 ASP~? 17.36 O2S EPE A 376 D 229 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -10.90 48.74 53.41 -12.98 48.90 53.67 51.10 6.85 29.91 51.20 5.36 31.38 coo 4.60 52.95 52.50 5.57 51.29 53.40 45.10 18.98 22.18 44.20 20.57 23.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 D 123 HIS B 21 HIS~? 17.19 ZN ZN B 375 D 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 D 229 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 4.60 52.95 52.50 5.57 51.29 53.40 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 10.05 41.79 49.80 7.94 44.71 53.76 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 D 123 HIS B 21 HIS~? 17.19 ZN ZN B 375 D 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 D 229 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 4.60 52.95 52.50 5.57 51.29 53.40 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 10.05 41.79 49.80 7.94 44.71 53.76 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 D 123 HIS B 21 HIS~? 17.19 ZN ZN B 375 D 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 D 229 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo 4.60 52.95 52.50 5.57 51.29 53.40 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 10.05 41.79 49.80 7.94 44.71 53.76 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 D 123 HIS B 42 HIS^? 26.13 ZN ZN B 375 D 200 ASP B 55 ASP~? 16.89 O3S EPE B 376 D 229 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 4.60 52.95 52.50 5.57 51.29 53.40 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 10.05 41.79 49.80 7.94 44.71 53.76 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 D 123 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 D 229 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 4.60 52.95 52.50 5.57 51.29 53.40 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 10.05 41.79 49.80 7.94 44.71 53.76 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 D 123 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 D 229 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 4.60 52.95 52.50 5.57 51.29 53.40 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 10.05 41.79 49.80 7.94 44.71 53.76 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 D 123 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 200 ASP B 368 ASP.? 11.70 ZN ZN B 374 D 229 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 4.60 52.95 52.50 5.57 51.29 53.40 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 D 123 HIS B 263 HIS~? 20.98 ZN ZN B 375 D 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 D 229 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 4.60 52.95 52.50 5.57 51.29 53.40 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 10.05 41.79 49.80 7.94 44.71 53.76 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 D 123 HIS B 263 HIS~? 20.98 ZN ZN B 375 D 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 D 229 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 4.60 52.95 52.50 5.57 51.29 53.40 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 10.05 41.79 49.80 7.94 44.71 53.76 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 D 123 HIS B 263 HIS~? 20.98 ZN ZN B 375 D 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 D 229 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 4.60 52.95 52.50 5.57 51.29 53.40 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 10.05 41.79 49.80 7.94 44.71 53.76 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 D 123 HIS B 319 HIS~? 24.73 ZN ZN B 374 D 200 ASP B 281 ASP.? 29.04 ZN ZN B 374 D 229 LYS B 285 LYS^? 22.19 ZN ZN B 375 coo -10.90 48.74 53.41 -12.98 48.90 53.67 8.16 23.53 21.75 7.85 25.60 21.62 coo 4.60 52.95 52.50 5.57 51.29 53.40 4.51 22.24 5.26 6.45 23.04 5.71 coo 10.05 41.79 49.80 7.94 44.71 53.76 1.97 10.60 4.02 5.48 5.38 4.89 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 D 123 HIS B 333 HIS~? -3.37 ZN ZN B 374s D 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 D 229 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 4.60 52.95 52.50 5.57 51.29 53.40 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 10.05 41.79 49.80 7.94 44.71 53.76 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 27 3 # 27 D 123 HIS B 359 HIS^? 24.30 ZN ZN B 375 D 200 ASP B 55 ASP~? 16.89 O3S EPE B 376 D 229 LYS B 94 LYS~? 17.44 O2S EPE B 376 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 4.60 52.95 52.50 5.57 51.29 53.40 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 10.05 41.79 49.80 7.94 44.71 53.76 -29.53 0.46 40.71 -30.43 3.58 45.55 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 28 3 # 28 D 123 HIS B 366 HIS.? 14.78 ZN ZN B 374 D 200 ASP B 55 ASP~? 16.89 O3S EPE B 376 D 229 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 4.60 52.95 52.50 5.57 51.29 53.40 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 10.05 41.79 49.80 7.94 44.71 53.76 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 29 3 # 29 D 123 HIS C 21 HIS~? 17.02 O1 TRS A 378 D 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 D 229 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 4.60 52.95 52.50 5.57 51.29 53.40 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 30 3 # 30 D 123 HIS C 21 HIS~? 17.02 O1 TRS A 378 D 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 D 229 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 4.60 52.95 52.50 5.57 51.29 53.40 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 31 3 # 31 D 123 HIS C 21 HIS~? 17.02 O1 TRS A 378 D 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 D 229 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo -10.90 48.74 53.41 -12.98 48.90 53.67 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 4.60 52.95 52.50 5.57 51.29 53.40 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 32 3 # 32 D 123 HIS C 42 HIS^? 26.23 ZN ZN C 375 D 200 ASP C 55 ASP~? 17.38 O3S EPE C 376 D 229 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo -10.90 48.74 53.41 -12.98 48.90 53.67 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 4.60 52.95 52.50 5.57 51.29 53.40 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 10.05 41.79 49.80 7.94 44.71 53.76 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 33 3 # 33 D 123 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 D 229 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 4.60 52.95 52.50 5.57 51.29 53.40 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 10.05 41.79 49.80 7.94 44.71 53.76 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 34 3 # 34 D 123 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 D 229 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 4.60 52.95 52.50 5.57 51.29 53.40 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 10.05 41.79 49.80 7.94 44.71 53.76 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 35 3 # 35 D 123 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 200 ASP C 368 ASP.? 11.74 ZN ZN C 374 D 229 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 4.60 52.95 52.50 5.57 51.29 53.40 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 10.05 41.79 49.80 7.94 44.71 53.76 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 36 3 # 36 D 123 HIS C 263 HIS~? 20.89 ZN ZN C 375 D 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 D 229 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 4.60 52.95 52.50 5.57 51.29 53.40 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 37 3 # 37 D 123 HIS C 263 HIS~? 20.89 ZN ZN C 375 D 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 D 229 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 4.60 52.95 52.50 5.57 51.29 53.40 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 38 3 # 38 D 123 HIS C 263 HIS~? 20.89 ZN ZN C 375 D 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 D 229 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 4.60 52.95 52.50 5.57 51.29 53.40 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 10.05 41.79 49.80 7.94 44.71 53.76 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 39 3 # 39 D 123 HIS C 319 HIS~? 24.70 ZN ZN C 374 D 200 ASP C 281 ASP.? 29.07 ZN ZN C 374 D 229 LYS C 285 LYS^? 22.29 ZN ZN C 375 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 4.60 52.95 52.50 5.57 51.29 53.40 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 -14.01 -33.36 45.98 -12.46 -31.50 40.58 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 40 3 # 40 D 123 HIS C 319 HIS~? 24.70 ZN ZN C 374 D 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 D 229 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 4.60 52.95 52.50 5.57 51.29 53.40 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 10.05 41.79 49.80 7.94 44.71 53.76 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 41 3 # 41 D 123 HIS C 333 HIS~? -3.37 ZN ZN C 374s D 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 D 229 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo -10.90 48.74 53.41 -12.98 48.90 53.67 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 4.60 52.95 52.50 5.57 51.29 53.40 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 42 3 # 42 D 123 HIS C 359 HIS^? 24.82 ZN ZN C 375 D 200 ASP C 55 ASP~? 17.38 O3S EPE C 376 D 229 LYS C 94 LYS~? 16.71 O3S EPE C 376 coo -10.90 48.74 53.41 -12.98 48.90 53.67 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 4.60 52.95 52.50 5.57 51.29 53.40 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 10.05 41.79 49.80 7.94 44.71 53.76 30.11 -27.61 67.14 30.55 -24.06 72.29 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 43 3 # 43 D 123 HIS C 366 HIS.? 14.85 ZN ZN C 374 D 200 ASP C 55 ASP~? 17.38 O3S EPE C 376 D 229 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo -10.90 48.74 53.41 -12.98 48.90 53.67 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 4.60 52.95 52.50 5.57 51.29 53.40 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 10.05 41.79 49.80 7.94 44.71 53.76 22.12 -22.06 69.94 21.88 -19.84 74.70 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 43 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 138 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 161 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 29.03 88.95 86.80 28.09 90.57 84.75 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 23.31 93.18 82.88 23.00 93.71 79.86 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 33.83 91.15 88.62 31.07 91.06 83.02 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 138 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 161 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 29.03 88.95 86.80 28.09 90.57 84.75 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 23.31 93.18 82.88 23.00 93.71 79.86 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 33.83 91.15 88.62 31.07 91.06 83.02 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 133 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 138 ARG B 203 ARG^? 8.69 O2S EPE A 377 A 161 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 29.03 88.95 86.80 28.09 90.57 84.75 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 23.31 93.18 82.88 23.00 93.71 79.86 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 33.83 91.15 88.62 31.07 91.06 83.02 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 133 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 138 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 161 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 29.03 88.95 86.80 28.09 90.57 84.75 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 23.31 93.18 82.88 23.00 93.71 79.86 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 33.83 91.15 88.62 31.07 91.06 83.02 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 133 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 138 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 161 LYS C 139 LYS^? 16.11 N TRS A 378 coo 29.03 88.95 86.80 28.09 90.57 84.75 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 23.31 93.18 82.88 23.00 93.71 79.86 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 33.83 91.15 88.62 31.07 91.06 83.02 13.08 -32.56 20.05 9.65 -36.55 18.68 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 5 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 138 ARG A 203 ARG^? 8.58 O3S EPE C 377 B 161 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 4.62 122.69 99.88 5.46 122.82 97.24 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 10.44 122.27 94.08 11.02 123.87 91.53 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -0.17 119.75 99.65 2.51 123.83 95.70 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 138 ARG A 203 ARG^? 8.58 O3S EPE C 377 B 161 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 4.62 122.69 99.88 5.46 122.82 97.24 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 10.44 122.27 94.08 11.02 123.87 91.53 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -0.17 119.75 99.65 2.51 123.83 95.70 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 133 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 138 ARG B 203 ARG^? 8.69 O2S EPE A 377 B 161 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 4.62 122.69 99.88 5.46 122.82 97.24 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 10.44 122.27 94.08 11.02 123.87 91.53 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -0.17 119.75 99.65 2.51 123.83 95.70 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 133 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 138 ARG C 203 ARG^? 8.27 O3S EPE C 377 B 161 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 4.62 122.69 99.88 5.46 122.82 97.24 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 10.44 122.27 94.08 11.02 123.87 91.53 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -0.17 119.75 99.65 2.51 123.83 95.70 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 133 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 138 ARG C 203 ARG^? 8.27 O3S EPE C 377 B 161 LYS C 139 LYS^? 16.11 N TRS A 378 coo 4.62 122.69 99.88 5.46 122.82 97.24 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 10.44 122.27 94.08 11.02 123.87 91.53 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -0.17 119.75 99.65 2.51 123.83 95.70 13.08 -32.56 20.05 9.65 -36.55 18.68 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 5 hits 1dhp_c01 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 18 TYR~? 11.08 ZN ZN A 375 150 LYS A 20 LYS~? 16.95 ZN ZN A 375 186 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 32.88 50.55 24.33 31.89 51.78 26.65 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 27.04 52.42 22.30 26.88 49.99 27.00 26.66 -3.22 19.04 24.73 2.41 18.30 coo 36.98 50.30 37.29 35.85 50.29 35.50 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 234 TYR^? 9.43 O2S EPE A 377 150 LYS A 138 LYS^? 13.11 N TRS A 378 186 ASN C 238 ASN^? 16.63 O2S EPE A 377 coo 32.88 50.55 24.33 31.89 51.78 26.65 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 27.04 52.42 22.30 26.88 49.99 27.00 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 36.98 50.30 37.29 35.85 50.29 35.50 5.28 -30.50 23.50 4.52 -30.81 21.55 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR A 234 TYR^? 9.43 O2S EPE A 377 150 LYS A 139 LYS^? -2.64 O3S EPE C 377s 186 ASN C 238 ASN^? 16.63 O2S EPE A 377 coo 32.88 50.55 24.33 31.89 51.78 26.65 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 27.04 52.42 22.30 26.88 49.99 27.00 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 36.98 50.30 37.29 35.85 50.29 35.50 5.28 -30.50 23.50 4.52 -30.81 21.55 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR B 18 TYR~? 10.93 ZN ZN B 375 150 LYS B 20 LYS~? 17.56 ZN ZN B 375 186 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo 32.88 50.55 24.33 31.89 51.78 26.65 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 27.04 52.42 22.30 26.88 49.99 27.00 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 36.98 50.30 37.29 35.85 50.29 35.50 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR B 234 TYR^? 11.34 O2S EPE A 377 150 LYS B 138 LYS^? 15.17 O1S EPE A 377 186 ASN A 238 ASN^? -4.13 C2 TRS A 378s coo 32.88 50.55 24.33 31.89 51.78 26.65 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 27.04 52.42 22.30 26.88 49.99 27.00 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 36.98 50.30 37.29 35.85 50.29 35.50 22.25 -25.65 17.52 21.37 -27.55 17.01 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 6 3 # 6 146 TYR B 234 TYR^? 11.34 O2S EPE A 377 150 LYS B 139 LYS^? -2.84 O2S EPE A 377s 186 ASN A 238 ASN^? -4.13 C2 TRS A 378s coo 32.88 50.55 24.33 31.89 51.78 26.65 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 27.04 52.42 22.30 26.88 49.99 27.00 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 36.98 50.30 37.29 35.85 50.29 35.50 22.25 -25.65 17.52 21.37 -27.55 17.01 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 7 3 # 7 146 TYR B 234 TYR^? 11.34 O2S EPE A 377 150 LYS C 139 LYS^? 16.11 N TRS A 378 186 ASN B 238 ASN^? 8.84 O1S EPE A 377 coo 32.88 50.55 24.33 31.89 51.78 26.65 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 27.04 52.42 22.30 26.88 49.99 27.00 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 36.98 50.30 37.29 35.85 50.29 35.50 7.11 -18.54 9.31 8.52 -20.00 8.45 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 8 3 # 8 146 TYR C 234 TYR^? 9.10 O2S EPE C 377 150 LYS C 138 LYS^? 8.30 N TRS A 378 186 ASN B 238 ASN^? 8.84 O1S EPE A 377 coo 32.88 50.55 24.33 31.89 51.78 26.65 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 27.04 52.42 22.30 26.88 49.99 27.00 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 36.98 50.30 37.29 35.85 50.29 35.50 7.11 -18.54 9.31 8.52 -20.00 8.45 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 9 3 # 9 146 TYR C 234 TYR^? 9.10 O2S EPE C 377 150 LYS C 139 LYS^? 16.11 N TRS A 378 186 ASN B 238 ASN^? 8.84 O1S EPE A 377 coo 32.88 50.55 24.33 31.89 51.78 26.65 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 27.04 52.42 22.30 26.88 49.99 27.00 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 36.98 50.30 37.29 35.85 50.29 35.50 7.11 -18.54 9.31 8.52 -20.00 8.45 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 9 hits 1dhr_c00 naa= 3 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 1 3 # 1 123 CYH A 170 CYH^? -4.87 C10 EPE C 377s 171 ASP A 158 ASP~? 15.23 O1S EPE C 377 202 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 13.53 50.63 6.92 14.43 49.91 4.38 25.74 -30.01 4.94 27.86 -30.22 6.82 coo 11.86 58.52 0.90 11.25 56.63 1.71 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 12.37 53.26 1.34 11.86 52.62 3.19 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 2 3 # 2 123 CYH B 170 CYH^? -5.04 N1 EPE A 377s 171 ASP B 158 ASP~? 14.93 O3S EPE A 377 202 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 13.53 50.63 6.92 14.43 49.91 4.38 -0.70 -28.36 2.22 -0.22 -26.07 0.51 coo 11.86 58.52 0.90 11.25 56.63 1.71 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 12.37 53.26 1.34 11.86 52.62 3.19 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 3 3 # 3 123 CYH C 170 CYH^? 22.19 N TRS A 378 171 ASP C 158 ASP~? 22.01 O1 TRS A 378 202 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 13.53 50.63 6.92 14.43 49.91 4.38 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 11.86 58.52 0.90 11.25 56.63 1.71 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 12.37 53.26 1.34 11.86 52.62 3.19 13.13 -47.52 24.96 14.34 -48.17 26.54 1din_c00 source 1din DIENELACTONE HYDROLASE : 3 hits 1din_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 183 LYS A 20 LYS~? 16.95 ZN ZN A 375 A 278 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 19.43 18.53 42.32 17.66 18.80 40.15 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 21.92 15.80 36.19 17.64 19.44 36.35 26.66 -3.22 19.04 24.73 2.41 18.30 coo 15.46 19.03 31.40 15.01 18.25 33.31 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR A 85 TYR~? -4.05 C2 EPE A 376s A 183 LYS A 87 LYS~? 10.99 O2S EPE A 376 A 278 ASP A 82 ASP.? 8.88 O2S EPE A 376 coo 19.43 18.53 42.32 17.66 18.80 40.15 33.18 16.26 32.13 31.71 14.36 30.75 coo 21.92 15.80 36.19 17.64 19.44 36.35 35.91 21.93 28.51 38.15 26.57 30.75 coo 15.46 19.03 31.40 15.01 18.25 33.31 34.38 27.71 34.24 32.73 27.59 35.53 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 183 LYS A 138 LYS^? 13.11 N TRS A 378 A 278 ASP A 237 ASP^? 6.80 N TRS A 378 coo 19.43 18.53 42.32 17.66 18.80 40.15 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 21.92 15.80 36.19 17.64 19.44 36.35 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 15.46 19.03 31.40 15.01 18.25 33.31 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1do8_c00 MALIC ENZYME user 4 3 # 4 A 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 278 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 19.43 18.53 42.32 17.66 18.80 40.15 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 21.92 15.80 36.19 17.64 19.44 36.35 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 15.46 19.03 31.40 15.01 18.25 33.31 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1do8_c00 MALIC ENZYME user 5 3 # 5 A 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 278 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 19.43 18.53 42.32 17.66 18.80 40.15 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 21.92 15.80 36.19 17.64 19.44 36.35 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 15.46 19.03 31.40 15.01 18.25 33.31 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1do8_c00 MALIC ENZYME user 6 3 # 6 A 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 183 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 278 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 19.43 18.53 42.32 17.66 18.80 40.15 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 21.92 15.80 36.19 17.64 19.44 36.35 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 15.46 19.03 31.40 15.01 18.25 33.31 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1do8_c00 MALIC ENZYME user 7 3 # 7 A 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 183 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 278 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 19.43 18.53 42.32 17.66 18.80 40.15 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 21.92 15.80 36.19 17.64 19.44 36.35 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 15.46 19.03 31.40 15.01 18.25 33.31 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1do8_c00 MALIC ENZYME user 8 3 # 8 A 112 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 183 LYS A 301 LYS~? 24.94 ZN ZN A 375 A 278 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 19.43 18.53 42.32 17.66 18.80 40.15 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 21.92 15.80 36.19 17.64 19.44 36.35 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 15.46 19.03 31.40 15.01 18.25 33.31 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1do8_c00 MALIC ENZYME user 9 3 # 9 A 112 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 183 LYS B 20 LYS~? 17.56 ZN ZN B 375 A 278 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 19.43 18.53 42.32 17.66 18.80 40.15 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 21.92 15.80 36.19 17.64 19.44 36.35 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 15.46 19.03 31.40 15.01 18.25 33.31 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1do8_c00 MALIC ENZYME user 10 3 # 10 A 112 TYR B 85 TYR~? 3.87 C2 EPE B 376 A 183 LYS B 87 LYS~? 9.60 O3S EPE B 376 A 278 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 19.43 18.53 42.32 17.66 18.80 40.15 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 21.92 15.80 36.19 17.64 19.44 36.35 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 15.46 19.03 31.40 15.01 18.25 33.31 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 1do8_c00 MALIC ENZYME user 11 3 # 11 A 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 278 ASP B 237 ASP^? 15.58 N TRS A 378 coo 19.43 18.53 42.32 17.66 18.80 40.15 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 21.92 15.80 36.19 17.64 19.44 36.35 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 15.46 19.03 31.40 15.01 18.25 33.31 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1do8_c00 MALIC ENZYME user 12 3 # 12 A 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 183 LYS C 138 LYS^? 8.30 N TRS A 378 A 278 ASP A 237 ASP^? 6.80 N TRS A 378 coo 19.43 18.53 42.32 17.66 18.80 40.15 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 21.92 15.80 36.19 17.64 19.44 36.35 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 15.46 19.03 31.40 15.01 18.25 33.31 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1do8_c00 MALIC ENZYME user 13 3 # 13 A 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 183 LYS C 138 LYS^? 8.30 N TRS A 378 A 278 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 19.43 18.53 42.32 17.66 18.80 40.15 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 21.92 15.80 36.19 17.64 19.44 36.35 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 15.46 19.03 31.40 15.01 18.25 33.31 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1do8_c00 MALIC ENZYME user 14 3 # 14 A 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 183 LYS C 139 LYS^? 16.11 N TRS A 378 A 278 ASP A 237 ASP^? 6.80 N TRS A 378 coo 19.43 18.53 42.32 17.66 18.80 40.15 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 21.92 15.80 36.19 17.64 19.44 36.35 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 15.46 19.03 31.40 15.01 18.25 33.31 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1do8_c00 MALIC ENZYME user 15 3 # 15 A 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 183 LYS C 139 LYS^? 16.11 N TRS A 378 A 278 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 19.43 18.53 42.32 17.66 18.80 40.15 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 21.92 15.80 36.19 17.64 19.44 36.35 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 15.46 19.03 31.40 15.01 18.25 33.31 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1do8_c00 MALIC ENZYME user 16 3 # 16 A 112 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 183 LYS B 301 LYS~? 25.03 ZN ZN B 375 A 278 ASP B 306 ASP.? 24.86 ZN ZN B 375 coo 19.43 18.53 42.32 17.66 18.80 40.15 1.32 11.76 14.56 0.84 10.00 16.68 coo 21.92 15.80 36.19 17.64 19.44 36.35 8.36 10.35 11.75 10.05 14.82 9.04 coo 15.46 19.03 31.40 15.01 18.25 33.31 3.99 14.73 5.36 5.18 14.04 3.76 ULMN 3 1do8_c00 MALIC ENZYME user 17 3 # 17 A 112 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 183 LYS C 20 LYS~? 17.53 ZN ZN C 375 A 278 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 19.43 18.53 42.32 17.66 18.80 40.15 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 21.92 15.80 36.19 17.64 19.44 36.35 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 15.46 19.03 31.40 15.01 18.25 33.31 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1do8_c00 MALIC ENZYME user 18 3 # 18 A 112 TYR C 85 TYR~? -3.91 C2 EPE C 376s A 183 LYS C 87 LYS~? 9.86 O3S EPE C 376 A 278 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 19.43 18.53 42.32 17.66 18.80 40.15 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 21.92 15.80 36.19 17.64 19.44 36.35 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 15.46 19.03 31.40 15.01 18.25 33.31 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 1do8_c00 MALIC ENZYME user 19 3 # 19 A 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 183 LYS A 138 LYS^? 13.11 N TRS A 378 A 278 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 19.43 18.53 42.32 17.66 18.80 40.15 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 21.92 15.80 36.19 17.64 19.44 36.35 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 15.46 19.03 31.40 15.01 18.25 33.31 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1do8_c00 MALIC ENZYME user 20 3 # 20 A 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 183 LYS A 138 LYS^? 13.11 N TRS A 378 A 278 ASP B 237 ASP^? 15.58 N TRS A 378 coo 19.43 18.53 42.32 17.66 18.80 40.15 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 21.92 15.80 36.19 17.64 19.44 36.35 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 15.46 19.03 31.40 15.01 18.25 33.31 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1do8_c00 MALIC ENZYME user 21 3 # 21 A 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 183 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 278 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 19.43 18.53 42.32 17.66 18.80 40.15 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 21.92 15.80 36.19 17.64 19.44 36.35 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 15.46 19.03 31.40 15.01 18.25 33.31 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1do8_c00 MALIC ENZYME user 22 3 # 22 A 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 183 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 278 ASP B 237 ASP^? 15.58 N TRS A 378 coo 19.43 18.53 42.32 17.66 18.80 40.15 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 21.92 15.80 36.19 17.64 19.44 36.35 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 15.46 19.03 31.40 15.01 18.25 33.31 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1do8_c00 MALIC ENZYME user 23 3 # 23 A 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 183 LYS C 138 LYS^? 8.30 N TRS A 378 A 278 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 19.43 18.53 42.32 17.66 18.80 40.15 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 21.92 15.80 36.19 17.64 19.44 36.35 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 15.46 19.03 31.40 15.01 18.25 33.31 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1do8_c00 MALIC ENZYME user 24 3 # 24 A 112 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 183 LYS C 301 LYS~? 24.63 ZN ZN C 375 A 278 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo 19.43 18.53 42.32 17.66 18.80 40.15 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 21.92 15.80 36.19 17.64 19.44 36.35 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 15.46 19.03 31.40 15.01 18.25 33.31 -16.81 -30.01 48.18 -17.96 -30.59 46.51 1do8_c00 source 1do8 MALIC ENZYME : 24 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 18 TYR~? 11.08 ZN ZN A 375 B 183 LYS A 20 LYS~? 16.95 ZN ZN A 375 B 278 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 58.62 15.99 58.34 60.98 14.60 58.93 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 60.11 10.60 53.63 62.59 10.74 58.67 26.66 -3.22 19.04 24.73 2.41 18.30 coo 66.50 7.32 58.45 66.26 9.42 58.23 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR A 85 TYR~? -4.05 C2 EPE A 376s B 183 LYS A 87 LYS~? 10.99 O2S EPE A 376 B 278 ASP A 82 ASP.? 8.88 O2S EPE A 376 coo 58.62 15.99 58.34 60.98 14.60 58.93 33.18 16.26 32.13 31.71 14.36 30.75 coo 60.11 10.60 53.63 62.59 10.74 58.67 35.91 21.93 28.51 38.15 26.57 30.75 coo 66.50 7.32 58.45 66.26 9.42 58.23 34.38 27.71 34.24 32.73 27.59 35.53 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 183 LYS A 138 LYS^? 13.11 N TRS A 378 B 278 ASP A 237 ASP^? 6.80 N TRS A 378 coo 58.62 15.99 58.34 60.98 14.60 58.93 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 60.11 10.60 53.63 62.59 10.74 58.67 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 66.50 7.32 58.45 66.26 9.42 58.23 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 B 278 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 58.62 15.99 58.34 60.98 14.60 58.93 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 60.11 10.60 53.63 62.59 10.74 58.67 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 66.50 7.32 58.45 66.26 9.42 58.23 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1do8_c01 MALIC ENZYME user 5 3 # 5 B 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 B 278 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 58.62 15.99 58.34 60.98 14.60 58.93 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 60.11 10.60 53.63 62.59 10.74 58.67 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 66.50 7.32 58.45 66.26 9.42 58.23 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1do8_c01 MALIC ENZYME user 6 3 # 6 B 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 183 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 278 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 58.62 15.99 58.34 60.98 14.60 58.93 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 60.11 10.60 53.63 62.59 10.74 58.67 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 66.50 7.32 58.45 66.26 9.42 58.23 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1do8_c01 MALIC ENZYME user 7 3 # 7 B 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 183 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 278 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 58.62 15.99 58.34 60.98 14.60 58.93 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 60.11 10.60 53.63 62.59 10.74 58.67 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 66.50 7.32 58.45 66.26 9.42 58.23 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1do8_c01 MALIC ENZYME user 8 3 # 8 B 112 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 183 LYS A 301 LYS~? 24.94 ZN ZN A 375 B 278 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 58.62 15.99 58.34 60.98 14.60 58.93 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 60.11 10.60 53.63 62.59 10.74 58.67 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 66.50 7.32 58.45 66.26 9.42 58.23 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1do8_c01 MALIC ENZYME user 9 3 # 9 B 112 TYR A 314 TYR~? 12.17 O8 EPE A 376 B 183 LYS A 295 LYS.? 12.61 ZN ZN A 374 B 278 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 58.62 15.99 58.34 60.98 14.60 58.93 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 60.11 10.60 53.63 62.59 10.74 58.67 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 66.50 7.32 58.45 66.26 9.42 58.23 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 1do8_c01 MALIC ENZYME user 10 3 # 10 B 112 TYR B 18 TYR~? 10.93 ZN ZN B 375 B 183 LYS B 20 LYS~? 17.56 ZN ZN B 375 B 278 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 58.62 15.99 58.34 60.98 14.60 58.93 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 60.11 10.60 53.63 62.59 10.74 58.67 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 66.50 7.32 58.45 66.26 9.42 58.23 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1do8_c01 MALIC ENZYME user 11 3 # 11 B 112 TYR B 85 TYR~? 3.87 C2 EPE B 376 B 183 LYS B 87 LYS~? 9.60 O3S EPE B 376 B 278 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 58.62 15.99 58.34 60.98 14.60 58.93 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 60.11 10.60 53.63 62.59 10.74 58.67 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 66.50 7.32 58.45 66.26 9.42 58.23 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 1do8_c01 MALIC ENZYME user 12 3 # 12 B 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 B 278 ASP B 237 ASP^? 15.58 N TRS A 378 coo 58.62 15.99 58.34 60.98 14.60 58.93 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 60.11 10.60 53.63 62.59 10.74 58.67 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 66.50 7.32 58.45 66.26 9.42 58.23 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1do8_c01 MALIC ENZYME user 13 3 # 13 B 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 183 LYS C 138 LYS^? 8.30 N TRS A 378 B 278 ASP A 237 ASP^? 6.80 N TRS A 378 coo 58.62 15.99 58.34 60.98 14.60 58.93 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 60.11 10.60 53.63 62.59 10.74 58.67 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 66.50 7.32 58.45 66.26 9.42 58.23 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1do8_c01 MALIC ENZYME user 14 3 # 14 B 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 183 LYS C 138 LYS^? 8.30 N TRS A 378 B 278 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 58.62 15.99 58.34 60.98 14.60 58.93 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 60.11 10.60 53.63 62.59 10.74 58.67 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 66.50 7.32 58.45 66.26 9.42 58.23 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1do8_c01 MALIC ENZYME user 15 3 # 15 B 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 183 LYS C 139 LYS^? 16.11 N TRS A 378 B 278 ASP A 237 ASP^? 6.80 N TRS A 378 coo 58.62 15.99 58.34 60.98 14.60 58.93 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 60.11 10.60 53.63 62.59 10.74 58.67 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 66.50 7.32 58.45 66.26 9.42 58.23 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1do8_c01 MALIC ENZYME user 16 3 # 16 B 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 183 LYS C 139 LYS^? 16.11 N TRS A 378 B 278 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 58.62 15.99 58.34 60.98 14.60 58.93 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 60.11 10.60 53.63 62.59 10.74 58.67 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 66.50 7.32 58.45 66.26 9.42 58.23 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1do8_c01 MALIC ENZYME user 17 3 # 17 B 112 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 183 LYS B 301 LYS~? 25.03 ZN ZN B 375 B 278 ASP B 306 ASP.? 24.86 ZN ZN B 375 coo 58.62 15.99 58.34 60.98 14.60 58.93 1.32 11.76 14.56 0.84 10.00 16.68 coo 60.11 10.60 53.63 62.59 10.74 58.67 8.36 10.35 11.75 10.05 14.82 9.04 coo 66.50 7.32 58.45 66.26 9.42 58.23 3.99 14.73 5.36 5.18 14.04 3.76 ULMN 3 1do8_c01 MALIC ENZYME user 18 3 # 18 B 112 TYR C 18 TYR.? 11.04 ZN ZN C 375 B 183 LYS C 20 LYS~? 17.53 ZN ZN C 375 B 278 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 58.62 15.99 58.34 60.98 14.60 58.93 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 60.11 10.60 53.63 62.59 10.74 58.67 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 66.50 7.32 58.45 66.26 9.42 58.23 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1do8_c01 MALIC ENZYME user 19 3 # 19 B 112 TYR C 85 TYR~? -3.91 C2 EPE C 376s B 183 LYS C 87 LYS~? 9.86 O3S EPE C 376 B 278 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 58.62 15.99 58.34 60.98 14.60 58.93 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 60.11 10.60 53.63 62.59 10.74 58.67 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 66.50 7.32 58.45 66.26 9.42 58.23 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 1do8_c01 MALIC ENZYME user 20 3 # 20 B 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 183 LYS A 138 LYS^? 13.11 N TRS A 378 B 278 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 58.62 15.99 58.34 60.98 14.60 58.93 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 60.11 10.60 53.63 62.59 10.74 58.67 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 66.50 7.32 58.45 66.26 9.42 58.23 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1do8_c01 MALIC ENZYME user 21 3 # 21 B 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 183 LYS A 138 LYS^? 13.11 N TRS A 378 B 278 ASP B 237 ASP^? 15.58 N TRS A 378 coo 58.62 15.99 58.34 60.98 14.60 58.93 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 60.11 10.60 53.63 62.59 10.74 58.67 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 66.50 7.32 58.45 66.26 9.42 58.23 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1do8_c01 MALIC ENZYME user 22 3 # 22 B 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 183 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 278 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 58.62 15.99 58.34 60.98 14.60 58.93 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 60.11 10.60 53.63 62.59 10.74 58.67 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 66.50 7.32 58.45 66.26 9.42 58.23 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1do8_c01 MALIC ENZYME user 23 3 # 23 B 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 183 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 278 ASP B 237 ASP^? 15.58 N TRS A 378 coo 58.62 15.99 58.34 60.98 14.60 58.93 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 60.11 10.60 53.63 62.59 10.74 58.67 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 66.50 7.32 58.45 66.26 9.42 58.23 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1do8_c01 MALIC ENZYME user 24 3 # 24 B 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 183 LYS C 138 LYS^? 8.30 N TRS A 378 B 278 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 58.62 15.99 58.34 60.98 14.60 58.93 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 60.11 10.60 53.63 62.59 10.74 58.67 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 66.50 7.32 58.45 66.26 9.42 58.23 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1do8_c01 MALIC ENZYME user 25 3 # 25 B 112 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 183 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 278 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 58.62 15.99 58.34 60.98 14.60 58.93 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 60.11 10.60 53.63 62.59 10.74 58.67 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 66.50 7.32 58.45 66.26 9.42 58.23 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1do8_c01 MALIC ENZYME user 26 3 # 26 B 112 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 183 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 278 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 58.62 15.99 58.34 60.98 14.60 58.93 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 60.11 10.60 53.63 62.59 10.74 58.67 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 66.50 7.32 58.45 66.26 9.42 58.23 -0.90 -20.80 57.97 0.71 -21.61 59.03 ULMN 3 1do8_c01 MALIC ENZYME user 27 3 # 27 B 112 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 183 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 278 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 58.62 15.99 58.34 60.98 14.60 58.93 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 60.11 10.60 53.63 62.59 10.74 58.67 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 66.50 7.32 58.45 66.26 9.42 58.23 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 1do8_c01 MALIC ENZYME user 28 3 # 28 B 112 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 183 LYS C 301 LYS~? 24.63 ZN ZN C 375 B 278 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo 58.62 15.99 58.34 60.98 14.60 58.93 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 60.11 10.60 53.63 62.59 10.74 58.67 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 66.50 7.32 58.45 66.26 9.42 58.23 -16.81 -30.01 48.18 -17.96 -30.59 46.51 1do8_c01 source 1do8 MALIC ENZYME : 28 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 18 TYR~? 11.08 ZN ZN A 375 C 183 LYS A 20 LYS~? 16.95 ZN ZN A 375 C 278 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 26.66 -3.22 19.04 24.73 2.41 18.30 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR A 85 TYR~? -4.05 C2 EPE A 376s C 183 LYS A 87 LYS~? 10.99 O2S EPE A 376 C 278 ASP A 82 ASP.? 8.88 O2S EPE A 376 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 33.18 16.26 32.13 31.71 14.36 30.75 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 35.91 21.93 28.51 38.15 26.57 30.75 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 34.38 27.71 34.24 32.73 27.59 35.53 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 C 183 LYS A 138 LYS^? 13.11 N TRS A 378 C 278 ASP A 237 ASP^? 6.80 N TRS A 378 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1do8_c02 MALIC ENZYME user 4 3 # 4 C 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 C 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 C 278 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1do8_c02 MALIC ENZYME user 5 3 # 5 C 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 C 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 C 278 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1do8_c02 MALIC ENZYME user 6 3 # 6 C 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 C 183 LYS B 139 LYS^? -2.84 O2S EPE A 377s C 278 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1do8_c02 MALIC ENZYME user 7 3 # 7 C 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 C 183 LYS B 139 LYS^? -2.84 O2S EPE A 377s C 278 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1do8_c02 MALIC ENZYME user 8 3 # 8 C 112 TYR A 308 TYR^? 13.26 ZN ZN A 375 C 183 LYS A 301 LYS~? 24.94 ZN ZN A 375 C 278 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1do8_c02 MALIC ENZYME user 9 3 # 9 C 112 TYR B 18 TYR~? 10.93 ZN ZN B 375 C 183 LYS B 20 LYS~? 17.56 ZN ZN B 375 C 278 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1do8_c02 MALIC ENZYME user 10 3 # 10 C 112 TYR B 85 TYR~? 3.87 C2 EPE B 376 C 183 LYS B 87 LYS~? 9.60 O3S EPE B 376 C 278 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 1do8_c02 MALIC ENZYME user 11 3 # 11 C 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 C 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 C 278 ASP B 237 ASP^? 15.58 N TRS A 378 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1do8_c02 MALIC ENZYME user 12 3 # 12 C 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 C 183 LYS C 138 LYS^? 8.30 N TRS A 378 C 278 ASP A 237 ASP^? 6.80 N TRS A 378 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1do8_c02 MALIC ENZYME user 13 3 # 13 C 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 C 183 LYS C 138 LYS^? 8.30 N TRS A 378 C 278 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1do8_c02 MALIC ENZYME user 14 3 # 14 C 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 C 183 LYS C 139 LYS^? 16.11 N TRS A 378 C 278 ASP A 237 ASP^? 6.80 N TRS A 378 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1do8_c02 MALIC ENZYME user 15 3 # 15 C 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 C 183 LYS C 139 LYS^? 16.11 N TRS A 378 C 278 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1do8_c02 MALIC ENZYME user 16 3 # 16 C 112 TYR B 308 TYR^? 13.33 ZN ZN B 375 C 183 LYS B 301 LYS~? 25.03 ZN ZN B 375 C 278 ASP B 306 ASP.? 24.86 ZN ZN B 375 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 1.32 11.76 14.56 0.84 10.00 16.68 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 8.36 10.35 11.75 10.05 14.82 9.04 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 3.99 14.73 5.36 5.18 14.04 3.76 ULMN 3 1do8_c02 MALIC ENZYME user 17 3 # 17 C 112 TYR C 18 TYR.? 11.04 ZN ZN C 375 C 183 LYS C 20 LYS~? 17.53 ZN ZN C 375 C 278 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1do8_c02 MALIC ENZYME user 18 3 # 18 C 112 TYR C 85 TYR~? -3.91 C2 EPE C 376s C 183 LYS C 87 LYS~? 9.86 O3S EPE C 376 C 278 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 1do8_c02 MALIC ENZYME user 19 3 # 19 C 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 C 183 LYS A 138 LYS^? 13.11 N TRS A 378 C 278 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1do8_c02 MALIC ENZYME user 20 3 # 20 C 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 C 183 LYS A 138 LYS^? 13.11 N TRS A 378 C 278 ASP B 237 ASP^? 15.58 N TRS A 378 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1do8_c02 MALIC ENZYME user 21 3 # 21 C 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 C 183 LYS A 139 LYS^? -2.64 O3S EPE C 377s C 278 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1do8_c02 MALIC ENZYME user 22 3 # 22 C 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 C 183 LYS A 139 LYS^? -2.64 O3S EPE C 377s C 278 ASP B 237 ASP^? 15.58 N TRS A 378 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1do8_c02 MALIC ENZYME user 23 3 # 23 C 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 C 183 LYS C 138 LYS^? 8.30 N TRS A 378 C 278 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1do8_c02 MALIC ENZYME user 24 3 # 24 C 112 TYR C 308 TYR^? 13.34 ZN ZN C 375 C 183 LYS C 301 LYS~? 24.63 ZN ZN C 375 C 278 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -16.81 -30.01 48.18 -17.96 -30.59 46.51 1do8_c02 source 1do8 MALIC ENZYME : 24 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 18 TYR~? 11.08 ZN ZN A 375 D 183 LYS A 20 LYS~? 16.95 ZN ZN A 375 D 278 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 26.66 -3.22 19.04 24.73 2.41 18.30 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR A 85 TYR~? -4.05 C2 EPE A 376s D 183 LYS A 87 LYS~? 10.99 O2S EPE A 376 D 278 ASP A 82 ASP.? 8.88 O2S EPE A 376 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 33.18 16.26 32.13 31.71 14.36 30.75 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 35.91 21.93 28.51 38.15 26.57 30.75 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 34.38 27.71 34.24 32.73 27.59 35.53 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 D 183 LYS A 138 LYS^? 13.11 N TRS A 378 D 278 ASP A 237 ASP^? 6.80 N TRS A 378 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 D 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 D 278 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1do8_c03 MALIC ENZYME user 5 3 # 5 D 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 D 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 D 278 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1do8_c03 MALIC ENZYME user 6 3 # 6 D 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 D 183 LYS B 139 LYS^? -2.84 O2S EPE A 377s D 278 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1do8_c03 MALIC ENZYME user 7 3 # 7 D 112 TYR A 234 TYR^? 9.43 O2S EPE A 377 D 183 LYS B 139 LYS^? -2.84 O2S EPE A 377s D 278 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1do8_c03 MALIC ENZYME user 8 3 # 8 D 112 TYR A 308 TYR^? 13.26 ZN ZN A 375 D 183 LYS A 301 LYS~? 24.94 ZN ZN A 375 D 278 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1do8_c03 MALIC ENZYME user 9 3 # 9 D 112 TYR B 18 TYR~? 10.93 ZN ZN B 375 D 183 LYS B 20 LYS~? 17.56 ZN ZN B 375 D 278 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1do8_c03 MALIC ENZYME user 10 3 # 10 D 112 TYR B 85 TYR~? 3.87 C2 EPE B 376 D 183 LYS B 87 LYS~? 9.60 O3S EPE B 376 D 278 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 1do8_c03 MALIC ENZYME user 11 3 # 11 D 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 D 183 LYS B 138 LYS^? 15.17 O1S EPE A 377 D 278 ASP B 237 ASP^? 15.58 N TRS A 378 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1do8_c03 MALIC ENZYME user 12 3 # 12 D 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 D 183 LYS C 138 LYS^? 8.30 N TRS A 378 D 278 ASP A 237 ASP^? 6.80 N TRS A 378 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1do8_c03 MALIC ENZYME user 13 3 # 13 D 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 D 183 LYS C 138 LYS^? 8.30 N TRS A 378 D 278 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1do8_c03 MALIC ENZYME user 14 3 # 14 D 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 D 183 LYS C 139 LYS^? 16.11 N TRS A 378 D 278 ASP A 237 ASP^? 6.80 N TRS A 378 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1do8_c03 MALIC ENZYME user 15 3 # 15 D 112 TYR B 234 TYR^? 11.34 O2S EPE A 377 D 183 LYS C 139 LYS^? 16.11 N TRS A 378 D 278 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1do8_c03 MALIC ENZYME user 16 3 # 16 D 112 TYR B 308 TYR^? 13.33 ZN ZN B 375 D 183 LYS B 301 LYS~? 25.03 ZN ZN B 375 D 278 ASP B 306 ASP.? 24.86 ZN ZN B 375 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 1.32 11.76 14.56 0.84 10.00 16.68 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 8.36 10.35 11.75 10.05 14.82 9.04 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 3.99 14.73 5.36 5.18 14.04 3.76 ULMN 3 1do8_c03 MALIC ENZYME user 17 3 # 17 D 112 TYR C 18 TYR.? 11.04 ZN ZN C 375 D 183 LYS C 20 LYS~? 17.53 ZN ZN C 375 D 278 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1do8_c03 MALIC ENZYME user 18 3 # 18 D 112 TYR C 85 TYR~? -3.91 C2 EPE C 376s D 183 LYS C 87 LYS~? 9.86 O3S EPE C 376 D 278 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 1do8_c03 MALIC ENZYME user 19 3 # 19 D 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 D 183 LYS A 138 LYS^? 13.11 N TRS A 378 D 278 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1do8_c03 MALIC ENZYME user 20 3 # 20 D 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 D 183 LYS A 138 LYS^? 13.11 N TRS A 378 D 278 ASP B 237 ASP^? 15.58 N TRS A 378 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1do8_c03 MALIC ENZYME user 21 3 # 21 D 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 D 183 LYS A 139 LYS^? -2.64 O3S EPE C 377s D 278 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1do8_c03 MALIC ENZYME user 22 3 # 22 D 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 D 183 LYS A 139 LYS^? -2.64 O3S EPE C 377s D 278 ASP B 237 ASP^? 15.58 N TRS A 378 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1do8_c03 MALIC ENZYME user 23 3 # 23 D 112 TYR C 234 TYR^? 9.10 O2S EPE C 377 D 183 LYS C 138 LYS^? 8.30 N TRS A 378 D 278 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1do8_c03 MALIC ENZYME user 24 3 # 24 D 112 TYR C 308 TYR^? 13.34 ZN ZN C 375 D 183 LYS C 301 LYS~? 24.63 ZN ZN C 375 D 278 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -16.81 -30.01 48.18 -17.96 -30.59 46.51 1do8_c03 source 1do8 MALIC ENZYME : 24 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 68 HIS.? -3.31 ZN ZN A 375s E 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s E 193 GLY A 342 GLY~? 12.90 ZN ZN A 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 37.80 0.44 25.56 37.02 -1.29 26.44 coo 10.90 32.83 25.96 10.83 30.68 25.98 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 4.57 20.60 30.29 4.74 21.36 30.66 44.89 -3.04 18.23 44.73 -2.27 17.91 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s E 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 E 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 37.42 3.90 29.26 38.47 2.36 30.22 coo 10.90 32.83 25.96 10.83 30.68 25.98 40.70 8.14 28.73 41.06 6.40 29.84 coo 4.57 20.60 30.29 4.74 21.36 30.66 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s E 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 E 193 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo 11.39 26.86 25.95 9.85 26.64 27.36 37.42 3.90 29.26 38.47 2.36 30.22 coo 10.90 32.83 25.96 10.83 30.68 25.98 40.70 8.14 28.73 41.06 6.40 29.84 coo 4.57 20.60 30.29 4.74 21.36 30.66 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 4 3 # 4 E 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 E 193 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 32.91 0.46 27.63 33.66 0.11 29.56 coo 10.90 32.83 25.96 10.83 30.68 25.98 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 4.57 20.60 30.29 4.74 21.36 30.66 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 5 3 # 5 E 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 E 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 32.91 0.46 27.63 33.66 0.11 29.56 coo 10.90 32.83 25.96 10.83 30.68 25.98 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 4.57 20.60 30.29 4.74 21.36 30.66 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 6 3 # 6 E 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 E 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo 11.39 26.86 25.95 9.85 26.64 27.36 32.91 0.46 27.63 33.66 0.11 29.56 coo 10.90 32.83 25.96 10.83 30.68 25.98 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 4.57 20.60 30.29 4.74 21.36 30.66 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 7 3 # 7 E 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s E 193 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 32.91 0.46 27.63 33.66 0.11 29.56 coo 10.90 32.83 25.96 10.83 30.68 25.98 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 4.57 20.60 30.29 4.74 21.36 30.66 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 8 3 # 8 E 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s E 193 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 32.91 0.46 27.63 33.66 0.11 29.56 coo 10.90 32.83 25.96 10.83 30.68 25.98 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 4.57 20.60 30.29 4.74 21.36 30.66 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 9 3 # 9 E 57 HIS A 319 HIS~? 24.64 ZN ZN A 374 E 102 ASP A 320 ASP~? -21.81 ZN ZN A 374s E 193 GLY A 277 GLY.? 24.28 ZN ZN A 374 coo 11.39 26.86 25.95 9.85 26.64 27.36 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 10.90 32.83 25.96 10.83 30.68 25.98 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 4.57 20.60 30.29 4.74 21.36 30.66 49.23 -14.07 46.91 49.73 -13.44 47.06 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 10 3 # 10 E 57 HIS B 68 HIS.? -3.38 ZN ZN B 375s E 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s E 193 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 10.90 32.83 25.96 10.83 30.68 25.98 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 4.57 20.60 30.29 4.74 21.36 30.66 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 11 3 # 11 E 57 HIS B 68 HIS.? -3.38 ZN ZN B 375s E 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s E 193 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 10.90 32.83 25.96 10.83 30.68 25.98 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 4.57 20.60 30.29 4.74 21.36 30.66 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 12 3 # 12 E 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s E 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 E 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 10.90 32.83 25.96 10.83 30.68 25.98 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 4.57 20.60 30.29 4.74 21.36 30.66 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 13 3 # 13 E 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s E 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 E 193 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo 11.39 26.86 25.95 9.85 26.64 27.36 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 10.90 32.83 25.96 10.83 30.68 25.98 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 4.57 20.60 30.29 4.74 21.36 30.66 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 14 3 # 14 E 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 E 193 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 10.90 32.83 25.96 10.83 30.68 25.98 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 4.57 20.60 30.29 4.74 21.36 30.66 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 15 3 # 15 E 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 E 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 10.90 32.83 25.96 10.83 30.68 25.98 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 4.57 20.60 30.29 4.74 21.36 30.66 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 16 3 # 16 E 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 E 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo 11.39 26.86 25.95 9.85 26.64 27.36 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 10.90 32.83 25.96 10.83 30.68 25.98 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 4.57 20.60 30.29 4.74 21.36 30.66 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 17 3 # 17 E 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s E 193 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 10.90 32.83 25.96 10.83 30.68 25.98 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 4.57 20.60 30.29 4.74 21.36 30.66 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 18 3 # 18 E 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s E 193 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 10.90 32.83 25.96 10.83 30.68 25.98 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 4.57 20.60 30.29 4.74 21.36 30.66 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 19 3 # 19 E 57 HIS B 319 HIS~? 24.73 ZN ZN B 374 E 102 ASP B 320 ASP~? -21.78 ZN ZN B 374s E 193 GLY B 277 GLY.? 24.23 ZN ZN B 374 coo 11.39 26.86 25.95 9.85 26.64 27.36 8.16 23.53 21.75 7.85 25.60 21.62 coo 10.90 32.83 25.96 10.83 30.68 25.98 9.35 16.65 21.02 10.22 16.89 22.90 coo 4.57 20.60 30.29 4.74 21.36 30.66 3.65 23.16 11.55 3.12 23.75 11.78 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 20 3 # 20 E 57 HIS C 68 HIS.? -3.41 ZN ZN C 375s E 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s E 193 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 10.90 32.83 25.96 10.83 30.68 25.98 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 4.57 20.60 30.29 4.74 21.36 30.66 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 21 3 # 21 E 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s E 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 E 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 10.90 32.83 25.96 10.83 30.68 25.98 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 4.57 20.60 30.29 4.74 21.36 30.66 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 22 3 # 22 E 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s E 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 E 193 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo 11.39 26.86 25.95 9.85 26.64 27.36 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 10.90 32.83 25.96 10.83 30.68 25.98 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 4.57 20.60 30.29 4.74 21.36 30.66 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 23 3 # 23 E 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 E 193 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 10.90 32.83 25.96 10.83 30.68 25.98 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 4.57 20.60 30.29 4.74 21.36 30.66 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 24 3 # 24 E 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 E 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 10.90 32.83 25.96 10.83 30.68 25.98 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 4.57 20.60 30.29 4.74 21.36 30.66 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 25 3 # 25 E 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 E 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo 11.39 26.86 25.95 9.85 26.64 27.36 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 10.90 32.83 25.96 10.83 30.68 25.98 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 4.57 20.60 30.29 4.74 21.36 30.66 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 26 3 # 26 E 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s E 193 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 10.90 32.83 25.96 10.83 30.68 25.98 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 4.57 20.60 30.29 4.74 21.36 30.66 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 27 3 # 27 E 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s E 193 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 11.39 26.86 25.95 9.85 26.64 27.36 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 10.90 32.83 25.96 10.83 30.68 25.98 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 4.57 20.60 30.29 4.74 21.36 30.66 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 28 3 # 28 E 57 HIS C 319 HIS~? 24.70 ZN ZN C 374 E 102 ASP C 320 ASP~? -21.75 ZN ZN C 374s E 193 GLY C 277 GLY.? 24.27 ZN ZN C 374 coo 11.39 26.86 25.95 9.85 26.64 27.36 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 10.90 32.83 25.96 10.83 30.68 25.98 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 4.57 20.60 30.29 4.74 21.36 30.66 -18.35 -23.56 56.48 -18.29 -23.66 57.31 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 28 hits 1ds2_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 B 144 GLU A 175 GLU^? 13.72 C8 EPE A 377 B 164 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 88.87 114.43 152.30 88.45 115.15 152.32 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 85.20 111.99 152.05 86.60 110.89 150.91 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 88.14 113.46 145.73 86.79 113.92 147.30 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 B 144 GLU A 175 GLU^? 13.72 C8 EPE A 377 B 164 GLU A 201 GLU^? -3.12 C2 EPE A 377s coo 88.87 114.43 152.30 88.45 115.15 152.32 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 85.20 111.99 152.05 86.60 110.89 150.91 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 88.14 113.46 145.73 86.79 113.92 147.30 7.01 -32.51 -2.93 6.57 -30.84 -1.85 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 3 3 # 3 B 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 B 144 GLU A 200 GLU^? 11.53 C6 EPE A 377 B 164 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 88.87 114.43 152.30 88.45 115.15 152.32 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 85.20 111.99 152.05 86.60 110.89 150.91 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 88.14 113.46 145.73 86.79 113.92 147.30 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 4 3 # 4 B 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 B 144 GLU A 200 GLU^? 11.53 C6 EPE A 377 B 164 GLU A 201 GLU^? -3.12 C2 EPE A 377s coo 88.87 114.43 152.30 88.45 115.15 152.32 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 85.20 111.99 152.05 86.60 110.89 150.91 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 88.14 113.46 145.73 86.79 113.92 147.30 7.01 -32.51 -2.93 6.57 -30.84 -1.85 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 5 3 # 5 B 141 GLY A 178 GLY^? 3.80 C6 EPE A 377 B 144 GLU A 201 GLU^? -3.12 C2 EPE A 377s B 164 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 88.87 114.43 152.30 88.45 115.15 152.32 3.25 -33.31 -0.46 2.85 -33.92 -0.95 coo 85.20 111.99 152.05 86.60 110.89 150.91 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 88.14 113.46 145.73 86.79 113.92 147.30 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 6 3 # 6 B 141 GLY A 240 GLY^? 7.12 C3 TRS A 378 B 144 GLU A 135 GLU^? 12.87 C3 TRS A 378 B 164 GLU A 136 GLU^? 12.15 O3 TRS A 378 coo 88.87 114.43 152.30 88.45 115.15 152.32 27.04 -20.59 17.45 27.05 -20.66 18.34 coo 85.20 111.99 152.05 86.60 110.89 150.91 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 88.14 113.46 145.73 86.79 113.92 147.30 19.87 -16.93 18.72 17.94 -16.19 18.72 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 7 3 # 7 B 141 GLY B 176 GLY^? 16.19 O2S EPE A 377 B 144 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 164 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 88.87 114.43 152.30 88.45 115.15 152.32 9.40 -43.99 8.52 8.65 -44.36 8.52 coo 85.20 111.99 152.05 86.60 110.89 150.91 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 88.14 113.46 145.73 86.79 113.92 147.30 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 8 3 # 8 B 141 GLY B 178 GLY^? 19.88 O2S EPE A 377 B 144 GLU B 201 GLU^? 17.83 O2S EPE A 377 B 164 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 88.87 114.43 152.30 88.45 115.15 152.32 8.41 -45.68 15.01 8.59 -46.49 14.79 coo 85.20 111.99 152.05 86.60 110.89 150.91 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 88.14 113.46 145.73 86.79 113.92 147.30 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 9 3 # 9 B 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 B 144 GLU B 135 GLU^? 15.63 O1S EPE A 377 B 164 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 88.87 114.43 152.30 88.45 115.15 152.32 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 85.20 111.99 152.05 86.60 110.89 150.91 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 88.14 113.46 145.73 86.79 113.92 147.30 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 10 3 # 10 B 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 B 144 GLU B 135 GLU^? 15.63 O1S EPE A 377 B 164 GLU B 241 GLU^? 19.53 O1S EPE A 377 coo 88.87 114.43 152.30 88.45 115.15 152.32 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 85.20 111.99 152.05 86.60 110.89 150.91 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 88.14 113.46 145.73 86.79 113.92 147.30 -1.76 -10.13 8.02 -3.43 -8.87 7.45 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 11 3 # 11 B 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 B 144 GLU B 241 GLU^? 19.53 O1S EPE A 377 B 164 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 88.87 114.43 152.30 88.45 115.15 152.32 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 85.20 111.99 152.05 86.60 110.89 150.91 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 88.14 113.46 145.73 86.79 113.92 147.30 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 12 3 # 12 B 141 GLY C 176 GLY^? 9.30 C6 EPE C 377 B 144 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 164 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 88.87 114.43 152.30 88.45 115.15 152.32 17.46 -39.97 3.60 18.08 -40.46 3.91 coo 85.20 111.99 152.05 86.60 110.89 150.91 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 88.14 113.46 145.73 86.79 113.92 147.30 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 13 3 # 13 B 141 GLY C 176 GLY^? 9.30 C6 EPE C 377 B 144 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 164 GLU C 201 GLU^? -3.18 C8 EPE C 377s coo 88.87 114.43 152.30 88.45 115.15 152.32 17.46 -39.97 3.60 18.08 -40.46 3.91 coo 85.20 111.99 152.05 86.60 110.89 150.91 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 88.14 113.46 145.73 86.79 113.92 147.30 23.53 -40.20 6.95 23.95 -38.27 7.71 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 14 3 # 14 B 141 GLY C 178 GLY^? 3.71 C6 EPE C 377 B 144 GLU C 201 GLU^? -3.18 C8 EPE C 377s B 164 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 88.87 114.43 152.30 88.45 115.15 152.32 23.14 -36.24 3.79 23.36 -36.64 3.06 coo 85.20 111.99 152.05 86.60 110.89 150.91 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 88.14 113.46 145.73 86.79 113.92 147.30 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 15 3 # 15 B 141 GLY C 240 GLY^? 19.25 N TRS A 378 B 144 GLU C 135 GLU^? 15.12 O1 TRS A 378 B 164 GLU C 241 GLU^? 18.99 ZN ZN C 375 coo 88.87 114.43 152.30 88.45 115.15 152.32 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 85.20 111.99 152.05 86.60 110.89 150.91 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 88.14 113.46 145.73 86.79 113.92 147.30 4.84 -34.67 34.91 4.64 -36.58 35.93 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 16 3 # 16 B 141 GLY C 240 GLY^? 19.25 N TRS A 378 B 144 GLU C 241 GLU^? 18.99 ZN ZN C 375 B 164 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 88.87 114.43 152.30 88.45 115.15 152.32 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 85.20 111.99 152.05 86.60 110.89 150.91 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 88.14 113.46 145.73 86.79 113.92 147.30 11.24 -30.50 31.64 12.59 -30.76 33.22 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 16 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 C 144 GLU A 175 GLU^? 13.72 C8 EPE A 377 C 164 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 56.28 104.55 135.84 56.09 105.34 136.05 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 58.46 103.90 139.48 57.57 102.00 139.16 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 51.71 102.03 140.09 53.02 103.62 140.54 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 C 144 GLU A 175 GLU^? 13.72 C8 EPE A 377 C 164 GLU A 201 GLU^? -3.12 C2 EPE A 377s coo 56.28 104.55 135.84 56.09 105.34 136.05 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 58.46 103.90 139.48 57.57 102.00 139.16 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 51.71 102.03 140.09 53.02 103.62 140.54 7.01 -32.51 -2.93 6.57 -30.84 -1.85 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 3 3 # 3 C 141 GLY A 178 GLY^? 3.80 C6 EPE A 377 C 144 GLU A 201 GLU^? -3.12 C2 EPE A 377s C 164 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 56.28 104.55 135.84 56.09 105.34 136.05 3.25 -33.31 -0.46 2.85 -33.92 -0.95 coo 58.46 103.90 139.48 57.57 102.00 139.16 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 51.71 102.03 140.09 53.02 103.62 140.54 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 4 3 # 4 C 141 GLY A 240 GLY^? 7.12 C3 TRS A 378 C 144 GLU A 135 GLU^? 12.87 C3 TRS A 378 C 164 GLU A 136 GLU^? 12.15 O3 TRS A 378 coo 56.28 104.55 135.84 56.09 105.34 136.05 27.04 -20.59 17.45 27.05 -20.66 18.34 coo 58.46 103.90 139.48 57.57 102.00 139.16 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 51.71 102.03 140.09 53.02 103.62 140.54 19.87 -16.93 18.72 17.94 -16.19 18.72 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 5 3 # 5 C 141 GLY B 176 GLY^? 16.19 O2S EPE A 377 C 144 GLU B 175 GLU^? 16.09 C9 EPE A 377 C 164 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 56.28 104.55 135.84 56.09 105.34 136.05 9.40 -43.99 8.52 8.65 -44.36 8.52 coo 58.46 103.90 139.48 57.57 102.00 139.16 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 51.71 102.03 140.09 53.02 103.62 140.54 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 6 3 # 6 C 141 GLY B 178 GLY^? 19.88 O2S EPE A 377 C 144 GLU B 201 GLU^? 17.83 O2S EPE A 377 C 164 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 56.28 104.55 135.84 56.09 105.34 136.05 8.41 -45.68 15.01 8.59 -46.49 14.79 coo 58.46 103.90 139.48 57.57 102.00 139.16 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 51.71 102.03 140.09 53.02 103.62 140.54 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 7 3 # 7 C 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 C 144 GLU B 135 GLU^? 15.63 O1S EPE A 377 C 164 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 56.28 104.55 135.84 56.09 105.34 136.05 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 58.46 103.90 139.48 57.57 102.00 139.16 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 51.71 102.03 140.09 53.02 103.62 140.54 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 8 3 # 8 C 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 C 144 GLU B 135 GLU^? 15.63 O1S EPE A 377 C 164 GLU B 241 GLU^? 19.53 O1S EPE A 377 coo 56.28 104.55 135.84 56.09 105.34 136.05 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 58.46 103.90 139.48 57.57 102.00 139.16 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 51.71 102.03 140.09 53.02 103.62 140.54 -1.76 -10.13 8.02 -3.43 -8.87 7.45 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 9 3 # 9 C 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 C 144 GLU B 241 GLU^? 19.53 O1S EPE A 377 C 164 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 56.28 104.55 135.84 56.09 105.34 136.05 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 58.46 103.90 139.48 57.57 102.00 139.16 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 51.71 102.03 140.09 53.02 103.62 140.54 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 10 3 # 10 C 141 GLY C 176 GLY^? 9.30 C6 EPE C 377 C 144 GLU C 175 GLU^? 13.76 O8 EPE C 377 C 164 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 56.28 104.55 135.84 56.09 105.34 136.05 17.46 -39.97 3.60 18.08 -40.46 3.91 coo 58.46 103.90 139.48 57.57 102.00 139.16 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 51.71 102.03 140.09 53.02 103.62 140.54 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 11 3 # 11 C 141 GLY C 176 GLY^? 9.30 C6 EPE C 377 C 144 GLU C 175 GLU^? 13.76 O8 EPE C 377 C 164 GLU C 201 GLU^? -3.18 C8 EPE C 377s coo 56.28 104.55 135.84 56.09 105.34 136.05 17.46 -39.97 3.60 18.08 -40.46 3.91 coo 58.46 103.90 139.48 57.57 102.00 139.16 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 51.71 102.03 140.09 53.02 103.62 140.54 23.53 -40.20 6.95 23.95 -38.27 7.71 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 12 3 # 12 C 141 GLY C 178 GLY^? 3.71 C6 EPE C 377 C 144 GLU C 201 GLU^? -3.18 C8 EPE C 377s C 164 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 56.28 104.55 135.84 56.09 105.34 136.05 23.14 -36.24 3.79 23.36 -36.64 3.06 coo 58.46 103.90 139.48 57.57 102.00 139.16 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 51.71 102.03 140.09 53.02 103.62 140.54 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 13 3 # 13 C 141 GLY C 240 GLY^? 19.25 N TRS A 378 C 144 GLU C 135 GLU^? 15.12 O1 TRS A 378 C 164 GLU C 241 GLU^? 18.99 ZN ZN C 375 coo 56.28 104.55 135.84 56.09 105.34 136.05 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 58.46 103.90 139.48 57.57 102.00 139.16 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 51.71 102.03 140.09 53.02 103.62 140.54 4.84 -34.67 34.91 4.64 -36.58 35.93 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 14 3 # 14 C 141 GLY C 240 GLY^? 19.25 N TRS A 378 C 144 GLU C 241 GLU^? 18.99 ZN ZN C 375 C 164 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 56.28 104.55 135.84 56.09 105.34 136.05 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 58.46 103.90 139.48 57.57 102.00 139.16 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 51.71 102.03 140.09 53.02 103.62 140.54 11.24 -30.50 31.64 12.59 -30.76 33.22 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 14 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 D 144 GLU A 175 GLU^? 13.72 C8 EPE A 377 D 164 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 86.19 80.64 132.77 86.38 79.85 132.93 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 84.75 81.24 136.88 85.62 83.14 136.43 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 91.47 83.05 136.24 90.35 81.38 136.84 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 D 144 GLU A 175 GLU^? 13.72 C8 EPE A 377 D 164 GLU A 201 GLU^? -3.12 C2 EPE A 377s coo 86.19 80.64 132.77 86.38 79.85 132.93 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 84.75 81.24 136.88 85.62 83.14 136.43 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 91.47 83.05 136.24 90.35 81.38 136.84 7.01 -32.51 -2.93 6.57 -30.84 -1.85 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 3 3 # 3 D 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 D 144 GLU A 200 GLU^? 11.53 C6 EPE A 377 D 164 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 86.19 80.64 132.77 86.38 79.85 132.93 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 84.75 81.24 136.88 85.62 83.14 136.43 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 91.47 83.05 136.24 90.35 81.38 136.84 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 4 3 # 4 D 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 D 144 GLU A 200 GLU^? 11.53 C6 EPE A 377 D 164 GLU A 201 GLU^? -3.12 C2 EPE A 377s coo 86.19 80.64 132.77 86.38 79.85 132.93 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 84.75 81.24 136.88 85.62 83.14 136.43 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 91.47 83.05 136.24 90.35 81.38 136.84 7.01 -32.51 -2.93 6.57 -30.84 -1.85 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 5 3 # 5 D 141 GLY A 178 GLY^? 3.80 C6 EPE A 377 D 144 GLU A 201 GLU^? -3.12 C2 EPE A 377s D 164 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 86.19 80.64 132.77 86.38 79.85 132.93 3.25 -33.31 -0.46 2.85 -33.92 -0.95 coo 84.75 81.24 136.88 85.62 83.14 136.43 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 91.47 83.05 136.24 90.35 81.38 136.84 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 6 3 # 6 D 141 GLY A 240 GLY^? 7.12 C3 TRS A 378 D 144 GLU A 135 GLU^? 12.87 C3 TRS A 378 D 164 GLU A 136 GLU^? 12.15 O3 TRS A 378 coo 86.19 80.64 132.77 86.38 79.85 132.93 27.04 -20.59 17.45 27.05 -20.66 18.34 coo 84.75 81.24 136.88 85.62 83.14 136.43 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 91.47 83.05 136.24 90.35 81.38 136.84 19.87 -16.93 18.72 17.94 -16.19 18.72 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 7 3 # 7 D 141 GLY B 176 GLY^? 16.19 O2S EPE A 377 D 144 GLU B 175 GLU^? 16.09 C9 EPE A 377 D 164 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 86.19 80.64 132.77 86.38 79.85 132.93 9.40 -43.99 8.52 8.65 -44.36 8.52 coo 84.75 81.24 136.88 85.62 83.14 136.43 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 91.47 83.05 136.24 90.35 81.38 136.84 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 8 3 # 8 D 141 GLY B 178 GLY^? 19.88 O2S EPE A 377 D 144 GLU B 201 GLU^? 17.83 O2S EPE A 377 D 164 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 86.19 80.64 132.77 86.38 79.85 132.93 8.41 -45.68 15.01 8.59 -46.49 14.79 coo 84.75 81.24 136.88 85.62 83.14 136.43 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 91.47 83.05 136.24 90.35 81.38 136.84 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 9 3 # 9 D 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 D 144 GLU B 135 GLU^? 15.63 O1S EPE A 377 D 164 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 86.19 80.64 132.77 86.38 79.85 132.93 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 84.75 81.24 136.88 85.62 83.14 136.43 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 91.47 83.05 136.24 90.35 81.38 136.84 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 10 3 # 10 D 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 D 144 GLU B 135 GLU^? 15.63 O1S EPE A 377 D 164 GLU B 241 GLU^? 19.53 O1S EPE A 377 coo 86.19 80.64 132.77 86.38 79.85 132.93 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 84.75 81.24 136.88 85.62 83.14 136.43 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 91.47 83.05 136.24 90.35 81.38 136.84 -1.76 -10.13 8.02 -3.43 -8.87 7.45 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 11 3 # 11 D 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 D 144 GLU B 241 GLU^? 19.53 O1S EPE A 377 D 164 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 86.19 80.64 132.77 86.38 79.85 132.93 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 84.75 81.24 136.88 85.62 83.14 136.43 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 91.47 83.05 136.24 90.35 81.38 136.84 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 12 3 # 12 D 141 GLY C 176 GLY^? 9.30 C6 EPE C 377 D 144 GLU C 175 GLU^? 13.76 O8 EPE C 377 D 164 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 86.19 80.64 132.77 86.38 79.85 132.93 17.46 -39.97 3.60 18.08 -40.46 3.91 coo 84.75 81.24 136.88 85.62 83.14 136.43 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 91.47 83.05 136.24 90.35 81.38 136.84 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 13 3 # 13 D 141 GLY C 176 GLY^? 9.30 C6 EPE C 377 D 144 GLU C 175 GLU^? 13.76 O8 EPE C 377 D 164 GLU C 201 GLU^? -3.18 C8 EPE C 377s coo 86.19 80.64 132.77 86.38 79.85 132.93 17.46 -39.97 3.60 18.08 -40.46 3.91 coo 84.75 81.24 136.88 85.62 83.14 136.43 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 91.47 83.05 136.24 90.35 81.38 136.84 23.53 -40.20 6.95 23.95 -38.27 7.71 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 14 3 # 14 D 141 GLY C 178 GLY^? 3.71 C6 EPE C 377 D 144 GLU C 201 GLU^? -3.18 C8 EPE C 377s D 164 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 86.19 80.64 132.77 86.38 79.85 132.93 23.14 -36.24 3.79 23.36 -36.64 3.06 coo 84.75 81.24 136.88 85.62 83.14 136.43 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 91.47 83.05 136.24 90.35 81.38 136.84 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 15 3 # 15 D 141 GLY C 240 GLY^? 19.25 N TRS A 378 D 144 GLU C 135 GLU^? 15.12 O1 TRS A 378 D 164 GLU C 136 GLU^? 12.99 N TRS A 378 coo 86.19 80.64 132.77 86.38 79.85 132.93 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 84.75 81.24 136.88 85.62 83.14 136.43 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 91.47 83.05 136.24 90.35 81.38 136.84 10.97 -24.78 28.83 12.54 -23.35 28.52 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 16 3 # 16 D 141 GLY C 240 GLY^? 19.25 N TRS A 378 D 144 GLU C 135 GLU^? 15.12 O1 TRS A 378 D 164 GLU C 241 GLU^? 18.99 ZN ZN C 375 coo 86.19 80.64 132.77 86.38 79.85 132.93 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 84.75 81.24 136.88 85.62 83.14 136.43 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 91.47 83.05 136.24 90.35 81.38 136.84 4.84 -34.67 34.91 4.64 -36.58 35.93 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 17 3 # 17 D 141 GLY C 240 GLY^? 19.25 N TRS A 378 D 144 GLU C 241 GLU^? 18.99 ZN ZN C 375 D 164 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 86.19 80.64 132.77 86.38 79.85 132.93 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 84.75 81.24 136.88 85.62 83.14 136.43 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 91.47 83.05 136.24 90.35 81.38 136.84 11.24 -30.50 31.64 12.59 -30.76 33.22 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 17 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 E 144 GLU A 175 GLU^? 13.72 C8 EPE A 377 E 164 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 90.07 81.07 170.50 90.23 80.26 170.38 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 87.05 81.30 167.53 86.38 82.74 168.94 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 84.40 80.02 173.80 85.08 79.06 172.03 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 E 144 GLU A 175 GLU^? 13.72 C8 EPE A 377 E 164 GLU A 201 GLU^? -3.12 C2 EPE A 377s coo 90.07 81.07 170.50 90.23 80.26 170.38 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 87.05 81.30 167.53 86.38 82.74 168.94 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 84.40 80.02 173.80 85.08 79.06 172.03 7.01 -32.51 -2.93 6.57 -30.84 -1.85 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 3 3 # 3 E 141 GLY A 178 GLY^? 3.80 C6 EPE A 377 E 144 GLU A 201 GLU^? -3.12 C2 EPE A 377s E 164 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 90.07 81.07 170.50 90.23 80.26 170.38 3.25 -33.31 -0.46 2.85 -33.92 -0.95 coo 87.05 81.30 167.53 86.38 82.74 168.94 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 84.40 80.02 173.80 85.08 79.06 172.03 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 4 3 # 4 E 141 GLY A 240 GLY^? 7.12 C3 TRS A 378 E 144 GLU A 135 GLU^? 12.87 C3 TRS A 378 E 164 GLU A 136 GLU^? 12.15 O3 TRS A 378 coo 90.07 81.07 170.50 90.23 80.26 170.38 27.04 -20.59 17.45 27.05 -20.66 18.34 coo 87.05 81.30 167.53 86.38 82.74 168.94 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 84.40 80.02 173.80 85.08 79.06 172.03 19.87 -16.93 18.72 17.94 -16.19 18.72 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 5 3 # 5 E 141 GLY B 176 GLY^? 16.19 O2S EPE A 377 E 144 GLU B 175 GLU^? 16.09 C9 EPE A 377 E 164 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 90.07 81.07 170.50 90.23 80.26 170.38 9.40 -43.99 8.52 8.65 -44.36 8.52 coo 87.05 81.30 167.53 86.38 82.74 168.94 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 84.40 80.02 173.80 85.08 79.06 172.03 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 6 3 # 6 E 141 GLY B 178 GLY^? 19.88 O2S EPE A 377 E 144 GLU B 201 GLU^? 17.83 O2S EPE A 377 E 164 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 90.07 81.07 170.50 90.23 80.26 170.38 8.41 -45.68 15.01 8.59 -46.49 14.79 coo 87.05 81.30 167.53 86.38 82.74 168.94 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 84.40 80.02 173.80 85.08 79.06 172.03 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 7 3 # 7 E 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 E 144 GLU B 135 GLU^? 15.63 O1S EPE A 377 E 164 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 90.07 81.07 170.50 90.23 80.26 170.38 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 87.05 81.30 167.53 86.38 82.74 168.94 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 84.40 80.02 173.80 85.08 79.06 172.03 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 8 3 # 8 E 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 E 144 GLU B 135 GLU^? 15.63 O1S EPE A 377 E 164 GLU B 241 GLU^? 19.53 O1S EPE A 377 coo 90.07 81.07 170.50 90.23 80.26 170.38 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 87.05 81.30 167.53 86.38 82.74 168.94 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 84.40 80.02 173.80 85.08 79.06 172.03 -1.76 -10.13 8.02 -3.43 -8.87 7.45 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 9 3 # 9 E 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 E 144 GLU B 241 GLU^? 19.53 O1S EPE A 377 E 164 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 90.07 81.07 170.50 90.23 80.26 170.38 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 87.05 81.30 167.53 86.38 82.74 168.94 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 84.40 80.02 173.80 85.08 79.06 172.03 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 10 3 # 10 E 141 GLY C 176 GLY^? 9.30 C6 EPE C 377 E 144 GLU C 175 GLU^? 13.76 O8 EPE C 377 E 164 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 90.07 81.07 170.50 90.23 80.26 170.38 17.46 -39.97 3.60 18.08 -40.46 3.91 coo 87.05 81.30 167.53 86.38 82.74 168.94 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 84.40 80.02 173.80 85.08 79.06 172.03 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 11 3 # 11 E 141 GLY C 176 GLY^? 9.30 C6 EPE C 377 E 144 GLU C 175 GLU^? 13.76 O8 EPE C 377 E 164 GLU C 201 GLU^? -3.18 C8 EPE C 377s coo 90.07 81.07 170.50 90.23 80.26 170.38 17.46 -39.97 3.60 18.08 -40.46 3.91 coo 87.05 81.30 167.53 86.38 82.74 168.94 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 84.40 80.02 173.80 85.08 79.06 172.03 23.53 -40.20 6.95 23.95 -38.27 7.71 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 12 3 # 12 E 141 GLY C 178 GLY^? 3.71 C6 EPE C 377 E 144 GLU C 201 GLU^? -3.18 C8 EPE C 377s E 164 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 90.07 81.07 170.50 90.23 80.26 170.38 23.14 -36.24 3.79 23.36 -36.64 3.06 coo 87.05 81.30 167.53 86.38 82.74 168.94 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 84.40 80.02 173.80 85.08 79.06 172.03 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 13 3 # 13 E 141 GLY C 240 GLY^? 19.25 N TRS A 378 E 144 GLU C 135 GLU^? 15.12 O1 TRS A 378 E 164 GLU C 241 GLU^? 18.99 ZN ZN C 375 coo 90.07 81.07 170.50 90.23 80.26 170.38 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 87.05 81.30 167.53 86.38 82.74 168.94 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 84.40 80.02 173.80 85.08 79.06 172.03 4.84 -34.67 34.91 4.64 -36.58 35.93 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 14 3 # 14 E 141 GLY C 240 GLY^? 19.25 N TRS A 378 E 144 GLU C 241 GLU^? 18.99 ZN ZN C 375 E 164 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 90.07 81.07 170.50 90.23 80.26 170.38 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 87.05 81.30 167.53 86.38 82.74 168.94 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 84.40 80.02 173.80 85.08 79.06 172.03 11.24 -30.50 31.64 12.59 -30.76 33.22 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 14 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 F 144 GLU A 175 GLU^? 13.72 C8 EPE A 377 F 164 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 57.12 70.68 155.10 57.52 69.95 155.02 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 60.62 73.13 154.21 59.05 74.26 153.35 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 56.75 71.71 148.46 58.44 71.01 149.54 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 F 144 GLU A 175 GLU^? 13.72 C8 EPE A 377 F 164 GLU A 201 GLU^? -3.12 C2 EPE A 377s coo 57.12 70.68 155.10 57.52 69.95 155.02 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 60.62 73.13 154.21 59.05 74.26 153.35 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 56.75 71.71 148.46 58.44 71.01 149.54 7.01 -32.51 -2.93 6.57 -30.84 -1.85 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 3 3 # 3 F 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 F 144 GLU A 200 GLU^? 11.53 C6 EPE A 377 F 164 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 57.12 70.68 155.10 57.52 69.95 155.02 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 60.62 73.13 154.21 59.05 74.26 153.35 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 56.75 71.71 148.46 58.44 71.01 149.54 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 4 3 # 4 F 141 GLY A 176 GLY^? 9.59 C9 EPE A 377 F 144 GLU A 200 GLU^? 11.53 C6 EPE A 377 F 164 GLU A 201 GLU^? -3.12 C2 EPE A 377s coo 57.12 70.68 155.10 57.52 69.95 155.02 7.94 -37.98 0.68 8.08 -37.55 -0.03 coo 60.62 73.13 154.21 59.05 74.26 153.35 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 56.75 71.71 148.46 58.44 71.01 149.54 7.01 -32.51 -2.93 6.57 -30.84 -1.85 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 5 3 # 5 F 141 GLY A 178 GLY^? 3.80 C6 EPE A 377 F 144 GLU A 201 GLU^? -3.12 C2 EPE A 377s F 164 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 57.12 70.68 155.10 57.52 69.95 155.02 3.25 -33.31 -0.46 2.85 -33.92 -0.95 coo 60.62 73.13 154.21 59.05 74.26 153.35 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo 56.75 71.71 148.46 58.44 71.01 149.54 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 6 3 # 6 F 141 GLY A 240 GLY^? 7.12 C3 TRS A 378 F 144 GLU A 135 GLU^? 12.87 C3 TRS A 378 F 164 GLU A 136 GLU^? 12.15 O3 TRS A 378 coo 57.12 70.68 155.10 57.52 69.95 155.02 27.04 -20.59 17.45 27.05 -20.66 18.34 coo 60.62 73.13 154.21 59.05 74.26 153.35 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 56.75 71.71 148.46 58.44 71.01 149.54 19.87 -16.93 18.72 17.94 -16.19 18.72 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 7 3 # 7 F 141 GLY B 176 GLY^? 16.19 O2S EPE A 377 F 144 GLU B 175 GLU^? 16.09 C9 EPE A 377 F 164 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 57.12 70.68 155.10 57.52 69.95 155.02 9.40 -43.99 8.52 8.65 -44.36 8.52 coo 60.62 73.13 154.21 59.05 74.26 153.35 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 56.75 71.71 148.46 58.44 71.01 149.54 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 8 3 # 8 F 141 GLY B 178 GLY^? 19.88 O2S EPE A 377 F 144 GLU B 201 GLU^? 17.83 O2S EPE A 377 F 164 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 57.12 70.68 155.10 57.52 69.95 155.02 8.41 -45.68 15.01 8.59 -46.49 14.79 coo 60.62 73.13 154.21 59.05 74.26 153.35 3.89 -44.87 12.99 4.21 -43.80 14.75 coo 56.75 71.71 148.46 58.44 71.01 149.54 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 9 3 # 9 F 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 F 144 GLU B 135 GLU^? 15.63 O1S EPE A 377 F 164 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 57.12 70.68 155.10 57.52 69.95 155.02 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 60.62 73.13 154.21 59.05 74.26 153.35 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 56.75 71.71 148.46 58.44 71.01 149.54 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 10 3 # 10 F 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 F 144 GLU B 135 GLU^? 15.63 O1S EPE A 377 F 164 GLU B 241 GLU^? 19.53 O1S EPE A 377 coo 57.12 70.68 155.10 57.52 69.95 155.02 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 60.62 73.13 154.21 59.05 74.26 153.35 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 56.75 71.71 148.46 58.44 71.01 149.54 -1.76 -10.13 8.02 -3.43 -8.87 7.45 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 11 3 # 11 F 141 GLY B 240 GLY^? 14.23 O1S EPE A 377 F 144 GLU B 241 GLU^? 19.53 O1S EPE A 377 F 164 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 57.12 70.68 155.10 57.52 69.95 155.02 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 60.62 73.13 154.21 59.05 74.26 153.35 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 56.75 71.71 148.46 58.44 71.01 149.54 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 12 3 # 12 F 141 GLY C 176 GLY^? 9.30 C6 EPE C 377 F 144 GLU C 175 GLU^? 13.76 O8 EPE C 377 F 164 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 57.12 70.68 155.10 57.52 69.95 155.02 17.46 -39.97 3.60 18.08 -40.46 3.91 coo 60.62 73.13 154.21 59.05 74.26 153.35 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 56.75 71.71 148.46 58.44 71.01 149.54 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 13 3 # 13 F 141 GLY C 176 GLY^? 9.30 C6 EPE C 377 F 144 GLU C 175 GLU^? 13.76 O8 EPE C 377 F 164 GLU C 201 GLU^? -3.18 C8 EPE C 377s coo 57.12 70.68 155.10 57.52 69.95 155.02 17.46 -39.97 3.60 18.08 -40.46 3.91 coo 60.62 73.13 154.21 59.05 74.26 153.35 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 56.75 71.71 148.46 58.44 71.01 149.54 23.53 -40.20 6.95 23.95 -38.27 7.71 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 14 3 # 14 F 141 GLY C 178 GLY^? 3.71 C6 EPE C 377 F 144 GLU C 201 GLU^? -3.18 C8 EPE C 377s F 164 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 57.12 70.68 155.10 57.52 69.95 155.02 23.14 -36.24 3.79 23.36 -36.64 3.06 coo 60.62 73.13 154.21 59.05 74.26 153.35 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 56.75 71.71 148.46 58.44 71.01 149.54 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 15 3 # 15 F 141 GLY C 240 GLY^? 19.25 N TRS A 378 F 144 GLU C 135 GLU^? 15.12 O1 TRS A 378 F 164 GLU C 241 GLU^? 18.99 ZN ZN C 375 coo 57.12 70.68 155.10 57.52 69.95 155.02 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 60.62 73.13 154.21 59.05 74.26 153.35 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 56.75 71.71 148.46 58.44 71.01 149.54 4.84 -34.67 34.91 4.64 -36.58 35.93 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 16 3 # 16 F 141 GLY C 240 GLY^? 19.25 N TRS A 378 F 144 GLU C 241 GLU^? 18.99 ZN ZN C 375 F 164 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 57.12 70.68 155.10 57.52 69.95 155.02 6.12 -31.91 30.25 5.48 -31.34 30.35 coo 60.62 73.13 154.21 59.05 74.26 153.35 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 56.75 71.71 148.46 58.44 71.01 149.54 11.24 -30.50 31.64 12.59 -30.76 33.22 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 16 hits 1dub_c17 naa= 3 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 168 SER^? 10.80 O1S EPE C 377 A 208 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 236 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 49.19 42.85 125.39 50.92 43.54 123.63 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 57.80 42.94 129.59 56.47 43.28 127.93 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 55.54 41.70 125.00 53.71 42.50 124.53 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER B 168 SER^? 10.59 O3S EPE A 377 A 208 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 236 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 49.19 42.85 125.39 50.92 43.54 123.63 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 57.80 42.94 129.59 56.47 43.28 127.93 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 55.54 41.70 125.00 53.71 42.50 124.53 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 3 3 # 3 A 80 SER C 168 SER^? 24.11 O1 TRS A 378 A 208 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 236 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 49.19 42.85 125.39 50.92 43.54 123.63 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 57.80 42.94 129.59 56.47 43.28 127.93 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 55.54 41.70 125.00 53.71 42.50 124.53 13.13 -47.52 24.96 14.34 -48.17 26.54 1dwo_c00 source 1dwo HYDROXYNITRILE LYASE : 3 hits 1dwo_c00 naa= 3 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 1 3 # 1 B 80 SER A 168 SER^? 10.80 O1S EPE C 377 B 208 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 236 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 55.25 19.46 97.60 53.04 19.32 98.76 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 57.34 11.46 102.30 56.11 13.10 101.70 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 55.03 16.17 103.08 54.39 17.23 101.45 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 2 3 # 2 B 80 SER B 168 SER^? 10.59 O3S EPE A 377 B 208 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 236 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 55.25 19.46 97.60 53.04 19.32 98.76 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 57.34 11.46 102.30 56.11 13.10 101.70 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 55.03 16.17 103.08 54.39 17.23 101.45 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 3 3 # 3 B 80 SER C 168 SER^? 24.11 O1 TRS A 378 B 208 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 236 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 55.25 19.46 97.60 53.04 19.32 98.76 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 57.34 11.46 102.30 56.11 13.10 101.70 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 55.03 16.17 103.08 54.39 17.23 101.45 13.13 -47.52 24.96 14.34 -48.17 26.54 1dwo_c01 source 1dwo HYDROXYNITRILE LYASE : 3 hits 1dwo_c01 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 215 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 277 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 0.50 24.09 51.68 1.51 29.34 52.35 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 13.06 30.79 51.73 11.40 35.76 53.48 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 13.04 31.88 60.72 10.57 35.34 57.49 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 278 LYS.? 33.16 ZN ZN A 374 A 215 LYS A 285 LYS^? 20.00 O3 TRS A 378 A 277 LYS A 301 LYS~? 24.94 ZN ZN A 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 52.59 -15.70 47.74 53.19 -20.67 51.64 coo 13.06 30.79 51.73 11.40 35.76 53.48 47.09 -21.09 34.01 41.69 -24.22 32.75 coo 13.04 31.88 60.72 10.57 35.34 57.49 39.11 -19.59 40.11 42.80 -21.77 43.38 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS A 278 LYS.? 33.16 ZN ZN A 374 A 215 LYS A 301 LYS~? 24.94 ZN ZN A 375 A 277 LYS A 285 LYS^? 20.00 O3 TRS A 378 coo 0.50 24.09 51.68 1.51 29.34 52.35 52.59 -15.70 47.74 53.19 -20.67 51.64 coo 13.06 30.79 51.73 11.40 35.76 53.48 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 13.04 31.88 60.72 10.57 35.34 57.49 47.09 -21.09 34.01 41.69 -24.22 32.75 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS A 295 LYS.? 12.61 ZN ZN A 374 A 215 LYS A 247 LYS^? 14.25 ZN ZN A 375 A 277 LYS A 285 LYS^? 20.00 O3 TRS A 378 coo 0.50 24.09 51.68 1.51 29.34 52.35 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 13.06 30.79 51.73 11.40 35.76 53.48 40.34 -15.07 28.39 38.70 -15.53 23.22 coo 13.04 31.88 60.72 10.57 35.34 57.49 47.09 -21.09 34.01 41.69 -24.22 32.75 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS A 295 LYS.? 12.61 ZN ZN A 374 A 215 LYS A 303 LYS~? 13.81 O3 TRS A 378 A 277 LYS A 285 LYS^? 20.00 O3 TRS A 378 coo 0.50 24.09 51.68 1.51 29.34 52.35 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 13.06 30.79 51.73 11.40 35.76 53.48 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 47.09 -21.09 34.01 41.69 -24.22 32.75 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 A 131 LYS A 301 LYS~? 24.94 ZN ZN A 375 A 215 LYS A 282 LYS^? 34.08 ZN ZN A 375 A 277 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 0.50 24.09 51.68 1.51 29.34 52.35 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 13.06 30.79 51.73 11.40 35.76 53.48 53.78 -21.68 41.24 59.13 -25.09 41.65 coo 13.04 31.88 60.72 10.57 35.34 57.49 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 A 131 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 215 LYS A 110 LYS.? 16.46 O3 TRS A 378 A 277 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 44.47 1.55 20.70 47.30 5.10 24.27 coo 13.06 30.79 51.73 11.40 35.76 53.48 37.52 -11.39 18.62 36.00 -16.08 14.56 coo 13.04 31.88 60.72 10.57 35.34 57.49 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 A 131 LYS B 38 LYS.? 21.80 C3 EPE B 376 A 215 LYS B 3 LYS.? 34.82 ZN ZN B 375 A 277 LYS B 354 LYS~? 28.15 ZN ZN B 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 -28.97 -12.32 32.11 -27.27 -6.31 33.15 coo 13.06 30.79 51.73 11.40 35.76 53.48 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo 13.04 31.88 60.72 10.57 35.34 57.49 -26.24 -16.01 14.73 -23.79 -17.66 13.12 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 A 131 LYS B 38 LYS.? 21.80 C3 EPE B 376 A 215 LYS B 3 LYS.? 34.82 ZN ZN B 375 A 277 LYS B 355 LYS.? 33.64 ZN ZN B 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 -28.97 -12.32 32.11 -27.27 -6.31 33.15 coo 13.06 30.79 51.73 11.40 35.76 53.48 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo 13.04 31.88 60.72 10.57 35.34 57.49 -29.99 -15.16 14.74 -32.16 -16.11 9.38 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 A 131 LYS B 110 LYS.? 16.94 ZN ZN B 375 A 215 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 277 LYS B 350 LYS~? 21.91 ZN ZN B 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo 13.06 30.79 51.73 11.40 35.76 53.48 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 13.04 31.88 60.72 10.57 35.34 57.49 -22.61 -10.64 13.95 -18.13 -13.35 13.22 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 A 131 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 215 LYS C 138 LYS^? 8.30 N TRS A 378 A 277 LYS C 239 LYS^? 16.29 N TRS A 378 coo 0.50 24.09 51.68 1.51 29.34 52.35 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 13.06 30.79 51.73 11.40 35.76 53.48 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 13.04 31.88 60.72 10.57 35.34 57.49 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 A 131 LYS B 215 LYS~? 17.38 O3S EPE A 377 A 215 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 277 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 0.50 24.09 51.68 1.51 29.34 52.35 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 13.06 30.79 51.73 11.40 35.76 53.48 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 13.04 31.88 60.72 10.57 35.34 57.49 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 A 131 LYS B 278 LYS.? 31.34 ZN ZN B 374 A 215 LYS B 285 LYS^? 22.19 ZN ZN B 375 A 277 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 3.65 25.62 8.65 8.47 28.09 9.23 coo 13.06 30.79 51.73 11.40 35.76 53.48 1.97 10.60 4.02 5.48 5.38 4.89 coo 13.04 31.88 60.72 10.57 35.34 57.49 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 A 131 LYS B 295 LYS.? 11.37 ZN ZN B 375 A 215 LYS B 247 LYS^? 11.69 ZN ZN B 375 A 277 LYS B 285 LYS^? 22.19 ZN ZN B 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 4.57 8.76 22.84 2.39 5.01 24.93 coo 13.06 30.79 51.73 11.40 35.76 53.48 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo 13.04 31.88 60.72 10.57 35.34 57.49 1.97 10.60 4.02 5.48 5.38 4.89 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 A 131 LYS B 295 LYS.? 11.37 ZN ZN B 375 A 215 LYS B 303 LYS~? 19.29 ZN ZN B 375 A 277 LYS B 285 LYS^? 22.19 ZN ZN B 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 4.57 8.76 22.84 2.39 5.01 24.93 coo 13.06 30.79 51.73 11.40 35.76 53.48 7.99 5.97 9.05 6.92 1.04 11.01 coo 13.04 31.88 60.72 10.57 35.34 57.49 1.97 10.60 4.02 5.48 5.38 4.89 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 A 131 LYS B 301 LYS~? 25.03 ZN ZN B 375 A 215 LYS B 282 LYS^? 32.80 ZN ZN B 375 A 277 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 0.50 24.09 51.68 1.51 29.34 52.35 8.36 10.35 11.75 10.05 14.82 9.04 coo 13.06 30.79 51.73 11.40 35.76 53.48 2.91 20.00 1.64 2.74 22.03 -3.14 coo 13.04 31.88 60.72 10.57 35.34 57.49 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 A 131 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 215 LYS B 110 LYS.? 16.94 ZN ZN B 375 A 277 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 13.06 30.79 51.73 11.40 35.76 53.48 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo 13.04 31.88 60.72 10.57 35.34 57.49 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 A 131 LYS C 38 LYS.? 22.67 C3 EPE C 376 A 215 LYS C 3 LYS.? 28.91 O1 TRS A 378 A 277 LYS C 354 LYS~? 23.72 O1 TRS A 378 coo 0.50 24.09 51.68 1.51 29.34 52.35 32.75 -36.42 54.75 28.25 -34.16 56.85 coo 13.06 30.79 51.73 11.40 35.76 53.48 30.63 -48.52 50.80 31.26 -43.98 46.49 coo 13.04 31.88 60.72 10.57 35.34 57.49 23.17 -48.48 45.31 22.31 -43.90 41.08 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 A 131 LYS C 110 LYS.? 19.48 ZN ZN C 375 A 215 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 277 LYS C 350 LYS~? 21.45 ZN ZN C 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 5.59 -36.33 42.73 4.93 -41.69 39.22 coo 13.06 30.79 51.73 11.40 35.76 53.48 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 13.04 31.88 60.72 10.57 35.34 57.49 17.69 -45.38 46.76 16.74 -42.84 42.17 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 A 131 LYS C 139 LYS^? 16.11 N TRS A 378 A 215 LYS A 138 LYS^? 13.11 N TRS A 378 A 277 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo 0.50 24.09 51.68 1.51 29.34 52.35 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 13.06 30.79 51.73 11.40 35.76 53.48 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 13.04 31.88 60.72 10.57 35.34 57.49 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 21 3 # 21 A 131 LYS C 278 LYS.? 30.91 ZN ZN C 374 A 215 LYS C 285 LYS^? 22.29 ZN ZN C 375 A 277 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 -21.60 -25.17 57.51 -24.75 -21.09 54.19 coo 13.06 30.79 51.73 11.40 35.76 53.48 -14.01 -33.36 45.98 -12.46 -31.50 40.58 coo 13.04 31.88 60.72 10.57 35.34 57.49 -12.73 -23.25 44.05 -17.55 -23.96 45.92 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 22 3 # 22 A 131 LYS C 295 LYS.? 14.49 ZN ZN C 374 A 215 LYS C 247 LYS^? 13.94 ZN ZN C 375 A 277 LYS C 285 LYS^? 22.29 ZN ZN C 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 13.06 30.79 51.73 11.40 35.76 53.48 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo 13.04 31.88 60.72 10.57 35.34 57.49 -14.01 -33.36 45.98 -12.46 -31.50 40.58 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 23 3 # 23 A 131 LYS C 295 LYS.? 14.49 ZN ZN C 374 A 215 LYS C 303 LYS~? 17.98 ZN ZN C 375 A 277 LYS C 285 LYS^? 22.29 ZN ZN C 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 13.06 30.79 51.73 11.40 35.76 53.48 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 13.04 31.88 60.72 10.57 35.34 57.49 -14.01 -33.36 45.98 -12.46 -31.50 40.58 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 24 3 # 24 A 131 LYS C 301 LYS~? 24.63 ZN ZN C 375 A 215 LYS C 282 LYS^? 31.82 ZN ZN C 375 A 277 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 0.50 24.09 51.68 1.51 29.34 52.35 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 13.06 30.79 51.73 11.40 35.76 53.48 -21.96 -32.19 51.48 -24.68 -36.28 53.46 coo 13.04 31.88 60.72 10.57 35.34 57.49 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 25 3 # 25 A 131 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 215 LYS C 110 LYS.? 19.48 ZN ZN C 375 A 277 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 0.50 24.09 51.68 1.51 29.34 52.35 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 13.06 30.79 51.73 11.40 35.76 53.48 5.59 -36.33 42.73 4.93 -41.69 39.22 coo 13.04 31.88 60.72 10.57 35.34 57.49 -3.51 -32.04 45.03 0.24 -34.55 41.94 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 25 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 110 LYS.? 16.46 O3 TRS A 378 B 215 LYS A 345 LYS~? 18.67 ZN ZN A 375 B 277 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 6.78 45.91 16.15 7.82 40.81 15.84 37.52 -11.39 18.62 36.00 -16.08 14.56 coo 17.88 38.77 19.81 16.38 34.23 17.24 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 20.33 37.78 11.20 16.77 34.53 13.47 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 110 LYS.? 16.46 O3 TRS A 378 B 215 LYS A 345 LYS~? 18.67 ZN ZN A 375 B 277 LYS A 350 LYS~? 21.83 ZN ZN A 375 coo 6.78 45.91 16.15 7.82 40.81 15.84 37.52 -11.39 18.62 36.00 -16.08 14.56 coo 17.88 38.77 19.81 16.38 34.23 17.24 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 20.33 37.78 11.20 16.77 34.53 13.47 39.19 -2.77 6.68 35.27 -5.97 7.17 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS A 138 LYS^? 13.11 N TRS A 378 B 215 LYS B 138 LYS^? 15.17 O1S EPE A 377 B 277 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 6.78 45.91 16.15 7.82 40.81 15.84 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 17.88 38.77 19.81 16.38 34.23 17.24 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 20.33 37.78 11.20 16.77 34.53 13.47 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS A 138 LYS^? 13.11 N TRS A 378 B 215 LYS B 239 LYS^? 16.51 O1S EPE A 377 B 277 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 6.78 45.91 16.15 7.82 40.81 15.84 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 17.88 38.77 19.81 16.38 34.23 17.24 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 20.33 37.78 11.20 16.77 34.53 13.47 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 B 131 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 215 LYS B 138 LYS^? 15.17 O1S EPE A 377 B 277 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 6.78 45.91 16.15 7.82 40.81 15.84 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 17.88 38.77 19.81 16.38 34.23 17.24 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 20.33 37.78 11.20 16.77 34.53 13.47 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 B 131 LYS A 301 LYS~? 24.94 ZN ZN A 375 B 215 LYS A 282 LYS^? 34.08 ZN ZN A 375 B 277 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 6.78 45.91 16.15 7.82 40.81 15.84 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 17.88 38.77 19.81 16.38 34.23 17.24 53.78 -21.68 41.24 59.13 -25.09 41.65 coo 20.33 37.78 11.20 16.77 34.53 13.47 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 B 131 LYS B 38 LYS.? 21.80 C3 EPE B 376 B 215 LYS B 3 LYS.? 34.82 ZN ZN B 375 B 277 LYS B 354 LYS~? 28.15 ZN ZN B 375 coo 6.78 45.91 16.15 7.82 40.81 15.84 -28.97 -12.32 32.11 -27.27 -6.31 33.15 coo 17.88 38.77 19.81 16.38 34.23 17.24 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo 20.33 37.78 11.20 16.77 34.53 13.47 -26.24 -16.01 14.73 -23.79 -17.66 13.12 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 B 131 LYS B 38 LYS.? 21.80 C3 EPE B 376 B 215 LYS B 3 LYS.? 34.82 ZN ZN B 375 B 277 LYS B 355 LYS.? 33.64 ZN ZN B 375 coo 6.78 45.91 16.15 7.82 40.81 15.84 -28.97 -12.32 32.11 -27.27 -6.31 33.15 coo 17.88 38.77 19.81 16.38 34.23 17.24 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo 20.33 37.78 11.20 16.77 34.53 13.47 -29.99 -15.16 14.74 -32.16 -16.11 9.38 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 B 131 LYS B 110 LYS.? 16.94 ZN ZN B 375 B 215 LYS B 345 LYS~? 20.14 ZN ZN B 375 B 277 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 6.78 45.91 16.15 7.82 40.81 15.84 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo 17.88 38.77 19.81 16.38 34.23 17.24 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 20.33 37.78 11.20 16.77 34.53 13.47 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 B 131 LYS B 110 LYS.? 16.94 ZN ZN B 375 B 215 LYS B 345 LYS~? 20.14 ZN ZN B 375 B 277 LYS B 350 LYS~? 21.91 ZN ZN B 375 coo 6.78 45.91 16.15 7.82 40.81 15.84 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo 17.88 38.77 19.81 16.38 34.23 17.24 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 20.33 37.78 11.20 16.77 34.53 13.47 -22.61 -10.64 13.95 -18.13 -13.35 13.22 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 B 131 LYS B 138 LYS^? 15.17 O1S EPE A 377 B 215 LYS C 138 LYS^? 8.30 N TRS A 378 B 277 LYS C 239 LYS^? 16.29 N TRS A 378 coo 6.78 45.91 16.15 7.82 40.81 15.84 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 17.88 38.77 19.81 16.38 34.23 17.24 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 20.33 37.78 11.20 16.77 34.53 13.47 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 B 131 LYS B 138 LYS^? 15.17 O1S EPE A 377 B 215 LYS C 239 LYS^? 16.29 N TRS A 378 B 277 LYS C 138 LYS^? 8.30 N TRS A 378 coo 6.78 45.91 16.15 7.82 40.81 15.84 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 17.88 38.77 19.81 16.38 34.23 17.24 5.15 -29.07 27.87 7.72 -24.69 27.36 coo 20.33 37.78 11.20 16.77 34.53 13.47 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 B 131 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 215 LYS C 138 LYS^? 8.30 N TRS A 378 B 277 LYS C 239 LYS^? 16.29 N TRS A 378 coo 6.78 45.91 16.15 7.82 40.81 15.84 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 17.88 38.77 19.81 16.38 34.23 17.24 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 20.33 37.78 11.20 16.77 34.53 13.47 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 B 131 LYS B 295 LYS.? 11.37 ZN ZN B 375 B 215 LYS B 303 LYS~? 19.29 ZN ZN B 375 B 277 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 6.78 45.91 16.15 7.82 40.81 15.84 4.57 8.76 22.84 2.39 5.01 24.93 coo 17.88 38.77 19.81 16.38 34.23 17.24 7.99 5.97 9.05 6.92 1.04 11.01 coo 20.33 37.78 11.20 16.77 34.53 13.47 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 B 131 LYS B 301 LYS~? 25.03 ZN ZN B 375 B 215 LYS B 282 LYS^? 32.80 ZN ZN B 375 B 277 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 6.78 45.91 16.15 7.82 40.81 15.84 8.36 10.35 11.75 10.05 14.82 9.04 coo 17.88 38.77 19.81 16.38 34.23 17.24 2.91 20.00 1.64 2.74 22.03 -3.14 coo 20.33 37.78 11.20 16.77 34.53 13.47 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 B 131 LYS C 38 LYS.? 22.67 C3 EPE C 376 B 215 LYS C 3 LYS.? 28.91 O1 TRS A 378 B 277 LYS C 354 LYS~? 23.72 O1 TRS A 378 coo 6.78 45.91 16.15 7.82 40.81 15.84 32.75 -36.42 54.75 28.25 -34.16 56.85 coo 17.88 38.77 19.81 16.38 34.23 17.24 30.63 -48.52 50.80 31.26 -43.98 46.49 coo 20.33 37.78 11.20 16.77 34.53 13.47 23.17 -48.48 45.31 22.31 -43.90 41.08 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 B 131 LYS C 110 LYS.? 19.48 ZN ZN C 375 B 215 LYS C 345 LYS~? 19.35 ZN ZN C 375 B 277 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 6.78 45.91 16.15 7.82 40.81 15.84 5.59 -36.33 42.73 4.93 -41.69 39.22 coo 17.88 38.77 19.81 16.38 34.23 17.24 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 20.33 37.78 11.20 16.77 34.53 13.47 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 B 131 LYS C 110 LYS.? 19.48 ZN ZN C 375 B 215 LYS C 345 LYS~? 19.35 ZN ZN C 375 B 277 LYS C 350 LYS~? 21.45 ZN ZN C 375 coo 6.78 45.91 16.15 7.82 40.81 15.84 5.59 -36.33 42.73 4.93 -41.69 39.22 coo 17.88 38.77 19.81 16.38 34.23 17.24 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 20.33 37.78 11.20 16.77 34.53 13.47 17.69 -45.38 46.76 16.74 -42.84 42.17 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 B 131 LYS C 139 LYS^? 16.11 N TRS A 378 B 215 LYS A 138 LYS^? 13.11 N TRS A 378 B 277 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo 6.78 45.91 16.15 7.82 40.81 15.84 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 17.88 38.77 19.81 16.38 34.23 17.24 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 20.33 37.78 11.20 16.77 34.53 13.47 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 B 131 LYS C 301 LYS~? 24.63 ZN ZN C 375 B 215 LYS C 282 LYS^? 31.82 ZN ZN C 375 B 277 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 6.78 45.91 16.15 7.82 40.81 15.84 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 17.88 38.77 19.81 16.38 34.23 17.24 -21.96 -32.19 51.48 -24.68 -36.28 53.46 coo 20.33 37.78 11.20 16.77 34.53 13.47 -21.60 -25.17 57.51 -24.75 -21.09 54.19 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 20 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 231 TYR^? 10.06 O1S EPE A 377 A 40 ASP B 237 ASP^? 15.58 N TRS A 378 A 103 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 40 ASP A 237 ASP^? 6.80 N TRS A 378 A 103 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 40 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 103 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 39.49 -1.24 39.18 39.76 0.49 37.96 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR A 314 TYR~? 12.17 O8 EPE A 376 A 40 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 103 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR B 231 TYR^? 16.39 O2S EPE A 377 A 40 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 103 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 40 ASP B 237 ASP^? 15.58 N TRS A 378 A 103 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 40 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 103 ASP B 312 ASP.? 7.53 ZN ZN B 374 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 2.08 17.58 27.10 3.13 18.35 29.60 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -4.08 14.12 24.69 -6.01 13.62 25.36 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR C 231 TYR^? -4.25 C2 TRS A 378s A 40 ASP A 237 ASP^? 6.80 N TRS A 378 A 103 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 40 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 103 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 40 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 103 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -0.90 -20.80 57.97 0.71 -21.61 59.03 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 10 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 231 TYR^? 10.06 O1S EPE A 377 B 40 ASP B 237 ASP^? 15.58 N TRS A 378 B 103 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 40 ASP A 237 ASP^? 6.80 N TRS A 378 B 103 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 40 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 103 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 39.49 -1.24 39.18 39.76 0.49 37.96 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR A 314 TYR~? 12.17 O8 EPE A 376 B 40 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 103 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR B 231 TYR^? 16.39 O2S EPE A 377 B 40 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 103 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 40 ASP B 237 ASP^? 15.58 N TRS A 378 B 103 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR B 314 TYR~? 14.73 O8 EPE B 376 B 40 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 103 ASP B 312 ASP.? 7.53 ZN ZN B 374 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 2.08 17.58 27.10 3.13 18.35 29.60 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -4.08 14.12 24.69 -6.01 13.62 25.36 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR C 231 TYR^? -4.25 C2 TRS A 378s B 40 ASP A 237 ASP^? 6.80 N TRS A 378 B 103 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 40 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 103 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR C 314 TYR~? 12.22 O8 EPE C 376 B 40 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 103 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -0.90 -20.80 57.97 0.71 -21.61 59.03 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 10 hits 1e3v_c03 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A 42 HIS^? 26.23 ZN ZN A 375 B 43 HIS A 361 HIS^? 22.47 ZN ZN A 375 B 65 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 20.15 22.08 34.36 20.84 20.10 34.21 43.48 12.60 9.22 44.86 13.19 7.76 coo 19.55 18.91 30.27 18.21 18.65 31.84 46.25 9.10 12.92 46.66 10.09 11.12 coo 10.90 21.31 28.81 12.14 22.15 30.31 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 43 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 65 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 20.15 22.08 34.36 20.84 20.10 34.21 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.55 18.91 30.27 18.21 18.65 31.84 37.42 3.90 29.26 38.47 2.36 30.22 coo 10.90 21.31 28.81 12.14 22.15 30.31 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS B 42 HIS^? 26.13 ZN ZN B 375 B 43 HIS B 361 HIS^? 22.30 ZN ZN B 375 B 65 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 20.15 22.08 34.36 20.84 20.10 34.21 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 19.55 18.91 30.27 18.21 18.65 31.84 -29.54 0.86 20.66 -31.47 0.05 20.77 coo 10.90 21.31 28.81 12.14 22.15 30.31 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 4 3 # 4 B 41 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 43 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 65 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 20.15 22.08 34.36 20.84 20.10 34.21 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.55 18.91 30.27 18.21 18.65 31.84 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 10.90 21.31 28.81 12.14 22.15 30.31 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 5 3 # 5 B 41 HIS B 359 HIS^? 24.30 ZN ZN B 375 B 43 HIS B 42 HIS^? 26.13 ZN ZN B 375 B 65 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 20.15 22.08 34.36 20.84 20.10 34.21 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 19.55 18.91 30.27 18.21 18.65 31.84 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 10.90 21.31 28.81 12.14 22.15 30.31 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 6 3 # 6 B 41 HIS B 359 HIS^? 24.30 ZN ZN B 375 B 43 HIS B 361 HIS^? 22.30 ZN ZN B 375 B 65 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 20.15 22.08 34.36 20.84 20.10 34.21 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 19.55 18.91 30.27 18.21 18.65 31.84 -29.54 0.86 20.66 -31.47 0.05 20.77 coo 10.90 21.31 28.81 12.14 22.15 30.31 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 7 3 # 7 B 41 HIS C 42 HIS^? 26.23 ZN ZN C 375 B 43 HIS C 361 HIS^? 22.27 ZN ZN C 375 B 65 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 20.15 22.08 34.36 20.84 20.10 34.21 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 19.55 18.91 30.27 18.21 18.65 31.84 17.80 -42.63 61.65 19.35 -43.97 62.12 coo 10.90 21.31 28.81 12.14 22.15 30.31 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 8 3 # 8 B 41 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 43 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 65 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 20.15 22.08 34.36 20.84 20.10 34.21 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.55 18.91 30.27 18.21 18.65 31.84 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 10.90 21.31 28.81 12.14 22.15 30.31 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 9 3 # 9 B 41 HIS C 148 HIS~? 13.04 O8 EPE C 377 B 43 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 65 GLU C 201 GLU^? -3.18 C8 EPE C 377s coo 20.15 22.08 34.36 20.84 20.10 34.21 27.13 -47.60 14.36 28.94 -48.66 14.50 coo 19.55 18.91 30.27 18.21 18.65 31.84 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 10.90 21.31 28.81 12.14 22.15 30.31 23.53 -40.20 6.95 23.95 -38.27 7.71 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 10 3 # 10 B 41 HIS C 148 HIS~? 13.04 O8 EPE C 377 B 43 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 65 GLU C 227 GLU.? 14.45 C7 EPE C 377 coo 20.15 22.08 34.36 20.84 20.10 34.21 27.13 -47.60 14.36 28.94 -48.66 14.50 coo 19.55 18.91 30.27 18.21 18.65 31.84 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 10.90 21.31 28.81 12.14 22.15 30.31 35.69 -39.75 16.92 37.70 -40.13 16.40 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 11 3 # 11 B 41 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 43 HIS C 148 HIS~? 13.04 O8 EPE C 377 B 65 GLU C 201 GLU^? -3.18 C8 EPE C 377s coo 20.15 22.08 34.36 20.84 20.10 34.21 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 19.55 18.91 30.27 18.21 18.65 31.84 27.13 -47.60 14.36 28.94 -48.66 14.50 coo 10.90 21.31 28.81 12.14 22.15 30.31 23.53 -40.20 6.95 23.95 -38.27 7.71 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 12 3 # 12 B 41 HIS C 359 HIS^? 24.82 ZN ZN C 375 B 43 HIS C 42 HIS^? 26.23 ZN ZN C 375 B 65 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 20.15 22.08 34.36 20.84 20.10 34.21 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 19.55 18.91 30.27 18.21 18.65 31.84 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 10.90 21.31 28.81 12.14 22.15 30.31 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 13 3 # 13 B 41 HIS C 359 HIS^? 24.82 ZN ZN C 375 B 43 HIS C 361 HIS^? 22.27 ZN ZN C 375 B 65 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 20.15 22.08 34.36 20.84 20.10 34.21 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 19.55 18.91 30.27 18.21 18.65 31.84 17.80 -42.63 61.65 19.35 -43.97 62.12 coo 10.90 21.31 28.81 12.14 22.15 30.31 16.30 -37.83 67.27 14.46 -37.72 66.25 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 13 hits 1e7l_c01 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 321 ALA~? 19.58 ZN ZN A 374 A 136 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 140 LYS A 301 LYS~? 24.94 ZN ZN A 375 coo 55.90 7.49 23.83 56.71 8.23 22.76 40.35 -13.63 46.22 41.15 -12.61 45.43 coo 59.38 10.02 17.51 59.95 9.89 20.21 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 59.52 3.69 18.67 62.31 6.19 22.58 39.11 -19.59 40.11 42.80 -21.77 43.38 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 136 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 140 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 55.90 7.49 23.83 56.71 8.23 22.76 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 59.38 10.02 17.51 59.95 9.89 20.21 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 59.52 3.69 18.67 62.31 6.19 22.58 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA B 287 ALA^? 15.22 ZN ZN B 375 A 136 TYR B 250 TYR^? 23.22 ZN ZN B 375 A 140 LYS B 285 LYS^? 22.19 ZN ZN B 375 coo 55.90 7.49 23.83 56.71 8.23 22.76 -0.09 8.91 10.38 1.12 8.85 11.22 coo 59.38 10.02 17.51 59.95 9.89 20.21 0.70 6.87 1.10 3.12 5.62 1.69 coo 59.52 3.69 18.67 62.31 6.19 22.58 1.97 10.60 4.02 5.48 5.38 4.89 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 4 3 # 4 A 107 ALA B 321 ALA~? 19.77 ZN ZN B 374 A 136 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 140 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo 55.90 7.49 23.83 56.71 8.23 22.76 7.50 17.37 16.99 6.00 17.39 16.91 coo 59.38 10.02 17.51 59.95 9.89 20.21 1.32 11.76 14.56 0.84 10.00 16.68 coo 59.52 3.69 18.67 62.31 6.19 22.58 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 5 3 # 5 A 107 ALA C 321 ALA~? 19.69 ZN ZN C 374 A 136 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 140 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo 55.90 7.49 23.83 56.71 8.23 22.76 -13.40 -18.49 51.25 -12.60 -19.47 52.03 coo 59.38 10.02 17.51 59.95 9.89 20.21 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 59.52 3.69 18.67 62.31 6.19 22.58 -12.73 -23.25 44.05 -17.55 -23.96 45.92 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 5 hits 1e7q_c01 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 207 LYS A 87 LYS~? 10.99 O2S EPE A 376 A 366 ASP A 55 ASP~? 17.36 O2S EPE A 376 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 36.23 21.81 22.32 41.86 22.67 23.70 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 35.91 21.93 28.51 38.15 26.57 30.75 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 45.10 18.98 22.18 44.20 20.57 23.21 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS A 94 LYS~? 16.25 O2S EPE A 376 A 207 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 366 ASP A 96 ASP.? 22.36 O2S EPE A 376 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 33.79 23.90 18.72 34.24 28.62 22.89 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 36.23 21.81 22.32 41.86 22.67 23.70 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 33.23 19.97 13.69 32.21 21.81 13.47 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS A 301 LYS~? 24.94 ZN ZN A 375 A 207 LYS A 303 LYS~? 13.81 O3 TRS A 378 A 366 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 39.11 -19.59 40.11 42.80 -21.77 43.38 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 37.93 -22.13 35.45 34.81 -22.43 31.07 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 4 3 # 4 A 205 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 207 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 366 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 45.66 0.76 26.15 51.53 0.58 28.90 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 44.47 1.55 20.70 47.30 5.10 24.27 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 5 3 # 5 A 205 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 207 LYS B 87 LYS~? 9.60 O3S EPE B 376 A 366 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -26.96 4.56 38.63 -29.49 9.20 36.26 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -23.51 8.76 41.04 -24.49 13.82 43.31 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 6 3 # 6 A 205 LYS B 94 LYS~? 17.44 O2S EPE B 376 A 207 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 366 ASP B 96 ASP.? 22.64 O2S EPE B 376 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -29.53 0.46 40.71 -30.43 3.58 45.55 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -26.96 4.56 38.63 -29.49 9.20 36.26 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -29.98 -4.37 36.65 -30.49 -4.93 38.64 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 7 3 # 7 A 205 LYS B 301 LYS~? 25.03 ZN ZN B 375 A 207 LYS B 303 LYS~? 19.29 ZN ZN B 375 A 366 ASP B 306 ASP.? 24.86 ZN ZN B 375 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 8.36 10.35 11.75 10.05 14.82 9.04 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 7.99 5.97 9.05 6.92 1.04 11.01 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 3.99 14.73 5.36 5.18 14.04 3.76 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 8 3 # 8 A 205 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 207 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 366 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 9 3 # 9 A 205 LYS B 355 LYS.? 33.64 ZN ZN B 375 A 207 LYS B 3 LYS.? 34.82 ZN ZN B 375 A 366 ASP B 352 ASP~? 25.82 ZN ZN B 375 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -28.14 -9.98 12.04 -29.16 -8.30 12.82 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 10 3 # 10 A 205 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 207 LYS C 87 LYS~? 9.86 O3S EPE C 376 A 366 ASP C 55 ASP~? 17.38 O3S EPE C 376 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 24.97 -26.94 68.30 21.78 -29.04 72.70 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 22.12 -22.06 69.94 21.88 -19.84 74.70 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 19.09 -33.39 71.33 19.50 -31.61 72.40 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 11 3 # 11 A 205 LYS C 94 LYS~? 16.71 O3S EPE C 376 A 207 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 366 ASP C 96 ASP.? 22.89 O3S EPE C 376 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 30.11 -27.61 67.14 30.55 -24.06 72.29 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 24.97 -26.94 68.30 21.78 -29.04 72.70 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 31.06 -32.15 62.51 32.92 -31.34 63.13 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 12 3 # 12 A 205 LYS C 301 LYS~? 24.63 ZN ZN C 375 A 207 LYS C 303 LYS~? 17.98 ZN ZN C 375 A 366 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -16.81 -30.01 48.18 -17.96 -30.59 46.51 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 13 3 # 13 A 205 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 207 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 366 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 14 3 # 14 A 205 LYS C 355 LYS.? 32.67 ZN ZN C 375 A 207 LYS C 3 LYS.? 28.91 O1 TRS A 378 A 366 ASP C 352 ASP~? 25.48 ZN ZN C 375 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 24.80 -50.74 47.95 22.71 -54.81 46.20 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 30.63 -48.52 50.80 31.26 -43.98 46.49 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 18.63 -50.25 49.90 18.47 -49.69 51.95 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 14 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 91 LYS~? 15.85 O2S EPE A 376 B 207 LYS A 87 LYS~? 10.99 O2S EPE A 376 B 366 ASP A 55 ASP~? 17.36 O2S EPE A 376 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 36.23 21.81 22.32 41.86 22.67 23.70 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 35.91 21.93 28.51 38.15 26.57 30.75 coo -11.13 25.71 4.86 -10.82 24.43 3.24 45.10 18.98 22.18 44.20 20.57 23.21 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS A 94 LYS~? 16.25 O2S EPE A 376 B 207 LYS A 91 LYS~? 15.85 O2S EPE A 376 B 366 ASP A 96 ASP.? 22.36 O2S EPE A 376 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 33.79 23.90 18.72 34.24 28.62 22.89 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 36.23 21.81 22.32 41.86 22.67 23.70 coo -11.13 25.71 4.86 -10.82 24.43 3.24 33.23 19.97 13.69 32.21 21.81 13.47 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS A 271 LYS.? 23.00 ZN ZN A 374 B 207 LYS A 265 LYS~? 22.38 ZN ZN A 374 B 366 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 56.12 0.48 35.73 59.67 4.01 35.99 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 54.99 -5.46 33.76 58.41 -3.92 38.21 coo -11.13 25.71 4.86 -10.82 24.43 3.24 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS A 301 LYS~? 24.94 ZN ZN A 375 B 207 LYS A 303 LYS~? 13.81 O3 TRS A 378 B 366 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 39.11 -19.59 40.11 42.80 -21.77 43.38 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 37.93 -22.13 35.45 34.81 -22.43 31.07 coo -11.13 25.71 4.86 -10.82 24.43 3.24 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 5 3 # 5 B 205 LYS A 337 LYS~? 14.02 ZN ZN A 374 B 207 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 366 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 45.66 0.76 26.15 51.53 0.58 28.90 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 44.47 1.55 20.70 47.30 5.10 24.27 coo -11.13 25.71 4.86 -10.82 24.43 3.24 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 6 3 # 6 B 205 LYS B 91 LYS~? 15.73 O3S EPE B 376 B 207 LYS B 87 LYS~? 9.60 O3S EPE B 376 B 366 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -26.96 4.56 38.63 -29.49 9.20 36.26 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -23.51 8.76 41.04 -24.49 13.82 43.31 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 7 3 # 7 B 205 LYS B 94 LYS~? 17.44 O2S EPE B 376 B 207 LYS B 91 LYS~? 15.73 O3S EPE B 376 B 366 ASP B 96 ASP.? 22.64 O2S EPE B 376 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -29.53 0.46 40.71 -30.43 3.58 45.55 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -26.96 4.56 38.63 -29.49 9.20 36.26 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -29.98 -4.37 36.65 -30.49 -4.93 38.64 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 8 3 # 8 B 205 LYS B 271 LYS.? 19.93 ZN ZN B 374 B 207 LYS B 265 LYS~? 21.91 ZN ZN B 374 B 366 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -15.49 22.23 14.65 -19.95 19.84 13.72 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -12.32 18.80 10.54 -12.89 23.62 10.63 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 9 3 # 9 B 205 LYS B 301 LYS~? 25.03 ZN ZN B 375 B 207 LYS B 303 LYS~? 19.29 ZN ZN B 375 B 366 ASP B 306 ASP.? 24.86 ZN ZN B 375 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 8.36 10.35 11.75 10.05 14.82 9.04 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 7.99 5.97 9.05 6.92 1.04 11.01 coo -11.13 25.71 4.86 -10.82 24.43 3.24 3.99 14.73 5.36 5.18 14.04 3.76 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 10 3 # 10 B 205 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 207 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 366 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 11 3 # 11 B 205 LYS B 355 LYS.? 33.64 ZN ZN B 375 B 207 LYS B 3 LYS.? 34.82 ZN ZN B 375 B 366 ASP B 352 ASP~? 25.82 ZN ZN B 375 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -28.14 -9.98 12.04 -29.16 -8.30 12.82 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 12 3 # 12 B 205 LYS C 91 LYS~? 15.57 O3S EPE C 376 B 207 LYS C 87 LYS~? 9.86 O3S EPE C 376 B 366 ASP C 55 ASP~? 17.38 O3S EPE C 376 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 24.97 -26.94 68.30 21.78 -29.04 72.70 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 22.12 -22.06 69.94 21.88 -19.84 74.70 coo -11.13 25.71 4.86 -10.82 24.43 3.24 19.09 -33.39 71.33 19.50 -31.61 72.40 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 13 3 # 13 B 205 LYS C 94 LYS~? 16.71 O3S EPE C 376 B 207 LYS C 91 LYS~? 15.57 O3S EPE C 376 B 366 ASP C 96 ASP.? 22.89 O3S EPE C 376 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 30.11 -27.61 67.14 30.55 -24.06 72.29 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 24.97 -26.94 68.30 21.78 -29.04 72.70 coo -11.13 25.71 4.86 -10.82 24.43 3.24 31.06 -32.15 62.51 32.92 -31.34 63.13 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 14 3 # 14 B 205 LYS C 301 LYS~? 24.63 ZN ZN C 375 B 207 LYS C 303 LYS~? 17.98 ZN ZN C 375 B 366 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -16.81 -30.01 48.18 -17.96 -30.59 46.51 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 15 3 # 15 B 205 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 207 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 366 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -11.13 25.71 4.86 -10.82 24.43 3.24 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 16 3 # 16 B 205 LYS C 355 LYS.? 32.67 ZN ZN C 375 B 207 LYS C 3 LYS.? 28.91 O1 TRS A 378 B 366 ASP C 352 ASP~? 25.48 ZN ZN C 375 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 24.80 -50.74 47.95 22.71 -54.81 46.20 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 30.63 -48.52 50.80 31.26 -43.98 46.49 coo -11.13 25.71 4.86 -10.82 24.43 3.24 18.63 -50.25 49.90 18.47 -49.69 51.95 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 16 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 91 LYS~? 15.85 O2S EPE A 376 C 207 LYS A 87 LYS~? 10.99 O2S EPE A 376 C 366 ASP A 55 ASP~? 17.36 O2S EPE A 376 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 36.23 21.81 22.32 41.86 22.67 23.70 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 35.91 21.93 28.51 38.15 26.57 30.75 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 45.10 18.98 22.18 44.20 20.57 23.21 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS A 94 LYS~? 16.25 O2S EPE A 376 C 207 LYS A 91 LYS~? 15.85 O2S EPE A 376 C 366 ASP A 96 ASP.? 22.36 O2S EPE A 376 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 33.79 23.90 18.72 34.24 28.62 22.89 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 36.23 21.81 22.32 41.86 22.67 23.70 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 33.23 19.97 13.69 32.21 21.81 13.47 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 3 3 # 3 C 205 LYS A 301 LYS~? 24.94 ZN ZN A 375 C 207 LYS A 303 LYS~? 13.81 O3 TRS A 378 C 366 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 4 3 # 4 C 205 LYS A 337 LYS~? 14.02 ZN ZN A 374 C 207 LYS A 340 LYS~? 12.75 ZN ZN A 374 C 366 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 45.66 0.76 26.15 51.53 0.58 28.90 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 44.47 1.55 20.70 47.30 5.10 24.27 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 5 3 # 5 C 205 LYS B 91 LYS~? 15.73 O3S EPE B 376 C 207 LYS B 87 LYS~? 9.60 O3S EPE B 376 C 366 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 6 3 # 6 C 205 LYS B 94 LYS~? 17.44 O2S EPE B 376 C 207 LYS B 91 LYS~? 15.73 O3S EPE B 376 C 366 ASP B 96 ASP.? 22.64 O2S EPE B 376 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -29.98 -4.37 36.65 -30.49 -4.93 38.64 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 7 3 # 7 C 205 LYS B 301 LYS~? 25.03 ZN ZN B 375 C 207 LYS B 303 LYS~? 19.29 ZN ZN B 375 C 366 ASP B 306 ASP.? 24.86 ZN ZN B 375 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 8.36 10.35 11.75 10.05 14.82 9.04 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 7.99 5.97 9.05 6.92 1.04 11.01 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 3.99 14.73 5.36 5.18 14.04 3.76 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 8 3 # 8 C 205 LYS B 337 LYS~? 13.35 ZN ZN B 374 C 207 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 366 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 9 3 # 9 C 205 LYS B 355 LYS.? 33.64 ZN ZN B 375 C 207 LYS B 3 LYS.? 34.82 ZN ZN B 375 C 366 ASP B 352 ASP~? 25.82 ZN ZN B 375 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -28.14 -9.98 12.04 -29.16 -8.30 12.82 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 10 3 # 10 C 205 LYS C 91 LYS~? 15.57 O3S EPE C 376 C 207 LYS C 87 LYS~? 9.86 O3S EPE C 376 C 366 ASP C 55 ASP~? 17.38 O3S EPE C 376 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 19.09 -33.39 71.33 19.50 -31.61 72.40 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 11 3 # 11 C 205 LYS C 94 LYS~? 16.71 O3S EPE C 376 C 207 LYS C 91 LYS~? 15.57 O3S EPE C 376 C 366 ASP C 96 ASP.? 22.89 O3S EPE C 376 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 31.06 -32.15 62.51 32.92 -31.34 63.13 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 12 3 # 12 C 205 LYS C 301 LYS~? 24.63 ZN ZN C 375 C 207 LYS C 303 LYS~? 17.98 ZN ZN C 375 C 366 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -16.81 -30.01 48.18 -17.96 -30.59 46.51 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 13 3 # 13 C 205 LYS C 337 LYS~? 12.69 ZN ZN C 374 C 207 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 366 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 14 3 # 14 C 205 LYS C 355 LYS.? 32.67 ZN ZN C 375 C 207 LYS C 3 LYS.? 28.91 O1 TRS A 378 C 366 ASP C 352 ASP~? 25.48 ZN ZN C 375 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 24.80 -50.74 47.95 22.71 -54.81 46.20 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 30.63 -48.52 50.80 31.26 -43.98 46.49 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 18.63 -50.25 49.90 18.47 -49.69 51.95 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 14 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 91 LYS~? 15.85 O2S EPE A 376 D 207 LYS A 87 LYS~? 10.99 O2S EPE A 376 D 366 ASP A 55 ASP~? 17.36 O2S EPE A 376 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 36.23 21.81 22.32 41.86 22.67 23.70 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 35.91 21.93 28.51 38.15 26.57 30.75 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 45.10 18.98 22.18 44.20 20.57 23.21 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS A 94 LYS~? 16.25 O2S EPE A 376 D 207 LYS A 91 LYS~? 15.85 O2S EPE A 376 D 366 ASP A 96 ASP.? 22.36 O2S EPE A 376 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 33.79 23.90 18.72 34.24 28.62 22.89 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 36.23 21.81 22.32 41.86 22.67 23.70 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 33.23 19.97 13.69 32.21 21.81 13.47 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 3 3 # 3 D 205 LYS A 301 LYS~? 24.94 ZN ZN A 375 D 207 LYS A 303 LYS~? 13.81 O3 TRS A 378 D 366 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 4 3 # 4 D 205 LYS A 337 LYS~? 14.02 ZN ZN A 374 D 207 LYS A 340 LYS~? 12.75 ZN ZN A 374 D 366 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 45.66 0.76 26.15 51.53 0.58 28.90 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 44.47 1.55 20.70 47.30 5.10 24.27 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 5 3 # 5 D 205 LYS B 91 LYS~? 15.73 O3S EPE B 376 D 207 LYS B 87 LYS~? 9.60 O3S EPE B 376 D 366 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 6 3 # 6 D 205 LYS B 94 LYS~? 17.44 O2S EPE B 376 D 207 LYS B 91 LYS~? 15.73 O3S EPE B 376 D 366 ASP B 96 ASP.? 22.64 O2S EPE B 376 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -29.98 -4.37 36.65 -30.49 -4.93 38.64 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 7 3 # 7 D 205 LYS B 301 LYS~? 25.03 ZN ZN B 375 D 207 LYS B 303 LYS~? 19.29 ZN ZN B 375 D 366 ASP B 306 ASP.? 24.86 ZN ZN B 375 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 8.36 10.35 11.75 10.05 14.82 9.04 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 7.99 5.97 9.05 6.92 1.04 11.01 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 3.99 14.73 5.36 5.18 14.04 3.76 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 8 3 # 8 D 205 LYS B 337 LYS~? 13.35 ZN ZN B 374 D 207 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 366 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 9 3 # 9 D 205 LYS B 355 LYS.? 33.64 ZN ZN B 375 D 207 LYS B 3 LYS.? 34.82 ZN ZN B 375 D 366 ASP B 352 ASP~? 25.82 ZN ZN B 375 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -28.14 -9.98 12.04 -29.16 -8.30 12.82 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 10 3 # 10 D 205 LYS C 91 LYS~? 15.57 O3S EPE C 376 D 207 LYS C 87 LYS~? 9.86 O3S EPE C 376 D 366 ASP C 55 ASP~? 17.38 O3S EPE C 376 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 19.09 -33.39 71.33 19.50 -31.61 72.40 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 11 3 # 11 D 205 LYS C 94 LYS~? 16.71 O3S EPE C 376 D 207 LYS C 91 LYS~? 15.57 O3S EPE C 376 D 366 ASP C 96 ASP.? 22.89 O3S EPE C 376 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 31.06 -32.15 62.51 32.92 -31.34 63.13 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 12 3 # 12 D 205 LYS C 301 LYS~? 24.63 ZN ZN C 375 D 207 LYS C 303 LYS~? 17.98 ZN ZN C 375 D 366 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -16.81 -30.01 48.18 -17.96 -30.59 46.51 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 13 3 # 13 D 205 LYS C 337 LYS~? 12.69 ZN ZN C 374 D 207 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 366 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 14 3 # 14 D 205 LYS C 355 LYS.? 32.67 ZN ZN C 375 D 207 LYS C 3 LYS.? 28.91 O1 TRS A 378 D 366 ASP C 352 ASP~? 25.48 ZN ZN C 375 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 24.80 -50.74 47.95 22.71 -54.81 46.20 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 30.63 -48.52 50.80 31.26 -43.98 46.49 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 18.63 -50.25 49.90 18.47 -49.69 51.95 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 14 hits 1ec9_c07 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 177 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 203 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 8.74 45.76 47.19 9.33 46.93 45.56 37.80 0.44 25.56 37.02 -1.29 26.44 coo 11.68 42.31 52.96 12.05 43.92 51.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 18.07 52.81 49.62 14.17 49.99 48.07 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 177 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 203 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 8.74 45.76 47.19 9.33 46.93 45.56 37.80 0.44 25.56 37.02 -1.29 26.44 coo 11.68 42.31 52.96 12.05 43.92 51.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 18.07 52.81 49.62 14.17 49.99 48.07 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 177 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 203 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 8.74 45.76 47.19 9.33 46.93 45.56 37.42 3.90 29.26 38.47 2.36 30.22 coo 11.68 42.31 52.96 12.05 43.92 51.65 40.70 8.14 28.73 41.06 6.40 29.84 coo 18.07 52.81 49.62 14.17 49.99 48.07 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 4 3 # 4 A 99 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 177 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 203 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 8.74 45.76 47.19 9.33 46.93 45.56 32.91 0.46 27.63 33.66 0.11 29.56 coo 11.68 42.31 52.96 12.05 43.92 51.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 18.07 52.81 49.62 14.17 49.99 48.07 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 5 3 # 5 A 99 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 177 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 203 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 8.74 45.76 47.19 9.33 46.93 45.56 32.91 0.46 27.63 33.66 0.11 29.56 coo 11.68 42.31 52.96 12.05 43.92 51.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 18.07 52.81 49.62 14.17 49.99 48.07 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 6 3 # 6 A 99 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 177 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 203 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 8.74 45.76 47.19 9.33 46.93 45.56 32.91 0.46 27.63 33.66 0.11 29.56 coo 11.68 42.31 52.96 12.05 43.92 51.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 18.07 52.81 49.62 14.17 49.99 48.07 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 7 3 # 7 A 99 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 177 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 203 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 8.74 45.76 47.19 9.33 46.93 45.56 51.10 6.85 29.91 51.20 5.36 31.38 coo 11.68 42.31 52.96 12.05 43.92 51.65 54.82 -1.21 28.36 56.43 0.27 28.67 coo 18.07 52.81 49.62 14.17 49.99 48.07 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 8 3 # 8 A 99 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 177 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 203 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 8.74 45.76 47.19 9.33 46.93 45.56 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 11.68 42.31 52.96 12.05 43.92 51.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 18.07 52.81 49.62 14.17 49.99 48.07 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 9 3 # 9 A 99 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 177 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 203 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 8.74 45.76 47.19 9.33 46.93 45.56 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 11.68 42.31 52.96 12.05 43.92 51.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 18.07 52.81 49.62 14.17 49.99 48.07 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 10 3 # 10 A 99 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 177 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 203 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 8.74 45.76 47.19 9.33 46.93 45.56 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 11.68 42.31 52.96 12.05 43.92 51.65 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 18.07 52.81 49.62 14.17 49.99 48.07 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 11 3 # 11 A 99 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 177 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 203 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 8.74 45.76 47.19 9.33 46.93 45.56 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 11.68 42.31 52.96 12.05 43.92 51.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 18.07 52.81 49.62 14.17 49.99 48.07 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 12 3 # 12 A 99 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 177 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 203 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 8.74 45.76 47.19 9.33 46.93 45.56 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 11.68 42.31 52.96 12.05 43.92 51.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 18.07 52.81 49.62 14.17 49.99 48.07 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 13 3 # 13 A 99 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 177 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 203 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 8.74 45.76 47.19 9.33 46.93 45.56 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 11.68 42.31 52.96 12.05 43.92 51.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 18.07 52.81 49.62 14.17 49.99 48.07 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 14 3 # 14 A 99 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 177 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 203 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 8.74 45.76 47.19 9.33 46.93 45.56 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 11.68 42.31 52.96 12.05 43.92 51.65 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 18.07 52.81 49.62 14.17 49.99 48.07 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 15 3 # 15 A 99 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 177 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 203 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 8.74 45.76 47.19 9.33 46.93 45.56 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 11.68 42.31 52.96 12.05 43.92 51.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 18.07 52.81 49.62 14.17 49.99 48.07 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 16 3 # 16 A 99 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 177 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 203 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 8.74 45.76 47.19 9.33 46.93 45.56 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 11.68 42.31 52.96 12.05 43.92 51.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 18.07 52.81 49.62 14.17 49.99 48.07 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 17 3 # 17 A 99 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 177 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 203 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 8.74 45.76 47.19 9.33 46.93 45.56 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 11.68 42.31 52.96 12.05 43.92 51.65 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 18.07 52.81 49.62 14.17 49.99 48.07 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 18 3 # 18 A 99 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 177 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 203 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 8.74 45.76 47.19 9.33 46.93 45.56 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 11.68 42.31 52.96 12.05 43.92 51.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 18.07 52.81 49.62 14.17 49.99 48.07 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 19 3 # 19 A 99 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 177 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 203 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 8.74 45.76 47.19 9.33 46.93 45.56 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 11.68 42.31 52.96 12.05 43.92 51.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 18.07 52.81 49.62 14.17 49.99 48.07 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 20 3 # 20 A 99 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 177 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 203 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 8.74 45.76 47.19 9.33 46.93 45.56 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 11.68 42.31 52.96 12.05 43.92 51.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 18.07 52.81 49.62 14.17 49.99 48.07 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 21 3 # 21 A 99 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 177 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 203 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 8.74 45.76 47.19 9.33 46.93 45.56 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 11.68 42.31 52.96 12.05 43.92 51.65 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 18.07 52.81 49.62 14.17 49.99 48.07 9.58 -37.42 57.24 8.41 -35.76 62.90 1ecx_c02 source 1ecx AMINOTRANSFERASE : 21 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 177 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 203 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 14.87 88.04 21.51 13.64 87.90 19.81 37.80 0.44 25.56 37.02 -1.29 26.44 coo 15.87 92.46 27.37 14.46 91.76 25.94 40.70 8.14 28.73 41.06 6.40 29.84 coo 3.60 91.42 23.52 8.20 89.55 22.63 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 177 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 203 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 14.87 88.04 21.51 13.64 87.90 19.81 37.80 0.44 25.56 37.02 -1.29 26.44 coo 15.87 92.46 27.37 14.46 91.76 25.94 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 3.60 91.42 23.52 8.20 89.55 22.63 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 177 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 203 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 14.87 88.04 21.51 13.64 87.90 19.81 37.80 0.44 25.56 37.02 -1.29 26.44 coo 15.87 92.46 27.37 14.46 91.76 25.94 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 3.60 91.42 23.52 8.20 89.55 22.63 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 177 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 203 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 14.87 88.04 21.51 13.64 87.90 19.81 32.91 0.46 27.63 33.66 0.11 29.56 coo 15.87 92.46 27.37 14.46 91.76 25.94 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 3.60 91.42 23.52 8.20 89.55 22.63 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 5 3 # 5 B 99 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 177 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 203 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 14.87 88.04 21.51 13.64 87.90 19.81 32.91 0.46 27.63 33.66 0.11 29.56 coo 15.87 92.46 27.37 14.46 91.76 25.94 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 3.60 91.42 23.52 8.20 89.55 22.63 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 6 3 # 6 B 99 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 177 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 203 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 14.87 88.04 21.51 13.64 87.90 19.81 32.91 0.46 27.63 33.66 0.11 29.56 coo 15.87 92.46 27.37 14.46 91.76 25.94 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 3.60 91.42 23.52 8.20 89.55 22.63 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 7 3 # 7 B 99 HIS A 366 HIS.? 14.86 ZN ZN A 374 B 177 ASP A 269 ASP.? 18.90 ZN ZN A 374 B 203 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 14.87 88.04 21.51 13.64 87.90 19.81 51.10 6.85 29.91 51.20 5.36 31.38 coo 15.87 92.46 27.37 14.46 91.76 25.94 54.82 -1.21 28.36 56.43 0.27 28.67 coo 3.60 91.42 23.52 8.20 89.55 22.63 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 8 3 # 8 B 99 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 177 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 203 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 14.87 88.04 21.51 13.64 87.90 19.81 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 15.87 92.46 27.37 14.46 91.76 25.94 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 3.60 91.42 23.52 8.20 89.55 22.63 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 9 3 # 9 B 99 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 177 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 203 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 14.87 88.04 21.51 13.64 87.90 19.81 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 15.87 92.46 27.37 14.46 91.76 25.94 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 3.60 91.42 23.52 8.20 89.55 22.63 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 10 3 # 10 B 99 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 177 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 203 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 14.87 88.04 21.51 13.64 87.90 19.81 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 15.87 92.46 27.37 14.46 91.76 25.94 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 3.60 91.42 23.52 8.20 89.55 22.63 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 11 3 # 11 B 99 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 177 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 203 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 14.87 88.04 21.51 13.64 87.90 19.81 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 15.87 92.46 27.37 14.46 91.76 25.94 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 3.60 91.42 23.52 8.20 89.55 22.63 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 12 3 # 12 B 99 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 177 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 203 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 14.87 88.04 21.51 13.64 87.90 19.81 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 15.87 92.46 27.37 14.46 91.76 25.94 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 3.60 91.42 23.52 8.20 89.55 22.63 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 13 3 # 13 B 99 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 177 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 203 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 14.87 88.04 21.51 13.64 87.90 19.81 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 15.87 92.46 27.37 14.46 91.76 25.94 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 3.60 91.42 23.52 8.20 89.55 22.63 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 14 3 # 14 B 99 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 177 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 203 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 14.87 88.04 21.51 13.64 87.90 19.81 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 15.87 92.46 27.37 14.46 91.76 25.94 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 3.60 91.42 23.52 8.20 89.55 22.63 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 15 3 # 15 B 99 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 177 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 203 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 14.87 88.04 21.51 13.64 87.90 19.81 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 15.87 92.46 27.37 14.46 91.76 25.94 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 3.60 91.42 23.52 8.20 89.55 22.63 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 16 3 # 16 B 99 HIS B 366 HIS.? 14.78 ZN ZN B 374 B 177 ASP B 269 ASP.? 18.26 ZN ZN B 374 B 203 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 14.87 88.04 21.51 13.64 87.90 19.81 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 15.87 92.46 27.37 14.46 91.76 25.94 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 3.60 91.42 23.52 8.20 89.55 22.63 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 17 3 # 17 B 99 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 177 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 203 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 14.87 88.04 21.51 13.64 87.90 19.81 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 15.87 92.46 27.37 14.46 91.76 25.94 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 3.60 91.42 23.52 8.20 89.55 22.63 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 18 3 # 18 B 99 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 177 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 203 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 14.87 88.04 21.51 13.64 87.90 19.81 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 15.87 92.46 27.37 14.46 91.76 25.94 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 3.60 91.42 23.52 8.20 89.55 22.63 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 19 3 # 19 B 99 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 177 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 203 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 14.87 88.04 21.51 13.64 87.90 19.81 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 15.87 92.46 27.37 14.46 91.76 25.94 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 3.60 91.42 23.52 8.20 89.55 22.63 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 20 3 # 20 B 99 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 177 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 203 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 14.87 88.04 21.51 13.64 87.90 19.81 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 15.87 92.46 27.37 14.46 91.76 25.94 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 3.60 91.42 23.52 8.20 89.55 22.63 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 21 3 # 21 B 99 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 177 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 203 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 14.87 88.04 21.51 13.64 87.90 19.81 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 15.87 92.46 27.37 14.46 91.76 25.94 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 3.60 91.42 23.52 8.20 89.55 22.63 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 22 3 # 22 B 99 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 177 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 203 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 14.87 88.04 21.51 13.64 87.90 19.81 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 15.87 92.46 27.37 14.46 91.76 25.94 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 3.60 91.42 23.52 8.20 89.55 22.63 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 23 3 # 23 B 99 HIS C 366 HIS.? 14.85 ZN ZN C 374 B 177 ASP C 269 ASP~? 18.04 ZN ZN C 374 B 203 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 14.87 88.04 21.51 13.64 87.90 19.81 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 15.87 92.46 27.37 14.46 91.76 25.94 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 3.60 91.42 23.52 8.20 89.55 22.63 9.58 -37.42 57.24 8.41 -35.76 62.90 1ecx_c03 source 1ecx AMINOTRANSFERASE : 23 hits 1ecx_c03 naa= 3 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 A 66 HIS A 163 HIS.? 11.18 O1S EPE C 377 A 110 GLY A 162 GLY.? 4.48 O1S EPE C 377 A 140 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo 24.53 0.12 1.91 23.47 1.90 2.27 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 22.96 1.26 5.85 23.32 1.32 6.60 25.38 -26.08 6.68 25.80 -25.42 6.56 coo 21.28 7.32 1.28 21.07 5.14 3.02 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 A 66 HIS B 163 HIS.? 11.54 O3S EPE A 377 A 110 GLY B 162 GLY.? 5.31 O3S EPE A 377 A 140 TYR B 167 TYR^? 5.54 O8 EPE A 377 coo 24.53 0.12 1.91 23.47 1.90 2.27 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 22.96 1.26 5.85 23.32 1.32 6.60 -1.71 -25.67 5.15 -2.30 -25.15 5.24 coo 21.28 7.32 1.28 21.07 5.14 3.02 -0.72 -24.00 -3.91 0.54 -23.91 -6.42 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 A 66 HIS B 163 HIS.? 11.54 O3S EPE A 377 A 110 GLY B 165 GLY.? 10.94 O1S EPE A 377 A 140 TYR B 167 TYR^? 5.54 O8 EPE A 377 coo 24.53 0.12 1.91 23.47 1.90 2.27 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 22.96 1.26 5.85 23.32 1.32 6.60 -0.63 -18.46 -0.95 -1.10 -19.11 -0.69 coo 21.28 7.32 1.28 21.07 5.14 3.02 -0.72 -24.00 -3.91 0.54 -23.91 -6.42 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 4 3 # 4 A 66 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 110 GLY C 162 GLY.? 17.81 N TRS A 378 A 140 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo 24.53 0.12 1.91 23.47 1.90 2.27 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 22.96 1.26 5.85 23.32 1.32 6.60 11.10 -40.67 24.41 11.25 -40.70 25.20 coo 21.28 7.32 1.28 21.07 5.14 3.02 3.31 -45.81 25.21 0.69 -46.75 24.83 1ef8_c00 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c00 naa= 3 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 B 66 HIS A 8 HIS~? 24.55 ZN ZN A 375 B 110 GLY A 7 GLY~? 22.99 ZN ZN A 375 B 140 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo 15.25 42.02 9.50 15.08 40.17 8.54 26.75 7.68 8.85 25.49 8.72 10.18 coo 16.54 37.86 10.86 17.07 37.78 11.48 31.92 8.80 9.28 31.38 8.48 8.65 coo 8.70 35.97 10.91 11.44 36.02 10.35 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 B 66 HIS A 163 HIS.? 11.18 O1S EPE C 377 B 110 GLY A 162 GLY.? 4.48 O1S EPE C 377 B 140 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo 15.25 42.02 9.50 15.08 40.17 8.54 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 16.54 37.86 10.86 17.07 37.78 11.48 25.38 -26.08 6.68 25.80 -25.42 6.56 coo 8.70 35.97 10.91 11.44 36.02 10.35 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 B 66 HIS B 8 HIS~? 24.51 ZN ZN B 375 B 110 GLY B 7 GLY~? 23.15 ZN ZN B 375 B 140 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 15.25 42.02 9.50 15.08 40.17 8.54 -21.73 -14.76 29.99 -21.14 -14.36 31.97 coo 16.54 37.86 10.86 17.07 37.78 11.48 -24.83 -11.10 27.95 -24.79 -11.89 27.82 coo 8.70 35.97 10.91 11.44 36.02 10.35 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 4 3 # 4 B 66 HIS B 163 HIS.? 11.54 O3S EPE A 377 B 110 GLY B 162 GLY.? 5.31 O3S EPE A 377 B 140 TYR B 167 TYR^? 5.54 O8 EPE A 377 coo 15.25 42.02 9.50 15.08 40.17 8.54 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 16.54 37.86 10.86 17.07 37.78 11.48 -1.71 -25.67 5.15 -2.30 -25.15 5.24 coo 8.70 35.97 10.91 11.44 36.02 10.35 -0.72 -24.00 -3.91 0.54 -23.91 -6.42 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 5 3 # 5 B 66 HIS B 163 HIS.? 11.54 O3S EPE A 377 B 110 GLY B 165 GLY.? 10.94 O1S EPE A 377 B 140 TYR B 167 TYR^? 5.54 O8 EPE A 377 coo 15.25 42.02 9.50 15.08 40.17 8.54 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 16.54 37.86 10.86 17.07 37.78 11.48 -0.63 -18.46 -0.95 -1.10 -19.11 -0.69 coo 8.70 35.97 10.91 11.44 36.02 10.35 -0.72 -24.00 -3.91 0.54 -23.91 -6.42 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 6 3 # 6 B 66 HIS C 8 HIS~? 24.89 ZN ZN C 375 B 110 GLY C 7 GLY~? 23.11 ZN ZN C 375 B 140 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo 15.25 42.02 9.50 15.08 40.17 8.54 29.42 -33.76 48.01 30.25 -31.91 48.55 coo 16.54 37.86 10.86 17.07 37.78 11.48 27.26 -36.33 52.02 27.65 -36.56 51.35 coo 8.70 35.97 10.91 11.44 36.02 10.35 20.27 -30.73 51.89 19.47 -30.85 49.23 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 7 3 # 7 B 66 HIS C 163 HIS.? 22.24 O1 TRS A 378 B 110 GLY C 162 GLY.? 17.81 N TRS A 378 B 140 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo 15.25 42.02 9.50 15.08 40.17 8.54 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 16.54 37.86 10.86 17.07 37.78 11.48 11.10 -40.67 24.41 11.25 -40.70 25.20 coo 8.70 35.97 10.91 11.44 36.02 10.35 3.31 -45.81 25.21 0.69 -46.75 24.83 1ef8_c01 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 7 hits 1ef8_c01 naa= 3 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 C 66 HIS A 8 HIS~? 24.55 ZN ZN A 375 C 110 GLY A 7 GLY~? 22.99 ZN ZN A 375 C 140 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo -9.82 10.01 28.41 -9.17 11.02 26.71 26.75 7.68 8.85 25.49 8.72 10.18 coo -5.73 12.49 27.77 -5.15 12.61 28.37 31.92 8.80 9.28 31.38 8.48 8.65 coo -4.68 8.05 21.05 -4.91 10.19 22.84 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 C 66 HIS A 163 HIS.? 11.18 O1S EPE C 377 C 110 GLY A 162 GLY.? 4.48 O1S EPE C 377 C 140 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo -9.82 10.01 28.41 -9.17 11.02 26.71 30.88 -23.32 6.66 32.97 -23.36 6.49 coo -5.73 12.49 27.77 -5.15 12.61 28.37 25.38 -26.08 6.68 25.80 -25.42 6.56 coo -4.68 8.05 21.05 -4.91 10.19 22.84 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 C 66 HIS B 8 HIS~? 24.51 ZN ZN B 375 C 110 GLY B 7 GLY~? 23.15 ZN ZN B 375 C 140 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -21.73 -14.76 29.99 -21.14 -14.36 31.97 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -24.83 -11.10 27.95 -24.79 -11.89 27.82 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 4 3 # 4 C 66 HIS B 163 HIS.? 11.54 O3S EPE A 377 C 110 GLY B 162 GLY.? 5.31 O3S EPE A 377 C 140 TYR B 167 TYR^? 5.54 O8 EPE A 377 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -1.71 -25.67 5.15 -2.30 -25.15 5.24 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -0.72 -24.00 -3.91 0.54 -23.91 -6.42 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 5 3 # 5 C 66 HIS B 163 HIS.? 11.54 O3S EPE A 377 C 110 GLY B 165 GLY.? 10.94 O1S EPE A 377 C 140 TYR B 167 TYR^? 5.54 O8 EPE A 377 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -0.63 -18.46 -0.95 -1.10 -19.11 -0.69 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -0.72 -24.00 -3.91 0.54 -23.91 -6.42 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 6 3 # 6 C 66 HIS C 8 HIS~? 24.89 ZN ZN C 375 C 110 GLY C 7 GLY~? 23.11 ZN ZN C 375 C 140 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo -9.82 10.01 28.41 -9.17 11.02 26.71 29.42 -33.76 48.01 30.25 -31.91 48.55 coo -5.73 12.49 27.77 -5.15 12.61 28.37 27.26 -36.33 52.02 27.65 -36.56 51.35 coo -4.68 8.05 21.05 -4.91 10.19 22.84 20.27 -30.73 51.89 19.47 -30.85 49.23 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 7 3 # 7 C 66 HIS C 163 HIS.? 22.24 O1 TRS A 378 C 110 GLY C 162 GLY.? 17.81 N TRS A 378 C 140 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo -9.82 10.01 28.41 -9.17 11.02 26.71 9.61 -42.49 30.12 8.57 -43.28 31.77 coo -5.73 12.49 27.77 -5.15 12.61 28.37 11.10 -40.67 24.41 11.25 -40.70 25.20 coo -4.68 8.05 21.05 -4.91 10.19 22.84 3.31 -45.81 25.21 0.69 -46.75 24.83 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 8 3 # 8 C 66 HIS C 163 HIS.? 22.24 O1 TRS A 378 C 110 GLY C 165 GLY.? 25.31 N TRS A 378 C 140 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo -9.82 10.01 28.41 -9.17 11.02 26.71 9.61 -42.49 30.12 8.57 -43.28 31.77 coo -5.73 12.49 27.77 -5.15 12.61 28.37 3.00 -41.27 29.42 3.80 -41.57 29.42 coo -4.68 8.05 21.05 -4.91 10.19 22.84 3.31 -45.81 25.21 0.69 -46.75 24.83 1ef8_c02 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 8 hits 1ef8_c02 naa= 3 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 A 107 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 246 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 275 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 28.44 37.56 46.79 26.87 37.11 48.10 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 22.84 50.35 52.24 23.24 48.32 52.90 40.70 8.14 28.73 41.06 6.40 29.84 coo 26.67 42.94 48.26 27.49 41.07 48.73 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 A 107 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 246 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 275 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 40.70 8.14 28.73 41.06 6.40 29.84 coo 22.84 50.35 52.24 23.24 48.32 52.90 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 26.67 42.94 48.26 27.49 41.07 48.73 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 A 107 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 246 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 275 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 40.70 8.14 28.73 41.06 6.40 29.84 coo 22.84 50.35 52.24 23.24 48.32 52.90 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 26.67 42.94 48.26 27.49 41.07 48.73 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 A 107 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 246 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 275 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 40.70 8.14 28.73 41.06 6.40 29.84 coo 22.84 50.35 52.24 23.24 48.32 52.90 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 26.67 42.94 48.26 27.49 41.07 48.73 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 A 107 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 246 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 275 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 28.44 37.56 46.79 26.87 37.11 48.10 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 22.84 50.35 52.24 23.24 48.32 52.90 40.70 8.14 28.73 41.06 6.40 29.84 coo 26.67 42.94 48.26 27.49 41.07 48.73 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 A 107 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 246 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 275 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 28.44 37.56 46.79 26.87 37.11 48.10 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 22.84 50.35 52.24 23.24 48.32 52.90 40.70 8.14 28.73 41.06 6.40 29.84 coo 26.67 42.94 48.26 27.49 41.07 48.73 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 A 107 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 246 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 275 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 22.84 50.35 52.24 23.24 48.32 52.90 40.70 8.14 28.73 41.06 6.40 29.84 coo 26.67 42.94 48.26 27.49 41.07 48.73 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 A 107 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 246 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 275 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 22.84 50.35 52.24 23.24 48.32 52.90 48.24 5.16 33.58 47.82 3.96 35.30 coo 26.67 42.94 48.26 27.49 41.07 48.73 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 A 107 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 246 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 275 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 39.49 -1.24 39.18 39.76 0.49 37.96 coo 22.84 50.35 52.24 23.24 48.32 52.90 40.70 8.14 28.73 41.06 6.40 29.84 coo 26.67 42.94 48.26 27.49 41.07 48.73 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 A 107 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 246 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 275 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 39.49 -1.24 39.18 39.76 0.49 37.96 coo 22.84 50.35 52.24 23.24 48.32 52.90 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 26.67 42.94 48.26 27.49 41.07 48.73 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 11 3 # 11 A 107 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 246 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 275 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 28.44 37.56 46.79 26.87 37.11 48.10 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 22.84 50.35 52.24 23.24 48.32 52.90 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 26.67 42.94 48.26 27.49 41.07 48.73 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 12 3 # 12 A 107 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 246 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 275 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 22.84 50.35 52.24 23.24 48.32 52.90 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 26.67 42.94 48.26 27.49 41.07 48.73 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 13 3 # 13 A 107 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 246 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 275 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 22.84 50.35 52.24 23.24 48.32 52.90 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 26.67 42.94 48.26 27.49 41.07 48.73 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 14 3 # 14 A 107 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 246 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 275 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 22.84 50.35 52.24 23.24 48.32 52.90 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 26.67 42.94 48.26 27.49 41.07 48.73 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 15 3 # 15 A 107 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 246 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 275 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 28.44 37.56 46.79 26.87 37.11 48.10 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 22.84 50.35 52.24 23.24 48.32 52.90 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 26.67 42.94 48.26 27.49 41.07 48.73 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 16 3 # 16 A 107 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 246 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 275 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 28.44 37.56 46.79 26.87 37.11 48.10 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 22.84 50.35 52.24 23.24 48.32 52.90 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 26.67 42.94 48.26 27.49 41.07 48.73 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 17 3 # 17 A 107 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 246 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 275 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 22.84 50.35 52.24 23.24 48.32 52.90 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 26.67 42.94 48.26 27.49 41.07 48.73 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 18 3 # 18 A 107 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 246 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 275 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 22.84 50.35 52.24 23.24 48.32 52.90 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 26.67 42.94 48.26 27.49 41.07 48.73 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 19 3 # 19 A 107 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 246 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 275 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 22.84 50.35 52.24 23.24 48.32 52.90 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 26.67 42.94 48.26 27.49 41.07 48.73 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 20 3 # 20 A 107 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 246 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 275 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 22.84 50.35 52.24 23.24 48.32 52.90 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 26.67 42.94 48.26 27.49 41.07 48.73 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 21 3 # 21 A 107 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 246 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 275 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 28.44 37.56 46.79 26.87 37.11 48.10 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 22.84 50.35 52.24 23.24 48.32 52.90 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 26.67 42.94 48.26 27.49 41.07 48.73 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 22 3 # 22 A 107 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 246 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 275 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 22.84 50.35 52.24 23.24 48.32 52.90 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 26.67 42.94 48.26 27.49 41.07 48.73 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 23 3 # 23 A 107 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 246 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 275 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 22.84 50.35 52.24 23.24 48.32 52.90 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 26.67 42.94 48.26 27.49 41.07 48.73 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 24 3 # 24 A 107 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 246 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 275 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 22.84 50.35 52.24 23.24 48.32 52.90 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 26.67 42.94 48.26 27.49 41.07 48.73 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 25 3 # 25 A 107 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 246 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 275 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 28.44 37.56 46.79 26.87 37.11 48.10 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 22.84 50.35 52.24 23.24 48.32 52.90 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 26.67 42.94 48.26 27.49 41.07 48.73 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 26 3 # 26 A 107 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 246 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 275 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 28.44 37.56 46.79 26.87 37.11 48.10 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 22.84 50.35 52.24 23.24 48.32 52.90 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 26.67 42.94 48.26 27.49 41.07 48.73 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 27 3 # 27 A 107 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 246 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 275 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 22.84 50.35 52.24 23.24 48.32 52.90 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 26.67 42.94 48.26 27.49 41.07 48.73 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 28 3 # 28 A 107 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 246 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 275 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 22.84 50.35 52.24 23.24 48.32 52.90 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 26.67 42.94 48.26 27.49 41.07 48.73 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 29 3 # 29 A 107 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 246 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 275 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 22.84 50.35 52.24 23.24 48.32 52.90 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 26.67 42.94 48.26 27.49 41.07 48.73 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 30 3 # 30 A 107 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 246 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 275 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 28.44 37.56 46.79 26.87 37.11 48.10 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 22.84 50.35 52.24 23.24 48.32 52.90 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 26.67 42.94 48.26 27.49 41.07 48.73 2.70 -25.03 58.20 4.12 -24.40 56.79 1ehy_c00 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 30 hits 1ehy_c00 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 246 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 275 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 34.84 56.77 81.62 34.95 54.74 82.03 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 43.18 49.30 68.39 44.75 49.87 69.78 40.70 8.14 28.73 41.06 6.40 29.84 coo 38.73 55.10 77.62 36.80 55.01 78.46 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 246 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 275 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 34.84 56.77 81.62 34.95 54.74 82.03 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 43.18 49.30 68.39 44.75 49.87 69.78 39.49 -1.24 39.18 39.76 0.49 37.96 coo 38.73 55.10 77.62 36.80 55.01 78.46 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 B 107 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 246 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 275 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 34.84 56.77 81.62 34.95 54.74 82.03 40.70 8.14 28.73 41.06 6.40 29.84 coo 43.18 49.30 68.39 44.75 49.87 69.78 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 38.73 55.10 77.62 36.80 55.01 78.46 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 B 107 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 246 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 275 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 34.84 56.77 81.62 34.95 54.74 82.03 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 43.18 49.30 68.39 44.75 49.87 69.78 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 38.73 55.10 77.62 36.80 55.01 78.46 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 B 107 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 246 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 275 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 34.84 56.77 81.62 34.95 54.74 82.03 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 43.18 49.30 68.39 44.75 49.87 69.78 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 38.73 55.10 77.62 36.80 55.01 78.46 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 B 107 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 246 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 275 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 34.84 56.77 81.62 34.95 54.74 82.03 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 43.18 49.30 68.39 44.75 49.87 69.78 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 38.73 55.10 77.62 36.80 55.01 78.46 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 B 107 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 246 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 275 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 34.84 56.77 81.62 34.95 54.74 82.03 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 43.18 49.30 68.39 44.75 49.87 69.78 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 38.73 55.10 77.62 36.80 55.01 78.46 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 B 107 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 246 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 275 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 34.84 56.77 81.62 34.95 54.74 82.03 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 43.18 49.30 68.39 44.75 49.87 69.78 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 38.73 55.10 77.62 36.80 55.01 78.46 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 B 107 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 246 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 275 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 34.84 56.77 81.62 34.95 54.74 82.03 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 43.18 49.30 68.39 44.75 49.87 69.78 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 38.73 55.10 77.62 36.80 55.01 78.46 9.38 -25.93 57.43 7.35 -26.43 57.48 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 9 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 246 ASP A 312 ASP.? 7.50 ZN ZN A 374 C 275 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 1.90 35.26 72.76 3.20 35.74 71.18 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 12.03 20.33 71.56 10.48 19.25 70.56 39.49 -1.24 39.18 39.76 0.49 37.96 coo 3.92 29.96 71.75 4.22 31.96 72.31 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 246 ASP A 368 ASP.? 11.85 ZN ZN A 374 C 275 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 1.90 35.26 72.76 3.20 35.74 71.18 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 12.03 20.33 71.56 10.48 19.25 70.56 48.24 5.16 33.58 47.82 3.96 35.30 coo 3.92 29.96 71.75 4.22 31.96 72.31 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 C 107 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 246 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 275 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 1.90 35.26 72.76 3.20 35.74 71.18 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 12.03 20.33 71.56 10.48 19.25 70.56 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 3.92 29.96 71.75 4.22 31.96 72.31 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 C 107 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 246 ASP B 312 ASP.? 7.53 ZN ZN B 374 C 275 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 1.90 35.26 72.76 3.20 35.74 71.18 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 12.03 20.33 71.56 10.48 19.25 70.56 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 3.92 29.96 71.75 4.22 31.96 72.31 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 C 107 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 246 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 275 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 1.90 35.26 72.76 3.20 35.74 71.18 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 12.03 20.33 71.56 10.48 19.25 70.56 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 3.92 29.96 71.75 4.22 31.96 72.31 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 C 107 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 246 ASP B 368 ASP.? 11.70 ZN ZN B 374 C 275 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 1.90 35.26 72.76 3.20 35.74 71.18 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 12.03 20.33 71.56 10.48 19.25 70.56 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 3.92 29.96 71.75 4.22 31.96 72.31 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 C 107 ASP C 27 ASP.? 8.23 ZN ZN C 375 C 246 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 275 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 1.90 35.26 72.76 3.20 35.74 71.18 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 12.03 20.33 71.56 10.48 19.25 70.56 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 3.92 29.96 71.75 4.22 31.96 72.31 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 C 107 ASP C 27 ASP.? 8.23 ZN ZN C 375 C 246 ASP C 312 ASP.? 7.48 ZN ZN C 374 C 275 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 1.90 35.26 72.76 3.20 35.74 71.18 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 12.03 20.33 71.56 10.48 19.25 70.56 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 3.92 29.96 71.75 4.22 31.96 72.31 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 C 107 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 246 ASP C 27 ASP.? 8.23 ZN ZN C 375 C 275 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 1.90 35.26 72.76 3.20 35.74 71.18 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 12.03 20.33 71.56 10.48 19.25 70.56 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 3.92 29.96 71.75 4.22 31.96 72.31 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 C 107 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 246 ASP C 368 ASP.? 11.74 ZN ZN C 374 C 275 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 1.90 35.26 72.76 3.20 35.74 71.18 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 12.03 20.33 71.56 10.48 19.25 70.56 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 3.92 29.96 71.75 4.22 31.96 72.31 9.33 -29.64 54.17 7.95 -29.11 52.67 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 10 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 246 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 275 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 37.41 19.89 81.58 37.64 21.98 81.53 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 23.50 26.43 88.52 24.76 26.47 90.29 40.70 8.14 28.73 41.06 6.40 29.84 coo 33.16 21.44 85.29 34.07 21.53 83.40 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 246 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 275 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 37.41 19.89 81.58 37.64 21.98 81.53 40.70 8.14 28.73 41.06 6.40 29.84 coo 23.50 26.43 88.52 24.76 26.47 90.29 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 33.16 21.44 85.29 34.07 21.53 83.40 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 D 107 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 246 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 275 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 37.41 19.89 81.58 37.64 21.98 81.53 40.70 8.14 28.73 41.06 6.40 29.84 coo 23.50 26.43 88.52 24.76 26.47 90.29 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 33.16 21.44 85.29 34.07 21.53 83.40 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 D 107 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 246 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 275 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 37.41 19.89 81.58 37.64 21.98 81.53 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 23.50 26.43 88.52 24.76 26.47 90.29 40.70 8.14 28.73 41.06 6.40 29.84 coo 33.16 21.44 85.29 34.07 21.53 83.40 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 D 107 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 246 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 275 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 37.41 19.89 81.58 37.64 21.98 81.53 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 23.50 26.43 88.52 24.76 26.47 90.29 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 33.16 21.44 85.29 34.07 21.53 83.40 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 D 107 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 246 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 275 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 37.41 19.89 81.58 37.64 21.98 81.53 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 23.50 26.43 88.52 24.76 26.47 90.29 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 33.16 21.44 85.29 34.07 21.53 83.40 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 D 107 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 246 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 275 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 37.41 19.89 81.58 37.64 21.98 81.53 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 23.50 26.43 88.52 24.76 26.47 90.29 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 33.16 21.44 85.29 34.07 21.53 83.40 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 D 107 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 246 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 275 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 37.41 19.89 81.58 37.64 21.98 81.53 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 23.50 26.43 88.52 24.76 26.47 90.29 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 33.16 21.44 85.29 34.07 21.53 83.40 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 D 107 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 246 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 275 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 37.41 19.89 81.58 37.64 21.98 81.53 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 23.50 26.43 88.52 24.76 26.47 90.29 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 33.16 21.44 85.29 34.07 21.53 83.40 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 D 107 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 246 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 275 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 37.41 19.89 81.58 37.64 21.98 81.53 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 23.50 26.43 88.52 24.76 26.47 90.29 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 33.16 21.44 85.29 34.07 21.53 83.40 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 11 3 # 11 D 107 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 246 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 275 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 37.41 19.89 81.58 37.64 21.98 81.53 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 23.50 26.43 88.52 24.76 26.47 90.29 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 33.16 21.44 85.29 34.07 21.53 83.40 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 12 3 # 12 D 107 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 246 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 275 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 37.41 19.89 81.58 37.64 21.98 81.53 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 23.50 26.43 88.52 24.76 26.47 90.29 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 33.16 21.44 85.29 34.07 21.53 83.40 10.51 -24.81 51.94 8.80 -23.79 52.62 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 12 hits 1ehy_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 197 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 223 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 37.80 0.44 25.56 37.02 -1.29 26.44 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 40.70 8.14 28.73 41.06 6.40 29.84 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 197 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 223 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 37.80 0.44 25.56 37.02 -1.29 26.44 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 197 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 223 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 37.80 0.44 25.56 37.02 -1.29 26.44 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS A 80 HIS.? 6.41 O2S EPE A 376 A 197 ASP A 82 ASP.? 8.88 O2S EPE A 376 A 223 LYS A 91 LYS~? 15.85 O2S EPE A 376 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 28.52 23.28 34.79 26.69 23.10 35.81 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 34.38 27.71 34.24 32.73 27.59 35.53 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 36.23 21.81 22.32 41.86 22.67 23.70 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 A 114 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 197 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 223 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 32.91 0.46 27.63 33.66 0.11 29.56 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 A 114 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 197 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 223 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 32.91 0.46 27.63 33.66 0.11 29.56 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 A 114 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 197 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 223 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 32.91 0.46 27.63 33.66 0.11 29.56 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 A 114 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 197 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 223 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 40.60 0.33 34.12 38.69 0.39 33.24 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 48.24 5.16 33.58 47.82 3.96 35.30 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 A 114 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 197 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 223 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 51.10 6.85 29.91 51.20 5.36 31.38 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 54.82 -1.21 28.36 56.43 0.27 28.67 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 A 114 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 197 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 223 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 A 114 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 197 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 223 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 A 114 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 197 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 223 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 13 3 # 13 A 114 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 197 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 223 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 14 3 # 14 A 114 HIS B 80 HIS.? 6.72 O2S EPE B 376 A 197 ASP B 82 ASP.? 10.62 O3S EPE B 376 A 223 LYS B 91 LYS~? 15.73 O3S EPE B 376 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -17.26 9.01 48.35 -15.80 8.65 49.80 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -22.38 12.66 48.09 -22.95 14.65 48.48 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -26.96 4.56 38.63 -29.49 9.20 36.26 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 15 3 # 15 A 114 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 197 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 223 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 16 3 # 16 A 114 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 197 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 223 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 17 3 # 17 A 114 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 197 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 223 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 18 3 # 18 A 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 197 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 223 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 19 3 # 19 A 114 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 197 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 223 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -20.57 16.04 20.92 -18.78 16.88 20.21 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -18.05 15.19 12.20 -19.75 16.35 12.84 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 20 3 # 20 A 114 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 197 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 223 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 21 3 # 21 A 114 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 197 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 223 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 22 3 # 22 A 114 HIS C 80 HIS.? 6.69 O2S EPE C 376 A 197 ASP C 82 ASP.? 10.22 O3S EPE C 376 A 223 LYS C 91 LYS~? 15.57 O3S EPE C 376 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 23.09 -12.52 68.61 23.48 -10.58 67.92 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 23.03 -14.86 74.18 22.44 -14.42 76.16 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 24.97 -26.94 68.30 21.78 -29.04 72.70 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 23 3 # 23 A 114 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 197 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 223 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 24 3 # 24 A 114 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 197 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 223 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 25 3 # 25 A 114 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 197 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 223 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 26 3 # 26 A 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 197 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 223 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 27 3 # 27 A 114 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 197 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 223 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 4.16 -33.39 68.22 2.28 -32.65 67.64 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 9.58 -37.42 57.24 8.41 -35.76 62.90 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 27 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 197 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 223 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 37.80 0.44 25.56 37.02 -1.29 26.44 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 40.70 8.14 28.73 41.06 6.40 29.84 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 197 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 223 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 37.80 0.44 25.56 37.02 -1.29 26.44 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 197 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 223 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 37.80 0.44 25.56 37.02 -1.29 26.44 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS A 80 HIS.? 6.41 O2S EPE A 376 B 197 ASP A 82 ASP.? 8.88 O2S EPE A 376 B 223 LYS A 91 LYS~? 15.85 O2S EPE A 376 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 28.52 23.28 34.79 26.69 23.10 35.81 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 34.38 27.71 34.24 32.73 27.59 35.53 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 36.23 21.81 22.32 41.86 22.67 23.70 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 B 114 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 197 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 223 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 32.91 0.46 27.63 33.66 0.11 29.56 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 B 114 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 197 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 223 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 32.91 0.46 27.63 33.66 0.11 29.56 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 B 114 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 197 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 223 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 32.91 0.46 27.63 33.66 0.11 29.56 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 B 114 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 197 ASP A 368 ASP.? 11.85 ZN ZN A 374 B 223 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 40.60 0.33 34.12 38.69 0.39 33.24 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 48.24 5.16 33.58 47.82 3.96 35.30 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 B 114 HIS A 366 HIS.? 14.86 ZN ZN A 374 B 197 ASP A 269 ASP.? 18.90 ZN ZN A 374 B 223 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 51.10 6.85 29.91 51.20 5.36 31.38 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 54.82 -1.21 28.36 56.43 0.27 28.67 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 B 114 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 197 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 223 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 B 114 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 197 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 223 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 B 114 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 197 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 223 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 13 3 # 13 B 114 HIS B 80 HIS.? 6.72 O2S EPE B 376 B 197 ASP B 82 ASP.? 10.62 O3S EPE B 376 B 223 LYS B 91 LYS~? 15.73 O3S EPE B 376 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -17.26 9.01 48.35 -15.80 8.65 49.80 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -22.38 12.66 48.09 -22.95 14.65 48.48 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -26.96 4.56 38.63 -29.49 9.20 36.26 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 14 3 # 14 B 114 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 197 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 223 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 15 3 # 15 B 114 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 197 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 223 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 16 3 # 16 B 114 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 197 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 223 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 17 3 # 17 B 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 197 ASP B 368 ASP.? 11.70 ZN ZN B 374 B 223 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 18 3 # 18 B 114 HIS B 366 HIS.? 14.78 ZN ZN B 374 B 197 ASP B 269 ASP.? 18.26 ZN ZN B 374 B 223 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -20.57 16.04 20.92 -18.78 16.88 20.21 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -18.05 15.19 12.20 -19.75 16.35 12.84 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 19 3 # 19 B 114 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 197 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 223 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 20 3 # 20 B 114 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 197 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 223 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 21 3 # 21 B 114 HIS C 80 HIS.? 6.69 O2S EPE C 376 B 197 ASP C 82 ASP.? 10.22 O3S EPE C 376 B 223 LYS C 91 LYS~? 15.57 O3S EPE C 376 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 23.09 -12.52 68.61 23.48 -10.58 67.92 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 23.03 -14.86 74.18 22.44 -14.42 76.16 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 24.97 -26.94 68.30 21.78 -29.04 72.70 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 22 3 # 22 B 114 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 197 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 223 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 23 3 # 23 B 114 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 197 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 223 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 24 3 # 24 B 114 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 197 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 223 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 25 3 # 25 B 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 197 ASP C 368 ASP.? 11.74 ZN ZN C 374 B 223 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 26 3 # 26 B 114 HIS C 366 HIS.? 14.85 ZN ZN C 374 B 197 ASP C 269 ASP~? 18.04 ZN ZN C 374 B 223 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 4.16 -33.39 68.22 2.28 -32.65 67.64 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 9.58 -37.42 57.24 8.41 -35.76 62.90 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 26 hits 1elq_c03 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 57 ALA~? 19.05 C2 EPE A 376 A 257 ALA A 62 ALA.? 21.75 ZN ZN A 374 A 328 ASP A 96 ASP.? 22.36 O2S EPE A 376 coo 39.84 24.12 8.44 38.50 24.23 9.11 42.98 14.90 17.25 41.58 14.60 17.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 41.03 13.97 12.85 41.56 12.98 13.85 coo 38.17 34.10 6.67 37.72 32.06 6.84 33.23 19.97 13.69 32.21 21.81 13.47 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 101 ALA^? 11.28 ZN ZN A 375 A 257 ALA A 67 ALA^? 10.32 ZN ZN A 374 A 328 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 39.84 24.12 8.44 38.50 24.23 9.11 32.09 5.17 22.05 31.25 5.48 23.29 coo 43.22 26.73 5.37 41.81 27.09 5.79 37.22 5.65 22.28 37.04 6.85 23.17 coo 38.17 34.10 6.67 37.72 32.06 6.84 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 101 ALA^? 11.28 ZN ZN A 375 A 257 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 328 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 39.84 24.12 8.44 38.50 24.23 9.11 32.09 5.17 22.05 31.25 5.48 23.29 coo 43.22 26.73 5.37 41.81 27.09 5.79 33.09 1.52 21.68 34.14 1.27 20.64 coo 38.17 34.10 6.67 37.72 32.06 6.84 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 257 ALA A 101 ALA^? 11.28 ZN ZN A 375 A 328 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 39.84 24.12 8.44 38.50 24.23 9.11 33.09 1.52 21.68 34.14 1.27 20.64 coo 43.22 26.73 5.37 41.81 27.09 5.79 32.09 5.17 22.05 31.25 5.48 23.29 coo 38.17 34.10 6.67 37.72 32.06 6.84 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 223 ALA~? 14.91 C7 EPE A 377 A 257 ALA A 219 ALA~? 15.37 O1S EPE C 377 A 328 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 39.84 24.12 8.44 38.50 24.23 9.11 17.38 -21.44 -7.38 18.48 -22.07 -6.57 coo 43.22 26.73 5.37 41.81 27.09 5.79 19.72 -17.73 -2.78 21.10 -18.09 -2.28 coo 38.17 34.10 6.67 37.72 32.06 6.84 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA A 287 ALA^? 15.21 ZN ZN A 375 A 257 ALA A 300 ALA~? 16.31 ZN ZN A 375 A 328 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 39.84 24.12 8.44 38.50 24.23 9.11 43.01 -15.52 33.51 41.87 -15.70 34.47 coo 43.22 26.73 5.37 41.81 27.09 5.79 38.46 -17.14 37.26 39.29 -15.90 37.59 coo 38.17 34.10 6.67 37.72 32.06 6.84 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA A 300 ALA~? 16.31 ZN ZN A 375 A 257 ALA A 287 ALA^? 15.21 ZN ZN A 375 A 328 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 39.84 24.12 8.44 38.50 24.23 9.11 38.46 -17.14 37.26 39.29 -15.90 37.59 coo 43.22 26.73 5.37 41.81 27.09 5.79 43.01 -15.52 33.51 41.87 -15.70 34.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA A 321 ALA~? 19.58 ZN ZN A 374 A 257 ALA A 318 ALA~? 19.12 ZN ZN A 374 A 328 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 39.84 24.12 8.44 38.50 24.23 9.11 40.35 -13.63 46.22 41.15 -12.61 45.43 coo 43.22 26.73 5.37 41.81 27.09 5.79 41.32 -8.99 47.30 42.41 -8.00 47.53 coo 38.17 34.10 6.67 37.72 32.06 6.84 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA B 35 ALA.? 22.69 C3 EPE B 376 A 257 ALA B 98 ALA^? 18.79 C3 EPE B 376 A 328 ASP B 96 ASP.? 22.64 O2S EPE B 376 coo 39.84 24.12 8.44 38.50 24.23 9.11 -23.34 -9.45 35.51 -24.16 -10.31 36.41 coo 43.22 26.73 5.37 41.81 27.09 5.79 -23.64 -3.90 33.07 -23.65 -5.30 32.62 coo 38.17 34.10 6.67 37.72 32.06 6.84 -29.98 -4.37 36.65 -30.49 -4.93 38.64 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA B 57 ALA~? 18.97 C2 EPE B 376 A 257 ALA B 62 ALA.? 21.54 ZN ZN B 374 A 328 ASP B 96 ASP.? 22.64 O2S EPE B 376 coo 39.84 24.12 8.44 38.50 24.23 9.11 -29.17 3.22 27.98 -28.03 2.53 28.68 coo 43.22 26.73 5.37 41.81 27.09 5.79 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo 38.17 34.10 6.67 37.72 32.06 6.84 -29.98 -4.37 36.65 -30.49 -4.93 38.64 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA B 101 ALA^? 11.06 ZN ZN B 375 A 257 ALA B 67 ALA^? 10.44 ZN ZN B 374 A 328 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 39.84 24.12 8.44 38.50 24.23 9.11 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 43.22 26.73 5.37 41.81 27.09 5.79 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 38.17 34.10 6.67 37.72 32.06 6.84 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA B 101 ALA^? 11.06 ZN ZN B 375 A 257 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 328 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 39.84 24.12 8.44 38.50 24.23 9.11 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 43.22 26.73 5.37 41.81 27.09 5.79 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 38.17 34.10 6.67 37.72 32.06 6.84 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 257 ALA B 101 ALA^? 11.06 ZN ZN B 375 A 328 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 39.84 24.12 8.44 38.50 24.23 9.11 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 43.22 26.73 5.37 41.81 27.09 5.79 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 38.17 34.10 6.67 37.72 32.06 6.84 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA B 223 ALA.? 17.38 O3S EPE A 377 A 257 ALA B 219 ALA~? 15.85 O3S EPE A 377 A 328 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 39.84 24.12 8.44 38.50 24.23 9.11 -9.77 -38.36 13.49 -9.66 -37.46 12.27 coo 43.22 26.73 5.37 41.81 27.09 5.79 -9.85 -32.42 14.17 -10.02 -31.40 13.03 coo 38.17 34.10 6.67 37.72 32.06 6.84 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA B 287 ALA^? 15.22 ZN ZN B 375 A 257 ALA B 300 ALA~? 16.49 ZN ZN B 375 A 328 ASP B 306 ASP.? 24.86 ZN ZN B 375 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.09 8.91 10.38 1.12 8.85 11.22 coo 43.22 26.73 5.37 41.81 27.09 5.79 5.39 8.45 13.10 4.54 9.60 13.56 coo 38.17 34.10 6.67 37.72 32.06 6.84 3.99 14.73 5.36 5.18 14.04 3.76 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA B 300 ALA~? 16.49 ZN ZN B 375 A 257 ALA B 287 ALA^? 15.22 ZN ZN B 375 A 328 ASP B 306 ASP.? 24.86 ZN ZN B 375 coo 39.84 24.12 8.44 38.50 24.23 9.11 5.39 8.45 13.10 4.54 9.60 13.56 coo 43.22 26.73 5.37 41.81 27.09 5.79 -0.09 8.91 10.38 1.12 8.85 11.22 coo 38.17 34.10 6.67 37.72 32.06 6.84 3.99 14.73 5.36 5.18 14.04 3.76 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA B 321 ALA~? 19.77 ZN ZN B 374 A 257 ALA B 318 ALA~? 19.05 ZN ZN B 374 A 328 ASP B 330 ASP^? 11.92 ZN ZN B 374 coo 39.84 24.12 8.44 38.50 24.23 9.11 7.50 17.37 16.99 6.00 17.39 16.91 coo 43.22 26.73 5.37 41.81 27.09 5.79 4.54 19.55 20.17 3.54 20.61 20.36 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.33 18.16 18.13 -5.04 17.21 19.90 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 18 3 # 18 A 229 ALA C 35 ALA.? 22.80 C3 EPE C 376 A 257 ALA C 98 ALA^? 19.12 C3 EPE C 376 A 328 ASP C 96 ASP.? 22.89 O3S EPE C 376 coo 39.84 24.12 8.44 38.50 24.23 9.11 29.99 -29.58 54.51 31.46 -29.62 54.71 coo 43.22 26.73 5.37 41.81 27.09 5.79 25.29 -30.67 58.07 25.77 -31.44 56.87 coo 38.17 34.10 6.67 37.72 32.06 6.84 31.06 -32.15 62.51 32.92 -31.34 63.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 19 3 # 19 A 229 ALA C 57 ALA~? 19.02 C3 EPE C 376 A 257 ALA C 62 ALA.? 21.65 ZN ZN C 375 A 328 ASP C 96 ASP.? 22.89 O3S EPE C 376 coo 39.84 24.12 8.44 38.50 24.23 9.11 20.74 -36.43 65.42 20.93 -35.24 64.51 coo 43.22 26.73 5.37 41.81 27.09 5.79 23.65 -38.52 62.14 22.14 -38.28 62.04 coo 38.17 34.10 6.67 37.72 32.06 6.84 31.06 -32.15 62.51 32.92 -31.34 63.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 20 3 # 20 A 229 ALA C 101 ALA^? 11.01 ZN ZN C 375 A 257 ALA C 67 ALA^? 10.56 ZN ZN C 374 A 328 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 39.84 24.12 8.44 38.50 24.23 9.11 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 43.22 26.73 5.37 41.81 27.09 5.79 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 38.17 34.10 6.67 37.72 32.06 6.84 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 21 3 # 21 A 229 ALA C 101 ALA^? 11.01 ZN ZN C 375 A 257 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 328 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 39.84 24.12 8.44 38.50 24.23 9.11 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 43.22 26.73 5.37 41.81 27.09 5.79 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 38.17 34.10 6.67 37.72 32.06 6.84 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 22 3 # 22 A 229 ALA C 101 ALA^? 11.01 ZN ZN C 375 A 257 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 328 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 39.84 24.12 8.44 38.50 24.23 9.11 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 43.22 26.73 5.37 41.81 27.09 5.79 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 38.17 34.10 6.67 37.72 32.06 6.84 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 23 3 # 23 A 229 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 257 ALA C 101 ALA^? 11.01 ZN ZN C 375 A 328 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 39.84 24.12 8.44 38.50 24.23 9.11 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 43.22 26.73 5.37 41.81 27.09 5.79 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 38.17 34.10 6.67 37.72 32.06 6.84 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 24 3 # 24 A 229 ALA C 219 ALA~? 14.00 C1 TRS A 378 A 257 ALA C 223 ALA~? 15.75 C3 EPE C 377 A 328 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 39.84 24.12 8.44 38.50 24.23 9.11 24.80 -41.31 25.72 23.52 -41.79 26.39 coo 43.22 26.73 5.37 41.81 27.09 5.79 26.89 -44.82 20.98 25.41 -45.05 21.20 coo 38.17 34.10 6.67 37.72 32.06 6.84 19.06 -47.14 27.83 18.62 -49.09 27.08 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 25 3 # 25 A 229 ALA C 223 ALA~? 15.75 C3 EPE C 377 A 257 ALA C 219 ALA~? 14.00 C1 TRS A 378 A 328 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 39.84 24.12 8.44 38.50 24.23 9.11 26.89 -44.82 20.98 25.41 -45.05 21.20 coo 43.22 26.73 5.37 41.81 27.09 5.79 24.80 -41.31 25.72 23.52 -41.79 26.39 coo 38.17 34.10 6.67 37.72 32.06 6.84 19.06 -47.14 27.83 18.62 -49.09 27.08 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 26 3 # 26 A 229 ALA C 287 ALA^? 15.31 ZN ZN C 375 A 257 ALA C 300 ALA~? 16.47 ZN ZN C 375 A 328 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo 39.84 24.12 8.44 38.50 24.23 9.11 -8.21 -29.95 47.66 -8.39 -28.51 47.16 coo 43.22 26.73 5.37 41.81 27.09 5.79 -9.24 -24.63 44.86 -9.08 -24.63 46.37 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.81 -30.01 48.18 -17.96 -30.59 46.51 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 27 3 # 27 A 229 ALA C 300 ALA~? 16.47 ZN ZN C 375 A 257 ALA C 287 ALA^? 15.31 ZN ZN C 375 A 328 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo 39.84 24.12 8.44 38.50 24.23 9.11 -9.24 -24.63 44.86 -9.08 -24.63 46.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.21 -29.95 47.66 -8.39 -28.51 47.16 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.81 -30.01 48.18 -17.96 -30.59 46.51 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 28 3 # 28 A 229 ALA C 321 ALA~? 19.69 ZN ZN C 374 A 257 ALA C 318 ALA~? 18.85 ZN ZN C 374 A 328 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 39.84 24.12 8.44 38.50 24.23 9.11 -13.40 -18.49 51.25 -12.60 -19.47 52.03 coo 43.22 26.73 5.37 41.81 27.09 5.79 -11.35 -17.41 55.53 -11.30 -17.89 56.96 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.16 -24.94 59.28 -5.20 -24.20 59.64 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 28 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 193 GLU A 52 GLU~? 13.77 C2 EPE A 376 A 217 VAL A 54 VAL~? 14.82 C2 EPE A 376 coo 2.10 10.68 61.44 -2.14 13.16 60.61 36.23 21.81 22.32 41.86 22.67 23.70 coo -5.33 11.71 69.72 -4.62 11.92 67.73 46.63 16.37 27.65 45.50 16.12 29.45 coo 0.07 12.29 66.53 -0.24 11.95 64.38 41.18 16.00 21.86 39.21 16.72 22.41 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS A 138 LYS^? 13.11 N TRS A 378 A 193 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 217 VAL A 140 VAL^? 8.90 O1S EPE C 377 coo 2.10 10.68 61.44 -2.14 13.16 60.61 18.11 -21.79 12.78 16.12 -17.81 15.44 coo -5.33 11.71 69.72 -4.62 11.92 67.73 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 0.07 12.29 66.53 -0.24 11.95 64.38 15.83 -24.08 7.28 16.34 -22.37 5.99 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 193 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 217 VAL A 338 VAL~? 10.31 ZN ZN A 375 coo 2.10 10.68 61.44 -2.14 13.16 60.61 44.47 1.55 20.70 47.30 5.10 24.27 coo -5.33 11.71 69.72 -4.62 11.92 67.73 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 0.07 12.29 66.53 -0.24 11.95 64.38 46.51 -2.21 23.86 46.85 -4.02 25.09 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS A 354 LYS~? 27.90 ZN ZN A 375 A 193 GLU A 349 GLU~? 21.94 ZN ZN A 375 A 217 VAL A 351 VAL~? 23.51 ZN ZN A 375 coo 2.10 10.68 61.44 -2.14 13.16 60.61 37.47 -0.90 0.73 32.51 -2.58 1.13 coo -5.33 11.71 69.72 -4.62 11.92 67.73 44.64 -4.62 8.34 45.23 -6.64 8.63 coo 0.07 12.29 66.53 -0.24 11.95 64.38 39.36 0.74 5.25 40.03 2.74 5.98 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 159 LYS A 355 LYS.? 33.47 ZN ZN A 375 A 193 GLU A 349 GLU~? 21.94 ZN ZN A 375 A 217 VAL A 351 VAL~? 23.51 ZN ZN A 375 coo 2.10 10.68 61.44 -2.14 13.16 60.61 39.94 1.41 -1.05 41.91 -2.04 -4.52 coo -5.33 11.71 69.72 -4.62 11.92 67.73 44.64 -4.62 8.34 45.23 -6.64 8.63 coo 0.07 12.29 66.53 -0.24 11.95 64.38 39.36 0.74 5.25 40.03 2.74 5.98 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 159 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 193 GLU B 52 GLU~? 15.59 C2 EPE B 376 A 217 VAL B 54 VAL~? 14.54 C2 EPE B 376 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -26.96 4.56 38.63 -29.49 9.20 36.26 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -26.20 13.19 30.44 -25.34 14.95 29.81 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -26.33 5.79 31.41 -25.28 5.09 33.22 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 159 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 193 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 217 VAL B 140 VAL^? 9.56 O2S EPE A 377 coo 2.10 10.68 61.44 -2.14 13.16 60.61 3.52 -23.27 14.19 3.97 -21.31 18.72 coo -5.33 11.71 69.72 -4.62 11.92 67.73 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 0.07 12.29 66.53 -0.24 11.95 64.38 2.40 -29.34 13.57 0.33 -29.29 14.30 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 159 LYS B 218 LYS~? 23.26 O3S EPE A 377 A 193 GLU B 227 GLU.? 24.58 O3S EPE A 377 A 217 VAL B 221 VAL~? 18.74 O3S EPE A 377 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -6.89 -36.18 17.46 -6.27 -35.67 19.54 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 159 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 193 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 217 VAL B 338 VAL~? 10.27 ZN ZN B 375 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -16.08 6.76 15.22 -14.33 7.50 14.21 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 159 LYS B 354 LYS~? 28.15 ZN ZN B 375 A 193 GLU B 349 GLU~? 21.77 ZN ZN B 375 A 217 VAL B 351 VAL~? 23.12 ZN ZN B 375 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -25.73 -10.98 16.11 -26.06 -9.19 17.33 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 159 LYS B 355 LYS.? 33.64 ZN ZN B 375 A 193 GLU B 349 GLU~? 21.77 ZN ZN B 375 A 217 VAL B 351 VAL~? 23.12 ZN ZN B 375 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -25.73 -10.98 16.11 -26.06 -9.19 17.33 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 12 3 # 12 A 159 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 193 GLU C 52 GLU~? 13.90 C2 EPE C 376 A 217 VAL C 54 VAL~? 14.84 C2 EPE C 376 coo 2.10 10.68 61.44 -2.14 13.16 60.61 24.97 -26.94 68.30 21.78 -29.04 72.70 coo -5.33 11.71 69.72 -4.62 11.92 67.73 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 0.07 12.29 66.53 -0.24 11.95 64.38 19.56 -31.70 66.67 20.73 -29.90 66.07 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 13 3 # 13 A 159 LYS C 138 LYS^? 8.30 N TRS A 378 A 193 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 217 VAL C 140 VAL^? 8.97 N TRS A 378 coo 2.10 10.68 61.44 -2.14 13.16 60.61 12.95 -30.51 23.19 15.44 -26.53 25.46 coo -5.33 11.71 69.72 -4.62 11.92 67.73 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 0.07 12.29 66.53 -0.24 11.95 64.38 16.48 -34.14 19.50 17.98 -34.81 20.89 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 14 3 # 14 A 159 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 193 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 217 VAL C 338 VAL~? 10.33 ZN ZN C 375 coo 2.10 10.68 61.44 -2.14 13.16 60.61 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -5.33 11.71 69.72 -4.62 11.92 67.73 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 0.07 12.29 66.53 -0.24 11.95 64.38 4.12 -36.97 56.83 2.21 -36.49 55.96 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 15 3 # 15 A 159 LYS C 354 LYS~? 23.72 O1 TRS A 378 A 193 GLU C 349 GLU~? 21.43 ZN ZN C 375 A 217 VAL C 351 VAL~? 23.21 ZN ZN C 375 coo 2.10 10.68 61.44 -2.14 13.16 60.61 23.17 -48.48 45.31 22.31 -43.90 41.08 coo -5.33 11.71 69.72 -4.62 11.92 67.73 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 0.07 12.29 66.53 -0.24 11.95 64.38 20.68 -45.91 49.04 20.48 -44.73 50.95 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 16 3 # 16 A 159 LYS C 355 LYS.? 32.67 ZN ZN C 375 A 193 GLU C 349 GLU~? 21.43 ZN ZN C 375 A 217 VAL C 351 VAL~? 23.21 ZN ZN C 375 coo 2.10 10.68 61.44 -2.14 13.16 60.61 24.80 -50.74 47.95 22.71 -54.81 46.20 coo -5.33 11.71 69.72 -4.62 11.92 67.73 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 0.07 12.29 66.53 -0.24 11.95 64.38 20.68 -45.91 49.04 20.48 -44.73 50.95 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 16 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 81 THR.? 10.12 O2S EPE A 376 A 159 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 193 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo -2.58 16.31 54.79 -4.02 14.93 55.64 32.45 25.22 30.56 31.45 26.31 28.96 coo 2.10 10.68 61.44 -2.14 13.16 60.61 36.23 21.81 22.32 41.86 22.67 23.70 coo -5.33 11.71 69.72 -4.62 11.92 67.73 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 126 THR^? 16.96 ZN ZN A 375 A 159 LYS A 285 LYS^? 20.00 O3 TRS A 378 A 193 GLU A 253 GLU^? 31.48 ZN ZN A 375 coo -2.58 16.31 54.79 -4.02 14.93 55.64 42.90 -19.47 25.31 43.76 -17.58 24.63 coo 2.10 10.68 61.44 -2.14 13.16 60.61 47.09 -21.09 34.01 41.69 -24.22 32.75 coo -5.33 11.71 69.72 -4.62 11.92 67.73 58.61 -23.45 31.31 60.40 -23.73 30.22 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 310 THR^? 10.34 ZN ZN A 374 A 159 LYS A 247 LYS^? 14.25 ZN ZN A 375 A 193 GLU A 119 GLU~? 15.23 ZN ZN A 375 coo -2.58 16.31 54.79 -4.02 14.93 55.64 42.72 -7.43 36.10 40.77 -7.66 37.11 coo 2.10 10.68 61.44 -2.14 13.16 60.61 40.34 -15.07 28.39 38.70 -15.53 23.22 coo -5.33 11.71 69.72 -4.62 11.92 67.73 47.50 -11.03 21.23 45.94 -11.22 19.71 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 81 THR.? 10.70 O2S EPE B 376 A 159 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 193 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -22.85 8.49 45.84 -23.89 7.07 47.06 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -26.96 4.56 38.63 -29.49 9.20 36.26 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR B 126 THR^? 16.92 ZN ZN B 375 A 159 LYS B 285 LYS^? 22.19 ZN ZN B 375 A 193 GLU B 253 GLU^? 31.12 ZN ZN B 375 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -2.13 1.87 5.25 -4.16 2.03 5.84 coo 2.10 10.68 61.44 -2.14 13.16 60.61 1.97 10.60 4.02 5.48 5.38 4.89 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -5.44 14.03 -5.56 -4.22 13.73 -7.31 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR B 206 THR^? 5.63 O3S EPE A 377 A 159 LYS B 154 LYS~? 18.23 O3S EPE A 377 A 193 GLU A 197 GLU^? 9.85 O8 EPE A 377 coo -2.58 16.31 54.79 -4.02 14.93 55.64 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -7.89 -34.48 4.91 -13.85 -35.95 3.01 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -4.05 -31.37 -7.20 -4.83 -32.55 -8.76 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR B 242 THR^? 18.76 ZN ZN B 375 A 159 LYS B 110 LYS.? 16.94 ZN ZN B 375 A 193 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo -2.58 16.31 54.79 -4.02 14.93 55.64 1.06 -7.67 12.24 3.05 -6.84 12.40 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 38 THR B 242 THR^? 18.76 ZN ZN B 375 A 159 LYS B 247 LYS^? 11.69 ZN ZN B 375 A 193 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo -2.58 16.31 54.79 -4.02 14.93 55.64 1.06 -7.67 12.24 3.05 -6.84 12.40 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 38 THR B 310 THR^? 10.23 ZN ZN B 374 A 159 LYS B 247 LYS^? 11.69 ZN ZN B 375 A 193 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -3.69 12.44 17.22 -2.10 11.84 18.57 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 38 THR C 81 THR.? 10.35 O3S EPE C 376 A 159 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 193 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo -2.58 16.31 54.79 -4.02 14.93 55.64 24.63 -17.88 70.86 26.72 -18.03 70.54 coo 2.10 10.68 61.44 -2.14 13.16 60.61 24.97 -26.94 68.30 21.78 -29.04 72.70 coo -5.33 11.71 69.72 -4.62 11.92 67.73 13.88 -30.69 72.19 13.68 -28.54 72.17 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 38 THR C 104 THR~? 6.99 ZN ZN C 375 A 159 LYS C 20 LYS~? 17.53 ZN ZN C 375 A 193 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo -2.58 16.31 54.79 -4.02 14.93 55.64 9.25 -26.14 47.92 9.13 -24.05 47.44 coo 2.10 10.68 61.44 -2.14 13.16 60.61 16.25 -27.94 42.71 21.97 -27.95 45.58 coo -5.33 11.71 69.72 -4.62 11.92 67.73 11.24 -30.50 31.64 12.59 -30.76 33.22 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 12 3 # 12 A 38 THR C 126 THR^? 16.85 ZN ZN C 375 A 159 LYS C 285 LYS^? 22.29 ZN ZN C 375 A 193 GLU C 253 GLU^? 31.42 ZN ZN C 375 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -5.70 -36.58 41.92 -4.55 -37.27 43.63 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -14.01 -33.36 45.98 -12.46 -31.50 40.58 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -18.88 -44.02 49.77 -19.94 -45.34 51.07 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 13 3 # 13 A 38 THR C 171 THR^? 17.48 C2 EPE C 377 A 159 LYS C 139 LYS^? 16.11 N TRS A 378 A 193 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo -2.58 16.31 54.79 -4.02 14.93 55.64 11.53 -42.54 18.55 13.17 -44.02 18.73 coo 2.10 10.68 61.44 -2.14 13.16 60.61 13.08 -32.56 20.05 9.65 -36.55 18.68 coo -5.33 11.71 69.72 -4.62 11.92 67.73 11.24 -30.50 31.64 12.59 -30.76 33.22 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 14 3 # 14 A 38 THR C 310 THR^? 10.44 ZN ZN C 374 A 159 LYS C 247 LYS^? 13.94 ZN ZN C 375 A 193 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -4.52 -26.41 54.31 -4.36 -24.52 53.23 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -0.72 -41.44 48.78 1.35 -42.03 49.11 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 14 hits 1et0_c02 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 262 GLU~? 24.15 ZN ZN A 374 A 260 ARG A 274 ARG^? 15.42 ZN ZN A 374 A 270 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 50.99 29.43 12.86 52.11 29.45 14.65 59.50 -9.24 37.85 59.47 -7.16 38.33 coo 39.80 27.50 22.98 42.20 26.56 21.34 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 48.83 21.70 19.50 47.44 24.99 15.25 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU B 9 GLU~? 28.41 ZN ZN B 375 A 260 ARG B 41 ARG.? 32.79 ZN ZN B 375 A 270 LYS B 3 LYS.? 34.82 ZN ZN B 375 coo 50.99 29.43 12.86 52.11 29.45 14.65 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 39.80 27.50 22.98 42.20 26.56 21.34 -35.98 -7.63 26.12 -37.66 -10.05 26.93 coo 48.83 21.70 19.50 47.44 24.99 15.25 -34.16 -15.88 20.56 -37.36 -15.32 22.01 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU B 9 GLU~? 28.41 ZN ZN B 375 A 260 ARG B 41 ARG.? 32.79 ZN ZN B 375 A 270 LYS B 38 LYS.? 21.80 C3 EPE B 376 coo 50.99 29.43 12.86 52.11 29.45 14.65 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 39.80 27.50 22.98 42.20 26.56 21.34 -35.98 -7.63 26.12 -37.66 -10.05 26.93 coo 48.83 21.70 19.50 47.44 24.99 15.25 -28.97 -12.32 32.11 -27.27 -6.31 33.15 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU B 262 GLU~? 24.13 ZN ZN B 374 A 260 ARG B 274 ARG^? 15.33 ZN ZN B 374 A 270 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 50.99 29.43 12.86 52.11 29.45 14.65 -9.48 23.81 6.41 -10.83 24.55 7.88 coo 39.80 27.50 22.98 42.20 26.56 21.34 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 48.83 21.70 19.50 47.44 24.99 15.25 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU C 9 GLU~? 28.11 O1 TRS A 378 A 260 ARG C 41 ARG.? 33.06 ZN ZN C 375 A 270 LYS C 3 LYS.? 28.91 O1 TRS A 378 coo 50.99 29.43 12.86 52.11 29.45 14.65 28.74 -39.91 47.06 29.82 -41.70 47.37 coo 39.80 27.50 22.98 42.20 26.56 21.34 29.45 -44.46 60.95 32.22 -45.79 60.75 coo 48.83 21.70 19.50 47.44 24.99 15.25 30.63 -48.52 50.80 31.26 -43.98 46.49 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU C 9 GLU~? 28.11 O1 TRS A 378 A 260 ARG C 41 ARG.? 33.06 ZN ZN C 375 A 270 LYS C 38 LYS.? 22.67 C3 EPE C 376 coo 50.99 29.43 12.86 52.11 29.45 14.65 28.74 -39.91 47.06 29.82 -41.70 47.37 coo 39.80 27.50 22.98 42.20 26.56 21.34 29.45 -44.46 60.95 32.22 -45.79 60.75 coo 48.83 21.70 19.50 47.44 24.99 15.25 32.75 -36.42 54.75 28.25 -34.16 56.85 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU C 262 GLU~? 24.05 ZN ZN C 374 A 260 ARG C 274 ARG^? 15.09 ZN ZN C 374 A 270 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 50.99 29.43 12.86 52.11 29.45 14.65 -15.17 -35.96 63.25 -14.01 -35.31 64.90 coo 39.80 27.50 22.98 42.20 26.56 21.34 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 48.83 21.70 19.50 47.44 24.99 15.25 -6.09 -33.65 68.04 -3.07 -37.10 68.37 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 7 hits 1euy_c00 naa= 3 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 1 3 # 1 A 233 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 254 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 301 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 32.91 0.46 27.63 33.66 0.11 29.56 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 2 3 # 2 A 233 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 254 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 301 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 3 3 # 3 A 233 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 254 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 301 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 12.27 -21.58 47.53 11.82 -22.95 49.16 1ez2_c00 source 1ez2 PHOSPHOTRIESTERASE : 3 hits 1ez2_c00 naa= 3 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 1 3 # 1 B 233 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 254 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 301 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 32.91 0.46 27.63 33.66 0.11 29.56 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 2 3 # 2 B 233 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 254 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 301 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 3 3 # 3 B 233 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 254 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 301 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 12.27 -21.58 47.53 11.82 -22.95 49.16 1ez2_c01 source 1ez2 PHOSPHOTRIESTERASE : 3 hits 1ez2_c01 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 55 ASP~? 17.36 O2S EPE A 376 C 117 GLU A 56 GLU~? 18.18 ZN ZN A 374 C 131 GLU A 51 GLU~? 11.89 O2S EPE A 376 coo 68.01 56.37 72.57 68.42 56.10 70.51 45.10 18.98 22.18 44.20 20.57 23.21 coo 66.59 62.50 67.44 67.57 60.64 67.12 47.24 13.21 19.42 47.19 11.28 20.29 coo 69.24 52.27 71.96 69.91 50.26 71.89 41.17 19.74 26.83 40.87 21.56 28.00 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 3 # 2 C 95 ASP B 55 ASP~? 16.89 O3S EPE B 376 C 117 GLU B 56 GLU~? 18.10 ZN ZN B 374 C 131 GLU B 51 GLU~? 11.61 O3S EPE B 376 coo 68.01 56.37 72.57 68.42 56.10 70.51 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 66.59 62.50 67.44 67.57 60.64 67.12 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 69.24 52.27 71.96 69.91 50.26 71.89 -25.55 10.19 35.45 -25.80 11.09 37.35 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 3 3 # 3 C 95 ASP C 55 ASP~? 17.38 O3S EPE C 376 C 117 GLU C 56 GLU~? 18.45 ZN ZN C 374 C 131 GLU C 51 GLU~? 12.03 O3S EPE C 376 coo 68.01 56.37 72.57 68.42 56.10 70.51 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 66.59 62.50 67.44 67.57 60.64 67.12 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 69.24 52.27 71.96 69.91 50.26 71.89 19.07 -27.28 70.66 19.78 -25.91 72.07 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 3 hits 1f6d_c02 naa= 3 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 1 3 # 1 A 156 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 159 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 162 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 45.66 0.76 26.15 51.53 0.58 28.90 coo 29.80 39.37 7.24 28.18 38.06 7.48 37.80 0.44 25.56 37.02 -1.29 26.44 coo 30.26 35.04 5.34 28.61 35.92 4.39 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 2 3 # 2 A 156 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 159 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 162 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 45.66 0.76 26.15 51.53 0.58 28.90 coo 29.80 39.37 7.24 28.18 38.06 7.48 37.42 3.90 29.26 38.47 2.36 30.22 coo 30.26 35.04 5.34 28.61 35.92 4.39 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 3 3 # 3 A 156 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 159 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 162 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 29.80 39.37 7.24 28.18 38.06 7.48 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 30.26 35.04 5.34 28.61 35.92 4.39 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 4 3 # 4 A 156 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 159 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 162 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 29.80 39.37 7.24 28.18 38.06 7.48 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 30.26 35.04 5.34 28.61 35.92 4.39 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 5 3 # 5 A 156 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 159 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 162 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 29.80 39.37 7.24 28.18 38.06 7.48 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 30.26 35.04 5.34 28.61 35.92 4.39 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 6 3 # 6 A 156 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 159 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 162 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 29.80 39.37 7.24 28.18 38.06 7.48 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 30.26 35.04 5.34 28.61 35.92 4.39 9.33 -29.64 54.17 7.95 -29.11 52.67 1f7u_c00 source 1f7u ARGINYL-TRNA SYNTHETASE : 6 hits 1f7u_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 62 LYS A 20 LYS~? 16.95 ZN ZN A 375 F 35 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 37.80 0.44 25.56 37.02 -1.29 26.44 coo 19.95 18.98 4.81 18.82 20.94 10.49 26.66 -3.22 19.04 24.73 2.41 18.30 coo 16.32 15.30 17.19 17.71 14.73 18.69 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 62 LYS A 28 LYS.? 12.48 C7 EPE A 376 F 35 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 15.40 22.79 16.66 13.93 24.10 15.98 37.80 0.44 25.56 37.02 -1.29 26.44 coo 19.95 18.98 4.81 18.82 20.94 10.49 26.87 3.56 26.76 22.81 3.70 30.35 coo 16.32 15.30 17.19 17.71 14.73 18.69 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 62 LYS A 28 LYS.? 12.48 C7 EPE A 376 F 35 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 37.80 0.44 25.56 37.02 -1.29 26.44 coo 19.95 18.98 4.81 18.82 20.94 10.49 26.87 3.56 26.76 22.81 3.70 30.35 coo 16.32 15.30 17.19 17.71 14.73 18.69 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS A 80 HIS.? 6.41 O2S EPE A 376 C 62 LYS A 91 LYS~? 15.85 O2S EPE A 376 F 35 ASP A 82 ASP.? 8.88 O2S EPE A 376 coo 15.40 22.79 16.66 13.93 24.10 15.98 28.52 23.28 34.79 26.69 23.10 35.81 coo 19.95 18.98 4.81 18.82 20.94 10.49 36.23 21.81 22.32 41.86 22.67 23.70 coo 16.32 15.30 17.19 17.71 14.73 18.69 34.38 27.71 34.24 32.73 27.59 35.53 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 5 3 # 5 A 105 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 62 LYS A 337 LYS~? 14.02 ZN ZN A 374 F 35 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.95 18.98 4.81 18.82 20.94 10.49 45.66 0.76 26.15 51.53 0.58 28.90 coo 16.32 15.30 17.19 17.71 14.73 18.69 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 6 3 # 6 A 105 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 62 LYS A 340 LYS~? 12.75 ZN ZN A 374 F 35 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.95 18.98 4.81 18.82 20.94 10.49 44.47 1.55 20.70 47.30 5.10 24.27 coo 16.32 15.30 17.19 17.71 14.73 18.69 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 7 3 # 7 A 105 HIS A 333 HIS~? -3.55 ZN ZN A 374s C 62 LYS A 340 LYS~? 12.75 ZN ZN A 374 F 35 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 15.40 22.79 16.66 13.93 24.10 15.98 40.60 0.33 34.12 38.69 0.39 33.24 coo 19.95 18.98 4.81 18.82 20.94 10.49 44.47 1.55 20.70 47.30 5.10 24.27 coo 16.32 15.30 17.19 17.71 14.73 18.69 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 8 3 # 8 A 105 HIS A 366 HIS.? 14.86 ZN ZN A 374 C 62 LYS A 340 LYS~? 12.75 ZN ZN A 374 F 35 ASP A 269 ASP.? 18.90 ZN ZN A 374 coo 15.40 22.79 16.66 13.93 24.10 15.98 51.10 6.85 29.91 51.20 5.36 31.38 coo 19.95 18.98 4.81 18.82 20.94 10.49 44.47 1.55 20.70 47.30 5.10 24.27 coo 16.32 15.30 17.19 17.71 14.73 18.69 54.82 -1.21 28.36 56.43 0.27 28.67 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 9 3 # 9 A 105 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 62 LYS B 20 LYS~? 17.56 ZN ZN B 375 F 35 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 19.95 18.98 4.81 18.82 20.94 10.49 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 16.32 15.30 17.19 17.71 14.73 18.69 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 10 3 # 10 A 105 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 62 LYS B 28 LYS.? 11.75 C7 EPE B 376 F 35 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 15.40 22.79 16.66 13.93 24.10 15.98 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 19.95 18.98 4.81 18.82 20.94 10.49 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 16.32 15.30 17.19 17.71 14.73 18.69 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 11 3 # 11 A 105 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 62 LYS B 28 LYS.? 11.75 C7 EPE B 376 F 35 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 19.95 18.98 4.81 18.82 20.94 10.49 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 16.32 15.30 17.19 17.71 14.73 18.69 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 12 3 # 12 A 105 HIS B 80 HIS.? 6.72 O2S EPE B 376 C 62 LYS B 91 LYS~? 15.73 O3S EPE B 376 F 35 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 15.40 22.79 16.66 13.93 24.10 15.98 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 19.95 18.98 4.81 18.82 20.94 10.49 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 16.32 15.30 17.19 17.71 14.73 18.69 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 13 3 # 13 A 105 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 62 LYS B 337 LYS~? 13.35 ZN ZN B 374 F 35 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.95 18.98 4.81 18.82 20.94 10.49 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 16.32 15.30 17.19 17.71 14.73 18.69 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 14 3 # 14 A 105 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 62 LYS B 340 LYS~? 12.84 ZN ZN B 374 F 35 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.95 18.98 4.81 18.82 20.94 10.49 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 16.32 15.30 17.19 17.71 14.73 18.69 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 15 3 # 15 A 105 HIS B 333 HIS~? -3.37 ZN ZN B 374s C 62 LYS B 340 LYS~? 12.84 ZN ZN B 374 F 35 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 15.40 22.79 16.66 13.93 24.10 15.98 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 19.95 18.98 4.81 18.82 20.94 10.49 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 16.32 15.30 17.19 17.71 14.73 18.69 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 16 3 # 16 A 105 HIS B 366 HIS.? 14.78 ZN ZN B 374 C 62 LYS B 340 LYS~? 12.84 ZN ZN B 374 F 35 ASP B 269 ASP.? 18.26 ZN ZN B 374 coo 15.40 22.79 16.66 13.93 24.10 15.98 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 19.95 18.98 4.81 18.82 20.94 10.49 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 16.32 15.30 17.19 17.71 14.73 18.69 -18.05 15.19 12.20 -19.75 16.35 12.84 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 17 3 # 17 A 105 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 62 LYS C 20 LYS~? 17.53 ZN ZN C 375 F 35 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 19.95 18.98 4.81 18.82 20.94 10.49 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 16.32 15.30 17.19 17.71 14.73 18.69 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 18 3 # 18 A 105 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 62 LYS C 28 LYS.? 13.32 C7 EPE C 376 F 35 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 15.40 22.79 16.66 13.93 24.10 15.98 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 19.95 18.98 4.81 18.82 20.94 10.49 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 16.32 15.30 17.19 17.71 14.73 18.69 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 19 3 # 19 A 105 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 62 LYS C 28 LYS.? 13.32 C7 EPE C 376 F 35 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 19.95 18.98 4.81 18.82 20.94 10.49 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 16.32 15.30 17.19 17.71 14.73 18.69 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 20 3 # 20 A 105 HIS C 80 HIS.? 6.69 O2S EPE C 376 C 62 LYS C 91 LYS~? 15.57 O3S EPE C 376 F 35 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 15.40 22.79 16.66 13.93 24.10 15.98 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 19.95 18.98 4.81 18.82 20.94 10.49 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 16.32 15.30 17.19 17.71 14.73 18.69 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 21 3 # 21 A 105 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 62 LYS C 20 LYS~? 17.53 ZN ZN C 375 F 35 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.95 18.98 4.81 18.82 20.94 10.49 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 16.32 15.30 17.19 17.71 14.73 18.69 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 22 3 # 22 A 105 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 62 LYS C 337 LYS~? 12.69 ZN ZN C 374 F 35 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.95 18.98 4.81 18.82 20.94 10.49 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 16.32 15.30 17.19 17.71 14.73 18.69 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 23 3 # 23 A 105 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 62 LYS C 340 LYS~? 12.92 ZN ZN C 374 F 35 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 15.40 22.79 16.66 13.93 24.10 15.98 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.95 18.98 4.81 18.82 20.94 10.49 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 16.32 15.30 17.19 17.71 14.73 18.69 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 24 3 # 24 A 105 HIS C 333 HIS~? -3.37 ZN ZN C 374s C 62 LYS C 340 LYS~? 12.92 ZN ZN C 374 F 35 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 15.40 22.79 16.66 13.93 24.10 15.98 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 19.95 18.98 4.81 18.82 20.94 10.49 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 16.32 15.30 17.19 17.71 14.73 18.69 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 25 3 # 25 A 105 HIS C 366 HIS.? 14.85 ZN ZN C 374 C 62 LYS C 340 LYS~? 12.92 ZN ZN C 374 F 35 ASP C 269 ASP~? 18.04 ZN ZN C 374 coo 15.40 22.79 16.66 13.93 24.10 15.98 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 19.95 18.98 4.81 18.82 20.94 10.49 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 16.32 15.30 17.19 17.71 14.73 18.69 -1.79 -38.40 63.28 -1.15 -38.99 65.26 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 25 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 28 LYS.? 12.48 C7 EPE A 376 C 105 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 35 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 38.76 28.25 7.87 36.33 26.41 13.58 26.87 3.56 26.76 22.81 3.70 30.35 coo 34.93 19.72 17.37 34.72 18.17 15.98 37.80 0.44 25.56 37.02 -1.29 26.44 coo 41.01 23.02 20.83 40.65 24.26 22.55 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS A 28 LYS.? 12.48 C7 EPE A 376 C 105 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 35 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 38.76 28.25 7.87 36.33 26.41 13.58 26.87 3.56 26.76 22.81 3.70 30.35 coo 34.93 19.72 17.37 34.72 18.17 15.98 37.80 0.44 25.56 37.02 -1.29 26.44 coo 41.01 23.02 20.83 40.65 24.26 22.55 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS A 91 LYS~? 15.85 O2S EPE A 376 C 105 HIS A 80 HIS.? 6.41 O2S EPE A 376 D 35 ASP A 82 ASP.? 8.88 O2S EPE A 376 coo 38.76 28.25 7.87 36.33 26.41 13.58 36.23 21.81 22.32 41.86 22.67 23.70 coo 34.93 19.72 17.37 34.72 18.17 15.98 28.52 23.28 34.79 26.69 23.10 35.81 coo 41.01 23.02 20.83 40.65 24.26 22.55 34.38 27.71 34.24 32.73 27.59 35.53 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS A 337 LYS~? 14.02 ZN ZN A 374 C 105 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 35 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 38.76 28.25 7.87 36.33 26.41 13.58 45.66 0.76 26.15 51.53 0.58 28.90 coo 34.93 19.72 17.37 34.72 18.17 15.98 32.91 0.46 27.63 33.66 0.11 29.56 coo 41.01 23.02 20.83 40.65 24.26 22.55 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 5 3 # 5 B 62 LYS A 340 LYS~? 12.75 ZN ZN A 374 C 105 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 35 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 38.76 28.25 7.87 36.33 26.41 13.58 44.47 1.55 20.70 47.30 5.10 24.27 coo 34.93 19.72 17.37 34.72 18.17 15.98 32.91 0.46 27.63 33.66 0.11 29.56 coo 41.01 23.02 20.83 40.65 24.26 22.55 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 6 3 # 6 B 62 LYS A 340 LYS~? 12.75 ZN ZN A 374 C 105 HIS A 333 HIS~? -3.55 ZN ZN A 374s D 35 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 38.76 28.25 7.87 36.33 26.41 13.58 44.47 1.55 20.70 47.30 5.10 24.27 coo 34.93 19.72 17.37 34.72 18.17 15.98 40.60 0.33 34.12 38.69 0.39 33.24 coo 41.01 23.02 20.83 40.65 24.26 22.55 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 7 3 # 7 B 62 LYS A 340 LYS~? 12.75 ZN ZN A 374 C 105 HIS A 366 HIS.? 14.86 ZN ZN A 374 D 35 ASP A 269 ASP.? 18.90 ZN ZN A 374 coo 38.76 28.25 7.87 36.33 26.41 13.58 44.47 1.55 20.70 47.30 5.10 24.27 coo 34.93 19.72 17.37 34.72 18.17 15.98 51.10 6.85 29.91 51.20 5.36 31.38 coo 41.01 23.02 20.83 40.65 24.26 22.55 54.82 -1.21 28.36 56.43 0.27 28.67 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 8 3 # 8 B 62 LYS B 28 LYS.? 11.75 C7 EPE B 376 C 105 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 35 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 38.76 28.25 7.87 36.33 26.41 13.58 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 34.93 19.72 17.37 34.72 18.17 15.98 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 41.01 23.02 20.83 40.65 24.26 22.55 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 9 3 # 9 B 62 LYS B 28 LYS.? 11.75 C7 EPE B 376 C 105 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 35 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 38.76 28.25 7.87 36.33 26.41 13.58 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 34.93 19.72 17.37 34.72 18.17 15.98 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 41.01 23.02 20.83 40.65 24.26 22.55 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 10 3 # 10 B 62 LYS B 91 LYS~? 15.73 O3S EPE B 376 C 105 HIS B 80 HIS.? 6.72 O2S EPE B 376 D 35 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 38.76 28.25 7.87 36.33 26.41 13.58 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 34.93 19.72 17.37 34.72 18.17 15.98 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 41.01 23.02 20.83 40.65 24.26 22.55 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 11 3 # 11 B 62 LYS B 337 LYS~? 13.35 ZN ZN B 374 C 105 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 35 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 38.76 28.25 7.87 36.33 26.41 13.58 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 34.93 19.72 17.37 34.72 18.17 15.98 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 41.01 23.02 20.83 40.65 24.26 22.55 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 12 3 # 12 B 62 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 105 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 35 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 38.76 28.25 7.87 36.33 26.41 13.58 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 34.93 19.72 17.37 34.72 18.17 15.98 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 41.01 23.02 20.83 40.65 24.26 22.55 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 13 3 # 13 B 62 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 105 HIS B 333 HIS~? -3.37 ZN ZN B 374s D 35 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 38.76 28.25 7.87 36.33 26.41 13.58 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 34.93 19.72 17.37 34.72 18.17 15.98 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 41.01 23.02 20.83 40.65 24.26 22.55 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 14 3 # 14 B 62 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 105 HIS B 366 HIS.? 14.78 ZN ZN B 374 D 35 ASP B 269 ASP.? 18.26 ZN ZN B 374 coo 38.76 28.25 7.87 36.33 26.41 13.58 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 34.93 19.72 17.37 34.72 18.17 15.98 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 41.01 23.02 20.83 40.65 24.26 22.55 -18.05 15.19 12.20 -19.75 16.35 12.84 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 15 3 # 15 B 62 LYS C 28 LYS.? 13.32 C7 EPE C 376 C 105 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 35 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 38.76 28.25 7.87 36.33 26.41 13.58 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 34.93 19.72 17.37 34.72 18.17 15.98 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 41.01 23.02 20.83 40.65 24.26 22.55 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 16 3 # 16 B 62 LYS C 28 LYS.? 13.32 C7 EPE C 376 C 105 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 35 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 38.76 28.25 7.87 36.33 26.41 13.58 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 34.93 19.72 17.37 34.72 18.17 15.98 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 41.01 23.02 20.83 40.65 24.26 22.55 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 17 3 # 17 B 62 LYS C 91 LYS~? 15.57 O3S EPE C 376 C 105 HIS C 80 HIS.? 6.69 O2S EPE C 376 D 35 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 38.76 28.25 7.87 36.33 26.41 13.58 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 34.93 19.72 17.37 34.72 18.17 15.98 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 41.01 23.02 20.83 40.65 24.26 22.55 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 18 3 # 18 B 62 LYS C 278 LYS.? 30.91 ZN ZN C 374 C 105 HIS C 319 HIS~? 24.70 ZN ZN C 374 D 35 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 38.76 28.25 7.87 36.33 26.41 13.58 -21.60 -25.17 57.51 -24.75 -21.09 54.19 coo 34.93 19.72 17.37 34.72 18.17 15.98 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 41.01 23.02 20.83 40.65 24.26 22.55 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 19 3 # 19 B 62 LYS C 337 LYS~? 12.69 ZN ZN C 374 C 105 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 35 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 38.76 28.25 7.87 36.33 26.41 13.58 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 34.93 19.72 17.37 34.72 18.17 15.98 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 41.01 23.02 20.83 40.65 24.26 22.55 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 20 3 # 20 B 62 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 105 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 35 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 38.76 28.25 7.87 36.33 26.41 13.58 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 34.93 19.72 17.37 34.72 18.17 15.98 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 41.01 23.02 20.83 40.65 24.26 22.55 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 21 3 # 21 B 62 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 105 HIS C 333 HIS~? -3.37 ZN ZN C 374s D 35 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 38.76 28.25 7.87 36.33 26.41 13.58 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 34.93 19.72 17.37 34.72 18.17 15.98 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 41.01 23.02 20.83 40.65 24.26 22.55 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 22 3 # 22 B 62 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 105 HIS C 366 HIS.? 14.85 ZN ZN C 374 D 35 ASP C 269 ASP~? 18.04 ZN ZN C 374 coo 38.76 28.25 7.87 36.33 26.41 13.58 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 34.93 19.72 17.37 34.72 18.17 15.98 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 41.01 23.02 20.83 40.65 24.26 22.55 -1.79 -38.40 63.28 -1.15 -38.99 65.26 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 22 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 20 LYS~? 16.95 ZN ZN A 375 B 105 HIS A 68 HIS.? -3.31 ZN ZN A 375s E 35 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 20.51 39.76 8.83 21.23 37.38 14.18 26.66 -3.22 19.04 24.73 2.41 18.30 coo 27.18 37.56 20.68 29.07 38.28 20.13 37.80 0.44 25.56 37.02 -1.29 26.44 coo 19.97 40.39 22.03 18.53 39.30 23.18 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS A 91 LYS~? 15.85 O2S EPE A 376 B 105 HIS A 80 HIS.? 6.41 O2S EPE A 376 E 35 ASP A 82 ASP.? 8.88 O2S EPE A 376 coo 20.51 39.76 8.83 21.23 37.38 14.18 36.23 21.81 22.32 41.86 22.67 23.70 coo 27.18 37.56 20.68 29.07 38.28 20.13 28.52 23.28 34.79 26.69 23.10 35.81 coo 19.97 40.39 22.03 18.53 39.30 23.18 34.38 27.71 34.24 32.73 27.59 35.53 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS A 265 LYS~? 22.38 ZN ZN A 374 B 105 HIS A 333 HIS~? -3.55 ZN ZN A 374s E 35 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 20.51 39.76 8.83 21.23 37.38 14.18 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 27.18 37.56 20.68 29.07 38.28 20.13 40.60 0.33 34.12 38.69 0.39 33.24 coo 19.97 40.39 22.03 18.53 39.30 23.18 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 4 3 # 4 A 62 LYS A 295 LYS.? 12.61 ZN ZN A 374 B 105 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 35 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 20.51 39.76 8.83 21.23 37.38 14.18 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 27.18 37.56 20.68 29.07 38.28 20.13 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.97 40.39 22.03 18.53 39.30 23.18 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 5 3 # 5 A 62 LYS A 337 LYS~? 14.02 ZN ZN A 374 B 105 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 35 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 20.51 39.76 8.83 21.23 37.38 14.18 45.66 0.76 26.15 51.53 0.58 28.90 coo 27.18 37.56 20.68 29.07 38.28 20.13 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.97 40.39 22.03 18.53 39.30 23.18 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 6 3 # 6 A 62 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 105 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 35 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 20.51 39.76 8.83 21.23 37.38 14.18 44.47 1.55 20.70 47.30 5.10 24.27 coo 27.18 37.56 20.68 29.07 38.28 20.13 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.97 40.39 22.03 18.53 39.30 23.18 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 7 3 # 7 A 62 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 105 HIS A 333 HIS~? -3.55 ZN ZN A 374s E 35 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 20.51 39.76 8.83 21.23 37.38 14.18 44.47 1.55 20.70 47.30 5.10 24.27 coo 27.18 37.56 20.68 29.07 38.28 20.13 40.60 0.33 34.12 38.69 0.39 33.24 coo 19.97 40.39 22.03 18.53 39.30 23.18 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 8 3 # 8 A 62 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 105 HIS A 366 HIS.? 14.86 ZN ZN A 374 E 35 ASP A 269 ASP.? 18.90 ZN ZN A 374 coo 20.51 39.76 8.83 21.23 37.38 14.18 44.47 1.55 20.70 47.30 5.10 24.27 coo 27.18 37.56 20.68 29.07 38.28 20.13 51.10 6.85 29.91 51.20 5.36 31.38 coo 19.97 40.39 22.03 18.53 39.30 23.18 54.82 -1.21 28.36 56.43 0.27 28.67 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 9 3 # 9 A 62 LYS B 20 LYS~? 17.56 ZN ZN B 375 B 105 HIS B 68 HIS.? -3.38 ZN ZN B 375s E 35 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 20.51 39.76 8.83 21.23 37.38 14.18 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 27.18 37.56 20.68 29.07 38.28 20.13 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 19.97 40.39 22.03 18.53 39.30 23.18 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 10 3 # 10 A 62 LYS B 91 LYS~? 15.73 O3S EPE B 376 B 105 HIS B 80 HIS.? 6.72 O2S EPE B 376 E 35 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 20.51 39.76 8.83 21.23 37.38 14.18 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 27.18 37.56 20.68 29.07 38.28 20.13 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 19.97 40.39 22.03 18.53 39.30 23.18 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 11 3 # 11 A 62 LYS B 265 LYS~? 21.91 ZN ZN B 374 B 105 HIS B 333 HIS~? -3.37 ZN ZN B 374s E 35 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 20.51 39.76 8.83 21.23 37.38 14.18 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 27.18 37.56 20.68 29.07 38.28 20.13 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 19.97 40.39 22.03 18.53 39.30 23.18 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 12 3 # 12 A 62 LYS B 295 LYS.? 11.37 ZN ZN B 375 B 105 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 35 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 20.51 39.76 8.83 21.23 37.38 14.18 4.57 8.76 22.84 2.39 5.01 24.93 coo 27.18 37.56 20.68 29.07 38.28 20.13 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.97 40.39 22.03 18.53 39.30 23.18 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 13 3 # 13 A 62 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 105 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 35 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 20.51 39.76 8.83 21.23 37.38 14.18 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 27.18 37.56 20.68 29.07 38.28 20.13 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.97 40.39 22.03 18.53 39.30 23.18 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 14 3 # 14 A 62 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 105 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 35 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 20.51 39.76 8.83 21.23 37.38 14.18 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 27.18 37.56 20.68 29.07 38.28 20.13 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.97 40.39 22.03 18.53 39.30 23.18 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 15 3 # 15 A 62 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 105 HIS B 333 HIS~? -3.37 ZN ZN B 374s E 35 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 20.51 39.76 8.83 21.23 37.38 14.18 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 27.18 37.56 20.68 29.07 38.28 20.13 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 19.97 40.39 22.03 18.53 39.30 23.18 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 16 3 # 16 A 62 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 105 HIS B 366 HIS.? 14.78 ZN ZN B 374 E 35 ASP B 269 ASP.? 18.26 ZN ZN B 374 coo 20.51 39.76 8.83 21.23 37.38 14.18 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 27.18 37.56 20.68 29.07 38.28 20.13 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 19.97 40.39 22.03 18.53 39.30 23.18 -18.05 15.19 12.20 -19.75 16.35 12.84 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 17 3 # 17 A 62 LYS C 20 LYS~? 17.53 ZN ZN C 375 B 105 HIS C 68 HIS.? -3.41 ZN ZN C 375s E 35 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 20.51 39.76 8.83 21.23 37.38 14.18 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 27.18 37.56 20.68 29.07 38.28 20.13 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 19.97 40.39 22.03 18.53 39.30 23.18 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 18 3 # 18 A 62 LYS C 91 LYS~? 15.57 O3S EPE C 376 B 105 HIS C 80 HIS.? 6.69 O2S EPE C 376 E 35 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 20.51 39.76 8.83 21.23 37.38 14.18 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 27.18 37.56 20.68 29.07 38.28 20.13 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 19.97 40.39 22.03 18.53 39.30 23.18 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 19 3 # 19 A 62 LYS C 265 LYS~? 21.95 ZN ZN C 374 B 105 HIS C 333 HIS~? -3.37 ZN ZN C 374s E 35 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 20.51 39.76 8.83 21.23 37.38 14.18 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 27.18 37.56 20.68 29.07 38.28 20.13 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 19.97 40.39 22.03 18.53 39.30 23.18 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 20 3 # 20 A 62 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 105 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 35 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 20.51 39.76 8.83 21.23 37.38 14.18 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 27.18 37.56 20.68 29.07 38.28 20.13 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.97 40.39 22.03 18.53 39.30 23.18 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 21 3 # 21 A 62 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 105 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 35 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 20.51 39.76 8.83 21.23 37.38 14.18 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 27.18 37.56 20.68 29.07 38.28 20.13 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.97 40.39 22.03 18.53 39.30 23.18 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 22 3 # 22 A 62 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 105 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 35 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 20.51 39.76 8.83 21.23 37.38 14.18 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 27.18 37.56 20.68 29.07 38.28 20.13 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.97 40.39 22.03 18.53 39.30 23.18 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 23 3 # 23 A 62 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 105 HIS C 333 HIS~? -3.37 ZN ZN C 374s E 35 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 20.51 39.76 8.83 21.23 37.38 14.18 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 27.18 37.56 20.68 29.07 38.28 20.13 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 19.97 40.39 22.03 18.53 39.30 23.18 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 24 3 # 24 A 62 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 105 HIS C 366 HIS.? 14.85 ZN ZN C 374 E 35 ASP C 269 ASP~? 18.04 ZN ZN C 374 coo 20.51 39.76 8.83 21.23 37.38 14.18 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 27.18 37.56 20.68 29.07 38.28 20.13 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 19.97 40.39 22.03 18.53 39.30 23.18 -1.79 -38.40 63.28 -1.15 -38.99 65.26 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 24 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 260 PHE~? 19.27 ZN ZN A 375 A 210 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 244 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 9.23 46.77 25.11 11.48 48.39 24.76 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -1.20 42.34 17.67 3.19 45.13 19.06 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 260 PHE~? 19.27 ZN ZN A 375 A 210 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 244 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 9.23 46.77 25.11 11.48 48.39 24.76 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -1.20 42.34 17.67 3.19 45.13 19.06 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 370 PHE.? 12.81 O8 EPE A 376 A 210 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 244 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 9.23 46.77 25.11 11.48 48.39 24.76 46.70 4.90 39.59 44.12 4.72 40.65 coo 10.51 37.86 19.71 9.07 39.38 20.04 39.49 -1.24 39.18 39.76 0.49 37.96 coo -1.20 42.34 17.67 3.19 45.13 19.06 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 370 PHE.? 12.81 O8 EPE A 376 A 210 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 244 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 9.23 46.77 25.11 11.48 48.39 24.76 46.70 4.90 39.59 44.12 4.72 40.65 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -1.20 42.34 17.67 3.19 45.13 19.06 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE B 260 PHE~? 19.39 ZN ZN B 375 A 210 ASP B 281 ASP.? 29.04 ZN ZN B 374 A 244 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo 9.23 46.77 25.11 11.48 48.39 24.76 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 10.51 37.86 19.71 9.07 39.38 20.04 4.51 22.24 5.26 6.45 23.04 5.71 coo -1.20 42.34 17.67 3.19 45.13 19.06 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE B 260 PHE~? 19.39 ZN ZN B 375 A 210 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 244 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 9.23 46.77 25.11 11.48 48.39 24.76 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 10.51 37.86 19.71 9.07 39.38 20.04 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -1.20 42.34 17.67 3.19 45.13 19.06 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE B 260 PHE~? 19.39 ZN ZN B 375 A 210 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 244 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 9.23 46.77 25.11 11.48 48.39 24.76 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 10.51 37.86 19.71 9.07 39.38 20.04 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -1.20 42.34 17.67 3.19 45.13 19.06 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE B 370 PHE.? 12.32 O8 EPE B 376 A 210 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 244 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 9.23 46.77 25.11 11.48 48.39 24.76 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -1.20 42.34 17.67 3.19 45.13 19.06 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE B 370 PHE.? 12.32 O8 EPE B 376 A 210 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 244 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 9.23 46.77 25.11 11.48 48.39 24.76 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -1.20 42.34 17.67 3.19 45.13 19.06 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE C 260 PHE~? 19.40 ZN ZN C 375 A 210 ASP C 281 ASP.? 29.07 ZN ZN C 374 A 244 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo 9.23 46.77 25.11 11.48 48.39 24.76 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 10.51 37.86 19.71 9.07 39.38 20.04 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo -1.20 42.34 17.67 3.19 45.13 19.06 -12.73 -23.25 44.05 -17.55 -23.96 45.92 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE C 260 PHE~? 19.40 ZN ZN C 375 A 210 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 244 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 9.23 46.77 25.11 11.48 48.39 24.76 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 10.51 37.86 19.71 9.07 39.38 20.04 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -1.20 42.34 17.67 3.19 45.13 19.06 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE C 260 PHE~? 19.40 ZN ZN C 375 A 210 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 244 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 9.23 46.77 25.11 11.48 48.39 24.76 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 10.51 37.86 19.71 9.07 39.38 20.04 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -1.20 42.34 17.67 3.19 45.13 19.06 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE C 370 PHE.? 12.75 O8 EPE C 376 A 210 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 244 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 9.23 46.77 25.11 11.48 48.39 24.76 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 10.51 37.86 19.71 9.07 39.38 20.04 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -1.20 42.34 17.67 3.19 45.13 19.06 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 112 PHE C 370 PHE.? 12.75 O8 EPE C 376 A 210 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 244 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 9.23 46.77 25.11 11.48 48.39 24.76 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 10.51 37.86 19.71 9.07 39.38 20.04 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -1.20 42.34 17.67 3.19 45.13 19.06 -8.06 -35.63 62.23 -11.30 -33.36 66.69 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 14 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 260 PHE~? 19.27 ZN ZN A 375 B 210 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 244 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 8.76 47.85 34.91 11.08 46.36 35.41 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -2.38 51.82 41.62 2.07 49.19 40.42 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 260 PHE~? 19.27 ZN ZN A 375 B 210 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 244 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 8.76 47.85 34.91 11.08 46.36 35.41 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -2.38 51.82 41.62 2.07 49.19 40.42 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 370 PHE.? 12.81 O8 EPE A 376 B 210 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 244 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 8.76 47.85 34.91 11.08 46.36 35.41 46.70 4.90 39.59 44.12 4.72 40.65 coo 9.06 56.85 40.30 7.71 55.27 39.90 39.49 -1.24 39.18 39.76 0.49 37.96 coo -2.38 51.82 41.62 2.07 49.19 40.42 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 370 PHE.? 12.81 O8 EPE A 376 B 210 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 244 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 8.76 47.85 34.91 11.08 46.36 35.41 46.70 4.90 39.59 44.12 4.72 40.65 coo 9.06 56.85 40.30 7.71 55.27 39.90 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -2.38 51.82 41.62 2.07 49.19 40.42 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE B 260 PHE~? 19.39 ZN ZN B 375 B 210 ASP B 281 ASP.? 29.04 ZN ZN B 374 B 244 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo 8.76 47.85 34.91 11.08 46.36 35.41 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 9.06 56.85 40.30 7.71 55.27 39.90 4.51 22.24 5.26 6.45 23.04 5.71 coo -2.38 51.82 41.62 2.07 49.19 40.42 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE B 260 PHE~? 19.39 ZN ZN B 375 B 210 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 244 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 8.76 47.85 34.91 11.08 46.36 35.41 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 9.06 56.85 40.30 7.71 55.27 39.90 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -2.38 51.82 41.62 2.07 49.19 40.42 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE B 260 PHE~? 19.39 ZN ZN B 375 B 210 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 244 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 8.76 47.85 34.91 11.08 46.36 35.41 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 9.06 56.85 40.30 7.71 55.27 39.90 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -2.38 51.82 41.62 2.07 49.19 40.42 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE B 370 PHE.? 12.32 O8 EPE B 376 B 210 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 244 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 8.76 47.85 34.91 11.08 46.36 35.41 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -2.38 51.82 41.62 2.07 49.19 40.42 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE C 260 PHE~? 19.40 ZN ZN C 375 B 210 ASP C 281 ASP.? 29.07 ZN ZN C 374 B 244 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo 8.76 47.85 34.91 11.08 46.36 35.41 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 9.06 56.85 40.30 7.71 55.27 39.90 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo -2.38 51.82 41.62 2.07 49.19 40.42 -12.73 -23.25 44.05 -17.55 -23.96 45.92 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE C 260 PHE~? 19.40 ZN ZN C 375 B 210 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 244 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 8.76 47.85 34.91 11.08 46.36 35.41 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 9.06 56.85 40.30 7.71 55.27 39.90 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -2.38 51.82 41.62 2.07 49.19 40.42 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE C 260 PHE~? 19.40 ZN ZN C 375 B 210 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 244 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 8.76 47.85 34.91 11.08 46.36 35.41 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 9.06 56.85 40.30 7.71 55.27 39.90 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -2.38 51.82 41.62 2.07 49.19 40.42 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE C 370 PHE.? 12.75 O8 EPE C 376 B 210 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 244 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 8.76 47.85 34.91 11.08 46.36 35.41 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 9.06 56.85 40.30 7.71 55.27 39.90 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -2.38 51.82 41.62 2.07 49.19 40.42 -8.06 -35.63 62.23 -11.30 -33.36 66.69 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 12 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 210 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 244 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 11.28 44.53 18.60 9.91 46.00 19.20 37.80 0.44 25.56 37.02 -1.29 26.44 coo 10.51 37.86 19.71 9.07 39.38 20.04 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -1.20 42.34 17.67 3.19 45.13 19.06 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 210 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 244 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 11.28 44.53 18.60 9.91 46.00 19.20 37.80 0.44 25.56 37.02 -1.29 26.44 coo 10.51 37.86 19.71 9.07 39.38 20.04 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -1.20 42.34 17.67 3.19 45.13 19.06 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 210 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 244 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 37.42 3.90 29.26 38.47 2.36 30.22 coo 10.51 37.86 19.71 9.07 39.38 20.04 40.70 8.14 28.73 41.06 6.40 29.84 coo -1.20 42.34 17.67 3.19 45.13 19.06 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 210 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 244 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 11.28 44.53 18.60 9.91 46.00 19.20 32.91 0.46 27.63 33.66 0.11 29.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -1.20 42.34 17.67 3.19 45.13 19.06 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 136 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 210 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 244 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 32.91 0.46 27.63 33.66 0.11 29.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -1.20 42.34 17.67 3.19 45.13 19.06 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 136 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 210 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 244 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 32.91 0.46 27.63 33.66 0.11 29.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -1.20 42.34 17.67 3.19 45.13 19.06 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 136 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 210 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 244 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 51.10 6.85 29.91 51.20 5.36 31.38 coo 10.51 37.86 19.71 9.07 39.38 20.04 48.24 5.16 33.58 47.82 3.96 35.30 coo -1.20 42.34 17.67 3.19 45.13 19.06 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 136 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 210 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 244 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 51.10 6.85 29.91 51.20 5.36 31.38 coo 10.51 37.86 19.71 9.07 39.38 20.04 48.24 5.16 33.58 47.82 3.96 35.30 coo -1.20 42.34 17.67 3.19 45.13 19.06 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 136 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 210 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 244 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 11.28 44.53 18.60 9.91 46.00 19.20 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 10.51 37.86 19.71 9.07 39.38 20.04 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -1.20 42.34 17.67 3.19 45.13 19.06 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 136 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 210 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 244 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 11.28 44.53 18.60 9.91 46.00 19.20 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 10.51 37.86 19.71 9.07 39.38 20.04 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -1.20 42.34 17.67 3.19 45.13 19.06 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 136 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 210 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 244 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 10.51 37.86 19.71 9.07 39.38 20.04 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -1.20 42.34 17.67 3.19 45.13 19.06 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 136 HIS B 80 HIS.? 6.72 O2S EPE B 376 A 210 ASP B 82 ASP.? 10.62 O3S EPE B 376 A 244 LYS B 91 LYS~? 15.73 O3S EPE B 376 coo 11.28 44.53 18.60 9.91 46.00 19.20 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 10.51 37.86 19.71 9.07 39.38 20.04 -22.38 12.66 48.09 -22.95 14.65 48.48 coo -1.20 42.34 17.67 3.19 45.13 19.06 -26.96 4.56 38.63 -29.49 9.20 36.26 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 136 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 210 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 244 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 11.28 44.53 18.60 9.91 46.00 19.20 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -1.20 42.34 17.67 3.19 45.13 19.06 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 136 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 210 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 244 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -1.20 42.34 17.67 3.19 45.13 19.06 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 A 136 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 210 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 244 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -1.20 42.34 17.67 3.19 45.13 19.06 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 A 136 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 210 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 244 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 10.51 37.86 19.71 9.07 39.38 20.04 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -1.20 42.34 17.67 3.19 45.13 19.06 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 A 136 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 210 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 244 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 10.51 37.86 19.71 9.07 39.38 20.04 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -1.20 42.34 17.67 3.19 45.13 19.06 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 A 136 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 210 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 244 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 11.28 44.53 18.60 9.91 46.00 19.20 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 A 136 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 210 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 244 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 11.28 44.53 18.60 9.91 46.00 19.20 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 A 136 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 210 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 244 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 10.51 37.86 19.71 9.07 39.38 20.04 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -1.20 42.34 17.67 3.19 45.13 19.06 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 A 136 HIS C 80 HIS.? 6.69 O2S EPE C 376 A 210 ASP C 82 ASP.? 10.22 O3S EPE C 376 A 244 LYS C 91 LYS~? 15.57 O3S EPE C 376 coo 11.28 44.53 18.60 9.91 46.00 19.20 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 10.51 37.86 19.71 9.07 39.38 20.04 23.03 -14.86 74.18 22.44 -14.42 76.16 coo -1.20 42.34 17.67 3.19 45.13 19.06 24.97 -26.94 68.30 21.78 -29.04 72.70 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 A 136 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 210 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 244 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 11.28 44.53 18.60 9.91 46.00 19.20 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 10.51 37.86 19.71 9.07 39.38 20.04 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 A 136 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 210 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 244 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 10.51 37.86 19.71 9.07 39.38 20.04 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 A 136 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 210 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 244 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 10.51 37.86 19.71 9.07 39.38 20.04 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 A 136 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 210 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 244 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 10.51 37.86 19.71 9.07 39.38 20.04 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -1.20 42.34 17.67 3.19 45.13 19.06 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 A 136 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 210 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 244 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 11.28 44.53 18.60 9.91 46.00 19.20 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 10.51 37.86 19.71 9.07 39.38 20.04 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -1.20 42.34 17.67 3.19 45.13 19.06 9.58 -37.42 57.24 8.41 -35.76 62.90 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 26 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 210 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 244 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 10.08 50.18 41.78 8.91 48.61 41.04 37.80 0.44 25.56 37.02 -1.29 26.44 coo 9.06 56.85 40.30 7.71 55.27 39.90 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -2.38 51.82 41.62 2.07 49.19 40.42 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 210 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 244 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 10.08 50.18 41.78 8.91 48.61 41.04 37.80 0.44 25.56 37.02 -1.29 26.44 coo 9.06 56.85 40.30 7.71 55.27 39.90 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -2.38 51.82 41.62 2.07 49.19 40.42 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 210 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 244 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 37.42 3.90 29.26 38.47 2.36 30.22 coo 9.06 56.85 40.30 7.71 55.27 39.90 40.70 8.14 28.73 41.06 6.40 29.84 coo -2.38 51.82 41.62 2.07 49.19 40.42 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 136 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 210 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 244 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 10.08 50.18 41.78 8.91 48.61 41.04 32.91 0.46 27.63 33.66 0.11 29.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -2.38 51.82 41.62 2.07 49.19 40.42 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 136 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 210 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 244 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 32.91 0.46 27.63 33.66 0.11 29.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -2.38 51.82 41.62 2.07 49.19 40.42 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 136 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 210 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 244 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 32.91 0.46 27.63 33.66 0.11 29.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -2.38 51.82 41.62 2.07 49.19 40.42 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 136 HIS A 366 HIS.? 14.86 ZN ZN A 374 B 210 ASP A 368 ASP.? 11.85 ZN ZN A 374 B 244 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 51.10 6.85 29.91 51.20 5.36 31.38 coo 9.06 56.85 40.30 7.71 55.27 39.90 48.24 5.16 33.58 47.82 3.96 35.30 coo -2.38 51.82 41.62 2.07 49.19 40.42 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 136 HIS A 366 HIS.? 14.86 ZN ZN A 374 B 210 ASP A 368 ASP.? 11.85 ZN ZN A 374 B 244 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 51.10 6.85 29.91 51.20 5.36 31.38 coo 9.06 56.85 40.30 7.71 55.27 39.90 48.24 5.16 33.58 47.82 3.96 35.30 coo -2.38 51.82 41.62 2.07 49.19 40.42 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 136 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 210 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 244 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 10.08 50.18 41.78 8.91 48.61 41.04 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 9.06 56.85 40.30 7.71 55.27 39.90 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -2.38 51.82 41.62 2.07 49.19 40.42 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 136 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 210 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 244 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 10.08 50.18 41.78 8.91 48.61 41.04 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 9.06 56.85 40.30 7.71 55.27 39.90 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -2.38 51.82 41.62 2.07 49.19 40.42 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 136 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 210 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 244 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 9.06 56.85 40.30 7.71 55.27 39.90 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -2.38 51.82 41.62 2.07 49.19 40.42 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 136 HIS B 80 HIS.? 6.72 O2S EPE B 376 B 210 ASP B 82 ASP.? 10.62 O3S EPE B 376 B 244 LYS B 91 LYS~? 15.73 O3S EPE B 376 coo 10.08 50.18 41.78 8.91 48.61 41.04 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 9.06 56.85 40.30 7.71 55.27 39.90 -22.38 12.66 48.09 -22.95 14.65 48.48 coo -2.38 51.82 41.62 2.07 49.19 40.42 -26.96 4.56 38.63 -29.49 9.20 36.26 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 136 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 210 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 244 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 10.08 50.18 41.78 8.91 48.61 41.04 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -2.38 51.82 41.62 2.07 49.19 40.42 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 136 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 210 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 244 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -2.38 51.82 41.62 2.07 49.19 40.42 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 B 136 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 210 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 244 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -2.38 51.82 41.62 2.07 49.19 40.42 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 B 136 HIS B 366 HIS.? 14.78 ZN ZN B 374 B 210 ASP B 368 ASP.? 11.70 ZN ZN B 374 B 244 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 9.06 56.85 40.30 7.71 55.27 39.90 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -2.38 51.82 41.62 2.07 49.19 40.42 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 B 136 HIS B 366 HIS.? 14.78 ZN ZN B 374 B 210 ASP B 368 ASP.? 11.70 ZN ZN B 374 B 244 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 9.06 56.85 40.30 7.71 55.27 39.90 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -2.38 51.82 41.62 2.07 49.19 40.42 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 B 136 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 210 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 244 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 10.08 50.18 41.78 8.91 48.61 41.04 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 B 136 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 210 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 244 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 10.08 50.18 41.78 8.91 48.61 41.04 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 B 136 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 210 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 244 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 9.06 56.85 40.30 7.71 55.27 39.90 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -2.38 51.82 41.62 2.07 49.19 40.42 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 B 136 HIS C 80 HIS.? 6.69 O2S EPE C 376 B 210 ASP C 82 ASP.? 10.22 O3S EPE C 376 B 244 LYS C 91 LYS~? 15.57 O3S EPE C 376 coo 10.08 50.18 41.78 8.91 48.61 41.04 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 9.06 56.85 40.30 7.71 55.27 39.90 23.03 -14.86 74.18 22.44 -14.42 76.16 coo -2.38 51.82 41.62 2.07 49.19 40.42 24.97 -26.94 68.30 21.78 -29.04 72.70 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 B 136 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 210 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 244 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 10.08 50.18 41.78 8.91 48.61 41.04 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 9.06 56.85 40.30 7.71 55.27 39.90 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 B 136 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 210 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 244 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 9.06 56.85 40.30 7.71 55.27 39.90 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 B 136 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 210 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 244 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 10.08 50.18 41.78 8.91 48.61 41.04 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 9.06 56.85 40.30 7.71 55.27 39.90 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 9.58 -37.42 57.24 8.41 -35.76 62.90 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 24 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s A 142 LEU A 71 LEU.? 8.24 C3 EPE A 376 A 165 LYS A 83 LYS~? -5.13 O1S EPE A 376s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 33.18 16.26 32.13 31.71 14.36 30.75 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 33.41 11.27 26.19 34.36 13.17 26.70 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 35.02 22.85 34.66 32.09 22.94 39.08 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s A 142 LEU A 71 LEU.? 8.24 C3 EPE A 376 A 165 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 33.18 16.26 32.13 31.71 14.36 30.75 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 33.41 11.27 26.19 34.36 13.17 26.70 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s A 142 LEU A 76 LEU.? 8.17 C10 EPE A 376 A 165 LYS A 83 LYS~? -5.13 O1S EPE A 376s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 33.18 16.26 32.13 31.71 14.36 30.75 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 25.42 15.99 30.19 27.44 15.46 29.53 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 35.02 22.85 34.66 32.09 22.94 39.08 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s A 142 LEU A 76 LEU.? 8.17 C10 EPE A 376 A 165 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 33.18 16.26 32.13 31.71 14.36 30.75 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 25.42 15.99 30.19 27.44 15.46 29.53 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 142 LEU A 236 LEU^? 7.58 N TRS A 378 A 165 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 18.21 -24.75 16.42 18.16 -26.24 14.91 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 142 LEU C 236 LEU^? 13.92 N TRS A 378 A 165 LYS A 138 LYS^? 13.11 N TRS A 378 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 8.65 -28.79 21.36 9.20 -30.53 20.21 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 137 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 142 LEU C 236 LEU^? 13.92 N TRS A 378 A 165 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 8.65 -28.79 21.36 9.20 -30.53 20.21 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 A 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 A 142 LEU B 71 LEU.? 7.97 C3 EPE B 376 A 165 LYS B 83 LYS~? 4.34 O1S EPE B 376 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -16.85 3.04 33.82 -18.31 4.35 34.89 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -20.11 12.86 43.96 -14.92 12.31 47.32 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 A 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 A 142 LEU B 71 LEU.? 7.97 C3 EPE B 376 A 165 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -16.85 3.04 33.82 -18.31 4.35 34.89 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 A 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 A 142 LEU B 76 LEU.? 8.52 N1 EPE B 376 A 165 LYS B 83 LYS~? 4.34 O1S EPE B 376 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -13.50 2.06 43.26 -14.66 2.49 41.49 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -20.11 12.86 43.96 -14.92 12.31 47.32 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 A 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 A 142 LEU B 76 LEU.? 8.52 N1 EPE B 376 A 165 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -13.50 2.06 43.26 -14.66 2.49 41.49 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 A 137 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 142 LEU A 236 LEU^? 7.58 N TRS A 378 A 165 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 8.50 -28.26 15.53 9.64 -30.80 15.55 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 18.21 -24.75 16.42 18.16 -26.24 14.91 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 A 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s A 142 LEU C 71 LEU.? 8.22 C3 EPE C 376 A 165 LYS C 83 LYS~? -3.65 O2S EPE C 376s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 17.95 -24.29 59.78 18.87 -24.21 61.77 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 19.52 -16.87 71.96 18.81 -11.07 69.68 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 A 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s A 142 LEU C 71 LEU.? 8.22 C3 EPE C 376 A 165 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 17.95 -24.29 59.78 18.87 -24.21 61.77 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 A 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s A 142 LEU C 76 LEU.? 8.49 N1 EPE C 376 A 165 LYS C 83 LYS~? -3.65 O2S EPE C 376s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 22.57 -15.31 59.67 21.47 -17.03 60.35 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 19.52 -16.87 71.96 18.81 -11.07 69.68 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 A 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s A 142 LEU C 76 LEU.? 8.49 N1 EPE C 376 A 165 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 22.57 -15.31 59.67 21.47 -17.03 60.35 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 A 137 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 142 LEU B 236 LEU^? 9.09 O1S EPE A 377 A 165 LYS C 139 LYS^? 16.11 N TRS A 378 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 14.09 -28.86 16.23 14.98 -29.39 13.69 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 7.64 -21.45 12.38 7.43 -23.27 11.24 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 A 137 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 142 LEU C 236 LEU^? 13.92 N TRS A 378 A 165 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 14.09 -28.86 16.23 14.98 -29.39 13.69 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 8.65 -28.79 21.36 9.20 -30.53 20.21 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 17.05 -24.82 10.77 19.64 -29.66 10.35 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 18 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 18 TYR~? 11.08 ZN ZN A 375 B 142 LEU A 347 LEU~? 17.28 ZN ZN A 375 B 165 LYS A 110 LYS.? 16.46 O3 TRS A 378 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 34.99 -4.02 17.62 37.68 -4.71 17.89 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 39.84 0.41 12.10 38.14 1.65 11.48 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 37.52 -11.39 18.62 36.00 -16.08 14.56 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s B 142 LEU A 71 LEU.? 8.24 C3 EPE A 376 B 165 LYS A 83 LYS~? -5.13 O1S EPE A 376s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 33.18 16.26 32.13 31.71 14.36 30.75 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 33.41 11.27 26.19 34.36 13.17 26.70 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 35.02 22.85 34.66 32.09 22.94 39.08 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s B 142 LEU A 71 LEU.? 8.24 C3 EPE A 376 B 165 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 33.18 16.26 32.13 31.71 14.36 30.75 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 33.41 11.27 26.19 34.36 13.17 26.70 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s B 142 LEU A 76 LEU.? 8.17 C10 EPE A 376 B 165 LYS A 83 LYS~? -5.13 O1S EPE A 376s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 33.18 16.26 32.13 31.71 14.36 30.75 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 25.42 15.99 30.19 27.44 15.46 29.53 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 35.02 22.85 34.66 32.09 22.94 39.08 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s B 142 LEU A 76 LEU.? 8.17 C10 EPE A 376 B 165 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 33.18 16.26 32.13 31.71 14.36 30.75 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 25.42 15.99 30.19 27.44 15.46 29.53 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 142 LEU A 236 LEU^? 7.58 N TRS A 378 B 165 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 18.21 -24.75 16.42 18.16 -26.24 14.91 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 137 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 142 LEU C 236 LEU^? 13.92 N TRS A 378 B 165 LYS A 138 LYS^? 13.11 N TRS A 378 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 8.65 -28.79 21.36 9.20 -30.53 20.21 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 B 137 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 142 LEU C 236 LEU^? 13.92 N TRS A 378 B 165 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 8.65 -28.79 21.36 9.20 -30.53 20.21 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 B 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 B 142 LEU B 71 LEU.? 7.97 C3 EPE B 376 B 165 LYS B 83 LYS~? 4.34 O1S EPE B 376 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -16.85 3.04 33.82 -18.31 4.35 34.89 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -20.11 12.86 43.96 -14.92 12.31 47.32 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 B 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 B 142 LEU B 71 LEU.? 7.97 C3 EPE B 376 B 165 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -16.85 3.04 33.82 -18.31 4.35 34.89 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 B 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 B 142 LEU B 76 LEU.? 8.52 N1 EPE B 376 B 165 LYS B 83 LYS~? 4.34 O1S EPE B 376 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -13.50 2.06 43.26 -14.66 2.49 41.49 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -20.11 12.86 43.96 -14.92 12.31 47.32 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 B 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 B 142 LEU B 76 LEU.? 8.52 N1 EPE B 376 B 165 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -13.50 2.06 43.26 -14.66 2.49 41.49 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 B 137 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 142 LEU A 236 LEU^? 7.58 N TRS A 378 B 165 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 8.50 -28.26 15.53 9.64 -30.80 15.55 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 18.21 -24.75 16.42 18.16 -26.24 14.91 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 B 137 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 142 LEU A 236 LEU^? 7.58 N TRS A 378 B 165 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 8.50 -28.26 15.53 9.64 -30.80 15.55 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 18.21 -24.75 16.42 18.16 -26.24 14.91 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 B 137 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 142 LEU B 236 LEU^? 9.09 O1S EPE A 377 B 165 LYS C 139 LYS^? 16.11 N TRS A 378 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 8.50 -28.26 15.53 9.64 -30.80 15.55 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 7.64 -21.45 12.38 7.43 -23.27 11.24 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 B 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s B 142 LEU C 71 LEU.? 8.22 C3 EPE C 376 B 165 LYS C 83 LYS~? -3.65 O2S EPE C 376s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 17.95 -24.29 59.78 18.87 -24.21 61.77 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 19.52 -16.87 71.96 18.81 -11.07 69.68 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 B 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s B 142 LEU C 71 LEU.? 8.22 C3 EPE C 376 B 165 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 17.95 -24.29 59.78 18.87 -24.21 61.77 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 B 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s B 142 LEU C 76 LEU.? 8.49 N1 EPE C 376 B 165 LYS C 83 LYS~? -3.65 O2S EPE C 376s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 22.57 -15.31 59.67 21.47 -17.03 60.35 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 19.52 -16.87 71.96 18.81 -11.07 69.68 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 B 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s B 142 LEU C 76 LEU.? 8.49 N1 EPE C 376 B 165 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 22.57 -15.31 59.67 21.47 -17.03 60.35 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 B 137 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 142 LEU B 236 LEU^? 9.09 O1S EPE A 377 B 165 LYS C 139 LYS^? 16.11 N TRS A 378 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 14.09 -28.86 16.23 14.98 -29.39 13.69 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 7.64 -21.45 12.38 7.43 -23.27 11.24 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 B 137 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 142 LEU C 236 LEU^? 13.92 N TRS A 378 B 165 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 14.09 -28.86 16.23 14.98 -29.39 13.69 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 8.65 -28.79 21.36 9.20 -30.53 20.21 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 17.05 -24.82 10.77 19.64 -29.66 10.35 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 21 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s C 142 LEU A 71 LEU.? 8.24 C3 EPE A 376 C 165 LYS A 83 LYS~? -5.13 O1S EPE A 376s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 33.18 16.26 32.13 31.71 14.36 30.75 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 33.41 11.27 26.19 34.36 13.17 26.70 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 35.02 22.85 34.66 32.09 22.94 39.08 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s C 142 LEU A 71 LEU.? 8.24 C3 EPE A 376 C 165 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 33.18 16.26 32.13 31.71 14.36 30.75 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 33.41 11.27 26.19 34.36 13.17 26.70 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s C 142 LEU A 76 LEU.? 8.17 C10 EPE A 376 C 165 LYS A 83 LYS~? -5.13 O1S EPE A 376s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 33.18 16.26 32.13 31.71 14.36 30.75 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 25.42 15.99 30.19 27.44 15.46 29.53 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 35.02 22.85 34.66 32.09 22.94 39.08 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s C 142 LEU A 76 LEU.? 8.17 C10 EPE A 376 C 165 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 33.18 16.26 32.13 31.71 14.36 30.75 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 25.42 15.99 30.19 27.44 15.46 29.53 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR A 234 TYR^? 9.43 O2S EPE A 377 C 142 LEU A 236 LEU^? 7.58 N TRS A 378 C 165 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 18.21 -24.75 16.42 18.16 -26.24 14.91 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 137 TYR A 234 TYR^? 9.43 O2S EPE A 377 C 142 LEU C 236 LEU^? 13.92 N TRS A 378 C 165 LYS A 138 LYS^? 13.11 N TRS A 378 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 8.65 -28.79 21.36 9.20 -30.53 20.21 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 137 TYR A 234 TYR^? 9.43 O2S EPE A 377 C 142 LEU C 236 LEU^? 13.92 N TRS A 378 C 165 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 8.65 -28.79 21.36 9.20 -30.53 20.21 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 C 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 C 142 LEU B 71 LEU.? 7.97 C3 EPE B 376 C 165 LYS B 83 LYS~? 4.34 O1S EPE B 376 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -16.85 3.04 33.82 -18.31 4.35 34.89 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -20.11 12.86 43.96 -14.92 12.31 47.32 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 C 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 C 142 LEU B 71 LEU.? 7.97 C3 EPE B 376 C 165 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -16.85 3.04 33.82 -18.31 4.35 34.89 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 C 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 C 142 LEU B 76 LEU.? 8.52 N1 EPE B 376 C 165 LYS B 83 LYS~? 4.34 O1S EPE B 376 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -13.50 2.06 43.26 -14.66 2.49 41.49 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -20.11 12.86 43.96 -14.92 12.31 47.32 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 C 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 C 142 LEU B 76 LEU.? 8.52 N1 EPE B 376 C 165 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -13.50 2.06 43.26 -14.66 2.49 41.49 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 C 137 TYR B 234 TYR^? 11.34 O2S EPE A 377 C 142 LEU A 236 LEU^? 7.58 N TRS A 378 C 165 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 8.50 -28.26 15.53 9.64 -30.80 15.55 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 18.21 -24.75 16.42 18.16 -26.24 14.91 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 C 137 TYR B 234 TYR^? 11.34 O2S EPE A 377 C 142 LEU A 236 LEU^? 7.58 N TRS A 378 C 165 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 8.50 -28.26 15.53 9.64 -30.80 15.55 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 18.21 -24.75 16.42 18.16 -26.24 14.91 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 C 137 TYR B 234 TYR^? 11.34 O2S EPE A 377 C 142 LEU B 236 LEU^? 9.09 O1S EPE A 377 C 165 LYS C 139 LYS^? 16.11 N TRS A 378 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 8.50 -28.26 15.53 9.64 -30.80 15.55 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 7.64 -21.45 12.38 7.43 -23.27 11.24 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 C 137 TYR B 296 TYR~? 11.48 ZN ZN B 375 C 142 LEU B 129 LEU^? 13.57 ZN ZN B 375 C 165 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 3.06 5.94 19.61 2.50 3.84 21.38 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 1.43 3.82 13.29 2.28 5.79 13.44 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 C 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s C 142 LEU C 71 LEU.? 8.22 C3 EPE C 376 C 165 LYS C 83 LYS~? -3.65 O2S EPE C 376s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 17.95 -24.29 59.78 18.87 -24.21 61.77 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 19.52 -16.87 71.96 18.81 -11.07 69.68 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 C 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s C 142 LEU C 71 LEU.? 8.22 C3 EPE C 376 C 165 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 17.95 -24.29 59.78 18.87 -24.21 61.77 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 C 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s C 142 LEU C 76 LEU.? 8.49 N1 EPE C 376 C 165 LYS C 83 LYS~? -3.65 O2S EPE C 376s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 22.57 -15.31 59.67 21.47 -17.03 60.35 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 19.52 -16.87 71.96 18.81 -11.07 69.68 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 C 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s C 142 LEU C 76 LEU.? 8.49 N1 EPE C 376 C 165 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 22.57 -15.31 59.67 21.47 -17.03 60.35 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 C 137 TYR C 234 TYR^? 9.10 O2S EPE C 377 C 142 LEU B 236 LEU^? 9.09 O1S EPE A 377 C 165 LYS C 138 LYS^? 8.30 N TRS A 378 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 14.09 -28.86 16.23 14.98 -29.39 13.69 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 7.64 -21.45 12.38 7.43 -23.27 11.24 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 C 137 TYR C 234 TYR^? 9.10 O2S EPE C 377 C 142 LEU B 236 LEU^? 9.09 O1S EPE A 377 C 165 LYS C 139 LYS^? 16.11 N TRS A 378 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 14.09 -28.86 16.23 14.98 -29.39 13.69 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 7.64 -21.45 12.38 7.43 -23.27 11.24 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 C 137 TYR C 234 TYR^? 9.10 O2S EPE C 377 C 142 LEU C 236 LEU^? 13.92 N TRS A 378 C 165 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 14.09 -28.86 16.23 14.98 -29.39 13.69 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 8.65 -28.79 21.36 9.20 -30.53 20.21 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 17.05 -24.82 10.77 19.64 -29.66 10.35 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 22 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 18 TYR~? 11.08 ZN ZN A 375 D 142 LEU A 347 LEU~? 17.28 ZN ZN A 375 D 165 LYS A 110 LYS.? 16.46 O3 TRS A 378 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 34.99 -4.02 17.62 37.68 -4.71 17.89 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 39.84 0.41 12.10 38.14 1.65 11.48 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 37.52 -11.39 18.62 36.00 -16.08 14.56 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s D 142 LEU A 71 LEU.? 8.24 C3 EPE A 376 D 165 LYS A 83 LYS~? -5.13 O1S EPE A 376s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 33.18 16.26 32.13 31.71 14.36 30.75 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 33.41 11.27 26.19 34.36 13.17 26.70 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 35.02 22.85 34.66 32.09 22.94 39.08 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s D 142 LEU A 71 LEU.? 8.24 C3 EPE A 376 D 165 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 33.18 16.26 32.13 31.71 14.36 30.75 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 33.41 11.27 26.19 34.36 13.17 26.70 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s D 142 LEU A 76 LEU.? 8.17 C10 EPE A 376 D 165 LYS A 83 LYS~? -5.13 O1S EPE A 376s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 33.18 16.26 32.13 31.71 14.36 30.75 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 25.42 15.99 30.19 27.44 15.46 29.53 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 35.02 22.85 34.66 32.09 22.94 39.08 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR A 85 TYR~? -4.05 C2 EPE A 376s D 142 LEU A 76 LEU.? 8.17 C10 EPE A 376 D 165 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 33.18 16.26 32.13 31.71 14.36 30.75 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 25.42 15.99 30.19 27.44 15.46 29.53 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR A 234 TYR^? 9.43 O2S EPE A 377 D 142 LEU A 236 LEU^? 7.58 N TRS A 378 D 165 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 18.21 -24.75 16.42 18.16 -26.24 14.91 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 137 TYR A 234 TYR^? 9.43 O2S EPE A 377 D 142 LEU C 236 LEU^? 13.92 N TRS A 378 D 165 LYS A 138 LYS^? 13.11 N TRS A 378 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 8.65 -28.79 21.36 9.20 -30.53 20.21 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 D 137 TYR A 234 TYR^? 9.43 O2S EPE A 377 D 142 LEU C 236 LEU^? 13.92 N TRS A 378 D 165 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 8.65 -28.79 21.36 9.20 -30.53 20.21 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 D 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 D 142 LEU B 71 LEU.? 7.97 C3 EPE B 376 D 165 LYS B 83 LYS~? 4.34 O1S EPE B 376 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -16.85 3.04 33.82 -18.31 4.35 34.89 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -20.11 12.86 43.96 -14.92 12.31 47.32 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 D 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 D 142 LEU B 71 LEU.? 7.97 C3 EPE B 376 D 165 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -16.85 3.04 33.82 -18.31 4.35 34.89 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 D 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 D 142 LEU B 76 LEU.? 8.52 N1 EPE B 376 D 165 LYS B 83 LYS~? 4.34 O1S EPE B 376 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -13.50 2.06 43.26 -14.66 2.49 41.49 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -20.11 12.86 43.96 -14.92 12.31 47.32 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 D 137 TYR B 85 TYR~? 3.87 C2 EPE B 376 D 142 LEU B 76 LEU.? 8.52 N1 EPE B 376 D 165 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -16.40 8.45 39.29 -15.27 6.03 38.43 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -13.50 2.06 43.26 -14.66 2.49 41.49 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 D 137 TYR B 234 TYR^? 11.34 O2S EPE A 377 D 142 LEU A 236 LEU^? 7.58 N TRS A 378 D 165 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 8.50 -28.26 15.53 9.64 -30.80 15.55 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 18.21 -24.75 16.42 18.16 -26.24 14.91 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 D 137 TYR B 234 TYR^? 11.34 O2S EPE A 377 D 142 LEU A 236 LEU^? 7.58 N TRS A 378 D 165 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 8.50 -28.26 15.53 9.64 -30.80 15.55 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 18.21 -24.75 16.42 18.16 -26.24 14.91 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 D 137 TYR B 234 TYR^? 11.34 O2S EPE A 377 D 142 LEU B 236 LEU^? 9.09 O1S EPE A 377 D 165 LYS C 139 LYS^? 16.11 N TRS A 378 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 8.50 -28.26 15.53 9.64 -30.80 15.55 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 7.64 -21.45 12.38 7.43 -23.27 11.24 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 D 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s D 142 LEU C 71 LEU.? 8.22 C3 EPE C 376 D 165 LYS C 83 LYS~? -3.65 O2S EPE C 376s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 17.95 -24.29 59.78 18.87 -24.21 61.77 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 19.52 -16.87 71.96 18.81 -11.07 69.68 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 D 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s D 142 LEU C 71 LEU.? 8.22 C3 EPE C 376 D 165 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 17.95 -24.29 59.78 18.87 -24.21 61.77 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 D 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s D 142 LEU C 76 LEU.? 8.49 N1 EPE C 376 D 165 LYS C 83 LYS~? -3.65 O2S EPE C 376s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 22.57 -15.31 59.67 21.47 -17.03 60.35 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 19.52 -16.87 71.96 18.81 -11.07 69.68 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 D 137 TYR C 85 TYR~? -3.91 C2 EPE C 376s D 142 LEU C 76 LEU.? 8.49 N1 EPE C 376 D 165 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 17.64 -18.79 65.22 18.00 -19.09 62.48 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 22.57 -15.31 59.67 21.47 -17.03 60.35 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 D 137 TYR C 234 TYR^? 9.10 O2S EPE C 377 D 142 LEU B 236 LEU^? 9.09 O1S EPE A 377 D 165 LYS C 139 LYS^? 16.11 N TRS A 378 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 14.09 -28.86 16.23 14.98 -29.39 13.69 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 7.64 -21.45 12.38 7.43 -23.27 11.24 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 D 137 TYR C 234 TYR^? 9.10 O2S EPE C 377 D 142 LEU C 236 LEU^? 13.92 N TRS A 378 D 165 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 14.09 -28.86 16.23 14.98 -29.39 13.69 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 8.65 -28.79 21.36 9.20 -30.53 20.21 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 17.05 -24.82 10.77 19.64 -29.66 10.35 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 21 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 173 SER^? 8.70 C6 EPE C 377 A 48 THR C 177 THR^? 8.04 C8 EPE C 377 A 165 LYS A 154 LYS~? 18.09 O1S EPE C 377 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 17.10 -34.58 2.20 18.37 -33.49 0.48 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 20.64 -38.60 2.16 21.28 -38.84 0.08 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 24.03 -26.17 -4.04 26.99 -24.22 -8.52 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER B 173 SER^? 8.63 C9 EPE A 377 A 48 THR A 177 THR^? 8.80 C6 EPE A 377 A 165 LYS B 154 LYS~? 18.23 O3S EPE A 377 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 4.35 -36.83 4.64 1.88 -36.99 4.49 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -7.89 -34.48 4.91 -13.85 -35.95 3.01 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER C 173 SER^? 14.26 C2 EPE C 377 A 48 THR B 177 THR^? 19.16 C2 EPE C 377 A 165 LYS C 154 LYS~? 23.94 C1 TRS A 378 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 13.37 -42.81 12.12 14.73 -44.10 13.72 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 9.43 -46.41 11.44 10.68 -47.97 10.55 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 18.67 -47.92 22.36 20.33 -51.69 25.99 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 173 SER^? 8.70 C6 EPE C 377 B 48 THR C 177 THR^? 8.04 C8 EPE C 377 B 165 LYS A 154 LYS~? 18.09 O1S EPE C 377 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 17.10 -34.58 2.20 18.37 -33.49 0.48 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 20.64 -38.60 2.16 21.28 -38.84 0.08 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 24.03 -26.17 -4.04 26.99 -24.22 -8.52 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 173 SER^? 8.63 C9 EPE A 377 B 48 THR A 177 THR^? 8.80 C6 EPE A 377 B 165 LYS B 154 LYS~? 18.23 O3S EPE A 377 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 4.35 -36.83 4.64 1.88 -36.99 4.49 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -7.89 -34.48 4.91 -13.85 -35.95 3.01 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER C 173 SER^? 14.26 C2 EPE C 377 B 48 THR B 177 THR^? 19.16 C2 EPE C 377 B 165 LYS C 154 LYS~? 23.94 C1 TRS A 378 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 13.37 -42.81 12.12 14.73 -44.10 13.72 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 9.43 -46.41 11.44 10.68 -47.97 10.55 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 18.67 -47.92 22.36 20.33 -51.69 25.99 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 173 SER^? 8.70 C6 EPE C 377 C 48 THR C 177 THR^? 8.04 C8 EPE C 377 C 165 LYS A 154 LYS~? 18.09 O1S EPE C 377 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 17.10 -34.58 2.20 18.37 -33.49 0.48 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 20.64 -38.60 2.16 21.28 -38.84 0.08 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 24.03 -26.17 -4.04 26.99 -24.22 -8.52 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER B 173 SER^? 8.63 C9 EPE A 377 C 48 THR A 177 THR^? 8.80 C6 EPE A 377 C 165 LYS B 154 LYS~? 18.23 O3S EPE A 377 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 4.35 -36.83 4.64 1.88 -36.99 4.49 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -7.89 -34.48 4.91 -13.85 -35.95 3.01 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER C 173 SER^? 14.26 C2 EPE C 377 C 48 THR B 177 THR^? 19.16 C2 EPE C 377 C 165 LYS C 154 LYS~? 23.94 C1 TRS A 378 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 13.37 -42.81 12.12 14.73 -44.10 13.72 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 9.43 -46.41 11.44 10.68 -47.97 10.55 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 18.67 -47.92 22.36 20.33 -51.69 25.99 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 173 SER^? 8.70 C6 EPE C 377 D 48 THR C 177 THR^? 8.04 C8 EPE C 377 D 165 LYS A 154 LYS~? 18.09 O1S EPE C 377 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 17.10 -34.58 2.20 18.37 -33.49 0.48 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 20.64 -38.60 2.16 21.28 -38.84 0.08 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 24.03 -26.17 -4.04 26.99 -24.22 -8.52 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER B 173 SER^? 8.63 C9 EPE A 377 D 48 THR A 177 THR^? 8.80 C6 EPE A 377 D 165 LYS B 154 LYS~? 18.23 O3S EPE A 377 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 4.35 -36.83 4.64 1.88 -36.99 4.49 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -7.89 -34.48 4.91 -13.85 -35.95 3.01 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER C 173 SER^? 14.26 C2 EPE C 377 D 48 THR B 177 THR^? 19.16 C2 EPE C 377 D 165 LYS C 154 LYS~? 23.94 C1 TRS A 378 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 13.37 -42.81 12.12 14.73 -44.10 13.72 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 9.43 -46.41 11.44 10.68 -47.97 10.55 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 18.67 -47.92 22.36 20.33 -51.69 25.99 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c07 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 153 ARG~? 11.00 C6 EPE C 377 A 136 GLU A 151 GLU~? 15.60 C7 EPE A 377 A 246 GLU A 150 GLU~? 12.50 C5 EPE C 377 coo 13.48 30.30 107.06 11.75 30.99 109.44 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo 9.46 32.37 115.82 8.50 34.20 115.47 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 11.99 34.33 109.92 10.08 34.19 110.77 22.60 -31.63 -7.22 23.33 -32.82 -5.63 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 153 ARG~? 10.73 C6 EPE A 377 A 136 GLU B 151 GLU~? 19.22 O3S EPE A 377 A 246 GLU B 150 GLU~? 12.97 C6 EPE A 377 coo 13.48 30.30 107.06 11.75 30.99 109.44 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo 9.46 32.37 115.82 8.50 34.20 115.47 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 11.99 34.33 109.92 10.08 34.19 110.77 -6.18 -40.46 2.00 -5.62 -38.68 0.95 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG B 284 ARG^? 30.04 ZN ZN B 375 A 136 GLU B 253 GLU^? 31.12 ZN ZN B 375 A 246 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 13.48 30.30 107.06 11.75 30.99 109.44 1.85 12.86 -2.25 0.88 12.89 -5.16 coo 9.46 32.37 115.82 8.50 34.20 115.47 -5.44 14.03 -5.56 -4.22 13.73 -7.31 coo 11.99 34.33 109.92 10.08 34.19 110.77 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG C 153 ARG~? 15.97 C2 EPE C 377 A 136 GLU C 151 GLU~? 17.15 O8 EPE C 377 A 246 GLU C 150 GLU~? 19.96 C2 EPE C 377 coo 13.48 30.30 107.06 11.75 30.99 109.44 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 9.46 32.37 115.82 8.50 34.20 115.47 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 11.99 34.33 109.92 10.08 34.19 110.77 18.79 -51.73 16.88 16.73 -51.34 17.24 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG C 198 ARG^? 10.55 C8 EPE C 377 A 136 GLU C 201 GLU^? -3.18 C8 EPE C 377s A 246 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 13.48 30.30 107.06 11.75 30.99 109.44 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo 9.46 32.37 115.82 8.50 34.20 115.47 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 11.99 34.33 109.92 10.08 34.19 110.77 22.01 -43.83 0.76 21.98 -45.84 -0.06 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 5 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 153 ARG~? 11.00 C6 EPE C 377 A 136 GLU A 151 GLU~? 15.60 C7 EPE A 377 A 246 GLU A 150 GLU~? 12.50 C5 EPE C 377 coo 13.94 29.84 106.80 11.67 30.40 108.79 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo 9.52 31.97 115.23 8.45 33.74 114.72 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 11.92 33.82 109.35 10.10 33.50 110.39 22.60 -31.63 -7.22 23.33 -32.82 -5.63 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 153 ARG~? 10.73 C6 EPE A 377 A 136 GLU B 151 GLU~? 19.22 O3S EPE A 377 A 246 GLU B 150 GLU~? 12.97 C6 EPE A 377 coo 13.94 29.84 106.80 11.67 30.40 108.79 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo 9.52 31.97 115.23 8.45 33.74 114.72 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 11.92 33.82 109.35 10.10 33.50 110.39 -6.18 -40.46 2.00 -5.62 -38.68 0.95 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG B 284 ARG^? 30.04 ZN ZN B 375 A 136 GLU B 253 GLU^? 31.12 ZN ZN B 375 A 246 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 13.94 29.84 106.80 11.67 30.40 108.79 1.85 12.86 -2.25 0.88 12.89 -5.16 coo 9.52 31.97 115.23 8.45 33.74 114.72 -5.44 14.03 -5.56 -4.22 13.73 -7.31 coo 11.92 33.82 109.35 10.10 33.50 110.39 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG C 153 ARG~? 15.97 C2 EPE C 377 A 136 GLU C 151 GLU~? 17.15 O8 EPE C 377 A 246 GLU C 150 GLU~? 19.96 C2 EPE C 377 coo 13.94 29.84 106.80 11.67 30.40 108.79 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 9.52 31.97 115.23 8.45 33.74 114.72 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 11.92 33.82 109.35 10.10 33.50 110.39 18.79 -51.73 16.88 16.73 -51.34 17.24 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG C 198 ARG^? 10.55 C8 EPE C 377 A 136 GLU C 201 GLU^? -3.18 C8 EPE C 377s A 246 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 13.94 29.84 106.80 11.67 30.40 108.79 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo 9.52 31.97 115.23 8.45 33.74 114.72 23.53 -40.20 6.95 23.95 -38.27 7.71 coo 11.92 33.82 109.35 10.10 33.50 110.39 22.01 -43.83 0.76 21.98 -45.84 -0.06 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 5 hits 1fob_c00 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 281 ARG A 274 ARG^? 15.42 ZN ZN A 374 A 289 TYR A 314 TYR~? 12.17 O8 EPE A 376 coo 54.86 40.00 47.23 55.57 38.60 48.67 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 52.08 40.18 50.14 50.83 38.93 47.73 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 57.82 31.70 50.73 57.94 34.00 49.17 36.88 -2.62 44.67 35.35 -1.67 42.53 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 281 ARG B 274 ARG^? 15.33 ZN ZN B 374 A 289 TYR B 314 TYR~? 14.73 O8 EPE B 376 coo 54.86 40.00 47.23 55.57 38.60 48.67 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 52.08 40.18 50.14 50.83 38.93 47.73 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 57.82 31.70 50.73 57.94 34.00 49.17 2.08 17.58 27.10 3.13 18.35 29.60 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 3 3 # 3 A 54 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 281 ARG C 274 ARG^? 15.09 ZN ZN C 374 A 289 TYR C 314 TYR~? 12.22 O8 EPE C 376 coo 54.86 40.00 47.23 55.57 38.60 48.67 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 52.08 40.18 50.14 50.83 38.93 47.73 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 57.82 31.70 50.73 57.94 34.00 49.17 -3.69 -15.10 57.54 -1.00 -15.00 58.41 1foh_c00 source 1foh PHENOL HYDROXYLASE : 3 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 281 ARG A 274 ARG^? 15.42 ZN ZN A 374 B 289 TYR A 314 TYR~? 12.17 O8 EPE A 376 coo 90.56 80.24 98.04 90.36 81.53 96.34 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 86.62 80.67 97.51 87.37 82.00 100.10 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 91.83 88.28 92.88 92.60 85.93 94.14 36.88 -2.62 44.67 35.35 -1.67 42.53 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 281 ARG B 274 ARG^? 15.33 ZN ZN B 374 B 289 TYR B 314 TYR~? 14.73 O8 EPE B 376 coo 90.56 80.24 98.04 90.36 81.53 96.34 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 86.62 80.67 97.51 87.37 82.00 100.10 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 91.83 88.28 92.88 92.60 85.93 94.14 2.08 17.58 27.10 3.13 18.35 29.60 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 3 3 # 3 B 54 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 281 ARG C 274 ARG^? 15.09 ZN ZN C 374 B 289 TYR C 314 TYR~? 12.22 O8 EPE C 376 coo 90.56 80.24 98.04 90.36 81.53 96.34 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 86.62 80.67 97.51 87.37 82.00 100.10 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 91.83 88.28 92.88 92.60 85.93 94.14 -3.69 -15.10 57.54 -1.00 -15.00 58.41 1foh_c01 source 1foh PHENOL HYDROXYLASE : 3 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 330 ASP^? 12.08 ZN ZN A 374 C 281 ARG A 274 ARG^? 15.42 ZN ZN A 374 C 289 TYR A 314 TYR~? 12.17 O8 EPE A 376 coo 42.34 76.83 49.10 43.06 78.59 50.01 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 46.12 77.15 48.13 44.44 77.61 45.70 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 42.69 86.18 51.69 41.59 83.63 51.54 36.88 -2.62 44.67 35.35 -1.67 42.53 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP B 330 ASP^? 11.92 ZN ZN B 374 C 281 ARG B 274 ARG^? 15.33 ZN ZN B 374 C 289 TYR B 314 TYR~? 14.73 O8 EPE B 376 coo 42.34 76.83 49.10 43.06 78.59 50.01 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 46.12 77.15 48.13 44.44 77.61 45.70 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 42.69 86.18 51.69 41.59 83.63 51.54 2.08 17.58 27.10 3.13 18.35 29.60 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 3 3 # 3 C 54 ASP C 330 ASP^? 11.91 ZN ZN C 374 C 281 ARG C 274 ARG^? 15.09 ZN ZN C 374 C 289 TYR C 314 TYR~? 12.22 O8 EPE C 376 coo 42.34 76.83 49.10 43.06 78.59 50.01 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 46.12 77.15 48.13 44.44 77.61 45.70 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 42.69 86.18 51.69 41.59 83.63 51.54 -3.69 -15.10 57.54 -1.00 -15.00 58.41 1foh_c02 source 1foh PHENOL HYDROXYLASE : 3 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP A 330 ASP^? 12.08 ZN ZN A 374 D 281 ARG A 274 ARG^? 15.42 ZN ZN A 374 D 289 TYR A 314 TYR~? 12.17 O8 EPE A 376 coo 75.05 45.80 106.18 74.73 43.88 105.51 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 78.52 44.93 104.78 78.72 44.49 107.76 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 72.35 36.51 104.82 72.00 39.20 105.46 36.88 -2.62 44.67 35.35 -1.67 42.53 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 2 3 # 2 D 54 ASP B 330 ASP^? 11.92 ZN ZN B 374 D 281 ARG B 274 ARG^? 15.33 ZN ZN B 374 D 289 TYR B 314 TYR~? 14.73 O8 EPE B 376 coo 75.05 45.80 106.18 74.73 43.88 105.51 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 78.52 44.93 104.78 78.72 44.49 107.76 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 72.35 36.51 104.82 72.00 39.20 105.46 2.08 17.58 27.10 3.13 18.35 29.60 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 3 3 # 3 D 54 ASP C 330 ASP^? 11.91 ZN ZN C 374 D 281 ARG C 274 ARG^? 15.09 ZN ZN C 374 D 289 TYR C 314 TYR~? 12.22 O8 EPE C 376 coo 75.05 45.80 106.18 74.73 43.88 105.51 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 78.52 44.93 104.78 78.72 44.49 107.76 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 72.35 36.51 104.82 72.00 39.20 105.46 -3.69 -15.10 57.54 -1.00 -15.00 58.41 1foh_c03 source 1foh PHENOL HYDROXYLASE : 3 hits 1foh_c03 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 331 GLU B 56 GLU~? 18.10 ZN ZN B 374 B 188 HIS B 361 HIS^? 22.30 ZN ZN B 375 coo 130.22 155.23 83.49 125.21 153.71 84.04 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 120.90 152.23 75.28 120.94 153.09 77.19 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 122.04 152.80 81.06 120.71 154.37 81.46 -29.54 0.86 20.66 -31.47 0.05 20.77 ULMN 3 1fuq_c00 FUMARASE C user 2 3 # 2 A 324 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 331 GLU C 56 GLU~? 18.45 ZN ZN C 374 B 188 HIS C 361 HIS^? 22.27 ZN ZN C 375 coo 130.22 155.23 83.49 125.21 153.71 84.04 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 120.90 152.23 75.28 120.94 153.09 77.19 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 122.04 152.80 81.06 120.71 154.37 81.46 17.80 -42.63 61.65 19.35 -43.97 62.12 1fuq_c00 source 1fuq FUMARASE C : 2 hits 1fuq_c00 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG A 153 ARG~? 11.00 C6 EPE C 377 A 201 HIS A 224 HIS~? 7.33 C7 EPE A 377 A 204 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo -27.47 20.45 37.96 -26.70 17.86 36.51 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo -15.08 14.90 41.58 -16.70 13.64 42.02 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo -15.44 20.23 39.72 -16.43 18.87 38.47 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG A 274 ARG^? 15.42 ZN ZN A 374 A 201 HIS A 316 HIS~? 20.33 O8 EPE A 376 A 204 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo -27.47 20.45 37.96 -26.70 17.86 36.51 47.87 -1.95 44.32 44.79 -1.96 44.32 coo -15.08 14.90 41.58 -16.70 13.64 42.02 36.36 -5.20 52.06 36.55 -4.24 53.92 coo -15.44 20.23 39.72 -16.43 18.87 38.47 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 3 3 # 3 A 197 ARG B 153 ARG~? 10.73 C6 EPE A 377 A 201 HIS B 224 HIS.? 17.79 O2S EPE A 377 A 204 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 4 3 # 4 A 197 ARG B 274 ARG^? 15.33 ZN ZN B 374 A 201 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 204 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -4.90 23.06 20.40 -3.60 21.04 22.31 coo -15.08 14.90 41.58 -16.70 13.64 42.02 7.45 20.77 27.47 7.65 22.47 28.71 coo -15.44 20.23 39.72 -16.43 18.87 38.47 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 5 3 # 5 A 197 ARG C 153 ARG~? 15.97 C2 EPE C 377 A 201 HIS C 224 HIS~? 8.36 C3 EPE C 377 A 204 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo -27.47 20.45 37.96 -26.70 17.86 36.51 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -15.08 14.90 41.58 -16.70 13.64 42.02 26.69 -40.96 16.23 26.39 -40.40 14.23 coo -15.44 20.23 39.72 -16.43 18.87 38.47 27.13 -47.60 14.36 28.94 -48.66 14.50 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 6 3 # 6 A 197 ARG C 274 ARG^? 15.09 ZN ZN C 374 A 201 HIS C 316 HIS~? -20.42 O8 EPE C 376s A 204 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 7 3 # 7 A 197 ARG C 274 ARG^? 15.09 ZN ZN C 374 A 201 HIS C 319 HIS~? 24.70 ZN ZN C 374 A 204 HIS C 316 HIS~? -20.42 O8 EPE C 376s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -9.15 -10.09 56.84 -9.69 -8.65 58.28 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 7 hits 1g8f_c00 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 56 GLU~? 18.18 ZN ZN A 374 516 HIS A 42 HIS^? 26.23 ZN ZN A 375 559 HIS A 361 HIS^? 22.47 ZN ZN A 375 coo 49.01 14.50 52.53 46.99 14.61 52.78 47.24 13.21 19.42 47.19 11.28 20.29 coo 41.59 7.83 54.15 41.16 9.87 53.87 43.48 12.60 9.22 44.86 13.19 7.76 coo 42.22 14.55 52.50 43.91 14.87 53.60 46.25 9.10 12.92 46.66 10.09 11.12 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 2 3 # 2 412 GLU A 151 GLU~? 15.60 C7 EPE A 377 516 HIS A 224 HIS~? 7.33 C7 EPE A 377 559 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo 49.01 14.50 52.53 46.99 14.61 52.78 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 41.59 7.83 54.15 41.16 9.87 53.87 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 42.22 14.55 52.50 43.91 14.87 53.60 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 3 3 # 3 412 GLU A 336 GLU~? 2.52 ZN ZN A 375s 516 HIS A 103 HIS~? -4.82 ZN ZN A 375s 559 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 49.01 14.50 52.53 46.99 14.61 52.78 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 41.59 7.83 54.15 41.16 9.87 53.87 32.91 0.46 27.63 33.66 0.11 29.56 coo 42.22 14.55 52.50 43.91 14.87 53.60 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 4 3 # 4 412 GLU A 336 GLU~? 2.52 ZN ZN A 375s 516 HIS A 103 HIS~? -4.82 ZN ZN A 375s 559 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 49.01 14.50 52.53 46.99 14.61 52.78 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 41.59 7.83 54.15 41.16 9.87 53.87 32.91 0.46 27.63 33.66 0.11 29.56 coo 42.22 14.55 52.50 43.91 14.87 53.60 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 5 3 # 5 412 GLU B 56 GLU~? 18.10 ZN ZN B 374 516 HIS B 42 HIS^? 26.13 ZN ZN B 375 559 HIS B 361 HIS^? 22.30 ZN ZN B 375 coo 49.01 14.50 52.53 46.99 14.61 52.78 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 41.59 7.83 54.15 41.16 9.87 53.87 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 42.22 14.55 52.50 43.91 14.87 53.60 -29.54 0.86 20.66 -31.47 0.05 20.77 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 6 3 # 6 412 GLU B 151 GLU~? 19.22 O3S EPE A 377 516 HIS B 224 HIS.? 17.79 O2S EPE A 377 559 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 49.01 14.50 52.53 46.99 14.61 52.78 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 41.59 7.83 54.15 41.16 9.87 53.87 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 42.22 14.55 52.50 43.91 14.87 53.60 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 7 3 # 7 412 GLU B 227 GLU.? 24.58 O3S EPE A 377 516 HIS B 148 HIS~? 20.83 O3S EPE A 377 559 HIS B 224 HIS.? 17.79 O2S EPE A 377 coo 49.01 14.50 52.53 46.99 14.61 52.78 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 41.59 7.83 54.15 41.16 9.87 53.87 -6.64 -44.75 10.12 -7.62 -46.49 10.77 coo 42.22 14.55 52.50 43.91 14.87 53.60 -4.29 -40.29 15.37 -2.45 -41.31 15.36 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 8 3 # 8 412 GLU B 336 GLU~? 2.48 ZN ZN B 375s 516 HIS B 103 HIS~? 5.04 ZN ZN B 375 559 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 49.01 14.50 52.53 46.99 14.61 52.78 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 41.59 7.83 54.15 41.16 9.87 53.87 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 42.22 14.55 52.50 43.91 14.87 53.60 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 9 3 # 9 412 GLU B 336 GLU~? 2.48 ZN ZN B 375s 516 HIS B 103 HIS~? 5.04 ZN ZN B 375 559 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 49.01 14.50 52.53 46.99 14.61 52.78 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 41.59 7.83 54.15 41.16 9.87 53.87 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 42.22 14.55 52.50 43.91 14.87 53.60 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 10 3 # 10 412 GLU C 56 GLU~? 18.45 ZN ZN C 374 516 HIS C 42 HIS^? 26.23 ZN ZN C 375 559 HIS C 361 HIS^? 22.27 ZN ZN C 375 coo 49.01 14.50 52.53 46.99 14.61 52.78 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 41.59 7.83 54.15 41.16 9.87 53.87 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 42.22 14.55 52.50 43.91 14.87 53.60 17.80 -42.63 61.65 19.35 -43.97 62.12 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 11 3 # 11 412 GLU C 151 GLU~? 17.15 O8 EPE C 377 516 HIS C 224 HIS~? 8.36 C3 EPE C 377 559 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo 49.01 14.50 52.53 46.99 14.61 52.78 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 41.59 7.83 54.15 41.16 9.87 53.87 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 42.22 14.55 52.50 43.91 14.87 53.60 27.13 -47.60 14.36 28.94 -48.66 14.50 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 12 3 # 12 412 GLU C 336 GLU~? 2.53 ZN ZN C 375s 516 HIS C 103 HIS~? 4.97 ZN ZN C 375 559 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 49.01 14.50 52.53 46.99 14.61 52.78 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 41.59 7.83 54.15 41.16 9.87 53.87 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 42.22 14.55 52.50 43.91 14.87 53.60 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 13 3 # 13 412 GLU C 336 GLU~? 2.53 ZN ZN C 375s 516 HIS C 103 HIS~? 4.97 ZN ZN C 375 559 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 49.01 14.50 52.53 46.99 14.61 52.78 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 41.59 7.83 54.15 41.16 9.87 53.87 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 42.22 14.55 52.50 43.91 14.87 53.60 9.38 -25.93 57.43 7.35 -26.43 57.48 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 13 hits 1gal_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 15 GLU~? 17.23 ZN ZN A 375 A 47 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 161 TYR A 18 TYR~? 11.08 ZN ZN A 375 coo 37.12 18.35 73.76 37.09 16.69 72.44 29.50 -0.46 14.62 27.65 0.59 14.66 coo 29.81 8.06 73.13 30.21 10.11 72.95 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 37.29 15.56 67.90 37.37 13.79 70.08 34.99 -4.02 17.62 37.68 -4.71 17.89 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU A 15 GLU~? 17.23 ZN ZN A 375 A 47 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 161 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo 37.12 18.35 73.76 37.09 16.69 72.44 29.50 -0.46 14.62 27.65 0.59 14.66 coo 29.81 8.06 73.13 30.21 10.11 72.95 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 37.29 15.56 67.90 37.37 13.79 70.08 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU B 15 GLU~? 17.09 ZN ZN B 375 A 47 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 161 TYR B 18 TYR~? 10.93 ZN ZN B 375 coo 37.12 18.35 73.76 37.09 16.69 72.44 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 29.81 8.06 73.13 30.21 10.11 72.95 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 37.29 15.56 67.90 37.37 13.79 70.08 -12.77 -5.58 18.92 -13.52 -3.89 16.83 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU B 15 GLU~? 17.09 ZN ZN B 375 A 47 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 161 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 37.12 18.35 73.76 37.09 16.69 72.44 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 29.81 8.06 73.13 30.21 10.11 72.95 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 37.29 15.56 67.90 37.37 13.79 70.08 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 A 36 GLU C 15 GLU~? 17.26 ZN ZN C 375 A 47 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 161 TYR C 18 TYR.? 11.04 ZN ZN C 375 coo 37.12 18.35 73.76 37.09 16.69 72.44 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 29.81 8.06 73.13 30.21 10.11 72.95 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 37.29 15.56 67.90 37.37 13.79 70.08 12.32 -34.51 46.53 10.40 -36.24 47.57 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 A 36 GLU C 15 GLU~? 17.26 ZN ZN C 375 A 47 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 161 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo 37.12 18.35 73.76 37.09 16.69 72.44 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 29.81 8.06 73.13 30.21 10.11 72.95 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 37.29 15.56 67.90 37.37 13.79 70.08 20.27 -30.73 51.89 19.47 -30.85 49.23 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 6 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 15 GLU~? 17.23 ZN ZN A 375 B 47 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 161 TYR A 18 TYR~? 11.08 ZN ZN A 375 coo 53.87 35.49 53.22 55.44 35.72 54.61 29.50 -0.46 14.62 27.65 0.59 14.66 coo 63.47 43.65 53.95 61.45 43.07 54.06 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 56.38 35.81 59.19 58.25 35.77 57.10 34.99 -4.02 17.62 37.68 -4.71 17.89 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU A 15 GLU~? 17.23 ZN ZN A 375 B 47 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 161 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo 53.87 35.49 53.22 55.44 35.72 54.61 29.50 -0.46 14.62 27.65 0.59 14.66 coo 63.47 43.65 53.95 61.45 43.07 54.06 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 56.38 35.81 59.19 58.25 35.77 57.10 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU B 15 GLU~? 17.09 ZN ZN B 375 B 47 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 161 TYR B 18 TYR~? 10.93 ZN ZN B 375 coo 53.87 35.49 53.22 55.44 35.72 54.61 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 63.47 43.65 53.95 61.45 43.07 54.06 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 56.38 35.81 59.19 58.25 35.77 57.10 -12.77 -5.58 18.92 -13.52 -3.89 16.83 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU B 15 GLU~? 17.09 ZN ZN B 375 B 47 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 161 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 53.87 35.49 53.22 55.44 35.72 54.61 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 63.47 43.65 53.95 61.45 43.07 54.06 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 56.38 35.81 59.19 58.25 35.77 57.10 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 B 36 GLU C 15 GLU~? 17.26 ZN ZN C 375 B 47 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 161 TYR C 18 TYR.? 11.04 ZN ZN C 375 coo 53.87 35.49 53.22 55.44 35.72 54.61 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 63.47 43.65 53.95 61.45 43.07 54.06 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 56.38 35.81 59.19 58.25 35.77 57.10 12.32 -34.51 46.53 10.40 -36.24 47.57 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 B 36 GLU C 15 GLU~? 17.26 ZN ZN C 375 B 47 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 161 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo 53.87 35.49 53.22 55.44 35.72 54.61 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 63.47 43.65 53.95 61.45 43.07 54.06 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 56.38 35.81 59.19 58.25 35.77 57.10 20.27 -30.73 51.89 19.47 -30.85 49.23 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 6 hits 1geq_c03 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 64 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 155 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 3.12 38.70 24.20 3.24 38.59 26.33 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 1.90 38.00 29.77 3.91 38.35 29.95 32.91 0.46 27.63 33.66 0.11 29.56 coo 9.89 36.55 37.38 9.27 37.99 36.08 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 64 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 155 ASN A 334 ASN~? 9.69 ZN ZN A 374 coo 3.12 38.70 24.20 3.24 38.59 26.33 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 1.90 38.00 29.77 3.91 38.35 29.95 37.80 0.44 25.56 37.02 -1.29 26.44 coo 9.89 36.55 37.38 9.27 37.99 36.08 45.98 2.64 32.26 46.53 3.77 30.56 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 64 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 155 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 3.12 38.70 24.20 3.24 38.59 26.33 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 1.90 38.00 29.77 3.91 38.35 29.95 40.60 0.33 34.12 38.69 0.39 33.24 coo 9.89 36.55 37.38 9.27 37.99 36.08 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 1gns_c00 SUBTILISIN BPN' user 4 3 # 4 A 32 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 64 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 155 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 3.12 38.70 24.20 3.24 38.59 26.33 39.49 -1.24 39.18 39.76 0.49 37.96 coo 1.90 38.00 29.77 3.91 38.35 29.95 40.60 0.33 34.12 38.69 0.39 33.24 coo 9.89 36.55 37.38 9.27 37.99 36.08 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 1gns_c00 SUBTILISIN BPN' user 5 3 # 5 A 32 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 64 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 155 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo 3.12 38.70 24.20 3.24 38.59 26.33 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 1.90 38.00 29.77 3.91 38.35 29.95 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 9.89 36.55 37.38 9.27 37.99 36.08 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 1gns_c00 SUBTILISIN BPN' user 6 3 # 6 A 32 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 64 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 155 ASN B 334 ASN~? 9.65 ZN ZN B 374 coo 3.12 38.70 24.20 3.24 38.59 26.33 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 1.90 38.00 29.77 3.91 38.35 29.95 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 9.89 36.55 37.38 9.27 37.99 36.08 -13.83 13.67 21.41 -15.89 13.09 21.50 ULMN 3 1gns_c00 SUBTILISIN BPN' user 7 3 # 7 A 32 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 64 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 155 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo 3.12 38.70 24.20 3.24 38.59 26.33 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 1.90 38.00 29.77 3.91 38.35 29.95 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 9.89 36.55 37.38 9.27 37.99 36.08 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 1gns_c00 SUBTILISIN BPN' user 8 3 # 8 A 32 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 64 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 155 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo 3.12 38.70 24.20 3.24 38.59 26.33 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 1.90 38.00 29.77 3.91 38.35 29.95 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 9.89 36.55 37.38 9.27 37.99 36.08 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 1gns_c00 SUBTILISIN BPN' user 9 3 # 9 A 32 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 64 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 155 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 3.12 38.70 24.20 3.24 38.59 26.33 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 1.90 38.00 29.77 3.91 38.35 29.95 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 9.89 36.55 37.38 9.27 37.99 36.08 0.77 -32.01 47.92 1.06 -30.12 48.87 ULMN 3 1gns_c00 SUBTILISIN BPN' user 10 3 # 10 A 32 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 64 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 155 ASN C 334 ASN~? 9.79 ZN ZN C 374 coo 3.12 38.70 24.20 3.24 38.59 26.33 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 1.90 38.00 29.77 3.91 38.35 29.95 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 9.89 36.55 37.38 9.27 37.99 36.08 2.44 -29.45 62.54 3.79 -30.90 63.32 ULMN 3 1gns_c00 SUBTILISIN BPN' user 11 3 # 11 A 32 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 64 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 155 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 3.12 38.70 24.20 3.24 38.59 26.33 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 1.90 38.00 29.77 3.91 38.35 29.95 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 9.89 36.55 37.38 9.27 37.99 36.08 0.77 -32.01 47.92 1.06 -30.12 48.87 1gns_c00 source 1gns SUBTILISIN BPN' : 11 hits 1gns_c00 naa= 3 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 105 ASN~? 9.65 ZN ZN A 375 A 108 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 144 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 51.28 61.14 17.85 51.16 61.61 19.96 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 52.62 57.63 23.12 50.77 57.51 22.26 32.91 0.46 27.63 33.66 0.11 29.56 coo 46.65 56.95 20.09 48.42 58.17 20.01 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN A 105 ASN~? 9.65 ZN ZN A 375 A 108 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 144 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 51.28 61.14 17.85 51.16 61.61 19.96 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 52.62 57.63 23.12 50.77 57.51 22.26 32.91 0.46 27.63 33.66 0.11 29.56 coo 46.65 56.95 20.09 48.42 58.17 20.01 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 A 106 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 108 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 144 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 51.28 61.14 17.85 51.16 61.61 19.96 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 52.62 57.63 23.12 50.77 57.51 22.26 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 46.65 56.95 20.09 48.42 58.17 20.01 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 A 106 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 108 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 144 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 51.28 61.14 17.85 51.16 61.61 19.96 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 52.62 57.63 23.12 50.77 57.51 22.26 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 46.65 56.95 20.09 48.42 58.17 20.01 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 A 106 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 108 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 144 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 51.28 61.14 17.85 51.16 61.61 19.96 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 52.62 57.63 23.12 50.77 57.51 22.26 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 46.65 56.95 20.09 48.42 58.17 20.01 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 3 # 6 A 106 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 108 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 144 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 51.28 61.14 17.85 51.16 61.61 19.96 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 52.62 57.63 23.12 50.77 57.51 22.26 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 46.65 56.95 20.09 48.42 58.17 20.01 5.80 -28.16 48.27 6.08 -27.64 50.28 1grc_c02 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 6 hits 1grc_c02 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 105 ASN~? 9.65 ZN ZN A 375 B 108 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 144 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 36.64 101.02 13.15 38.55 101.84 12.78 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 41.00 107.18 12.86 42.70 107.82 11.96 37.80 0.44 25.56 37.02 -1.29 26.44 coo 31.60 110.69 6.14 29.69 109.74 5.94 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN A 334 ASN~? 9.69 ZN ZN A 374 B 108 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 144 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 36.64 101.02 13.15 38.55 101.84 12.78 45.98 2.64 32.26 46.53 3.77 30.56 coo 41.00 107.18 12.86 42.70 107.82 11.96 37.42 3.90 29.26 38.47 2.36 30.22 coo 31.60 110.69 6.14 29.69 109.74 5.94 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN A 334 ASN~? 9.69 ZN ZN A 374 B 108 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 144 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 36.64 101.02 13.15 38.55 101.84 12.78 45.98 2.64 32.26 46.53 3.77 30.56 coo 41.00 107.18 12.86 42.70 107.82 11.96 40.60 0.33 34.12 38.69 0.39 33.24 coo 31.60 110.69 6.14 29.69 109.74 5.94 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN B 105 ASN~? 9.47 ZN ZN B 375 B 108 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 144 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 36.64 101.02 13.15 38.55 101.84 12.78 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 41.00 107.18 12.86 42.70 107.82 11.96 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 31.60 110.69 6.14 29.69 109.74 5.94 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 B 106 ASN B 334 ASN~? 9.65 ZN ZN B 374 B 108 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 144 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 36.64 101.02 13.15 38.55 101.84 12.78 -13.83 13.67 21.41 -15.89 13.09 21.50 coo 41.00 107.18 12.86 42.70 107.82 11.96 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 31.60 110.69 6.14 29.69 109.74 5.94 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 3 # 6 B 106 ASN B 334 ASN~? 9.65 ZN ZN B 374 B 108 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 144 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 36.64 101.02 13.15 38.55 101.84 12.78 -13.83 13.67 21.41 -15.89 13.09 21.50 coo 41.00 107.18 12.86 42.70 107.82 11.96 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 31.60 110.69 6.14 29.69 109.74 5.94 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 7 3 # 7 B 106 ASN C 105 ASN~? 9.60 ZN ZN C 375 B 108 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 144 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 36.64 101.02 13.15 38.55 101.84 12.78 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 41.00 107.18 12.86 42.70 107.82 11.96 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 31.60 110.69 6.14 29.69 109.74 5.94 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 8 3 # 8 B 106 ASN C 334 ASN~? 9.79 ZN ZN C 374 B 108 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 144 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 36.64 101.02 13.15 38.55 101.84 12.78 2.44 -29.45 62.54 3.79 -30.90 63.32 coo 41.00 107.18 12.86 42.70 107.82 11.96 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 31.60 110.69 6.14 29.69 109.74 5.94 5.80 -28.16 48.27 6.08 -27.64 50.28 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 8 hits 1grc_c03 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 154 LYS~? 18.09 O1S EPE C 377 210 ARG A 203 ARG^? 8.58 O3S EPE C 377 225 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 17.51 28.50 73.42 17.24 23.02 75.86 24.03 -26.17 -4.04 26.99 -24.22 -8.52 coo 24.74 11.56 73.05 25.29 14.32 71.80 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 27.81 15.44 77.10 25.66 16.50 75.19 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 154 LYS~? 18.09 O1S EPE C 377 210 ARG C 203 ARG^? 8.27 O3S EPE C 377 225 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 17.51 28.50 73.42 17.24 23.02 75.86 24.03 -26.17 -4.04 26.99 -24.22 -8.52 coo 24.74 11.56 73.05 25.29 14.32 71.80 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 27.81 15.44 77.10 25.66 16.50 75.19 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS B 154 LYS~? 18.23 O3S EPE A 377 210 ARG A 203 ARG^? 8.58 O3S EPE C 377 225 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 17.51 28.50 73.42 17.24 23.02 75.86 -7.89 -34.48 4.91 -13.85 -35.95 3.01 coo 24.74 11.56 73.05 25.29 14.32 71.80 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 27.81 15.44 77.10 25.66 16.50 75.19 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS B 154 LYS~? 18.23 O3S EPE A 377 210 ARG B 203 ARG^? 8.69 O2S EPE A 377 225 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 17.51 28.50 73.42 17.24 23.02 75.86 -7.89 -34.48 4.91 -13.85 -35.95 3.01 coo 24.74 11.56 73.05 25.29 14.32 71.80 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 27.81 15.44 77.10 25.66 16.50 75.19 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS C 154 LYS~? 23.94 C1 TRS A 378 210 ARG B 203 ARG^? 8.69 O2S EPE A 377 225 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 17.51 28.50 73.42 17.24 23.02 75.86 18.67 -47.92 22.36 20.33 -51.69 25.99 coo 24.74 11.56 73.05 25.29 14.32 71.80 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 27.81 15.44 77.10 25.66 16.50 75.19 15.41 -35.90 9.66 13.77 -33.95 11.43 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 5 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 260 PHE~? 19.27 ZN ZN A 375 A 298 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 329 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 2.59 0.29 25.55 4.65 0.18 25.07 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 12.42 6.10 23.27 9.95 1.57 20.16 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 370 PHE.? 12.81 O8 EPE A 376 A 298 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 329 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 46.70 4.90 39.59 44.12 4.72 40.65 coo 2.59 0.29 25.55 4.65 0.18 25.07 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 12.42 6.10 23.27 9.95 1.57 20.16 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 370 PHE.? 12.81 O8 EPE A 376 A 298 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 329 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 46.70 4.90 39.59 44.12 4.72 40.65 coo 2.59 0.29 25.55 4.65 0.18 25.07 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 12.42 6.10 23.27 9.95 1.57 20.16 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE B 260 PHE~? 19.39 ZN ZN B 375 A 298 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 329 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 2.59 0.29 25.55 4.65 0.18 25.07 3.99 14.73 5.36 5.18 14.04 3.76 coo 12.42 6.10 23.27 9.95 1.57 20.16 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE B 370 PHE.? 12.32 O8 EPE B 376 A 298 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 329 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 2.59 0.29 25.55 4.65 0.18 25.07 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 12.42 6.10 23.27 9.95 1.57 20.16 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE B 370 PHE.? 12.32 O8 EPE B 376 A 298 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 329 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 2.59 0.29 25.55 4.65 0.18 25.07 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 12.42 6.10 23.27 9.95 1.57 20.16 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE C 260 PHE~? 19.40 ZN ZN C 375 A 298 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 329 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 2.59 0.29 25.55 4.65 0.18 25.07 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 12.42 6.10 23.27 9.95 1.57 20.16 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE C 370 PHE.? 12.75 O8 EPE C 376 A 298 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 329 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 2.59 0.29 25.55 4.65 0.18 25.07 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 12.42 6.10 23.27 9.95 1.57 20.16 -6.09 -33.65 68.04 -3.07 -37.10 68.37 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 260 PHE~? 19.27 ZN ZN A 375 B 298 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 329 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 370 PHE.? 12.81 O8 EPE A 376 B 298 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 329 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 46.70 4.90 39.59 44.12 4.72 40.65 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 370 PHE.? 12.81 O8 EPE A 376 B 298 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 329 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 46.70 4.90 39.59 44.12 4.72 40.65 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE B 260 PHE~? 19.39 ZN ZN B 375 B 298 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 329 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 3.99 14.73 5.36 5.18 14.04 3.76 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE B 370 PHE.? 12.32 O8 EPE B 376 B 298 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 329 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE B 370 PHE.? 12.32 O8 EPE B 376 B 298 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 329 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE C 260 PHE~? 19.40 ZN ZN C 375 B 298 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 329 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE C 370 PHE.? 12.75 O8 EPE C 376 B 298 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 329 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -6.09 -33.65 68.04 -3.07 -37.10 68.37 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 260 PHE~? 19.27 ZN ZN A 375 C 298 ASP A 306 ASP.? 24.91 ZN ZN A 375 C 329 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 17.41 60.57 64.39 18.40 58.12 65.34 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 24.10 66.43 63.33 24.18 64.30 63.40 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 27.64 56.61 58.17 22.18 57.92 60.36 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 370 PHE.? 12.81 O8 EPE A 376 C 298 ASP A 330 ASP^? 12.08 ZN ZN A 374 C 329 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 17.41 60.57 64.39 18.40 58.12 65.34 46.70 4.90 39.59 44.12 4.72 40.65 coo 24.10 66.43 63.33 24.18 64.30 63.40 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 27.64 56.61 58.17 22.18 57.92 60.36 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 370 PHE.? 12.81 O8 EPE A 376 C 298 ASP A 330 ASP^? 12.08 ZN ZN A 374 C 329 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 17.41 60.57 64.39 18.40 58.12 65.34 46.70 4.90 39.59 44.12 4.72 40.65 coo 24.10 66.43 63.33 24.18 64.30 63.40 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 27.64 56.61 58.17 22.18 57.92 60.36 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE B 260 PHE~? 19.39 ZN ZN B 375 C 298 ASP B 306 ASP.? 24.86 ZN ZN B 375 C 329 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 17.41 60.57 64.39 18.40 58.12 65.34 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 24.10 66.43 63.33 24.18 64.30 63.40 3.99 14.73 5.36 5.18 14.04 3.76 coo 27.64 56.61 58.17 22.18 57.92 60.36 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE B 370 PHE.? 12.32 O8 EPE B 376 C 298 ASP B 330 ASP^? 11.92 ZN ZN B 374 C 329 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 17.41 60.57 64.39 18.40 58.12 65.34 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 24.10 66.43 63.33 24.18 64.30 63.40 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 27.64 56.61 58.17 22.18 57.92 60.36 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE B 370 PHE.? 12.32 O8 EPE B 376 C 298 ASP B 330 ASP^? 11.92 ZN ZN B 374 C 329 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 17.41 60.57 64.39 18.40 58.12 65.34 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 24.10 66.43 63.33 24.18 64.30 63.40 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 27.64 56.61 58.17 22.18 57.92 60.36 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE C 260 PHE~? 19.40 ZN ZN C 375 C 298 ASP C 306 ASP.? 24.81 ZN ZN C 375 C 329 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 17.41 60.57 64.39 18.40 58.12 65.34 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 24.10 66.43 63.33 24.18 64.30 63.40 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 27.64 56.61 58.17 22.18 57.92 60.36 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE C 370 PHE.? 12.75 O8 EPE C 376 C 298 ASP C 330 ASP^? 11.91 ZN ZN C 374 C 329 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 17.41 60.57 64.39 18.40 58.12 65.34 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 24.10 66.43 63.33 24.18 64.30 63.40 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 27.64 56.61 58.17 22.18 57.92 60.36 -6.09 -33.65 68.04 -3.07 -37.10 68.37 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 260 PHE~? 19.27 ZN ZN A 375 D 298 ASP A 306 ASP.? 24.91 ZN ZN A 375 D 329 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 35.44 53.35 83.81 35.65 54.53 81.28 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 29.72 46.46 83.60 30.79 47.36 81.99 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 36.89 44.91 74.55 37.33 48.94 79.01 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 370 PHE.? 12.81 O8 EPE A 376 D 298 ASP A 330 ASP^? 12.08 ZN ZN A 374 D 329 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 35.44 53.35 83.81 35.65 54.53 81.28 46.70 4.90 39.59 44.12 4.72 40.65 coo 29.72 46.46 83.60 30.79 47.36 81.99 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 36.89 44.91 74.55 37.33 48.94 79.01 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 370 PHE.? 12.81 O8 EPE A 376 D 298 ASP A 330 ASP^? 12.08 ZN ZN A 374 D 329 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 35.44 53.35 83.81 35.65 54.53 81.28 46.70 4.90 39.59 44.12 4.72 40.65 coo 29.72 46.46 83.60 30.79 47.36 81.99 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 36.89 44.91 74.55 37.33 48.94 79.01 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE B 260 PHE~? 19.39 ZN ZN B 375 D 298 ASP B 306 ASP.? 24.86 ZN ZN B 375 D 329 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 35.44 53.35 83.81 35.65 54.53 81.28 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 29.72 46.46 83.60 30.79 47.36 81.99 3.99 14.73 5.36 5.18 14.04 3.76 coo 36.89 44.91 74.55 37.33 48.94 79.01 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE B 370 PHE.? 12.32 O8 EPE B 376 D 298 ASP B 330 ASP^? 11.92 ZN ZN B 374 D 329 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 35.44 53.35 83.81 35.65 54.53 81.28 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 29.72 46.46 83.60 30.79 47.36 81.99 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 36.89 44.91 74.55 37.33 48.94 79.01 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE B 370 PHE.? 12.32 O8 EPE B 376 D 298 ASP B 330 ASP^? 11.92 ZN ZN B 374 D 329 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 35.44 53.35 83.81 35.65 54.53 81.28 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 29.72 46.46 83.60 30.79 47.36 81.99 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 36.89 44.91 74.55 37.33 48.94 79.01 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE C 260 PHE~? 19.40 ZN ZN C 375 D 298 ASP C 306 ASP.? 24.81 ZN ZN C 375 D 329 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 35.44 53.35 83.81 35.65 54.53 81.28 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 29.72 46.46 83.60 30.79 47.36 81.99 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 36.89 44.91 74.55 37.33 48.94 79.01 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE C 370 PHE.? 12.75 O8 EPE C 376 D 298 ASP C 330 ASP^? 11.91 ZN ZN C 374 D 329 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 35.44 53.35 83.81 35.65 54.53 81.28 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 29.72 46.46 83.60 30.79 47.36 81.99 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 36.89 44.91 74.55 37.33 48.94 79.01 -6.09 -33.65 68.04 -3.07 -37.10 68.37 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN B 195 GLN.? 33.03 C2 EPE C 377 A 296 GLU B 197 GLU^? 29.51 O2S EPE A 377 A 383 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 7.50 -55.59 25.09 5.78 -56.84 25.13 coo 40.93 4.45 2.36 38.91 3.75 2.26 6.54 -53.58 20.85 4.69 -53.18 21.76 coo 30.54 7.22 6.23 31.38 5.79 3.97 3.31 -45.81 25.21 0.69 -46.75 24.83 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN C 252 GLN^? 27.68 ZN ZN C 375 A 296 GLU C 253 GLU^? 31.42 ZN ZN C 375 A 383 TYR C 250 TYR^? 23.68 ZN ZN C 375 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -14.38 -45.23 48.69 -13.74 -46.18 46.86 coo 40.93 4.45 2.36 38.91 3.75 2.26 -18.88 -44.02 49.77 -19.94 -45.34 51.07 coo 30.54 7.22 6.23 31.38 5.79 3.97 -13.28 -36.84 42.94 -13.77 -34.96 40.91 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 2 hits 1h19_c00 naa= 3 ULMN 3 1hrk_c00 FERROCHELATASE user 1 3 # 1 A 263 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 341 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 343 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 37.80 0.44 25.56 37.02 -1.29 26.44 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 40.60 0.33 34.12 38.69 0.39 33.24 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1hrk_c00 FERROCHELATASE user 2 3 # 2 A 263 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 341 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 343 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 40.60 0.33 34.12 38.69 0.39 33.24 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 37.80 0.44 25.56 37.02 -1.29 26.44 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1hrk_c00 FERROCHELATASE user 3 3 # 3 A 263 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 341 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 343 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1hrk_c00 FERROCHELATASE user 4 3 # 4 A 263 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 341 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 343 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1hrk_c00 FERROCHELATASE user 5 3 # 5 A 263 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 341 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 343 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1hrk_c00 FERROCHELATASE user 6 3 # 6 A 263 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 341 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 343 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 3.38 -29.70 55.34 4.58 -28.10 54.66 1hrk_c00 source 1hrk FERROCHELATASE : 6 hits 1hrk_c00 naa= 3 ULMN 3 1hrk_c01 FERROCHELATASE user 1 3 # 1 B 263 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 341 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 343 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 37.80 0.44 25.56 37.02 -1.29 26.44 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 40.60 0.33 34.12 38.69 0.39 33.24 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1hrk_c01 FERROCHELATASE user 2 3 # 2 B 263 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 341 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 343 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 40.60 0.33 34.12 38.69 0.39 33.24 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 37.80 0.44 25.56 37.02 -1.29 26.44 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1hrk_c01 FERROCHELATASE user 3 3 # 3 B 263 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 341 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 343 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1hrk_c01 FERROCHELATASE user 4 3 # 4 B 263 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 341 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 343 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1hrk_c01 FERROCHELATASE user 5 3 # 5 B 263 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 341 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 343 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1hrk_c01 FERROCHELATASE user 6 3 # 6 B 263 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 341 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 343 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 3.38 -29.70 55.34 4.58 -28.10 54.66 1hrk_c01 source 1hrk FERROCHELATASE : 6 hits 1hrk_c01 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 327 GLU A 150 GLU~? 12.50 C5 EPE C 377 A 339 ARG C 198 ARG^? 10.55 C8 EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 75.11 41.01 160.30 76.65 40.06 161.41 22.60 -31.63 -7.22 23.33 -32.82 -5.63 coo 82.23 40.35 159.87 85.09 40.67 161.01 24.16 -38.26 -3.08 24.91 -35.49 -4.23 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 327 GLU C 150 GLU~? 19.96 C2 EPE C 377 A 339 ARG C 153 ARG~? 15.97 C2 EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 75.11 41.01 160.30 76.65 40.06 161.41 18.79 -51.73 16.88 16.73 -51.34 17.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 15.73 -46.74 16.59 16.35 -47.76 13.75 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 327 GLU C 200 GLU^? 10.81 O8 EPE C 377 A 339 ARG C 198 ARG^? 10.55 C8 EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 75.11 41.01 160.30 76.65 40.06 161.41 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 82.23 40.35 159.87 85.09 40.67 161.01 24.16 -38.26 -3.08 24.91 -35.49 -4.23 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 327 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 339 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 75.11 41.01 160.30 76.65 40.06 161.41 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 82.23 40.35 159.87 85.09 40.67 161.01 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 327 GLU C 150 GLU~? 19.96 C2 EPE C 377 A 339 ARG C 153 ARG~? 15.97 C2 EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 75.11 41.01 160.30 76.65 40.06 161.41 18.79 -51.73 16.88 16.73 -51.34 17.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 15.73 -46.74 16.59 16.35 -47.76 13.75 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP A 352 ASP~? 25.70 ZN ZN A 375 A 327 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 339 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 43.66 -0.56 3.32 44.78 0.99 4.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 82.23 40.35 159.87 85.09 40.67 161.01 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP A 352 ASP~? 25.70 ZN ZN A 375 A 327 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 339 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 43.66 -0.56 3.32 44.78 0.99 4.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 82.23 40.35 159.87 85.09 40.67 161.01 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 327 GLU B 150 GLU~? 12.97 C6 EPE A 377 A 339 ARG A 198 ARG^? 11.16 C6 EPE A 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 75.11 41.01 160.30 76.65 40.06 161.41 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 -1.05 -38.83 -3.85 -3.04 -38.62 -1.48 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 327 GLU A 200 GLU^? 11.53 C6 EPE A 377 A 339 ARG A 198 ARG^? 11.16 C6 EPE A 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 75.11 41.01 160.30 76.65 40.06 161.41 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 82.23 40.35 159.87 85.09 40.67 161.01 -1.05 -38.83 -3.85 -3.04 -38.62 -1.48 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 327 GLU C 254 GLU^? 30.85 ZN ZN C 375 A 339 ARG C 284 ARG^? 27.80 ZN ZN C 375 coo 85.81 57.99 116.01 86.03 55.86 115.89 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 75.11 41.01 160.30 76.65 40.06 161.41 -21.46 -36.51 49.50 -23.48 -36.16 48.85 coo 82.23 40.35 159.87 85.09 40.67 161.01 -17.70 -37.64 45.94 -17.45 -40.51 44.86 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 327 GLU B 253 GLU^? 31.12 ZN ZN B 375 A 339 ARG B 284 ARG^? 30.04 ZN ZN B 375 coo 85.81 57.99 116.01 86.03 55.86 115.89 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 75.11 41.01 160.30 76.65 40.06 161.41 -5.44 14.03 -5.56 -4.22 13.73 -7.31 coo 82.23 40.35 159.87 85.09 40.67 161.01 1.85 12.86 -2.25 0.88 12.89 -5.16 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP B 237 ASP^? 15.58 N TRS A 378 A 327 GLU A 254 GLU^? 30.93 ZN ZN A 375 A 339 ARG A 284 ARG^? 28.58 ZN ZN A 375 coo 85.81 57.99 116.01 86.03 55.86 115.89 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 75.11 41.01 160.30 76.65 40.06 161.41 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 52.06 -24.03 32.92 53.49 -25.85 30.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 13 3 # 13 A 50 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 327 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 339 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 75.11 41.01 160.30 76.65 40.06 161.41 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 82.23 40.35 159.87 85.09 40.67 161.01 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 14 3 # 14 A 50 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 327 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 339 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 3.99 14.73 5.36 5.18 14.04 3.76 coo 75.11 41.01 160.30 76.65 40.06 161.41 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 82.23 40.35 159.87 85.09 40.67 161.01 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 15 3 # 15 A 50 ASP B 352 ASP~? 25.82 ZN ZN B 375 A 327 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 339 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 82.23 40.35 159.87 85.09 40.67 161.01 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 16 3 # 16 A 50 ASP B 352 ASP~? 25.82 ZN ZN B 375 A 327 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 339 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 82.23 40.35 159.87 85.09 40.67 161.01 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 17 3 # 17 A 50 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 327 GLU B 200 GLU^? 21.89 O2S EPE A 377 A 339 ARG B 198 ARG^? 21.95 C2 EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 11.64 -52.94 14.57 14.19 -52.83 16.31 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 18 3 # 18 A 50 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 327 GLU B 150 GLU~? 12.97 C6 EPE A 377 A 339 ARG B 153 ARG~? 10.73 C6 EPE A 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 75.11 41.01 160.30 76.65 40.06 161.41 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 -1.46 -36.52 4.12 -1.19 -38.78 2.09 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 19 3 # 19 A 50 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 327 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 339 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 75.11 41.01 160.30 76.65 40.06 161.41 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 82.23 40.35 159.87 85.09 40.67 161.01 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 20 3 # 20 A 50 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 327 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 339 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 75.11 41.01 160.30 76.65 40.06 161.41 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 82.23 40.35 159.87 85.09 40.67 161.01 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 21 3 # 21 A 50 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 327 GLU B 150 GLU~? 12.97 C6 EPE A 377 A 339 ARG B 153 ARG~? 10.73 C6 EPE A 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 75.11 41.01 160.30 76.65 40.06 161.41 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 -1.46 -36.52 4.12 -1.19 -38.78 2.09 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 22 3 # 22 A 50 ASP C 352 ASP~? 25.48 ZN ZN C 375 A 327 GLU A 254 GLU^? 30.93 ZN ZN A 375 A 339 ARG A 284 ARG^? 28.58 ZN ZN A 375 coo 85.81 57.99 116.01 86.03 55.86 115.89 18.63 -50.25 49.90 18.47 -49.69 51.95 coo 75.11 41.01 160.30 76.65 40.06 161.41 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 52.06 -24.03 32.92 53.49 -25.85 30.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 23 3 # 23 A 50 ASP C 352 ASP~? 25.48 ZN ZN C 375 A 327 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 339 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 85.81 57.99 116.01 86.03 55.86 115.89 18.63 -50.25 49.90 18.47 -49.69 51.95 coo 75.11 41.01 160.30 76.65 40.06 161.41 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 82.23 40.35 159.87 85.09 40.67 161.01 10.96 -32.82 5.66 12.34 -31.74 8.19 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 23 hits 1hto_c00 naa= 3 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 A 47 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 107 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 137 SER A 363 SER.? 15.15 ZN ZN A 374 coo 5.11 -0.55 31.43 1.36 1.90 33.24 44.47 1.55 20.70 47.30 5.10 24.27 coo 6.14 -0.73 24.01 6.05 0.83 25.40 37.80 0.44 25.56 37.02 -1.29 26.44 coo 1.06 -1.40 35.67 2.72 0.28 35.10 46.51 8.06 20.34 45.84 9.37 22.25 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 A 47 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 107 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 137 SER B 363 SER.? 15.02 ZN ZN B 374 coo 5.11 -0.55 31.43 1.36 1.90 33.24 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 6.14 -0.73 24.01 6.05 0.83 25.40 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 1.06 -1.40 35.67 2.72 0.28 35.10 -24.68 6.36 21.71 -24.04 7.63 23.71 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 3 3 # 3 A 47 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 107 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 137 SER C 363 SER.? 15.25 ZN ZN C 374 coo 5.11 -0.55 31.43 1.36 1.90 33.24 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 6.14 -0.73 24.01 6.05 0.83 25.40 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 1.06 -1.40 35.67 2.72 0.28 35.10 12.66 -37.79 63.35 12.77 -35.67 64.45 1hy3_c00 source 1hy3 ESTROGEN SULFOTRANSFERASE : 3 hits 1hy3_c00 naa= 3 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 B 47 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 107 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 137 SER A 363 SER.? 15.15 ZN ZN A 374 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 44.47 1.55 20.70 47.30 5.10 24.27 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 37.80 0.44 25.56 37.02 -1.29 26.44 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 46.51 8.06 20.34 45.84 9.37 22.25 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 B 47 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 107 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 137 SER B 363 SER.? 15.02 ZN ZN B 374 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 -24.68 6.36 21.71 -24.04 7.63 23.71 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 3 3 # 3 B 47 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 107 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 137 SER C 363 SER.? 15.25 ZN ZN C 374 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 12.66 -37.79 63.35 12.77 -35.67 64.45 1hy3_c01 source 1hy3 ESTROGEN SULFOTRANSFERASE : 3 hits 1hy3_c01 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 200 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 226 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 23.24 46.58 4.39 24.43 46.59 2.66 37.80 0.44 25.56 37.02 -1.29 26.44 coo 24.51 43.28 11.18 25.17 44.50 9.58 40.70 8.14 28.73 41.06 6.40 29.84 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 23.24 46.58 4.39 24.43 46.59 2.66 37.80 0.44 25.56 37.02 -1.29 26.44 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 23.24 46.58 4.39 24.43 46.59 2.66 37.80 0.44 25.56 37.02 -1.29 26.44 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1i29_c01 CSDB user 4 3 # 4 A 123 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 23.24 46.58 4.39 24.43 46.59 2.66 32.91 0.46 27.63 33.66 0.11 29.56 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1i29_c01 CSDB user 5 3 # 5 A 123 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 23.24 46.58 4.39 24.43 46.59 2.66 32.91 0.46 27.63 33.66 0.11 29.56 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1i29_c01 CSDB user 6 3 # 6 A 123 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 23.24 46.58 4.39 24.43 46.59 2.66 32.91 0.46 27.63 33.66 0.11 29.56 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1i29_c01 CSDB user 7 3 # 7 A 123 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 200 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 226 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 23.24 46.58 4.39 24.43 46.59 2.66 40.60 0.33 34.12 38.69 0.39 33.24 coo 24.51 43.28 11.18 25.17 44.50 9.58 48.24 5.16 33.58 47.82 3.96 35.30 coo 34.47 51.09 7.19 28.58 51.18 7.53 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1i29_c01 CSDB user 8 3 # 8 A 123 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 200 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 226 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 23.24 46.58 4.39 24.43 46.59 2.66 51.10 6.85 29.91 51.20 5.36 31.38 coo 24.51 43.28 11.18 25.17 44.50 9.58 54.82 -1.21 28.36 56.43 0.27 28.67 coo 34.47 51.09 7.19 28.58 51.18 7.53 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1i29_c01 CSDB user 9 3 # 9 A 123 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 200 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 226 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 23.24 46.58 4.39 24.43 46.59 2.66 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 24.51 43.28 11.18 25.17 44.50 9.58 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1i29_c01 CSDB user 10 3 # 10 A 123 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 23.24 46.58 4.39 24.43 46.59 2.66 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1i29_c01 CSDB user 11 3 # 11 A 123 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 23.24 46.58 4.39 24.43 46.59 2.66 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1i29_c01 CSDB user 12 3 # 12 A 123 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 23.24 46.58 4.39 24.43 46.59 2.66 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1i29_c01 CSDB user 13 3 # 13 A 123 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 23.24 46.58 4.39 24.43 46.59 2.66 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1i29_c01 CSDB user 14 3 # 14 A 123 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 23.24 46.58 4.39 24.43 46.59 2.66 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1i29_c01 CSDB user 15 3 # 15 A 123 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 200 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 226 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 23.24 46.58 4.39 24.43 46.59 2.66 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 24.51 43.28 11.18 25.17 44.50 9.58 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 34.47 51.09 7.19 28.58 51.18 7.53 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1i29_c01 CSDB user 16 3 # 16 A 123 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 200 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 226 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 23.24 46.58 4.39 24.43 46.59 2.66 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 24.51 43.28 11.18 25.17 44.50 9.58 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 34.47 51.09 7.19 28.58 51.18 7.53 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1i29_c01 CSDB user 17 3 # 17 A 123 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 200 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 226 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 23.24 46.58 4.39 24.43 46.59 2.66 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 24.51 43.28 11.18 25.17 44.50 9.58 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1i29_c01 CSDB user 18 3 # 18 A 123 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 23.24 46.58 4.39 24.43 46.59 2.66 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1i29_c01 CSDB user 19 3 # 19 A 123 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 23.24 46.58 4.39 24.43 46.59 2.66 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1i29_c01 CSDB user 20 3 # 20 A 123 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 23.24 46.58 4.39 24.43 46.59 2.66 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1i29_c01 CSDB user 21 3 # 21 A 123 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 23.24 46.58 4.39 24.43 46.59 2.66 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1i29_c01 CSDB user 22 3 # 22 A 123 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 23.24 46.58 4.39 24.43 46.59 2.66 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1i29_c01 CSDB user 23 3 # 23 A 123 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 200 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 226 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 23.24 46.58 4.39 24.43 46.59 2.66 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 24.51 43.28 11.18 25.17 44.50 9.58 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 34.47 51.09 7.19 28.58 51.18 7.53 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1i29_c01 CSDB user 24 3 # 24 A 123 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 200 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 226 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 23.24 46.58 4.39 24.43 46.59 2.66 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 24.51 43.28 11.18 25.17 44.50 9.58 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 34.47 51.09 7.19 28.58 51.18 7.53 9.58 -37.42 57.24 8.41 -35.76 62.90 1i29_c01 source 1i29 CSDB : 24 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 43 VAL^? 19.44 ZN ZN A 375 A 200 ASP A 96 ASP.? 22.36 O2S EPE A 376 A 226 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 40.37 8.91 12.63 38.72 7.45 12.36 coo 24.51 43.28 11.18 25.17 44.50 9.58 33.23 19.97 13.69 32.21 21.81 13.47 coo 34.47 51.09 7.19 28.58 51.18 7.53 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 54 VAL~? 14.82 C2 EPE A 376 A 200 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 226 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 41.18 16.00 21.86 39.21 16.72 22.41 coo 24.51 43.28 11.18 25.17 44.50 9.58 40.70 8.14 28.73 41.06 6.40 29.84 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 128 VAL^? 14.60 O3 TRS A 378 A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 36.57 -17.31 27.04 34.80 -16.49 26.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 128 VAL^? 14.60 O3 TRS A 378 A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 36.57 -17.31 27.04 34.80 -16.49 26.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 128 VAL^? 14.60 O3 TRS A 378 A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 36.57 -17.31 27.04 34.80 -16.49 26.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL A 142 VAL^? 8.16 C2 EPE A 377 A 200 ASP B 237 ASP^? 15.58 N TRS A 378 A 226 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.52 -26.27 1.96 13.69 -25.47 0.25 coo 24.51 43.28 11.18 25.17 44.50 9.58 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 34.47 51.09 7.19 28.58 51.18 7.53 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL A 181 VAL^? 10.03 C5 EPE A 377 A 200 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 226 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -5.53 -28.06 -3.45 -7.50 -28.73 -2.70 coo 24.51 43.28 11.18 25.17 44.50 9.58 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL A 202 VAL^? 9.55 C2 EPE A 377 A 200 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 226 LYS A 218 LYS~? 21.49 C3 EPE A 377 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.15 -33.71 -1.42 14.04 -34.10 -2.36 coo 24.51 43.28 11.18 25.17 44.50 9.58 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 34.47 51.09 7.19 28.58 51.18 7.53 17.38 -15.22 -1.06 17.49 -9.91 -3.23 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL A 202 VAL^? 9.55 C2 EPE A 377 A 200 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 226 LYS C 139 LYS^? 16.11 N TRS A 378 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.15 -33.71 -1.42 14.04 -34.10 -2.36 coo 24.51 43.28 11.18 25.17 44.50 9.58 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 34.47 51.09 7.19 28.58 51.18 7.53 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL A 216 VAL~? 11.74 O1S EPE C 377 A 200 ASP B 237 ASP^? 15.58 N TRS A 378 A 226 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 19.13 38.05 1.41 19.72 38.80 -0.53 20.56 -17.95 2.37 21.08 -19.60 3.74 coo 24.51 43.28 11.18 25.17 44.50 9.58 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 34.47 51.09 7.19 28.58 51.18 7.53 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1i29_c03 CSDB user 11 3 # 11 A 128 VAL A 233 VAL^? 11.84 O1S EPE A 377 A 200 ASP A 237 ASP^? 6.80 N TRS A 378 A 226 LYS C 239 LYS^? 16.29 N TRS A 378 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.65 -21.47 9.47 13.76 -19.72 8.97 coo 24.51 43.28 11.18 25.17 44.50 9.58 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 34.47 51.09 7.19 28.58 51.18 7.53 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1i29_c03 CSDB user 12 3 # 12 A 128 VAL A 264 VAL~? 17.06 ZN ZN A 375 A 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 226 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 53.11 -8.79 33.29 51.21 -9.10 34.32 coo 24.51 43.28 11.18 25.17 44.50 9.58 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 34.47 51.09 7.19 28.58 51.18 7.53 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1i29_c03 CSDB user 13 3 # 13 A 128 VAL A 270 VAL.? 15.39 ZN ZN A 374 A 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 226 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 53.65 -0.86 33.12 51.87 -2.05 33.62 coo 24.51 43.28 11.18 25.17 44.50 9.58 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 34.47 51.09 7.19 28.58 51.18 7.53 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1i29_c03 CSDB user 14 3 # 14 A 128 VAL A 275 VAL^? 20.43 ZN ZN A 374 A 200 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 226 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 50.08 -8.59 43.71 51.74 -9.86 43.03 coo 24.51 43.28 11.18 25.17 44.50 9.58 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 34.47 51.09 7.19 28.58 51.18 7.53 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1i29_c03 CSDB user 15 3 # 15 A 128 VAL A 275 VAL^? 20.43 ZN ZN A 374 A 200 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 226 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 50.08 -8.59 43.71 51.74 -9.86 43.03 coo 24.51 43.28 11.18 25.17 44.50 9.58 39.49 -1.24 39.18 39.76 0.49 37.96 coo 34.47 51.09 7.19 28.58 51.18 7.53 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1i29_c03 CSDB user 16 3 # 16 A 128 VAL A 276 VAL^? 20.58 ZN ZN A 374 A 200 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 226 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 47.74 -10.69 45.84 45.65 -10.33 46.28 coo 24.51 43.28 11.18 25.17 44.50 9.58 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 34.47 51.09 7.19 28.58 51.18 7.53 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1i29_c03 CSDB user 17 3 # 17 A 128 VAL A 276 VAL^? 20.58 ZN ZN A 374 A 200 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 226 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 47.74 -10.69 45.84 45.65 -10.33 46.28 coo 24.51 43.28 11.18 25.17 44.50 9.58 39.49 -1.24 39.18 39.76 0.49 37.96 coo 34.47 51.09 7.19 28.58 51.18 7.53 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1i29_c03 CSDB user 18 3 # 18 A 128 VAL A 286 VAL^? 18.04 ZN ZN A 375 A 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 226 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 46.33 -17.37 33.74 47.98 -15.99 33.42 coo 24.51 43.28 11.18 25.17 44.50 9.58 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 34.47 51.09 7.19 28.58 51.18 7.53 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1i29_c03 CSDB user 19 3 # 19 A 128 VAL A 288 VAL^? 11.42 ZN ZN A 375 A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 43.05 -11.94 32.21 44.10 -11.19 30.38 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1i29_c03 CSDB user 20 3 # 20 A 128 VAL A 288 VAL^? 11.42 ZN ZN A 375 A 200 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 226 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 43.05 -11.94 32.21 44.10 -11.19 30.38 coo 24.51 43.28 11.18 25.17 44.50 9.58 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 34.47 51.09 7.19 28.58 51.18 7.53 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1i29_c03 CSDB user 21 3 # 21 A 128 VAL A 307 VAL^? 19.34 ZN ZN A 375 A 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 226 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 46.44 -16.28 38.69 48.29 -15.22 38.04 coo 24.51 43.28 11.18 25.17 44.50 9.58 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 34.47 51.09 7.19 28.58 51.18 7.53 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1i29_c03 CSDB user 22 3 # 22 A 128 VAL A 309 VAL^? 13.46 ZN ZN A 375 A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 45.28 -10.30 35.78 47.06 -9.94 34.57 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1i29_c03 CSDB user 23 3 # 23 A 128 VAL A 335 VAL~? 9.46 ZN ZN A 374 A 200 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 226 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 46.65 -1.70 30.63 46.83 -3.74 31.34 coo 24.51 43.28 11.18 25.17 44.50 9.58 40.70 8.14 28.73 41.06 6.40 29.84 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1i29_c03 CSDB user 24 3 # 24 A 128 VAL A 335 VAL~? 9.46 ZN ZN A 374 A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 46.65 -1.70 30.63 46.83 -3.74 31.34 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1i29_c03 CSDB user 25 3 # 25 A 128 VAL A 335 VAL~? 9.46 ZN ZN A 374 A 200 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 226 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 46.65 -1.70 30.63 46.83 -3.74 31.34 coo 24.51 43.28 11.18 25.17 44.50 9.58 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1i29_c03 CSDB user 26 3 # 26 A 128 VAL A 335 VAL~? 9.46 ZN ZN A 374 A 200 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 226 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 46.65 -1.70 30.63 46.83 -3.74 31.34 coo 24.51 43.28 11.18 25.17 44.50 9.58 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 34.47 51.09 7.19 28.58 51.18 7.53 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1i29_c03 CSDB user 27 3 # 27 A 128 VAL A 338 VAL~? 10.31 ZN ZN A 375 A 200 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 226 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 46.51 -2.21 23.86 46.85 -4.02 25.09 coo 24.51 43.28 11.18 25.17 44.50 9.58 40.70 8.14 28.73 41.06 6.40 29.84 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1i29_c03 CSDB user 28 3 # 28 A 128 VAL A 338 VAL~? 10.31 ZN ZN A 375 A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 46.51 -2.21 23.86 46.85 -4.02 25.09 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1i29_c03 CSDB user 29 3 # 29 A 128 VAL A 338 VAL~? 10.31 ZN ZN A 375 A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 46.51 -2.21 23.86 46.85 -4.02 25.09 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1i29_c03 CSDB user 30 3 # 30 A 128 VAL A 338 VAL~? 10.31 ZN ZN A 375 A 200 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 226 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 46.51 -2.21 23.86 46.85 -4.02 25.09 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1i29_c03 CSDB user 31 3 # 31 A 128 VAL B 43 VAL^? 19.41 ZN ZN B 375 A 200 ASP B 96 ASP.? 22.64 O2S EPE B 376 A 226 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -26.87 -3.18 23.92 -25.28 -4.67 23.63 coo 24.51 43.28 11.18 25.17 44.50 9.58 -29.98 -4.37 36.65 -30.49 -4.93 38.64 coo 34.47 51.09 7.19 28.58 51.18 7.53 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1i29_c03 CSDB user 32 3 # 32 A 128 VAL B 54 VAL~? 14.54 C2 EPE B 376 A 200 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 226 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -26.33 5.79 31.41 -25.28 5.09 33.22 coo 24.51 43.28 11.18 25.17 44.50 9.58 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1i29_c03 CSDB user 33 3 # 33 A 128 VAL B 128 VAL^? 14.57 ZN ZN B 375 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 0.39 -0.46 11.26 0.17 -2.24 12.58 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1i29_c03 CSDB user 34 3 # 34 A 128 VAL B 128 VAL^? 14.57 ZN ZN B 375 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 0.39 -0.46 11.26 0.17 -2.24 12.58 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1i29_c03 CSDB user 35 3 # 35 A 128 VAL B 128 VAL^? 14.57 ZN ZN B 375 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 0.39 -0.46 11.26 0.17 -2.24 12.58 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1i29_c03 CSDB user 36 3 # 36 A 128 VAL B 142 VAL^? 11.88 O2S EPE A 377 A 200 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 226 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 19.13 38.05 1.41 19.72 38.80 -0.53 1.69 -35.93 13.75 -0.47 -36.17 13.24 coo 24.51 43.28 11.18 25.17 44.50 9.58 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 34.47 51.09 7.19 28.58 51.18 7.53 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1i29_c03 CSDB user 37 3 # 37 A 128 VAL B 181 VAL^? 27.14 O1 TRS A 378 A 200 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 226 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 19.13 38.05 1.41 19.72 38.80 -0.53 7.78 -49.90 24.77 9.59 -50.98 25.42 coo 24.51 43.28 11.18 25.17 44.50 9.58 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1i29_c03 CSDB user 38 3 # 38 A 128 VAL B 202 VAL^? 13.09 O2S EPE A 377 A 200 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 226 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 19.13 38.05 1.41 19.72 38.80 -0.53 3.82 -41.64 8.59 2.58 -41.50 6.80 coo 24.51 43.28 11.18 25.17 44.50 9.58 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 34.47 51.09 7.19 28.58 51.18 7.53 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1i29_c03 CSDB user 39 3 # 39 A 128 VAL B 216 VAL~? 12.75 O3S EPE A 377 A 200 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 226 LYS C 139 LYS^? 16.11 N TRS A 378 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -6.83 -28.22 14.05 -5.28 -27.59 12.58 coo 24.51 43.28 11.18 25.17 44.50 9.58 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 34.47 51.09 7.19 28.58 51.18 7.53 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1i29_c03 CSDB user 40 3 # 40 A 128 VAL B 264 VAL~? 17.12 ZN ZN B 375 A 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 226 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -9.61 16.51 9.16 -7.89 16.02 10.42 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1i29_c03 CSDB user 41 3 # 41 A 128 VAL B 270 VAL.? 15.40 ZN ZN B 374 A 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 226 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -15.04 18.43 14.51 -13.13 17.45 15.02 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1i29_c03 CSDB user 42 3 # 42 A 128 VAL B 275 VAL^? 20.37 ZN ZN B 374 A 200 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 226 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -2.07 22.44 14.13 -2.67 22.68 12.03 coo 24.51 43.28 11.18 25.17 44.50 9.58 3.99 14.73 5.36 5.18 14.04 3.76 coo 34.47 51.09 7.19 28.58 51.18 7.53 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1i29_c03 CSDB user 43 3 # 43 A 128 VAL B 275 VAL^? 20.37 ZN ZN B 374 A 200 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 226 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -2.07 22.44 14.13 -2.67 22.68 12.03 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 34.47 51.09 7.19 28.58 51.18 7.53 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1i29_c03 CSDB user 44 3 # 44 A 128 VAL B 276 VAL^? 20.62 ZN ZN B 374 A 200 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 226 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 1.67 22.27 14.69 2.71 21.36 16.39 coo 24.51 43.28 11.18 25.17 44.50 9.58 3.99 14.73 5.36 5.18 14.04 3.76 coo 34.47 51.09 7.19 28.58 51.18 7.53 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1i29_c03 CSDB user 45 3 # 45 A 128 VAL B 286 VAL^? 18.11 ZN ZN B 375 A 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 226 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -0.28 10.71 7.05 -2.27 11.65 6.87 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1i29_c03 CSDB user 46 3 # 46 A 128 VAL B 288 VAL^? 11.46 ZN ZN B 375 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -3.11 8.72 12.69 -5.08 8.23 11.99 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1i29_c03 CSDB user 47 3 # 47 A 128 VAL B 288 VAL^? 11.46 ZN ZN B 375 A 200 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 226 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -3.11 8.72 12.69 -5.08 8.23 11.99 coo 24.51 43.28 11.18 25.17 44.50 9.58 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 34.47 51.09 7.19 28.58 51.18 7.53 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1i29_c03 CSDB user 48 3 # 48 A 128 VAL B 307 VAL^? 19.39 ZN ZN B 375 A 200 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 226 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 1.76 14.81 9.29 -0.23 15.57 8.69 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1i29_c03 CSDB user 49 3 # 49 A 128 VAL B 309 VAL^? 13.64 ZN ZN B 375 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -3.15 13.12 13.51 -4.89 13.43 12.13 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1i29_c03 CSDB user 50 3 # 50 A 128 VAL B 335 VAL~? 9.42 ZN ZN B 374 A 200 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 226 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -12.57 11.63 17.36 -10.94 12.67 16.39 coo 24.51 43.28 11.18 25.17 44.50 9.58 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1i29_c03 CSDB user 51 3 # 51 A 128 VAL B 335 VAL~? 9.42 ZN ZN B 374 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -12.57 11.63 17.36 -10.94 12.67 16.39 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1i29_c03 CSDB user 52 3 # 52 A 128 VAL B 335 VAL~? 9.42 ZN ZN B 374 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -12.57 11.63 17.36 -10.94 12.67 16.39 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1i29_c03 CSDB user 53 3 # 53 A 128 VAL B 335 VAL~? 9.42 ZN ZN B 374 A 200 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 226 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -12.57 11.63 17.36 -10.94 12.67 16.39 coo 24.51 43.28 11.18 25.17 44.50 9.58 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1i29_c03 CSDB user 54 3 # 54 A 128 VAL B 338 VAL~? 10.27 ZN ZN B 375 A 200 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 226 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -16.08 6.76 15.22 -14.33 7.50 14.21 coo 24.51 43.28 11.18 25.17 44.50 9.58 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1i29_c03 CSDB user 55 3 # 55 A 128 VAL B 338 VAL~? 10.27 ZN ZN B 375 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -16.08 6.76 15.22 -14.33 7.50 14.21 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1i29_c03 CSDB user 56 3 # 56 A 128 VAL B 338 VAL~? 10.27 ZN ZN B 375 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -16.08 6.76 15.22 -14.33 7.50 14.21 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1i29_c03 CSDB user 57 3 # 57 A 128 VAL B 338 VAL~? 10.27 ZN ZN B 375 A 200 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 226 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -16.08 6.76 15.22 -14.33 7.50 14.21 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.47 51.09 7.19 28.58 51.18 7.53 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1i29_c03 CSDB user 58 3 # 58 A 128 VAL B 343 VAL~? 12.08 ZN ZN B 375 A 200 ASP B 352 ASP~? 25.82 ZN ZN B 375 A 226 LYS B 3 LYS.? 34.82 ZN ZN B 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -18.57 -1.46 16.53 -17.55 -1.89 18.48 coo 24.51 43.28 11.18 25.17 44.50 9.58 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo 34.47 51.09 7.19 28.58 51.18 7.53 -34.16 -15.88 20.56 -37.36 -15.32 22.01 ULMN 3 1i29_c03 CSDB user 59 3 # 59 A 128 VAL C 54 VAL~? 14.84 C2 EPE C 376 A 200 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 226 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 19.56 -31.70 66.67 20.73 -29.90 66.07 coo 24.51 43.28 11.18 25.17 44.50 9.58 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1i29_c03 CSDB user 60 3 # 60 A 128 VAL C 128 VAL^? 14.35 ZN ZN C 375 A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -2.00 -30.83 40.65 0.02 -30.12 40.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1i29_c03 CSDB user 61 3 # 61 A 128 VAL C 128 VAL^? 14.35 ZN ZN C 375 A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -2.00 -30.83 40.65 0.02 -30.12 40.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1i29_c03 CSDB user 62 3 # 62 A 128 VAL C 128 VAL^? 14.35 ZN ZN C 375 A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -2.00 -30.83 40.65 0.02 -30.12 40.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1i29_c03 CSDB user 63 3 # 63 A 128 VAL C 142 VAL^? 8.28 C2 EPE C 377 A 200 ASP A 237 ASP^? 6.80 N TRS A 378 A 226 LYS C 239 LYS^? 16.29 N TRS A 378 coo 19.13 38.05 1.41 19.72 38.80 -0.53 20.31 -37.06 15.27 21.29 -38.59 16.57 coo 24.51 43.28 11.18 25.17 44.50 9.58 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 34.47 51.09 7.19 28.58 51.18 7.53 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1i29_c03 CSDB user 64 3 # 64 A 128 VAL C 181 VAL^? 9.67 C5 EPE C 377 A 200 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 226 LYS A 218 LYS~? 21.49 C3 EPE A 377 coo 19.13 38.05 1.41 19.72 38.80 -0.53 32.10 -30.99 1.69 32.13 -29.59 -0.03 coo 24.51 43.28 11.18 25.17 44.50 9.58 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 34.47 51.09 7.19 28.58 51.18 7.53 17.38 -15.22 -1.06 17.49 -9.91 -3.23 ULMN 3 1i29_c03 CSDB user 65 3 # 65 A 128 VAL C 202 VAL^? 10.27 C2 EPE C 377 A 200 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 226 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 19.13 38.05 1.41 19.72 38.80 -0.53 18.93 -42.23 9.15 18.29 -44.18 9.93 coo 24.51 43.28 11.18 25.17 44.50 9.58 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 34.47 51.09 7.19 28.58 51.18 7.53 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1i29_c03 CSDB user 66 3 # 66 A 128 VAL C 202 VAL^? 10.27 C2 EPE C 377 A 200 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 226 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 19.13 38.05 1.41 19.72 38.80 -0.53 18.93 -42.23 9.15 18.29 -44.18 9.93 coo 24.51 43.28 11.18 25.17 44.50 9.58 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 34.47 51.09 7.19 28.58 51.18 7.53 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1i29_c03 CSDB user 67 3 # 67 A 128 VAL C 233 VAL^? 5.14 N TRS A 378 A 200 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 226 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 19.13 38.05 1.41 19.72 38.80 -0.53 17.83 -29.66 19.44 18.57 -29.94 21.47 coo 24.51 43.28 11.18 25.17 44.50 9.58 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 34.47 51.09 7.19 28.58 51.18 7.53 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1i29_c03 CSDB user 68 3 # 68 A 128 VAL C 264 VAL~? 17.06 ZN ZN C 375 A 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 226 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -8.92 -35.27 58.51 -8.62 -33.33 57.61 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 34.47 51.09 7.19 28.58 51.18 7.53 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1i29_c03 CSDB user 69 3 # 69 A 128 VAL C 270 VAL.? 15.47 ZN ZN C 374 A 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 226 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -4.18 -34.36 64.84 -4.13 -33.01 63.12 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 34.47 51.09 7.19 28.58 51.18 7.53 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 1i29_c03 CSDB user 70 3 # 70 A 128 VAL C 275 VAL^? 20.28 ZN ZN C 374 A 200 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 226 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -13.34 -25.57 60.06 -14.48 -27.44 59.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1i29_c03 CSDB user 71 3 # 71 A 128 VAL C 275 VAL^? 20.28 ZN ZN C 374 A 200 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 226 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -13.34 -25.57 60.06 -14.48 -27.44 59.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 34.47 51.09 7.19 28.58 51.18 7.53 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1i29_c03 CSDB user 72 3 # 72 A 128 VAL C 276 VAL^? 20.51 ZN ZN C 374 A 200 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 226 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -14.81 -22.90 57.79 -13.74 -21.16 57.03 coo 24.51 43.28 11.18 25.17 44.50 9.58 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1i29_c03 CSDB user 73 3 # 73 A 128 VAL C 286 VAL^? 18.11 ZN ZN C 375 A 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 226 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -11.20 -32.24 48.22 -10.98 -33.34 50.12 coo 24.51 43.28 11.18 25.17 44.50 9.58 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 34.47 51.09 7.19 28.58 51.18 7.53 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1i29_c03 CSDB user 74 3 # 74 A 128 VAL C 286 VAL^? 18.11 ZN ZN C 375 A 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 226 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -11.20 -32.24 48.22 -10.98 -33.34 50.12 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 34.47 51.09 7.19 28.58 51.18 7.53 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1i29_c03 CSDB user 75 3 # 75 A 128 VAL C 288 VAL^? 11.43 ZN ZN C 375 A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -5.15 -30.28 49.94 -4.23 -32.15 50.68 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1i29_c03 CSDB user 76 3 # 76 A 128 VAL C 288 VAL^? 11.43 ZN ZN C 375 A 200 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 226 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -5.15 -30.28 49.94 -4.23 -32.15 50.68 coo 24.51 43.28 11.18 25.17 44.50 9.58 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 34.47 51.09 7.19 28.58 51.18 7.53 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1i29_c03 CSDB user 77 3 # 77 A 128 VAL C 307 VAL^? 19.37 ZN ZN C 375 A 200 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 226 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -13.56 -28.36 50.80 -13.18 -29.95 52.27 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 34.47 51.09 7.19 28.58 51.18 7.53 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1i29_c03 CSDB user 78 3 # 78 A 128 VAL C 309 VAL^? 13.63 ZN ZN C 375 A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -7.46 -28.74 53.58 -7.50 -30.78 54.33 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1i29_c03 CSDB user 79 3 # 79 A 128 VAL C 335 VAL~? 9.47 ZN ZN C 374 A 200 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 226 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 0.52 -32.05 59.08 -1.54 -31.45 58.56 coo 24.51 43.28 11.18 25.17 44.50 9.58 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1i29_c03 CSDB user 80 3 # 80 A 128 VAL C 335 VAL~? 9.47 ZN ZN C 374 A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 0.52 -32.05 59.08 -1.54 -31.45 58.56 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1i29_c03 CSDB user 81 3 # 81 A 128 VAL C 335 VAL~? 9.47 ZN ZN C 374 A 200 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 226 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 0.52 -32.05 59.08 -1.54 -31.45 58.56 coo 24.51 43.28 11.18 25.17 44.50 9.58 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1i29_c03 CSDB user 82 3 # 82 A 128 VAL C 338 VAL~? 10.33 ZN ZN C 375 A 200 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 226 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 4.12 -36.97 56.83 2.21 -36.49 55.96 coo 24.51 43.28 11.18 25.17 44.50 9.58 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1i29_c03 CSDB user 83 3 # 83 A 128 VAL C 338 VAL~? 10.33 ZN ZN C 375 A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 19.13 38.05 1.41 19.72 38.80 -0.53 4.12 -36.97 56.83 2.21 -36.49 55.96 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1i29_c03 CSDB user 84 3 # 84 A 128 VAL C 338 VAL~? 10.33 ZN ZN C 375 A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 19.13 38.05 1.41 19.72 38.80 -0.53 4.12 -36.97 56.83 2.21 -36.49 55.96 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1i29_c03 CSDB user 85 3 # 85 A 128 VAL C 338 VAL~? 10.33 ZN ZN C 375 A 200 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 226 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 19.13 38.05 1.41 19.72 38.80 -0.53 4.12 -36.97 56.83 2.21 -36.49 55.96 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.47 51.09 7.19 28.58 51.18 7.53 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1i29_c03 CSDB user 86 3 # 86 A 128 VAL C 343 VAL~? 12.12 ZN ZN C 375 A 200 ASP C 352 ASP~? 25.48 ZN ZN C 375 A 226 LYS C 3 LYS.? 28.91 O1 TRS A 378 coo 19.13 38.05 1.41 19.72 38.80 -0.53 11.23 -39.18 52.40 12.11 -37.19 52.15 coo 24.51 43.28 11.18 25.17 44.50 9.58 18.63 -50.25 49.90 18.47 -49.69 51.95 coo 34.47 51.09 7.19 28.58 51.18 7.53 30.63 -48.52 50.80 31.26 -43.98 46.49 1i29_c03 source 1i29 CSDB : 86 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 87 LYS~? 10.99 O2S EPE A 376 A 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 35.91 21.93 28.51 38.15 26.57 30.75 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 36.23 21.81 22.32 41.86 22.67 23.70 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 265 LYS~? 22.38 ZN ZN A 374 A 74 LYS A 271 LYS.? 23.00 ZN ZN A 374 A 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 56.12 0.48 35.73 59.67 4.01 35.99 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 271 LYS.? 23.00 ZN ZN A 374 A 74 LYS A 265 LYS~? 22.38 ZN ZN A 374 A 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 56.12 0.48 35.73 59.67 4.01 35.99 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS A 278 LYS.? 33.16 ZN ZN A 374 A 74 LYS A 282 LYS^? 34.08 ZN ZN A 375 A 165 GLU A 262 GLU~? 24.15 ZN ZN A 374 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 52.59 -15.70 47.74 53.19 -20.67 51.64 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 53.78 -21.68 41.24 59.13 -25.09 41.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 59.50 -9.24 37.85 59.47 -7.16 38.33 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS A 282 LYS^? 34.08 ZN ZN A 375 A 74 LYS A 278 LYS.? 33.16 ZN ZN A 374 A 165 GLU A 262 GLU~? 24.15 ZN ZN A 374 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 53.78 -21.68 41.24 59.13 -25.09 41.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 52.59 -15.70 47.74 53.19 -20.67 51.64 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 59.50 -9.24 37.85 59.47 -7.16 38.33 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 74 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 45.66 0.76 26.15 51.53 0.58 28.90 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 44.47 1.55 20.70 47.30 5.10 24.27 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 74 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 44.47 1.55 20.70 47.30 5.10 24.27 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 45.66 0.76 26.15 51.53 0.58 28.90 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 74 LYS A 345 LYS~? 18.67 ZN ZN A 375 A 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 44.47 1.55 20.70 47.30 5.10 24.27 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS A 345 LYS~? 18.67 ZN ZN A 375 A 74 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 44.47 1.55 20.70 47.30 5.10 24.27 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS A 345 LYS~? 18.67 ZN ZN A 375 A 74 LYS A 350 LYS~? 21.83 ZN ZN A 375 A 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 A 14 LYS A 354 LYS~? 27.90 ZN ZN A 375 A 74 LYS A 350 LYS~? 21.83 ZN ZN A 375 A 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 A 14 LYS B 87 LYS~? 9.60 O3S EPE B 376 A 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 A 14 LYS B 94 LYS~? 17.44 O2S EPE B 376 A 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 A 14 LYS B 215 LYS~? 17.38 O3S EPE A 377 A 74 LYS B 218 LYS~? 23.26 O3S EPE A 377 A 165 GLU B 151 GLU~? 19.22 O3S EPE A 377 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -9.61 -39.78 7.97 -10.79 -41.15 9.06 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 A 14 LYS B 265 LYS~? 21.91 ZN ZN B 374 A 74 LYS B 271 LYS.? 19.93 ZN ZN B 374 A 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 A 14 LYS B 271 LYS.? 19.93 ZN ZN B 374 A 74 LYS B 265 LYS~? 21.91 ZN ZN B 374 A 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 A 14 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 A 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 165 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 19 3 # 19 A 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 20 3 # 20 A 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 74 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 21 3 # 21 A 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 74 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 22 3 # 22 A 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 23 3 # 23 A 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 24 3 # 24 A 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 25 3 # 25 A 14 LYS B 354 LYS~? 28.15 ZN ZN B 375 A 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 26 3 # 26 A 14 LYS C 87 LYS~? 9.86 O3S EPE C 376 A 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 27 3 # 27 A 14 LYS C 94 LYS~? 16.71 O3S EPE C 376 A 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 28 3 # 28 A 14 LYS C 215 LYS~? 17.39 O1 TRS A 378 A 74 LYS C 218 LYS~? 12.80 O1 TRS A 378 A 165 GLU C 151 GLU~? 17.15 O8 EPE C 377 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 24.82 -49.12 19.40 26.74 -49.67 18.68 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 29 3 # 29 A 14 LYS C 265 LYS~? 21.95 ZN ZN C 374 A 74 LYS C 271 LYS.? 19.51 ZN ZN C 374 A 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 30 3 # 30 A 14 LYS C 271 LYS.? 19.51 ZN ZN C 374 A 74 LYS C 265 LYS~? 21.95 ZN ZN C 374 A 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 31 3 # 31 A 14 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 32 3 # 32 A 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 165 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 13.88 -30.69 72.19 13.68 -28.54 72.17 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 33 3 # 33 A 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 34 3 # 34 A 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 74 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 35 3 # 35 A 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 74 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 36 3 # 36 A 14 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 37 3 # 37 A 14 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 74 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 38 3 # 38 A 14 LYS C 354 LYS~? 23.72 O1 TRS A 378 A 74 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 19.30 -32.62 45.28 21.00 -31.37 45.17 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 38 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 87 LYS~? 10.99 O2S EPE A 376 B 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 B 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 35.91 21.93 28.51 38.15 26.57 30.75 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 36.23 21.81 22.32 41.86 22.67 23.70 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 91 LYS~? 15.85 O2S EPE A 376 B 74 LYS A 87 LYS~? 10.99 O2S EPE A 376 B 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 36.23 21.81 22.32 41.86 22.67 23.70 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 35.91 21.93 28.51 38.15 26.57 30.75 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS A 265 LYS~? 22.38 ZN ZN A 374 B 74 LYS A 271 LYS.? 23.00 ZN ZN A 374 B 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 54.99 -5.46 33.76 58.41 -3.92 38.21 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 56.12 0.48 35.73 59.67 4.01 35.99 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS A 271 LYS.? 23.00 ZN ZN A 374 B 74 LYS A 265 LYS~? 22.38 ZN ZN A 374 B 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 56.12 0.48 35.73 59.67 4.01 35.99 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 54.99 -5.46 33.76 58.41 -3.92 38.21 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS A 337 LYS~? 14.02 ZN ZN A 374 B 74 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 45.66 0.76 26.15 51.53 0.58 28.90 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 44.47 1.55 20.70 47.30 5.10 24.27 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 74 LYS A 337 LYS~? 14.02 ZN ZN A 374 B 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 44.47 1.55 20.70 47.30 5.10 24.27 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 45.66 0.76 26.15 51.53 0.58 28.90 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 74 LYS A 345 LYS~? 18.67 ZN ZN A 375 B 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 44.47 1.55 20.70 47.30 5.10 24.27 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 45.56 -1.99 12.81 45.09 -7.18 12.35 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS A 345 LYS~? 18.67 ZN ZN A 375 B 74 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 45.56 -1.99 12.81 45.09 -7.18 12.35 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 44.47 1.55 20.70 47.30 5.10 24.27 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 B 14 LYS B 87 LYS~? 9.60 O3S EPE B 376 B 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 B 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -23.51 8.76 41.04 -24.49 13.82 43.31 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -26.96 4.56 38.63 -29.49 9.20 36.26 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 B 14 LYS B 94 LYS~? 17.44 O2S EPE B 376 B 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 B 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -29.53 0.46 40.71 -30.43 3.58 45.55 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -26.96 4.56 38.63 -29.49 9.20 36.26 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 B 14 LYS B 265 LYS~? 21.91 ZN ZN B 374 B 74 LYS B 271 LYS.? 19.93 ZN ZN B 374 B 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -12.32 18.80 10.54 -12.89 23.62 10.63 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -15.49 22.23 14.65 -19.95 19.84 13.72 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 B 14 LYS B 271 LYS.? 19.93 ZN ZN B 374 B 74 LYS B 265 LYS~? 21.91 ZN ZN B 374 B 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -15.49 22.23 14.65 -19.95 19.84 13.72 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -12.32 18.80 10.54 -12.89 23.62 10.63 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 B 14 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 165 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 B 14 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 B 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 165 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 B 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 B 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 74 LYS B 345 LYS~? 20.14 ZN ZN B 375 B 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 B 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 74 LYS B 345 LYS~? 20.14 ZN ZN B 375 B 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 19 3 # 19 B 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 B 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 20 3 # 20 B 14 LYS C 87 LYS~? 9.86 O3S EPE C 376 B 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 B 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 22.12 -22.06 69.94 21.88 -19.84 74.70 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 24.97 -26.94 68.30 21.78 -29.04 72.70 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 21 3 # 21 B 14 LYS C 94 LYS~? 16.71 O3S EPE C 376 B 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 B 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 30.11 -27.61 67.14 30.55 -24.06 72.29 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 24.97 -26.94 68.30 21.78 -29.04 72.70 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 22 3 # 22 B 14 LYS C 215 LYS~? 17.39 O1 TRS A 378 B 74 LYS C 218 LYS~? 12.80 O1 TRS A 378 B 165 GLU C 151 GLU~? 17.15 O8 EPE C 377 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 22.70 -37.10 29.95 20.60 -41.87 33.53 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 26.24 -37.78 26.13 29.59 -36.75 30.95 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 24.82 -49.12 19.40 26.74 -49.67 18.68 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 23 3 # 23 B 14 LYS C 218 LYS~? 12.80 O1 TRS A 378 B 74 LYS C 215 LYS~? 17.39 O1 TRS A 378 B 165 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 26.24 -37.78 26.13 29.59 -36.75 30.95 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 22.70 -37.10 29.95 20.60 -41.87 33.53 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.24 -30.50 31.64 12.59 -30.76 33.22 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 24 3 # 24 B 14 LYS C 265 LYS~? 21.95 ZN ZN C 374 B 74 LYS C 271 LYS.? 19.51 ZN ZN C 374 B 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 25 3 # 25 B 14 LYS C 271 LYS.? 19.51 ZN ZN C 374 B 74 LYS C 265 LYS~? 21.95 ZN ZN C 374 B 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 26 3 # 26 B 14 LYS C 303 LYS~? 17.98 ZN ZN C 375 B 74 LYS C 301 LYS~? 24.63 ZN ZN C 375 B 165 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -21.46 -36.51 49.50 -23.48 -36.16 48.85 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 27 3 # 27 B 14 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 165 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 13.88 -30.69 72.19 13.68 -28.54 72.17 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 28 3 # 28 B 14 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 29 3 # 29 B 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 165 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 13.88 -30.69 72.19 13.68 -28.54 72.17 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 30 3 # 30 B 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 31 3 # 31 B 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 74 LYS C 345 LYS~? 19.35 ZN ZN C 375 B 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 11.31 -44.62 52.77 6.74 -46.86 52.89 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 32 3 # 32 B 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 74 LYS C 345 LYS~? 19.35 ZN ZN C 375 B 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 11.31 -44.62 52.77 6.74 -46.86 52.89 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 33 3 # 33 B 14 LYS C 345 LYS~? 19.35 ZN ZN C 375 B 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 11.31 -44.62 52.77 6.74 -46.86 52.89 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 19.30 -32.62 45.28 21.00 -31.37 45.17 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 33 hits 1idt_c01 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 232 ASP^? 4.68 O1S EPE A 377 158 THR B 206 THR^? 5.63 O3S EPE A 377 317 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo -2.63 8.40 35.07 -3.66 9.81 36.17 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -5.30 12.75 41.86 -4.34 13.05 39.99 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo -12.63 17.64 33.66 -10.65 17.90 34.40 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 292 ASP^? 8.63 ZN ZN A 374 158 THR A 310 THR^? 10.34 ZN ZN A 374 317 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo -2.63 8.40 35.07 -3.66 9.81 36.17 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -5.30 12.75 41.86 -4.34 13.05 39.99 42.72 -7.43 36.10 40.77 -7.66 37.11 coo -12.63 17.64 33.66 -10.65 17.90 34.40 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP A 312 ASP.? 7.50 ZN ZN A 374 158 THR A 310 THR^? 10.34 ZN ZN A 374 317 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -2.63 8.40 35.07 -3.66 9.81 36.17 39.49 -1.24 39.18 39.76 0.49 37.96 coo -5.30 12.75 41.86 -4.34 13.05 39.99 42.72 -7.43 36.10 40.77 -7.66 37.11 coo -12.63 17.64 33.66 -10.65 17.90 34.40 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP A 312 ASP.? 7.50 ZN ZN A 374 158 THR A 310 THR^? 10.34 ZN ZN A 374 317 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo -2.63 8.40 35.07 -3.66 9.81 36.17 39.49 -1.24 39.18 39.76 0.49 37.96 coo -5.30 12.75 41.86 -4.34 13.05 39.99 42.72 -7.43 36.10 40.77 -7.66 37.11 coo -12.63 17.64 33.66 -10.65 17.90 34.40 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 3 # 5 54 ASP B 232 ASP^? 14.54 O2S EPE A 377 158 THR C 206 THR^? 14.70 N TRS A 378 317 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo -2.63 8.40 35.07 -3.66 9.81 36.17 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -5.30 12.75 41.86 -4.34 13.05 39.99 12.97 -38.24 19.88 14.05 -39.36 21.39 coo -12.63 17.64 33.66 -10.65 17.90 34.40 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 3 # 6 54 ASP B 292 ASP^? 8.88 ZN ZN B 374 158 THR B 310 THR^? 10.23 ZN ZN B 374 317 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -3.69 12.44 17.22 -2.10 11.84 18.57 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 7 3 # 7 54 ASP B 312 ASP.? 7.53 ZN ZN B 374 158 THR B 310 THR^? 10.23 ZN ZN B 374 317 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -3.69 12.44 17.22 -2.10 11.84 18.57 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 8 3 # 8 54 ASP B 312 ASP.? 7.53 ZN ZN B 374 158 THR B 310 THR^? 10.23 ZN ZN B 374 317 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -3.69 12.44 17.22 -2.10 11.84 18.57 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 9 3 # 9 54 ASP C 232 ASP^? 3.77 O2S EPE C 377 158 THR A 206 THR^? -4.52 O1S EPE C 377s 317 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo -2.63 8.40 35.07 -3.66 9.81 36.17 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -5.30 12.75 41.86 -4.34 13.05 39.99 19.99 -27.38 6.69 21.08 -26.14 5.25 coo -12.63 17.64 33.66 -10.65 17.90 34.40 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 10 3 # 10 54 ASP C 232 ASP^? 3.77 O2S EPE C 377 158 THR A 206 THR^? -4.52 O1S EPE C 377s 317 ASP B 237 ASP^? 15.58 N TRS A 378 coo -2.63 8.40 35.07 -3.66 9.81 36.17 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -5.30 12.75 41.86 -4.34 13.05 39.99 19.99 -27.38 6.69 21.08 -26.14 5.25 coo -12.63 17.64 33.66 -10.65 17.90 34.40 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 11 3 # 11 54 ASP C 312 ASP.? 7.48 ZN ZN C 374 158 THR C 310 THR^? 10.44 ZN ZN C 374 317 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -4.52 -26.41 54.31 -4.36 -24.52 53.23 coo -12.63 17.64 33.66 -10.65 17.90 34.40 5.80 -28.16 48.27 6.08 -27.64 50.28 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 11 hits 1inp_c02 naa= 3 ULMN 3 1iph_c00 CATALASE HPII user 1 3 # 1 A 128 HIS A 163 HIS.? 11.18 O1S EPE C 377 A 167 SER A 168 SER^? 10.80 O1S EPE C 377 A 201 ASN A 166 ASN.? 13.31 C3 EPE C 377 coo 12.95 4.49 19.05 14.87 4.39 19.77 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 10.44 7.96 22.51 12.16 7.57 20.82 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 19.43 6.74 22.83 19.09 5.15 21.60 36.29 -29.92 9.78 37.81 -29.21 11.04 ULMN 3 1iph_c00 CATALASE HPII user 2 3 # 2 A 128 HIS B 163 HIS.? 11.54 O3S EPE A 377 A 167 SER B 168 SER^? 10.59 O3S EPE A 377 A 201 ASN B 166 ASN.? 12.55 O8 EPE A 377 coo 12.95 4.49 19.05 14.87 4.39 19.77 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 10.44 7.96 22.51 12.16 7.57 20.82 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 19.43 6.74 22.83 19.09 5.15 21.60 -2.65 -19.38 -5.26 -2.77 -17.28 -5.58 ULMN 3 1iph_c00 CATALASE HPII user 3 3 # 3 A 128 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 167 SER C 168 SER^? 24.11 O1 TRS A 378 A 201 ASN C 166 ASN.? 27.69 ZN ZN C 375 coo 12.95 4.49 19.05 14.87 4.39 19.77 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 10.44 7.96 22.51 12.16 7.57 20.82 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 19.43 6.74 22.83 19.09 5.15 21.60 1.70 -45.88 30.14 0.89 -45.44 32.06 1iph_c00 source 1iph CATALASE HPII : 3 hits 1iph_c00 naa= 3 ULMN 3 1iph_c01 CATALASE HPII user 1 3 # 1 B 128 HIS A 163 HIS.? 11.18 O1S EPE C 377 B 167 SER A 168 SER^? 10.80 O1S EPE C 377 B 201 ASN A 166 ASN.? 13.31 C3 EPE C 377 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 30.88 -23.32 6.66 32.97 -23.36 6.49 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 30.58 -27.33 4.57 31.12 -25.87 2.65 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 36.29 -29.92 9.78 37.81 -29.21 11.04 ULMN 3 1iph_c01 CATALASE HPII user 2 3 # 2 B 128 HIS B 163 HIS.? 11.54 O3S EPE A 377 B 167 SER B 168 SER^? 10.59 O3S EPE A 377 B 201 ASN B 166 ASN.? 12.55 O8 EPE A 377 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -2.65 -19.38 -5.26 -2.77 -17.28 -5.58 ULMN 3 1iph_c01 CATALASE HPII user 3 3 # 3 B 128 HIS C 163 HIS.? 22.24 O1 TRS A 378 B 167 SER C 168 SER^? 24.11 O1 TRS A 378 B 201 ASN C 166 ASN.? 27.69 ZN ZN C 375 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 9.61 -42.49 30.12 8.57 -43.28 31.77 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 9.08 -45.42 26.78 10.19 -47.47 27.43 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 1.70 -45.88 30.14 0.89 -45.44 32.06 1iph_c01 source 1iph CATALASE HPII : 3 hits 1iph_c01 naa= 3 ULMN 3 1iph_c02 CATALASE HPII user 1 3 # 1 C 128 HIS A 163 HIS.? 11.18 O1S EPE C 377 C 167 SER A 168 SER^? 10.80 O1S EPE C 377 C 201 ASN A 166 ASN.? 13.31 C3 EPE C 377 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 30.88 -23.32 6.66 32.97 -23.36 6.49 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 30.58 -27.33 4.57 31.12 -25.87 2.65 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 36.29 -29.92 9.78 37.81 -29.21 11.04 ULMN 3 1iph_c02 CATALASE HPII user 2 3 # 2 C 128 HIS B 163 HIS.? 11.54 O3S EPE A 377 C 167 SER B 168 SER^? 10.59 O3S EPE A 377 C 201 ASN B 166 ASN.? 12.55 O8 EPE A 377 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -2.65 -19.38 -5.26 -2.77 -17.28 -5.58 ULMN 3 1iph_c02 CATALASE HPII user 3 3 # 3 C 128 HIS C 163 HIS.? 22.24 O1 TRS A 378 C 167 SER C 168 SER^? 24.11 O1 TRS A 378 C 201 ASN C 166 ASN.? 27.69 ZN ZN C 375 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 9.61 -42.49 30.12 8.57 -43.28 31.77 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 9.08 -45.42 26.78 10.19 -47.47 27.43 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 1.70 -45.88 30.14 0.89 -45.44 32.06 1iph_c02 source 1iph CATALASE HPII : 3 hits 1iph_c02 naa= 3 ULMN 3 1iph_c03 CATALASE HPII user 1 3 # 1 D 128 HIS A 163 HIS.? 11.18 O1S EPE C 377 D 167 SER A 168 SER^? 10.80 O1S EPE C 377 D 201 ASN A 166 ASN.? 13.31 C3 EPE C 377 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 36.29 -29.92 9.78 37.81 -29.21 11.04 ULMN 3 1iph_c03 CATALASE HPII user 2 3 # 2 D 128 HIS B 163 HIS.? 11.54 O3S EPE A 377 D 167 SER B 168 SER^? 10.59 O3S EPE A 377 D 201 ASN B 166 ASN.? 12.55 O8 EPE A 377 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -2.65 -19.38 -5.26 -2.77 -17.28 -5.58 ULMN 3 1iph_c03 CATALASE HPII user 3 3 # 3 D 128 HIS C 163 HIS.? 22.24 O1 TRS A 378 D 167 SER C 168 SER^? 24.11 O1 TRS A 378 D 201 ASN C 166 ASN.? 27.69 ZN ZN C 375 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 1.70 -45.88 30.14 0.89 -45.44 32.06 1iph_c03 source 1iph CATALASE HPII : 3 hits 1iph_c03 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 96 ASP.? 22.36 O2S EPE A 376 A1134 ALA A 98 ALA^? 19.17 C3 EPE A 376 A1137 ASN A 63 ASN.? 24.76 C2 EPE A 376 coo -27.05 34.58 17.12 -25.81 32.84 17.16 33.23 19.97 13.69 32.21 21.81 13.47 coo -20.53 36.39 15.81 -20.80 35.01 16.40 32.69 13.47 16.67 32.07 12.82 15.47 coo -23.72 34.69 12.49 -24.32 32.83 13.34 36.61 15.52 12.09 36.23 14.54 10.24 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP A 107 ASP~? -2.33 ZN ZN A 375s A1134 ALA A 23 ALA~? 10.67 ZN ZN A 375 A1137 ASN A 105 ASN~? 9.65 ZN ZN A 375 coo -27.05 34.58 17.12 -25.81 32.84 17.16 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -20.53 36.39 15.81 -20.80 35.01 16.40 27.83 -4.85 24.60 27.58 -3.36 24.26 coo -23.72 34.69 12.49 -24.32 32.83 13.34 30.92 -4.10 21.33 31.10 -1.93 21.21 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 3 3 # 3 A1132 ASP A 107 ASP~? -2.33 ZN ZN A 375s A1134 ALA A 109 ALA~? 11.42 ZN ZN A 375 A1137 ASN A 105 ASN~? 9.65 ZN ZN A 375 coo -27.05 34.58 17.12 -25.81 32.84 17.16 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -20.53 36.39 15.81 -20.80 35.01 16.40 34.68 -9.30 20.20 34.40 -8.19 19.19 coo -23.72 34.69 12.49 -24.32 32.83 13.34 30.92 -4.10 21.33 31.10 -1.93 21.21 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 4 3 # 4 A1132 ASP A 115 ASP~? 13.24 ZN ZN A 375 A1134 ALA A 118 ALA~? 13.84 ZN ZN A 375 A1137 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo -27.05 34.58 17.12 -25.81 32.84 17.16 41.88 -11.27 21.52 40.65 -12.98 21.39 coo -20.53 36.39 15.81 -20.80 35.01 16.40 46.25 -12.61 26.18 45.07 -13.50 25.76 coo -23.72 34.69 12.49 -24.32 32.83 13.34 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 5 3 # 5 A1132 ASP B 96 ASP.? 22.64 O2S EPE B 376 A1134 ALA B 98 ALA^? 18.79 C3 EPE B 376 A1137 ASN B 63 ASN.? 24.52 C3 EPE B 376 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -29.98 -4.37 36.65 -30.49 -4.93 38.64 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -23.64 -3.90 33.07 -23.65 -5.30 32.62 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -29.72 -4.44 30.85 -30.01 -6.28 29.82 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 6 3 # 6 A1132 ASP B 107 ASP~? -2.23 ZN ZN B 375s A1134 ALA B 23 ALA~? 10.82 ZN ZN B 375 A1137 ASN B 105 ASN~? 9.47 ZN ZN B 375 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -4.97 -5.23 25.00 -5.92 -5.35 26.16 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -8.71 -5.38 22.66 -10.29 -4.82 23.98 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 7 3 # 7 A1132 ASP B 107 ASP~? -2.23 ZN ZN B 375s A1134 ALA B 109 ALA~? 11.08 ZN ZN B 375 A1137 ASN B 105 ASN~? 9.47 ZN ZN B 375 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -7.64 -4.92 16.15 -8.93 -5.45 16.76 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -8.71 -5.38 22.66 -10.29 -4.82 23.98 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 8 3 # 8 A1132 ASP B 115 ASP~? 12.98 ZN ZN B 375 A1134 ALA B 118 ALA~? 13.77 ZN ZN B 375 A1137 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -7.92 6.00 8.46 -6.87 4.90 8.37 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 9 3 # 9 A1132 ASP C 27 ASP.? 8.23 ZN ZN C 375 A1134 ALA C 23 ALA~? 11.04 ZN ZN C 375 A1137 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo -27.05 34.58 17.12 -25.81 32.84 17.16 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -20.53 36.39 15.81 -20.80 35.01 16.40 11.77 -25.07 43.97 13.11 -24.84 44.66 coo -23.72 34.69 12.49 -24.32 32.83 13.34 12.40 -28.97 45.42 13.67 -29.13 47.17 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 10 3 # 10 A1132 ASP C 27 ASP.? 8.23 ZN ZN C 375 A1134 ALA C 102 ALA.? 9.31 ZN ZN C 375 A1137 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo -27.05 34.58 17.12 -25.81 32.84 17.16 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -20.53 36.39 15.81 -20.80 35.01 16.40 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -23.72 34.69 12.49 -24.32 32.83 13.34 12.40 -28.97 45.42 13.67 -29.13 47.17 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 11 3 # 11 A1132 ASP C 96 ASP.? 22.89 O3S EPE C 376 A1134 ALA C 98 ALA^? 19.12 C3 EPE C 376 A1137 ASN C 63 ASN.? 24.62 C3 EPE C 376 coo -27.05 34.58 17.12 -25.81 32.84 17.16 31.06 -32.15 62.51 32.92 -31.34 63.13 coo -20.53 36.39 15.81 -20.80 35.01 16.40 25.29 -30.67 58.07 25.77 -31.44 56.87 coo -23.72 34.69 12.49 -24.32 32.83 13.34 27.42 -36.13 60.56 28.02 -37.46 59.02 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 12 3 # 12 A1132 ASP C 107 ASP~? -2.30 ZN ZN C 375s A1134 ALA C 23 ALA~? 11.04 ZN ZN C 375 A1137 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo -27.05 34.58 17.12 -25.81 32.84 17.16 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -20.53 36.39 15.81 -20.80 35.01 16.40 11.77 -25.07 43.97 13.11 -24.84 44.66 coo -23.72 34.69 12.49 -24.32 32.83 13.34 12.40 -28.97 45.42 13.67 -29.13 47.17 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 13 3 # 13 A1132 ASP C 107 ASP~? -2.30 ZN ZN C 375s A1134 ALA C 109 ALA~? 11.05 ZN ZN C 375 A1137 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo -27.05 34.58 17.12 -25.81 32.84 17.16 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -20.53 36.39 15.81 -20.80 35.01 16.40 7.53 -33.10 43.39 8.93 -33.54 43.81 coo -23.72 34.69 12.49 -24.32 32.83 13.34 12.40 -28.97 45.42 13.67 -29.13 47.17 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 13 hits 1ir3_c02 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 9 GLU~? 28.50 ZN ZN A 375 A 61 GLU A 15 GLU~? 17.23 ZN ZN A 375 A 162 HIS A 8 HIS~? 24.55 ZN ZN A 375 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 31.54 5.84 4.26 31.09 6.26 2.19 coo -4.89 20.85 5.22 -3.95 21.69 6.91 29.50 -0.46 14.62 27.65 0.59 14.66 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 26.75 7.68 8.85 25.49 8.72 10.18 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU A 228 GLU.? 8.71 C3 EPE A 377 A 61 GLU A 201 GLU^? -3.12 C2 EPE A 377s A 162 HIS A 224 HIS~? 7.33 C7 EPE A 377 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo -4.89 20.85 5.22 -3.95 21.69 6.91 7.01 -32.51 -2.93 6.57 -30.84 -1.85 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 12.08 -23.60 -5.02 10.59 -24.98 -4.54 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU B 9 GLU~? 28.41 ZN ZN B 375 A 61 GLU B 15 GLU~? 17.09 ZN ZN B 375 A 162 HIS B 8 HIS~? 24.51 ZN ZN B 375 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -21.73 -14.76 29.99 -21.14 -14.36 31.97 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 4 3 # 4 A 14 GLU B 151 GLU~? 19.22 O3S EPE A 377 A 61 GLU B 227 GLU.? 24.58 O3S EPE A 377 A 162 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 5 3 # 5 A 14 GLU C 9 GLU~? 28.11 O1 TRS A 378 A 61 GLU C 15 GLU~? 17.26 ZN ZN C 375 A 162 HIS C 8 HIS~? 24.89 ZN ZN C 375 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 28.74 -39.91 47.06 29.82 -41.70 47.37 coo -4.89 20.85 5.22 -3.95 21.69 6.91 19.30 -32.62 45.28 21.00 -31.37 45.17 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 29.42 -33.76 48.01 30.25 -31.91 48.55 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 6 3 # 6 A 14 GLU C 151 GLU~? 17.15 O8 EPE C 377 A 61 GLU C 227 GLU.? 14.45 C7 EPE C 377 A 162 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 24.82 -49.12 19.40 26.74 -49.67 18.68 coo -4.89 20.85 5.22 -3.95 21.69 6.91 35.69 -39.75 16.92 37.70 -40.13 16.40 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 27.13 -47.60 14.36 28.94 -48.66 14.50 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 6 hits 1j53_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 153 ARG~? 11.00 C6 EPE C 377 A 201 HIS A 224 HIS~? 7.33 C7 EPE A 377 A 204 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG A 274 ARG^? 15.42 ZN ZN A 374 A 201 HIS A 316 HIS~? 20.33 O8 EPE A 376 A 204 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 47.87 -1.95 44.32 44.79 -1.96 44.32 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 36.36 -5.20 52.06 36.55 -4.24 53.92 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG A 274 ARG^? 15.42 ZN ZN A 374 A 201 HIS A 319 HIS~? 24.64 ZN ZN A 374 A 204 HIS A 316 HIS~? 20.33 O8 EPE A 376 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 47.87 -1.95 44.32 44.79 -1.96 44.32 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 41.01 -9.30 52.79 42.52 -8.54 54.04 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 36.36 -5.20 52.06 36.55 -4.24 53.92 ULMN 3 1j70_c00 ATP SULPHURYLASE user 4 3 # 4 A 197 ARG B 153 ARG~? 10.73 C6 EPE A 377 A 201 HIS B 224 HIS.? 17.79 O2S EPE A 377 A 204 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1j70_c00 ATP SULPHURYLASE user 5 3 # 5 A 197 ARG B 274 ARG^? 15.33 ZN ZN B 374 A 201 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 204 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -4.90 23.06 20.40 -3.60 21.04 22.31 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 7.45 20.77 27.47 7.65 22.47 28.71 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1j70_c00 ATP SULPHURYLASE user 6 3 # 6 A 197 ARG C 153 ARG~? 15.97 C2 EPE C 377 A 201 HIS C 224 HIS~? 8.36 C3 EPE C 377 A 204 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 26.69 -40.96 16.23 26.39 -40.40 14.23 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 27.13 -47.60 14.36 28.94 -48.66 14.50 ULMN 3 1j70_c00 ATP SULPHURYLASE user 7 3 # 7 A 197 ARG C 274 ARG^? 15.09 ZN ZN C 374 A 201 HIS C 316 HIS~? -20.42 O8 EPE C 376s A 204 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1j70_c00 ATP SULPHURYLASE user 8 3 # 8 A 197 ARG C 274 ARG^? 15.09 ZN ZN C 374 A 201 HIS C 319 HIS~? 24.70 ZN ZN C 374 A 204 HIS C 316 HIS~? -20.42 O8 EPE C 376s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -9.15 -10.09 56.84 -9.69 -8.65 58.28 1j70_c00 source 1j70 ATP SULPHURYLASE : 8 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG A 153 ARG~? 11.00 C6 EPE C 377 B 201 HIS A 224 HIS~? 7.33 C7 EPE A 377 B 204 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo -18.85 104.93 27.44 -18.03 106.58 29.88 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo -8.48 114.03 24.38 -10.47 114.55 23.97 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo -6.99 108.94 26.28 -8.54 109.57 27.55 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG A 274 ARG^? 15.42 ZN ZN A 374 B 201 HIS A 316 HIS~? 20.33 O8 EPE A 376 B 204 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo -18.85 104.93 27.44 -18.03 106.58 29.88 47.87 -1.95 44.32 44.79 -1.96 44.32 coo -8.48 114.03 24.38 -10.47 114.55 23.97 36.36 -5.20 52.06 36.55 -4.24 53.92 coo -6.99 108.94 26.28 -8.54 109.57 27.55 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG A 274 ARG^? 15.42 ZN ZN A 374 B 201 HIS A 319 HIS~? 24.64 ZN ZN A 374 B 204 HIS A 316 HIS~? 20.33 O8 EPE A 376 coo -18.85 104.93 27.44 -18.03 106.58 29.88 47.87 -1.95 44.32 44.79 -1.96 44.32 coo -8.48 114.03 24.38 -10.47 114.55 23.97 41.01 -9.30 52.79 42.52 -8.54 54.04 coo -6.99 108.94 26.28 -8.54 109.57 27.55 36.36 -5.20 52.06 36.55 -4.24 53.92 ULMN 3 1j70_c01 ATP SULPHURYLASE user 4 3 # 4 B 197 ARG B 153 ARG~? 10.73 C6 EPE A 377 B 201 HIS B 224 HIS.? 17.79 O2S EPE A 377 B 204 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1j70_c01 ATP SULPHURYLASE user 5 3 # 5 B 197 ARG B 274 ARG^? 15.33 ZN ZN B 374 B 201 HIS B 316 HIS~? 20.54 O8 EPE B 376 B 204 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -4.90 23.06 20.40 -3.60 21.04 22.31 coo -8.48 114.03 24.38 -10.47 114.55 23.97 7.45 20.77 27.47 7.65 22.47 28.71 coo -6.99 108.94 26.28 -8.54 109.57 27.55 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1j70_c01 ATP SULPHURYLASE user 6 3 # 6 B 197 ARG B 274 ARG^? 15.33 ZN ZN B 374 B 201 HIS B 319 HIS~? 24.73 ZN ZN B 374 B 204 HIS B 316 HIS~? 20.54 O8 EPE B 376 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -4.90 23.06 20.40 -3.60 21.04 22.31 coo -8.48 114.03 24.38 -10.47 114.55 23.97 8.16 23.53 21.75 7.85 25.60 21.62 coo -6.99 108.94 26.28 -8.54 109.57 27.55 7.45 20.77 27.47 7.65 22.47 28.71 ULMN 3 1j70_c01 ATP SULPHURYLASE user 7 3 # 7 B 197 ARG C 153 ARG~? 15.97 C2 EPE C 377 B 201 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 204 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo -18.85 104.93 27.44 -18.03 106.58 29.88 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -8.48 114.03 24.38 -10.47 114.55 23.97 26.69 -40.96 16.23 26.39 -40.40 14.23 coo -6.99 108.94 26.28 -8.54 109.57 27.55 27.13 -47.60 14.36 28.94 -48.66 14.50 ULMN 3 1j70_c01 ATP SULPHURYLASE user 8 3 # 8 B 197 ARG C 274 ARG^? 15.09 ZN ZN C 374 B 201 HIS C 316 HIS~? -20.42 O8 EPE C 376s B 204 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1j70_c01 ATP SULPHURYLASE user 9 3 # 9 B 197 ARG C 274 ARG^? 15.09 ZN ZN C 374 B 201 HIS C 319 HIS~? 24.70 ZN ZN C 374 B 204 HIS C 316 HIS~? -20.42 O8 EPE C 376s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -9.15 -10.09 56.84 -9.69 -8.65 58.28 1j70_c01 source 1j70 ATP SULPHURYLASE : 9 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 153 ARG~? 11.00 C6 EPE C 377 C 201 HIS A 224 HIS~? 7.33 C7 EPE A 377 C 204 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo 30.92 14.23 15.70 28.82 13.90 13.48 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo 20.16 5.55 18.86 20.00 7.59 19.34 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 24.92 3.29 16.90 24.41 4.92 15.69 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG A 274 ARG^? 15.42 ZN ZN A 374 C 201 HIS A 316 HIS~? 20.33 O8 EPE A 376 C 204 HIS A 319 HIS~? 24.64 ZN ZN A 374 coo 30.92 14.23 15.70 28.82 13.90 13.48 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 20.16 5.55 18.86 20.00 7.59 19.34 36.36 -5.20 52.06 36.55 -4.24 53.92 coo 24.92 3.29 16.90 24.41 4.92 15.69 41.01 -9.30 52.79 42.52 -8.54 54.04 ULMN 3 1j70_c02 ATP SULPHURYLASE user 3 3 # 3 C 197 ARG A 274 ARG^? 15.42 ZN ZN A 374 C 201 HIS A 319 HIS~? 24.64 ZN ZN A 374 C 204 HIS A 316 HIS~? 20.33 O8 EPE A 376 coo 30.92 14.23 15.70 28.82 13.90 13.48 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 20.16 5.55 18.86 20.00 7.59 19.34 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 24.92 3.29 16.90 24.41 4.92 15.69 36.36 -5.20 52.06 36.55 -4.24 53.92 ULMN 3 1j70_c02 ATP SULPHURYLASE user 4 3 # 4 C 197 ARG B 274 ARG^? 15.33 ZN ZN B 374 C 201 HIS B 316 HIS~? 20.54 O8 EPE B 376 C 204 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 30.92 14.23 15.70 28.82 13.90 13.48 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 20.16 5.55 18.86 20.00 7.59 19.34 7.45 20.77 27.47 7.65 22.47 28.71 coo 24.92 3.29 16.90 24.41 4.92 15.69 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 1j70_c02 ATP SULPHURYLASE user 5 3 # 5 C 197 ARG B 274 ARG^? 15.33 ZN ZN B 374 C 201 HIS B 319 HIS~? 24.73 ZN ZN B 374 C 204 HIS B 316 HIS~? 20.54 O8 EPE B 376 coo 30.92 14.23 15.70 28.82 13.90 13.48 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 20.16 5.55 18.86 20.00 7.59 19.34 8.16 23.53 21.75 7.85 25.60 21.62 coo 24.92 3.29 16.90 24.41 4.92 15.69 7.45 20.77 27.47 7.65 22.47 28.71 ULMN 3 1j70_c02 ATP SULPHURYLASE user 6 3 # 6 C 197 ARG C 153 ARG~? 15.97 C2 EPE C 377 C 201 HIS C 224 HIS~? 8.36 C3 EPE C 377 C 204 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo 30.92 14.23 15.70 28.82 13.90 13.48 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 20.16 5.55 18.86 20.00 7.59 19.34 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 24.92 3.29 16.90 24.41 4.92 15.69 27.13 -47.60 14.36 28.94 -48.66 14.50 ULMN 3 1j70_c02 ATP SULPHURYLASE user 7 3 # 7 C 197 ARG C 274 ARG^? 15.09 ZN ZN C 374 C 201 HIS C 316 HIS~? -20.42 O8 EPE C 376s C 204 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 30.92 14.23 15.70 28.82 13.90 13.48 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 20.16 5.55 18.86 20.00 7.59 19.34 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 24.92 3.29 16.90 24.41 4.92 15.69 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 1j70_c02 ATP SULPHURYLASE user 8 3 # 8 C 197 ARG C 274 ARG^? 15.09 ZN ZN C 374 C 201 HIS C 319 HIS~? 24.70 ZN ZN C 374 C 204 HIS C 316 HIS~? -20.42 O8 EPE C 376s coo 30.92 14.23 15.70 28.82 13.90 13.48 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 20.16 5.55 18.86 20.00 7.59 19.34 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 24.92 3.29 16.90 24.41 4.92 15.69 -9.15 -10.09 56.84 -9.69 -8.65 58.28 1j70_c02 source 1j70 ATP SULPHURYLASE : 8 hits 1j70_c02 naa= 3 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN A 259 GLN~? 28.90 ZN ZN A 375 A 79 PHE A 260 PHE~? 19.27 ZN ZN A 375 A 80 THR A 256 THR^? 28.88 ZN ZN A 375 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 58.90 -16.16 37.51 60.42 -17.61 36.90 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 56.69 -18.34 40.21 58.60 -17.57 40.86 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 2 3 # 2 A 78 GLN B 259 GLN~? 29.53 ZN ZN B 375 A 79 PHE B 260 PHE~? 19.39 ZN ZN B 375 A 80 THR B 256 THR^? 29.14 ZN ZN B 375 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -5.41 23.11 1.24 -4.67 22.70 -0.73 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -1.04 21.83 2.11 -1.77 23.76 1.44 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 3 3 # 3 A 78 GLN C 259 GLN~? 29.09 ZN ZN C 375 A 79 PHE C 260 PHE~? 19.40 ZN ZN C 375 A 80 THR C 256 THR^? 29.06 ZN ZN C 375 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -19.24 -36.63 57.84 -20.75 -38.09 57.58 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -20.65 -33.80 55.44 -22.00 -34.26 57.11 1j7g_c00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 3 hits 1j7g_c00 naa= 3 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 1 3 # 1 254 ASP A 158 ASP~? 15.23 O1S EPE C 377 303 HIS A 169 HIS^? 11.22 O1S EPE C 377 407 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo 49.08 66.55 9.14 50.71 67.89 8.88 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 47.11 68.57 13.19 49.07 68.74 12.45 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 49.32 64.84 19.61 47.95 67.13 18.88 25.74 -30.01 4.94 27.86 -30.22 6.82 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 2 3 # 2 254 ASP B 158 ASP~? 14.93 O3S EPE A 377 303 HIS B 169 HIS^? 10.86 O3S EPE A 377 407 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo 49.08 66.55 9.14 50.71 67.89 8.88 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 47.11 68.57 13.19 49.07 68.74 12.45 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 49.32 64.84 19.61 47.95 67.13 18.88 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1jdw_c01 L-ARGININE-GLYCINE AMIDINOTRANSFERASuser 3 3 # 3 254 ASP C 158 ASP~? 22.01 O1 TRS A 378 303 HIS C 169 HIS^? 22.39 O1 TRS A 378 407 CYH C 170 CYH^? 22.19 N TRS A 378 coo 49.08 66.55 9.14 50.71 67.89 8.88 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 47.11 68.57 13.19 49.07 68.74 12.45 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 49.32 64.84 19.61 47.95 67.13 18.88 9.66 -43.43 21.72 7.18 -43.27 22.99 1jdw_c01 source 1jdw L-ARGININE-GLYCINE AMIDINOTRANSFERASE : 3 hits 1jdw_c01 naa= 3 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 1 3 # 1 A 202 SER A 168 SER^? 10.80 O1S EPE C 377 A 308 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 338 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 37.44 15.05 21.90 37.18 17.02 20.71 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 45.75 18.77 19.41 43.72 18.70 19.99 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 41.13 18.39 17.83 39.67 17.70 19.17 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 2 3 # 2 A 202 SER B 168 SER^? 10.59 O3S EPE A 377 A 308 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 338 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 37.44 15.05 21.90 37.18 17.02 20.71 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 45.75 18.77 19.41 43.72 18.70 19.99 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 41.13 18.39 17.83 39.67 17.70 19.17 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 3 3 # 3 A 202 SER C 168 SER^? 24.11 O1 TRS A 378 A 308 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 338 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 37.44 15.05 21.90 37.18 17.02 20.71 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 45.75 18.77 19.41 43.72 18.70 19.99 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 41.13 18.39 17.83 39.67 17.70 19.17 13.13 -47.52 24.96 14.34 -48.17 26.54 1jkm_c00 source 1jkm BREFELDIN A ESTERASE : 3 hits 1jkm_c00 naa= 3 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 1 3 # 1 B 202 SER A 168 SER^? 10.80 O1S EPE C 377 B 308 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 338 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 67.81 2.11 21.29 69.09 3.00 23.04 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 64.20 9.21 26.15 65.67 7.96 25.24 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 66.92 5.20 26.82 67.69 4.22 25.14 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 2 3 # 2 B 202 SER B 168 SER^? 10.59 O3S EPE A 377 B 308 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 338 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 67.81 2.11 21.29 69.09 3.00 23.04 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 64.20 9.21 26.15 65.67 7.96 25.24 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 66.92 5.20 26.82 67.69 4.22 25.14 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 3 3 # 3 B 202 SER C 168 SER^? 24.11 O1 TRS A 378 B 308 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 338 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 67.81 2.11 21.29 69.09 3.00 23.04 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 64.20 9.21 26.15 65.67 7.96 25.24 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 66.92 5.20 26.82 67.69 4.22 25.14 13.13 -47.52 24.96 14.34 -48.17 26.54 1jkm_c01 source 1jkm BREFELDIN A ESTERASE : 3 hits 1jkm_c01 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 58 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 424 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 58.42 47.76 20.67 58.01 49.10 19.12 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 58.59 41.80 18.81 58.94 43.89 18.94 39.49 -1.24 39.18 39.76 0.49 37.96 coo 52.85 46.34 13.34 54.09 44.97 14.42 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 58 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 424 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 58.42 47.76 20.67 58.01 49.10 19.12 39.49 -1.24 39.18 39.76 0.49 37.96 coo 58.59 41.80 18.81 58.94 43.89 18.94 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 52.85 46.34 13.34 54.09 44.97 14.42 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP B 281 ASP.? 29.04 ZN ZN B 374 A 58 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 424 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 58.42 47.76 20.67 58.01 49.10 19.12 4.51 22.24 5.26 6.45 23.04 5.71 coo 58.59 41.80 18.81 58.94 43.89 18.94 3.99 14.73 5.36 5.18 14.04 3.76 coo 52.85 46.34 13.34 54.09 44.97 14.42 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 58 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 424 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 58.42 47.76 20.67 58.01 49.10 19.12 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 58.59 41.80 18.81 58.94 43.89 18.94 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 52.85 46.34 13.34 54.09 44.97 14.42 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 5 3 # 5 A 55 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 58 ASP B 281 ASP.? 29.04 ZN ZN B 374 A 424 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 58.42 47.76 20.67 58.01 49.10 19.12 3.99 14.73 5.36 5.18 14.04 3.76 coo 58.59 41.80 18.81 58.94 43.89 18.94 4.51 22.24 5.26 6.45 23.04 5.71 coo 52.85 46.34 13.34 54.09 44.97 14.42 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 6 3 # 6 A 55 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 58 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 424 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 58.42 47.76 20.67 58.01 49.10 19.12 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 58.59 41.80 18.81 58.94 43.89 18.94 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 52.85 46.34 13.34 54.09 44.97 14.42 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 7 3 # 7 A 55 ASP C 280 ASP.? 31.92 ZN ZN C 374 A 58 ASP C 281 ASP.? 29.07 ZN ZN C 374 A 424 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 58.42 47.76 20.67 58.01 49.10 19.12 -25.13 -30.20 58.02 -25.85 -28.27 58.51 coo 58.59 41.80 18.81 58.94 43.89 18.94 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 52.85 46.34 13.34 54.09 44.97 14.42 -21.46 -36.51 49.50 -23.48 -36.16 48.85 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 8 3 # 8 A 55 ASP C 281 ASP.? 29.07 ZN ZN C 374 A 58 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 424 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 58.42 47.76 20.67 58.01 49.10 19.12 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 58.59 41.80 18.81 58.94 43.89 18.94 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 52.85 46.34 13.34 54.09 44.97 14.42 -21.46 -36.51 49.50 -23.48 -36.16 48.85 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 9 3 # 9 A 55 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 58 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 424 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 58.42 47.76 20.67 58.01 49.10 19.12 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 58.59 41.80 18.81 58.94 43.89 18.94 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 52.85 46.34 13.34 54.09 44.97 14.42 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 10 3 # 10 A 55 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 58 ASP C 281 ASP.? 29.07 ZN ZN C 374 A 424 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 58.42 47.76 20.67 58.01 49.10 19.12 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 58.59 41.80 18.81 58.94 43.89 18.94 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 52.85 46.34 13.34 54.09 44.97 14.42 -21.46 -36.51 49.50 -23.48 -36.16 48.85 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 11 3 # 11 A 55 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 58 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 424 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 58.42 47.76 20.67 58.01 49.10 19.12 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 58.59 41.80 18.81 58.94 43.89 18.94 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 52.85 46.34 13.34 54.09 44.97 14.42 3.38 -29.70 55.34 4.58 -28.10 54.66 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 11 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 58 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 424 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 112.10 61.46 19.99 111.82 60.65 18.07 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 117.85 63.62 21.08 115.96 63.25 20.18 39.49 -1.24 39.18 39.76 0.49 37.96 coo 118.47 57.23 15.57 119.32 58.77 16.73 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 58 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 424 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 112.10 61.46 19.99 111.82 60.65 18.07 39.49 -1.24 39.18 39.76 0.49 37.96 coo 117.85 63.62 21.08 115.96 63.25 20.18 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 118.47 57.23 15.57 119.32 58.77 16.73 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP B 281 ASP.? 29.04 ZN ZN B 374 B 58 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 424 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 112.10 61.46 19.99 111.82 60.65 18.07 4.51 22.24 5.26 6.45 23.04 5.71 coo 117.85 63.62 21.08 115.96 63.25 20.18 3.99 14.73 5.36 5.18 14.04 3.76 coo 118.47 57.23 15.57 119.32 58.77 16.73 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 4 3 # 4 B 55 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 58 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 424 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 112.10 61.46 19.99 111.82 60.65 18.07 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 117.85 63.62 21.08 115.96 63.25 20.18 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 118.47 57.23 15.57 119.32 58.77 16.73 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 5 3 # 5 B 55 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 58 ASP B 281 ASP.? 29.04 ZN ZN B 374 B 424 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 112.10 61.46 19.99 111.82 60.65 18.07 3.99 14.73 5.36 5.18 14.04 3.76 coo 117.85 63.62 21.08 115.96 63.25 20.18 4.51 22.24 5.26 6.45 23.04 5.71 coo 118.47 57.23 15.57 119.32 58.77 16.73 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 6 3 # 6 B 55 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 58 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 424 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 112.10 61.46 19.99 111.82 60.65 18.07 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 117.85 63.62 21.08 115.96 63.25 20.18 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 118.47 57.23 15.57 119.32 58.77 16.73 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 7 3 # 7 B 55 ASP C 281 ASP.? 29.07 ZN ZN C 374 B 58 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 424 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 112.10 61.46 19.99 111.82 60.65 18.07 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 117.85 63.62 21.08 115.96 63.25 20.18 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 118.47 57.23 15.57 119.32 58.77 16.73 -21.46 -36.51 49.50 -23.48 -36.16 48.85 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 8 3 # 8 B 55 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 58 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 424 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 112.10 61.46 19.99 111.82 60.65 18.07 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 117.85 63.62 21.08 115.96 63.25 20.18 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 118.47 57.23 15.57 119.32 58.77 16.73 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 9 3 # 9 B 55 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 58 ASP C 281 ASP.? 29.07 ZN ZN C 374 B 424 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 112.10 61.46 19.99 111.82 60.65 18.07 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 117.85 63.62 21.08 115.96 63.25 20.18 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 118.47 57.23 15.57 119.32 58.77 16.73 -21.46 -36.51 49.50 -23.48 -36.16 48.85 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 10 3 # 10 B 55 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 58 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 424 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 112.10 61.46 19.99 111.82 60.65 18.07 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 117.85 63.62 21.08 115.96 63.25 20.18 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 118.47 57.23 15.57 119.32 58.77 16.73 3.38 -29.70 55.34 4.58 -28.10 54.66 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 10 hits 1js4_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 9 GLU~? 28.50 ZN ZN A 375 A 56 LYS A 354 LYS~? 27.90 ZN ZN A 375 A 258 ARG A 41 ARG.? 31.19 ZN ZN A 375 coo 42.33 1.56 26.99 42.38 2.91 28.66 31.54 5.84 4.26 31.09 6.26 2.19 coo 38.45 -0.44 19.89 37.36 0.90 25.90 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 42.11 12.31 4.12 44.66 13.27 2.71 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 56 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 258 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo 42.33 1.56 26.99 42.38 2.91 28.66 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 38.45 -0.44 19.89 37.36 0.90 25.90 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 56 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 258 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 42.33 1.56 26.99 42.38 2.91 28.66 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 38.45 -0.44 19.89 37.36 0.90 25.90 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU B 135 GLU^? 15.63 O1S EPE A 377 A 56 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 258 ARG B 214 ARG~? 23.93 O3S EPE A 377 coo 42.33 1.56 26.99 42.38 2.91 28.66 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 38.45 -0.44 19.89 37.36 0.90 25.90 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -7.68 -23.63 22.44 -8.04 -24.96 25.17 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 A 2 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 56 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 258 ARG B 153 ARG~? 10.73 C6 EPE A 377 coo 42.33 1.56 26.99 42.38 2.91 28.66 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 38.45 -0.44 19.89 37.36 0.90 25.90 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -1.46 -36.52 4.12 -1.19 -38.78 2.09 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 A 2 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 56 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 258 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 42.33 1.56 26.99 42.38 2.91 28.66 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 38.45 -0.44 19.89 37.36 0.90 25.90 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 A 2 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 56 LYS C 139 LYS^? 16.11 N TRS A 378 A 258 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 42.33 1.56 26.99 42.38 2.91 28.66 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 38.45 -0.44 19.89 37.36 0.90 25.90 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 A 2 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 56 LYS C 139 LYS^? 16.11 N TRS A 378 A 258 ARG C 153 ARG~? 15.97 C2 EPE C 377 coo 42.33 1.56 26.99 42.38 2.91 28.66 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 38.45 -0.44 19.89 37.36 0.90 25.90 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 15.73 -46.74 16.59 16.35 -47.76 13.75 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 8 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 9 GLU~? 28.50 ZN ZN A 375 B 56 LYS A 354 LYS~? 27.90 ZN ZN A 375 B 258 ARG A 41 ARG.? 31.19 ZN ZN A 375 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 31.54 5.84 4.26 31.09 6.26 2.19 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 2.64 1.83 34.81 1.56 1.13 32.02 42.11 12.31 4.12 44.66 13.27 2.71 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 56 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 258 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 2.64 1.83 34.81 1.56 1.13 32.02 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 56 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 258 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 2.64 1.83 34.81 1.56 1.13 32.02 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU B 135 GLU^? 15.63 O1S EPE A 377 B 56 LYS B 138 LYS^? 15.17 O1S EPE A 377 B 258 ARG B 214 ARG~? 23.93 O3S EPE A 377 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 2.64 1.83 34.81 1.56 1.13 32.02 -7.68 -23.63 22.44 -8.04 -24.96 25.17 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 56 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 258 ARG B 153 ARG~? 10.73 C6 EPE A 377 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 2.64 1.83 34.81 1.56 1.13 32.02 -1.46 -36.52 4.12 -1.19 -38.78 2.09 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 B 2 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 56 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 258 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 2.64 1.83 34.81 1.56 1.13 32.02 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 B 2 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 56 LYS C 139 LYS^? 16.11 N TRS A 378 B 258 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 2.64 1.83 34.81 1.56 1.13 32.02 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 B 2 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 56 LYS C 139 LYS^? 16.11 N TRS A 378 B 258 ARG C 153 ARG~? 15.97 C2 EPE C 377 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 2.64 1.83 34.81 1.56 1.13 32.02 15.73 -46.74 16.59 16.35 -47.76 13.75 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 8 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 9 GLU~? 28.50 ZN ZN A 375 C 56 LYS A 354 LYS~? 27.90 ZN ZN A 375 C 258 ARG A 41 ARG.? 31.19 ZN ZN A 375 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 31.54 5.84 4.26 31.09 6.26 2.19 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 42.11 12.31 4.12 44.66 13.27 2.71 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 205 GLU^? -4.84 O3S EPE C 377s C 56 LYS A 139 LYS^? -2.64 O3S EPE C 377s C 258 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU A 205 GLU^? -4.84 O3S EPE C 377s C 56 LYS A 139 LYS^? -2.64 O3S EPE C 377s C 258 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU B 135 GLU^? 15.63 O1S EPE A 377 C 56 LYS B 138 LYS^? 15.17 O1S EPE A 377 C 258 ARG B 214 ARG~? 23.93 O3S EPE A 377 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -7.68 -23.63 22.44 -8.04 -24.96 25.17 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU B 205 GLU^? 4.50 O2S EPE A 377 C 56 LYS B 139 LYS^? -2.84 O2S EPE A 377s C 258 ARG B 153 ARG~? 10.73 C6 EPE A 377 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -1.46 -36.52 4.12 -1.19 -38.78 2.09 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 C 2 GLU B 205 GLU^? 4.50 O2S EPE A 377 C 56 LYS B 139 LYS^? -2.84 O2S EPE A 377s C 258 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 C 2 GLU C 205 GLU^? 12.89 O3S EPE C 377 C 56 LYS C 139 LYS^? 16.11 N TRS A 378 C 258 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 C 2 GLU C 205 GLU^? 12.89 O3S EPE C 377 C 56 LYS C 139 LYS^? 16.11 N TRS A 378 C 258 ARG C 153 ARG~? 15.97 C2 EPE C 377 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 15.73 -46.74 16.59 16.35 -47.76 13.75 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 8 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 9 GLU~? 28.50 ZN ZN A 375 D 56 LYS A 354 LYS~? 27.90 ZN ZN A 375 D 258 ARG A 41 ARG.? 31.19 ZN ZN A 375 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 31.54 5.84 4.26 31.09 6.26 2.19 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 42.11 12.31 4.12 44.66 13.27 2.71 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 205 GLU^? -4.84 O3S EPE C 377s D 56 LYS A 139 LYS^? -2.64 O3S EPE C 377s D 258 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU A 205 GLU^? -4.84 O3S EPE C 377s D 56 LYS A 139 LYS^? -2.64 O3S EPE C 377s D 258 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU B 135 GLU^? 15.63 O1S EPE A 377 D 56 LYS B 138 LYS^? 15.17 O1S EPE A 377 D 258 ARG B 214 ARG~? 23.93 O3S EPE A 377 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -7.68 -23.63 22.44 -8.04 -24.96 25.17 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU B 205 GLU^? 4.50 O2S EPE A 377 D 56 LYS B 139 LYS^? -2.84 O2S EPE A 377s D 258 ARG B 153 ARG~? 10.73 C6 EPE A 377 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -1.46 -36.52 4.12 -1.19 -38.78 2.09 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 D 2 GLU B 205 GLU^? 4.50 O2S EPE A 377 D 56 LYS B 139 LYS^? -2.84 O2S EPE A 377s D 258 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 D 2 GLU C 205 GLU^? 12.89 O3S EPE C 377 D 56 LYS C 139 LYS^? 16.11 N TRS A 378 D 258 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 D 2 GLU C 205 GLU^? 12.89 O3S EPE C 377 D 56 LYS C 139 LYS^? 16.11 N TRS A 378 D 258 ARG C 153 ARG~? 15.97 C2 EPE C 377 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 15.73 -46.74 16.59 16.35 -47.76 13.75 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 8 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 150 GLU~? 12.50 C5 EPE C 377 A 163 ARG A 153 ARG~? 11.00 C6 EPE C 377 A 222 ARG C 198 ARG^? 10.55 C8 EPE C 377 coo 51.27 81.34 48.31 51.67 80.79 50.28 22.60 -31.63 -7.22 23.33 -32.82 -5.63 coo 48.06 78.22 50.94 48.51 78.27 53.98 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo 54.85 84.16 52.60 54.26 81.23 53.34 24.16 -38.26 -3.08 24.91 -35.49 -4.23 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU B 150 GLU~? 12.97 C6 EPE A 377 A 163 ARG B 153 ARG~? 10.73 C6 EPE A 377 A 222 ARG A 198 ARG^? 11.16 C6 EPE A 377 coo 51.27 81.34 48.31 51.67 80.79 50.28 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 48.06 78.22 50.94 48.51 78.27 53.98 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo 54.85 84.16 52.60 54.26 81.23 53.34 -1.05 -38.83 -3.85 -3.04 -38.62 -1.48 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU C 150 GLU~? 19.96 C2 EPE C 377 A 163 ARG C 153 ARG~? 15.97 C2 EPE C 377 A 222 ARG B 198 ARG^? 21.95 C2 EPE C 377 coo 51.27 81.34 48.31 51.67 80.79 50.28 18.79 -51.73 16.88 16.73 -51.34 17.24 coo 48.06 78.22 50.94 48.51 78.27 53.98 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 54.85 84.16 52.60 54.26 81.23 53.34 11.64 -52.94 14.57 14.19 -52.83 16.31 1kim_c00 source 1kim THYMIDINE KINASE : 3 hits 1kim_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 87 LYS~? 10.99 O2S EPE A 376 A 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 24.97 5.82 58.78 26.79 1.97 55.46 35.91 21.93 28.51 38.15 26.57 30.75 coo 19.46 3.44 61.93 23.95 1.12 60.13 36.23 21.81 22.32 41.86 22.67 23.70 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 94 LYS~? 16.25 O2S EPE A 376 A 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 24.97 5.82 58.78 26.79 1.97 55.46 33.79 23.90 18.72 34.24 28.62 22.89 coo 19.46 3.44 61.93 23.95 1.12 60.13 36.23 21.81 22.32 41.86 22.67 23.70 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 94 LYS~? 16.25 O2S EPE A 376 A 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 24.97 5.82 58.78 26.79 1.97 55.46 33.79 23.90 18.72 34.24 28.62 22.89 coo 19.46 3.44 61.93 23.95 1.12 60.13 36.23 21.81 22.32 41.86 22.67 23.70 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 265 LYS~? 22.38 ZN ZN A 374 A 74 LYS A 271 LYS.? 23.00 ZN ZN A 374 A 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 24.97 5.82 58.78 26.79 1.97 55.46 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 19.46 3.44 61.93 23.95 1.12 60.13 56.12 0.48 35.73 59.67 4.01 35.99 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 271 LYS.? 23.00 ZN ZN A 374 A 74 LYS A 265 LYS~? 22.38 ZN ZN A 374 A 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 24.97 5.82 58.78 26.79 1.97 55.46 56.12 0.48 35.73 59.67 4.01 35.99 coo 19.46 3.44 61.93 23.95 1.12 60.13 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 74 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 24.97 5.82 58.78 26.79 1.97 55.46 45.66 0.76 26.15 51.53 0.58 28.90 coo 19.46 3.44 61.93 23.95 1.12 60.13 44.47 1.55 20.70 47.30 5.10 24.27 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 74 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 24.97 5.82 58.78 26.79 1.97 55.46 44.47 1.55 20.70 47.30 5.10 24.27 coo 19.46 3.44 61.93 23.95 1.12 60.13 45.66 0.76 26.15 51.53 0.58 28.90 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 74 LYS A 345 LYS~? 18.67 ZN ZN A 375 A 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 44.47 1.55 20.70 47.30 5.10 24.27 coo 19.46 3.44 61.93 23.95 1.12 60.13 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS A 345 LYS~? 18.67 ZN ZN A 375 A 74 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 19.46 3.44 61.93 23.95 1.12 60.13 44.47 1.55 20.70 47.30 5.10 24.27 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS B 87 LYS~? 9.60 O3S EPE B 376 A 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 24.97 5.82 58.78 26.79 1.97 55.46 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 19.46 3.44 61.93 23.95 1.12 60.13 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS B 94 LYS~? 17.44 O2S EPE B 376 A 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 24.97 5.82 58.78 26.79 1.97 55.46 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 19.46 3.44 61.93 23.95 1.12 60.13 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS B 215 LYS~? 17.38 O3S EPE A 377 A 74 LYS B 218 LYS~? 23.26 O3S EPE A 377 A 165 GLU B 151 GLU~? 19.22 O3S EPE A 377 coo 24.97 5.82 58.78 26.79 1.97 55.46 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 19.46 3.44 61.93 23.95 1.12 60.13 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -9.61 -39.78 7.97 -10.79 -41.15 9.06 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS B 265 LYS~? 21.91 ZN ZN B 374 A 74 LYS B 271 LYS.? 19.93 ZN ZN B 374 A 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 24.97 5.82 58.78 26.79 1.97 55.46 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 19.46 3.44 61.93 23.95 1.12 60.13 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS B 271 LYS.? 19.93 ZN ZN B 374 A 74 LYS B 265 LYS~? 21.91 ZN ZN B 374 A 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 24.97 5.82 58.78 26.79 1.97 55.46 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 19.46 3.44 61.93 23.95 1.12 60.13 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 19.46 3.44 61.93 23.95 1.12 60.13 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 165 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo 24.97 5.82 58.78 26.79 1.97 55.46 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 19.46 3.44 61.93 23.95 1.12 60.13 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 19.46 3.44 61.93 23.95 1.12 60.13 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 74 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 19.46 3.44 61.93 23.95 1.12 60.13 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 A 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 74 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 19.46 3.44 61.93 23.95 1.12 60.13 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 A 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 19.46 3.44 61.93 23.95 1.12 60.13 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 A 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 19.46 3.44 61.93 23.95 1.12 60.13 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 A 14 LYS B 354 LYS~? 28.15 ZN ZN B 375 A 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 19.46 3.44 61.93 23.95 1.12 60.13 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 A 14 LYS C 87 LYS~? 9.86 O3S EPE C 376 A 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 24.97 5.82 58.78 26.79 1.97 55.46 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 19.46 3.44 61.93 23.95 1.12 60.13 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 A 14 LYS C 94 LYS~? 16.71 O3S EPE C 376 A 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 24.97 5.82 58.78 26.79 1.97 55.46 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 19.46 3.44 61.93 23.95 1.12 60.13 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 A 14 LYS C 215 LYS~? 17.39 O1 TRS A 378 A 74 LYS C 218 LYS~? 12.80 O1 TRS A 378 A 165 GLU C 151 GLU~? 17.15 O8 EPE C 377 coo 24.97 5.82 58.78 26.79 1.97 55.46 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 19.46 3.44 61.93 23.95 1.12 60.13 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 24.82 -49.12 19.40 26.74 -49.67 18.68 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 A 14 LYS C 265 LYS~? 21.95 ZN ZN C 374 A 74 LYS C 271 LYS.? 19.51 ZN ZN C 374 A 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 24.97 5.82 58.78 26.79 1.97 55.46 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 19.46 3.44 61.93 23.95 1.12 60.13 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 A 14 LYS C 271 LYS.? 19.51 ZN ZN C 374 A 74 LYS C 265 LYS~? 21.95 ZN ZN C 374 A 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 24.97 5.82 58.78 26.79 1.97 55.46 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 19.46 3.44 61.93 23.95 1.12 60.13 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 28 3 # 28 A 14 LYS C 303 LYS~? 17.98 ZN ZN C 375 A 74 LYS C 301 LYS~? 24.63 ZN ZN C 375 A 165 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 19.46 3.44 61.93 23.95 1.12 60.13 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -21.46 -36.51 49.50 -23.48 -36.16 48.85 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 29 3 # 29 A 14 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 30 3 # 30 A 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 165 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 19.46 3.44 61.93 23.95 1.12 60.13 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 13.88 -30.69 72.19 13.68 -28.54 72.17 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 31 3 # 31 A 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 19.46 3.44 61.93 23.95 1.12 60.13 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 32 3 # 32 A 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 74 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 19.46 3.44 61.93 23.95 1.12 60.13 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 33 3 # 33 A 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 74 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 19.46 3.44 61.93 23.95 1.12 60.13 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 34 3 # 34 A 14 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 35 3 # 35 A 14 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 74 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 19.46 3.44 61.93 23.95 1.12 60.13 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 36 3 # 36 A 14 LYS C 354 LYS~? 23.72 O1 TRS A 378 A 74 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 24.97 5.82 58.78 26.79 1.97 55.46 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 19.46 3.44 61.93 23.95 1.12 60.13 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.30 -32.62 45.28 21.00 -31.37 45.17 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 36 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 87 LYS~? 10.99 O2S EPE A 376 B 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 B 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 4.84 5.09 23.75 3.30 1.39 27.48 35.91 21.93 28.51 38.15 26.57 30.75 coo 10.43 2.88 20.75 5.72 0.41 23.95 36.23 21.81 22.32 41.86 22.67 23.70 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 94 LYS~? 16.25 O2S EPE A 376 B 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 B 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 4.84 5.09 23.75 3.30 1.39 27.48 33.79 23.90 18.72 34.24 28.62 22.89 coo 10.43 2.88 20.75 5.72 0.41 23.95 36.23 21.81 22.32 41.86 22.67 23.70 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 94 LYS~? 16.25 O2S EPE A 376 B 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 B 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 4.84 5.09 23.75 3.30 1.39 27.48 33.79 23.90 18.72 34.24 28.62 22.89 coo 10.43 2.88 20.75 5.72 0.41 23.95 36.23 21.81 22.32 41.86 22.67 23.70 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 265 LYS~? 22.38 ZN ZN A 374 B 74 LYS A 271 LYS.? 23.00 ZN ZN A 374 B 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 4.84 5.09 23.75 3.30 1.39 27.48 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 10.43 2.88 20.75 5.72 0.41 23.95 56.12 0.48 35.73 59.67 4.01 35.99 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 271 LYS.? 23.00 ZN ZN A 374 B 74 LYS A 265 LYS~? 22.38 ZN ZN A 374 B 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 4.84 5.09 23.75 3.30 1.39 27.48 56.12 0.48 35.73 59.67 4.01 35.99 coo 10.43 2.88 20.75 5.72 0.41 23.95 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS A 337 LYS~? 14.02 ZN ZN A 374 B 74 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 4.84 5.09 23.75 3.30 1.39 27.48 45.66 0.76 26.15 51.53 0.58 28.90 coo 10.43 2.88 20.75 5.72 0.41 23.95 44.47 1.55 20.70 47.30 5.10 24.27 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 74 LYS A 337 LYS~? 14.02 ZN ZN A 374 B 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 4.84 5.09 23.75 3.30 1.39 27.48 44.47 1.55 20.70 47.30 5.10 24.27 coo 10.43 2.88 20.75 5.72 0.41 23.95 45.66 0.76 26.15 51.53 0.58 28.90 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS B 87 LYS~? 9.60 O3S EPE B 376 B 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 B 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 4.84 5.09 23.75 3.30 1.39 27.48 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 10.43 2.88 20.75 5.72 0.41 23.95 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS B 94 LYS~? 17.44 O2S EPE B 376 B 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 B 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 4.84 5.09 23.75 3.30 1.39 27.48 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 10.43 2.88 20.75 5.72 0.41 23.95 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS B 215 LYS~? 17.38 O3S EPE A 377 B 74 LYS B 218 LYS~? 23.26 O3S EPE A 377 B 165 GLU B 151 GLU~? 19.22 O3S EPE A 377 coo 4.84 5.09 23.75 3.30 1.39 27.48 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 10.43 2.88 20.75 5.72 0.41 23.95 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -9.61 -39.78 7.97 -10.79 -41.15 9.06 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS B 265 LYS~? 21.91 ZN ZN B 374 B 74 LYS B 271 LYS.? 19.93 ZN ZN B 374 B 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 4.84 5.09 23.75 3.30 1.39 27.48 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 10.43 2.88 20.75 5.72 0.41 23.95 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS B 271 LYS.? 19.93 ZN ZN B 374 B 74 LYS B 265 LYS~? 21.91 ZN ZN B 374 B 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 4.84 5.09 23.75 3.30 1.39 27.48 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 10.43 2.88 20.75 5.72 0.41 23.95 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 10.43 2.88 20.75 5.72 0.41 23.95 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 165 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo 4.84 5.09 23.75 3.30 1.39 27.48 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 10.43 2.88 20.75 5.72 0.41 23.95 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 10.43 2.88 20.75 5.72 0.41 23.95 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 74 LYS B 345 LYS~? 20.14 ZN ZN B 375 B 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 10.43 2.88 20.75 5.72 0.41 23.95 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 74 LYS B 345 LYS~? 20.14 ZN ZN B 375 B 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 10.43 2.88 20.75 5.72 0.41 23.95 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 B 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 10.43 2.88 20.75 5.72 0.41 23.95 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 B 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 B 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 10.43 2.88 20.75 5.72 0.41 23.95 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 B 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 B 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 B 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 10.43 2.88 20.75 5.72 0.41 23.95 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 B 14 LYS B 354 LYS~? 28.15 ZN ZN B 375 B 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 B 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 10.43 2.88 20.75 5.72 0.41 23.95 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 B 14 LYS C 87 LYS~? 9.86 O3S EPE C 376 B 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 B 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 4.84 5.09 23.75 3.30 1.39 27.48 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 10.43 2.88 20.75 5.72 0.41 23.95 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 B 14 LYS C 94 LYS~? 16.71 O3S EPE C 376 B 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 B 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 4.84 5.09 23.75 3.30 1.39 27.48 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 10.43 2.88 20.75 5.72 0.41 23.95 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 B 14 LYS C 215 LYS~? 17.39 O1 TRS A 378 B 74 LYS C 218 LYS~? 12.80 O1 TRS A 378 B 165 GLU C 151 GLU~? 17.15 O8 EPE C 377 coo 4.84 5.09 23.75 3.30 1.39 27.48 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 10.43 2.88 20.75 5.72 0.41 23.95 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 24.82 -49.12 19.40 26.74 -49.67 18.68 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 B 14 LYS C 265 LYS~? 21.95 ZN ZN C 374 B 74 LYS C 271 LYS.? 19.51 ZN ZN C 374 B 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 4.84 5.09 23.75 3.30 1.39 27.48 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 10.43 2.88 20.75 5.72 0.41 23.95 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 B 14 LYS C 271 LYS.? 19.51 ZN ZN C 374 B 74 LYS C 265 LYS~? 21.95 ZN ZN C 374 B 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 4.84 5.09 23.75 3.30 1.39 27.48 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 10.43 2.88 20.75 5.72 0.41 23.95 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 B 14 LYS C 303 LYS~? 17.98 ZN ZN C 375 B 74 LYS C 301 LYS~? 24.63 ZN ZN C 375 B 165 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 10.43 2.88 20.75 5.72 0.41 23.95 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -21.46 -36.51 49.50 -23.48 -36.16 48.85 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 28 3 # 28 B 14 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 29 3 # 29 B 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 165 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 10.43 2.88 20.75 5.72 0.41 23.95 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 13.88 -30.69 72.19 13.68 -28.54 72.17 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 30 3 # 30 B 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 10.43 2.88 20.75 5.72 0.41 23.95 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 31 3 # 31 B 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 74 LYS C 345 LYS~? 19.35 ZN ZN C 375 B 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 10.43 2.88 20.75 5.72 0.41 23.95 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 32 3 # 32 B 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 74 LYS C 345 LYS~? 19.35 ZN ZN C 375 B 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 10.43 2.88 20.75 5.72 0.41 23.95 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 33 3 # 33 B 14 LYS C 345 LYS~? 19.35 ZN ZN C 375 B 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 34 3 # 34 B 14 LYS C 354 LYS~? 23.72 O1 TRS A 378 B 74 LYS C 350 LYS~? 21.45 ZN ZN C 375 B 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 4.84 5.09 23.75 3.30 1.39 27.48 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 10.43 2.88 20.75 5.72 0.41 23.95 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 19.30 -32.62 45.28 21.00 -31.37 45.17 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 34 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 87 LYS~? 10.99 O2S EPE A 376 C 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 C 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 17.59 37.25 25.80 19.64 34.15 21.60 35.91 21.93 28.51 38.15 26.57 30.75 coo 12.29 34.52 28.11 16.84 32.47 25.43 36.23 21.81 22.32 41.86 22.67 23.70 coo 12.06 27.10 15.56 13.23 27.02 13.80 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 94 LYS~? 16.25 O2S EPE A 376 C 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 C 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 17.59 37.25 25.80 19.64 34.15 21.60 33.79 23.90 18.72 34.24 28.62 22.89 coo 12.29 34.52 28.11 16.84 32.47 25.43 36.23 21.81 22.32 41.86 22.67 23.70 coo 12.06 27.10 15.56 13.23 27.02 13.80 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS A 94 LYS~? 16.25 O2S EPE A 376 C 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 C 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 17.59 37.25 25.80 19.64 34.15 21.60 33.79 23.90 18.72 34.24 28.62 22.89 coo 12.29 34.52 28.11 16.84 32.47 25.43 36.23 21.81 22.32 41.86 22.67 23.70 coo 12.06 27.10 15.56 13.23 27.02 13.80 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS A 265 LYS~? 22.38 ZN ZN A 374 C 74 LYS A 271 LYS.? 23.00 ZN ZN A 374 C 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 17.59 37.25 25.80 19.64 34.15 21.60 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 12.29 34.52 28.11 16.84 32.47 25.43 56.12 0.48 35.73 59.67 4.01 35.99 coo 12.06 27.10 15.56 13.23 27.02 13.80 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS A 271 LYS.? 23.00 ZN ZN A 374 C 74 LYS A 265 LYS~? 22.38 ZN ZN A 374 C 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 17.59 37.25 25.80 19.64 34.15 21.60 56.12 0.48 35.73 59.67 4.01 35.99 coo 12.29 34.52 28.11 16.84 32.47 25.43 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 12.06 27.10 15.56 13.23 27.02 13.80 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS A 337 LYS~? 14.02 ZN ZN A 374 C 74 LYS A 340 LYS~? 12.75 ZN ZN A 374 C 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 17.59 37.25 25.80 19.64 34.15 21.60 45.66 0.76 26.15 51.53 0.58 28.90 coo 12.29 34.52 28.11 16.84 32.47 25.43 44.47 1.55 20.70 47.30 5.10 24.27 coo 12.06 27.10 15.56 13.23 27.02 13.80 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS A 340 LYS~? 12.75 ZN ZN A 374 C 74 LYS A 337 LYS~? 14.02 ZN ZN A 374 C 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 17.59 37.25 25.80 19.64 34.15 21.60 44.47 1.55 20.70 47.30 5.10 24.27 coo 12.29 34.52 28.11 16.84 32.47 25.43 45.66 0.76 26.15 51.53 0.58 28.90 coo 12.06 27.10 15.56 13.23 27.02 13.80 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 C 14 LYS A 354 LYS~? 27.90 ZN ZN A 375 C 74 LYS A 350 LYS~? 21.83 ZN ZN A 375 C 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo 17.59 37.25 25.80 19.64 34.15 21.60 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 12.29 34.52 28.11 16.84 32.47 25.43 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 12.06 27.10 15.56 13.23 27.02 13.80 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 C 14 LYS B 87 LYS~? 9.60 O3S EPE B 376 C 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 C 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 17.59 37.25 25.80 19.64 34.15 21.60 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 12.29 34.52 28.11 16.84 32.47 25.43 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 12.06 27.10 15.56 13.23 27.02 13.80 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 C 14 LYS B 94 LYS~? 17.44 O2S EPE B 376 C 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 C 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 17.59 37.25 25.80 19.64 34.15 21.60 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 12.29 34.52 28.11 16.84 32.47 25.43 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 12.06 27.10 15.56 13.23 27.02 13.80 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 C 14 LYS B 215 LYS~? 17.38 O3S EPE A 377 C 74 LYS B 218 LYS~? 23.26 O3S EPE A 377 C 165 GLU B 151 GLU~? 19.22 O3S EPE A 377 coo 17.59 37.25 25.80 19.64 34.15 21.60 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 12.29 34.52 28.11 16.84 32.47 25.43 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 12.06 27.10 15.56 13.23 27.02 13.80 -9.61 -39.78 7.97 -10.79 -41.15 9.06 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 C 14 LYS B 265 LYS~? 21.91 ZN ZN B 374 C 74 LYS B 271 LYS.? 19.93 ZN ZN B 374 C 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 17.59 37.25 25.80 19.64 34.15 21.60 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 12.29 34.52 28.11 16.84 32.47 25.43 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 12.06 27.10 15.56 13.23 27.02 13.80 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 C 14 LYS B 271 LYS.? 19.93 ZN ZN B 374 C 74 LYS B 265 LYS~? 21.91 ZN ZN B 374 C 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 17.59 37.25 25.80 19.64 34.15 21.60 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 12.29 34.52 28.11 16.84 32.47 25.43 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 12.06 27.10 15.56 13.23 27.02 13.80 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 C 14 LYS B 337 LYS~? 13.35 ZN ZN B 374 C 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 17.59 37.25 25.80 19.64 34.15 21.60 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 12.29 34.52 28.11 16.84 32.47 25.43 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 12.06 27.10 15.56 13.23 27.02 13.80 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 C 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 C 165 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo 17.59 37.25 25.80 19.64 34.15 21.60 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 12.29 34.52 28.11 16.84 32.47 25.43 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 12.06 27.10 15.56 13.23 27.02 13.80 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 C 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 C 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 17.59 37.25 25.80 19.64 34.15 21.60 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 12.29 34.52 28.11 16.84 32.47 25.43 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 12.06 27.10 15.56 13.23 27.02 13.80 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 C 14 LYS B 354 LYS~? 28.15 ZN ZN B 375 C 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 C 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 17.59 37.25 25.80 19.64 34.15 21.60 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 12.29 34.52 28.11 16.84 32.47 25.43 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 12.06 27.10 15.56 13.23 27.02 13.80 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 C 14 LYS C 87 LYS~? 9.86 O3S EPE C 376 C 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 C 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 17.59 37.25 25.80 19.64 34.15 21.60 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 12.29 34.52 28.11 16.84 32.47 25.43 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 12.06 27.10 15.56 13.23 27.02 13.80 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 C 14 LYS C 94 LYS~? 16.71 O3S EPE C 376 C 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 C 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 17.59 37.25 25.80 19.64 34.15 21.60 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 12.29 34.52 28.11 16.84 32.47 25.43 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 12.06 27.10 15.56 13.23 27.02 13.80 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 C 14 LYS C 215 LYS~? 17.39 O1 TRS A 378 C 74 LYS C 218 LYS~? 12.80 O1 TRS A 378 C 165 GLU C 151 GLU~? 17.15 O8 EPE C 377 coo 17.59 37.25 25.80 19.64 34.15 21.60 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 12.29 34.52 28.11 16.84 32.47 25.43 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 12.06 27.10 15.56 13.23 27.02 13.80 24.82 -49.12 19.40 26.74 -49.67 18.68 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 C 14 LYS C 265 LYS~? 21.95 ZN ZN C 374 C 74 LYS C 271 LYS.? 19.51 ZN ZN C 374 C 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 17.59 37.25 25.80 19.64 34.15 21.60 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 12.29 34.52 28.11 16.84 32.47 25.43 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 12.06 27.10 15.56 13.23 27.02 13.80 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 C 14 LYS C 271 LYS.? 19.51 ZN ZN C 374 C 74 LYS C 265 LYS~? 21.95 ZN ZN C 374 C 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 17.59 37.25 25.80 19.64 34.15 21.60 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 12.29 34.52 28.11 16.84 32.47 25.43 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 12.06 27.10 15.56 13.23 27.02 13.80 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 C 14 LYS C 337 LYS~? 12.69 ZN ZN C 374 C 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 17.59 37.25 25.80 19.64 34.15 21.60 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 12.29 34.52 28.11 16.84 32.47 25.43 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 12.06 27.10 15.56 13.23 27.02 13.80 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 C 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 C 165 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 12.29 34.52 28.11 16.84 32.47 25.43 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 12.06 27.10 15.56 13.23 27.02 13.80 13.88 -30.69 72.19 13.68 -28.54 72.17 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 C 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 C 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 12.29 34.52 28.11 16.84 32.47 25.43 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 12.06 27.10 15.56 13.23 27.02 13.80 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 C 14 LYS C 354 LYS~? 23.72 O1 TRS A 378 C 74 LYS C 350 LYS~? 21.45 ZN ZN C 375 C 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 17.59 37.25 25.80 19.64 34.15 21.60 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 12.29 34.52 28.11 16.84 32.47 25.43 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 12.06 27.10 15.56 13.23 27.02 13.80 19.30 -32.62 45.28 21.00 -31.37 45.17 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 26 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 87 LYS~? 10.99 O2S EPE A 376 D 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 D 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 35.91 21.93 28.51 38.15 26.57 30.75 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 36.23 21.81 22.32 41.86 22.67 23.70 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 94 LYS~? 16.25 O2S EPE A 376 D 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 D 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 33.79 23.90 18.72 34.24 28.62 22.89 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 36.23 21.81 22.32 41.86 22.67 23.70 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 94 LYS~? 16.25 O2S EPE A 376 D 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 D 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 33.79 23.90 18.72 34.24 28.62 22.89 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 36.23 21.81 22.32 41.86 22.67 23.70 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS A 265 LYS~? 22.38 ZN ZN A 374 D 74 LYS A 271 LYS.? 23.00 ZN ZN A 374 D 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 56.12 0.48 35.73 59.67 4.01 35.99 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS A 271 LYS.? 23.00 ZN ZN A 374 D 74 LYS A 265 LYS~? 22.38 ZN ZN A 374 D 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 56.12 0.48 35.73 59.67 4.01 35.99 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS A 337 LYS~? 14.02 ZN ZN A 374 D 74 LYS A 340 LYS~? 12.75 ZN ZN A 374 D 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 45.66 0.76 26.15 51.53 0.58 28.90 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 44.47 1.55 20.70 47.30 5.10 24.27 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS A 340 LYS~? 12.75 ZN ZN A 374 D 74 LYS A 337 LYS~? 14.02 ZN ZN A 374 D 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 44.47 1.55 20.70 47.30 5.10 24.27 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 45.66 0.76 26.15 51.53 0.58 28.90 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS A 340 LYS~? 12.75 ZN ZN A 374 D 74 LYS A 345 LYS~? 18.67 ZN ZN A 375 D 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 44.47 1.55 20.70 47.30 5.10 24.27 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 D 14 LYS A 345 LYS~? 18.67 ZN ZN A 375 D 74 LYS A 340 LYS~? 12.75 ZN ZN A 374 D 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 44.47 1.55 20.70 47.30 5.10 24.27 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 D 14 LYS A 354 LYS~? 27.90 ZN ZN A 375 D 74 LYS A 350 LYS~? 21.83 ZN ZN A 375 D 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 D 14 LYS B 87 LYS~? 9.60 O3S EPE B 376 D 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 D 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 D 14 LYS B 94 LYS~? 17.44 O2S EPE B 376 D 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 D 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 D 14 LYS B 215 LYS~? 17.38 O3S EPE A 377 D 74 LYS B 218 LYS~? 23.26 O3S EPE A 377 D 165 GLU B 151 GLU~? 19.22 O3S EPE A 377 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -9.61 -39.78 7.97 -10.79 -41.15 9.06 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 D 14 LYS B 265 LYS~? 21.91 ZN ZN B 374 D 74 LYS B 271 LYS.? 19.93 ZN ZN B 374 D 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 D 14 LYS B 271 LYS.? 19.93 ZN ZN B 374 D 74 LYS B 265 LYS~? 21.91 ZN ZN B 374 D 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 D 14 LYS B 337 LYS~? 13.35 ZN ZN B 374 D 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 D 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 D 165 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 D 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 D 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 D 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 74 LYS B 345 LYS~? 20.14 ZN ZN B 375 D 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 D 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 74 LYS B 345 LYS~? 20.14 ZN ZN B 375 D 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 D 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 D 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 D 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 D 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 D 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 D 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 D 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 D 14 LYS B 354 LYS~? 28.15 ZN ZN B 375 D 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 D 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 D 14 LYS C 87 LYS~? 9.86 O3S EPE C 376 D 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 D 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 D 14 LYS C 94 LYS~? 16.71 O3S EPE C 376 D 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 D 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 D 14 LYS C 215 LYS~? 17.39 O1 TRS A 378 D 74 LYS C 218 LYS~? 12.80 O1 TRS A 378 D 165 GLU C 151 GLU~? 17.15 O8 EPE C 377 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 24.82 -49.12 19.40 26.74 -49.67 18.68 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 28 3 # 28 D 14 LYS C 265 LYS~? 21.95 ZN ZN C 374 D 74 LYS C 271 LYS.? 19.51 ZN ZN C 374 D 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 29 3 # 29 D 14 LYS C 271 LYS.? 19.51 ZN ZN C 374 D 74 LYS C 265 LYS~? 21.95 ZN ZN C 374 D 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 30 3 # 30 D 14 LYS C 337 LYS~? 12.69 ZN ZN C 374 D 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 31 3 # 31 D 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 D 165 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 13.88 -30.69 72.19 13.68 -28.54 72.17 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 32 3 # 32 D 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 D 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 33 3 # 33 D 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 74 LYS C 345 LYS~? 19.35 ZN ZN C 375 D 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 34 3 # 34 D 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 74 LYS C 345 LYS~? 19.35 ZN ZN C 375 D 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 35 3 # 35 D 14 LYS C 345 LYS~? 19.35 ZN ZN C 375 D 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 36 3 # 36 D 14 LYS C 345 LYS~? 19.35 ZN ZN C 375 D 74 LYS C 350 LYS~? 21.45 ZN ZN C 375 D 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 37 3 # 37 D 14 LYS C 354 LYS~? 23.72 O1 TRS A 378 D 74 LYS C 350 LYS~? 21.45 ZN ZN C 375 D 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.30 -32.62 45.28 21.00 -31.37 45.17 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 37 hits 1kqc_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 232 ASP^? 4.68 O1S EPE A 377 262 LYS A 138 LYS^? 13.11 N TRS A 378 336 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 63.59 44.40 18.32 63.20 49.74 17.95 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 72.60 57.42 15.86 71.61 56.68 18.70 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP A 232 ASP^? 4.68 O1S EPE A 377 262 LYS A 138 LYS^? 13.11 N TRS A 378 336 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 63.59 44.40 18.32 63.20 49.74 17.95 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 72.60 57.42 15.86 71.61 56.68 18.70 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP A 232 ASP^? 4.68 O1S EPE A 377 262 LYS A 139 LYS^? -2.64 O3S EPE C 377s 336 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 63.59 44.40 18.32 63.20 49.74 17.95 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 72.60 57.42 15.86 71.61 56.68 18.70 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP A 232 ASP^? 4.68 O1S EPE A 377 262 LYS B 138 LYS^? 15.17 O1S EPE A 377 336 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 63.59 44.40 18.32 63.20 49.74 17.95 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 72.60 57.42 15.86 71.61 56.68 18.70 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP A 232 ASP^? 4.68 O1S EPE A 377 262 LYS B 138 LYS^? 15.17 O1S EPE A 377 336 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 63.59 44.40 18.32 63.20 49.74 17.95 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 72.60 57.42 15.86 71.61 56.68 18.70 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 6 3 # 6 255 ASP A 232 ASP^? 4.68 O1S EPE A 377 262 LYS B 139 LYS^? -2.84 O2S EPE A 377s 336 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 63.59 44.40 18.32 63.20 49.74 17.95 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 72.60 57.42 15.86 71.61 56.68 18.70 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 7 3 # 7 255 ASP A 237 ASP^? 6.80 N TRS A 378 262 LYS A 239 LYS^? -7.47 O3 TRS A 378s 336 ARG C 214 ARG~? 11.90 O1 TRS A 378 coo 61.88 50.78 12.96 63.84 50.60 13.71 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 63.59 44.40 18.32 63.20 49.74 17.95 24.38 -22.19 19.59 20.35 -19.68 21.34 coo 72.60 57.42 15.86 71.61 56.68 18.70 25.43 -31.91 31.60 26.96 -33.72 33.51 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 8 3 # 8 255 ASP A 237 ASP^? 6.80 N TRS A 378 262 LYS C 138 LYS^? 8.30 N TRS A 378 336 ARG C 214 ARG~? 11.90 O1 TRS A 378 coo 61.88 50.78 12.96 63.84 50.60 13.71 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 63.59 44.40 18.32 63.20 49.74 17.95 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 72.60 57.42 15.86 71.61 56.68 18.70 25.43 -31.91 31.60 26.96 -33.72 33.51 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 9 3 # 9 255 ASP A 237 ASP^? 6.80 N TRS A 378 262 LYS C 139 LYS^? 16.11 N TRS A 378 336 ARG C 214 ARG~? 11.90 O1 TRS A 378 coo 61.88 50.78 12.96 63.84 50.60 13.71 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 63.59 44.40 18.32 63.20 49.74 17.95 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 72.60 57.42 15.86 71.61 56.68 18.70 25.43 -31.91 31.60 26.96 -33.72 33.51 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 10 3 # 10 255 ASP A 292 ASP^? 8.63 ZN ZN A 374 262 LYS A 295 LYS.? 12.61 ZN ZN A 374 336 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 61.88 50.78 12.96 63.84 50.60 13.71 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 63.59 44.40 18.32 63.20 49.74 17.95 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 72.60 57.42 15.86 71.61 56.68 18.70 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 11 3 # 11 255 ASP A 352 ASP~? 25.70 ZN ZN A 375 262 LYS A 345 LYS~? 18.67 ZN ZN A 375 336 ARG A 41 ARG.? 31.19 ZN ZN A 375 coo 61.88 50.78 12.96 63.84 50.60 13.71 43.66 -0.56 3.32 44.78 0.99 4.29 coo 63.59 44.40 18.32 63.20 49.74 17.95 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 72.60 57.42 15.86 71.61 56.68 18.70 42.11 12.31 4.12 44.66 13.27 2.71 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 12 3 # 12 255 ASP A 352 ASP~? 25.70 ZN ZN A 375 262 LYS A 354 LYS~? 27.90 ZN ZN A 375 336 ARG A 41 ARG.? 31.19 ZN ZN A 375 coo 61.88 50.78 12.96 63.84 50.60 13.71 43.66 -0.56 3.32 44.78 0.99 4.29 coo 63.59 44.40 18.32 63.20 49.74 17.95 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 72.60 57.42 15.86 71.61 56.68 18.70 42.11 12.31 4.12 44.66 13.27 2.71 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 13 3 # 13 255 ASP B 232 ASP^? 14.54 O2S EPE A 377 262 LYS B 138 LYS^? 15.17 O1S EPE A 377 336 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 63.59 44.40 18.32 63.20 49.74 17.95 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 72.60 57.42 15.86 71.61 56.68 18.70 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 14 3 # 14 255 ASP B 232 ASP^? 14.54 O2S EPE A 377 262 LYS B 138 LYS^? 15.17 O1S EPE A 377 336 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 63.59 44.40 18.32 63.20 49.74 17.95 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 72.60 57.42 15.86 71.61 56.68 18.70 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 15 3 # 15 255 ASP B 232 ASP^? 14.54 O2S EPE A 377 262 LYS B 139 LYS^? -2.84 O2S EPE A 377s 336 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 63.59 44.40 18.32 63.20 49.74 17.95 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 72.60 57.42 15.86 71.61 56.68 18.70 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 16 3 # 16 255 ASP B 232 ASP^? 14.54 O2S EPE A 377 262 LYS C 138 LYS^? 8.30 N TRS A 378 336 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 63.59 44.40 18.32 63.20 49.74 17.95 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 72.60 57.42 15.86 71.61 56.68 18.70 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 17 3 # 17 255 ASP B 232 ASP^? 14.54 O2S EPE A 377 262 LYS C 138 LYS^? 8.30 N TRS A 378 336 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 63.59 44.40 18.32 63.20 49.74 17.95 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 72.60 57.42 15.86 71.61 56.68 18.70 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 18 3 # 18 255 ASP B 232 ASP^? 14.54 O2S EPE A 377 262 LYS C 139 LYS^? 16.11 N TRS A 378 336 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 63.59 44.40 18.32 63.20 49.74 17.95 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 72.60 57.42 15.86 71.61 56.68 18.70 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 19 3 # 19 255 ASP B 237 ASP^? 15.58 N TRS A 378 262 LYS A 138 LYS^? 13.11 N TRS A 378 336 ARG A 214 ARG~? 20.32 O1S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 63.59 44.40 18.32 63.20 49.74 17.95 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 72.60 57.42 15.86 71.61 56.68 18.70 17.59 -9.46 5.35 20.56 -9.02 6.23 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 20 3 # 20 255 ASP B 237 ASP^? 15.58 N TRS A 378 262 LYS A 139 LYS^? -2.64 O3S EPE C 377s 336 ARG A 214 ARG~? 20.32 O1S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 63.59 44.40 18.32 63.20 49.74 17.95 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 72.60 57.42 15.86 71.61 56.68 18.70 17.59 -9.46 5.35 20.56 -9.02 6.23 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 21 3 # 21 255 ASP B 237 ASP^? 15.58 N TRS A 378 262 LYS B 239 LYS^? 16.51 O1S EPE A 377 336 ARG A 214 ARG~? 20.32 O1S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 63.59 44.40 18.32 63.20 49.74 17.95 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 72.60 57.42 15.86 71.61 56.68 18.70 17.59 -9.46 5.35 20.56 -9.02 6.23 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 22 3 # 22 255 ASP B 292 ASP^? 8.88 ZN ZN B 374 262 LYS B 295 LYS.? 11.37 ZN ZN B 375 336 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 61.88 50.78 12.96 63.84 50.60 13.71 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 63.59 44.40 18.32 63.20 49.74 17.95 4.57 8.76 22.84 2.39 5.01 24.93 coo 72.60 57.42 15.86 71.61 56.68 18.70 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 23 3 # 23 255 ASP C 96 ASP.? 22.89 O3S EPE C 376 262 LYS C 94 LYS~? 16.71 O3S EPE C 376 336 ARG C 41 ARG.? 33.06 ZN ZN C 375 coo 61.88 50.78 12.96 63.84 50.60 13.71 31.06 -32.15 62.51 32.92 -31.34 63.13 coo 63.59 44.40 18.32 63.20 49.74 17.95 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 72.60 57.42 15.86 71.61 56.68 18.70 29.45 -44.46 60.95 32.22 -45.79 60.75 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 24 3 # 24 255 ASP C 232 ASP^? 3.77 O2S EPE C 377 262 LYS A 138 LYS^? 13.11 N TRS A 378 336 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 63.59 44.40 18.32 63.20 49.74 17.95 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 72.60 57.42 15.86 71.61 56.68 18.70 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 25 3 # 25 255 ASP C 232 ASP^? 3.77 O2S EPE C 377 262 LYS A 138 LYS^? 13.11 N TRS A 378 336 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 63.59 44.40 18.32 63.20 49.74 17.95 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 72.60 57.42 15.86 71.61 56.68 18.70 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 26 3 # 26 255 ASP C 232 ASP^? 3.77 O2S EPE C 377 262 LYS A 139 LYS^? -2.64 O3S EPE C 377s 336 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 63.59 44.40 18.32 63.20 49.74 17.95 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 72.60 57.42 15.86 71.61 56.68 18.70 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 27 3 # 27 255 ASP C 232 ASP^? 3.77 O2S EPE C 377 262 LYS C 138 LYS^? 8.30 N TRS A 378 336 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 63.59 44.40 18.32 63.20 49.74 17.95 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 72.60 57.42 15.86 71.61 56.68 18.70 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 28 3 # 28 255 ASP C 232 ASP^? 3.77 O2S EPE C 377 262 LYS C 138 LYS^? 8.30 N TRS A 378 336 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 63.59 44.40 18.32 63.20 49.74 17.95 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 72.60 57.42 15.86 71.61 56.68 18.70 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 29 3 # 29 255 ASP C 232 ASP^? 3.77 O2S EPE C 377 262 LYS C 139 LYS^? 16.11 N TRS A 378 336 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 63.59 44.40 18.32 63.20 49.74 17.95 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 72.60 57.42 15.86 71.61 56.68 18.70 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 30 3 # 30 255 ASP C 237 ASP^? 16.80 O1S EPE A 377 262 LYS B 139 LYS^? -2.84 O2S EPE A 377s 336 ARG B 214 ARG~? 23.93 O3S EPE A 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 63.59 44.40 18.32 63.20 49.74 17.95 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 72.60 57.42 15.86 71.61 56.68 18.70 -7.68 -23.63 22.44 -8.04 -24.96 25.17 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 31 3 # 31 255 ASP C 237 ASP^? 16.80 O1S EPE A 377 262 LYS C 239 LYS^? 16.29 N TRS A 378 336 ARG B 214 ARG~? 23.93 O3S EPE A 377 coo 61.88 50.78 12.96 63.84 50.60 13.71 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 63.59 44.40 18.32 63.20 49.74 17.95 5.15 -29.07 27.87 7.72 -24.69 27.36 coo 72.60 57.42 15.86 71.61 56.68 18.70 -7.68 -23.63 22.44 -8.04 -24.96 25.17 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 32 3 # 32 255 ASP C 292 ASP^? 8.69 ZN ZN C 374 262 LYS C 295 LYS.? 14.49 ZN ZN C 374 336 ARG C 274 ARG^? 15.09 ZN ZN C 374 coo 61.88 50.78 12.96 63.84 50.60 13.71 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 63.59 44.40 18.32 63.20 49.74 17.95 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 72.60 57.42 15.86 71.61 56.68 18.70 -8.42 -22.35 63.85 -6.68 -20.58 62.11 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 32 hits 1lam_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 198 ARG^? 11.16 C6 EPE A 377 245 HIS B 169 HIS^? 10.86 O3S EPE A 377 343 THR B 171 THR^? -5.46 O3S EPE A 377s coo 18.11 85.25 41.19 18.04 83.33 43.59 -1.05 -38.83 -3.85 -3.04 -38.62 -1.48 coo 5.34 86.23 43.48 6.16 87.26 45.12 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 9.06 92.76 42.80 7.04 92.63 42.14 0.89 -31.19 4.26 -0.81 -32.58 4.42 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG A 274 ARG^? 15.42 ZN ZN A 374 245 HIS A 333 HIS~? -3.55 ZN ZN A 374s 343 THR A 310 THR^? 10.34 ZN ZN A 374 coo 18.11 85.25 41.19 18.04 83.33 43.59 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 5.34 86.23 43.48 6.16 87.26 45.12 40.60 0.33 34.12 38.69 0.39 33.24 coo 9.06 92.76 42.80 7.04 92.63 42.14 42.72 -7.43 36.10 40.77 -7.66 37.11 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG B 198 ARG^? 21.95 C2 EPE C 377 245 HIS C 169 HIS^? 22.39 O1 TRS A 378 343 THR C 171 THR^? 17.48 C2 EPE C 377 coo 18.11 85.25 41.19 18.04 83.33 43.59 11.64 -52.94 14.57 14.19 -52.83 16.31 coo 5.34 86.23 43.48 6.16 87.26 45.12 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 9.06 92.76 42.80 7.04 92.63 42.14 11.53 -42.54 18.55 13.17 -44.02 18.73 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG B 274 ARG^? 15.33 ZN ZN B 374 245 HIS B 333 HIS~? -3.37 ZN ZN B 374s 343 THR B 310 THR^? 10.23 ZN ZN B 374 coo 18.11 85.25 41.19 18.04 83.33 43.59 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 5.34 86.23 43.48 6.16 87.26 45.12 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 9.06 92.76 42.80 7.04 92.63 42.14 -3.69 12.44 17.22 -2.10 11.84 18.57 ULMN 3 1lci_c00 LUCIFERASE user 5 3 # 5 218 ARG C 198 ARG^? 10.55 C8 EPE C 377 245 HIS A 169 HIS^? 11.22 O1S EPE C 377 343 THR A 171 THR^? -6.32 O1S EPE C 377s coo 18.11 85.25 41.19 18.04 83.33 43.59 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo 5.34 86.23 43.48 6.16 87.26 45.12 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 9.06 92.76 42.80 7.04 92.63 42.14 22.07 -30.68 4.19 22.03 -30.09 2.08 ULMN 3 1lci_c00 LUCIFERASE user 6 3 # 6 218 ARG C 274 ARG^? 15.09 ZN ZN C 374 245 HIS C 333 HIS~? -3.37 ZN ZN C 374s 343 THR C 310 THR^? 10.44 ZN ZN C 374 coo 18.11 85.25 41.19 18.04 83.33 43.59 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 5.34 86.23 43.48 6.16 87.26 45.12 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 9.06 92.76 42.80 7.04 92.63 42.14 -4.52 -26.41 54.31 -4.36 -24.52 53.23 1lci_c00 source 1lci LUCIFERASE : 6 hits 1lci_c00 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 109 ALA~? 11.42 ZN ZN A 375 A 317 GLY A 112 GLY~? 9.06 ZN ZN A 375 A 318 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 34.68 -9.30 20.20 34.40 -8.19 19.19 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 39.28 -7.29 21.25 39.96 -7.72 21.33 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 155 ALA~? 14.27 O1S EPE C 377 A 317 GLY A 157 GLY~? 9.65 O1S EPE C 377 A 318 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 22.46 -22.68 -3.71 21.06 -22.28 -4.12 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA A 159 ALA~? 13.04 O1S EPE C 377 A 317 GLY A 157 GLY~? 9.65 O1S EPE C 377 A 318 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 25.41 -19.15 0.31 23.88 -18.99 0.22 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA A 159 ALA~? 13.04 O1S EPE C 377 A 317 GLY A 160 GLY.? 10.75 O1S EPE C 377 A 318 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 25.41 -19.15 0.31 23.88 -18.99 0.22 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 26.87 -20.51 3.59 26.23 -20.86 3.40 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1lij_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA B 109 ALA~? 11.08 ZN ZN B 375 A 317 GLY B 112 GLY~? 9.09 ZN ZN B 375 A 318 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -7.64 -4.92 16.15 -8.93 -5.45 16.76 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -10.98 -0.97 15.01 -10.85 -0.63 14.30 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 1lij_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA B 155 ALA~? 14.26 O3S EPE A 377 A 317 GLY B 157 GLY~? 9.55 O3S EPE A 377 A 318 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -8.89 -33.90 8.54 -8.69 -34.90 9.66 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1lij_c01 ADENOSINE KINASE user 7 3 # 7 A 316 ALA B 159 ALA~? 13.92 O3S EPE A 377 A 317 GLY B 157 GLY~? 9.55 O3S EPE A 377 A 318 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -9.80 -27.22 9.41 -9.47 -27.83 10.78 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1lij_c01 ADENOSINE KINASE user 8 3 # 8 A 316 ALA B 159 ALA~? 13.92 O3S EPE A 377 A 317 GLY B 160 GLY.? 11.45 O3S EPE A 377 A 318 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -9.80 -27.22 9.41 -9.47 -27.83 10.78 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -7.67 -24.84 7.30 -7.31 -25.39 7.61 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1lij_c01 ADENOSINE KINASE user 9 3 # 9 A 316 ALA C 109 ALA~? 11.05 ZN ZN C 375 A 317 GLY C 112 GLY~? 9.08 ZN ZN C 375 A 318 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 7.53 -33.10 43.39 8.93 -33.54 43.81 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 6.12 -35.35 47.97 5.41 -35.71 47.93 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 1lij_c01 ADENOSINE KINASE user 10 3 # 10 A 316 ALA C 155 ALA~? 16.73 C1 TRS A 378 A 317 GLY C 157 GLY~? 18.60 O1 TRS A 378 A 318 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 21.09 -45.45 23.92 22.34 -44.97 23.23 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 15.82 -44.70 25.16 16.57 -44.60 25.47 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 19.06 -47.14 27.83 18.62 -49.09 27.08 ULMN 3 1lij_c01 ADENOSINE KINASE user 11 3 # 11 A 316 ALA C 159 ALA~? 15.13 O1 TRS A 378 A 317 GLY C 157 GLY~? 18.60 O1 TRS A 378 A 318 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 18.93 -42.72 28.88 19.93 -41.91 28.03 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 15.82 -44.70 25.16 16.57 -44.60 25.47 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 19.06 -47.14 27.83 18.62 -49.09 27.08 ULMN 3 1lij_c01 ADENOSINE KINASE user 12 3 # 12 A 316 ALA C 159 ALA~? 15.13 O1 TRS A 378 A 317 GLY C 160 GLY.? 17.10 O1 TRS A 378 A 318 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 18.93 -42.72 28.88 19.93 -41.91 28.03 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 15.27 -41.63 29.25 15.56 -41.55 28.55 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 19.06 -47.14 27.83 18.62 -49.09 27.08 1lij_c01 source 1lij ADENOSINE KINASE : 12 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 155 ALA~? 14.27 O1S EPE C 377 A 317 GLY A 157 GLY~? 9.65 O1S EPE C 377 A 318 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 27.04 23.54 41.85 25.72 24.19 42.18 22.46 -22.68 -3.71 21.06 -22.28 -4.12 coo 27.87 23.16 38.17 28.43 22.97 38.87 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 32.11 22.71 40.58 33.42 24.22 39.78 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 159 ALA~? 13.04 O1S EPE C 377 A 317 GLY A 157 GLY~? 9.65 O1S EPE C 377 A 318 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 27.04 23.54 41.85 25.72 24.19 42.18 25.41 -19.15 0.31 23.88 -18.99 0.22 coo 27.87 23.16 38.17 28.43 22.97 38.87 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 32.11 22.71 40.58 33.42 24.22 39.78 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA A 159 ALA~? 13.04 O1S EPE C 377 A 317 GLY A 160 GLY.? 10.75 O1S EPE C 377 A 318 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 27.04 23.54 41.85 25.72 24.19 42.18 25.41 -19.15 0.31 23.88 -18.99 0.22 coo 27.87 23.16 38.17 28.43 22.97 38.87 26.87 -20.51 3.59 26.23 -20.86 3.40 coo 32.11 22.71 40.58 33.42 24.22 39.78 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA B 155 ALA~? 14.26 O3S EPE A 377 A 317 GLY B 157 GLY~? 9.55 O3S EPE A 377 A 318 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 27.04 23.54 41.85 25.72 24.19 42.18 -8.89 -33.90 8.54 -8.69 -34.90 9.66 coo 27.87 23.16 38.17 28.43 22.97 38.87 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo 32.11 22.71 40.58 33.42 24.22 39.78 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1lio_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA B 159 ALA~? 13.92 O3S EPE A 377 A 317 GLY B 157 GLY~? 9.55 O3S EPE A 377 A 318 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 27.04 23.54 41.85 25.72 24.19 42.18 -9.80 -27.22 9.41 -9.47 -27.83 10.78 coo 27.87 23.16 38.17 28.43 22.97 38.87 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo 32.11 22.71 40.58 33.42 24.22 39.78 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1lio_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA B 159 ALA~? 13.92 O3S EPE A 377 A 317 GLY B 160 GLY.? 11.45 O3S EPE A 377 A 318 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 27.04 23.54 41.85 25.72 24.19 42.18 -9.80 -27.22 9.41 -9.47 -27.83 10.78 coo 27.87 23.16 38.17 28.43 22.97 38.87 -7.67 -24.84 7.30 -7.31 -25.39 7.61 coo 32.11 22.71 40.58 33.42 24.22 39.78 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1lio_c01 ADENOSINE KINASE user 7 3 # 7 A 316 ALA C 155 ALA~? 16.73 C1 TRS A 378 A 317 GLY C 157 GLY~? 18.60 O1 TRS A 378 A 318 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 27.04 23.54 41.85 25.72 24.19 42.18 21.09 -45.45 23.92 22.34 -44.97 23.23 coo 27.87 23.16 38.17 28.43 22.97 38.87 15.82 -44.70 25.16 16.57 -44.60 25.47 coo 32.11 22.71 40.58 33.42 24.22 39.78 19.06 -47.14 27.83 18.62 -49.09 27.08 ULMN 3 1lio_c01 ADENOSINE KINASE user 8 3 # 8 A 316 ALA C 159 ALA~? 15.13 O1 TRS A 378 A 317 GLY C 157 GLY~? 18.60 O1 TRS A 378 A 318 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 27.04 23.54 41.85 25.72 24.19 42.18 18.93 -42.72 28.88 19.93 -41.91 28.03 coo 27.87 23.16 38.17 28.43 22.97 38.87 15.82 -44.70 25.16 16.57 -44.60 25.47 coo 32.11 22.71 40.58 33.42 24.22 39.78 19.06 -47.14 27.83 18.62 -49.09 27.08 ULMN 3 1lio_c01 ADENOSINE KINASE user 9 3 # 9 A 316 ALA C 159 ALA~? 15.13 O1 TRS A 378 A 317 GLY C 160 GLY.? 17.10 O1 TRS A 378 A 318 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 27.04 23.54 41.85 25.72 24.19 42.18 18.93 -42.72 28.88 19.93 -41.91 28.03 coo 27.87 23.16 38.17 28.43 22.97 38.87 15.27 -41.63 29.25 15.56 -41.55 28.55 coo 32.11 22.71 40.58 33.42 24.22 39.78 19.06 -47.14 27.83 18.62 -49.09 27.08 1lio_c01 source 1lio ADENOSINE KINASE : 9 hits 1lio_c01 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 45 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 261 PHE A 14 PHE~? 13.00 ZN ZN A 375 coo 49.89 1.93 30.83 50.54 1.43 32.81 37.80 0.44 25.56 37.02 -1.29 26.44 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 32.91 0.46 27.63 33.66 0.11 29.56 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 34.51 0.34 14.77 34.92 -0.05 17.51 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 45 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 261 PHE A 14 PHE~? 13.00 ZN ZN A 375 coo 49.89 1.93 30.83 50.54 1.43 32.81 32.91 0.46 27.63 33.66 0.11 29.56 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 37.80 0.44 25.56 37.02 -1.29 26.44 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 34.51 0.34 14.77 34.92 -0.05 17.51 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 3 3 # 3 A 44 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 45 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 261 PHE B 14 PHE~? 12.83 ZN ZN B 375 coo 49.89 1.93 30.83 50.54 1.43 32.81 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -17.27 -6.95 21.62 -15.57 -4.76 21.74 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 4 3 # 4 A 44 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 45 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 261 PHE B 14 PHE~? 12.83 ZN ZN B 375 coo 49.89 1.93 30.83 50.54 1.43 32.81 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -17.27 -6.95 21.62 -15.57 -4.76 21.74 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 5 3 # 5 A 44 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 45 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 261 PHE B 14 PHE~? 12.83 ZN ZN B 375 coo 49.89 1.93 30.83 50.54 1.43 32.81 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -17.27 -6.95 21.62 -15.57 -4.76 21.74 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 6 3 # 6 A 44 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 45 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 261 PHE C 14 PHE~? 12.81 ZN ZN C 375 coo 49.89 1.93 30.83 50.54 1.43 32.81 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 17.06 -35.49 48.83 14.82 -33.96 49.59 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 7 3 # 7 A 44 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 45 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 261 PHE C 14 PHE~? 12.81 ZN ZN C 375 coo 49.89 1.93 30.83 50.54 1.43 32.81 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 17.06 -35.49 48.83 14.82 -33.96 49.59 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 8 3 # 8 A 44 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 45 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 261 PHE C 14 PHE~? 12.81 ZN ZN C 375 coo 49.89 1.93 30.83 50.54 1.43 32.81 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 17.06 -35.49 48.83 14.82 -33.96 49.59 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 8 hits 1luc_c00 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 20 LYS~? 16.95 ZN ZN A 375 A 202 SER A 12 SER~? 22.68 ZN ZN A 375 A 226 SER A 16 SER~? 19.64 ZN ZN A 375 coo 1.62 6.10 69.30 3.81 1.25 65.91 26.66 -3.22 19.04 24.73 2.41 18.30 coo 4.43 1.89 61.79 4.31 0.09 63.40 29.97 0.68 9.55 29.00 -0.35 7.61 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS A 20 LYS~? 16.95 ZN ZN A 375 A 202 SER A 16 SER~? 19.64 ZN ZN A 375 A 226 SER A 12 SER~? 22.68 ZN ZN A 375 coo 1.62 6.10 69.30 3.81 1.25 65.91 26.66 -3.22 19.04 24.73 2.41 18.30 coo 4.43 1.89 61.79 4.31 0.09 63.40 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 3 3 # 3 A 123 LYS A 350 LYS~? 21.83 ZN ZN A 375 A 202 SER A 12 SER~? 22.68 ZN ZN A 375 A 226 SER A 16 SER~? 19.64 ZN ZN A 375 coo 1.62 6.10 69.30 3.81 1.25 65.91 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 4.43 1.89 61.79 4.31 0.09 63.40 29.97 0.68 9.55 29.00 -0.35 7.61 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 4 3 # 4 A 123 LYS A 350 LYS~? 21.83 ZN ZN A 375 A 202 SER A 16 SER~? 19.64 ZN ZN A 375 A 226 SER A 12 SER~? 22.68 ZN ZN A 375 coo 1.62 6.10 69.30 3.81 1.25 65.91 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 4.43 1.89 61.79 4.31 0.09 63.40 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 5 3 # 5 A 123 LYS B 20 LYS~? 17.56 ZN ZN B 375 A 202 SER B 16 SER~? 19.34 ZN ZN B 375 A 226 SER B 12 SER~? 22.72 ZN ZN B 375 coo 1.62 6.10 69.30 3.81 1.25 65.91 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 4.43 1.89 61.79 4.31 0.09 63.40 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 6 3 # 6 A 123 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 202 SER B 12 SER~? 22.72 ZN ZN B 375 A 226 SER B 16 SER~? 19.34 ZN ZN B 375 coo 1.62 6.10 69.30 3.81 1.25 65.91 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 4.43 1.89 61.79 4.31 0.09 63.40 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 7 3 # 7 A 123 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 202 SER B 16 SER~? 19.34 ZN ZN B 375 A 226 SER B 12 SER~? 22.72 ZN ZN B 375 coo 1.62 6.10 69.30 3.81 1.25 65.91 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 4.43 1.89 61.79 4.31 0.09 63.40 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 8 3 # 8 A 123 LYS C 20 LYS~? 17.53 ZN ZN C 375 A 202 SER C 12 SER~? 21.06 O1 TRS A 378 A 226 SER C 16 SER.? 19.22 ZN ZN C 375 coo 1.62 6.10 69.30 3.81 1.25 65.91 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 4.43 1.89 61.79 4.31 0.09 63.40 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 9 3 # 9 A 123 LYS C 20 LYS~? 17.53 ZN ZN C 375 A 202 SER C 16 SER.? 19.22 ZN ZN C 375 A 226 SER C 12 SER~? 21.06 O1 TRS A 378 coo 1.62 6.10 69.30 3.81 1.25 65.91 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 4.43 1.89 61.79 4.31 0.09 63.40 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 10 3 # 10 A 123 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 202 SER C 12 SER~? 21.06 O1 TRS A 378 A 226 SER C 16 SER.? 19.22 ZN ZN C 375 coo 1.62 6.10 69.30 3.81 1.25 65.91 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 4.43 1.89 61.79 4.31 0.09 63.40 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 11 3 # 11 A 123 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 202 SER C 16 SER.? 19.22 ZN ZN C 375 A 226 SER C 12 SER~? 21.06 O1 TRS A 378 coo 1.62 6.10 69.30 3.81 1.25 65.91 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 4.43 1.89 61.79 4.31 0.09 63.40 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 22.92 -36.29 44.84 24.16 -36.52 42.80 1m21_c00 source 1m21 PEPTIDE AMIDASE : 11 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 20 LYS~? 16.95 ZN ZN A 375 B 202 SER A 12 SER~? 22.68 ZN ZN A 375 B 226 SER A 16 SER~? 19.64 ZN ZN A 375 coo 35.67 -0.01 18.11 33.47 4.84 14.73 26.66 -3.22 19.04 24.73 2.41 18.30 coo 32.81 4.27 10.70 32.87 6.07 12.31 29.97 0.68 9.55 29.00 -0.35 7.61 coo 28.77 6.36 12.44 30.83 7.25 11.75 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS A 20 LYS~? 16.95 ZN ZN A 375 B 202 SER A 16 SER~? 19.64 ZN ZN A 375 B 226 SER A 12 SER~? 22.68 ZN ZN A 375 coo 35.67 -0.01 18.11 33.47 4.84 14.73 26.66 -3.22 19.04 24.73 2.41 18.30 coo 32.81 4.27 10.70 32.87 6.07 12.31 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 28.77 6.36 12.44 30.83 7.25 11.75 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 3 3 # 3 B 123 LYS A 350 LYS~? 21.83 ZN ZN A 375 B 202 SER A 12 SER~? 22.68 ZN ZN A 375 B 226 SER A 16 SER~? 19.64 ZN ZN A 375 coo 35.67 -0.01 18.11 33.47 4.84 14.73 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 32.81 4.27 10.70 32.87 6.07 12.31 29.97 0.68 9.55 29.00 -0.35 7.61 coo 28.77 6.36 12.44 30.83 7.25 11.75 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 4 3 # 4 B 123 LYS A 350 LYS~? 21.83 ZN ZN A 375 B 202 SER A 16 SER~? 19.64 ZN ZN A 375 B 226 SER A 12 SER~? 22.68 ZN ZN A 375 coo 35.67 -0.01 18.11 33.47 4.84 14.73 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 32.81 4.27 10.70 32.87 6.07 12.31 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 28.77 6.36 12.44 30.83 7.25 11.75 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 5 3 # 5 B 123 LYS B 20 LYS~? 17.56 ZN ZN B 375 B 202 SER B 16 SER~? 19.34 ZN ZN B 375 B 226 SER B 12 SER~? 22.72 ZN ZN B 375 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 32.81 4.27 10.70 32.87 6.07 12.31 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 28.77 6.36 12.44 30.83 7.25 11.75 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 6 3 # 6 B 123 LYS B 350 LYS~? 21.91 ZN ZN B 375 B 202 SER B 12 SER~? 22.72 ZN ZN B 375 B 226 SER B 16 SER~? 19.34 ZN ZN B 375 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 32.81 4.27 10.70 32.87 6.07 12.31 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 28.77 6.36 12.44 30.83 7.25 11.75 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 7 3 # 7 B 123 LYS B 350 LYS~? 21.91 ZN ZN B 375 B 202 SER B 16 SER~? 19.34 ZN ZN B 375 B 226 SER B 12 SER~? 22.72 ZN ZN B 375 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 32.81 4.27 10.70 32.87 6.07 12.31 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 28.77 6.36 12.44 30.83 7.25 11.75 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 8 3 # 8 B 123 LYS C 20 LYS~? 17.53 ZN ZN C 375 B 202 SER C 12 SER~? 21.06 O1 TRS A 378 B 226 SER C 16 SER.? 19.22 ZN ZN C 375 coo 35.67 -0.01 18.11 33.47 4.84 14.73 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 32.81 4.27 10.70 32.87 6.07 12.31 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 28.77 6.36 12.44 30.83 7.25 11.75 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 9 3 # 9 B 123 LYS C 20 LYS~? 17.53 ZN ZN C 375 B 202 SER C 16 SER.? 19.22 ZN ZN C 375 B 226 SER C 12 SER~? 21.06 O1 TRS A 378 coo 35.67 -0.01 18.11 33.47 4.84 14.73 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 32.81 4.27 10.70 32.87 6.07 12.31 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 28.77 6.36 12.44 30.83 7.25 11.75 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 10 3 # 10 B 123 LYS C 350 LYS~? 21.45 ZN ZN C 375 B 202 SER C 12 SER~? 21.06 O1 TRS A 378 B 226 SER C 16 SER.? 19.22 ZN ZN C 375 coo 35.67 -0.01 18.11 33.47 4.84 14.73 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 32.81 4.27 10.70 32.87 6.07 12.31 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 28.77 6.36 12.44 30.83 7.25 11.75 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 11 3 # 11 B 123 LYS C 350 LYS~? 21.45 ZN ZN C 375 B 202 SER C 16 SER.? 19.22 ZN ZN C 375 B 226 SER C 12 SER~? 21.06 O1 TRS A 378 coo 35.67 -0.01 18.11 33.47 4.84 14.73 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 32.81 4.27 10.70 32.87 6.07 12.31 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 28.77 6.36 12.44 30.83 7.25 11.75 22.92 -36.29 44.84 24.16 -36.52 42.80 1m21_c01 source 1m21 PEPTIDE AMIDASE : 11 hits 1m21_c01 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 295 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 369 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 16.11 33.72 80.99 14.10 33.54 81.63 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 12.19 31.08 87.29 11.13 32.66 86.38 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 295 GLU A 254 GLU^? 30.93 ZN ZN A 375 A 369 ASP A 281 ASP.? 28.06 ZN ZN A 375 coo 11.74 38.14 80.19 10.63 36.40 80.65 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 16.11 33.72 80.99 14.10 33.54 81.63 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 12.19 31.08 87.29 11.13 32.66 86.38 52.87 -20.75 45.53 51.52 -19.24 45.99 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 295 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 369 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 16.11 33.72 80.99 14.10 33.54 81.63 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 295 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 369 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 16.11 33.72 80.99 14.10 33.54 81.63 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.43 -20.86 54.35 0.32 -19.00 54.12 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 4 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 265 GLU A 135 GLU^? 12.87 C3 TRS A 378 A 369 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 11.74 38.14 80.19 10.63 36.40 80.65 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 17.36 23.57 72.04 18.68 21.92 71.98 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 12.19 31.08 87.29 11.13 32.66 86.38 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 265 GLU A 135 GLU^? 12.87 C3 TRS A 378 A 369 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 11.74 38.14 80.19 10.63 36.40 80.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 12.19 31.08 87.29 11.13 32.66 86.38 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 265 GLU A 135 GLU^? 12.87 C3 TRS A 378 A 369 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 11.74 38.14 80.19 10.63 36.40 80.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 12.19 31.08 87.29 11.13 32.66 86.38 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 265 GLU A 135 GLU^? 12.87 C3 TRS A 378 A 369 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 11.74 38.14 80.19 10.63 36.40 80.65 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 17.36 23.57 72.04 18.68 21.92 71.98 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 12.19 31.08 87.29 11.13 32.66 86.38 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 265 GLU B 241 GLU^? 19.53 O1S EPE A 377 A 369 ASP B 237 ASP^? 15.58 N TRS A 378 coo 11.74 38.14 80.19 10.63 36.40 80.65 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 17.36 23.57 72.04 18.68 21.92 71.98 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 12.19 31.08 87.29 11.13 32.66 86.38 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 237 ASP^? 6.80 N TRS A 378 A 265 GLU A 241 GLU^? 13.09 O3 TRS A 378 A 369 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 11.74 38.14 80.19 10.63 36.40 80.65 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 17.36 23.57 72.04 18.68 21.92 71.98 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 12.19 31.08 87.29 11.13 32.66 86.38 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 265 GLU A 56 GLU~? 18.18 ZN ZN A 374 A 369 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 54.82 -1.21 28.36 56.43 0.27 28.67 coo 17.36 23.57 72.04 18.68 21.92 71.98 47.24 13.21 19.42 47.19 11.28 20.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 265 GLU A 56 GLU~? 18.18 ZN ZN A 374 A 369 ASP A 269 ASP.? 18.90 ZN ZN A 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 48.24 5.16 33.58 47.82 3.96 35.30 coo 17.36 23.57 72.04 18.68 21.92 71.98 47.24 13.21 19.42 47.19 11.28 20.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 54.82 -1.21 28.36 56.43 0.27 28.67 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 265 GLU B 135 GLU^? 15.63 O1S EPE A 377 A 369 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 11.74 38.14 80.19 10.63 36.40 80.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 17.36 23.57 72.04 18.68 21.92 71.98 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 265 GLU B 135 GLU^? 15.63 O1S EPE A 377 A 369 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 11.74 38.14 80.19 10.63 36.40 80.65 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 265 GLU C 241 GLU^? 18.99 ZN ZN C 375 A 369 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 17.36 23.57 72.04 18.68 21.92 71.98 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 12.19 31.08 87.29 11.13 32.66 86.38 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP B 237 ASP^? 15.58 N TRS A 378 A 265 GLU B 241 GLU^? 19.53 O1S EPE A 377 A 369 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 11.74 38.14 80.19 10.63 36.40 80.65 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 17.36 23.57 72.04 18.68 21.92 71.98 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 12.19 31.08 87.29 11.13 32.66 86.38 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 265 GLU B 56 GLU~? 18.10 ZN ZN B 374 A 369 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 17.36 23.57 72.04 18.68 21.92 71.98 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 265 GLU B 56 GLU~? 18.10 ZN ZN B 374 A 369 ASP B 269 ASP.? 18.26 ZN ZN B 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 17.36 23.57 72.04 18.68 21.92 71.98 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 12.19 31.08 87.29 11.13 32.66 86.38 -18.05 15.19 12.20 -19.75 16.35 12.84 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 265 GLU C 135 GLU^? 15.12 O1 TRS A 378 A 369 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 11.74 38.14 80.19 10.63 36.40 80.65 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 265 GLU C 135 GLU^? 15.12 O1 TRS A 378 A 369 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 11.74 38.14 80.19 10.63 36.40 80.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 265 GLU C 135 GLU^? 15.12 O1 TRS A 378 A 369 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 11.74 38.14 80.19 10.63 36.40 80.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 265 GLU C 135 GLU^? 15.12 O1 TRS A 378 A 369 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 11.74 38.14 80.19 10.63 36.40 80.65 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 265 GLU A 241 GLU^? 13.09 O3 TRS A 378 A 369 ASP A 237 ASP^? 6.80 N TRS A 378 coo 11.74 38.14 80.19 10.63 36.40 80.65 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 17.36 23.57 72.04 18.68 21.92 71.98 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 12.19 31.08 87.29 11.13 32.66 86.38 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 265 GLU C 241 GLU^? 18.99 ZN ZN C 375 A 369 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 11.74 38.14 80.19 10.63 36.40 80.65 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 17.36 23.57 72.04 18.68 21.92 71.98 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 265 GLU C 56 GLU~? 18.45 ZN ZN C 374 A 369 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 17.36 23.57 72.04 18.68 21.92 71.98 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 12.19 31.08 87.29 11.13 32.66 86.38 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 22 3 # 22 A 241 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 265 GLU C 56 GLU~? 18.45 ZN ZN C 374 A 369 ASP C 269 ASP~? 18.04 ZN ZN C 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 17.36 23.57 72.04 18.68 21.92 71.98 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.79 -38.40 63.28 -1.15 -38.99 65.26 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 22 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 279 GLU A 15 GLU~? 17.23 ZN ZN A 375 A 369 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 40.70 8.14 28.73 41.06 6.40 29.84 coo 16.54 46.37 63.94 14.77 45.79 62.95 29.50 -0.46 14.62 27.65 0.59 14.66 coo 12.19 31.08 87.29 11.13 32.66 86.38 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 279 GLU A 135 GLU^? 12.87 C3 TRS A 378 A 369 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 16.54 46.37 63.94 14.77 45.79 62.95 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 12.19 31.08 87.29 11.13 32.66 86.38 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 279 GLU A 136 GLU^? 12.15 O3 TRS A 378 A 369 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 16.54 46.37 63.94 14.77 45.79 62.95 19.87 -16.93 18.72 17.94 -16.19 18.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 279 GLU A 349 GLU~? 21.94 ZN ZN A 375 A 369 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 16.54 46.37 63.94 14.77 45.79 62.95 44.64 -4.62 8.34 45.23 -6.64 8.63 coo 12.19 31.08 87.29 11.13 32.66 86.38 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 279 GLU A 200 GLU^? 11.53 C6 EPE A 377 A 369 ASP B 237 ASP^? 15.58 N TRS A 378 coo 11.74 38.14 80.19 10.63 36.40 80.65 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 16.54 46.37 63.94 14.77 45.79 62.95 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 279 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 369 ASP B 237 ASP^? 15.58 N TRS A 378 coo 11.74 38.14 80.19 10.63 36.40 80.65 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 16.54 46.37 63.94 14.77 45.79 62.95 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 12.19 31.08 87.29 11.13 32.66 86.38 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 279 GLU A 119 GLU~? 15.23 ZN ZN A 375 A 369 ASP A 281 ASP.? 28.06 ZN ZN A 375 coo 11.74 38.14 80.19 10.63 36.40 80.65 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 16.54 46.37 63.94 14.77 45.79 62.95 47.50 -11.03 21.23 45.94 -11.22 19.71 coo 12.19 31.08 87.29 11.13 32.66 86.38 52.87 -20.75 45.53 51.52 -19.24 45.99 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 279 GLU A 262 GLU~? 24.15 ZN ZN A 374 A 369 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 48.24 5.16 33.58 47.82 3.96 35.30 coo 16.54 46.37 63.94 14.77 45.79 62.95 59.50 -9.24 37.85 59.47 -7.16 38.33 coo 12.19 31.08 87.29 11.13 32.66 86.38 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 279 GLU B 15 GLU~? 17.09 ZN ZN B 375 A 369 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 16.54 46.37 63.94 14.77 45.79 62.95 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 279 GLU B 135 GLU^? 15.63 O1S EPE A 377 A 369 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 16.54 46.37 63.94 14.77 45.79 62.95 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 279 GLU B 136 GLU^? 17.92 O1S EPE A 377 A 369 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 16.54 46.37 63.94 14.77 45.79 62.95 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 279 GLU B 241 GLU^? 19.53 O1S EPE A 377 A 369 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 16.54 46.37 63.94 14.77 45.79 62.95 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 279 GLU B 200 GLU^? 21.89 O2S EPE A 377 A 369 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 16.54 46.37 63.94 14.77 45.79 62.95 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 12.19 31.08 87.29 11.13 32.66 86.38 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 279 GLU C 175 GLU^? 13.76 O8 EPE C 377 A 369 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 16.54 46.37 63.94 14.77 45.79 62.95 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 12.19 31.08 87.29 11.13 32.66 86.38 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 279 GLU B 25 GLU.? 18.70 ZN ZN B 375 A 369 ASP B 330 ASP^? 11.92 ZN ZN B 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 16.54 46.37 63.94 14.77 45.79 62.95 1.46 -5.92 31.01 3.44 -6.69 31.23 coo 12.19 31.08 87.29 11.13 32.66 86.38 -4.33 18.16 18.13 -5.04 17.21 19.90 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 279 GLU B 262 GLU~? 24.13 ZN ZN B 374 A 369 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 16.54 46.37 63.94 14.77 45.79 62.95 -9.48 23.81 6.41 -10.83 24.55 7.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 279 GLU C 15 GLU~? 17.26 ZN ZN C 375 A 369 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 16.54 46.37 63.94 14.77 45.79 62.95 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 12.19 31.08 87.29 11.13 32.66 86.38 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 279 GLU C 135 GLU^? 15.12 O1 TRS A 378 A 369 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 16.54 46.37 63.94 14.77 45.79 62.95 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 279 GLU C 136 GLU^? 12.99 N TRS A 378 A 369 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 16.54 46.37 63.94 14.77 45.79 62.95 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 279 GLU A 175 GLU^? 13.72 C8 EPE A 377 A 369 ASP A 237 ASP^? 6.80 N TRS A 378 coo 11.74 38.14 80.19 10.63 36.40 80.65 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 16.54 46.37 63.94 14.77 45.79 62.95 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 279 GLU C 197 GLU^? 9.42 O8 EPE C 377 A 369 ASP A 237 ASP^? 6.80 N TRS A 378 coo 11.74 38.14 80.19 10.63 36.40 80.65 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 16.54 46.37 63.94 14.77 45.79 62.95 32.51 -36.09 0.58 33.81 -36.84 -0.90 coo 12.19 31.08 87.29 11.13 32.66 86.38 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 22 3 # 22 A 241 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 279 GLU C 200 GLU^? 10.81 O8 EPE C 377 A 369 ASP A 237 ASP^? 6.80 N TRS A 378 coo 11.74 38.14 80.19 10.63 36.40 80.65 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 16.54 46.37 63.94 14.77 45.79 62.95 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 12.19 31.08 87.29 11.13 32.66 86.38 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 23 3 # 23 A 241 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 279 GLU C 262 GLU~? 24.05 ZN ZN C 374 A 369 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 11.74 38.14 80.19 10.63 36.40 80.65 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 16.54 46.37 63.94 14.77 45.79 62.95 -15.17 -35.96 63.25 -14.01 -35.31 64.90 coo 12.19 31.08 87.29 11.13 32.66 86.38 10.65 -27.85 62.57 8.78 -27.40 61.73 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 23 hits 1m53_c06 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 168 ASN A 105 ASN~? 9.65 ZN ZN A 375 A 241 HIS A 21 HIS~? 17.08 ZN ZN A 375 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 30.92 -4.10 21.33 31.10 -1.93 21.21 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 24.93 -8.05 18.54 26.13 -9.04 17.11 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 A 10 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 168 ASN A 105 ASN~? 9.65 ZN ZN A 375 A 241 HIS A 21 HIS~? 17.08 ZN ZN A 375 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 30.92 -4.10 21.33 31.10 -1.93 21.21 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 24.93 -8.05 18.54 26.13 -9.04 17.11 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 3 3 # 3 A 10 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 168 ASN A 294 ASN.? 12.36 ZN ZN A 374 A 241 HIS A 316 HIS~? 20.33 O8 EPE A 376 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 39.49 -1.24 39.18 39.76 0.49 37.96 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 35.77 -6.31 41.36 37.34 -5.07 42.10 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 36.36 -5.20 52.06 36.55 -4.24 53.92 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 4 3 # 4 A 10 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 168 ASN A 334 ASN~? 9.69 ZN ZN A 374 A 241 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 2.16 -17.86 7.84 1.13 -18.57 9.58 39.49 -1.24 39.18 39.76 0.49 37.96 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 45.98 2.64 32.26 46.53 3.77 30.56 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 5 3 # 5 A 10 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 168 ASN A 334 ASN~? 9.69 ZN ZN A 374 A 241 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 2.16 -17.86 7.84 1.13 -18.57 9.58 39.49 -1.24 39.18 39.76 0.49 37.96 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 45.98 2.64 32.26 46.53 3.77 30.56 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 6 3 # 6 A 10 ASP A 352 ASP~? 25.70 ZN ZN A 375 A 168 ASN A 357 ASN.? 31.19 ZN ZN A 375 A 241 HIS A 42 HIS^? 26.23 ZN ZN A 375 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 43.66 -0.56 3.32 44.78 0.99 4.29 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 41.74 8.14 0.39 43.66 9.05 0.34 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 43.48 12.60 9.22 44.86 13.19 7.76 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 7 3 # 7 A 10 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 168 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 241 HIS B 21 HIS~? 17.19 ZN ZN B 375 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -4.82 -12.30 22.40 -5.26 -12.74 20.40 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 8 3 # 8 A 10 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 168 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 241 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 9 3 # 9 A 10 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 168 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 241 HIS B 21 HIS~? 17.19 ZN ZN B 375 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -4.82 -12.30 22.40 -5.26 -12.74 20.40 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 10 3 # 10 A 10 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 168 ASN B 294 ASN.? 12.27 ZN ZN B 374 A 241 HIS B 316 HIS~? 20.54 O8 EPE B 376 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 2.18 12.34 23.84 0.88 14.02 24.05 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 7.45 20.77 27.47 7.65 22.47 28.71 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 11 3 # 11 A 10 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 168 ASN B 334 ASN~? 9.65 ZN ZN B 374 A 241 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -13.83 13.67 21.41 -15.89 13.09 21.50 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 12 3 # 12 A 10 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 168 ASN B 334 ASN~? 9.65 ZN ZN B 374 A 241 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -13.83 13.67 21.41 -15.89 13.09 21.50 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 13 3 # 13 A 10 ASP B 352 ASP~? 25.82 ZN ZN B 375 A 168 ASN B 357 ASN.? 31.68 ZN ZN B 375 A 241 HIS B 42 HIS^? 26.13 ZN ZN B 375 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -34.36 -10.98 18.28 -35.73 -11.88 19.64 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -32.72 -2.76 23.44 -34.69 -2.87 22.69 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 14 3 # 14 A 10 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 168 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 241 HIS C 21 HIS~? 17.02 O1 TRS A 378 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 12.40 -28.97 45.42 13.67 -29.13 47.17 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 14.59 -28.36 37.80 14.05 -30.33 37.30 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 15 3 # 15 A 10 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 168 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 241 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 2.16 -17.86 7.84 1.13 -18.57 9.58 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 12.40 -28.97 45.42 13.67 -29.13 47.17 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 16 3 # 16 A 10 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 168 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 241 HIS C 21 HIS~? 17.02 O1 TRS A 378 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 12.40 -28.97 45.42 13.67 -29.13 47.17 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 14.59 -28.36 37.80 14.05 -30.33 37.30 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 17 3 # 17 A 10 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 168 ASN C 334 ASN~? 9.79 ZN ZN C 374 A 241 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 2.44 -29.45 62.54 3.79 -30.90 63.32 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 18 3 # 18 A 10 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 168 ASN C 334 ASN~? 9.79 ZN ZN C 374 A 241 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 2.44 -29.45 62.54 3.79 -30.90 63.32 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 19 3 # 19 A 10 ASP C 352 ASP~? 25.48 ZN ZN C 375 A 168 ASN C 357 ASN.? 31.03 ZN ZN C 375 A 241 HIS C 42 HIS^? 26.23 ZN ZN C 375 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 18.63 -50.25 49.90 18.47 -49.69 51.95 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 27.30 -48.88 54.43 27.23 -49.76 56.37 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 23.45 -43.42 61.49 24.00 -45.25 62.37 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 19 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 168 ASN A 105 ASN~? 9.65 ZN ZN A 375 B 241 HIS A 21 HIS~? 17.08 ZN ZN A 375 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 30.92 -4.10 21.33 31.10 -1.93 21.21 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 24.93 -8.05 18.54 26.13 -9.04 17.11 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 B 10 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 168 ASN A 105 ASN~? 9.65 ZN ZN A 375 B 241 HIS A 21 HIS~? 17.08 ZN ZN A 375 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 30.92 -4.10 21.33 31.10 -1.93 21.21 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 24.93 -8.05 18.54 26.13 -9.04 17.11 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 3 3 # 3 B 10 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 168 ASN A 294 ASN.? 12.36 ZN ZN A 374 B 241 HIS A 316 HIS~? 20.33 O8 EPE A 376 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 39.49 -1.24 39.18 39.76 0.49 37.96 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 35.77 -6.31 41.36 37.34 -5.07 42.10 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 36.36 -5.20 52.06 36.55 -4.24 53.92 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 4 3 # 4 B 10 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 168 ASN A 334 ASN~? 9.69 ZN ZN A 374 B 241 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 39.49 -1.24 39.18 39.76 0.49 37.96 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 45.98 2.64 32.26 46.53 3.77 30.56 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 5 3 # 5 B 10 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 168 ASN A 334 ASN~? 9.69 ZN ZN A 374 B 241 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 39.49 -1.24 39.18 39.76 0.49 37.96 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 45.98 2.64 32.26 46.53 3.77 30.56 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 6 3 # 6 B 10 ASP A 352 ASP~? 25.70 ZN ZN A 375 B 168 ASN A 357 ASN.? 31.19 ZN ZN A 375 B 241 HIS A 42 HIS^? 26.23 ZN ZN A 375 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 43.66 -0.56 3.32 44.78 0.99 4.29 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 41.74 8.14 0.39 43.66 9.05 0.34 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 43.48 12.60 9.22 44.86 13.19 7.76 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 7 3 # 7 B 10 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 168 ASN B 105 ASN~? 9.47 ZN ZN B 375 B 241 HIS B 21 HIS~? 17.19 ZN ZN B 375 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -4.82 -12.30 22.40 -5.26 -12.74 20.40 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 8 3 # 8 B 10 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 168 ASN B 105 ASN~? 9.47 ZN ZN B 375 B 241 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 9 3 # 9 B 10 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 168 ASN B 105 ASN~? 9.47 ZN ZN B 375 B 241 HIS B 21 HIS~? 17.19 ZN ZN B 375 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -4.82 -12.30 22.40 -5.26 -12.74 20.40 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 10 3 # 10 B 10 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 168 ASN B 294 ASN.? 12.27 ZN ZN B 374 B 241 HIS B 316 HIS~? 20.54 O8 EPE B 376 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 2.18 12.34 23.84 0.88 14.02 24.05 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 7.45 20.77 27.47 7.65 22.47 28.71 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 11 3 # 11 B 10 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 168 ASN B 334 ASN~? 9.65 ZN ZN B 374 B 241 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -13.83 13.67 21.41 -15.89 13.09 21.50 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 12 3 # 12 B 10 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 168 ASN B 334 ASN~? 9.65 ZN ZN B 374 B 241 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -13.83 13.67 21.41 -15.89 13.09 21.50 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 13 3 # 13 B 10 ASP B 352 ASP~? 25.82 ZN ZN B 375 B 168 ASN B 357 ASN.? 31.68 ZN ZN B 375 B 241 HIS B 42 HIS^? 26.13 ZN ZN B 375 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -34.36 -10.98 18.28 -35.73 -11.88 19.64 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -32.72 -2.76 23.44 -34.69 -2.87 22.69 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 14 3 # 14 B 10 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 168 ASN C 105 ASN~? 9.60 ZN ZN C 375 B 241 HIS C 21 HIS~? 17.02 O1 TRS A 378 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 12.40 -28.97 45.42 13.67 -29.13 47.17 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 14.59 -28.36 37.80 14.05 -30.33 37.30 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 15 3 # 15 B 10 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 168 ASN C 105 ASN~? 9.60 ZN ZN C 375 B 241 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 12.40 -28.97 45.42 13.67 -29.13 47.17 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 16 3 # 16 B 10 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 168 ASN C 105 ASN~? 9.60 ZN ZN C 375 B 241 HIS C 21 HIS~? 17.02 O1 TRS A 378 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 12.40 -28.97 45.42 13.67 -29.13 47.17 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 14.59 -28.36 37.80 14.05 -30.33 37.30 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 17 3 # 17 B 10 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 168 ASN C 294 ASN.? 11.92 ZN ZN C 374 B 241 HIS C 316 HIS~? -20.42 O8 EPE C 376s coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -3.30 -17.98 52.78 -3.53 -18.25 54.87 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -9.15 -10.09 56.84 -9.69 -8.65 58.28 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 18 3 # 18 B 10 ASP C 352 ASP~? 25.48 ZN ZN C 375 B 168 ASN C 357 ASN.? 31.03 ZN ZN C 375 B 241 HIS C 42 HIS^? 26.23 ZN ZN C 375 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 18.63 -50.25 49.90 18.47 -49.69 51.95 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 27.30 -48.88 54.43 27.23 -49.76 56.37 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 23.45 -43.42 61.49 24.00 -45.25 62.37 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 18 hits 1mas_c01 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 203 ARG^? 8.58 O3S EPE C 377 229 SER B 173 SER^? 8.63 C9 EPE A 377 325 GLU B 205 GLU^? 4.50 O2S EPE A 377 coo 2.54 15.84 18.57 3.24 17.85 16.30 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 10.17 13.48 15.92 9.61 15.76 15.27 4.35 -36.83 4.64 1.88 -36.99 4.49 coo 5.42 13.04 19.75 5.74 13.81 17.79 5.77 -31.61 7.46 7.86 -31.06 7.53 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG A 203 ARG^? 8.58 O3S EPE C 377 229 SER B 174 SER^? 9.21 O2S EPE A 377 325 GLU B 205 GLU^? 4.50 O2S EPE A 377 coo 2.54 15.84 18.57 3.24 17.85 16.30 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 10.17 13.48 15.92 9.61 15.76 15.27 7.43 -39.02 5.18 8.88 -37.11 5.67 coo 5.42 13.04 19.75 5.74 13.81 17.79 5.77 -31.61 7.46 7.86 -31.06 7.53 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 3 3 # 3 159 ARG B 203 ARG^? 8.69 O2S EPE A 377 229 SER C 173 SER^? 14.26 C2 EPE C 377 325 GLU C 205 GLU^? 12.89 O3S EPE C 377 coo 2.54 15.84 18.57 3.24 17.85 16.30 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 10.17 13.48 15.92 9.61 15.76 15.27 13.37 -42.81 12.12 14.73 -44.10 13.72 coo 5.42 13.04 19.75 5.74 13.81 17.79 11.89 -37.55 15.12 10.61 -36.09 14.30 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 4 3 # 4 159 ARG C 203 ARG^? 8.27 O3S EPE C 377 229 SER A 173 SER^? 8.70 C6 EPE C 377 325 GLU A 205 GLU^? -4.84 O3S EPE C 377s coo 2.54 15.84 18.57 3.24 17.85 16.30 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 10.17 13.48 15.92 9.61 15.76 15.27 17.10 -34.58 2.20 18.37 -33.49 0.48 coo 5.42 13.04 19.75 5.74 13.81 17.79 16.97 -31.31 7.38 16.25 -32.10 9.22 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 5 3 # 5 159 ARG C 203 ARG^? 8.27 O3S EPE C 377 229 SER A 174 SER^? 9.43 O3S EPE C 377 325 GLU A 205 GLU^? -4.84 O3S EPE C 377s coo 2.54 15.84 18.57 3.24 17.85 16.30 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 10.17 13.48 15.92 9.61 15.76 15.27 14.12 -36.94 2.65 13.97 -36.44 5.09 coo 5.42 13.04 19.75 5.74 13.81 17.79 16.97 -31.31 7.38 16.25 -32.10 9.22 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 5 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 215 LYS~? 16.65 O1S EPE C 377 166 LYS A 218 LYS~? 21.49 C3 EPE A 377 324 SER A 174 SER^? 9.43 O3S EPE C 377 coo 25.93 8.11 25.51 26.40 7.80 19.66 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 27.27 1.43 25.09 29.18 5.25 22.89 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 46.32 14.55 19.93 45.95 12.72 21.27 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 218 LYS~? 21.49 C3 EPE A 377 166 LYS A 215 LYS~? 16.65 O1S EPE C 377 324 SER A 174 SER^? 9.43 O3S EPE C 377 coo 25.93 8.11 25.51 26.40 7.80 19.66 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 27.27 1.43 25.09 29.18 5.25 22.89 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 46.32 14.55 19.93 45.95 12.72 21.27 14.12 -36.94 2.65 13.97 -36.44 5.09 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 301 LYS~? 24.94 ZN ZN A 375 166 LYS A 303 LYS~? 13.81 O3 TRS A 378 324 SER A 267 SER~? 18.73 ZN ZN A 375 coo 25.93 8.11 25.51 26.40 7.80 19.66 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 27.27 1.43 25.09 29.18 5.25 22.89 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 46.32 14.55 19.93 45.95 12.72 21.27 54.41 -7.54 28.59 54.43 -9.91 28.92 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS A 301 LYS~? 24.94 ZN ZN A 375 166 LYS A 303 LYS~? 13.81 O3 TRS A 378 324 SER C 12 SER~? 21.06 O1 TRS A 378 coo 25.93 8.11 25.51 26.40 7.80 19.66 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 27.27 1.43 25.09 29.18 5.25 22.89 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 46.32 14.55 19.93 45.95 12.72 21.27 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS A 303 LYS~? 13.81 O3 TRS A 378 166 LYS A 301 LYS~? 24.94 ZN ZN A 375 324 SER A 267 SER~? 18.73 ZN ZN A 375 coo 25.93 8.11 25.51 26.40 7.80 19.66 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 27.27 1.43 25.09 29.18 5.25 22.89 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 46.32 14.55 19.93 45.95 12.72 21.27 54.41 -7.54 28.59 54.43 -9.91 28.92 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS A 303 LYS~? 13.81 O3 TRS A 378 166 LYS A 301 LYS~? 24.94 ZN ZN A 375 324 SER C 12 SER~? 21.06 O1 TRS A 378 coo 25.93 8.11 25.51 26.40 7.80 19.66 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 27.27 1.43 25.09 29.18 5.25 22.89 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 46.32 14.55 19.93 45.95 12.72 21.27 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS A 350 LYS~? 21.83 ZN ZN A 375 166 LYS A 354 LYS~? 27.90 ZN ZN A 375 324 SER A 211 SER.? 15.47 O1S EPE C 377 coo 25.93 8.11 25.51 26.40 7.80 19.66 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 27.27 1.43 25.09 29.18 5.25 22.89 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 46.32 14.55 19.93 45.95 12.72 21.27 22.77 -13.70 10.58 25.20 -14.10 10.82 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS B 215 LYS~? 17.38 O3S EPE A 377 166 LYS B 218 LYS~? 23.26 O3S EPE A 377 324 SER B 174 SER^? 9.21 O2S EPE A 377 coo 25.93 8.11 25.51 26.40 7.80 19.66 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 27.27 1.43 25.09 29.18 5.25 22.89 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 46.32 14.55 19.93 45.95 12.72 21.27 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 3 # 9 164 LYS B 218 LYS~? 23.26 O3S EPE A 377 166 LYS B 215 LYS~? 17.38 O3S EPE A 377 324 SER B 174 SER^? 9.21 O2S EPE A 377 coo 25.93 8.11 25.51 26.40 7.80 19.66 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 27.27 1.43 25.09 29.18 5.25 22.89 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 46.32 14.55 19.93 45.95 12.72 21.27 7.43 -39.02 5.18 8.88 -37.11 5.67 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 3 # 10 164 LYS B 301 LYS~? 25.03 ZN ZN B 375 166 LYS B 303 LYS~? 19.29 ZN ZN B 375 324 SER A 12 SER~? 22.68 ZN ZN A 375 coo 25.93 8.11 25.51 26.40 7.80 19.66 8.36 10.35 11.75 10.05 14.82 9.04 coo 27.27 1.43 25.09 29.18 5.25 22.89 7.99 5.97 9.05 6.92 1.04 11.01 coo 46.32 14.55 19.93 45.95 12.72 21.27 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 11 3 # 11 164 LYS B 301 LYS~? 25.03 ZN ZN B 375 166 LYS B 303 LYS~? 19.29 ZN ZN B 375 324 SER B 267 SER~? 18.54 ZN ZN B 375 coo 25.93 8.11 25.51 26.40 7.80 19.66 8.36 10.35 11.75 10.05 14.82 9.04 coo 27.27 1.43 25.09 29.18 5.25 22.89 7.99 5.97 9.05 6.92 1.04 11.01 coo 46.32 14.55 19.93 45.95 12.72 21.27 -13.83 13.99 7.82 -11.74 14.03 6.57 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 12 3 # 12 164 LYS B 303 LYS~? 19.29 ZN ZN B 375 166 LYS B 301 LYS~? 25.03 ZN ZN B 375 324 SER A 12 SER~? 22.68 ZN ZN A 375 coo 25.93 8.11 25.51 26.40 7.80 19.66 7.99 5.97 9.05 6.92 1.04 11.01 coo 27.27 1.43 25.09 29.18 5.25 22.89 8.36 10.35 11.75 10.05 14.82 9.04 coo 46.32 14.55 19.93 45.95 12.72 21.27 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 13 3 # 13 164 LYS B 303 LYS~? 19.29 ZN ZN B 375 166 LYS B 301 LYS~? 25.03 ZN ZN B 375 324 SER B 267 SER~? 18.54 ZN ZN B 375 coo 25.93 8.11 25.51 26.40 7.80 19.66 7.99 5.97 9.05 6.92 1.04 11.01 coo 27.27 1.43 25.09 29.18 5.25 22.89 8.36 10.35 11.75 10.05 14.82 9.04 coo 46.32 14.55 19.93 45.95 12.72 21.27 -13.83 13.99 7.82 -11.74 14.03 6.57 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 14 3 # 14 164 LYS B 355 LYS.? 33.64 ZN ZN B 375 166 LYS B 3 LYS.? 34.82 ZN ZN B 375 324 SER B 363 SER.? 15.02 ZN ZN B 374 coo 25.93 8.11 25.51 26.40 7.80 19.66 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo 27.27 1.43 25.09 29.18 5.25 22.89 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo 46.32 14.55 19.93 45.95 12.72 21.27 -24.68 6.36 21.71 -24.04 7.63 23.71 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 15 3 # 15 164 LYS C 215 LYS~? 17.39 O1 TRS A 378 166 LYS C 218 LYS~? 12.80 O1 TRS A 378 324 SER C 174 SER^? 11.73 O3S EPE C 377 coo 25.93 8.11 25.51 26.40 7.80 19.66 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 27.27 1.43 25.09 29.18 5.25 22.89 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 46.32 14.55 19.93 45.95 12.72 21.27 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 16 3 # 16 164 LYS C 218 LYS~? 12.80 O1 TRS A 378 166 LYS C 215 LYS~? 17.39 O1 TRS A 378 324 SER C 174 SER^? 11.73 O3S EPE C 377 coo 25.93 8.11 25.51 26.40 7.80 19.66 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 27.27 1.43 25.09 29.18 5.25 22.89 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 46.32 14.55 19.93 45.95 12.72 21.27 13.31 -42.10 8.38 13.05 -39.69 8.34 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 17 3 # 17 164 LYS C 301 LYS~? 24.63 ZN ZN C 375 166 LYS C 303 LYS~? 17.98 ZN ZN C 375 324 SER B 12 SER~? 22.72 ZN ZN B 375 coo 25.93 8.11 25.51 26.40 7.80 19.66 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 27.27 1.43 25.09 29.18 5.25 22.89 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 46.32 14.55 19.93 45.95 12.72 21.27 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 18 3 # 18 164 LYS C 301 LYS~? 24.63 ZN ZN C 375 166 LYS C 303 LYS~? 17.98 ZN ZN C 375 324 SER C 267 SER~? 17.79 ZN ZN C 375 coo 25.93 8.11 25.51 26.40 7.80 19.66 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 27.27 1.43 25.09 29.18 5.25 22.89 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 46.32 14.55 19.93 45.95 12.72 21.27 -6.30 -39.53 58.90 -6.77 -39.38 56.53 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 19 3 # 19 164 LYS C 303 LYS~? 17.98 ZN ZN C 375 166 LYS C 301 LYS~? 24.63 ZN ZN C 375 324 SER B 12 SER~? 22.72 ZN ZN B 375 coo 25.93 8.11 25.51 26.40 7.80 19.66 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 27.27 1.43 25.09 29.18 5.25 22.89 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 46.32 14.55 19.93 45.95 12.72 21.27 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 20 3 # 20 164 LYS C 303 LYS~? 17.98 ZN ZN C 375 166 LYS C 301 LYS~? 24.63 ZN ZN C 375 324 SER C 267 SER~? 17.79 ZN ZN C 375 coo 25.93 8.11 25.51 26.40 7.80 19.66 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 27.27 1.43 25.09 29.18 5.25 22.89 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 46.32 14.55 19.93 45.95 12.72 21.27 -6.30 -39.53 58.90 -6.77 -39.38 56.53 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 21 3 # 21 164 LYS C 350 LYS~? 21.45 ZN ZN C 375 166 LYS C 354 LYS~? 23.72 O1 TRS A 378 324 SER C 168 SER^? 24.11 O1 TRS A 378 coo 25.93 8.11 25.51 26.40 7.80 19.66 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 27.27 1.43 25.09 29.18 5.25 22.89 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 46.32 14.55 19.93 45.95 12.72 21.27 9.08 -45.42 26.78 10.19 -47.47 27.43 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 22 3 # 22 164 LYS C 354 LYS~? 23.72 O1 TRS A 378 166 LYS C 350 LYS~? 21.45 ZN ZN C 375 324 SER C 168 SER^? 24.11 O1 TRS A 378 coo 25.93 8.11 25.51 26.40 7.80 19.66 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 27.27 1.43 25.09 29.18 5.25 22.89 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 46.32 14.55 19.93 45.95 12.72 21.27 9.08 -45.42 26.78 10.19 -47.47 27.43 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 23 3 # 23 164 LYS C 355 LYS.? 32.67 ZN ZN C 375 166 LYS C 3 LYS.? 28.91 O1 TRS A 378 324 SER C 363 SER.? 15.25 ZN ZN C 374 coo 25.93 8.11 25.51 26.40 7.80 19.66 24.80 -50.74 47.95 22.71 -54.81 46.20 coo 27.27 1.43 25.09 29.18 5.25 22.89 30.63 -48.52 50.80 31.26 -43.98 46.49 coo 46.32 14.55 19.93 45.95 12.72 21.27 12.66 -37.79 63.35 12.77 -35.67 64.45 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 23 hits 1mdr_c01 naa= 3 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 1 3 # 1 92 SER A 168 SER^? 10.80 O1S EPE C 377 201 HIS A 163 HIS.? 11.18 O1S EPE C 377 250 GLN C 183 GLN.? 13.97 C5 EPE C 377 coo 38.34 0.72 11.82 37.33 1.15 14.05 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 35.42 -27.01 4.58 35.93 -26.02 2.76 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 2 3 # 2 92 SER A 267 SER~? 18.73 ZN ZN A 375 201 HIS A 263 HIS~? 20.93 ZN ZN A 375 250 GLN A 266 GLN~? 23.95 ZN ZN A 374 coo 38.34 0.72 11.82 37.33 1.15 14.05 54.41 -7.54 28.59 54.43 -9.91 28.92 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 59.53 -7.13 31.68 60.94 -5.69 30.89 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 3 3 # 3 92 SER B 168 SER^? 10.59 O3S EPE A 377 201 HIS B 163 HIS.? 11.54 O3S EPE A 377 250 GLN A 183 GLN.? 13.75 O8 EPE A 377 coo 38.34 0.72 11.82 37.33 1.15 14.05 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 -6.86 -21.61 -3.42 -8.75 -22.47 -2.89 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 4 3 # 4 92 SER B 267 SER~? 18.54 ZN ZN B 375 201 HIS B 263 HIS~? 20.98 ZN ZN B 375 250 GLN B 266 GLN~? 23.22 ZN ZN B 374 coo 38.34 0.72 11.82 37.33 1.15 14.05 -13.83 13.99 7.82 -11.74 14.03 6.57 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 -14.31 19.60 6.00 -15.56 21.05 7.00 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 5 3 # 5 92 SER C 267 SER~? 17.79 ZN ZN C 375 201 HIS C 263 HIS~? 20.89 ZN ZN C 375 250 GLN C 266 GLN~? 22.05 ZN ZN C 375 coo 38.34 0.72 11.82 37.33 1.15 14.05 -6.30 -39.53 58.90 -6.77 -39.38 56.53 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 -8.78 -41.84 62.14 -8.45 -42.48 60.10 1mla_c00 source 1mla MALONYL-COENZYME A ACYL CARRIER PROTEIN TRANSA: 5 hits 1mla_c00 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 7 GLY~? 22.99 ZN ZN A 375 A 501 ASP A 55 ASP~? 17.36 O2S EPE A 376 B 367 TYR A 133 TYR^? 12.87 O3 TRS A 378 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 31.92 8.80 9.28 31.38 8.48 8.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 45.10 18.98 22.18 44.20 20.57 23.21 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 26.66 -12.84 21.54 25.55 -13.01 18.92 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 30 GLY^? 14.83 ZN ZN A 375 A 501 ASP A 55 ASP~? 17.36 O2S EPE A 376 B 367 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 27.68 4.60 19.76 28.15 4.96 20.33 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 45.10 18.98 22.18 44.20 20.57 23.21 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 30 GLY^? 14.83 ZN ZN A 375 A 501 ASP A 352 ASP~? 25.70 ZN ZN A 375 B 367 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 27.68 4.60 19.76 28.15 4.96 20.33 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 43.66 -0.56 3.32 44.78 0.99 4.29 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 34 GLY.? 18.52 C3 EPE A 376 A 501 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 367 TYR B 296 TYR~? 11.48 ZN ZN B 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 28.75 15.24 16.90 28.17 14.75 17.10 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.06 5.94 19.61 2.50 3.84 21.38 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY A 111 GLY.? 12.81 ZN ZN A 375 A 501 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 367 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 40.78 -9.44 18.50 40.17 -9.34 19.07 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY A 112 GLY~? 9.06 ZN ZN A 375 A 501 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 367 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 39.28 -7.29 21.25 39.96 -7.72 21.33 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY A 122 GLY.? 19.60 ZN ZN A 375 A 501 ASP A 281 ASP.? 28.06 ZN ZN A 375 B 367 TYR A 133 TYR^? 12.87 O3 TRS A 378 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 51.97 -15.01 25.49 51.32 -15.01 26.00 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 26.66 -12.84 21.54 25.55 -13.01 18.92 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY A 244 GLY^? 11.92 ZN ZN A 375 A 501 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 367 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 32.51 -13.15 26.46 33.13 -12.90 26.03 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY A 249 GLY^? 18.94 ZN ZN A 375 A 501 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 367 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 44.87 -19.78 28.98 45.04 -19.55 29.74 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 23.23 -33.44 18.32 24.66 -32.16 20.35 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY A 272 GLY.? 18.36 ZN ZN A 374 A 501 ASP A 281 ASP.? 28.06 ZN ZN A 375 B 367 TYR A 18 TYR~? 11.08 ZN ZN A 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 54.23 -1.17 38.61 53.76 -1.27 37.97 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 34.99 -4.02 17.62 37.68 -4.71 17.89 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY A 304 GLY.? 22.37 O3 TRS A 378 A 501 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 367 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 41.24 -23.22 37.09 41.16 -22.48 36.89 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.27 -30.73 51.89 19.47 -30.85 49.23 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY A 304 GLY.? 22.37 O3 TRS A 378 A 501 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 367 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 41.24 -23.22 37.09 41.16 -22.48 36.89 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.27 -30.73 51.89 19.47 -30.85 49.23 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY A 304 GLY.? 22.37 O3 TRS A 378 A 501 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 367 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 41.24 -23.22 37.09 41.16 -22.48 36.89 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 23.23 -33.44 18.32 24.66 -32.16 20.35 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY A 304 GLY.? 22.37 O3 TRS A 378 A 501 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 367 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 41.24 -23.22 37.09 41.16 -22.48 36.89 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 39.49 -1.24 39.18 39.76 0.49 37.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.27 -30.73 51.89 19.47 -30.85 49.23 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY A 325 GLY~? 25.53 ZN ZN A 375 A 501 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 367 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 43.05 -19.34 46.86 42.56 -18.83 46.33 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.27 -30.73 51.89 19.47 -30.85 49.23 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY A 332 GLY~? 10.15 ZN ZN A 374 A 501 ASP A 281 ASP.? 28.06 ZN ZN A 375 B 367 TYR A 133 TYR^? 12.87 O3 TRS A 378 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 46.00 -1.11 36.47 45.93 -1.81 36.02 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 26.66 -12.84 21.54 25.55 -13.01 18.92 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY B 7 GLY~? 23.15 ZN ZN B 375 A 501 ASP B 55 ASP~? 16.89 O3S EPE B 376 B 367 TYR B 133 TYR^? 17.24 ZN ZN B 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -24.83 -11.10 27.95 -24.79 -11.89 27.82 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -0.70 -9.54 18.25 -1.85 -12.04 17.66 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 18 3 # 18 A 465 GLY B 30 GLY^? 14.63 ZN ZN B 375 A 501 ASP B 55 ASP~? 16.89 O3S EPE B 376 B 367 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -13.71 -6.55 30.41 -13.82 -5.76 30.60 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 19 3 # 19 A 465 GLY B 30 GLY^? 14.63 ZN ZN B 375 A 501 ASP B 352 ASP~? 25.82 ZN ZN B 375 B 367 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -13.71 -6.55 30.41 -13.82 -5.76 30.60 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 20 3 # 20 A 465 GLY B 165 GLY.? 10.94 O1S EPE A 377 A 501 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 367 TYR B 250 TYR^? 23.22 ZN ZN B 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -0.63 -18.46 -0.95 -1.10 -19.11 -0.69 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 0.70 6.87 1.10 3.12 5.62 1.69 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 21 3 # 21 A 465 GLY B 240 GLY^? 14.23 O1S EPE A 377 A 501 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 367 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 22 3 # 22 A 465 GLY B 244 GLY^? 11.85 ZN ZN B 375 A 501 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 367 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -0.61 -2.61 16.62 -1.32 -2.49 16.19 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 3.99 14.73 5.36 5.18 14.04 3.76 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 23 3 # 23 A 465 GLY B 304 GLY.? 23.11 ZN ZN B 375 A 501 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 367 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 8.09 9.00 6.73 7.56 8.93 7.27 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 24 3 # 24 A 465 GLY B 304 GLY.? 23.11 ZN ZN B 375 A 501 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 367 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 8.09 9.00 6.73 7.56 8.93 7.27 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 25 3 # 25 A 465 GLY B 304 GLY.? 23.11 ZN ZN B 375 A 501 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 367 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 8.09 9.00 6.73 7.56 8.93 7.27 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 26 3 # 26 A 465 GLY B 325 GLY~? 25.63 ZN ZN B 375 A 501 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 367 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 10.15 18.18 11.38 9.73 17.62 11.87 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 27 3 # 27 A 465 GLY C 7 GLY~? 23.11 ZN ZN C 375 A 501 ASP C 55 ASP~? 17.38 O3S EPE C 376 B 367 TYR C 133 TYR^? 16.76 ZN ZN C 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 27.26 -36.33 52.02 27.65 -36.56 51.35 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 8.59 -26.93 36.99 10.82 -27.74 35.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 28 3 # 28 A 465 GLY C 30 GLY^? 14.80 ZN ZN C 375 A 501 ASP C 55 ASP~? 17.38 O3S EPE C 376 B 367 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 20.37 -26.80 49.54 20.07 -26.59 50.27 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 29 3 # 29 A 465 GLY C 30 GLY^? 14.80 ZN ZN C 375 A 501 ASP C 352 ASP~? 25.48 ZN ZN C 375 B 367 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 20.37 -26.80 49.54 20.07 -26.59 50.27 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 18.63 -50.25 49.90 18.47 -49.69 51.95 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 30 3 # 30 A 465 GLY C 34 GLY.? 18.40 C3 EPE C 376 A 501 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 367 TYR A 296 TYR~? 11.37 ZN ZN A 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 28.32 -27.49 57.24 28.16 -27.07 56.58 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 34.09 -11.35 35.81 31.97 -10.07 34.54 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 31 3 # 31 A 465 GLY C 111 GLY.? 12.85 ZN ZN C 375 A 501 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 367 TYR B 226 TYR.? 21.63 O2S EPE A 377 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 5.64 -38.51 45.88 5.60 -37.66 45.90 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -2.18 -44.73 18.44 0.01 -45.92 17.08 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 32 3 # 32 A 465 GLY C 122 GLY~? 19.71 ZN ZN C 375 A 501 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 367 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -7.79 -41.59 50.69 -7.69 -40.80 50.48 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.31 -45.81 25.21 0.69 -46.75 24.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 33 3 # 33 A 465 GLY C 165 GLY.? 25.31 N TRS A 378 A 501 ASP A 237 ASP^? 6.80 N TRS A 378 B 367 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 3.00 -41.27 29.42 3.80 -41.57 29.42 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 34 3 # 34 A 465 GLY C 165 GLY.? 25.31 N TRS A 378 A 501 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 367 TYR C 296 TYR~? 11.54 ZN ZN C 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 3.00 -41.27 29.42 3.80 -41.57 29.42 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -2.51 -21.77 46.19 0.10 -20.95 45.58 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 35 3 # 35 A 465 GLY C 244 GLY^? 11.70 ZN ZN C 375 A 501 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 367 TYR B 226 TYR.? 21.63 O2S EPE A 377 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 2.79 -27.67 41.30 2.83 -28.37 41.63 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -2.18 -44.73 18.44 0.01 -45.92 17.08 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 36 3 # 36 A 465 GLY C 249 GLY^? 18.92 ZN ZN C 375 A 501 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 367 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -9.08 -35.38 44.08 -9.51 -34.84 44.55 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 37 3 # 37 A 465 GLY C 304 GLY.? 22.89 ZN ZN C 375 A 501 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 367 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -14.35 -27.24 41.90 -13.76 -27.25 42.32 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 38 3 # 38 A 465 GLY C 304 GLY.? 22.89 ZN ZN C 375 A 501 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 367 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -14.35 -27.24 41.90 -13.76 -27.25 42.32 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 39 3 # 39 A 465 GLY C 304 GLY.? 22.89 ZN ZN C 375 A 501 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 367 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -14.35 -27.24 41.90 -13.76 -27.25 42.32 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 40 3 # 40 A 465 GLY C 304 GLY.? 22.89 ZN ZN C 375 A 501 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 367 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -14.35 -27.24 41.90 -13.76 -27.25 42.32 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 41 3 # 41 A 465 GLY C 325 GLY~? 25.60 ZN ZN C 375 A 501 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 367 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -18.52 -20.89 48.72 -17.66 -20.90 48.73 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 42 3 # 42 A 465 GLY C 342 GLY~? 13.18 ZN ZN C 375 A 501 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 367 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 7.81 -40.56 53.34 8.53 -40.45 53.72 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.31 -45.81 25.21 0.69 -46.75 24.83 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 42 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 7 GLY~? 22.99 ZN ZN A 375 D 501 ASP A 55 ASP~? 17.36 O2S EPE A 376 E 367 TYR A 133 TYR^? 12.87 O3 TRS A 378 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 31.92 8.80 9.28 31.38 8.48 8.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 45.10 18.98 22.18 44.20 20.57 23.21 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 26.66 -12.84 21.54 25.55 -13.01 18.92 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 30 GLY^? 14.83 ZN ZN A 375 D 501 ASP A 55 ASP~? 17.36 O2S EPE A 376 E 367 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 27.68 4.60 19.76 28.15 4.96 20.33 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 45.10 18.98 22.18 44.20 20.57 23.21 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 30 GLY^? 14.83 ZN ZN A 375 D 501 ASP A 352 ASP~? 25.70 ZN ZN A 375 E 367 TYR A 308 TYR^? 13.26 ZN ZN A 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 27.68 4.60 19.76 28.15 4.96 20.33 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 43.66 -0.56 3.32 44.78 0.99 4.29 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 41.62 -12.73 37.70 39.41 -11.19 36.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 34 GLY.? 18.52 C3 EPE A 376 D 501 ASP A 107 ASP~? -2.33 ZN ZN A 375s E 367 TYR B 296 TYR~? 11.48 ZN ZN B 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 28.75 15.24 16.90 28.17 14.75 17.10 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.06 5.94 19.61 2.50 3.84 21.38 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY A 111 GLY.? 12.81 ZN ZN A 375 D 501 ASP A 306 ASP.? 24.91 ZN ZN A 375 E 367 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 40.78 -9.44 18.50 40.17 -9.34 19.07 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY A 112 GLY~? 9.06 ZN ZN A 375 D 501 ASP A 306 ASP.? 24.91 ZN ZN A 375 E 367 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 39.28 -7.29 21.25 39.96 -7.72 21.33 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY A 122 GLY.? 19.60 ZN ZN A 375 D 501 ASP A 281 ASP.? 28.06 ZN ZN A 375 E 367 TYR A 133 TYR^? 12.87 O3 TRS A 378 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 51.97 -15.01 25.49 51.32 -15.01 26.00 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 26.66 -12.84 21.54 25.55 -13.01 18.92 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY A 244 GLY^? 11.92 ZN ZN A 375 D 501 ASP A 306 ASP.? 24.91 ZN ZN A 375 E 367 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 32.51 -13.15 26.46 33.13 -12.90 26.03 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY A 249 GLY^? 18.94 ZN ZN A 375 D 501 ASP A 292 ASP^? 8.63 ZN ZN A 374 E 367 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 44.87 -19.78 28.98 45.04 -19.55 29.74 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 23.23 -33.44 18.32 24.66 -32.16 20.35 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY A 272 GLY.? 18.36 ZN ZN A 374 D 501 ASP A 281 ASP.? 28.06 ZN ZN A 375 E 367 TYR A 18 TYR~? 11.08 ZN ZN A 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 54.23 -1.17 38.61 53.76 -1.27 37.97 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 34.99 -4.02 17.62 37.68 -4.71 17.89 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY A 304 GLY.? 22.37 O3 TRS A 378 D 501 ASP A 107 ASP~? -2.33 ZN ZN A 375s E 367 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 41.24 -23.22 37.09 41.16 -22.48 36.89 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.27 -30.73 51.89 19.47 -30.85 49.23 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY A 304 GLY.? 22.37 O3 TRS A 378 D 501 ASP A 292 ASP^? 8.63 ZN ZN A 374 E 367 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 41.24 -23.22 37.09 41.16 -22.48 36.89 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.27 -30.73 51.89 19.47 -30.85 49.23 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY A 304 GLY.? 22.37 O3 TRS A 378 D 501 ASP A 292 ASP^? 8.63 ZN ZN A 374 E 367 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 41.24 -23.22 37.09 41.16 -22.48 36.89 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 23.23 -33.44 18.32 24.66 -32.16 20.35 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY A 304 GLY.? 22.37 O3 TRS A 378 D 501 ASP A 312 ASP.? 7.50 ZN ZN A 374 E 367 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 41.24 -23.22 37.09 41.16 -22.48 36.89 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 39.49 -1.24 39.18 39.76 0.49 37.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.27 -30.73 51.89 19.47 -30.85 49.23 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY A 325 GLY~? 25.53 ZN ZN A 375 D 501 ASP A 292 ASP^? 8.63 ZN ZN A 374 E 367 TYR C 100 TYR^? 14.49 ZN ZN C 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 43.05 -19.34 46.86 42.56 -18.83 46.33 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.27 -30.73 51.89 19.47 -30.85 49.23 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY A 332 GLY~? 10.15 ZN ZN A 374 D 501 ASP A 281 ASP.? 28.06 ZN ZN A 375 E 367 TYR A 133 TYR^? 12.87 O3 TRS A 378 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 46.00 -1.11 36.47 45.93 -1.81 36.02 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 26.66 -12.84 21.54 25.55 -13.01 18.92 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY B 7 GLY~? 23.15 ZN ZN B 375 D 501 ASP B 55 ASP~? 16.89 O3S EPE B 376 E 367 TYR B 133 TYR^? 17.24 ZN ZN B 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -24.83 -11.10 27.95 -24.79 -11.89 27.82 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -0.70 -9.54 18.25 -1.85 -12.04 17.66 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY B 30 GLY^? 14.63 ZN ZN B 375 D 501 ASP B 55 ASP~? 16.89 O3S EPE B 376 E 367 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -13.71 -6.55 30.41 -13.82 -5.76 30.60 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 19 3 # 19 D 465 GLY B 30 GLY^? 14.63 ZN ZN B 375 D 501 ASP B 352 ASP~? 25.82 ZN ZN B 375 E 367 TYR B 308 TYR^? 13.33 ZN ZN B 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -13.71 -6.55 30.41 -13.82 -5.76 30.60 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 1.32 11.76 14.56 0.84 10.00 16.68 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 20 3 # 20 D 465 GLY B 165 GLY.? 10.94 O1S EPE A 377 D 501 ASP C 237 ASP^? 16.80 O1S EPE A 377 E 367 TYR B 250 TYR^? 23.22 ZN ZN B 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -0.63 -18.46 -0.95 -1.10 -19.11 -0.69 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 0.70 6.87 1.10 3.12 5.62 1.69 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 21 3 # 21 D 465 GLY B 240 GLY^? 14.23 O1S EPE A 377 D 501 ASP B 232 ASP^? 14.54 O2S EPE A 377 E 367 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 22 3 # 22 D 465 GLY B 244 GLY^? 11.85 ZN ZN B 375 D 501 ASP B 306 ASP.? 24.86 ZN ZN B 375 E 367 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -0.61 -2.61 16.62 -1.32 -2.49 16.19 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 3.99 14.73 5.36 5.18 14.04 3.76 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 23 3 # 23 D 465 GLY B 304 GLY.? 23.11 ZN ZN B 375 D 501 ASP B 107 ASP~? -2.23 ZN ZN B 375s E 367 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 8.09 9.00 6.73 7.56 8.93 7.27 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 24 3 # 24 D 465 GLY B 304 GLY.? 23.11 ZN ZN B 375 D 501 ASP B 292 ASP^? 8.88 ZN ZN B 374 E 367 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 8.09 9.00 6.73 7.56 8.93 7.27 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 25 3 # 25 D 465 GLY B 304 GLY.? 23.11 ZN ZN B 375 D 501 ASP B 312 ASP.? 7.53 ZN ZN B 374 E 367 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 8.09 9.00 6.73 7.56 8.93 7.27 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 26 3 # 26 D 465 GLY B 325 GLY~? 25.63 ZN ZN B 375 D 501 ASP B 292 ASP^? 8.88 ZN ZN B 374 E 367 TYR A 100 TYR^? 14.62 ZN ZN A 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 10.15 18.18 11.38 9.73 17.62 11.87 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 31.64 5.60 17.48 30.43 3.13 17.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 27 3 # 27 D 465 GLY C 7 GLY~? 23.11 ZN ZN C 375 D 501 ASP C 55 ASP~? 17.38 O3S EPE C 376 E 367 TYR C 133 TYR^? 16.76 ZN ZN C 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 27.26 -36.33 52.02 27.65 -36.56 51.35 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 8.59 -26.93 36.99 10.82 -27.74 35.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 28 3 # 28 D 465 GLY C 30 GLY^? 14.80 ZN ZN C 375 D 501 ASP C 55 ASP~? 17.38 O3S EPE C 376 E 367 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 20.37 -26.80 49.54 20.07 -26.59 50.27 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 29 3 # 29 D 465 GLY C 30 GLY^? 14.80 ZN ZN C 375 D 501 ASP C 352 ASP~? 25.48 ZN ZN C 375 E 367 TYR C 308 TYR^? 13.34 ZN ZN C 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 20.37 -26.80 49.54 20.07 -26.59 50.27 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 18.63 -50.25 49.90 18.47 -49.69 51.95 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -8.26 -25.36 50.23 -5.59 -24.48 49.71 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 30 3 # 30 D 465 GLY C 34 GLY.? 18.40 C3 EPE C 376 D 501 ASP C 82 ASP.? 10.22 O3S EPE C 376 E 367 TYR A 314 TYR~? 12.17 O8 EPE A 376 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 28.32 -27.49 57.24 28.16 -27.07 56.58 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 23.03 -14.86 74.18 22.44 -14.42 76.16 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 36.88 -2.62 44.67 35.35 -1.67 42.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 31 3 # 31 D 465 GLY C 34 GLY.? 18.40 C3 EPE C 376 D 501 ASP C 107 ASP~? -2.30 ZN ZN C 375s E 367 TYR A 296 TYR~? 11.37 ZN ZN A 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 28.32 -27.49 57.24 28.16 -27.07 56.58 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 34.09 -11.35 35.81 31.97 -10.07 34.54 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 32 3 # 32 D 465 GLY C 122 GLY~? 19.71 ZN ZN C 375 D 501 ASP C 292 ASP^? 8.69 ZN ZN C 374 E 367 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -7.79 -41.59 50.69 -7.69 -40.80 50.48 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.31 -45.81 25.21 0.69 -46.75 24.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 33 3 # 33 D 465 GLY C 165 GLY.? 25.31 N TRS A 378 D 501 ASP C 232 ASP^? 3.77 O2S EPE C 377 E 367 TYR C 296 TYR~? 11.54 ZN ZN C 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 3.00 -41.27 29.42 3.80 -41.57 29.42 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -2.51 -21.77 46.19 0.10 -20.95 45.58 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 34 3 # 34 D 465 GLY C 244 GLY^? 11.70 ZN ZN C 375 D 501 ASP C 306 ASP.? 24.81 ZN ZN C 375 E 367 TYR B 226 TYR.? 21.63 O2S EPE A 377 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 2.79 -27.67 41.30 2.83 -28.37 41.63 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -2.18 -44.73 18.44 0.01 -45.92 17.08 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 35 3 # 35 D 465 GLY C 249 GLY^? 18.92 ZN ZN C 375 D 501 ASP C 292 ASP^? 8.69 ZN ZN C 374 E 367 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -9.08 -35.38 44.08 -9.51 -34.84 44.55 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 36 3 # 36 D 465 GLY C 304 GLY.? 22.89 ZN ZN C 375 D 501 ASP C 107 ASP~? -2.30 ZN ZN C 375s E 367 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -14.35 -27.24 41.90 -13.76 -27.25 42.32 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 37 3 # 37 D 465 GLY C 304 GLY.? 22.89 ZN ZN C 375 D 501 ASP C 292 ASP^? 8.69 ZN ZN C 374 E 367 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -14.35 -27.24 41.90 -13.76 -27.25 42.32 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 38 3 # 38 D 465 GLY C 304 GLY.? 22.89 ZN ZN C 375 D 501 ASP C 292 ASP^? 8.69 ZN ZN C 374 E 367 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -14.35 -27.24 41.90 -13.76 -27.25 42.32 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 39 3 # 39 D 465 GLY C 304 GLY.? 22.89 ZN ZN C 375 D 501 ASP C 312 ASP.? 7.48 ZN ZN C 374 E 367 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -14.35 -27.24 41.90 -13.76 -27.25 42.32 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 40 3 # 40 D 465 GLY C 325 GLY~? 25.60 ZN ZN C 375 D 501 ASP C 292 ASP^? 8.69 ZN ZN C 374 E 367 TYR B 100 TYR^? 14.57 ZN ZN B 375 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -18.52 -20.89 48.72 -17.66 -20.90 48.73 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -17.63 -5.70 28.19 -15.74 -7.29 26.85 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 41 3 # 41 D 465 GLY C 342 GLY~? 13.18 ZN ZN C 375 D 501 ASP C 292 ASP^? 8.69 ZN ZN C 374 E 367 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 7.81 -40.56 53.34 8.53 -40.45 53.72 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.31 -45.81 25.21 0.69 -46.75 24.83 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 41 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 55 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 84 LYS A 110 LYS.? 16.46 O3 TRS A 378 coo 11.09 42.89 24.44 11.32 42.06 22.49 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 4.60 40.33 20.42 7.25 39.50 20.05 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 9.71 44.83 15.47 10.13 41.43 19.93 37.52 -11.39 18.62 36.00 -16.08 14.56 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 55 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 84 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 11.09 42.89 24.44 11.32 42.06 22.49 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 4.60 40.33 20.42 7.25 39.50 20.05 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 9.71 44.83 15.47 10.13 41.43 19.93 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 55 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 84 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 11.09 42.89 24.44 11.32 42.06 22.49 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 4.60 40.33 20.42 7.25 39.50 20.05 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 9.71 44.83 15.47 10.13 41.43 19.93 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP A 237 ASP^? 6.80 N TRS A 378 A 55 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 84 LYS A 138 LYS^? 13.11 N TRS A 378 coo 11.09 42.89 24.44 11.32 42.06 22.49 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 4.60 40.33 20.42 7.25 39.50 20.05 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 9.71 44.83 15.47 10.13 41.43 19.93 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 3 # 5 A 50 ASP A 237 ASP^? 6.80 N TRS A 378 A 55 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 84 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 11.09 42.89 24.44 11.32 42.06 22.49 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 4.60 40.33 20.42 7.25 39.50 20.05 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 9.71 44.83 15.47 10.13 41.43 19.93 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 3 # 6 A 50 ASP A 237 ASP^? 6.80 N TRS A 378 A 55 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 84 LYS C 138 LYS^? 8.30 N TRS A 378 coo 11.09 42.89 24.44 11.32 42.06 22.49 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 4.60 40.33 20.42 7.25 39.50 20.05 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 9.71 44.83 15.47 10.13 41.43 19.93 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 7 3 # 7 A 50 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 55 TYR A 314 TYR~? 12.17 O8 EPE A 376 A 84 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 11.09 42.89 24.44 11.32 42.06 22.49 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 4.60 40.33 20.42 7.25 39.50 20.05 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 9.71 44.83 15.47 10.13 41.43 19.93 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 8 3 # 8 A 50 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 55 TYR A 314 TYR~? 12.17 O8 EPE A 376 A 84 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 11.09 42.89 24.44 11.32 42.06 22.49 39.49 -1.24 39.18 39.76 0.49 37.96 coo 4.60 40.33 20.42 7.25 39.50 20.05 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 9.71 44.83 15.47 10.13 41.43 19.93 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 9 3 # 9 A 50 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 55 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 84 LYS B 110 LYS.? 16.94 ZN ZN B 375 coo 11.09 42.89 24.44 11.32 42.06 22.49 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 4.60 40.33 20.42 7.25 39.50 20.05 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 9.71 44.83 15.47 10.13 41.43 19.93 -8.36 -4.86 12.39 -7.58 -9.04 11.62 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 10 3 # 10 A 50 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 55 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 84 LYS C 138 LYS^? 8.30 N TRS A 378 coo 11.09 42.89 24.44 11.32 42.06 22.49 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 4.60 40.33 20.42 7.25 39.50 20.05 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 9.71 44.83 15.47 10.13 41.43 19.93 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 11 3 # 11 A 50 ASP B 237 ASP^? 15.58 N TRS A 378 A 55 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 84 LYS A 138 LYS^? 13.11 N TRS A 378 coo 11.09 42.89 24.44 11.32 42.06 22.49 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 4.60 40.33 20.42 7.25 39.50 20.05 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 9.71 44.83 15.47 10.13 41.43 19.93 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 12 3 # 12 A 50 ASP B 237 ASP^? 15.58 N TRS A 378 A 55 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 84 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 11.09 42.89 24.44 11.32 42.06 22.49 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 4.60 40.33 20.42 7.25 39.50 20.05 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 9.71 44.83 15.47 10.13 41.43 19.93 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 13 3 # 13 A 50 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 55 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 84 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 11.09 42.89 24.44 11.32 42.06 22.49 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 4.60 40.33 20.42 7.25 39.50 20.05 2.08 17.58 27.10 3.13 18.35 29.60 coo 9.71 44.83 15.47 10.13 41.43 19.93 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 14 3 # 14 A 50 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 55 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 84 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 11.09 42.89 24.44 11.32 42.06 22.49 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 4.60 40.33 20.42 7.25 39.50 20.05 2.08 17.58 27.10 3.13 18.35 29.60 coo 9.71 44.83 15.47 10.13 41.43 19.93 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 15 3 # 15 A 50 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 55 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 84 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 11.09 42.89 24.44 11.32 42.06 22.49 9.35 16.65 21.02 10.22 16.89 22.90 coo 4.60 40.33 20.42 7.25 39.50 20.05 2.08 17.58 27.10 3.13 18.35 29.60 coo 9.71 44.83 15.47 10.13 41.43 19.93 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 16 3 # 16 A 50 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 55 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 84 LYS C 110 LYS.? 19.48 ZN ZN C 375 coo 11.09 42.89 24.44 11.32 42.06 22.49 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 4.60 40.33 20.42 7.25 39.50 20.05 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 9.71 44.83 15.47 10.13 41.43 19.93 5.59 -36.33 42.73 4.93 -41.69 39.22 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 17 3 # 17 A 50 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 55 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 84 LYS A 138 LYS^? 13.11 N TRS A 378 coo 11.09 42.89 24.44 11.32 42.06 22.49 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 4.60 40.33 20.42 7.25 39.50 20.05 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 9.71 44.83 15.47 10.13 41.43 19.93 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 18 3 # 18 A 50 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 55 TYR C 231 TYR^? -4.25 C2 TRS A 378s A 84 LYS C 139 LYS^? 16.11 N TRS A 378 coo 11.09 42.89 24.44 11.32 42.06 22.49 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 4.60 40.33 20.42 7.25 39.50 20.05 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 9.71 44.83 15.47 10.13 41.43 19.93 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 19 3 # 19 A 50 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 55 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 84 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 11.09 42.89 24.44 11.32 42.06 22.49 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 4.60 40.33 20.42 7.25 39.50 20.05 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 9.71 44.83 15.47 10.13 41.43 19.93 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 20 3 # 20 A 50 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 55 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 84 LYS C 138 LYS^? 8.30 N TRS A 378 coo 11.09 42.89 24.44 11.32 42.06 22.49 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 4.60 40.33 20.42 7.25 39.50 20.05 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 9.71 44.83 15.47 10.13 41.43 19.93 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 21 3 # 21 A 50 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 55 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 84 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 11.09 42.89 24.44 11.32 42.06 22.49 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 4.60 40.33 20.42 7.25 39.50 20.05 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 9.71 44.83 15.47 10.13 41.43 19.93 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 22 3 # 22 A 50 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 55 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 84 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo 11.09 42.89 24.44 11.32 42.06 22.49 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 4.60 40.33 20.42 7.25 39.50 20.05 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 9.71 44.83 15.47 10.13 41.43 19.93 -12.73 -23.25 44.05 -17.55 -23.96 45.92 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 23 3 # 23 A 50 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 55 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 84 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 11.09 42.89 24.44 11.32 42.06 22.49 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 4.60 40.33 20.42 7.25 39.50 20.05 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 9.71 44.83 15.47 10.13 41.43 19.93 -2.95 -18.00 48.43 1.84 -13.91 47.77 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 23 hits 1mrq_c02 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 A 217 SER A 12 SER~? 22.68 ZN ZN A 375 A 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 26.66 -3.22 19.04 24.73 2.41 18.30 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 29.97 0.68 9.55 29.00 -0.35 7.61 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 A 217 SER A 16 SER~? 19.64 ZN ZN A 375 A 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 26.66 -3.22 19.04 24.73 2.41 18.30 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 A 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 A 217 SER A 12 SER~? 22.68 ZN ZN A 375 A 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 29.97 0.68 9.55 29.00 -0.35 7.61 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 A 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 A 217 SER A 16 SER~? 19.64 ZN ZN A 375 A 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 A 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 A 217 SER B 12 SER~? 22.72 ZN ZN B 375 A 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 A 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 A 217 SER B 16 SER~? 19.34 ZN ZN B 375 A 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 A 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 217 SER B 12 SER~? 22.72 ZN ZN B 375 A 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 A 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 217 SER B 16 SER~? 19.34 ZN ZN B 375 A 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 A 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 A 217 SER C 16 SER.? 19.22 ZN ZN C 375 A 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 A 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 217 SER C 12 SER~? 21.06 O1 TRS A 378 A 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 A 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 217 SER C 16 SER.? 19.22 ZN ZN C 375 A 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 11 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 B 217 SER A 12 SER~? 22.68 ZN ZN A 375 B 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 26.66 -3.22 19.04 24.73 2.41 18.30 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 29.97 0.68 9.55 29.00 -0.35 7.61 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 B 217 SER A 16 SER~? 19.64 ZN ZN A 375 B 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 26.66 -3.22 19.04 24.73 2.41 18.30 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 31.20 -5.28 11.30 32.92 -4.97 9.64 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 B 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 B 217 SER A 12 SER~? 22.68 ZN ZN A 375 B 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 39.19 -2.77 6.68 35.27 -5.97 7.17 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 29.97 0.68 9.55 29.00 -0.35 7.61 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 B 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 B 217 SER A 16 SER~? 19.64 ZN ZN A 375 B 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 39.19 -2.77 6.68 35.27 -5.97 7.17 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 31.20 -5.28 11.30 32.92 -4.97 9.64 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 B 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 B 217 SER B 12 SER~? 22.72 ZN ZN B 375 B 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 B 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 B 217 SER B 16 SER~? 19.34 ZN ZN B 375 B 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 B 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 B 217 SER B 12 SER~? 22.72 ZN ZN B 375 B 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 B 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 B 217 SER B 16 SER~? 19.34 ZN ZN B 375 B 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 B 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 B 217 SER C 12 SER~? 21.06 O1 TRS A 378 B 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 16.25 -27.94 42.71 21.97 -27.95 45.58 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 22.92 -36.29 44.84 24.16 -36.52 42.80 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 B 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 B 217 SER C 16 SER.? 19.22 ZN ZN C 375 B 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 16.25 -27.94 42.71 21.97 -27.95 45.58 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 17.18 -37.24 41.79 17.35 -39.47 42.79 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 B 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 B 217 SER C 12 SER~? 21.06 O1 TRS A 378 B 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 17.69 -45.38 46.76 16.74 -42.84 42.17 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 22.92 -36.29 44.84 24.16 -36.52 42.80 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 B 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 B 217 SER C 16 SER.? 19.22 ZN ZN C 375 B 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 17.69 -45.38 46.76 16.74 -42.84 42.17 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 17.18 -37.24 41.79 17.35 -39.47 42.79 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 12 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 C 217 SER A 12 SER~? 22.68 ZN ZN A 375 C 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo -12.07 2.83 63.52 -8.95 7.56 61.01 26.66 -3.22 19.04 24.73 2.41 18.30 coo -11.64 10.12 58.62 -9.34 9.31 58.79 29.97 0.68 9.55 29.00 -0.35 7.61 coo -9.31 12.91 61.58 -8.56 11.90 59.50 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 C 217 SER A 16 SER~? 19.64 ZN ZN A 375 C 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo -12.07 2.83 63.52 -8.95 7.56 61.01 26.66 -3.22 19.04 24.73 2.41 18.30 coo -11.64 10.12 58.62 -9.34 9.31 58.79 31.20 -5.28 11.30 32.92 -4.97 9.64 coo -9.31 12.91 61.58 -8.56 11.90 59.50 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 C 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 C 217 SER A 12 SER~? 22.68 ZN ZN A 375 C 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo -12.07 2.83 63.52 -8.95 7.56 61.01 39.19 -2.77 6.68 35.27 -5.97 7.17 coo -11.64 10.12 58.62 -9.34 9.31 58.79 29.97 0.68 9.55 29.00 -0.35 7.61 coo -9.31 12.91 61.58 -8.56 11.90 59.50 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 C 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 C 217 SER A 16 SER~? 19.64 ZN ZN A 375 C 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo -12.07 2.83 63.52 -8.95 7.56 61.01 39.19 -2.77 6.68 35.27 -5.97 7.17 coo -11.64 10.12 58.62 -9.34 9.31 58.79 31.20 -5.28 11.30 32.92 -4.97 9.64 coo -9.31 12.91 61.58 -8.56 11.90 59.50 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 C 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 C 217 SER B 12 SER~? 22.72 ZN ZN B 375 C 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 C 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 C 217 SER B 16 SER~? 19.34 ZN ZN B 375 C 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 C 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 C 217 SER B 12 SER~? 22.72 ZN ZN B 375 C 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 C 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 C 217 SER B 16 SER~? 19.34 ZN ZN B 375 C 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 C 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 C 217 SER C 16 SER.? 19.22 ZN ZN C 375 C 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo -12.07 2.83 63.52 -8.95 7.56 61.01 16.25 -27.94 42.71 21.97 -27.95 45.58 coo -11.64 10.12 58.62 -9.34 9.31 58.79 17.18 -37.24 41.79 17.35 -39.47 42.79 coo -9.31 12.91 61.58 -8.56 11.90 59.50 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 C 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 C 217 SER C 12 SER~? 21.06 O1 TRS A 378 C 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo -12.07 2.83 63.52 -8.95 7.56 61.01 17.69 -45.38 46.76 16.74 -42.84 42.17 coo -11.64 10.12 58.62 -9.34 9.31 58.79 22.92 -36.29 44.84 24.16 -36.52 42.80 coo -9.31 12.91 61.58 -8.56 11.90 59.50 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 C 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 C 217 SER C 16 SER.? 19.22 ZN ZN C 375 C 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo -12.07 2.83 63.52 -8.95 7.56 61.01 17.69 -45.38 46.76 16.74 -42.84 42.17 coo -11.64 10.12 58.62 -9.34 9.31 58.79 17.18 -37.24 41.79 17.35 -39.47 42.79 coo -9.31 12.91 61.58 -8.56 11.90 59.50 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 11 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 D 217 SER A 12 SER~? 22.68 ZN ZN A 375 D 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 32.93 17.78 71.88 30.89 13.50 67.83 26.66 -3.22 19.04 24.73 2.41 18.30 coo 34.38 11.17 66.10 32.18 12.14 65.65 29.97 0.68 9.55 29.00 -0.35 7.61 coo 31.34 7.96 67.74 31.44 9.08 65.62 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 D 217 SER A 16 SER~? 19.64 ZN ZN A 375 D 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 32.93 17.78 71.88 30.89 13.50 67.83 26.66 -3.22 19.04 24.73 2.41 18.30 coo 34.38 11.17 66.10 32.18 12.14 65.65 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 31.34 7.96 67.74 31.44 9.08 65.62 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 D 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 D 217 SER A 12 SER~? 22.68 ZN ZN A 375 D 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 32.93 17.78 71.88 30.89 13.50 67.83 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 34.38 11.17 66.10 32.18 12.14 65.65 29.97 0.68 9.55 29.00 -0.35 7.61 coo 31.34 7.96 67.74 31.44 9.08 65.62 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 D 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 D 217 SER A 16 SER~? 19.64 ZN ZN A 375 D 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 32.93 17.78 71.88 30.89 13.50 67.83 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 34.38 11.17 66.10 32.18 12.14 65.65 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 31.34 7.96 67.74 31.44 9.08 65.62 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 D 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 D 217 SER B 12 SER~? 22.72 ZN ZN B 375 D 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 32.93 17.78 71.88 30.89 13.50 67.83 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 34.38 11.17 66.10 32.18 12.14 65.65 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 31.34 7.96 67.74 31.44 9.08 65.62 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 D 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 D 217 SER B 16 SER~? 19.34 ZN ZN B 375 D 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 32.93 17.78 71.88 30.89 13.50 67.83 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 34.38 11.17 66.10 32.18 12.14 65.65 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 31.34 7.96 67.74 31.44 9.08 65.62 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 D 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 D 217 SER B 12 SER~? 22.72 ZN ZN B 375 D 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 32.93 17.78 71.88 30.89 13.50 67.83 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 34.38 11.17 66.10 32.18 12.14 65.65 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 31.34 7.96 67.74 31.44 9.08 65.62 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 D 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 D 217 SER B 16 SER~? 19.34 ZN ZN B 375 D 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 32.93 17.78 71.88 30.89 13.50 67.83 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 34.38 11.17 66.10 32.18 12.14 65.65 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 31.34 7.96 67.74 31.44 9.08 65.62 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 D 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 D 217 SER C 12 SER~? 21.06 O1 TRS A 378 D 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 32.93 17.78 71.88 30.89 13.50 67.83 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 34.38 11.17 66.10 32.18 12.14 65.65 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 31.34 7.96 67.74 31.44 9.08 65.62 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 D 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 D 217 SER C 16 SER.? 19.22 ZN ZN C 375 D 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 32.93 17.78 71.88 30.89 13.50 67.83 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 34.38 11.17 66.10 32.18 12.14 65.65 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 31.34 7.96 67.74 31.44 9.08 65.62 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 D 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 D 217 SER C 12 SER~? 21.06 O1 TRS A 378 D 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 32.93 17.78 71.88 30.89 13.50 67.83 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 34.38 11.17 66.10 32.18 12.14 65.65 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 31.34 7.96 67.74 31.44 9.08 65.62 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 D 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 D 217 SER C 16 SER.? 19.22 ZN ZN C 375 D 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 32.93 17.78 71.88 30.89 13.50 67.83 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 34.38 11.17 66.10 32.18 12.14 65.65 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 31.34 7.96 67.74 31.44 9.08 65.62 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 12 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 E 217 SER A 12 SER~? 22.68 ZN ZN A 375 E 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 26.66 -3.22 19.04 24.73 2.41 18.30 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 29.97 0.68 9.55 29.00 -0.35 7.61 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 E 217 SER A 16 SER~? 19.64 ZN ZN A 375 E 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 26.66 -3.22 19.04 24.73 2.41 18.30 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 E 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 E 217 SER A 12 SER~? 22.68 ZN ZN A 375 E 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 29.97 0.68 9.55 29.00 -0.35 7.61 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 E 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 E 217 SER A 16 SER~? 19.64 ZN ZN A 375 E 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 E 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 E 217 SER B 12 SER~? 22.72 ZN ZN B 375 E 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 E 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 E 217 SER B 16 SER~? 19.34 ZN ZN B 375 E 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 E 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 E 217 SER B 12 SER~? 22.72 ZN ZN B 375 E 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 E 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 E 217 SER B 16 SER~? 19.34 ZN ZN B 375 E 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 E 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 E 217 SER C 16 SER.? 19.22 ZN ZN C 375 E 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 E 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 E 217 SER C 12 SER~? 21.06 O1 TRS A 378 E 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 E 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 E 217 SER C 16 SER.? 19.22 ZN ZN C 375 E 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 11 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 F 217 SER A 12 SER~? 22.68 ZN ZN A 375 F 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 85.78 13.19 64.96 85.47 13.47 58.63 26.66 -3.22 19.04 24.73 2.41 18.30 coo 87.43 17.13 57.15 85.84 15.39 56.76 29.97 0.68 9.55 29.00 -0.35 7.61 coo 89.69 13.60 54.86 87.60 14.67 54.46 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 F 217 SER A 16 SER~? 19.64 ZN ZN A 375 F 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 85.78 13.19 64.96 85.47 13.47 58.63 26.66 -3.22 19.04 24.73 2.41 18.30 coo 87.43 17.13 57.15 85.84 15.39 56.76 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 89.69 13.60 54.86 87.60 14.67 54.46 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 F 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 F 217 SER A 12 SER~? 22.68 ZN ZN A 375 F 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 85.78 13.19 64.96 85.47 13.47 58.63 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 87.43 17.13 57.15 85.84 15.39 56.76 29.97 0.68 9.55 29.00 -0.35 7.61 coo 89.69 13.60 54.86 87.60 14.67 54.46 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 F 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 F 217 SER A 16 SER~? 19.64 ZN ZN A 375 F 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 85.78 13.19 64.96 85.47 13.47 58.63 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 87.43 17.13 57.15 85.84 15.39 56.76 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 89.69 13.60 54.86 87.60 14.67 54.46 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 F 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 F 217 SER B 12 SER~? 22.72 ZN ZN B 375 F 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 85.78 13.19 64.96 85.47 13.47 58.63 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 87.43 17.13 57.15 85.84 15.39 56.76 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 89.69 13.60 54.86 87.60 14.67 54.46 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 F 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 F 217 SER B 16 SER~? 19.34 ZN ZN B 375 F 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 85.78 13.19 64.96 85.47 13.47 58.63 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 87.43 17.13 57.15 85.84 15.39 56.76 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 89.69 13.60 54.86 87.60 14.67 54.46 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 F 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 F 217 SER B 12 SER~? 22.72 ZN ZN B 375 F 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 85.78 13.19 64.96 85.47 13.47 58.63 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 87.43 17.13 57.15 85.84 15.39 56.76 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 89.69 13.60 54.86 87.60 14.67 54.46 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 F 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 F 217 SER B 16 SER~? 19.34 ZN ZN B 375 F 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 85.78 13.19 64.96 85.47 13.47 58.63 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 87.43 17.13 57.15 85.84 15.39 56.76 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 89.69 13.60 54.86 87.60 14.67 54.46 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 F 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 F 217 SER C 12 SER~? 21.06 O1 TRS A 378 F 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 85.78 13.19 64.96 85.47 13.47 58.63 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 87.43 17.13 57.15 85.84 15.39 56.76 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 89.69 13.60 54.86 87.60 14.67 54.46 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 F 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 F 217 SER C 16 SER.? 19.22 ZN ZN C 375 F 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 85.78 13.19 64.96 85.47 13.47 58.63 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 87.43 17.13 57.15 85.84 15.39 56.76 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 89.69 13.60 54.86 87.60 14.67 54.46 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 F 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 F 217 SER C 12 SER~? 21.06 O1 TRS A 378 F 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 85.78 13.19 64.96 85.47 13.47 58.63 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 87.43 17.13 57.15 85.84 15.39 56.76 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 89.69 13.60 54.86 87.60 14.67 54.46 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 F 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 F 217 SER C 16 SER.? 19.22 ZN ZN C 375 F 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 85.78 13.19 64.96 85.47 13.47 58.63 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 87.43 17.13 57.15 85.84 15.39 56.76 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 89.69 13.60 54.86 87.60 14.67 54.46 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 12 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 G 217 SER A 16 SER~? 19.64 ZN ZN A 375 G 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 26.66 -3.22 19.04 24.73 2.41 18.30 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 G 217 SER A 12 SER~? 22.68 ZN ZN A 375 G 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 29.97 0.68 9.55 29.00 -0.35 7.61 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 G 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 G 217 SER A 16 SER~? 19.64 ZN ZN A 375 G 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 G 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 G 217 SER B 16 SER~? 19.34 ZN ZN B 375 G 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 G 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 G 217 SER B 12 SER~? 22.72 ZN ZN B 375 G 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 G 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 G 217 SER B 16 SER~? 19.34 ZN ZN B 375 G 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 G 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 G 217 SER C 16 SER.? 19.22 ZN ZN C 375 G 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 G 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 G 217 SER C 12 SER~? 21.06 O1 TRS A 378 G 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 G 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 G 217 SER C 16 SER.? 19.22 ZN ZN C 375 G 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 9 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 H 217 SER A 12 SER~? 22.68 ZN ZN A 375 H 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 26.66 -3.22 19.04 24.73 2.41 18.30 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 29.97 0.68 9.55 29.00 -0.35 7.61 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 H 217 SER A 16 SER~? 19.64 ZN ZN A 375 H 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 26.66 -3.22 19.04 24.73 2.41 18.30 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 H 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 H 217 SER A 12 SER~? 22.68 ZN ZN A 375 H 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 29.97 0.68 9.55 29.00 -0.35 7.61 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 H 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 H 217 SER A 16 SER~? 19.64 ZN ZN A 375 H 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 H 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 H 217 SER B 12 SER~? 22.72 ZN ZN B 375 H 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 H 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 H 217 SER B 16 SER~? 19.34 ZN ZN B 375 H 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 H 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 H 217 SER B 12 SER~? 22.72 ZN ZN B 375 H 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 H 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 H 217 SER B 16 SER~? 19.34 ZN ZN B 375 H 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 H 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 H 217 SER C 16 SER.? 19.22 ZN ZN C 375 H 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 H 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 H 217 SER C 12 SER~? 21.06 O1 TRS A 378 H 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 H 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 H 217 SER C 16 SER.? 19.22 ZN ZN C 375 H 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 11 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 I 217 SER A 16 SER~? 19.64 ZN ZN A 375 I 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo -5.05 91.11 27.04 -1.24 87.39 30.21 26.66 -3.22 19.04 24.73 2.41 18.30 coo 2.83 88.63 29.54 1.30 86.82 30.03 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 2.37 88.32 34.25 2.82 86.58 32.61 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 I 217 SER A 12 SER~? 22.68 ZN ZN A 375 I 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo -5.05 91.11 27.04 -1.24 87.39 30.21 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 2.83 88.63 29.54 1.30 86.82 30.03 29.97 0.68 9.55 29.00 -0.35 7.61 coo 2.37 88.32 34.25 2.82 86.58 32.61 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 I 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 I 217 SER A 16 SER~? 19.64 ZN ZN A 375 I 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo -5.05 91.11 27.04 -1.24 87.39 30.21 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 2.83 88.63 29.54 1.30 86.82 30.03 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 2.37 88.32 34.25 2.82 86.58 32.61 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 I 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 I 217 SER B 16 SER~? 19.34 ZN ZN B 375 I 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 2.83 88.63 29.54 1.30 86.82 30.03 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 2.37 88.32 34.25 2.82 86.58 32.61 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 I 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 I 217 SER B 12 SER~? 22.72 ZN ZN B 375 I 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 2.83 88.63 29.54 1.30 86.82 30.03 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 2.37 88.32 34.25 2.82 86.58 32.61 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 I 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 I 217 SER B 16 SER~? 19.34 ZN ZN B 375 I 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 2.83 88.63 29.54 1.30 86.82 30.03 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 2.37 88.32 34.25 2.82 86.58 32.61 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 I 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 I 217 SER C 16 SER.? 19.22 ZN ZN C 375 I 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo -5.05 91.11 27.04 -1.24 87.39 30.21 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 2.83 88.63 29.54 1.30 86.82 30.03 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 2.37 88.32 34.25 2.82 86.58 32.61 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 I 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 I 217 SER C 16 SER.? 19.22 ZN ZN C 375 I 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo -5.05 91.11 27.04 -1.24 87.39 30.21 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 2.83 88.63 29.54 1.30 86.82 30.03 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 2.37 88.32 34.25 2.82 86.58 32.61 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 J 217 SER A 12 SER~? 22.68 ZN ZN A 375 J 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo -16.11 59.78 61.53 -15.92 58.68 55.43 26.66 -3.22 19.04 24.73 2.41 18.30 coo -17.65 54.92 54.17 -15.81 56.46 53.79 29.97 0.68 9.55 29.00 -0.35 7.61 coo -19.92 58.10 51.57 -17.75 57.08 51.34 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 J 217 SER A 16 SER~? 19.64 ZN ZN A 375 J 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo -16.11 59.78 61.53 -15.92 58.68 55.43 26.66 -3.22 19.04 24.73 2.41 18.30 coo -17.65 54.92 54.17 -15.81 56.46 53.79 31.20 -5.28 11.30 32.92 -4.97 9.64 coo -19.92 58.10 51.57 -17.75 57.08 51.34 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 J 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 J 217 SER A 12 SER~? 22.68 ZN ZN A 375 J 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo -16.11 59.78 61.53 -15.92 58.68 55.43 39.19 -2.77 6.68 35.27 -5.97 7.17 coo -17.65 54.92 54.17 -15.81 56.46 53.79 29.97 0.68 9.55 29.00 -0.35 7.61 coo -19.92 58.10 51.57 -17.75 57.08 51.34 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 J 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 J 217 SER A 16 SER~? 19.64 ZN ZN A 375 J 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo -16.11 59.78 61.53 -15.92 58.68 55.43 39.19 -2.77 6.68 35.27 -5.97 7.17 coo -17.65 54.92 54.17 -15.81 56.46 53.79 31.20 -5.28 11.30 32.92 -4.97 9.64 coo -19.92 58.10 51.57 -17.75 57.08 51.34 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 J 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 J 217 SER B 12 SER~? 22.72 ZN ZN B 375 J 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 J 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 J 217 SER B 16 SER~? 19.34 ZN ZN B 375 J 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 J 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 J 217 SER B 12 SER~? 22.72 ZN ZN B 375 J 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 J 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 J 217 SER B 16 SER~? 19.34 ZN ZN B 375 J 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 J 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 J 217 SER C 12 SER~? 21.06 O1 TRS A 378 J 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo -16.11 59.78 61.53 -15.92 58.68 55.43 16.25 -27.94 42.71 21.97 -27.95 45.58 coo -17.65 54.92 54.17 -15.81 56.46 53.79 22.92 -36.29 44.84 24.16 -36.52 42.80 coo -19.92 58.10 51.57 -17.75 57.08 51.34 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 J 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 J 217 SER C 16 SER.? 19.22 ZN ZN C 375 J 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo -16.11 59.78 61.53 -15.92 58.68 55.43 16.25 -27.94 42.71 21.97 -27.95 45.58 coo -17.65 54.92 54.17 -15.81 56.46 53.79 17.18 -37.24 41.79 17.35 -39.47 42.79 coo -19.92 58.10 51.57 -17.75 57.08 51.34 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 J 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 J 217 SER C 12 SER~? 21.06 O1 TRS A 378 J 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo -16.11 59.78 61.53 -15.92 58.68 55.43 17.69 -45.38 46.76 16.74 -42.84 42.17 coo -17.65 54.92 54.17 -15.81 56.46 53.79 22.92 -36.29 44.84 24.16 -36.52 42.80 coo -19.92 58.10 51.57 -17.75 57.08 51.34 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 J 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 J 217 SER C 16 SER.? 19.22 ZN ZN C 375 J 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo -16.11 59.78 61.53 -15.92 58.68 55.43 17.69 -45.38 46.76 16.74 -42.84 42.17 coo -17.65 54.92 54.17 -15.81 56.46 53.79 17.18 -37.24 41.79 17.35 -39.47 42.79 coo -19.92 58.10 51.57 -17.75 57.08 51.34 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 12 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 K 217 SER A 12 SER~? 22.68 ZN ZN A 375 K 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 26.66 -3.22 19.04 24.73 2.41 18.30 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 29.97 0.68 9.55 29.00 -0.35 7.61 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 K 217 SER A 16 SER~? 19.64 ZN ZN A 375 K 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 26.66 -3.22 19.04 24.73 2.41 18.30 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 31.20 -5.28 11.30 32.92 -4.97 9.64 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 K 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 K 217 SER A 12 SER~? 22.68 ZN ZN A 375 K 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 39.19 -2.77 6.68 35.27 -5.97 7.17 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 29.97 0.68 9.55 29.00 -0.35 7.61 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 K 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 K 217 SER A 16 SER~? 19.64 ZN ZN A 375 K 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 39.19 -2.77 6.68 35.27 -5.97 7.17 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 31.20 -5.28 11.30 32.92 -4.97 9.64 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 K 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 K 217 SER B 12 SER~? 22.72 ZN ZN B 375 K 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 K 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 K 217 SER B 16 SER~? 19.34 ZN ZN B 375 K 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 K 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 K 217 SER B 12 SER~? 22.72 ZN ZN B 375 K 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 K 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 K 217 SER B 16 SER~? 19.34 ZN ZN B 375 K 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 K 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 K 217 SER C 16 SER.? 19.22 ZN ZN C 375 K 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 16.25 -27.94 42.71 21.97 -27.95 45.58 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 17.18 -37.24 41.79 17.35 -39.47 42.79 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 K 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 K 217 SER C 12 SER~? 21.06 O1 TRS A 378 K 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 17.69 -45.38 46.76 16.74 -42.84 42.17 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 22.92 -36.29 44.84 24.16 -36.52 42.80 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 K 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 K 217 SER C 16 SER.? 19.22 ZN ZN C 375 K 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 17.69 -45.38 46.76 16.74 -42.84 42.17 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 17.18 -37.24 41.79 17.35 -39.47 42.79 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 11 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 L 217 SER A 12 SER~? 22.68 ZN ZN A 375 L 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 26.66 -3.22 19.04 24.73 2.41 18.30 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 29.97 0.68 9.55 29.00 -0.35 7.61 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 L 217 SER A 16 SER~? 19.64 ZN ZN A 375 L 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 26.66 -3.22 19.04 24.73 2.41 18.30 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 L 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 L 217 SER A 12 SER~? 22.68 ZN ZN A 375 L 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 29.97 0.68 9.55 29.00 -0.35 7.61 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 L 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 L 217 SER A 16 SER~? 19.64 ZN ZN A 375 L 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 L 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 L 217 SER B 12 SER~? 22.72 ZN ZN B 375 L 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 L 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 L 217 SER B 16 SER~? 19.34 ZN ZN B 375 L 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 L 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 L 217 SER B 12 SER~? 22.72 ZN ZN B 375 L 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 L 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 L 217 SER B 16 SER~? 19.34 ZN ZN B 375 L 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 L 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 L 217 SER C 12 SER~? 21.06 O1 TRS A 378 L 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 L 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 L 217 SER C 16 SER.? 19.22 ZN ZN C 375 L 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 L 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 L 217 SER C 12 SER~? 21.06 O1 TRS A 378 L 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 L 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 L 217 SER C 16 SER.? 19.22 ZN ZN C 375 L 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 12 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 M 217 SER A 12 SER~? 22.68 ZN ZN A 375 M 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 57.83 99.61 24.25 54.90 95.14 20.60 26.66 -3.22 19.04 24.73 2.41 18.30 coo 51.07 94.66 21.52 53.18 93.49 22.20 29.97 0.68 9.55 29.00 -0.35 7.61 coo 51.67 94.23 16.93 51.60 92.47 18.57 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 M 217 SER A 16 SER~? 19.64 ZN ZN A 375 M 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 57.83 99.61 24.25 54.90 95.14 20.60 26.66 -3.22 19.04 24.73 2.41 18.30 coo 51.07 94.66 21.52 53.18 93.49 22.20 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 51.67 94.23 16.93 51.60 92.47 18.57 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 M 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 M 217 SER A 12 SER~? 22.68 ZN ZN A 375 M 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 57.83 99.61 24.25 54.90 95.14 20.60 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 51.07 94.66 21.52 53.18 93.49 22.20 29.97 0.68 9.55 29.00 -0.35 7.61 coo 51.67 94.23 16.93 51.60 92.47 18.57 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 M 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 M 217 SER A 16 SER~? 19.64 ZN ZN A 375 M 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 57.83 99.61 24.25 54.90 95.14 20.60 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 51.07 94.66 21.52 53.18 93.49 22.20 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 51.67 94.23 16.93 51.60 92.47 18.57 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 M 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 M 217 SER B 16 SER~? 19.34 ZN ZN B 375 M 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 57.83 99.61 24.25 54.90 95.14 20.60 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 51.07 94.66 21.52 53.18 93.49 22.20 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 51.67 94.23 16.93 51.60 92.47 18.57 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 M 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 M 217 SER B 12 SER~? 22.72 ZN ZN B 375 M 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 57.83 99.61 24.25 54.90 95.14 20.60 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 51.07 94.66 21.52 53.18 93.49 22.20 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 51.67 94.23 16.93 51.60 92.47 18.57 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 M 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 M 217 SER B 16 SER~? 19.34 ZN ZN B 375 M 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 57.83 99.61 24.25 54.90 95.14 20.60 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 51.07 94.66 21.52 53.18 93.49 22.20 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 51.67 94.23 16.93 51.60 92.47 18.57 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 M 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 M 217 SER C 16 SER.? 19.22 ZN ZN C 375 M 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 57.83 99.61 24.25 54.90 95.14 20.60 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 51.07 94.66 21.52 53.18 93.49 22.20 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 51.67 94.23 16.93 51.60 92.47 18.57 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 M 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 M 217 SER C 12 SER~? 21.06 O1 TRS A 378 M 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 57.83 99.61 24.25 54.90 95.14 20.60 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 51.07 94.66 21.52 53.18 93.49 22.20 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 51.67 94.23 16.93 51.60 92.47 18.57 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 M 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 M 217 SER C 16 SER.? 19.22 ZN ZN C 375 M 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 57.83 99.61 24.25 54.90 95.14 20.60 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 51.07 94.66 21.52 53.18 93.49 22.20 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 51.67 94.23 16.93 51.60 92.47 18.57 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 10 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 N 217 SER A 12 SER~? 22.68 ZN ZN A 375 N 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 26.66 -3.22 19.04 24.73 2.41 18.30 coo 81.67 67.31 -0.58 79.53 68.28 0.00 29.97 0.68 9.55 29.00 -0.35 7.61 coo 82.47 71.15 2.07 80.82 69.44 2.28 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 N 217 SER A 16 SER~? 19.64 ZN ZN A 375 N 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 26.66 -3.22 19.04 24.73 2.41 18.30 coo 81.67 67.31 -0.58 79.53 68.28 0.00 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 82.47 71.15 2.07 80.82 69.44 2.28 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 N 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 N 217 SER A 12 SER~? 22.68 ZN ZN A 375 N 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 81.67 67.31 -0.58 79.53 68.28 0.00 29.97 0.68 9.55 29.00 -0.35 7.61 coo 82.47 71.15 2.07 80.82 69.44 2.28 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 N 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 N 217 SER A 16 SER~? 19.64 ZN ZN A 375 N 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 81.67 67.31 -0.58 79.53 68.28 0.00 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 82.47 71.15 2.07 80.82 69.44 2.28 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 N 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 N 217 SER B 12 SER~? 22.72 ZN ZN B 375 N 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 82.47 71.15 2.07 80.82 69.44 2.28 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 N 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 N 217 SER B 16 SER~? 19.34 ZN ZN B 375 N 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 82.47 71.15 2.07 80.82 69.44 2.28 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 N 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 N 217 SER B 12 SER~? 22.72 ZN ZN B 375 N 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 82.47 71.15 2.07 80.82 69.44 2.28 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 N 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 N 217 SER B 16 SER~? 19.34 ZN ZN B 375 N 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 82.47 71.15 2.07 80.82 69.44 2.28 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 N 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 N 217 SER C 12 SER~? 21.06 O1 TRS A 378 N 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 81.67 67.31 -0.58 79.53 68.28 0.00 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 82.47 71.15 2.07 80.82 69.44 2.28 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 N 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 N 217 SER C 16 SER.? 19.22 ZN ZN C 375 N 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 81.67 67.31 -0.58 79.53 68.28 0.00 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 82.47 71.15 2.07 80.82 69.44 2.28 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 N 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 N 217 SER C 12 SER~? 21.06 O1 TRS A 378 N 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 81.67 67.31 -0.58 79.53 68.28 0.00 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 82.47 71.15 2.07 80.82 69.44 2.28 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 N 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 N 217 SER C 16 SER.? 19.22 ZN ZN C 375 N 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 81.67 67.31 -0.58 79.53 68.28 0.00 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 82.47 71.15 2.07 80.82 69.44 2.28 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 12 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 O 217 SER A 16 SER~? 19.64 ZN ZN A 375 O 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 81.67 70.12 58.71 78.82 64.87 57.22 26.66 -3.22 19.04 24.73 2.41 18.30 coo 81.62 62.23 55.05 79.32 62.93 55.20 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 79.39 59.54 58.42 78.72 60.00 56.11 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 O 217 SER A 12 SER~? 22.68 ZN ZN A 375 O 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 81.67 70.12 58.71 78.82 64.87 57.22 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 81.62 62.23 55.05 79.32 62.93 55.20 29.97 0.68 9.55 29.00 -0.35 7.61 coo 79.39 59.54 58.42 78.72 60.00 56.11 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 O 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 O 217 SER A 16 SER~? 19.64 ZN ZN A 375 O 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 81.67 70.12 58.71 78.82 64.87 57.22 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 81.62 62.23 55.05 79.32 62.93 55.20 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 79.39 59.54 58.42 78.72 60.00 56.11 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 O 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 O 217 SER B 16 SER~? 19.34 ZN ZN B 375 O 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 81.67 70.12 58.71 78.82 64.87 57.22 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 81.62 62.23 55.05 79.32 62.93 55.20 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 79.39 59.54 58.42 78.72 60.00 56.11 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 O 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 O 217 SER B 12 SER~? 22.72 ZN ZN B 375 O 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 81.67 70.12 58.71 78.82 64.87 57.22 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 81.62 62.23 55.05 79.32 62.93 55.20 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 79.39 59.54 58.42 78.72 60.00 56.11 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 O 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 O 217 SER B 16 SER~? 19.34 ZN ZN B 375 O 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 81.67 70.12 58.71 78.82 64.87 57.22 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 81.62 62.23 55.05 79.32 62.93 55.20 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 79.39 59.54 58.42 78.72 60.00 56.11 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 O 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 O 217 SER C 16 SER.? 19.22 ZN ZN C 375 O 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 81.67 70.12 58.71 78.82 64.87 57.22 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 81.62 62.23 55.05 79.32 62.93 55.20 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 79.39 59.54 58.42 78.72 60.00 56.11 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 O 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 O 217 SER C 12 SER~? 21.06 O1 TRS A 378 O 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 81.67 70.12 58.71 78.82 64.87 57.22 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 81.62 62.23 55.05 79.32 62.93 55.20 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 79.39 59.54 58.42 78.72 60.00 56.11 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 O 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 O 217 SER C 16 SER.? 19.22 ZN ZN C 375 O 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 81.67 70.12 58.71 78.82 64.87 57.22 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 81.62 62.23 55.05 79.32 62.93 55.20 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 79.39 59.54 58.42 78.72 60.00 56.11 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 9 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 P 217 SER A 12 SER~? 22.68 ZN ZN A 375 P 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 37.29 55.72 69.54 38.73 59.85 65.07 26.66 -3.22 19.04 24.73 2.41 18.30 coo 35.55 61.40 62.96 37.72 60.41 62.66 29.97 0.68 9.55 29.00 -0.35 7.61 coo 38.60 64.77 64.10 38.63 63.28 62.26 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS A 20 LYS~? 16.95 ZN ZN A 375 P 217 SER A 16 SER~? 19.64 ZN ZN A 375 P 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 37.29 55.72 69.54 38.73 59.85 65.07 26.66 -3.22 19.04 24.73 2.41 18.30 coo 35.55 61.40 62.96 37.72 60.41 62.66 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 38.60 64.77 64.10 38.63 63.28 62.26 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 P 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 P 217 SER A 12 SER~? 22.68 ZN ZN A 375 P 241 SER A 16 SER~? 19.64 ZN ZN A 375 coo 37.29 55.72 69.54 38.73 59.85 65.07 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 35.55 61.40 62.96 37.72 60.41 62.66 29.97 0.68 9.55 29.00 -0.35 7.61 coo 38.60 64.77 64.10 38.63 63.28 62.26 31.20 -5.28 11.30 32.92 -4.97 9.64 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 P 142 LYS A 350 LYS~? 21.83 ZN ZN A 375 P 217 SER A 16 SER~? 19.64 ZN ZN A 375 P 241 SER A 12 SER~? 22.68 ZN ZN A 375 coo 37.29 55.72 69.54 38.73 59.85 65.07 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 35.55 61.40 62.96 37.72 60.41 62.66 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 38.60 64.77 64.10 38.63 63.28 62.26 29.97 0.68 9.55 29.00 -0.35 7.61 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 P 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 P 217 SER B 12 SER~? 22.72 ZN ZN B 375 P 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 37.29 55.72 69.54 38.73 59.85 65.07 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 35.55 61.40 62.96 37.72 60.41 62.66 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 38.60 64.77 64.10 38.63 63.28 62.26 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 P 142 LYS B 20 LYS~? 17.56 ZN ZN B 375 P 217 SER B 16 SER~? 19.34 ZN ZN B 375 P 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 37.29 55.72 69.54 38.73 59.85 65.07 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 35.55 61.40 62.96 37.72 60.41 62.66 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 38.60 64.77 64.10 38.63 63.28 62.26 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 P 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 P 217 SER B 12 SER~? 22.72 ZN ZN B 375 P 241 SER B 16 SER~? 19.34 ZN ZN B 375 coo 37.29 55.72 69.54 38.73 59.85 65.07 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 35.55 61.40 62.96 37.72 60.41 62.66 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 38.60 64.77 64.10 38.63 63.28 62.26 -14.13 -12.84 18.48 -16.27 -12.81 17.28 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 P 142 LYS B 350 LYS~? 21.91 ZN ZN B 375 P 217 SER B 16 SER~? 19.34 ZN ZN B 375 P 241 SER B 12 SER~? 22.72 ZN ZN B 375 coo 37.29 55.72 69.54 38.73 59.85 65.07 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 35.55 61.40 62.96 37.72 60.41 62.66 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 38.60 64.77 64.10 38.63 63.28 62.26 -18.37 -13.85 22.96 -18.51 -16.07 23.80 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 P 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 P 217 SER C 12 SER~? 21.06 O1 TRS A 378 P 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 37.29 55.72 69.54 38.73 59.85 65.07 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 35.55 61.40 62.96 37.72 60.41 62.66 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 38.60 64.77 64.10 38.63 63.28 62.26 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 P 142 LYS C 20 LYS~? 17.53 ZN ZN C 375 P 217 SER C 16 SER.? 19.22 ZN ZN C 375 P 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 37.29 55.72 69.54 38.73 59.85 65.07 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 35.55 61.40 62.96 37.72 60.41 62.66 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 38.60 64.77 64.10 38.63 63.28 62.26 22.92 -36.29 44.84 24.16 -36.52 42.80 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 P 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 P 217 SER C 12 SER~? 21.06 O1 TRS A 378 P 241 SER C 16 SER.? 19.22 ZN ZN C 375 coo 37.29 55.72 69.54 38.73 59.85 65.07 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 35.55 61.40 62.96 37.72 60.41 62.66 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 38.60 64.77 64.10 38.63 63.28 62.26 17.18 -37.24 41.79 17.35 -39.47 42.79 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 P 142 LYS C 350 LYS~? 21.45 ZN ZN C 375 P 217 SER C 16 SER.? 19.22 ZN ZN C 375 P 241 SER C 12 SER~? 21.06 O1 TRS A 378 coo 37.29 55.72 69.54 38.73 59.85 65.07 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 35.55 61.40 62.96 37.72 60.41 62.66 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 38.60 64.77 64.10 38.63 63.28 62.26 22.92 -36.29 44.84 24.16 -36.52 42.80 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 12 hits 1mt5_c15 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 169 LYS A 94 LYS~? 16.25 O2S EPE A 376 A 327 GLU A 51 GLU~? 11.89 O2S EPE A 376 coo 20.73 15.53 25.54 22.09 15.64 19.40 36.23 21.81 22.32 41.86 22.67 23.70 coo 24.31 10.25 23.71 29.02 12.05 20.75 33.79 23.90 18.72 34.24 28.62 22.89 coo 21.86 20.40 18.59 22.12 18.33 18.33 41.17 19.74 26.83 40.87 21.56 28.00 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS A 265 LYS~? 22.38 ZN ZN A 374 A 169 LYS A 271 LYS.? 23.00 ZN ZN A 374 A 327 GLU A 262 GLU~? 24.15 ZN ZN A 374 coo 20.73 15.53 25.54 22.09 15.64 19.40 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 24.31 10.25 23.71 29.02 12.05 20.75 56.12 0.48 35.73 59.67 4.01 35.99 coo 21.86 20.40 18.59 22.12 18.33 18.33 59.50 -9.24 37.85 59.47 -7.16 38.33 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS A 354 LYS~? 27.90 ZN ZN A 375 A 169 LYS A 350 LYS~? 21.83 ZN ZN A 375 A 327 GLU A 9 GLU~? 28.50 ZN ZN A 375 coo 20.73 15.53 25.54 22.09 15.64 19.40 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 24.31 10.25 23.71 29.02 12.05 20.75 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 21.86 20.40 18.59 22.12 18.33 18.33 31.54 5.84 4.26 31.09 6.26 2.19 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 4 3 # 4 A 167 LYS B 3 LYS.? 34.82 ZN ZN B 375 A 169 LYS B 355 LYS.? 33.64 ZN ZN B 375 A 327 GLU B 9 GLU~? 28.41 ZN ZN B 375 coo 20.73 15.53 25.54 22.09 15.64 19.40 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo 24.31 10.25 23.71 29.02 12.05 20.75 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo 21.86 20.40 18.59 22.12 18.33 18.33 -25.03 -16.61 24.42 -27.11 -17.15 24.13 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 5 3 # 5 A 167 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 169 LYS B 94 LYS~? 17.44 O2S EPE B 376 A 327 GLU B 51 GLU~? 11.61 O3S EPE B 376 coo 20.73 15.53 25.54 22.09 15.64 19.40 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 24.31 10.25 23.71 29.02 12.05 20.75 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 21.86 20.40 18.59 22.12 18.33 18.33 -25.55 10.19 35.45 -25.80 11.09 37.35 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 6 3 # 6 A 167 LYS B 265 LYS~? 21.91 ZN ZN B 374 A 169 LYS B 271 LYS.? 19.93 ZN ZN B 374 A 327 GLU B 262 GLU~? 24.13 ZN ZN B 374 coo 20.73 15.53 25.54 22.09 15.64 19.40 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 24.31 10.25 23.71 29.02 12.05 20.75 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 21.86 20.40 18.59 22.12 18.33 18.33 -9.48 23.81 6.41 -10.83 24.55 7.88 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 7 3 # 7 A 167 LYS B 354 LYS~? 28.15 ZN ZN B 375 A 169 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 327 GLU B 9 GLU~? 28.41 ZN ZN B 375 coo 20.73 15.53 25.54 22.09 15.64 19.40 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 24.31 10.25 23.71 29.02 12.05 20.75 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 21.86 20.40 18.59 22.12 18.33 18.33 -25.03 -16.61 24.42 -27.11 -17.15 24.13 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 8 3 # 8 A 167 LYS C 3 LYS.? 28.91 O1 TRS A 378 A 169 LYS C 355 LYS.? 32.67 ZN ZN C 375 A 327 GLU C 9 GLU~? 28.11 O1 TRS A 378 coo 20.73 15.53 25.54 22.09 15.64 19.40 30.63 -48.52 50.80 31.26 -43.98 46.49 coo 24.31 10.25 23.71 29.02 12.05 20.75 24.80 -50.74 47.95 22.71 -54.81 46.20 coo 21.86 20.40 18.59 22.12 18.33 18.33 28.74 -39.91 47.06 29.82 -41.70 47.37 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 9 3 # 9 A 167 LYS C 265 LYS~? 21.95 ZN ZN C 374 A 169 LYS C 271 LYS.? 19.51 ZN ZN C 374 A 327 GLU C 262 GLU~? 24.05 ZN ZN C 374 coo 20.73 15.53 25.54 22.09 15.64 19.40 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 24.31 10.25 23.71 29.02 12.05 20.75 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 21.86 20.40 18.59 22.12 18.33 18.33 -15.17 -35.96 63.25 -14.01 -35.31 64.90 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 10 3 # 10 A 167 LYS C 303 LYS~? 17.98 ZN ZN C 375 A 169 LYS C 301 LYS~? 24.63 ZN ZN C 375 A 327 GLU C 127 GLU^? 21.05 ZN ZN C 375 coo 20.73 15.53 25.54 22.09 15.64 19.40 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 24.31 10.25 23.71 29.02 12.05 20.75 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 21.86 20.40 18.59 22.12 18.33 18.33 -6.33 -33.63 38.15 -7.56 -32.26 37.10 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 11 3 # 11 A 167 LYS C 354 LYS~? 23.72 O1 TRS A 378 A 169 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 327 GLU C 9 GLU~? 28.11 O1 TRS A 378 coo 20.73 15.53 25.54 22.09 15.64 19.40 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 24.31 10.25 23.71 29.02 12.05 20.75 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 21.86 20.40 18.59 22.12 18.33 18.33 28.74 -39.91 47.06 29.82 -41.70 47.37 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 11 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 91 LYS~? 15.85 O2S EPE A 376 B 169 LYS A 94 LYS~? 16.25 O2S EPE A 376 B 327 GLU A 51 GLU~? 11.89 O2S EPE A 376 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 36.23 21.81 22.32 41.86 22.67 23.70 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 33.79 23.90 18.72 34.24 28.62 22.89 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 41.17 19.74 26.83 40.87 21.56 28.00 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS A 265 LYS~? 22.38 ZN ZN A 374 B 169 LYS A 271 LYS.? 23.00 ZN ZN A 374 B 327 GLU A 262 GLU~? 24.15 ZN ZN A 374 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 56.12 0.48 35.73 59.67 4.01 35.99 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 59.50 -9.24 37.85 59.47 -7.16 38.33 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS A 354 LYS~? 27.90 ZN ZN A 375 B 169 LYS A 350 LYS~? 21.83 ZN ZN A 375 B 327 GLU A 9 GLU~? 28.50 ZN ZN A 375 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 31.54 5.84 4.26 31.09 6.26 2.19 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 4 3 # 4 B 167 LYS B 3 LYS.? 34.82 ZN ZN B 375 B 169 LYS B 355 LYS.? 33.64 ZN ZN B 375 B 327 GLU B 9 GLU~? 28.41 ZN ZN B 375 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -34.16 -15.88 20.56 -37.36 -15.32 22.01 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -25.03 -16.61 24.42 -27.11 -17.15 24.13 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 5 3 # 5 B 167 LYS B 265 LYS~? 21.91 ZN ZN B 374 B 169 LYS B 271 LYS.? 19.93 ZN ZN B 374 B 327 GLU B 262 GLU~? 24.13 ZN ZN B 374 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -9.48 23.81 6.41 -10.83 24.55 7.88 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 6 3 # 6 B 167 LYS B 354 LYS~? 28.15 ZN ZN B 375 B 169 LYS B 350 LYS~? 21.91 ZN ZN B 375 B 327 GLU B 9 GLU~? 28.41 ZN ZN B 375 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -25.03 -16.61 24.42 -27.11 -17.15 24.13 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 7 3 # 7 B 167 LYS C 3 LYS.? 28.91 O1 TRS A 378 B 169 LYS C 355 LYS.? 32.67 ZN ZN C 375 B 327 GLU C 9 GLU~? 28.11 O1 TRS A 378 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 30.63 -48.52 50.80 31.26 -43.98 46.49 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 24.80 -50.74 47.95 22.71 -54.81 46.20 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 28.74 -39.91 47.06 29.82 -41.70 47.37 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 8 3 # 8 B 167 LYS C 265 LYS~? 21.95 ZN ZN C 374 B 169 LYS C 271 LYS.? 19.51 ZN ZN C 374 B 327 GLU C 262 GLU~? 24.05 ZN ZN C 374 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -15.17 -35.96 63.25 -14.01 -35.31 64.90 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 9 3 # 9 B 167 LYS C 303 LYS~? 17.98 ZN ZN C 375 B 169 LYS C 301 LYS~? 24.63 ZN ZN C 375 B 327 GLU C 127 GLU^? 21.05 ZN ZN C 375 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -6.33 -33.63 38.15 -7.56 -32.26 37.10 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 10 3 # 10 B 167 LYS C 354 LYS~? 23.72 O1 TRS A 378 B 169 LYS C 350 LYS~? 21.45 ZN ZN C 375 B 327 GLU C 9 GLU~? 28.11 O1 TRS A 378 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 28.74 -39.91 47.06 29.82 -41.70 47.37 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 10 hits 1muc_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 197 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 223 ALA A 362 ALA^? 15.97 ZN ZN A 375 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 37.80 0.44 25.56 37.02 -1.29 26.44 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 40.70 8.14 28.73 41.06 6.40 29.84 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 46.25 5.46 17.59 47.00 4.15 17.82 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 197 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 223 ALA A 46 ALA^? 12.15 ZN ZN A 374 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 32.91 0.46 27.63 33.66 0.11 29.56 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 41.72 6.36 22.02 41.31 7.82 22.33 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 197 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 223 ALA A 149 ALA~? 12.22 C7 EPE A 377 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 16.74 -30.68 -5.41 16.48 -32.10 -4.88 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 197 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 223 ALA A 102 ALA.? 9.34 ZN ZN A 375 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 40.60 0.33 34.12 38.69 0.39 33.24 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 40.70 8.14 28.73 41.06 6.40 29.84 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 33.09 1.52 21.68 34.14 1.27 20.64 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 197 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 223 ALA A 46 ALA^? 12.15 ZN ZN A 374 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 40.60 0.33 34.12 38.69 0.39 33.24 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 48.24 5.16 33.58 47.82 3.96 35.30 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 41.72 6.36 22.02 41.31 7.82 22.33 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 197 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 223 ALA A 273 ALA.? 17.12 ZN ZN A 374 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 51.10 6.85 29.91 51.20 5.36 31.38 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 54.82 -1.21 28.36 56.43 0.27 28.67 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 51.72 -3.77 39.72 51.92 -5.01 38.86 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 197 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 223 ALA A 362 ALA^? 15.97 ZN ZN A 375 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 51.10 6.85 29.91 51.20 5.36 31.38 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 54.82 -1.21 28.36 56.43 0.27 28.67 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 46.25 5.46 17.59 47.00 4.15 17.82 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 197 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 223 ALA B 362 ALA^? 16.08 ZN ZN B 375 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -24.59 3.58 19.16 -24.10 3.96 17.83 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 A 114 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 197 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 223 ALA B 109 ALA~? 11.08 ZN ZN B 375 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -7.64 -4.92 16.15 -8.93 -5.45 16.76 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 A 114 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 197 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 223 ALA B 46 ALA^? 12.02 ZN ZN B 374 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -20.28 4.12 23.98 -20.70 4.20 25.49 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 11 3 # 11 A 114 HIS B 169 HIS^? 10.86 O3S EPE A 377 A 197 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 223 ALA B 149 ALA~? 14.00 O3S EPE A 377 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -2.60 -41.23 7.10 -1.27 -41.62 6.49 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 12 3 # 12 A 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 197 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 223 ALA B 102 ALA.? 9.36 ZN ZN B 375 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -13.15 -2.66 25.34 -14.20 -2.84 24.29 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 13 3 # 13 A 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 197 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 223 ALA B 273 ALA.? 17.02 ZN ZN B 374 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -8.43 21.62 15.62 -8.14 20.75 14.42 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 14 3 # 14 A 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 197 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 223 ALA B 46 ALA^? 12.02 ZN ZN B 374 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -20.28 4.12 23.98 -20.70 4.20 25.49 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 15 3 # 15 A 114 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 197 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 223 ALA B 273 ALA.? 17.02 ZN ZN B 374 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -20.57 16.04 20.92 -18.78 16.88 20.21 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -18.05 15.19 12.20 -19.75 16.35 12.84 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -8.43 21.62 15.62 -8.14 20.75 14.42 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 16 3 # 16 A 114 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 197 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 223 ALA B 362 ALA^? 16.08 ZN ZN B 375 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -20.57 16.04 20.92 -18.78 16.88 20.21 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -18.05 15.19 12.20 -19.75 16.35 12.84 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -24.59 3.58 19.16 -24.10 3.96 17.83 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 17 3 # 17 A 114 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 197 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 223 ALA C 362 ALA^? 16.16 ZN ZN C 375 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 12.58 -40.21 60.40 11.32 -40.85 59.95 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 18 3 # 18 A 114 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 197 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 223 ALA C 362 ALA^? 16.16 ZN ZN C 375 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 12.58 -40.21 60.40 11.32 -40.85 59.95 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 19 3 # 19 A 114 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 197 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 223 ALA C 109 ALA~? 11.05 ZN ZN C 375 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 7.53 -33.10 43.39 8.93 -33.54 43.81 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 20 3 # 20 A 114 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 197 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 223 ALA C 46 ALA^? 12.13 ZN ZN C 374 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 13.15 -33.59 59.71 14.10 -32.75 60.59 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 21 3 # 21 A 114 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 197 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 223 ALA C 149 ALA~? 12.95 O8 EPE C 377 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 13.13 -47.52 24.96 14.34 -48.17 26.54 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 19.06 -47.14 27.83 18.62 -49.09 27.08 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 21.04 -46.59 14.02 20.14 -46.59 12.80 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 22 3 # 22 A 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 197 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 223 ALA C 102 ALA.? 9.31 ZN ZN C 375 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 14.49 -29.28 50.81 14.45 -30.75 50.81 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 23 3 # 23 A 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 197 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 223 ALA C 46 ALA^? 12.13 ZN ZN C 374 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 13.15 -33.59 59.71 14.10 -32.75 60.59 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 24 3 # 24 A 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 197 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 223 ALA C 273 ALA.? 16.96 ZN ZN C 374 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -8.76 -28.60 63.60 -9.11 -29.51 62.39 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 25 3 # 25 A 114 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 197 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 223 ALA C 273 ALA.? 16.96 ZN ZN C 374 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 4.16 -33.39 68.22 2.28 -32.65 67.64 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -8.76 -28.60 63.60 -9.11 -29.51 62.39 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 26 3 # 26 A 114 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 197 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 223 ALA C 362 ALA^? 16.16 ZN ZN C 375 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 4.16 -33.39 68.22 2.28 -32.65 67.64 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 12.58 -40.21 60.40 11.32 -40.85 59.95 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 26 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 197 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 223 ALA A 362 ALA^? 15.97 ZN ZN A 375 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 37.80 0.44 25.56 37.02 -1.29 26.44 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 40.70 8.14 28.73 41.06 6.40 29.84 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 46.25 5.46 17.59 47.00 4.15 17.82 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 197 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 223 ALA A 46 ALA^? 12.15 ZN ZN A 374 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 32.91 0.46 27.63 33.66 0.11 29.56 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 41.72 6.36 22.02 41.31 7.82 22.33 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS A 169 HIS^? 11.22 O1S EPE C 377 B 197 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 223 ALA A 149 ALA~? 12.22 C7 EPE A 377 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 16.74 -30.68 -5.41 16.48 -32.10 -4.88 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 197 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 223 ALA A 102 ALA.? 9.34 ZN ZN A 375 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 40.60 0.33 34.12 38.69 0.39 33.24 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 40.70 8.14 28.73 41.06 6.40 29.84 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 33.09 1.52 21.68 34.14 1.27 20.64 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 197 ASP A 368 ASP.? 11.85 ZN ZN A 374 B 223 ALA A 46 ALA^? 12.15 ZN ZN A 374 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 40.60 0.33 34.12 38.69 0.39 33.24 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 48.24 5.16 33.58 47.82 3.96 35.30 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 41.72 6.36 22.02 41.31 7.82 22.33 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS A 366 HIS.? 14.86 ZN ZN A 374 B 197 ASP A 269 ASP.? 18.90 ZN ZN A 374 B 223 ALA A 273 ALA.? 17.12 ZN ZN A 374 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 51.10 6.85 29.91 51.20 5.36 31.38 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 54.82 -1.21 28.36 56.43 0.27 28.67 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 51.72 -3.77 39.72 51.92 -5.01 38.86 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS A 366 HIS.? 14.86 ZN ZN A 374 B 197 ASP A 269 ASP.? 18.90 ZN ZN A 374 B 223 ALA A 362 ALA^? 15.97 ZN ZN A 375 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 51.10 6.85 29.91 51.20 5.36 31.38 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 54.82 -1.21 28.36 56.43 0.27 28.67 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 46.25 5.46 17.59 47.00 4.15 17.82 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 197 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 223 ALA B 362 ALA^? 16.08 ZN ZN B 375 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -24.59 3.58 19.16 -24.10 3.96 17.83 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 B 114 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 197 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 223 ALA B 109 ALA~? 11.08 ZN ZN B 375 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -7.64 -4.92 16.15 -8.93 -5.45 16.76 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 B 114 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 197 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 223 ALA B 46 ALA^? 12.02 ZN ZN B 374 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -20.28 4.12 23.98 -20.70 4.20 25.49 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 11 3 # 11 B 114 HIS B 169 HIS^? 10.86 O3S EPE A 377 B 197 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 223 ALA B 149 ALA~? 14.00 O3S EPE A 377 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -2.60 -41.23 7.10 -1.27 -41.62 6.49 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 12 3 # 12 B 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 197 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 223 ALA B 102 ALA.? 9.36 ZN ZN B 375 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -13.15 -2.66 25.34 -14.20 -2.84 24.29 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 13 3 # 13 B 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 197 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 223 ALA B 273 ALA.? 17.02 ZN ZN B 374 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -8.43 21.62 15.62 -8.14 20.75 14.42 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 14 3 # 14 B 114 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 197 ASP B 368 ASP.? 11.70 ZN ZN B 374 B 223 ALA B 46 ALA^? 12.02 ZN ZN B 374 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -20.28 4.12 23.98 -20.70 4.20 25.49 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 15 3 # 15 B 114 HIS B 366 HIS.? 14.78 ZN ZN B 374 B 197 ASP B 269 ASP.? 18.26 ZN ZN B 374 B 223 ALA B 273 ALA.? 17.02 ZN ZN B 374 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -20.57 16.04 20.92 -18.78 16.88 20.21 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -18.05 15.19 12.20 -19.75 16.35 12.84 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -8.43 21.62 15.62 -8.14 20.75 14.42 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 16 3 # 16 B 114 HIS B 366 HIS.? 14.78 ZN ZN B 374 B 197 ASP B 269 ASP.? 18.26 ZN ZN B 374 B 223 ALA B 362 ALA^? 16.08 ZN ZN B 375 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -20.57 16.04 20.92 -18.78 16.88 20.21 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -18.05 15.19 12.20 -19.75 16.35 12.84 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -24.59 3.58 19.16 -24.10 3.96 17.83 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 17 3 # 17 B 114 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 197 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 223 ALA C 362 ALA^? 16.16 ZN ZN C 375 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 12.58 -40.21 60.40 11.32 -40.85 59.95 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 18 3 # 18 B 114 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 197 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 223 ALA C 362 ALA^? 16.16 ZN ZN C 375 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 12.58 -40.21 60.40 11.32 -40.85 59.95 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 19 3 # 19 B 114 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 197 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 223 ALA C 109 ALA~? 11.05 ZN ZN C 375 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 7.53 -33.10 43.39 8.93 -33.54 43.81 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 20 3 # 20 B 114 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 197 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 223 ALA C 46 ALA^? 12.13 ZN ZN C 374 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 13.15 -33.59 59.71 14.10 -32.75 60.59 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 21 3 # 21 B 114 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 197 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 223 ALA C 149 ALA~? 12.95 O8 EPE C 377 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 13.13 -47.52 24.96 14.34 -48.17 26.54 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 19.06 -47.14 27.83 18.62 -49.09 27.08 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 21.04 -46.59 14.02 20.14 -46.59 12.80 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 22 3 # 22 B 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 197 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 223 ALA C 102 ALA.? 9.31 ZN ZN C 375 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 14.49 -29.28 50.81 14.45 -30.75 50.81 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 23 3 # 23 B 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 197 ASP C 368 ASP.? 11.74 ZN ZN C 374 B 223 ALA C 46 ALA^? 12.13 ZN ZN C 374 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 13.15 -33.59 59.71 14.10 -32.75 60.59 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 24 3 # 24 B 114 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 197 ASP C 368 ASP.? 11.74 ZN ZN C 374 B 223 ALA C 273 ALA.? 16.96 ZN ZN C 374 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -8.76 -28.60 63.60 -9.11 -29.51 62.39 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 25 3 # 25 B 114 HIS C 366 HIS.? 14.85 ZN ZN C 374 B 197 ASP C 269 ASP~? 18.04 ZN ZN C 374 B 223 ALA C 273 ALA.? 16.96 ZN ZN C 374 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 4.16 -33.39 68.22 2.28 -32.65 67.64 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -8.76 -28.60 63.60 -9.11 -29.51 62.39 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 26 3 # 26 B 114 HIS C 366 HIS.? 14.85 ZN ZN C 374 B 197 ASP C 269 ASP~? 18.04 ZN ZN C 374 B 223 ALA C 362 ALA^? 16.16 ZN ZN C 375 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 4.16 -33.39 68.22 2.28 -32.65 67.64 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 12.58 -40.21 60.40 11.32 -40.85 59.95 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 26 hits 1n2t_c03 naa= 3 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 205 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 208 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 104 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 20.72 31.33 73.27 20.15 33.36 73.56 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 17.00 33.82 71.84 16.59 31.98 70.88 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 20.06 38.06 74.21 21.19 36.81 72.96 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 205 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 208 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 104 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 20.72 31.33 73.27 20.15 33.36 73.56 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 17.00 33.82 71.84 16.59 31.98 70.88 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 20.06 38.06 74.21 21.19 36.81 72.96 9.33 -29.64 54.17 7.95 -29.11 52.67 1ndo_c00 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 2 hits 1ndo_c00 naa= 3 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 104 HIS C 68 HIS.? -3.41 ZN ZN C 375s E 205 ASP C 48 ASP.? 7.30 ZN ZN C 374 E 208 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 36.32 11.24 30.83 37.00 13.22 30.81 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 38.79 15.70 26.44 37.66 14.35 27.62 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 34.24 14.63 26.81 34.14 16.25 25.49 9.38 -25.93 57.43 7.35 -26.43 57.48 1ndo_c01 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 1 hits 1ndo_c01 naa= 3 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 C 205 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 208 HIS B 69 HIS.? -3.36 ZN ZN B 374s E 104 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 36.50 67.03 37.59 36.77 66.38 35.61 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 33.45 66.12 34.16 32.13 66.40 35.76 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 38.29 64.94 31.33 38.08 64.16 33.27 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 C 205 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 208 HIS C 69 HIS.? -3.39 ZN ZN C 374s E 104 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 36.50 67.03 37.59 36.77 66.38 35.61 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 33.45 66.12 34.16 32.13 66.40 35.76 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 38.29 64.94 31.33 38.08 64.16 33.27 9.33 -29.64 54.17 7.95 -29.11 52.67 1ndo_c02 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 2 hits 1ndo_c02 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 52 GLU~? 13.77 C2 EPE A 376 B 128 HIS A 366 HIS.? 14.86 ZN ZN A 374 C 263 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 6.12 5.94 82.00 7.16 6.32 83.81 46.63 16.37 27.65 45.50 16.12 29.45 coo 12.51 16.35 80.99 13.16 14.90 82.37 51.10 6.85 29.91 51.20 5.36 31.38 coo 11.58 14.94 93.26 12.25 14.03 91.50 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU A 56 GLU~? 18.18 ZN ZN A 374 B 128 HIS A 366 HIS.? 14.86 ZN ZN A 374 C 263 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 6.12 5.94 82.00 7.16 6.32 83.81 47.24 13.21 19.42 47.19 11.28 20.29 coo 12.51 16.35 80.99 13.16 14.90 82.37 51.10 6.85 29.91 51.20 5.36 31.38 coo 11.58 14.94 93.26 12.25 14.03 91.50 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU B 52 GLU~? 15.59 C2 EPE B 376 B 128 HIS B 366 HIS.? 14.78 ZN ZN B 374 C 263 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 6.12 5.94 82.00 7.16 6.32 83.81 -26.20 13.19 30.44 -25.34 14.95 29.81 coo 12.51 16.35 80.99 13.16 14.90 82.37 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 11.58 14.94 93.26 12.25 14.03 91.50 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 B 59 GLU B 56 GLU~? 18.10 ZN ZN B 374 B 128 HIS B 366 HIS.? 14.78 ZN ZN B 374 C 263 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 6.12 5.94 82.00 7.16 6.32 83.81 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 12.51 16.35 80.99 13.16 14.90 82.37 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 11.58 14.94 93.26 12.25 14.03 91.50 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 B 59 GLU C 52 GLU~? 13.90 C2 EPE C 376 B 128 HIS C 366 HIS.? 14.85 ZN ZN C 374 C 263 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 6.12 5.94 82.00 7.16 6.32 83.81 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 12.51 16.35 80.99 13.16 14.90 82.37 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 11.58 14.94 93.26 12.25 14.03 91.50 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 B 59 GLU C 56 GLU~? 18.45 ZN ZN C 374 B 128 HIS C 366 HIS.? 14.85 ZN ZN C 374 C 263 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 6.12 5.94 82.00 7.16 6.32 83.81 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 12.51 16.35 80.99 13.16 14.90 82.37 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 11.58 14.94 93.26 12.25 14.03 91.50 9.38 -25.93 57.43 7.35 -26.43 57.48 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 6 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 59 GLU A 52 GLU~? 13.77 C2 EPE A 376 D 128 HIS A 366 HIS.? 14.86 ZN ZN A 374 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 37.42 3.90 29.26 38.47 2.36 30.22 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 46.63 16.37 27.65 45.50 16.12 29.45 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 51.10 6.85 29.91 51.20 5.36 31.38 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 59 GLU A 56 GLU~? 18.18 ZN ZN A 374 D 128 HIS A 366 HIS.? 14.86 ZN ZN A 374 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 37.42 3.90 29.26 38.47 2.36 30.22 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 47.24 13.21 19.42 47.19 11.28 20.29 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 51.10 6.85 29.91 51.20 5.36 31.38 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 59 GLU B 52 GLU~? 15.59 C2 EPE B 376 D 128 HIS B 366 HIS.? 14.78 ZN ZN B 374 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -26.20 13.19 30.44 -25.34 14.95 29.81 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -20.57 16.04 20.92 -18.78 16.88 20.21 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 59 GLU B 56 GLU~? 18.10 ZN ZN B 374 D 128 HIS B 366 HIS.? 14.78 ZN ZN B 374 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -20.57 16.04 20.92 -18.78 16.88 20.21 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 A 263 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 59 GLU C 52 GLU~? 13.90 C2 EPE C 376 D 128 HIS C 366 HIS.? 14.85 ZN ZN C 374 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 4.16 -33.39 68.22 2.28 -32.65 67.64 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 A 263 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 59 GLU C 56 GLU~? 18.45 ZN ZN C 374 D 128 HIS C 366 HIS.? 14.85 ZN ZN C 374 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 4.16 -33.39 68.22 2.28 -32.65 67.64 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 6 hits 1ni4_c01 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 20 LYS~? 16.95 ZN ZN A 375 631 LYS A 138 LYS^? 13.11 N TRS A 378 708 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 8.61 33.06 11.15 10.12 29.19 8.82 26.66 -3.22 19.04 24.73 2.41 18.30 coo -11.99 27.40 17.14 -13.60 24.52 11.71 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 18.16 32.86 9.85 16.06 28.20 13.56 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 20 LYS~? 16.95 ZN ZN A 375 631 LYS A 215 LYS~? 16.65 O1S EPE C 377 708 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 8.61 33.06 11.15 10.12 29.19 8.82 26.66 -3.22 19.04 24.73 2.41 18.30 coo -11.99 27.40 17.14 -13.60 24.52 11.71 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 18.16 32.86 9.85 16.06 28.20 13.56 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS A 28 LYS.? 12.48 C7 EPE A 376 631 LYS A 83 LYS~? -5.13 O1S EPE A 376s 708 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 26.87 3.56 26.76 22.81 3.70 30.35 coo -11.99 27.40 17.14 -13.60 24.52 11.71 35.02 22.85 34.66 32.09 22.94 39.08 coo 18.16 32.86 9.85 16.06 28.20 13.56 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS A 110 LYS.? 16.46 O3 TRS A 378 631 LYS A 215 LYS~? 16.65 O1S EPE C 377 708 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 37.52 -11.39 18.62 36.00 -16.08 14.56 coo -11.99 27.40 17.14 -13.60 24.52 11.71 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 18.16 32.86 9.85 16.06 28.20 13.56 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 5 3 # 5 549 LYS A 110 LYS.? 16.46 O3 TRS A 378 631 LYS A 354 LYS~? 27.90 ZN ZN A 375 708 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 37.52 -11.39 18.62 36.00 -16.08 14.56 coo -11.99 27.40 17.14 -13.60 24.52 11.71 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 18.16 32.86 9.85 16.06 28.20 13.56 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 6 3 # 6 549 LYS A 239 LYS^? -7.47 O3 TRS A 378s 631 LYS A 303 LYS~? 13.81 O3 TRS A 378 708 LYS A 138 LYS^? 13.11 N TRS A 378 coo 8.61 33.06 11.15 10.12 29.19 8.82 24.38 -22.19 19.59 20.35 -19.68 21.34 coo -11.99 27.40 17.14 -13.60 24.52 11.71 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 18.16 32.86 9.85 16.06 28.20 13.56 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 7 3 # 7 549 LYS A 247 LYS^? 14.25 ZN ZN A 375 631 LYS A 20 LYS~? 16.95 ZN ZN A 375 708 LYS A 285 LYS^? 20.00 O3 TRS A 378 coo 8.61 33.06 11.15 10.12 29.19 8.82 40.34 -15.07 28.39 38.70 -15.53 23.22 coo -11.99 27.40 17.14 -13.60 24.52 11.71 26.66 -3.22 19.04 24.73 2.41 18.30 coo 18.16 32.86 9.85 16.06 28.20 13.56 47.09 -21.09 34.01 41.69 -24.22 32.75 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 8 3 # 8 549 LYS A 247 LYS^? 14.25 ZN ZN A 375 631 LYS A 28 LYS.? 12.48 C7 EPE A 376 708 LYS A 285 LYS^? 20.00 O3 TRS A 378 coo 8.61 33.06 11.15 10.12 29.19 8.82 40.34 -15.07 28.39 38.70 -15.53 23.22 coo -11.99 27.40 17.14 -13.60 24.52 11.71 26.87 3.56 26.76 22.81 3.70 30.35 coo 18.16 32.86 9.85 16.06 28.20 13.56 47.09 -21.09 34.01 41.69 -24.22 32.75 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 9 3 # 9 549 LYS A 247 LYS^? 14.25 ZN ZN A 375 631 LYS A 278 LYS.? 33.16 ZN ZN A 374 708 LYS A 110 LYS.? 16.46 O3 TRS A 378 coo 8.61 33.06 11.15 10.12 29.19 8.82 40.34 -15.07 28.39 38.70 -15.53 23.22 coo -11.99 27.40 17.14 -13.60 24.52 11.71 52.59 -15.70 47.74 53.19 -20.67 51.64 coo 18.16 32.86 9.85 16.06 28.20 13.56 37.52 -11.39 18.62 36.00 -16.08 14.56 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 10 3 # 10 549 LYS A 247 LYS^? 14.25 ZN ZN A 375 631 LYS A 345 LYS~? 18.67 ZN ZN A 375 708 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 8.61 33.06 11.15 10.12 29.19 8.82 40.34 -15.07 28.39 38.70 -15.53 23.22 coo -11.99 27.40 17.14 -13.60 24.52 11.71 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 18.16 32.86 9.85 16.06 28.20 13.56 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 11 3 # 11 549 LYS A 285 LYS^? 20.00 O3 TRS A 378 631 LYS A 110 LYS.? 16.46 O3 TRS A 378 708 LYS A 282 LYS^? 34.08 ZN ZN A 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 47.09 -21.09 34.01 41.69 -24.22 32.75 coo -11.99 27.40 17.14 -13.60 24.52 11.71 37.52 -11.39 18.62 36.00 -16.08 14.56 coo 18.16 32.86 9.85 16.06 28.20 13.56 53.78 -21.68 41.24 59.13 -25.09 41.65 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 12 3 # 12 549 LYS A 301 LYS~? 24.94 ZN ZN A 375 631 LYS C 38 LYS.? 22.67 C3 EPE C 376 708 LYS A 285 LYS^? 20.00 O3 TRS A 378 coo 8.61 33.06 11.15 10.12 29.19 8.82 39.11 -19.59 40.11 42.80 -21.77 43.38 coo -11.99 27.40 17.14 -13.60 24.52 11.71 32.75 -36.42 54.75 28.25 -34.16 56.85 coo 18.16 32.86 9.85 16.06 28.20 13.56 47.09 -21.09 34.01 41.69 -24.22 32.75 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 13 3 # 13 549 LYS A 303 LYS~? 13.81 O3 TRS A 378 631 LYS C 20 LYS~? 17.53 ZN ZN C 375 708 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 37.93 -22.13 35.45 34.81 -22.43 31.07 coo -11.99 27.40 17.14 -13.60 24.52 11.71 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 18.16 32.86 9.85 16.06 28.20 13.56 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 14 3 # 14 549 LYS A 303 LYS~? 13.81 O3 TRS A 378 631 LYS C 20 LYS~? 17.53 ZN ZN C 375 708 LYS A 285 LYS^? 20.00 O3 TRS A 378 coo 8.61 33.06 11.15 10.12 29.19 8.82 37.93 -22.13 35.45 34.81 -22.43 31.07 coo -11.99 27.40 17.14 -13.60 24.52 11.71 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 18.16 32.86 9.85 16.06 28.20 13.56 47.09 -21.09 34.01 41.69 -24.22 32.75 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 15 3 # 15 549 LYS A 340 LYS~? 12.75 ZN ZN A 374 631 LYS A 87 LYS~? 10.99 O2S EPE A 376 708 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 44.47 1.55 20.70 47.30 5.10 24.27 coo -11.99 27.40 17.14 -13.60 24.52 11.71 35.91 21.93 28.51 38.15 26.57 30.75 coo 18.16 32.86 9.85 16.06 28.20 13.56 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 16 3 # 16 549 LYS A 345 LYS~? 18.67 ZN ZN A 375 631 LYS A 265 LYS~? 22.38 ZN ZN A 374 708 LYS A 350 LYS~? 21.83 ZN ZN A 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 45.56 -1.99 12.81 45.09 -7.18 12.35 coo -11.99 27.40 17.14 -13.60 24.52 11.71 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 18.16 32.86 9.85 16.06 28.20 13.56 39.19 -2.77 6.68 35.27 -5.97 7.17 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 17 3 # 17 549 LYS B 20 LYS~? 17.56 ZN ZN B 375 631 LYS B 138 LYS^? 15.17 O1S EPE A 377 708 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 8.61 33.06 11.15 10.12 29.19 8.82 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -11.99 27.40 17.14 -13.60 24.52 11.71 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 18.16 32.86 9.85 16.06 28.20 13.56 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 18 3 # 18 549 LYS B 20 LYS~? 17.56 ZN ZN B 375 631 LYS B 218 LYS~? 23.26 O3S EPE A 377 708 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 8.61 33.06 11.15 10.12 29.19 8.82 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 18.16 32.86 9.85 16.06 28.20 13.56 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 19 3 # 19 549 LYS B 20 LYS~? 17.56 ZN ZN B 375 631 LYS C 239 LYS^? 16.29 N TRS A 378 708 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 8.61 33.06 11.15 10.12 29.19 8.82 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -11.99 27.40 17.14 -13.60 24.52 11.71 5.15 -29.07 27.87 7.72 -24.69 27.36 coo 18.16 32.86 9.85 16.06 28.20 13.56 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 20 3 # 20 549 LYS B 28 LYS.? 11.75 C7 EPE B 376 631 LYS B 83 LYS~? 4.34 O1S EPE B 376 708 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -20.11 12.86 43.96 -14.92 12.31 47.32 coo 18.16 32.86 9.85 16.06 28.20 13.56 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 21 3 # 21 549 LYS B 110 LYS.? 16.94 ZN ZN B 375 631 LYS B 215 LYS~? 17.38 O3S EPE A 377 708 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 18.16 32.86 9.85 16.06 28.20 13.56 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 22 3 # 22 549 LYS B 110 LYS.? 16.94 ZN ZN B 375 631 LYS B 354 LYS~? 28.15 ZN ZN B 375 708 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 18.16 32.86 9.85 16.06 28.20 13.56 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 23 3 # 23 549 LYS B 239 LYS^? 16.51 O1S EPE A 377 631 LYS B 303 LYS~? 19.29 ZN ZN B 375 708 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 8.61 33.06 11.15 10.12 29.19 8.82 5.23 -14.71 11.35 7.06 -15.38 16.25 coo -11.99 27.40 17.14 -13.60 24.52 11.71 7.99 5.97 9.05 6.92 1.04 11.01 coo 18.16 32.86 9.85 16.06 28.20 13.56 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 24 3 # 24 549 LYS B 247 LYS^? 11.69 ZN ZN B 375 631 LYS B 28 LYS.? 11.75 C7 EPE B 376 708 LYS B 285 LYS^? 22.19 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 18.16 32.86 9.85 16.06 28.20 13.56 1.97 10.60 4.02 5.48 5.38 4.89 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 25 3 # 25 549 LYS B 247 LYS^? 11.69 ZN ZN B 375 631 LYS B 28 LYS.? 11.75 C7 EPE B 376 708 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 18.16 32.86 9.85 16.06 28.20 13.56 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 26 3 # 26 549 LYS B 247 LYS^? 11.69 ZN ZN B 375 631 LYS B 278 LYS.? 31.34 ZN ZN B 374 708 LYS B 110 LYS.? 16.94 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo -11.99 27.40 17.14 -13.60 24.52 11.71 3.65 25.62 8.65 8.47 28.09 9.23 coo 18.16 32.86 9.85 16.06 28.20 13.56 -8.36 -4.86 12.39 -7.58 -9.04 11.62 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 27 3 # 27 549 LYS B 247 LYS^? 11.69 ZN ZN B 375 631 LYS B 345 LYS~? 20.14 ZN ZN B 375 708 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 18.16 32.86 9.85 16.06 28.20 13.56 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 28 3 # 28 549 LYS B 301 LYS~? 25.03 ZN ZN B 375 631 LYS A 20 LYS~? 16.95 ZN ZN A 375 708 LYS B 285 LYS^? 22.19 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 8.36 10.35 11.75 10.05 14.82 9.04 coo -11.99 27.40 17.14 -13.60 24.52 11.71 26.66 -3.22 19.04 24.73 2.41 18.30 coo 18.16 32.86 9.85 16.06 28.20 13.56 1.97 10.60 4.02 5.48 5.38 4.89 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 29 3 # 29 549 LYS B 303 LYS~? 19.29 ZN ZN B 375 631 LYS A 20 LYS~? 16.95 ZN ZN A 375 708 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 7.99 5.97 9.05 6.92 1.04 11.01 coo -11.99 27.40 17.14 -13.60 24.52 11.71 26.66 -3.22 19.04 24.73 2.41 18.30 coo 18.16 32.86 9.85 16.06 28.20 13.56 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 30 3 # 30 549 LYS B 303 LYS~? 19.29 ZN ZN B 375 631 LYS A 20 LYS~? 16.95 ZN ZN A 375 708 LYS B 285 LYS^? 22.19 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 7.99 5.97 9.05 6.92 1.04 11.01 coo -11.99 27.40 17.14 -13.60 24.52 11.71 26.66 -3.22 19.04 24.73 2.41 18.30 coo 18.16 32.86 9.85 16.06 28.20 13.56 1.97 10.60 4.02 5.48 5.38 4.89 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 31 3 # 31 549 LYS B 340 LYS~? 12.84 ZN ZN B 374 631 LYS B 87 LYS~? 9.60 O3S EPE B 376 708 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 18.16 32.86 9.85 16.06 28.20 13.56 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 32 3 # 32 549 LYS B 345 LYS~? 20.14 ZN ZN B 375 631 LYS B 265 LYS~? 21.91 ZN ZN B 374 708 LYS B 350 LYS~? 21.91 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 18.16 32.86 9.85 16.06 28.20 13.56 -22.61 -10.64 13.95 -18.13 -13.35 13.22 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 33 3 # 33 549 LYS B 354 LYS~? 28.15 ZN ZN B 375 631 LYS B 218 LYS~? 23.26 O3S EPE A 377 708 LYS B 3 LYS.? 34.82 ZN ZN B 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 18.16 32.86 9.85 16.06 28.20 13.56 -34.16 -15.88 20.56 -37.36 -15.32 22.01 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 34 3 # 34 549 LYS C 20 LYS~? 17.53 ZN ZN C 375 631 LYS C 139 LYS^? 16.11 N TRS A 378 708 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 8.61 33.06 11.15 10.12 29.19 8.82 16.25 -27.94 42.71 21.97 -27.95 45.58 coo -11.99 27.40 17.14 -13.60 24.52 11.71 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 18.16 32.86 9.85 16.06 28.20 13.56 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 35 3 # 35 549 LYS C 20 LYS~? 17.53 ZN ZN C 375 631 LYS C 218 LYS~? 12.80 O1 TRS A 378 708 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 8.61 33.06 11.15 10.12 29.19 8.82 16.25 -27.94 42.71 21.97 -27.95 45.58 coo -11.99 27.40 17.14 -13.60 24.52 11.71 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 18.16 32.86 9.85 16.06 28.20 13.56 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 36 3 # 36 549 LYS C 28 LYS.? 13.32 C7 EPE C 376 631 LYS C 83 LYS~? -3.65 O2S EPE C 376s 708 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 15.95 -21.05 50.17 18.02 -16.90 49.10 coo -11.99 27.40 17.14 -13.60 24.52 11.71 19.52 -16.87 71.96 18.81 -11.07 69.68 coo 18.16 32.86 9.85 16.06 28.20 13.56 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 37 3 # 37 549 LYS C 110 LYS.? 19.48 ZN ZN C 375 631 LYS C 139 LYS^? 16.11 N TRS A 378 708 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 5.59 -36.33 42.73 4.93 -41.69 39.22 coo -11.99 27.40 17.14 -13.60 24.52 11.71 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 18.16 32.86 9.85 16.06 28.20 13.56 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 38 3 # 38 549 LYS C 110 LYS.? 19.48 ZN ZN C 375 631 LYS C 215 LYS~? 17.39 O1 TRS A 378 708 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 5.59 -36.33 42.73 4.93 -41.69 39.22 coo -11.99 27.40 17.14 -13.60 24.52 11.71 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 18.16 32.86 9.85 16.06 28.20 13.56 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 39 3 # 39 549 LYS C 110 LYS.? 19.48 ZN ZN C 375 631 LYS C 354 LYS~? 23.72 O1 TRS A 378 708 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 5.59 -36.33 42.73 4.93 -41.69 39.22 coo -11.99 27.40 17.14 -13.60 24.52 11.71 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 18.16 32.86 9.85 16.06 28.20 13.56 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 40 3 # 40 549 LYS C 239 LYS^? 16.29 N TRS A 378 631 LYS B 20 LYS~? 17.56 ZN ZN B 375 708 LYS C 138 LYS^? 8.30 N TRS A 378 coo 8.61 33.06 11.15 10.12 29.19 8.82 5.15 -29.07 27.87 7.72 -24.69 27.36 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 18.16 32.86 9.85 16.06 28.20 13.56 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 41 3 # 41 549 LYS C 239 LYS^? 16.29 N TRS A 378 631 LYS C 303 LYS~? 17.98 ZN ZN C 375 708 LYS C 138 LYS^? 8.30 N TRS A 378 coo 8.61 33.06 11.15 10.12 29.19 8.82 5.15 -29.07 27.87 7.72 -24.69 27.36 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 18.16 32.86 9.85 16.06 28.20 13.56 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 42 3 # 42 549 LYS C 247 LYS^? 13.94 ZN ZN C 375 631 LYS C 20 LYS~? 17.53 ZN ZN C 375 708 LYS C 285 LYS^? 22.29 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo -11.99 27.40 17.14 -13.60 24.52 11.71 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 18.16 32.86 9.85 16.06 28.20 13.56 -14.01 -33.36 45.98 -12.46 -31.50 40.58 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 43 3 # 43 549 LYS C 247 LYS^? 13.94 ZN ZN C 375 631 LYS C 28 LYS.? 13.32 C7 EPE C 376 708 LYS C 285 LYS^? 22.29 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo -11.99 27.40 17.14 -13.60 24.52 11.71 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 18.16 32.86 9.85 16.06 28.20 13.56 -14.01 -33.36 45.98 -12.46 -31.50 40.58 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 44 3 # 44 549 LYS C 247 LYS^? 13.94 ZN ZN C 375 631 LYS C 278 LYS.? 30.91 ZN ZN C 374 708 LYS C 110 LYS.? 19.48 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -21.60 -25.17 57.51 -24.75 -21.09 54.19 coo 18.16 32.86 9.85 16.06 28.20 13.56 5.59 -36.33 42.73 4.93 -41.69 39.22 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 45 3 # 45 549 LYS C 247 LYS^? 13.94 ZN ZN C 375 631 LYS C 345 LYS~? 19.35 ZN ZN C 375 708 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo -11.99 27.40 17.14 -13.60 24.52 11.71 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 18.16 32.86 9.85 16.06 28.20 13.56 -11.06 -26.43 40.09 -5.81 -27.52 38.93 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 46 3 # 46 549 LYS C 301 LYS~? 24.63 ZN ZN C 375 631 LYS B 20 LYS~? 17.56 ZN ZN B 375 708 LYS C 285 LYS^? 22.29 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 18.16 32.86 9.85 16.06 28.20 13.56 -14.01 -33.36 45.98 -12.46 -31.50 40.58 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 47 3 # 47 549 LYS C 303 LYS~? 17.98 ZN ZN C 375 631 LYS B 20 LYS~? 17.56 ZN ZN B 375 708 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 18.16 32.86 9.85 16.06 28.20 13.56 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 48 3 # 48 549 LYS C 303 LYS~? 17.98 ZN ZN C 375 631 LYS B 20 LYS~? 17.56 ZN ZN B 375 708 LYS C 285 LYS^? 22.29 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo 18.16 32.86 9.85 16.06 28.20 13.56 -14.01 -33.36 45.98 -12.46 -31.50 40.58 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 49 3 # 49 549 LYS C 303 LYS~? 17.98 ZN ZN C 375 631 LYS B 215 LYS~? 17.38 O3S EPE A 377 708 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 18.16 32.86 9.85 16.06 28.20 13.56 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 50 3 # 50 549 LYS C 303 LYS~? 17.98 ZN ZN C 375 631 LYS B 215 LYS~? 17.38 O3S EPE A 377 708 LYS C 285 LYS^? 22.29 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 18.16 32.86 9.85 16.06 28.20 13.56 -14.01 -33.36 45.98 -12.46 -31.50 40.58 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 51 3 # 51 549 LYS C 340 LYS~? 12.92 ZN ZN C 374 631 LYS C 87 LYS~? 9.86 O3S EPE C 376 708 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -11.99 27.40 17.14 -13.60 24.52 11.71 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 18.16 32.86 9.85 16.06 28.20 13.56 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 52 3 # 52 549 LYS C 345 LYS~? 19.35 ZN ZN C 375 631 LYS C 265 LYS~? 21.95 ZN ZN C 374 708 LYS C 350 LYS~? 21.45 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 11.31 -44.62 52.77 6.74 -46.86 52.89 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 18.16 32.86 9.85 16.06 28.20 13.56 17.69 -45.38 46.76 16.74 -42.84 42.17 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 53 3 # 53 549 LYS C 350 LYS~? 21.45 ZN ZN C 375 631 LYS C 218 LYS~? 12.80 O1 TRS A 378 708 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 8.61 33.06 11.15 10.12 29.19 8.82 17.69 -45.38 46.76 16.74 -42.84 42.17 coo -11.99 27.40 17.14 -13.60 24.52 11.71 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 18.16 32.86 9.85 16.06 28.20 13.56 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 54 3 # 54 549 LYS C 354 LYS~? 23.72 O1 TRS A 378 631 LYS C 154 LYS~? 23.94 C1 TRS A 378 708 LYS C 3 LYS.? 28.91 O1 TRS A 378 coo 8.61 33.06 11.15 10.12 29.19 8.82 23.17 -48.48 45.31 22.31 -43.90 41.08 coo -11.99 27.40 17.14 -13.60 24.52 11.71 18.67 -47.92 22.36 20.33 -51.69 25.99 coo 18.16 32.86 9.85 16.06 28.20 13.56 30.63 -48.52 50.80 31.26 -43.98 46.49 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 54 hits 1nsf_c00 naa= 3 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 1 3 # 1 B 237 HIS A 169 HIS^? 11.22 O1S EPE C 377 B 238 GLY A 157 GLY~? 9.65 O1S EPE C 377 B 287 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo 51.19 11.65 88.44 53.07 12.52 88.13 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 45.40 11.66 89.13 45.79 11.98 88.49 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 48.33 16.15 90.44 50.61 16.80 91.98 25.74 -30.01 4.94 27.86 -30.22 6.82 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 2 3 # 2 B 237 HIS A 169 HIS^? 11.22 O1S EPE C 377 B 238 GLY A 162 GLY.? 4.48 O1S EPE C 377 B 287 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo 51.19 11.65 88.44 53.07 12.52 88.13 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 45.40 11.66 89.13 45.79 11.98 88.49 25.38 -26.08 6.68 25.80 -25.42 6.56 coo 48.33 16.15 90.44 50.61 16.80 91.98 25.74 -30.01 4.94 27.86 -30.22 6.82 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 3 3 # 3 B 237 HIS B 169 HIS^? 10.86 O3S EPE A 377 B 238 GLY B 157 GLY~? 9.55 O3S EPE A 377 B 287 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo 51.19 11.65 88.44 53.07 12.52 88.13 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 45.40 11.66 89.13 45.79 11.98 88.49 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo 48.33 16.15 90.44 50.61 16.80 91.98 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 4 3 # 4 B 237 HIS B 169 HIS^? 10.86 O3S EPE A 377 B 238 GLY B 162 GLY.? 5.31 O3S EPE A 377 B 287 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo 51.19 11.65 88.44 53.07 12.52 88.13 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 45.40 11.66 89.13 45.79 11.98 88.49 -1.71 -25.67 5.15 -2.30 -25.15 5.24 coo 48.33 16.15 90.44 50.61 16.80 91.98 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 5 3 # 5 B 237 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 238 GLY C 157 GLY~? 18.60 O1 TRS A 378 B 287 CYH C 170 CYH^? 22.19 N TRS A 378 coo 51.19 11.65 88.44 53.07 12.52 88.13 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 45.40 11.66 89.13 45.79 11.98 88.49 15.82 -44.70 25.16 16.57 -44.60 25.47 coo 48.33 16.15 90.44 50.61 16.80 91.98 9.66 -43.43 21.72 7.18 -43.27 22.99 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 6 3 # 6 B 237 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 238 GLY C 162 GLY.? 17.81 N TRS A 378 B 287 CYH C 170 CYH^? 22.19 N TRS A 378 coo 51.19 11.65 88.44 53.07 12.52 88.13 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 45.40 11.66 89.13 45.79 11.98 88.49 11.10 -40.67 24.41 11.25 -40.70 25.20 coo 48.33 16.15 90.44 50.61 16.80 91.98 9.66 -43.43 21.72 7.18 -43.27 22.99 1nw9_c02 source 1nw9 CASPASE 9, APOPTOSIS-RELATED CYSTEINE PROTEASE: 6 hits 1nw9_c02 naa= 3 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 A 1 CYH A 92 CYH~? 13.19 C2 EPE A 376 A 903 GLU A 349 GLU~? 21.94 ZN ZN A 375 A 972 LYS A 354 LYS~? 27.90 ZN ZN A 375 coo 88.42 112.53 24.94 87.72 110.88 27.11 34.89 18.67 20.72 35.44 16.35 22.18 coo 61.58 117.15 13.99 62.31 115.51 15.12 44.64 -4.62 8.34 45.23 -6.64 8.63 coo 60.18 107.64 21.53 58.13 110.55 17.14 37.47 -0.90 0.73 32.51 -2.58 1.13 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 A 1 CYH A 92 CYH~? 13.19 C2 EPE A 376 A 903 GLU A 349 GLU~? 21.94 ZN ZN A 375 A 972 LYS A 355 LYS.? 33.47 ZN ZN A 375 coo 88.42 112.53 24.94 87.72 110.88 27.11 34.89 18.67 20.72 35.44 16.35 22.18 coo 61.58 117.15 13.99 62.31 115.51 15.12 44.64 -4.62 8.34 45.23 -6.64 8.63 coo 60.18 107.64 21.53 58.13 110.55 17.14 39.94 1.41 -1.05 41.91 -2.04 -4.52 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 A 1 CYH A 170 CYH^? -4.87 C10 EPE C 377s A 903 GLU A 15 GLU~? 17.23 ZN ZN A 375 A 972 LYS A 350 LYS~? 21.83 ZN ZN A 375 coo 88.42 112.53 24.94 87.72 110.88 27.11 25.74 -30.01 4.94 27.86 -30.22 6.82 coo 61.58 117.15 13.99 62.31 115.51 15.12 29.50 -0.46 14.62 27.65 0.59 14.66 coo 60.18 107.64 21.53 58.13 110.55 17.14 39.19 -2.77 6.68 35.27 -5.97 7.17 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 A 1 CYH B 92 CYH~? 13.05 C2 EPE B 376 A 903 GLU B 349 GLU~? 21.77 ZN ZN B 375 A 972 LYS B 354 LYS~? 28.15 ZN ZN B 375 coo 88.42 112.53 24.94 87.72 110.88 27.11 -25.52 1.51 36.84 -23.55 2.45 35.15 coo 61.58 117.15 13.99 62.31 115.51 15.12 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 60.18 107.64 21.53 58.13 110.55 17.14 -26.24 -16.01 14.73 -23.79 -17.66 13.12 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 5 3 # 5 A 1 CYH B 92 CYH~? 13.05 C2 EPE B 376 A 903 GLU B 349 GLU~? 21.77 ZN ZN B 375 A 972 LYS B 355 LYS.? 33.64 ZN ZN B 375 coo 88.42 112.53 24.94 87.72 110.88 27.11 -25.52 1.51 36.84 -23.55 2.45 35.15 coo 61.58 117.15 13.99 62.31 115.51 15.12 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 60.18 107.64 21.53 58.13 110.55 17.14 -29.99 -15.16 14.74 -32.16 -16.11 9.38 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 6 3 # 6 A 1 CYH C 92 CYH~? 13.12 C2 EPE C 376 A 903 GLU C 349 GLU~? 21.43 ZN ZN C 375 A 972 LYS C 354 LYS~? 23.72 O1 TRS A 378 coo 88.42 112.53 24.94 87.72 110.88 27.11 25.07 -27.93 64.57 22.49 -27.62 63.56 coo 61.58 117.15 13.99 62.31 115.51 15.12 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 60.18 107.64 21.53 58.13 110.55 17.14 23.17 -48.48 45.31 22.31 -43.90 41.08 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 7 3 # 7 A 1 CYH C 92 CYH~? 13.12 C2 EPE C 376 A 903 GLU C 349 GLU~? 21.43 ZN ZN C 375 A 972 LYS C 355 LYS.? 32.67 ZN ZN C 375 coo 88.42 112.53 24.94 87.72 110.88 27.11 25.07 -27.93 64.57 22.49 -27.62 63.56 coo 61.58 117.15 13.99 62.31 115.51 15.12 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 60.18 107.64 21.53 58.13 110.55 17.14 24.80 -50.74 47.95 22.71 -54.81 46.20 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 8 3 # 8 A 1 CYH C 170 CYH^? 22.19 N TRS A 378 A 903 GLU C 119 GLU~? 15.59 ZN ZN C 375 A 972 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 88.42 112.53 24.94 87.72 110.88 27.11 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 61.58 117.15 13.99 62.31 115.51 15.12 -0.72 -41.44 48.78 1.35 -42.03 49.11 coo 60.18 107.64 21.53 58.13 110.55 17.14 -3.51 -32.04 45.03 0.24 -34.55 41.94 1ofd_c02 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 8 hits 1ofd_c02 naa= 3 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 B 1 CYH A 92 CYH~? 13.19 C2 EPE A 376 B 903 GLU A 349 GLU~? 21.94 ZN ZN A 375 B 972 LYS A 110 LYS.? 16.46 O3 TRS A 378 coo 31.47 38.87 24.90 30.94 36.98 26.93 34.89 18.67 20.72 35.44 16.35 22.18 coo 4.13 40.53 14.21 5.06 38.89 15.19 44.64 -4.62 8.34 45.23 -6.64 8.63 coo 4.08 30.40 21.12 1.62 33.28 16.83 37.52 -11.39 18.62 36.00 -16.08 14.56 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 B 1 CYH A 92 CYH~? 13.19 C2 EPE A 376 B 903 GLU A 349 GLU~? 21.94 ZN ZN A 375 B 972 LYS A 354 LYS~? 27.90 ZN ZN A 375 coo 31.47 38.87 24.90 30.94 36.98 26.93 34.89 18.67 20.72 35.44 16.35 22.18 coo 4.13 40.53 14.21 5.06 38.89 15.19 44.64 -4.62 8.34 45.23 -6.64 8.63 coo 4.08 30.40 21.12 1.62 33.28 16.83 37.47 -0.90 0.73 32.51 -2.58 1.13 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 B 1 CYH A 92 CYH~? 13.19 C2 EPE A 376 B 903 GLU A 349 GLU~? 21.94 ZN ZN A 375 B 972 LYS A 355 LYS.? 33.47 ZN ZN A 375 coo 31.47 38.87 24.90 30.94 36.98 26.93 34.89 18.67 20.72 35.44 16.35 22.18 coo 4.13 40.53 14.21 5.06 38.89 15.19 44.64 -4.62 8.34 45.23 -6.64 8.63 coo 4.08 30.40 21.12 1.62 33.28 16.83 39.94 1.41 -1.05 41.91 -2.04 -4.52 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 B 1 CYH A 170 CYH^? -4.87 C10 EPE C 377s B 903 GLU A 15 GLU~? 17.23 ZN ZN A 375 B 972 LYS A 350 LYS~? 21.83 ZN ZN A 375 coo 31.47 38.87 24.90 30.94 36.98 26.93 25.74 -30.01 4.94 27.86 -30.22 6.82 coo 4.13 40.53 14.21 5.06 38.89 15.19 29.50 -0.46 14.62 27.65 0.59 14.66 coo 4.08 30.40 21.12 1.62 33.28 16.83 39.19 -2.77 6.68 35.27 -5.97 7.17 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 5 3 # 5 B 1 CYH B 92 CYH~? 13.05 C2 EPE B 376 B 903 GLU B 349 GLU~? 21.77 ZN ZN B 375 B 972 LYS B 355 LYS.? 33.64 ZN ZN B 375 coo 31.47 38.87 24.90 30.94 36.98 26.93 -25.52 1.51 36.84 -23.55 2.45 35.15 coo 4.13 40.53 14.21 5.06 38.89 15.19 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 4.08 30.40 21.12 1.62 33.28 16.83 -29.99 -15.16 14.74 -32.16 -16.11 9.38 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 6 3 # 6 B 1 CYH C 92 CYH~? 13.12 C2 EPE C 376 B 903 GLU C 349 GLU~? 21.43 ZN ZN C 375 B 972 LYS C 355 LYS.? 32.67 ZN ZN C 375 coo 31.47 38.87 24.90 30.94 36.98 26.93 25.07 -27.93 64.57 22.49 -27.62 63.56 coo 4.13 40.53 14.21 5.06 38.89 15.19 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 4.08 30.40 21.12 1.62 33.28 16.83 24.80 -50.74 47.95 22.71 -54.81 46.20 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 7 3 # 7 B 1 CYH C 170 CYH^? 22.19 N TRS A 378 B 903 GLU C 119 GLU~? 15.59 ZN ZN C 375 B 972 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 31.47 38.87 24.90 30.94 36.98 26.93 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 4.13 40.53 14.21 5.06 38.89 15.19 -0.72 -41.44 48.78 1.35 -42.03 49.11 coo 4.08 30.40 21.12 1.62 33.28 16.83 -3.51 -32.04 45.03 0.24 -34.55 41.94 1ofd_c03 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 7 hits 1ofd_c03 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS A 239 LYS^? -7.47 O3 TRS A 378s A 208 GLN C 213 GLN~? -4.56 O1 TRS A 378s A 209 LYS C 138 LYS^? 8.30 N TRS A 378 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 24.38 -22.19 19.59 20.35 -19.68 21.34 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 20.02 -31.25 25.96 19.87 -29.21 25.35 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 A 175 LYS A 239 LYS^? -7.47 O3 TRS A 378s A 208 GLN C 213 GLN~? -4.56 O1 TRS A 378s A 209 LYS C 215 LYS~? 17.39 O1 TRS A 378 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 24.38 -22.19 19.59 20.35 -19.68 21.34 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 20.02 -31.25 25.96 19.87 -29.21 25.35 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 22.70 -37.10 29.95 20.60 -41.87 33.53 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 A 175 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 208 GLN A 348 GLN~? 22.76 ZN ZN A 375 A 209 LYS A 350 LYS~? 21.83 ZN ZN A 375 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 44.47 1.55 20.70 47.30 5.10 24.27 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 45.30 1.40 7.97 44.85 3.48 7.99 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 39.19 -2.77 6.68 35.27 -5.97 7.17 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 A 175 LYS A 350 LYS~? 21.83 ZN ZN A 375 A 208 GLN A 344 GLN~? 19.01 ZN ZN A 375 A 209 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 45.67 2.52 13.85 47.64 2.01 13.33 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 A 175 LYS A 354 LYS~? 27.90 ZN ZN A 375 A 208 GLN A 348 GLN~? 22.76 ZN ZN A 375 A 209 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 45.30 1.40 7.97 44.85 3.48 7.99 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 A 175 LYS A 355 LYS.? 33.47 ZN ZN A 375 A 208 GLN A 348 GLN~? 22.76 ZN ZN A 375 A 209 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 39.94 1.41 -1.05 41.91 -2.04 -4.52 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 45.30 1.40 7.97 44.85 3.48 7.99 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 A 175 LYS B 239 LYS^? 16.51 O1S EPE A 377 A 208 GLN A 213 GLN~? 14.95 O1S EPE C 377 A 209 LYS A 138 LYS^? 13.11 N TRS A 378 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 16.78 -16.27 7.73 15.34 -16.06 9.27 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 A 175 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 208 GLN B 348 GLN~? 22.96 ZN ZN B 375 A 209 LYS B 350 LYS~? 21.91 ZN ZN B 375 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -22.61 -10.64 13.95 -18.13 -13.35 13.22 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 9 3 # 9 A 175 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 208 GLN B 344 GLN~? 18.67 ZN ZN B 375 A 209 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -24.61 -0.12 16.09 -25.84 1.53 15.46 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 10 3 # 10 A 175 LYS B 354 LYS~? 28.15 ZN ZN B 375 A 208 GLN B 348 GLN~? 22.96 ZN ZN B 375 A 209 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 11 3 # 11 A 175 LYS B 355 LYS.? 33.64 ZN ZN B 375 A 208 GLN B 348 GLN~? 22.96 ZN ZN B 375 A 209 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 12 3 # 12 A 175 LYS C 239 LYS^? 16.29 N TRS A 378 A 208 GLN B 213 GLN~? 15.99 O1S EPE A 377 A 209 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 5.15 -29.07 27.87 7.72 -24.69 27.36 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -2.28 -25.33 18.62 -0.54 -24.65 19.67 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 13 3 # 13 A 175 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 208 GLN C 348 GLN~? 22.89 ZN ZN C 375 A 209 LYS C 350 LYS~? 21.45 ZN ZN C 375 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 17.69 -45.38 46.76 16.74 -42.84 42.17 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 14 3 # 14 A 175 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 208 GLN C 344 GLN~? 18.56 ZN ZN C 375 A 209 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 13.15 -43.20 56.87 12.11 -43.96 58.60 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 15 3 # 15 A 175 LYS C 354 LYS~? 23.72 O1 TRS A 378 A 208 GLN C 348 GLN~? 22.89 ZN ZN C 375 A 209 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 16 3 # 16 A 175 LYS C 355 LYS.? 32.67 ZN ZN C 375 A 208 GLN C 348 GLN~? 22.89 ZN ZN C 375 A 209 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 24.80 -50.74 47.95 22.71 -54.81 46.20 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 11.31 -44.62 52.77 6.74 -46.86 52.89 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 16 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 208 GLN A 213 GLN~? 14.95 O1S EPE C 377 B 209 LYS A 215 LYS~? 16.65 O1S EPE C 377 coo 105.03 46.01 19.55 106.59 42.35 15.55 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 113.93 46.99 13.56 113.37 48.52 14.95 16.78 -16.27 7.73 15.34 -16.06 9.27 coo 115.66 49.12 8.60 111.19 49.52 4.73 21.25 -14.20 2.18 27.53 -14.97 1.13 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS A 218 LYS~? 21.49 C3 EPE A 377 B 208 GLN A 213 GLN~? 14.95 O1S EPE C 377 B 209 LYS A 138 LYS^? 13.11 N TRS A 378 coo 105.03 46.01 19.55 106.59 42.35 15.55 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 113.93 46.99 13.56 113.37 48.52 14.95 16.78 -16.27 7.73 15.34 -16.06 9.27 coo 115.66 49.12 8.60 111.19 49.52 4.73 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 B 175 LYS A 239 LYS^? -7.47 O3 TRS A 378s B 208 GLN C 213 GLN~? -4.56 O1 TRS A 378s B 209 LYS C 138 LYS^? 8.30 N TRS A 378 coo 105.03 46.01 19.55 106.59 42.35 15.55 24.38 -22.19 19.59 20.35 -19.68 21.34 coo 113.93 46.99 13.56 113.37 48.52 14.95 20.02 -31.25 25.96 19.87 -29.21 25.35 coo 115.66 49.12 8.60 111.19 49.52 4.73 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 B 175 LYS A 295 LYS.? 12.61 ZN ZN A 374 B 208 GLN A 299 GLN~? 16.37 O3 TRS A 378 B 209 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 105.03 46.01 19.55 106.59 42.35 15.55 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 113.93 46.99 13.56 113.37 48.52 14.95 33.95 -17.11 35.05 32.58 -18.75 34.74 coo 115.66 49.12 8.60 111.19 49.52 4.73 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 B 175 LYS A 337 LYS~? 14.02 ZN ZN A 374 B 208 GLN A 344 GLN~? 19.01 ZN ZN A 375 B 209 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 45.66 0.76 26.15 51.53 0.58 28.90 coo 113.93 46.99 13.56 113.37 48.52 14.95 45.67 2.52 13.85 47.64 2.01 13.33 coo 115.66 49.12 8.60 111.19 49.52 4.73 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 B 175 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 208 GLN A 348 GLN~? 22.76 ZN ZN A 375 B 209 LYS A 350 LYS~? 21.83 ZN ZN A 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 44.47 1.55 20.70 47.30 5.10 24.27 coo 113.93 46.99 13.56 113.37 48.52 14.95 45.30 1.40 7.97 44.85 3.48 7.99 coo 115.66 49.12 8.60 111.19 49.52 4.73 39.19 -2.77 6.68 35.27 -5.97 7.17 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 B 175 LYS A 350 LYS~? 21.83 ZN ZN A 375 B 208 GLN A 344 GLN~? 19.01 ZN ZN A 375 B 209 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 105.03 46.01 19.55 106.59 42.35 15.55 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 113.93 46.99 13.56 113.37 48.52 14.95 45.67 2.52 13.85 47.64 2.01 13.33 coo 115.66 49.12 8.60 111.19 49.52 4.73 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 B 175 LYS A 354 LYS~? 27.90 ZN ZN A 375 B 208 GLN A 348 GLN~? 22.76 ZN ZN A 375 B 209 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 113.93 46.99 13.56 113.37 48.52 14.95 45.30 1.40 7.97 44.85 3.48 7.99 coo 115.66 49.12 8.60 111.19 49.52 4.73 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 9 3 # 9 B 175 LYS A 355 LYS.? 33.47 ZN ZN A 375 B 208 GLN A 348 GLN~? 22.76 ZN ZN A 375 B 209 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 39.94 1.41 -1.05 41.91 -2.04 -4.52 coo 113.93 46.99 13.56 113.37 48.52 14.95 45.30 1.40 7.97 44.85 3.48 7.99 coo 115.66 49.12 8.60 111.19 49.52 4.73 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 10 3 # 10 B 175 LYS B 110 LYS.? 16.94 ZN ZN B 375 B 208 GLN B 346 GLN~? 13.15 ZN ZN B 375 B 209 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo 113.93 46.99 13.56 113.37 48.52 14.95 -17.50 -3.97 12.92 -15.77 -3.25 13.99 coo 115.66 49.12 8.60 111.19 49.52 4.73 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 11 3 # 11 B 175 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 208 GLN B 213 GLN~? 15.99 O1S EPE A 377 B 209 LYS B 215 LYS~? 17.38 O3S EPE A 377 coo 105.03 46.01 19.55 106.59 42.35 15.55 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 113.93 46.99 13.56 113.37 48.52 14.95 -2.28 -25.33 18.62 -0.54 -24.65 19.67 coo 115.66 49.12 8.60 111.19 49.52 4.73 -9.31 -26.31 16.29 -12.50 -24.00 11.24 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 12 3 # 12 B 175 LYS B 218 LYS~? 23.26 O3S EPE A 377 B 208 GLN B 213 GLN~? 15.99 O1S EPE A 377 B 209 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 105.03 46.01 19.55 106.59 42.35 15.55 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 113.93 46.99 13.56 113.37 48.52 14.95 -2.28 -25.33 18.62 -0.54 -24.65 19.67 coo 115.66 49.12 8.60 111.19 49.52 4.73 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 13 3 # 13 B 175 LYS B 239 LYS^? 16.51 O1S EPE A 377 B 208 GLN A 213 GLN~? 14.95 O1S EPE C 377 B 209 LYS A 138 LYS^? 13.11 N TRS A 378 coo 105.03 46.01 19.55 106.59 42.35 15.55 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 113.93 46.99 13.56 113.37 48.52 14.95 16.78 -16.27 7.73 15.34 -16.06 9.27 coo 115.66 49.12 8.60 111.19 49.52 4.73 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 14 3 # 14 B 175 LYS B 295 LYS.? 11.37 ZN ZN B 375 B 208 GLN B 299 GLN~? 17.46 ZN ZN B 375 B 209 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 4.57 8.76 22.84 2.39 5.01 24.93 coo 113.93 46.99 13.56 113.37 48.52 14.95 6.31 4.03 15.31 7.61 2.36 15.77 coo 115.66 49.12 8.60 111.19 49.52 4.73 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 15 3 # 15 B 175 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 208 GLN B 341 GLN~? 17.79 ZN ZN B 375 B 209 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 113.93 46.99 13.56 113.37 48.52 14.95 -22.50 4.14 12.90 -22.55 5.29 11.05 coo 115.66 49.12 8.60 111.19 49.52 4.73 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 16 3 # 16 B 175 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 208 GLN B 344 GLN~? 18.67 ZN ZN B 375 B 209 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 113.93 46.99 13.56 113.37 48.52 14.95 -24.61 -0.12 16.09 -25.84 1.53 15.46 coo 115.66 49.12 8.60 111.19 49.52 4.73 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 17 3 # 17 B 175 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 208 GLN B 348 GLN~? 22.96 ZN ZN B 375 B 209 LYS B 350 LYS~? 21.91 ZN ZN B 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 113.93 46.99 13.56 113.37 48.52 14.95 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 115.66 49.12 8.60 111.19 49.52 4.73 -22.61 -10.64 13.95 -18.13 -13.35 13.22 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 18 3 # 18 B 175 LYS B 350 LYS~? 21.91 ZN ZN B 375 B 208 GLN B 344 GLN~? 18.67 ZN ZN B 375 B 209 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 105.03 46.01 19.55 106.59 42.35 15.55 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 113.93 46.99 13.56 113.37 48.52 14.95 -24.61 -0.12 16.09 -25.84 1.53 15.46 coo 115.66 49.12 8.60 111.19 49.52 4.73 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 19 3 # 19 B 175 LYS B 354 LYS~? 28.15 ZN ZN B 375 B 208 GLN B 348 GLN~? 22.96 ZN ZN B 375 B 209 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 113.93 46.99 13.56 113.37 48.52 14.95 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 115.66 49.12 8.60 111.19 49.52 4.73 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 20 3 # 20 B 175 LYS B 355 LYS.? 33.64 ZN ZN B 375 B 208 GLN B 348 GLN~? 22.96 ZN ZN B 375 B 209 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo 113.93 46.99 13.56 113.37 48.52 14.95 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 115.66 49.12 8.60 111.19 49.52 4.73 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 21 3 # 21 B 175 LYS C 110 LYS.? 19.48 ZN ZN C 375 B 208 GLN C 346 GLN~? 13.37 ZN ZN C 375 B 209 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 5.59 -36.33 42.73 4.93 -41.69 39.22 coo 113.93 46.99 13.56 113.37 48.52 14.95 10.15 -41.70 48.35 9.41 -39.67 48.22 coo 115.66 49.12 8.60 111.19 49.52 4.73 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 22 3 # 22 B 175 LYS C 139 LYS^? 16.11 N TRS A 378 B 208 GLN C 213 GLN~? -4.56 O1 TRS A 378s B 209 LYS C 215 LYS~? 17.39 O1 TRS A 378 coo 105.03 46.01 19.55 106.59 42.35 15.55 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 113.93 46.99 13.56 113.37 48.52 14.95 20.02 -31.25 25.96 19.87 -29.21 25.35 coo 115.66 49.12 8.60 111.19 49.52 4.73 22.70 -37.10 29.95 20.60 -41.87 33.53 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 23 3 # 23 B 175 LYS C 218 LYS~? 12.80 O1 TRS A 378 B 208 GLN C 213 GLN~? -4.56 O1 TRS A 378s B 209 LYS C 138 LYS^? 8.30 N TRS A 378 coo 105.03 46.01 19.55 106.59 42.35 15.55 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 113.93 46.99 13.56 113.37 48.52 14.95 20.02 -31.25 25.96 19.87 -29.21 25.35 coo 115.66 49.12 8.60 111.19 49.52 4.73 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 24 3 # 24 B 175 LYS C 239 LYS^? 16.29 N TRS A 378 B 208 GLN B 213 GLN~? 15.99 O1S EPE A 377 B 209 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 105.03 46.01 19.55 106.59 42.35 15.55 5.15 -29.07 27.87 7.72 -24.69 27.36 coo 113.93 46.99 13.56 113.37 48.52 14.95 -2.28 -25.33 18.62 -0.54 -24.65 19.67 coo 115.66 49.12 8.60 111.19 49.52 4.73 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 25 3 # 25 B 175 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 208 GLN C 299 GLN~? 18.18 ZN ZN C 375 B 209 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 113.93 46.99 13.56 113.37 48.52 14.95 -5.59 -23.33 41.58 -5.78 -22.85 39.46 coo 115.66 49.12 8.60 111.19 49.52 4.73 -11.06 -26.43 40.09 -5.81 -27.52 38.93 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 26 3 # 26 B 175 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 208 GLN C 344 GLN~? 18.56 ZN ZN C 375 B 209 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 113.93 46.99 13.56 113.37 48.52 14.95 13.15 -43.20 56.87 12.11 -43.96 58.60 coo 115.66 49.12 8.60 111.19 49.52 4.73 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 27 3 # 27 B 175 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 208 GLN C 348 GLN~? 22.89 ZN ZN C 375 B 209 LYS C 350 LYS~? 21.45 ZN ZN C 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 113.93 46.99 13.56 113.37 48.52 14.95 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 115.66 49.12 8.60 111.19 49.52 4.73 17.69 -45.38 46.76 16.74 -42.84 42.17 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 28 3 # 28 B 175 LYS C 350 LYS~? 21.45 ZN ZN C 375 B 208 GLN C 344 GLN~? 18.56 ZN ZN C 375 B 209 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 105.03 46.01 19.55 106.59 42.35 15.55 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 113.93 46.99 13.56 113.37 48.52 14.95 13.15 -43.20 56.87 12.11 -43.96 58.60 coo 115.66 49.12 8.60 111.19 49.52 4.73 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 29 3 # 29 B 175 LYS C 354 LYS~? 23.72 O1 TRS A 378 B 208 GLN C 348 GLN~? 22.89 ZN ZN C 375 B 209 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 113.93 46.99 13.56 113.37 48.52 14.95 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 115.66 49.12 8.60 111.19 49.52 4.73 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 30 3 # 30 B 175 LYS C 355 LYS.? 32.67 ZN ZN C 375 B 208 GLN C 348 GLN~? 22.89 ZN ZN C 375 B 209 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 105.03 46.01 19.55 106.59 42.35 15.55 24.80 -50.74 47.95 22.71 -54.81 46.20 coo 113.93 46.99 13.56 113.37 48.52 14.95 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 115.66 49.12 8.60 111.19 49.52 4.73 11.31 -44.62 52.77 6.74 -46.86 52.89 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 30 hits 1ohh_c07 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS A 354 LYS~? 27.90 ZN ZN A 375 C 208 GLN A 348 GLN~? 22.76 ZN ZN A 375 C 209 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 100.54 -2.78 25.52 103.29 2.02 24.05 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 45.30 1.40 7.97 44.85 3.48 7.99 coo 113.62 1.19 33.65 109.52 3.92 36.47 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 C 175 LYS A 355 LYS.? 33.47 ZN ZN A 375 C 208 GLN A 348 GLN~? 22.76 ZN ZN A 375 C 209 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 100.54 -2.78 25.52 103.29 2.02 24.05 39.94 1.41 -1.05 41.91 -2.04 -4.52 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 45.30 1.40 7.97 44.85 3.48 7.99 coo 113.62 1.19 33.65 109.52 3.92 36.47 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 C 175 LYS B 354 LYS~? 28.15 ZN ZN B 375 C 208 GLN B 348 GLN~? 22.96 ZN ZN B 375 C 209 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 113.62 1.19 33.65 109.52 3.92 36.47 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 C 175 LYS B 355 LYS.? 33.64 ZN ZN B 375 C 208 GLN B 348 GLN~? 22.96 ZN ZN B 375 C 209 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 113.62 1.19 33.65 109.52 3.92 36.47 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 C 175 LYS C 354 LYS~? 23.72 O1 TRS A 378 C 208 GLN C 348 GLN~? 22.89 ZN ZN C 375 C 209 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 100.54 -2.78 25.52 103.29 2.02 24.05 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 113.62 1.19 33.65 109.52 3.92 36.47 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 C 175 LYS C 355 LYS.? 32.67 ZN ZN C 375 C 208 GLN C 348 GLN~? 22.89 ZN ZN C 375 C 209 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 100.54 -2.78 25.52 103.29 2.02 24.05 24.80 -50.74 47.95 22.71 -54.81 46.20 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 113.62 1.19 33.65 109.52 3.92 36.47 11.31 -44.62 52.77 6.74 -46.86 52.89 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 6 hits 1ohh_c08 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 146 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 177 LYS A 301 LYS~? 24.94 ZN ZN A 375 coo -3.50 124.89 25.05 -2.25 124.77 23.26 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 1.87 119.38 16.45 1.41 122.11 16.84 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -2.59 124.07 12.67 -0.91 126.17 18.42 39.11 -19.59 40.11 42.80 -21.77 43.38 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 146 TYR A 314 TYR~? 12.17 O8 EPE A 376 A 177 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -3.50 124.89 25.05 -2.25 124.77 23.26 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 1.87 119.38 16.45 1.41 122.11 16.84 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -2.59 124.07 12.67 -0.91 126.17 18.42 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 146 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 177 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo -3.50 124.89 25.05 -2.25 124.77 23.26 9.35 16.65 21.02 10.22 16.89 22.90 coo 1.87 119.38 16.45 1.41 122.11 16.84 1.32 11.76 14.56 0.84 10.00 16.68 coo -2.59 124.07 12.67 -0.91 126.17 18.42 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 146 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 177 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 1.87 119.38 16.45 1.41 122.11 16.84 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -12.73 -23.25 44.05 -17.55 -23.96 45.92 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 146 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 177 LYS A 301 LYS~? 24.94 ZN ZN A 375 coo -7.43 109.06 51.23 -5.84 110.54 50.86 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 0.22 114.56 44.62 -0.76 115.18 47.18 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -4.18 120.17 46.85 -4.02 115.31 51.00 39.11 -19.59 40.11 42.80 -21.77 43.38 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 146 TYR A 314 TYR~? 12.17 O8 EPE A 376 B 177 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -7.43 109.06 51.23 -5.84 110.54 50.86 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 0.22 114.56 44.62 -0.76 115.18 47.18 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -4.18 120.17 46.85 -4.02 115.31 51.00 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 146 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 177 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo -7.43 109.06 51.23 -5.84 110.54 50.86 9.35 16.65 21.02 10.22 16.89 22.90 coo 0.22 114.56 44.62 -0.76 115.18 47.18 1.32 11.76 14.56 0.84 10.00 16.68 coo -4.18 120.17 46.85 -4.02 115.31 51.00 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 146 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 177 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -12.73 -23.25 44.05 -17.55 -23.96 45.92 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 320 ASP~? -21.81 ZN ZN A 374s C 146 TYR A 308 TYR^? 13.26 ZN ZN A 375 C 177 LYS A 301 LYS~? 24.94 ZN ZN A 375 coo -13.49 79.65 43.90 -12.13 80.29 45.45 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -5.65 86.78 48.49 -7.16 84.72 49.65 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -11.22 87.18 53.49 -10.94 81.64 50.31 39.11 -19.59 40.11 42.80 -21.77 43.38 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 330 ASP^? 12.08 ZN ZN A 374 C 146 TYR A 314 TYR~? 12.17 O8 EPE A 376 C 177 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -13.49 79.65 43.90 -12.13 80.29 45.45 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -5.65 86.78 48.49 -7.16 84.72 49.65 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -11.22 87.18 53.49 -10.94 81.64 50.31 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP B 320 ASP~? -21.78 ZN ZN B 374s C 146 TYR B 308 TYR^? 13.33 ZN ZN B 375 C 177 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo -13.49 79.65 43.90 -12.13 80.29 45.45 9.35 16.65 21.02 10.22 16.89 22.90 coo -5.65 86.78 48.49 -7.16 84.72 49.65 1.32 11.76 14.56 0.84 10.00 16.68 coo -11.22 87.18 53.49 -10.94 81.64 50.31 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP C 320 ASP~? -21.75 ZN ZN C 374s C 146 TYR C 308 TYR^? 13.34 ZN ZN C 375 C 177 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -12.73 -23.25 44.05 -17.55 -23.96 45.92 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 320 ASP~? -21.81 ZN ZN A 374s D 146 TYR A 308 TYR^? 13.26 ZN ZN A 375 D 177 LYS A 301 LYS~? 24.94 ZN ZN A 375 coo -13.44 77.36 13.12 -12.53 75.97 14.48 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -7.85 74.44 22.75 -9.22 72.86 20.89 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -14.24 70.61 23.48 -12.55 71.73 17.42 39.11 -19.59 40.11 42.80 -21.77 43.38 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 330 ASP^? 12.08 ZN ZN A 374 D 146 TYR A 314 TYR~? 12.17 O8 EPE A 376 D 177 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -13.44 77.36 13.12 -12.53 75.97 14.48 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -7.85 74.44 22.75 -9.22 72.86 20.89 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -14.24 70.61 23.48 -12.55 71.73 17.42 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP B 320 ASP~? -21.78 ZN ZN B 374s D 146 TYR B 308 TYR^? 13.33 ZN ZN B 375 D 177 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo -13.44 77.36 13.12 -12.53 75.97 14.48 9.35 16.65 21.02 10.22 16.89 22.90 coo -7.85 74.44 22.75 -9.22 72.86 20.89 1.32 11.76 14.56 0.84 10.00 16.68 coo -14.24 70.61 23.48 -12.55 71.73 17.42 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP C 320 ASP~? -21.75 ZN ZN C 374s D 146 TYR C 308 TYR^? 13.34 ZN ZN C 375 D 177 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -12.73 -23.25 44.05 -17.55 -23.96 45.92 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 320 ASP~? -21.81 ZN ZN A 374s E 146 TYR A 308 TYR^? 13.26 ZN ZN A 375 E 177 LYS A 301 LYS~? 24.94 ZN ZN A 375 coo -7.12 105.25 1.43 -6.30 103.34 0.77 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -3.11 94.55 3.01 -3.83 95.92 0.66 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 39.11 -19.59 40.11 42.80 -21.77 43.38 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 330 ASP^? 12.08 ZN ZN A 374 E 146 TYR A 314 TYR~? 12.17 O8 EPE A 376 E 177 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -7.12 105.25 1.43 -6.30 103.34 0.77 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -3.11 94.55 3.01 -3.83 95.92 0.66 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP B 320 ASP~? -21.78 ZN ZN B 374s E 146 TYR B 308 TYR^? 13.33 ZN ZN B 375 E 177 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo -7.12 105.25 1.43 -6.30 103.34 0.77 9.35 16.65 21.02 10.22 16.89 22.90 coo -3.11 94.55 3.01 -3.83 95.92 0.66 1.32 11.76 14.56 0.84 10.00 16.68 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP C 320 ASP~? -21.75 ZN ZN C 374s E 146 TYR C 308 TYR^? 13.34 ZN ZN C 375 E 177 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -12.73 -23.25 44.05 -17.55 -23.96 45.92 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 320 ASP~? -21.81 ZN ZN A 374s F 146 TYR A 308 TYR^? 13.26 ZN ZN A 375 F 177 LYS A 301 LYS~? 24.94 ZN ZN A 375 coo -44.75 128.15 10.28 -45.68 129.67 11.55 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -50.43 131.90 19.60 -49.04 133.31 17.60 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -44.10 135.86 19.99 -45.67 134.21 14.07 39.11 -19.59 40.11 42.80 -21.77 43.38 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 330 ASP^? 12.08 ZN ZN A 374 F 146 TYR A 314 TYR~? 12.17 O8 EPE A 376 F 177 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -44.75 128.15 10.28 -45.68 129.67 11.55 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -50.43 131.90 19.60 -49.04 133.31 17.60 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -44.10 135.86 19.99 -45.67 134.21 14.07 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP B 320 ASP~? -21.78 ZN ZN B 374s F 146 TYR B 308 TYR^? 13.33 ZN ZN B 375 F 177 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo -44.75 128.15 10.28 -45.68 129.67 11.55 9.35 16.65 21.02 10.22 16.89 22.90 coo -50.43 131.90 19.60 -49.04 133.31 17.60 1.32 11.76 14.56 0.84 10.00 16.68 coo -44.10 135.86 19.99 -45.67 134.21 14.07 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP C 320 ASP~? -21.75 ZN ZN C 374s F 146 TYR C 308 TYR^? 13.34 ZN ZN C 375 F 177 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -12.73 -23.25 44.05 -17.55 -23.96 45.92 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 320 ASP~? -21.81 ZN ZN A 374s G 146 TYR A 308 TYR^? 13.26 ZN ZN A 375 G 177 LYS A 301 LYS~? 24.94 ZN ZN A 375 coo -44.97 128.78 41.20 -46.32 128.26 42.83 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -52.83 122.13 46.42 -51.31 124.30 47.39 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -47.30 122.24 51.49 -47.46 127.44 47.81 39.11 -19.59 40.11 42.80 -21.77 43.38 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 330 ASP^? 12.08 ZN ZN A 374 G 146 TYR A 314 TYR~? 12.17 O8 EPE A 376 G 177 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -44.97 128.78 41.20 -46.32 128.26 42.83 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -52.83 122.13 46.42 -51.31 124.30 47.39 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -47.30 122.24 51.49 -47.46 127.44 47.81 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP B 320 ASP~? -21.78 ZN ZN B 374s G 146 TYR B 308 TYR^? 13.33 ZN ZN B 375 G 177 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo -44.97 128.78 41.20 -46.32 128.26 42.83 9.35 16.65 21.02 10.22 16.89 22.90 coo -52.83 122.13 46.42 -51.31 124.30 47.39 1.32 11.76 14.56 0.84 10.00 16.68 coo -47.30 122.24 51.49 -47.46 127.44 47.81 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP C 320 ASP~? -21.75 ZN ZN C 374s G 146 TYR C 308 TYR^? 13.34 ZN ZN C 375 G 177 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -12.73 -23.25 44.05 -17.55 -23.96 45.92 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 320 ASP~? -21.81 ZN ZN A 374s H 146 TYR A 308 TYR^? 13.26 ZN ZN A 375 H 177 LYS A 301 LYS~? 24.94 ZN ZN A 375 coo -51.11 100.30 51.41 -52.67 98.82 51.12 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -58.70 94.17 45.32 -57.76 93.82 47.92 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -54.32 88.79 48.13 -54.61 94.04 51.74 39.11 -19.59 40.11 42.80 -21.77 43.38 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 330 ASP^? 12.08 ZN ZN A 374 H 146 TYR A 314 TYR~? 12.17 O8 EPE A 376 H 177 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -51.11 100.30 51.41 -52.67 98.82 51.12 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -58.70 94.17 45.32 -57.76 93.82 47.92 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -54.32 88.79 48.13 -54.61 94.04 51.74 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP B 320 ASP~? -21.78 ZN ZN B 374s H 146 TYR B 308 TYR^? 13.33 ZN ZN B 375 H 177 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo -51.11 100.30 51.41 -52.67 98.82 51.12 9.35 16.65 21.02 10.22 16.89 22.90 coo -58.70 94.17 45.32 -57.76 93.82 47.92 1.32 11.76 14.56 0.84 10.00 16.68 coo -54.32 88.79 48.13 -54.61 94.04 51.74 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP C 320 ASP~? -21.75 ZN ZN C 374s H 146 TYR C 308 TYR^? 13.34 ZN ZN C 375 H 177 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -12.73 -23.25 44.05 -17.55 -23.96 45.92 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 320 ASP~? -21.81 ZN ZN A 374s I 146 TYR A 308 TYR^? 13.26 ZN ZN A 375 I 177 LYS A 301 LYS~? 24.94 ZN ZN A 375 coo -54.65 81.97 26.87 -55.88 81.89 25.07 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -59.92 86.62 17.74 -59.42 83.94 18.40 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -55.38 81.61 14.50 -57.11 80.05 20.41 39.11 -19.59 40.11 42.80 -21.77 43.38 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 330 ASP^? 12.08 ZN ZN A 374 I 146 TYR A 314 TYR~? 12.17 O8 EPE A 376 I 177 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -54.65 81.97 26.87 -55.88 81.89 25.07 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -59.92 86.62 17.74 -59.42 83.94 18.40 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -55.38 81.61 14.50 -57.11 80.05 20.41 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP B 320 ASP~? -21.78 ZN ZN B 374s I 146 TYR B 308 TYR^? 13.33 ZN ZN B 375 I 177 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo -54.65 81.97 26.87 -55.88 81.89 25.07 9.35 16.65 21.02 10.22 16.89 22.90 coo -59.92 86.62 17.74 -59.42 83.94 18.40 1.32 11.76 14.56 0.84 10.00 16.68 coo -55.38 81.61 14.50 -57.11 80.05 20.41 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP C 320 ASP~? -21.75 ZN ZN C 374s I 146 TYR C 308 TYR^? 13.34 ZN ZN C 375 I 177 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -12.73 -23.25 44.05 -17.55 -23.96 45.92 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 320 ASP~? -21.81 ZN ZN A 374s J 146 TYR A 308 TYR^? 13.26 ZN ZN A 375 J 177 LYS A 301 LYS~? 24.94 ZN ZN A 375 coo -50.64 99.08 1.52 -51.52 100.83 0.67 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 39.11 -19.59 40.11 42.80 -21.77 43.38 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 330 ASP^? 12.08 ZN ZN A 374 J 146 TYR A 314 TYR~? 12.17 O8 EPE A 376 J 177 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -50.64 99.08 1.52 -51.52 100.83 0.67 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP B 320 ASP~? -21.78 ZN ZN B 374s J 146 TYR B 308 TYR^? 13.33 ZN ZN B 375 J 177 LYS B 301 LYS~? 25.03 ZN ZN B 375 coo -50.64 99.08 1.52 -51.52 100.83 0.67 9.35 16.65 21.02 10.22 16.89 22.90 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 1.32 11.76 14.56 0.84 10.00 16.68 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 8.36 10.35 11.75 10.05 14.82 9.04 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP C 320 ASP~? -21.75 ZN ZN C 374s J 146 TYR C 308 TYR^? 13.34 ZN ZN C 375 J 177 LYS C 301 LYS~? 24.63 ZN ZN C 375 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -12.73 -23.25 44.05 -17.55 -23.96 45.92 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 96 GLU A 51 GLU~? 11.89 O2S EPE A 376 A 132 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 31.23 12.29 16.44 30.82 11.56 18.39 40.70 8.14 28.73 41.06 6.40 29.84 coo 26.82 3.20 24.36 27.99 4.86 24.98 41.17 19.74 26.83 40.87 21.56 28.00 coo 29.99 0.62 22.18 30.38 6.69 20.81 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 55 ASP~? 17.36 O2S EPE A 376 A 96 GLU A 90 GLU~? 12.44 O2S EPE A 376 A 132 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 31.23 12.29 16.44 30.82 11.56 18.39 45.10 18.98 22.18 44.20 20.57 23.21 coo 26.82 3.20 24.36 27.99 4.86 24.98 33.69 24.77 24.85 34.29 26.39 26.04 coo 29.99 0.62 22.18 30.38 6.69 20.81 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP A 55 ASP~? 17.36 O2S EPE A 376 A 96 GLU A 90 GLU~? 12.44 O2S EPE A 376 A 132 LYS A 94 LYS~? 16.25 O2S EPE A 376 coo 31.23 12.29 16.44 30.82 11.56 18.39 45.10 18.98 22.18 44.20 20.57 23.21 coo 26.82 3.20 24.36 27.99 4.86 24.98 33.69 24.77 24.85 34.29 26.39 26.04 coo 29.99 0.62 22.18 30.38 6.69 20.81 33.79 23.90 18.72 34.24 28.62 22.89 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 96 GLU A 15 GLU~? 17.23 ZN ZN A 375 A 132 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 31.23 12.29 16.44 30.82 11.56 18.39 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 26.82 3.20 24.36 27.99 4.86 24.98 29.50 -0.46 14.62 27.65 0.59 14.66 coo 29.99 0.62 22.18 30.38 6.69 20.81 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 96 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 132 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 31.23 12.29 16.44 30.82 11.56 18.39 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 26.82 3.20 24.36 27.99 4.86 24.98 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 29.99 0.62 22.18 30.38 6.69 20.81 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 96 GLU B 51 GLU~? 11.61 O3S EPE B 376 A 132 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 31.23 12.29 16.44 30.82 11.56 18.39 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 26.82 3.20 24.36 27.99 4.86 24.98 -25.55 10.19 35.45 -25.80 11.09 37.35 coo 29.99 0.62 22.18 30.38 6.69 20.81 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1onr_c00 TRANSALDOLASE B user 7 3 # 7 A 17 ASP B 55 ASP~? 16.89 O3S EPE B 376 A 96 GLU B 90 GLU~? 12.95 O2S EPE B 376 A 132 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 31.23 12.29 16.44 30.82 11.56 18.39 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 26.82 3.20 24.36 27.99 4.86 24.98 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 29.99 0.62 22.18 30.38 6.69 20.81 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1onr_c00 TRANSALDOLASE B user 8 3 # 8 A 17 ASP B 55 ASP~? 16.89 O3S EPE B 376 A 96 GLU B 90 GLU~? 12.95 O2S EPE B 376 A 132 LYS B 94 LYS~? 17.44 O2S EPE B 376 coo 31.23 12.29 16.44 30.82 11.56 18.39 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 26.82 3.20 24.36 27.99 4.86 24.98 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 29.99 0.62 22.18 30.38 6.69 20.81 -29.53 0.46 40.71 -30.43 3.58 45.55 ULMN 3 1onr_c00 TRANSALDOLASE B user 9 3 # 9 A 17 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 96 GLU B 15 GLU~? 17.09 ZN ZN B 375 A 132 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 31.23 12.29 16.44 30.82 11.56 18.39 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 26.82 3.20 24.36 27.99 4.86 24.98 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 29.99 0.62 22.18 30.38 6.69 20.81 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1onr_c00 TRANSALDOLASE B user 10 3 # 10 A 17 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 96 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 132 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 31.23 12.29 16.44 30.82 11.56 18.39 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 26.82 3.20 24.36 27.99 4.86 24.98 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 29.99 0.62 22.18 30.38 6.69 20.81 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1onr_c00 TRANSALDOLASE B user 11 3 # 11 A 17 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 96 GLU C 51 GLU~? 12.03 O3S EPE C 376 A 132 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 31.23 12.29 16.44 30.82 11.56 18.39 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 26.82 3.20 24.36 27.99 4.86 24.98 19.07 -27.28 70.66 19.78 -25.91 72.07 coo 29.99 0.62 22.18 30.38 6.69 20.81 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1onr_c00 TRANSALDOLASE B user 12 3 # 12 A 17 ASP C 55 ASP~? 17.38 O3S EPE C 376 A 96 GLU C 90 GLU~? 12.50 O3S EPE C 376 A 132 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 31.23 12.29 16.44 30.82 11.56 18.39 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 26.82 3.20 24.36 27.99 4.86 24.98 27.07 -22.98 69.65 26.90 -21.97 71.52 coo 29.99 0.62 22.18 30.38 6.69 20.81 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1onr_c00 TRANSALDOLASE B user 13 3 # 13 A 17 ASP C 55 ASP~? 17.38 O3S EPE C 376 A 96 GLU C 90 GLU~? 12.50 O3S EPE C 376 A 132 LYS C 94 LYS~? 16.71 O3S EPE C 376 coo 31.23 12.29 16.44 30.82 11.56 18.39 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 26.82 3.20 24.36 27.99 4.86 24.98 27.07 -22.98 69.65 26.90 -21.97 71.52 coo 29.99 0.62 22.18 30.38 6.69 20.81 30.11 -27.61 67.14 30.55 -24.06 72.29 ULMN 3 1onr_c00 TRANSALDOLASE B user 14 3 # 14 A 17 ASP C 82 ASP.? 10.22 O3S EPE C 376 A 96 GLU C 51 GLU~? 12.03 O3S EPE C 376 A 132 LYS C 91 LYS~? 15.57 O3S EPE C 376 coo 31.23 12.29 16.44 30.82 11.56 18.39 23.03 -14.86 74.18 22.44 -14.42 76.16 coo 26.82 3.20 24.36 27.99 4.86 24.98 19.07 -27.28 70.66 19.78 -25.91 72.07 coo 29.99 0.62 22.18 30.38 6.69 20.81 24.97 -26.94 68.30 21.78 -29.04 72.70 ULMN 3 1onr_c00 TRANSALDOLASE B user 15 3 # 15 A 17 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 96 GLU C 15 GLU~? 17.26 ZN ZN C 375 A 132 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 31.23 12.29 16.44 30.82 11.56 18.39 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 26.82 3.20 24.36 27.99 4.86 24.98 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 29.99 0.62 22.18 30.38 6.69 20.81 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1onr_c00 TRANSALDOLASE B user 16 3 # 16 A 17 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 96 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 132 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 31.23 12.29 16.44 30.82 11.56 18.39 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 26.82 3.20 24.36 27.99 4.86 24.98 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 29.99 0.62 22.18 30.38 6.69 20.81 5.23 -34.02 59.10 0.53 -34.86 62.24 1onr_c00 source 1onr TRANSALDOLASE B : 16 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 96 GLU A 51 GLU~? 11.89 O2S EPE A 376 B 132 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 31.16 57.31 -0.94 30.73 56.64 1.01 40.70 8.14 28.73 41.06 6.40 29.84 coo 26.69 48.45 7.18 27.85 50.13 7.74 41.17 19.74 26.83 40.87 21.56 28.00 coo 29.82 45.80 5.07 30.26 51.81 3.56 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 55 ASP~? 17.36 O2S EPE A 376 B 96 GLU A 90 GLU~? 12.44 O2S EPE A 376 B 132 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 31.16 57.31 -0.94 30.73 56.64 1.01 45.10 18.98 22.18 44.20 20.57 23.21 coo 26.69 48.45 7.18 27.85 50.13 7.74 33.69 24.77 24.85 34.29 26.39 26.04 coo 29.82 45.80 5.07 30.26 51.81 3.56 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP A 55 ASP~? 17.36 O2S EPE A 376 B 96 GLU A 90 GLU~? 12.44 O2S EPE A 376 B 132 LYS A 94 LYS~? 16.25 O2S EPE A 376 coo 31.16 57.31 -0.94 30.73 56.64 1.01 45.10 18.98 22.18 44.20 20.57 23.21 coo 26.69 48.45 7.18 27.85 50.13 7.74 33.69 24.77 24.85 34.29 26.39 26.04 coo 29.82 45.80 5.07 30.26 51.81 3.56 33.79 23.90 18.72 34.24 28.62 22.89 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 96 GLU A 15 GLU~? 17.23 ZN ZN A 375 B 132 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 31.16 57.31 -0.94 30.73 56.64 1.01 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 26.69 48.45 7.18 27.85 50.13 7.74 29.50 -0.46 14.62 27.65 0.59 14.66 coo 29.82 45.80 5.07 30.26 51.81 3.56 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP A 115 ASP~? 13.24 ZN ZN A 375 B 96 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 132 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 31.16 57.31 -0.94 30.73 56.64 1.01 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 26.69 48.45 7.18 27.85 50.13 7.74 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 29.82 45.80 5.07 30.26 51.81 3.56 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 96 GLU B 51 GLU~? 11.61 O3S EPE B 376 B 132 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 26.69 48.45 7.18 27.85 50.13 7.74 -25.55 10.19 35.45 -25.80 11.09 37.35 coo 29.82 45.80 5.07 30.26 51.81 3.56 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1onr_c01 TRANSALDOLASE B user 7 3 # 7 B 17 ASP B 55 ASP~? 16.89 O3S EPE B 376 B 96 GLU B 90 GLU~? 12.95 O2S EPE B 376 B 132 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 26.69 48.45 7.18 27.85 50.13 7.74 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 29.82 45.80 5.07 30.26 51.81 3.56 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1onr_c01 TRANSALDOLASE B user 8 3 # 8 B 17 ASP B 55 ASP~? 16.89 O3S EPE B 376 B 96 GLU B 90 GLU~? 12.95 O2S EPE B 376 B 132 LYS B 94 LYS~? 17.44 O2S EPE B 376 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 26.69 48.45 7.18 27.85 50.13 7.74 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 29.82 45.80 5.07 30.26 51.81 3.56 -29.53 0.46 40.71 -30.43 3.58 45.55 ULMN 3 1onr_c01 TRANSALDOLASE B user 9 3 # 9 B 17 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 96 GLU B 15 GLU~? 17.09 ZN ZN B 375 B 132 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 26.69 48.45 7.18 27.85 50.13 7.74 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 29.82 45.80 5.07 30.26 51.81 3.56 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1onr_c01 TRANSALDOLASE B user 10 3 # 10 B 17 ASP B 115 ASP~? 12.98 ZN ZN B 375 B 96 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 132 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 26.69 48.45 7.18 27.85 50.13 7.74 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 29.82 45.80 5.07 30.26 51.81 3.56 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1onr_c01 TRANSALDOLASE B user 11 3 # 11 B 17 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 96 GLU C 51 GLU~? 12.03 O3S EPE C 376 B 132 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 31.16 57.31 -0.94 30.73 56.64 1.01 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 26.69 48.45 7.18 27.85 50.13 7.74 19.07 -27.28 70.66 19.78 -25.91 72.07 coo 29.82 45.80 5.07 30.26 51.81 3.56 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1onr_c01 TRANSALDOLASE B user 12 3 # 12 B 17 ASP C 55 ASP~? 17.38 O3S EPE C 376 B 96 GLU C 90 GLU~? 12.50 O3S EPE C 376 B 132 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 31.16 57.31 -0.94 30.73 56.64 1.01 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 26.69 48.45 7.18 27.85 50.13 7.74 27.07 -22.98 69.65 26.90 -21.97 71.52 coo 29.82 45.80 5.07 30.26 51.81 3.56 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1onr_c01 TRANSALDOLASE B user 13 3 # 13 B 17 ASP C 55 ASP~? 17.38 O3S EPE C 376 B 96 GLU C 90 GLU~? 12.50 O3S EPE C 376 B 132 LYS C 94 LYS~? 16.71 O3S EPE C 376 coo 31.16 57.31 -0.94 30.73 56.64 1.01 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 26.69 48.45 7.18 27.85 50.13 7.74 27.07 -22.98 69.65 26.90 -21.97 71.52 coo 29.82 45.80 5.07 30.26 51.81 3.56 30.11 -27.61 67.14 30.55 -24.06 72.29 ULMN 3 1onr_c01 TRANSALDOLASE B user 14 3 # 14 B 17 ASP C 82 ASP.? 10.22 O3S EPE C 376 B 96 GLU C 51 GLU~? 12.03 O3S EPE C 376 B 132 LYS C 91 LYS~? 15.57 O3S EPE C 376 coo 31.16 57.31 -0.94 30.73 56.64 1.01 23.03 -14.86 74.18 22.44 -14.42 76.16 coo 26.69 48.45 7.18 27.85 50.13 7.74 19.07 -27.28 70.66 19.78 -25.91 72.07 coo 29.82 45.80 5.07 30.26 51.81 3.56 24.97 -26.94 68.30 21.78 -29.04 72.70 ULMN 3 1onr_c01 TRANSALDOLASE B user 15 3 # 15 B 17 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 96 GLU C 15 GLU~? 17.26 ZN ZN C 375 B 132 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 31.16 57.31 -0.94 30.73 56.64 1.01 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 26.69 48.45 7.18 27.85 50.13 7.74 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 29.82 45.80 5.07 30.26 51.81 3.56 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1onr_c01 TRANSALDOLASE B user 16 3 # 16 B 17 ASP C 115 ASP~? 12.87 ZN ZN C 375 B 96 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 132 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 31.16 57.31 -0.94 30.73 56.64 1.01 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 26.69 48.45 7.18 27.85 50.13 7.74 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 29.82 45.80 5.07 30.26 51.81 3.56 5.23 -34.02 59.10 0.53 -34.86 62.24 1onr_c01 source 1onr TRANSALDOLASE B : 16 hits 1onr_c01 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 281 ASP.? 28.06 ZN ZN A 375 A 247 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 342 GLU A 254 GLU^? 30.93 ZN ZN A 375 coo 44.36 35.68 9.71 43.29 36.20 11.51 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 41.40 28.81 12.91 40.82 30.90 12.97 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 40.37 33.11 18.06 39.99 34.93 17.06 55.35 -23.67 37.01 55.67 -25.35 38.24 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP B 281 ASP.? 29.04 ZN ZN B 374 A 247 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 342 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 44.36 35.68 9.71 43.29 36.20 11.51 4.51 22.24 5.26 6.45 23.04 5.71 coo 41.40 28.81 12.91 40.82 30.90 12.97 3.99 14.73 5.36 5.18 14.04 3.76 coo 40.37 33.11 18.06 39.99 34.93 17.06 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 1oyg_c00 LEVANSUCRASE user 3 3 # 3 A 86 ASP C 281 ASP.? 29.07 ZN ZN C 374 A 247 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 342 GLU C 254 GLU^? 30.85 ZN ZN C 375 coo 44.36 35.68 9.71 43.29 36.20 11.51 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 41.40 28.81 12.91 40.82 30.90 12.97 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 40.37 33.11 18.06 39.99 34.93 17.06 -21.46 -36.51 49.50 -23.48 -36.16 48.85 1oyg_c00 source 1oyg LEVANSUCRASE : 3 hits 1oyg_c00 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 167 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 201 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 26.53 8.31 20.37 28.45 8.41 19.40 40.70 8.14 28.73 41.06 6.40 29.84 coo 24.92 6.08 13.38 27.75 4.33 18.83 45.66 0.76 26.15 51.53 0.58 28.90 coo 29.08 5.53 11.69 30.46 5.61 17.93 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 A 102 ASP A 96 ASP.? 22.36 O2S EPE A 376 A 167 LYS A 94 LYS~? 16.25 O2S EPE A 376 A 201 LYS A 91 LYS~? 15.85 O2S EPE A 376 coo 26.53 8.31 20.37 28.45 8.41 19.40 33.23 19.97 13.69 32.21 21.81 13.47 coo 24.92 6.08 13.38 27.75 4.33 18.83 33.79 23.90 18.72 34.24 28.62 22.89 coo 29.08 5.53 11.69 30.46 5.61 17.93 36.23 21.81 22.32 41.86 22.67 23.70 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 A 102 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 167 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 201 LYS A 138 LYS^? 13.11 N TRS A 378 coo 26.53 8.31 20.37 28.45 8.41 19.40 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 24.92 6.08 13.38 27.75 4.33 18.83 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 29.08 5.53 11.69 30.46 5.61 17.93 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 A 102 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 167 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 201 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 26.53 8.31 20.37 28.45 8.41 19.40 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 24.92 6.08 13.38 27.75 4.33 18.83 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 29.08 5.53 11.69 30.46 5.61 17.93 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 5 3 # 5 A 102 ASP A 237 ASP^? 6.80 N TRS A 378 A 167 LYS C 138 LYS^? 8.30 N TRS A 378 A 201 LYS C 139 LYS^? 16.11 N TRS A 378 coo 26.53 8.31 20.37 28.45 8.41 19.40 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 24.92 6.08 13.38 27.75 4.33 18.83 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 29.08 5.53 11.69 30.46 5.61 17.93 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 6 3 # 6 A 102 ASP A 237 ASP^? 6.80 N TRS A 378 A 167 LYS C 139 LYS^? 16.11 N TRS A 378 A 201 LYS C 138 LYS^? 8.30 N TRS A 378 coo 26.53 8.31 20.37 28.45 8.41 19.40 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 24.92 6.08 13.38 27.75 4.33 18.83 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 29.08 5.53 11.69 30.46 5.61 17.93 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 7 3 # 7 A 102 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 167 LYS A 265 LYS~? 22.38 ZN ZN A 374 A 201 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 26.53 8.31 20.37 28.45 8.41 19.40 54.82 -1.21 28.36 56.43 0.27 28.67 coo 24.92 6.08 13.38 27.75 4.33 18.83 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 29.08 5.53 11.69 30.46 5.61 17.93 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 8 3 # 8 A 102 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 167 LYS A 301 LYS~? 24.94 ZN ZN A 375 A 201 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 26.53 8.31 20.37 28.45 8.41 19.40 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 24.92 6.08 13.38 27.75 4.33 18.83 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 29.08 5.53 11.69 30.46 5.61 17.93 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 9 3 # 9 A 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 167 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 201 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 26.53 8.31 20.37 28.45 8.41 19.40 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 24.92 6.08 13.38 27.75 4.33 18.83 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 29.08 5.53 11.69 30.46 5.61 17.93 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 10 3 # 10 A 102 ASP B 96 ASP.? 22.64 O2S EPE B 376 A 167 LYS B 94 LYS~? 17.44 O2S EPE B 376 A 201 LYS B 91 LYS~? 15.73 O3S EPE B 376 coo 26.53 8.31 20.37 28.45 8.41 19.40 -29.98 -4.37 36.65 -30.49 -4.93 38.64 coo 24.92 6.08 13.38 27.75 4.33 18.83 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 29.08 5.53 11.69 30.46 5.61 17.93 -26.96 4.56 38.63 -29.49 9.20 36.26 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 11 3 # 11 A 102 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 167 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 201 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 26.53 8.31 20.37 28.45 8.41 19.40 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 24.92 6.08 13.38 27.75 4.33 18.83 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 29.08 5.53 11.69 30.46 5.61 17.93 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 12 3 # 12 A 102 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 167 LYS C 139 LYS^? 16.11 N TRS A 378 A 201 LYS C 138 LYS^? 8.30 N TRS A 378 coo 26.53 8.31 20.37 28.45 8.41 19.40 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 24.92 6.08 13.38 27.75 4.33 18.83 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 29.08 5.53 11.69 30.46 5.61 17.93 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 13 3 # 13 A 102 ASP B 237 ASP^? 15.58 N TRS A 378 A 167 LYS A 138 LYS^? 13.11 N TRS A 378 A 201 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 26.53 8.31 20.37 28.45 8.41 19.40 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 24.92 6.08 13.38 27.75 4.33 18.83 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 29.08 5.53 11.69 30.46 5.61 17.93 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 14 3 # 14 A 102 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 167 LYS B 265 LYS~? 21.91 ZN ZN B 374 A 201 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 26.53 8.31 20.37 28.45 8.41 19.40 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 24.92 6.08 13.38 27.75 4.33 18.83 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 29.08 5.53 11.69 30.46 5.61 17.93 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 15 3 # 15 A 102 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 167 LYS B 301 LYS~? 25.03 ZN ZN B 375 A 201 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 26.53 8.31 20.37 28.45 8.41 19.40 3.99 14.73 5.36 5.18 14.04 3.76 coo 24.92 6.08 13.38 27.75 4.33 18.83 8.36 10.35 11.75 10.05 14.82 9.04 coo 29.08 5.53 11.69 30.46 5.61 17.93 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 16 3 # 16 A 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 167 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 201 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 26.53 8.31 20.37 28.45 8.41 19.40 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 24.92 6.08 13.38 27.75 4.33 18.83 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 29.08 5.53 11.69 30.46 5.61 17.93 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 17 3 # 17 A 102 ASP C 96 ASP.? 22.89 O3S EPE C 376 A 167 LYS C 94 LYS~? 16.71 O3S EPE C 376 A 201 LYS C 91 LYS~? 15.57 O3S EPE C 376 coo 26.53 8.31 20.37 28.45 8.41 19.40 31.06 -32.15 62.51 32.92 -31.34 63.13 coo 24.92 6.08 13.38 27.75 4.33 18.83 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 29.08 5.53 11.69 30.46 5.61 17.93 24.97 -26.94 68.30 21.78 -29.04 72.70 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 18 3 # 18 A 102 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 167 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 201 LYS A 138 LYS^? 13.11 N TRS A 378 coo 26.53 8.31 20.37 28.45 8.41 19.40 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 24.92 6.08 13.38 27.75 4.33 18.83 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 29.08 5.53 11.69 30.46 5.61 17.93 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 19 3 # 19 A 102 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 167 LYS C 139 LYS^? 16.11 N TRS A 378 A 201 LYS C 138 LYS^? 8.30 N TRS A 378 coo 26.53 8.31 20.37 28.45 8.41 19.40 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 24.92 6.08 13.38 27.75 4.33 18.83 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 29.08 5.53 11.69 30.46 5.61 17.93 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 20 3 # 20 A 102 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 167 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 201 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 26.53 8.31 20.37 28.45 8.41 19.40 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 24.92 6.08 13.38 27.75 4.33 18.83 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 29.08 5.53 11.69 30.46 5.61 17.93 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 21 3 # 21 A 102 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 167 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 201 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 26.53 8.31 20.37 28.45 8.41 19.40 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 24.92 6.08 13.38 27.75 4.33 18.83 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 29.08 5.53 11.69 30.46 5.61 17.93 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 22 3 # 22 A 102 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 167 LYS C 265 LYS~? 21.95 ZN ZN C 374 A 201 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 26.53 8.31 20.37 28.45 8.41 19.40 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 24.92 6.08 13.38 27.75 4.33 18.83 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 29.08 5.53 11.69 30.46 5.61 17.93 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 23 3 # 23 A 102 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 167 LYS C 301 LYS~? 24.63 ZN ZN C 375 A 201 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 26.53 8.31 20.37 28.45 8.41 19.40 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 24.92 6.08 13.38 27.75 4.33 18.83 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 29.08 5.53 11.69 30.46 5.61 17.93 -11.06 -26.43 40.09 -5.81 -27.52 38.93 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 23 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP A 48 ASP.? 7.40 ZN ZN A 374 B1167 LYS A 337 LYS~? 14.02 ZN ZN A 374 B1201 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 26.10 12.11 49.61 24.19 12.48 50.51 40.70 8.14 28.73 41.06 6.40 29.84 coo 27.70 11.69 56.92 24.82 8.55 52.12 45.66 0.76 26.15 51.53 0.58 28.90 coo 23.50 11.64 58.67 22.19 10.19 52.59 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 B1102 ASP A 96 ASP.? 22.36 O2S EPE A 376 B1167 LYS A 94 LYS~? 16.25 O2S EPE A 376 B1201 LYS A 91 LYS~? 15.85 O2S EPE A 376 coo 26.10 12.11 49.61 24.19 12.48 50.51 33.23 19.97 13.69 32.21 21.81 13.47 coo 27.70 11.69 56.92 24.82 8.55 52.12 33.79 23.90 18.72 34.24 28.62 22.89 coo 23.50 11.64 58.67 22.19 10.19 52.59 36.23 21.81 22.32 41.86 22.67 23.70 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 B1102 ASP A 232 ASP^? 4.68 O1S EPE A 377 B1167 LYS A 139 LYS^? -2.64 O3S EPE C 377s B1201 LYS A 138 LYS^? 13.11 N TRS A 378 coo 26.10 12.11 49.61 24.19 12.48 50.51 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 27.70 11.69 56.92 24.82 8.55 52.12 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 23.50 11.64 58.67 22.19 10.19 52.59 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 B1102 ASP A 232 ASP^? 4.68 O1S EPE A 377 B1167 LYS B 139 LYS^? -2.84 O2S EPE A 377s B1201 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 26.10 12.11 49.61 24.19 12.48 50.51 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 27.70 11.69 56.92 24.82 8.55 52.12 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 23.50 11.64 58.67 22.19 10.19 52.59 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 5 3 # 5 B1102 ASP A 237 ASP^? 6.80 N TRS A 378 B1167 LYS C 138 LYS^? 8.30 N TRS A 378 B1201 LYS C 139 LYS^? 16.11 N TRS A 378 coo 26.10 12.11 49.61 24.19 12.48 50.51 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 27.70 11.69 56.92 24.82 8.55 52.12 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 23.50 11.64 58.67 22.19 10.19 52.59 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 6 3 # 6 B1102 ASP A 237 ASP^? 6.80 N TRS A 378 B1167 LYS C 139 LYS^? 16.11 N TRS A 378 B1201 LYS C 138 LYS^? 8.30 N TRS A 378 coo 26.10 12.11 49.61 24.19 12.48 50.51 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 27.70 11.69 56.92 24.82 8.55 52.12 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 23.50 11.64 58.67 22.19 10.19 52.59 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 7 3 # 7 B1102 ASP A 269 ASP.? 18.90 ZN ZN A 374 B1167 LYS A 265 LYS~? 22.38 ZN ZN A 374 B1201 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 26.10 12.11 49.61 24.19 12.48 50.51 54.82 -1.21 28.36 56.43 0.27 28.67 coo 27.70 11.69 56.92 24.82 8.55 52.12 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 23.50 11.64 58.67 22.19 10.19 52.59 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 8 3 # 8 B1102 ASP A 306 ASP.? 24.91 ZN ZN A 375 B1167 LYS A 301 LYS~? 24.94 ZN ZN A 375 B1201 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 26.10 12.11 49.61 24.19 12.48 50.51 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 27.70 11.69 56.92 24.82 8.55 52.12 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 23.50 11.64 58.67 22.19 10.19 52.59 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 9 3 # 9 B1102 ASP B 48 ASP.? 7.36 ZN ZN B 374 B1167 LYS B 337 LYS~? 13.35 ZN ZN B 374 B1201 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 26.10 12.11 49.61 24.19 12.48 50.51 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 27.70 11.69 56.92 24.82 8.55 52.12 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 23.50 11.64 58.67 22.19 10.19 52.59 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 10 3 # 10 B1102 ASP B 96 ASP.? 22.64 O2S EPE B 376 B1167 LYS B 94 LYS~? 17.44 O2S EPE B 376 B1201 LYS B 91 LYS~? 15.73 O3S EPE B 376 coo 26.10 12.11 49.61 24.19 12.48 50.51 -29.98 -4.37 36.65 -30.49 -4.93 38.64 coo 27.70 11.69 56.92 24.82 8.55 52.12 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 23.50 11.64 58.67 22.19 10.19 52.59 -26.96 4.56 38.63 -29.49 9.20 36.26 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 11 3 # 11 B1102 ASP B 232 ASP^? 14.54 O2S EPE A 377 B1167 LYS B 139 LYS^? -2.84 O2S EPE A 377s B1201 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 26.10 12.11 49.61 24.19 12.48 50.51 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 27.70 11.69 56.92 24.82 8.55 52.12 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 23.50 11.64 58.67 22.19 10.19 52.59 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 12 3 # 12 B1102 ASP B 232 ASP^? 14.54 O2S EPE A 377 B1167 LYS C 139 LYS^? 16.11 N TRS A 378 B1201 LYS C 138 LYS^? 8.30 N TRS A 378 coo 26.10 12.11 49.61 24.19 12.48 50.51 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 27.70 11.69 56.92 24.82 8.55 52.12 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 23.50 11.64 58.67 22.19 10.19 52.59 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 13 3 # 13 B1102 ASP B 237 ASP^? 15.58 N TRS A 378 B1167 LYS A 138 LYS^? 13.11 N TRS A 378 B1201 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 26.10 12.11 49.61 24.19 12.48 50.51 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 27.70 11.69 56.92 24.82 8.55 52.12 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 23.50 11.64 58.67 22.19 10.19 52.59 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 14 3 # 14 B1102 ASP B 237 ASP^? 15.58 N TRS A 378 B1167 LYS A 139 LYS^? -2.64 O3S EPE C 377s B1201 LYS A 138 LYS^? 13.11 N TRS A 378 coo 26.10 12.11 49.61 24.19 12.48 50.51 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 27.70 11.69 56.92 24.82 8.55 52.12 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 23.50 11.64 58.67 22.19 10.19 52.59 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 15 3 # 15 B1102 ASP B 269 ASP.? 18.26 ZN ZN B 374 B1167 LYS B 265 LYS~? 21.91 ZN ZN B 374 B1201 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 26.10 12.11 49.61 24.19 12.48 50.51 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 27.70 11.69 56.92 24.82 8.55 52.12 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 23.50 11.64 58.67 22.19 10.19 52.59 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 16 3 # 16 B1102 ASP B 306 ASP.? 24.86 ZN ZN B 375 B1167 LYS B 301 LYS~? 25.03 ZN ZN B 375 B1201 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 26.10 12.11 49.61 24.19 12.48 50.51 3.99 14.73 5.36 5.18 14.04 3.76 coo 27.70 11.69 56.92 24.82 8.55 52.12 8.36 10.35 11.75 10.05 14.82 9.04 coo 23.50 11.64 58.67 22.19 10.19 52.59 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 17 3 # 17 B1102 ASP C 48 ASP.? 7.30 ZN ZN C 374 B1167 LYS C 337 LYS~? 12.69 ZN ZN C 374 B1201 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 26.10 12.11 49.61 24.19 12.48 50.51 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 27.70 11.69 56.92 24.82 8.55 52.12 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 23.50 11.64 58.67 22.19 10.19 52.59 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 18 3 # 18 B1102 ASP C 96 ASP.? 22.89 O3S EPE C 376 B1167 LYS C 94 LYS~? 16.71 O3S EPE C 376 B1201 LYS C 91 LYS~? 15.57 O3S EPE C 376 coo 26.10 12.11 49.61 24.19 12.48 50.51 31.06 -32.15 62.51 32.92 -31.34 63.13 coo 27.70 11.69 56.92 24.82 8.55 52.12 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 23.50 11.64 58.67 22.19 10.19 52.59 24.97 -26.94 68.30 21.78 -29.04 72.70 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 19 3 # 19 B1102 ASP C 232 ASP^? 3.77 O2S EPE C 377 B1167 LYS A 139 LYS^? -2.64 O3S EPE C 377s B1201 LYS A 138 LYS^? 13.11 N TRS A 378 coo 26.10 12.11 49.61 24.19 12.48 50.51 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 27.70 11.69 56.92 24.82 8.55 52.12 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 23.50 11.64 58.67 22.19 10.19 52.59 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 20 3 # 20 B1102 ASP C 232 ASP^? 3.77 O2S EPE C 377 B1167 LYS C 139 LYS^? 16.11 N TRS A 378 B1201 LYS C 138 LYS^? 8.30 N TRS A 378 coo 26.10 12.11 49.61 24.19 12.48 50.51 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 27.70 11.69 56.92 24.82 8.55 52.12 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 23.50 11.64 58.67 22.19 10.19 52.59 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 21 3 # 21 B1102 ASP C 237 ASP^? 16.80 O1S EPE A 377 B1167 LYS B 138 LYS^? 15.17 O1S EPE A 377 B1201 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 26.10 12.11 49.61 24.19 12.48 50.51 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 27.70 11.69 56.92 24.82 8.55 52.12 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 23.50 11.64 58.67 22.19 10.19 52.59 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 22 3 # 22 B1102 ASP C 237 ASP^? 16.80 O1S EPE A 377 B1167 LYS B 139 LYS^? -2.84 O2S EPE A 377s B1201 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 26.10 12.11 49.61 24.19 12.48 50.51 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 27.70 11.69 56.92 24.82 8.55 52.12 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 23.50 11.64 58.67 22.19 10.19 52.59 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 23 3 # 23 B1102 ASP C 269 ASP~? 18.04 ZN ZN C 374 B1167 LYS C 265 LYS~? 21.95 ZN ZN C 374 B1201 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 26.10 12.11 49.61 24.19 12.48 50.51 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 27.70 11.69 56.92 24.82 8.55 52.12 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 23.50 11.64 58.67 22.19 10.19 52.59 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 24 3 # 24 B1102 ASP C 306 ASP.? 24.81 ZN ZN C 375 B1167 LYS C 301 LYS~? 24.63 ZN ZN C 375 B1201 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 26.10 12.11 49.61 24.19 12.48 50.51 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 27.70 11.69 56.92 24.82 8.55 52.12 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 23.50 11.64 58.67 22.19 10.19 52.59 -11.06 -26.43 40.09 -5.81 -27.52 38.93 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 24 hits 1p1x_c01 naa= 3 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 168 SER^? 10.80 O1S EPE C 377 A 708 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 740 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo -7.09 7.44 6.22 -7.53 5.14 5.59 30.58 -27.33 4.57 31.12 -25.87 2.65 coo -5.35 2.36 14.19 -6.28 2.60 12.26 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -8.70 2.86 9.96 -8.03 3.92 8.29 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 168 SER^? 10.59 O3S EPE A 377 A 708 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 740 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER C 168 SER^? 24.11 O1 TRS A 378 A 708 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 740 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo -7.09 7.44 6.22 -7.53 5.14 5.59 9.08 -45.42 26.78 10.19 -47.47 27.43 coo -5.35 2.36 14.19 -6.28 2.60 12.26 19.06 -47.14 27.83 18.62 -49.09 27.08 coo -8.70 2.86 9.96 -8.03 3.92 8.29 13.13 -47.52 24.96 14.34 -48.17 26.54 1pfq_c00 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 3 hits 1pfq_c00 naa= 3 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 168 SER^? 10.80 O1S EPE C 377 B 708 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 740 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 4.44 13.29 37.64 6.01 11.66 38.49 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 6.39 7.18 30.33 6.92 8.20 32.17 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 8.57 10.09 34.47 7.10 10.73 35.82 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 168 SER^? 10.59 O3S EPE A 377 B 708 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 740 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 4.44 13.29 37.64 6.01 11.66 38.49 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 6.39 7.18 30.33 6.92 8.20 32.17 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 8.57 10.09 34.47 7.10 10.73 35.82 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER C 168 SER^? 24.11 O1 TRS A 378 B 708 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 740 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 4.44 13.29 37.64 6.01 11.66 38.49 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 6.39 7.18 30.33 6.92 8.20 32.17 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 8.57 10.09 34.47 7.10 10.73 35.82 13.13 -47.52 24.96 14.34 -48.17 26.54 1pfq_c01 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 3 hits 1pfq_c01 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 259 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 552 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 11.34 95.90 25.54 12.13 96.42 23.67 37.80 0.44 25.56 37.02 -1.29 26.44 coo 14.91 97.39 18.63 13.39 95.60 20.20 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 46.37 82.54 38.83 45.97 84.66 38.77 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS A 80 HIS.? 6.41 O2S EPE A 376 A 259 TYR A 85 TYR~? -4.05 C2 EPE A 376s A 552 ASP B 281 ASP.? 29.04 ZN ZN B 374 coo 11.34 95.90 25.54 12.13 96.42 23.67 28.52 23.28 34.79 26.69 23.10 35.81 coo 14.91 97.39 18.63 13.39 95.60 20.20 33.18 16.26 32.13 31.71 14.36 30.75 coo 46.37 82.54 38.83 45.97 84.66 38.77 4.51 22.24 5.26 6.45 23.04 5.71 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS A 80 HIS.? 6.41 O2S EPE A 376 A 259 TYR A 85 TYR~? -4.05 C2 EPE A 376s A 552 ASP B 306 ASP.? 24.86 ZN ZN B 375 coo 11.34 95.90 25.54 12.13 96.42 23.67 28.52 23.28 34.79 26.69 23.10 35.81 coo 14.91 97.39 18.63 13.39 95.60 20.20 33.18 16.26 32.13 31.71 14.36 30.75 coo 46.37 82.54 38.83 45.97 84.66 38.77 3.99 14.73 5.36 5.18 14.04 3.76 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS A 224 HIS~? 7.33 C7 EPE A 377 A 259 TYR A 231 TYR^? 10.06 O1S EPE A 377 A 552 ASP A 352 ASP~? 25.70 ZN ZN A 375 coo 11.34 95.90 25.54 12.13 96.42 23.67 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 14.91 97.39 18.63 13.39 95.60 20.20 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 46.37 82.54 38.83 45.97 84.66 38.77 43.66 -0.56 3.32 44.78 0.99 4.29 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS A 316 HIS~? 20.33 O8 EPE A 376 A 259 TYR A 314 TYR~? 12.17 O8 EPE A 376 A 552 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 11.34 95.90 25.54 12.13 96.42 23.67 36.36 -5.20 52.06 36.55 -4.24 53.92 coo 14.91 97.39 18.63 13.39 95.60 20.20 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 46.37 82.54 38.83 45.97 84.66 38.77 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 6 3 # 6 A 225 HIS A 316 HIS~? 20.33 O8 EPE A 376 A 259 TYR A 314 TYR~? 12.17 O8 EPE A 376 A 552 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 11.34 95.90 25.54 12.13 96.42 23.67 36.36 -5.20 52.06 36.55 -4.24 53.92 coo 14.91 97.39 18.63 13.39 95.60 20.20 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 46.37 82.54 38.83 45.97 84.66 38.77 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 7 3 # 7 A 225 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 259 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 552 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 11.34 95.90 25.54 12.13 96.42 23.67 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 14.91 97.39 18.63 13.39 95.60 20.20 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 46.37 82.54 38.83 45.97 84.66 38.77 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 8 3 # 8 A 225 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 259 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 552 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 11.34 95.90 25.54 12.13 96.42 23.67 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 14.91 97.39 18.63 13.39 95.60 20.20 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 46.37 82.54 38.83 45.97 84.66 38.77 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 9 3 # 9 A 225 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 259 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 552 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo 11.34 95.90 25.54 12.13 96.42 23.67 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 14.91 97.39 18.63 13.39 95.60 20.20 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 46.37 82.54 38.83 45.97 84.66 38.77 -16.81 -30.01 48.18 -17.96 -30.59 46.51 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 10 3 # 10 A 225 HIS B 80 HIS.? 6.72 O2S EPE B 376 A 259 TYR B 85 TYR~? 3.87 C2 EPE B 376 A 552 ASP C 306 ASP.? 24.81 ZN ZN C 375 coo 11.34 95.90 25.54 12.13 96.42 23.67 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 14.91 97.39 18.63 13.39 95.60 20.20 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 46.37 82.54 38.83 45.97 84.66 38.77 -16.81 -30.01 48.18 -17.96 -30.59 46.51 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 11 3 # 11 A 225 HIS B 169 HIS^? 10.86 O3S EPE A 377 A 259 TYR B 167 TYR^? 5.54 O8 EPE A 377 A 552 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 11.34 95.90 25.54 12.13 96.42 23.67 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 14.91 97.39 18.63 13.39 95.60 20.20 -0.72 -24.00 -3.91 0.54 -23.91 -6.42 coo 46.37 82.54 38.83 45.97 84.66 38.77 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 12 3 # 12 A 225 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 259 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 552 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 11.34 95.90 25.54 12.13 96.42 23.67 7.45 20.77 27.47 7.65 22.47 28.71 coo 14.91 97.39 18.63 13.39 95.60 20.20 2.08 17.58 27.10 3.13 18.35 29.60 coo 46.37 82.54 38.83 45.97 84.66 38.77 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 13 3 # 13 A 225 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 259 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 552 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 11.34 95.90 25.54 12.13 96.42 23.67 7.45 20.77 27.47 7.65 22.47 28.71 coo 14.91 97.39 18.63 13.39 95.60 20.20 2.08 17.58 27.10 3.13 18.35 29.60 coo 46.37 82.54 38.83 45.97 84.66 38.77 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 14 3 # 14 A 225 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 259 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 552 ASP B 237 ASP^? 15.58 N TRS A 378 coo 11.34 95.90 25.54 12.13 96.42 23.67 7.45 20.77 27.47 7.65 22.47 28.71 coo 14.91 97.39 18.63 13.39 95.60 20.20 2.08 17.58 27.10 3.13 18.35 29.60 coo 46.37 82.54 38.83 45.97 84.66 38.77 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 15 3 # 15 A 225 HIS C 21 HIS~? 17.02 O1 TRS A 378 A 259 TYR C 133 TYR^? 16.76 ZN ZN C 375 A 552 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 11.34 95.90 25.54 12.13 96.42 23.67 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 14.91 97.39 18.63 13.39 95.60 20.20 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 46.37 82.54 38.83 45.97 84.66 38.77 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 16 3 # 16 A 225 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 259 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 552 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 11.34 95.90 25.54 12.13 96.42 23.67 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 14.91 97.39 18.63 13.39 95.60 20.20 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 46.37 82.54 38.83 45.97 84.66 38.77 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 17 3 # 17 A 225 HIS C 80 HIS.? 6.69 O2S EPE C 376 A 259 TYR C 85 TYR~? -3.91 C2 EPE C 376s A 552 ASP A 281 ASP.? 28.06 ZN ZN A 375 coo 11.34 95.90 25.54 12.13 96.42 23.67 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 14.91 97.39 18.63 13.39 95.60 20.20 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 46.37 82.54 38.83 45.97 84.66 38.77 52.87 -20.75 45.53 51.52 -19.24 45.99 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 18 3 # 18 A 225 HIS C 80 HIS.? 6.69 O2S EPE C 376 A 259 TYR C 85 TYR~? -3.91 C2 EPE C 376s A 552 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 11.34 95.90 25.54 12.13 96.42 23.67 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 14.91 97.39 18.63 13.39 95.60 20.20 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 46.37 82.54 38.83 45.97 84.66 38.77 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 19 3 # 19 A 225 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 259 TYR C 167 TYR^? 26.66 O2S EPE A 377 A 552 ASP C 281 ASP.? 29.07 ZN ZN C 374 coo 11.34 95.90 25.54 12.13 96.42 23.67 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 14.91 97.39 18.63 13.39 95.60 20.20 3.31 -45.81 25.21 0.69 -46.75 24.83 coo 46.37 82.54 38.83 45.97 84.66 38.77 -22.02 -28.08 53.32 -23.19 -26.28 53.39 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 20 3 # 20 A 225 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 259 TYR C 167 TYR^? 26.66 O2S EPE A 377 A 552 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 11.34 95.90 25.54 12.13 96.42 23.67 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 14.91 97.39 18.63 13.39 95.60 20.20 3.31 -45.81 25.21 0.69 -46.75 24.83 coo 46.37 82.54 38.83 45.97 84.66 38.77 -7.16 -24.94 59.28 -5.20 -24.20 59.64 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 21 3 # 21 A 225 HIS C 316 HIS~? -20.42 O8 EPE C 376s A 259 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 552 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 11.34 95.90 25.54 12.13 96.42 23.67 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 14.91 97.39 18.63 13.39 95.60 20.20 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 46.37 82.54 38.83 45.97 84.66 38.77 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 22 3 # 22 A 225 HIS C 316 HIS~? -20.42 O8 EPE C 376s A 259 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 552 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 11.34 95.90 25.54 12.13 96.42 23.67 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 14.91 97.39 18.63 13.39 95.60 20.20 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 46.37 82.54 38.83 45.97 84.66 38.77 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 23 3 # 23 A 225 HIS C 316 HIS~? -20.42 O8 EPE C 376s A 259 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 552 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 11.34 95.90 25.54 12.13 96.42 23.67 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 14.91 97.39 18.63 13.39 95.60 20.20 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 46.37 82.54 38.83 45.97 84.66 38.77 4.59 -25.19 21.63 5.07 -23.28 20.96 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 23 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 46 ALA^? 12.15 ZN ZN A 374 A 126 LEU A 44 LEU^? 17.64 ZN ZN A 374 A 158 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -2.29 37.66 144.73 -1.46 37.12 145.87 41.72 6.36 22.02 41.31 7.82 22.33 coo -4.62 32.83 147.14 -5.50 32.85 149.12 42.07 10.13 16.85 43.67 10.58 18.27 coo -0.83 29.57 149.77 -0.39 31.47 148.95 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 46 ALA^? 12.15 ZN ZN A 374 A 126 LEU A 47 LEU.? 6.92 ZN ZN A 374 A 158 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo -2.29 37.66 144.73 -1.46 37.12 145.87 41.72 6.36 22.02 41.31 7.82 22.33 coo -4.62 32.83 147.14 -5.50 32.85 149.12 42.30 4.26 26.28 42.13 2.67 27.73 coo -0.83 29.57 149.77 -0.39 31.47 148.95 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 62 ALA.? 21.75 ZN ZN A 374 A 126 LEU A 44 LEU^? 17.64 ZN ZN A 374 A 158 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -2.29 37.66 144.73 -1.46 37.12 145.87 41.03 13.97 12.85 41.56 12.98 13.85 coo -4.62 32.83 147.14 -5.50 32.85 149.12 42.07 10.13 16.85 43.67 10.58 18.27 coo -0.83 29.57 149.77 -0.39 31.47 148.95 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 62 ALA.? 21.75 ZN ZN A 374 A 126 LEU A 60 LEU~? 22.83 ZN ZN A 374 A 158 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -2.29 37.66 144.73 -1.46 37.12 145.87 41.03 13.97 12.85 41.56 12.98 13.85 coo -4.62 32.83 147.14 -5.50 32.85 149.12 45.69 14.02 13.98 46.89 12.37 14.74 coo -0.83 29.57 149.77 -0.39 31.47 148.95 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA A 67 ALA^? 10.32 ZN ZN A 374 A 126 LEU A 47 LEU.? 6.92 ZN ZN A 374 A 158 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo -2.29 37.66 144.73 -1.46 37.12 145.87 37.22 5.65 22.28 37.04 6.85 23.17 coo -4.62 32.83 147.14 -5.50 32.85 149.12 42.30 4.26 26.28 42.13 2.67 27.73 coo -0.83 29.57 149.77 -0.39 31.47 148.95 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA A 109 ALA~? 11.42 ZN ZN A 375 A 126 LEU A 243 LEU^? 14.05 O3 TRS A 378 A 158 GLU A 241 GLU^? 13.09 O3 TRS A 378 coo -2.29 37.66 144.73 -1.46 37.12 145.87 34.68 -9.30 20.20 34.40 -8.19 19.19 coo -4.62 32.83 147.14 -5.50 32.85 149.12 31.75 -13.70 22.02 32.50 -13.55 19.95 coo -0.83 29.57 149.77 -0.39 31.47 148.95 32.85 -18.83 18.59 34.29 -17.80 17.42 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA A 362 ALA^? 15.97 ZN ZN A 375 A 126 LEU A 44 LEU^? 17.64 ZN ZN A 374 A 158 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -2.29 37.66 144.73 -1.46 37.12 145.87 46.25 5.46 17.59 47.00 4.15 17.82 coo -4.62 32.83 147.14 -5.50 32.85 149.12 42.07 10.13 16.85 43.67 10.58 18.27 coo -0.83 29.57 149.77 -0.39 31.47 148.95 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA B 46 ALA^? 12.02 ZN ZN B 374 A 126 LEU B 44 LEU^? 17.53 ZN ZN B 374 A 158 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -20.28 4.12 23.98 -20.70 4.20 25.49 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -25.93 1.38 24.86 -26.10 3.53 24.59 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA B 46 ALA^? 12.02 ZN ZN B 374 A 126 LEU B 47 LEU.? 6.75 ZN ZN B 374 A 158 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo -2.29 37.66 144.73 -1.46 37.12 145.87 -20.28 4.12 23.98 -20.70 4.20 25.49 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -16.64 7.19 23.14 -14.64 7.83 22.57 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA B 62 ALA.? 21.54 ZN ZN B 374 A 126 LEU B 44 LEU^? 17.53 ZN ZN B 374 A 158 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -25.93 1.38 24.86 -26.10 3.53 24.59 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA B 62 ALA.? 21.54 ZN ZN B 374 A 126 LEU B 60 LEU~? 22.96 ZN ZN B 374 A 158 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -32.08 2.39 24.63 -31.26 3.48 22.97 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA B 67 ALA^? 10.44 ZN ZN B 374 A 126 LEU B 47 LEU.? 6.75 ZN ZN B 374 A 158 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo -2.29 37.66 144.73 -1.46 37.12 145.87 -17.51 1.20 26.23 -17.65 1.96 27.53 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -16.64 7.19 23.14 -14.64 7.83 22.57 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 A 70 ALA B 362 ALA^? 16.08 ZN ZN B 375 A 126 LEU B 44 LEU^? 17.53 ZN ZN B 374 A 158 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -24.59 3.58 19.16 -24.10 3.96 17.83 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -25.93 1.38 24.86 -26.10 3.53 24.59 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 A 70 ALA C 46 ALA^? 12.13 ZN ZN C 374 A 126 LEU C 44 LEU^? 17.58 ZN ZN C 374 A 158 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.15 -33.59 59.71 14.10 -32.75 60.59 coo -4.62 32.83 147.14 -5.50 32.85 149.12 18.12 -36.96 61.09 16.83 -36.96 62.86 coo -0.83 29.57 149.77 -0.39 31.47 148.95 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 A 70 ALA C 46 ALA^? 12.13 ZN ZN C 374 A 126 LEU C 47 LEU.? 6.79 ZN ZN C 374 A 158 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.15 -33.59 59.71 14.10 -32.75 60.59 coo -4.62 32.83 147.14 -5.50 32.85 149.12 8.91 -31.30 59.57 7.16 -30.19 58.83 coo -0.83 29.57 149.77 -0.39 31.47 148.95 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 A 70 ALA C 62 ALA.? 21.65 ZN ZN C 375 A 126 LEU C 44 LEU^? 17.58 ZN ZN C 374 A 158 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -2.29 37.66 144.73 -1.46 37.12 145.87 23.65 -38.52 62.14 22.14 -38.28 62.04 coo -4.62 32.83 147.14 -5.50 32.85 149.12 18.12 -36.96 61.09 16.83 -36.96 62.86 coo -0.83 29.57 149.77 -0.39 31.47 148.95 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 A 70 ALA C 62 ALA.? 21.65 ZN ZN C 375 A 126 LEU C 60 LEU~? 23.23 ZN ZN C 374 A 158 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -2.29 37.66 144.73 -1.46 37.12 145.87 23.65 -38.52 62.14 22.14 -38.28 62.04 coo -4.62 32.83 147.14 -5.50 32.85 149.12 20.70 -41.02 65.46 18.61 -41.53 65.48 coo -0.83 29.57 149.77 -0.39 31.47 148.95 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 A 70 ALA C 67 ALA^? 10.56 ZN ZN C 374 A 126 LEU C 47 LEU.? 6.79 ZN ZN C 374 A 158 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo -2.29 37.66 144.73 -1.46 37.12 145.87 14.85 -30.74 56.60 15.29 -29.68 57.59 coo -4.62 32.83 147.14 -5.50 32.85 149.12 8.91 -31.30 59.57 7.16 -30.19 58.83 coo -0.83 29.57 149.77 -0.39 31.47 148.95 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 A 70 ALA C 109 ALA~? 11.05 ZN ZN C 375 A 126 LEU C 243 LEU^? 14.43 ZN ZN C 375 A 158 GLU C 241 GLU^? 18.99 ZN ZN C 375 coo -2.29 37.66 144.73 -1.46 37.12 145.87 7.53 -33.10 43.39 8.93 -33.54 43.81 coo -4.62 32.83 147.14 -5.50 32.85 149.12 5.40 -30.33 38.72 6.46 -32.27 38.57 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.84 -34.67 34.91 4.64 -36.58 35.93 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 A 70 ALA C 362 ALA^? 16.16 ZN ZN C 375 A 126 LEU C 44 LEU^? 17.58 ZN ZN C 374 A 158 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -2.29 37.66 144.73 -1.46 37.12 145.87 12.58 -40.21 60.40 11.32 -40.85 59.95 coo -4.62 32.83 147.14 -5.50 32.85 149.12 18.12 -36.96 61.09 16.83 -36.96 62.86 coo -0.83 29.57 149.77 -0.39 31.47 148.95 16.30 -37.83 67.27 14.46 -37.72 66.25 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 20 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 46 ALA^? 12.15 ZN ZN A 374 B 126 LEU A 44 LEU^? 17.64 ZN ZN A 374 B 158 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -39.79 4.61 147.27 -39.61 5.56 148.47 41.72 6.36 22.02 41.31 7.82 22.33 coo -34.22 5.06 149.25 -33.65 4.24 151.15 42.07 10.13 16.85 43.67 10.58 18.27 coo -33.03 9.93 151.71 -34.98 9.38 151.11 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 46 ALA^? 12.15 ZN ZN A 374 B 126 LEU A 47 LEU.? 6.92 ZN ZN A 374 B 158 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo -39.79 4.61 147.27 -39.61 5.56 148.47 41.72 6.36 22.02 41.31 7.82 22.33 coo -34.22 5.06 149.25 -33.65 4.24 151.15 42.30 4.26 26.28 42.13 2.67 27.73 coo -33.03 9.93 151.71 -34.98 9.38 151.11 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 62 ALA.? 21.75 ZN ZN A 374 B 126 LEU A 44 LEU^? 17.64 ZN ZN A 374 B 158 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -39.79 4.61 147.27 -39.61 5.56 148.47 41.03 13.97 12.85 41.56 12.98 13.85 coo -34.22 5.06 149.25 -33.65 4.24 151.15 42.07 10.13 16.85 43.67 10.58 18.27 coo -33.03 9.93 151.71 -34.98 9.38 151.11 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 62 ALA.? 21.75 ZN ZN A 374 B 126 LEU A 60 LEU~? 22.83 ZN ZN A 374 B 158 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -39.79 4.61 147.27 -39.61 5.56 148.47 41.03 13.97 12.85 41.56 12.98 13.85 coo -34.22 5.06 149.25 -33.65 4.24 151.15 45.69 14.02 13.98 46.89 12.37 14.74 coo -33.03 9.93 151.71 -34.98 9.38 151.11 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA A 67 ALA^? 10.32 ZN ZN A 374 B 126 LEU A 47 LEU.? 6.92 ZN ZN A 374 B 158 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo -39.79 4.61 147.27 -39.61 5.56 148.47 37.22 5.65 22.28 37.04 6.85 23.17 coo -34.22 5.06 149.25 -33.65 4.24 151.15 42.30 4.26 26.28 42.13 2.67 27.73 coo -33.03 9.93 151.71 -34.98 9.38 151.11 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA A 109 ALA~? 11.42 ZN ZN A 375 B 126 LEU A 243 LEU^? 14.05 O3 TRS A 378 B 158 GLU A 241 GLU^? 13.09 O3 TRS A 378 coo -39.79 4.61 147.27 -39.61 5.56 148.47 34.68 -9.30 20.20 34.40 -8.19 19.19 coo -34.22 5.06 149.25 -33.65 4.24 151.15 31.75 -13.70 22.02 32.50 -13.55 19.95 coo -33.03 9.93 151.71 -34.98 9.38 151.11 32.85 -18.83 18.59 34.29 -17.80 17.42 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA A 362 ALA^? 15.97 ZN ZN A 375 B 126 LEU A 44 LEU^? 17.64 ZN ZN A 374 B 158 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -39.79 4.61 147.27 -39.61 5.56 148.47 46.25 5.46 17.59 47.00 4.15 17.82 coo -34.22 5.06 149.25 -33.65 4.24 151.15 42.07 10.13 16.85 43.67 10.58 18.27 coo -33.03 9.93 151.71 -34.98 9.38 151.11 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA B 46 ALA^? 12.02 ZN ZN B 374 B 126 LEU B 44 LEU^? 17.53 ZN ZN B 374 B 158 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -20.28 4.12 23.98 -20.70 4.20 25.49 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -25.93 1.38 24.86 -26.10 3.53 24.59 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA B 46 ALA^? 12.02 ZN ZN B 374 B 126 LEU B 47 LEU.? 6.75 ZN ZN B 374 B 158 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo -39.79 4.61 147.27 -39.61 5.56 148.47 -20.28 4.12 23.98 -20.70 4.20 25.49 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -16.64 7.19 23.14 -14.64 7.83 22.57 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA B 62 ALA.? 21.54 ZN ZN B 374 B 126 LEU B 44 LEU^? 17.53 ZN ZN B 374 B 158 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -25.93 1.38 24.86 -26.10 3.53 24.59 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA B 62 ALA.? 21.54 ZN ZN B 374 B 126 LEU B 60 LEU~? 22.96 ZN ZN B 374 B 158 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -32.08 2.39 24.63 -31.26 3.48 22.97 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 B 70 ALA B 67 ALA^? 10.44 ZN ZN B 374 B 126 LEU B 47 LEU.? 6.75 ZN ZN B 374 B 158 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo -39.79 4.61 147.27 -39.61 5.56 148.47 -17.51 1.20 26.23 -17.65 1.96 27.53 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -16.64 7.19 23.14 -14.64 7.83 22.57 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 B 70 ALA B 362 ALA^? 16.08 ZN ZN B 375 B 126 LEU B 44 LEU^? 17.53 ZN ZN B 374 B 158 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -24.59 3.58 19.16 -24.10 3.96 17.83 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -25.93 1.38 24.86 -26.10 3.53 24.59 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 B 70 ALA C 46 ALA^? 12.13 ZN ZN C 374 B 126 LEU C 44 LEU^? 17.58 ZN ZN C 374 B 158 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.15 -33.59 59.71 14.10 -32.75 60.59 coo -34.22 5.06 149.25 -33.65 4.24 151.15 18.12 -36.96 61.09 16.83 -36.96 62.86 coo -33.03 9.93 151.71 -34.98 9.38 151.11 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 B 70 ALA C 46 ALA^? 12.13 ZN ZN C 374 B 126 LEU C 47 LEU.? 6.79 ZN ZN C 374 B 158 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.15 -33.59 59.71 14.10 -32.75 60.59 coo -34.22 5.06 149.25 -33.65 4.24 151.15 8.91 -31.30 59.57 7.16 -30.19 58.83 coo -33.03 9.93 151.71 -34.98 9.38 151.11 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 B 70 ALA C 62 ALA.? 21.65 ZN ZN C 375 B 126 LEU C 44 LEU^? 17.58 ZN ZN C 374 B 158 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -39.79 4.61 147.27 -39.61 5.56 148.47 23.65 -38.52 62.14 22.14 -38.28 62.04 coo -34.22 5.06 149.25 -33.65 4.24 151.15 18.12 -36.96 61.09 16.83 -36.96 62.86 coo -33.03 9.93 151.71 -34.98 9.38 151.11 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 B 70 ALA C 62 ALA.? 21.65 ZN ZN C 375 B 126 LEU C 60 LEU~? 23.23 ZN ZN C 374 B 158 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -39.79 4.61 147.27 -39.61 5.56 148.47 23.65 -38.52 62.14 22.14 -38.28 62.04 coo -34.22 5.06 149.25 -33.65 4.24 151.15 20.70 -41.02 65.46 18.61 -41.53 65.48 coo -33.03 9.93 151.71 -34.98 9.38 151.11 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 B 70 ALA C 67 ALA^? 10.56 ZN ZN C 374 B 126 LEU C 47 LEU.? 6.79 ZN ZN C 374 B 158 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo -39.79 4.61 147.27 -39.61 5.56 148.47 14.85 -30.74 56.60 15.29 -29.68 57.59 coo -34.22 5.06 149.25 -33.65 4.24 151.15 8.91 -31.30 59.57 7.16 -30.19 58.83 coo -33.03 9.93 151.71 -34.98 9.38 151.11 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 B 70 ALA C 109 ALA~? 11.05 ZN ZN C 375 B 126 LEU C 243 LEU^? 14.43 ZN ZN C 375 B 158 GLU C 241 GLU^? 18.99 ZN ZN C 375 coo -39.79 4.61 147.27 -39.61 5.56 148.47 7.53 -33.10 43.39 8.93 -33.54 43.81 coo -34.22 5.06 149.25 -33.65 4.24 151.15 5.40 -30.33 38.72 6.46 -32.27 38.57 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.84 -34.67 34.91 4.64 -36.58 35.93 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 B 70 ALA C 362 ALA^? 16.16 ZN ZN C 375 B 126 LEU C 44 LEU^? 17.58 ZN ZN C 374 B 158 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -39.79 4.61 147.27 -39.61 5.56 148.47 12.58 -40.21 60.40 11.32 -40.85 59.95 coo -34.22 5.06 149.25 -33.65 4.24 151.15 18.12 -36.96 61.09 16.83 -36.96 62.86 coo -33.03 9.93 151.71 -34.98 9.38 151.11 16.30 -37.83 67.27 14.46 -37.72 66.25 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 20 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 46 ALA^? 12.15 ZN ZN A 374 C 126 LEU A 44 LEU^? 17.64 ZN ZN A 374 C 158 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 41.72 6.36 22.02 41.31 7.82 22.33 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 42.07 10.13 16.85 43.67 10.58 18.27 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 46 ALA^? 12.15 ZN ZN A 374 C 126 LEU A 47 LEU.? 6.92 ZN ZN A 374 C 158 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 41.72 6.36 22.02 41.31 7.82 22.33 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 42.30 4.26 26.28 42.13 2.67 27.73 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 62 ALA.? 21.75 ZN ZN A 374 C 126 LEU A 44 LEU^? 17.64 ZN ZN A 374 C 158 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 41.03 13.97 12.85 41.56 12.98 13.85 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 42.07 10.13 16.85 43.67 10.58 18.27 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 62 ALA.? 21.75 ZN ZN A 374 C 126 LEU A 60 LEU~? 22.83 ZN ZN A 374 C 158 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 41.03 13.97 12.85 41.56 12.98 13.85 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 45.69 14.02 13.98 46.89 12.37 14.74 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA A 67 ALA^? 10.32 ZN ZN A 374 C 126 LEU A 47 LEU.? 6.92 ZN ZN A 374 C 158 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 37.22 5.65 22.28 37.04 6.85 23.17 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 42.30 4.26 26.28 42.13 2.67 27.73 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA A 109 ALA~? 11.42 ZN ZN A 375 C 126 LEU A 243 LEU^? 14.05 O3 TRS A 378 C 158 GLU A 241 GLU^? 13.09 O3 TRS A 378 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 34.68 -9.30 20.20 34.40 -8.19 19.19 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 31.75 -13.70 22.02 32.50 -13.55 19.95 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 32.85 -18.83 18.59 34.29 -17.80 17.42 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA A 362 ALA^? 15.97 ZN ZN A 375 C 126 LEU A 44 LEU^? 17.64 ZN ZN A 374 C 158 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 46.25 5.46 17.59 47.00 4.15 17.82 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 42.07 10.13 16.85 43.67 10.58 18.27 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA B 46 ALA^? 12.02 ZN ZN B 374 C 126 LEU B 44 LEU^? 17.53 ZN ZN B 374 C 158 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -20.28 4.12 23.98 -20.70 4.20 25.49 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -25.93 1.38 24.86 -26.10 3.53 24.59 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA B 46 ALA^? 12.02 ZN ZN B 374 C 126 LEU B 47 LEU.? 6.75 ZN ZN B 374 C 158 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -20.28 4.12 23.98 -20.70 4.20 25.49 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -16.64 7.19 23.14 -14.64 7.83 22.57 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA B 62 ALA.? 21.54 ZN ZN B 374 C 126 LEU B 44 LEU^? 17.53 ZN ZN B 374 C 158 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -25.93 1.38 24.86 -26.10 3.53 24.59 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA B 62 ALA.? 21.54 ZN ZN B 374 C 126 LEU B 60 LEU~? 22.96 ZN ZN B 374 C 158 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -32.08 2.39 24.63 -31.26 3.48 22.97 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 C 70 ALA B 67 ALA^? 10.44 ZN ZN B 374 C 126 LEU B 47 LEU.? 6.75 ZN ZN B 374 C 158 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -16.64 7.19 23.14 -14.64 7.83 22.57 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 C 70 ALA B 362 ALA^? 16.08 ZN ZN B 375 C 126 LEU B 44 LEU^? 17.53 ZN ZN B 374 C 158 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -24.59 3.58 19.16 -24.10 3.96 17.83 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -25.93 1.38 24.86 -26.10 3.53 24.59 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 C 70 ALA C 46 ALA^? 12.13 ZN ZN C 374 C 126 LEU C 44 LEU^? 17.58 ZN ZN C 374 C 158 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.15 -33.59 59.71 14.10 -32.75 60.59 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 18.12 -36.96 61.09 16.83 -36.96 62.86 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 C 70 ALA C 46 ALA^? 12.13 ZN ZN C 374 C 126 LEU C 47 LEU.? 6.79 ZN ZN C 374 C 158 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.15 -33.59 59.71 14.10 -32.75 60.59 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 8.91 -31.30 59.57 7.16 -30.19 58.83 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 C 70 ALA C 62 ALA.? 21.65 ZN ZN C 375 C 126 LEU C 44 LEU^? 17.58 ZN ZN C 374 C 158 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 23.65 -38.52 62.14 22.14 -38.28 62.04 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 18.12 -36.96 61.09 16.83 -36.96 62.86 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 C 70 ALA C 62 ALA.? 21.65 ZN ZN C 375 C 126 LEU C 60 LEU~? 23.23 ZN ZN C 374 C 158 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 23.65 -38.52 62.14 22.14 -38.28 62.04 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 20.70 -41.02 65.46 18.61 -41.53 65.48 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 C 70 ALA C 67 ALA^? 10.56 ZN ZN C 374 C 126 LEU C 47 LEU.? 6.79 ZN ZN C 374 C 158 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 8.91 -31.30 59.57 7.16 -30.19 58.83 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 C 70 ALA C 109 ALA~? 11.05 ZN ZN C 375 C 126 LEU C 243 LEU^? 14.43 ZN ZN C 375 C 158 GLU C 241 GLU^? 18.99 ZN ZN C 375 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 7.53 -33.10 43.39 8.93 -33.54 43.81 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 5.40 -30.33 38.72 6.46 -32.27 38.57 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.84 -34.67 34.91 4.64 -36.58 35.93 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 C 70 ALA C 161 ALA.? 14.45 O1 TRS A 378 C 126 LEU C 212 LEU~? 13.73 O1 TRS A 378 C 158 GLU C 135 GLU^? 15.12 O1 TRS A 378 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 14.54 -40.01 25.90 15.56 -39.75 24.83 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 16.61 -35.95 30.24 15.92 -37.59 31.51 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 11.24 -30.50 31.64 12.59 -30.76 33.22 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 C 70 ALA C 362 ALA^? 16.16 ZN ZN C 375 C 126 LEU C 44 LEU^? 17.58 ZN ZN C 374 C 158 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 12.58 -40.21 60.40 11.32 -40.85 59.95 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 18.12 -36.96 61.09 16.83 -36.96 62.86 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 16.30 -37.83 67.27 14.46 -37.72 66.25 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 21 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 270 LYS A 20 LYS~? 16.95 ZN ZN A 375 A 382 MET A 339 MET~? 7.71 ZN ZN A 375 coo -27.63 121.99 45.48 -26.66 123.86 45.68 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -32.20 115.91 49.56 -31.37 121.03 53.12 26.66 -3.22 19.04 24.73 2.41 18.30 coo -23.75 127.89 58.42 -26.02 128.79 55.12 43.12 -1.71 22.29 41.25 0.94 22.96 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 270 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 382 MET A 137 MET^? 8.23 C3 TRS A 378 coo -27.63 121.99 45.48 -26.66 123.86 45.68 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -32.20 115.91 49.56 -31.37 121.03 53.12 3.52 -23.27 14.19 3.97 -21.31 18.72 coo -23.75 127.89 58.42 -26.02 128.79 55.12 21.20 -20.99 14.90 24.40 -21.15 14.55 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 270 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 382 MET A 137 MET^? 8.23 C3 TRS A 378 coo -27.63 121.99 45.48 -26.66 123.86 45.68 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -32.20 115.91 49.56 -31.37 121.03 53.12 4.48 -26.42 12.36 5.89 -27.34 7.19 coo -23.75 127.89 58.42 -26.02 128.79 55.12 21.20 -20.99 14.90 24.40 -21.15 14.55 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP A 237 ASP^? 6.80 N TRS A 378 A 270 LYS A 239 LYS^? -7.47 O3 TRS A 378s A 382 MET C 220 MET~? 9.16 C2 TRS A 378 coo -27.63 121.99 45.48 -26.66 123.86 45.68 18.36 -25.38 21.90 16.49 -24.92 22.81 coo -32.20 115.91 49.56 -31.37 121.03 53.12 24.38 -22.19 19.59 20.35 -19.68 21.34 coo -23.75 127.89 58.42 -26.02 128.79 55.12 23.85 -40.53 22.14 22.02 -37.51 20.07 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 5 3 # 5 A 248 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 270 LYS A 265 LYS~? 22.38 ZN ZN A 374 A 382 MET A 339 MET~? 7.71 ZN ZN A 375 coo -27.63 121.99 45.48 -26.66 123.86 45.68 54.82 -1.21 28.36 56.43 0.27 28.67 coo -32.20 115.91 49.56 -31.37 121.03 53.12 54.99 -5.46 33.76 58.41 -3.92 38.21 coo -23.75 127.89 58.42 -26.02 128.79 55.12 43.12 -1.71 22.29 41.25 0.94 22.96 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 6 3 # 6 A 248 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 270 LYS A 271 LYS.? 23.00 ZN ZN A 374 A 382 MET A 339 MET~? 7.71 ZN ZN A 375 coo -27.63 121.99 45.48 -26.66 123.86 45.68 54.82 -1.21 28.36 56.43 0.27 28.67 coo -32.20 115.91 49.56 -31.37 121.03 53.12 56.12 0.48 35.73 59.67 4.01 35.99 coo -23.75 127.89 58.42 -26.02 128.79 55.12 43.12 -1.71 22.29 41.25 0.94 22.96 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 7 3 # 7 A 248 ASP A 280 ASP.? 32.54 ZN ZN A 374 A 270 LYS A 282 LYS^? 34.08 ZN ZN A 375 A 382 MET A 322 MET~? 24.63 ZN ZN A 374 coo -27.63 121.99 45.48 -26.66 123.86 45.68 57.62 -18.45 47.11 59.50 -17.52 47.44 coo -32.20 115.91 49.56 -31.37 121.03 53.12 53.78 -21.68 41.24 59.13 -25.09 41.65 coo -23.75 127.89 58.42 -26.02 128.79 55.12 42.74 -14.71 48.99 44.93 -11.90 51.14 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 8 3 # 8 A 248 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 270 LYS A 282 LYS^? 34.08 ZN ZN A 375 A 382 MET A 322 MET~? 24.63 ZN ZN A 374 coo -27.63 121.99 45.48 -26.66 123.86 45.68 47.82 -20.71 38.37 47.81 -22.84 38.27 coo -32.20 115.91 49.56 -31.37 121.03 53.12 53.78 -21.68 41.24 59.13 -25.09 41.65 coo -23.75 127.89 58.42 -26.02 128.79 55.12 42.74 -14.71 48.99 44.93 -11.90 51.14 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 9 3 # 9 A 248 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 270 LYS A 282 LYS^? 34.08 ZN ZN A 375 A 382 MET A 323 MET~? 24.46 O3S EPE C 376 coo -27.63 121.99 45.48 -26.66 123.86 45.68 47.82 -20.71 38.37 47.81 -22.84 38.27 coo -32.20 115.91 49.56 -31.37 121.03 53.12 53.78 -21.68 41.24 59.13 -25.09 41.65 coo -23.75 127.89 58.42 -26.02 128.79 55.12 40.04 -16.78 50.64 37.55 -15.19 53.60 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 10 3 # 10 A 248 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 270 LYS A 303 LYS~? 13.81 O3 TRS A 378 A 382 MET A 322 MET~? 24.63 ZN ZN A 374 coo -27.63 121.99 45.48 -26.66 123.86 45.68 47.82 -20.71 38.37 47.81 -22.84 38.27 coo -32.20 115.91 49.56 -31.37 121.03 53.12 37.93 -22.13 35.45 34.81 -22.43 31.07 coo -23.75 127.89 58.42 -26.02 128.79 55.12 42.74 -14.71 48.99 44.93 -11.90 51.14 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 11 3 # 11 A 248 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 270 LYS A 303 LYS~? 13.81 O3 TRS A 378 A 382 MET A 323 MET~? 24.46 O3S EPE C 376 coo -27.63 121.99 45.48 -26.66 123.86 45.68 47.82 -20.71 38.37 47.81 -22.84 38.27 coo -32.20 115.91 49.56 -31.37 121.03 53.12 37.93 -22.13 35.45 34.81 -22.43 31.07 coo -23.75 127.89 58.42 -26.02 128.79 55.12 40.04 -16.78 50.64 37.55 -15.19 53.60 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 12 3 # 12 A 248 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 270 LYS A 271 LYS.? 23.00 ZN ZN A 374 A 382 MET A 313 MET.? 14.44 ZN ZN A 374 coo -27.63 121.99 45.48 -26.66 123.86 45.68 48.24 5.16 33.58 47.82 3.96 35.30 coo -32.20 115.91 49.56 -31.37 121.03 53.12 56.12 0.48 35.73 59.67 4.01 35.99 coo -23.75 127.89 58.42 -26.02 128.79 55.12 41.01 -4.53 42.47 40.91 -7.82 42.53 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 13 3 # 13 A 248 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 270 LYS A 271 LYS.? 23.00 ZN ZN A 374 A 382 MET A 339 MET~? 7.71 ZN ZN A 375 coo -27.63 121.99 45.48 -26.66 123.86 45.68 48.24 5.16 33.58 47.82 3.96 35.30 coo -32.20 115.91 49.56 -31.37 121.03 53.12 56.12 0.48 35.73 59.67 4.01 35.99 coo -23.75 127.89 58.42 -26.02 128.79 55.12 43.12 -1.71 22.29 41.25 0.94 22.96 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 14 3 # 14 A 248 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 270 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 382 MET A 313 MET.? 14.44 ZN ZN A 374 coo -27.63 121.99 45.48 -26.66 123.86 45.68 48.24 5.16 33.58 47.82 3.96 35.30 coo -32.20 115.91 49.56 -31.37 121.03 53.12 45.66 0.76 26.15 51.53 0.58 28.90 coo -23.75 127.89 58.42 -26.02 128.79 55.12 41.01 -4.53 42.47 40.91 -7.82 42.53 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 15 3 # 15 A 248 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 270 LYS B 247 LYS^? 11.69 ZN ZN B 375 A 382 MET B 17 MET~? 16.48 ZN ZN B 375 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -13.48 -9.52 16.64 -17.15 -8.03 15.19 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 16 3 # 16 A 248 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 270 LYS C 138 LYS^? 8.30 N TRS A 378 A 382 MET B 137 MET^? 10.79 O1S EPE A 377 coo -27.63 121.99 45.48 -26.66 123.86 45.68 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -32.20 115.91 49.56 -31.37 121.03 53.12 12.95 -30.51 23.19 15.44 -26.53 25.46 coo -23.75 127.89 58.42 -26.02 128.79 55.12 3.03 -19.66 13.17 1.49 -18.13 10.61 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 17 3 # 17 A 248 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 270 LYS C 139 LYS^? 16.11 N TRS A 378 A 382 MET B 137 MET^? 10.79 O1S EPE A 377 coo -27.63 121.99 45.48 -26.66 123.86 45.68 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -32.20 115.91 49.56 -31.37 121.03 53.12 13.08 -32.56 20.05 9.65 -36.55 18.68 coo -23.75 127.89 58.42 -26.02 128.79 55.12 3.03 -19.66 13.17 1.49 -18.13 10.61 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 18 3 # 18 A 248 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 270 LYS B 265 LYS~? 21.91 ZN ZN B 374 A 382 MET B 339 MET~? 7.80 ZN ZN B 375 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -18.05 15.19 12.20 -19.75 16.35 12.84 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -12.32 18.80 10.54 -12.89 23.62 10.63 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -15.74 3.47 17.20 -16.17 3.12 20.66 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 19 3 # 19 A 248 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 270 LYS B 271 LYS.? 19.93 ZN ZN B 374 A 382 MET B 339 MET~? 7.80 ZN ZN B 375 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -18.05 15.19 12.20 -19.75 16.35 12.84 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -15.49 22.23 14.65 -19.95 19.84 13.72 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -15.74 3.47 17.20 -16.17 3.12 20.66 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 20 3 # 20 A 248 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 270 LYS B 303 LYS~? 19.29 ZN ZN B 375 A 382 MET B 323 MET~? 24.24 O2S EPE A 376 coo -27.63 121.99 45.48 -26.66 123.86 45.68 3.99 14.73 5.36 5.18 14.04 3.76 coo -32.20 115.91 49.56 -31.37 121.03 53.12 7.99 5.97 9.05 6.92 1.04 11.01 coo -23.75 127.89 58.42 -26.02 128.79 55.12 12.24 19.68 16.05 14.16 20.76 19.55 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 21 3 # 21 A 248 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 270 LYS B 271 LYS.? 19.93 ZN ZN B 374 A 382 MET B 313 MET.? 15.01 ZN ZN B 374 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -15.49 22.23 14.65 -19.95 19.84 13.72 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -1.01 16.88 22.10 1.78 16.47 20.27 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 22 3 # 22 A 248 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 270 LYS B 271 LYS.? 19.93 ZN ZN B 374 A 382 MET B 339 MET~? 7.80 ZN ZN B 375 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -15.49 22.23 14.65 -19.95 19.84 13.72 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -15.74 3.47 17.20 -16.17 3.12 20.66 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 23 3 # 23 A 248 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 270 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 382 MET B 313 MET.? 15.01 ZN ZN B 374 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -1.01 16.88 22.10 1.78 16.47 20.27 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 24 3 # 24 A 248 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 270 LYS C 247 LYS^? 13.94 ZN ZN C 375 A 382 MET C 17 MET.? 16.53 ZN ZN C 375 coo -27.63 121.99 45.48 -26.66 123.86 45.68 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo -23.75 127.89 58.42 -26.02 128.79 55.12 13.75 -37.43 43.44 13.77 -40.60 46.20 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 25 3 # 25 A 248 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 270 LYS A 138 LYS^? 13.11 N TRS A 378 A 382 MET C 137 MET^? 16.10 N TRS A 378 coo -27.63 121.99 45.48 -26.66 123.86 45.68 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -32.20 115.91 49.56 -31.37 121.03 53.12 18.11 -21.79 12.78 16.12 -17.81 15.44 coo -23.75 127.89 58.42 -26.02 128.79 55.12 10.38 -30.05 25.93 8.74 -32.72 27.60 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 26 3 # 26 A 248 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 270 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 382 MET C 137 MET^? 16.10 N TRS A 378 coo -27.63 121.99 45.48 -26.66 123.86 45.68 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -32.20 115.91 49.56 -31.37 121.03 53.12 17.05 -24.82 10.77 19.64 -29.66 10.35 coo -23.75 127.89 58.42 -26.02 128.79 55.12 10.38 -30.05 25.93 8.74 -32.72 27.60 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 27 3 # 27 A 248 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 270 LYS C 239 LYS^? 16.29 N TRS A 378 A 382 MET B 220 MET~? 13.50 O3S EPE A 377 coo -27.63 121.99 45.48 -26.66 123.86 45.68 4.59 -25.19 21.63 5.07 -23.28 20.96 coo -32.20 115.91 49.56 -31.37 121.03 53.12 5.15 -29.07 27.87 7.72 -24.69 27.36 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -6.53 -34.33 14.17 -2.53 -33.87 15.25 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 28 3 # 28 A 248 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 270 LYS C 303 LYS~? 17.98 ZN ZN C 375 A 382 MET C 323 MET~? 23.81 O2S EPE B 376 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -17.70 -15.74 49.94 -17.30 -11.60 50.59 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 29 3 # 29 A 248 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 270 LYS C 271 LYS.? 19.51 ZN ZN C 374 A 382 MET C 313 MET.? 14.23 ZN ZN C 374 coo -27.63 121.99 45.48 -26.66 123.86 45.68 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -5.68 -20.02 57.53 -7.42 -20.42 54.94 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 30 3 # 30 A 248 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 270 LYS C 271 LYS.? 19.51 ZN ZN C 374 A 382 MET C 339 MET~? 7.62 ZN ZN C 375 coo -27.63 121.99 45.48 -26.66 123.86 45.68 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo -23.75 127.89 58.42 -26.02 128.79 55.12 7.06 -36.01 54.74 9.35 -33.59 55.66 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 31 3 # 31 A 248 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 270 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 382 MET C 313 MET.? 14.23 ZN ZN C 374 coo -27.63 121.99 45.48 -26.66 123.86 45.68 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -32.20 115.91 49.56 -31.37 121.03 53.12 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -5.68 -20.02 57.53 -7.42 -20.42 54.94 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 31 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 270 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 382 MET A 220 MET~? 11.61 C3 EPE A 377 coo -11.82 154.51 43.38 -12.86 152.74 43.79 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -5.09 158.39 43.41 -0.74 158.80 47.15 17.05 -24.82 10.77 19.64 -29.66 10.35 coo -2.79 145.52 50.38 -5.75 148.14 51.66 17.48 -20.70 -2.10 15.36 -22.19 1.11 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP A 237 ASP^? 6.80 N TRS A 378 B 270 LYS C 138 LYS^? 8.30 N TRS A 378 B 382 MET C 220 MET~? 9.16 C2 TRS A 378 coo -11.82 154.51 43.38 -12.86 152.74 43.79 18.36 -25.38 21.90 16.49 -24.92 22.81 coo -5.09 158.39 43.41 -0.74 158.80 47.15 12.95 -30.51 23.19 15.44 -26.53 25.46 coo -2.79 145.52 50.38 -5.75 148.14 51.66 23.85 -40.53 22.14 22.02 -37.51 20.07 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 3 3 # 3 B 248 ASP A 237 ASP^? 6.80 N TRS A 378 B 270 LYS C 139 LYS^? 16.11 N TRS A 378 B 382 MET C 220 MET~? 9.16 C2 TRS A 378 coo -11.82 154.51 43.38 -12.86 152.74 43.79 18.36 -25.38 21.90 16.49 -24.92 22.81 coo -5.09 158.39 43.41 -0.74 158.80 47.15 13.08 -32.56 20.05 9.65 -36.55 18.68 coo -2.79 145.52 50.38 -5.75 148.14 51.66 23.85 -40.53 22.14 22.02 -37.51 20.07 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 4 3 # 4 B 248 ASP A 280 ASP.? 32.54 ZN ZN A 374 B 270 LYS A 282 LYS^? 34.08 ZN ZN A 375 B 382 MET A 322 MET~? 24.63 ZN ZN A 374 coo -11.82 154.51 43.38 -12.86 152.74 43.79 57.62 -18.45 47.11 59.50 -17.52 47.44 coo -5.09 158.39 43.41 -0.74 158.80 47.15 53.78 -21.68 41.24 59.13 -25.09 41.65 coo -2.79 145.52 50.38 -5.75 148.14 51.66 42.74 -14.71 48.99 44.93 -11.90 51.14 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 5 3 # 5 B 248 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 270 LYS A 295 LYS.? 12.61 ZN ZN A 374 B 382 MET A 24 MET.? 9.96 ZN ZN A 375 coo -11.82 154.51 43.38 -12.86 152.74 43.79 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -5.09 158.39 43.41 -0.74 158.80 47.15 32.96 -9.31 39.54 28.55 -6.00 37.21 coo -2.79 145.52 50.38 -5.75 148.14 51.66 26.57 -5.51 28.15 29.00 -7.95 29.25 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 6 3 # 6 B 248 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 270 LYS A 282 LYS^? 34.08 ZN ZN A 375 B 382 MET A 322 MET~? 24.63 ZN ZN A 374 coo -11.82 154.51 43.38 -12.86 152.74 43.79 47.82 -20.71 38.37 47.81 -22.84 38.27 coo -5.09 158.39 43.41 -0.74 158.80 47.15 53.78 -21.68 41.24 59.13 -25.09 41.65 coo -2.79 145.52 50.38 -5.75 148.14 51.66 42.74 -14.71 48.99 44.93 -11.90 51.14 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 7 3 # 7 B 248 ASP A 352 ASP~? 25.70 ZN ZN A 375 B 270 LYS A 354 LYS~? 27.90 ZN ZN A 375 B 382 MET A 17 MET~? 16.55 ZN ZN A 375 coo -11.82 154.51 43.38 -12.86 152.74 43.79 43.66 -0.56 3.32 44.78 0.99 4.29 coo -5.09 158.39 43.41 -0.74 158.80 47.15 37.47 -0.90 0.73 32.51 -2.58 1.13 coo -2.79 145.52 50.38 -5.75 148.14 51.66 34.23 -6.11 13.54 37.82 -4.55 12.22 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 8 3 # 8 B 248 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 270 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 382 MET B 220 MET~? 13.50 O3S EPE A 377 coo -11.82 154.51 43.38 -12.86 152.74 43.79 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -5.09 158.39 43.41 -0.74 158.80 47.15 4.48 -26.42 12.36 5.89 -27.34 7.19 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -6.53 -34.33 14.17 -2.53 -33.87 15.25 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 9 3 # 9 B 248 ASP B 237 ASP^? 15.58 N TRS A 378 B 270 LYS A 138 LYS^? 13.11 N TRS A 378 B 382 MET A 220 MET~? 11.61 C3 EPE A 377 coo -11.82 154.51 43.38 -12.86 152.74 43.79 11.84 -17.75 12.41 13.28 -17.47 14.02 coo -5.09 158.39 43.41 -0.74 158.80 47.15 18.11 -21.79 12.78 16.12 -17.81 15.44 coo -2.79 145.52 50.38 -5.75 148.14 51.66 17.48 -20.70 -2.10 15.36 -22.19 1.11 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 10 3 # 10 B 248 ASP B 237 ASP^? 15.58 N TRS A 378 B 270 LYS A 139 LYS^? -2.64 O3S EPE C 377s B 382 MET A 220 MET~? 11.61 C3 EPE A 377 coo -11.82 154.51 43.38 -12.86 152.74 43.79 11.84 -17.75 12.41 13.28 -17.47 14.02 coo -5.09 158.39 43.41 -0.74 158.80 47.15 17.05 -24.82 10.77 19.64 -29.66 10.35 coo -2.79 145.52 50.38 -5.75 148.14 51.66 17.48 -20.70 -2.10 15.36 -22.19 1.11 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 11 3 # 11 B 248 ASP B 280 ASP.? 32.17 ZN ZN B 374 B 270 LYS B 282 LYS^? 32.80 ZN ZN B 375 B 382 MET B 322 MET~? 24.52 ZN ZN B 374 coo -11.82 154.51 43.38 -12.86 152.74 43.79 2.63 27.37 3.18 1.41 29.12 3.45 coo -5.09 158.39 43.41 -0.74 158.80 47.15 2.91 20.00 1.64 2.74 22.03 -3.14 coo -2.79 145.52 50.38 -5.75 148.14 51.66 8.65 20.69 15.41 6.89 24.05 17.05 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 12 3 # 12 B 248 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 270 LYS B 295 LYS.? 11.37 ZN ZN B 375 B 382 MET B 24 MET.? 9.91 ZN ZN B 375 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -5.09 158.39 43.41 -0.74 158.80 47.15 4.57 8.76 22.84 2.39 5.01 24.93 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -1.79 -3.46 26.26 -0.86 -1.70 23.68 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 13 3 # 13 B 248 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 270 LYS B 282 LYS^? 32.80 ZN ZN B 375 B 382 MET B 322 MET~? 24.52 ZN ZN B 374 coo -11.82 154.51 43.38 -12.86 152.74 43.79 3.99 14.73 5.36 5.18 14.04 3.76 coo -5.09 158.39 43.41 -0.74 158.80 47.15 2.91 20.00 1.64 2.74 22.03 -3.14 coo -2.79 145.52 50.38 -5.75 148.14 51.66 8.65 20.69 15.41 6.89 24.05 17.05 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 14 3 # 14 B 248 ASP B 352 ASP~? 25.82 ZN ZN B 375 B 270 LYS B 354 LYS~? 28.15 ZN ZN B 375 B 382 MET B 17 MET~? 16.48 ZN ZN B 375 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -13.48 -9.52 16.64 -17.15 -8.03 15.19 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 15 3 # 15 B 248 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 270 LYS C 139 LYS^? 16.11 N TRS A 378 B 382 MET C 220 MET~? 9.16 C2 TRS A 378 coo -11.82 154.51 43.38 -12.86 152.74 43.79 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -5.09 158.39 43.41 -0.74 158.80 47.15 13.08 -32.56 20.05 9.65 -36.55 18.68 coo -2.79 145.52 50.38 -5.75 148.14 51.66 23.85 -40.53 22.14 22.02 -37.51 20.07 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 16 3 # 16 B 248 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 270 LYS B 138 LYS^? 15.17 O1S EPE A 377 B 382 MET B 220 MET~? 13.50 O3S EPE A 377 coo -11.82 154.51 43.38 -12.86 152.74 43.79 4.59 -25.19 21.63 5.07 -23.28 20.96 coo -5.09 158.39 43.41 -0.74 158.80 47.15 3.52 -23.27 14.19 3.97 -21.31 18.72 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -6.53 -34.33 14.17 -2.53 -33.87 15.25 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 17 3 # 17 B 248 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 270 LYS B 139 LYS^? -2.84 O2S EPE A 377s B 382 MET B 220 MET~? 13.50 O3S EPE A 377 coo -11.82 154.51 43.38 -12.86 152.74 43.79 4.59 -25.19 21.63 5.07 -23.28 20.96 coo -5.09 158.39 43.41 -0.74 158.80 47.15 4.48 -26.42 12.36 5.89 -27.34 7.19 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -6.53 -34.33 14.17 -2.53 -33.87 15.25 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 18 3 # 18 B 248 ASP C 280 ASP.? 31.92 ZN ZN C 374 B 270 LYS C 282 LYS^? 31.82 ZN ZN C 375 B 382 MET C 322 MET~? 24.52 ZN ZN C 374 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -25.13 -30.20 58.02 -25.85 -28.27 58.51 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -21.96 -32.19 51.48 -24.68 -36.28 53.46 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -16.94 -18.33 52.69 -17.35 -17.70 56.74 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 19 3 # 19 B 248 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 270 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 382 MET C 24 MET.? 9.26 ZN ZN C 375 coo -11.82 154.51 43.38 -12.86 152.74 43.79 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo -2.79 145.52 50.38 -5.75 148.14 51.66 9.83 -21.81 43.70 5.99 -22.24 44.97 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 20 3 # 20 B 248 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 270 LYS C 282 LYS^? 31.82 ZN ZN C 375 B 382 MET C 322 MET~? 24.52 ZN ZN C 374 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -21.96 -32.19 51.48 -24.68 -36.28 53.46 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -16.94 -18.33 52.69 -17.35 -17.70 56.74 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 21 3 # 21 B 248 ASP C 352 ASP~? 25.48 ZN ZN C 375 B 270 LYS C 354 LYS~? 23.72 O1 TRS A 378 B 382 MET C 17 MET.? 16.53 ZN ZN C 375 coo -11.82 154.51 43.38 -12.86 152.74 43.79 18.63 -50.25 49.90 18.47 -49.69 51.95 coo -5.09 158.39 43.41 -0.74 158.80 47.15 23.17 -48.48 45.31 22.31 -43.90 41.08 coo -2.79 145.52 50.38 -5.75 148.14 51.66 13.75 -37.43 43.44 13.77 -40.60 46.20 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 21 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 124 GLN^? 23.69 ZN ZN A 375 294 GLU A 127 GLU^? 14.05 O3 TRS A 378 304 ARG A 284 ARG^? 28.58 ZN ZN A 375 coo 15.89 18.45 46.53 15.82 16.91 48.02 50.96 -21.19 24.69 51.48 -20.44 22.75 coo 22.84 13.44 52.91 20.84 13.18 52.38 39.39 -22.49 26.46 38.47 -23.38 24.73 coo 8.71 17.11 46.51 7.23 17.64 49.20 52.06 -24.03 32.92 53.49 -25.85 30.90 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN A 213 GLN~? 14.95 O1S EPE C 377 294 GLU A 135 GLU^? 12.87 C3 TRS A 378 304 ARG A 214 ARG~? 20.32 O1S EPE C 377 coo 15.89 18.45 46.53 15.82 16.91 48.02 16.78 -16.27 7.73 15.34 -16.06 9.27 coo 22.84 13.44 52.91 20.84 13.18 52.38 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 8.71 17.11 46.51 7.23 17.64 49.20 17.59 -9.46 5.35 20.56 -9.02 6.23 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN A 213 GLN~? 14.95 O1S EPE C 377 294 GLU A 136 GLU^? 12.15 O3 TRS A 378 304 ARG A 214 ARG~? 20.32 O1S EPE C 377 coo 15.89 18.45 46.53 15.82 16.91 48.02 16.78 -16.27 7.73 15.34 -16.06 9.27 coo 22.84 13.44 52.91 20.84 13.18 52.38 19.87 -16.93 18.72 17.94 -16.19 18.72 coo 8.71 17.11 46.51 7.23 17.64 49.20 17.59 -9.46 5.35 20.56 -9.02 6.23 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 4 3 # 4 111 GLN C 213 GLN~? -4.56 O1 TRS A 378s 294 GLU C 135 GLU^? 15.12 O1 TRS A 378 304 ARG C 214 ARG~? 11.90 O1 TRS A 378 coo 15.89 18.45 46.53 15.82 16.91 48.02 20.02 -31.25 25.96 19.87 -29.21 25.35 coo 22.84 13.44 52.91 20.84 13.18 52.38 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 8.71 17.11 46.51 7.23 17.64 49.20 25.43 -31.91 31.60 26.96 -33.72 33.51 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 5 3 # 5 111 GLN C 213 GLN~? -4.56 O1 TRS A 378s 294 GLU C 136 GLU^? 12.99 N TRS A 378 304 ARG C 214 ARG~? 11.90 O1 TRS A 378 coo 15.89 18.45 46.53 15.82 16.91 48.02 20.02 -31.25 25.96 19.87 -29.21 25.35 coo 22.84 13.44 52.91 20.84 13.18 52.38 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 8.71 17.11 46.51 7.23 17.64 49.20 25.43 -31.91 31.60 26.96 -33.72 33.51 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 5 hits 1pmi_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 479 PHE A 143 PHE^? -3.89 C10 EPE A 377s A 483 GLU B 205 GLU^? 4.50 O2S EPE A 377 coo 17.33 52.29 2.24 18.71 54.03 0.18 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 20.06 57.44 1.28 18.39 56.19 3.12 8.68 -28.97 1.51 8.47 -29.44 4.22 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 5.77 -31.61 7.46 7.86 -31.06 7.53 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 479 PHE B 172 PHE^? 6.04 C9 EPE A 377 A 483 GLU B 205 GLU^? 4.50 O2S EPE A 377 coo 17.33 52.29 2.24 18.71 54.03 0.18 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 20.06 57.44 1.28 18.39 56.19 3.12 6.52 -33.24 3.28 8.59 -34.82 2.34 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 5.77 -31.61 7.46 7.86 -31.06 7.53 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 A 264 ARG B 203 ARG^? 8.69 O2S EPE A 377 A 479 PHE B 143 PHE^? 13.71 O2S EPE A 377 A 483 GLU C 205 GLU^? 12.89 O3S EPE C 377 coo 17.33 52.29 2.24 18.71 54.03 0.18 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 20.06 57.44 1.28 18.39 56.19 3.12 4.74 -39.41 14.59 7.03 -37.80 14.65 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 11.89 -37.55 15.12 10.61 -36.09 14.30 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 A 264 ARG B 203 ARG^? 8.69 O2S EPE A 377 A 479 PHE C 172 PHE^? 14.49 O2S EPE A 377 A 483 GLU C 205 GLU^? 12.89 O3S EPE C 377 coo 17.33 52.29 2.24 18.71 54.03 0.18 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 20.06 57.44 1.28 18.39 56.19 3.12 9.48 -40.91 13.04 8.71 -41.08 10.37 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 11.89 -37.55 15.12 10.61 -36.09 14.30 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 A 264 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 479 PHE A 172 PHE^? 6.53 C9 EPE C 377 A 483 GLU A 205 GLU^? -4.84 O3S EPE C 377s coo 17.33 52.29 2.24 18.71 54.03 0.18 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 20.06 57.44 1.28 18.39 56.19 3.12 18.79 -35.53 6.28 17.39 -37.92 6.30 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 16.97 -31.31 7.38 16.25 -32.10 9.22 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 A 264 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 479 PHE C 143 PHE^? 4.11 C9 EPE C 377 A 483 GLU A 205 GLU^? -4.84 O3S EPE C 377s coo 17.33 52.29 2.24 18.71 54.03 0.18 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 20.06 57.44 1.28 18.39 56.19 3.12 21.21 -36.18 10.80 19.31 -34.15 10.67 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 16.97 -31.31 7.38 16.25 -32.10 9.22 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 6 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 203 ARG^? 8.58 O3S EPE C 377 B 479 PHE A 143 PHE^? -3.89 C10 EPE A 377s B 483 GLU B 205 GLU^? 4.50 O2S EPE A 377 coo -26.72 93.28 20.13 -28.02 93.55 17.39 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -29.34 90.48 15.69 -27.62 89.95 17.80 8.68 -28.97 1.51 8.47 -29.44 4.22 coo -26.63 95.49 14.65 -25.77 93.77 13.77 5.77 -31.61 7.46 7.86 -31.06 7.53 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG A 203 ARG^? 8.58 O3S EPE C 377 B 479 PHE B 172 PHE^? 6.04 C9 EPE A 377 B 483 GLU B 205 GLU^? 4.50 O2S EPE A 377 coo -26.72 93.28 20.13 -28.02 93.55 17.39 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -29.34 90.48 15.69 -27.62 89.95 17.80 6.52 -33.24 3.28 8.59 -34.82 2.34 coo -26.63 95.49 14.65 -25.77 93.77 13.77 5.77 -31.61 7.46 7.86 -31.06 7.53 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG B 203 ARG^? 8.69 O2S EPE A 377 B 479 PHE B 143 PHE^? 13.71 O2S EPE A 377 B 483 GLU C 205 GLU^? 12.89 O3S EPE C 377 coo -26.72 93.28 20.13 -28.02 93.55 17.39 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -29.34 90.48 15.69 -27.62 89.95 17.80 4.74 -39.41 14.59 7.03 -37.80 14.65 coo -26.63 95.49 14.65 -25.77 93.77 13.77 11.89 -37.55 15.12 10.61 -36.09 14.30 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 B 264 ARG B 203 ARG^? 8.69 O2S EPE A 377 B 479 PHE C 172 PHE^? 14.49 O2S EPE A 377 B 483 GLU C 205 GLU^? 12.89 O3S EPE C 377 coo -26.72 93.28 20.13 -28.02 93.55 17.39 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -29.34 90.48 15.69 -27.62 89.95 17.80 9.48 -40.91 13.04 8.71 -41.08 10.37 coo -26.63 95.49 14.65 -25.77 93.77 13.77 11.89 -37.55 15.12 10.61 -36.09 14.30 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 B 264 ARG C 203 ARG^? 8.27 O3S EPE C 377 B 479 PHE A 172 PHE^? 6.53 C9 EPE C 377 B 483 GLU A 205 GLU^? -4.84 O3S EPE C 377s coo -26.72 93.28 20.13 -28.02 93.55 17.39 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -29.34 90.48 15.69 -27.62 89.95 17.80 18.79 -35.53 6.28 17.39 -37.92 6.30 coo -26.63 95.49 14.65 -25.77 93.77 13.77 16.97 -31.31 7.38 16.25 -32.10 9.22 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 B 264 ARG C 203 ARG^? 8.27 O3S EPE C 377 B 479 PHE C 143 PHE^? 4.11 C9 EPE C 377 B 483 GLU A 205 GLU^? -4.84 O3S EPE C 377s coo -26.72 93.28 20.13 -28.02 93.55 17.39 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -29.34 90.48 15.69 -27.62 89.95 17.80 21.21 -36.18 10.80 19.31 -34.15 10.67 coo -26.63 95.49 14.65 -25.77 93.77 13.77 16.97 -31.31 7.38 16.25 -32.10 9.22 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 6 hits 1pow_c03 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 114 ASN~? 6.65 ZN ZN A 375 A 192 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 195 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo -4.84 51.77 30.37 -3.89 50.12 29.46 39.96 -10.05 26.73 39.22 -8.78 28.27 coo 2.03 47.14 19.75 1.72 46.26 21.64 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 1.41 44.84 24.92 -0.49 45.70 25.19 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN A 114 ASN~? 6.65 ZN ZN A 375 A 192 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 195 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo -4.84 51.77 30.37 -3.89 50.12 29.46 39.96 -10.05 26.73 39.22 -8.78 28.27 coo 2.03 47.14 19.75 1.72 46.26 21.64 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 1.41 44.84 24.92 -0.49 45.70 25.19 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 A 74 ASN A 114 ASN~? 6.65 ZN ZN A 375 A 192 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 195 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo -4.84 51.77 30.37 -3.89 50.12 29.46 39.96 -10.05 26.73 39.22 -8.78 28.27 coo 2.03 47.14 19.75 1.72 46.26 21.64 39.49 -1.24 39.18 39.76 0.49 37.96 coo 1.41 44.84 24.92 -0.49 45.70 25.19 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 A 74 ASN A 334 ASN~? 9.69 ZN ZN A 374 A 192 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 195 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo -4.84 51.77 30.37 -3.89 50.12 29.46 45.98 2.64 32.26 46.53 3.77 30.56 coo 2.03 47.14 19.75 1.72 46.26 21.64 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 1.41 44.84 24.92 -0.49 45.70 25.19 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 A 74 ASN B 114 ASN~? 6.61 ZN ZN B 375 A 192 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 195 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -6.09 3.05 14.26 -5.63 4.05 16.11 coo 2.03 47.14 19.75 1.72 46.26 21.64 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 A 74 ASN B 114 ASN~? 6.61 ZN ZN B 375 A 192 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 195 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -6.09 3.05 14.26 -5.63 4.05 16.11 coo 2.03 47.14 19.75 1.72 46.26 21.64 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 7 3 # 7 A 74 ASN B 334 ASN~? 9.65 ZN ZN B 374 A 192 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 195 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -13.83 13.67 21.41 -15.89 13.09 21.50 coo 2.03 47.14 19.75 1.72 46.26 21.64 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 8 3 # 8 A 74 ASN C 114 ASN~? 6.62 ZN ZN C 375 A 192 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 195 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo -4.84 51.77 30.37 -3.89 50.12 29.46 0.77 -32.01 47.92 1.06 -30.12 48.87 coo 2.03 47.14 19.75 1.72 46.26 21.64 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 1.41 44.84 24.92 -0.49 45.70 25.19 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 9 3 # 9 A 74 ASN C 114 ASN~? 6.62 ZN ZN C 375 A 192 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 195 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo -4.84 51.77 30.37 -3.89 50.12 29.46 0.77 -32.01 47.92 1.06 -30.12 48.87 coo 2.03 47.14 19.75 1.72 46.26 21.64 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 1.41 44.84 24.92 -0.49 45.70 25.19 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 10 3 # 10 A 74 ASN C 334 ASN~? 9.79 ZN ZN C 374 A 192 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 195 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo -4.84 51.77 30.37 -3.89 50.12 29.46 2.44 -29.45 62.54 3.79 -30.90 63.32 coo 2.03 47.14 19.75 1.72 46.26 21.64 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 1.41 44.84 24.92 -0.49 45.70 25.19 9.33 -29.64 54.17 7.95 -29.11 52.67 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 10 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 114 ASN~? 6.65 ZN ZN A 375 B 192 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 195 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo -1.08 51.41 10.34 0.65 52.62 10.17 39.96 -10.05 26.73 39.22 -8.78 28.27 coo 11.36 52.33 5.59 10.18 53.87 6.47 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 7.99 56.74 7.55 6.88 55.39 8.70 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN A 114 ASN~? 6.65 ZN ZN A 375 B 192 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 195 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo -1.08 51.41 10.34 0.65 52.62 10.17 39.96 -10.05 26.73 39.22 -8.78 28.27 coo 11.36 52.33 5.59 10.18 53.87 6.47 39.49 -1.24 39.18 39.76 0.49 37.96 coo 7.99 56.74 7.55 6.88 55.39 8.70 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 B 74 ASN A 334 ASN~? 9.69 ZN ZN A 374 B 192 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 195 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo -1.08 51.41 10.34 0.65 52.62 10.17 45.98 2.64 32.26 46.53 3.77 30.56 coo 11.36 52.33 5.59 10.18 53.87 6.47 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 7.99 56.74 7.55 6.88 55.39 8.70 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 B 74 ASN B 114 ASN~? 6.61 ZN ZN B 375 B 192 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 195 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo -1.08 51.41 10.34 0.65 52.62 10.17 -6.09 3.05 14.26 -5.63 4.05 16.11 coo 11.36 52.33 5.59 10.18 53.87 6.47 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 7.99 56.74 7.55 6.88 55.39 8.70 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 B 74 ASN B 334 ASN~? 9.65 ZN ZN B 374 B 192 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 195 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo -1.08 51.41 10.34 0.65 52.62 10.17 -13.83 13.67 21.41 -15.89 13.09 21.50 coo 11.36 52.33 5.59 10.18 53.87 6.47 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 7.99 56.74 7.55 6.88 55.39 8.70 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 B 74 ASN C 114 ASN~? 6.62 ZN ZN C 375 B 192 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 195 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo -1.08 51.41 10.34 0.65 52.62 10.17 0.77 -32.01 47.92 1.06 -30.12 48.87 coo 11.36 52.33 5.59 10.18 53.87 6.47 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 7.99 56.74 7.55 6.88 55.39 8.70 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 7 3 # 7 B 74 ASN C 114 ASN~? 6.62 ZN ZN C 375 B 192 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 195 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo -1.08 51.41 10.34 0.65 52.62 10.17 0.77 -32.01 47.92 1.06 -30.12 48.87 coo 11.36 52.33 5.59 10.18 53.87 6.47 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 7.99 56.74 7.55 6.88 55.39 8.70 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 8 3 # 8 B 74 ASN C 334 ASN~? 9.79 ZN ZN C 374 B 192 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 195 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo -1.08 51.41 10.34 0.65 52.62 10.17 2.44 -29.45 62.54 3.79 -30.90 63.32 coo 11.36 52.33 5.59 10.18 53.87 6.47 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 7.99 56.74 7.55 6.88 55.39 8.70 9.33 -29.64 54.17 7.95 -29.11 52.67 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 8 hits 1pp4_c03 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 116 LEU~? 10.96 ZN ZN A 375 A 58 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 120 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 34.02 69.29 75.26 34.82 67.82 76.74 44.83 -6.96 22.51 44.39 -5.97 20.61 coo 34.46 72.45 78.57 32.82 72.75 77.28 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 28.96 77.64 81.19 29.05 74.53 77.51 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU A 236 LEU^? 7.58 N TRS A 378 A 58 ASP A 237 ASP^? 6.80 N TRS A 378 A 120 LYS C 138 LYS^? 8.30 N TRS A 378 coo 34.02 69.29 75.26 34.82 67.82 76.74 18.21 -24.75 16.42 18.16 -26.24 14.91 coo 34.46 72.45 78.57 32.82 72.75 77.28 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 28.96 77.64 81.19 29.05 74.53 77.51 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 A 48 LEU A 236 LEU^? 7.58 N TRS A 378 A 58 ASP A 237 ASP^? 6.80 N TRS A 378 A 120 LYS C 139 LYS^? 16.11 N TRS A 378 coo 34.02 69.29 75.26 34.82 67.82 76.74 18.21 -24.75 16.42 18.16 -26.24 14.91 coo 34.46 72.45 78.57 32.82 72.75 77.28 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 28.96 77.64 81.19 29.05 74.53 77.51 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 A 48 LEU A 236 LEU^? 7.58 N TRS A 378 A 58 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 120 LYS C 139 LYS^? 16.11 N TRS A 378 coo 34.02 69.29 75.26 34.82 67.82 76.74 18.21 -24.75 16.42 18.16 -26.24 14.91 coo 34.46 72.45 78.57 32.82 72.75 77.28 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 28.96 77.64 81.19 29.05 74.53 77.51 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 A 48 LEU A 268 LEU~? 13.36 ZN ZN A 375 A 58 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 120 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 34.02 69.29 75.26 34.82 67.82 76.74 50.77 -5.10 30.22 49.37 -6.88 29.87 coo 34.46 72.45 78.57 32.82 72.75 77.28 54.82 -1.21 28.36 56.43 0.27 28.67 coo 28.96 77.64 81.19 29.05 74.53 77.51 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 6 3 # 6 A 48 LEU A 279 LEU.? 26.84 ZN ZN A 374 A 58 ASP A 280 ASP.? 32.54 ZN ZN A 374 A 120 LYS A 282 LYS^? 34.08 ZN ZN A 375 coo 34.02 69.29 75.26 34.82 67.82 76.74 56.39 -13.42 45.75 56.01 -11.28 45.87 coo 34.46 72.45 78.57 32.82 72.75 77.28 57.62 -18.45 47.11 59.50 -17.52 47.44 coo 28.96 77.64 81.19 29.05 74.53 77.51 53.78 -21.68 41.24 59.13 -25.09 41.65 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 7 3 # 7 A 48 LEU A 324 LEU~? 22.85 ZN ZN A 375 A 58 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 120 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 34.02 69.29 75.26 34.82 67.82 76.74 38.83 -17.83 45.97 36.79 -17.52 45.31 coo 34.46 72.45 78.57 32.82 72.75 77.28 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 28.96 77.64 81.19 29.05 74.53 77.51 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 8 3 # 8 A 48 LEU B 116 LEU~? 11.00 ZN ZN B 375 A 58 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 120 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 34.02 69.29 75.26 34.82 67.82 76.74 -12.97 3.46 12.27 -14.57 2.06 12.63 coo 34.46 72.45 78.57 32.82 72.75 77.28 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 28.96 77.64 81.19 29.05 74.53 77.51 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 9 3 # 9 A 48 LEU B 236 LEU^? 9.09 O1S EPE A 377 A 58 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 120 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 34.02 69.29 75.26 34.82 67.82 76.74 7.64 -21.45 12.38 7.43 -23.27 11.24 coo 34.46 72.45 78.57 32.82 72.75 77.28 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 28.96 77.64 81.19 29.05 74.53 77.51 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 10 3 # 10 A 48 LEU B 236 LEU^? 9.09 O1S EPE A 377 A 58 ASP B 237 ASP^? 15.58 N TRS A 378 A 120 LYS A 138 LYS^? 13.11 N TRS A 378 coo 34.02 69.29 75.26 34.82 67.82 76.74 7.64 -21.45 12.38 7.43 -23.27 11.24 coo 34.46 72.45 78.57 32.82 72.75 77.28 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 28.96 77.64 81.19 29.05 74.53 77.51 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 11 3 # 11 A 48 LEU B 236 LEU^? 9.09 O1S EPE A 377 A 58 ASP B 237 ASP^? 15.58 N TRS A 378 A 120 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 34.02 69.29 75.26 34.82 67.82 76.74 7.64 -21.45 12.38 7.43 -23.27 11.24 coo 34.46 72.45 78.57 32.82 72.75 77.28 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 28.96 77.64 81.19 29.05 74.53 77.51 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 12 3 # 12 A 48 LEU B 245 LEU^? 7.82 ZN ZN B 375 A 58 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 120 LYS B 110 LYS.? 16.94 ZN ZN B 375 coo 34.02 69.29 75.26 34.82 67.82 76.74 -1.29 1.71 18.65 -1.87 1.75 20.66 coo 34.46 72.45 78.57 32.82 72.75 77.28 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 28.96 77.64 81.19 29.05 74.53 77.51 -8.36 -4.86 12.39 -7.58 -9.04 11.62 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 13 3 # 13 A 48 LEU B 268 LEU~? 13.46 ZN ZN B 375 A 58 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 120 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 34.02 69.29 75.26 34.82 67.82 76.74 -12.70 13.50 12.39 -11.06 12.13 11.91 coo 34.46 72.45 78.57 32.82 72.75 77.28 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 28.96 77.64 81.19 29.05 74.53 77.51 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 14 3 # 14 A 48 LEU B 279 LEU.? 26.56 ZN ZN B 374 A 58 ASP B 280 ASP.? 32.17 ZN ZN B 374 A 120 LYS B 282 LYS^? 32.80 ZN ZN B 375 coo 34.02 69.29 75.26 34.82 67.82 76.74 -0.89 26.78 7.31 -2.14 26.58 9.09 coo 34.46 72.45 78.57 32.82 72.75 77.28 2.63 27.37 3.18 1.41 29.12 3.45 coo 28.96 77.64 81.19 29.05 74.53 77.51 2.91 20.00 1.64 2.74 22.03 -3.14 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 15 3 # 15 A 48 LEU B 324 LEU~? 22.99 ZN ZN B 375 A 58 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 120 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 34.02 69.29 75.26 34.82 67.82 76.74 10.75 15.22 14.78 11.25 13.52 16.05 coo 34.46 72.45 78.57 32.82 72.75 77.28 9.35 16.65 21.02 10.22 16.89 22.90 coo 28.96 77.64 81.19 29.05 74.53 77.51 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 16 3 # 16 A 48 LEU C 116 LEU~? 11.00 ZN ZN C 375 A 58 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 120 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 34.02 69.29 75.26 34.82 67.82 76.74 2.87 -37.78 51.67 4.81 -38.81 51.54 coo 34.46 72.45 78.57 32.82 72.75 77.28 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 28.96 77.64 81.19 29.05 74.53 77.51 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 17 3 # 17 A 48 LEU C 236 LEU^? 13.92 N TRS A 378 A 58 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 120 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 34.02 69.29 75.26 34.82 67.82 76.74 8.65 -28.79 21.36 9.20 -30.53 20.21 coo 34.46 72.45 78.57 32.82 72.75 77.28 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 28.96 77.64 81.19 29.05 74.53 77.51 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 18 3 # 18 A 48 LEU C 236 LEU^? 13.92 N TRS A 378 A 58 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 120 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 34.02 69.29 75.26 34.82 67.82 76.74 8.65 -28.79 21.36 9.20 -30.53 20.21 coo 34.46 72.45 78.57 32.82 72.75 77.28 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 28.96 77.64 81.19 29.05 74.53 77.51 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 19 3 # 19 A 48 LEU C 236 LEU^? 13.92 N TRS A 378 A 58 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 120 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 34.02 69.29 75.26 34.82 67.82 76.74 8.65 -28.79 21.36 9.20 -30.53 20.21 coo 34.46 72.45 78.57 32.82 72.75 77.28 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 28.96 77.64 81.19 29.05 74.53 77.51 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 20 3 # 20 A 48 LEU C 245 LEU^? 8.02 ZN ZN C 375 A 58 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 120 LYS C 110 LYS.? 19.48 ZN ZN C 375 coo 34.02 69.29 75.26 34.82 67.82 76.74 1.49 -25.70 45.40 3.20 -24.70 46.16 coo 34.46 72.45 78.57 32.82 72.75 77.28 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 28.96 77.64 81.19 29.05 74.53 77.51 5.59 -36.33 42.73 4.93 -41.69 39.22 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 21 3 # 21 A 48 LEU C 268 LEU~? 13.50 ZN ZN C 375 A 58 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 120 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 34.02 69.29 75.26 34.82 67.82 76.74 -3.82 -35.45 58.97 -3.83 -35.02 56.84 coo 34.46 72.45 78.57 32.82 72.75 77.28 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 28.96 77.64 81.19 29.05 74.53 77.51 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 22 3 # 22 A 48 LEU C 279 LEU.? 26.42 ZN ZN C 374 A 58 ASP C 280 ASP.? 31.92 ZN ZN C 374 A 120 LYS C 282 LYS^? 31.82 ZN ZN C 375 coo 34.02 69.29 75.26 34.82 67.82 76.74 -20.60 -28.88 60.53 -19.01 -28.02 61.74 coo 34.46 72.45 78.57 32.82 72.75 77.28 -25.13 -30.20 58.02 -25.85 -28.27 58.51 coo 28.96 77.64 81.19 29.05 74.53 77.51 -21.96 -32.19 51.48 -24.68 -36.28 53.46 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 23 3 # 23 A 48 LEU C 324 LEU~? 22.87 ZN ZN C 375 A 58 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 120 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 34.02 69.29 75.26 34.82 67.82 76.74 -14.93 -18.61 47.10 -13.23 -17.62 46.16 coo 34.46 72.45 78.57 32.82 72.75 77.28 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 28.96 77.64 81.19 29.05 74.53 77.51 -2.95 -18.00 48.43 1.84 -13.91 47.77 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 23 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 116 LEU~? 10.96 ZN ZN A 375 B 58 ASP A 115 ASP~? 13.24 ZN ZN A 375 B 120 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 54.50 104.32 58.69 55.83 105.69 59.81 44.83 -6.96 22.51 44.39 -5.97 20.61 coo 57.63 101.19 59.83 56.60 100.89 57.99 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 61.58 95.88 55.22 58.18 99.30 54.71 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU A 236 LEU^? 7.58 N TRS A 378 B 58 ASP A 237 ASP^? 6.80 N TRS A 378 B 120 LYS C 138 LYS^? 8.30 N TRS A 378 coo 54.50 104.32 58.69 55.83 105.69 59.81 18.21 -24.75 16.42 18.16 -26.24 14.91 coo 57.63 101.19 59.83 56.60 100.89 57.99 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 61.58 95.88 55.22 58.18 99.30 54.71 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 B 48 LEU A 236 LEU^? 7.58 N TRS A 378 B 58 ASP A 237 ASP^? 6.80 N TRS A 378 B 120 LYS C 139 LYS^? 16.11 N TRS A 378 coo 54.50 104.32 58.69 55.83 105.69 59.81 18.21 -24.75 16.42 18.16 -26.24 14.91 coo 57.63 101.19 59.83 56.60 100.89 57.99 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 61.58 95.88 55.22 58.18 99.30 54.71 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 B 48 LEU A 236 LEU^? 7.58 N TRS A 378 B 58 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 120 LYS C 138 LYS^? 8.30 N TRS A 378 coo 54.50 104.32 58.69 55.83 105.69 59.81 18.21 -24.75 16.42 18.16 -26.24 14.91 coo 57.63 101.19 59.83 56.60 100.89 57.99 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 61.58 95.88 55.22 58.18 99.30 54.71 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 B 48 LEU A 236 LEU^? 7.58 N TRS A 378 B 58 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 120 LYS C 139 LYS^? 16.11 N TRS A 378 coo 54.50 104.32 58.69 55.83 105.69 59.81 18.21 -24.75 16.42 18.16 -26.24 14.91 coo 57.63 101.19 59.83 56.60 100.89 57.99 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 61.58 95.88 55.22 58.18 99.30 54.71 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 6 3 # 6 B 48 LEU A 279 LEU.? 26.84 ZN ZN A 374 B 58 ASP A 280 ASP.? 32.54 ZN ZN A 374 B 120 LYS A 282 LYS^? 34.08 ZN ZN A 375 coo 54.50 104.32 58.69 55.83 105.69 59.81 56.39 -13.42 45.75 56.01 -11.28 45.87 coo 57.63 101.19 59.83 56.60 100.89 57.99 57.62 -18.45 47.11 59.50 -17.52 47.44 coo 61.58 95.88 55.22 58.18 99.30 54.71 53.78 -21.68 41.24 59.13 -25.09 41.65 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 7 3 # 7 B 48 LEU A 324 LEU~? 22.85 ZN ZN A 375 B 58 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 120 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo 54.50 104.32 58.69 55.83 105.69 59.81 38.83 -17.83 45.97 36.79 -17.52 45.31 coo 57.63 101.19 59.83 56.60 100.89 57.99 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 61.58 95.88 55.22 58.18 99.30 54.71 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 8 3 # 8 B 48 LEU B 116 LEU~? 11.00 ZN ZN B 375 B 58 ASP B 115 ASP~? 12.98 ZN ZN B 375 B 120 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 54.50 104.32 58.69 55.83 105.69 59.81 -12.97 3.46 12.27 -14.57 2.06 12.63 coo 57.63 101.19 59.83 56.60 100.89 57.99 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 61.58 95.88 55.22 58.18 99.30 54.71 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 9 3 # 9 B 48 LEU B 236 LEU^? 9.09 O1S EPE A 377 B 58 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 120 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 54.50 104.32 58.69 55.83 105.69 59.81 7.64 -21.45 12.38 7.43 -23.27 11.24 coo 57.63 101.19 59.83 56.60 100.89 57.99 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 61.58 95.88 55.22 58.18 99.30 54.71 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 10 3 # 10 B 48 LEU B 236 LEU^? 9.09 O1S EPE A 377 B 58 ASP B 237 ASP^? 15.58 N TRS A 378 B 120 LYS A 138 LYS^? 13.11 N TRS A 378 coo 54.50 104.32 58.69 55.83 105.69 59.81 7.64 -21.45 12.38 7.43 -23.27 11.24 coo 57.63 101.19 59.83 56.60 100.89 57.99 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 61.58 95.88 55.22 58.18 99.30 54.71 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 11 3 # 11 B 48 LEU B 236 LEU^? 9.09 O1S EPE A 377 B 58 ASP B 237 ASP^? 15.58 N TRS A 378 B 120 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 54.50 104.32 58.69 55.83 105.69 59.81 7.64 -21.45 12.38 7.43 -23.27 11.24 coo 57.63 101.19 59.83 56.60 100.89 57.99 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 61.58 95.88 55.22 58.18 99.30 54.71 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 12 3 # 12 B 48 LEU B 245 LEU^? 7.82 ZN ZN B 375 B 58 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 120 LYS B 110 LYS.? 16.94 ZN ZN B 375 coo 54.50 104.32 58.69 55.83 105.69 59.81 -1.29 1.71 18.65 -1.87 1.75 20.66 coo 57.63 101.19 59.83 56.60 100.89 57.99 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 61.58 95.88 55.22 58.18 99.30 54.71 -8.36 -4.86 12.39 -7.58 -9.04 11.62 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 13 3 # 13 B 48 LEU B 279 LEU.? 26.56 ZN ZN B 374 B 58 ASP B 280 ASP.? 32.17 ZN ZN B 374 B 120 LYS B 282 LYS^? 32.80 ZN ZN B 375 coo 54.50 104.32 58.69 55.83 105.69 59.81 -0.89 26.78 7.31 -2.14 26.58 9.09 coo 57.63 101.19 59.83 56.60 100.89 57.99 2.63 27.37 3.18 1.41 29.12 3.45 coo 61.58 95.88 55.22 58.18 99.30 54.71 2.91 20.00 1.64 2.74 22.03 -3.14 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 14 3 # 14 B 48 LEU B 324 LEU~? 22.99 ZN ZN B 375 B 58 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 120 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 54.50 104.32 58.69 55.83 105.69 59.81 10.75 15.22 14.78 11.25 13.52 16.05 coo 57.63 101.19 59.83 56.60 100.89 57.99 9.35 16.65 21.02 10.22 16.89 22.90 coo 61.58 95.88 55.22 58.18 99.30 54.71 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 15 3 # 15 B 48 LEU C 116 LEU~? 11.00 ZN ZN C 375 B 58 ASP C 115 ASP~? 12.87 ZN ZN C 375 B 120 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 54.50 104.32 58.69 55.83 105.69 59.81 2.87 -37.78 51.67 4.81 -38.81 51.54 coo 57.63 101.19 59.83 56.60 100.89 57.99 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 61.58 95.88 55.22 58.18 99.30 54.71 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 16 3 # 16 B 48 LEU C 236 LEU^? 13.92 N TRS A 378 B 58 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 120 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 54.50 104.32 58.69 55.83 105.69 59.81 8.65 -28.79 21.36 9.20 -30.53 20.21 coo 57.63 101.19 59.83 56.60 100.89 57.99 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 61.58 95.88 55.22 58.18 99.30 54.71 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 17 3 # 17 B 48 LEU C 236 LEU^? 13.92 N TRS A 378 B 58 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 120 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 54.50 104.32 58.69 55.83 105.69 59.81 8.65 -28.79 21.36 9.20 -30.53 20.21 coo 57.63 101.19 59.83 56.60 100.89 57.99 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 61.58 95.88 55.22 58.18 99.30 54.71 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 18 3 # 18 B 48 LEU C 236 LEU^? 13.92 N TRS A 378 B 58 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 120 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 54.50 104.32 58.69 55.83 105.69 59.81 8.65 -28.79 21.36 9.20 -30.53 20.21 coo 57.63 101.19 59.83 56.60 100.89 57.99 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 61.58 95.88 55.22 58.18 99.30 54.71 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 19 3 # 19 B 48 LEU C 245 LEU^? 8.02 ZN ZN C 375 B 58 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 120 LYS C 110 LYS.? 19.48 ZN ZN C 375 coo 54.50 104.32 58.69 55.83 105.69 59.81 1.49 -25.70 45.40 3.20 -24.70 46.16 coo 57.63 101.19 59.83 56.60 100.89 57.99 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 61.58 95.88 55.22 58.18 99.30 54.71 5.59 -36.33 42.73 4.93 -41.69 39.22 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 20 3 # 20 B 48 LEU C 268 LEU~? 13.50 ZN ZN C 375 B 58 ASP C 269 ASP~? 18.04 ZN ZN C 374 B 120 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 54.50 104.32 58.69 55.83 105.69 59.81 -3.82 -35.45 58.97 -3.83 -35.02 56.84 coo 57.63 101.19 59.83 56.60 100.89 57.99 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 61.58 95.88 55.22 58.18 99.30 54.71 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 21 3 # 21 B 48 LEU C 279 LEU.? 26.42 ZN ZN C 374 B 58 ASP C 280 ASP.? 31.92 ZN ZN C 374 B 120 LYS C 282 LYS^? 31.82 ZN ZN C 375 coo 54.50 104.32 58.69 55.83 105.69 59.81 -20.60 -28.88 60.53 -19.01 -28.02 61.74 coo 57.63 101.19 59.83 56.60 100.89 57.99 -25.13 -30.20 58.02 -25.85 -28.27 58.51 coo 61.58 95.88 55.22 58.18 99.30 54.71 -21.96 -32.19 51.48 -24.68 -36.28 53.46 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 22 3 # 22 B 48 LEU C 324 LEU~? 22.87 ZN ZN C 375 B 58 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 120 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo 54.50 104.32 58.69 55.83 105.69 59.81 -14.93 -18.61 47.10 -13.23 -17.62 46.16 coo 57.63 101.19 59.83 56.60 100.89 57.99 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 61.58 95.88 55.22 58.18 99.30 54.71 -2.95 -18.00 48.43 1.84 -13.91 47.77 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 22 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 68 ALA A 23 ALA~? 10.67 ZN ZN A 375 A 72 LEU A 22 LEU~? 12.61 ZN ZN A 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 48.88 4.35 16.59 48.73 5.09 15.20 27.83 -4.85 24.60 27.58 -3.36 24.26 coo 53.89 6.25 15.09 52.88 7.92 14.14 29.35 -7.69 21.29 29.92 -9.34 19.97 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 68 ALA A 155 ALA~? 14.27 O1S EPE C 377 A 72 LEU A 156 LEU~? 8.97 O1S EPE C 377 coo 46.76 7.59 18.65 45.27 6.01 18.52 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 48.88 4.35 16.59 48.73 5.09 15.20 22.46 -22.68 -3.71 21.06 -22.28 -4.12 coo 53.89 6.25 15.09 52.88 7.92 14.14 21.27 -24.43 0.63 19.23 -24.51 1.36 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 68 ALA A 159 ALA~? 13.04 O1S EPE C 377 A 72 LEU A 156 LEU~? 8.97 O1S EPE C 377 coo 46.76 7.59 18.65 45.27 6.01 18.52 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 48.88 4.35 16.59 48.73 5.09 15.20 25.41 -19.15 0.31 23.88 -18.99 0.22 coo 53.89 6.25 15.09 52.88 7.92 14.14 21.27 -24.43 0.63 19.23 -24.51 1.36 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 68 ALA A 305 ALA.? 18.87 ZN ZN A 375 A 72 LEU A 326 LEU.? 19.87 ZN ZN A 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 48.88 4.35 16.59 48.73 5.09 15.20 43.26 -20.00 36.94 42.76 -18.58 36.69 coo 53.89 6.25 15.09 52.88 7.92 14.14 41.91 -16.58 43.18 41.53 -16.00 41.11 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 68 ALA A 321 ALA~? 19.58 ZN ZN A 374 A 72 LEU A 324 LEU~? 22.85 ZN ZN A 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 48.88 4.35 16.59 48.73 5.09 15.20 40.35 -13.63 46.22 41.15 -12.61 45.43 coo 53.89 6.25 15.09 52.88 7.92 14.14 38.83 -17.83 45.97 36.79 -17.52 45.31 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 68 ALA A 321 ALA~? 19.58 ZN ZN A 374 A 72 LEU A 326 LEU.? 19.87 ZN ZN A 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 48.88 4.35 16.59 48.73 5.09 15.20 40.35 -13.63 46.22 41.15 -12.61 45.43 coo 53.89 6.25 15.09 52.88 7.92 14.14 41.91 -16.58 43.18 41.53 -16.00 41.11 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 7 3 # 7 A 67 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 68 ALA B 23 ALA~? 10.82 ZN ZN B 375 A 72 LEU B 22 LEU~? 12.66 ZN ZN B 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 48.88 4.35 16.59 48.73 5.09 15.20 -4.97 -5.23 25.00 -5.92 -5.35 26.16 coo 53.89 6.25 15.09 52.88 7.92 14.14 -5.60 -7.41 20.91 -5.31 -8.17 18.89 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 8 3 # 8 A 67 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 68 ALA B 155 ALA~? 14.26 O3S EPE A 377 A 72 LEU B 156 LEU~? 9.59 O3S EPE A 377 coo 46.76 7.59 18.65 45.27 6.01 18.52 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 48.88 4.35 16.59 48.73 5.09 15.20 -8.89 -33.90 8.54 -8.69 -34.90 9.66 coo 53.89 6.25 15.09 52.88 7.92 14.14 -4.58 -31.69 9.17 -3.25 -32.44 10.76 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 9 3 # 9 A 67 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 68 ALA B 159 ALA~? 13.92 O3S EPE A 377 A 72 LEU B 156 LEU~? 9.59 O3S EPE A 377 coo 46.76 7.59 18.65 45.27 6.01 18.52 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 48.88 4.35 16.59 48.73 5.09 15.20 -9.80 -27.22 9.41 -9.47 -27.83 10.78 coo 53.89 6.25 15.09 52.88 7.92 14.14 -4.58 -31.69 9.17 -3.25 -32.44 10.76 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 10 3 # 10 A 67 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 68 ALA B 305 ALA.? 19.14 ZN ZN B 375 A 72 LEU B 326 LEU.? 20.03 ZN ZN B 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 3.99 14.73 5.36 5.18 14.04 3.76 coo 48.88 4.35 16.59 48.73 5.09 15.20 4.93 10.77 7.95 4.24 10.56 9.28 coo 53.89 6.25 15.09 52.88 7.92 14.14 6.72 15.30 12.83 5.45 13.58 12.99 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 11 3 # 11 A 67 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 68 ALA B 321 ALA~? 19.77 ZN ZN B 374 A 72 LEU B 324 LEU~? 22.99 ZN ZN B 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 9.35 16.65 21.02 10.22 16.89 22.90 coo 48.88 4.35 16.59 48.73 5.09 15.20 7.50 17.37 16.99 6.00 17.39 16.91 coo 53.89 6.25 15.09 52.88 7.92 14.14 10.75 15.22 14.78 11.25 13.52 16.05 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 12 3 # 12 A 67 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 68 ALA B 321 ALA~? 19.77 ZN ZN B 374 A 72 LEU B 326 LEU.? 20.03 ZN ZN B 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 9.35 16.65 21.02 10.22 16.89 22.90 coo 48.88 4.35 16.59 48.73 5.09 15.20 7.50 17.37 16.99 6.00 17.39 16.91 coo 53.89 6.25 15.09 52.88 7.92 14.14 6.72 15.30 12.83 5.45 13.58 12.99 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 13 3 # 13 A 67 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 68 ALA C 23 ALA~? 11.04 ZN ZN C 375 A 72 LEU C 22 LEU~? 12.70 ZN ZN C 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 48.88 4.35 16.59 48.73 5.09 15.20 11.77 -25.07 43.97 13.11 -24.84 44.66 coo 53.89 6.25 15.09 52.88 7.92 14.14 10.89 -28.97 41.64 10.34 -30.58 40.35 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 14 3 # 14 A 67 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 68 ALA C 118 ALA~? 14.03 ZN ZN C 375 A 72 LEU C 117 LEU~? 9.33 ZN ZN C 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 48.88 4.35 16.59 48.73 5.09 15.20 -3.69 -37.06 49.43 -3.51 -36.86 47.95 coo 53.89 6.25 15.09 52.88 7.92 14.14 -1.33 -34.53 52.42 -0.48 -33.25 53.96 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 15 3 # 15 A 67 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 68 ALA C 118 ALA~? 14.03 ZN ZN C 375 A 72 LEU C 123 LEU.? 17.43 ZN ZN C 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 48.88 4.35 16.59 48.73 5.09 15.20 -3.69 -37.06 49.43 -3.51 -36.86 47.95 coo 53.89 6.25 15.09 52.88 7.92 14.14 -7.65 -37.78 47.66 -8.55 -36.07 48.64 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 16 3 # 16 A 67 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 68 ALA C 155 ALA~? 16.73 C1 TRS A 378 A 72 LEU C 156 LEU~? 14.05 C2 TRS A 378 coo 46.76 7.59 18.65 45.27 6.01 18.52 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 48.88 4.35 16.59 48.73 5.09 15.20 21.09 -45.45 23.92 22.34 -44.97 23.23 coo 53.89 6.25 15.09 52.88 7.92 14.14 18.00 -42.09 22.36 18.67 -40.46 21.10 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 17 3 # 17 A 67 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 68 ALA C 159 ALA~? 15.13 O1 TRS A 378 A 72 LEU C 156 LEU~? 14.05 C2 TRS A 378 coo 46.76 7.59 18.65 45.27 6.01 18.52 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 48.88 4.35 16.59 48.73 5.09 15.20 18.93 -42.72 28.88 19.93 -41.91 28.03 coo 53.89 6.25 15.09 52.88 7.92 14.14 18.00 -42.09 22.36 18.67 -40.46 21.10 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 18 3 # 18 A 67 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 68 ALA C 305 ALA.? 19.06 ZN ZN C 375 A 72 LEU C 326 LEU.? 19.90 ZN ZN C 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 48.88 4.35 16.59 48.73 5.09 15.20 -13.32 -28.27 45.43 -12.06 -27.81 46.19 coo 53.89 6.25 15.09 52.88 7.92 14.14 -14.03 -22.47 49.19 -12.29 -23.67 48.73 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 19 3 # 19 A 67 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 68 ALA C 321 ALA~? 19.69 ZN ZN C 374 A 72 LEU C 324 LEU~? 22.87 ZN ZN C 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 48.88 4.35 16.59 48.73 5.09 15.20 -13.40 -18.49 51.25 -12.60 -19.47 52.03 coo 53.89 6.25 15.09 52.88 7.92 14.14 -14.93 -18.61 47.10 -13.23 -17.62 46.16 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 20 3 # 20 A 67 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 68 ALA C 321 ALA~? 19.69 ZN ZN C 374 A 72 LEU C 326 LEU.? 19.90 ZN ZN C 375 coo 46.76 7.59 18.65 45.27 6.01 18.52 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 48.88 4.35 16.59 48.73 5.09 15.20 -13.40 -18.49 51.25 -12.60 -19.47 52.03 coo 53.89 6.25 15.09 52.88 7.92 14.14 -14.03 -22.47 49.19 -12.29 -23.67 48.73 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 20 hits 1q6l_c05 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 125 ASN^? 21.73 O3 TRS A 378 A 239 ARG A 284 ARG^? 28.58 ZN ZN A 375 A 246 TYR A 250 TYR^? 23.04 O3 TRS A 378 coo 2.50 7.27 18.06 0.76 7.28 16.81 45.28 -23.75 24.72 46.53 -25.05 23.61 coo -1.16 0.95 13.41 -2.50 3.71 13.61 52.06 -24.03 32.92 53.49 -25.85 30.90 coo 1.59 5.18 12.30 -0.74 6.52 11.61 47.39 -23.45 29.84 45.28 -25.08 30.70 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 2 3 # 2 A 191 ASN C 125 ASN^? 24.77 ZN ZN C 375 A 239 ARG C 284 ARG^? 27.80 ZN ZN C 375 A 246 TYR C 250 TYR^? 23.68 ZN ZN C 375 coo 2.50 7.27 18.06 0.76 7.28 16.81 -9.33 -39.33 40.03 -9.99 -41.26 39.43 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -17.70 -37.64 45.94 -17.45 -40.51 44.86 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -13.28 -36.84 42.94 -13.77 -34.96 40.91 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 2 hits 1qaz_c00 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER A 12 SER~? 22.68 ZN ZN A 375 A 310 GLU A 9 GLU~? 28.50 ZN ZN A 375 A 399 HIS A 8 HIS~? 24.55 ZN ZN A 375 coo 2.67 37.96 55.23 1.78 40.01 56.16 29.97 0.68 9.55 29.00 -0.35 7.61 coo 6.61 38.44 63.61 6.69 38.31 61.50 31.54 5.84 4.26 31.09 6.26 2.19 coo 4.95 41.82 59.53 3.85 40.70 58.14 26.75 7.68 8.85 25.49 8.72 10.18 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 2 3 # 2 A 189 SER B 12 SER~? 22.72 ZN ZN B 375 A 310 GLU B 9 GLU~? 28.41 ZN ZN B 375 A 399 HIS B 8 HIS~? 24.51 ZN ZN B 375 coo 2.67 37.96 55.23 1.78 40.01 56.16 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 6.61 38.44 63.61 6.69 38.31 61.50 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 4.95 41.82 59.53 3.85 40.70 58.14 -21.73 -14.76 29.99 -21.14 -14.36 31.97 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 2 hits 1qe3_c00 naa= 3 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 A 86 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 143 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 170 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo -2.40 27.37 52.92 -1.22 29.09 52.71 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 1.36 26.79 49.43 3.17 26.89 50.50 37.80 0.44 25.56 37.02 -1.29 26.44 coo 7.24 31.80 48.14 6.27 25.92 49.70 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 A 86 GLU B 9 GLU~? 28.41 ZN ZN B 375 A 143 HIS B 8 HIS~? 24.51 ZN ZN B 375 A 170 LYS B 38 LYS.? 21.80 C3 EPE B 376 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 1.36 26.79 49.43 3.17 26.89 50.50 -21.73 -14.76 29.99 -21.14 -14.36 31.97 coo 7.24 31.80 48.14 6.27 25.92 49.70 -28.97 -12.32 32.11 -27.27 -6.31 33.15 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 A 86 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 143 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 170 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 1.36 26.79 49.43 3.17 26.89 50.50 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 7.24 31.80 48.14 6.27 25.92 49.70 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 4 3 # 4 A 86 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 143 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 170 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo -2.40 27.37 52.92 -1.22 29.09 52.71 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 1.36 26.79 49.43 3.17 26.89 50.50 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 7.24 31.80 48.14 6.27 25.92 49.70 9.58 -37.42 57.24 8.41 -35.76 62.90 1qfe_c00 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 4 hits 1qfe_c00 naa= 3 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 B 86 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 143 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 170 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 13.90 37.16 5.96 12.00 36.26 6.12 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 13.52 33.69 9.79 13.20 31.83 8.88 37.80 0.44 25.56 37.02 -1.29 26.44 coo 7.52 28.83 11.02 13.59 28.74 9.95 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 B 86 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 143 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 170 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 13.90 37.16 5.96 12.00 36.26 6.12 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 13.52 33.69 9.79 13.20 31.83 8.88 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 7.52 28.83 11.02 13.59 28.74 9.95 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 B 86 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 143 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 170 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 13.90 37.16 5.96 12.00 36.26 6.12 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 13.52 33.69 9.79 13.20 31.83 8.88 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 7.52 28.83 11.02 13.59 28.74 9.95 9.58 -37.42 57.24 8.41 -35.76 62.90 1qfe_c01 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 3 hits 1qfe_c01 naa= 3 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 1 3 # 1 A 348 HIS B 163 HIS.? 11.54 O3S EPE A 377 A 378 CYH B 170 CYH^? -5.04 N1 EPE A 377s A 380 GLY B 157 GLY~? 9.55 O3S EPE A 377 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -0.70 -28.36 2.22 -0.22 -26.07 0.51 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -6.61 -29.59 5.82 -7.19 -29.80 6.34 1qfl_c00 source 1qfl ACETOACETYL-COA THIOLASE : 1 hits 1qfl_c00 naa= 3 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 1 3 # 1 B 348 HIS B 163 HIS.? 11.54 O3S EPE A 377 B 378 CYH B 170 CYH^? -5.04 N1 EPE A 377s B 380 GLY B 157 GLY~? 9.55 O3S EPE A 377 coo 13.24 15.55 12.21 14.75 15.10 10.80 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 20.14 17.58 5.68 19.50 18.95 7.99 -0.70 -28.36 2.22 -0.22 -26.07 0.51 coo 24.06 14.49 10.58 24.24 14.15 9.79 -6.61 -29.59 5.82 -7.19 -29.80 6.34 1qfl_c01 source 1qfl ACETOACETYL-COA THIOLASE : 1 hits 1qfl_c01 naa= 3 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 1 3 # 1 C 348 HIS B 163 HIS.? 11.54 O3S EPE A 377 C 378 CYH B 170 CYH^? -5.04 N1 EPE A 377s C 380 GLY B 157 GLY~? 9.55 O3S EPE A 377 coo 39.92 0.27 55.80 38.80 1.56 57.03 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 38.90 7.44 62.34 40.19 7.59 59.85 -0.70 -28.36 2.22 -0.22 -26.07 0.51 coo 34.29 9.51 57.55 33.93 9.43 58.29 -6.61 -29.59 5.82 -7.19 -29.80 6.34 1qfl_c02 source 1qfl ACETOACETYL-COA THIOLASE : 1 hits 1qfl_c02 naa= 3 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 1 3 # 1 D 348 HIS B 163 HIS.? 11.54 O3S EPE A 377 D 378 CYH B 170 CYH^? -5.04 N1 EPE A 377s D 380 GLY B 157 GLY~? 9.55 O3S EPE A 377 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -0.70 -28.36 2.22 -0.22 -26.07 0.51 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -6.61 -29.59 5.82 -7.19 -29.80 6.34 1qfl_c03 source 1qfl ACETOACETYL-COA THIOLASE : 1 hits 1qfl_c03 naa= 3 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 1 3 # 1 A 554 SER A 168 SER^? 10.80 O1S EPE C 377 A 641 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 680 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 34.48 40.33 79.08 36.40 39.98 80.55 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 40.64 47.22 77.43 39.90 45.49 78.43 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 38.53 44.50 81.45 37.60 42.73 80.84 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 2 3 # 2 A 554 SER B 168 SER^? 10.59 O3S EPE A 377 A 641 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 680 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 34.48 40.33 79.08 36.40 39.98 80.55 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 40.64 47.22 77.43 39.90 45.49 78.43 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 38.53 44.50 81.45 37.60 42.73 80.84 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 3 3 # 3 A 554 SER C 168 SER^? 24.11 O1 TRS A 378 A 641 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 680 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 34.48 40.33 79.08 36.40 39.98 80.55 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 40.64 47.22 77.43 39.90 45.49 78.43 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 38.53 44.50 81.45 37.60 42.73 80.84 13.13 -47.52 24.96 14.34 -48.17 26.54 1qfm_c00 source 1qfm PROLYL OLIGOPEPTIDASE : 3 hits 1qfm_c00 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 80 HIS.? 6.41 O2S EPE A 376 A 236 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 55.45 46.76 42.08 57.34 46.16 42.75 28.52 23.28 34.79 26.69 23.10 35.81 coo 48.87 29.19 44.63 49.10 27.34 43.63 40.70 8.14 28.73 41.06 6.40 29.84 coo 47.58 17.35 41.83 51.40 20.85 40.83 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 261 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 55.45 46.76 42.08 57.34 46.16 42.75 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 48.87 29.19 44.63 49.10 27.34 43.63 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 47.58 17.35 41.83 51.40 20.85 40.83 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 155 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 261 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 55.45 46.76 42.08 57.34 46.16 42.75 51.10 6.85 29.91 51.20 5.36 31.38 coo 48.87 29.19 44.63 49.10 27.34 43.63 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 47.58 17.35 41.83 51.40 20.85 40.83 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 155 HIS B 80 HIS.? 6.72 O2S EPE B 376 A 236 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 55.45 46.76 42.08 57.34 46.16 42.75 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 48.87 29.19 44.63 49.10 27.34 43.63 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 47.58 17.35 41.83 51.40 20.85 40.83 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 155 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 261 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 55.45 46.76 42.08 57.34 46.16 42.75 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 48.87 29.19 44.63 49.10 27.34 43.63 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 47.58 17.35 41.83 51.40 20.85 40.83 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 155 HIS C 80 HIS.? 6.69 O2S EPE C 376 A 236 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 55.45 46.76 42.08 57.34 46.16 42.75 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 48.87 29.19 44.63 49.10 27.34 43.63 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 47.58 17.35 41.83 51.40 20.85 40.83 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 155 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 236 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 261 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 55.45 46.76 42.08 57.34 46.16 42.75 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 48.87 29.19 44.63 49.10 27.34 43.63 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 47.58 17.35 41.83 51.40 20.85 40.83 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 155 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 261 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 55.45 46.76 42.08 57.34 46.16 42.75 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 48.87 29.19 44.63 49.10 27.34 43.63 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 47.58 17.35 41.83 51.40 20.85 40.83 16.25 -27.94 42.71 21.97 -27.95 45.58 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 80 HIS.? 6.41 O2S EPE A 376 B 236 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 28.52 23.28 34.79 26.69 23.10 35.81 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 40.70 8.14 28.73 41.06 6.40 29.84 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS A 169 HIS^? 11.22 O1S EPE C 377 B 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 261 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 155 HIS A 366 HIS.? 14.86 ZN ZN A 374 B 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 261 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 51.10 6.85 29.91 51.20 5.36 31.38 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 155 HIS B 366 HIS.? 14.78 ZN ZN B 374 B 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 261 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 155 HIS C 80 HIS.? 6.69 O2S EPE C 376 B 236 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 155 HIS C 163 HIS.? 22.24 O1 TRS A 378 B 236 ASP C 115 ASP~? 12.87 ZN ZN C 375 B 261 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 155 HIS C 366 HIS.? 14.85 ZN ZN C 374 B 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 261 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 16.25 -27.94 42.71 21.97 -27.95 45.58 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 80 HIS.? 6.41 O2S EPE A 376 C 236 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 55.11 47.10 12.61 53.44 47.85 11.58 28.52 23.28 34.79 26.69 23.10 35.81 coo 45.78 31.11 9.51 44.25 30.06 10.53 40.70 8.14 28.73 41.06 6.40 29.84 coo 37.54 22.37 12.10 37.83 27.55 13.24 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS A 169 HIS^? 11.22 O1S EPE C 377 C 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 C 261 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 55.11 47.10 12.61 53.44 47.85 11.58 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 45.78 31.11 9.51 44.25 30.06 10.53 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 37.54 22.37 12.10 37.83 27.55 13.24 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 155 HIS A 366 HIS.? 14.86 ZN ZN A 374 C 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 261 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 55.11 47.10 12.61 53.44 47.85 11.58 51.10 6.85 29.91 51.20 5.36 31.38 coo 45.78 31.11 9.51 44.25 30.06 10.53 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 37.54 22.37 12.10 37.83 27.55 13.24 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 155 HIS B 80 HIS.? 6.72 O2S EPE B 376 C 236 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 55.11 47.10 12.61 53.44 47.85 11.58 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 45.78 31.11 9.51 44.25 30.06 10.53 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 37.54 22.37 12.10 37.83 27.55 13.24 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 155 HIS B 366 HIS.? 14.78 ZN ZN B 374 C 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 261 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 55.11 47.10 12.61 53.44 47.85 11.58 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 45.78 31.11 9.51 44.25 30.06 10.53 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 37.54 22.37 12.10 37.83 27.55 13.24 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 155 HIS C 80 HIS.? 6.69 O2S EPE C 376 C 236 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 55.11 47.10 12.61 53.44 47.85 11.58 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 45.78 31.11 9.51 44.25 30.06 10.53 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 37.54 22.37 12.10 37.83 27.55 13.24 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 155 HIS C 163 HIS.? 22.24 O1 TRS A 378 C 236 ASP C 115 ASP~? 12.87 ZN ZN C 375 C 261 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 55.11 47.10 12.61 53.44 47.85 11.58 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 45.78 31.11 9.51 44.25 30.06 10.53 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 37.54 22.37 12.10 37.83 27.55 13.24 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 155 HIS C 366 HIS.? 14.85 ZN ZN C 374 C 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 261 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 55.11 47.10 12.61 53.44 47.85 11.58 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 45.78 31.11 9.51 44.25 30.06 10.53 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 37.54 22.37 12.10 37.83 27.55 13.24 16.25 -27.94 42.71 21.97 -27.95 45.58 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 80 HIS.? 6.41 O2S EPE A 376 D 236 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 28.52 23.28 34.79 26.69 23.10 35.81 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 40.70 8.14 28.73 41.06 6.40 29.84 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS A 169 HIS^? 11.22 O1S EPE C 377 D 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 D 261 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 155 HIS A 366 HIS.? 14.86 ZN ZN A 374 D 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 261 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 51.10 6.85 29.91 51.20 5.36 31.38 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 155 HIS B 80 HIS.? 6.72 O2S EPE B 376 D 236 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 155 HIS B 366 HIS.? 14.78 ZN ZN B 374 D 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 261 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 155 HIS C 80 HIS.? 6.69 O2S EPE C 376 D 236 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 155 HIS C 163 HIS.? 22.24 O1 TRS A 378 D 236 ASP C 115 ASP~? 12.87 ZN ZN C 375 D 261 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 155 HIS C 366 HIS.? 14.85 ZN ZN C 374 D 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 261 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 16.25 -27.94 42.71 21.97 -27.95 45.58 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 80 HIS.? 6.41 O2S EPE A 376 E 236 ASP A 48 ASP.? 7.40 ZN ZN A 374 E 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 28.52 23.28 34.79 26.69 23.10 35.81 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 40.70 8.14 28.73 41.06 6.40 29.84 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS A 169 HIS^? 11.22 O1S EPE C 377 E 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 E 261 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 155 HIS A 366 HIS.? 14.86 ZN ZN A 374 E 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s E 261 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 51.10 6.85 29.91 51.20 5.36 31.38 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 155 HIS B 80 HIS.? 6.72 O2S EPE B 376 E 236 ASP B 48 ASP.? 7.36 ZN ZN B 374 E 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 155 HIS B 366 HIS.? 14.78 ZN ZN B 374 E 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s E 261 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 155 HIS C 80 HIS.? 6.69 O2S EPE C 376 E 236 ASP C 48 ASP.? 7.30 ZN ZN C 374 E 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 155 HIS C 163 HIS.? 22.24 O1 TRS A 378 E 236 ASP C 115 ASP~? 12.87 ZN ZN C 375 E 261 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 155 HIS C 366 HIS.? 14.85 ZN ZN C 374 E 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s E 261 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 16.25 -27.94 42.71 21.97 -27.95 45.58 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 80 HIS.? 6.41 O2S EPE A 376 F 236 ASP A 48 ASP.? 7.40 ZN ZN A 374 F 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 28.52 23.28 34.79 26.69 23.10 35.81 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 40.70 8.14 28.73 41.06 6.40 29.84 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS A 169 HIS^? 11.22 O1S EPE C 377 F 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 F 261 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 155 HIS A 366 HIS.? 14.86 ZN ZN A 374 F 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s F 261 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 51.10 6.85 29.91 51.20 5.36 31.38 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 155 HIS B 80 HIS.? 6.72 O2S EPE B 376 F 236 ASP B 48 ASP.? 7.36 ZN ZN B 374 F 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 155 HIS B 366 HIS.? 14.78 ZN ZN B 374 F 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s F 261 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 155 HIS C 80 HIS.? 6.69 O2S EPE C 376 F 236 ASP C 48 ASP.? 7.30 ZN ZN C 374 F 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 155 HIS C 163 HIS.? 22.24 O1 TRS A 378 F 236 ASP C 115 ASP~? 12.87 ZN ZN C 375 F 261 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 155 HIS C 366 HIS.? 14.85 ZN ZN C 374 F 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s F 261 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 16.25 -27.94 42.71 21.97 -27.95 45.58 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 80 HIS.? 6.41 O2S EPE A 376 G 236 ASP A 48 ASP.? 7.40 ZN ZN A 374 G 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 28.52 23.28 34.79 26.69 23.10 35.81 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 40.70 8.14 28.73 41.06 6.40 29.84 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS A 169 HIS^? 11.22 O1S EPE C 377 G 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 G 261 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 155 HIS A 366 HIS.? 14.86 ZN ZN A 374 G 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s G 261 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 51.10 6.85 29.91 51.20 5.36 31.38 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 155 HIS B 80 HIS.? 6.72 O2S EPE B 376 G 236 ASP B 48 ASP.? 7.36 ZN ZN B 374 G 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 155 HIS B 366 HIS.? 14.78 ZN ZN B 374 G 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s G 261 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 155 HIS C 80 HIS.? 6.69 O2S EPE C 376 G 236 ASP C 48 ASP.? 7.30 ZN ZN C 374 G 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 155 HIS C 163 HIS.? 22.24 O1 TRS A 378 G 236 ASP C 115 ASP~? 12.87 ZN ZN C 375 G 261 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 155 HIS C 366 HIS.? 14.85 ZN ZN C 374 G 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s G 261 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 16.25 -27.94 42.71 21.97 -27.95 45.58 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 80 HIS.? 6.41 O2S EPE A 376 H 236 ASP A 48 ASP.? 7.40 ZN ZN A 374 H 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 28.52 23.28 34.79 26.69 23.10 35.81 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 40.70 8.14 28.73 41.06 6.40 29.84 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS A 169 HIS^? 11.22 O1S EPE C 377 H 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 H 261 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 155 HIS A 366 HIS.? 14.86 ZN ZN A 374 H 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s H 261 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 51.10 6.85 29.91 51.20 5.36 31.38 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 155 HIS B 80 HIS.? 6.72 O2S EPE B 376 H 236 ASP B 48 ASP.? 7.36 ZN ZN B 374 H 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 155 HIS B 366 HIS.? 14.78 ZN ZN B 374 H 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s H 261 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 155 HIS C 80 HIS.? 6.69 O2S EPE C 376 H 236 ASP C 48 ASP.? 7.30 ZN ZN C 374 H 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 23.09 -12.52 68.61 23.48 -10.58 67.92 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 155 HIS C 163 HIS.? 22.24 O1 TRS A 378 H 236 ASP C 115 ASP~? 12.87 ZN ZN C 375 H 261 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 155 HIS C 366 HIS.? 14.85 ZN ZN C 374 H 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s H 261 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 16.25 -27.94 42.71 21.97 -27.95 45.58 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 55.48 26.51 40.65 55.39 23.99 39.43 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 48.87 29.19 44.63 49.10 27.34 43.63 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 47.58 17.35 41.83 51.40 20.85 40.83 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 231 TYR^? 10.06 O1S EPE A 377 A 236 ASP B 237 ASP^? 15.58 N TRS A 378 A 261 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 55.48 26.51 40.65 55.39 23.99 39.43 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 48.87 29.19 44.63 49.10 27.34 43.63 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 47.58 17.35 41.83 51.40 20.85 40.83 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 A 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 261 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 55.48 26.51 40.65 55.39 23.99 39.43 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 48.87 29.19 44.63 49.10 27.34 43.63 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 47.58 17.35 41.83 51.40 20.85 40.83 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 A 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 55.48 26.51 40.65 55.39 23.99 39.43 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 48.87 29.19 44.63 49.10 27.34 43.63 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 47.58 17.35 41.83 51.40 20.85 40.83 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 55.48 26.51 40.65 55.39 23.99 39.43 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 48.87 29.19 44.63 49.10 27.34 43.63 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 47.58 17.35 41.83 51.40 20.85 40.83 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 55.48 26.51 40.65 55.39 23.99 39.43 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 48.87 29.19 44.63 49.10 27.34 43.63 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 47.58 17.35 41.83 51.40 20.85 40.83 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 A 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 261 LYS C 239 LYS^? 16.29 N TRS A 378 coo 55.48 26.51 40.65 55.39 23.99 39.43 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 48.87 29.19 44.63 49.10 27.34 43.63 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 47.58 17.35 41.83 51.40 20.85 40.83 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 A 236 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 261 LYS C 139 LYS^? 16.11 N TRS A 378 coo 55.48 26.51 40.65 55.39 23.99 39.43 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 48.87 29.19 44.63 49.10 27.34 43.63 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 47.58 17.35 41.83 51.40 20.85 40.83 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 A 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 261 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 55.48 26.51 40.65 55.39 23.99 39.43 0.70 6.87 1.10 3.12 5.62 1.69 coo 48.87 29.19 44.63 49.10 27.34 43.63 3.99 14.73 5.36 5.18 14.04 3.76 coo 47.58 17.35 41.83 51.40 20.85 40.83 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 A 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 55.48 26.51 40.65 55.39 23.99 39.43 0.70 6.87 1.10 3.12 5.62 1.69 coo 48.87 29.19 44.63 49.10 27.34 43.63 3.99 14.73 5.36 5.18 14.04 3.76 coo 47.58 17.35 41.83 51.40 20.85 40.83 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 163 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 55.48 26.51 40.65 55.39 23.99 39.43 1.32 11.76 14.56 0.84 10.00 16.68 coo 48.87 29.19 44.63 49.10 27.34 43.63 3.99 14.73 5.36 5.18 14.04 3.76 coo 47.58 17.35 41.83 51.40 20.85 40.83 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 163 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 55.48 26.51 40.65 55.39 23.99 39.43 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 48.87 29.19 44.63 49.10 27.34 43.63 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 47.58 17.35 41.83 51.40 20.85 40.83 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 A 163 TYR C 231 TYR^? -4.25 C2 TRS A 378s A 236 ASP A 237 ASP^? 6.80 N TRS A 378 A 261 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 55.48 26.51 40.65 55.39 23.99 39.43 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 48.87 29.19 44.63 49.10 27.34 43.63 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 47.58 17.35 41.83 51.40 20.85 40.83 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 A 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 A 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 261 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 55.48 26.51 40.65 55.39 23.99 39.43 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 48.87 29.19 44.63 49.10 27.34 43.63 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 47.58 17.35 41.83 51.40 20.85 40.83 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 A 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 A 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 55.48 26.51 40.65 55.39 23.99 39.43 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 48.87 29.19 44.63 49.10 27.34 43.63 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 47.58 17.35 41.83 51.40 20.85 40.83 -11.06 -26.43 40.09 -5.81 -27.52 38.93 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 A 163 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 55.48 26.51 40.65 55.39 23.99 39.43 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 48.87 29.19 44.63 49.10 27.34 43.63 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 47.58 17.35 41.83 51.40 20.85 40.83 -11.06 -26.43 40.09 -5.81 -27.52 38.93 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 18 TYR~? 11.08 ZN ZN A 375 B 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 231 TYR^? 10.06 O1S EPE A 377 B 236 ASP B 237 ASP^? 15.58 N TRS A 378 B 261 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 B 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 261 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 B 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR B 18 TYR~? 10.93 ZN ZN B 375 B 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 B 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 261 LYS C 239 LYS^? 16.29 N TRS A 378 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 B 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 261 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 0.70 6.87 1.10 3.12 5.62 1.69 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 3.99 14.73 5.36 5.18 14.04 3.76 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 B 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 0.70 6.87 1.10 3.12 5.62 1.69 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 3.99 14.73 5.36 5.18 14.04 3.76 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 163 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 1.32 11.76 14.56 0.84 10.00 16.68 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 3.99 14.73 5.36 5.18 14.04 3.76 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 163 TYR C 18 TYR.? 11.04 ZN ZN C 375 B 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 163 TYR C 231 TYR^? -4.25 C2 TRS A 378s B 236 ASP A 237 ASP^? 6.80 N TRS A 378 B 261 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 163 TYR C 231 TYR^? -4.25 C2 TRS A 378s B 236 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 261 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 B 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 261 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 B 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 B 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -11.06 -26.43 40.09 -5.81 -27.52 38.93 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 B 163 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -11.06 -26.43 40.09 -5.81 -27.52 38.93 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 15 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 18 TYR~? 11.08 ZN ZN A 375 C 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 39.51 34.34 13.63 37.63 32.61 14.79 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 45.78 31.11 9.51 44.25 30.06 10.53 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 37.54 22.37 12.10 37.83 27.55 13.24 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR A 231 TYR^? 10.06 O1S EPE A 377 C 236 ASP B 237 ASP^? 15.58 N TRS A 378 C 261 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 39.51 34.34 13.63 37.63 32.61 14.79 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 45.78 31.11 9.51 44.25 30.06 10.53 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 37.54 22.37 12.10 37.83 27.55 13.24 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 C 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 C 261 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 39.51 34.34 13.63 37.63 32.61 14.79 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 45.78 31.11 9.51 44.25 30.06 10.53 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 37.54 22.37 12.10 37.83 27.55 13.24 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 C 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 C 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 39.51 34.34 13.63 37.63 32.61 14.79 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 45.78 31.11 9.51 44.25 30.06 10.53 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 37.54 22.37 12.10 37.83 27.55 13.24 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 163 TYR A 308 TYR^? 13.26 ZN ZN A 375 C 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 C 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 39.51 34.34 13.63 37.63 32.61 14.79 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 45.78 31.11 9.51 44.25 30.06 10.53 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 37.54 22.37 12.10 37.83 27.55 13.24 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 163 TYR B 18 TYR~? 10.93 ZN ZN B 375 C 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 39.51 34.34 13.63 37.63 32.61 14.79 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 45.78 31.11 9.51 44.25 30.06 10.53 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 37.54 22.37 12.10 37.83 27.55 13.24 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 C 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 C 261 LYS C 239 LYS^? 16.29 N TRS A 378 coo 39.51 34.34 13.63 37.63 32.61 14.79 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 45.78 31.11 9.51 44.25 30.06 10.53 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 37.54 22.37 12.10 37.83 27.55 13.24 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 C 236 ASP C 237 ASP^? 16.80 O1S EPE A 377 C 261 LYS C 139 LYS^? 16.11 N TRS A 378 coo 39.51 34.34 13.63 37.63 32.61 14.79 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 45.78 31.11 9.51 44.25 30.06 10.53 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 37.54 22.37 12.10 37.83 27.55 13.24 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 C 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 C 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 C 261 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 39.51 34.34 13.63 37.63 32.61 14.79 0.70 6.87 1.10 3.12 5.62 1.69 coo 45.78 31.11 9.51 44.25 30.06 10.53 3.99 14.73 5.36 5.18 14.04 3.76 coo 37.54 22.37 12.10 37.83 27.55 13.24 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 C 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 C 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 C 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 39.51 34.34 13.63 37.63 32.61 14.79 0.70 6.87 1.10 3.12 5.62 1.69 coo 45.78 31.11 9.51 44.25 30.06 10.53 3.99 14.73 5.36 5.18 14.04 3.76 coo 37.54 22.37 12.10 37.83 27.55 13.24 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 C 163 TYR B 308 TYR^? 13.33 ZN ZN B 375 C 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 C 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 39.51 34.34 13.63 37.63 32.61 14.79 1.32 11.76 14.56 0.84 10.00 16.68 coo 45.78 31.11 9.51 44.25 30.06 10.53 3.99 14.73 5.36 5.18 14.04 3.76 coo 37.54 22.37 12.10 37.83 27.55 13.24 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 C 163 TYR C 18 TYR.? 11.04 ZN ZN C 375 C 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 39.51 34.34 13.63 37.63 32.61 14.79 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 45.78 31.11 9.51 44.25 30.06 10.53 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 37.54 22.37 12.10 37.83 27.55 13.24 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 C 163 TYR C 231 TYR^? -4.25 C2 TRS A 378s C 236 ASP A 237 ASP^? 6.80 N TRS A 378 C 261 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 39.51 34.34 13.63 37.63 32.61 14.79 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 45.78 31.11 9.51 44.25 30.06 10.53 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 37.54 22.37 12.10 37.83 27.55 13.24 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 C 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 C 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 C 261 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 39.51 34.34 13.63 37.63 32.61 14.79 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 45.78 31.11 9.51 44.25 30.06 10.53 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 37.54 22.37 12.10 37.83 27.55 13.24 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 C 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 C 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 C 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 39.51 34.34 13.63 37.63 32.61 14.79 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 45.78 31.11 9.51 44.25 30.06 10.53 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 37.54 22.37 12.10 37.83 27.55 13.24 -11.06 -26.43 40.09 -5.81 -27.52 38.93 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 C 163 TYR C 308 TYR^? 13.34 ZN ZN C 375 C 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 C 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 39.51 34.34 13.63 37.63 32.61 14.79 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 45.78 31.11 9.51 44.25 30.06 10.53 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 37.54 22.37 12.10 37.83 27.55 13.24 -11.06 -26.43 40.09 -5.81 -27.52 38.93 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 18 TYR~? 11.08 ZN ZN A 375 D 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR A 231 TYR^? 10.06 O1S EPE A 377 D 236 ASP B 237 ASP^? 15.58 N TRS A 378 D 261 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 21.28 -11.43 41.42 21.14 -8.83 40.39 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 D 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 D 261 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 D 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 D 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 163 TYR A 308 TYR^? 13.26 ZN ZN A 375 D 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 D 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 163 TYR B 18 TYR~? 10.93 ZN ZN B 375 D 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 D 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 D 261 LYS C 239 LYS^? 16.29 N TRS A 378 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 D 236 ASP C 237 ASP^? 16.80 O1S EPE A 377 D 261 LYS C 139 LYS^? 16.11 N TRS A 378 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 D 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 D 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 D 261 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 0.70 6.87 1.10 3.12 5.62 1.69 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 3.99 14.73 5.36 5.18 14.04 3.76 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 D 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 D 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 D 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 0.70 6.87 1.10 3.12 5.62 1.69 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 3.99 14.73 5.36 5.18 14.04 3.76 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 D 163 TYR B 308 TYR^? 13.33 ZN ZN B 375 D 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 D 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 1.32 11.76 14.56 0.84 10.00 16.68 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 3.99 14.73 5.36 5.18 14.04 3.76 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 D 163 TYR C 18 TYR.? 11.04 ZN ZN C 375 D 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 D 163 TYR C 231 TYR^? -4.25 C2 TRS A 378s D 236 ASP A 237 ASP^? 6.80 N TRS A 378 D 261 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 21.28 -11.43 41.42 21.14 -8.83 40.39 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 D 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 D 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 D 261 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 D 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 D 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 D 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -11.06 -26.43 40.09 -5.81 -27.52 38.93 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 D 163 TYR C 308 TYR^? 13.34 ZN ZN C 375 D 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 D 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -11.06 -26.43 40.09 -5.81 -27.52 38.93 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 18 TYR~? 11.08 ZN ZN A 375 E 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s E 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 231 TYR^? 10.06 O1S EPE A 377 E 236 ASP B 237 ASP^? 15.58 N TRS A 378 E 261 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 E 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 E 261 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 E 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 E 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR B 18 TYR~? 10.93 ZN ZN B 375 E 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s E 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 E 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 E 261 LYS C 239 LYS^? 16.29 N TRS A 378 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 E 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 E 261 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 0.70 6.87 1.10 3.12 5.62 1.69 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 3.99 14.73 5.36 5.18 14.04 3.76 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 E 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 E 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 0.70 6.87 1.10 3.12 5.62 1.69 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 3.99 14.73 5.36 5.18 14.04 3.76 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 163 TYR B 308 TYR^? 13.33 ZN ZN B 375 E 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 E 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 1.32 11.76 14.56 0.84 10.00 16.68 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 3.99 14.73 5.36 5.18 14.04 3.76 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 E 236 ASP B 312 ASP.? 7.53 ZN ZN B 374 E 261 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 2.08 17.58 27.10 3.13 18.35 29.60 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 163 TYR C 18 TYR.? 11.04 ZN ZN C 375 E 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s E 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 163 TYR C 231 TYR^? -4.25 C2 TRS A 378s E 236 ASP A 237 ASP^? 6.80 N TRS A 378 E 261 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 E 163 TYR C 231 TYR^? -4.25 C2 TRS A 378s E 236 ASP C 232 ASP^? 3.77 O2S EPE C 377 E 261 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 E 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 E 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 E 261 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 E 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 E 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 E 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -11.06 -26.43 40.09 -5.81 -27.52 38.93 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 E 163 TYR C 308 TYR^? 13.34 ZN ZN C 375 E 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 E 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -11.06 -26.43 40.09 -5.81 -27.52 38.93 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 18 TYR~? 11.08 ZN ZN A 375 F 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s F 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 231 TYR^? 10.06 O1S EPE A 377 F 236 ASP B 237 ASP^? 15.58 N TRS A 378 F 261 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 F 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 F 261 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 F 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 F 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR A 308 TYR^? 13.26 ZN ZN A 375 F 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 F 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR B 18 TYR~? 10.93 ZN ZN B 375 F 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s F 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 F 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 F 261 LYS C 239 LYS^? 16.29 N TRS A 378 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 F 236 ASP C 237 ASP^? 16.80 O1S EPE A 377 F 261 LYS C 139 LYS^? 16.11 N TRS A 378 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 F 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 F 261 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 0.70 6.87 1.10 3.12 5.62 1.69 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 3.99 14.73 5.36 5.18 14.04 3.76 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 F 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 F 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 0.70 6.87 1.10 3.12 5.62 1.69 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 3.99 14.73 5.36 5.18 14.04 3.76 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 163 TYR B 308 TYR^? 13.33 ZN ZN B 375 F 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 F 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 1.32 11.76 14.56 0.84 10.00 16.68 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 3.99 14.73 5.36 5.18 14.04 3.76 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 F 236 ASP B 312 ASP.? 7.53 ZN ZN B 374 F 261 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 2.08 17.58 27.10 3.13 18.35 29.60 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 F 163 TYR C 18 TYR.? 11.04 ZN ZN C 375 F 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s F 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 F 163 TYR C 231 TYR^? -4.25 C2 TRS A 378s F 236 ASP A 237 ASP^? 6.80 N TRS A 378 F 261 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 F 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 F 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 F 261 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 F 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 F 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 F 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -11.06 -26.43 40.09 -5.81 -27.52 38.93 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 F 163 TYR C 308 TYR^? 13.34 ZN ZN C 375 F 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 F 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -11.06 -26.43 40.09 -5.81 -27.52 38.93 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 17 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 18 TYR~? 11.08 ZN ZN A 375 G 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s G 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR A 231 TYR^? 10.06 O1S EPE A 377 G 236 ASP B 237 ASP^? 15.58 N TRS A 378 G 261 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 G 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 G 261 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 G 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 G 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 163 TYR A 308 TYR^? 13.26 ZN ZN A 375 G 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 G 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 163 TYR B 18 TYR~? 10.93 ZN ZN B 375 G 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s G 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 G 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 G 261 LYS C 239 LYS^? 16.29 N TRS A 378 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 G 236 ASP C 237 ASP^? 16.80 O1S EPE A 377 G 261 LYS C 139 LYS^? 16.11 N TRS A 378 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 G 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 G 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 G 261 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 0.70 6.87 1.10 3.12 5.62 1.69 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 3.99 14.73 5.36 5.18 14.04 3.76 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 G 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 G 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 G 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 0.70 6.87 1.10 3.12 5.62 1.69 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 3.99 14.73 5.36 5.18 14.04 3.76 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 G 163 TYR B 308 TYR^? 13.33 ZN ZN B 375 G 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 G 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 1.32 11.76 14.56 0.84 10.00 16.68 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 3.99 14.73 5.36 5.18 14.04 3.76 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 G 163 TYR C 18 TYR.? 11.04 ZN ZN C 375 G 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s G 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 G 163 TYR C 231 TYR^? -4.25 C2 TRS A 378s G 236 ASP A 237 ASP^? 6.80 N TRS A 378 G 261 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 G 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 G 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 G 261 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 G 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 G 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 G 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -11.06 -26.43 40.09 -5.81 -27.52 38.93 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 G 163 TYR C 308 TYR^? 13.34 ZN ZN C 375 G 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 G 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -11.06 -26.43 40.09 -5.81 -27.52 38.93 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 18 TYR~? 11.08 ZN ZN A 375 H 236 ASP A 107 ASP~? -2.33 ZN ZN A 375s H 261 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR A 231 TYR^? 10.06 O1S EPE A 377 H 236 ASP B 237 ASP^? 15.58 N TRS A 378 H 261 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 20.90 10.83 -36.23 23.51 10.75 -37.23 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 H 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 H 261 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 163 TYR A 250 TYR^? 23.04 O3 TRS A 378 H 236 ASP A 306 ASP.? 24.91 ZN ZN A 375 H 261 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 163 TYR B 18 TYR~? 10.93 ZN ZN B 375 H 236 ASP B 107 ASP~? -2.23 ZN ZN B 375s H 261 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 163 TYR B 231 TYR^? 16.39 O2S EPE A 377 H 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 H 261 LYS C 239 LYS^? 16.29 N TRS A 378 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 H 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 H 261 LYS B 247 LYS^? 11.69 ZN ZN B 375 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 0.70 6.87 1.10 3.12 5.62 1.69 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 3.99 14.73 5.36 5.18 14.04 3.76 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -2.25 3.53 11.00 -3.66 -0.30 12.47 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 163 TYR B 250 TYR^? 23.22 ZN ZN B 375 H 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 H 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 0.70 6.87 1.10 3.12 5.62 1.69 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 3.99 14.73 5.36 5.18 14.04 3.76 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 H 163 TYR B 308 TYR^? 13.33 ZN ZN B 375 H 236 ASP B 306 ASP.? 24.86 ZN ZN B 375 H 261 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 1.32 11.76 14.56 0.84 10.00 16.68 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 3.99 14.73 5.36 5.18 14.04 3.76 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 H 163 TYR C 18 TYR.? 11.04 ZN ZN C 375 H 236 ASP C 107 ASP~? -2.30 ZN ZN C 375s H 261 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 H 163 TYR C 231 TYR^? -4.25 C2 TRS A 378s H 236 ASP A 237 ASP^? 6.80 N TRS A 378 H 261 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 20.90 10.83 -36.23 23.51 10.75 -37.23 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 H 163 TYR C 231 TYR^? -4.25 C2 TRS A 378s H 236 ASP C 232 ASP^? 3.77 O2S EPE C 377 H 261 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo 20.90 10.83 -36.23 23.51 10.75 -37.23 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 H 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 H 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 H 261 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 H 163 TYR C 250 TYR^? 23.68 ZN ZN C 375 H 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 H 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -11.06 -26.43 40.09 -5.81 -27.52 38.93 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 H 163 TYR C 308 TYR^? 13.34 ZN ZN C 375 H 236 ASP C 306 ASP.? 24.81 ZN ZN C 375 H 261 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -11.06 -26.43 40.09 -5.81 -27.52 38.93 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 15 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 203 ARG^? 8.58 O3S EPE C 377 C 163 TYR A 234 TYR^? 9.43 O2S EPE A 377 C 236 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 39.01 29.77 22.02 37.48 31.30 19.84 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 39.51 34.34 13.63 37.63 32.61 14.79 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 45.78 31.11 9.51 44.25 30.06 10.53 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 C 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 C 236 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 39.01 29.77 22.02 37.48 31.30 19.84 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 39.51 34.34 13.63 37.63 32.61 14.79 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 45.78 31.11 9.51 44.25 30.06 10.53 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 C 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 C 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 39.01 29.77 22.02 37.48 31.30 19.84 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 39.51 34.34 13.63 37.63 32.61 14.79 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 45.78 31.11 9.51 44.25 30.06 10.53 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 C 163 TYR A 315 TYR~? 21.30 O8 EPE A 376 C 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 39.01 29.77 22.02 37.48 31.30 19.84 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 39.51 34.34 13.63 37.63 32.61 14.79 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 45.78 31.11 9.51 44.25 30.06 10.53 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 110 ARG B 203 ARG^? 8.69 O2S EPE A 377 C 163 TYR B 234 TYR^? 11.34 O2S EPE A 377 C 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 39.01 29.77 22.02 37.48 31.30 19.84 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 39.51 34.34 13.63 37.63 32.61 14.79 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 45.78 31.11 9.51 44.25 30.06 10.53 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 C 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 C 236 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 39.01 29.77 22.02 37.48 31.30 19.84 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 39.51 34.34 13.63 37.63 32.61 14.79 2.08 17.58 27.10 3.13 18.35 29.60 coo 45.78 31.11 9.51 44.25 30.06 10.53 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 C 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 C 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 39.01 29.77 22.02 37.48 31.30 19.84 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 39.51 34.34 13.63 37.63 32.61 14.79 2.08 17.58 27.10 3.13 18.35 29.60 coo 45.78 31.11 9.51 44.25 30.06 10.53 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 C 163 TYR B 315 TYR~? 21.53 O8 EPE B 376 C 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 39.01 29.77 22.02 37.48 31.30 19.84 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 39.51 34.34 13.63 37.63 32.61 14.79 4.11 23.72 25.55 5.20 26.22 24.94 coo 45.78 31.11 9.51 44.25 30.06 10.53 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 110 ARG C 203 ARG^? 8.27 O3S EPE C 377 C 163 TYR C 234 TYR^? 9.10 O2S EPE C 377 C 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 39.01 29.77 22.02 37.48 31.30 19.84 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 39.51 34.34 13.63 37.63 32.61 14.79 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 45.78 31.11 9.51 44.25 30.06 10.53 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 C 163 TYR C 314 TYR~? 12.22 O8 EPE C 376 C 236 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 39.01 29.77 22.02 37.48 31.30 19.84 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 39.51 34.34 13.63 37.63 32.61 14.79 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 45.78 31.11 9.51 44.25 30.06 10.53 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 C 163 TYR C 315 TYR~? 21.59 O8 EPE C 376 C 236 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 39.01 29.77 22.02 37.48 31.30 19.84 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 39.51 34.34 13.63 37.63 32.61 14.79 -10.50 -13.02 60.73 -13.04 -12.15 61.66 coo 45.78 31.11 9.51 44.25 30.06 10.53 -11.50 -14.47 50.76 -10.89 -12.44 50.87 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 203 ARG^? 8.58 O3S EPE C 377 D 163 TYR A 234 TYR^? 9.43 O2S EPE A 377 D 236 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 D 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 D 236 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 D 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 D 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 D 163 TYR A 315 TYR~? 21.30 O8 EPE A 376 D 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 110 ARG B 203 ARG^? 8.69 O2S EPE A 377 D 163 TYR B 234 TYR^? 11.34 O2S EPE A 377 D 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 D 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 D 236 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 2.08 17.58 27.10 3.13 18.35 29.60 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 D 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 D 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 2.08 17.58 27.10 3.13 18.35 29.60 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 D 163 TYR B 315 TYR~? 21.53 O8 EPE B 376 D 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 4.11 23.72 25.55 5.20 26.22 24.94 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 110 ARG C 203 ARG^? 8.27 O3S EPE C 377 D 163 TYR C 234 TYR^? 9.10 O2S EPE C 377 D 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 D 163 TYR C 314 TYR~? 12.22 O8 EPE C 376 D 236 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 D 163 TYR C 315 TYR~? 21.59 O8 EPE C 376 D 236 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -10.50 -13.02 60.73 -13.04 -12.15 61.66 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -11.50 -14.47 50.76 -10.89 -12.44 50.87 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 236 ASP C 232 ASP^? 3.77 O2S EPE C 377 C 110 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 55.48 26.51 40.65 55.39 23.99 39.43 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 48.87 29.19 44.63 49.10 27.34 43.63 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 52.39 23.42 32.10 54.51 23.27 34.29 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 A 236 ASP A 292 ASP^? 8.63 ZN ZN A 374 C 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 55.48 26.51 40.65 55.39 23.99 39.43 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 48.87 29.19 44.63 49.10 27.34 43.63 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 52.39 23.42 32.10 54.51 23.27 34.29 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 A 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s C 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 55.48 26.51 40.65 55.39 23.99 39.43 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 48.87 29.19 44.63 49.10 27.34 43.63 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 52.39 23.42 32.10 54.51 23.27 34.29 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR A 315 TYR~? 21.30 O8 EPE A 376 A 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s C 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 55.48 26.51 40.65 55.39 23.99 39.43 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 48.87 29.19 44.63 49.10 27.34 43.63 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 52.39 23.42 32.10 54.51 23.27 34.29 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 C 110 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 55.48 26.51 40.65 55.39 23.99 39.43 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 48.87 29.19 44.63 49.10 27.34 43.63 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 52.39 23.42 32.10 54.51 23.27 34.29 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 236 ASP B 292 ASP^? 8.88 ZN ZN B 374 C 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 55.48 26.51 40.65 55.39 23.99 39.43 2.08 17.58 27.10 3.13 18.35 29.60 coo 48.87 29.19 44.63 49.10 27.34 43.63 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 52.39 23.42 32.10 54.51 23.27 34.29 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s C 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 55.48 26.51 40.65 55.39 23.99 39.43 2.08 17.58 27.10 3.13 18.35 29.60 coo 48.87 29.19 44.63 49.10 27.34 43.63 9.35 16.65 21.02 10.22 16.89 22.90 coo 52.39 23.42 32.10 54.51 23.27 34.29 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR B 315 TYR~? 21.53 O8 EPE B 376 A 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s C 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 55.48 26.51 40.65 55.39 23.99 39.43 4.11 23.72 25.55 5.20 26.22 24.94 coo 48.87 29.19 44.63 49.10 27.34 43.63 9.35 16.65 21.02 10.22 16.89 22.90 coo 52.39 23.42 32.10 54.51 23.27 34.29 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 C 110 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 55.48 26.51 40.65 55.39 23.99 39.43 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 48.87 29.19 44.63 49.10 27.34 43.63 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 52.39 23.42 32.10 54.51 23.27 34.29 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 163 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 236 ASP C 292 ASP^? 8.69 ZN ZN C 374 C 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 coo 55.48 26.51 40.65 55.39 23.99 39.43 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 48.87 29.19 44.63 49.10 27.34 43.63 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 52.39 23.42 32.10 54.51 23.27 34.29 -8.42 -22.35 63.85 -6.68 -20.58 62.11 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 163 TYR C 315 TYR~? 21.59 O8 EPE C 376 A 236 ASP C 320 ASP~? -21.75 ZN ZN C 374s C 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 coo 55.48 26.51 40.65 55.39 23.99 39.43 -10.50 -13.02 60.73 -13.04 -12.15 61.66 coo 48.87 29.19 44.63 49.10 27.34 43.63 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 52.39 23.42 32.10 54.51 23.27 34.29 -8.42 -22.35 63.85 -6.68 -20.58 62.11 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 236 ASP C 232 ASP^? 3.77 O2S EPE C 377 D 110 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 B 236 ASP A 292 ASP^? 8.63 ZN ZN A 374 D 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR A 315 TYR~? 21.30 O8 EPE A 376 B 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s D 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 D 110 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 B 236 ASP B 292 ASP^? 8.88 ZN ZN B 374 D 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 2.08 17.58 27.10 3.13 18.35 29.60 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 B 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s D 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 2.08 17.58 27.10 3.13 18.35 29.60 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 9.35 16.65 21.02 10.22 16.89 22.90 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR B 315 TYR~? 21.53 O8 EPE B 376 B 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s D 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 4.11 23.72 25.55 5.20 26.22 24.94 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 9.35 16.65 21.02 10.22 16.89 22.90 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 D 110 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 163 TYR C 314 TYR~? 12.22 O8 EPE C 376 B 236 ASP C 292 ASP^? 8.69 ZN ZN C 374 D 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -8.42 -22.35 63.85 -6.68 -20.58 62.11 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 203 ARG^? 8.58 O3S EPE C 377 G 163 TYR A 234 TYR^? 9.43 O2S EPE A 377 G 236 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 G 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 G 236 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 G 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 G 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 G 163 TYR A 315 TYR~? 21.30 O8 EPE A 376 G 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 110 ARG B 203 ARG^? 8.69 O2S EPE A 377 G 163 TYR B 234 TYR^? 11.34 O2S EPE A 377 G 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 G 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 G 236 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 2.08 17.58 27.10 3.13 18.35 29.60 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 G 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 G 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 2.08 17.58 27.10 3.13 18.35 29.60 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 G 163 TYR B 315 TYR~? 21.53 O8 EPE B 376 G 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 4.11 23.72 25.55 5.20 26.22 24.94 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 110 ARG C 203 ARG^? 8.27 O3S EPE C 377 G 163 TYR C 234 TYR^? 9.10 O2S EPE C 377 G 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 G 163 TYR C 314 TYR~? 12.22 O8 EPE C 376 G 236 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 G 163 TYR C 315 TYR~? 21.59 O8 EPE C 376 G 236 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -10.50 -13.02 60.73 -13.04 -12.15 61.66 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -11.50 -14.47 50.76 -10.89 -12.44 50.87 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 203 ARG^? 8.58 O3S EPE C 377 H 163 TYR A 234 TYR^? 9.43 O2S EPE A 377 H 236 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 H 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 H 236 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 H 163 TYR A 315 TYR~? 21.30 O8 EPE A 376 H 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG B 203 ARG^? 8.69 O2S EPE A 377 H 163 TYR B 234 TYR^? 11.34 O2S EPE A 377 H 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 H 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 H 236 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 2.08 17.58 27.10 3.13 18.35 29.60 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 H 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 H 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 2.08 17.58 27.10 3.13 18.35 29.60 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 H 163 TYR B 315 TYR~? 21.53 O8 EPE B 376 H 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 4.11 23.72 25.55 5.20 26.22 24.94 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 110 ARG C 203 ARG^? 8.27 O3S EPE C 377 H 163 TYR C 234 TYR^? 9.10 O2S EPE C 377 H 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 H 163 TYR C 314 TYR~? 12.22 O8 EPE C 376 H 236 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 1.43 -20.86 54.35 0.32 -19.00 54.12 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 234 TYR^? 9.43 O2S EPE A 377 E 236 ASP C 232 ASP^? 3.77 O2S EPE C 377 G 110 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 E 236 ASP A 292 ASP^? 8.63 ZN ZN A 374 G 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR A 315 TYR~? 21.30 O8 EPE A 376 E 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s G 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 234 TYR^? 11.34 O2S EPE A 377 E 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 G 110 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 E 236 ASP B 292 ASP^? 8.88 ZN ZN B 374 G 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 2.08 17.58 27.10 3.13 18.35 29.60 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 E 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s G 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 2.08 17.58 27.10 3.13 18.35 29.60 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 9.35 16.65 21.02 10.22 16.89 22.90 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR B 315 TYR~? 21.53 O8 EPE B 376 E 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s G 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 4.11 23.72 25.55 5.20 26.22 24.94 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 9.35 16.65 21.02 10.22 16.89 22.90 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR C 234 TYR^? 9.10 O2S EPE C 377 E 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 G 110 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 163 TYR C 314 TYR~? 12.22 O8 EPE C 376 E 236 ASP C 292 ASP^? 8.69 ZN ZN C 374 G 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -8.42 -22.35 63.85 -6.68 -20.58 62.11 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 234 TYR^? 9.43 O2S EPE A 377 F 236 ASP C 232 ASP^? 3.77 O2S EPE C 377 H 110 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 F 236 ASP A 292 ASP^? 8.63 ZN ZN A 374 H 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 314 TYR~? 12.17 O8 EPE A 376 F 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s H 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 36.88 -2.62 44.67 35.35 -1.67 42.53 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR A 315 TYR~? 21.30 O8 EPE A 376 F 236 ASP A 320 ASP~? -21.81 ZN ZN A 374s H 110 ARG A 274 ARG^? 15.42 ZN ZN A 374 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 47.87 -1.95 44.32 44.79 -1.96 44.32 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR B 234 TYR^? 11.34 O2S EPE A 377 F 236 ASP A 232 ASP^? 4.68 O1S EPE A 377 H 110 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 F 236 ASP B 292 ASP^? 8.88 ZN ZN B 374 H 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 2.08 17.58 27.10 3.13 18.35 29.60 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR B 314 TYR~? 14.73 O8 EPE B 376 F 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s H 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 2.08 17.58 27.10 3.13 18.35 29.60 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 9.35 16.65 21.02 10.22 16.89 22.90 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR B 315 TYR~? 21.53 O8 EPE B 376 F 236 ASP B 320 ASP~? -21.78 ZN ZN B 374s H 110 ARG B 274 ARG^? 15.33 ZN ZN B 374 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 4.11 23.72 25.55 5.20 26.22 24.94 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 9.35 16.65 21.02 10.22 16.89 22.90 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -4.90 23.06 20.40 -3.60 21.04 22.31 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR C 234 TYR^? 9.10 O2S EPE C 377 F 236 ASP B 232 ASP^? 14.54 O2S EPE A 377 H 110 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 163 TYR C 314 TYR~? 12.22 O8 EPE C 376 F 236 ASP C 292 ASP^? 8.69 ZN ZN C 374 H 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -8.42 -22.35 63.85 -6.68 -20.58 62.11 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 163 TYR C 315 TYR~? 21.59 O8 EPE C 376 F 236 ASP C 320 ASP~? -21.75 ZN ZN C 374s H 110 ARG C 274 ARG^? 15.09 ZN ZN C 374 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -10.50 -13.02 60.73 -13.04 -12.15 61.66 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -8.42 -22.35 63.85 -6.68 -20.58 62.11 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 147 THR A 104 THR~? 6.76 ZN ZN A 375 A 294 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 32.17 -3.62 26.15 30.67 -3.61 27.70 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 147 THR A 367 THR.? 11.13 ZN ZN A 374 A 294 ASP A 55 ASP~? 17.36 O2S EPE A 376 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 40.70 8.14 28.73 41.06 6.40 29.84 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 46.41 8.27 30.19 44.93 8.03 28.58 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 45.10 18.98 22.18 44.20 20.57 23.21 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 147 THR A 310 THR^? 10.34 ZN ZN A 374 A 294 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 39.49 -1.24 39.18 39.76 0.49 37.96 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 42.72 -7.43 36.10 40.77 -7.66 37.11 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 4 3 # 4 A 49 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 147 THR B 104 THR~? 6.79 ZN ZN B 375 A 294 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.78 -0.91 23.63 -5.15 -0.73 25.06 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 5 3 # 5 A 49 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 147 THR B 367 THR.? 10.99 ZN ZN B 374 A 294 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -18.95 13.55 24.81 -19.03 11.36 25.00 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 6 3 # 6 A 49 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 147 THR B 310 THR^? 10.23 ZN ZN B 374 A 294 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -3.69 12.44 17.22 -2.10 11.84 18.57 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 7 3 # 7 A 49 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 147 THR C 104 THR~? 6.99 ZN ZN C 375 A 294 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 9.25 -26.14 47.92 9.13 -24.05 47.44 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 8 3 # 8 A 49 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 147 THR C 367 THR.? 11.10 ZN ZN C 374 A 294 ASP C 55 ASP~? 17.38 O3S EPE C 376 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 7.09 -30.04 66.37 8.69 -30.35 64.94 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 19.09 -33.39 71.33 19.50 -31.61 72.40 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 9 3 # 9 A 49 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 147 THR C 310 THR^? 10.44 ZN ZN C 374 A 294 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -4.52 -26.41 54.31 -4.36 -24.52 53.23 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 5.80 -28.16 48.27 6.08 -27.64 50.28 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 9 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 256 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 329 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 30.54 71.65 32.58 31.73 72.26 30.92 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 256 GLU A 254 GLU^? 30.93 ZN ZN A 375 A 329 ASP A 281 ASP.? 28.06 ZN ZN A 375 coo 28.46 69.88 26.74 30.40 70.70 26.53 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 30.54 71.65 32.58 31.73 72.26 30.92 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 37.87 70.12 31.80 36.61 69.74 30.15 52.87 -20.75 45.53 51.52 -19.24 45.99 ULMN 3 1qho_c04 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 256 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 329 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 30.54 71.65 32.58 31.73 72.26 30.92 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 37.87 70.12 31.80 36.61 69.74 30.15 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1qho_c04 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 256 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 329 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 30.54 71.65 32.58 31.73 72.26 30.92 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.43 -20.86 54.35 0.32 -19.00 54.12 1qho_c04 source 1qho ALPHA-AMYLASE : 4 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 261 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 329 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 34.02 79.89 42.60 34.73 78.01 41.86 48.24 5.16 33.58 47.82 3.96 35.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 261 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 329 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 34.02 79.89 42.60 34.73 78.01 41.86 40.70 8.14 28.73 41.06 6.40 29.84 coo 37.87 70.12 31.80 36.61 69.74 30.15 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 261 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 329 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 34.02 79.89 42.60 34.73 78.01 41.86 39.49 -1.24 39.18 39.76 0.49 37.96 coo 37.87 70.12 31.80 36.61 69.74 30.15 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 261 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 329 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 54.82 -1.21 28.36 56.43 0.27 28.67 coo 34.02 79.89 42.60 34.73 78.01 41.86 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 37.87 70.12 31.80 36.61 69.74 30.15 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 281 ASP.? 28.06 ZN ZN A 375 A 261 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 329 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 28.46 69.88 26.74 30.40 70.70 26.53 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 34.02 79.89 42.60 34.73 78.01 41.86 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 37.87 70.12 31.80 36.61 69.74 30.15 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 261 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 329 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 34.02 79.89 42.60 34.73 78.01 41.86 54.82 -1.21 28.36 56.43 0.27 28.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 261 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 329 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 34.02 79.89 42.60 34.73 78.01 41.86 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 37.87 70.12 31.80 36.61 69.74 30.15 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 261 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 329 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 34.02 79.89 42.60 34.73 78.01 41.86 40.70 8.14 28.73 41.06 6.40 29.84 coo 37.87 70.12 31.80 36.61 69.74 30.15 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 261 ASP A 55 ASP~? 17.36 O2S EPE A 376 A 329 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 48.24 5.16 33.58 47.82 3.96 35.30 coo 34.02 79.89 42.60 34.73 78.01 41.86 45.10 18.98 22.18 44.20 20.57 23.21 coo 37.87 70.12 31.80 36.61 69.74 30.15 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qho_c05 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 261 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 329 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 48.24 5.16 33.58 47.82 3.96 35.30 coo 34.02 79.89 42.60 34.73 78.01 41.86 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 37.87 70.12 31.80 36.61 69.74 30.15 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qho_c05 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 261 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 329 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 48.24 5.16 33.58 47.82 3.96 35.30 coo 34.02 79.89 42.60 34.73 78.01 41.86 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 37.87 70.12 31.80 36.61 69.74 30.15 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 3 1qho_c05 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 261 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 329 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 34.02 79.89 42.60 34.73 78.01 41.86 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 37.87 70.12 31.80 36.61 69.74 30.15 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1qho_c05 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 261 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 329 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 34.02 79.89 42.60 34.73 78.01 41.86 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 37.87 70.12 31.80 36.61 69.74 30.15 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qho_c05 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 261 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 329 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 34.02 79.89 42.60 34.73 78.01 41.86 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 37.87 70.12 31.80 36.61 69.74 30.15 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qho_c05 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 261 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 329 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 34.02 79.89 42.60 34.73 78.01 41.86 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1qho_c05 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 261 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 329 ASP B 330 ASP^? 11.92 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 34.02 79.89 42.60 34.73 78.01 41.86 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 37.87 70.12 31.80 36.61 69.74 30.15 -4.33 18.16 18.13 -5.04 17.21 19.90 ULMN 3 1qho_c05 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 261 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 329 ASP B 330 ASP^? 11.92 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 34.02 79.89 42.60 34.73 78.01 41.86 3.99 14.73 5.36 5.18 14.04 3.76 coo 37.87 70.12 31.80 36.61 69.74 30.15 -4.33 18.16 18.13 -5.04 17.21 19.90 ULMN 3 1qho_c05 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 261 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 329 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 34.02 79.89 42.60 34.73 78.01 41.86 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 37.87 70.12 31.80 36.61 69.74 30.15 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1qho_c05 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 261 ASP B 55 ASP~? 16.89 O3S EPE B 376 A 329 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 34.02 79.89 42.60 34.73 78.01 41.86 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qho_c05 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 261 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 329 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 34.02 79.89 42.60 34.73 78.01 41.86 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 37.87 70.12 31.80 36.61 69.74 30.15 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qho_c05 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 261 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 329 ASP B 312 ASP.? 7.53 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 34.02 79.89 42.60 34.73 78.01 41.86 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 37.87 70.12 31.80 36.61 69.74 30.15 -4.08 14.12 24.69 -6.01 13.62 25.36 ULMN 3 1qho_c05 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 261 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 329 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 34.02 79.89 42.60 34.73 78.01 41.86 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1qho_c05 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 261 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 329 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 34.02 79.89 42.60 34.73 78.01 41.86 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qho_c05 ALPHA-AMYLASE user 24 3 # 24 A 228 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 261 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 329 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 34.02 79.89 42.60 34.73 78.01 41.86 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qho_c05 ALPHA-AMYLASE user 25 3 # 25 A 228 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 261 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 329 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 34.02 79.89 42.60 34.73 78.01 41.86 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 37.87 70.12 31.80 36.61 69.74 30.15 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1qho_c05 ALPHA-AMYLASE user 26 3 # 26 A 228 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 261 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 329 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 34.02 79.89 42.60 34.73 78.01 41.86 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.16 -24.94 59.28 -5.20 -24.20 59.64 ULMN 3 1qho_c05 ALPHA-AMYLASE user 27 3 # 27 A 228 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 261 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 329 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 34.02 79.89 42.60 34.73 78.01 41.86 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.16 -24.94 59.28 -5.20 -24.20 59.64 ULMN 3 1qho_c05 ALPHA-AMYLASE user 28 3 # 28 A 228 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 261 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 329 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 34.02 79.89 42.60 34.73 78.01 41.86 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1qho_c05 ALPHA-AMYLASE user 29 3 # 29 A 228 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 261 ASP C 55 ASP~? 17.38 O3S EPE C 376 A 329 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 34.02 79.89 42.60 34.73 78.01 41.86 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 37.87 70.12 31.80 36.61 69.74 30.15 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qho_c05 ALPHA-AMYLASE user 30 3 # 30 A 228 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 261 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 329 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 34.02 79.89 42.60 34.73 78.01 41.86 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 37.87 70.12 31.80 36.61 69.74 30.15 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qho_c05 ALPHA-AMYLASE user 31 3 # 31 A 228 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 261 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 329 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 34.02 79.89 42.60 34.73 78.01 41.86 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 37.87 70.12 31.80 36.61 69.74 30.15 -0.90 -20.80 57.97 0.71 -21.61 59.03 1qho_c05 source 1qho ALPHA-AMYLASE : 31 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 260 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 329 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 30.73 81.29 37.61 31.23 82.07 35.69 40.70 8.14 28.73 41.06 6.40 29.84 coo 37.87 70.12 31.80 36.61 69.74 30.15 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 260 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 329 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 30.73 81.29 37.61 31.23 82.07 35.69 39.49 -1.24 39.18 39.76 0.49 37.96 coo 37.87 70.12 31.80 36.61 69.74 30.15 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 260 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 329 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 40.70 8.14 28.73 41.06 6.40 29.84 coo 30.73 81.29 37.61 31.23 82.07 35.69 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 37.87 70.12 31.80 36.61 69.74 30.15 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 260 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 329 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 28.46 69.88 26.74 30.40 70.70 26.53 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 30.73 81.29 37.61 31.23 82.07 35.69 40.70 8.14 28.73 41.06 6.40 29.84 coo 37.87 70.12 31.80 36.61 69.74 30.15 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 260 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 329 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 30.73 81.29 37.61 31.23 82.07 35.69 40.70 8.14 28.73 41.06 6.40 29.84 coo 37.87 70.12 31.80 36.61 69.74 30.15 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 260 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 329 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 54.82 -1.21 28.36 56.43 0.27 28.67 coo 30.73 81.29 37.61 31.23 82.07 35.69 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 37.87 70.12 31.80 36.61 69.74 30.15 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP A 281 ASP.? 28.06 ZN ZN A 375 A 260 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 329 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 28.46 69.88 26.74 30.40 70.70 26.53 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 30.73 81.29 37.61 31.23 82.07 35.69 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 37.87 70.12 31.80 36.61 69.74 30.15 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 260 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 329 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 30.73 81.29 37.61 31.23 82.07 35.69 40.70 8.14 28.73 41.06 6.40 29.84 coo 37.87 70.12 31.80 36.61 69.74 30.15 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 260 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 329 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 30.73 81.29 37.61 31.23 82.07 35.69 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 260 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 329 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 30.73 81.29 37.61 31.23 82.07 35.69 48.24 5.16 33.58 47.82 3.96 35.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 1qho_c07 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 260 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 329 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 30.73 81.29 37.61 31.23 82.07 35.69 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1qho_c07 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 260 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 329 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 48.24 5.16 33.58 47.82 3.96 35.30 coo 30.73 81.29 37.61 31.23 82.07 35.69 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 37.87 70.12 31.80 36.61 69.74 30.15 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qho_c07 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 260 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 329 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 30.73 81.29 37.61 31.23 82.07 35.69 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 37.87 70.12 31.80 36.61 69.74 30.15 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qho_c07 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 260 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 329 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 30.73 81.29 37.61 31.23 82.07 35.69 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 37.87 70.12 31.80 36.61 69.74 30.15 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qho_c07 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 260 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 329 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 30.73 81.29 37.61 31.23 82.07 35.69 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1qho_c07 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 260 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 329 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 28.46 69.88 26.74 30.40 70.70 26.53 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 30.73 81.29 37.61 31.23 82.07 35.69 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 37.87 70.12 31.80 36.61 69.74 30.15 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qho_c07 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 260 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 329 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 30.73 81.29 37.61 31.23 82.07 35.69 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 37.87 70.12 31.80 36.61 69.74 30.15 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1qho_c07 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 260 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 329 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 30.73 81.29 37.61 31.23 82.07 35.69 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 37.87 70.12 31.80 36.61 69.74 30.15 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qho_c07 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 260 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 329 ASP B 330 ASP^? 11.92 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 30.73 81.29 37.61 31.23 82.07 35.69 9.35 16.65 21.02 10.22 16.89 22.90 coo 37.87 70.12 31.80 36.61 69.74 30.15 -4.33 18.16 18.13 -5.04 17.21 19.90 ULMN 3 1qho_c07 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 260 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 329 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 30.73 81.29 37.61 31.23 82.07 35.69 9.35 16.65 21.02 10.22 16.89 22.90 coo 37.87 70.12 31.80 36.61 69.74 30.15 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1qho_c07 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 260 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 329 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 30.73 81.29 37.61 31.23 82.07 35.69 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qho_c07 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 260 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 329 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 30.73 81.29 37.61 31.23 82.07 35.69 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qho_c07 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 260 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 329 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 30.73 81.29 37.61 31.23 82.07 35.69 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qho_c07 ALPHA-AMYLASE user 24 3 # 24 A 228 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 260 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 329 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 30.73 81.29 37.61 31.23 82.07 35.69 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 37.87 70.12 31.80 36.61 69.74 30.15 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1qho_c07 ALPHA-AMYLASE user 25 3 # 25 A 228 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 260 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 329 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 28.46 69.88 26.74 30.40 70.70 26.53 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 30.73 81.29 37.61 31.23 82.07 35.69 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 37.87 70.12 31.80 36.61 69.74 30.15 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qho_c07 ALPHA-AMYLASE user 26 3 # 26 A 228 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 260 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 329 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 30.73 81.29 37.61 31.23 82.07 35.69 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1qho_c07 ALPHA-AMYLASE user 27 3 # 27 A 228 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 260 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 329 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 37.87 70.12 31.80 36.61 69.74 30.15 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1qho_c07 ALPHA-AMYLASE user 28 3 # 28 A 228 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 260 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 329 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 28.46 69.88 26.74 30.40 70.70 26.53 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 30.73 81.29 37.61 31.23 82.07 35.69 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qho_c07 ALPHA-AMYLASE user 29 3 # 29 A 228 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 260 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 329 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 30.73 81.29 37.61 31.23 82.07 35.69 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.16 -24.94 59.28 -5.20 -24.20 59.64 ULMN 3 1qho_c07 ALPHA-AMYLASE user 30 3 # 30 A 228 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 260 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 329 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 30.73 81.29 37.61 31.23 82.07 35.69 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.16 -24.94 59.28 -5.20 -24.20 59.64 ULMN 3 1qho_c07 ALPHA-AMYLASE user 31 3 # 31 A 228 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 260 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 329 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 30.73 81.29 37.61 31.23 82.07 35.69 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1qho_c07 ALPHA-AMYLASE user 32 3 # 32 A 228 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 260 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 329 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 28.46 69.88 26.74 30.40 70.70 26.53 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 30.73 81.29 37.61 31.23 82.07 35.69 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 37.87 70.12 31.80 36.61 69.74 30.15 10.65 -27.85 62.57 8.78 -27.40 61.73 1qho_c07 source 1qho ALPHA-AMYLASE : 32 hits 1qho_c07 naa= 3 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 168 SER^? 10.80 O1S EPE C 377 A 207 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 235 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 15.54 46.73 17.13 17.06 48.44 16.17 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 23.60 50.31 20.82 21.66 50.51 20.06 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 20.17 51.16 17.08 18.31 50.28 17.44 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER B 168 SER^? 10.59 O3S EPE A 377 A 207 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 235 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 15.54 46.73 17.13 17.06 48.44 16.17 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 23.60 50.31 20.82 21.66 50.51 20.06 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 20.17 51.16 17.08 18.31 50.28 17.44 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 3 3 # 3 A 80 SER C 168 SER^? 24.11 O1 TRS A 378 A 207 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 235 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 15.54 46.73 17.13 17.06 48.44 16.17 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 23.60 50.31 20.82 21.66 50.51 20.06 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 20.17 51.16 17.08 18.31 50.28 17.44 13.13 -47.52 24.96 14.34 -48.17 26.54 1qj4_c00 source 1qj4 HYDROXYNITRILE LYASE : 3 hits 1qj4_c00 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 23 ALA~? 10.67 ZN ZN A 375 A 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 1.42 19.18 21.84 1.11 19.57 23.28 27.83 -4.85 24.60 27.58 -3.36 24.26 coo 0.71 19.67 27.92 2.43 19.16 26.83 32.91 0.46 27.63 33.66 0.11 29.56 coo 7.15 16.22 27.50 6.15 18.00 27.94 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA A 46 ALA^? 12.15 ZN ZN A 374 A 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 1.42 19.18 21.84 1.11 19.57 23.28 41.72 6.36 22.02 41.31 7.82 22.33 coo 0.71 19.67 27.92 2.43 19.16 26.83 37.80 0.44 25.56 37.02 -1.29 26.44 coo 7.15 16.22 27.50 6.15 18.00 27.94 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 A 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 1.42 19.18 21.84 1.11 19.57 23.28 37.22 5.65 22.28 37.04 6.85 23.17 coo 0.71 19.67 27.92 2.43 19.16 26.83 37.80 0.44 25.56 37.02 -1.29 26.44 coo 7.15 16.22 27.50 6.15 18.00 27.94 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 A 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 A 148 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 1.42 19.18 21.84 1.11 19.57 23.28 37.22 5.65 22.28 37.04 6.85 23.17 coo 0.71 19.67 27.92 2.43 19.16 26.83 37.42 3.90 29.26 38.47 2.36 30.22 coo 7.15 16.22 27.50 6.15 18.00 27.94 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 A 51 ALA A 101 ALA^? 11.28 ZN ZN A 375 A 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 1.42 19.18 21.84 1.11 19.57 23.28 32.09 5.17 22.05 31.25 5.48 23.29 coo 0.71 19.67 27.92 2.43 19.16 26.83 32.91 0.46 27.63 33.66 0.11 29.56 coo 7.15 16.22 27.50 6.15 18.00 27.94 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 A 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 1.42 19.18 21.84 1.11 19.57 23.28 33.09 1.52 21.68 34.14 1.27 20.64 coo 0.71 19.67 27.92 2.43 19.16 26.83 37.80 0.44 25.56 37.02 -1.29 26.44 coo 7.15 16.22 27.50 6.15 18.00 27.94 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 A 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 1.42 19.18 21.84 1.11 19.57 23.28 33.09 1.52 21.68 34.14 1.27 20.64 coo 0.71 19.67 27.92 2.43 19.16 26.83 32.91 0.46 27.63 33.66 0.11 29.56 coo 7.15 16.22 27.50 6.15 18.00 27.94 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 A 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 1.42 19.18 21.84 1.11 19.57 23.28 33.09 1.52 21.68 34.14 1.27 20.64 coo 0.71 19.67 27.92 2.43 19.16 26.83 32.91 0.46 27.63 33.66 0.11 29.56 coo 7.15 16.22 27.50 6.15 18.00 27.94 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 A 51 ALA A 161 ALA.? 7.16 O1S EPE C 377 A 148 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 163 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 1.42 19.18 21.84 1.11 19.57 23.28 24.22 -22.86 5.01 22.88 -23.16 4.38 coo 0.71 19.67 27.92 2.43 19.16 26.83 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 7.15 16.22 27.50 6.15 18.00 27.94 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 A 51 ALA B 23 ALA~? 10.82 ZN ZN B 375 A 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 1.42 19.18 21.84 1.11 19.57 23.28 -4.97 -5.23 25.00 -5.92 -5.35 26.16 coo 0.71 19.67 27.92 2.43 19.16 26.83 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 7.15 16.22 27.50 6.15 18.00 27.94 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 11 3 # 11 A 51 ALA B 46 ALA^? 12.02 ZN ZN B 374 A 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 1.42 19.18 21.84 1.11 19.57 23.28 -20.28 4.12 23.98 -20.70 4.20 25.49 coo 0.71 19.67 27.92 2.43 19.16 26.83 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 7.15 16.22 27.50 6.15 18.00 27.94 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 12 3 # 12 A 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 A 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 1.42 19.18 21.84 1.11 19.57 23.28 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 0.71 19.67 27.92 2.43 19.16 26.83 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 7.15 16.22 27.50 6.15 18.00 27.94 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 13 3 # 13 A 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 A 148 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 1.42 19.18 21.84 1.11 19.57 23.28 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 0.71 19.67 27.92 2.43 19.16 26.83 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 7.15 16.22 27.50 6.15 18.00 27.94 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 14 3 # 14 A 51 ALA B 101 ALA^? 11.06 ZN ZN B 375 A 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 1.42 19.18 21.84 1.11 19.57 23.28 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 0.71 19.67 27.92 2.43 19.16 26.83 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 7.15 16.22 27.50 6.15 18.00 27.94 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 15 3 # 15 A 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 1.42 19.18 21.84 1.11 19.57 23.28 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 0.71 19.67 27.92 2.43 19.16 26.83 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 7.15 16.22 27.50 6.15 18.00 27.94 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 16 3 # 16 A 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 1.42 19.18 21.84 1.11 19.57 23.28 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 0.71 19.67 27.92 2.43 19.16 26.83 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 7.15 16.22 27.50 6.15 18.00 27.94 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 17 3 # 17 A 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 1.42 19.18 21.84 1.11 19.57 23.28 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 0.71 19.67 27.92 2.43 19.16 26.83 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 7.15 16.22 27.50 6.15 18.00 27.94 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 18 3 # 18 A 51 ALA B 161 ALA.? 8.19 O3S EPE A 377 A 148 HIS B 169 HIS^? 10.86 O3S EPE A 377 A 163 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 1.42 19.18 21.84 1.11 19.57 23.28 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo 0.71 19.67 27.92 2.43 19.16 26.83 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 7.15 16.22 27.50 6.15 18.00 27.94 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 19 3 # 19 A 51 ALA C 23 ALA~? 11.04 ZN ZN C 375 A 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 1.42 19.18 21.84 1.11 19.57 23.28 11.77 -25.07 43.97 13.11 -24.84 44.66 coo 0.71 19.67 27.92 2.43 19.16 26.83 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 7.15 16.22 27.50 6.15 18.00 27.94 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 20 3 # 20 A 51 ALA C 46 ALA^? 12.13 ZN ZN C 374 A 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 1.42 19.18 21.84 1.11 19.57 23.28 13.15 -33.59 59.71 14.10 -32.75 60.59 coo 0.71 19.67 27.92 2.43 19.16 26.83 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 7.15 16.22 27.50 6.15 18.00 27.94 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 21 3 # 21 A 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 A 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 1.42 19.18 21.84 1.11 19.57 23.28 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 0.71 19.67 27.92 2.43 19.16 26.83 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 7.15 16.22 27.50 6.15 18.00 27.94 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 22 3 # 22 A 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 A 148 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 1.42 19.18 21.84 1.11 19.57 23.28 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 0.71 19.67 27.92 2.43 19.16 26.83 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 7.15 16.22 27.50 6.15 18.00 27.94 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 23 3 # 23 A 51 ALA C 101 ALA^? 11.01 ZN ZN C 375 A 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 1.42 19.18 21.84 1.11 19.57 23.28 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 0.71 19.67 27.92 2.43 19.16 26.83 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 7.15 16.22 27.50 6.15 18.00 27.94 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 24 3 # 24 A 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 1.42 19.18 21.84 1.11 19.57 23.28 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 0.71 19.67 27.92 2.43 19.16 26.83 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 7.15 16.22 27.50 6.15 18.00 27.94 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 25 3 # 25 A 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 1.42 19.18 21.84 1.11 19.57 23.28 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 0.71 19.67 27.92 2.43 19.16 26.83 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 7.15 16.22 27.50 6.15 18.00 27.94 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 26 3 # 26 A 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 1.42 19.18 21.84 1.11 19.57 23.28 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 0.71 19.67 27.92 2.43 19.16 26.83 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 7.15 16.22 27.50 6.15 18.00 27.94 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 27 3 # 27 A 51 ALA C 161 ALA.? 14.45 O1 TRS A 378 A 148 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 163 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 1.42 19.18 21.84 1.11 19.57 23.28 14.54 -40.01 25.90 15.56 -39.75 24.83 coo 0.71 19.67 27.92 2.43 19.16 26.83 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 7.15 16.22 27.50 6.15 18.00 27.94 19.06 -47.14 27.83 18.62 -49.09 27.08 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 27 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 23 ALA~? 10.67 ZN ZN A 375 B 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -33.97 19.78 54.18 -33.40 20.11 52.82 27.83 -4.85 24.60 27.58 -3.36 24.26 coo -33.17 20.01 48.16 -34.95 19.37 49.06 32.91 0.46 27.63 33.66 0.11 29.56 coo -39.82 16.62 48.85 -38.59 18.24 48.48 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA A 46 ALA^? 12.15 ZN ZN A 374 B 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -33.97 19.78 54.18 -33.40 20.11 52.82 41.72 6.36 22.02 41.31 7.82 22.33 coo -33.17 20.01 48.16 -34.95 19.37 49.06 37.80 0.44 25.56 37.02 -1.29 26.44 coo -39.82 16.62 48.85 -38.59 18.24 48.48 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 B 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -33.97 19.78 54.18 -33.40 20.11 52.82 37.22 5.65 22.28 37.04 6.85 23.17 coo -33.17 20.01 48.16 -34.95 19.37 49.06 37.80 0.44 25.56 37.02 -1.29 26.44 coo -39.82 16.62 48.85 -38.59 18.24 48.48 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 B 51 ALA A 101 ALA^? 11.28 ZN ZN A 375 B 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -33.97 19.78 54.18 -33.40 20.11 52.82 32.09 5.17 22.05 31.25 5.48 23.29 coo -33.17 20.01 48.16 -34.95 19.37 49.06 32.91 0.46 27.63 33.66 0.11 29.56 coo -39.82 16.62 48.85 -38.59 18.24 48.48 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 B 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 B 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -33.97 19.78 54.18 -33.40 20.11 52.82 33.09 1.52 21.68 34.14 1.27 20.64 coo -33.17 20.01 48.16 -34.95 19.37 49.06 37.80 0.44 25.56 37.02 -1.29 26.44 coo -39.82 16.62 48.85 -38.59 18.24 48.48 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 B 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 B 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -33.97 19.78 54.18 -33.40 20.11 52.82 33.09 1.52 21.68 34.14 1.27 20.64 coo -33.17 20.01 48.16 -34.95 19.37 49.06 32.91 0.46 27.63 33.66 0.11 29.56 coo -39.82 16.62 48.85 -38.59 18.24 48.48 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 B 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 B 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -33.97 19.78 54.18 -33.40 20.11 52.82 33.09 1.52 21.68 34.14 1.27 20.64 coo -33.17 20.01 48.16 -34.95 19.37 49.06 32.91 0.46 27.63 33.66 0.11 29.56 coo -39.82 16.62 48.85 -38.59 18.24 48.48 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 B 51 ALA A 161 ALA.? 7.16 O1S EPE C 377 B 148 HIS A 169 HIS^? 11.22 O1S EPE C 377 B 163 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo -33.97 19.78 54.18 -33.40 20.11 52.82 24.22 -22.86 5.01 22.88 -23.16 4.38 coo -33.17 20.01 48.16 -34.95 19.37 49.06 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo -39.82 16.62 48.85 -38.59 18.24 48.48 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 B 51 ALA B 23 ALA~? 10.82 ZN ZN B 375 B 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -33.97 19.78 54.18 -33.40 20.11 52.82 -4.97 -5.23 25.00 -5.92 -5.35 26.16 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 B 51 ALA B 46 ALA^? 12.02 ZN ZN B 374 B 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -20.28 4.12 23.98 -20.70 4.20 25.49 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 11 3 # 11 B 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 B 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -17.51 1.20 26.23 -17.65 1.96 27.53 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 12 3 # 12 B 51 ALA B 101 ALA^? 11.06 ZN ZN B 375 B 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 13 3 # 13 B 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 B 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -33.97 19.78 54.18 -33.40 20.11 52.82 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 14 3 # 14 B 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 B 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 15 3 # 15 B 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 B 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -33.97 19.78 54.18 -33.40 20.11 52.82 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 16 3 # 16 B 51 ALA B 161 ALA.? 8.19 O3S EPE A 377 B 148 HIS B 169 HIS^? 10.86 O3S EPE A 377 B 163 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 17 3 # 17 B 51 ALA C 23 ALA~? 11.04 ZN ZN C 375 B 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -33.97 19.78 54.18 -33.40 20.11 52.82 11.77 -25.07 43.97 13.11 -24.84 44.66 coo -33.17 20.01 48.16 -34.95 19.37 49.06 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -39.82 16.62 48.85 -38.59 18.24 48.48 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 18 3 # 18 B 51 ALA C 46 ALA^? 12.13 ZN ZN C 374 B 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -33.97 19.78 54.18 -33.40 20.11 52.82 13.15 -33.59 59.71 14.10 -32.75 60.59 coo -33.17 20.01 48.16 -34.95 19.37 49.06 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -39.82 16.62 48.85 -38.59 18.24 48.48 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 19 3 # 19 B 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 B 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -33.97 19.78 54.18 -33.40 20.11 52.82 14.85 -30.74 56.60 15.29 -29.68 57.59 coo -33.17 20.01 48.16 -34.95 19.37 49.06 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -39.82 16.62 48.85 -38.59 18.24 48.48 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 20 3 # 20 B 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 B 148 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -33.97 19.78 54.18 -33.40 20.11 52.82 14.85 -30.74 56.60 15.29 -29.68 57.59 coo -33.17 20.01 48.16 -34.95 19.37 49.06 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -39.82 16.62 48.85 -38.59 18.24 48.48 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 21 3 # 21 B 51 ALA C 101 ALA^? 11.01 ZN ZN C 375 B 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -33.97 19.78 54.18 -33.40 20.11 52.82 17.04 -27.71 53.14 16.81 -26.24 53.31 coo -33.17 20.01 48.16 -34.95 19.37 49.06 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -39.82 16.62 48.85 -38.59 18.24 48.48 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 22 3 # 22 B 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 B 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -33.97 19.78 54.18 -33.40 20.11 52.82 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -33.17 20.01 48.16 -34.95 19.37 49.06 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -39.82 16.62 48.85 -38.59 18.24 48.48 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 23 3 # 23 B 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 B 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -33.97 19.78 54.18 -33.40 20.11 52.82 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -33.17 20.01 48.16 -34.95 19.37 49.06 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -39.82 16.62 48.85 -38.59 18.24 48.48 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 24 3 # 24 B 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 B 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -33.97 19.78 54.18 -33.40 20.11 52.82 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -33.17 20.01 48.16 -34.95 19.37 49.06 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -39.82 16.62 48.85 -38.59 18.24 48.48 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 25 3 # 25 B 51 ALA C 161 ALA.? 14.45 O1 TRS A 378 B 148 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 163 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo -33.97 19.78 54.18 -33.40 20.11 52.82 14.54 -40.01 25.90 15.56 -39.75 24.83 coo -33.17 20.01 48.16 -34.95 19.37 49.06 13.13 -47.52 24.96 14.34 -48.17 26.54 coo -39.82 16.62 48.85 -38.59 18.24 48.48 19.06 -47.14 27.83 18.62 -49.09 27.08 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 25 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 C 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 37.22 5.65 22.28 37.04 6.85 23.17 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 37.80 0.44 25.56 37.02 -1.29 26.44 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 C 148 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 37.22 5.65 22.28 37.04 6.85 23.17 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 37.42 3.90 29.26 38.47 2.36 30.22 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 C 51 ALA A 101 ALA^? 11.28 ZN ZN A 375 C 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 32.09 5.17 22.05 31.25 5.48 23.29 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 32.91 0.46 27.63 33.66 0.11 29.56 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 C 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 C 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 33.09 1.52 21.68 34.14 1.27 20.64 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 37.80 0.44 25.56 37.02 -1.29 26.44 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 C 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 C 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 33.09 1.52 21.68 34.14 1.27 20.64 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 32.91 0.46 27.63 33.66 0.11 29.56 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 C 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 C 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 33.09 1.52 21.68 34.14 1.27 20.64 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 32.91 0.46 27.63 33.66 0.11 29.56 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 C 51 ALA A 161 ALA.? 7.16 O1S EPE C 377 C 148 HIS A 169 HIS^? 11.22 O1S EPE C 377 C 163 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 24.22 -22.86 5.01 22.88 -23.16 4.38 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 C 51 ALA B 46 ALA^? 12.02 ZN ZN B 374 C 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -20.28 4.12 23.98 -20.70 4.20 25.49 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 C 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 C 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -17.51 1.20 26.23 -17.65 1.96 27.53 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 C 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 C 148 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -17.51 1.20 26.23 -17.65 1.96 27.53 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 11 3 # 11 C 51 ALA B 101 ALA^? 11.06 ZN ZN B 375 C 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 12 3 # 12 C 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 C 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 13 3 # 13 C 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 C 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 14 3 # 14 C 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 C 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 15 3 # 15 C 51 ALA B 161 ALA.? 8.19 O3S EPE A 377 C 148 HIS B 169 HIS^? 10.86 O3S EPE A 377 C 163 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 16 3 # 16 C 51 ALA C 46 ALA^? 12.13 ZN ZN C 374 C 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 13.15 -33.59 59.71 14.10 -32.75 60.59 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 17 3 # 17 C 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 C 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 14.85 -30.74 56.60 15.29 -29.68 57.59 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 18 3 # 18 C 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 C 148 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 14.85 -30.74 56.60 15.29 -29.68 57.59 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 19 3 # 19 C 51 ALA C 101 ALA^? 11.01 ZN ZN C 375 C 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 17.04 -27.71 53.14 16.81 -26.24 53.31 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 20 3 # 20 C 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 C 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 21 3 # 21 C 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 C 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 22 3 # 22 C 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 C 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 23 3 # 23 C 51 ALA C 161 ALA.? 14.45 O1 TRS A 378 C 148 HIS C 169 HIS^? 22.39 O1 TRS A 378 C 163 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 14.54 -40.01 25.90 15.56 -39.75 24.83 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 13.13 -47.52 24.96 14.34 -48.17 26.54 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 19.06 -47.14 27.83 18.62 -49.09 27.08 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 23 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 23 ALA~? 10.67 ZN ZN A 375 D 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 27.83 -4.85 24.60 27.58 -3.36 24.26 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 32.91 0.46 27.63 33.66 0.11 29.56 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA A 46 ALA^? 12.15 ZN ZN A 374 D 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 41.72 6.36 22.02 41.31 7.82 22.33 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 37.80 0.44 25.56 37.02 -1.29 26.44 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 D 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 37.22 5.65 22.28 37.04 6.85 23.17 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 37.80 0.44 25.56 37.02 -1.29 26.44 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 D 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 D 148 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 37.22 5.65 22.28 37.04 6.85 23.17 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 37.42 3.90 29.26 38.47 2.36 30.22 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 D 51 ALA A 101 ALA^? 11.28 ZN ZN A 375 D 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 32.09 5.17 22.05 31.25 5.48 23.29 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 32.91 0.46 27.63 33.66 0.11 29.56 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 D 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 D 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 33.09 1.52 21.68 34.14 1.27 20.64 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 37.80 0.44 25.56 37.02 -1.29 26.44 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 D 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 D 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 33.09 1.52 21.68 34.14 1.27 20.64 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 32.91 0.46 27.63 33.66 0.11 29.56 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 D 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 D 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 33.09 1.52 21.68 34.14 1.27 20.64 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 32.91 0.46 27.63 33.66 0.11 29.56 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 D 51 ALA A 161 ALA.? 7.16 O1S EPE C 377 D 148 HIS A 169 HIS^? 11.22 O1S EPE C 377 D 163 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 24.22 -22.86 5.01 22.88 -23.16 4.38 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 D 51 ALA B 23 ALA~? 10.82 ZN ZN B 375 D 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -4.97 -5.23 25.00 -5.92 -5.35 26.16 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 11 3 # 11 D 51 ALA B 46 ALA^? 12.02 ZN ZN B 374 D 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -20.28 4.12 23.98 -20.70 4.20 25.49 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 12 3 # 12 D 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 D 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -17.51 1.20 26.23 -17.65 1.96 27.53 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 13 3 # 13 D 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 D 148 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -17.51 1.20 26.23 -17.65 1.96 27.53 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 14 3 # 14 D 51 ALA B 101 ALA^? 11.06 ZN ZN B 375 D 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 15 3 # 15 D 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 D 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 16 3 # 16 D 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 D 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 17 3 # 17 D 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 D 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 18 3 # 18 D 51 ALA B 161 ALA.? 8.19 O3S EPE A 377 D 148 HIS B 169 HIS^? 10.86 O3S EPE A 377 D 163 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 19 3 # 19 D 51 ALA C 23 ALA~? 11.04 ZN ZN C 375 D 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 11.77 -25.07 43.97 13.11 -24.84 44.66 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 20 3 # 20 D 51 ALA C 46 ALA^? 12.13 ZN ZN C 374 D 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 13.15 -33.59 59.71 14.10 -32.75 60.59 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 21 3 # 21 D 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 D 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 14.85 -30.74 56.60 15.29 -29.68 57.59 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 22 3 # 22 D 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 D 148 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 14.85 -30.74 56.60 15.29 -29.68 57.59 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 23 3 # 23 D 51 ALA C 101 ALA^? 11.01 ZN ZN C 375 D 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 17.04 -27.71 53.14 16.81 -26.24 53.31 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 24 3 # 24 D 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 D 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 25 3 # 25 D 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 D 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 26 3 # 26 D 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 D 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 27 3 # 27 D 51 ALA C 161 ALA.? 14.45 O1 TRS A 378 D 148 HIS C 169 HIS^? 22.39 O1 TRS A 378 D 163 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 14.54 -40.01 25.90 15.56 -39.75 24.83 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 13.13 -47.52 24.96 14.34 -48.17 26.54 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 19.06 -47.14 27.83 18.62 -49.09 27.08 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 27 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 E 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s E 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 37.22 5.65 22.28 37.04 6.85 23.17 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 37.80 0.44 25.56 37.02 -1.29 26.44 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 E 148 HIS A 69 HIS.? -3.40 ZN ZN A 374s E 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 37.22 5.65 22.28 37.04 6.85 23.17 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 37.42 3.90 29.26 38.47 2.36 30.22 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 E 51 ALA A 101 ALA^? 11.28 ZN ZN A 375 E 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 32.09 5.17 22.05 31.25 5.48 23.29 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 32.91 0.46 27.63 33.66 0.11 29.56 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 E 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 E 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s E 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 33.09 1.52 21.68 34.14 1.27 20.64 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 37.80 0.44 25.56 37.02 -1.29 26.44 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 E 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 E 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 33.09 1.52 21.68 34.14 1.27 20.64 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 32.91 0.46 27.63 33.66 0.11 29.56 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 E 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 E 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s E 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 33.09 1.52 21.68 34.14 1.27 20.64 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 32.91 0.46 27.63 33.66 0.11 29.56 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 E 51 ALA A 161 ALA.? 7.16 O1S EPE C 377 E 148 HIS A 169 HIS^? 11.22 O1S EPE C 377 E 163 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 24.22 -22.86 5.01 22.88 -23.16 4.38 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 E 51 ALA B 46 ALA^? 12.02 ZN ZN B 374 E 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s E 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -20.28 4.12 23.98 -20.70 4.20 25.49 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 E 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 E 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s E 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 E 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 E 148 HIS B 69 HIS.? -3.36 ZN ZN B 374s E 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 11 3 # 11 E 51 ALA B 101 ALA^? 11.06 ZN ZN B 375 E 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 12 3 # 12 E 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 E 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s E 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 13 3 # 13 E 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 E 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 14 3 # 14 E 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 E 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 E 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 15 3 # 15 E 51 ALA B 161 ALA.? 8.19 O3S EPE A 377 E 148 HIS B 169 HIS^? 10.86 O3S EPE A 377 E 163 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 16 3 # 16 E 51 ALA C 46 ALA^? 12.13 ZN ZN C 374 E 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s E 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 13.15 -33.59 59.71 14.10 -32.75 60.59 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 17 3 # 17 E 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 E 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s E 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 18 3 # 18 E 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 E 148 HIS C 69 HIS.? -3.39 ZN ZN C 374s E 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 19 3 # 19 E 51 ALA C 101 ALA^? 11.01 ZN ZN C 375 E 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 20 3 # 20 E 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 E 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s E 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 21 3 # 21 E 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 E 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 22 3 # 22 E 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 E 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 E 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 23 3 # 23 E 51 ALA C 161 ALA.? 14.45 O1 TRS A 378 E 148 HIS C 169 HIS^? 22.39 O1 TRS A 378 E 163 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 14.54 -40.01 25.90 15.56 -39.75 24.83 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 19.06 -47.14 27.83 18.62 -49.09 27.08 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 23 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 F 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s F 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 37.22 5.65 22.28 37.04 6.85 23.17 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 37.80 0.44 25.56 37.02 -1.29 26.44 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA A 101 ALA^? 11.28 ZN ZN A 375 F 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s F 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 32.09 5.17 22.05 31.25 5.48 23.29 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 32.91 0.46 27.63 33.66 0.11 29.56 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 F 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 F 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s F 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 5.33 15.59 -14.28 5.80 15.15 -15.64 33.09 1.52 21.68 34.14 1.27 20.64 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 37.80 0.44 25.56 37.02 -1.29 26.44 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 F 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 F 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s F 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 33.09 1.52 21.68 34.14 1.27 20.64 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 32.91 0.46 27.63 33.66 0.11 29.56 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 F 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 F 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s F 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 5.33 15.59 -14.28 5.80 15.15 -15.64 33.09 1.52 21.68 34.14 1.27 20.64 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 32.91 0.46 27.63 33.66 0.11 29.56 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 F 51 ALA A 161 ALA.? 7.16 O1S EPE C 377 F 148 HIS A 169 HIS^? 11.22 O1S EPE C 377 F 163 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 24.22 -22.86 5.01 22.88 -23.16 4.38 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 F 51 ALA B 46 ALA^? 12.02 ZN ZN B 374 F 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s F 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -20.28 4.12 23.98 -20.70 4.20 25.49 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 F 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 F 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s F 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 F 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 F 148 HIS B 69 HIS.? -3.36 ZN ZN B 374s F 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 F 51 ALA B 101 ALA^? 11.06 ZN ZN B 375 F 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 F 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 11 3 # 11 F 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 F 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s F 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 12 3 # 12 F 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 F 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 F 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 13 3 # 13 F 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 F 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 F 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 14 3 # 14 F 51 ALA B 161 ALA.? 8.19 O3S EPE A 377 F 148 HIS B 169 HIS^? 10.86 O3S EPE A 377 F 163 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 15 3 # 15 F 51 ALA C 46 ALA^? 12.13 ZN ZN C 374 F 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s F 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 13.15 -33.59 59.71 14.10 -32.75 60.59 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 16 3 # 16 F 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 F 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s F 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 17 3 # 17 F 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 F 148 HIS C 69 HIS.? -3.39 ZN ZN C 374s F 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 18 3 # 18 F 51 ALA C 101 ALA^? 11.01 ZN ZN C 375 F 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 F 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 19 3 # 19 F 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 F 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s F 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 5.33 15.59 -14.28 5.80 15.15 -15.64 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 20 3 # 20 F 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 F 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 F 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 21 3 # 21 F 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 F 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 F 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 5.33 15.59 -14.28 5.80 15.15 -15.64 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 22 3 # 22 F 51 ALA C 161 ALA.? 14.45 O1 TRS A 378 F 148 HIS C 169 HIS^? 22.39 O1 TRS A 378 F 163 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 14.54 -40.01 25.90 15.56 -39.75 24.83 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 19.06 -47.14 27.83 18.62 -49.09 27.08 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 22 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 23 ALA~? 10.67 ZN ZN A 375 G 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s G 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 27.83 -4.85 24.60 27.58 -3.36 24.26 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 32.91 0.46 27.63 33.66 0.11 29.56 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA A 46 ALA^? 12.15 ZN ZN A 374 G 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s G 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 41.72 6.36 22.02 41.31 7.82 22.33 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 37.80 0.44 25.56 37.02 -1.29 26.44 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 G 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 G 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s G 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 37.22 5.65 22.28 37.04 6.85 23.17 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 37.80 0.44 25.56 37.02 -1.29 26.44 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 G 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 G 148 HIS A 69 HIS.? -3.40 ZN ZN A 374s G 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 37.22 5.65 22.28 37.04 6.85 23.17 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 37.42 3.90 29.26 38.47 2.36 30.22 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 G 51 ALA A 101 ALA^? 11.28 ZN ZN A 375 G 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s G 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 32.09 5.17 22.05 31.25 5.48 23.29 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 32.91 0.46 27.63 33.66 0.11 29.56 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 G 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 G 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s G 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 33.09 1.52 21.68 34.14 1.27 20.64 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 37.80 0.44 25.56 37.02 -1.29 26.44 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 G 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 G 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s G 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 33.09 1.52 21.68 34.14 1.27 20.64 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 32.91 0.46 27.63 33.66 0.11 29.56 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 G 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 G 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s G 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 33.09 1.52 21.68 34.14 1.27 20.64 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 32.91 0.46 27.63 33.66 0.11 29.56 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 G 51 ALA A 161 ALA.? 7.16 O1S EPE C 377 G 148 HIS A 169 HIS^? 11.22 O1S EPE C 377 G 163 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 24.22 -22.86 5.01 22.88 -23.16 4.38 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 G 51 ALA B 23 ALA~? 10.82 ZN ZN B 375 G 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 G 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -4.97 -5.23 25.00 -5.92 -5.35 26.16 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 11 3 # 11 G 51 ALA B 46 ALA^? 12.02 ZN ZN B 374 G 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s G 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -20.28 4.12 23.98 -20.70 4.20 25.49 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 12 3 # 12 G 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 G 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s G 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -17.51 1.20 26.23 -17.65 1.96 27.53 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 13 3 # 13 G 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 G 148 HIS B 69 HIS.? -3.36 ZN ZN B 374s G 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -17.51 1.20 26.23 -17.65 1.96 27.53 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 14 3 # 14 G 51 ALA B 101 ALA^? 11.06 ZN ZN B 375 G 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 G 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 15 3 # 15 G 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 G 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s G 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 16 3 # 16 G 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 G 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 G 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 17 3 # 17 G 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 G 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 G 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 18 3 # 18 G 51 ALA B 161 ALA.? 8.19 O3S EPE A 377 G 148 HIS B 169 HIS^? 10.86 O3S EPE A 377 G 163 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 19 3 # 19 G 51 ALA C 23 ALA~? 11.04 ZN ZN C 375 G 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 G 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 11.77 -25.07 43.97 13.11 -24.84 44.66 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 20 3 # 20 G 51 ALA C 46 ALA^? 12.13 ZN ZN C 374 G 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s G 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 13.15 -33.59 59.71 14.10 -32.75 60.59 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 21 3 # 21 G 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 G 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s G 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 14.85 -30.74 56.60 15.29 -29.68 57.59 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 22 3 # 22 G 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 G 148 HIS C 69 HIS.? -3.39 ZN ZN C 374s G 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 14.85 -30.74 56.60 15.29 -29.68 57.59 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 23 3 # 23 G 51 ALA C 101 ALA^? 11.01 ZN ZN C 375 G 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 G 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 17.04 -27.71 53.14 16.81 -26.24 53.31 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 24 3 # 24 G 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 G 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s G 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 25 3 # 25 G 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 G 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 G 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 26 3 # 26 G 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 G 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 G 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 27 3 # 27 G 51 ALA C 161 ALA.? 14.45 O1 TRS A 378 G 148 HIS C 169 HIS^? 22.39 O1 TRS A 378 G 163 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 14.54 -40.01 25.90 15.56 -39.75 24.83 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 13.13 -47.52 24.96 14.34 -48.17 26.54 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 19.06 -47.14 27.83 18.62 -49.09 27.08 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 27 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 23 ALA~? 10.67 ZN ZN A 375 H 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s H 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 27.83 -4.85 24.60 27.58 -3.36 24.26 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 32.91 0.46 27.63 33.66 0.11 29.56 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA A 46 ALA^? 12.15 ZN ZN A 374 H 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s H 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 41.72 6.36 22.02 41.31 7.82 22.33 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 37.80 0.44 25.56 37.02 -1.29 26.44 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 H 51 ALA A 67 ALA^? 10.32 ZN ZN A 374 H 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s H 163 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 37.22 5.65 22.28 37.04 6.85 23.17 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 37.80 0.44 25.56 37.02 -1.29 26.44 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 H 51 ALA A 101 ALA^? 11.28 ZN ZN A 375 H 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s H 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 32.09 5.17 22.05 31.25 5.48 23.29 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 32.91 0.46 27.63 33.66 0.11 29.56 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 H 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 H 148 HIS A 68 HIS.? -3.31 ZN ZN A 375s H 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 33.09 1.52 21.68 34.14 1.27 20.64 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 37.80 0.44 25.56 37.02 -1.29 26.44 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 H 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 H 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s H 163 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 33.09 1.52 21.68 34.14 1.27 20.64 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 32.91 0.46 27.63 33.66 0.11 29.56 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 H 51 ALA A 102 ALA.? 9.34 ZN ZN A 375 H 148 HIS A 103 HIS~? -4.82 ZN ZN A 375s H 163 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 33.09 1.52 21.68 34.14 1.27 20.64 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 32.91 0.46 27.63 33.66 0.11 29.56 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 H 51 ALA A 161 ALA.? 7.16 O1S EPE C 377 H 148 HIS A 169 HIS^? 11.22 O1S EPE C 377 H 163 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 24.22 -22.86 5.01 22.88 -23.16 4.38 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 H 51 ALA B 23 ALA~? 10.82 ZN ZN B 375 H 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 H 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -4.97 -5.23 25.00 -5.92 -5.35 26.16 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 H 51 ALA B 46 ALA^? 12.02 ZN ZN B 374 H 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s H 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -20.28 4.12 23.98 -20.70 4.20 25.49 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 11 3 # 11 H 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 H 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s H 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -17.51 1.20 26.23 -17.65 1.96 27.53 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 12 3 # 12 H 51 ALA B 67 ALA^? 10.44 ZN ZN B 374 H 148 HIS B 69 HIS.? -3.36 ZN ZN B 374s H 163 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -17.51 1.20 26.23 -17.65 1.96 27.53 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 13 3 # 13 H 51 ALA B 101 ALA^? 11.06 ZN ZN B 375 H 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 H 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 14 3 # 14 H 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 H 148 HIS B 68 HIS.? -3.38 ZN ZN B 375s H 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 15 3 # 15 H 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 H 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 H 163 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 16 3 # 16 H 51 ALA B 102 ALA.? 9.36 ZN ZN B 375 H 148 HIS B 103 HIS~? 5.04 ZN ZN B 375 H 163 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 17 3 # 17 H 51 ALA B 161 ALA.? 8.19 O3S EPE A 377 H 148 HIS B 169 HIS^? 10.86 O3S EPE A 377 H 163 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 18 3 # 18 H 51 ALA C 46 ALA^? 12.13 ZN ZN C 374 H 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s H 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 13.15 -33.59 59.71 14.10 -32.75 60.59 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 19 3 # 19 H 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 H 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s H 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 14.85 -30.74 56.60 15.29 -29.68 57.59 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 20 3 # 20 H 51 ALA C 67 ALA^? 10.56 ZN ZN C 374 H 148 HIS C 69 HIS.? -3.39 ZN ZN C 374s H 163 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 14.85 -30.74 56.60 15.29 -29.68 57.59 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 21 3 # 21 H 51 ALA C 101 ALA^? 11.01 ZN ZN C 375 H 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 H 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 17.04 -27.71 53.14 16.81 -26.24 53.31 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 22 3 # 22 H 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 H 148 HIS C 68 HIS.? -3.41 ZN ZN C 375s H 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 23 3 # 23 H 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 H 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 H 163 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 24 3 # 24 H 51 ALA C 102 ALA.? 9.31 ZN ZN C 375 H 148 HIS C 103 HIS~? 4.97 ZN ZN C 375 H 163 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 14.49 -29.28 50.81 14.45 -30.75 50.81 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 25 3 # 25 H 51 ALA C 161 ALA.? 14.45 O1 TRS A 378 H 148 HIS C 169 HIS^? 22.39 O1 TRS A 378 H 163 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 14.54 -40.01 25.90 15.56 -39.75 24.83 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 13.13 -47.52 24.96 14.34 -48.17 26.54 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 19.06 -47.14 27.83 18.62 -49.09 27.08 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 25 hits 1qol_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 81 THR.? 10.12 O2S EPE A 376 A 182 TYR A 85 TYR~? -4.05 C2 EPE A 376s A 186 LYS A 83 LYS~? -5.13 O1S EPE A 376s coo 69.38 87.38 24.64 71.11 88.47 25.40 32.45 25.22 30.56 31.45 26.31 28.96 coo 73.61 90.42 31.12 71.36 89.66 29.64 33.18 16.26 32.13 31.71 14.36 30.75 coo 73.54 84.00 28.64 69.01 86.68 29.71 35.02 22.85 34.66 32.09 22.94 39.08 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR A 81 THR.? 10.12 O2S EPE A 376 A 182 TYR A 85 TYR~? -4.05 C2 EPE A 376s A 186 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 69.38 87.38 24.64 71.11 88.47 25.40 32.45 25.22 30.56 31.45 26.31 28.96 coo 73.61 90.42 31.12 71.36 89.66 29.64 33.18 16.26 32.13 31.71 14.36 30.75 coo 73.54 84.00 28.64 69.01 86.68 29.71 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 3 # 3 A 145 THR A 206 THR^? -4.52 O1S EPE C 377s A 182 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 186 LYS A 138 LYS^? 13.11 N TRS A 378 coo 69.38 87.38 24.64 71.11 88.47 25.40 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 73.61 90.42 31.12 71.36 89.66 29.64 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 73.54 84.00 28.64 69.01 86.68 29.71 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 4 3 # 4 A 145 THR A 206 THR^? -4.52 O1S EPE C 377s A 182 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 186 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 69.38 87.38 24.64 71.11 88.47 25.40 19.99 -27.38 6.69 21.08 -26.14 5.25 coo 73.61 90.42 31.12 71.36 89.66 29.64 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 73.54 84.00 28.64 69.01 86.68 29.71 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 5 3 # 5 A 145 THR B 81 THR.? 10.70 O2S EPE B 376 A 182 TYR B 85 TYR~? 3.87 C2 EPE B 376 A 186 LYS B 83 LYS~? 4.34 O1S EPE B 376 coo 69.38 87.38 24.64 71.11 88.47 25.40 -22.85 8.49 45.84 -23.89 7.07 47.06 coo 73.61 90.42 31.12 71.36 89.66 29.64 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 73.54 84.00 28.64 69.01 86.68 29.71 -20.11 12.86 43.96 -14.92 12.31 47.32 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 6 3 # 6 A 145 THR B 81 THR.? 10.70 O2S EPE B 376 A 182 TYR B 85 TYR~? 3.87 C2 EPE B 376 A 186 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 69.38 87.38 24.64 71.11 88.47 25.40 -22.85 8.49 45.84 -23.89 7.07 47.06 coo 73.61 90.42 31.12 71.36 89.66 29.64 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 73.54 84.00 28.64 69.01 86.68 29.71 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 7 3 # 7 A 145 THR B 206 THR^? 5.63 O3S EPE A 377 A 182 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 186 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 69.38 87.38 24.64 71.11 88.47 25.40 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo 73.61 90.42 31.12 71.36 89.66 29.64 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 73.54 84.00 28.64 69.01 86.68 29.71 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 8 3 # 8 A 145 THR B 206 THR^? 5.63 O3S EPE A 377 A 182 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 186 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 69.38 87.38 24.64 71.11 88.47 25.40 1.50 -28.89 8.33 -0.67 -28.86 8.55 coo 73.61 90.42 31.12 71.36 89.66 29.64 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 73.54 84.00 28.64 69.01 86.68 29.71 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 9 3 # 9 A 145 THR C 81 THR.? 10.35 O3S EPE C 376 A 182 TYR C 85 TYR~? -3.91 C2 EPE C 376s A 186 LYS C 83 LYS~? -3.65 O2S EPE C 376s coo 69.38 87.38 24.64 71.11 88.47 25.40 24.63 -17.88 70.86 26.72 -18.03 70.54 coo 73.61 90.42 31.12 71.36 89.66 29.64 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 73.54 84.00 28.64 69.01 86.68 29.71 19.52 -16.87 71.96 18.81 -11.07 69.68 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 10 3 # 10 A 145 THR C 81 THR.? 10.35 O3S EPE C 376 A 182 TYR C 85 TYR~? -3.91 C2 EPE C 376s A 186 LYS C 87 LYS~? 9.86 O3S EPE C 376 coo 69.38 87.38 24.64 71.11 88.47 25.40 24.63 -17.88 70.86 26.72 -18.03 70.54 coo 73.61 90.42 31.12 71.36 89.66 29.64 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 73.54 84.00 28.64 69.01 86.68 29.71 22.12 -22.06 69.94 21.88 -19.84 74.70 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 11 3 # 11 A 145 THR C 206 THR^? 14.70 N TRS A 378 A 182 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 186 LYS C 138 LYS^? 8.30 N TRS A 378 coo 69.38 87.38 24.64 71.11 88.47 25.40 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 73.61 90.42 31.12 71.36 89.66 29.64 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 73.54 84.00 28.64 69.01 86.68 29.71 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 12 3 # 12 A 145 THR C 206 THR^? 14.70 N TRS A 378 A 182 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 186 LYS C 139 LYS^? 16.11 N TRS A 378 coo 69.38 87.38 24.64 71.11 88.47 25.40 12.97 -38.24 19.88 14.05 -39.36 21.39 coo 73.61 90.42 31.12 71.36 89.66 29.64 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 73.54 84.00 28.64 69.01 86.68 29.71 13.08 -32.56 20.05 9.65 -36.55 18.68 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 12 hits 1qrr_c01 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 739 GLY A 111 GLY.? 12.81 ZN ZN A 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 37.80 0.44 25.56 37.02 -1.29 26.44 coo -18.83 7.68 26.86 -20.89 7.78 26.56 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 40.78 -9.44 18.50 40.17 -9.34 19.07 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 37.80 0.44 25.56 37.02 -1.29 26.44 coo -18.83 7.68 26.86 -20.89 7.78 26.56 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 37.80 0.44 25.56 37.02 -1.29 26.44 coo -18.83 7.68 26.86 -20.89 7.78 26.56 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1qrz_c20 PLASMINOGEN user 4 3 # 4 A 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 37.80 0.44 25.56 37.02 -1.29 26.44 coo -18.83 7.68 26.86 -20.89 7.78 26.56 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1qrz_c20 PLASMINOGEN user 5 3 # 5 A 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 37.80 0.44 25.56 37.02 -1.29 26.44 coo -18.83 7.68 26.86 -20.89 7.78 26.56 40.70 8.14 28.73 41.06 6.40 29.84 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1qrz_c20 PLASMINOGEN user 6 3 # 6 A 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 37.80 0.44 25.56 37.02 -1.29 26.44 coo -18.83 7.68 26.86 -20.89 7.78 26.56 40.70 8.14 28.73 41.06 6.40 29.84 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1qrz_c20 PLASMINOGEN user 7 3 # 7 A 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 37.80 0.44 25.56 37.02 -1.29 26.44 coo -18.83 7.68 26.86 -20.89 7.78 26.56 40.70 8.14 28.73 41.06 6.40 29.84 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1qrz_c20 PLASMINOGEN user 8 3 # 8 A 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 37.42 3.90 29.26 38.47 2.36 30.22 coo -18.83 7.68 26.86 -20.89 7.78 26.56 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1qrz_c20 PLASMINOGEN user 9 3 # 9 A 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 37.42 3.90 29.26 38.47 2.36 30.22 coo -18.83 7.68 26.86 -20.89 7.78 26.56 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1qrz_c20 PLASMINOGEN user 10 3 # 10 A 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 37.42 3.90 29.26 38.47 2.36 30.22 coo -18.83 7.68 26.86 -20.89 7.78 26.56 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c20 PLASMINOGEN user 11 3 # 11 A 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 32.91 0.46 27.63 33.66 0.11 29.56 coo -18.83 7.68 26.86 -20.89 7.78 26.56 40.70 8.14 28.73 41.06 6.40 29.84 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c20 PLASMINOGEN user 12 3 # 12 A 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 32.91 0.46 27.63 33.66 0.11 29.56 coo -18.83 7.68 26.86 -20.89 7.78 26.56 40.70 8.14 28.73 41.06 6.40 29.84 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1qrz_c20 PLASMINOGEN user 13 3 # 13 A 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 32.91 0.46 27.63 33.66 0.11 29.56 coo -18.83 7.68 26.86 -20.89 7.78 26.56 40.70 8.14 28.73 41.06 6.40 29.84 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1qrz_c20 PLASMINOGEN user 14 3 # 14 A 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 32.91 0.46 27.63 33.66 0.11 29.56 coo -18.83 7.68 26.86 -20.89 7.78 26.56 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c20 PLASMINOGEN user 15 3 # 15 A 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 739 GLY A 244 GLY^? 11.92 ZN ZN A 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 32.91 0.46 27.63 33.66 0.11 29.56 coo -18.83 7.68 26.86 -20.89 7.78 26.56 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 32.51 -13.15 26.46 33.13 -12.90 26.03 ULMN 3 1qrz_c20 PLASMINOGEN user 16 3 # 16 A 603 HIS A 163 HIS.? 11.18 O1S EPE C 377 A 646 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 739 GLY C 178 GLY^? 3.71 C6 EPE C 377 coo -20.72 2.99 34.37 -21.94 1.82 35.61 30.88 -23.32 6.66 32.97 -23.36 6.49 coo -18.83 7.68 26.86 -20.89 7.78 26.56 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 23.14 -36.24 3.79 23.36 -36.64 3.06 ULMN 3 1qrz_c20 PLASMINOGEN user 17 3 # 17 A 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 40.60 0.33 34.12 38.69 0.39 33.24 coo -18.83 7.68 26.86 -20.89 7.78 26.56 40.70 8.14 28.73 41.06 6.40 29.84 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c20 PLASMINOGEN user 18 3 # 18 A 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 646 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 40.60 0.33 34.12 38.69 0.39 33.24 coo -18.83 7.68 26.86 -20.89 7.78 26.56 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1qrz_c20 PLASMINOGEN user 19 3 # 19 A 603 HIS A 359 HIS^? 27.14 ZN ZN A 375 A 646 ASP A 352 ASP~? 25.70 ZN ZN A 375 A 739 GLY A 7 GLY~? 22.99 ZN ZN A 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 45.80 8.64 6.53 46.53 8.87 4.58 coo -18.83 7.68 26.86 -20.89 7.78 26.56 43.66 -0.56 3.32 44.78 0.99 4.29 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 31.92 8.80 9.28 31.38 8.48 8.65 ULMN 3 1qrz_c20 PLASMINOGEN user 20 3 # 20 A 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1qrz_c20 PLASMINOGEN user 21 3 # 21 A 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 739 GLY B 293 GLY.? 9.60 ZN ZN B 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -0.50 9.63 20.82 -0.36 10.23 21.34 ULMN 3 1qrz_c20 PLASMINOGEN user 22 3 # 22 A 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1qrz_c20 PLASMINOGEN user 23 3 # 23 A 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1qrz_c20 PLASMINOGEN user 24 3 # 24 A 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 739 GLY B 293 GLY.? 9.60 ZN ZN B 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -0.50 9.63 20.82 -0.36 10.23 21.34 ULMN 3 1qrz_c20 PLASMINOGEN user 25 3 # 25 A 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1qrz_c20 PLASMINOGEN user 26 3 # 26 A 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1qrz_c20 PLASMINOGEN user 27 3 # 27 A 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1qrz_c20 PLASMINOGEN user 28 3 # 28 A 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 739 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1qrz_c20 PLASMINOGEN user 29 3 # 29 A 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c20 PLASMINOGEN user 30 3 # 30 A 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c20 PLASMINOGEN user 31 3 # 31 A 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 739 GLY B 293 GLY.? 9.60 ZN ZN B 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -0.50 9.63 20.82 -0.36 10.23 21.34 ULMN 3 1qrz_c20 PLASMINOGEN user 32 3 # 32 A 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1qrz_c20 PLASMINOGEN user 33 3 # 33 A 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c20 PLASMINOGEN user 34 3 # 34 A 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 739 GLY B 244 GLY^? 11.85 ZN ZN B 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -0.61 -2.61 16.62 -1.32 -2.49 16.19 ULMN 3 1qrz_c20 PLASMINOGEN user 35 3 # 35 A 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c20 PLASMINOGEN user 36 3 # 36 A 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 646 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1qrz_c20 PLASMINOGEN user 37 3 # 37 A 603 HIS B 359 HIS^? 24.30 ZN ZN B 375 A 646 ASP B 352 ASP~? 25.82 ZN ZN B 375 A 739 GLY B 7 GLY~? 23.15 ZN ZN B 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -24.83 -11.10 27.95 -24.79 -11.89 27.82 ULMN 3 1qrz_c20 PLASMINOGEN user 38 3 # 38 A 603 HIS B 359 HIS^? 24.30 ZN ZN B 375 A 646 ASP B 352 ASP~? 25.82 ZN ZN B 375 A 739 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1qrz_c20 PLASMINOGEN user 39 3 # 39 A 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 739 GLY C 111 GLY.? 12.85 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -18.83 7.68 26.86 -20.89 7.78 26.56 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 5.64 -38.51 45.88 5.60 -37.66 45.90 ULMN 3 1qrz_c20 PLASMINOGEN user 40 3 # 40 A 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -18.83 7.68 26.86 -20.89 7.78 26.56 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1qrz_c20 PLASMINOGEN user 41 3 # 41 A 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 739 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -18.83 7.68 26.86 -20.89 7.78 26.56 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1qrz_c20 PLASMINOGEN user 42 3 # 42 A 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -18.83 7.68 26.86 -20.89 7.78 26.56 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1qrz_c20 PLASMINOGEN user 43 3 # 43 A 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -18.83 7.68 26.86 -20.89 7.78 26.56 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1qrz_c20 PLASMINOGEN user 44 3 # 44 A 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 739 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -18.83 7.68 26.86 -20.89 7.78 26.56 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1qrz_c20 PLASMINOGEN user 45 3 # 45 A 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -18.83 7.68 26.86 -20.89 7.78 26.56 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1qrz_c20 PLASMINOGEN user 46 3 # 46 A 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -18.83 7.68 26.86 -20.89 7.78 26.56 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1qrz_c20 PLASMINOGEN user 47 3 # 47 A 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -18.83 7.68 26.86 -20.89 7.78 26.56 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1qrz_c20 PLASMINOGEN user 48 3 # 48 A 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 739 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -18.83 7.68 26.86 -20.89 7.78 26.56 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1qrz_c20 PLASMINOGEN user 49 3 # 49 A 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -18.83 7.68 26.86 -20.89 7.78 26.56 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c20 PLASMINOGEN user 50 3 # 50 A 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -18.83 7.68 26.86 -20.89 7.78 26.56 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c20 PLASMINOGEN user 51 3 # 51 A 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 739 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -18.83 7.68 26.86 -20.89 7.78 26.56 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1qrz_c20 PLASMINOGEN user 52 3 # 52 A 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -20.72 2.99 34.37 -21.94 1.82 35.61 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -18.83 7.68 26.86 -20.89 7.78 26.56 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1qrz_c20 PLASMINOGEN user 53 3 # 53 A 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -18.83 7.68 26.86 -20.89 7.78 26.56 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c20 PLASMINOGEN user 54 3 # 54 A 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 739 GLY C 244 GLY^? 11.70 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -18.83 7.68 26.86 -20.89 7.78 26.56 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 2.79 -27.67 41.30 2.83 -28.37 41.63 ULMN 3 1qrz_c20 PLASMINOGEN user 55 3 # 55 A 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -18.83 7.68 26.86 -20.89 7.78 26.56 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c20 PLASMINOGEN user 56 3 # 56 A 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 646 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1qrz_c20 PLASMINOGEN user 57 3 # 57 A 603 HIS C 359 HIS^? 24.82 ZN ZN C 375 A 646 ASP C 352 ASP~? 25.48 ZN ZN C 375 A 739 GLY C 7 GLY~? 23.11 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 19.80 -46.87 59.86 18.04 -47.50 60.82 coo -18.83 7.68 26.86 -20.89 7.78 26.56 18.63 -50.25 49.90 18.47 -49.69 51.95 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 27.26 -36.33 52.02 27.65 -36.56 51.35 ULMN 3 1qrz_c20 PLASMINOGEN user 58 3 # 58 A 603 HIS C 359 HIS^? 24.82 ZN ZN C 375 A 646 ASP C 352 ASP~? 25.48 ZN ZN C 375 A 739 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo -20.72 2.99 34.37 -21.94 1.82 35.61 19.80 -46.87 59.86 18.04 -47.50 60.82 coo -18.83 7.68 26.86 -20.89 7.78 26.56 18.63 -50.25 49.90 18.47 -49.69 51.95 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 7.81 -40.56 53.34 8.53 -40.45 53.72 1qrz_c20 source 1qrz PLASMINOGEN : 58 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 37.80 0.44 25.56 37.02 -1.29 26.44 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 37.80 0.44 25.56 37.02 -1.29 26.44 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1qrz_c21 PLASMINOGEN user 3 3 # 3 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 37.80 0.44 25.56 37.02 -1.29 26.44 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1qrz_c21 PLASMINOGEN user 4 3 # 4 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 37.80 0.44 25.56 37.02 -1.29 26.44 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 40.70 8.14 28.73 41.06 6.40 29.84 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1qrz_c21 PLASMINOGEN user 5 3 # 5 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 37.80 0.44 25.56 37.02 -1.29 26.44 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 40.70 8.14 28.73 41.06 6.40 29.84 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1qrz_c21 PLASMINOGEN user 6 3 # 6 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 37.80 0.44 25.56 37.02 -1.29 26.44 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 40.70 8.14 28.73 41.06 6.40 29.84 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1qrz_c21 PLASMINOGEN user 7 3 # 7 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 37.80 0.44 25.56 37.02 -1.29 26.44 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1qrz_c21 PLASMINOGEN user 8 3 # 8 B 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 37.80 0.44 25.56 37.02 -1.29 26.44 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1qrz_c21 PLASMINOGEN user 9 3 # 9 B 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 37.42 3.90 29.26 38.47 2.36 30.22 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1qrz_c21 PLASMINOGEN user 10 3 # 10 B 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 37.42 3.90 29.26 38.47 2.36 30.22 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1qrz_c21 PLASMINOGEN user 11 3 # 11 B 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 739 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 37.42 3.90 29.26 38.47 2.36 30.22 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1qrz_c21 PLASMINOGEN user 12 3 # 12 B 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 37.42 3.90 29.26 38.47 2.36 30.22 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c21 PLASMINOGEN user 13 3 # 13 B 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 32.91 0.46 27.63 33.66 0.11 29.56 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c21 PLASMINOGEN user 14 3 # 14 B 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 739 GLY A 244 GLY^? 11.92 ZN ZN A 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 32.91 0.46 27.63 33.66 0.11 29.56 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 32.51 -13.15 26.46 33.13 -12.90 26.03 ULMN 3 1qrz_c21 PLASMINOGEN user 15 3 # 15 B 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 40.60 0.33 34.12 38.69 0.39 33.24 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 40.70 8.14 28.73 41.06 6.40 29.84 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c21 PLASMINOGEN user 16 3 # 16 B 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 646 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 40.60 0.33 34.12 38.69 0.39 33.24 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1qrz_c21 PLASMINOGEN user 17 3 # 17 B 603 HIS A 359 HIS^? 27.14 ZN ZN A 375 B 646 ASP A 352 ASP~? 25.70 ZN ZN A 375 B 739 GLY A 7 GLY~? 22.99 ZN ZN A 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 45.80 8.64 6.53 46.53 8.87 4.58 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 43.66 -0.56 3.32 44.78 0.99 4.29 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 31.92 8.80 9.28 31.38 8.48 8.65 ULMN 3 1qrz_c21 PLASMINOGEN user 18 3 # 18 B 603 HIS A 366 HIS.? 14.86 ZN ZN A 374 B 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 51.10 6.85 29.91 51.20 5.36 31.38 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 40.70 8.14 28.73 41.06 6.40 29.84 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1qrz_c21 PLASMINOGEN user 19 3 # 19 B 603 HIS A 366 HIS.? 14.86 ZN ZN A 374 B 646 ASP A 269 ASP.? 18.90 ZN ZN A 374 B 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 51.10 6.85 29.91 51.20 5.36 31.38 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 54.82 -1.21 28.36 56.43 0.27 28.67 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1qrz_c21 PLASMINOGEN user 20 3 # 20 B 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1qrz_c21 PLASMINOGEN user 21 3 # 21 B 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 739 GLY B 293 GLY.? 9.60 ZN ZN B 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -0.50 9.63 20.82 -0.36 10.23 21.34 ULMN 3 1qrz_c21 PLASMINOGEN user 22 3 # 22 B 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1qrz_c21 PLASMINOGEN user 23 3 # 23 B 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1qrz_c21 PLASMINOGEN user 24 3 # 24 B 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1qrz_c21 PLASMINOGEN user 25 3 # 25 B 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1qrz_c21 PLASMINOGEN user 26 3 # 26 B 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1qrz_c21 PLASMINOGEN user 27 3 # 27 B 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 739 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1qrz_c21 PLASMINOGEN user 28 3 # 28 B 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c21 PLASMINOGEN user 29 3 # 29 B 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c21 PLASMINOGEN user 30 3 # 30 B 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 739 GLY B 244 GLY^? 11.85 ZN ZN B 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -0.61 -2.61 16.62 -1.32 -2.49 16.19 ULMN 3 1qrz_c21 PLASMINOGEN user 31 3 # 31 B 603 HIS B 169 HIS^? 10.86 O3S EPE A 377 B 646 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 739 GLY B 165 GLY.? 10.94 O1S EPE A 377 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -0.63 -18.46 -0.95 -1.10 -19.11 -0.69 ULMN 3 1qrz_c21 PLASMINOGEN user 32 3 # 32 B 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c21 PLASMINOGEN user 33 3 # 33 B 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 646 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1qrz_c21 PLASMINOGEN user 34 3 # 34 B 603 HIS B 359 HIS^? 24.30 ZN ZN B 375 B 646 ASP B 352 ASP~? 25.82 ZN ZN B 375 B 739 GLY B 7 GLY~? 23.15 ZN ZN B 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -24.83 -11.10 27.95 -24.79 -11.89 27.82 ULMN 3 1qrz_c21 PLASMINOGEN user 35 3 # 35 B 603 HIS B 359 HIS^? 24.30 ZN ZN B 375 B 646 ASP B 352 ASP~? 25.82 ZN ZN B 375 B 739 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1qrz_c21 PLASMINOGEN user 36 3 # 36 B 603 HIS B 366 HIS.? 14.78 ZN ZN B 374 B 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -20.57 16.04 20.92 -18.78 16.88 20.21 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1qrz_c21 PLASMINOGEN user 37 3 # 37 B 603 HIS B 366 HIS.? 14.78 ZN ZN B 374 B 646 ASP B 269 ASP.? 18.26 ZN ZN B 374 B 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -20.57 16.04 20.92 -18.78 16.88 20.21 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -18.05 15.19 12.20 -19.75 16.35 12.84 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1qrz_c21 PLASMINOGEN user 38 3 # 38 B 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1qrz_c21 PLASMINOGEN user 39 3 # 39 B 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 739 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1qrz_c21 PLASMINOGEN user 40 3 # 40 B 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1qrz_c21 PLASMINOGEN user 41 3 # 41 B 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1qrz_c21 PLASMINOGEN user 42 3 # 42 B 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1qrz_c21 PLASMINOGEN user 43 3 # 43 B 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1qrz_c21 PLASMINOGEN user 44 3 # 44 B 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1qrz_c21 PLASMINOGEN user 45 3 # 45 B 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 739 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1qrz_c21 PLASMINOGEN user 46 3 # 46 B 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c21 PLASMINOGEN user 47 3 # 47 B 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c21 PLASMINOGEN user 48 3 # 48 B 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 739 GLY C 244 GLY^? 11.70 ZN ZN C 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 2.79 -27.67 41.30 2.83 -28.37 41.63 ULMN 3 1qrz_c21 PLASMINOGEN user 49 3 # 49 B 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c21 PLASMINOGEN user 50 3 # 50 B 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 646 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1qrz_c21 PLASMINOGEN user 51 3 # 51 B 603 HIS C 359 HIS^? 24.82 ZN ZN C 375 B 646 ASP C 352 ASP~? 25.48 ZN ZN C 375 B 739 GLY C 7 GLY~? 23.11 ZN ZN C 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 19.80 -46.87 59.86 18.04 -47.50 60.82 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 18.63 -50.25 49.90 18.47 -49.69 51.95 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 27.26 -36.33 52.02 27.65 -36.56 51.35 ULMN 3 1qrz_c21 PLASMINOGEN user 52 3 # 52 B 603 HIS C 359 HIS^? 24.82 ZN ZN C 375 B 646 ASP C 352 ASP~? 25.48 ZN ZN C 375 B 739 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 19.80 -46.87 59.86 18.04 -47.50 60.82 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 18.63 -50.25 49.90 18.47 -49.69 51.95 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 1qrz_c21 PLASMINOGEN user 53 3 # 53 B 603 HIS C 366 HIS.? 14.85 ZN ZN C 374 B 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 4.16 -33.39 68.22 2.28 -32.65 67.64 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1qrz_c21 PLASMINOGEN user 54 3 # 54 B 603 HIS C 366 HIS.? 14.85 ZN ZN C 374 B 646 ASP C 269 ASP~? 18.04 ZN ZN C 374 B 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 4.16 -33.39 68.22 2.28 -32.65 67.64 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -2.62 -24.75 57.19 -2.77 -24.31 56.55 1qrz_c21 source 1qrz PLASMINOGEN : 54 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 37.80 0.44 25.56 37.02 -1.29 26.44 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 7.82 1.25 3.03 7.30 1.31 3.65 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 37.80 0.44 25.56 37.02 -1.29 26.44 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 7.82 1.25 3.03 7.30 1.31 3.65 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 C 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 37.80 0.44 25.56 37.02 -1.29 26.44 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 7.82 1.25 3.03 7.30 1.31 3.65 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1qrz_c22 PLASMINOGEN user 4 3 # 4 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 37.80 0.44 25.56 37.02 -1.29 26.44 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 40.70 8.14 28.73 41.06 6.40 29.84 coo 7.82 1.25 3.03 7.30 1.31 3.65 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1qrz_c22 PLASMINOGEN user 5 3 # 5 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 37.80 0.44 25.56 37.02 -1.29 26.44 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 40.70 8.14 28.73 41.06 6.40 29.84 coo 7.82 1.25 3.03 7.30 1.31 3.65 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1qrz_c22 PLASMINOGEN user 6 3 # 6 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 37.80 0.44 25.56 37.02 -1.29 26.44 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 40.70 8.14 28.73 41.06 6.40 29.84 coo 7.82 1.25 3.03 7.30 1.31 3.65 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1qrz_c22 PLASMINOGEN user 7 3 # 7 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 37.80 0.44 25.56 37.02 -1.29 26.44 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 7.82 1.25 3.03 7.30 1.31 3.65 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1qrz_c22 PLASMINOGEN user 8 3 # 8 C 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s C 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 37.80 0.44 25.56 37.02 -1.29 26.44 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 7.82 1.25 3.03 7.30 1.31 3.65 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1qrz_c22 PLASMINOGEN user 9 3 # 9 C 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 37.42 3.90 29.26 38.47 2.36 30.22 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 7.82 1.25 3.03 7.30 1.31 3.65 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1qrz_c22 PLASMINOGEN user 10 3 # 10 C 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s C 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 37.42 3.90 29.26 38.47 2.36 30.22 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 7.82 1.25 3.03 7.30 1.31 3.65 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1qrz_c22 PLASMINOGEN user 11 3 # 11 C 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 C 739 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 37.42 3.90 29.26 38.47 2.36 30.22 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 7.82 1.25 3.03 7.30 1.31 3.65 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1qrz_c22 PLASMINOGEN user 12 3 # 12 C 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 C 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 37.42 3.90 29.26 38.47 2.36 30.22 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 7.82 1.25 3.03 7.30 1.31 3.65 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c22 PLASMINOGEN user 13 3 # 13 C 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 C 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 32.91 0.46 27.63 33.66 0.11 29.56 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 7.82 1.25 3.03 7.30 1.31 3.65 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c22 PLASMINOGEN user 14 3 # 14 C 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 C 739 GLY A 244 GLY^? 11.92 ZN ZN A 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 32.91 0.46 27.63 33.66 0.11 29.56 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 7.82 1.25 3.03 7.30 1.31 3.65 32.51 -13.15 26.46 33.13 -12.90 26.03 ULMN 3 1qrz_c22 PLASMINOGEN user 15 3 # 15 C 603 HIS A 163 HIS.? 11.18 O1S EPE C 377 C 646 ASP A 158 ASP~? 15.23 O1S EPE C 377 C 739 GLY C 178 GLY^? 3.71 C6 EPE C 377 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 7.82 1.25 3.03 7.30 1.31 3.65 23.14 -36.24 3.79 23.36 -36.64 3.06 ULMN 3 1qrz_c22 PLASMINOGEN user 16 3 # 16 C 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s C 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 40.60 0.33 34.12 38.69 0.39 33.24 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 40.70 8.14 28.73 41.06 6.40 29.84 coo 7.82 1.25 3.03 7.30 1.31 3.65 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c22 PLASMINOGEN user 17 3 # 17 C 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s C 646 ASP A 330 ASP^? 12.08 ZN ZN A 374 C 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 40.60 0.33 34.12 38.69 0.39 33.24 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 7.82 1.25 3.03 7.30 1.31 3.65 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1qrz_c22 PLASMINOGEN user 18 3 # 18 C 603 HIS A 359 HIS^? 27.14 ZN ZN A 375 C 646 ASP A 352 ASP~? 25.70 ZN ZN A 375 C 739 GLY A 7 GLY~? 22.99 ZN ZN A 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 45.80 8.64 6.53 46.53 8.87 4.58 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 43.66 -0.56 3.32 44.78 0.99 4.29 coo 7.82 1.25 3.03 7.30 1.31 3.65 31.92 8.80 9.28 31.38 8.48 8.65 ULMN 3 1qrz_c22 PLASMINOGEN user 19 3 # 19 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 7.82 1.25 3.03 7.30 1.31 3.65 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1qrz_c22 PLASMINOGEN user 20 3 # 20 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 739 GLY B 293 GLY.? 9.60 ZN ZN B 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 7.82 1.25 3.03 7.30 1.31 3.65 -0.50 9.63 20.82 -0.36 10.23 21.34 ULMN 3 1qrz_c22 PLASMINOGEN user 21 3 # 21 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 C 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 7.82 1.25 3.03 7.30 1.31 3.65 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1qrz_c22 PLASMINOGEN user 22 3 # 22 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 7.82 1.25 3.03 7.30 1.31 3.65 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1qrz_c22 PLASMINOGEN user 23 3 # 23 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 739 GLY B 293 GLY.? 9.60 ZN ZN B 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 7.82 1.25 3.03 7.30 1.31 3.65 -0.50 9.63 20.82 -0.36 10.23 21.34 ULMN 3 1qrz_c22 PLASMINOGEN user 24 3 # 24 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 7.82 1.25 3.03 7.30 1.31 3.65 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1qrz_c22 PLASMINOGEN user 25 3 # 25 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 7.82 1.25 3.03 7.30 1.31 3.65 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1qrz_c22 PLASMINOGEN user 26 3 # 26 C 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s C 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 7.82 1.25 3.03 7.30 1.31 3.65 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1qrz_c22 PLASMINOGEN user 27 3 # 27 C 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 7.82 1.25 3.03 7.30 1.31 3.65 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1qrz_c22 PLASMINOGEN user 28 3 # 28 C 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s C 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 7.82 1.25 3.03 7.30 1.31 3.65 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1qrz_c22 PLASMINOGEN user 29 3 # 29 C 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 C 739 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 7.82 1.25 3.03 7.30 1.31 3.65 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1qrz_c22 PLASMINOGEN user 30 3 # 30 C 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 C 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 7.82 1.25 3.03 7.30 1.31 3.65 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c22 PLASMINOGEN user 31 3 # 31 C 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 C 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 7.82 1.25 3.03 7.30 1.31 3.65 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c22 PLASMINOGEN user 32 3 # 32 C 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 C 739 GLY B 244 GLY^? 11.85 ZN ZN B 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 7.82 1.25 3.03 7.30 1.31 3.65 -0.61 -2.61 16.62 -1.32 -2.49 16.19 ULMN 3 1qrz_c22 PLASMINOGEN user 33 3 # 33 C 603 HIS B 169 HIS^? 10.86 O3S EPE A 377 C 646 ASP B 158 ASP~? 14.93 O3S EPE A 377 C 739 GLY B 165 GLY.? 10.94 O1S EPE A 377 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 7.82 1.25 3.03 7.30 1.31 3.65 -0.63 -18.46 -0.95 -1.10 -19.11 -0.69 ULMN 3 1qrz_c22 PLASMINOGEN user 34 3 # 34 C 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s C 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 7.82 1.25 3.03 7.30 1.31 3.65 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c22 PLASMINOGEN user 35 3 # 35 C 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s C 646 ASP B 330 ASP^? 11.92 ZN ZN B 374 C 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 7.82 1.25 3.03 7.30 1.31 3.65 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1qrz_c22 PLASMINOGEN user 36 3 # 36 C 603 HIS B 359 HIS^? 24.30 ZN ZN B 375 C 646 ASP B 352 ASP~? 25.82 ZN ZN B 375 C 739 GLY B 7 GLY~? 23.15 ZN ZN B 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo 7.82 1.25 3.03 7.30 1.31 3.65 -24.83 -11.10 27.95 -24.79 -11.89 27.82 ULMN 3 1qrz_c22 PLASMINOGEN user 37 3 # 37 C 603 HIS B 359 HIS^? 24.30 ZN ZN B 375 C 646 ASP B 352 ASP~? 25.82 ZN ZN B 375 C 739 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo 7.82 1.25 3.03 7.30 1.31 3.65 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1qrz_c22 PLASMINOGEN user 38 3 # 38 C 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 7.82 1.25 3.03 7.30 1.31 3.65 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1qrz_c22 PLASMINOGEN user 39 3 # 39 C 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 739 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 7.82 1.25 3.03 7.30 1.31 3.65 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1qrz_c22 PLASMINOGEN user 40 3 # 40 C 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 7.82 1.25 3.03 7.30 1.31 3.65 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1qrz_c22 PLASMINOGEN user 41 3 # 41 C 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 7.82 1.25 3.03 7.30 1.31 3.65 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1qrz_c22 PLASMINOGEN user 42 3 # 42 C 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s C 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 7.82 1.25 3.03 7.30 1.31 3.65 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1qrz_c22 PLASMINOGEN user 43 3 # 43 C 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 7.82 1.25 3.03 7.30 1.31 3.65 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1qrz_c22 PLASMINOGEN user 44 3 # 44 C 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s C 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 7.82 1.25 3.03 7.30 1.31 3.65 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1qrz_c22 PLASMINOGEN user 45 3 # 45 C 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 C 739 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 7.82 1.25 3.03 7.30 1.31 3.65 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1qrz_c22 PLASMINOGEN user 46 3 # 46 C 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 C 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 7.82 1.25 3.03 7.30 1.31 3.65 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c22 PLASMINOGEN user 47 3 # 47 C 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 C 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 7.82 1.25 3.03 7.30 1.31 3.65 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c22 PLASMINOGEN user 48 3 # 48 C 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 C 739 GLY C 244 GLY^? 11.70 ZN ZN C 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 7.82 1.25 3.03 7.30 1.31 3.65 2.79 -27.67 41.30 2.83 -28.37 41.63 ULMN 3 1qrz_c22 PLASMINOGEN user 49 3 # 49 C 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s C 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 7.82 1.25 3.03 7.30 1.31 3.65 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c22 PLASMINOGEN user 50 3 # 50 C 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s C 646 ASP C 330 ASP^? 11.91 ZN ZN C 374 C 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 7.82 1.25 3.03 7.30 1.31 3.65 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1qrz_c22 PLASMINOGEN user 51 3 # 51 C 603 HIS C 359 HIS^? 24.82 ZN ZN C 375 C 646 ASP C 352 ASP~? 25.48 ZN ZN C 375 C 739 GLY C 7 GLY~? 23.11 ZN ZN C 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 18.63 -50.25 49.90 18.47 -49.69 51.95 coo 7.82 1.25 3.03 7.30 1.31 3.65 27.26 -36.33 52.02 27.65 -36.56 51.35 ULMN 3 1qrz_c22 PLASMINOGEN user 52 3 # 52 C 603 HIS C 359 HIS^? 24.82 ZN ZN C 375 C 646 ASP C 352 ASP~? 25.48 ZN ZN C 375 C 739 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 18.63 -50.25 49.90 18.47 -49.69 51.95 coo 7.82 1.25 3.03 7.30 1.31 3.65 7.81 -40.56 53.34 8.53 -40.45 53.72 1qrz_c22 source 1qrz PLASMINOGEN : 52 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 37.80 0.44 25.56 37.02 -1.29 26.44 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -45.82 1.31 41.67 -46.38 1.39 42.31 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 37.80 0.44 25.56 37.02 -1.29 26.44 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -45.82 1.31 41.67 -46.38 1.39 42.31 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 27 ASP.? 8.12 ZN ZN A 375 D 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 37.80 0.44 25.56 37.02 -1.29 26.44 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -45.82 1.31 41.67 -46.38 1.39 42.31 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1qrz_c23 PLASMINOGEN user 4 3 # 4 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 37.80 0.44 25.56 37.02 -1.29 26.44 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 40.70 8.14 28.73 41.06 6.40 29.84 coo -45.82 1.31 41.67 -46.38 1.39 42.31 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1qrz_c23 PLASMINOGEN user 5 3 # 5 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 739 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 37.80 0.44 25.56 37.02 -1.29 26.44 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 40.70 8.14 28.73 41.06 6.40 29.84 coo -45.82 1.31 41.67 -46.38 1.39 42.31 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1qrz_c23 PLASMINOGEN user 6 3 # 6 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 739 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 37.80 0.44 25.56 37.02 -1.29 26.44 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 40.70 8.14 28.73 41.06 6.40 29.84 coo -45.82 1.31 41.67 -46.38 1.39 42.31 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1qrz_c23 PLASMINOGEN user 7 3 # 7 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 37.80 0.44 25.56 37.02 -1.29 26.44 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -45.82 1.31 41.67 -46.38 1.39 42.31 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1qrz_c23 PLASMINOGEN user 8 3 # 8 D 603 HIS A 68 HIS.? -3.31 ZN ZN A 375s D 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 37.80 0.44 25.56 37.02 -1.29 26.44 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -45.82 1.31 41.67 -46.38 1.39 42.31 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1qrz_c23 PLASMINOGEN user 9 3 # 9 D 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 739 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 37.42 3.90 29.26 38.47 2.36 30.22 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -45.82 1.31 41.67 -46.38 1.39 42.31 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1qrz_c23 PLASMINOGEN user 10 3 # 10 D 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 646 ASP A 107 ASP~? -2.33 ZN ZN A 375s D 739 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 37.42 3.90 29.26 38.47 2.36 30.22 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -45.82 1.31 41.67 -46.38 1.39 42.31 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1qrz_c23 PLASMINOGEN user 11 3 # 11 D 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 D 739 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 37.42 3.90 29.26 38.47 2.36 30.22 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -45.82 1.31 41.67 -46.38 1.39 42.31 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1qrz_c23 PLASMINOGEN user 12 3 # 12 D 603 HIS A 69 HIS.? -3.40 ZN ZN A 374s D 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 D 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 37.42 3.90 29.26 38.47 2.36 30.22 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -45.82 1.31 41.67 -46.38 1.39 42.31 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c23 PLASMINOGEN user 13 3 # 13 D 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 D 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 32.91 0.46 27.63 33.66 0.11 29.56 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -45.82 1.31 41.67 -46.38 1.39 42.31 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c23 PLASMINOGEN user 14 3 # 14 D 603 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 646 ASP A 292 ASP^? 8.63 ZN ZN A 374 D 739 GLY A 244 GLY^? 11.92 ZN ZN A 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 32.91 0.46 27.63 33.66 0.11 29.56 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -45.82 1.31 41.67 -46.38 1.39 42.31 32.51 -13.15 26.46 33.13 -12.90 26.03 ULMN 3 1qrz_c23 PLASMINOGEN user 15 3 # 15 D 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s D 646 ASP A 48 ASP.? 7.40 ZN ZN A 374 D 739 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 40.60 0.33 34.12 38.69 0.39 33.24 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 40.70 8.14 28.73 41.06 6.40 29.84 coo -45.82 1.31 41.67 -46.38 1.39 42.31 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1qrz_c23 PLASMINOGEN user 16 3 # 16 D 603 HIS A 333 HIS~? -3.55 ZN ZN A 374s D 646 ASP A 330 ASP^? 12.08 ZN ZN A 374 D 739 GLY A 246 GLY^? 9.76 ZN ZN A 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 40.60 0.33 34.12 38.69 0.39 33.24 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -45.82 1.31 41.67 -46.38 1.39 42.31 38.31 -12.10 29.42 37.83 -12.45 28.86 ULMN 3 1qrz_c23 PLASMINOGEN user 17 3 # 17 D 603 HIS A 359 HIS^? 27.14 ZN ZN A 375 D 646 ASP A 352 ASP~? 25.70 ZN ZN A 375 D 739 GLY A 7 GLY~? 22.99 ZN ZN A 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 45.80 8.64 6.53 46.53 8.87 4.58 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 43.66 -0.56 3.32 44.78 0.99 4.29 coo -45.82 1.31 41.67 -46.38 1.39 42.31 31.92 8.80 9.28 31.38 8.48 8.65 ULMN 3 1qrz_c23 PLASMINOGEN user 18 3 # 18 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1qrz_c23 PLASMINOGEN user 19 3 # 19 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 739 GLY B 293 GLY.? 9.60 ZN ZN B 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -0.50 9.63 20.82 -0.36 10.23 21.34 ULMN 3 1qrz_c23 PLASMINOGEN user 20 3 # 20 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 27 ASP.? 8.17 ZN ZN B 375 D 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1qrz_c23 PLASMINOGEN user 21 3 # 21 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1qrz_c23 PLASMINOGEN user 22 3 # 22 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 739 GLY B 293 GLY.? 9.60 ZN ZN B 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -0.50 9.63 20.82 -0.36 10.23 21.34 ULMN 3 1qrz_c23 PLASMINOGEN user 23 3 # 23 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 739 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1qrz_c23 PLASMINOGEN user 24 3 # 24 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1qrz_c23 PLASMINOGEN user 25 3 # 25 D 603 HIS B 68 HIS.? -3.38 ZN ZN B 375s D 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1qrz_c23 PLASMINOGEN user 26 3 # 26 D 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 739 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1qrz_c23 PLASMINOGEN user 27 3 # 27 D 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 646 ASP B 107 ASP~? -2.23 ZN ZN B 375s D 739 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1qrz_c23 PLASMINOGEN user 28 3 # 28 D 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 D 739 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1qrz_c23 PLASMINOGEN user 29 3 # 29 D 603 HIS B 69 HIS.? -3.36 ZN ZN B 374s D 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 D 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c23 PLASMINOGEN user 30 3 # 30 D 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 D 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c23 PLASMINOGEN user 31 3 # 31 D 603 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 646 ASP B 292 ASP^? 8.88 ZN ZN B 374 D 739 GLY B 244 GLY^? 11.85 ZN ZN B 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -0.61 -2.61 16.62 -1.32 -2.49 16.19 ULMN 3 1qrz_c23 PLASMINOGEN user 32 3 # 32 D 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s D 646 ASP B 48 ASP.? 7.36 ZN ZN B 374 D 739 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1qrz_c23 PLASMINOGEN user 33 3 # 33 D 603 HIS B 333 HIS~? -3.37 ZN ZN B 374s D 646 ASP B 330 ASP^? 11.92 ZN ZN B 374 D 739 GLY B 246 GLY^? 9.61 ZN ZN B 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -2.31 3.58 14.78 -2.28 2.80 14.58 ULMN 3 1qrz_c23 PLASMINOGEN user 34 3 # 34 D 603 HIS B 359 HIS^? 24.30 ZN ZN B 375 D 646 ASP B 352 ASP~? 25.82 ZN ZN B 375 D 739 GLY B 7 GLY~? 23.15 ZN ZN B 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -24.83 -11.10 27.95 -24.79 -11.89 27.82 ULMN 3 1qrz_c23 PLASMINOGEN user 35 3 # 35 D 603 HIS B 359 HIS^? 24.30 ZN ZN B 375 D 646 ASP B 352 ASP~? 25.82 ZN ZN B 375 D 739 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1qrz_c23 PLASMINOGEN user 36 3 # 36 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1qrz_c23 PLASMINOGEN user 37 3 # 37 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 739 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1qrz_c23 PLASMINOGEN user 38 3 # 38 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 27 ASP.? 8.23 ZN ZN C 375 D 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1qrz_c23 PLASMINOGEN user 39 3 # 39 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -45.82 1.31 41.67 -46.38 1.39 42.31 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1qrz_c23 PLASMINOGEN user 40 3 # 40 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 739 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1qrz_c23 PLASMINOGEN user 41 3 # 41 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 739 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1qrz_c23 PLASMINOGEN user 42 3 # 42 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -45.82 1.31 41.67 -46.38 1.39 42.31 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1qrz_c23 PLASMINOGEN user 43 3 # 43 D 603 HIS C 68 HIS.? -3.41 ZN ZN C 375s D 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1qrz_c23 PLASMINOGEN user 44 3 # 44 D 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 739 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -45.82 1.31 41.67 -46.38 1.39 42.31 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1qrz_c23 PLASMINOGEN user 45 3 # 45 D 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 646 ASP C 107 ASP~? -2.30 ZN ZN C 375s D 739 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -2.36 -27.10 61.01 -2.45 -27.52 60.29 ULMN 3 1qrz_c23 PLASMINOGEN user 46 3 # 46 D 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 D 739 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -45.82 1.31 41.67 -46.38 1.39 42.31 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1qrz_c23 PLASMINOGEN user 47 3 # 47 D 603 HIS C 69 HIS.? -3.39 ZN ZN C 374s D 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 D 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -45.82 1.31 41.67 -46.38 1.39 42.31 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c23 PLASMINOGEN user 48 3 # 48 D 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 D 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -45.82 1.31 41.67 -46.38 1.39 42.31 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c23 PLASMINOGEN user 49 3 # 49 D 603 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 646 ASP C 292 ASP^? 8.69 ZN ZN C 374 D 739 GLY C 244 GLY^? 11.70 ZN ZN C 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -45.82 1.31 41.67 -46.38 1.39 42.31 2.79 -27.67 41.30 2.83 -28.37 41.63 ULMN 3 1qrz_c23 PLASMINOGEN user 50 3 # 50 D 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s D 646 ASP C 48 ASP.? 7.30 ZN ZN C 374 D 739 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -45.82 1.31 41.67 -46.38 1.39 42.31 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1qrz_c23 PLASMINOGEN user 51 3 # 51 D 603 HIS C 333 HIS~? -3.37 ZN ZN C 374s D 646 ASP C 330 ASP^? 11.91 ZN ZN C 374 D 739 GLY C 246 GLY^? 9.60 ZN ZN C 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -1.22 -29.27 46.37 -0.90 -29.41 45.67 ULMN 3 1qrz_c23 PLASMINOGEN user 52 3 # 52 D 603 HIS C 359 HIS^? 24.82 ZN ZN C 375 D 646 ASP C 352 ASP~? 25.48 ZN ZN C 375 D 739 GLY C 7 GLY~? 23.11 ZN ZN C 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 19.80 -46.87 59.86 18.04 -47.50 60.82 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 18.63 -50.25 49.90 18.47 -49.69 51.95 coo -45.82 1.31 41.67 -46.38 1.39 42.31 27.26 -36.33 52.02 27.65 -36.56 51.35 ULMN 3 1qrz_c23 PLASMINOGEN user 53 3 # 53 D 603 HIS C 359 HIS^? 24.82 ZN ZN C 375 D 646 ASP C 352 ASP~? 25.48 ZN ZN C 375 D 739 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 19.80 -46.87 59.86 18.04 -47.50 60.82 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 18.63 -50.25 49.90 18.47 -49.69 51.95 coo -45.82 1.31 41.67 -46.38 1.39 42.31 7.81 -40.56 53.34 8.53 -40.45 53.72 1qrz_c23 source 1qrz PLASMINOGEN : 53 hits 1qrz_c23 naa= 3 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 1 3 # 1 A 317 HIS A 163 HIS.? 11.18 O1S EPE C 377 A 318 GLY A 162 GLY.? 4.48 O1S EPE C 377 A 360 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo -8.43 39.80 36.26 -8.18 39.59 38.31 30.88 -23.32 6.66 32.97 -23.36 6.49 coo -11.14 38.10 31.61 -11.46 38.10 32.37 25.38 -26.08 6.68 25.80 -25.42 6.56 coo -11.95 34.09 34.07 -11.89 34.73 36.80 25.74 -30.01 4.94 27.86 -30.22 6.82 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 2 3 # 2 A 317 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 318 GLY A 162 GLY.? 4.48 O1S EPE C 377 A 360 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo -8.43 39.80 36.26 -8.18 39.59 38.31 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo -11.14 38.10 31.61 -11.46 38.10 32.37 25.38 -26.08 6.68 25.80 -25.42 6.56 coo -11.95 34.09 34.07 -11.89 34.73 36.80 25.74 -30.01 4.94 27.86 -30.22 6.82 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 3 3 # 3 A 317 HIS B 163 HIS.? 11.54 O3S EPE A 377 A 318 GLY B 162 GLY.? 5.31 O3S EPE A 377 A 360 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo -8.43 39.80 36.26 -8.18 39.59 38.31 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo -11.14 38.10 31.61 -11.46 38.10 32.37 -1.71 -25.67 5.15 -2.30 -25.15 5.24 coo -11.95 34.09 34.07 -11.89 34.73 36.80 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 4 3 # 4 A 317 HIS B 169 HIS^? 10.86 O3S EPE A 377 A 318 GLY B 162 GLY.? 5.31 O3S EPE A 377 A 360 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo -8.43 39.80 36.26 -8.18 39.59 38.31 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -11.14 38.10 31.61 -11.46 38.10 32.37 -1.71 -25.67 5.15 -2.30 -25.15 5.24 coo -11.95 34.09 34.07 -11.89 34.73 36.80 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 5 3 # 5 A 317 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 318 GLY C 162 GLY.? 17.81 N TRS A 378 A 360 CYH C 170 CYH^? 22.19 N TRS A 378 coo -8.43 39.80 36.26 -8.18 39.59 38.31 9.61 -42.49 30.12 8.57 -43.28 31.77 coo -11.14 38.10 31.61 -11.46 38.10 32.37 11.10 -40.67 24.41 11.25 -40.70 25.20 coo -11.95 34.09 34.07 -11.89 34.73 36.80 9.66 -43.43 21.72 7.18 -43.27 22.99 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 6 3 # 6 A 317 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 318 GLY C 162 GLY.? 17.81 N TRS A 378 A 360 CYH C 170 CYH^? 22.19 N TRS A 378 coo -8.43 39.80 36.26 -8.18 39.59 38.31 13.13 -47.52 24.96 14.34 -48.17 26.54 coo -11.14 38.10 31.61 -11.46 38.10 32.37 11.10 -40.67 24.41 11.25 -40.70 25.20 coo -11.95 34.09 34.07 -11.89 34.73 36.80 9.66 -43.43 21.72 7.18 -43.27 22.99 1qtn_c02 source 1qtn ACETYL-ILE-GLU-THR-ASP-ALDEHYDE : 6 hits 1qtn_c02 naa= 3 ULMN 3 1qx3_c00 APOPAIN user 1 3 # 1 A 121 HIS A 163 HIS.? 11.18 O1S EPE C 377 A 122 GLY A 162 GLY.? 4.48 O1S EPE C 377 A 163 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo 2.23 29.11 15.20 1.24 27.27 15.13 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 2.54 34.86 14.60 1.83 34.53 14.82 25.38 -26.08 6.68 25.80 -25.42 6.56 coo -1.20 35.13 11.95 -2.11 32.67 12.98 25.74 -30.01 4.94 27.86 -30.22 6.82 ULMN 3 1qx3_c00 APOPAIN user 2 3 # 2 A 121 HIS A 169 HIS^? 11.22 O1S EPE C 377 A 122 GLY A 162 GLY.? 4.48 O1S EPE C 377 A 163 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo 2.23 29.11 15.20 1.24 27.27 15.13 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 2.54 34.86 14.60 1.83 34.53 14.82 25.38 -26.08 6.68 25.80 -25.42 6.56 coo -1.20 35.13 11.95 -2.11 32.67 12.98 25.74 -30.01 4.94 27.86 -30.22 6.82 ULMN 3 1qx3_c00 APOPAIN user 3 3 # 3 A 121 HIS B 163 HIS.? 11.54 O3S EPE A 377 A 122 GLY B 162 GLY.? 5.31 O3S EPE A 377 A 163 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo 2.23 29.11 15.20 1.24 27.27 15.13 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 2.54 34.86 14.60 1.83 34.53 14.82 -1.71 -25.67 5.15 -2.30 -25.15 5.24 coo -1.20 35.13 11.95 -2.11 32.67 12.98 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1qx3_c00 APOPAIN user 4 3 # 4 A 121 HIS B 169 HIS^? 10.86 O3S EPE A 377 A 122 GLY B 162 GLY.? 5.31 O3S EPE A 377 A 163 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo 2.23 29.11 15.20 1.24 27.27 15.13 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 2.54 34.86 14.60 1.83 34.53 14.82 -1.71 -25.67 5.15 -2.30 -25.15 5.24 coo -1.20 35.13 11.95 -2.11 32.67 12.98 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1qx3_c00 APOPAIN user 5 3 # 5 A 121 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 122 GLY C 162 GLY.? 17.81 N TRS A 378 A 163 CYH C 170 CYH^? 22.19 N TRS A 378 coo 2.23 29.11 15.20 1.24 27.27 15.13 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 2.54 34.86 14.60 1.83 34.53 14.82 11.10 -40.67 24.41 11.25 -40.70 25.20 coo -1.20 35.13 11.95 -2.11 32.67 12.98 9.66 -43.43 21.72 7.18 -43.27 22.99 ULMN 3 1qx3_c00 APOPAIN user 6 3 # 6 A 121 HIS C 169 HIS^? 22.39 O1 TRS A 378 A 122 GLY C 162 GLY.? 17.81 N TRS A 378 A 163 CYH C 170 CYH^? 22.19 N TRS A 378 coo 2.23 29.11 15.20 1.24 27.27 15.13 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 2.54 34.86 14.60 1.83 34.53 14.82 11.10 -40.67 24.41 11.25 -40.70 25.20 coo -1.20 35.13 11.95 -2.11 32.67 12.98 9.66 -43.43 21.72 7.18 -43.27 22.99 1qx3_c00 source 1qx3 APOPAIN : 6 hits 1qx3_c00 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 260 PHE~? 19.27 ZN ZN A 375 A 201 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 227 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 23.39 49.81 32.16 21.33 51.68 32.26 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 25.52 45.12 37.98 23.98 46.65 37.85 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 12.68 46.83 36.69 18.26 48.67 34.51 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 372 PHE.? 17.32 ZN ZN A 374 A 201 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 227 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 23.39 49.81 32.16 21.33 51.68 32.26 52.79 1.59 40.88 50.60 -0.15 40.87 coo 25.52 45.12 37.98 23.98 46.65 37.85 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 12.68 46.83 36.69 18.26 48.67 34.51 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 372 PHE.? 17.32 ZN ZN A 374 A 201 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 227 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 23.39 49.81 32.16 21.33 51.68 32.26 52.79 1.59 40.88 50.60 -0.15 40.87 coo 25.52 45.12 37.98 23.98 46.65 37.85 48.24 5.16 33.58 47.82 3.96 35.30 coo 12.68 46.83 36.69 18.26 48.67 34.51 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE B 260 PHE~? 19.39 ZN ZN B 375 A 201 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 227 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 23.39 49.81 32.16 21.33 51.68 32.26 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 25.52 45.12 37.98 23.98 46.65 37.85 3.99 14.73 5.36 5.18 14.04 3.76 coo 12.68 46.83 36.69 18.26 48.67 34.51 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE B 372 PHE.? 17.31 ZN ZN B 374 A 201 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 227 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 23.39 49.81 32.16 21.33 51.68 32.26 -11.64 24.23 19.14 -9.49 22.46 19.29 coo 25.52 45.12 37.98 23.98 46.65 37.85 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 12.68 46.83 36.69 18.26 48.67 34.51 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE B 372 PHE.? 17.31 ZN ZN B 374 A 201 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 227 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 23.39 49.81 32.16 21.33 51.68 32.26 -11.64 24.23 19.14 -9.49 22.46 19.29 coo 25.52 45.12 37.98 23.98 46.65 37.85 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 12.68 46.83 36.69 18.26 48.67 34.51 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE C 260 PHE~? 19.40 ZN ZN C 375 A 201 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 227 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 23.39 49.81 32.16 21.33 51.68 32.26 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 12.68 46.83 36.69 18.26 48.67 34.51 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 1qz9_c02 KYNURENINASE user 8 3 # 8 A 129 PHE C 372 PHE.? 17.18 ZN ZN C 374 A 201 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 227 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 23.39 49.81 32.16 21.33 51.68 32.26 -6.66 -27.35 68.48 -6.43 -26.37 65.89 coo 25.52 45.12 37.98 23.98 46.65 37.85 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 12.68 46.83 36.69 18.26 48.67 34.51 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 1qz9_c02 KYNURENINASE user 9 3 # 9 A 129 PHE C 372 PHE.? 17.18 ZN ZN C 374 A 201 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 227 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 23.39 49.81 32.16 21.33 51.68 32.26 -6.66 -27.35 68.48 -6.43 -26.37 65.89 coo 25.52 45.12 37.98 23.98 46.65 37.85 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 12.68 46.83 36.69 18.26 48.67 34.51 -8.06 -35.63 62.23 -11.30 -33.36 66.69 1qz9_c02 source 1qz9 KYNURENINASE : 9 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 186 ASN A 105 ASN~? 9.65 ZN ZN A 375 A 260 ALA A 67 ALA^? 10.32 ZN ZN A 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 11.43 26.53 7.41 13.01 27.56 8.43 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 21.53 26.33 6.96 20.26 25.69 7.52 37.22 5.65 22.28 37.04 6.85 23.17 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 55 ASP~? 17.36 O2S EPE A 376 A 186 ASN A 95 ASN~? 18.99 O2S EPE A 376 A 260 ALA A 62 ALA.? 21.75 ZN ZN A 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 45.10 18.98 22.18 44.20 20.57 23.21 coo 11.43 26.53 7.41 13.01 27.56 8.43 37.50 21.37 17.07 38.56 22.79 18.19 coo 21.53 26.33 6.96 20.26 25.69 7.52 41.03 13.97 12.85 41.56 12.98 13.85 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP A 55 ASP~? 17.36 O2S EPE A 376 A 186 ASN A 95 ASN~? 18.99 O2S EPE A 376 A 260 ALA A 98 ALA^? 19.17 C3 EPE A 376 coo 11.81 33.10 11.71 13.07 31.45 11.40 45.10 18.98 22.18 44.20 20.57 23.21 coo 11.43 26.53 7.41 13.01 27.56 8.43 37.50 21.37 17.07 38.56 22.79 18.19 coo 21.53 26.33 6.96 20.26 25.69 7.52 32.69 13.47 16.67 32.07 12.82 15.47 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 186 ASN A 105 ASN~? 9.65 ZN ZN A 375 A 260 ALA A 67 ALA^? 10.32 ZN ZN A 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.43 26.53 7.41 13.01 27.56 8.43 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 21.53 26.33 6.96 20.26 25.69 7.52 37.22 5.65 22.28 37.04 6.85 23.17 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 186 ASN A 105 ASN~? 9.65 ZN ZN A 375 A 260 ALA A 101 ALA^? 11.28 ZN ZN A 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.43 26.53 7.41 13.01 27.56 8.43 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 21.53 26.33 6.96 20.26 25.69 7.52 32.09 5.17 22.05 31.25 5.48 23.29 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 186 ASN A 114 ASN~? 6.65 ZN ZN A 375 A 260 ALA A 287 ALA^? 15.21 ZN ZN A 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.43 26.53 7.41 13.01 27.56 8.43 39.96 -10.05 26.73 39.22 -8.78 28.27 coo 21.53 26.33 6.96 20.26 25.69 7.52 43.01 -15.52 33.51 41.87 -15.70 34.47 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 7 3 # 7 A 10 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 186 ASN B 238 ASN^? 8.84 O1S EPE A 377 A 260 ALA B 210 ALA.? 15.50 O1S EPE A 377 coo 11.81 33.10 11.71 13.07 31.45 11.40 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 11.43 26.53 7.41 13.01 27.56 8.43 7.11 -18.54 9.31 8.52 -20.00 8.45 coo 21.53 26.33 6.96 20.26 25.69 7.52 -1.53 -20.24 16.39 -0.69 -19.53 17.41 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 8 3 # 8 A 10 ASP A 281 ASP.? 28.06 ZN ZN A 375 A 186 ASN A 327 ASN^? 23.94 ZN ZN A 375 A 260 ALA A 261 ALA~? 21.36 ZN ZN A 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 11.43 26.53 7.41 13.01 27.56 8.43 47.65 -15.59 42.64 48.42 -17.07 43.94 coo 21.53 26.33 6.96 20.26 25.69 7.52 54.29 -10.44 37.93 54.37 -10.19 39.44 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 9 3 # 9 A 10 ASP A 281 ASP.? 28.06 ZN ZN A 375 A 186 ASN A 327 ASN^? 23.94 ZN ZN A 375 A 260 ALA A 305 ALA.? 18.87 ZN ZN A 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 11.43 26.53 7.41 13.01 27.56 8.43 47.65 -15.59 42.64 48.42 -17.07 43.94 coo 21.53 26.33 6.96 20.26 25.69 7.52 43.26 -20.00 36.94 42.76 -18.58 36.69 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 10 3 # 10 A 10 ASP A 281 ASP.? 28.06 ZN ZN A 375 A 186 ASN A 327 ASN^? 23.94 ZN ZN A 375 A 260 ALA A 321 ALA~? 19.58 ZN ZN A 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 11.43 26.53 7.41 13.01 27.56 8.43 47.65 -15.59 42.64 48.42 -17.07 43.94 coo 21.53 26.33 6.96 20.26 25.69 7.52 40.35 -13.63 46.22 41.15 -12.61 45.43 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 11 3 # 11 A 10 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 186 ASN A 294 ASN.? 12.36 ZN ZN A 374 A 260 ALA A 300 ALA~? 16.31 ZN ZN A 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 11.43 26.53 7.41 13.01 27.56 8.43 35.77 -6.31 41.36 37.34 -5.07 42.10 coo 21.53 26.33 6.96 20.26 25.69 7.52 38.46 -17.14 37.26 39.29 -15.90 37.59 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 12 3 # 12 A 10 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 186 ASN A 294 ASN.? 12.36 ZN ZN A 374 A 260 ALA A 318 ALA~? 19.12 ZN ZN A 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 11.43 26.53 7.41 13.01 27.56 8.43 35.77 -6.31 41.36 37.34 -5.07 42.10 coo 21.53 26.33 6.96 20.26 25.69 7.52 41.32 -8.99 47.30 42.41 -8.00 47.53 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 13 3 # 13 A 10 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 186 ASN A 327 ASN^? 23.94 ZN ZN A 375 A 260 ALA A 261 ALA~? 21.36 ZN ZN A 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 11.43 26.53 7.41 13.01 27.56 8.43 47.65 -15.59 42.64 48.42 -17.07 43.94 coo 21.53 26.33 6.96 20.26 25.69 7.52 54.29 -10.44 37.93 54.37 -10.19 39.44 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 14 3 # 14 A 10 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 186 ASN A 327 ASN^? 23.94 ZN ZN A 375 A 260 ALA A 321 ALA~? 19.58 ZN ZN A 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 11.43 26.53 7.41 13.01 27.56 8.43 47.65 -15.59 42.64 48.42 -17.07 43.94 coo 21.53 26.33 6.96 20.26 25.69 7.52 40.35 -13.63 46.22 41.15 -12.61 45.43 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 15 3 # 15 A 10 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 186 ASN A 294 ASN.? 12.36 ZN ZN A 374 A 260 ALA A 318 ALA~? 19.12 ZN ZN A 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 39.49 -1.24 39.18 39.76 0.49 37.96 coo 11.43 26.53 7.41 13.01 27.56 8.43 35.77 -6.31 41.36 37.34 -5.07 42.10 coo 21.53 26.33 6.96 20.26 25.69 7.52 41.32 -8.99 47.30 42.41 -8.00 47.53 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 16 3 # 16 A 10 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 186 ASN A 294 ASN.? 12.36 ZN ZN A 374 A 260 ALA A 321 ALA~? 19.58 ZN ZN A 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 39.49 -1.24 39.18 39.76 0.49 37.96 coo 11.43 26.53 7.41 13.01 27.56 8.43 35.77 -6.31 41.36 37.34 -5.07 42.10 coo 21.53 26.33 6.96 20.26 25.69 7.52 40.35 -13.63 46.22 41.15 -12.61 45.43 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 17 3 # 17 A 10 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 186 ASN A 294 ASN.? 12.36 ZN ZN A 374 A 260 ALA A 300 ALA~? 16.31 ZN ZN A 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 11.43 26.53 7.41 13.01 27.56 8.43 35.77 -6.31 41.36 37.34 -5.07 42.10 coo 21.53 26.33 6.96 20.26 25.69 7.52 38.46 -17.14 37.26 39.29 -15.90 37.59 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 18 3 # 18 A 10 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 186 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 260 ALA B 67 ALA^? 10.44 ZN ZN B 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 11.43 26.53 7.41 13.01 27.56 8.43 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 21.53 26.33 6.96 20.26 25.69 7.52 -17.51 1.20 26.23 -17.65 1.96 27.53 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 19 3 # 19 A 10 ASP B 55 ASP~? 16.89 O3S EPE B 376 A 186 ASN B 95 ASN~? 19.50 O2S EPE B 376 A 260 ALA B 62 ALA.? 21.54 ZN ZN B 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 11.43 26.53 7.41 13.01 27.56 8.43 -30.82 1.14 36.18 -31.61 2.89 37.07 coo 21.53 26.33 6.96 20.26 25.69 7.52 -30.17 -1.37 27.22 -29.17 -0.49 26.46 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 20 3 # 20 A 10 ASP B 55 ASP~? 16.89 O3S EPE B 376 A 186 ASN B 95 ASN~? 19.50 O2S EPE B 376 A 260 ALA B 98 ALA^? 18.79 C3 EPE B 376 coo 11.81 33.10 11.71 13.07 31.45 11.40 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 11.43 26.53 7.41 13.01 27.56 8.43 -30.82 1.14 36.18 -31.61 2.89 37.07 coo 21.53 26.33 6.96 20.26 25.69 7.52 -23.64 -3.90 33.07 -23.65 -5.30 32.62 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 21 3 # 21 A 10 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 186 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 260 ALA B 67 ALA^? 10.44 ZN ZN B 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.43 26.53 7.41 13.01 27.56 8.43 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 21.53 26.33 6.96 20.26 25.69 7.52 -17.51 1.20 26.23 -17.65 1.96 27.53 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 22 3 # 22 A 10 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 186 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 260 ALA B 101 ALA^? 11.06 ZN ZN B 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.43 26.53 7.41 13.01 27.56 8.43 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 21.53 26.33 6.96 20.26 25.69 7.52 -14.73 -2.17 28.75 -13.66 -1.71 29.80 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 23 3 # 23 A 10 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 186 ASN B 114 ASN~? 6.61 ZN ZN B 375 A 260 ALA B 287 ALA^? 15.22 ZN ZN B 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.43 26.53 7.41 13.01 27.56 8.43 -6.09 3.05 14.26 -5.63 4.05 16.11 coo 21.53 26.33 6.96 20.26 25.69 7.52 -0.09 8.91 10.38 1.12 8.85 11.22 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 24 3 # 24 A 10 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 186 ASN C 238 ASN^? 16.63 O2S EPE A 377 A 260 ALA C 210 ALA.? 10.68 O1 TRS A 378 coo 11.81 33.10 11.71 13.07 31.45 11.40 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 11.43 26.53 7.41 13.01 27.56 8.43 5.28 -30.50 23.50 4.52 -30.81 21.55 coo 21.53 26.33 6.96 20.26 25.69 7.52 15.20 -30.13 29.07 14.89 -28.65 29.26 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 25 3 # 25 A 10 ASP B 281 ASP.? 29.04 ZN ZN B 374 A 186 ASN B 327 ASN^? 24.15 ZN ZN B 374 A 260 ALA B 261 ALA~? 21.05 ZN ZN B 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 4.51 22.24 5.26 6.45 23.04 5.71 coo 11.43 26.53 7.41 13.01 27.56 8.43 3.03 18.84 10.12 4.53 19.91 9.07 coo 21.53 26.33 6.96 20.26 25.69 7.52 -6.29 20.23 8.69 -5.64 21.42 9.38 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 26 3 # 26 A 10 ASP B 281 ASP.? 29.04 ZN ZN B 374 A 186 ASN B 327 ASN^? 24.15 ZN ZN B 374 A 260 ALA B 305 ALA.? 19.14 ZN ZN B 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 4.51 22.24 5.26 6.45 23.04 5.71 coo 11.43 26.53 7.41 13.01 27.56 8.43 3.03 18.84 10.12 4.53 19.91 9.07 coo 21.53 26.33 6.96 20.26 25.69 7.52 4.93 10.77 7.95 4.24 10.56 9.28 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 27 3 # 27 A 10 ASP B 281 ASP.? 29.04 ZN ZN B 374 A 186 ASN B 327 ASN^? 24.15 ZN ZN B 374 A 260 ALA B 321 ALA~? 19.77 ZN ZN B 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 4.51 22.24 5.26 6.45 23.04 5.71 coo 11.43 26.53 7.41 13.01 27.56 8.43 3.03 18.84 10.12 4.53 19.91 9.07 coo 21.53 26.33 6.96 20.26 25.69 7.52 7.50 17.37 16.99 6.00 17.39 16.91 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 28 3 # 28 A 10 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 186 ASN B 294 ASN.? 12.27 ZN ZN B 374 A 260 ALA B 300 ALA~? 16.49 ZN ZN B 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 11.43 26.53 7.41 13.01 27.56 8.43 2.18 12.34 23.84 0.88 14.02 24.05 coo 21.53 26.33 6.96 20.26 25.69 7.52 5.39 8.45 13.10 4.54 9.60 13.56 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 29 3 # 29 A 10 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 186 ASN B 294 ASN.? 12.27 ZN ZN B 374 A 260 ALA B 318 ALA~? 19.05 ZN ZN B 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 11.43 26.53 7.41 13.01 27.56 8.43 2.18 12.34 23.84 0.88 14.02 24.05 coo 21.53 26.33 6.96 20.26 25.69 7.52 4.54 19.55 20.17 3.54 20.61 20.36 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 30 3 # 30 A 10 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 186 ASN B 327 ASN^? 24.15 ZN ZN B 374 A 260 ALA B 261 ALA~? 21.05 ZN ZN B 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 3.99 14.73 5.36 5.18 14.04 3.76 coo 11.43 26.53 7.41 13.01 27.56 8.43 3.03 18.84 10.12 4.53 19.91 9.07 coo 21.53 26.33 6.96 20.26 25.69 7.52 -6.29 20.23 8.69 -5.64 21.42 9.38 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 31 3 # 31 A 10 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 186 ASN B 327 ASN^? 24.15 ZN ZN B 374 A 260 ALA B 321 ALA~? 19.77 ZN ZN B 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 3.99 14.73 5.36 5.18 14.04 3.76 coo 11.43 26.53 7.41 13.01 27.56 8.43 3.03 18.84 10.12 4.53 19.91 9.07 coo 21.53 26.33 6.96 20.26 25.69 7.52 7.50 17.37 16.99 6.00 17.39 16.91 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 32 3 # 32 A 10 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 186 ASN B 294 ASN.? 12.27 ZN ZN B 374 A 260 ALA B 318 ALA~? 19.05 ZN ZN B 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 11.43 26.53 7.41 13.01 27.56 8.43 2.18 12.34 23.84 0.88 14.02 24.05 coo 21.53 26.33 6.96 20.26 25.69 7.52 4.54 19.55 20.17 3.54 20.61 20.36 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 33 3 # 33 A 10 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 186 ASN B 294 ASN.? 12.27 ZN ZN B 374 A 260 ALA B 321 ALA~? 19.77 ZN ZN B 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 11.43 26.53 7.41 13.01 27.56 8.43 2.18 12.34 23.84 0.88 14.02 24.05 coo 21.53 26.33 6.96 20.26 25.69 7.52 7.50 17.37 16.99 6.00 17.39 16.91 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 34 3 # 34 A 10 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 186 ASN B 294 ASN.? 12.27 ZN ZN B 374 A 260 ALA B 300 ALA~? 16.49 ZN ZN B 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 9.35 16.65 21.02 10.22 16.89 22.90 coo 11.43 26.53 7.41 13.01 27.56 8.43 2.18 12.34 23.84 0.88 14.02 24.05 coo 21.53 26.33 6.96 20.26 25.69 7.52 5.39 8.45 13.10 4.54 9.60 13.56 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 35 3 # 35 A 10 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 186 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 260 ALA C 67 ALA^? 10.56 ZN ZN C 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 11.43 26.53 7.41 13.01 27.56 8.43 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 21.53 26.33 6.96 20.26 25.69 7.52 14.85 -30.74 56.60 15.29 -29.68 57.59 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 36 3 # 36 A 10 ASP C 55 ASP~? 17.38 O3S EPE C 376 A 186 ASN C 95 ASN~? 19.32 O3S EPE C 376 A 260 ALA C 62 ALA.? 21.65 ZN ZN C 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 11.43 26.53 7.41 13.01 27.56 8.43 27.60 -31.58 66.97 27.57 -31.41 69.09 coo 21.53 26.33 6.96 20.26 25.69 7.52 23.65 -38.52 62.14 22.14 -38.28 62.04 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 37 3 # 37 A 10 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 186 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 260 ALA C 67 ALA^? 10.56 ZN ZN C 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.43 26.53 7.41 13.01 27.56 8.43 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 21.53 26.33 6.96 20.26 25.69 7.52 14.85 -30.74 56.60 15.29 -29.68 57.59 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 38 3 # 38 A 10 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 186 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 260 ALA C 101 ALA^? 11.01 ZN ZN C 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.43 26.53 7.41 13.01 27.56 8.43 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 21.53 26.33 6.96 20.26 25.69 7.52 17.04 -27.71 53.14 16.81 -26.24 53.31 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 39 3 # 39 A 10 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 186 ASN C 114 ASN~? 6.62 ZN ZN C 375 A 260 ALA C 287 ALA^? 15.31 ZN ZN C 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.43 26.53 7.41 13.01 27.56 8.43 0.77 -32.01 47.92 1.06 -30.12 48.87 coo 21.53 26.33 6.96 20.26 25.69 7.52 -8.21 -29.95 47.66 -8.39 -28.51 47.16 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 40 3 # 40 A 10 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 186 ASN A 238 ASN^? -4.13 C2 TRS A 378s A 260 ALA A 210 ALA.? 13.63 C3 TRS A 378 coo 11.81 33.10 11.71 13.07 31.45 11.40 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 11.43 26.53 7.41 13.01 27.56 8.43 22.25 -25.65 17.52 21.37 -27.55 17.01 coo 21.53 26.33 6.96 20.26 25.69 7.52 20.67 -16.34 12.32 20.26 -15.76 13.68 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 41 3 # 41 A 10 ASP C 281 ASP.? 29.07 ZN ZN C 374 A 186 ASN C 327 ASN^? 24.03 ZN ZN C 374 A 260 ALA C 261 ALA~? 21.12 ZN ZN C 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 11.43 26.53 7.41 13.01 27.56 8.43 -16.01 -26.28 53.09 -18.10 -26.10 52.88 coo 21.53 26.33 6.96 20.26 25.69 7.52 -13.17 -32.79 59.35 -13.86 -31.71 60.07 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 42 3 # 42 A 10 ASP C 281 ASP.? 29.07 ZN ZN C 374 A 186 ASN C 327 ASN^? 24.03 ZN ZN C 374 A 260 ALA C 305 ALA.? 19.06 ZN ZN C 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 11.43 26.53 7.41 13.01 27.56 8.43 -16.01 -26.28 53.09 -18.10 -26.10 52.88 coo 21.53 26.33 6.96 20.26 25.69 7.52 -13.32 -28.27 45.43 -12.06 -27.81 46.19 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 43 3 # 43 A 10 ASP C 281 ASP.? 29.07 ZN ZN C 374 A 186 ASN C 327 ASN^? 24.03 ZN ZN C 374 A 260 ALA C 321 ALA~? 19.69 ZN ZN C 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 11.43 26.53 7.41 13.01 27.56 8.43 -16.01 -26.28 53.09 -18.10 -26.10 52.88 coo 21.53 26.33 6.96 20.26 25.69 7.52 -13.40 -18.49 51.25 -12.60 -19.47 52.03 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 44 3 # 44 A 10 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 186 ASN C 327 ASN^? 24.03 ZN ZN C 374 A 260 ALA C 261 ALA~? 21.12 ZN ZN C 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 11.43 26.53 7.41 13.01 27.56 8.43 -16.01 -26.28 53.09 -18.10 -26.10 52.88 coo 21.53 26.33 6.96 20.26 25.69 7.52 -13.17 -32.79 59.35 -13.86 -31.71 60.07 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 45 3 # 45 A 10 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 186 ASN C 327 ASN^? 24.03 ZN ZN C 374 A 260 ALA C 321 ALA~? 19.69 ZN ZN C 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 11.43 26.53 7.41 13.01 27.56 8.43 -16.01 -26.28 53.09 -18.10 -26.10 52.88 coo 21.53 26.33 6.96 20.26 25.69 7.52 -13.40 -18.49 51.25 -12.60 -19.47 52.03 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 46 3 # 46 A 10 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 186 ASN C 294 ASN.? 11.92 ZN ZN C 374 A 260 ALA C 318 ALA~? 18.85 ZN ZN C 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 11.43 26.53 7.41 13.01 27.56 8.43 -3.30 -17.98 52.78 -3.53 -18.25 54.87 coo 21.53 26.33 6.96 20.26 25.69 7.52 -11.35 -17.41 55.53 -11.30 -17.89 56.96 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 47 3 # 47 A 10 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 186 ASN C 294 ASN.? 11.92 ZN ZN C 374 A 260 ALA C 321 ALA~? 19.69 ZN ZN C 374 coo 11.81 33.10 11.71 13.07 31.45 11.40 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 11.43 26.53 7.41 13.01 27.56 8.43 -3.30 -17.98 52.78 -3.53 -18.25 54.87 coo 21.53 26.33 6.96 20.26 25.69 7.52 -13.40 -18.49 51.25 -12.60 -19.47 52.03 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 48 3 # 48 A 10 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 186 ASN C 294 ASN.? 11.92 ZN ZN C 374 A 260 ALA C 300 ALA~? 16.47 ZN ZN C 375 coo 11.81 33.10 11.71 13.07 31.45 11.40 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 11.43 26.53 7.41 13.01 27.56 8.43 -3.30 -17.98 52.78 -3.53 -18.25 54.87 coo 21.53 26.33 6.96 20.26 25.69 7.52 -9.24 -24.63 44.86 -9.08 -24.63 46.37 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 48 hits 1r4f_c00 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 41 LYS A 28 LYS.? 12.48 C7 EPE A 376 A 119 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 37.80 0.44 25.56 37.02 -1.29 26.44 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 26.87 3.56 26.76 22.81 3.70 30.35 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 41 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 119 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 32.91 0.46 27.63 33.66 0.11 29.56 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 44.47 1.55 20.70 47.30 5.10 24.27 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 3 3 # 3 A 12 HIS A 224 HIS~? 7.33 C7 EPE A 377 A 41 LYS A 218 LYS~? 21.49 C3 EPE A 377 A 119 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 4 3 # 4 A 12 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 41 LYS A 295 LYS.? 12.61 ZN ZN A 374 A 119 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 40.60 0.33 34.12 38.69 0.39 33.24 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 5 3 # 5 A 12 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 41 LYS B 28 LYS.? 11.75 C7 EPE B 376 A 119 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 6 3 # 6 A 12 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 41 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 119 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 7 3 # 7 A 12 HIS B 224 HIS.? 17.79 O2S EPE A 377 A 41 LYS B 218 LYS~? 23.26 O3S EPE A 377 A 119 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 8 3 # 8 A 12 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 41 LYS B 295 LYS.? 11.37 ZN ZN B 375 A 119 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 4.57 8.76 22.84 2.39 5.01 24.93 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 9 3 # 9 A 12 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 41 LYS C 28 LYS.? 13.32 C7 EPE C 376 A 119 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 10 3 # 10 A 12 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 41 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 119 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 11 3 # 11 A 12 HIS C 224 HIS~? 8.36 C3 EPE C 377 A 41 LYS C 218 LYS~? 12.80 O1 TRS A 378 A 119 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 27.13 -47.60 14.36 28.94 -48.66 14.50 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 12 3 # 12 A 12 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 41 LYS C 295 LYS.? 14.49 ZN ZN C 374 A 119 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 10.51 -24.81 51.94 8.80 -23.79 52.62 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 12 hits 1rbn_c01 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 610 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 661 HIS A 366 HIS.? 14.86 ZN ZN A 374 coo 75.99 81.56 1.86 73.91 81.34 2.28 40.70 8.14 28.73 41.06 6.40 29.84 coo 71.04 78.84 0.46 71.54 76.90 1.02 37.42 3.90 29.26 38.47 2.36 30.22 coo 75.40 81.38 12.06 74.88 79.42 12.63 51.10 6.85 29.91 51.20 5.36 31.38 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 610 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 661 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 75.99 81.56 1.86 73.91 81.34 2.28 48.24 5.16 33.58 47.82 3.96 35.30 coo 71.04 78.84 0.46 71.54 76.90 1.02 51.10 6.85 29.91 51.20 5.36 31.38 coo 75.40 81.38 12.06 74.88 79.42 12.63 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 3 3 # 3 A 608 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 610 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 661 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 75.99 81.56 1.86 73.91 81.34 2.28 48.24 5.16 33.58 47.82 3.96 35.30 coo 71.04 78.84 0.46 71.54 76.90 1.02 51.10 6.85 29.91 51.20 5.36 31.38 coo 75.40 81.38 12.06 74.88 79.42 12.63 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 4 3 # 4 A 608 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 610 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 661 HIS B 366 HIS.? 14.78 ZN ZN B 374 coo 75.99 81.56 1.86 73.91 81.34 2.28 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 71.04 78.84 0.46 71.54 76.90 1.02 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 75.40 81.38 12.06 74.88 79.42 12.63 -20.57 16.04 20.92 -18.78 16.88 20.21 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 5 3 # 5 A 608 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 610 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 661 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 75.99 81.56 1.86 73.91 81.34 2.28 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 71.04 78.84 0.46 71.54 76.90 1.02 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 75.40 81.38 12.06 74.88 79.42 12.63 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 6 3 # 6 A 608 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 610 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 661 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 75.99 81.56 1.86 73.91 81.34 2.28 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 71.04 78.84 0.46 71.54 76.90 1.02 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 75.40 81.38 12.06 74.88 79.42 12.63 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 7 3 # 7 A 608 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 610 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 661 HIS C 366 HIS.? 14.85 ZN ZN C 374 coo 75.99 81.56 1.86 73.91 81.34 2.28 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 71.04 78.84 0.46 71.54 76.90 1.02 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 75.40 81.38 12.06 74.88 79.42 12.63 4.16 -33.39 68.22 2.28 -32.65 67.64 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 8 3 # 8 A 608 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 610 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 661 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 75.99 81.56 1.86 73.91 81.34 2.28 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 71.04 78.84 0.46 71.54 76.90 1.02 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 75.40 81.38 12.06 74.88 79.42 12.63 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 9 3 # 9 A 608 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 610 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 661 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 75.99 81.56 1.86 73.91 81.34 2.28 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 71.04 78.84 0.46 71.54 76.90 1.02 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 75.40 81.38 12.06 74.88 79.42 12.63 2.70 -25.03 58.20 4.12 -24.40 56.79 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 9 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP A 48 ASP.? 7.40 ZN ZN A 374 C 610 HIS A 69 HIS.? -3.40 ZN ZN A 374s C 661 HIS A 366 HIS.? 14.86 ZN ZN A 374 coo -17.65 80.52 58.00 -16.23 80.79 56.41 40.70 8.14 28.73 41.06 6.40 29.84 coo -16.56 83.18 53.03 -16.33 85.18 53.60 37.42 3.90 29.26 38.47 2.36 30.22 coo -8.38 80.78 62.24 -7.53 82.67 62.02 51.10 6.85 29.91 51.20 5.36 31.38 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP A 368 ASP.? 11.85 ZN ZN A 374 C 610 HIS A 366 HIS.? 14.86 ZN ZN A 374 C 661 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo -17.65 80.52 58.00 -16.23 80.79 56.41 48.24 5.16 33.58 47.82 3.96 35.30 coo -16.56 83.18 53.03 -16.33 85.18 53.60 51.10 6.85 29.91 51.20 5.36 31.38 coo -8.38 80.78 62.24 -7.53 82.67 62.02 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 3 3 # 3 C 608 ASP A 368 ASP.? 11.85 ZN ZN A 374 C 610 HIS A 366 HIS.? 14.86 ZN ZN A 374 C 661 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo -17.65 80.52 58.00 -16.23 80.79 56.41 48.24 5.16 33.58 47.82 3.96 35.30 coo -16.56 83.18 53.03 -16.33 85.18 53.60 51.10 6.85 29.91 51.20 5.36 31.38 coo -8.38 80.78 62.24 -7.53 82.67 62.02 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 4 3 # 4 C 608 ASP B 48 ASP.? 7.36 ZN ZN B 374 C 610 HIS B 69 HIS.? -3.36 ZN ZN B 374s C 661 HIS B 366 HIS.? 14.78 ZN ZN B 374 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -20.57 16.04 20.92 -18.78 16.88 20.21 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 5 3 # 5 C 608 ASP B 368 ASP.? 11.70 ZN ZN B 374 C 610 HIS B 366 HIS.? 14.78 ZN ZN B 374 C 661 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo -17.65 80.52 58.00 -16.23 80.79 56.41 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -20.57 16.04 20.92 -18.78 16.88 20.21 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 6 3 # 6 C 608 ASP B 368 ASP.? 11.70 ZN ZN B 374 C 610 HIS B 366 HIS.? 14.78 ZN ZN B 374 C 661 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo -17.65 80.52 58.00 -16.23 80.79 56.41 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -20.57 16.04 20.92 -18.78 16.88 20.21 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 7 3 # 7 C 608 ASP C 48 ASP.? 7.30 ZN ZN C 374 C 610 HIS C 69 HIS.? -3.39 ZN ZN C 374s C 661 HIS C 366 HIS.? 14.85 ZN ZN C 374 coo -17.65 80.52 58.00 -16.23 80.79 56.41 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -16.56 83.18 53.03 -16.33 85.18 53.60 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -8.38 80.78 62.24 -7.53 82.67 62.02 4.16 -33.39 68.22 2.28 -32.65 67.64 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 8 3 # 8 C 608 ASP C 368 ASP.? 11.74 ZN ZN C 374 C 610 HIS C 366 HIS.? 14.85 ZN ZN C 374 C 661 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo -17.65 80.52 58.00 -16.23 80.79 56.41 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -16.56 83.18 53.03 -16.33 85.18 53.60 4.16 -33.39 68.22 2.28 -32.65 67.64 coo -8.38 80.78 62.24 -7.53 82.67 62.02 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 9 3 # 9 C 608 ASP C 368 ASP.? 11.74 ZN ZN C 374 C 610 HIS C 366 HIS.? 14.85 ZN ZN C 374 C 661 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo -17.65 80.52 58.00 -16.23 80.79 56.41 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -16.56 83.18 53.03 -16.33 85.18 53.60 4.16 -33.39 68.22 2.28 -32.65 67.64 coo -8.38 80.78 62.24 -7.53 82.67 62.02 2.70 -25.03 58.20 4.12 -24.40 56.79 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 9 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 84 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 140 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 37.80 0.44 25.56 37.02 -1.29 26.44 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 84 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 140 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 37.42 3.90 29.26 38.47 2.36 30.22 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 40.70 8.14 28.73 41.06 6.40 29.84 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1rgq_c01 NS4A PEPTIDE user 3 3 # 3 B 60 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 84 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 140 GLY A 311 GLY^? 8.82 ZN ZN A 374 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 37.42 3.90 29.26 38.47 2.36 30.22 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 40.70 8.14 28.73 41.06 6.40 29.84 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 42.54 -3.74 37.15 41.89 -4.18 37.32 ULMN 3 1rgq_c01 NS4A PEPTIDE user 4 3 # 4 B 60 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 84 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 140 GLY A 112 GLY~? 9.06 ZN ZN A 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 32.91 0.46 27.63 33.66 0.11 29.56 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 39.28 -7.29 21.25 39.96 -7.72 21.33 ULMN 3 1rgq_c01 NS4A PEPTIDE user 5 3 # 5 B 60 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 84 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 140 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 32.91 0.46 27.63 33.66 0.11 29.56 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1rgq_c01 NS4A PEPTIDE user 6 3 # 6 B 60 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 84 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 140 GLY A 293 GLY.? 9.40 ZN ZN A 374 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 32.91 0.46 27.63 33.66 0.11 29.56 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 37.16 -7.31 36.80 37.28 -6.91 37.48 ULMN 3 1rgq_c01 NS4A PEPTIDE user 7 3 # 7 B 60 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 84 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 140 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 32.91 0.46 27.63 33.66 0.11 29.56 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1rgq_c01 NS4A PEPTIDE user 8 3 # 8 B 60 HIS A 169 HIS^? 11.22 O1S EPE C 377 B 84 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 140 GLY C 178 GLY^? 3.71 C6 EPE C 377 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 23.14 -36.24 3.79 23.36 -36.64 3.06 ULMN 3 1rgq_c01 NS4A PEPTIDE user 9 3 # 9 B 60 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 84 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 140 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1rgq_c01 NS4A PEPTIDE user 10 3 # 10 B 60 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 84 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 140 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1rgq_c01 NS4A PEPTIDE user 11 3 # 11 B 60 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 84 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 140 GLY B 311 GLY^? 8.79 ZN ZN B 374 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -5.28 13.83 20.42 -4.55 13.48 20.52 ULMN 3 1rgq_c01 NS4A PEPTIDE user 12 3 # 12 B 60 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 84 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 140 GLY B 112 GLY~? 9.09 ZN ZN B 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -10.98 -0.97 15.01 -10.85 -0.63 14.30 ULMN 3 1rgq_c01 NS4A PEPTIDE user 13 3 # 13 B 60 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 84 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 140 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1rgq_c01 NS4A PEPTIDE user 14 3 # 14 B 60 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 84 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 140 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1rgq_c01 NS4A PEPTIDE user 15 3 # 15 B 60 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 84 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 140 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1rgq_c01 NS4A PEPTIDE user 16 3 # 16 B 60 HIS B 169 HIS^? 10.86 O3S EPE A 377 B 84 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 140 GLY A 178 GLY^? 3.80 C6 EPE A 377 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 3.25 -33.31 -0.46 2.85 -33.92 -0.95 ULMN 3 1rgq_c01 NS4A PEPTIDE user 17 3 # 17 B 60 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 84 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 140 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1rgq_c01 NS4A PEPTIDE user 18 3 # 18 B 60 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 84 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 140 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 1rgq_c01 NS4A PEPTIDE user 19 3 # 19 B 60 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 84 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 140 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1rgq_c01 NS4A PEPTIDE user 20 3 # 20 B 60 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 84 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 140 GLY C 311 GLY^? 8.68 ZN ZN C 374 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -2.62 -24.75 57.19 -2.77 -24.31 56.55 ULMN 3 1rgq_c01 NS4A PEPTIDE user 21 3 # 21 B 60 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 84 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 140 GLY C 112 GLY~? 9.08 ZN ZN C 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 6.12 -35.35 47.97 5.41 -35.71 47.93 ULMN 3 1rgq_c01 NS4A PEPTIDE user 22 3 # 22 B 60 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 84 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 140 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1rgq_c01 NS4A PEPTIDE user 23 3 # 23 B 60 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 84 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 140 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 1rgq_c01 NS4A PEPTIDE user 24 3 # 24 B 60 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 84 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 140 GLY C 293 GLY.? 9.40 ZN ZN C 374 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -2.07 -22.34 51.37 -2.27 -21.83 51.93 ULMN 3 1rgq_c01 NS4A PEPTIDE user 25 3 # 25 B 60 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 84 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 140 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1rgq_c01 NS4A PEPTIDE user 26 3 # 26 B 60 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 84 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 140 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1rgq_c01 NS4A PEPTIDE user 27 3 # 27 B 60 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 84 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 140 GLY B 178 GLY^? 19.88 O2S EPE A 377 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 8.41 -45.68 15.01 8.59 -46.49 14.79 ULMN 3 1rgq_c01 NS4A PEPTIDE user 28 3 # 28 B 60 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 84 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 140 GLY C 165 GLY.? 25.31 N TRS A 378 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 3.00 -41.27 29.42 3.80 -41.57 29.42 1rgq_c01 source 1rgq NS4A PEPTIDE : 28 hits 1rgq_c01 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 51 GLU~? 11.89 O2S EPE A 376 A 288 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 329 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 29.27 18.78 14.99 27.16 18.62 14.76 41.17 19.74 26.83 40.87 21.56 28.00 coo 49.52 10.06 10.36 50.99 9.65 8.92 32.91 0.46 27.63 33.66 0.11 29.56 coo 57.80 12.92 13.83 53.77 8.42 12.15 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU A 52 GLU~? 13.77 C2 EPE A 376 A 288 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 329 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 29.27 18.78 14.99 27.16 18.62 14.76 46.63 16.37 27.65 45.50 16.12 29.45 coo 49.52 10.06 10.36 50.99 9.65 8.92 32.91 0.46 27.63 33.66 0.11 29.56 coo 57.80 12.92 13.83 53.77 8.42 12.15 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU A 90 GLU~? 12.44 O2S EPE A 376 A 288 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 329 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 29.27 18.78 14.99 27.16 18.62 14.76 33.69 24.77 24.85 34.29 26.39 26.04 coo 49.52 10.06 10.36 50.99 9.65 8.92 32.91 0.46 27.63 33.66 0.11 29.56 coo 57.80 12.92 13.83 53.77 8.42 12.15 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU A 135 GLU^? 12.87 C3 TRS A 378 A 288 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 329 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 29.27 18.78 14.99 27.16 18.62 14.76 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 49.52 10.06 10.36 50.99 9.65 8.92 37.80 0.44 25.56 37.02 -1.29 26.44 coo 57.80 12.92 13.83 53.77 8.42 12.15 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 A 137 GLU A 200 GLU^? 11.53 C6 EPE A 377 A 288 HIS B 224 HIS.? 17.79 O2S EPE A 377 A 329 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 29.27 18.78 14.99 27.16 18.62 14.76 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 49.52 10.06 10.36 50.99 9.65 8.92 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 57.80 12.92 13.83 53.77 8.42 12.15 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 A 137 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 288 HIS B 224 HIS.? 17.79 O2S EPE A 377 A 329 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 29.27 18.78 14.99 27.16 18.62 14.76 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 49.52 10.06 10.36 50.99 9.65 8.92 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 57.80 12.92 13.83 53.77 8.42 12.15 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 A 137 GLU B 9 GLU~? 28.41 ZN ZN B 375 A 288 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 329 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 29.27 18.78 14.99 27.16 18.62 14.76 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 49.52 10.06 10.36 50.99 9.65 8.92 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 57.80 12.92 13.83 53.77 8.42 12.15 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 A 137 GLU B 51 GLU~? 11.61 O3S EPE B 376 A 288 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 329 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 29.27 18.78 14.99 27.16 18.62 14.76 -25.55 10.19 35.45 -25.80 11.09 37.35 coo 49.52 10.06 10.36 50.99 9.65 8.92 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 57.80 12.92 13.83 53.77 8.42 12.15 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 A 137 GLU B 52 GLU~? 15.59 C2 EPE B 376 A 288 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 329 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 29.27 18.78 14.99 27.16 18.62 14.76 -26.20 13.19 30.44 -25.34 14.95 29.81 coo 49.52 10.06 10.36 50.99 9.65 8.92 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 57.80 12.92 13.83 53.77 8.42 12.15 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 A 137 GLU B 90 GLU~? 12.95 O2S EPE B 376 A 288 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 329 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 29.27 18.78 14.99 27.16 18.62 14.76 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 49.52 10.06 10.36 50.99 9.65 8.92 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 57.80 12.92 13.83 53.77 8.42 12.15 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 A 137 GLU B 135 GLU^? 15.63 O1S EPE A 377 A 288 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 329 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 29.27 18.78 14.99 27.16 18.62 14.76 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 49.52 10.06 10.36 50.99 9.65 8.92 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 57.80 12.92 13.83 53.77 8.42 12.15 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 A 137 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 288 HIS A 224 HIS~? 7.33 C7 EPE A 377 A 329 LYS A 218 LYS~? 21.49 C3 EPE A 377 coo 29.27 18.78 14.99 27.16 18.62 14.76 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 49.52 10.06 10.36 50.99 9.65 8.92 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 57.80 12.92 13.83 53.77 8.42 12.15 17.38 -15.22 -1.06 17.49 -9.91 -3.23 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 A 137 GLU B 175 GLU^? 16.09 C9 EPE A 377 A 288 HIS C 224 HIS~? 8.36 C3 EPE C 377 A 329 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 29.27 18.78 14.99 27.16 18.62 14.76 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 49.52 10.06 10.36 50.99 9.65 8.92 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 57.80 12.92 13.83 53.77 8.42 12.15 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 14 3 # 14 A 137 GLU B 200 GLU^? 21.89 O2S EPE A 377 A 288 HIS C 224 HIS~? 8.36 C3 EPE C 377 A 329 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 29.27 18.78 14.99 27.16 18.62 14.76 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 49.52 10.06 10.36 50.99 9.65 8.92 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 57.80 12.92 13.83 53.77 8.42 12.15 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 15 3 # 15 A 137 GLU C 51 GLU~? 12.03 O3S EPE C 376 A 288 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 329 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 29.27 18.78 14.99 27.16 18.62 14.76 19.07 -27.28 70.66 19.78 -25.91 72.07 coo 49.52 10.06 10.36 50.99 9.65 8.92 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 57.80 12.92 13.83 53.77 8.42 12.15 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 16 3 # 16 A 137 GLU C 52 GLU~? 13.90 C2 EPE C 376 A 288 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 329 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 29.27 18.78 14.99 27.16 18.62 14.76 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 49.52 10.06 10.36 50.99 9.65 8.92 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 57.80 12.92 13.83 53.77 8.42 12.15 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 17 3 # 17 A 137 GLU C 90 GLU~? 12.50 O3S EPE C 376 A 288 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 329 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 29.27 18.78 14.99 27.16 18.62 14.76 27.07 -22.98 69.65 26.90 -21.97 71.52 coo 49.52 10.06 10.36 50.99 9.65 8.92 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 57.80 12.92 13.83 53.77 8.42 12.15 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 18 3 # 18 A 137 GLU C 135 GLU^? 15.12 O1 TRS A 378 A 288 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 329 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 29.27 18.78 14.99 27.16 18.62 14.76 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 49.52 10.06 10.36 50.99 9.65 8.92 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 57.80 12.92 13.83 53.77 8.42 12.15 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 19 3 # 19 A 137 GLU C 184 GLU.? 20.48 N4 EPE C 377 A 288 HIS C 224 HIS~? 8.36 C3 EPE C 377 A 329 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 29.27 18.78 14.99 27.16 18.62 14.76 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 49.52 10.06 10.36 50.99 9.65 8.92 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 57.80 12.92 13.83 53.77 8.42 12.15 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 20 3 # 20 A 137 GLU C 200 GLU^? 10.81 O8 EPE C 377 A 288 HIS A 224 HIS~? 7.33 C7 EPE A 377 A 329 LYS A 218 LYS~? 21.49 C3 EPE A 377 coo 29.27 18.78 14.99 27.16 18.62 14.76 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 49.52 10.06 10.36 50.99 9.65 8.92 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 57.80 12.92 13.83 53.77 8.42 12.15 17.38 -15.22 -1.06 17.49 -9.91 -3.23 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 20 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 51 GLU~? 11.89 O2S EPE A 376 B 288 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 329 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 41.17 19.74 26.83 40.87 21.56 28.00 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 32.91 0.46 27.63 33.66 0.11 29.56 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 52 GLU~? 13.77 C2 EPE A 376 B 288 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 329 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 46.63 16.37 27.65 45.50 16.12 29.45 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 32.91 0.46 27.63 33.66 0.11 29.56 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU A 90 GLU~? 12.44 O2S EPE A 376 B 288 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 329 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 33.69 24.77 24.85 34.29 26.39 26.04 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 32.91 0.46 27.63 33.66 0.11 29.56 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU A 135 GLU^? 12.87 C3 TRS A 378 B 288 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 329 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 37.80 0.44 25.56 37.02 -1.29 26.44 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU A 175 GLU^? 13.72 C8 EPE A 377 B 288 HIS B 224 HIS.? 17.79 O2S EPE A 377 B 329 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 12.76 -38.43 -2.33 12.71 -39.82 -3.96 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 B 137 GLU A 200 GLU^? 11.53 C6 EPE A 377 B 288 HIS B 224 HIS.? 17.79 O2S EPE A 377 B 329 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 6.52 -39.28 -5.41 6.61 -40.27 -3.48 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 B 137 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 288 HIS B 224 HIS.? 17.79 O2S EPE A 377 B 329 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 B 137 GLU B 52 GLU~? 15.59 C2 EPE B 376 B 288 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 329 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -26.20 13.19 30.44 -25.34 14.95 29.81 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 B 137 GLU B 90 GLU~? 12.95 O2S EPE B 376 B 288 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 329 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 B 137 GLU B 135 GLU^? 15.63 O1S EPE A 377 B 288 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 329 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 B 137 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 288 HIS A 224 HIS~? 7.33 C7 EPE A 377 B 329 LYS A 218 LYS~? 21.49 C3 EPE A 377 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 17.38 -15.22 -1.06 17.49 -9.91 -3.23 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 B 137 GLU B 175 GLU^? 16.09 C9 EPE A 377 B 288 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 329 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 6.08 -43.60 3.61 5.68 -45.21 2.31 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 B 137 GLU B 200 GLU^? 21.89 O2S EPE A 377 B 288 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 329 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 6.58 -49.91 8.32 6.28 -50.66 6.33 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 14 3 # 14 B 137 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 288 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 329 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 15 3 # 15 B 137 GLU B 349 GLU~? 21.77 ZN ZN B 375 B 288 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 329 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 16 3 # 16 B 137 GLU C 52 GLU~? 13.90 C2 EPE C 376 B 288 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 329 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 17 3 # 17 B 137 GLU C 90 GLU~? 12.50 O3S EPE C 376 B 288 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 329 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 27.07 -22.98 69.65 26.90 -21.97 71.52 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 18 3 # 18 B 137 GLU C 135 GLU^? 15.12 O1 TRS A 378 B 288 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 329 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 19 3 # 19 B 137 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 288 HIS A 224 HIS~? 7.33 C7 EPE A 377 B 329 LYS A 218 LYS~? 21.49 C3 EPE A 377 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 17.38 -15.22 -1.06 17.49 -9.91 -3.23 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 20 3 # 20 B 137 GLU C 175 GLU^? 13.76 O8 EPE C 377 B 288 HIS B 224 HIS.? 17.79 O2S EPE A 377 B 329 LYS B 218 LYS~? 23.26 O3S EPE A 377 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 16.33 -45.08 6.01 16.53 -46.96 5.10 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -9.21 -31.38 17.78 -12.41 -28.97 21.74 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 21 3 # 21 B 137 GLU C 184 GLU.? 20.48 N4 EPE C 377 B 288 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 329 LYS C 218 LYS~? 12.80 O1 TRS A 378 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 26.24 -37.78 26.13 29.59 -36.75 30.95 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 22 3 # 22 B 137 GLU C 200 GLU^? 10.81 O8 EPE C 377 B 288 HIS A 224 HIS~? 7.33 C7 EPE A 377 B 329 LYS A 218 LYS~? 21.49 C3 EPE A 377 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 17.38 -15.22 -1.06 17.49 -9.91 -3.23 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 23 3 # 23 B 137 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 288 HIS A 224 HIS~? 7.33 C7 EPE A 377 B 329 LYS A 218 LYS~? 21.49 C3 EPE A 377 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 17.38 -15.22 -1.06 17.49 -9.91 -3.23 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 23 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 169 HIS^? 11.22 O1S EPE C 377 B 102 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 195 SER A 168 SER^? 10.80 O1S EPE C 377 coo -4.60 27.52 42.88 -4.63 27.41 40.76 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo -0.27 31.24 43.51 -1.49 29.62 42.98 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -2.83 25.96 36.71 -4.77 27.03 37.63 30.58 -27.33 4.57 31.12 -25.87 2.65 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 169 HIS^? 10.86 O3S EPE A 377 B 102 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 195 SER B 168 SER^? 10.59 O3S EPE A 377 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -6.90 -28.98 1.72 -8.94 -28.69 2.07 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -4.73 -25.07 0.35 -6.94 -24.95 1.40 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS C 169 HIS^? 22.39 O1 TRS A 378 B 102 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 195 SER C 168 SER^? 24.11 O1 TRS A 378 coo -4.60 27.52 42.88 -4.63 27.41 40.76 13.13 -47.52 24.96 14.34 -48.17 26.54 coo -0.27 31.24 43.51 -1.49 29.62 42.98 19.06 -47.14 27.83 18.62 -49.09 27.08 coo -2.83 25.96 36.71 -4.77 27.03 37.63 9.08 -45.42 26.78 10.19 -47.47 27.43 1rtf_c03 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 3 hits 1rtf_c03 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 193 GLY A 342 GLY~? 12.90 ZN ZN A 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 37.80 0.44 25.56 37.02 -1.29 26.44 coo -0.27 31.24 43.51 -1.49 29.62 42.98 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -6.81 22.81 34.74 -6.42 23.54 34.62 44.89 -3.04 18.23 44.73 -2.27 17.91 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 37.42 3.90 29.26 38.47 2.36 30.22 coo -0.27 31.24 43.51 -1.49 29.62 42.98 40.70 8.14 28.73 41.06 6.40 29.84 coo -6.81 22.81 34.74 -6.42 23.54 34.62 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo -4.60 27.52 42.88 -4.63 27.41 40.76 37.42 3.90 29.26 38.47 2.36 30.22 coo -0.27 31.24 43.51 -1.49 29.62 42.98 40.70 8.14 28.73 41.06 6.40 29.84 coo -6.81 22.81 34.74 -6.42 23.54 34.62 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 32.91 0.46 27.63 33.66 0.11 29.56 coo -0.27 31.24 43.51 -1.49 29.62 42.98 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -6.81 22.81 34.74 -6.42 23.54 34.62 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 3 # 5 B 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo -4.60 27.52 42.88 -4.63 27.41 40.76 32.91 0.46 27.63 33.66 0.11 29.56 coo -0.27 31.24 43.51 -1.49 29.62 42.98 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -6.81 22.81 34.74 -6.42 23.54 34.62 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 6 3 # 6 B 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 193 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 32.91 0.46 27.63 33.66 0.11 29.56 coo -0.27 31.24 43.51 -1.49 29.62 42.98 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -6.81 22.81 34.74 -6.42 23.54 34.62 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 7 3 # 7 B 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 193 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 32.91 0.46 27.63 33.66 0.11 29.56 coo -0.27 31.24 43.51 -1.49 29.62 42.98 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -6.81 22.81 34.74 -6.42 23.54 34.62 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 8 3 # 8 B 57 HIS A 319 HIS~? 24.64 ZN ZN A 374 B 102 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 193 GLY A 277 GLY.? 24.28 ZN ZN A 374 coo -4.60 27.52 42.88 -4.63 27.41 40.76 41.01 -9.30 52.79 42.52 -8.54 54.04 coo -0.27 31.24 43.51 -1.49 29.62 42.98 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -6.81 22.81 34.74 -6.42 23.54 34.62 49.23 -14.07 46.91 49.73 -13.44 47.06 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 9 3 # 9 B 57 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 193 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 10 3 # 10 B 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 11 3 # 11 B 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 12 3 # 12 B 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 13 3 # 13 B 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 B 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 14 3 # 14 B 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 193 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 15 3 # 15 B 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 193 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 16 3 # 16 B 57 HIS B 319 HIS~? 24.73 ZN ZN B 374 B 102 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 193 GLY B 277 GLY.? 24.23 ZN ZN B 374 coo -4.60 27.52 42.88 -4.63 27.41 40.76 8.16 23.53 21.75 7.85 25.60 21.62 coo -0.27 31.24 43.51 -1.49 29.62 42.98 9.35 16.65 21.02 10.22 16.89 22.90 coo -6.81 22.81 34.74 -6.42 23.54 34.62 3.65 23.16 11.55 3.12 23.75 11.78 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 17 3 # 17 B 57 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 193 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -0.27 31.24 43.51 -1.49 29.62 42.98 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -6.81 22.81 34.74 -6.42 23.54 34.62 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 18 3 # 18 B 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -0.27 31.24 43.51 -1.49 29.62 42.98 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -6.81 22.81 34.74 -6.42 23.54 34.62 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 19 3 # 19 B 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo -4.60 27.52 42.88 -4.63 27.41 40.76 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -0.27 31.24 43.51 -1.49 29.62 42.98 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -6.81 22.81 34.74 -6.42 23.54 34.62 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 20 3 # 20 B 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -0.27 31.24 43.51 -1.49 29.62 42.98 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -6.81 22.81 34.74 -6.42 23.54 34.62 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 21 3 # 21 B 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo -4.60 27.52 42.88 -4.63 27.41 40.76 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -0.27 31.24 43.51 -1.49 29.62 42.98 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -6.81 22.81 34.74 -6.42 23.54 34.62 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 22 3 # 22 B 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 193 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -0.27 31.24 43.51 -1.49 29.62 42.98 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -6.81 22.81 34.74 -6.42 23.54 34.62 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 23 3 # 23 B 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 193 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo -4.60 27.52 42.88 -4.63 27.41 40.76 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -0.27 31.24 43.51 -1.49 29.62 42.98 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -6.81 22.81 34.74 -6.42 23.54 34.62 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 24 3 # 24 B 57 HIS C 319 HIS~? 24.70 ZN ZN C 374 B 102 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 193 GLY C 277 GLY.? 24.27 ZN ZN C 374 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -18.35 -23.56 56.48 -18.29 -23.66 57.31 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 24 hits 1rtf_c06 naa= 3 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 1 3 # 1 41 HIS A 333 HIS~? -3.55 ZN ZN A 374s 62 GLU A 336 GLU~? 2.52 ZN ZN A 375s 101 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 13.91 26.31 13.70 14.98 27.08 12.06 40.60 0.33 34.12 38.69 0.39 33.24 coo 9.15 26.32 13.85 8.75 28.20 13.02 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 7.90 34.31 7.89 9.24 33.73 9.42 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 2 3 # 2 41 HIS B 333 HIS~? -3.37 ZN ZN B 374s 62 GLU B 336 GLU~? 2.48 ZN ZN B 375s 101 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 13.91 26.31 13.70 14.98 27.08 12.06 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 9.15 26.32 13.85 8.75 28.20 13.02 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 7.90 34.31 7.89 9.24 33.73 9.42 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 3 3 # 3 41 HIS C 333 HIS~? -3.37 ZN ZN C 374s 62 GLU C 336 GLU~? 2.53 ZN ZN C 375s 101 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 13.91 26.31 13.70 14.98 27.08 12.06 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 9.15 26.32 13.85 8.75 28.20 13.02 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 7.90 34.31 7.89 9.24 33.73 9.42 10.51 -24.81 51.94 8.80 -23.79 52.62 1rtu_c00 source 1rtu RIBONUCLEASE U2 : 3 hits 1rtu_c00 naa= 3 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 158 ASP~? 15.23 O1S EPE C 377 64 HIS A 169 HIS^? 11.22 O1S EPE C 377 221 SER A 168 SER^? 10.80 O1S EPE C 377 coo 80.16 73.25 62.48 80.01 71.25 61.82 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 78.27 67.69 61.83 79.58 67.76 60.19 28.51 -27.02 0.13 29.35 -25.45 -0.99 coo 83.63 66.07 58.16 81.31 66.75 57.98 30.58 -27.33 4.57 31.12 -25.87 2.65 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP C 158 ASP~? 22.01 O1 TRS A 378 64 HIS C 169 HIS^? 22.39 O1 TRS A 378 221 SER C 168 SER^? 24.11 O1 TRS A 378 coo 80.16 73.25 62.48 80.01 71.25 61.82 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 78.27 67.69 61.83 79.58 67.76 60.19 13.13 -47.52 24.96 14.34 -48.17 26.54 coo 83.63 66.07 58.16 81.31 66.75 57.98 9.08 -45.42 26.78 10.19 -47.47 27.43 1sca_c00 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 2 hits 1sca_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 27 ASP.? 8.12 ZN ZN A 375 64 HIS A 103 HIS~? -4.82 ZN ZN A 375s 155 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 80.16 73.25 62.48 80.01 71.25 61.82 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 78.27 67.69 61.83 79.58 67.76 60.19 32.91 0.46 27.63 33.66 0.11 29.56 coo 80.34 61.88 52.75 81.25 63.19 54.35 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 107 ASP~? -2.33 ZN ZN A 375s 64 HIS A 68 HIS.? -3.31 ZN ZN A 375s 155 ASN A 334 ASN~? 9.69 ZN ZN A 374 coo 80.16 73.25 62.48 80.01 71.25 61.82 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 78.27 67.69 61.83 79.58 67.76 60.19 37.80 0.44 25.56 37.02 -1.29 26.44 coo 80.34 61.88 52.75 81.25 63.19 54.35 45.98 2.64 32.26 46.53 3.77 30.56 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP A 292 ASP^? 8.63 ZN ZN A 374 64 HIS A 333 HIS~? -3.55 ZN ZN A 374s 155 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 80.16 73.25 62.48 80.01 71.25 61.82 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 78.27 67.69 61.83 79.58 67.76 60.19 40.60 0.33 34.12 38.69 0.39 33.24 coo 80.34 61.88 52.75 81.25 63.19 54.35 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP A 312 ASP.? 7.50 ZN ZN A 374 64 HIS A 333 HIS~? -3.55 ZN ZN A 374s 155 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 80.16 73.25 62.48 80.01 71.25 61.82 39.49 -1.24 39.18 39.76 0.49 37.96 coo 78.27 67.69 61.83 79.58 67.76 60.19 40.60 0.33 34.12 38.69 0.39 33.24 coo 80.34 61.88 52.75 81.25 63.19 54.35 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 5 3 # 5 32 ASP B 27 ASP.? 8.17 ZN ZN B 375 64 HIS B 103 HIS~? 5.04 ZN ZN B 375 155 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo 80.16 73.25 62.48 80.01 71.25 61.82 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 78.27 67.69 61.83 79.58 67.76 60.19 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 80.34 61.88 52.75 81.25 63.19 54.35 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 6 3 # 6 32 ASP B 107 ASP~? -2.23 ZN ZN B 375s 64 HIS B 68 HIS.? -3.38 ZN ZN B 375s 155 ASN B 334 ASN~? 9.65 ZN ZN B 374 coo 80.16 73.25 62.48 80.01 71.25 61.82 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 78.27 67.69 61.83 79.58 67.76 60.19 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 80.34 61.88 52.75 81.25 63.19 54.35 -13.83 13.67 21.41 -15.89 13.09 21.50 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 7 3 # 7 32 ASP B 292 ASP^? 8.88 ZN ZN B 374 64 HIS B 333 HIS~? -3.37 ZN ZN B 374s 155 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo 80.16 73.25 62.48 80.01 71.25 61.82 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 78.27 67.69 61.83 79.58 67.76 60.19 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 80.34 61.88 52.75 81.25 63.19 54.35 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 8 3 # 8 32 ASP B 312 ASP.? 7.53 ZN ZN B 374 64 HIS B 333 HIS~? -3.37 ZN ZN B 374s 155 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo 80.16 73.25 62.48 80.01 71.25 61.82 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 78.27 67.69 61.83 79.58 67.76 60.19 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 80.34 61.88 52.75 81.25 63.19 54.35 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 9 3 # 9 32 ASP C 27 ASP.? 8.23 ZN ZN C 375 64 HIS C 103 HIS~? 4.97 ZN ZN C 375 155 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 80.16 73.25 62.48 80.01 71.25 61.82 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 78.27 67.69 61.83 79.58 67.76 60.19 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 80.34 61.88 52.75 81.25 63.19 54.35 0.77 -32.01 47.92 1.06 -30.12 48.87 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 10 3 # 10 32 ASP C 107 ASP~? -2.30 ZN ZN C 375s 64 HIS C 68 HIS.? -3.41 ZN ZN C 375s 155 ASN C 334 ASN~? 9.79 ZN ZN C 374 coo 80.16 73.25 62.48 80.01 71.25 61.82 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 78.27 67.69 61.83 79.58 67.76 60.19 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 80.34 61.88 52.75 81.25 63.19 54.35 2.44 -29.45 62.54 3.79 -30.90 63.32 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 11 3 # 11 32 ASP C 312 ASP.? 7.48 ZN ZN C 374 64 HIS C 333 HIS~? -3.37 ZN ZN C 374s 155 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 80.16 73.25 62.48 80.01 71.25 61.82 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 78.27 67.69 61.83 79.58 67.76 60.19 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 80.34 61.88 52.75 81.25 63.19 54.35 0.77 -32.01 47.92 1.06 -30.12 48.87 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 11 hits 1sca_c01 naa= 3 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 A 87 ARG B 41 ARG.? 32.79 ZN ZN B 375 A 89 HIS B 359 HIS^? 24.30 ZN ZN B 375 A 119 ASN B 357 ASN.? 31.68 ZN ZN B 375 coo 28.44 23.52 73.95 30.13 24.84 76.11 -35.98 -7.63 26.12 -37.66 -10.05 26.93 coo 21.34 20.13 69.47 22.14 19.11 71.12 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 19.69 29.00 71.61 19.80 26.98 72.20 -34.36 -10.98 18.28 -35.73 -11.88 19.64 1smn_c00 source 1smn EXTRACELLULAR ENDONUCLEASE : 1 hits 1smn_c00 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 193 GLY A 342 GLY~? 12.90 ZN ZN A 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 37.80 0.44 25.56 37.02 -1.29 26.44 coo 19.67 30.58 22.61 18.30 29.87 21.17 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 14.52 29.10 10.01 15.08 29.66 10.19 44.89 -3.04 18.23 44.73 -2.27 17.91 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 37.42 3.90 29.26 38.47 2.36 30.22 coo 19.67 30.58 22.61 18.30 29.87 21.17 40.70 8.14 28.73 41.06 6.40 29.84 coo 14.52 29.10 10.01 15.08 29.66 10.19 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo 15.02 29.17 19.44 15.63 29.96 17.60 37.42 3.90 29.26 38.47 2.36 30.22 coo 19.67 30.58 22.61 18.30 29.87 21.17 40.70 8.14 28.73 41.06 6.40 29.84 coo 14.52 29.10 10.01 15.08 29.66 10.19 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.67 30.58 22.61 18.30 29.87 21.17 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 14.52 29.10 10.01 15.08 29.66 10.19 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo 15.02 29.17 19.44 15.63 29.96 17.60 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.67 30.58 22.61 18.30 29.87 21.17 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 14.52 29.10 10.01 15.08 29.66 10.19 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 6 3 # 6 A 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 193 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.67 30.58 22.61 18.30 29.87 21.17 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 14.52 29.10 10.01 15.08 29.66 10.19 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 7 3 # 7 A 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 193 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.67 30.58 22.61 18.30 29.87 21.17 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 14.52 29.10 10.01 15.08 29.66 10.19 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 8 3 # 8 A 57 HIS A 319 HIS~? 24.64 ZN ZN A 374 A 102 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 193 GLY A 277 GLY.? 24.28 ZN ZN A 374 coo 15.02 29.17 19.44 15.63 29.96 17.60 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 19.67 30.58 22.61 18.30 29.87 21.17 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 14.52 29.10 10.01 15.08 29.66 10.19 49.23 -14.07 46.91 49.73 -13.44 47.06 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 9 3 # 9 A 57 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 193 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 19.67 30.58 22.61 18.30 29.87 21.17 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 14.52 29.10 10.01 15.08 29.66 10.19 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 10 3 # 10 A 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 19.67 30.58 22.61 18.30 29.87 21.17 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 14.52 29.10 10.01 15.08 29.66 10.19 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 11 3 # 11 A 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo 15.02 29.17 19.44 15.63 29.96 17.60 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 19.67 30.58 22.61 18.30 29.87 21.17 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 14.52 29.10 10.01 15.08 29.66 10.19 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 12 3 # 12 A 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 14.52 29.10 10.01 15.08 29.66 10.19 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 13 3 # 13 A 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo 15.02 29.17 19.44 15.63 29.96 17.60 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 14.52 29.10 10.01 15.08 29.66 10.19 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 14 3 # 14 A 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 193 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 14.52 29.10 10.01 15.08 29.66 10.19 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 15 3 # 15 A 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 193 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 14.52 29.10 10.01 15.08 29.66 10.19 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 16 3 # 16 A 57 HIS B 319 HIS~? 24.73 ZN ZN B 374 A 102 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 193 GLY B 277 GLY.? 24.23 ZN ZN B 374 coo 15.02 29.17 19.44 15.63 29.96 17.60 8.16 23.53 21.75 7.85 25.60 21.62 coo 19.67 30.58 22.61 18.30 29.87 21.17 9.35 16.65 21.02 10.22 16.89 22.90 coo 14.52 29.10 10.01 15.08 29.66 10.19 3.65 23.16 11.55 3.12 23.75 11.78 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 17 3 # 17 A 57 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 193 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 19.67 30.58 22.61 18.30 29.87 21.17 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 14.52 29.10 10.01 15.08 29.66 10.19 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 18 3 # 18 A 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 19.67 30.58 22.61 18.30 29.87 21.17 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 14.52 29.10 10.01 15.08 29.66 10.19 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 19 3 # 19 A 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo 15.02 29.17 19.44 15.63 29.96 17.60 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 19.67 30.58 22.61 18.30 29.87 21.17 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 14.52 29.10 10.01 15.08 29.66 10.19 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 20 3 # 20 A 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.67 30.58 22.61 18.30 29.87 21.17 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 14.52 29.10 10.01 15.08 29.66 10.19 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 21 3 # 21 A 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo 15.02 29.17 19.44 15.63 29.96 17.60 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.67 30.58 22.61 18.30 29.87 21.17 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 14.52 29.10 10.01 15.08 29.66 10.19 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 22 3 # 22 A 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 193 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.67 30.58 22.61 18.30 29.87 21.17 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 14.52 29.10 10.01 15.08 29.66 10.19 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 23 3 # 23 A 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 193 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 15.02 29.17 19.44 15.63 29.96 17.60 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.67 30.58 22.61 18.30 29.87 21.17 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 14.52 29.10 10.01 15.08 29.66 10.19 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 24 3 # 24 A 57 HIS C 319 HIS~? 24.70 ZN ZN C 374 A 102 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 193 GLY C 277 GLY.? 24.27 ZN ZN C 374 coo 15.02 29.17 19.44 15.63 29.96 17.60 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 19.67 30.58 22.61 18.30 29.87 21.17 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 14.52 29.10 10.01 15.08 29.66 10.19 -18.35 -23.56 56.48 -18.29 -23.66 57.31 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 24 hits 1ssx_c02 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 232 ASP^? 4.68 O1S EPE A 377 E 168 LYS B 138 LYS^? 15.17 O1S EPE A 377 E 201 THR B 206 THR^? 5.63 O3S EPE A 377 coo 5.36 16.20 22.10 3.88 17.00 23.31 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 5.06 22.32 18.11 1.02 22.08 22.74 3.52 -23.27 14.19 3.97 -21.31 18.72 coo -1.79 18.29 19.05 -1.19 20.28 19.71 1.50 -28.89 8.33 -0.67 -28.86 8.55 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP A 280 ASP.? 32.54 ZN ZN A 374 E 168 LYS A 278 LYS.? 33.16 ZN ZN A 374 E 201 THR A 256 THR^? 28.88 ZN ZN A 375 coo 5.36 16.20 22.10 3.88 17.00 23.31 57.62 -18.45 47.11 59.50 -17.52 47.44 coo 5.06 22.32 18.11 1.02 22.08 22.74 52.59 -15.70 47.74 53.19 -20.67 51.64 coo -1.79 18.29 19.05 -1.19 20.28 19.71 56.69 -18.34 40.21 58.60 -17.57 40.86 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP A 281 ASP.? 28.06 ZN ZN A 375 E 168 LYS A 278 LYS.? 33.16 ZN ZN A 374 E 201 THR A 256 THR^? 28.88 ZN ZN A 375 coo 5.36 16.20 22.10 3.88 17.00 23.31 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 5.06 22.32 18.11 1.02 22.08 22.74 52.59 -15.70 47.74 53.19 -20.67 51.64 coo -1.79 18.29 19.05 -1.19 20.28 19.71 56.69 -18.34 40.21 58.60 -17.57 40.86 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP B 232 ASP^? 14.54 O2S EPE A 377 E 168 LYS C 138 LYS^? 8.30 N TRS A 378 E 201 THR C 206 THR^? 14.70 N TRS A 378 coo 5.36 16.20 22.10 3.88 17.00 23.31 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 5.06 22.32 18.11 1.02 22.08 22.74 12.95 -30.51 23.19 15.44 -26.53 25.46 coo -1.79 18.29 19.05 -1.19 20.28 19.71 12.97 -38.24 19.88 14.05 -39.36 21.39 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 5 3 # 5 E 166 ASP B 280 ASP.? 32.17 ZN ZN B 374 E 168 LYS B 278 LYS.? 31.34 ZN ZN B 374 E 201 THR B 256 THR^? 29.14 ZN ZN B 375 coo 5.36 16.20 22.10 3.88 17.00 23.31 2.63 27.37 3.18 1.41 29.12 3.45 coo 5.06 22.32 18.11 1.02 22.08 22.74 3.65 25.62 8.65 8.47 28.09 9.23 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -1.04 21.83 2.11 -1.77 23.76 1.44 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 6 3 # 6 E 166 ASP C 232 ASP^? 3.77 O2S EPE C 377 E 168 LYS A 138 LYS^? 13.11 N TRS A 378 E 201 THR A 206 THR^? -4.52 O1S EPE C 377s coo 5.36 16.20 22.10 3.88 17.00 23.31 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 5.06 22.32 18.11 1.02 22.08 22.74 18.11 -21.79 12.78 16.12 -17.81 15.44 coo -1.79 18.29 19.05 -1.19 20.28 19.71 19.99 -27.38 6.69 21.08 -26.14 5.25 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 7 3 # 7 E 166 ASP C 280 ASP.? 31.92 ZN ZN C 374 E 168 LYS C 278 LYS.? 30.91 ZN ZN C 374 E 201 THR C 256 THR^? 29.06 ZN ZN C 375 coo 5.36 16.20 22.10 3.88 17.00 23.31 -25.13 -30.20 58.02 -25.85 -28.27 58.51 coo 5.06 22.32 18.11 1.02 22.08 22.74 -21.60 -25.17 57.51 -24.75 -21.09 54.19 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -20.65 -33.80 55.44 -22.00 -34.26 57.11 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 7 hits 1stc_c02 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 96 ASP.? 22.36 O2S EPE A 376 E 168 LYS A 94 LYS~? 16.25 O2S EPE A 376 E 171 ASN A 95 ASN~? 18.99 O2S EPE A 376 coo 5.36 16.20 22.10 3.88 17.00 23.31 33.23 19.97 13.69 32.21 21.81 13.47 coo 5.06 22.32 18.11 1.02 22.08 22.74 33.79 23.90 18.72 34.24 28.62 22.89 coo 6.68 21.78 22.39 5.28 20.74 23.60 37.50 21.37 17.07 38.56 22.79 18.19 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP A 115 ASP~? 13.24 ZN ZN A 375 E 168 LYS A 247 LYS^? 14.25 ZN ZN A 375 E 171 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 5.36 16.20 22.10 3.88 17.00 23.31 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 5.06 22.32 18.11 1.02 22.08 22.74 40.34 -15.07 28.39 38.70 -15.53 23.22 coo 6.68 21.78 22.39 5.28 20.74 23.60 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP A 237 ASP^? 6.80 N TRS A 378 E 168 LYS A 239 LYS^? -7.47 O3 TRS A 378s E 171 ASN A 238 ASN^? -4.13 C2 TRS A 378s coo 5.36 16.20 22.10 3.88 17.00 23.31 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 5.06 22.32 18.11 1.02 22.08 22.74 24.38 -22.19 19.59 20.35 -19.68 21.34 coo 6.68 21.78 22.39 5.28 20.74 23.60 22.25 -25.65 17.52 21.37 -27.55 17.01 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP A 292 ASP^? 8.63 ZN ZN A 374 E 168 LYS A 295 LYS.? 12.61 ZN ZN A 374 E 171 ASN A 294 ASN.? 12.36 ZN ZN A 374 coo 5.36 16.20 22.10 3.88 17.00 23.31 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 5.06 22.32 18.11 1.02 22.08 22.74 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 6.68 21.78 22.39 5.28 20.74 23.60 35.77 -6.31 41.36 37.34 -5.07 42.10 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 5 3 # 5 E 166 ASP B 96 ASP.? 22.64 O2S EPE B 376 E 168 LYS B 94 LYS~? 17.44 O2S EPE B 376 E 171 ASN B 95 ASN~? 19.50 O2S EPE B 376 coo 5.36 16.20 22.10 3.88 17.00 23.31 -29.98 -4.37 36.65 -30.49 -4.93 38.64 coo 5.06 22.32 18.11 1.02 22.08 22.74 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 6.68 21.78 22.39 5.28 20.74 23.60 -30.82 1.14 36.18 -31.61 2.89 37.07 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 6 3 # 6 E 166 ASP B 115 ASP~? 12.98 ZN ZN B 375 E 168 LYS B 247 LYS^? 11.69 ZN ZN B 375 E 171 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo 5.36 16.20 22.10 3.88 17.00 23.31 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 5.06 22.32 18.11 1.02 22.08 22.74 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo 6.68 21.78 22.39 5.28 20.74 23.60 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 7 3 # 7 E 166 ASP B 237 ASP^? 15.58 N TRS A 378 E 168 LYS B 239 LYS^? 16.51 O1S EPE A 377 E 171 ASN B 238 ASN^? 8.84 O1S EPE A 377 coo 5.36 16.20 22.10 3.88 17.00 23.31 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 5.06 22.32 18.11 1.02 22.08 22.74 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 6.68 21.78 22.39 5.28 20.74 23.60 7.11 -18.54 9.31 8.52 -20.00 8.45 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 8 3 # 8 E 166 ASP B 292 ASP^? 8.88 ZN ZN B 374 E 168 LYS B 295 LYS.? 11.37 ZN ZN B 375 E 171 ASN B 294 ASN.? 12.27 ZN ZN B 374 coo 5.36 16.20 22.10 3.88 17.00 23.31 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 5.06 22.32 18.11 1.02 22.08 22.74 4.57 8.76 22.84 2.39 5.01 24.93 coo 6.68 21.78 22.39 5.28 20.74 23.60 2.18 12.34 23.84 0.88 14.02 24.05 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 9 3 # 9 E 166 ASP C 27 ASP.? 8.23 ZN ZN C 375 E 168 LYS C 20 LYS~? 17.53 ZN ZN C 375 E 171 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo 5.36 16.20 22.10 3.88 17.00 23.31 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 5.06 22.32 18.11 1.02 22.08 22.74 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 6.68 21.78 22.39 5.28 20.74 23.60 12.40 -28.97 45.42 13.67 -29.13 47.17 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 10 3 # 10 E 166 ASP C 96 ASP.? 22.89 O3S EPE C 376 E 168 LYS C 94 LYS~? 16.71 O3S EPE C 376 E 171 ASN C 95 ASN~? 19.32 O3S EPE C 376 coo 5.36 16.20 22.10 3.88 17.00 23.31 31.06 -32.15 62.51 32.92 -31.34 63.13 coo 5.06 22.32 18.11 1.02 22.08 22.74 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 6.68 21.78 22.39 5.28 20.74 23.60 27.60 -31.58 66.97 27.57 -31.41 69.09 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 11 3 # 11 E 166 ASP C 115 ASP~? 12.87 ZN ZN C 375 E 168 LYS C 247 LYS^? 13.94 ZN ZN C 375 E 171 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 5.36 16.20 22.10 3.88 17.00 23.31 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 5.06 22.32 18.11 1.02 22.08 22.74 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo 6.68 21.78 22.39 5.28 20.74 23.60 0.77 -32.01 47.92 1.06 -30.12 48.87 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 12 3 # 12 E 166 ASP C 237 ASP^? 16.80 O1S EPE A 377 E 168 LYS C 239 LYS^? 16.29 N TRS A 378 E 171 ASN C 238 ASN^? 16.63 O2S EPE A 377 coo 5.36 16.20 22.10 3.88 17.00 23.31 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 5.06 22.32 18.11 1.02 22.08 22.74 5.15 -29.07 27.87 7.72 -24.69 27.36 coo 6.68 21.78 22.39 5.28 20.74 23.60 5.28 -30.50 23.50 4.52 -30.81 21.55 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 13 3 # 13 E 166 ASP C 292 ASP^? 8.69 ZN ZN C 374 E 168 LYS C 295 LYS.? 14.49 ZN ZN C 374 E 171 ASN C 294 ASN.? 11.92 ZN ZN C 374 coo 5.36 16.20 22.10 3.88 17.00 23.31 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 5.06 22.32 18.11 1.02 22.08 22.74 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 6.68 21.78 22.39 5.28 20.74 23.60 -3.30 -17.98 52.78 -3.53 -18.25 54.87 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 14 3 # 14 E 166 ASP C 368 ASP.? 11.74 ZN ZN C 374 E 168 LYS C 337 LYS~? 12.69 ZN ZN C 374 E 171 ASN C 334 ASN~? 9.79 ZN ZN C 374 coo 5.36 16.20 22.10 3.88 17.00 23.31 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 5.06 22.32 18.11 1.02 22.08 22.74 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 6.68 21.78 22.39 5.28 20.74 23.60 2.44 -29.45 62.54 3.79 -30.90 63.32 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 14 hits 1stc_c03 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 148 HIS~? 11.43 C8 EPE A 377 B 80 GLU A 151 GLU~? 15.60 C7 EPE A 377 B 223 ARG C 153 ARG~? 15.97 C2 EPE C 377 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 14.41 -28.00 -10.43 13.63 -27.83 -12.37 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 15.73 -46.74 16.59 16.35 -47.76 13.75 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 80 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 223 ARG B 214 ARG~? 23.93 O3S EPE A 377 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -10.29 7.50 19.92 -9.48 6.56 21.59 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -7.68 -23.63 22.44 -8.04 -24.96 25.17 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 148 HIS~? 20.83 O3S EPE A 377 B 80 GLU B 151 GLU~? 19.22 O3S EPE A 377 B 223 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -6.64 -44.75 10.12 -7.62 -46.49 10.77 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 80 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 223 ARG C 214 ARG~? 11.90 O1 TRS A 378 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 3.38 -29.70 55.34 4.58 -28.10 54.66 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 25.43 -31.91 31.60 26.96 -33.72 33.51 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 5 3 # 5 B 8 HIS C 148 HIS~? 13.04 O8 EPE C 377 B 80 GLU C 151 GLU~? 17.15 O8 EPE C 377 B 223 ARG B 153 ARG~? 10.73 C6 EPE A 377 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 27.13 -47.60 14.36 28.94 -48.66 14.50 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 24.82 -49.12 19.40 26.74 -49.67 18.68 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -1.46 -36.52 4.12 -1.19 -38.78 2.09 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 5 hits 1t0u_c01 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY C 185 GLY.? 16.41 C7 EPE C 377 B 17 GLN C 183 GLN.? 13.97 C5 EPE C 377 B 140 GLU C 184 GLU.? 20.48 N4 EPE C 377 coo 61.49 19.86 5.96 61.52 19.46 5.16 42.18 -30.37 7.74 41.51 -30.52 7.27 coo 63.76 11.90 7.93 65.18 13.07 6.77 35.42 -27.01 4.58 35.93 -26.02 2.76 coo 66.44 19.00 7.38 67.69 17.67 8.37 42.98 -26.30 5.30 43.52 -24.37 5.98 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 1 hits 1t4c_c02 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 12 SER~? 22.68 ZN ZN A 375 A 90 SER A 16 SER~? 19.64 ZN ZN A 375 A 145 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo -3.31 40.95 15.56 -0.94 40.79 14.97 29.97 0.68 9.55 29.00 -0.35 7.61 coo 1.47 40.03 18.48 2.45 41.37 16.68 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 7.35 44.71 16.29 4.71 40.98 14.52 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER A 12 SER~? 22.68 ZN ZN A 375 A 90 SER A 16 SER~? 19.64 ZN ZN A 375 A 145 LYS A 350 LYS~? 21.83 ZN ZN A 375 coo -3.31 40.95 15.56 -0.94 40.79 14.97 29.97 0.68 9.55 29.00 -0.35 7.61 coo 1.47 40.03 18.48 2.45 41.37 16.68 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 7.35 44.71 16.29 4.71 40.98 14.52 39.19 -2.77 6.68 35.27 -5.97 7.17 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 3 3 # 3 A 88 SER B 12 SER~? 22.72 ZN ZN B 375 A 90 SER B 16 SER~? 19.34 ZN ZN B 375 A 145 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 1.47 40.03 18.48 2.45 41.37 16.68 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 7.35 44.71 16.29 4.71 40.98 14.52 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 4 3 # 4 A 88 SER C 12 SER~? 21.06 O1 TRS A 378 A 90 SER C 16 SER.? 19.22 ZN ZN C 375 A 145 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo -3.31 40.95 15.56 -0.94 40.79 14.97 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 1.47 40.03 18.48 2.45 41.37 16.68 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 7.35 44.71 16.29 4.71 40.98 14.52 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 5 3 # 5 A 88 SER C 12 SER~? 21.06 O1 TRS A 378 A 90 SER C 16 SER.? 19.22 ZN ZN C 375 A 145 LYS C 350 LYS~? 21.45 ZN ZN C 375 coo -3.31 40.95 15.56 -0.94 40.79 14.97 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 1.47 40.03 18.48 2.45 41.37 16.68 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 7.35 44.71 16.29 4.71 40.98 14.52 17.69 -45.38 46.76 16.74 -42.84 42.17 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 5 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER A 12 SER~? 22.68 ZN ZN A 375 B 90 SER A 16 SER~? 19.64 ZN ZN A 375 B 145 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo 61.01 10.03 12.97 58.78 10.97 12.69 29.97 0.68 9.55 29.00 -0.35 7.61 coo 56.85 12.22 16.37 55.62 11.34 14.45 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 49.80 9.51 14.88 53.14 11.99 12.77 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 2 3 # 2 B 88 SER A 12 SER~? 22.68 ZN ZN A 375 B 90 SER A 16 SER~? 19.64 ZN ZN A 375 B 145 LYS A 350 LYS~? 21.83 ZN ZN A 375 coo 61.01 10.03 12.97 58.78 10.97 12.69 29.97 0.68 9.55 29.00 -0.35 7.61 coo 56.85 12.22 16.37 55.62 11.34 14.45 31.20 -5.28 11.30 32.92 -4.97 9.64 coo 49.80 9.51 14.88 53.14 11.99 12.77 39.19 -2.77 6.68 35.27 -5.97 7.17 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 3 3 # 3 B 88 SER B 12 SER~? 22.72 ZN ZN B 375 B 90 SER B 16 SER~? 19.34 ZN ZN B 375 B 145 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo 61.01 10.03 12.97 58.78 10.97 12.69 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 56.85 12.22 16.37 55.62 11.34 14.45 -14.13 -12.84 18.48 -16.27 -12.81 17.28 coo 49.80 9.51 14.88 53.14 11.99 12.77 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 4 3 # 4 B 88 SER C 12 SER~? 21.06 O1 TRS A 378 B 90 SER C 16 SER.? 19.22 ZN ZN C 375 B 145 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo 61.01 10.03 12.97 58.78 10.97 12.69 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 56.85 12.22 16.37 55.62 11.34 14.45 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 49.80 9.51 14.88 53.14 11.99 12.77 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 5 3 # 5 B 88 SER C 12 SER~? 21.06 O1 TRS A 378 B 90 SER C 16 SER.? 19.22 ZN ZN C 375 B 145 LYS C 350 LYS~? 21.45 ZN ZN C 375 coo 61.01 10.03 12.97 58.78 10.97 12.69 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 56.85 12.22 16.37 55.62 11.34 14.45 17.18 -37.24 41.79 17.35 -39.47 42.79 coo 49.80 9.51 14.88 53.14 11.99 12.77 17.69 -45.38 46.76 16.74 -42.84 42.17 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 5 hits 1t7d_c01 naa= 3 ULMN 3 1tah_c00 LIPASE user 1 3 # 1 B 87 SER A 168 SER^? 10.80 O1S EPE C 377 B 263 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 285 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1tah_c00 LIPASE user 2 3 # 2 B 87 SER B 168 SER^? 10.59 O3S EPE A 377 B 263 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 285 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1tah_c00 LIPASE user 3 3 # 3 B 87 SER C 168 SER^? 24.11 O1 TRS A 378 B 263 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 285 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 13.13 -47.52 24.96 14.34 -48.17 26.54 1tah_c00 source 1tah LIPASE : 3 hits 1tah_c00 naa= 3 ULMN 3 1tah_c01 LIPASE user 1 3 # 1 A 87 SER A 168 SER^? 10.80 O1S EPE C 377 A 263 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 285 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1tah_c01 LIPASE user 2 3 # 2 A 87 SER B 168 SER^? 10.59 O3S EPE A 377 A 263 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 285 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1tah_c01 LIPASE user 3 3 # 3 A 87 SER C 168 SER^? 24.11 O1 TRS A 378 A 263 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 285 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 13.13 -47.52 24.96 14.34 -48.17 26.54 1tah_c01 source 1tah LIPASE : 3 hits 1tah_c01 naa= 3 ULMN 3 1tah_c02 LIPASE user 1 3 # 1 C 87 SER A 168 SER^? 10.80 O1S EPE C 377 C 263 ASP A 158 ASP~? 15.23 O1S EPE C 377 C 285 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 30.58 -27.33 4.57 31.12 -25.87 2.65 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1tah_c02 LIPASE user 2 3 # 2 C 87 SER B 168 SER^? 10.59 O3S EPE A 377 C 263 ASP B 158 ASP~? 14.93 O3S EPE A 377 C 285 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1tah_c02 LIPASE user 3 3 # 3 C 87 SER C 168 SER^? 24.11 O1 TRS A 378 C 263 ASP C 158 ASP~? 22.01 O1 TRS A 378 C 285 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 9.08 -45.42 26.78 10.19 -47.47 27.43 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 19.06 -47.14 27.83 18.62 -49.09 27.08 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 13.13 -47.52 24.96 14.34 -48.17 26.54 1tah_c02 source 1tah LIPASE : 3 hits 1tah_c02 naa= 3 ULMN 3 1tah_c03 LIPASE user 1 3 # 1 D 87 SER A 168 SER^? 10.80 O1S EPE C 377 D 263 ASP A 158 ASP~? 15.23 O1S EPE C 377 D 285 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 30.58 -27.33 4.57 31.12 -25.87 2.65 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1tah_c03 LIPASE user 2 3 # 2 D 87 SER B 168 SER^? 10.59 O3S EPE A 377 D 263 ASP B 158 ASP~? 14.93 O3S EPE A 377 D 285 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1tah_c03 LIPASE user 3 3 # 3 D 87 SER C 168 SER^? 24.11 O1 TRS A 378 D 263 ASP C 158 ASP~? 22.01 O1 TRS A 378 D 285 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 9.08 -45.42 26.78 10.19 -47.47 27.43 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 19.06 -47.14 27.83 18.62 -49.09 27.08 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 13.13 -47.52 24.96 14.34 -48.17 26.54 1tah_c03 source 1tah LIPASE : 3 hits 1tah_c03 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER A 12 SER~? 22.68 ZN ZN A 375 354 GLU A 9 GLU~? 28.50 ZN ZN A 375 463 HIS A 8 HIS~? 24.55 ZN ZN A 375 coo 48.87 13.74 2.81 48.49 11.54 3.93 29.97 0.68 9.55 29.00 -0.35 7.61 coo 39.95 14.43 3.01 41.55 14.10 1.63 31.54 5.84 4.26 31.09 6.26 2.19 coo 43.90 10.50 2.81 45.63 11.48 3.27 26.75 7.68 8.85 25.49 8.72 10.18 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 2 3 # 2 217 SER B 12 SER~? 22.72 ZN ZN B 375 354 GLU B 9 GLU~? 28.41 ZN ZN B 375 463 HIS B 8 HIS~? 24.51 ZN ZN B 375 coo 48.87 13.74 2.81 48.49 11.54 3.93 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 39.95 14.43 3.01 41.55 14.10 1.63 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 43.90 10.50 2.81 45.63 11.48 3.27 -21.73 -14.76 29.99 -21.14 -14.36 31.97 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 3 3 # 3 217 SER C 12 SER~? 21.06 O1 TRS A 378 354 GLU C 9 GLU~? 28.11 O1 TRS A 378 463 HIS C 8 HIS~? 24.89 ZN ZN C 375 coo 48.87 13.74 2.81 48.49 11.54 3.93 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 39.95 14.43 3.01 41.55 14.10 1.63 28.74 -39.91 47.06 29.82 -41.70 47.37 coo 43.90 10.50 2.81 45.63 11.48 3.27 29.42 -33.76 48.01 30.25 -31.91 48.55 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 3 hits 1thg_c00 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 163 HIS.? 11.18 O1S EPE C 377 A 174 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 404 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 174 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 404 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 3.31 -45.81 25.21 0.69 -46.75 24.83 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 163 HIS.? 11.18 O1S EPE C 377 C 174 ASP A 158 ASP~? 15.23 O1S EPE C 377 C 404 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 30.88 -23.32 6.66 32.97 -23.36 6.49 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS C 163 HIS.? 22.24 O1 TRS A 378 C 174 ASP C 158 ASP~? 22.01 O1 TRS A 378 C 404 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 9.61 -42.49 30.12 8.57 -43.28 31.77 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 19.06 -47.14 27.83 18.62 -49.09 27.08 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 3.31 -45.81 25.21 0.69 -46.75 24.83 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 163 HIS.? 11.18 O1S EPE C 377 E 174 ASP A 158 ASP~? 15.23 O1S EPE C 377 E 404 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo -7.53-107.59 75.19 -8.14-106.04 76.47 30.88 -23.32 6.66 32.97 -23.36 6.49 coo -3.55-105.39 83.13 -5.21-106.24 82.09 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -16.31-108.78 75.35 -14.20-107.14 76.16 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS C 163 HIS.? 22.24 O1 TRS A 378 E 174 ASP C 158 ASP~? 22.01 O1 TRS A 378 E 404 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo -7.53-107.59 75.19 -8.14-106.04 76.47 9.61 -42.49 30.12 8.57 -43.28 31.77 coo -3.55-105.39 83.13 -5.21-106.24 82.09 19.06 -47.14 27.83 18.62 -49.09 27.08 coo -16.31-108.78 75.35 -14.20-107.14 76.16 3.31 -45.81 25.21 0.69 -46.75 24.83 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 163 HIS.? 11.18 O1S EPE C 377 G 174 ASP A 158 ASP~? 15.23 O1S EPE C 377 G 404 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo 60.48-101.16 45.95 60.56-101.20 43.85 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 58.10-108.15 40.62 59.57-106.86 41.51 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS C 163 HIS.? 22.24 O1 TRS A 378 G 174 ASP C 158 ASP~? 22.01 O1 TRS A 378 G 404 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo 60.48-101.16 45.95 60.56-101.20 43.85 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 58.10-108.15 40.62 59.57-106.86 41.51 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 3.31 -45.81 25.21 0.69 -46.75 24.83 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 163 HIS.? 11.18 O1S EPE C 377 I 174 ASP A 158 ASP~? 15.23 O1S EPE C 377 I 404 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 30.88 -23.32 6.66 32.97 -23.36 6.49 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS C 163 HIS.? 22.24 O1 TRS A 378 I 174 ASP C 158 ASP~? 22.01 O1 TRS A 378 I 404 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 9.61 -42.49 30.12 8.57 -43.28 31.77 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 19.06 -47.14 27.83 18.62 -49.09 27.08 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 3.31 -45.81 25.21 0.69 -46.75 24.83 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 163 HIS.? 11.18 O1S EPE C 377 K 174 ASP A 158 ASP~? 15.23 O1S EPE C 377 K 404 TYR A 167 TYR^? 7.08 C7 EPE C 377 coo 100.18 26.45 -1.32 99.24 26.12 0.53 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 102.36 30.86 6.31 102.45 29.08 5.12 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 99.93 17.48 -0.85 99.14 19.86 0.39 32.29 -31.90 7.76 33.83 -34.20 8.34 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS C 163 HIS.? 22.24 O1 TRS A 378 K 174 ASP C 158 ASP~? 22.01 O1 TRS A 378 K 404 TYR C 167 TYR^? 26.66 O2S EPE A 377 coo 100.18 26.45 -1.32 99.24 26.12 0.53 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 102.36 30.86 6.31 102.45 29.08 5.12 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 99.93 17.48 -0.85 99.14 19.86 0.39 3.31 -45.81 25.21 0.69 -46.75 24.83 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c11 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 109 ALA~? 11.42 ZN ZN A 375 A 251 GLY A 112 GLY~? 9.06 ZN ZN A 375 A 252 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 34.68 -9.30 20.20 34.40 -8.19 19.19 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 39.28 -7.29 21.25 39.96 -7.72 21.33 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA A 155 ALA~? 14.27 O1S EPE C 377 A 251 GLY A 157 GLY~? 9.65 O1S EPE C 377 A 252 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 22.46 -22.68 -3.71 21.06 -22.28 -4.12 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA A 159 ALA~? 13.04 O1S EPE C 377 A 251 GLY A 157 GLY~? 9.65 O1S EPE C 377 A 252 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 25.41 -19.15 0.31 23.88 -18.99 0.22 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA B 109 ALA~? 11.08 ZN ZN B 375 A 251 GLY B 112 GLY~? 9.09 ZN ZN B 375 A 252 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -7.64 -4.92 16.15 -8.93 -5.45 16.76 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -10.98 -0.97 15.01 -10.85 -0.63 14.30 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 5 3 # 5 A 250 ALA B 155 ALA~? 14.26 O3S EPE A 377 A 251 GLY B 157 GLY~? 9.55 O3S EPE A 377 A 252 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -8.89 -33.90 8.54 -8.69 -34.90 9.66 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 6 3 # 6 A 250 ALA B 159 ALA~? 13.92 O3S EPE A 377 A 251 GLY B 157 GLY~? 9.55 O3S EPE A 377 A 252 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -9.80 -27.22 9.41 -9.47 -27.83 10.78 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 7 3 # 7 A 250 ALA C 109 ALA~? 11.05 ZN ZN C 375 A 251 GLY C 112 GLY~? 9.08 ZN ZN C 375 A 252 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 7.53 -33.10 43.39 8.93 -33.54 43.81 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 6.12 -35.35 47.97 5.41 -35.71 47.93 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 8 3 # 8 A 250 ALA C 155 ALA~? 16.73 C1 TRS A 378 A 251 GLY C 157 GLY~? 18.60 O1 TRS A 378 A 252 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 21.09 -45.45 23.92 22.34 -44.97 23.23 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 15.82 -44.70 25.16 16.57 -44.60 25.47 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 19.06 -47.14 27.83 18.62 -49.09 27.08 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 9 3 # 9 A 250 ALA C 159 ALA~? 15.13 O1 TRS A 378 A 251 GLY C 157 GLY~? 18.60 O1 TRS A 378 A 252 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 18.93 -42.72 28.88 19.93 -41.91 28.03 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 15.82 -44.70 25.16 16.57 -44.60 25.47 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 19.06 -47.14 27.83 18.62 -49.09 27.08 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 9 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 109 ALA~? 11.42 ZN ZN A 375 B 251 GLY A 112 GLY~? 9.06 ZN ZN A 375 B 252 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 34.68 -9.30 20.20 34.40 -8.19 19.19 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 39.28 -7.29 21.25 39.96 -7.72 21.33 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA A 155 ALA~? 14.27 O1S EPE C 377 B 251 GLY A 157 GLY~? 9.65 O1S EPE C 377 B 252 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 22.46 -22.68 -3.71 21.06 -22.28 -4.12 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA A 159 ALA~? 13.04 O1S EPE C 377 B 251 GLY A 157 GLY~? 9.65 O1S EPE C 377 B 252 ASP A 158 ASP~? 15.23 O1S EPE C 377 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 25.41 -19.15 0.31 23.88 -18.99 0.22 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 27.01 -21.53 -3.21 27.96 -22.95 -4.50 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA B 109 ALA~? 11.08 ZN ZN B 375 B 251 GLY B 112 GLY~? 9.09 ZN ZN B 375 B 252 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -7.64 -4.92 16.15 -8.93 -5.45 16.76 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -10.98 -0.97 15.01 -10.85 -0.63 14.30 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 5 3 # 5 B 250 ALA B 155 ALA~? 14.26 O3S EPE A 377 B 251 GLY B 157 GLY~? 9.55 O3S EPE A 377 B 252 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -8.89 -33.90 8.54 -8.69 -34.90 9.66 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 6 3 # 6 B 250 ALA B 159 ALA~? 13.92 O3S EPE A 377 B 251 GLY B 157 GLY~? 9.55 O3S EPE A 377 B 252 ASP B 158 ASP~? 14.93 O3S EPE A 377 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -9.80 -27.22 9.41 -9.47 -27.83 10.78 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -11.33 -30.60 6.63 -11.83 -31.70 4.85 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 7 3 # 7 B 250 ALA C 109 ALA~? 11.05 ZN ZN C 375 B 251 GLY C 112 GLY~? 9.08 ZN ZN C 375 B 252 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 7.53 -33.10 43.39 8.93 -33.54 43.81 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 6.12 -35.35 47.97 5.41 -35.71 47.93 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 8 3 # 8 B 250 ALA C 155 ALA~? 16.73 C1 TRS A 378 B 251 GLY C 157 GLY~? 18.60 O1 TRS A 378 B 252 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 21.09 -45.45 23.92 22.34 -44.97 23.23 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 15.82 -44.70 25.16 16.57 -44.60 25.47 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 19.06 -47.14 27.83 18.62 -49.09 27.08 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 9 3 # 9 B 250 ALA C 159 ALA~? 15.13 O1 TRS A 378 B 251 GLY C 157 GLY~? 18.60 O1 TRS A 378 B 252 ASP C 158 ASP~? 22.01 O1 TRS A 378 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 18.93 -42.72 28.88 19.93 -41.91 28.03 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 15.82 -44.70 25.16 16.57 -44.60 25.47 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 19.06 -47.14 27.83 18.62 -49.09 27.08 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 9 hits 1tz3_c03 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS A 110 LYS.? 16.46 O3 TRS A 378 138 ASN A 114 ASN~? 6.65 ZN ZN A 375 183 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 37.52 -11.39 18.62 36.00 -16.08 14.56 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 39.96 -10.05 26.73 39.22 -8.78 28.27 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS B 28 LYS.? 11.75 C7 EPE B 376 138 ASN B 105 ASN~? 9.47 ZN ZN B 375 183 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 3 3 # 3 115 LYS B 110 LYS.? 16.94 ZN ZN B 375 138 ASN B 114 ASN~? 6.61 ZN ZN B 375 183 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -8.36 -4.86 12.39 -7.58 -9.04 11.62 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -6.09 3.05 14.26 -5.63 4.05 16.11 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 4 3 # 4 115 LYS B 354 LYS~? 28.15 ZN ZN B 375 138 ASN B 357 ASN.? 31.68 ZN ZN B 375 183 HIS B 359 HIS^? 24.30 ZN ZN B 375 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -34.36 -10.98 18.28 -35.73 -11.88 19.64 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -31.70 -2.47 18.00 -31.61 -0.90 16.60 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 5 3 # 5 115 LYS B 355 LYS.? 33.64 ZN ZN B 375 138 ASN B 357 ASN.? 31.68 ZN ZN B 375 183 HIS B 359 HIS^? 24.30 ZN ZN B 375 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -29.99 -15.16 14.74 -32.16 -16.11 9.38 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -34.36 -10.98 18.28 -35.73 -11.88 19.64 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -31.70 -2.47 18.00 -31.61 -0.90 16.60 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 6 3 # 6 115 LYS C 28 LYS.? 13.32 C7 EPE C 376 138 ASN C 105 ASN~? 9.60 ZN ZN C 375 183 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 7 3 # 7 115 LYS C 110 LYS.? 19.48 ZN ZN C 375 138 ASN C 114 ASN~? 6.62 ZN ZN C 375 183 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 5.59 -36.33 42.73 4.93 -41.69 39.22 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 0.77 -32.01 47.92 1.06 -30.12 48.87 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 8 3 # 8 115 LYS C 354 LYS~? 23.72 O1 TRS A 378 138 ASN C 357 ASN.? 31.03 ZN ZN C 375 183 HIS C 359 HIS^? 24.82 ZN ZN C 375 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 27.30 -48.88 54.43 27.23 -49.76 56.37 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 19.80 -46.87 59.86 18.04 -47.50 60.82 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 9 3 # 9 115 LYS C 355 LYS.? 32.67 ZN ZN C 375 138 ASN C 357 ASN.? 31.03 ZN ZN C 375 183 HIS C 359 HIS^? 24.82 ZN ZN C 375 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 24.80 -50.74 47.95 22.71 -54.81 46.20 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 27.30 -48.88 54.43 27.23 -49.76 56.37 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 19.80 -46.87 59.86 18.04 -47.50 60.82 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 9 hits 1uag_c01 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 135 GLU^? 12.87 C3 TRS A 378 A 126 LYS A 239 LYS^? -7.47 O3 TRS A 378s A 171 ALA A 210 ALA.? 13.63 C3 TRS A 378 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 24.38 -22.19 19.59 20.35 -19.68 21.34 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 20.67 -16.34 12.32 20.26 -15.76 13.68 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU A 136 GLU^? 12.15 O3 TRS A 378 A 126 LYS A 239 LYS^? -7.47 O3 TRS A 378s A 171 ALA A 210 ALA.? 13.63 C3 TRS A 378 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 19.87 -16.93 18.72 17.94 -16.19 18.72 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 24.38 -22.19 19.59 20.35 -19.68 21.34 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 20.67 -16.34 12.32 20.26 -15.76 13.68 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU A 150 GLU~? 12.50 C5 EPE C 377 A 126 LYS A 154 LYS~? 18.09 O1S EPE C 377 A 171 ALA A 149 ALA~? 12.22 C7 EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 22.60 -31.63 -7.22 23.33 -32.82 -5.63 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 24.03 -26.17 -4.04 26.99 -24.22 -8.52 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 16.74 -30.68 -5.41 16.48 -32.10 -4.88 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU A 151 GLU~? 15.60 C7 EPE A 377 A 126 LYS A 154 LYS~? 18.09 O1S EPE C 377 A 171 ALA A 149 ALA~? 12.22 C7 EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 24.03 -26.17 -4.04 26.99 -24.22 -8.52 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 16.74 -30.68 -5.41 16.48 -32.10 -4.88 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 A 46 GLU A 151 GLU~? 15.60 C7 EPE A 377 A 126 LYS A 154 LYS~? 18.09 O1S EPE C 377 A 171 ALA A 223 ALA~? 14.91 C7 EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 24.03 -26.17 -4.04 26.99 -24.22 -8.52 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 17.38 -21.44 -7.38 18.48 -22.07 -6.57 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 A 46 GLU A 262 GLU~? 24.15 ZN ZN A 374 A 126 LYS A 265 LYS~? 22.38 ZN ZN A 374 A 171 ALA A 261 ALA~? 21.36 ZN ZN A 374 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 59.50 -9.24 37.85 59.47 -7.16 38.33 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 54.29 -10.44 37.93 54.37 -10.19 39.44 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 7 3 # 7 A 46 GLU B 135 GLU^? 15.63 O1S EPE A 377 A 126 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 171 ALA B 210 ALA.? 15.50 O1S EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -1.53 -20.24 16.39 -0.69 -19.53 17.41 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 8 3 # 8 A 46 GLU B 135 GLU^? 15.63 O1S EPE A 377 A 126 LYS B 239 LYS^? 16.51 O1S EPE A 377 A 171 ALA B 134 ALA^? 19.13 O1S EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 2.44 -10.57 15.47 3.90 -10.65 15.03 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 9 3 # 9 A 46 GLU B 135 GLU^? 15.63 O1S EPE A 377 A 126 LYS B 239 LYS^? 16.51 O1S EPE A 377 A 171 ALA B 210 ALA.? 15.50 O1S EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -1.53 -20.24 16.39 -0.69 -19.53 17.41 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 10 3 # 10 A 46 GLU B 136 GLU^? 17.92 O1S EPE A 377 A 126 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 171 ALA B 210 ALA.? 15.50 O1S EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -1.53 -20.24 16.39 -0.69 -19.53 17.41 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 11 3 # 11 A 46 GLU B 136 GLU^? 17.92 O1S EPE A 377 A 126 LYS B 239 LYS^? 16.51 O1S EPE A 377 A 171 ALA B 134 ALA^? 19.13 O1S EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 2.44 -10.57 15.47 3.90 -10.65 15.03 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 12 3 # 12 A 46 GLU B 136 GLU^? 17.92 O1S EPE A 377 A 126 LYS B 239 LYS^? 16.51 O1S EPE A 377 A 171 ALA B 210 ALA.? 15.50 O1S EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -1.53 -20.24 16.39 -0.69 -19.53 17.41 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 13 3 # 13 A 46 GLU B 150 GLU~? 12.97 C6 EPE A 377 A 126 LYS B 154 LYS~? 18.23 O3S EPE A 377 A 171 ALA B 149 ALA~? 14.00 O3S EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -7.89 -34.48 4.91 -13.85 -35.95 3.01 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -2.60 -41.23 7.10 -1.27 -41.62 6.49 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 14 3 # 14 A 46 GLU B 151 GLU~? 19.22 O3S EPE A 377 A 126 LYS B 154 LYS~? 18.23 O3S EPE A 377 A 171 ALA B 149 ALA~? 14.00 O3S EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -7.89 -34.48 4.91 -13.85 -35.95 3.01 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -2.60 -41.23 7.10 -1.27 -41.62 6.49 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 15 3 # 15 A 46 GLU B 151 GLU~? 19.22 O3S EPE A 377 A 126 LYS B 154 LYS~? 18.23 O3S EPE A 377 A 171 ALA B 223 ALA.? 17.38 O3S EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -7.89 -34.48 4.91 -13.85 -35.95 3.01 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -9.77 -38.36 13.49 -9.66 -37.46 12.27 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 16 3 # 16 A 46 GLU B 227 GLU.? 24.58 O3S EPE A 377 A 126 LYS B 218 LYS~? 23.26 O3S EPE A 377 A 171 ALA B 223 ALA.? 17.38 O3S EPE A 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -9.77 -38.36 13.49 -9.66 -37.46 12.27 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 17 3 # 17 A 46 GLU B 262 GLU~? 24.13 ZN ZN B 374 A 126 LYS B 265 LYS~? 21.91 ZN ZN B 374 A 171 ALA B 261 ALA~? 21.05 ZN ZN B 374 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -9.48 23.81 6.41 -10.83 24.55 7.88 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -6.29 20.23 8.69 -5.64 21.42 9.38 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 18 3 # 18 A 46 GLU C 135 GLU^? 15.12 O1 TRS A 378 A 126 LYS C 138 LYS^? 8.30 N TRS A 378 A 171 ALA C 210 ALA.? 10.68 O1 TRS A 378 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 15.20 -30.13 29.07 14.89 -28.65 29.26 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 19 3 # 19 A 46 GLU C 135 GLU^? 15.12 O1 TRS A 378 A 126 LYS C 239 LYS^? 16.29 N TRS A 378 A 171 ALA C 210 ALA.? 10.68 O1 TRS A 378 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 5.15 -29.07 27.87 7.72 -24.69 27.36 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 15.20 -30.13 29.07 14.89 -28.65 29.26 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 20 3 # 20 A 46 GLU C 136 GLU^? 12.99 N TRS A 378 A 126 LYS C 138 LYS^? 8.30 N TRS A 378 A 171 ALA C 210 ALA.? 10.68 O1 TRS A 378 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 15.20 -30.13 29.07 14.89 -28.65 29.26 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 21 3 # 21 A 46 GLU C 136 GLU^? 12.99 N TRS A 378 A 126 LYS C 239 LYS^? 16.29 N TRS A 378 A 171 ALA C 210 ALA.? 10.68 O1 TRS A 378 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 5.15 -29.07 27.87 7.72 -24.69 27.36 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 15.20 -30.13 29.07 14.89 -28.65 29.26 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 22 3 # 22 A 46 GLU C 150 GLU~? 19.96 C2 EPE C 377 A 126 LYS C 154 LYS~? 23.94 C1 TRS A 378 A 171 ALA C 149 ALA~? 12.95 O8 EPE C 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 18.79 -51.73 16.88 16.73 -51.34 17.24 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 18.67 -47.92 22.36 20.33 -51.69 25.99 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 21.04 -46.59 14.02 20.14 -46.59 12.80 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 23 3 # 23 A 46 GLU C 151 GLU~? 17.15 O8 EPE C 377 A 126 LYS C 154 LYS~? 23.94 C1 TRS A 378 A 171 ALA C 149 ALA~? 12.95 O8 EPE C 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 18.67 -47.92 22.36 20.33 -51.69 25.99 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 21.04 -46.59 14.02 20.14 -46.59 12.80 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 24 3 # 24 A 46 GLU C 151 GLU~? 17.15 O8 EPE C 377 A 126 LYS C 154 LYS~? 23.94 C1 TRS A 378 A 171 ALA C 223 ALA~? 15.75 C3 EPE C 377 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 18.67 -47.92 22.36 20.33 -51.69 25.99 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 26.89 -44.82 20.98 25.41 -45.05 21.20 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 25 3 # 25 A 46 GLU C 262 GLU~? 24.05 ZN ZN C 374 A 126 LYS C 265 LYS~? 21.95 ZN ZN C 374 A 171 ALA C 261 ALA~? 21.12 ZN ZN C 374 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -15.17 -35.96 63.25 -14.01 -35.31 64.90 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -13.17 -32.79 59.35 -13.86 -31.71 60.07 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 25 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 135 GLU^? 12.87 C3 TRS A 378 B 126 LYS A 239 LYS^? -7.47 O3 TRS A 378s B 171 ALA A 210 ALA.? 13.63 C3 TRS A 378 coo 20.47 87.42 16.54 20.16 87.17 14.45 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 24.73 94.37 14.59 21.08 89.84 11.98 24.38 -22.19 19.59 20.35 -19.68 21.34 coo 24.38 86.32 12.71 22.88 86.54 12.71 20.67 -16.34 12.32 20.26 -15.76 13.68 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU A 136 GLU^? 12.15 O3 TRS A 378 B 126 LYS A 239 LYS^? -7.47 O3 TRS A 378s B 171 ALA A 210 ALA.? 13.63 C3 TRS A 378 coo 20.47 87.42 16.54 20.16 87.17 14.45 19.87 -16.93 18.72 17.94 -16.19 18.72 coo 24.73 94.37 14.59 21.08 89.84 11.98 24.38 -22.19 19.59 20.35 -19.68 21.34 coo 24.38 86.32 12.71 22.88 86.54 12.71 20.67 -16.34 12.32 20.26 -15.76 13.68 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU A 150 GLU~? 12.50 C5 EPE C 377 B 126 LYS A 154 LYS~? 18.09 O1S EPE C 377 B 171 ALA A 149 ALA~? 12.22 C7 EPE A 377 coo 20.47 87.42 16.54 20.16 87.17 14.45 22.60 -31.63 -7.22 23.33 -32.82 -5.63 coo 24.73 94.37 14.59 21.08 89.84 11.98 24.03 -26.17 -4.04 26.99 -24.22 -8.52 coo 24.38 86.32 12.71 22.88 86.54 12.71 16.74 -30.68 -5.41 16.48 -32.10 -4.88 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU A 151 GLU~? 15.60 C7 EPE A 377 B 126 LYS A 154 LYS~? 18.09 O1S EPE C 377 B 171 ALA A 149 ALA~? 12.22 C7 EPE A 377 coo 20.47 87.42 16.54 20.16 87.17 14.45 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 24.73 94.37 14.59 21.08 89.84 11.98 24.03 -26.17 -4.04 26.99 -24.22 -8.52 coo 24.38 86.32 12.71 22.88 86.54 12.71 16.74 -30.68 -5.41 16.48 -32.10 -4.88 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 B 46 GLU A 151 GLU~? 15.60 C7 EPE A 377 B 126 LYS A 154 LYS~? 18.09 O1S EPE C 377 B 171 ALA A 223 ALA~? 14.91 C7 EPE A 377 coo 20.47 87.42 16.54 20.16 87.17 14.45 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 24.73 94.37 14.59 21.08 89.84 11.98 24.03 -26.17 -4.04 26.99 -24.22 -8.52 coo 24.38 86.32 12.71 22.88 86.54 12.71 17.38 -21.44 -7.38 18.48 -22.07 -6.57 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 B 46 GLU A 262 GLU~? 24.15 ZN ZN A 374 B 126 LYS A 265 LYS~? 22.38 ZN ZN A 374 B 171 ALA A 261 ALA~? 21.36 ZN ZN A 374 coo 20.47 87.42 16.54 20.16 87.17 14.45 59.50 -9.24 37.85 59.47 -7.16 38.33 coo 24.73 94.37 14.59 21.08 89.84 11.98 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 24.38 86.32 12.71 22.88 86.54 12.71 54.29 -10.44 37.93 54.37 -10.19 39.44 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 7 3 # 7 B 46 GLU B 135 GLU^? 15.63 O1S EPE A 377 B 126 LYS B 239 LYS^? 16.51 O1S EPE A 377 B 171 ALA B 134 ALA^? 19.13 O1S EPE A 377 coo 20.47 87.42 16.54 20.16 87.17 14.45 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 24.73 94.37 14.59 21.08 89.84 11.98 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 24.38 86.32 12.71 22.88 86.54 12.71 2.44 -10.57 15.47 3.90 -10.65 15.03 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 8 3 # 8 B 46 GLU B 135 GLU^? 15.63 O1S EPE A 377 B 126 LYS B 239 LYS^? 16.51 O1S EPE A 377 B 171 ALA B 210 ALA.? 15.50 O1S EPE A 377 coo 20.47 87.42 16.54 20.16 87.17 14.45 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 24.73 94.37 14.59 21.08 89.84 11.98 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 24.38 86.32 12.71 22.88 86.54 12.71 -1.53 -20.24 16.39 -0.69 -19.53 17.41 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 9 3 # 9 B 46 GLU B 136 GLU^? 17.92 O1S EPE A 377 B 126 LYS B 239 LYS^? 16.51 O1S EPE A 377 B 171 ALA B 134 ALA^? 19.13 O1S EPE A 377 coo 20.47 87.42 16.54 20.16 87.17 14.45 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 24.73 94.37 14.59 21.08 89.84 11.98 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 24.38 86.32 12.71 22.88 86.54 12.71 2.44 -10.57 15.47 3.90 -10.65 15.03 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 10 3 # 10 B 46 GLU B 136 GLU^? 17.92 O1S EPE A 377 B 126 LYS B 239 LYS^? 16.51 O1S EPE A 377 B 171 ALA B 210 ALA.? 15.50 O1S EPE A 377 coo 20.47 87.42 16.54 20.16 87.17 14.45 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 24.73 94.37 14.59 21.08 89.84 11.98 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 24.38 86.32 12.71 22.88 86.54 12.71 -1.53 -20.24 16.39 -0.69 -19.53 17.41 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 11 3 # 11 B 46 GLU B 150 GLU~? 12.97 C6 EPE A 377 B 126 LYS B 154 LYS~? 18.23 O3S EPE A 377 B 171 ALA B 149 ALA~? 14.00 O3S EPE A 377 coo 20.47 87.42 16.54 20.16 87.17 14.45 -6.18 -40.46 2.00 -5.62 -38.68 0.95 coo 24.73 94.37 14.59 21.08 89.84 11.98 -7.89 -34.48 4.91 -13.85 -35.95 3.01 coo 24.38 86.32 12.71 22.88 86.54 12.71 -2.60 -41.23 7.10 -1.27 -41.62 6.49 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 12 3 # 12 B 46 GLU B 227 GLU.? 24.58 O3S EPE A 377 B 126 LYS B 218 LYS~? 23.26 O3S EPE A 377 B 171 ALA B 223 ALA.? 17.38 O3S EPE A 377 coo 20.47 87.42 16.54 20.16 87.17 14.45 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 24.73 94.37 14.59 21.08 89.84 11.98 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 24.38 86.32 12.71 22.88 86.54 12.71 -9.77 -38.36 13.49 -9.66 -37.46 12.27 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 13 3 # 13 B 46 GLU B 262 GLU~? 24.13 ZN ZN B 374 B 126 LYS B 265 LYS~? 21.91 ZN ZN B 374 B 171 ALA B 261 ALA~? 21.05 ZN ZN B 374 coo 20.47 87.42 16.54 20.16 87.17 14.45 -9.48 23.81 6.41 -10.83 24.55 7.88 coo 24.73 94.37 14.59 21.08 89.84 11.98 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 24.38 86.32 12.71 22.88 86.54 12.71 -6.29 20.23 8.69 -5.64 21.42 9.38 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 14 3 # 14 B 46 GLU C 135 GLU^? 15.12 O1 TRS A 378 B 126 LYS C 138 LYS^? 8.30 N TRS A 378 B 171 ALA C 210 ALA.? 10.68 O1 TRS A 378 coo 20.47 87.42 16.54 20.16 87.17 14.45 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 24.73 94.37 14.59 21.08 89.84 11.98 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 24.38 86.32 12.71 22.88 86.54 12.71 15.20 -30.13 29.07 14.89 -28.65 29.26 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 15 3 # 15 B 46 GLU C 135 GLU^? 15.12 O1 TRS A 378 B 126 LYS C 239 LYS^? 16.29 N TRS A 378 B 171 ALA C 210 ALA.? 10.68 O1 TRS A 378 coo 20.47 87.42 16.54 20.16 87.17 14.45 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 24.73 94.37 14.59 21.08 89.84 11.98 5.15 -29.07 27.87 7.72 -24.69 27.36 coo 24.38 86.32 12.71 22.88 86.54 12.71 15.20 -30.13 29.07 14.89 -28.65 29.26 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 16 3 # 16 B 46 GLU C 136 GLU^? 12.99 N TRS A 378 B 126 LYS C 138 LYS^? 8.30 N TRS A 378 B 171 ALA C 210 ALA.? 10.68 O1 TRS A 378 coo 20.47 87.42 16.54 20.16 87.17 14.45 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 24.73 94.37 14.59 21.08 89.84 11.98 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 24.38 86.32 12.71 22.88 86.54 12.71 15.20 -30.13 29.07 14.89 -28.65 29.26 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 17 3 # 17 B 46 GLU C 136 GLU^? 12.99 N TRS A 378 B 126 LYS C 239 LYS^? 16.29 N TRS A 378 B 171 ALA C 210 ALA.? 10.68 O1 TRS A 378 coo 20.47 87.42 16.54 20.16 87.17 14.45 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 24.73 94.37 14.59 21.08 89.84 11.98 5.15 -29.07 27.87 7.72 -24.69 27.36 coo 24.38 86.32 12.71 22.88 86.54 12.71 15.20 -30.13 29.07 14.89 -28.65 29.26 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 18 3 # 18 B 46 GLU C 150 GLU~? 19.96 C2 EPE C 377 B 126 LYS C 154 LYS~? 23.94 C1 TRS A 378 B 171 ALA C 149 ALA~? 12.95 O8 EPE C 377 coo 20.47 87.42 16.54 20.16 87.17 14.45 18.79 -51.73 16.88 16.73 -51.34 17.24 coo 24.73 94.37 14.59 21.08 89.84 11.98 18.67 -47.92 22.36 20.33 -51.69 25.99 coo 24.38 86.32 12.71 22.88 86.54 12.71 21.04 -46.59 14.02 20.14 -46.59 12.80 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 19 3 # 19 B 46 GLU C 151 GLU~? 17.15 O8 EPE C 377 B 126 LYS C 154 LYS~? 23.94 C1 TRS A 378 B 171 ALA C 149 ALA~? 12.95 O8 EPE C 377 coo 20.47 87.42 16.54 20.16 87.17 14.45 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 24.73 94.37 14.59 21.08 89.84 11.98 18.67 -47.92 22.36 20.33 -51.69 25.99 coo 24.38 86.32 12.71 22.88 86.54 12.71 21.04 -46.59 14.02 20.14 -46.59 12.80 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 20 3 # 20 B 46 GLU C 151 GLU~? 17.15 O8 EPE C 377 B 126 LYS C 154 LYS~? 23.94 C1 TRS A 378 B 171 ALA C 223 ALA~? 15.75 C3 EPE C 377 coo 20.47 87.42 16.54 20.16 87.17 14.45 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 24.73 94.37 14.59 21.08 89.84 11.98 18.67 -47.92 22.36 20.33 -51.69 25.99 coo 24.38 86.32 12.71 22.88 86.54 12.71 26.89 -44.82 20.98 25.41 -45.05 21.20 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 21 3 # 21 B 46 GLU C 262 GLU~? 24.05 ZN ZN C 374 B 126 LYS C 265 LYS~? 21.95 ZN ZN C 374 B 171 ALA C 261 ALA~? 21.12 ZN ZN C 374 coo 20.47 87.42 16.54 20.16 87.17 14.45 -15.17 -35.96 63.25 -14.01 -35.31 64.90 coo 24.73 94.37 14.59 21.08 89.84 11.98 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 24.38 86.32 12.71 22.88 86.54 12.71 -13.17 -32.79 59.35 -13.86 -31.71 60.07 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 21 hits 1uf7_c01 naa= 3 ULMN 3 1uk7_c00 3.07.01.0009 user 1 3 # 1 A 103 ALA A 23 ALA~? 10.67 ZN ZN A 375 A 224 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 252 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 27.83 -4.85 24.60 27.58 -3.36 24.26 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1uk7_c00 3.07.01.0009 user 2 3 # 2 A 103 ALA A 67 ALA^? 10.32 ZN ZN A 374 A 224 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 252 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 37.22 5.65 22.28 37.04 6.85 23.17 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 40.70 8.14 28.73 41.06 6.40 29.84 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1uk7_c00 3.07.01.0009 user 3 3 # 3 A 103 ALA A 101 ALA^? 11.28 ZN ZN A 375 A 224 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 252 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 32.09 5.17 22.05 31.25 5.48 23.29 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1uk7_c00 3.07.01.0009 user 4 3 # 4 A 103 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 224 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 252 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 33.09 1.52 21.68 34.14 1.27 20.64 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1uk7_c00 3.07.01.0009 user 5 3 # 5 A 103 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 224 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 252 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 33.09 1.52 21.68 34.14 1.27 20.64 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1uk7_c00 3.07.01.0009 user 6 3 # 6 A 103 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 224 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 252 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 33.09 1.52 21.68 34.14 1.27 20.64 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1uk7_c00 3.07.01.0009 user 7 3 # 7 A 103 ALA A 161 ALA.? 7.16 O1S EPE C 377 A 224 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 252 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 24.22 -22.86 5.01 22.88 -23.16 4.38 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1uk7_c00 3.07.01.0009 user 8 3 # 8 A 103 ALA B 23 ALA~? 10.82 ZN ZN B 375 A 224 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 252 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -4.97 -5.23 25.00 -5.92 -5.35 26.16 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1uk7_c00 3.07.01.0009 user 9 3 # 9 A 103 ALA B 67 ALA^? 10.44 ZN ZN B 374 A 224 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 252 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1uk7_c00 3.07.01.0009 user 10 3 # 10 A 103 ALA B 78 ALA.? 7.78 O2S EPE B 376 A 224 ASP B 82 ASP.? 10.62 O3S EPE B 376 A 252 HIS B 80 HIS.? 6.72 O2S EPE B 376 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -14.76 4.18 47.71 -14.60 5.45 48.54 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -22.38 12.66 48.09 -22.95 14.65 48.48 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -17.26 9.01 48.35 -15.80 8.65 49.80 ULMN 3 1uk7_c00 3.07.01.0009 user 11 3 # 11 A 103 ALA B 101 ALA^? 11.06 ZN ZN B 375 A 224 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 252 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1uk7_c00 3.07.01.0009 user 12 3 # 12 A 103 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 224 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 252 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1uk7_c00 3.07.01.0009 user 13 3 # 13 A 103 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 224 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 252 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1uk7_c00 3.07.01.0009 user 14 3 # 14 A 103 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 224 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 252 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1uk7_c00 3.07.01.0009 user 15 3 # 15 A 103 ALA B 161 ALA.? 8.19 O3S EPE A 377 A 224 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 252 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1uk7_c00 3.07.01.0009 user 16 3 # 16 A 103 ALA C 23 ALA~? 11.04 ZN ZN C 375 A 224 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 252 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 11.77 -25.07 43.97 13.11 -24.84 44.66 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1uk7_c00 3.07.01.0009 user 17 3 # 17 A 103 ALA C 67 ALA^? 10.56 ZN ZN C 374 A 224 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 252 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1uk7_c00 3.07.01.0009 user 18 3 # 18 A 103 ALA C 78 ALA.? 7.87 O2S EPE C 376 A 224 ASP C 82 ASP.? 10.22 O3S EPE C 376 A 252 HIS C 80 HIS.? 6.69 O2S EPE C 376 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 24.39 -12.24 63.20 23.97 -11.24 64.29 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 23.03 -14.86 74.18 22.44 -14.42 76.16 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 23.09 -12.52 68.61 23.48 -10.58 67.92 ULMN 3 1uk7_c00 3.07.01.0009 user 19 3 # 19 A 103 ALA C 101 ALA^? 11.01 ZN ZN C 375 A 224 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 252 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1uk7_c00 3.07.01.0009 user 20 3 # 20 A 103 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 224 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 252 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1uk7_c00 3.07.01.0009 user 21 3 # 21 A 103 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 224 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 252 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1uk7_c00 3.07.01.0009 user 22 3 # 22 A 103 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 224 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 252 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1uk7_c00 3.07.01.0009 user 23 3 # 23 A 103 ALA C 161 ALA.? 14.45 O1 TRS A 378 A 224 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 252 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 14.54 -40.01 25.90 15.56 -39.75 24.83 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 13.13 -47.52 24.96 14.34 -48.17 26.54 1uk7_c00 source 1uk7 3.07.01.0009 : 23 hits 1uk7_c00 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 68 HIS.? -3.31 ZN ZN A 375s 89 GLU A 336 GLU~? 2.52 ZN ZN A 375s 243 ASN A 74 ASN.? -4.28 C7 EPE A 376s coo 5.83 15.74 17.38 6.41 17.70 17.86 37.80 0.44 25.56 37.02 -1.29 26.44 coo 3.11 16.19 13.44 4.96 17.09 13.42 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 0.53 21.81 31.33 1.05 20.47 29.70 26.98 10.15 34.57 28.23 8.78 35.68 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS A 333 HIS~? -3.55 ZN ZN A 374s 89 GLU A 336 GLU~? 2.52 ZN ZN A 375s 243 ASN A 74 ASN.? -4.28 C7 EPE A 376s coo 5.83 15.74 17.38 6.41 17.70 17.86 40.60 0.33 34.12 38.69 0.39 33.24 coo 3.11 16.19 13.44 4.96 17.09 13.42 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 0.53 21.81 31.33 1.05 20.47 29.70 26.98 10.15 34.57 28.23 8.78 35.68 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS B 8 HIS~? 24.51 ZN ZN B 375 89 GLU B 9 GLU~? 28.41 ZN ZN B 375 243 ASN B 105 ASN~? 9.47 ZN ZN B 375 coo 5.83 15.74 17.38 6.41 17.70 17.86 -21.73 -14.76 29.99 -21.14 -14.36 31.97 coo 3.11 16.19 13.44 4.96 17.09 13.42 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 0.53 21.81 31.33 1.05 20.47 29.70 -8.71 -5.38 22.66 -10.29 -4.82 23.98 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 4 3 # 4 86 HIS B 68 HIS.? -3.38 ZN ZN B 375s 89 GLU B 336 GLU~? 2.48 ZN ZN B 375s 243 ASN B 74 ASN.? -4.36 C8 EPE B 376s coo 5.83 15.74 17.38 6.41 17.70 17.86 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 3.11 16.19 13.44 4.96 17.09 13.42 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 0.53 21.81 31.33 1.05 20.47 29.70 -8.12 5.35 39.22 -7.06 6.68 37.98 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 5 3 # 5 86 HIS B 333 HIS~? -3.37 ZN ZN B 374s 89 GLU B 336 GLU~? 2.48 ZN ZN B 375s 243 ASN B 74 ASN.? -4.36 C8 EPE B 376s coo 5.83 15.74 17.38 6.41 17.70 17.86 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 3.11 16.19 13.44 4.96 17.09 13.42 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 0.53 21.81 31.33 1.05 20.47 29.70 -8.12 5.35 39.22 -7.06 6.68 37.98 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 6 3 # 6 86 HIS C 8 HIS~? 24.89 ZN ZN C 375 89 GLU C 9 GLU~? 28.11 O1 TRS A 378 243 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo 5.83 15.74 17.38 6.41 17.70 17.86 29.42 -33.76 48.01 30.25 -31.91 48.55 coo 3.11 16.19 13.44 4.96 17.09 13.42 28.74 -39.91 47.06 29.82 -41.70 47.37 coo 0.53 21.81 31.33 1.05 20.47 29.70 12.40 -28.97 45.42 13.67 -29.13 47.17 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 7 3 # 7 86 HIS C 68 HIS.? -3.41 ZN ZN C 375s 89 GLU C 336 GLU~? 2.53 ZN ZN C 375s 243 ASN C 74 ASN.? -4.45 C8 EPE C 376s coo 5.83 15.74 17.38 6.41 17.70 17.86 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 3.11 16.19 13.44 4.96 17.09 13.42 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 0.53 21.81 31.33 1.05 20.47 29.70 15.47 -13.97 57.59 13.34 -13.80 57.59 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 8 3 # 8 86 HIS C 333 HIS~? -3.37 ZN ZN C 374s 89 GLU C 336 GLU~? 2.53 ZN ZN C 375s 243 ASN C 74 ASN.? -4.45 C8 EPE C 376s coo 5.83 15.74 17.38 6.41 17.70 17.86 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 3.11 16.19 13.44 4.96 17.09 13.42 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 0.53 21.81 31.33 1.05 20.47 29.70 15.47 -13.97 57.59 13.34 -13.80 57.59 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 8 hits 1ula_c00 naa= 3 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 A 85 GLU A 56 GLU~? 18.18 ZN ZN A 374 A 87 ASP A 55 ASP~? 17.36 O2S EPE A 376 A 89 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 47.24 13.21 19.42 47.19 11.28 20.29 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 45.10 18.98 22.18 44.20 20.57 23.21 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 A 85 GLU B 56 GLU~? 18.10 ZN ZN B 374 A 87 ASP B 55 ASP~? 16.89 O3S EPE B 376 A 89 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 3 3 # 3 A 85 GLU C 56 GLU~? 18.45 ZN ZN C 374 A 87 ASP C 55 ASP~? 17.38 O3S EPE C 376 A 89 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 13.88 -30.69 72.19 13.68 -28.54 72.17 1un1_c00 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 3 hits 1un1_c00 naa= 3 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 B 85 GLU A 51 GLU~? 11.89 O2S EPE A 376 B 87 ASP A 55 ASP~? 17.36 O2S EPE A 376 B 89 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 19.32 178.30 3.72 20.56 176.87 2.77 41.17 19.74 26.83 40.87 21.56 28.00 coo 22.91 179.81 6.56 22.10 178.65 5.00 45.10 18.98 22.18 44.20 20.57 23.21 coo 26.74 177.55 7.48 27.16 177.47 5.41 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 B 85 GLU A 52 GLU~? 13.77 C2 EPE A 376 B 87 ASP A 55 ASP~? 17.36 O2S EPE A 376 B 89 GLU A 51 GLU~? 11.89 O2S EPE A 376 coo 19.32 178.30 3.72 20.56 176.87 2.77 46.63 16.37 27.65 45.50 16.12 29.45 coo 22.91 179.81 6.56 22.10 178.65 5.00 45.10 18.98 22.18 44.20 20.57 23.21 coo 26.74 177.55 7.48 27.16 177.47 5.41 41.17 19.74 26.83 40.87 21.56 28.00 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 3 3 # 3 B 85 GLU A 56 GLU~? 18.18 ZN ZN A 374 B 87 ASP A 55 ASP~? 17.36 O2S EPE A 376 B 89 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 19.32 178.30 3.72 20.56 176.87 2.77 47.24 13.21 19.42 47.19 11.28 20.29 coo 22.91 179.81 6.56 22.10 178.65 5.00 45.10 18.98 22.18 44.20 20.57 23.21 coo 26.74 177.55 7.48 27.16 177.47 5.41 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 4 3 # 4 B 85 GLU B 56 GLU~? 18.10 ZN ZN B 374 B 87 ASP B 55 ASP~? 16.89 O3S EPE B 376 B 89 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo 19.32 178.30 3.72 20.56 176.87 2.77 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 22.91 179.81 6.56 22.10 178.65 5.00 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 26.74 177.55 7.48 27.16 177.47 5.41 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 5 3 # 5 B 85 GLU C 56 GLU~? 18.45 ZN ZN C 374 B 87 ASP C 55 ASP~? 17.38 O3S EPE C 376 B 89 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo 19.32 178.30 3.72 20.56 176.87 2.77 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 22.91 179.81 6.56 22.10 178.65 5.00 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 26.74 177.55 7.48 27.16 177.47 5.41 13.88 -30.69 72.19 13.68 -28.54 72.17 1un1_c01 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 5 hits 1un1_c01 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 107 ASP~? -2.33 ZN ZN A 375s 255 GLU A 336 GLU~? 2.52 ZN ZN A 375s 329 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 52.57 37.12 10.17 53.37 35.95 11.75 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 59.16 37.82 13.95 57.63 37.03 15.12 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 306 ASP.? 24.91 ZN ZN A 375 255 GLU A 254 GLU^? 30.93 ZN ZN A 375 329 ASP A 281 ASP.? 28.06 ZN ZN A 375 coo 49.16 35.16 15.19 51.08 34.43 15.65 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 52.57 37.12 10.17 53.37 35.95 11.75 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 59.16 37.82 13.95 57.63 37.03 15.12 52.87 -20.75 45.53 51.52 -19.24 45.99 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 107 ASP~? -2.23 ZN ZN B 375s 255 GLU B 336 GLU~? 2.48 ZN ZN B 375s 329 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 52.57 37.12 10.17 53.37 35.95 11.75 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP C 107 ASP~? -2.30 ZN ZN C 375s 255 GLU C 336 GLU~? 2.53 ZN ZN C 375s 329 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 52.57 37.12 10.17 53.37 35.95 11.75 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.43 -20.86 54.35 0.32 -19.00 54.12 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 4 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 48 ASP.? 7.40 ZN ZN A 374 218 GLU A 127 GLU^? 14.05 O3 TRS A 378 329 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 40.70 8.14 28.73 41.06 6.40 29.84 coo 70.09 11.71 8.46 70.56 12.89 6.77 39.39 -22.49 26.46 38.47 -23.38 24.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 107 ASP~? -2.33 ZN ZN A 375s 218 GLU A 90 GLU~? 12.44 O2S EPE A 376 329 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 33.69 24.77 24.85 34.29 26.39 26.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 107 ASP~? -2.33 ZN ZN A 375s 218 GLU C 25 GLU.? 17.70 ZN ZN C 375 329 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 10.47 -15.76 42.35 12.38 -15.28 41.57 coo 59.16 37.82 13.95 57.63 37.03 15.12 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 107 ASP~? -2.33 ZN ZN A 375s 218 GLU C 25 GLU.? 17.70 ZN ZN C 375 329 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 10.47 -15.76 42.35 12.38 -15.28 41.57 coo 59.16 37.82 13.95 57.63 37.03 15.12 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 107 ASP~? -2.33 ZN ZN A 375s 218 GLU C 136 GLU^? 12.99 N TRS A 378 329 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 269 ASP.? 18.90 ZN ZN A 374 218 GLU A 25 GLU.? 17.13 ZN ZN A 375 329 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 54.82 -1.21 28.36 56.43 0.27 28.67 coo 70.09 11.71 8.46 70.56 12.89 6.77 21.52 -4.56 31.66 21.12 -5.25 33.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 281 ASP.? 28.06 ZN ZN A 375 218 GLU C 9 GLU~? 28.11 O1 TRS A 378 329 ASP A 306 ASP.? 24.91 ZN ZN A 375 coo 49.16 35.16 15.19 51.08 34.43 15.65 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 70.09 11.71 8.46 70.56 12.89 6.77 28.74 -39.91 47.06 29.82 -41.70 47.37 coo 59.16 37.82 13.95 57.63 37.03 15.12 47.82 -20.71 38.37 47.81 -22.84 38.27 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP A 292 ASP^? 8.63 ZN ZN A 374 218 GLU A 253 GLU^? 31.48 ZN ZN A 375 329 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 49.16 35.16 15.19 51.08 34.43 15.65 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 59.16 37.82 13.95 57.63 37.03 15.12 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP A 312 ASP.? 7.50 ZN ZN A 374 218 GLU A 253 GLU^? 31.48 ZN ZN A 375 329 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 39.49 -1.24 39.18 39.76 0.49 37.96 coo 70.09 11.71 8.46 70.56 12.89 6.77 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 59.16 37.82 13.95 57.63 37.03 15.12 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP A 312 ASP.? 7.50 ZN ZN A 374 218 GLU A 349 GLU~? 21.94 ZN ZN A 375 329 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 39.49 -1.24 39.18 39.76 0.49 37.96 coo 70.09 11.71 8.46 70.56 12.89 6.77 44.64 -4.62 8.34 45.23 -6.64 8.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP A 330 ASP^? 12.08 ZN ZN A 374 218 GLU A 349 GLU~? 21.94 ZN ZN A 375 329 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 70.09 11.71 8.46 70.56 12.89 6.77 44.64 -4.62 8.34 45.23 -6.64 8.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP A 368 ASP.? 11.85 ZN ZN A 374 218 GLU A 241 GLU^? 13.09 O3 TRS A 378 329 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 48.24 5.16 33.58 47.82 3.96 35.30 coo 70.09 11.71 8.46 70.56 12.89 6.77 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP A 368 ASP.? 11.85 ZN ZN A 374 218 GLU A 241 GLU^? 13.09 O3 TRS A 378 329 ASP A 269 ASP.? 18.90 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 48.24 5.16 33.58 47.82 3.96 35.30 coo 70.09 11.71 8.46 70.56 12.89 6.77 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 54.82 -1.21 28.36 56.43 0.27 28.67 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP A 368 ASP.? 11.85 ZN ZN A 374 218 GLU A 241 GLU^? 13.09 O3 TRS A 378 329 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 48.24 5.16 33.58 47.82 3.96 35.30 coo 70.09 11.71 8.46 70.56 12.89 6.77 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP A 368 ASP.? 11.85 ZN ZN A 374 218 GLU A 253 GLU^? 31.48 ZN ZN A 375 329 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 48.24 5.16 33.58 47.82 3.96 35.30 coo 70.09 11.71 8.46 70.56 12.89 6.77 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 59.16 37.82 13.95 57.63 37.03 15.12 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP B 48 ASP.? 7.36 ZN ZN B 374 218 GLU B 127 GLU^? 21.05 ZN ZN B 375 329 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 70.09 11.71 8.46 70.56 12.89 6.77 2.11 -0.28 5.62 1.83 -2.30 4.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP B 107 ASP~? -2.23 ZN ZN B 375s 218 GLU A 25 GLU.? 17.13 ZN ZN A 375 329 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 70.09 11.71 8.46 70.56 12.89 6.77 21.52 -4.56 31.66 21.12 -5.25 33.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP B 107 ASP~? -2.23 ZN ZN B 375s 218 GLU A 25 GLU.? 17.13 ZN ZN A 375 329 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 70.09 11.71 8.46 70.56 12.89 6.77 21.52 -4.56 31.66 21.12 -5.25 33.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP B 107 ASP~? -2.23 ZN ZN B 375s 218 GLU A 228 GLU.? 8.71 C3 EPE A 377 329 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 70.09 11.71 8.46 70.56 12.89 6.77 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP B 107 ASP~? -2.23 ZN ZN B 375s 218 GLU B 90 GLU~? 12.95 O2S EPE B 376 329 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 70.09 11.71 8.46 70.56 12.89 6.77 -26.35 5.03 43.39 -26.95 6.71 44.51 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP B 107 ASP~? -2.23 ZN ZN B 375s 218 GLU C 136 GLU^? 12.99 N TRS A 378 329 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 70.09 11.71 8.46 70.56 12.89 6.77 10.97 -24.78 28.83 12.54 -23.35 28.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP B 292 ASP^? 8.88 ZN ZN B 374 218 GLU B 253 GLU^? 31.12 ZN ZN B 375 329 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 49.16 35.16 15.19 51.08 34.43 15.65 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 70.09 11.71 8.46 70.56 12.89 6.77 -5.44 14.03 -5.56 -4.22 13.73 -7.31 coo 59.16 37.82 13.95 57.63 37.03 15.12 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP B 312 ASP.? 7.53 ZN ZN B 374 218 GLU B 253 GLU^? 31.12 ZN ZN B 375 329 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 70.09 11.71 8.46 70.56 12.89 6.77 -5.44 14.03 -5.56 -4.22 13.73 -7.31 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP B 312 ASP.? 7.53 ZN ZN B 374 218 GLU B 349 GLU~? 21.77 ZN ZN B 375 329 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP B 330 ASP^? 11.92 ZN ZN B 374 218 GLU B 15 GLU~? 17.09 ZN ZN B 375 329 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 -14.60 -10.45 24.17 -14.29 -11.30 26.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP B 330 ASP^? 11.92 ZN ZN B 374 218 GLU B 135 GLU^? 15.63 O1S EPE A 377 329 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 -1.29 -15.58 14.93 -2.99 -16.30 13.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 27 3 # 27 199 ASP B 330 ASP^? 11.92 ZN ZN B 374 218 GLU B 349 GLU~? 21.77 ZN ZN B 375 329 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 28 3 # 28 199 ASP B 330 ASP^? 11.92 ZN ZN B 374 218 GLU B 349 GLU~? 21.77 ZN ZN B 375 329 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 29 3 # 29 199 ASP B 368 ASP.? 11.70 ZN ZN B 374 218 GLU B 241 GLU^? 19.53 O1S EPE A 377 329 ASP B 269 ASP.? 18.26 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 70.09 11.71 8.46 70.56 12.89 6.77 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 -18.05 15.19 12.20 -19.75 16.35 12.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 30 3 # 30 199 ASP B 368 ASP.? 11.70 ZN ZN B 374 218 GLU B 241 GLU^? 19.53 O1S EPE A 377 329 ASP B 312 ASP.? 7.53 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 70.09 11.71 8.46 70.56 12.89 6.77 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 -4.08 14.12 24.69 -6.01 13.62 25.36 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 31 3 # 31 199 ASP B 368 ASP.? 11.70 ZN ZN B 374 218 GLU B 241 GLU^? 19.53 O1S EPE A 377 329 ASP B 330 ASP^? 11.92 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 70.09 11.71 8.46 70.56 12.89 6.77 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 -4.33 18.16 18.13 -5.04 17.21 19.90 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 32 3 # 32 199 ASP C 27 ASP.? 8.23 ZN ZN C 375 218 GLU B 228 GLU.? 26.61 O2S EPE A 377 329 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 49.16 35.16 15.19 51.08 34.43 15.65 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 70.09 11.71 8.46 70.56 12.89 6.77 -2.18 -42.16 24.63 -2.03 -43.87 25.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 33 3 # 33 199 ASP C 48 ASP.? 7.30 ZN ZN C 374 218 GLU C 127 GLU^? 21.05 ZN ZN C 375 329 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 70.09 11.71 8.46 70.56 12.89 6.77 -6.33 -33.63 38.15 -7.56 -32.26 37.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 34 3 # 34 199 ASP C 107 ASP~? -2.30 ZN ZN C 375s 218 GLU C 90 GLU~? 12.50 O3S EPE C 376 329 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 70.09 11.71 8.46 70.56 12.89 6.77 27.07 -22.98 69.65 26.90 -21.97 71.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 35 3 # 35 199 ASP C 269 ASP~? 18.04 ZN ZN C 374 218 GLU C 25 GLU.? 17.70 ZN ZN C 375 329 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 70.09 11.71 8.46 70.56 12.89 6.77 10.47 -15.76 42.35 12.38 -15.28 41.57 coo 59.16 37.82 13.95 57.63 37.03 15.12 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 36 3 # 36 199 ASP C 292 ASP^? 8.69 ZN ZN C 374 218 GLU C 253 GLU^? 31.42 ZN ZN C 375 329 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 49.16 35.16 15.19 51.08 34.43 15.65 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 70.09 11.71 8.46 70.56 12.89 6.77 -18.88 -44.02 49.77 -19.94 -45.34 51.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 37 3 # 37 199 ASP C 312 ASP.? 7.48 ZN ZN C 374 218 GLU C 253 GLU^? 31.42 ZN ZN C 375 329 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 70.09 11.71 8.46 70.56 12.89 6.77 -18.88 -44.02 49.77 -19.94 -45.34 51.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 38 3 # 38 199 ASP C 312 ASP.? 7.48 ZN ZN C 374 218 GLU C 349 GLU~? 21.43 ZN ZN C 375 329 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 70.09 11.71 8.46 70.56 12.89 6.77 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 39 3 # 39 199 ASP C 330 ASP^? 11.91 ZN ZN C 374 218 GLU C 349 GLU~? 21.43 ZN ZN C 375 329 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 70.09 11.71 8.46 70.56 12.89 6.77 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 40 3 # 40 199 ASP C 368 ASP.? 11.74 ZN ZN C 374 218 GLU C 241 GLU^? 18.99 ZN ZN C 375 329 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 70.09 11.71 8.46 70.56 12.89 6.77 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 41 3 # 41 199 ASP C 368 ASP.? 11.74 ZN ZN C 374 218 GLU C 241 GLU^? 18.99 ZN ZN C 375 329 ASP C 269 ASP~? 18.04 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 70.09 11.71 8.46 70.56 12.89 6.77 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.79 -38.40 63.28 -1.15 -38.99 65.26 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 42 3 # 42 199 ASP C 368 ASP.? 11.74 ZN ZN C 374 218 GLU C 241 GLU^? 18.99 ZN ZN C 375 329 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 70.09 11.71 8.46 70.56 12.89 6.77 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 -0.90 -20.80 57.97 0.71 -21.61 59.03 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 43 3 # 43 199 ASP C 368 ASP.? 11.74 ZN ZN C 374 218 GLU C 253 GLU^? 31.42 ZN ZN C 375 329 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 70.09 11.71 8.46 70.56 12.89 6.77 -18.88 -44.02 49.77 -19.94 -45.34 51.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 -0.90 -20.80 57.97 0.71 -21.61 59.03 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 43 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 48 ASP.? 7.40 ZN ZN A 374 242 GLU A 25 GLU.? 17.13 ZN ZN A 375 329 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 40.70 8.14 28.73 41.06 6.40 29.84 coo 30.42 34.74 5.00 29.09 35.09 3.38 21.52 -4.56 31.66 21.12 -5.25 33.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 107 ASP~? -2.33 ZN ZN A 375s 242 GLU A 136 GLU^? 12.15 O3 TRS A 378 329 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 30.42 34.74 5.00 29.09 35.09 3.38 19.87 -16.93 18.72 17.94 -16.19 18.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 107 ASP~? -2.33 ZN ZN A 375s 242 GLU A 349 GLU~? 21.94 ZN ZN A 375 329 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 30.42 34.74 5.00 29.09 35.09 3.38 44.64 -4.62 8.34 45.23 -6.64 8.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 115 ASP~? 13.24 ZN ZN A 375 242 GLU A 253 GLU^? 31.48 ZN ZN A 375 329 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 49.16 35.16 15.19 51.08 34.43 15.65 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 30.42 34.74 5.00 29.09 35.09 3.38 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 59.16 37.82 13.95 57.63 37.03 15.12 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 115 ASP~? 13.24 ZN ZN A 375 242 GLU C 184 GLU.? 20.48 N4 EPE C 377 329 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 49.16 35.16 15.19 51.08 34.43 15.65 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 30.42 34.74 5.00 29.09 35.09 3.38 42.98 -26.30 5.30 43.52 -24.37 5.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 269 ASP.? 18.90 ZN ZN A 374 242 GLU A 253 GLU^? 31.48 ZN ZN A 375 329 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 54.82 -1.21 28.36 56.43 0.27 28.67 coo 30.42 34.74 5.00 29.09 35.09 3.38 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 59.16 37.82 13.95 57.63 37.03 15.12 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 292 ASP^? 8.63 ZN ZN A 374 242 GLU A 15 GLU~? 17.23 ZN ZN A 375 329 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 30.42 34.74 5.00 29.09 35.09 3.38 29.50 -0.46 14.62 27.65 0.59 14.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP A 312 ASP.? 7.50 ZN ZN A 374 242 GLU A 25 GLU.? 17.13 ZN ZN A 375 329 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 39.49 -1.24 39.18 39.76 0.49 37.96 coo 30.42 34.74 5.00 29.09 35.09 3.38 21.52 -4.56 31.66 21.12 -5.25 33.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP A 330 ASP^? 12.08 ZN ZN A 374 242 GLU A 254 GLU^? 30.93 ZN ZN A 375 329 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 30.42 34.74 5.00 29.09 35.09 3.38 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 59.16 37.82 13.95 57.63 37.03 15.12 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 107 ASP~? -2.23 ZN ZN B 375s 242 GLU B 136 GLU^? 17.92 O1S EPE A 377 329 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 30.42 34.74 5.00 29.09 35.09 3.38 3.06 -17.26 18.13 4.41 -17.23 19.78 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP B 107 ASP~? -2.23 ZN ZN B 375s 242 GLU B 349 GLU~? 21.77 ZN ZN B 375 329 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 30.42 34.74 5.00 29.09 35.09 3.38 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP B 115 ASP~? 12.98 ZN ZN B 375 242 GLU B 253 GLU^? 31.12 ZN ZN B 375 329 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 49.16 35.16 15.19 51.08 34.43 15.65 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 -5.44 14.03 -5.56 -4.22 13.73 -7.31 coo 59.16 37.82 13.95 57.63 37.03 15.12 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP B 269 ASP.? 18.26 ZN ZN B 374 242 GLU B 253 GLU^? 31.12 ZN ZN B 375 329 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 30.42 34.74 5.00 29.09 35.09 3.38 -5.44 14.03 -5.56 -4.22 13.73 -7.31 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP B 312 ASP.? 7.53 ZN ZN B 374 242 GLU B 25 GLU.? 18.70 ZN ZN B 375 329 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.08 14.12 24.69 -6.01 13.62 25.36 coo 30.42 34.74 5.00 29.09 35.09 3.38 1.46 -5.92 31.01 3.44 -6.69 31.23 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP B 330 ASP^? 11.92 ZN ZN B 374 242 GLU B 127 GLU^? 21.05 ZN ZN B 375 329 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 30.42 34.74 5.00 29.09 35.09 3.38 2.11 -0.28 5.62 1.83 -2.30 4.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP B 330 ASP^? 11.92 ZN ZN B 374 242 GLU B 254 GLU^? 30.73 ZN ZN B 375 329 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 30.42 34.74 5.00 29.09 35.09 3.38 1.12 17.35 -1.99 2.87 17.99 -2.99 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP C 107 ASP~? -2.30 ZN ZN C 375s 242 GLU C 349 GLU~? 21.43 ZN ZN C 375 329 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 30.42 34.74 5.00 29.09 35.09 3.38 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP C 115 ASP~? 12.87 ZN ZN C 375 242 GLU B 228 GLU.? 26.61 O2S EPE A 377 329 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 49.16 35.16 15.19 51.08 34.43 15.65 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -2.18 -42.16 24.63 -2.03 -43.87 25.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP C 115 ASP~? 12.87 ZN ZN C 375 242 GLU C 253 GLU^? 31.42 ZN ZN C 375 329 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 49.16 35.16 15.19 51.08 34.43 15.65 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -18.88 -44.02 49.77 -19.94 -45.34 51.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP C 269 ASP~? 18.04 ZN ZN C 374 242 GLU C 253 GLU^? 31.42 ZN ZN C 375 329 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 30.42 34.74 5.00 29.09 35.09 3.38 -18.88 -44.02 49.77 -19.94 -45.34 51.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP C 292 ASP^? 8.69 ZN ZN C 374 242 GLU C 15 GLU~? 17.26 ZN ZN C 375 329 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 30.42 34.74 5.00 29.09 35.09 3.38 19.30 -32.62 45.28 21.00 -31.37 45.17 coo 59.16 37.82 13.95 57.63 37.03 15.12 -7.16 -24.94 59.28 -5.20 -24.20 59.64 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP C 312 ASP.? 7.48 ZN ZN C 374 242 GLU C 25 GLU.? 17.70 ZN ZN C 375 329 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 49.16 35.16 15.19 51.08 34.43 15.65 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 30.42 34.74 5.00 29.09 35.09 3.38 10.47 -15.76 42.35 12.38 -15.28 41.57 coo 59.16 37.82 13.95 57.63 37.03 15.12 2.31 -29.36 66.29 0.59 -28.37 65.47 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 22 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 596 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 647 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 70.89 37.31 29.70 69.54 36.29 32.39 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 66.09 40.54 34.70 66.92 37.69 35.49 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU A 205 GLU^? -4.84 O3S EPE C 377s A 596 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 647 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 69.13 32.20 28.58 68.39 32.96 30.44 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 70.89 37.31 29.70 69.54 36.29 32.39 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 66.09 40.54 34.70 66.92 37.69 35.49 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 596 ARG A 203 ARG^? 8.58 O3S EPE C 377 A 647 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 69.13 32.20 28.58 68.39 32.96 30.44 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 70.89 37.31 29.70 69.54 36.29 32.39 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 66.09 40.54 34.70 66.92 37.69 35.49 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 4 3 # 4 A 581 GLU B 205 GLU^? 4.50 O2S EPE A 377 A 596 ARG B 203 ARG^? 8.69 O2S EPE A 377 A 647 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 69.13 32.20 28.58 68.39 32.96 30.44 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 70.89 37.31 29.70 69.54 36.29 32.39 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 66.09 40.54 34.70 66.92 37.69 35.49 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 5 3 # 5 A 581 GLU C 200 GLU^? 10.81 O8 EPE C 377 A 596 ARG C 198 ARG^? 10.55 C8 EPE C 377 A 647 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo 69.13 32.20 28.58 68.39 32.96 30.44 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 70.89 37.31 29.70 69.54 36.29 32.39 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo 66.09 40.54 34.70 66.92 37.69 35.49 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 6 3 # 6 A 581 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 596 ARG B 203 ARG^? 8.69 O2S EPE A 377 A 647 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 70.89 37.31 29.70 69.54 36.29 32.39 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 66.09 40.54 34.70 66.92 37.69 35.49 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 7 3 # 7 A 581 GLU C 205 GLU^? 12.89 O3S EPE C 377 A 596 ARG C 203 ARG^? 8.27 O3S EPE C 377 A 647 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 70.89 37.31 29.70 69.54 36.29 32.39 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 66.09 40.54 34.70 66.92 37.69 35.49 10.96 -32.82 5.66 12.34 -31.74 8.19 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 7 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 596 ARG A 203 ARG^? 8.58 O3S EPE C 377 B 647 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 34.24 60.89 68.08 33.31 57.93 67.63 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 31.43 57.38 61.97 31.90 55.58 64.41 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU A 205 GLU^? -4.84 O3S EPE C 377s B 596 ARG C 203 ARG^? 8.27 O3S EPE C 377 B 647 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 38.22 57.83 70.36 36.82 56.74 69.18 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 34.24 60.89 68.08 33.31 57.93 67.63 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 31.43 57.38 61.97 31.90 55.58 64.41 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 596 ARG A 203 ARG^? 8.58 O3S EPE C 377 B 647 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 38.22 57.83 70.36 36.82 56.74 69.18 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 34.24 60.89 68.08 33.31 57.93 67.63 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 31.43 57.38 61.97 31.90 55.58 64.41 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 4 3 # 4 B 581 GLU B 205 GLU^? 4.50 O2S EPE A 377 B 596 ARG B 203 ARG^? 8.69 O2S EPE A 377 B 647 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 38.22 57.83 70.36 36.82 56.74 69.18 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 34.24 60.89 68.08 33.31 57.93 67.63 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 31.43 57.38 61.97 31.90 55.58 64.41 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 5 3 # 5 B 581 GLU C 200 GLU^? 10.81 O8 EPE C 377 B 596 ARG C 198 ARG^? 10.55 C8 EPE C 377 B 647 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo 38.22 57.83 70.36 36.82 56.74 69.18 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 34.24 60.89 68.08 33.31 57.93 67.63 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo 31.43 57.38 61.97 31.90 55.58 64.41 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 6 3 # 6 B 581 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 596 ARG B 203 ARG^? 8.69 O2S EPE A 377 B 647 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 34.24 60.89 68.08 33.31 57.93 67.63 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 31.43 57.38 61.97 31.90 55.58 64.41 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 7 3 # 7 B 581 GLU C 205 GLU^? 12.89 O3S EPE C 377 B 596 ARG C 203 ARG^? 8.27 O3S EPE C 377 B 647 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 34.24 60.89 68.08 33.31 57.93 67.63 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 31.43 57.38 61.97 31.90 55.58 64.41 10.96 -32.82 5.66 12.34 -31.74 8.19 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 7 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 205 GLU^? -4.84 O3S EPE C 377s C 596 ARG A 203 ARG^? 8.58 O3S EPE C 377 C 647 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 13.44 32.78 22.07 15.56 30.91 23.37 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 21.00 33.35 22.82 19.83 30.82 24.09 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU A 205 GLU^? -4.84 O3S EPE C 377s C 596 ARG C 203 ARG^? 8.27 O3S EPE C 377 C 647 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 11.31 31.26 27.00 13.31 30.71 26.58 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 13.44 32.78 22.07 15.56 30.91 23.37 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 21.00 33.35 22.82 19.83 30.82 24.09 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU B 205 GLU^? 4.50 O2S EPE A 377 C 596 ARG A 203 ARG^? 8.58 O3S EPE C 377 C 647 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 11.31 31.26 27.00 13.31 30.71 26.58 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 13.44 32.78 22.07 15.56 30.91 23.37 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 21.00 33.35 22.82 19.83 30.82 24.09 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 4 3 # 4 C 581 GLU B 205 GLU^? 4.50 O2S EPE A 377 C 596 ARG B 203 ARG^? 8.69 O2S EPE A 377 C 647 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 11.31 31.26 27.00 13.31 30.71 26.58 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 13.44 32.78 22.07 15.56 30.91 23.37 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 21.00 33.35 22.82 19.83 30.82 24.09 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 5 3 # 5 C 581 GLU C 200 GLU^? 10.81 O8 EPE C 377 C 596 ARG C 198 ARG^? 10.55 C8 EPE C 377 C 647 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo 11.31 31.26 27.00 13.31 30.71 26.58 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 13.44 32.78 22.07 15.56 30.91 23.37 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo 21.00 33.35 22.82 19.83 30.82 24.09 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 6 3 # 6 C 581 GLU C 205 GLU^? 12.89 O3S EPE C 377 C 596 ARG B 203 ARG^? 8.69 O2S EPE A 377 C 647 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 13.44 32.78 22.07 15.56 30.91 23.37 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 21.00 33.35 22.82 19.83 30.82 24.09 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 7 3 # 7 C 581 GLU C 205 GLU^? 12.89 O3S EPE C 377 C 596 ARG C 203 ARG^? 8.27 O3S EPE C 377 C 647 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 13.44 32.78 22.07 15.56 30.91 23.37 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 21.00 33.35 22.82 19.83 30.82 24.09 10.96 -32.82 5.66 12.34 -31.74 8.19 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 7 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 205 GLU^? -4.84 O3S EPE C 377s D 596 ARG A 203 ARG^? 8.58 O3S EPE C 377 D 647 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.97 -31.31 7.38 16.25 -32.10 9.22 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU A 205 GLU^? -4.84 O3S EPE C 377s D 596 ARG C 203 ARG^? 8.27 O3S EPE C 377 D 647 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 16.97 -31.31 7.38 16.25 -32.10 9.22 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU B 205 GLU^? 4.50 O2S EPE A 377 D 596 ARG A 203 ARG^? 8.58 O3S EPE C 377 D 647 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 5.77 -31.61 7.46 7.86 -31.06 7.53 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 4 3 # 4 D 581 GLU B 205 GLU^? 4.50 O2S EPE A 377 D 596 ARG B 203 ARG^? 8.69 O2S EPE A 377 D 647 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 5.77 -31.61 7.46 7.86 -31.06 7.53 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 5 3 # 5 D 581 GLU C 200 GLU^? 10.81 O8 EPE C 377 D 596 ARG C 198 ARG^? 10.55 C8 EPE C 377 D 647 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 6 3 # 6 D 581 GLU C 205 GLU^? 12.89 O3S EPE C 377 D 596 ARG B 203 ARG^? 8.69 O2S EPE A 377 D 647 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.89 -37.55 15.12 10.61 -36.09 14.30 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 7 3 # 7 D 581 GLU C 205 GLU^? 12.89 O3S EPE C 377 D 596 ARG C 203 ARG^? 8.27 O3S EPE C 377 D 647 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.89 -37.55 15.12 10.61 -36.09 14.30 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 10.96 -32.82 5.66 12.34 -31.74 8.19 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 7 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 205 GLU^? -4.84 O3S EPE C 377s E 596 ARG A 203 ARG^? 8.58 O3S EPE C 377 E 647 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU A 205 GLU^? -4.84 O3S EPE C 377s E 596 ARG C 203 ARG^? 8.27 O3S EPE C 377 E 647 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 16.97 -31.31 7.38 16.25 -32.10 9.22 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU B 205 GLU^? 4.50 O2S EPE A 377 E 596 ARG A 203 ARG^? 8.58 O3S EPE C 377 E 647 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 4 3 # 4 E 581 GLU B 205 GLU^? 4.50 O2S EPE A 377 E 596 ARG B 203 ARG^? 8.69 O2S EPE A 377 E 647 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 5.77 -31.61 7.46 7.86 -31.06 7.53 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 5 3 # 5 E 581 GLU C 200 GLU^? 10.81 O8 EPE C 377 E 596 ARG C 198 ARG^? 10.55 C8 EPE C 377 E 647 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 6 3 # 6 E 581 GLU C 205 GLU^? 12.89 O3S EPE C 377 E 596 ARG B 203 ARG^? 8.69 O2S EPE A 377 E 647 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 7 3 # 7 E 581 GLU C 205 GLU^? 12.89 O3S EPE C 377 E 596 ARG C 203 ARG^? 8.27 O3S EPE C 377 E 647 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.89 -37.55 15.12 10.61 -36.09 14.30 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 10.96 -32.82 5.66 12.34 -31.74 8.19 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 7 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 205 GLU^? -4.84 O3S EPE C 377s F 596 ARG A 203 ARG^? 8.58 O3S EPE C 377 F 647 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.97 -31.31 7.38 16.25 -32.10 9.22 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU A 205 GLU^? -4.84 O3S EPE C 377s F 596 ARG C 203 ARG^? 8.27 O3S EPE C 377 F 647 ARG B 203 ARG^? 8.69 O2S EPE A 377 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 16.97 -31.31 7.38 16.25 -32.10 9.22 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 8.58 -36.69 10.51 9.21 -33.68 10.79 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 3 3 # 3 F 581 GLU B 205 GLU^? 4.50 O2S EPE A 377 F 596 ARG A 203 ARG^? 8.58 O3S EPE C 377 F 647 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 5.77 -31.61 7.46 7.86 -31.06 7.53 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 4 3 # 4 F 581 GLU B 205 GLU^? 4.50 O2S EPE A 377 F 596 ARG B 203 ARG^? 8.69 O2S EPE A 377 F 647 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 5.77 -31.61 7.46 7.86 -31.06 7.53 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 15.41 -35.90 9.66 13.77 -33.95 11.43 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 5 3 # 5 F 581 GLU C 200 GLU^? 10.81 O8 EPE C 377 F 596 ARG C 198 ARG^? 10.55 C8 EPE C 377 F 647 ARG A 153 ARG~? 11.00 C6 EPE C 377 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 22.01 -43.83 0.76 21.98 -45.84 -0.06 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 24.16 -38.26 -3.08 24.91 -35.49 -4.23 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 20.83 -31.38 -1.20 19.50 -33.43 -3.04 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 6 3 # 6 F 581 GLU C 205 GLU^? 12.89 O3S EPE C 377 F 596 ARG B 203 ARG^? 8.69 O2S EPE A 377 F 647 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.89 -37.55 15.12 10.61 -36.09 14.30 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 10.96 -32.82 5.66 12.34 -31.74 8.19 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 7 3 # 7 F 581 GLU C 205 GLU^? 12.89 O3S EPE C 377 F 596 ARG C 203 ARG^? 8.27 O3S EPE C 377 F 647 ARG A 203 ARG^? 8.58 O3S EPE C 377 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.89 -37.55 15.12 10.61 -36.09 14.30 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 10.96 -32.82 5.66 12.34 -31.74 8.19 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 7 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 37 ASN.? 27.11 C3 EPE A 376 457 GLY A 7 GLY~? 22.99 ZN ZN A 375 459 GLU A 9 GLU~? 28.50 ZN ZN A 375 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 25.93 12.74 7.54 24.88 14.13 8.79 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 31.92 8.80 9.28 31.38 8.48 8.65 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 31.54 5.84 4.26 31.09 6.26 2.19 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 105 ASN~? 9.65 ZN ZN A 375 457 GLY A 30 GLY^? 14.83 ZN ZN A 375 459 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 27.68 4.60 19.76 28.15 4.96 20.33 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN A 114 ASN~? 6.65 ZN ZN A 375 457 GLY A 111 GLY.? 12.81 ZN ZN A 375 459 GLU A 119 GLU~? 15.23 ZN ZN A 375 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 39.96 -10.05 26.73 39.22 -8.78 28.27 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 40.78 -9.44 18.50 40.17 -9.34 19.07 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 47.50 -11.03 21.23 45.94 -11.22 19.71 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN A 114 ASN~? 6.65 ZN ZN A 375 457 GLY A 291 GLY^? 4.06 ZN ZN A 374 459 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 59.14 42.15 -25.87 60.93 42.86 -24.97 39.96 -10.05 26.73 39.22 -8.78 28.27 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 39.29 -3.03 33.06 39.67 -3.69 33.42 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1vom_c00 MYOSIN user 5 3 # 5 233 ASN B 37 ASN.? 26.70 C3 EPE B 376 457 GLY B 7 GLY~? 23.15 ZN ZN B 375 459 GLU B 9 GLU~? 28.41 ZN ZN B 375 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -25.23 -15.05 33.87 -25.13 -14.38 35.90 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -24.83 -11.10 27.95 -24.79 -11.89 27.82 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -25.03 -16.61 24.42 -27.11 -17.15 24.13 ULMN 3 1vom_c00 MYOSIN user 6 3 # 6 233 ASN B 105 ASN~? 9.47 ZN ZN B 375 457 GLY B 30 GLY^? 14.63 ZN ZN B 375 459 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -13.71 -6.55 30.41 -13.82 -5.76 30.60 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1vom_c00 MYOSIN user 7 3 # 7 233 ASN B 114 ASN~? 6.61 ZN ZN B 375 457 GLY B 111 GLY.? 12.91 ZN ZN B 375 459 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -6.09 3.05 14.26 -5.63 4.05 16.11 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -11.60 -2.92 11.75 -11.04 -2.69 12.33 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1vom_c00 MYOSIN user 8 3 # 8 233 ASN B 114 ASN~? 6.61 ZN ZN B 375 457 GLY B 291 GLY^? 4.09 ZN ZN B 374 459 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -6.09 3.05 14.26 -5.63 4.05 16.11 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -6.52 8.91 21.71 -6.06 9.31 21.13 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1vom_c00 MYOSIN user 9 3 # 9 233 ASN B 238 ASN^? 8.84 O1S EPE A 377 457 GLY B 240 GLY^? 14.23 O1S EPE A 377 459 GLU B 135 GLU^? 15.63 O1S EPE A 377 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 7.11 -18.54 9.31 8.52 -20.00 8.45 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 1.60 -13.95 10.45 2.15 -13.33 10.77 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -1.29 -15.58 14.93 -2.99 -16.30 13.82 ULMN 3 1vom_c00 MYOSIN user 10 3 # 10 233 ASN C 37 ASN.? 26.80 C3 EPE C 376 457 GLY C 7 GLY~? 23.11 ZN ZN C 375 459 GLU C 9 GLU~? 28.11 O1 TRS A 378 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 33.59 -33.22 51.01 34.15 -31.40 51.99 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 27.26 -36.33 52.02 27.65 -36.56 51.35 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 28.74 -39.91 47.06 29.82 -41.70 47.37 ULMN 3 1vom_c00 MYOSIN user 11 3 # 11 233 ASN C 105 ASN~? 9.60 ZN ZN C 375 457 GLY C 30 GLY^? 14.80 ZN ZN C 375 459 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 20.37 -26.80 49.54 20.07 -26.59 50.27 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1vom_c00 MYOSIN user 12 3 # 12 233 ASN C 114 ASN~? 6.62 ZN ZN C 375 457 GLY C 111 GLY.? 12.85 ZN ZN C 375 459 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 0.77 -32.01 47.92 1.06 -30.12 48.87 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 5.64 -38.51 45.88 5.60 -37.66 45.90 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1vom_c00 MYOSIN user 13 3 # 13 233 ASN C 114 ASN~? 6.62 ZN ZN C 375 457 GLY C 291 GLY^? 4.07 ZN ZN C 374 459 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 59.14 42.15 -25.87 60.93 42.86 -24.97 0.77 -32.01 47.92 1.06 -30.12 48.87 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 1.77 -25.71 54.72 0.95 -25.76 54.56 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 3.38 -29.70 55.34 4.58 -28.10 54.66 1vom_c00 source 1vom MYOSIN : 13 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 14 PHE~? 13.00 ZN ZN A 375 A 197 ASN A 105 ASN~? 9.65 ZN ZN A 375 A 198 PRO A 19 PRO~? 15.14 ZN ZN A 375 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 34.51 0.34 14.77 34.92 -0.05 17.51 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 29.44 -7.44 15.80 29.61 -5.36 16.66 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE B 14 PHE~? 12.83 ZN ZN B 375 A 197 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 198 PRO B 19 PRO~? 15.10 ZN ZN B 375 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -17.27 -6.95 21.62 -15.57 -4.76 21.74 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -8.98 -11.22 19.12 -9.96 -10.08 20.78 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 A 100 PHE C 14 PHE~? 12.81 ZN ZN C 375 A 197 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 198 PRO C 19 PRO~? 14.95 ZN ZN C 375 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 17.06 -35.49 48.83 14.82 -33.96 49.59 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 13.85 -32.50 40.26 14.91 -32.07 42.18 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 3 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 14 PHE~? 13.00 ZN ZN A 375 B 197 ASN A 105 ASN~? 9.65 ZN ZN A 375 B 198 PRO A 19 PRO~? 15.14 ZN ZN A 375 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 34.51 0.34 14.77 34.92 -0.05 17.51 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 29.44 -7.44 15.80 29.61 -5.36 16.66 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE B 14 PHE~? 12.83 ZN ZN B 375 B 197 ASN B 105 ASN~? 9.47 ZN ZN B 375 B 198 PRO B 19 PRO~? 15.10 ZN ZN B 375 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -17.27 -6.95 21.62 -15.57 -4.76 21.74 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -8.98 -11.22 19.12 -9.96 -10.08 20.78 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 B 100 PHE C 14 PHE~? 12.81 ZN ZN C 375 B 197 ASN C 105 ASN~? 9.60 ZN ZN C 375 B 198 PRO C 19 PRO~? 14.95 ZN ZN C 375 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 17.06 -35.49 48.83 14.82 -33.96 49.59 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 13.85 -32.50 40.26 14.91 -32.07 42.18 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 3 hits 1vq1_c01 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 40 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 103 LEU A 22 LEU~? 12.61 ZN ZN A 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 7.55 25.51 14.34 9.65 25.73 14.24 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 11.83 18.73 16.99 10.99 19.71 15.26 29.35 -7.69 21.29 29.92 -9.34 19.97 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 40 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 103 LEU A 22 LEU~? 12.61 ZN ZN A 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 7.55 25.51 14.34 9.65 25.73 14.24 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.83 18.73 16.99 10.99 19.71 15.26 29.35 -7.69 21.29 29.92 -9.34 19.97 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 85 TYR~? -4.05 C2 EPE A 376s A 40 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 103 LEU A 71 LEU.? 8.24 C3 EPE A 376 coo 12.09 16.13 10.57 11.28 18.80 10.73 33.18 16.26 32.13 31.71 14.36 30.75 coo 7.55 25.51 14.34 9.65 25.73 14.24 40.70 8.14 28.73 41.06 6.40 29.84 coo 11.83 18.73 16.99 10.99 19.71 15.26 33.41 11.27 26.19 34.36 13.17 26.70 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR A 133 TYR^? 12.87 O3 TRS A 378 A 40 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 103 LEU A 22 LEU~? 12.61 ZN ZN A 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 26.66 -12.84 21.54 25.55 -13.01 18.92 coo 7.55 25.51 14.34 9.65 25.73 14.24 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.83 18.73 16.99 10.99 19.71 15.26 29.35 -7.69 21.29 29.92 -9.34 19.97 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR A 133 TYR^? 12.87 O3 TRS A 378 A 40 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 103 LEU A 243 LEU^? 14.05 O3 TRS A 378 coo 12.09 16.13 10.57 11.28 18.80 10.73 26.66 -12.84 21.54 25.55 -13.01 18.92 coo 7.55 25.51 14.34 9.65 25.73 14.24 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.83 18.73 16.99 10.99 19.71 15.26 31.75 -13.70 22.02 32.50 -13.55 19.95 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 40 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 103 LEU B 236 LEU^? 9.09 O1S EPE A 377 coo 12.09 16.13 10.57 11.28 18.80 10.73 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 7.55 25.51 14.34 9.65 25.73 14.24 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 11.83 18.73 16.99 10.99 19.71 15.26 7.64 -21.45 12.38 7.43 -23.27 11.24 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR A 296 TYR~? 11.37 ZN ZN A 375 A 40 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 103 LEU A 289 LEU^? 8.10 ZN ZN A 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 34.09 -11.35 35.81 31.97 -10.07 34.54 coo 7.55 25.51 14.34 9.65 25.73 14.24 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 11.83 18.73 16.99 10.99 19.71 15.26 39.10 -9.73 32.85 36.96 -9.23 32.27 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR A 296 TYR~? 11.37 ZN ZN A 375 A 40 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 103 LEU A 289 LEU^? 8.10 ZN ZN A 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 34.09 -11.35 35.81 31.97 -10.07 34.54 coo 7.55 25.51 14.34 9.65 25.73 14.24 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 11.83 18.73 16.99 10.99 19.71 15.26 39.10 -9.73 32.85 36.96 -9.23 32.27 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 40 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 103 LEU A 289 LEU^? 8.10 ZN ZN A 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 7.55 25.51 14.34 9.65 25.73 14.24 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 11.83 18.73 16.99 10.99 19.71 15.26 39.10 -9.73 32.85 36.96 -9.23 32.27 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 40 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 103 LEU A 326 LEU.? 19.87 ZN ZN A 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 7.55 25.51 14.34 9.65 25.73 14.24 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 11.83 18.73 16.99 10.99 19.71 15.26 41.91 -16.58 43.18 41.53 -16.00 41.11 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 40 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 103 LEU A 326 LEU.? 19.87 ZN ZN A 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 7.55 25.51 14.34 9.65 25.73 14.24 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 11.83 18.73 16.99 10.99 19.71 15.26 41.91 -16.58 43.18 41.53 -16.00 41.11 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 12 3 # 12 A 16 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 40 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 103 LEU B 22 LEU~? 12.66 ZN ZN B 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 7.55 25.51 14.34 9.65 25.73 14.24 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 11.83 18.73 16.99 10.99 19.71 15.26 -5.60 -7.41 20.91 -5.31 -8.17 18.89 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 13 3 # 13 A 16 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 40 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 103 LEU B 22 LEU~? 12.66 ZN ZN B 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 7.55 25.51 14.34 9.65 25.73 14.24 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.83 18.73 16.99 10.99 19.71 15.26 -5.60 -7.41 20.91 -5.31 -8.17 18.89 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 14 3 # 14 A 16 TYR B 85 TYR~? 3.87 C2 EPE B 376 A 40 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 103 LEU B 71 LEU.? 7.97 C3 EPE B 376 coo 12.09 16.13 10.57 11.28 18.80 10.73 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 7.55 25.51 14.34 9.65 25.73 14.24 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 11.83 18.73 16.99 10.99 19.71 15.26 -16.85 3.04 33.82 -18.31 4.35 34.89 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 15 3 # 15 A 16 TYR B 133 TYR^? 17.24 ZN ZN B 375 A 40 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 103 LEU B 22 LEU~? 12.66 ZN ZN B 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo 7.55 25.51 14.34 9.65 25.73 14.24 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.83 18.73 16.99 10.99 19.71 15.26 -5.60 -7.41 20.91 -5.31 -8.17 18.89 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 16 3 # 16 A 16 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 40 ASP A 237 ASP^? 6.80 N TRS A 378 A 103 LEU C 236 LEU^? 13.92 N TRS A 378 coo 12.09 16.13 10.57 11.28 18.80 10.73 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 7.55 25.51 14.34 9.65 25.73 14.24 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 11.83 18.73 16.99 10.99 19.71 15.26 8.65 -28.79 21.36 9.20 -30.53 20.21 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 17 3 # 17 A 16 TYR B 250 TYR^? 23.22 ZN ZN B 375 A 40 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 103 LEU B 251 LEU^? 22.61 ZN ZN B 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 0.70 6.87 1.10 3.12 5.62 1.69 coo 7.55 25.51 14.34 9.65 25.73 14.24 3.99 14.73 5.36 5.18 14.04 3.76 coo 11.83 18.73 16.99 10.99 19.71 15.26 -3.28 12.31 0.94 -3.84 13.59 2.55 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 18 3 # 18 A 16 TYR B 296 TYR~? 11.48 ZN ZN B 375 A 40 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 103 LEU B 289 LEU^? 8.28 ZN ZN B 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 3.06 5.94 19.61 2.50 3.84 21.38 coo 7.55 25.51 14.34 9.65 25.73 14.24 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 11.83 18.73 16.99 10.99 19.71 15.26 -2.28 7.12 16.77 -1.56 6.18 18.64 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 19 3 # 19 A 16 TYR B 296 TYR~? 11.48 ZN ZN B 375 A 40 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 103 LEU B 289 LEU^? 8.28 ZN ZN B 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 3.06 5.94 19.61 2.50 3.84 21.38 coo 7.55 25.51 14.34 9.65 25.73 14.24 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 11.83 18.73 16.99 10.99 19.71 15.26 -2.28 7.12 16.77 -1.56 6.18 18.64 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 20 3 # 20 A 16 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 40 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 103 LEU B 289 LEU^? 8.28 ZN ZN B 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 1.32 11.76 14.56 0.84 10.00 16.68 coo 7.55 25.51 14.34 9.65 25.73 14.24 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 11.83 18.73 16.99 10.99 19.71 15.26 -2.28 7.12 16.77 -1.56 6.18 18.64 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 21 3 # 21 A 16 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 40 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 103 LEU B 326 LEU.? 20.03 ZN ZN B 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 1.32 11.76 14.56 0.84 10.00 16.68 coo 7.55 25.51 14.34 9.65 25.73 14.24 3.99 14.73 5.36 5.18 14.04 3.76 coo 11.83 18.73 16.99 10.99 19.71 15.26 6.72 15.30 12.83 5.45 13.58 12.99 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 22 3 # 22 A 16 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 40 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 103 LEU B 326 LEU.? 20.03 ZN ZN B 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 1.32 11.76 14.56 0.84 10.00 16.68 coo 7.55 25.51 14.34 9.65 25.73 14.24 9.35 16.65 21.02 10.22 16.89 22.90 coo 11.83 18.73 16.99 10.99 19.71 15.26 6.72 15.30 12.83 5.45 13.58 12.99 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 23 3 # 23 A 16 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 40 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 103 LEU C 22 LEU~? 12.70 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 7.55 25.51 14.34 9.65 25.73 14.24 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 11.83 18.73 16.99 10.99 19.71 15.26 10.89 -28.97 41.64 10.34 -30.58 40.35 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 24 3 # 24 A 16 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 40 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 103 LEU C 22 LEU~? 12.70 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 7.55 25.51 14.34 9.65 25.73 14.24 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.83 18.73 16.99 10.99 19.71 15.26 10.89 -28.97 41.64 10.34 -30.58 40.35 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 25 3 # 25 A 16 TYR C 85 TYR~? -3.91 C2 EPE C 376s A 40 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 103 LEU C 71 LEU.? 8.22 C3 EPE C 376 coo 12.09 16.13 10.57 11.28 18.80 10.73 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 7.55 25.51 14.34 9.65 25.73 14.24 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 11.83 18.73 16.99 10.99 19.71 15.26 17.95 -24.29 59.78 18.87 -24.21 61.77 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 26 3 # 26 A 16 TYR C 133 TYR^? 16.76 ZN ZN C 375 A 40 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 103 LEU C 22 LEU~? 12.70 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 7.55 25.51 14.34 9.65 25.73 14.24 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 11.83 18.73 16.99 10.99 19.71 15.26 10.89 -28.97 41.64 10.34 -30.58 40.35 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 27 3 # 27 A 16 TYR C 133 TYR^? 16.76 ZN ZN C 375 A 40 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 103 LEU C 22 LEU~? 12.70 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 7.55 25.51 14.34 9.65 25.73 14.24 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.83 18.73 16.99 10.99 19.71 15.26 10.89 -28.97 41.64 10.34 -30.58 40.35 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 28 3 # 28 A 16 TYR C 133 TYR^? 16.76 ZN ZN C 375 A 40 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 103 LEU C 243 LEU^? 14.43 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 7.55 25.51 14.34 9.65 25.73 14.24 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.83 18.73 16.99 10.99 19.71 15.26 5.40 -30.33 38.72 6.46 -32.27 38.57 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 29 3 # 29 A 16 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 40 ASP B 237 ASP^? 15.58 N TRS A 378 A 103 LEU A 236 LEU^? 7.58 N TRS A 378 coo 12.09 16.13 10.57 11.28 18.80 10.73 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 7.55 25.51 14.34 9.65 25.73 14.24 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 11.83 18.73 16.99 10.99 19.71 15.26 18.21 -24.75 16.42 18.16 -26.24 14.91 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 30 3 # 30 A 16 TYR C 250 TYR^? 23.68 ZN ZN C 375 A 40 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 103 LEU C 251 LEU^? 22.30 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 7.55 25.51 14.34 9.65 25.73 14.24 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 11.83 18.73 16.99 10.99 19.71 15.26 -14.08 -38.44 49.58 -13.43 -37.26 51.32 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 31 3 # 31 A 16 TYR C 296 TYR~? 11.54 ZN ZN C 375 A 40 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 103 LEU C 289 LEU^? 8.24 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo 7.55 25.51 14.34 9.65 25.73 14.24 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 11.83 18.73 16.99 10.99 19.71 15.26 -2.20 -26.86 49.50 -0.78 -25.32 48.95 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 32 3 # 32 A 16 TYR C 296 TYR~? 11.54 ZN ZN C 375 A 40 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 103 LEU C 245 LEU^? 8.02 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo 7.55 25.51 14.34 9.65 25.73 14.24 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 11.83 18.73 16.99 10.99 19.71 15.26 1.49 -25.70 45.40 3.20 -24.70 46.16 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 33 3 # 33 A 16 TYR C 296 TYR~? 11.54 ZN ZN C 375 A 40 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 103 LEU C 289 LEU^? 8.24 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo 7.55 25.51 14.34 9.65 25.73 14.24 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 11.83 18.73 16.99 10.99 19.71 15.26 -2.20 -26.86 49.50 -0.78 -25.32 48.95 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 34 3 # 34 A 16 TYR C 296 TYR~? 11.54 ZN ZN C 375 A 40 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 103 LEU C 289 LEU^? 8.24 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo 7.55 25.51 14.34 9.65 25.73 14.24 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 11.83 18.73 16.99 10.99 19.71 15.26 -2.20 -26.86 49.50 -0.78 -25.32 48.95 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 35 3 # 35 A 16 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 40 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 103 LEU C 289 LEU^? 8.24 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 7.55 25.51 14.34 9.65 25.73 14.24 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 11.83 18.73 16.99 10.99 19.71 15.26 -2.20 -26.86 49.50 -0.78 -25.32 48.95 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 36 3 # 36 A 16 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 40 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 103 LEU C 326 LEU.? 19.90 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 7.55 25.51 14.34 9.65 25.73 14.24 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 11.83 18.73 16.99 10.99 19.71 15.26 -14.03 -22.47 49.19 -12.29 -23.67 48.73 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 37 3 # 37 A 16 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 40 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 103 LEU C 289 LEU^? 8.24 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 7.55 25.51 14.34 9.65 25.73 14.24 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo 11.83 18.73 16.99 10.99 19.71 15.26 -2.20 -26.86 49.50 -0.78 -25.32 48.95 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 38 3 # 38 A 16 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 40 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 103 LEU C 326 LEU.? 19.90 ZN ZN C 375 coo 12.09 16.13 10.57 11.28 18.80 10.73 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 7.55 25.51 14.34 9.65 25.73 14.24 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 11.83 18.73 16.99 10.99 19.71 15.26 -14.03 -22.47 49.19 -12.29 -23.67 48.73 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 38 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 18 TYR~? 11.08 ZN ZN A 375 B 40 ASP A 27 ASP.? 8.12 ZN ZN A 375 B 103 LEU A 22 LEU~? 12.61 ZN ZN A 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 9.39 10.77 34.53 11.50 10.63 34.41 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 12.89 17.60 31.13 12.34 16.51 32.90 29.35 -7.69 21.29 29.92 -9.34 19.97 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 18 TYR~? 11.08 ZN ZN A 375 B 40 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 103 LEU A 22 LEU~? 12.61 ZN ZN A 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 9.39 10.77 34.53 11.50 10.63 34.41 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 12.89 17.60 31.13 12.34 16.51 32.90 29.35 -7.69 21.29 29.92 -9.34 19.97 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 85 TYR~? -4.05 C2 EPE A 376s B 40 ASP A 48 ASP.? 7.40 ZN ZN A 374 B 103 LEU A 71 LEU.? 8.24 C3 EPE A 376 coo 14.25 20.09 37.35 13.48 17.40 37.38 33.18 16.26 32.13 31.71 14.36 30.75 coo 9.39 10.77 34.53 11.50 10.63 34.41 40.70 8.14 28.73 41.06 6.40 29.84 coo 12.89 17.60 31.13 12.34 16.51 32.90 33.41 11.27 26.19 34.36 13.17 26.70 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR A 133 TYR^? 12.87 O3 TRS A 378 B 40 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 103 LEU A 22 LEU~? 12.61 ZN ZN A 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 26.66 -12.84 21.54 25.55 -13.01 18.92 coo 9.39 10.77 34.53 11.50 10.63 34.41 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 12.89 17.60 31.13 12.34 16.51 32.90 29.35 -7.69 21.29 29.92 -9.34 19.97 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR A 133 TYR^? 12.87 O3 TRS A 378 B 40 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 103 LEU A 243 LEU^? 14.05 O3 TRS A 378 coo 14.25 20.09 37.35 13.48 17.40 37.38 26.66 -12.84 21.54 25.55 -13.01 18.92 coo 9.39 10.77 34.53 11.50 10.63 34.41 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 12.89 17.60 31.13 12.34 16.51 32.90 31.75 -13.70 22.02 32.50 -13.55 19.95 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR A 250 TYR^? 23.04 O3 TRS A 378 B 40 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 103 LEU A 251 LEU^? 22.24 ZN ZN A 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 9.39 10.77 34.53 11.50 10.63 34.41 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 12.89 17.60 31.13 12.34 16.51 32.90 52.57 -19.38 31.15 52.41 -17.39 31.96 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR A 296 TYR~? 11.37 ZN ZN A 375 B 40 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 103 LEU A 289 LEU^? 8.10 ZN ZN A 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 34.09 -11.35 35.81 31.97 -10.07 34.54 coo 9.39 10.77 34.53 11.50 10.63 34.41 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 12.89 17.60 31.13 12.34 16.51 32.90 39.10 -9.73 32.85 36.96 -9.23 32.27 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR A 296 TYR~? 11.37 ZN ZN A 375 B 40 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 103 LEU A 289 LEU^? 8.10 ZN ZN A 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 34.09 -11.35 35.81 31.97 -10.07 34.54 coo 9.39 10.77 34.53 11.50 10.63 34.41 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 12.89 17.60 31.13 12.34 16.51 32.90 39.10 -9.73 32.85 36.96 -9.23 32.27 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 40 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 103 LEU A 289 LEU^? 8.10 ZN ZN A 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 9.39 10.77 34.53 11.50 10.63 34.41 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 12.89 17.60 31.13 12.34 16.51 32.90 39.10 -9.73 32.85 36.96 -9.23 32.27 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 40 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 103 LEU A 326 LEU.? 19.87 ZN ZN A 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 9.39 10.77 34.53 11.50 10.63 34.41 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 12.89 17.60 31.13 12.34 16.51 32.90 41.91 -16.58 43.18 41.53 -16.00 41.11 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 40 ASP A 320 ASP~? -21.81 ZN ZN A 374s B 103 LEU A 326 LEU.? 19.87 ZN ZN A 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 9.39 10.77 34.53 11.50 10.63 34.41 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 12.89 17.60 31.13 12.34 16.51 32.90 41.91 -16.58 43.18 41.53 -16.00 41.11 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 12 3 # 12 B 16 TYR B 18 TYR~? 10.93 ZN ZN B 375 B 40 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 103 LEU B 22 LEU~? 12.66 ZN ZN B 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 9.39 10.77 34.53 11.50 10.63 34.41 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 12.89 17.60 31.13 12.34 16.51 32.90 -5.60 -7.41 20.91 -5.31 -8.17 18.89 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 13 3 # 13 B 16 TYR B 85 TYR~? 3.87 C2 EPE B 376 B 40 ASP B 48 ASP.? 7.36 ZN ZN B 374 B 103 LEU B 71 LEU.? 7.97 C3 EPE B 376 coo 14.25 20.09 37.35 13.48 17.40 37.38 -16.40 8.45 39.29 -15.27 6.03 38.43 coo 9.39 10.77 34.53 11.50 10.63 34.41 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 12.89 17.60 31.13 12.34 16.51 32.90 -16.85 3.04 33.82 -18.31 4.35 34.89 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 14 3 # 14 B 16 TYR B 133 TYR^? 17.24 ZN ZN B 375 B 40 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 103 LEU B 22 LEU~? 12.66 ZN ZN B 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo 9.39 10.77 34.53 11.50 10.63 34.41 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 12.89 17.60 31.13 12.34 16.51 32.90 -5.60 -7.41 20.91 -5.31 -8.17 18.89 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 15 3 # 15 B 16 TYR B 234 TYR^? 11.34 O2S EPE A 377 B 40 ASP A 237 ASP^? 6.80 N TRS A 378 B 103 LEU C 236 LEU^? 13.92 N TRS A 378 coo 14.25 20.09 37.35 13.48 17.40 37.38 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 9.39 10.77 34.53 11.50 10.63 34.41 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 12.89 17.60 31.13 12.34 16.51 32.90 8.65 -28.79 21.36 9.20 -30.53 20.21 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 16 3 # 16 B 16 TYR B 250 TYR^? 23.22 ZN ZN B 375 B 40 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 103 LEU B 251 LEU^? 22.61 ZN ZN B 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 0.70 6.87 1.10 3.12 5.62 1.69 coo 9.39 10.77 34.53 11.50 10.63 34.41 3.99 14.73 5.36 5.18 14.04 3.76 coo 12.89 17.60 31.13 12.34 16.51 32.90 -3.28 12.31 0.94 -3.84 13.59 2.55 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 17 3 # 17 B 16 TYR B 296 TYR~? 11.48 ZN ZN B 375 B 40 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 103 LEU B 289 LEU^? 8.28 ZN ZN B 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 3.06 5.94 19.61 2.50 3.84 21.38 coo 9.39 10.77 34.53 11.50 10.63 34.41 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 12.89 17.60 31.13 12.34 16.51 32.90 -2.28 7.12 16.77 -1.56 6.18 18.64 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 18 3 # 18 B 16 TYR B 296 TYR~? 11.48 ZN ZN B 375 B 40 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 103 LEU B 289 LEU^? 8.28 ZN ZN B 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 3.06 5.94 19.61 2.50 3.84 21.38 coo 9.39 10.77 34.53 11.50 10.63 34.41 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 12.89 17.60 31.13 12.34 16.51 32.90 -2.28 7.12 16.77 -1.56 6.18 18.64 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 19 3 # 19 B 16 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 40 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 103 LEU B 289 LEU^? 8.28 ZN ZN B 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 1.32 11.76 14.56 0.84 10.00 16.68 coo 9.39 10.77 34.53 11.50 10.63 34.41 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 12.89 17.60 31.13 12.34 16.51 32.90 -2.28 7.12 16.77 -1.56 6.18 18.64 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 20 3 # 20 B 16 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 40 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 103 LEU B 326 LEU.? 20.03 ZN ZN B 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 1.32 11.76 14.56 0.84 10.00 16.68 coo 9.39 10.77 34.53 11.50 10.63 34.41 3.99 14.73 5.36 5.18 14.04 3.76 coo 12.89 17.60 31.13 12.34 16.51 32.90 6.72 15.30 12.83 5.45 13.58 12.99 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 21 3 # 21 B 16 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 40 ASP B 320 ASP~? -21.78 ZN ZN B 374s B 103 LEU B 326 LEU.? 20.03 ZN ZN B 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 1.32 11.76 14.56 0.84 10.00 16.68 coo 9.39 10.77 34.53 11.50 10.63 34.41 9.35 16.65 21.02 10.22 16.89 22.90 coo 12.89 17.60 31.13 12.34 16.51 32.90 6.72 15.30 12.83 5.45 13.58 12.99 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 22 3 # 22 B 16 TYR C 18 TYR.? 11.04 ZN ZN C 375 B 40 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 103 LEU C 22 LEU~? 12.70 ZN ZN C 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 9.39 10.77 34.53 11.50 10.63 34.41 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 12.89 17.60 31.13 12.34 16.51 32.90 10.89 -28.97 41.64 10.34 -30.58 40.35 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 23 3 # 23 B 16 TYR C 85 TYR~? -3.91 C2 EPE C 376s B 40 ASP C 48 ASP.? 7.30 ZN ZN C 374 B 103 LEU C 71 LEU.? 8.22 C3 EPE C 376 coo 14.25 20.09 37.35 13.48 17.40 37.38 17.64 -18.79 65.22 18.00 -19.09 62.48 coo 9.39 10.77 34.53 11.50 10.63 34.41 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 12.89 17.60 31.13 12.34 16.51 32.90 17.95 -24.29 59.78 18.87 -24.21 61.77 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 24 3 # 24 B 16 TYR C 133 TYR^? 16.76 ZN ZN C 375 B 40 ASP C 27 ASP.? 8.23 ZN ZN C 375 B 103 LEU C 22 LEU~? 12.70 ZN ZN C 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 9.39 10.77 34.53 11.50 10.63 34.41 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 12.89 17.60 31.13 12.34 16.51 32.90 10.89 -28.97 41.64 10.34 -30.58 40.35 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 25 3 # 25 B 16 TYR C 133 TYR^? 16.76 ZN ZN C 375 B 40 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 103 LEU C 22 LEU~? 12.70 ZN ZN C 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 9.39 10.77 34.53 11.50 10.63 34.41 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 12.89 17.60 31.13 12.34 16.51 32.90 10.89 -28.97 41.64 10.34 -30.58 40.35 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 26 3 # 26 B 16 TYR C 133 TYR^? 16.76 ZN ZN C 375 B 40 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 103 LEU C 243 LEU^? 14.43 ZN ZN C 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 9.39 10.77 34.53 11.50 10.63 34.41 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 12.89 17.60 31.13 12.34 16.51 32.90 5.40 -30.33 38.72 6.46 -32.27 38.57 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 27 3 # 27 B 16 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 40 ASP B 237 ASP^? 15.58 N TRS A 378 B 103 LEU A 236 LEU^? 7.58 N TRS A 378 coo 14.25 20.09 37.35 13.48 17.40 37.38 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 9.39 10.77 34.53 11.50 10.63 34.41 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 12.89 17.60 31.13 12.34 16.51 32.90 18.21 -24.75 16.42 18.16 -26.24 14.91 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 28 3 # 28 B 16 TYR C 250 TYR^? 23.68 ZN ZN C 375 B 40 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 103 LEU C 251 LEU^? 22.30 ZN ZN C 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 9.39 10.77 34.53 11.50 10.63 34.41 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 12.89 17.60 31.13 12.34 16.51 32.90 -14.08 -38.44 49.58 -13.43 -37.26 51.32 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 29 3 # 29 B 16 TYR C 296 TYR~? 11.54 ZN ZN C 375 B 40 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 103 LEU C 289 LEU^? 8.24 ZN ZN C 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo 9.39 10.77 34.53 11.50 10.63 34.41 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 12.89 17.60 31.13 12.34 16.51 32.90 -2.20 -26.86 49.50 -0.78 -25.32 48.95 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 30 3 # 30 B 16 TYR C 296 TYR~? 11.54 ZN ZN C 375 B 40 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 103 LEU C 245 LEU^? 8.02 ZN ZN C 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo 9.39 10.77 34.53 11.50 10.63 34.41 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 12.89 17.60 31.13 12.34 16.51 32.90 1.49 -25.70 45.40 3.20 -24.70 46.16 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 31 3 # 31 B 16 TYR C 296 TYR~? 11.54 ZN ZN C 375 B 40 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 103 LEU C 289 LEU^? 8.24 ZN ZN C 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo 9.39 10.77 34.53 11.50 10.63 34.41 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 12.89 17.60 31.13 12.34 16.51 32.90 -2.20 -26.86 49.50 -0.78 -25.32 48.95 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 32 3 # 32 B 16 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 40 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 103 LEU C 289 LEU^? 8.24 ZN ZN C 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 9.39 10.77 34.53 11.50 10.63 34.41 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 12.89 17.60 31.13 12.34 16.51 32.90 -2.20 -26.86 49.50 -0.78 -25.32 48.95 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 33 3 # 33 B 16 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 40 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 103 LEU C 326 LEU.? 19.90 ZN ZN C 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 9.39 10.77 34.53 11.50 10.63 34.41 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 12.89 17.60 31.13 12.34 16.51 32.90 -14.03 -22.47 49.19 -12.29 -23.67 48.73 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 34 3 # 34 B 16 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 40 ASP C 320 ASP~? -21.75 ZN ZN C 374s B 103 LEU C 326 LEU.? 19.90 ZN ZN C 375 coo 14.25 20.09 37.35 13.48 17.40 37.38 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 9.39 10.77 34.53 11.50 10.63 34.41 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 12.89 17.60 31.13 12.34 16.51 32.90 -14.03 -22.47 49.19 -12.29 -23.67 48.73 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 34 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 169 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 288 GLU A 25 GLU.? 17.13 ZN ZN A 375 coo 67.72 35.99 30.87 69.77 36.13 31.33 37.80 0.44 25.56 37.02 -1.29 26.44 coo 73.17 30.66 22.56 72.87 30.30 20.46 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 74.06 28.51 15.92 73.77 29.56 17.73 21.52 -4.56 31.66 21.12 -5.25 33.61 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 169 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 288 GLU A 25 GLU.? 17.13 ZN ZN A 375 coo 67.72 35.99 30.87 69.77 36.13 31.33 37.42 3.90 29.26 38.47 2.36 30.22 coo 73.17 30.66 22.56 72.87 30.30 20.46 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 74.06 28.51 15.92 73.77 29.56 17.73 21.52 -4.56 31.66 21.12 -5.25 33.61 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 3 3 # 3 A 105 HIS A 224 HIS~? 7.33 C7 EPE A 377 A 169 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 288 GLU B 205 GLU^? 4.50 O2S EPE A 377 coo 67.72 35.99 30.87 69.77 36.13 31.33 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 73.17 30.66 22.56 72.87 30.30 20.46 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 74.06 28.51 15.92 73.77 29.56 17.73 5.77 -31.61 7.46 7.86 -31.06 7.53 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 4 3 # 4 A 105 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 169 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 288 GLU B 25 GLU.? 18.70 ZN ZN B 375 coo 67.72 35.99 30.87 69.77 36.13 31.33 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 73.17 30.66 22.56 72.87 30.30 20.46 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 74.06 28.51 15.92 73.77 29.56 17.73 1.46 -5.92 31.01 3.44 -6.69 31.23 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 5 3 # 5 A 105 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 169 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 288 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 67.72 35.99 30.87 69.77 36.13 31.33 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 73.17 30.66 22.56 72.87 30.30 20.46 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 74.06 28.51 15.92 73.77 29.56 17.73 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 6 3 # 6 A 105 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 169 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 288 GLU B 25 GLU.? 18.70 ZN ZN B 375 coo 67.72 35.99 30.87 69.77 36.13 31.33 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 73.17 30.66 22.56 72.87 30.30 20.46 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 74.06 28.51 15.92 73.77 29.56 17.73 1.46 -5.92 31.01 3.44 -6.69 31.23 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 7 3 # 7 A 105 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 169 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 288 GLU C 25 GLU.? 17.70 ZN ZN C 375 coo 67.72 35.99 30.87 69.77 36.13 31.33 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 73.17 30.66 22.56 72.87 30.30 20.46 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 74.06 28.51 15.92 73.77 29.56 17.73 10.47 -15.76 42.35 12.38 -15.28 41.57 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 8 3 # 8 A 105 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 169 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 288 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 67.72 35.99 30.87 69.77 36.13 31.33 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 73.17 30.66 22.56 72.87 30.30 20.46 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 74.06 28.51 15.92 73.77 29.56 17.73 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 9 3 # 9 A 105 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 169 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 288 GLU C 25 GLU.? 17.70 ZN ZN C 375 coo 67.72 35.99 30.87 69.77 36.13 31.33 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 73.17 30.66 22.56 72.87 30.30 20.46 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 74.06 28.51 15.92 73.77 29.56 17.73 10.47 -15.76 42.35 12.38 -15.28 41.57 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 10 3 # 10 A 105 HIS C 224 HIS~? 8.36 C3 EPE C 377 A 169 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 288 GLU A 205 GLU^? -4.84 O3S EPE C 377s coo 67.72 35.99 30.87 69.77 36.13 31.33 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 73.17 30.66 22.56 72.87 30.30 20.46 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 74.06 28.51 15.92 73.77 29.56 17.73 16.97 -31.31 7.38 16.25 -32.10 9.22 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 10 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 111 GLY.? 12.81 ZN ZN A 375 B 419 GLY A 112 GLY~? 9.06 ZN ZN A 375 B 420 ALA A 109 ALA~? 11.42 ZN ZN A 375 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 40.78 -9.44 18.50 40.17 -9.34 19.07 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 39.28 -7.29 21.25 39.96 -7.72 21.33 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 34.68 -9.30 20.20 34.40 -8.19 19.19 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY A 160 GLY.? 10.75 O1S EPE C 377 B 419 GLY A 157 GLY~? 9.65 O1S EPE C 377 B 420 ALA A 155 ALA~? 14.27 O1S EPE C 377 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 26.87 -20.51 3.59 26.23 -20.86 3.40 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 25.68 -24.30 0.57 25.46 -23.69 0.10 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 22.46 -22.68 -3.71 21.06 -22.28 -4.12 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 183 GLY B 111 GLY.? 12.91 ZN ZN B 375 B 419 GLY B 112 GLY~? 9.09 ZN ZN B 375 B 420 ALA B 109 ALA~? 11.08 ZN ZN B 375 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -11.60 -2.92 11.75 -11.04 -2.69 12.33 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -10.98 -0.97 15.01 -10.85 -0.63 14.30 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -7.64 -4.92 16.15 -8.93 -5.45 16.76 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 183 GLY B 157 GLY~? 9.55 O3S EPE A 377 B 419 GLY B 160 GLY.? 11.45 O3S EPE A 377 B 420 ALA B 159 ALA~? 13.92 O3S EPE A 377 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -7.67 -24.84 7.30 -7.31 -25.39 7.61 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -9.80 -27.22 9.41 -9.47 -27.83 10.78 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 183 GLY C 111 GLY.? 12.85 ZN ZN C 375 B 419 GLY C 112 GLY~? 9.08 ZN ZN C 375 B 420 ALA C 109 ALA~? 11.05 ZN ZN C 375 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 5.64 -38.51 45.88 5.60 -37.66 45.90 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 6.12 -35.35 47.97 5.41 -35.71 47.93 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 7.53 -33.10 43.39 8.93 -33.54 43.81 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 183 GLY C 157 GLY~? 18.60 O1 TRS A 378 B 419 GLY C 160 GLY.? 17.10 O1 TRS A 378 B 420 ALA C 159 ALA~? 15.13 O1 TRS A 378 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 15.82 -44.70 25.16 16.57 -44.60 25.47 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 15.27 -41.63 29.25 15.56 -41.55 28.55 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 18.93 -42.72 28.88 19.93 -41.91 28.03 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 183 GLY C 160 GLY.? 17.10 O1 TRS A 378 B 419 GLY C 157 GLY~? 18.60 O1 TRS A 378 B 420 ALA C 155 ALA~? 16.73 C1 TRS A 378 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 15.27 -41.63 29.25 15.56 -41.55 28.55 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 15.82 -44.70 25.16 16.57 -44.60 25.47 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 21.09 -45.45 23.92 22.34 -44.97 23.23 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 7 hits 1xny_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 155 ALA~? 14.27 O1S EPE C 377 B 182 GLY A 160 GLY.? 10.75 O1S EPE C 377 B 183 GLY A 157 GLY~? 9.65 O1S EPE C 377 coo 38.36-101.47-135.52 39.62-101.29-136.35 22.46 -22.68 -3.71 21.06 -22.28 -4.12 coo 41.93-102.35-126.87 41.52-101.89-126.30 26.87 -20.51 3.59 26.23 -20.86 3.40 coo 38.37-101.99-128.11 38.63-102.24-127.37 25.68 -24.30 0.57 25.46 -23.69 0.10 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 273 ALA.? 17.12 ZN ZN A 374 B 182 GLY A 311 GLY^? 8.82 ZN ZN A 374 B 183 GLY A 332 GLY~? 10.15 ZN ZN A 374 coo 38.36-101.47-135.52 39.62-101.29-136.35 51.72 -3.77 39.72 51.92 -5.01 38.86 coo 41.93-102.35-126.87 41.52-101.89-126.30 42.54 -3.74 37.15 41.89 -4.18 37.32 coo 38.37-101.99-128.11 38.63-102.24-127.37 46.00 -1.11 36.47 45.93 -1.81 36.02 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA B 155 ALA~? 14.26 O3S EPE A 377 B 182 GLY B 160 GLY.? 11.45 O3S EPE A 377 B 183 GLY B 157 GLY~? 9.55 O3S EPE A 377 coo 38.36-101.47-135.52 39.62-101.29-136.35 -8.89 -33.90 8.54 -8.69 -34.90 9.66 coo 41.93-102.35-126.87 41.52-101.89-126.30 -7.67 -24.84 7.30 -7.31 -25.39 7.61 coo 38.37-101.99-128.11 38.63-102.24-127.37 -6.61 -29.59 5.82 -7.19 -29.80 6.34 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA B 219 ALA~? 15.85 O3S EPE A 377 B 182 GLY B 160 GLY.? 11.45 O3S EPE A 377 B 183 GLY B 157 GLY~? 9.55 O3S EPE A 377 coo 38.36-101.47-135.52 39.62-101.29-136.35 -9.85 -32.42 14.17 -10.02 -31.40 13.03 coo 41.93-102.35-126.87 41.52-101.89-126.30 -7.67 -24.84 7.30 -7.31 -25.39 7.61 coo 38.37-101.99-128.11 38.63-102.24-127.37 -6.61 -29.59 5.82 -7.19 -29.80 6.34 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA B 273 ALA.? 17.02 ZN ZN B 374 B 182 GLY B 311 GLY^? 8.79 ZN ZN B 374 B 183 GLY B 332 GLY~? 10.10 ZN ZN B 374 coo 38.36-101.47-135.52 39.62-101.29-136.35 -8.43 21.62 15.62 -8.14 20.75 14.42 coo 41.93-102.35-126.87 41.52-101.89-126.30 -5.28 13.83 20.42 -4.55 13.48 20.52 coo 38.37-101.99-128.11 38.63-102.24-127.37 -9.10 15.99 19.91 -8.87 15.45 19.32 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 420 ALA C 155 ALA~? 16.73 C1 TRS A 378 B 182 GLY C 160 GLY.? 17.10 O1 TRS A 378 B 183 GLY C 157 GLY~? 18.60 O1 TRS A 378 coo 38.36-101.47-135.52 39.62-101.29-136.35 21.09 -45.45 23.92 22.34 -44.97 23.23 coo 41.93-102.35-126.87 41.52-101.89-126.30 15.27 -41.63 29.25 15.56 -41.55 28.55 coo 38.37-101.99-128.11 38.63-102.24-127.37 15.82 -44.70 25.16 16.57 -44.60 25.47 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 420 ALA C 273 ALA.? 16.96 ZN ZN C 374 B 182 GLY C 311 GLY^? 8.68 ZN ZN C 374 B 183 GLY C 332 GLY~? 10.07 ZN ZN C 374 coo 38.36-101.47-135.52 39.62-101.29-136.35 -8.76 -28.60 63.60 -9.11 -29.51 62.39 coo 41.93-102.35-126.87 41.52-101.89-126.30 -2.62 -24.75 57.19 -2.77 -24.31 56.55 coo 38.37-101.99-128.11 38.63-102.24-127.37 -2.36 -27.10 61.01 -2.45 -27.52 60.29 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 7 hits 1xny_c01 naa= 3 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 1 3 # 1 A 243 THR A 177 THR^? 8.80 C6 EPE A 377 A 345 PHE A 180 PHE^? 4.05 O8 EPE A 377 A 352 CYH B 170 CYH^? -5.04 N1 EPE A 377s coo 9.58 21.79 21.50 11.25 23.03 20.90 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo 19.40 19.75 18.58 17.39 17.81 18.80 -0.71 -29.06 -4.30 -0.06 -29.96 -6.91 coo 21.57 22.52 22.79 19.20 21.13 23.26 -0.70 -28.36 2.22 -0.22 -26.07 0.51 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 2 3 # 2 A 243 THR B 177 THR^? 19.16 C2 EPE C 377 A 345 PHE B 180 PHE^? 25.23 O2S EPE A 377 A 352 CYH C 170 CYH^? 22.19 N TRS A 378 coo 9.58 21.79 21.50 11.25 23.03 20.90 9.43 -46.41 11.44 10.68 -47.97 10.55 coo 19.40 19.75 18.58 17.39 17.81 18.80 5.49 -47.88 21.09 3.41 -49.53 20.15 coo 21.57 22.52 22.79 19.20 21.13 23.26 9.66 -43.43 21.72 7.18 -43.27 22.99 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 3 3 # 3 A 243 THR C 177 THR^? 8.04 C8 EPE C 377 A 345 PHE C 180 PHE^? -4.33 O8 EPE C 377s A 352 CYH A 170 CYH^? -4.87 C10 EPE C 377s coo 9.58 21.79 21.50 11.25 23.03 20.90 20.64 -38.60 2.16 21.28 -38.84 0.08 coo 19.40 19.75 18.58 17.39 17.81 18.80 29.90 -34.68 4.21 31.04 -37.24 4.01 coo 21.57 22.52 22.79 19.20 21.13 23.26 25.74 -30.01 4.94 27.86 -30.22 6.82 1xqd_c02 source 1xqd CYTOCHROME P450 55A1 : 3 hits 1xqd_c02 naa= 3 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 105 ALA A 23 ALA~? 10.67 ZN ZN A 375 A 244 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 271 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 15.05 3.71 6.93 14.58 4.88 7.78 27.83 -4.85 24.60 27.58 -3.36 24.26 coo 9.85 8.15 0.76 10.61 7.04 2.39 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 10.61 7.65 6.01 12.39 6.55 6.23 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 105 ALA A 67 ALA^? 10.32 ZN ZN A 374 A 244 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 271 HIS A 69 HIS.? -3.40 ZN ZN A 374s coo 15.05 3.71 6.93 14.58 4.88 7.78 37.22 5.65 22.28 37.04 6.85 23.17 coo 9.85 8.15 0.76 10.61 7.04 2.39 40.70 8.14 28.73 41.06 6.40 29.84 coo 10.61 7.65 6.01 12.39 6.55 6.23 37.42 3.90 29.26 38.47 2.36 30.22 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 105 ALA A 101 ALA^? 11.28 ZN ZN A 375 A 244 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 271 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 15.05 3.71 6.93 14.58 4.88 7.78 32.09 5.17 22.05 31.25 5.48 23.29 coo 9.85 8.15 0.76 10.61 7.04 2.39 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 10.61 7.65 6.01 12.39 6.55 6.23 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 105 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 244 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 271 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 15.05 3.71 6.93 14.58 4.88 7.78 33.09 1.52 21.68 34.14 1.27 20.64 coo 9.85 8.15 0.76 10.61 7.04 2.39 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 10.61 7.65 6.01 12.39 6.55 6.23 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 5 3 # 5 A 105 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 244 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 271 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 15.05 3.71 6.93 14.58 4.88 7.78 33.09 1.52 21.68 34.14 1.27 20.64 coo 9.85 8.15 0.76 10.61 7.04 2.39 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 10.61 7.65 6.01 12.39 6.55 6.23 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 6 3 # 6 A 105 ALA A 102 ALA.? 9.34 ZN ZN A 375 A 244 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 271 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 15.05 3.71 6.93 14.58 4.88 7.78 33.09 1.52 21.68 34.14 1.27 20.64 coo 9.85 8.15 0.76 10.61 7.04 2.39 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 10.61 7.65 6.01 12.39 6.55 6.23 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 7 3 # 7 A 105 ALA A 161 ALA.? 7.16 O1S EPE C 377 A 244 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 271 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 15.05 3.71 6.93 14.58 4.88 7.78 24.22 -22.86 5.01 22.88 -23.16 4.38 coo 9.85 8.15 0.76 10.61 7.04 2.39 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 10.61 7.65 6.01 12.39 6.55 6.23 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 8 3 # 8 A 105 ALA B 23 ALA~? 10.82 ZN ZN B 375 A 244 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 271 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 15.05 3.71 6.93 14.58 4.88 7.78 -4.97 -5.23 25.00 -5.92 -5.35 26.16 coo 9.85 8.15 0.76 10.61 7.04 2.39 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 10.61 7.65 6.01 12.39 6.55 6.23 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 9 3 # 9 A 105 ALA B 67 ALA^? 10.44 ZN ZN B 374 A 244 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 271 HIS B 69 HIS.? -3.36 ZN ZN B 374s coo 15.05 3.71 6.93 14.58 4.88 7.78 -17.51 1.20 26.23 -17.65 1.96 27.53 coo 9.85 8.15 0.76 10.61 7.04 2.39 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 10.61 7.65 6.01 12.39 6.55 6.23 -12.32 6.27 26.70 -11.45 7.45 25.21 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 10 3 # 10 A 105 ALA B 101 ALA^? 11.06 ZN ZN B 375 A 244 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 271 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 15.05 3.71 6.93 14.58 4.88 7.78 -14.73 -2.17 28.75 -13.66 -1.71 29.80 coo 9.85 8.15 0.76 10.61 7.04 2.39 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 10.61 7.65 6.01 12.39 6.55 6.23 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 11 3 # 11 A 105 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 244 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 271 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 15.05 3.71 6.93 14.58 4.88 7.78 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 9.85 8.15 0.76 10.61 7.04 2.39 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 10.61 7.65 6.01 12.39 6.55 6.23 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 12 3 # 12 A 105 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 244 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 271 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 15.05 3.71 6.93 14.58 4.88 7.78 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 9.85 8.15 0.76 10.61 7.04 2.39 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 10.61 7.65 6.01 12.39 6.55 6.23 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 13 3 # 13 A 105 ALA B 102 ALA.? 9.36 ZN ZN B 375 A 244 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 271 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 15.05 3.71 6.93 14.58 4.88 7.78 -13.15 -2.66 25.34 -14.20 -2.84 24.29 coo 9.85 8.15 0.76 10.61 7.04 2.39 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 10.61 7.65 6.01 12.39 6.55 6.23 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 14 3 # 14 A 105 ALA B 161 ALA.? 8.19 O3S EPE A 377 A 244 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 271 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 15.05 3.71 6.93 14.58 4.88 7.78 -4.10 -26.00 8.07 -3.75 -27.17 8.94 coo 9.85 8.15 0.76 10.61 7.04 2.39 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 10.61 7.65 6.01 12.39 6.55 6.23 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 15 3 # 15 A 105 ALA C 67 ALA^? 10.56 ZN ZN C 374 A 244 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 271 HIS C 69 HIS.? -3.39 ZN ZN C 374s coo 15.05 3.71 6.93 14.58 4.88 7.78 14.85 -30.74 56.60 15.29 -29.68 57.59 coo 9.85 8.15 0.76 10.61 7.04 2.39 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 10.61 7.65 6.01 12.39 6.55 6.23 9.38 -25.93 57.43 7.35 -26.43 57.48 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 16 3 # 16 A 105 ALA C 101 ALA^? 11.01 ZN ZN C 375 A 244 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 271 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 15.05 3.71 6.93 14.58 4.88 7.78 17.04 -27.71 53.14 16.81 -26.24 53.31 coo 9.85 8.15 0.76 10.61 7.04 2.39 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 10.61 7.65 6.01 12.39 6.55 6.23 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 17 3 # 17 A 105 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 244 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 271 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 15.05 3.71 6.93 14.58 4.88 7.78 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 9.85 8.15 0.76 10.61 7.04 2.39 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 10.61 7.65 6.01 12.39 6.55 6.23 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 18 3 # 18 A 105 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 244 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 271 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 15.05 3.71 6.93 14.58 4.88 7.78 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 9.85 8.15 0.76 10.61 7.04 2.39 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 10.61 7.65 6.01 12.39 6.55 6.23 9.33 -29.64 54.17 7.95 -29.11 52.67 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 19 3 # 19 A 105 ALA C 102 ALA.? 9.31 ZN ZN C 375 A 244 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 271 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 15.05 3.71 6.93 14.58 4.88 7.78 14.49 -29.28 50.81 14.45 -30.75 50.81 coo 9.85 8.15 0.76 10.61 7.04 2.39 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 10.61 7.65 6.01 12.39 6.55 6.23 10.51 -24.81 51.94 8.80 -23.79 52.62 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 20 3 # 20 A 105 ALA C 161 ALA.? 14.45 O1 TRS A 378 A 244 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 271 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 15.05 3.71 6.93 14.58 4.88 7.78 14.54 -40.01 25.90 15.56 -39.75 24.83 coo 9.85 8.15 0.76 10.61 7.04 2.39 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 10.61 7.65 6.01 12.39 6.55 6.23 13.13 -47.52 24.96 14.34 -48.17 26.54 1xqw_c00 source 1xqw PROLINE IMINOPEPTIDASE : 20 hits 1xqw_c00 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 62 ALA.? 21.75 ZN ZN A 374 B 126 ARG A 41 ARG.? 31.19 ZN ZN A 375 B 138 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 2.11 4.00 19.31 3.14 4.86 19.99 41.03 13.97 12.85 41.56 12.98 13.85 coo 2.45 5.53 11.28 3.59 7.56 13.29 42.11 12.31 4.12 44.66 13.27 2.71 coo 6.10 2.00 25.24 6.12 1.84 23.13 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA B 62 ALA.? 21.54 ZN ZN B 374 B 126 ARG B 41 ARG.? 32.79 ZN ZN B 375 B 138 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 2.11 4.00 19.31 3.14 4.86 19.99 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo 2.45 5.53 11.28 3.59 7.56 13.29 -35.98 -7.63 26.12 -37.66 -10.05 26.93 coo 6.10 2.00 25.24 6.12 1.84 23.13 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA B 210 ALA.? 15.50 O1S EPE A 377 B 126 ARG B 214 ARG~? 23.93 O3S EPE A 377 B 138 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 2.11 4.00 19.31 3.14 4.86 19.99 -1.53 -20.24 16.39 -0.69 -19.53 17.41 coo 2.45 5.53 11.28 3.59 7.56 13.29 -7.68 -23.63 22.44 -8.04 -24.96 25.17 coo 6.10 2.00 25.24 6.12 1.84 23.13 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA C 62 ALA.? 21.65 ZN ZN C 375 B 126 ARG C 41 ARG.? 33.06 ZN ZN C 375 B 138 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 2.11 4.00 19.31 3.14 4.86 19.99 23.65 -38.52 62.14 22.14 -38.28 62.04 coo 2.45 5.53 11.28 3.59 7.56 13.29 29.45 -44.46 60.95 32.22 -45.79 60.75 coo 6.10 2.00 25.24 6.12 1.84 23.13 16.30 -37.83 67.27 14.46 -37.72 66.25 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 62 ALA.? 21.75 ZN ZN A 374 C 126 ARG A 41 ARG.? 31.19 ZN ZN A 375 C 138 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 41.03 13.97 12.85 41.56 12.98 13.85 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 42.11 12.31 4.12 44.66 13.27 2.71 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA B 62 ALA.? 21.54 ZN ZN B 374 C 126 ARG B 41 ARG.? 32.79 ZN ZN B 375 C 138 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -35.98 -7.63 26.12 -37.66 -10.05 26.93 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA B 210 ALA.? 15.50 O1S EPE A 377 C 126 ARG B 214 ARG~? 23.93 O3S EPE A 377 C 138 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -1.53 -20.24 16.39 -0.69 -19.53 17.41 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -7.68 -23.63 22.44 -8.04 -24.96 25.17 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA C 62 ALA.? 21.65 ZN ZN C 375 C 126 ARG C 41 ARG.? 33.06 ZN ZN C 375 C 138 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 23.65 -38.52 62.14 22.14 -38.28 62.04 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 29.45 -44.46 60.95 32.22 -45.79 60.75 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 16.30 -37.83 67.27 14.46 -37.72 66.25 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 62 ALA.? 21.75 ZN ZN A 374 D 126 ARG A 41 ARG.? 31.19 ZN ZN A 375 D 138 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 41.03 13.97 12.85 41.56 12.98 13.85 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 42.11 12.31 4.12 44.66 13.27 2.71 coo 6.23 0.50 57.10 5.93 0.72 59.19 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA B 62 ALA.? 21.54 ZN ZN B 374 D 126 ARG B 41 ARG.? 32.79 ZN ZN B 375 D 138 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -35.98 -7.63 26.12 -37.66 -10.05 26.93 coo 6.23 0.50 57.10 5.93 0.72 59.19 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA B 210 ALA.? 15.50 O1S EPE A 377 D 126 ARG B 214 ARG~? 23.93 O3S EPE A 377 D 138 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -1.53 -20.24 16.39 -0.69 -19.53 17.41 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -7.68 -23.63 22.44 -8.04 -24.96 25.17 coo 6.23 0.50 57.10 5.93 0.72 59.19 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA C 62 ALA.? 21.65 ZN ZN C 375 D 126 ARG C 41 ARG.? 33.06 ZN ZN C 375 D 138 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 23.65 -38.52 62.14 22.14 -38.28 62.04 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 29.45 -44.46 60.95 32.22 -45.79 60.75 coo 6.23 0.50 57.10 5.93 0.72 59.19 16.30 -37.83 67.27 14.46 -37.72 66.25 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 62 ALA.? 21.75 ZN ZN A 374 E 126 ARG A 41 ARG.? 31.19 ZN ZN A 375 E 138 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -4.56 10.03 62.36 -4.38 11.31 61.55 41.03 13.97 12.85 41.56 12.98 13.85 coo -3.02 12.00 70.07 -1.94 13.84 67.82 42.11 12.31 4.12 44.66 13.27 2.71 coo -8.67 12.22 56.54 -8.68 12.09 58.65 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA B 62 ALA.? 21.54 ZN ZN B 374 E 126 ARG B 41 ARG.? 32.79 ZN ZN B 375 E 138 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -35.98 -7.63 26.12 -37.66 -10.05 26.93 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA B 210 ALA.? 15.50 O1S EPE A 377 E 126 ARG B 214 ARG~? 23.93 O3S EPE A 377 E 138 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -1.53 -20.24 16.39 -0.69 -19.53 17.41 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -7.68 -23.63 22.44 -8.04 -24.96 25.17 coo -8.67 12.22 56.54 -8.68 12.09 58.65 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA C 62 ALA.? 21.65 ZN ZN C 375 E 126 ARG C 41 ARG.? 33.06 ZN ZN C 375 E 138 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -4.56 10.03 62.36 -4.38 11.31 61.55 23.65 -38.52 62.14 22.14 -38.28 62.04 coo -3.02 12.00 70.07 -1.94 13.84 67.82 29.45 -44.46 60.95 32.22 -45.79 60.75 coo -8.67 12.22 56.54 -8.68 12.09 58.65 16.30 -37.83 67.27 14.46 -37.72 66.25 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 62 ALA.? 21.75 ZN ZN A 374 F 126 ARG A 41 ARG.? 31.19 ZN ZN A 375 F 138 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 41.03 13.97 12.85 41.56 12.98 13.85 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 42.11 12.31 4.12 44.66 13.27 2.71 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA B 62 ALA.? 21.54 ZN ZN B 374 F 126 ARG B 41 ARG.? 32.79 ZN ZN B 375 F 138 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -30.17 -1.37 27.22 -29.17 -0.49 26.46 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -35.98 -7.63 26.12 -37.66 -10.05 26.93 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA B 210 ALA.? 15.50 O1S EPE A 377 F 126 ARG B 214 ARG~? 23.93 O3S EPE A 377 F 138 GLU B 136 GLU^? 17.92 O1S EPE A 377 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -1.53 -20.24 16.39 -0.69 -19.53 17.41 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -7.68 -23.63 22.44 -8.04 -24.96 25.17 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 3.06 -17.26 18.13 4.41 -17.23 19.78 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA C 62 ALA.? 21.65 ZN ZN C 375 F 126 ARG C 41 ARG.? 33.06 ZN ZN C 375 F 138 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 23.65 -38.52 62.14 22.14 -38.28 62.04 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 29.45 -44.46 60.95 32.22 -45.79 60.75 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 16.30 -37.83 67.27 14.46 -37.72 66.25 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c11 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 87 LYS~? 10.99 O2S EPE A 376 A 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 18.28 7.83 36.39 22.82 8.75 39.52 35.91 21.93 28.51 38.15 26.57 30.75 coo 14.16 13.09 37.03 20.00 12.44 37.49 36.23 21.81 22.32 41.86 22.67 23.70 coo 22.22 16.06 48.76 23.94 15.33 49.78 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 94 LYS~? 16.25 O2S EPE A 376 A 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 18.28 7.83 36.39 22.82 8.75 39.52 33.79 23.90 18.72 34.24 28.62 22.89 coo 14.16 13.09 37.03 20.00 12.44 37.49 36.23 21.81 22.32 41.86 22.67 23.70 coo 22.22 16.06 48.76 23.94 15.33 49.78 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 94 LYS~? 16.25 O2S EPE A 376 A 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 18.28 7.83 36.39 22.82 8.75 39.52 33.79 23.90 18.72 34.24 28.62 22.89 coo 14.16 13.09 37.03 20.00 12.44 37.49 36.23 21.81 22.32 41.86 22.67 23.70 coo 22.22 16.06 48.76 23.94 15.33 49.78 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 265 LYS~? 22.38 ZN ZN A 374 A 74 LYS A 271 LYS.? 23.00 ZN ZN A 374 A 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 18.28 7.83 36.39 22.82 8.75 39.52 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 14.16 13.09 37.03 20.00 12.44 37.49 56.12 0.48 35.73 59.67 4.01 35.99 coo 22.22 16.06 48.76 23.94 15.33 49.78 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 271 LYS.? 23.00 ZN ZN A 374 A 74 LYS A 265 LYS~? 22.38 ZN ZN A 374 A 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 18.28 7.83 36.39 22.82 8.75 39.52 56.12 0.48 35.73 59.67 4.01 35.99 coo 14.16 13.09 37.03 20.00 12.44 37.49 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 22.22 16.06 48.76 23.94 15.33 49.78 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 74 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 18.28 7.83 36.39 22.82 8.75 39.52 44.47 1.55 20.70 47.30 5.10 24.27 coo 14.16 13.09 37.03 20.00 12.44 37.49 45.66 0.76 26.15 51.53 0.58 28.90 coo 22.22 16.06 48.76 23.94 15.33 49.78 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS A 354 LYS~? 27.90 ZN ZN A 375 A 74 LYS A 350 LYS~? 21.83 ZN ZN A 375 A 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 14.16 13.09 37.03 20.00 12.44 37.49 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 22.22 16.06 48.76 23.94 15.33 49.78 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS B 87 LYS~? 9.60 O3S EPE B 376 A 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 18.28 7.83 36.39 22.82 8.75 39.52 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 14.16 13.09 37.03 20.00 12.44 37.49 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 22.22 16.06 48.76 23.94 15.33 49.78 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS B 94 LYS~? 17.44 O2S EPE B 376 A 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 18.28 7.83 36.39 22.82 8.75 39.52 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 14.16 13.09 37.03 20.00 12.44 37.49 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 22.22 16.06 48.76 23.94 15.33 49.78 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS B 215 LYS~? 17.38 O3S EPE A 377 A 74 LYS B 218 LYS~? 23.26 O3S EPE A 377 A 165 GLU B 151 GLU~? 19.22 O3S EPE A 377 coo 18.28 7.83 36.39 22.82 8.75 39.52 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 14.16 13.09 37.03 20.00 12.44 37.49 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 22.22 16.06 48.76 23.94 15.33 49.78 -9.61 -39.78 7.97 -10.79 -41.15 9.06 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS B 265 LYS~? 21.91 ZN ZN B 374 A 74 LYS B 271 LYS.? 19.93 ZN ZN B 374 A 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 18.28 7.83 36.39 22.82 8.75 39.52 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 14.16 13.09 37.03 20.00 12.44 37.49 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 22.22 16.06 48.76 23.94 15.33 49.78 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS B 271 LYS.? 19.93 ZN ZN B 374 A 74 LYS B 265 LYS~? 21.91 ZN ZN B 374 A 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 18.28 7.83 36.39 22.82 8.75 39.52 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 14.16 13.09 37.03 20.00 12.44 37.49 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 22.22 16.06 48.76 23.94 15.33 49.78 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 14.16 13.09 37.03 20.00 12.44 37.49 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 22.22 16.06 48.76 23.94 15.33 49.78 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 165 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo 18.28 7.83 36.39 22.82 8.75 39.52 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 14.16 13.09 37.03 20.00 12.44 37.49 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 22.22 16.06 48.76 23.94 15.33 49.78 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 14.16 13.09 37.03 20.00 12.44 37.49 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 22.22 16.06 48.76 23.94 15.33 49.78 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 74 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 14.16 13.09 37.03 20.00 12.44 37.49 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 22.22 16.06 48.76 23.94 15.33 49.78 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 74 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 14.16 13.09 37.03 20.00 12.44 37.49 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 22.22 16.06 48.76 23.94 15.33 49.78 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 14.16 13.09 37.03 20.00 12.44 37.49 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 22.22 16.06 48.76 23.94 15.33 49.78 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 A 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 14.16 13.09 37.03 20.00 12.44 37.49 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 22.22 16.06 48.76 23.94 15.33 49.78 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 A 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 14.16 13.09 37.03 20.00 12.44 37.49 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 22.22 16.06 48.76 23.94 15.33 49.78 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 A 14 LYS B 354 LYS~? 28.15 ZN ZN B 375 A 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 A 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 14.16 13.09 37.03 20.00 12.44 37.49 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 22.22 16.06 48.76 23.94 15.33 49.78 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 A 14 LYS C 87 LYS~? 9.86 O3S EPE C 376 A 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 18.28 7.83 36.39 22.82 8.75 39.52 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 14.16 13.09 37.03 20.00 12.44 37.49 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 22.22 16.06 48.76 23.94 15.33 49.78 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 A 14 LYS C 94 LYS~? 16.71 O3S EPE C 376 A 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 18.28 7.83 36.39 22.82 8.75 39.52 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 14.16 13.09 37.03 20.00 12.44 37.49 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 22.22 16.06 48.76 23.94 15.33 49.78 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 A 14 LYS C 215 LYS~? 17.39 O1 TRS A 378 A 74 LYS C 218 LYS~? 12.80 O1 TRS A 378 A 165 GLU C 151 GLU~? 17.15 O8 EPE C 377 coo 18.28 7.83 36.39 22.82 8.75 39.52 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 14.16 13.09 37.03 20.00 12.44 37.49 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 22.22 16.06 48.76 23.94 15.33 49.78 24.82 -49.12 19.40 26.74 -49.67 18.68 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 A 14 LYS C 265 LYS~? 21.95 ZN ZN C 374 A 74 LYS C 271 LYS.? 19.51 ZN ZN C 374 A 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 18.28 7.83 36.39 22.82 8.75 39.52 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 14.16 13.09 37.03 20.00 12.44 37.49 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 22.22 16.06 48.76 23.94 15.33 49.78 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 A 14 LYS C 271 LYS.? 19.51 ZN ZN C 374 A 74 LYS C 265 LYS~? 21.95 ZN ZN C 374 A 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 18.28 7.83 36.39 22.82 8.75 39.52 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 14.16 13.09 37.03 20.00 12.44 37.49 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 22.22 16.06 48.76 23.94 15.33 49.78 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 A 14 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 22.22 16.06 48.76 23.94 15.33 49.78 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 28 3 # 28 A 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 165 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 14.16 13.09 37.03 20.00 12.44 37.49 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 22.22 16.06 48.76 23.94 15.33 49.78 13.88 -30.69 72.19 13.68 -28.54 72.17 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 29 3 # 29 A 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 14.16 13.09 37.03 20.00 12.44 37.49 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 22.22 16.06 48.76 23.94 15.33 49.78 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 30 3 # 30 A 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 74 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 14.16 13.09 37.03 20.00 12.44 37.49 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 22.22 16.06 48.76 23.94 15.33 49.78 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 31 3 # 31 A 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 74 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 14.16 13.09 37.03 20.00 12.44 37.49 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 22.22 16.06 48.76 23.94 15.33 49.78 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 32 3 # 32 A 14 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 22.22 16.06 48.76 23.94 15.33 49.78 19.30 -32.62 45.28 21.00 -31.37 45.17 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 33 3 # 33 A 14 LYS C 354 LYS~? 23.72 O1 TRS A 378 A 74 LYS C 350 LYS~? 21.45 ZN ZN C 375 A 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 18.28 7.83 36.39 22.82 8.75 39.52 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 14.16 13.09 37.03 20.00 12.44 37.49 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 22.22 16.06 48.76 23.94 15.33 49.78 19.30 -32.62 45.28 21.00 -31.37 45.17 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 33 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 87 LYS~? 10.99 O2S EPE A 376 B 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 B 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 13.51 0.92 76.10 12.98 6.13 74.68 35.91 21.93 28.51 38.15 26.57 30.75 coo 19.89 -0.55 76.51 17.10 4.32 77.43 36.23 21.81 22.32 41.86 22.67 23.70 coo 21.39 11.56 68.52 20.24 13.13 67.73 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 94 LYS~? 16.25 O2S EPE A 376 B 74 LYS A 91 LYS~? 15.85 O2S EPE A 376 B 165 GLU A 56 GLU~? 18.18 ZN ZN A 374 coo 13.51 0.92 76.10 12.98 6.13 74.68 33.79 23.90 18.72 34.24 28.62 22.89 coo 19.89 -0.55 76.51 17.10 4.32 77.43 36.23 21.81 22.32 41.86 22.67 23.70 coo 21.39 11.56 68.52 20.24 13.13 67.73 47.24 13.21 19.42 47.19 11.28 20.29 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 265 LYS~? 22.38 ZN ZN A 374 B 74 LYS A 271 LYS.? 23.00 ZN ZN A 374 B 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 13.51 0.92 76.10 12.98 6.13 74.68 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 19.89 -0.55 76.51 17.10 4.32 77.43 56.12 0.48 35.73 59.67 4.01 35.99 coo 21.39 11.56 68.52 20.24 13.13 67.73 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 271 LYS.? 23.00 ZN ZN A 374 B 74 LYS A 265 LYS~? 22.38 ZN ZN A 374 B 165 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 13.51 0.92 76.10 12.98 6.13 74.68 56.12 0.48 35.73 59.67 4.01 35.99 coo 19.89 -0.55 76.51 17.10 4.32 77.43 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 21.39 11.56 68.52 20.24 13.13 67.73 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 337 LYS~? 14.02 ZN ZN A 374 B 74 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 13.51 0.92 76.10 12.98 6.13 74.68 45.66 0.76 26.15 51.53 0.58 28.90 coo 19.89 -0.55 76.51 17.10 4.32 77.43 44.47 1.55 20.70 47.30 5.10 24.27 coo 21.39 11.56 68.52 20.24 13.13 67.73 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 74 LYS A 337 LYS~? 14.02 ZN ZN A 374 B 165 GLU A 52 GLU~? 13.77 C2 EPE A 376 coo 13.51 0.92 76.10 12.98 6.13 74.68 44.47 1.55 20.70 47.30 5.10 24.27 coo 19.89 -0.55 76.51 17.10 4.32 77.43 45.66 0.76 26.15 51.53 0.58 28.90 coo 21.39 11.56 68.52 20.24 13.13 67.73 46.63 16.37 27.65 45.50 16.12 29.45 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS A 354 LYS~? 27.90 ZN ZN A 375 B 74 LYS A 350 LYS~? 21.83 ZN ZN A 375 B 165 GLU A 15 GLU~? 17.23 ZN ZN A 375 coo 13.51 0.92 76.10 12.98 6.13 74.68 37.47 -0.90 0.73 32.51 -2.58 1.13 coo 19.89 -0.55 76.51 17.10 4.32 77.43 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 21.39 11.56 68.52 20.24 13.13 67.73 29.50 -0.46 14.62 27.65 0.59 14.66 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS B 87 LYS~? 9.60 O3S EPE B 376 B 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 B 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 13.51 0.92 76.10 12.98 6.13 74.68 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 21.39 11.56 68.52 20.24 13.13 67.73 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS B 94 LYS~? 17.44 O2S EPE B 376 B 74 LYS B 91 LYS~? 15.73 O3S EPE B 376 B 165 GLU B 56 GLU~? 18.10 ZN ZN B 374 coo 13.51 0.92 76.10 12.98 6.13 74.68 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 21.39 11.56 68.52 20.24 13.13 67.73 -28.81 7.12 24.95 -27.13 7.39 23.64 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS B 215 LYS~? 17.38 O3S EPE A 377 B 74 LYS B 218 LYS~? 23.26 O3S EPE A 377 B 165 GLU B 151 GLU~? 19.22 O3S EPE A 377 coo 13.51 0.92 76.10 12.98 6.13 74.68 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 21.39 11.56 68.52 20.24 13.13 67.73 -9.61 -39.78 7.97 -10.79 -41.15 9.06 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS B 265 LYS~? 21.91 ZN ZN B 374 B 74 LYS B 271 LYS.? 19.93 ZN ZN B 374 B 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 13.51 0.92 76.10 12.98 6.13 74.68 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 21.39 11.56 68.52 20.24 13.13 67.73 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS B 271 LYS.? 19.93 ZN ZN B 374 B 74 LYS B 265 LYS~? 21.91 ZN ZN B 374 B 165 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 13.51 0.92 76.10 12.98 6.13 74.68 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 21.39 11.56 68.52 20.24 13.13 67.73 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 74 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 13.51 0.92 76.10 12.98 6.13 74.68 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 21.39 11.56 68.52 20.24 13.13 67.73 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 165 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo 13.51 0.92 76.10 12.98 6.13 74.68 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 21.39 11.56 68.52 20.24 13.13 67.73 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 74 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 165 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 13.51 0.92 76.10 12.98 6.13 74.68 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 21.39 11.56 68.52 20.24 13.13 67.73 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS B 345 LYS~? 20.14 ZN ZN B 375 B 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 B 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 13.51 0.92 76.10 12.98 6.13 74.68 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 21.39 11.56 68.52 20.24 13.13 67.73 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS B 354 LYS~? 28.15 ZN ZN B 375 B 74 LYS B 350 LYS~? 21.91 ZN ZN B 375 B 165 GLU B 15 GLU~? 17.09 ZN ZN B 375 coo 13.51 0.92 76.10 12.98 6.13 74.68 -26.24 -16.01 14.73 -23.79 -17.66 13.12 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 21.39 11.56 68.52 20.24 13.13 67.73 -14.60 -10.45 24.17 -14.29 -11.30 26.10 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS C 87 LYS~? 9.86 O3S EPE C 376 B 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 B 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 13.51 0.92 76.10 12.98 6.13 74.68 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 19.89 -0.55 76.51 17.10 4.32 77.43 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 21.39 11.56 68.52 20.24 13.13 67.73 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 B 14 LYS C 94 LYS~? 16.71 O3S EPE C 376 B 74 LYS C 91 LYS~? 15.57 O3S EPE C 376 B 165 GLU C 56 GLU~? 18.45 ZN ZN C 374 coo 13.51 0.92 76.10 12.98 6.13 74.68 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 19.89 -0.55 76.51 17.10 4.32 77.43 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 21.39 11.56 68.52 20.24 13.13 67.73 16.30 -37.83 67.27 14.46 -37.72 66.25 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 B 14 LYS C 215 LYS~? 17.39 O1 TRS A 378 B 74 LYS C 218 LYS~? 12.80 O1 TRS A 378 B 165 GLU C 151 GLU~? 17.15 O8 EPE C 377 coo 13.51 0.92 76.10 12.98 6.13 74.68 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 19.89 -0.55 76.51 17.10 4.32 77.43 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 21.39 11.56 68.52 20.24 13.13 67.73 24.82 -49.12 19.40 26.74 -49.67 18.68 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 B 14 LYS C 265 LYS~? 21.95 ZN ZN C 374 B 74 LYS C 271 LYS.? 19.51 ZN ZN C 374 B 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 13.51 0.92 76.10 12.98 6.13 74.68 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 21.39 11.56 68.52 20.24 13.13 67.73 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 B 14 LYS C 271 LYS.? 19.51 ZN ZN C 374 B 74 LYS C 265 LYS~? 21.95 ZN ZN C 374 B 165 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 13.51 0.92 76.10 12.98 6.13 74.68 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 21.39 11.56 68.52 20.24 13.13 67.73 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 B 14 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 74 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 13.51 0.92 76.10 12.98 6.13 74.68 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 19.89 -0.55 76.51 17.10 4.32 77.43 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 21.39 11.56 68.52 20.24 13.13 67.73 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 B 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 165 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 19.89 -0.55 76.51 17.10 4.32 77.43 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 21.39 11.56 68.52 20.24 13.13 67.73 13.88 -30.69 72.19 13.68 -28.54 72.17 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 B 14 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 74 LYS C 337 LYS~? 12.69 ZN ZN C 374 B 165 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 19.89 -0.55 76.51 17.10 4.32 77.43 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 21.39 11.56 68.52 20.24 13.13 67.73 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 B 14 LYS C 354 LYS~? 23.72 O1 TRS A 378 B 74 LYS C 350 LYS~? 21.45 ZN ZN C 375 B 165 GLU C 15 GLU~? 17.26 ZN ZN C 375 coo 13.51 0.92 76.10 12.98 6.13 74.68 23.17 -48.48 45.31 22.31 -43.90 41.08 coo 19.89 -0.55 76.51 17.10 4.32 77.43 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 21.39 11.56 68.52 20.24 13.13 67.73 19.30 -32.62 45.28 21.00 -31.37 45.17 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 26 hits 1ylu_c01 naa= 3 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 1 3 # 1 146 SER A 168 SER^? 10.80 O1S EPE C 377 338 ASP A 158 ASP~? 15.23 O1S EPE C 377 397 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 2 3 # 2 146 SER B 168 SER^? 10.59 O3S EPE A 377 338 ASP B 158 ASP~? 14.93 O3S EPE A 377 397 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 3 3 # 3 146 SER C 168 SER^? 24.11 O1 TRS A 378 338 ASP C 158 ASP~? 22.01 O1 TRS A 378 397 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 13.13 -47.52 24.96 14.34 -48.17 26.54 1ysc_c01 source 1ysc SERINE CARBOXYPEPTIDASE (CPY, CPD-Y, OR PROTEI: 3 hits 1ysc_c01 naa= 3 ULMN 3 1zoi_c00 ESTERASE user 1 3 # 1 A 97 SER A 168 SER^? 10.80 O1S EPE C 377 A 227 ASP A 158 ASP~? 15.23 O1S EPE C 377 A 256 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 64.84 24.93 59.62 66.28 24.42 57.72 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 73.80 27.56 60.96 72.24 26.45 60.08 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 70.86 23.63 59.28 68.91 24.23 58.80 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1zoi_c00 ESTERASE user 2 3 # 2 A 97 SER B 168 SER^? 10.59 O3S EPE A 377 A 227 ASP B 158 ASP~? 14.93 O3S EPE A 377 A 256 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 64.84 24.93 59.62 66.28 24.42 57.72 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 73.80 27.56 60.96 72.24 26.45 60.08 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 70.86 23.63 59.28 68.91 24.23 58.80 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1zoi_c00 ESTERASE user 3 3 # 3 A 97 SER C 168 SER^? 24.11 O1 TRS A 378 A 227 ASP C 158 ASP~? 22.01 O1 TRS A 378 A 256 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 64.84 24.93 59.62 66.28 24.42 57.72 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 73.80 27.56 60.96 72.24 26.45 60.08 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 70.86 23.63 59.28 68.91 24.23 58.80 13.13 -47.52 24.96 14.34 -48.17 26.54 1zoi_c00 source 1zoi ESTERASE : 3 hits 1zoi_c00 naa= 3 ULMN 3 1zoi_c01 ESTERASE user 1 3 # 1 B 97 SER A 168 SER^? 10.80 O1S EPE C 377 B 227 ASP A 158 ASP~? 15.23 O1S EPE C 377 B 256 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1zoi_c01 ESTERASE user 2 3 # 2 B 97 SER B 168 SER^? 10.59 O3S EPE A 377 B 227 ASP B 158 ASP~? 14.93 O3S EPE A 377 B 256 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1zoi_c01 ESTERASE user 3 3 # 3 B 97 SER C 168 SER^? 24.11 O1 TRS A 378 B 227 ASP C 158 ASP~? 22.01 O1 TRS A 378 B 256 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 13.13 -47.52 24.96 14.34 -48.17 26.54 1zoi_c01 source 1zoi ESTERASE : 3 hits 1zoi_c01 naa= 3 ULMN 3 1zoi_c02 ESTERASE user 1 3 # 1 C 97 SER A 168 SER^? 10.80 O1S EPE C 377 C 227 ASP A 158 ASP~? 15.23 O1S EPE C 377 C 256 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 1zoi_c02 ESTERASE user 2 3 # 2 C 97 SER B 168 SER^? 10.59 O3S EPE A 377 C 227 ASP B 158 ASP~? 14.93 O3S EPE A 377 C 256 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 1zoi_c02 ESTERASE user 3 3 # 3 C 97 SER C 168 SER^? 24.11 O1 TRS A 378 C 227 ASP C 158 ASP~? 22.01 O1 TRS A 378 C 256 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 13.13 -47.52 24.96 14.34 -48.17 26.54 1zoi_c02 source 1zoi ESTERASE : 3 hits 1zoi_c02 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 371 LYS A 20 LYS~? 16.95 ZN ZN A 375 A 407 THR A 104 THR~? 6.76 ZN ZN A 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -4.43 30.92 22.89 -6.61 31.91 19.71 26.66 -3.22 19.04 24.73 2.41 18.30 coo -8.38 36.02 19.06 -8.83 34.10 19.89 32.17 -3.62 26.15 30.67 -3.61 27.70 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 280 ASP.? 32.54 ZN ZN A 374 A 371 LYS A 278 LYS.? 33.16 ZN ZN A 374 A 407 THR A 256 THR^? 28.88 ZN ZN A 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 57.62 -18.45 47.11 59.50 -17.52 47.44 coo -4.43 30.92 22.89 -6.61 31.91 19.71 52.59 -15.70 47.74 53.19 -20.67 51.64 coo -8.38 36.02 19.06 -8.83 34.10 19.89 56.69 -18.34 40.21 58.60 -17.57 40.86 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP A 281 ASP.? 28.06 ZN ZN A 375 A 371 LYS A 278 LYS.? 33.16 ZN ZN A 374 A 407 THR A 256 THR^? 28.88 ZN ZN A 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 52.87 -20.75 45.53 51.52 -19.24 45.99 coo -4.43 30.92 22.89 -6.61 31.91 19.71 52.59 -15.70 47.74 53.19 -20.67 51.64 coo -8.38 36.02 19.06 -8.83 34.10 19.89 56.69 -18.34 40.21 58.60 -17.57 40.86 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 371 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 407 THR A 367 THR.? 11.13 ZN ZN A 374 coo -5.17 31.09 15.73 -7.07 31.12 16.73 48.24 5.16 33.58 47.82 3.96 35.30 coo -4.43 30.92 22.89 -6.61 31.91 19.71 45.66 0.76 26.15 51.53 0.58 28.90 coo -8.38 36.02 19.06 -8.83 34.10 19.89 46.41 8.27 30.19 44.93 8.03 28.58 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 371 LYS B 20 LYS~? 17.56 ZN ZN B 375 A 407 THR B 104 THR~? 6.79 ZN ZN B 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -6.78 -0.91 23.63 -5.15 -0.73 25.06 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 6 3 # 6 A 369 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 371 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 407 THR B 367 THR.? 10.99 ZN ZN B 374 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -18.95 13.55 24.81 -19.03 11.36 25.00 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 7 3 # 7 A 369 ASP B 280 ASP.? 32.17 ZN ZN B 374 A 371 LYS B 278 LYS.? 31.34 ZN ZN B 374 A 407 THR B 256 THR^? 29.14 ZN ZN B 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 2.63 27.37 3.18 1.41 29.12 3.45 coo -4.43 30.92 22.89 -6.61 31.91 19.71 3.65 25.62 8.65 8.47 28.09 9.23 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -1.04 21.83 2.11 -1.77 23.76 1.44 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 8 3 # 8 A 369 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 371 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 407 THR B 367 THR.? 10.99 ZN ZN B 374 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -15.86 16.57 22.39 -13.84 17.32 22.21 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -18.95 13.55 24.81 -19.03 11.36 25.00 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 9 3 # 9 A 369 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 371 LYS C 20 LYS~? 17.53 ZN ZN C 375 A 407 THR C 104 THR~? 6.99 ZN ZN C 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -4.43 30.92 22.89 -6.61 31.91 19.71 16.25 -27.94 42.71 21.97 -27.95 45.58 coo -8.38 36.02 19.06 -8.83 34.10 19.89 9.25 -26.14 47.92 9.13 -24.05 47.44 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 10 3 # 10 A 369 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 371 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 407 THR C 367 THR.? 11.10 ZN ZN C 374 coo -5.17 31.09 15.73 -7.07 31.12 16.73 10.65 -27.85 62.57 8.78 -27.40 61.73 coo -4.43 30.92 22.89 -6.61 31.91 19.71 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -8.38 36.02 19.06 -8.83 34.10 19.89 7.09 -30.04 66.37 8.69 -30.35 64.94 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 11 3 # 11 A 369 ASP C 280 ASP.? 31.92 ZN ZN C 374 A 371 LYS C 278 LYS.? 30.91 ZN ZN C 374 A 407 THR C 256 THR^? 29.06 ZN ZN C 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -25.13 -30.20 58.02 -25.85 -28.27 58.51 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -21.60 -25.17 57.51 -24.75 -21.09 54.19 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -20.65 -33.80 55.44 -22.00 -34.26 57.11 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 12 3 # 12 A 369 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 371 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 407 THR C 367 THR.? 11.10 ZN ZN C 374 coo -5.17 31.09 15.73 -7.07 31.12 16.73 2.31 -29.36 66.29 0.59 -28.37 65.47 coo -4.43 30.92 22.89 -6.61 31.91 19.71 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -8.38 36.02 19.06 -8.83 34.10 19.89 7.09 -30.04 66.37 8.69 -30.35 64.94 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 12 hits 1zrz_c02 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 371 LYS A 20 LYS~? 16.95 ZN ZN A 375 A 374 ASN A 105 ASN~? 9.65 ZN ZN A 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -4.43 30.92 22.89 -6.61 31.91 19.71 26.66 -3.22 19.04 24.73 2.41 18.30 coo -4.84 27.04 20.49 -6.40 27.76 19.26 30.92 -4.10 21.33 31.10 -1.93 21.21 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 96 ASP.? 22.36 O2S EPE A 376 A 371 LYS A 94 LYS~? 16.25 O2S EPE A 376 A 374 ASN A 95 ASN~? 18.99 O2S EPE A 376 coo -5.17 31.09 15.73 -7.07 31.12 16.73 33.23 19.97 13.69 32.21 21.81 13.47 coo -4.43 30.92 22.89 -6.61 31.91 19.71 33.79 23.90 18.72 34.24 28.62 22.89 coo -4.84 27.04 20.49 -6.40 27.76 19.26 37.50 21.37 17.07 38.56 22.79 18.19 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 371 LYS A 247 LYS^? 14.25 ZN ZN A 375 A 374 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 41.88 -11.27 21.52 40.65 -12.98 21.39 coo -4.43 30.92 22.89 -6.61 31.91 19.71 40.34 -15.07 28.39 38.70 -15.53 23.22 coo -4.84 27.04 20.49 -6.40 27.76 19.26 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP A 237 ASP^? 6.80 N TRS A 378 A 371 LYS A 239 LYS^? -7.47 O3 TRS A 378s A 374 ASN A 238 ASN^? -4.13 C2 TRS A 378s coo -5.17 31.09 15.73 -7.07 31.12 16.73 18.36 -25.38 21.90 16.49 -24.92 22.81 coo -4.43 30.92 22.89 -6.61 31.91 19.71 24.38 -22.19 19.59 20.35 -19.68 21.34 coo -4.84 27.04 20.49 -6.40 27.76 19.26 22.25 -25.65 17.52 21.37 -27.55 17.01 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 371 LYS A 295 LYS.? 12.61 ZN ZN A 374 A 374 ASN A 294 ASN.? 12.36 ZN ZN A 374 coo -5.17 31.09 15.73 -7.07 31.12 16.73 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -4.43 30.92 22.89 -6.61 31.91 19.71 32.96 -9.31 39.54 28.55 -6.00 37.21 coo -4.84 27.04 20.49 -6.40 27.76 19.26 35.77 -6.31 41.36 37.34 -5.07 42.10 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 6 3 # 6 A 369 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 371 LYS B 20 LYS~? 17.56 ZN ZN B 375 A 374 ASN B 105 ASN~? 9.47 ZN ZN B 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -8.72 -9.62 24.89 -11.95 -11.12 29.74 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -8.71 -5.38 22.66 -10.29 -4.82 23.98 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 7 3 # 7 A 369 ASP B 96 ASP.? 22.64 O2S EPE B 376 A 371 LYS B 94 LYS~? 17.44 O2S EPE B 376 A 374 ASN B 95 ASN~? 19.50 O2S EPE B 376 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -29.98 -4.37 36.65 -30.49 -4.93 38.64 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -29.53 0.46 40.71 -30.43 3.58 45.55 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -30.82 1.14 36.18 -31.61 2.89 37.07 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 8 3 # 8 A 369 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 371 LYS B 247 LYS^? 11.69 ZN ZN B 375 A 374 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 9 3 # 9 A 369 ASP B 237 ASP^? 15.58 N TRS A 378 A 371 LYS B 239 LYS^? 16.51 O1S EPE A 377 A 374 ASN B 238 ASN^? 8.84 O1S EPE A 377 coo -5.17 31.09 15.73 -7.07 31.12 16.73 11.84 -17.75 12.41 13.28 -17.47 14.02 coo -4.43 30.92 22.89 -6.61 31.91 19.71 5.23 -14.71 11.35 7.06 -15.38 16.25 coo -4.84 27.04 20.49 -6.40 27.76 19.26 7.11 -18.54 9.31 8.52 -20.00 8.45 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 10 3 # 10 A 369 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 371 LYS B 295 LYS.? 11.37 ZN ZN B 375 A 374 ASN B 294 ASN.? 12.27 ZN ZN B 374 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -4.43 30.92 22.89 -6.61 31.91 19.71 4.57 8.76 22.84 2.39 5.01 24.93 coo -4.84 27.04 20.49 -6.40 27.76 19.26 2.18 12.34 23.84 0.88 14.02 24.05 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 11 3 # 11 A 369 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 371 LYS C 20 LYS~? 17.53 ZN ZN C 375 A 374 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 12.27 -21.58 47.53 11.82 -22.95 49.16 coo -4.43 30.92 22.89 -6.61 31.91 19.71 16.25 -27.94 42.71 21.97 -27.95 45.58 coo -4.84 27.04 20.49 -6.40 27.76 19.26 12.40 -28.97 45.42 13.67 -29.13 47.17 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 12 3 # 12 A 369 ASP C 96 ASP.? 22.89 O3S EPE C 376 A 371 LYS C 94 LYS~? 16.71 O3S EPE C 376 A 374 ASN C 95 ASN~? 19.32 O3S EPE C 376 coo -5.17 31.09 15.73 -7.07 31.12 16.73 31.06 -32.15 62.51 32.92 -31.34 63.13 coo -4.43 30.92 22.89 -6.61 31.91 19.71 30.11 -27.61 67.14 30.55 -24.06 72.29 coo -4.84 27.04 20.49 -6.40 27.76 19.26 27.60 -31.58 66.97 27.57 -31.41 69.09 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 13 3 # 13 A 369 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 371 LYS C 247 LYS^? 13.94 ZN ZN C 375 A 374 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo -5.17 31.09 15.73 -7.07 31.12 16.73 1.88 -37.38 46.52 1.77 -36.70 44.54 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo -4.84 27.04 20.49 -6.40 27.76 19.26 0.77 -32.01 47.92 1.06 -30.12 48.87 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 14 3 # 14 A 369 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 371 LYS C 239 LYS^? 16.29 N TRS A 378 A 374 ASN C 238 ASN^? 16.63 O2S EPE A 377 coo -5.17 31.09 15.73 -7.07 31.12 16.73 4.59 -25.19 21.63 5.07 -23.28 20.96 coo -4.43 30.92 22.89 -6.61 31.91 19.71 5.15 -29.07 27.87 7.72 -24.69 27.36 coo -4.84 27.04 20.49 -6.40 27.76 19.26 5.28 -30.50 23.50 4.52 -30.81 21.55 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 15 3 # 15 A 369 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 371 LYS C 295 LYS.? 14.49 ZN ZN C 374 A 374 ASN C 294 ASN.? 11.92 ZN ZN C 374 coo -5.17 31.09 15.73 -7.07 31.12 16.73 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -3.30 -17.98 52.78 -3.53 -18.25 54.87 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 15 hits 1zrz_c03 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER A 12 SER~? 22.68 ZN ZN A 375 327 GLU A 9 GLU~? 28.50 ZN ZN A 375 440 HIS A 8 HIS~? 24.55 ZN ZN A 375 coo 6.96 64.04 57.84 6.74 63.69 60.26 29.97 0.68 9.55 29.00 -0.35 7.61 coo 14.82 64.63 62.37 13.47 65.72 61.17 31.54 5.84 4.26 31.09 6.26 2.19 coo 9.52 66.51 63.07 8.75 65.02 61.81 26.75 7.68 8.85 25.49 8.72 10.18 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER B 12 SER~? 22.72 ZN ZN B 375 327 GLU B 9 GLU~? 28.41 ZN ZN B 375 440 HIS B 8 HIS~? 24.51 ZN ZN B 375 coo 6.96 64.04 57.84 6.74 63.69 60.26 -18.37 -13.85 22.96 -18.51 -16.07 23.80 coo 14.82 64.63 62.37 13.47 65.72 61.17 -25.03 -16.61 24.42 -27.11 -17.15 24.13 coo 9.52 66.51 63.07 8.75 65.02 61.81 -21.73 -14.76 29.99 -21.14 -14.36 31.97 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 3 3 # 3 200 SER C 12 SER~? 21.06 O1 TRS A 378 327 GLU C 9 GLU~? 28.11 O1 TRS A 378 440 HIS C 8 HIS~? 24.89 ZN ZN C 375 coo 6.96 64.04 57.84 6.74 63.69 60.26 22.92 -36.29 44.84 24.16 -36.52 42.80 coo 14.82 64.63 62.37 13.47 65.72 61.17 28.74 -39.91 47.06 29.82 -41.70 47.37 coo 9.52 66.51 63.07 8.75 65.02 61.81 29.42 -33.76 48.01 30.25 -31.91 48.55 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 3 hits 2ace_c00 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 48 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 77 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 40.70 8.14 28.73 41.06 6.40 29.84 coo 12.77 23.50 68.33 13.58 25.42 68.49 37.80 0.44 25.56 37.02 -1.29 26.44 coo 7.53 29.84 65.06 12.29 29.41 67.79 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 2 3 # 2 A 43 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 48 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 77 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 40.70 8.14 28.73 41.06 6.40 29.84 coo 12.77 23.50 68.33 13.58 25.42 68.49 37.80 0.44 25.56 37.02 -1.29 26.44 coo 7.53 29.84 65.06 12.29 29.41 67.79 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 3 3 # 3 A 43 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 48 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 77 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 40.70 8.14 28.73 41.06 6.40 29.84 coo 12.77 23.50 68.33 13.58 25.42 68.49 40.60 0.33 34.12 38.69 0.39 33.24 coo 7.53 29.84 65.06 12.29 29.41 67.79 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 4 3 # 4 A 43 ASP A 82 ASP.? 8.88 O2S EPE A 376 A 48 HIS A 80 HIS.? 6.41 O2S EPE A 376 A 77 LYS A 87 LYS~? 10.99 O2S EPE A 376 coo 13.04 30.41 72.50 12.95 30.65 70.36 34.38 27.71 34.24 32.73 27.59 35.53 coo 12.77 23.50 68.33 13.58 25.42 68.49 28.52 23.28 34.79 26.69 23.10 35.81 coo 7.53 29.84 65.06 12.29 29.41 67.79 35.91 21.93 28.51 38.15 26.57 30.75 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 5 3 # 5 A 43 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 48 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 77 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 54.82 -1.21 28.36 56.43 0.27 28.67 coo 12.77 23.50 68.33 13.58 25.42 68.49 51.10 6.85 29.91 51.20 5.36 31.38 coo 7.53 29.84 65.06 12.29 29.41 67.79 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 6 3 # 6 A 43 ASP A 269 ASP.? 18.90 ZN ZN A 374 A 48 HIS A 366 HIS.? 14.86 ZN ZN A 374 A 77 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 54.82 -1.21 28.36 56.43 0.27 28.67 coo 12.77 23.50 68.33 13.58 25.42 68.49 51.10 6.85 29.91 51.20 5.36 31.38 coo 7.53 29.84 65.06 12.29 29.41 67.79 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 7 3 # 7 A 43 ASP A 368 ASP.? 11.85 ZN ZN A 374 A 48 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 77 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 48.24 5.16 33.58 47.82 3.96 35.30 coo 12.77 23.50 68.33 13.58 25.42 68.49 40.60 0.33 34.12 38.69 0.39 33.24 coo 7.53 29.84 65.06 12.29 29.41 67.79 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 8 3 # 8 A 43 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 48 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 77 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 12.77 23.50 68.33 13.58 25.42 68.49 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 7.53 29.84 65.06 12.29 29.41 67.79 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 9 3 # 9 A 43 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 48 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 77 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 12.77 23.50 68.33 13.58 25.42 68.49 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 7.53 29.84 65.06 12.29 29.41 67.79 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 10 3 # 10 A 43 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 48 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 77 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 12.77 23.50 68.33 13.58 25.42 68.49 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 7.53 29.84 65.06 12.29 29.41 67.79 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 11 3 # 11 A 43 ASP B 82 ASP.? 10.62 O3S EPE B 376 A 48 HIS B 80 HIS.? 6.72 O2S EPE B 376 A 77 LYS B 87 LYS~? 9.60 O3S EPE B 376 coo 13.04 30.41 72.50 12.95 30.65 70.36 -22.38 12.66 48.09 -22.95 14.65 48.48 coo 12.77 23.50 68.33 13.58 25.42 68.49 -17.26 9.01 48.35 -15.80 8.65 49.80 coo 7.53 29.84 65.06 12.29 29.41 67.79 -23.51 8.76 41.04 -24.49 13.82 43.31 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 12 3 # 12 A 43 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 48 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 77 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 12.77 23.50 68.33 13.58 25.42 68.49 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 7.53 29.84 65.06 12.29 29.41 67.79 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 13 3 # 13 A 43 ASP B 269 ASP.? 18.26 ZN ZN B 374 A 48 HIS B 366 HIS.? 14.78 ZN ZN B 374 A 77 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 12.77 23.50 68.33 13.58 25.42 68.49 -20.57 16.04 20.92 -18.78 16.88 20.21 coo 7.53 29.84 65.06 12.29 29.41 67.79 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 14 3 # 14 A 43 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 48 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 77 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 12.77 23.50 68.33 13.58 25.42 68.49 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 7.53 29.84 65.06 12.29 29.41 67.79 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 15 3 # 15 A 43 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 48 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 77 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 12.77 23.50 68.33 13.58 25.42 68.49 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 7.53 29.84 65.06 12.29 29.41 67.79 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 16 3 # 16 A 43 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 48 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 77 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 12.77 23.50 68.33 13.58 25.42 68.49 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 7.53 29.84 65.06 12.29 29.41 67.79 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 17 3 # 17 A 43 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 48 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 77 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 12.77 23.50 68.33 13.58 25.42 68.49 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 7.53 29.84 65.06 12.29 29.41 67.79 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 18 3 # 18 A 43 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 48 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 77 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 12.77 23.50 68.33 13.58 25.42 68.49 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 7.53 29.84 65.06 12.29 29.41 67.79 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 19 3 # 19 A 43 ASP C 269 ASP~? 18.04 ZN ZN C 374 A 48 HIS C 366 HIS.? 14.85 ZN ZN C 374 A 77 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 12.77 23.50 68.33 13.58 25.42 68.49 4.16 -33.39 68.22 2.28 -32.65 67.64 coo 7.53 29.84 65.06 12.29 29.41 67.79 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 20 3 # 20 A 43 ASP C 368 ASP.? 11.74 ZN ZN C 374 A 48 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 77 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 13.04 30.41 72.50 12.95 30.65 70.36 2.31 -29.36 66.29 0.59 -28.37 65.47 coo 12.77 23.50 68.33 13.58 25.42 68.49 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 7.53 29.84 65.06 12.29 29.41 67.79 5.23 -34.02 59.10 0.53 -34.86 62.24 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 20 hits 2acu_c01 naa= 3 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 A 105 ASN A 105 ASN~? 9.65 ZN ZN A 375 A 106 PRO A 19 PRO~? 15.14 ZN ZN A 375 A 108 TYR A 18 TYR~? 11.08 ZN ZN A 375 coo 34.91 38.94 20.48 33.53 38.20 19.00 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 36.18 33.51 20.99 37.11 35.33 20.14 29.44 -7.44 15.80 29.61 -5.36 16.66 coo 33.01 33.46 15.68 31.96 34.97 17.80 34.99 -4.02 17.62 37.68 -4.71 17.89 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 2 3 # 2 A 105 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 106 PRO B 19 PRO~? 15.10 ZN ZN B 375 A 108 TYR B 18 TYR~? 10.93 ZN ZN B 375 coo 34.91 38.94 20.48 33.53 38.20 19.00 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 36.18 33.51 20.99 37.11 35.33 20.14 -8.98 -11.22 19.12 -9.96 -10.08 20.78 coo 33.01 33.46 15.68 31.96 34.97 17.80 -12.77 -5.58 18.92 -13.52 -3.89 16.83 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 3 3 # 3 A 105 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 106 PRO C 19 PRO~? 14.95 ZN ZN C 375 A 108 TYR C 18 TYR.? 11.04 ZN ZN C 375 coo 34.91 38.94 20.48 33.53 38.20 19.00 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 36.18 33.51 20.99 37.11 35.33 20.14 13.85 -32.50 40.26 14.91 -32.07 42.18 coo 33.01 33.46 15.68 31.96 34.97 17.80 12.32 -34.51 46.53 10.40 -36.24 47.57 2adm_c00 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 3 hits 2adm_c00 naa= 3 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 B 105 ASN C 105 ASN~? 9.60 ZN ZN C 375 B 106 PRO C 19 PRO~? 14.95 ZN ZN C 375 B 108 TYR C 18 TYR.? 11.04 ZN ZN C 375 coo 5.98 38.14 46.94 7.30 38.92 45.46 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 4.66 43.53 47.47 3.74 41.73 46.59 13.85 -32.50 40.26 14.91 -32.07 42.18 coo 7.86 43.80 42.15 8.87 42.26 44.27 12.32 -34.51 46.53 10.40 -36.24 47.57 2adm_c01 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 1 hits 2adm_c01 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 163 HIS.? 11.18 O1S EPE C 377 B 50 GLU C 228 GLU.? 9.65 C7 EPE C 377 B 113 GLN C 183 GLN.? 13.97 C5 EPE C 377 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 35.42 -27.01 4.58 35.93 -26.02 2.76 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS A 263 HIS~? 20.93 ZN ZN A 375 B 50 GLU A 253 GLU^? 31.48 ZN ZN A 375 B 113 GLN A 259 GLN~? 28.90 ZN ZN A 375 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 58.90 -16.16 37.51 60.42 -17.61 36.90 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS B 163 HIS.? 11.54 O3S EPE A 377 B 50 GLU A 228 GLU.? 8.71 C3 EPE A 377 B 113 GLN A 183 GLN.? 13.75 O8 EPE A 377 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -6.86 -21.61 -3.42 -8.75 -22.47 -2.89 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS B 359 HIS^? 24.30 ZN ZN B 375 B 50 GLU B 56 GLU~? 18.10 ZN ZN B 374 B 113 GLN B 344 GLN~? 18.67 ZN ZN B 375 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -24.61 -0.12 16.09 -25.84 1.53 15.46 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS B 359 HIS^? 24.30 ZN ZN B 375 B 50 GLU B 349 GLU~? 21.77 ZN ZN B 375 B 113 GLN B 344 GLN~? 18.67 ZN ZN B 375 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -24.61 -0.12 16.09 -25.84 1.53 15.46 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 6 3 # 6 B 29 HIS C 163 HIS.? 22.24 O1 TRS A 378 B 50 GLU B 228 GLU.? 26.61 O2S EPE A 377 B 113 GLN B 183 GLN.? 25.94 O1 TRS A 378 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -2.18 -42.16 24.63 -2.03 -43.87 25.91 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 7.41 -49.44 30.49 8.75 -47.79 30.78 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 7 3 # 7 B 29 HIS C 359 HIS^? 24.82 ZN ZN C 375 B 50 GLU C 56 GLU~? 18.45 ZN ZN C 374 B 113 GLN C 344 GLN~? 18.56 ZN ZN C 375 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 13.15 -43.20 56.87 12.11 -43.96 58.60 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 8 3 # 8 B 29 HIS C 359 HIS^? 24.82 ZN ZN C 375 B 50 GLU C 349 GLU~? 21.43 ZN ZN C 375 B 113 GLN C 344 GLN~? 18.56 ZN ZN C 375 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 13.15 -43.20 56.87 12.11 -43.96 58.60 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 8 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 163 HIS.? 11.18 O1S EPE C 377 B 50 GLU C 228 GLU.? 9.65 C7 EPE C 377 B 113 GLN C 183 GLN.? 13.97 C5 EPE C 377 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 35.42 -27.01 4.58 35.93 -26.02 2.76 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS A 263 HIS~? 20.93 ZN ZN A 375 B 50 GLU A 253 GLU^? 31.48 ZN ZN A 375 B 113 GLN A 259 GLN~? 28.90 ZN ZN A 375 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 58.90 -16.16 37.51 60.42 -17.61 36.90 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS B 163 HIS.? 11.54 O3S EPE A 377 B 50 GLU A 228 GLU.? 8.71 C3 EPE A 377 B 113 GLN A 183 GLN.? 13.75 O8 EPE A 377 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -6.86 -21.61 -3.42 -8.75 -22.47 -2.89 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS B 359 HIS^? 24.30 ZN ZN B 375 B 50 GLU B 56 GLU~? 18.10 ZN ZN B 374 B 113 GLN B 344 GLN~? 18.67 ZN ZN B 375 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -24.61 -0.12 16.09 -25.84 1.53 15.46 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS B 359 HIS^? 24.30 ZN ZN B 375 B 50 GLU B 349 GLU~? 21.77 ZN ZN B 375 B 113 GLN B 344 GLN~? 18.67 ZN ZN B 375 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -24.61 -0.12 16.09 -25.84 1.53 15.46 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 6 3 # 6 B 29 HIS C 163 HIS.? 22.24 O1 TRS A 378 B 50 GLU B 228 GLU.? 26.61 O2S EPE A 377 B 113 GLN B 183 GLN.? 25.94 O1 TRS A 378 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -2.18 -42.16 24.63 -2.03 -43.87 25.91 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 7.41 -49.44 30.49 8.75 -47.79 30.78 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 7 3 # 7 B 29 HIS C 359 HIS^? 24.82 ZN ZN C 375 B 50 GLU C 56 GLU~? 18.45 ZN ZN C 374 B 113 GLN C 344 GLN~? 18.56 ZN ZN C 375 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 13.15 -43.20 56.87 12.11 -43.96 58.60 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 8 3 # 8 B 29 HIS C 359 HIS^? 24.82 ZN ZN C 375 B 50 GLU C 349 GLU~? 21.43 ZN ZN C 375 B 113 GLN C 344 GLN~? 18.56 ZN ZN C 375 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 13.15 -43.20 56.87 12.11 -43.96 58.60 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 8 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS A 163 HIS.? 11.18 O1S EPE C 377 A 50 GLU C 228 GLU.? 9.65 C7 EPE C 377 A 113 GLN C 183 GLN.? 13.97 C5 EPE C 377 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 35.42 -27.01 4.58 35.93 -26.02 2.76 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 2 3 # 2 A 29 HIS A 263 HIS~? 20.93 ZN ZN A 375 A 50 GLU A 253 GLU^? 31.48 ZN ZN A 375 A 113 GLN A 259 GLN~? 28.90 ZN ZN A 375 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 58.90 -16.16 37.51 60.42 -17.61 36.90 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 3 3 # 3 A 29 HIS B 163 HIS.? 11.54 O3S EPE A 377 A 50 GLU A 228 GLU.? 8.71 C3 EPE A 377 A 113 GLN A 183 GLN.? 13.75 O8 EPE A 377 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -6.86 -21.61 -3.42 -8.75 -22.47 -2.89 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 4 3 # 4 A 29 HIS B 359 HIS^? 24.30 ZN ZN B 375 A 50 GLU B 56 GLU~? 18.10 ZN ZN B 374 A 113 GLN B 344 GLN~? 18.67 ZN ZN B 375 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -24.61 -0.12 16.09 -25.84 1.53 15.46 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 5 3 # 5 A 29 HIS B 359 HIS^? 24.30 ZN ZN B 375 A 50 GLU B 349 GLU~? 21.77 ZN ZN B 375 A 113 GLN B 344 GLN~? 18.67 ZN ZN B 375 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -24.61 -0.12 16.09 -25.84 1.53 15.46 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 6 3 # 6 A 29 HIS C 163 HIS.? 22.24 O1 TRS A 378 A 50 GLU B 228 GLU.? 26.61 O2S EPE A 377 A 113 GLN B 183 GLN.? 25.94 O1 TRS A 378 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -2.18 -42.16 24.63 -2.03 -43.87 25.91 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 7.41 -49.44 30.49 8.75 -47.79 30.78 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 7 3 # 7 A 29 HIS C 359 HIS^? 24.82 ZN ZN C 375 A 50 GLU C 56 GLU~? 18.45 ZN ZN C 374 A 113 GLN C 344 GLN~? 18.56 ZN ZN C 375 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 13.15 -43.20 56.87 12.11 -43.96 58.60 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 8 3 # 8 A 29 HIS C 359 HIS^? 24.82 ZN ZN C 375 A 50 GLU C 349 GLU~? 21.43 ZN ZN C 375 A 113 GLN C 344 GLN~? 18.56 ZN ZN C 375 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 13.15 -43.20 56.87 12.11 -43.96 58.60 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 8 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS A 163 HIS.? 11.18 O1S EPE C 377 C 50 GLU C 228 GLU.? 9.65 C7 EPE C 377 C 113 GLN C 183 GLN.? 13.97 C5 EPE C 377 coo 74.92 8.52 28.42 74.88 6.86 29.70 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 65.25 15.95 28.73 65.73 15.63 30.78 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 70.80 6.73 32.72 71.88 8.55 32.53 35.42 -27.01 4.58 35.93 -26.02 2.76 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 2 3 # 2 C 29 HIS A 263 HIS~? 20.93 ZN ZN A 375 C 50 GLU A 253 GLU^? 31.48 ZN ZN A 375 C 113 GLN A 259 GLN~? 28.90 ZN ZN A 375 coo 74.92 8.52 28.42 74.88 6.86 29.70 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 65.25 15.95 28.73 65.73 15.63 30.78 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 70.80 6.73 32.72 71.88 8.55 32.53 58.90 -16.16 37.51 60.42 -17.61 36.90 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 3 3 # 3 C 29 HIS B 163 HIS.? 11.54 O3S EPE A 377 C 50 GLU A 228 GLU.? 8.71 C3 EPE A 377 C 113 GLN A 183 GLN.? 13.75 O8 EPE A 377 coo 74.92 8.52 28.42 74.88 6.86 29.70 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 65.25 15.95 28.73 65.73 15.63 30.78 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 70.80 6.73 32.72 71.88 8.55 32.53 -6.86 -21.61 -3.42 -8.75 -22.47 -2.89 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 4 3 # 4 C 29 HIS B 359 HIS^? 24.30 ZN ZN B 375 C 50 GLU B 56 GLU~? 18.10 ZN ZN B 374 C 113 GLN B 344 GLN~? 18.67 ZN ZN B 375 coo 74.92 8.52 28.42 74.88 6.86 29.70 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 65.25 15.95 28.73 65.73 15.63 30.78 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 70.80 6.73 32.72 71.88 8.55 32.53 -24.61 -0.12 16.09 -25.84 1.53 15.46 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 5 3 # 5 C 29 HIS B 359 HIS^? 24.30 ZN ZN B 375 C 50 GLU B 349 GLU~? 21.77 ZN ZN B 375 C 113 GLN B 344 GLN~? 18.67 ZN ZN B 375 coo 74.92 8.52 28.42 74.88 6.86 29.70 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 65.25 15.95 28.73 65.73 15.63 30.78 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 70.80 6.73 32.72 71.88 8.55 32.53 -24.61 -0.12 16.09 -25.84 1.53 15.46 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 6 3 # 6 C 29 HIS C 163 HIS.? 22.24 O1 TRS A 378 C 50 GLU B 228 GLU.? 26.61 O2S EPE A 377 C 113 GLN B 183 GLN.? 25.94 O1 TRS A 378 coo 74.92 8.52 28.42 74.88 6.86 29.70 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 65.25 15.95 28.73 65.73 15.63 30.78 -2.18 -42.16 24.63 -2.03 -43.87 25.91 coo 70.80 6.73 32.72 71.88 8.55 32.53 7.41 -49.44 30.49 8.75 -47.79 30.78 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 7 3 # 7 C 29 HIS C 359 HIS^? 24.82 ZN ZN C 375 C 50 GLU C 56 GLU~? 18.45 ZN ZN C 374 C 113 GLN C 344 GLN~? 18.56 ZN ZN C 375 coo 74.92 8.52 28.42 74.88 6.86 29.70 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 65.25 15.95 28.73 65.73 15.63 30.78 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 70.80 6.73 32.72 71.88 8.55 32.53 13.15 -43.20 56.87 12.11 -43.96 58.60 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 8 3 # 8 C 29 HIS C 359 HIS^? 24.82 ZN ZN C 375 C 50 GLU C 349 GLU~? 21.43 ZN ZN C 375 C 113 GLN C 344 GLN~? 18.56 ZN ZN C 375 coo 74.92 8.52 28.42 74.88 6.86 29.70 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 65.25 15.95 28.73 65.73 15.63 30.78 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 70.80 6.73 32.72 71.88 8.55 32.53 13.15 -43.20 56.87 12.11 -43.96 58.60 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 8 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS A 163 HIS.? 11.18 O1S EPE C 377 D 50 GLU C 228 GLU.? 9.65 C7 EPE C 377 D 113 GLN C 183 GLN.? 13.97 C5 EPE C 377 coo 38.66 11.31 27.15 38.67 12.13 25.22 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 48.72 12.85 33.83 48.36 14.77 32.95 33.17 -34.88 12.75 35.01 -35.99 12.68 coo 42.85 14.77 24.15 41.85 15.11 26.02 35.42 -27.01 4.58 35.93 -26.02 2.76 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 2 3 # 2 D 29 HIS A 263 HIS~? 20.93 ZN ZN A 375 D 50 GLU A 253 GLU^? 31.48 ZN ZN A 375 D 113 GLN A 259 GLN~? 28.90 ZN ZN A 375 coo 38.66 11.31 27.15 38.67 12.13 25.22 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 48.72 12.85 33.83 48.36 14.77 32.95 58.61 -23.45 31.31 60.40 -23.73 30.22 coo 42.85 14.77 24.15 41.85 15.11 26.02 58.90 -16.16 37.51 60.42 -17.61 36.90 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 3 3 # 3 D 29 HIS B 163 HIS.? 11.54 O3S EPE A 377 D 50 GLU A 228 GLU.? 8.71 C3 EPE A 377 D 113 GLN A 183 GLN.? 13.75 O8 EPE A 377 coo 38.66 11.31 27.15 38.67 12.13 25.22 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 48.72 12.85 33.83 48.36 14.77 32.95 3.91 -21.00 -3.12 3.67 -19.15 -2.10 coo 42.85 14.77 24.15 41.85 15.11 26.02 -6.86 -21.61 -3.42 -8.75 -22.47 -2.89 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 4 3 # 4 D 29 HIS B 359 HIS^? 24.30 ZN ZN B 375 D 50 GLU B 56 GLU~? 18.10 ZN ZN B 374 D 113 GLN B 344 GLN~? 18.67 ZN ZN B 375 coo 38.66 11.31 27.15 38.67 12.13 25.22 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 48.72 12.85 33.83 48.36 14.77 32.95 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 42.85 14.77 24.15 41.85 15.11 26.02 -24.61 -0.12 16.09 -25.84 1.53 15.46 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 5 3 # 5 D 29 HIS B 359 HIS^? 24.30 ZN ZN B 375 D 50 GLU B 349 GLU~? 21.77 ZN ZN B 375 D 113 GLN B 344 GLN~? 18.67 ZN ZN B 375 coo 38.66 11.31 27.15 38.67 12.13 25.22 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 48.72 12.85 33.83 48.36 14.77 32.95 -22.55 -8.05 9.47 -20.93 -7.23 8.30 coo 42.85 14.77 24.15 41.85 15.11 26.02 -24.61 -0.12 16.09 -25.84 1.53 15.46 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 6 3 # 6 D 29 HIS C 163 HIS.? 22.24 O1 TRS A 378 D 50 GLU B 228 GLU.? 26.61 O2S EPE A 377 D 113 GLN B 183 GLN.? 25.94 O1 TRS A 378 coo 38.66 11.31 27.15 38.67 12.13 25.22 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 48.72 12.85 33.83 48.36 14.77 32.95 -2.18 -42.16 24.63 -2.03 -43.87 25.91 coo 42.85 14.77 24.15 41.85 15.11 26.02 7.41 -49.44 30.49 8.75 -47.79 30.78 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 7 3 # 7 D 29 HIS C 359 HIS^? 24.82 ZN ZN C 375 D 50 GLU C 56 GLU~? 18.45 ZN ZN C 374 D 113 GLN C 344 GLN~? 18.56 ZN ZN C 375 coo 38.66 11.31 27.15 38.67 12.13 25.22 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 48.72 12.85 33.83 48.36 14.77 32.95 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 42.85 14.77 24.15 41.85 15.11 26.02 13.15 -43.20 56.87 12.11 -43.96 58.60 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 8 3 # 8 D 29 HIS C 359 HIS^? 24.82 ZN ZN C 375 D 50 GLU C 349 GLU~? 21.43 ZN ZN C 375 D 113 GLN C 344 GLN~? 18.56 ZN ZN C 375 coo 38.66 11.31 27.15 38.67 12.13 25.22 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 48.72 12.85 33.83 48.36 14.77 32.95 13.16 -47.99 47.44 11.07 -47.60 47.14 coo 42.85 14.77 24.15 41.85 15.11 26.02 13.15 -43.20 56.87 12.11 -43.96 58.60 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 8 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 107 ASP~? -2.33 ZN ZN A 375s 219 GLU A 336 GLU~? 2.52 ZN ZN A 375s 294 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 27.89 102.52 14.98 29.35 101.92 13.57 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 25.84 105.87 9.06 27.86 105.55 8.74 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 33.16 106.80 7.72 33.34 104.87 6.92 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 292 ASP^? 8.63 ZN ZN A 374 219 GLU A 336 GLU~? 2.52 ZN ZN A 375s 294 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 27.89 102.52 14.98 29.35 101.92 13.57 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 25.84 105.87 9.06 27.86 105.55 8.74 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 33.16 106.80 7.72 33.34 104.87 6.92 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 306 ASP.? 24.91 ZN ZN A 375 219 GLU A 254 GLU^? 30.93 ZN ZN A 375 294 ASP A 281 ASP.? 28.06 ZN ZN A 375 coo 27.89 102.52 14.98 29.35 101.92 13.57 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 25.84 105.87 9.06 27.86 105.55 8.74 55.35 -23.67 37.01 55.67 -25.35 38.24 coo 33.16 106.80 7.72 33.34 104.87 6.92 52.87 -20.75 45.53 51.52 -19.24 45.99 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP B 107 ASP~? -2.23 ZN ZN B 375s 219 GLU B 336 GLU~? 2.48 ZN ZN B 375s 294 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 27.89 102.52 14.98 29.35 101.92 13.57 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 25.84 105.87 9.06 27.86 105.55 8.74 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 33.16 106.80 7.72 33.34 104.87 6.92 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP B 292 ASP^? 8.88 ZN ZN B 374 219 GLU B 336 GLU~? 2.48 ZN ZN B 375s 294 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 27.89 102.52 14.98 29.35 101.92 13.57 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 25.84 105.87 9.06 27.86 105.55 8.74 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 33.16 106.80 7.72 33.34 104.87 6.92 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP C 107 ASP~? -2.30 ZN ZN C 375s 219 GLU C 336 GLU~? 2.53 ZN ZN C 375s 294 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 27.89 102.52 14.98 29.35 101.92 13.57 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 25.84 105.87 9.06 27.86 105.55 8.74 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 33.16 106.80 7.72 33.34 104.87 6.92 1.43 -20.86 54.35 0.32 -19.00 54.12 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 6 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 48 ASP.? 7.40 ZN ZN A 374 231 ASP A 82 ASP.? 8.88 O2S EPE A 376 294 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 27.89 102.52 14.98 29.35 101.92 13.57 40.70 8.14 28.73 41.06 6.40 29.84 coo 14.74 93.05 -1.00 14.30 94.22 0.73 34.38 27.71 34.24 32.73 27.59 35.53 coo 33.16 106.80 7.72 33.34 104.87 6.92 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 107 ASP~? -2.33 ZN ZN A 375s 231 ASP A 320 ASP~? -21.81 ZN ZN A 374s 294 ASP A 27 ASP.? 8.12 ZN ZN A 375 coo 27.89 102.52 14.98 29.35 101.92 13.57 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 14.74 93.05 -1.00 14.30 94.22 0.73 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 33.16 106.80 7.72 33.34 104.87 6.92 27.49 -0.90 27.62 29.53 -0.28 27.44 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 115 ASP~? 13.24 ZN ZN A 375 231 ASP A 352 ASP~? 25.70 ZN ZN A 375 294 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 27.89 102.52 14.98 29.35 101.92 13.57 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 14.74 93.05 -1.00 14.30 94.22 0.73 43.66 -0.56 3.32 44.78 0.99 4.29 coo 33.16 106.80 7.72 33.34 104.87 6.92 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 269 ASP.? 18.90 ZN ZN A 374 231 ASP A 306 ASP.? 24.91 ZN ZN A 375 294 ASP A 368 ASP.? 11.85 ZN ZN A 374 coo 27.89 102.52 14.98 29.35 101.92 13.57 54.82 -1.21 28.36 56.43 0.27 28.67 coo 14.74 93.05 -1.00 14.30 94.22 0.73 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 33.16 106.80 7.72 33.34 104.87 6.92 48.24 5.16 33.58 47.82 3.96 35.30 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP A 292 ASP^? 8.63 ZN ZN A 374 231 ASP A 306 ASP.? 24.91 ZN ZN A 375 294 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 27.89 102.52 14.98 29.35 101.92 13.57 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 14.74 93.05 -1.00 14.30 94.22 0.73 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 33.16 106.80 7.72 33.34 104.87 6.92 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP A 306 ASP.? 24.91 ZN ZN A 375 231 ASP A 269 ASP.? 18.90 ZN ZN A 374 294 ASP A 281 ASP.? 28.06 ZN ZN A 375 coo 27.89 102.52 14.98 29.35 101.92 13.57 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 14.74 93.05 -1.00 14.30 94.22 0.73 54.82 -1.21 28.36 56.43 0.27 28.67 coo 33.16 106.80 7.72 33.34 104.87 6.92 52.87 -20.75 45.53 51.52 -19.24 45.99 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP A 306 ASP.? 24.91 ZN ZN A 375 231 ASP A 292 ASP^? 8.63 ZN ZN A 374 294 ASP A 281 ASP.? 28.06 ZN ZN A 375 coo 27.89 102.52 14.98 29.35 101.92 13.57 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 14.74 93.05 -1.00 14.30 94.22 0.73 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 33.16 106.80 7.72 33.34 104.87 6.92 52.87 -20.75 45.53 51.52 -19.24 45.99 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP A 306 ASP.? 24.91 ZN ZN A 375 231 ASP A 312 ASP.? 7.50 ZN ZN A 374 294 ASP A 281 ASP.? 28.06 ZN ZN A 375 coo 27.89 102.52 14.98 29.35 101.92 13.57 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 14.74 93.05 -1.00 14.30 94.22 0.73 39.49 -1.24 39.18 39.76 0.49 37.96 coo 33.16 106.80 7.72 33.34 104.87 6.92 52.87 -20.75 45.53 51.52 -19.24 45.99 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP B 107 ASP~? -2.23 ZN ZN B 375s 231 ASP B 320 ASP~? -21.78 ZN ZN B 374s 294 ASP B 27 ASP.? 8.17 ZN ZN B 375 coo 27.89 102.52 14.98 29.35 101.92 13.57 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 14.74 93.05 -1.00 14.30 94.22 0.73 9.35 16.65 21.02 10.22 16.89 22.90 coo 33.16 106.80 7.72 33.34 104.87 6.92 -5.26 -2.13 28.94 -6.77 -0.82 28.14 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP B 115 ASP~? 12.98 ZN ZN B 375 231 ASP B 352 ASP~? 25.82 ZN ZN B 375 294 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 27.89 102.52 14.98 29.35 101.92 13.57 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo 33.16 106.80 7.72 33.34 104.87 6.92 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP B 269 ASP.? 18.26 ZN ZN B 374 231 ASP B 306 ASP.? 24.86 ZN ZN B 375 294 ASP B 368 ASP.? 11.70 ZN ZN B 374 coo 27.89 102.52 14.98 29.35 101.92 13.57 -18.05 15.19 12.20 -19.75 16.35 12.84 coo 14.74 93.05 -1.00 14.30 94.22 0.73 3.99 14.73 5.36 5.18 14.04 3.76 coo 33.16 106.80 7.72 33.34 104.87 6.92 -15.86 16.57 22.39 -13.84 17.32 22.21 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP B 292 ASP^? 8.88 ZN ZN B 374 231 ASP B 306 ASP.? 24.86 ZN ZN B 375 294 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 27.89 102.52 14.98 29.35 101.92 13.57 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 14.74 93.05 -1.00 14.30 94.22 0.73 3.99 14.73 5.36 5.18 14.04 3.76 coo 33.16 106.80 7.72 33.34 104.87 6.92 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP C 48 ASP.? 7.30 ZN ZN C 374 231 ASP C 82 ASP.? 10.22 O3S EPE C 376 294 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 14.74 93.05 -1.00 14.30 94.22 0.73 23.03 -14.86 74.18 22.44 -14.42 76.16 coo 33.16 106.80 7.72 33.34 104.87 6.92 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 14 3 # 14 193 ASP C 107 ASP~? -2.30 ZN ZN C 375s 231 ASP C 320 ASP~? -21.75 ZN ZN C 374s 294 ASP C 27 ASP.? 8.23 ZN ZN C 375 coo 27.89 102.52 14.98 29.35 101.92 13.57 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 33.16 106.80 7.72 33.34 104.87 6.92 12.27 -21.58 47.53 11.82 -22.95 49.16 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 15 3 # 15 193 ASP C 115 ASP~? 12.87 ZN ZN C 375 231 ASP C 352 ASP~? 25.48 ZN ZN C 375 294 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 27.89 102.52 14.98 29.35 101.92 13.57 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 14.74 93.05 -1.00 14.30 94.22 0.73 18.63 -50.25 49.90 18.47 -49.69 51.95 coo 33.16 106.80 7.72 33.34 104.87 6.92 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 16 3 # 16 193 ASP C 269 ASP~? 18.04 ZN ZN C 374 231 ASP C 306 ASP.? 24.81 ZN ZN C 375 294 ASP C 368 ASP.? 11.74 ZN ZN C 374 coo 27.89 102.52 14.98 29.35 101.92 13.57 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 33.16 106.80 7.72 33.34 104.87 6.92 2.31 -29.36 66.29 0.59 -28.37 65.47 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 17 3 # 17 193 ASP C 292 ASP^? 8.69 ZN ZN C 374 231 ASP C 306 ASP.? 24.81 ZN ZN C 375 294 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 27.89 102.52 14.98 29.35 101.92 13.57 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 33.16 106.80 7.72 33.34 104.87 6.92 5.80 -28.16 48.27 6.08 -27.64 50.28 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 17 hits 2amg_c06 naa= 3 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 1 3 # 1 105 GLU B 56 GLU~? 18.10 ZN ZN B 374 107 ASP B 55 ASP~? 16.89 O3S EPE B 376 109 GLU B 52 GLU~? 15.59 C2 EPE B 376 coo 15.97 13.58 10.29 15.12 15.36 9.48 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 20.07 16.34 11.47 18.03 16.15 11.04 -29.80 9.25 31.21 -29.50 10.07 33.15 coo 20.99 19.84 9.56 19.07 20.34 10.22 -26.20 13.19 30.44 -25.34 14.95 29.81 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 2 3 # 2 105 GLU C 51 GLU~? 12.03 O3S EPE C 376 107 ASP C 55 ASP~? 17.38 O3S EPE C 376 109 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo 15.97 13.58 10.29 15.12 15.36 9.48 19.07 -27.28 70.66 19.78 -25.91 72.07 coo 20.07 16.34 11.47 18.03 16.15 11.04 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 20.99 19.84 9.56 19.07 20.34 10.22 13.88 -30.69 72.19 13.68 -28.54 72.17 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 3 3 # 3 105 GLU C 56 GLU~? 18.45 ZN ZN C 374 107 ASP C 55 ASP~? 17.38 O3S EPE C 376 109 GLU C 52 GLU~? 13.90 C2 EPE C 376 coo 15.97 13.58 10.29 15.12 15.36 9.48 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 20.07 16.34 11.47 18.03 16.15 11.04 19.09 -33.39 71.33 19.50 -31.61 72.40 coo 20.99 19.84 9.56 19.07 20.34 10.22 13.88 -30.69 72.19 13.68 -28.54 72.17 2ayh_c00 source 2ayh 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROLASE (E.C.: 3 hits 2ayh_c00 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 263 HIS~? 20.93 ZN ZN A 375 B 163 ALA A 120 ALA~? 14.58 ZN ZN A 375 B 182 SER A 267 SER~? 18.73 ZN ZN A 375 coo 30.42 1.98 4.36 29.07 0.41 4.68 55.65 -12.70 31.62 54.70 -13.41 29.88 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 50.64 -9.84 24.82 50.10 -8.49 25.27 coo 24.00 -0.17 2.07 24.51 1.00 0.04 54.41 -7.54 28.59 54.43 -9.91 28.92 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS A 361 HIS^? 22.47 ZN ZN A 375 B 163 ALA A 362 ALA^? 15.97 ZN ZN A 375 B 182 SER A 363 SER.? 15.15 ZN ZN A 374 coo 30.42 1.98 4.36 29.07 0.41 4.68 46.25 9.10 12.92 46.66 10.09 11.12 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 46.25 5.46 17.59 47.00 4.15 17.82 coo 24.00 -0.17 2.07 24.51 1.00 0.04 46.51 8.06 20.34 45.84 9.37 22.25 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS B 263 HIS~? 20.98 ZN ZN B 375 B 163 ALA B 120 ALA~? 14.73 ZN ZN B 375 B 182 SER B 267 SER~? 18.54 ZN ZN B 375 coo 30.42 1.98 4.36 29.07 0.41 4.68 -9.35 15.85 4.33 -10.07 14.01 3.63 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -12.64 8.39 7.33 -13.08 8.77 8.73 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -13.83 13.99 7.82 -11.74 14.03 6.57 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS C 21 HIS~? 17.02 O1 TRS A 378 B 163 ALA C 210 ALA.? 10.68 O1 TRS A 378 B 182 SER C 211 SER.? 14.21 O1 TRS A 378 coo 30.42 1.98 4.36 29.07 0.41 4.68 14.59 -28.36 37.80 14.05 -30.33 37.30 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 15.20 -30.13 29.07 14.89 -28.65 29.26 coo 24.00 -0.17 2.07 24.51 1.00 0.04 16.63 -31.54 32.35 15.08 -33.00 33.51 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 5 3 # 5 B 46 HIS C 263 HIS~? 20.89 ZN ZN C 375 B 163 ALA C 120 ALA~? 14.58 ZN ZN C 375 B 182 SER C 267 SER~? 17.79 ZN ZN C 375 coo 30.42 1.98 4.36 29.07 0.41 4.68 -11.47 -39.00 56.70 -10.25 -40.03 55.33 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -3.31 -40.28 53.77 -2.51 -39.27 54.59 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -6.30 -39.53 58.90 -6.77 -39.38 56.53 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 5 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 153 ARG~? 11.00 C6 EPE C 377 A 161 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 174 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 214 ARG~? 20.32 O1S EPE C 377 A 161 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 174 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 17.59 -9.46 5.35 20.56 -9.02 6.23 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG B 153 ARG~? 10.73 C6 EPE A 377 A 161 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 174 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG B 214 ARG~? 23.93 O3S EPE A 377 A 161 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 174 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -7.68 -23.63 22.44 -8.04 -24.96 25.17 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 5 3 # 5 A 14 ARG C 153 ARG~? 15.97 C2 EPE C 377 A 161 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 174 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 23.23 -33.44 18.32 24.66 -32.16 20.35 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 5 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 153 ARG~? 11.00 C6 EPE C 377 B 161 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 174 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo -14.86 10.19 8.14 -14.82 12.31 8.42 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -21.46 12.70 8.53 -19.04 12.30 7.24 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 214 ARG~? 20.32 O1S EPE C 377 B 161 ASP A 232 ASP^? 4.68 O1S EPE A 377 B 174 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 17.59 -9.46 5.35 20.56 -9.02 6.23 coo -14.86 10.19 8.14 -14.82 12.31 8.42 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -21.46 12.70 8.53 -19.04 12.30 7.24 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG B 153 ARG~? 10.73 C6 EPE A 377 B 161 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 174 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo -14.86 10.19 8.14 -14.82 12.31 8.42 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -21.46 12.70 8.53 -19.04 12.30 7.24 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG B 214 ARG~? 23.93 O3S EPE A 377 B 161 ASP B 232 ASP^? 14.54 O2S EPE A 377 B 174 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -7.68 -23.63 22.44 -8.04 -24.96 25.17 coo -14.86 10.19 8.14 -14.82 12.31 8.42 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -21.46 12.70 8.53 -19.04 12.30 7.24 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 5 3 # 5 B 14 ARG C 153 ARG~? 15.97 C2 EPE C 377 B 161 ASP C 232 ASP^? 3.77 O2S EPE C 377 B 174 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -14.86 10.19 8.14 -14.82 12.31 8.42 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -21.46 12.70 8.53 -19.04 12.30 7.24 23.23 -33.44 18.32 24.66 -32.16 20.35 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 5 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 153 ARG~? 11.00 C6 EPE C 377 C 161 ASP A 232 ASP^? 4.68 O1S EPE A 377 C 174 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo 2.84 19.43 40.34 1.59 20.35 37.65 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo -0.62 11.10 28.05 -0.65 13.15 27.46 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 5.94 13.28 27.17 3.53 13.05 28.58 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 214 ARG~? 20.32 O1S EPE C 377 C 161 ASP A 232 ASP^? 4.68 O1S EPE A 377 C 174 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo 2.84 19.43 40.34 1.59 20.35 37.65 17.59 -9.46 5.35 20.56 -9.02 6.23 coo -0.62 11.10 28.05 -0.65 13.15 27.46 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 5.94 13.28 27.17 3.53 13.05 28.58 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG B 153 ARG~? 10.73 C6 EPE A 377 C 161 ASP B 232 ASP^? 14.54 O2S EPE A 377 C 174 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo 2.84 19.43 40.34 1.59 20.35 37.65 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo -0.62 11.10 28.05 -0.65 13.15 27.46 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 5.94 13.28 27.17 3.53 13.05 28.58 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG B 214 ARG~? 23.93 O3S EPE A 377 C 161 ASP B 232 ASP^? 14.54 O2S EPE A 377 C 174 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo 2.84 19.43 40.34 1.59 20.35 37.65 -7.68 -23.63 22.44 -8.04 -24.96 25.17 coo -0.62 11.10 28.05 -0.65 13.15 27.46 6.16 -32.41 17.86 6.89 -34.31 18.36 coo 5.94 13.28 27.17 3.53 13.05 28.58 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG C 153 ARG~? 15.97 C2 EPE C 377 C 161 ASP C 232 ASP^? 3.77 O2S EPE C 377 C 174 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo 2.84 19.43 40.34 1.59 20.35 37.65 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -0.62 11.10 28.05 -0.65 13.15 27.46 18.91 -30.34 15.16 19.98 -30.20 13.32 coo 5.94 13.28 27.17 3.53 13.05 28.58 23.23 -33.44 18.32 24.66 -32.16 20.35 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 6 3 # 6 C 14 ARG C 203 ARG^? 8.27 O3S EPE C 377 C 161 ASP A 232 ASP^? 4.68 O1S EPE A 377 C 174 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo 2.84 19.43 40.34 1.59 20.35 37.65 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -0.62 11.10 28.05 -0.65 13.15 27.46 9.54 -24.20 7.87 7.70 -24.91 7.05 coo 5.94 13.28 27.17 3.53 13.05 28.58 11.27 -20.99 3.01 11.22 -18.21 3.38 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 6 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 153 ARG~? 11.00 C6 EPE C 377 D 161 ASP A 232 ASP^? 4.68 O1S EPE A 377 D 174 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 214 ARG~? 20.32 O1S EPE C 377 D 161 ASP A 232 ASP^? 4.68 O1S EPE A 377 D 174 TYR A 231 TYR^? 10.06 O1S EPE A 377 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 17.59 -9.46 5.35 20.56 -9.02 6.23 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 11.27 -20.99 3.01 11.22 -18.21 3.38 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG B 153 ARG~? 10.73 C6 EPE A 377 D 161 ASP B 232 ASP^? 14.54 O2S EPE A 377 D 174 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG B 214 ARG~? 23.93 O3S EPE A 377 D 161 ASP B 232 ASP^? 14.54 O2S EPE A 377 D 174 TYR B 231 TYR^? 16.39 O2S EPE A 377 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -7.68 -23.63 22.44 -8.04 -24.96 25.17 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 0.21 -33.87 18.84 -0.97 -32.67 21.03 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 5 3 # 5 D 14 ARG C 153 ARG~? 15.97 C2 EPE C 377 D 161 ASP C 232 ASP^? 3.77 O2S EPE C 377 D 174 TYR C 231 TYR^? -4.25 C2 TRS A 378s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 23.23 -33.44 18.32 24.66 -32.16 20.35 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 5 hits 2c7v_c11 naa= 3 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 1 3 # 1 65 THR A 177 THR^? 8.80 C6 EPE A 377 242 CYH B 170 CYH^? -5.04 N1 EPE A 377s 270 PHE A 180 PHE^? 4.05 O8 EPE A 377 coo 12.97 28.35 3.84 11.81 28.07 2.09 4.52 -36.86 -0.44 3.03 -38.32 -1.01 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -0.70 -28.36 2.22 -0.22 -26.07 0.51 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -0.71 -29.06 -4.30 -0.06 -29.96 -6.91 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 2 3 # 2 65 THR B 177 THR^? 19.16 C2 EPE C 377 242 CYH C 170 CYH^? 22.19 N TRS A 378 270 PHE B 180 PHE^? 25.23 O2S EPE A 377 coo 12.97 28.35 3.84 11.81 28.07 2.09 9.43 -46.41 11.44 10.68 -47.97 10.55 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 9.66 -43.43 21.72 7.18 -43.27 22.99 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 5.49 -47.88 21.09 3.41 -49.53 20.15 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 3 3 # 3 65 THR C 177 THR^? 8.04 C8 EPE C 377 242 CYH A 170 CYH^? -4.87 C10 EPE C 377s 270 PHE C 180 PHE^? -4.33 O8 EPE C 377s coo 12.97 28.35 3.84 11.81 28.07 2.09 20.64 -38.60 2.16 21.28 -38.84 0.08 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 25.74 -30.01 4.94 27.86 -30.22 6.82 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 29.90 -34.68 4.21 31.04 -37.24 4.01 2cnd_c01 source 2cnd NADH-DEPENDENT NITRATE REDUCTASE (CYTOCHROME B: 3 hits 2cnd_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 56 GLU~? 18.18 ZN ZN A 374 A 156 GLU A 52 GLU~? 13.77 C2 EPE A 376 A 194 ASN A 95 ASN~? 18.99 O2S EPE A 376 coo 74.14 15.91 8.55 72.08 15.36 8.63 47.24 13.21 19.42 47.19 11.28 20.29 coo 67.47 20.07 1.34 65.99 20.06 2.88 46.63 16.37 27.65 45.50 16.12 29.45 coo 67.44 25.26 13.91 67.54 23.65 15.28 37.50 21.37 17.07 38.56 22.79 18.19 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 127 GLU^? 14.05 O3 TRS A 378 A 156 GLU A 241 GLU^? 13.09 O3 TRS A 378 A 194 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 74.14 15.91 8.55 72.08 15.36 8.63 39.39 -22.49 26.46 38.47 -23.38 24.73 coo 67.47 20.07 1.34 65.99 20.06 2.88 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 67.44 25.26 13.91 67.54 23.65 15.28 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 135 GLU^? 12.87 C3 TRS A 378 A 156 GLU A 241 GLU^? 13.09 O3 TRS A 378 A 194 ASN A 105 ASN~? 9.65 ZN ZN A 375 coo 74.14 15.91 8.55 72.08 15.36 8.63 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 67.47 20.07 1.34 65.99 20.06 2.88 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 67.44 25.26 13.91 67.54 23.65 15.28 30.92 -4.10 21.33 31.10 -1.93 21.21 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU A 241 GLU^? 13.09 O3 TRS A 378 A 156 GLU A 127 GLU^? 14.05 O3 TRS A 378 A 194 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 74.14 15.91 8.55 72.08 15.36 8.63 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 67.47 20.07 1.34 65.99 20.06 2.88 39.39 -22.49 26.46 38.47 -23.38 24.73 coo 67.44 25.26 13.91 67.54 23.65 15.28 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU B 127 GLU^? 21.05 ZN ZN B 375 A 156 GLU B 241 GLU^? 19.53 O1S EPE A 377 A 194 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo 74.14 15.91 8.55 72.08 15.36 8.63 2.11 -0.28 5.62 1.83 -2.30 4.96 coo 67.47 20.07 1.34 65.99 20.06 2.88 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 67.44 25.26 13.91 67.54 23.65 15.28 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU C 56 GLU~? 18.45 ZN ZN C 374 A 156 GLU C 52 GLU~? 13.90 C2 EPE C 376 A 194 ASN C 95 ASN~? 19.32 O3S EPE C 376 coo 74.14 15.91 8.55 72.08 15.36 8.63 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 67.47 20.07 1.34 65.99 20.06 2.88 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 67.44 25.26 13.91 67.54 23.65 15.28 27.60 -31.58 66.97 27.57 -31.41 69.09 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU C 127 GLU^? 21.05 ZN ZN C 375 A 156 GLU C 241 GLU^? 18.99 ZN ZN C 375 A 194 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 74.14 15.91 8.55 72.08 15.36 8.63 -6.33 -33.63 38.15 -7.56 -32.26 37.10 coo 67.47 20.07 1.34 65.99 20.06 2.88 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 67.44 25.26 13.91 67.54 23.65 15.28 0.77 -32.01 47.92 1.06 -30.12 48.87 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU C 241 GLU^? 18.99 ZN ZN C 375 A 156 GLU C 127 GLU^? 21.05 ZN ZN C 375 A 194 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 74.14 15.91 8.55 72.08 15.36 8.63 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 67.47 20.07 1.34 65.99 20.06 2.88 -6.33 -33.63 38.15 -7.56 -32.26 37.10 coo 67.44 25.26 13.91 67.54 23.65 15.28 0.77 -32.01 47.92 1.06 -30.12 48.87 2dbt_c00 source 2dbt CHITINASE C : 8 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 56 GLU~? 18.18 ZN ZN A 374 B 156 GLU A 52 GLU~? 13.77 C2 EPE A 376 B 194 ASN A 95 ASN~? 18.99 O2S EPE A 376 coo 45.64 63.11 17.20 47.48 62.43 16.45 47.24 13.21 19.42 47.19 11.28 20.29 coo 54.43 67.89 19.82 55.62 67.90 18.07 46.63 16.37 27.65 45.50 16.12 29.45 coo 49.79 70.75 7.78 50.10 68.90 6.86 37.50 21.37 17.07 38.56 22.79 18.19 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 127 GLU^? 14.05 O3 TRS A 378 B 156 GLU A 241 GLU^? 13.09 O3 TRS A 378 B 194 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 45.64 63.11 17.20 47.48 62.43 16.45 39.39 -22.49 26.46 38.47 -23.38 24.73 coo 54.43 67.89 19.82 55.62 67.90 18.07 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 49.79 70.75 7.78 50.10 68.90 6.86 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 135 GLU^? 12.87 C3 TRS A 378 B 156 GLU A 241 GLU^? 13.09 O3 TRS A 378 B 194 ASN A 105 ASN~? 9.65 ZN ZN A 375 coo 45.64 63.11 17.20 47.48 62.43 16.45 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 54.43 67.89 19.82 55.62 67.90 18.07 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 49.79 70.75 7.78 50.10 68.90 6.86 30.92 -4.10 21.33 31.10 -1.93 21.21 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU A 241 GLU^? 13.09 O3 TRS A 378 B 156 GLU A 127 GLU^? 14.05 O3 TRS A 378 B 194 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 45.64 63.11 17.20 47.48 62.43 16.45 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 54.43 67.89 19.82 55.62 67.90 18.07 39.39 -22.49 26.46 38.47 -23.38 24.73 coo 49.79 70.75 7.78 50.10 68.90 6.86 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU B 52 GLU~? 15.59 C2 EPE B 376 B 156 GLU B 56 GLU~? 18.10 ZN ZN B 374 B 194 ASN B 95 ASN~? 19.50 O2S EPE B 376 coo 45.64 63.11 17.20 47.48 62.43 16.45 -26.20 13.19 30.44 -25.34 14.95 29.81 coo 54.43 67.89 19.82 55.62 67.90 18.07 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 49.79 70.75 7.78 50.10 68.90 6.86 -30.82 1.14 36.18 -31.61 2.89 37.07 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU B 56 GLU~? 18.10 ZN ZN B 374 B 156 GLU B 52 GLU~? 15.59 C2 EPE B 376 B 194 ASN B 95 ASN~? 19.50 O2S EPE B 376 coo 45.64 63.11 17.20 47.48 62.43 16.45 -28.81 7.12 24.95 -27.13 7.39 23.64 coo 54.43 67.89 19.82 55.62 67.90 18.07 -26.20 13.19 30.44 -25.34 14.95 29.81 coo 49.79 70.75 7.78 50.10 68.90 6.86 -30.82 1.14 36.18 -31.61 2.89 37.07 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU C 52 GLU~? 13.90 C2 EPE C 376 B 156 GLU C 56 GLU~? 18.45 ZN ZN C 374 B 194 ASN C 95 ASN~? 19.32 O3S EPE C 376 coo 45.64 63.11 17.20 47.48 62.43 16.45 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 54.43 67.89 19.82 55.62 67.90 18.07 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 49.79 70.75 7.78 50.10 68.90 6.86 27.60 -31.58 66.97 27.57 -31.41 69.09 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU C 56 GLU~? 18.45 ZN ZN C 374 B 156 GLU C 52 GLU~? 13.90 C2 EPE C 376 B 194 ASN C 95 ASN~? 19.32 O3S EPE C 376 coo 45.64 63.11 17.20 47.48 62.43 16.45 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 54.43 67.89 19.82 55.62 67.90 18.07 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 49.79 70.75 7.78 50.10 68.90 6.86 27.60 -31.58 66.97 27.57 -31.41 69.09 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU C 127 GLU^? 21.05 ZN ZN C 375 B 156 GLU C 241 GLU^? 18.99 ZN ZN C 375 B 194 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 45.64 63.11 17.20 47.48 62.43 16.45 -6.33 -33.63 38.15 -7.56 -32.26 37.10 coo 54.43 67.89 19.82 55.62 67.90 18.07 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 49.79 70.75 7.78 50.10 68.90 6.86 0.77 -32.01 47.92 1.06 -30.12 48.87 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU C 135 GLU^? 15.12 O1 TRS A 378 B 156 GLU C 241 GLU^? 18.99 ZN ZN C 375 B 194 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo 45.64 63.11 17.20 47.48 62.43 16.45 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 54.43 67.89 19.82 55.62 67.90 18.07 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 49.79 70.75 7.78 50.10 68.90 6.86 12.40 -28.97 45.42 13.67 -29.13 47.17 ULMN 3 2dbt_c01 CHITINASE C user 11 3 # 11 B 147 GLU C 241 GLU^? 18.99 ZN ZN C 375 B 156 GLU C 127 GLU^? 21.05 ZN ZN C 375 B 194 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 45.64 63.11 17.20 47.48 62.43 16.45 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 54.43 67.89 19.82 55.62 67.90 18.07 -6.33 -33.63 38.15 -7.56 -32.26 37.10 coo 49.79 70.75 7.78 50.10 68.90 6.86 0.77 -32.01 47.92 1.06 -30.12 48.87 ULMN 3 2dbt_c01 CHITINASE C user 12 3 # 12 B 147 GLU C 241 GLU^? 18.99 ZN ZN C 375 B 156 GLU C 135 GLU^? 15.12 O1 TRS A 378 B 194 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo 45.64 63.11 17.20 47.48 62.43 16.45 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 54.43 67.89 19.82 55.62 67.90 18.07 11.24 -30.50 31.64 12.59 -30.76 33.22 coo 49.79 70.75 7.78 50.10 68.90 6.86 12.40 -28.97 45.42 13.67 -29.13 47.17 2dbt_c01 source 2dbt CHITINASE C : 12 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 56 GLU~? 18.18 ZN ZN A 374 C 156 GLU A 52 GLU~? 13.77 C2 EPE A 376 C 194 ASN A 95 ASN~? 18.99 O2S EPE A 376 coo 41.23 29.31 13.28 43.03 29.85 12.29 47.24 13.21 19.42 47.19 11.28 20.29 coo 44.75 23.09 5.51 46.77 22.91 6.12 46.63 16.37 27.65 45.50 16.12 29.45 coo 49.75 21.00 18.12 50.45 23.02 18.26 37.50 21.37 17.07 38.56 22.79 18.19 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 127 GLU^? 14.05 O3 TRS A 378 C 156 GLU A 241 GLU^? 13.09 O3 TRS A 378 C 194 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 41.23 29.31 13.28 43.03 29.85 12.29 39.39 -22.49 26.46 38.47 -23.38 24.73 coo 44.75 23.09 5.51 46.77 22.91 6.12 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 49.75 21.00 18.12 50.45 23.02 18.26 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 135 GLU^? 12.87 C3 TRS A 378 C 156 GLU A 241 GLU^? 13.09 O3 TRS A 378 C 194 ASN A 105 ASN~? 9.65 ZN ZN A 375 coo 41.23 29.31 13.28 43.03 29.85 12.29 24.60 -15.96 15.66 25.54 -15.70 13.79 coo 44.75 23.09 5.51 46.77 22.91 6.12 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 49.75 21.00 18.12 50.45 23.02 18.26 30.92 -4.10 21.33 31.10 -1.93 21.21 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU A 241 GLU^? 13.09 O3 TRS A 378 C 156 GLU A 127 GLU^? 14.05 O3 TRS A 378 C 194 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 41.23 29.31 13.28 43.03 29.85 12.29 32.85 -18.83 18.59 34.29 -17.80 17.42 coo 44.75 23.09 5.51 46.77 22.91 6.12 39.39 -22.49 26.46 38.47 -23.38 24.73 coo 49.75 21.00 18.12 50.45 23.02 18.26 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU B 127 GLU^? 21.05 ZN ZN B 375 C 156 GLU B 241 GLU^? 19.53 O1S EPE A 377 C 194 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo 41.23 29.31 13.28 43.03 29.85 12.29 2.11 -0.28 5.62 1.83 -2.30 4.96 coo 44.75 23.09 5.51 46.77 22.91 6.12 -1.76 -10.13 8.02 -3.43 -8.87 7.45 coo 49.75 21.00 18.12 50.45 23.02 18.26 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU C 52 GLU~? 13.90 C2 EPE C 376 C 156 GLU C 56 GLU~? 18.45 ZN ZN C 374 C 194 ASN C 95 ASN~? 19.32 O3S EPE C 376 coo 41.23 29.31 13.28 43.03 29.85 12.29 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 44.75 23.09 5.51 46.77 22.91 6.12 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 49.75 21.00 18.12 50.45 23.02 18.26 27.60 -31.58 66.97 27.57 -31.41 69.09 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU C 56 GLU~? 18.45 ZN ZN C 374 C 156 GLU C 52 GLU~? 13.90 C2 EPE C 376 C 194 ASN C 95 ASN~? 19.32 O3S EPE C 376 coo 41.23 29.31 13.28 43.03 29.85 12.29 16.30 -37.83 67.27 14.46 -37.72 66.25 coo 44.75 23.09 5.51 46.77 22.91 6.12 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 49.75 21.00 18.12 50.45 23.02 18.26 27.60 -31.58 66.97 27.57 -31.41 69.09 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU C 127 GLU^? 21.05 ZN ZN C 375 C 156 GLU C 241 GLU^? 18.99 ZN ZN C 375 C 194 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 41.23 29.31 13.28 43.03 29.85 12.29 -6.33 -33.63 38.15 -7.56 -32.26 37.10 coo 44.75 23.09 5.51 46.77 22.91 6.12 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 49.75 21.00 18.12 50.45 23.02 18.26 0.77 -32.01 47.92 1.06 -30.12 48.87 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU C 241 GLU^? 18.99 ZN ZN C 375 C 156 GLU C 127 GLU^? 21.05 ZN ZN C 375 C 194 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 41.23 29.31 13.28 43.03 29.85 12.29 4.84 -34.67 34.91 4.64 -36.58 35.93 coo 44.75 23.09 5.51 46.77 22.91 6.12 -6.33 -33.63 38.15 -7.56 -32.26 37.10 coo 49.75 21.00 18.12 50.45 23.02 18.26 0.77 -32.01 47.92 1.06 -30.12 48.87 2dbt_c02 source 2dbt CHITINASE C : 9 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 A 184 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 5.98 42.76 7.73 10.19 38.62 9.02 35.91 21.93 28.51 38.15 26.57 30.75 coo 2.77 37.17 4.99 6.33 34.76 8.06 36.23 21.81 22.32 41.86 22.67 23.70 coo 0.07 40.30 18.65 -0.21 42.34 18.18 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 A 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 A 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 5.98 42.76 7.73 10.19 38.62 9.02 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 2.77 37.17 4.99 6.33 34.76 8.06 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 0.07 40.30 18.65 -0.21 42.34 18.18 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 3 3 # 3 A 182 LYS A 265 LYS~? 22.38 ZN ZN A 374 A 184 LYS A 271 LYS.? 23.00 ZN ZN A 374 A 345 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 5.98 42.76 7.73 10.19 38.62 9.02 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 2.77 37.17 4.99 6.33 34.76 8.06 56.12 0.48 35.73 59.67 4.01 35.99 coo 0.07 40.30 18.65 -0.21 42.34 18.18 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 4 3 # 4 A 182 LYS A 301 LYS~? 24.94 ZN ZN A 375 A 184 LYS A 303 LYS~? 13.81 O3 TRS A 378 A 345 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 5.98 42.76 7.73 10.19 38.62 9.02 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 2.77 37.17 4.99 6.33 34.76 8.06 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 0.07 40.30 18.65 -0.21 42.34 18.18 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 5 3 # 5 A 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 5.98 42.76 7.73 10.19 38.62 9.02 45.66 0.76 26.15 51.53 0.58 28.90 coo 2.77 37.17 4.99 6.33 34.76 8.06 44.47 1.55 20.70 47.30 5.10 24.27 coo 0.07 40.30 18.65 -0.21 42.34 18.18 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 6 3 # 6 A 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 5.98 42.76 7.73 10.19 38.62 9.02 45.66 0.76 26.15 51.53 0.58 28.90 coo 2.77 37.17 4.99 6.33 34.76 8.06 44.47 1.55 20.70 47.30 5.10 24.27 coo 0.07 40.30 18.65 -0.21 42.34 18.18 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 7 3 # 7 A 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 5.98 42.76 7.73 10.19 38.62 9.02 44.47 1.55 20.70 47.30 5.10 24.27 coo 2.77 37.17 4.99 6.33 34.76 8.06 45.66 0.76 26.15 51.53 0.58 28.90 coo 0.07 40.30 18.65 -0.21 42.34 18.18 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 8 3 # 8 A 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 A 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 5.98 42.76 7.73 10.19 38.62 9.02 44.47 1.55 20.70 47.30 5.10 24.27 coo 2.77 37.17 4.99 6.33 34.76 8.06 45.66 0.76 26.15 51.53 0.58 28.90 coo 0.07 40.30 18.65 -0.21 42.34 18.18 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 9 3 # 9 A 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 A 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 5.98 42.76 7.73 10.19 38.62 9.02 44.47 1.55 20.70 47.30 5.10 24.27 coo 2.77 37.17 4.99 6.33 34.76 8.06 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 0.07 40.30 18.65 -0.21 42.34 18.18 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 10 3 # 10 A 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 A 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 5.98 42.76 7.73 10.19 38.62 9.02 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 2.77 37.17 4.99 6.33 34.76 8.06 44.47 1.55 20.70 47.30 5.10 24.27 coo 0.07 40.30 18.65 -0.21 42.34 18.18 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 11 3 # 11 A 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 A 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 5.98 42.76 7.73 10.19 38.62 9.02 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 2.77 37.17 4.99 6.33 34.76 8.06 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 12 3 # 12 A 182 LYS B 265 LYS~? 21.91 ZN ZN B 374 A 184 LYS B 271 LYS.? 19.93 ZN ZN B 374 A 345 ASP B 330 ASP^? 11.92 ZN ZN B 374 coo 5.98 42.76 7.73 10.19 38.62 9.02 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 2.77 37.17 4.99 6.33 34.76 8.06 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -4.33 18.16 18.13 -5.04 17.21 19.90 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 13 3 # 13 A 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 A 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 A 345 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 5.98 42.76 7.73 10.19 38.62 9.02 8.36 10.35 11.75 10.05 14.82 9.04 coo 2.77 37.17 4.99 6.33 34.76 8.06 7.99 5.97 9.05 6.92 1.04 11.01 coo 0.07 40.30 18.65 -0.21 42.34 18.18 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 14 3 # 14 A 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 5.98 42.76 7.73 10.19 38.62 9.02 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 2.77 37.17 4.99 6.33 34.76 8.06 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 15 3 # 15 A 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 5.98 42.76 7.73 10.19 38.62 9.02 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 2.77 37.17 4.99 6.33 34.76 8.06 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 16 3 # 16 A 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 5.98 42.76 7.73 10.19 38.62 9.02 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 2.77 37.17 4.99 6.33 34.76 8.06 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 17 3 # 17 A 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 5.98 42.76 7.73 10.19 38.62 9.02 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 2.77 37.17 4.99 6.33 34.76 8.06 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 18 3 # 18 A 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 A 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 5.98 42.76 7.73 10.19 38.62 9.02 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 2.77 37.17 4.99 6.33 34.76 8.06 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 19 3 # 19 A 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 A 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 5.98 42.76 7.73 10.19 38.62 9.02 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 2.77 37.17 4.99 6.33 34.76 8.06 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 0.07 40.30 18.65 -0.21 42.34 18.18 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 20 3 # 20 A 182 LYS C 265 LYS~? 21.95 ZN ZN C 374 A 184 LYS C 271 LYS.? 19.51 ZN ZN C 374 A 345 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 5.98 42.76 7.73 10.19 38.62 9.02 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 2.77 37.17 4.99 6.33 34.76 8.06 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -7.16 -24.94 59.28 -5.20 -24.20 59.64 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 21 3 # 21 A 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 A 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 A 345 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 5.98 42.76 7.73 10.19 38.62 9.02 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 2.77 37.17 4.99 6.33 34.76 8.06 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 22 3 # 22 A 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 5.98 42.76 7.73 10.19 38.62 9.02 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 2.77 37.17 4.99 6.33 34.76 8.06 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 0.07 40.30 18.65 -0.21 42.34 18.18 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 23 3 # 23 A 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 5.98 42.76 7.73 10.19 38.62 9.02 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 2.77 37.17 4.99 6.33 34.76 8.06 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 0.07 40.30 18.65 -0.21 42.34 18.18 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 24 3 # 24 A 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 5.98 42.76 7.73 10.19 38.62 9.02 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 2.77 37.17 4.99 6.33 34.76 8.06 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 0.07 40.30 18.65 -0.21 42.34 18.18 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 25 3 # 25 A 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 5.98 42.76 7.73 10.19 38.62 9.02 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 2.77 37.17 4.99 6.33 34.76 8.06 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 0.07 40.30 18.65 -0.21 42.34 18.18 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 26 3 # 26 A 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 5.98 42.76 7.73 10.19 38.62 9.02 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 2.77 37.17 4.99 6.33 34.76 8.06 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 0.07 40.30 18.65 -0.21 42.34 18.18 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 27 3 # 27 A 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 A 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 5.98 42.76 7.73 10.19 38.62 9.02 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 2.77 37.17 4.99 6.33 34.76 8.06 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 0.07 40.30 18.65 -0.21 42.34 18.18 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 27 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 B 184 LYS A 83 LYS~? -5.13 O1S EPE A 376s B 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 38.76 2.27 4.00 34.00 5.99 4.37 35.91 21.93 28.51 38.15 26.57 30.75 coo 40.63 7.13 9.06 35.85 7.36 8.95 35.02 22.85 34.66 32.09 22.94 39.08 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 B 184 LYS A 91 LYS~? 15.85 O2S EPE A 376 B 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 38.76 2.27 4.00 34.00 5.99 4.37 35.91 21.93 28.51 38.15 26.57 30.75 coo 40.63 7.13 9.06 35.85 7.36 8.95 36.23 21.81 22.32 41.86 22.67 23.70 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 B 184 LYS A 350 LYS~? 21.83 ZN ZN A 375 B 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 38.76 2.27 4.00 34.00 5.99 4.37 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 40.63 7.13 9.06 35.85 7.36 8.95 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 B 184 LYS B 83 LYS~? 4.34 O1S EPE B 376 B 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 38.76 2.27 4.00 34.00 5.99 4.37 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 40.63 7.13 9.06 35.85 7.36 8.95 -20.11 12.86 43.96 -14.92 12.31 47.32 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 B 184 LYS B 91 LYS~? 15.73 O3S EPE B 376 B 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 38.76 2.27 4.00 34.00 5.99 4.37 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 40.63 7.13 9.06 35.85 7.36 8.95 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 B 184 LYS B 87 LYS~? 9.60 O3S EPE B 376 B 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 38.76 2.27 4.00 34.00 5.99 4.37 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 40.63 7.13 9.06 35.85 7.36 8.95 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 7 3 # 7 B 182 LYS B 285 LYS^? 22.19 ZN ZN B 375 B 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 B 345 ASP B 281 ASP.? 29.04 ZN ZN B 374 coo 38.76 2.27 4.00 34.00 5.99 4.37 1.97 10.60 4.02 5.48 5.38 4.89 coo 40.63 7.13 9.06 35.85 7.36 8.95 7.99 5.97 9.05 6.92 1.04 11.01 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 4.51 22.24 5.26 6.45 23.04 5.71 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 8 3 # 8 B 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 B 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 38.76 2.27 4.00 34.00 5.99 4.37 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 40.63 7.13 9.06 35.85 7.36 8.95 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 9 3 # 9 B 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 B 184 LYS B 350 LYS~? 21.91 ZN ZN B 375 B 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 38.76 2.27 4.00 34.00 5.99 4.37 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 40.63 7.13 9.06 35.85 7.36 8.95 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 10 3 # 10 B 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 B 184 LYS C 83 LYS~? -3.65 O2S EPE C 376s B 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 38.76 2.27 4.00 34.00 5.99 4.37 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 40.63 7.13 9.06 35.85 7.36 8.95 19.52 -16.87 71.96 18.81 -11.07 69.68 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 11 3 # 11 B 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 B 184 LYS C 83 LYS~? -3.65 O2S EPE C 376s B 345 ASP C 55 ASP~? 17.38 O3S EPE C 376 coo 38.76 2.27 4.00 34.00 5.99 4.37 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 40.63 7.13 9.06 35.85 7.36 8.95 19.52 -16.87 71.96 18.81 -11.07 69.68 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 19.09 -33.39 71.33 19.50 -31.61 72.40 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 12 3 # 12 B 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 B 184 LYS C 91 LYS~? 15.57 O3S EPE C 376 B 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 38.76 2.27 4.00 34.00 5.99 4.37 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 40.63 7.13 9.06 35.85 7.36 8.95 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 13 3 # 13 B 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 B 184 LYS C 87 LYS~? 9.86 O3S EPE C 376 B 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 38.76 2.27 4.00 34.00 5.99 4.37 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 40.63 7.13 9.06 35.85 7.36 8.95 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 14 3 # 14 B 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 B 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 B 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 38.76 2.27 4.00 34.00 5.99 4.37 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 40.63 7.13 9.06 35.85 7.36 8.95 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 15 3 # 15 B 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 B 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 B 345 ASP C 281 ASP.? 29.07 ZN ZN C 374 coo 38.76 2.27 4.00 34.00 5.99 4.37 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 40.63 7.13 9.06 35.85 7.36 8.95 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -22.02 -28.08 53.32 -23.19 -26.28 53.39 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 15 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 C 184 LYS A 91 LYS~? 15.85 O2S EPE A 376 C 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -5.66 12.40 71.13 -2.66 9.98 66.50 35.91 21.93 28.51 38.15 26.57 30.75 coo 0.95 12.72 73.51 1.58 12.72 68.31 36.23 21.81 22.32 41.86 22.67 23.70 coo -4.59 24.28 66.67 -6.26 24.34 67.99 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 C 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 C 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo -5.66 12.40 71.13 -2.66 9.98 66.50 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 0.95 12.72 73.51 1.58 12.72 68.31 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo -4.59 24.28 66.67 -6.26 24.34 67.99 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 3 3 # 3 C 182 LYS A 265 LYS~? 22.38 ZN ZN A 374 C 184 LYS A 271 LYS.? 23.00 ZN ZN A 374 C 345 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo -5.66 12.40 71.13 -2.66 9.98 66.50 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 0.95 12.72 73.51 1.58 12.72 68.31 56.12 0.48 35.73 59.67 4.01 35.99 coo -4.59 24.28 66.67 -6.26 24.34 67.99 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 4 3 # 4 C 182 LYS A 301 LYS~? 24.94 ZN ZN A 375 C 184 LYS A 303 LYS~? 13.81 O3 TRS A 378 C 345 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo -5.66 12.40 71.13 -2.66 9.98 66.50 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 0.95 12.72 73.51 1.58 12.72 68.31 37.93 -22.13 35.45 34.81 -22.43 31.07 coo -4.59 24.28 66.67 -6.26 24.34 67.99 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 5 3 # 5 C 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 C 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 C 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -5.66 12.40 71.13 -2.66 9.98 66.50 45.66 0.76 26.15 51.53 0.58 28.90 coo 0.95 12.72 73.51 1.58 12.72 68.31 44.47 1.55 20.70 47.30 5.10 24.27 coo -4.59 24.28 66.67 -6.26 24.34 67.99 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 6 3 # 6 C 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 C 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 C 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 45.66 0.76 26.15 51.53 0.58 28.90 coo 0.95 12.72 73.51 1.58 12.72 68.31 44.47 1.55 20.70 47.30 5.10 24.27 coo -4.59 24.28 66.67 -6.26 24.34 67.99 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 7 3 # 7 C 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 C 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 C 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 44.47 1.55 20.70 47.30 5.10 24.27 coo 0.95 12.72 73.51 1.58 12.72 68.31 45.66 0.76 26.15 51.53 0.58 28.90 coo -4.59 24.28 66.67 -6.26 24.34 67.99 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 8 3 # 8 C 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 C 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 C 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 44.47 1.55 20.70 47.30 5.10 24.27 coo 0.95 12.72 73.51 1.58 12.72 68.31 45.56 -1.99 12.81 45.09 -7.18 12.35 coo -4.59 24.28 66.67 -6.26 24.34 67.99 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 9 3 # 9 C 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 C 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 C 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 0.95 12.72 73.51 1.58 12.72 68.31 44.47 1.55 20.70 47.30 5.10 24.27 coo -4.59 24.28 66.67 -6.26 24.34 67.99 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 10 3 # 10 C 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 C 184 LYS B 83 LYS~? 4.34 O1S EPE B 376 C 345 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 0.95 12.72 73.51 1.58 12.72 68.31 -20.11 12.86 43.96 -14.92 12.31 47.32 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 11 3 # 11 C 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 C 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 C 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 0.95 12.72 73.51 1.58 12.72 68.31 -29.53 0.46 40.71 -30.43 3.58 45.55 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 12 3 # 12 C 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 C 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 C 345 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo -5.66 12.40 71.13 -2.66 9.98 66.50 8.36 10.35 11.75 10.05 14.82 9.04 coo 0.95 12.72 73.51 1.58 12.72 68.31 7.99 5.97 9.05 6.92 1.04 11.01 coo -4.59 24.28 66.67 -6.26 24.34 67.99 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 13 3 # 13 C 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 C 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -5.66 12.40 71.13 -2.66 9.98 66.50 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 0.95 12.72 73.51 1.58 12.72 68.31 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 14 3 # 14 C 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 C 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 0.95 12.72 73.51 1.58 12.72 68.31 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 15 3 # 15 C 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 C 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 0.95 12.72 73.51 1.58 12.72 68.31 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 16 3 # 16 C 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 C 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 0.95 12.72 73.51 1.58 12.72 68.31 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 17 3 # 17 C 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 C 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 C 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 0.95 12.72 73.51 1.58 12.72 68.31 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 18 3 # 18 C 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 C 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 C 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo -5.66 12.40 71.13 -2.66 9.98 66.50 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 0.95 12.72 73.51 1.58 12.72 68.31 30.11 -27.61 67.14 30.55 -24.06 72.29 coo -4.59 24.28 66.67 -6.26 24.34 67.99 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 19 3 # 19 C 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 C 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 C 345 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo -5.66 12.40 71.13 -2.66 9.98 66.50 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 0.95 12.72 73.51 1.58 12.72 68.31 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 20 3 # 20 C 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 C 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -5.66 12.40 71.13 -2.66 9.98 66.50 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 0.95 12.72 73.51 1.58 12.72 68.31 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -4.59 24.28 66.67 -6.26 24.34 67.99 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 21 3 # 21 C 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 C 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 0.95 12.72 73.51 1.58 12.72 68.31 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -4.59 24.28 66.67 -6.26 24.34 67.99 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 22 3 # 22 C 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 C 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 0.95 12.72 73.51 1.58 12.72 68.31 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -4.59 24.28 66.67 -6.26 24.34 67.99 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 23 3 # 23 C 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 C 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 0.95 12.72 73.51 1.58 12.72 68.31 11.31 -44.62 52.77 6.74 -46.86 52.89 coo -4.59 24.28 66.67 -6.26 24.34 67.99 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 24 3 # 24 C 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 C 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 C 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -5.66 12.40 71.13 -2.66 9.98 66.50 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 0.95 12.72 73.51 1.58 12.72 68.31 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -4.59 24.28 66.67 -6.26 24.34 67.99 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 24 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 D 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 D 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS A 265 LYS~? 22.38 ZN ZN A 374 D 184 LYS A 271 LYS.? 23.00 ZN ZN A 374 D 345 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 56.12 0.48 35.73 59.67 4.01 35.99 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS A 301 LYS~? 24.94 ZN ZN A 375 D 184 LYS A 303 LYS~? 13.81 O3 TRS A 378 D 345 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 D 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 D 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 45.66 0.76 26.15 51.53 0.58 28.90 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 44.47 1.55 20.70 47.30 5.10 24.27 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 5 3 # 5 D 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 D 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 D 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 45.66 0.76 26.15 51.53 0.58 28.90 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 44.47 1.55 20.70 47.30 5.10 24.27 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 6 3 # 6 D 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 D 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 D 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 44.47 1.55 20.70 47.30 5.10 24.27 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 45.66 0.76 26.15 51.53 0.58 28.90 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 7 3 # 7 D 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 D 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 D 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 44.47 1.55 20.70 47.30 5.10 24.27 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 8 3 # 8 D 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 D 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 D 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 44.47 1.55 20.70 47.30 5.10 24.27 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 9 3 # 9 D 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 D 184 LYS B 83 LYS~? 4.34 O1S EPE B 376 D 345 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -20.11 12.86 43.96 -14.92 12.31 47.32 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 10 3 # 10 D 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 D 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 D 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 11 3 # 11 D 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 D 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 D 345 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 8.36 10.35 11.75 10.05 14.82 9.04 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 7.99 5.97 9.05 6.92 1.04 11.01 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 12 3 # 12 D 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 D 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 13 3 # 13 D 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 D 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 14 3 # 14 D 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 D 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 15 3 # 15 D 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 D 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 16 3 # 16 D 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 D 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 D 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 17 3 # 17 D 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 D 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 D 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 18 3 # 18 D 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 D 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 D 345 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 19 3 # 19 D 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 D 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 20 3 # 20 D 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 D 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 21 3 # 21 D 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 D 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 22 3 # 22 D 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 D 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 23 3 # 23 D 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 D 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 D 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 23 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 E 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 E 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo -21.16 62.58 121.86 -16.35 60.33 119.23 21.25 -14.20 2.18 27.53 -14.97 1.13 coo -23.22 55.98 120.74 -18.11 55.31 120.43 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo -17.15 59.71 133.33 -17.96 61.54 134.01 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS A 265 LYS~? 22.38 ZN ZN A 374 E 184 LYS A 271 LYS.? 23.00 ZN ZN A 374 E 345 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo -21.16 62.58 121.86 -16.35 60.33 119.23 54.99 -5.46 33.76 58.41 -3.92 38.21 coo -23.22 55.98 120.74 -18.11 55.31 120.43 56.12 0.48 35.73 59.67 4.01 35.99 coo -17.15 59.71 133.33 -17.96 61.54 134.01 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS A 301 LYS~? 24.94 ZN ZN A 375 E 184 LYS A 303 LYS~? 13.81 O3 TRS A 378 E 345 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo -21.16 62.58 121.86 -16.35 60.33 119.23 39.11 -19.59 40.11 42.80 -21.77 43.38 coo -23.22 55.98 120.74 -18.11 55.31 120.43 37.93 -22.13 35.45 34.81 -22.43 31.07 coo -17.15 59.71 133.33 -17.96 61.54 134.01 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 E 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 E 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -21.16 62.58 121.86 -16.35 60.33 119.23 45.66 0.76 26.15 51.53 0.58 28.90 coo -23.22 55.98 120.74 -18.11 55.31 120.43 44.47 1.55 20.70 47.30 5.10 24.27 coo -17.15 59.71 133.33 -17.96 61.54 134.01 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 5 3 # 5 E 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 E 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 E 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 45.66 0.76 26.15 51.53 0.58 28.90 coo -23.22 55.98 120.74 -18.11 55.31 120.43 44.47 1.55 20.70 47.30 5.10 24.27 coo -17.15 59.71 133.33 -17.96 61.54 134.01 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 6 3 # 6 E 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 E 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 E 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 44.47 1.55 20.70 47.30 5.10 24.27 coo -23.22 55.98 120.74 -18.11 55.31 120.43 45.66 0.76 26.15 51.53 0.58 28.90 coo -17.15 59.71 133.33 -17.96 61.54 134.01 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 7 3 # 7 E 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 E 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 E 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 44.47 1.55 20.70 47.30 5.10 24.27 coo -23.22 55.98 120.74 -18.11 55.31 120.43 45.56 -1.99 12.81 45.09 -7.18 12.35 coo -17.15 59.71 133.33 -17.96 61.54 134.01 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 8 3 # 8 E 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 E 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 E 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 45.56 -1.99 12.81 45.09 -7.18 12.35 coo -23.22 55.98 120.74 -18.11 55.31 120.43 44.47 1.55 20.70 47.30 5.10 24.27 coo -17.15 59.71 133.33 -17.96 61.54 134.01 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 9 3 # 9 E 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 E 184 LYS B 83 LYS~? 4.34 O1S EPE B 376 E 345 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -23.51 8.76 41.04 -24.49 13.82 43.31 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -20.11 12.86 43.96 -14.92 12.31 47.32 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 10 3 # 10 E 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 E 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 E 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -26.96 4.56 38.63 -29.49 9.20 36.26 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -29.53 0.46 40.71 -30.43 3.58 45.55 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 11 3 # 11 E 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 E 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 E 345 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo -21.16 62.58 121.86 -16.35 60.33 119.23 8.36 10.35 11.75 10.05 14.82 9.04 coo -23.22 55.98 120.74 -18.11 55.31 120.43 7.99 5.97 9.05 6.92 1.04 11.01 coo -17.15 59.71 133.33 -17.96 61.54 134.01 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 12 3 # 12 E 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 E 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 E 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -21.16 62.58 121.86 -16.35 60.33 119.23 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 13 3 # 13 E 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 E 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 E 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 14 3 # 14 E 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 E 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 E 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -16.19 8.44 18.66 -16.77 14.07 16.03 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 15 3 # 15 E 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 E 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 E 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 16 3 # 16 E 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 E 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 E 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 17 3 # 17 E 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 E 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 E 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo -21.16 62.58 121.86 -16.35 60.33 119.23 24.97 -26.94 68.30 21.78 -29.04 72.70 coo -23.22 55.98 120.74 -18.11 55.31 120.43 30.11 -27.61 67.14 30.55 -24.06 72.29 coo -17.15 59.71 133.33 -17.96 61.54 134.01 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 18 3 # 18 E 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 E 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 E 345 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo -21.16 62.58 121.86 -16.35 60.33 119.23 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 19 3 # 19 E 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 E 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 E 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -21.16 62.58 121.86 -16.35 60.33 119.23 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -23.22 55.98 120.74 -18.11 55.31 120.43 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -17.15 59.71 133.33 -17.96 61.54 134.01 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 20 3 # 20 E 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 E 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 E 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -23.22 55.98 120.74 -18.11 55.31 120.43 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -17.15 59.71 133.33 -17.96 61.54 134.01 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 21 3 # 21 E 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 E 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 E 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -23.22 55.98 120.74 -18.11 55.31 120.43 5.23 -34.02 59.10 0.53 -34.86 62.24 coo -17.15 59.71 133.33 -17.96 61.54 134.01 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 22 3 # 22 E 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 E 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 E 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -23.22 55.98 120.74 -18.11 55.31 120.43 11.31 -44.62 52.77 6.74 -46.86 52.89 coo -17.15 59.71 133.33 -17.96 61.54 134.01 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 23 3 # 23 E 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 E 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 E 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -21.16 62.58 121.86 -16.35 60.33 119.23 11.31 -44.62 52.77 6.74 -46.86 52.89 coo -23.22 55.98 120.74 -18.11 55.31 120.43 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -17.15 59.71 133.33 -17.96 61.54 134.01 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 23 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 265 LYS~? 22.38 ZN ZN A 374 F 184 LYS A 271 LYS.? 23.00 ZN ZN A 374 F 345 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 10.64 34.02 91.30 6.30 35.60 95.11 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 13.75 39.76 94.12 11.42 37.23 97.89 56.12 0.48 35.73 59.67 4.01 35.99 coo 16.35 26.90 99.56 16.81 25.90 97.75 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 F 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 F 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 10.64 34.02 91.30 6.30 35.60 95.11 45.66 0.76 26.15 51.53 0.58 28.90 coo 13.75 39.76 94.12 11.42 37.23 97.89 44.47 1.55 20.70 47.30 5.10 24.27 coo 16.35 26.90 99.56 16.81 25.90 97.75 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 F 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 F 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 10.64 34.02 91.30 6.30 35.60 95.11 45.66 0.76 26.15 51.53 0.58 28.90 coo 13.75 39.76 94.12 11.42 37.23 97.89 44.47 1.55 20.70 47.30 5.10 24.27 coo 16.35 26.90 99.56 16.81 25.90 97.75 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 F 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 F 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 10.64 34.02 91.30 6.30 35.60 95.11 44.47 1.55 20.70 47.30 5.10 24.27 coo 13.75 39.76 94.12 11.42 37.23 97.89 45.66 0.76 26.15 51.53 0.58 28.90 coo 16.35 26.90 99.56 16.81 25.90 97.75 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 5 3 # 5 F 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 F 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 F 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 10.64 34.02 91.30 6.30 35.60 95.11 44.47 1.55 20.70 47.30 5.10 24.27 coo 13.75 39.76 94.12 11.42 37.23 97.89 45.66 0.76 26.15 51.53 0.58 28.90 coo 16.35 26.90 99.56 16.81 25.90 97.75 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 6 3 # 6 F 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 F 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 F 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 10.64 34.02 91.30 6.30 35.60 95.11 44.47 1.55 20.70 47.30 5.10 24.27 coo 13.75 39.76 94.12 11.42 37.23 97.89 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 16.35 26.90 99.56 16.81 25.90 97.75 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 7 3 # 7 F 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 F 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 F 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 10.64 34.02 91.30 6.30 35.60 95.11 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 13.75 39.76 94.12 11.42 37.23 97.89 44.47 1.55 20.70 47.30 5.10 24.27 coo 16.35 26.90 99.56 16.81 25.90 97.75 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 8 3 # 8 F 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 F 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 F 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 10.64 34.02 91.30 6.30 35.60 95.11 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 13.75 39.76 94.12 11.42 37.23 97.89 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 16.35 26.90 99.56 16.81 25.90 97.75 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 9 3 # 9 F 182 LYS B 265 LYS~? 21.91 ZN ZN B 374 F 184 LYS B 271 LYS.? 19.93 ZN ZN B 374 F 345 ASP B 330 ASP^? 11.92 ZN ZN B 374 coo 10.64 34.02 91.30 6.30 35.60 95.11 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 13.75 39.76 94.12 11.42 37.23 97.89 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 16.35 26.90 99.56 16.81 25.90 97.75 -4.33 18.16 18.13 -5.04 17.21 19.90 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 10 3 # 10 F 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 F 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 F 345 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 10.64 34.02 91.30 6.30 35.60 95.11 8.36 10.35 11.75 10.05 14.82 9.04 coo 13.75 39.76 94.12 11.42 37.23 97.89 7.99 5.97 9.05 6.92 1.04 11.01 coo 16.35 26.90 99.56 16.81 25.90 97.75 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 11 3 # 11 F 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 F 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 F 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 10.64 34.02 91.30 6.30 35.60 95.11 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 13.75 39.76 94.12 11.42 37.23 97.89 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 16.35 26.90 99.56 16.81 25.90 97.75 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 12 3 # 12 F 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 F 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 F 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 10.64 34.02 91.30 6.30 35.60 95.11 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 13.75 39.76 94.12 11.42 37.23 97.89 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 16.35 26.90 99.56 16.81 25.90 97.75 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 13 3 # 13 F 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 F 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 F 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 10.64 34.02 91.30 6.30 35.60 95.11 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 13.75 39.76 94.12 11.42 37.23 97.89 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 16.35 26.90 99.56 16.81 25.90 97.75 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 14 3 # 14 F 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 F 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 F 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 10.64 34.02 91.30 6.30 35.60 95.11 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 13.75 39.76 94.12 11.42 37.23 97.89 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 16.35 26.90 99.56 16.81 25.90 97.75 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 15 3 # 15 F 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 F 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 F 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 10.64 34.02 91.30 6.30 35.60 95.11 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 13.75 39.76 94.12 11.42 37.23 97.89 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 16.35 26.90 99.56 16.81 25.90 97.75 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 16 3 # 16 F 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 F 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 F 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 10.64 34.02 91.30 6.30 35.60 95.11 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 13.75 39.76 94.12 11.42 37.23 97.89 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 16.35 26.90 99.56 16.81 25.90 97.75 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 17 3 # 17 F 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 F 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 F 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 10.64 34.02 91.30 6.30 35.60 95.11 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 13.75 39.76 94.12 11.42 37.23 97.89 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 16.35 26.90 99.56 16.81 25.90 97.75 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 18 3 # 18 F 182 LYS C 265 LYS~? 21.95 ZN ZN C 374 F 184 LYS C 271 LYS.? 19.51 ZN ZN C 374 F 345 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 10.64 34.02 91.30 6.30 35.60 95.11 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 13.75 39.76 94.12 11.42 37.23 97.89 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 16.35 26.90 99.56 16.81 25.90 97.75 -7.16 -24.94 59.28 -5.20 -24.20 59.64 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 19 3 # 19 F 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 F 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 F 345 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 10.64 34.02 91.30 6.30 35.60 95.11 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 13.75 39.76 94.12 11.42 37.23 97.89 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 16.35 26.90 99.56 16.81 25.90 97.75 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 20 3 # 20 F 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 F 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 F 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 10.64 34.02 91.30 6.30 35.60 95.11 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 13.75 39.76 94.12 11.42 37.23 97.89 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 16.35 26.90 99.56 16.81 25.90 97.75 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 21 3 # 21 F 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 F 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 F 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 10.64 34.02 91.30 6.30 35.60 95.11 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 13.75 39.76 94.12 11.42 37.23 97.89 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 16.35 26.90 99.56 16.81 25.90 97.75 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 22 3 # 22 F 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 F 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 F 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 10.64 34.02 91.30 6.30 35.60 95.11 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 13.75 39.76 94.12 11.42 37.23 97.89 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 16.35 26.90 99.56 16.81 25.90 97.75 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 23 3 # 23 F 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 F 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 F 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 10.64 34.02 91.30 6.30 35.60 95.11 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 13.75 39.76 94.12 11.42 37.23 97.89 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 16.35 26.90 99.56 16.81 25.90 97.75 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 24 3 # 24 F 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 F 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 F 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 10.64 34.02 91.30 6.30 35.60 95.11 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 13.75 39.76 94.12 11.42 37.23 97.89 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 16.35 26.90 99.56 16.81 25.90 97.75 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 25 3 # 25 F 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 F 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 F 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 10.64 34.02 91.30 6.30 35.60 95.11 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 13.75 39.76 94.12 11.42 37.23 97.89 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 16.35 26.90 99.56 16.81 25.90 97.75 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 25 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 G 184 LYS A 91 LYS~? 15.85 O2S EPE A 376 G 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 39.68 42.04 76.11 43.42 46.43 74.96 35.91 21.93 28.51 38.15 26.57 30.75 coo 36.69 47.69 78.93 39.38 50.40 75.35 36.23 21.81 22.32 41.86 22.67 23.70 coo 33.43 44.37 65.47 33.10 42.30 65.37 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 G 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 G 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 39.68 42.04 76.11 43.42 46.43 74.96 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 36.69 47.69 78.93 39.38 50.40 75.35 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 33.43 44.37 65.47 33.10 42.30 65.37 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 3 3 # 3 G 182 LYS A 265 LYS~? 22.38 ZN ZN A 374 G 184 LYS A 271 LYS.? 23.00 ZN ZN A 374 G 345 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 39.68 42.04 76.11 43.42 46.43 74.96 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 36.69 47.69 78.93 39.38 50.40 75.35 56.12 0.48 35.73 59.67 4.01 35.99 coo 33.43 44.37 65.47 33.10 42.30 65.37 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 4 3 # 4 G 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 G 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 G 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 39.68 42.04 76.11 43.42 46.43 74.96 45.66 0.76 26.15 51.53 0.58 28.90 coo 36.69 47.69 78.93 39.38 50.40 75.35 44.47 1.55 20.70 47.30 5.10 24.27 coo 33.43 44.37 65.47 33.10 42.30 65.37 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 5 3 # 5 G 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 G 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 G 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 39.68 42.04 76.11 43.42 46.43 74.96 45.66 0.76 26.15 51.53 0.58 28.90 coo 36.69 47.69 78.93 39.38 50.40 75.35 44.47 1.55 20.70 47.30 5.10 24.27 coo 33.43 44.37 65.47 33.10 42.30 65.37 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 6 3 # 6 G 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 G 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 G 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 39.68 42.04 76.11 43.42 46.43 74.96 44.47 1.55 20.70 47.30 5.10 24.27 coo 36.69 47.69 78.93 39.38 50.40 75.35 45.66 0.76 26.15 51.53 0.58 28.90 coo 33.43 44.37 65.47 33.10 42.30 65.37 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 7 3 # 7 G 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 G 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 G 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 39.68 42.04 76.11 43.42 46.43 74.96 44.47 1.55 20.70 47.30 5.10 24.27 coo 36.69 47.69 78.93 39.38 50.40 75.35 45.66 0.76 26.15 51.53 0.58 28.90 coo 33.43 44.37 65.47 33.10 42.30 65.37 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 8 3 # 8 G 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 G 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 G 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 39.68 42.04 76.11 43.42 46.43 74.96 44.47 1.55 20.70 47.30 5.10 24.27 coo 36.69 47.69 78.93 39.38 50.40 75.35 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 33.43 44.37 65.47 33.10 42.30 65.37 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 9 3 # 9 G 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 G 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 G 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 39.68 42.04 76.11 43.42 46.43 74.96 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 36.69 47.69 78.93 39.38 50.40 75.35 44.47 1.55 20.70 47.30 5.10 24.27 coo 33.43 44.37 65.47 33.10 42.30 65.37 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 10 3 # 10 G 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 G 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 G 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 39.68 42.04 76.11 43.42 46.43 74.96 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 36.69 47.69 78.93 39.38 50.40 75.35 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 33.43 44.37 65.47 33.10 42.30 65.37 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 11 3 # 11 G 182 LYS B 265 LYS~? 21.91 ZN ZN B 374 G 184 LYS B 271 LYS.? 19.93 ZN ZN B 374 G 345 ASP B 330 ASP^? 11.92 ZN ZN B 374 coo 39.68 42.04 76.11 43.42 46.43 74.96 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 36.69 47.69 78.93 39.38 50.40 75.35 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 33.43 44.37 65.47 33.10 42.30 65.37 -4.33 18.16 18.13 -5.04 17.21 19.90 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 12 3 # 12 G 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 G 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 G 345 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 39.68 42.04 76.11 43.42 46.43 74.96 8.36 10.35 11.75 10.05 14.82 9.04 coo 36.69 47.69 78.93 39.38 50.40 75.35 7.99 5.97 9.05 6.92 1.04 11.01 coo 33.43 44.37 65.47 33.10 42.30 65.37 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 13 3 # 13 G 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 G 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 G 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 39.68 42.04 76.11 43.42 46.43 74.96 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 36.69 47.69 78.93 39.38 50.40 75.35 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 33.43 44.37 65.47 33.10 42.30 65.37 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 14 3 # 14 G 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 G 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 G 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 39.68 42.04 76.11 43.42 46.43 74.96 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 36.69 47.69 78.93 39.38 50.40 75.35 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 33.43 44.37 65.47 33.10 42.30 65.37 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 15 3 # 15 G 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 G 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 G 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 39.68 42.04 76.11 43.42 46.43 74.96 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 36.69 47.69 78.93 39.38 50.40 75.35 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 33.43 44.37 65.47 33.10 42.30 65.37 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 16 3 # 16 G 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 G 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 G 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 39.68 42.04 76.11 43.42 46.43 74.96 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 36.69 47.69 78.93 39.38 50.40 75.35 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 33.43 44.37 65.47 33.10 42.30 65.37 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 17 3 # 17 G 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 G 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 G 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 39.68 42.04 76.11 43.42 46.43 74.96 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 36.69 47.69 78.93 39.38 50.40 75.35 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 33.43 44.37 65.47 33.10 42.30 65.37 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 18 3 # 18 G 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 G 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 G 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 39.68 42.04 76.11 43.42 46.43 74.96 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 36.69 47.69 78.93 39.38 50.40 75.35 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 33.43 44.37 65.47 33.10 42.30 65.37 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 19 3 # 19 G 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 G 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 G 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 39.68 42.04 76.11 43.42 46.43 74.96 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 36.69 47.69 78.93 39.38 50.40 75.35 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 33.43 44.37 65.47 33.10 42.30 65.37 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 20 3 # 20 G 182 LYS C 265 LYS~? 21.95 ZN ZN C 374 G 184 LYS C 271 LYS.? 19.51 ZN ZN C 374 G 345 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 39.68 42.04 76.11 43.42 46.43 74.96 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 36.69 47.69 78.93 39.38 50.40 75.35 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 33.43 44.37 65.47 33.10 42.30 65.37 -7.16 -24.94 59.28 -5.20 -24.20 59.64 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 21 3 # 21 G 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 G 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 G 345 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 39.68 42.04 76.11 43.42 46.43 74.96 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 36.69 47.69 78.93 39.38 50.40 75.35 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 33.43 44.37 65.47 33.10 42.30 65.37 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 22 3 # 22 G 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 G 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 G 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 39.68 42.04 76.11 43.42 46.43 74.96 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 36.69 47.69 78.93 39.38 50.40 75.35 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 33.43 44.37 65.47 33.10 42.30 65.37 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 23 3 # 23 G 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 G 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 G 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 39.68 42.04 76.11 43.42 46.43 74.96 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 36.69 47.69 78.93 39.38 50.40 75.35 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 33.43 44.37 65.47 33.10 42.30 65.37 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 24 3 # 24 G 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 G 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 G 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 39.68 42.04 76.11 43.42 46.43 74.96 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 36.69 47.69 78.93 39.38 50.40 75.35 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 33.43 44.37 65.47 33.10 42.30 65.37 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 25 3 # 25 G 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 G 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 G 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 39.68 42.04 76.11 43.42 46.43 74.96 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 36.69 47.69 78.93 39.38 50.40 75.35 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 33.43 44.37 65.47 33.10 42.30 65.37 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 26 3 # 26 G 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 G 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 G 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 39.68 42.04 76.11 43.42 46.43 74.96 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 36.69 47.69 78.93 39.38 50.40 75.35 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 33.43 44.37 65.47 33.10 42.30 65.37 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 27 3 # 27 G 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 G 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 G 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 39.68 42.04 76.11 43.42 46.43 74.96 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 36.69 47.69 78.93 39.38 50.40 75.35 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 33.43 44.37 65.47 33.10 42.30 65.37 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 27 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 H 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 H 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 71.58 83.18 80.51 66.88 79.77 79.84 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 73.65 78.64 75.66 68.14 79.07 75.04 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 67.43 90.73 71.39 68.27 92.30 72.52 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS A 265 LYS~? 22.38 ZN ZN A 374 H 184 LYS A 271 LYS.? 23.00 ZN ZN A 374 H 345 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 71.58 83.18 80.51 66.88 79.77 79.84 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 73.65 78.64 75.66 68.14 79.07 75.04 56.12 0.48 35.73 59.67 4.01 35.99 coo 67.43 90.73 71.39 68.27 92.30 72.52 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS A 301 LYS~? 24.94 ZN ZN A 375 H 184 LYS A 303 LYS~? 13.81 O3 TRS A 378 H 345 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 71.58 83.18 80.51 66.88 79.77 79.84 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 73.65 78.64 75.66 68.14 79.07 75.04 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 67.43 90.73 71.39 68.27 92.30 72.52 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 4 3 # 4 H 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 H 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 H 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 71.58 83.18 80.51 66.88 79.77 79.84 45.66 0.76 26.15 51.53 0.58 28.90 coo 73.65 78.64 75.66 68.14 79.07 75.04 44.47 1.55 20.70 47.30 5.10 24.27 coo 67.43 90.73 71.39 68.27 92.30 72.52 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 5 3 # 5 H 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 H 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 H 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 71.58 83.18 80.51 66.88 79.77 79.84 45.66 0.76 26.15 51.53 0.58 28.90 coo 73.65 78.64 75.66 68.14 79.07 75.04 44.47 1.55 20.70 47.30 5.10 24.27 coo 67.43 90.73 71.39 68.27 92.30 72.52 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 6 3 # 6 H 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 H 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 H 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 71.58 83.18 80.51 66.88 79.77 79.84 44.47 1.55 20.70 47.30 5.10 24.27 coo 73.65 78.64 75.66 68.14 79.07 75.04 45.66 0.76 26.15 51.53 0.58 28.90 coo 67.43 90.73 71.39 68.27 92.30 72.52 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 7 3 # 7 H 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 H 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 H 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 71.58 83.18 80.51 66.88 79.77 79.84 44.47 1.55 20.70 47.30 5.10 24.27 coo 73.65 78.64 75.66 68.14 79.07 75.04 45.66 0.76 26.15 51.53 0.58 28.90 coo 67.43 90.73 71.39 68.27 92.30 72.52 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 8 3 # 8 H 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 H 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 H 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 71.58 83.18 80.51 66.88 79.77 79.84 44.47 1.55 20.70 47.30 5.10 24.27 coo 73.65 78.64 75.66 68.14 79.07 75.04 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 67.43 90.73 71.39 68.27 92.30 72.52 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 9 3 # 9 H 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 H 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 H 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 71.58 83.18 80.51 66.88 79.77 79.84 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 73.65 78.64 75.66 68.14 79.07 75.04 44.47 1.55 20.70 47.30 5.10 24.27 coo 67.43 90.73 71.39 68.27 92.30 72.52 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 10 3 # 10 H 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 H 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 H 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 71.58 83.18 80.51 66.88 79.77 79.84 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 73.65 78.64 75.66 68.14 79.07 75.04 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 67.43 90.73 71.39 68.27 92.30 72.52 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 11 3 # 11 H 182 LYS B 265 LYS~? 21.91 ZN ZN B 374 H 184 LYS B 271 LYS.? 19.93 ZN ZN B 374 H 345 ASP B 330 ASP^? 11.92 ZN ZN B 374 coo 71.58 83.18 80.51 66.88 79.77 79.84 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 73.65 78.64 75.66 68.14 79.07 75.04 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 67.43 90.73 71.39 68.27 92.30 72.52 -4.33 18.16 18.13 -5.04 17.21 19.90 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 12 3 # 12 H 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 H 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 H 345 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 71.58 83.18 80.51 66.88 79.77 79.84 8.36 10.35 11.75 10.05 14.82 9.04 coo 73.65 78.64 75.66 68.14 79.07 75.04 7.99 5.97 9.05 6.92 1.04 11.01 coo 67.43 90.73 71.39 68.27 92.30 72.52 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 13 3 # 13 H 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 H 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 H 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 71.58 83.18 80.51 66.88 79.77 79.84 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 73.65 78.64 75.66 68.14 79.07 75.04 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 67.43 90.73 71.39 68.27 92.30 72.52 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 14 3 # 14 H 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 H 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 H 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 71.58 83.18 80.51 66.88 79.77 79.84 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 73.65 78.64 75.66 68.14 79.07 75.04 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 67.43 90.73 71.39 68.27 92.30 72.52 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 15 3 # 15 H 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 H 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 H 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 71.58 83.18 80.51 66.88 79.77 79.84 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 73.65 78.64 75.66 68.14 79.07 75.04 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 67.43 90.73 71.39 68.27 92.30 72.52 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 16 3 # 16 H 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 H 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 H 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 71.58 83.18 80.51 66.88 79.77 79.84 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 73.65 78.64 75.66 68.14 79.07 75.04 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 67.43 90.73 71.39 68.27 92.30 72.52 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 17 3 # 17 H 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 H 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 H 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 71.58 83.18 80.51 66.88 79.77 79.84 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 73.65 78.64 75.66 68.14 79.07 75.04 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 67.43 90.73 71.39 68.27 92.30 72.52 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 18 3 # 18 H 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 H 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 H 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 71.58 83.18 80.51 66.88 79.77 79.84 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 73.65 78.64 75.66 68.14 79.07 75.04 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 67.43 90.73 71.39 68.27 92.30 72.52 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 19 3 # 19 H 182 LYS C 265 LYS~? 21.95 ZN ZN C 374 H 184 LYS C 271 LYS.? 19.51 ZN ZN C 374 H 345 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 71.58 83.18 80.51 66.88 79.77 79.84 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 73.65 78.64 75.66 68.14 79.07 75.04 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 67.43 90.73 71.39 68.27 92.30 72.52 -7.16 -24.94 59.28 -5.20 -24.20 59.64 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 20 3 # 20 H 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 H 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 H 345 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 71.58 83.18 80.51 66.88 79.77 79.84 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 73.65 78.64 75.66 68.14 79.07 75.04 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 67.43 90.73 71.39 68.27 92.30 72.52 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 21 3 # 21 H 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 H 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 H 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 71.58 83.18 80.51 66.88 79.77 79.84 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 73.65 78.64 75.66 68.14 79.07 75.04 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 67.43 90.73 71.39 68.27 92.30 72.52 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 22 3 # 22 H 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 H 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 H 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 71.58 83.18 80.51 66.88 79.77 79.84 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 73.65 78.64 75.66 68.14 79.07 75.04 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 67.43 90.73 71.39 68.27 92.30 72.52 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 23 3 # 23 H 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 H 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 H 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 71.58 83.18 80.51 66.88 79.77 79.84 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 73.65 78.64 75.66 68.14 79.07 75.04 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 67.43 90.73 71.39 68.27 92.30 72.52 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 24 3 # 24 H 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 H 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 H 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 71.58 83.18 80.51 66.88 79.77 79.84 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 73.65 78.64 75.66 68.14 79.07 75.04 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 67.43 90.73 71.39 68.27 92.30 72.52 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 25 3 # 25 H 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 H 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 H 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 71.58 83.18 80.51 66.88 79.77 79.84 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 73.65 78.64 75.66 68.14 79.07 75.04 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 67.43 90.73 71.39 68.27 92.30 72.52 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 26 3 # 26 H 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 H 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 H 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 71.58 83.18 80.51 66.88 79.77 79.84 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 73.65 78.64 75.66 68.14 79.07 75.04 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 67.43 90.73 71.39 68.27 92.30 72.52 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 26 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 I 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 I 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 60.20 96.92 42.53 57.60 93.13 38.67 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 54.31 95.46 46.01 55.34 91.59 42.65 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 66.35 87.81 48.53 68.10 89.01 48.77 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS A 265 LYS~? 22.38 ZN ZN A 374 I 184 LYS A 271 LYS.? 23.00 ZN ZN A 374 I 345 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 60.20 96.92 42.53 57.60 93.13 38.67 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 54.31 95.46 46.01 55.34 91.59 42.65 56.12 0.48 35.73 59.67 4.01 35.99 coo 66.35 87.81 48.53 68.10 89.01 48.77 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS A 301 LYS~? 24.94 ZN ZN A 375 I 184 LYS A 303 LYS~? 13.81 O3 TRS A 378 I 345 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 60.20 96.92 42.53 57.60 93.13 38.67 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 54.31 95.46 46.01 55.34 91.59 42.65 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 66.35 87.81 48.53 68.10 89.01 48.77 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 I 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 I 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 60.20 96.92 42.53 57.60 93.13 38.67 45.66 0.76 26.15 51.53 0.58 28.90 coo 54.31 95.46 46.01 55.34 91.59 42.65 44.47 1.55 20.70 47.30 5.10 24.27 coo 66.35 87.81 48.53 68.10 89.01 48.77 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 5 3 # 5 I 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 I 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 I 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 45.66 0.76 26.15 51.53 0.58 28.90 coo 54.31 95.46 46.01 55.34 91.59 42.65 44.47 1.55 20.70 47.30 5.10 24.27 coo 66.35 87.81 48.53 68.10 89.01 48.77 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 6 3 # 6 I 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 I 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 I 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 44.47 1.55 20.70 47.30 5.10 24.27 coo 54.31 95.46 46.01 55.34 91.59 42.65 45.66 0.76 26.15 51.53 0.58 28.90 coo 66.35 87.81 48.53 68.10 89.01 48.77 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 7 3 # 7 I 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 I 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 I 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 44.47 1.55 20.70 47.30 5.10 24.27 coo 54.31 95.46 46.01 55.34 91.59 42.65 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 66.35 87.81 48.53 68.10 89.01 48.77 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 8 3 # 8 I 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 I 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 I 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 54.31 95.46 46.01 55.34 91.59 42.65 44.47 1.55 20.70 47.30 5.10 24.27 coo 66.35 87.81 48.53 68.10 89.01 48.77 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 9 3 # 9 I 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 I 184 LYS B 83 LYS~? 4.34 O1S EPE B 376 I 345 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo 60.20 96.92 42.53 57.60 93.13 38.67 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 54.31 95.46 46.01 55.34 91.59 42.65 -20.11 12.86 43.96 -14.92 12.31 47.32 coo 66.35 87.81 48.53 68.10 89.01 48.77 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 10 3 # 10 I 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 I 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 I 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 60.20 96.92 42.53 57.60 93.13 38.67 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 54.31 95.46 46.01 55.34 91.59 42.65 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 66.35 87.81 48.53 68.10 89.01 48.77 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 11 3 # 11 I 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 I 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 I 345 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 60.20 96.92 42.53 57.60 93.13 38.67 8.36 10.35 11.75 10.05 14.82 9.04 coo 54.31 95.46 46.01 55.34 91.59 42.65 7.99 5.97 9.05 6.92 1.04 11.01 coo 66.35 87.81 48.53 68.10 89.01 48.77 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 12 3 # 12 I 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 I 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 I 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 60.20 96.92 42.53 57.60 93.13 38.67 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 54.31 95.46 46.01 55.34 91.59 42.65 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 66.35 87.81 48.53 68.10 89.01 48.77 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 13 3 # 13 I 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 I 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 I 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 54.31 95.46 46.01 55.34 91.59 42.65 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 66.35 87.81 48.53 68.10 89.01 48.77 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 14 3 # 14 I 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 I 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 I 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 54.31 95.46 46.01 55.34 91.59 42.65 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 66.35 87.81 48.53 68.10 89.01 48.77 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 15 3 # 15 I 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 I 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 I 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 54.31 95.46 46.01 55.34 91.59 42.65 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 66.35 87.81 48.53 68.10 89.01 48.77 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 16 3 # 16 I 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 I 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 I 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 54.31 95.46 46.01 55.34 91.59 42.65 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 66.35 87.81 48.53 68.10 89.01 48.77 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 17 3 # 17 I 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 I 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 I 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 60.20 96.92 42.53 57.60 93.13 38.67 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 54.31 95.46 46.01 55.34 91.59 42.65 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 66.35 87.81 48.53 68.10 89.01 48.77 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 18 3 # 18 I 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 I 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 I 345 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 60.20 96.92 42.53 57.60 93.13 38.67 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 54.31 95.46 46.01 55.34 91.59 42.65 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 66.35 87.81 48.53 68.10 89.01 48.77 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 19 3 # 19 I 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 I 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 I 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 60.20 96.92 42.53 57.60 93.13 38.67 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 54.31 95.46 46.01 55.34 91.59 42.65 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 66.35 87.81 48.53 68.10 89.01 48.77 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 20 3 # 20 I 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 I 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 I 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 54.31 95.46 46.01 55.34 91.59 42.65 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 66.35 87.81 48.53 68.10 89.01 48.77 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 21 3 # 21 I 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 I 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 I 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 54.31 95.46 46.01 55.34 91.59 42.65 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 66.35 87.81 48.53 68.10 89.01 48.77 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 22 3 # 22 I 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 I 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 I 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 54.31 95.46 46.01 55.34 91.59 42.65 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 66.35 87.81 48.53 68.10 89.01 48.77 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 23 3 # 23 I 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 I 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 I 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 60.20 96.92 42.53 57.60 93.13 38.67 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 54.31 95.46 46.01 55.34 91.59 42.65 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 66.35 87.81 48.53 68.10 89.01 48.77 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 23 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 J 184 LYS A 83 LYS~? -5.13 O1S EPE A 376s J 345 ASP A 55 ASP~? 17.36 O2S EPE A 376 coo 25.22 70.55 14.03 27.64 73.07 18.65 35.91 21.93 28.51 38.15 26.57 30.75 coo 31.73 69.87 11.50 32.73 70.19 16.40 35.02 22.85 34.66 32.09 22.94 39.08 coo 25.87 58.42 18.79 23.95 58.54 17.90 45.10 18.98 22.18 44.20 20.57 23.21 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 J 184 LYS A 91 LYS~? 15.85 O2S EPE A 376 J 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 25.22 70.55 14.03 27.64 73.07 18.65 35.91 21.93 28.51 38.15 26.57 30.75 coo 31.73 69.87 11.50 32.73 70.19 16.40 36.23 21.81 22.32 41.86 22.67 23.70 coo 25.87 58.42 18.79 23.95 58.54 17.90 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 J 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 J 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 25.22 70.55 14.03 27.64 73.07 18.65 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 31.73 69.87 11.50 32.73 70.19 16.40 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 25.87 58.42 18.79 23.95 58.54 17.90 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS A 218 LYS~? 21.49 C3 EPE A 377 J 184 LYS A 215 LYS~? 16.65 O1S EPE C 377 J 345 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 25.22 70.55 14.03 27.64 73.07 18.65 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 31.73 69.87 11.50 32.73 70.19 16.40 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 25.87 58.42 18.79 23.95 58.54 17.90 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 5 3 # 5 J 182 LYS A 218 LYS~? 21.49 C3 EPE A 377 J 184 LYS A 215 LYS~? 16.65 O1S EPE C 377 J 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 25.22 70.55 14.03 27.64 73.07 18.65 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 31.73 69.87 11.50 32.73 70.19 16.40 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 25.87 58.42 18.79 23.95 58.54 17.90 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 6 3 # 6 J 182 LYS A 301 LYS~? 24.94 ZN ZN A 375 J 184 LYS A 303 LYS~? 13.81 O3 TRS A 378 J 345 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 25.22 70.55 14.03 27.64 73.07 18.65 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 31.73 69.87 11.50 32.73 70.19 16.40 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 25.87 58.42 18.79 23.95 58.54 17.90 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 7 3 # 7 J 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 J 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 J 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 25.22 70.55 14.03 27.64 73.07 18.65 45.66 0.76 26.15 51.53 0.58 28.90 coo 31.73 69.87 11.50 32.73 70.19 16.40 44.47 1.55 20.70 47.30 5.10 24.27 coo 25.87 58.42 18.79 23.95 58.54 17.90 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 8 3 # 8 J 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 J 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 J 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 25.22 70.55 14.03 27.64 73.07 18.65 45.66 0.76 26.15 51.53 0.58 28.90 coo 31.73 69.87 11.50 32.73 70.19 16.40 44.47 1.55 20.70 47.30 5.10 24.27 coo 25.87 58.42 18.79 23.95 58.54 17.90 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 9 3 # 9 J 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 J 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 J 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 25.22 70.55 14.03 27.64 73.07 18.65 44.47 1.55 20.70 47.30 5.10 24.27 coo 31.73 69.87 11.50 32.73 70.19 16.40 45.66 0.76 26.15 51.53 0.58 28.90 coo 25.87 58.42 18.79 23.95 58.54 17.90 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 10 3 # 10 J 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 J 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 J 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 25.22 70.55 14.03 27.64 73.07 18.65 44.47 1.55 20.70 47.30 5.10 24.27 coo 31.73 69.87 11.50 32.73 70.19 16.40 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 25.87 58.42 18.79 23.95 58.54 17.90 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 11 3 # 11 J 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 J 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 J 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 25.22 70.55 14.03 27.64 73.07 18.65 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 31.73 69.87 11.50 32.73 70.19 16.40 44.47 1.55 20.70 47.30 5.10 24.27 coo 25.87 58.42 18.79 23.95 58.54 17.90 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 12 3 # 12 J 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 J 184 LYS B 83 LYS~? 4.34 O1S EPE B 376 J 345 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo 25.22 70.55 14.03 27.64 73.07 18.65 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 31.73 69.87 11.50 32.73 70.19 16.40 -20.11 12.86 43.96 -14.92 12.31 47.32 coo 25.87 58.42 18.79 23.95 58.54 17.90 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 13 3 # 13 J 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 J 184 LYS B 91 LYS~? 15.73 O3S EPE B 376 J 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 25.22 70.55 14.03 27.64 73.07 18.65 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 31.73 69.87 11.50 32.73 70.19 16.40 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 25.87 58.42 18.79 23.95 58.54 17.90 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 14 3 # 14 J 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 J 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 J 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 25.22 70.55 14.03 27.64 73.07 18.65 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 31.73 69.87 11.50 32.73 70.19 16.40 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 25.87 58.42 18.79 23.95 58.54 17.90 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 15 3 # 15 J 182 LYS B 215 LYS~? 17.38 O3S EPE A 377 J 184 LYS B 218 LYS~? 23.26 O3S EPE A 377 J 345 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 25.22 70.55 14.03 27.64 73.07 18.65 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 31.73 69.87 11.50 32.73 70.19 16.40 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 25.87 58.42 18.79 23.95 58.54 17.90 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 16 3 # 16 J 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 J 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 J 345 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 25.22 70.55 14.03 27.64 73.07 18.65 8.36 10.35 11.75 10.05 14.82 9.04 coo 31.73 69.87 11.50 32.73 70.19 16.40 7.99 5.97 9.05 6.92 1.04 11.01 coo 25.87 58.42 18.79 23.95 58.54 17.90 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 17 3 # 17 J 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 J 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 J 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 25.22 70.55 14.03 27.64 73.07 18.65 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 31.73 69.87 11.50 32.73 70.19 16.40 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 25.87 58.42 18.79 23.95 58.54 17.90 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 18 3 # 18 J 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 J 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 J 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 25.22 70.55 14.03 27.64 73.07 18.65 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 31.73 69.87 11.50 32.73 70.19 16.40 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 25.87 58.42 18.79 23.95 58.54 17.90 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 19 3 # 19 J 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 J 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 J 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 25.22 70.55 14.03 27.64 73.07 18.65 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 31.73 69.87 11.50 32.73 70.19 16.40 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 25.87 58.42 18.79 23.95 58.54 17.90 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 20 3 # 20 J 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 J 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 J 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 25.22 70.55 14.03 27.64 73.07 18.65 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 31.73 69.87 11.50 32.73 70.19 16.40 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 25.87 58.42 18.79 23.95 58.54 17.90 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 21 3 # 21 J 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 J 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 J 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 25.22 70.55 14.03 27.64 73.07 18.65 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 31.73 69.87 11.50 32.73 70.19 16.40 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 25.87 58.42 18.79 23.95 58.54 17.90 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 22 3 # 22 J 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 J 184 LYS C 83 LYS~? -3.65 O2S EPE C 376s J 345 ASP C 55 ASP~? 17.38 O3S EPE C 376 coo 25.22 70.55 14.03 27.64 73.07 18.65 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 31.73 69.87 11.50 32.73 70.19 16.40 19.52 -16.87 71.96 18.81 -11.07 69.68 coo 25.87 58.42 18.79 23.95 58.54 17.90 19.09 -33.39 71.33 19.50 -31.61 72.40 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 23 3 # 23 J 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 J 184 LYS C 91 LYS~? 15.57 O3S EPE C 376 J 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 25.22 70.55 14.03 27.64 73.07 18.65 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 31.73 69.87 11.50 32.73 70.19 16.40 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 25.87 58.42 18.79 23.95 58.54 17.90 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 24 3 # 24 J 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 J 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 J 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 25.22 70.55 14.03 27.64 73.07 18.65 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 31.73 69.87 11.50 32.73 70.19 16.40 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 25.87 58.42 18.79 23.95 58.54 17.90 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 25 3 # 25 J 182 LYS C 215 LYS~? 17.39 O1 TRS A 378 J 184 LYS C 218 LYS~? 12.80 O1 TRS A 378 J 345 ASP A 237 ASP^? 6.80 N TRS A 378 coo 25.22 70.55 14.03 27.64 73.07 18.65 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 31.73 69.87 11.50 32.73 70.19 16.40 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 25.87 58.42 18.79 23.95 58.54 17.90 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 26 3 # 26 J 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 J 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 J 345 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 25.22 70.55 14.03 27.64 73.07 18.65 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 31.73 69.87 11.50 32.73 70.19 16.40 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 25.87 58.42 18.79 23.95 58.54 17.90 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 27 3 # 27 J 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 J 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 J 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 25.22 70.55 14.03 27.64 73.07 18.65 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 31.73 69.87 11.50 32.73 70.19 16.40 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 25.87 58.42 18.79 23.95 58.54 17.90 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 28 3 # 28 J 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 J 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 J 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 25.22 70.55 14.03 27.64 73.07 18.65 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 31.73 69.87 11.50 32.73 70.19 16.40 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 25.87 58.42 18.79 23.95 58.54 17.90 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 29 3 # 29 J 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 J 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 J 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 25.22 70.55 14.03 27.64 73.07 18.65 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 31.73 69.87 11.50 32.73 70.19 16.40 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 25.87 58.42 18.79 23.95 58.54 17.90 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 30 3 # 30 J 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 J 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 J 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 25.22 70.55 14.03 27.64 73.07 18.65 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 31.73 69.87 11.50 32.73 70.19 16.40 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 25.87 58.42 18.79 23.95 58.54 17.90 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 31 3 # 31 J 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 J 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 J 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 25.22 70.55 14.03 27.64 73.07 18.65 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 31.73 69.87 11.50 32.73 70.19 16.40 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 25.87 58.42 18.79 23.95 58.54 17.90 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 31 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 K 184 LYS A 83 LYS~? -5.13 O1S EPE A 376s K 345 ASP A 55 ASP~? 17.36 O2S EPE A 376 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 35.91 21.93 28.51 38.15 26.57 30.75 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 35.02 22.85 34.66 32.09 22.94 39.08 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 45.10 18.98 22.18 44.20 20.57 23.21 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 K 184 LYS A 91 LYS~? 15.85 O2S EPE A 376 K 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 35.91 21.93 28.51 38.15 26.57 30.75 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 36.23 21.81 22.32 41.86 22.67 23.70 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 3 3 # 3 K 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 K 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 K 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 4 3 # 4 K 182 LYS A 301 LYS~? 24.94 ZN ZN A 375 K 184 LYS A 303 LYS~? 13.81 O3 TRS A 378 K 345 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 5 3 # 5 K 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 K 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 K 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 45.66 0.76 26.15 51.53 0.58 28.90 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 44.47 1.55 20.70 47.30 5.10 24.27 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 6 3 # 6 K 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 K 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 K 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 45.66 0.76 26.15 51.53 0.58 28.90 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 44.47 1.55 20.70 47.30 5.10 24.27 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 7 3 # 7 K 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 K 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 K 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 44.47 1.55 20.70 47.30 5.10 24.27 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 45.66 0.76 26.15 51.53 0.58 28.90 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 8 3 # 8 K 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 K 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 K 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 44.47 1.55 20.70 47.30 5.10 24.27 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 9 3 # 9 K 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 K 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 K 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 44.47 1.55 20.70 47.30 5.10 24.27 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 10 3 # 10 K 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 K 184 LYS B 83 LYS~? 4.34 O1S EPE B 376 K 345 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -20.11 12.86 43.96 -14.92 12.31 47.32 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 11 3 # 11 K 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 K 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 K 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 12 3 # 12 K 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 K 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 K 345 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 8.36 10.35 11.75 10.05 14.82 9.04 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 7.99 5.97 9.05 6.92 1.04 11.01 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 13 3 # 13 K 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 K 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 K 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 14 3 # 14 K 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 K 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 K 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 15 3 # 15 K 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 K 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 K 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 16 3 # 16 K 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 K 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 K 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 17 3 # 17 K 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 K 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 K 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 18 3 # 18 K 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 K 184 LYS C 83 LYS~? -3.65 O2S EPE C 376s K 345 ASP C 55 ASP~? 17.38 O3S EPE C 376 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 19.52 -16.87 71.96 18.81 -11.07 69.68 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 19.09 -33.39 71.33 19.50 -31.61 72.40 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 19 3 # 19 K 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 K 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 K 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 20 3 # 20 K 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 K 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 K 345 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 21 3 # 21 K 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 K 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 K 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 22 3 # 22 K 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 K 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 K 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 23 3 # 23 K 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 K 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 K 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 24 3 # 24 K 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 K 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 K 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 25 3 # 25 K 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 K 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 K 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 25 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 L 184 LYS A 83 LYS~? -5.13 O1S EPE A 376s L 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 35.91 21.93 28.51 38.15 26.57 30.75 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 35.02 22.85 34.66 32.09 22.94 39.08 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 L 184 LYS A 91 LYS~? 15.85 O2S EPE A 376 L 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 35.91 21.93 28.51 38.15 26.57 30.75 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 36.23 21.81 22.32 41.86 22.67 23.70 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 L 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 L 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS A 218 LYS~? 21.49 C3 EPE A 377 L 184 LYS A 215 LYS~? 16.65 O1S EPE C 377 L 345 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS A 218 LYS~? 21.49 C3 EPE A 377 L 184 LYS A 215 LYS~? 16.65 O1S EPE C 377 L 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 L 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 L 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 44.47 1.55 20.70 47.30 5.10 24.27 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 7 3 # 7 L 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 L 184 LYS A 350 LYS~? 21.83 ZN ZN A 375 L 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 8 3 # 8 L 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 L 184 LYS B 83 LYS~? 4.34 O1S EPE B 376 L 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -20.11 12.86 43.96 -14.92 12.31 47.32 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 9 3 # 9 L 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 L 184 LYS B 83 LYS~? 4.34 O1S EPE B 376 L 345 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -20.11 12.86 43.96 -14.92 12.31 47.32 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 10 3 # 10 L 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 L 184 LYS B 91 LYS~? 15.73 O3S EPE B 376 L 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 11 3 # 11 L 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 L 184 LYS B 87 LYS~? 9.60 O3S EPE B 376 L 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 12 3 # 12 L 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 L 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 L 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 13 3 # 13 L 182 LYS B 215 LYS~? 17.38 O3S EPE A 377 L 184 LYS B 218 LYS~? 23.26 O3S EPE A 377 L 345 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 14 3 # 14 L 182 LYS B 218 LYS~? 23.26 O3S EPE A 377 L 184 LYS B 215 LYS~? 17.38 O3S EPE A 377 L 345 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 15 3 # 15 L 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 L 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 L 345 ASP B 281 ASP.? 29.04 ZN ZN B 374 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 8.36 10.35 11.75 10.05 14.82 9.04 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 7.99 5.97 9.05 6.92 1.04 11.01 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 4.51 22.24 5.26 6.45 23.04 5.71 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 16 3 # 16 L 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 L 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 L 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 17 3 # 17 L 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 L 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 L 345 ASP B 269 ASP.? 18.26 ZN ZN B 374 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -18.05 15.19 12.20 -19.75 16.35 12.84 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 18 3 # 18 L 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 L 184 LYS B 350 LYS~? 21.91 ZN ZN B 375 L 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 19 3 # 19 L 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 L 184 LYS C 83 LYS~? -3.65 O2S EPE C 376s L 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 19.52 -16.87 71.96 18.81 -11.07 69.68 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 20 3 # 20 L 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 L 184 LYS C 83 LYS~? -3.65 O2S EPE C 376s L 345 ASP C 55 ASP~? 17.38 O3S EPE C 376 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 19.52 -16.87 71.96 18.81 -11.07 69.68 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 19.09 -33.39 71.33 19.50 -31.61 72.40 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 21 3 # 21 L 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 L 184 LYS C 91 LYS~? 15.57 O3S EPE C 376 L 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 22 3 # 22 L 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 L 184 LYS C 87 LYS~? 9.86 O3S EPE C 376 L 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 23 3 # 23 L 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 L 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 L 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 24 3 # 24 L 182 LYS C 215 LYS~? 17.39 O1 TRS A 378 L 184 LYS C 218 LYS~? 12.80 O1 TRS A 378 L 345 ASP A 237 ASP^? 6.80 N TRS A 378 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 25 3 # 25 L 182 LYS C 218 LYS~? 12.80 O1 TRS A 378 L 184 LYS C 215 LYS~? 17.39 O1 TRS A 378 L 345 ASP A 237 ASP^? 6.80 N TRS A 378 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 26 3 # 26 L 182 LYS C 218 LYS~? 12.80 O1 TRS A 378 L 184 LYS C 215 LYS~? 17.39 O1 TRS A 378 L 345 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 27 3 # 27 L 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 L 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 L 345 ASP C 281 ASP.? 29.07 ZN ZN C 374 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -22.02 -28.08 53.32 -23.19 -26.28 53.39 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 28 3 # 28 L 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 L 184 LYS C 350 LYS~? 21.45 ZN ZN C 375 L 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 28 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 M 184 LYS A 83 LYS~? -5.13 O1S EPE A 376s M 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 35.91 21.93 28.51 38.15 26.57 30.75 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 35.02 22.85 34.66 32.09 22.94 39.08 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 M 184 LYS A 91 LYS~? 15.85 O2S EPE A 376 M 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 35.91 21.93 28.51 38.15 26.57 30.75 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 36.23 21.81 22.32 41.86 22.67 23.70 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS A 91 LYS~? 15.85 O2S EPE A 376 M 184 LYS A 87 LYS~? 10.99 O2S EPE A 376 M 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 36.23 21.81 22.32 41.86 22.67 23.70 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 35.91 21.93 28.51 38.15 26.57 30.75 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 M 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 M 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 21.25 -14.20 2.18 27.53 -14.97 1.13 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS A 218 LYS~? 21.49 C3 EPE A 377 M 184 LYS A 215 LYS~? 16.65 O1S EPE C 377 M 345 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 21.25 -14.20 2.18 27.53 -14.97 1.13 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS A 218 LYS~? 21.49 C3 EPE A 377 M 184 LYS A 215 LYS~? 16.65 O1S EPE C 377 M 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 21.25 -14.20 2.18 27.53 -14.97 1.13 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 7 3 # 7 M 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 M 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 M 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 44.47 1.55 20.70 47.30 5.10 24.27 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 45.56 -1.99 12.81 45.09 -7.18 12.35 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 8 3 # 8 M 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 M 184 LYS A 350 LYS~? 21.83 ZN ZN A 375 M 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 45.56 -1.99 12.81 45.09 -7.18 12.35 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 39.19 -2.77 6.68 35.27 -5.97 7.17 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 9 3 # 9 M 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 M 184 LYS B 83 LYS~? 4.34 O1S EPE B 376 M 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -23.51 8.76 41.04 -24.49 13.82 43.31 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -20.11 12.86 43.96 -14.92 12.31 47.32 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 10 3 # 10 M 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 M 184 LYS B 91 LYS~? 15.73 O3S EPE B 376 M 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -23.51 8.76 41.04 -24.49 13.82 43.31 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -26.96 4.56 38.63 -29.49 9.20 36.26 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 11 3 # 11 M 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 M 184 LYS B 87 LYS~? 9.60 O3S EPE B 376 M 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -26.96 4.56 38.63 -29.49 9.20 36.26 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -23.51 8.76 41.04 -24.49 13.82 43.31 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 12 3 # 12 M 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 M 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 M 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -26.96 4.56 38.63 -29.49 9.20 36.26 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -29.53 0.46 40.71 -30.43 3.58 45.55 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 13 3 # 13 M 182 LYS B 215 LYS~? 17.38 O3S EPE A 377 M 184 LYS B 218 LYS~? 23.26 O3S EPE A 377 M 345 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 14 3 # 14 M 182 LYS B 218 LYS~? 23.26 O3S EPE A 377 M 184 LYS B 215 LYS~? 17.38 O3S EPE A 377 M 345 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 15 3 # 15 M 182 LYS B 218 LYS~? 23.26 O3S EPE A 377 M 184 LYS B 215 LYS~? 17.38 O3S EPE A 377 M 345 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 16 3 # 16 M 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 M 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 M 345 ASP B 281 ASP.? 29.04 ZN ZN B 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 8.36 10.35 11.75 10.05 14.82 9.04 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 7.99 5.97 9.05 6.92 1.04 11.01 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 4.51 22.24 5.26 6.45 23.04 5.71 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 17 3 # 17 M 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 M 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 M 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 18 3 # 18 M 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 M 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 M 345 ASP B 269 ASP.? 18.26 ZN ZN B 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -18.05 15.19 12.20 -19.75 16.35 12.84 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 19 3 # 19 M 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 M 184 LYS B 350 LYS~? 21.91 ZN ZN B 375 M 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 20 3 # 20 M 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 M 184 LYS C 83 LYS~? -3.65 O2S EPE C 376s M 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 22.12 -22.06 69.94 21.88 -19.84 74.70 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 19.52 -16.87 71.96 18.81 -11.07 69.68 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 21 3 # 21 M 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 M 184 LYS C 83 LYS~? -3.65 O2S EPE C 376s M 345 ASP C 55 ASP~? 17.38 O3S EPE C 376 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 22.12 -22.06 69.94 21.88 -19.84 74.70 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 19.52 -16.87 71.96 18.81 -11.07 69.68 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 19.09 -33.39 71.33 19.50 -31.61 72.40 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 22 3 # 22 M 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 M 184 LYS C 91 LYS~? 15.57 O3S EPE C 376 M 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 22.12 -22.06 69.94 21.88 -19.84 74.70 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 24.97 -26.94 68.30 21.78 -29.04 72.70 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 23 3 # 23 M 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 M 184 LYS C 87 LYS~? 9.86 O3S EPE C 376 M 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 24.97 -26.94 68.30 21.78 -29.04 72.70 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 22.12 -22.06 69.94 21.88 -19.84 74.70 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 24 3 # 24 M 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 M 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 M 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 24.97 -26.94 68.30 21.78 -29.04 72.70 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 30.11 -27.61 67.14 30.55 -24.06 72.29 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 25 3 # 25 M 182 LYS C 215 LYS~? 17.39 O1 TRS A 378 M 184 LYS C 218 LYS~? 12.80 O1 TRS A 378 M 345 ASP A 237 ASP^? 6.80 N TRS A 378 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 22.70 -37.10 29.95 20.60 -41.87 33.53 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 26.24 -37.78 26.13 29.59 -36.75 30.95 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 26 3 # 26 M 182 LYS C 218 LYS~? 12.80 O1 TRS A 378 M 184 LYS C 215 LYS~? 17.39 O1 TRS A 378 M 345 ASP A 237 ASP^? 6.80 N TRS A 378 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 26.24 -37.78 26.13 29.59 -36.75 30.95 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 22.70 -37.10 29.95 20.60 -41.87 33.53 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 27 3 # 27 M 182 LYS C 218 LYS~? 12.80 O1 TRS A 378 M 184 LYS C 215 LYS~? 17.39 O1 TRS A 378 M 345 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 26.24 -37.78 26.13 29.59 -36.75 30.95 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 22.70 -37.10 29.95 20.60 -41.87 33.53 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 28 3 # 28 M 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 M 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 M 345 ASP C 281 ASP.? 29.07 ZN ZN C 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -22.02 -28.08 53.32 -23.19 -26.28 53.39 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 29 3 # 29 M 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 M 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 M 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 11.31 -44.62 52.77 6.74 -46.86 52.89 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 30 3 # 30 M 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 M 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 M 345 ASP C 269 ASP~? 18.04 ZN ZN C 374 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 11.31 -44.62 52.77 6.74 -46.86 52.89 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -1.79 -38.40 63.28 -1.15 -38.99 65.26 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 31 3 # 31 M 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 M 184 LYS C 350 LYS~? 21.45 ZN ZN C 375 M 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 11.31 -44.62 52.77 6.74 -46.86 52.89 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 17.69 -45.38 46.76 16.74 -42.84 42.17 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 31 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 265 LYS~? 22.38 ZN ZN A 374 N 184 LYS A 271 LYS.? 23.00 ZN ZN A 374 N 345 ASP A 330 ASP^? 12.08 ZN ZN A 374 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 54.99 -5.46 33.76 58.41 -3.92 38.21 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 56.12 0.48 35.73 59.67 4.01 35.99 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 45.96 -5.26 40.35 44.85 -3.42 39.89 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 N 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 N 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 45.66 0.76 26.15 51.53 0.58 28.90 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 44.47 1.55 20.70 47.30 5.10 24.27 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 N 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 N 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 45.66 0.76 26.15 51.53 0.58 28.90 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 44.47 1.55 20.70 47.30 5.10 24.27 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 4 3 # 4 N 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 N 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 N 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 44.47 1.55 20.70 47.30 5.10 24.27 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 45.66 0.76 26.15 51.53 0.58 28.90 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 5 3 # 5 N 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 N 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 N 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 44.47 1.55 20.70 47.30 5.10 24.27 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 45.66 0.76 26.15 51.53 0.58 28.90 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 6 3 # 6 N 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 N 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 N 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 44.47 1.55 20.70 47.30 5.10 24.27 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 7 3 # 7 N 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 N 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 N 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 44.47 1.55 20.70 47.30 5.10 24.27 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 8 3 # 8 N 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 N 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 N 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 9 3 # 9 N 182 LYS B 265 LYS~? 21.91 ZN ZN B 374 N 184 LYS B 271 LYS.? 19.93 ZN ZN B 374 N 345 ASP B 330 ASP^? 11.92 ZN ZN B 374 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -12.32 18.80 10.54 -12.89 23.62 10.63 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -15.49 22.23 14.65 -19.95 19.84 13.72 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -4.33 18.16 18.13 -5.04 17.21 19.90 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 10 3 # 10 N 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 N 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 N 345 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 8.36 10.35 11.75 10.05 14.82 9.04 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 7.99 5.97 9.05 6.92 1.04 11.01 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 11 3 # 11 N 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 N 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 N 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 12 3 # 12 N 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 N 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 N 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 13 3 # 13 N 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 N 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 N 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 14 3 # 14 N 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 N 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 N 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 15 3 # 15 N 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 N 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 N 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 16 3 # 16 N 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 N 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 N 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 17 3 # 17 N 182 LYS C 265 LYS~? 21.95 ZN ZN C 374 N 184 LYS C 271 LYS.? 19.51 ZN ZN C 374 N 345 ASP C 330 ASP^? 11.91 ZN ZN C 374 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -6.09 -33.65 68.04 -3.07 -37.10 68.37 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -7.16 -24.94 59.28 -5.20 -24.20 59.64 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 18 3 # 18 N 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 N 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 N 345 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 19 3 # 19 N 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 N 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 N 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 20 3 # 20 N 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 N 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 N 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 21 3 # 21 N 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 N 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 N 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 22.75 -28.13 87.31 18.89 -29.87 83.00 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 22 3 # 22 N 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 N 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 N 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 23 3 # 23 N 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 N 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 N 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 24 3 # 24 N 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 N 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 N 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 24 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 O 184 LYS A 83 LYS~? -5.13 O1S EPE A 376s O 345 ASP A 55 ASP~? 17.36 O2S EPE A 376 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 35.91 21.93 28.51 38.15 26.57 30.75 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 35.02 22.85 34.66 32.09 22.94 39.08 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 45.10 18.98 22.18 44.20 20.57 23.21 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 O 184 LYS A 91 LYS~? 15.85 O2S EPE A 376 O 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 35.91 21.93 28.51 38.15 26.57 30.75 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 36.23 21.81 22.32 41.86 22.67 23.70 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 O 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 O 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 4 3 # 4 O 182 LYS A 301 LYS~? 24.94 ZN ZN A 375 O 184 LYS A 303 LYS~? 13.81 O3 TRS A 378 O 345 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 5 3 # 5 O 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 O 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 O 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 45.66 0.76 26.15 51.53 0.58 28.90 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 44.47 1.55 20.70 47.30 5.10 24.27 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 6 3 # 6 O 182 LYS A 337 LYS~? 14.02 ZN ZN A 374 O 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 O 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 45.66 0.76 26.15 51.53 0.58 28.90 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 44.47 1.55 20.70 47.30 5.10 24.27 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 7 3 # 7 O 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 O 184 LYS A 337 LYS~? 14.02 ZN ZN A 374 O 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 44.47 1.55 20.70 47.30 5.10 24.27 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 45.66 0.76 26.15 51.53 0.58 28.90 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 8 3 # 8 O 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 O 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 O 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 44.47 1.55 20.70 47.30 5.10 24.27 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 9 3 # 9 O 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 O 184 LYS A 340 LYS~? 12.75 ZN ZN A 374 O 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 44.47 1.55 20.70 47.30 5.10 24.27 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 10 3 # 10 O 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 O 184 LYS B 83 LYS~? 4.34 O1S EPE B 376 O 345 ASP B 55 ASP~? 16.89 O3S EPE B 376 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -20.11 12.86 43.96 -14.92 12.31 47.32 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -29.80 9.25 31.21 -29.50 10.07 33.15 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 11 3 # 11 O 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 O 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 O 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 12 3 # 12 O 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 O 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 O 345 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 8.36 10.35 11.75 10.05 14.82 9.04 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 7.99 5.97 9.05 6.92 1.04 11.01 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 13 3 # 13 O 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 O 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 O 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 14 3 # 14 O 182 LYS B 337 LYS~? 13.35 ZN ZN B 374 O 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 O 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 15 3 # 15 O 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 O 184 LYS B 337 LYS~? 13.35 ZN ZN B 374 O 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 16 3 # 16 O 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 O 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 O 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 17 3 # 17 O 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 O 184 LYS B 340 LYS~? 12.84 ZN ZN B 374 O 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 18 3 # 18 O 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 O 184 LYS C 83 LYS~? -3.65 O2S EPE C 376s O 345 ASP C 55 ASP~? 17.38 O3S EPE C 376 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 19.52 -16.87 71.96 18.81 -11.07 69.68 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 19.09 -33.39 71.33 19.50 -31.61 72.40 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 19 3 # 19 O 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 O 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 O 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 20 3 # 20 O 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 O 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 O 345 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 21 3 # 21 O 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 O 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 O 345 ASP C 107 ASP~? -2.30 ZN ZN C 375s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 5.80 -28.16 48.27 6.08 -27.64 50.28 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 22 3 # 22 O 182 LYS C 337 LYS~? 12.69 ZN ZN C 374 O 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 O 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 23 3 # 23 O 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 O 184 LYS C 337 LYS~? 12.69 ZN ZN C 374 O 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 24 3 # 24 O 182 LYS C 340 LYS~? 12.92 ZN ZN C 374 O 184 LYS C 345 LYS~? 19.35 ZN ZN C 375 O 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 1.88 -37.38 46.52 1.77 -36.70 44.54 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 25 3 # 25 O 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 O 184 LYS C 340 LYS~? 12.92 ZN ZN C 374 O 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 25 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 P 184 LYS A 83 LYS~? -5.13 O1S EPE A 376s P 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 35.91 21.93 28.51 38.15 26.57 30.75 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 35.02 22.85 34.66 32.09 22.94 39.08 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 87 LYS~? 10.99 O2S EPE A 376 P 184 LYS A 91 LYS~? 15.85 O2S EPE A 376 P 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 35.91 21.93 28.51 38.15 26.57 30.75 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 36.23 21.81 22.32 41.86 22.67 23.70 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS A 91 LYS~? 15.85 O2S EPE A 376 P 184 LYS A 87 LYS~? 10.99 O2S EPE A 376 P 345 ASP A 48 ASP.? 7.40 ZN ZN A 374 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 36.23 21.81 22.32 41.86 22.67 23.70 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 35.91 21.93 28.51 38.15 26.57 30.75 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 40.70 8.14 28.73 41.06 6.40 29.84 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS A 215 LYS~? 16.65 O1S EPE C 377 P 184 LYS A 218 LYS~? 21.49 C3 EPE A 377 P 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS A 218 LYS~? 21.49 C3 EPE A 377 P 184 LYS A 215 LYS~? 16.65 O1S EPE C 377 P 345 ASP A 232 ASP^? 4.68 O1S EPE A 377 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 9.54 -24.20 7.87 7.70 -24.91 7.05 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS A 218 LYS~? 21.49 C3 EPE A 377 P 184 LYS A 215 LYS~? 16.65 O1S EPE C 377 P 345 ASP B 237 ASP^? 15.58 N TRS A 378 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 11.84 -17.75 12.41 13.28 -17.47 14.02 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 7 3 # 7 P 182 LYS A 340 LYS~? 12.75 ZN ZN A 374 P 184 LYS A 345 LYS~? 18.67 ZN ZN A 375 P 345 ASP A 107 ASP~? -2.33 ZN ZN A 375s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 44.47 1.55 20.70 47.30 5.10 24.27 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 35.27 -5.88 26.81 35.94 -4.18 27.85 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 8 3 # 8 P 182 LYS A 345 LYS~? 18.67 ZN ZN A 375 P 184 LYS A 350 LYS~? 21.83 ZN ZN A 375 P 345 ASP A 115 ASP~? 13.24 ZN ZN A 375 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 45.56 -1.99 12.81 45.09 -7.18 12.35 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 41.88 -11.27 21.52 40.65 -12.98 21.39 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 9 3 # 9 P 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 P 184 LYS B 83 LYS~? 4.34 O1S EPE B 376 P 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -20.11 12.86 43.96 -14.92 12.31 47.32 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 10 3 # 10 P 182 LYS B 87 LYS~? 9.60 O3S EPE B 376 P 184 LYS B 91 LYS~? 15.73 O3S EPE B 376 P 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 11 3 # 11 P 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 P 184 LYS B 87 LYS~? 9.60 O3S EPE B 376 P 345 ASP B 48 ASP.? 7.36 ZN ZN B 374 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -23.51 8.76 41.04 -24.49 13.82 43.31 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -17.03 8.88 27.62 -15.41 9.62 26.60 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 12 3 # 12 P 182 LYS B 91 LYS~? 15.73 O3S EPE B 376 P 184 LYS B 94 LYS~? 17.44 O2S EPE B 376 P 345 ASP B 82 ASP.? 10.62 O3S EPE B 376 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -22.38 12.66 48.09 -22.95 14.65 48.48 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 13 3 # 13 P 182 LYS B 215 LYS~? 17.38 O3S EPE A 377 P 184 LYS B 218 LYS~? 23.26 O3S EPE A 377 P 345 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 14 3 # 14 P 182 LYS B 218 LYS~? 23.26 O3S EPE A 377 P 184 LYS B 215 LYS~? 17.38 O3S EPE A 377 P 345 ASP B 232 ASP^? 14.54 O2S EPE A 377 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 6.16 -32.41 17.86 6.89 -34.31 18.36 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 15 3 # 15 P 182 LYS B 218 LYS~? 23.26 O3S EPE A 377 P 184 LYS B 215 LYS~? 17.38 O3S EPE A 377 P 345 ASP C 237 ASP^? 16.80 O1S EPE A 377 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 4.59 -25.19 21.63 5.07 -23.28 20.96 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 16 3 # 16 P 182 LYS B 301 LYS~? 25.03 ZN ZN B 375 P 184 LYS B 303 LYS~? 19.29 ZN ZN B 375 P 345 ASP B 281 ASP.? 29.04 ZN ZN B 374 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 8.36 10.35 11.75 10.05 14.82 9.04 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 7.99 5.97 9.05 6.92 1.04 11.01 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 4.51 22.24 5.26 6.45 23.04 5.71 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 17 3 # 17 P 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 P 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 P 345 ASP B 107 ASP~? -2.23 ZN ZN B 375s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -6.47 1.09 20.08 -7.49 2.52 21.22 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 18 3 # 18 P 182 LYS B 340 LYS~? 12.84 ZN ZN B 374 P 184 LYS B 345 LYS~? 20.14 ZN ZN B 375 P 345 ASP B 269 ASP.? 18.26 ZN ZN B 374 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -18.05 15.19 12.20 -19.75 16.35 12.84 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 19 3 # 19 P 182 LYS B 345 LYS~? 20.14 ZN ZN B 375 P 184 LYS B 350 LYS~? 21.91 ZN ZN B 375 P 345 ASP B 115 ASP~? 12.98 ZN ZN B 375 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -22.26 -2.20 12.60 -22.46 0.95 7.82 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -22.61 -10.64 13.95 -18.13 -13.35 13.22 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -9.21 0.02 10.54 -7.53 -1.35 10.38 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 20 3 # 20 P 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 P 184 LYS C 83 LYS~? -3.65 O2S EPE C 376s P 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 19.52 -16.87 71.96 18.81 -11.07 69.68 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 21 3 # 21 P 182 LYS C 87 LYS~? 9.86 O3S EPE C 376 P 184 LYS C 91 LYS~? 15.57 O3S EPE C 376 P 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 22 3 # 22 P 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 P 184 LYS C 87 LYS~? 9.86 O3S EPE C 376 P 345 ASP C 48 ASP.? 7.30 ZN ZN C 374 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 22.12 -22.06 69.94 21.88 -19.84 74.70 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 10.65 -27.85 62.57 8.78 -27.40 61.73 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 23 3 # 23 P 182 LYS C 91 LYS~? 15.57 O3S EPE C 376 P 184 LYS C 94 LYS~? 16.71 O3S EPE C 376 P 345 ASP C 82 ASP.? 10.22 O3S EPE C 376 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 23.03 -14.86 74.18 22.44 -14.42 76.16 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 24 3 # 24 P 182 LYS C 215 LYS~? 17.39 O1 TRS A 378 P 184 LYS C 218 LYS~? 12.80 O1 TRS A 378 P 345 ASP A 237 ASP^? 6.80 N TRS A 378 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 25 3 # 25 P 182 LYS C 218 LYS~? 12.80 O1 TRS A 378 P 184 LYS C 215 LYS~? 17.39 O1 TRS A 378 P 345 ASP A 237 ASP^? 6.80 N TRS A 378 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 18.36 -25.38 21.90 16.49 -24.92 22.81 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 26 3 # 26 P 182 LYS C 218 LYS~? 12.80 O1 TRS A 378 P 184 LYS C 215 LYS~? 17.39 O1 TRS A 378 P 345 ASP C 232 ASP^? 3.77 O2S EPE C 377 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 18.91 -30.34 15.16 19.98 -30.20 13.32 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 27 3 # 27 P 182 LYS C 301 LYS~? 24.63 ZN ZN C 375 P 184 LYS C 303 LYS~? 17.98 ZN ZN C 375 P 345 ASP C 281 ASP.? 29.07 ZN ZN C 374 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -22.02 -28.08 53.32 -23.19 -26.28 53.39 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 28 3 # 28 P 182 LYS C 345 LYS~? 19.35 ZN ZN C 375 P 184 LYS C 350 LYS~? 21.45 ZN ZN C 375 P 345 ASP C 115 ASP~? 12.87 ZN ZN C 375 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 11.31 -44.62 52.77 6.74 -46.86 52.89 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 17.69 -45.38 46.76 16.74 -42.84 42.17 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 1.88 -37.38 46.52 1.77 -36.70 44.54 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 28 hits 2dw7_c47 naa= 3 ULMN 3 2f61_c01 ACID BETA-GLUCOSIDASE user 1 3 # 1 B 235 GLU C 52 GLU~? 13.90 C2 EPE C 376 B 340 GLU C 51 GLU~? 12.03 O3S EPE C 376 B 342 CYH C 92 CYH~? 13.12 C2 EPE C 376 coo 41.63 98.81 4.74 43.45 99.80 5.19 13.88 -30.69 72.19 13.68 -28.54 72.17 coo 40.49 105.59 6.14 40.82 103.64 6.89 19.07 -27.28 70.66 19.78 -25.91 72.07 coo 45.58 109.64 7.60 45.90 106.93 8.23 25.07 -27.93 64.57 22.49 -27.62 63.56 2f61_c01 source 2f61 ACID BETA-GLUCOSIDASE : 1 hits 2f61_c01 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 245 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 273 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 245 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 273 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 245 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 273 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 245 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 273 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 41.88 -11.27 21.52 40.65 -12.98 21.39 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 150 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 245 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 273 LYS A 340 LYS~? 12.75 ZN ZN A 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 41.88 -11.27 21.52 40.65 -12.98 21.39 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 44.47 1.55 20.70 47.30 5.10 24.27 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 150 TYR A 18 TYR~? 11.08 ZN ZN A 375 A 245 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 273 LYS A 345 LYS~? 18.67 ZN ZN A 375 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 41.88 -11.27 21.52 40.65 -12.98 21.39 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 45.56 -1.99 12.81 45.09 -7.18 12.35 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 150 TYR A 231 TYR^? 10.06 O1S EPE A 377 A 245 ASP B 237 ASP^? 15.58 N TRS A 378 A 273 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 11.84 -17.75 12.41 13.28 -17.47 14.02 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 150 TYR A 231 TYR^? 10.06 O1S EPE A 377 A 245 ASP B 237 ASP^? 15.58 N TRS A 378 A 273 LYS B 139 LYS^? -2.84 O2S EPE A 377s coo 9.74 16.83 -36.21 11.10 17.13 -33.77 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 11.84 -17.75 12.41 13.28 -17.47 14.02 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 4.48 -26.42 12.36 5.89 -27.34 7.19 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 150 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 245 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 273 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo 9.74 16.83 -36.21 11.10 17.13 -33.77 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 150 TYR A 234 TYR^? 9.43 O2S EPE A 377 A 245 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 273 LYS C 138 LYS^? 8.30 N TRS A 378 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 150 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 245 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 273 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 47.82 -20.71 38.37 47.81 -22.84 38.27 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 12 3 # 12 A 150 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 245 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 273 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 13 3 # 13 A 150 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 245 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 273 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 14 3 # 14 A 150 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 245 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 273 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 15 3 # 15 A 150 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 245 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 273 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 16 3 # 16 A 150 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 245 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 273 LYS B 340 LYS~? 12.84 ZN ZN B 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -19.41 3.70 18.30 -21.14 8.87 20.36 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 17 3 # 17 A 150 TYR B 18 TYR~? 10.93 ZN ZN B 375 A 245 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 273 LYS B 345 LYS~? 20.14 ZN ZN B 375 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -12.77 -5.58 18.92 -13.52 -3.89 16.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -22.26 -2.20 12.60 -22.46 0.95 7.82 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 18 3 # 18 A 150 TYR B 231 TYR^? 16.39 O2S EPE A 377 A 245 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 273 LYS C 138 LYS^? 8.30 N TRS A 378 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 4.59 -25.19 21.63 5.07 -23.28 20.96 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 19 3 # 19 A 150 TYR B 231 TYR^? 16.39 O2S EPE A 377 A 245 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 273 LYS C 139 LYS^? 16.11 N TRS A 378 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 4.59 -25.19 21.63 5.07 -23.28 20.96 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 13.08 -32.56 20.05 9.65 -36.55 18.68 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 20 3 # 20 A 150 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 245 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 273 LYS A 138 LYS^? 13.11 N TRS A 378 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 21 3 # 21 A 150 TYR B 234 TYR^? 11.34 O2S EPE A 377 A 245 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 273 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 22 3 # 22 A 150 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 245 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 273 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 23 3 # 23 A 150 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 245 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 273 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 24 3 # 24 A 150 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 245 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 273 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 25 3 # 25 A 150 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 245 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 273 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 1.88 -37.38 46.52 1.77 -36.70 44.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 26 3 # 26 A 150 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 245 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 273 LYS C 340 LYS~? 12.92 ZN ZN C 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 1.88 -37.38 46.52 1.77 -36.70 44.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 9.58 -37.42 57.24 8.41 -35.76 62.90 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 27 3 # 27 A 150 TYR C 18 TYR.? 11.04 ZN ZN C 375 A 245 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 273 LYS C 345 LYS~? 19.35 ZN ZN C 375 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 12.32 -34.51 46.53 10.40 -36.24 47.57 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 1.88 -37.38 46.52 1.77 -36.70 44.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 11.31 -44.62 52.77 6.74 -46.86 52.89 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 28 3 # 28 A 150 TYR C 231 TYR^? -4.25 C2 TRS A 378s A 245 ASP A 237 ASP^? 6.80 N TRS A 378 A 273 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 9.74 16.83 -36.21 11.10 17.13 -33.77 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 18.36 -25.38 21.90 16.49 -24.92 22.81 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 17.05 -24.82 10.77 19.64 -29.66 10.35 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 29 3 # 29 A 150 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 245 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 273 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 30 3 # 30 A 150 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 245 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 273 LYS C 239 LYS^? 16.29 N TRS A 378 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 31 3 # 31 A 150 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 245 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 273 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -21.60 -25.17 57.51 -24.75 -21.09 54.19 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 31 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 143 PHE^? -3.89 C10 EPE A 377s A 245 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 273 LYS A 138 LYS^? 13.11 N TRS A 378 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 8.68 -28.97 1.51 8.47 -29.44 4.22 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE A 143 PHE^? -3.89 C10 EPE A 377s A 245 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 273 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 8.68 -28.97 1.51 8.47 -29.44 4.22 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE A 172 PHE^? 6.53 C9 EPE C 377 A 245 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 273 LYS C 138 LYS^? 8.30 N TRS A 378 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 18.79 -35.53 6.28 17.39 -37.92 6.30 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE A 260 PHE~? 19.27 ZN ZN A 375 A 245 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 273 LYS A 303 LYS~? 13.81 O3 TRS A 378 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 47.82 -20.71 38.37 47.81 -22.84 38.27 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 37.93 -22.13 35.45 34.81 -22.43 31.07 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE B 143 PHE^? 13.71 O2S EPE A 377 A 245 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 273 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 4.74 -39.41 14.59 7.03 -37.80 14.65 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE B 143 PHE^? 13.71 O2S EPE A 377 A 245 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 273 LYS C 239 LYS^? 16.29 N TRS A 378 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 4.74 -39.41 14.59 7.03 -37.80 14.65 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 157 PHE B 172 PHE^? 6.04 C9 EPE A 377 A 245 ASP A 232 ASP^? 4.68 O1S EPE A 377 A 273 LYS A 138 LYS^? 13.11 N TRS A 378 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 6.52 -33.24 3.28 8.59 -34.82 2.34 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 18.11 -21.79 12.78 16.12 -17.81 15.44 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 157 PHE B 260 PHE~? 19.39 ZN ZN B 375 A 245 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 273 LYS B 303 LYS~? 19.29 ZN ZN B 375 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 3.99 14.73 5.36 5.18 14.04 3.76 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 7.99 5.97 9.05 6.92 1.04 11.01 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 157 PHE C 143 PHE^? 4.11 C9 EPE C 377 A 245 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 273 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 21.21 -36.18 10.80 19.31 -34.15 10.67 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 157 PHE C 143 PHE^? 4.11 C9 EPE C 377 A 245 ASP C 232 ASP^? 3.77 O2S EPE C 377 A 273 LYS C 138 LYS^? 8.30 N TRS A 378 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 21.21 -36.18 10.80 19.31 -34.15 10.67 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 12.95 -30.51 23.19 15.44 -26.53 25.46 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 157 PHE C 172 PHE^? 14.49 O2S EPE A 377 A 245 ASP B 232 ASP^? 14.54 O2S EPE A 377 A 273 LYS B 138 LYS^? 15.17 O1S EPE A 377 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 9.48 -40.91 13.04 8.71 -41.08 10.37 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 3.52 -23.27 14.19 3.97 -21.31 18.72 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 12 3 # 12 A 157 PHE C 260 PHE~? 19.40 ZN ZN C 375 A 245 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 273 LYS C 303 LYS~? 17.98 ZN ZN C 375 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -11.06 -26.43 40.09 -5.81 -27.52 38.93 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 12 hits 2gsa_c04 naa= 3 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 1 3 # 1 B 137 SER A 168 SER^? 10.80 O1S EPE C 377 B 158 HIS A 163 HIS.? 11.18 O1S EPE C 377 B 208 ASN A 166 ASN.? 13.31 C3 EPE C 377 coo 50.29 50.10 71.46 47.85 50.06 71.46 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 48.67 45.40 71.68 47.67 46.90 70.60 30.88 -23.32 6.66 32.97 -23.36 6.49 coo 48.91 49.12 65.17 47.29 49.14 66.54 36.29 -29.92 9.78 37.81 -29.21 11.04 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 2 3 # 2 B 137 SER B 168 SER^? 10.59 O3S EPE A 377 B 158 HIS B 163 HIS.? 11.54 O3S EPE A 377 B 208 ASN B 166 ASN.? 12.55 O8 EPE A 377 coo 50.29 50.10 71.46 47.85 50.06 71.46 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 48.67 45.40 71.68 47.67 46.90 70.60 -4.89 -20.97 2.80 -5.63 -19.63 1.37 coo 48.91 49.12 65.17 47.29 49.14 66.54 -2.65 -19.38 -5.26 -2.77 -17.28 -5.58 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 3 3 # 3 B 137 SER C 168 SER^? 24.11 O1 TRS A 378 B 158 HIS C 163 HIS.? 22.24 O1 TRS A 378 B 208 ASN C 166 ASN.? 27.69 ZN ZN C 375 coo 50.29 50.10 71.46 47.85 50.06 71.46 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 48.67 45.40 71.68 47.67 46.90 70.60 9.61 -42.49 30.12 8.57 -43.28 31.77 coo 48.91 49.12 65.17 47.29 49.14 66.54 1.70 -45.88 30.14 0.89 -45.44 32.06 2hdh_c02 source 2hdh L-3-HYDROXYACYL COA DEHYDROGENASE : 3 hits 2hdh_c02 naa= 3 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 1 3 # 1 B 185 HIS A 224 HIS~? 7.33 C7 EPE A 377 B 188 HIS A 148 HIS~? 11.43 C8 EPE A 377 B 190 TYR A 226 TYR.? 5.45 C8 EPE A 377 coo -2.40 8.56 71.48 -2.16 8.28 69.42 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo -0.71 6.39 65.98 -1.92 4.69 66.21 14.41 -28.00 -10.43 13.63 -27.83 -12.37 coo 0.03 12.24 67.96 -1.63 12.38 65.68 7.72 -24.64 -8.18 7.45 -27.31 -8.97 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 2 3 # 2 B 185 HIS A 316 HIS~? 20.33 O8 EPE A 376 B 188 HIS A 319 HIS~? 24.64 ZN ZN A 374 B 190 TYR A 315 TYR~? 21.30 O8 EPE A 376 coo -2.40 8.56 71.48 -2.16 8.28 69.42 36.36 -5.20 52.06 36.55 -4.24 53.92 coo -0.71 6.39 65.98 -1.92 4.69 66.21 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 0.03 12.24 67.96 -1.63 12.38 65.68 41.01 -3.77 51.66 42.24 -4.43 54.10 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 3 3 # 3 B 185 HIS A 319 HIS~? 24.64 ZN ZN A 374 B 188 HIS A 316 HIS~? 20.33 O8 EPE A 376 B 190 TYR A 315 TYR~? 21.30 O8 EPE A 376 coo -2.40 8.56 71.48 -2.16 8.28 69.42 41.01 -9.30 52.79 42.52 -8.54 54.04 coo -0.71 6.39 65.98 -1.92 4.69 66.21 36.36 -5.20 52.06 36.55 -4.24 53.92 coo 0.03 12.24 67.96 -1.63 12.38 65.68 41.01 -3.77 51.66 42.24 -4.43 54.10 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 4 3 # 4 B 185 HIS B 316 HIS~? 20.54 O8 EPE B 376 B 188 HIS B 319 HIS~? 24.73 ZN ZN B 374 B 190 TYR B 315 TYR~? 21.53 O8 EPE B 376 coo -2.40 8.56 71.48 -2.16 8.28 69.42 7.45 20.77 27.47 7.65 22.47 28.71 coo -0.71 6.39 65.98 -1.92 4.69 66.21 8.16 23.53 21.75 7.85 25.60 21.62 coo 0.03 12.24 67.96 -1.63 12.38 65.68 4.11 23.72 25.55 5.20 26.22 24.94 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 5 3 # 5 B 185 HIS B 319 HIS~? 24.73 ZN ZN B 374 B 188 HIS B 316 HIS~? 20.54 O8 EPE B 376 B 190 TYR B 315 TYR~? 21.53 O8 EPE B 376 coo -2.40 8.56 71.48 -2.16 8.28 69.42 8.16 23.53 21.75 7.85 25.60 21.62 coo -0.71 6.39 65.98 -1.92 4.69 66.21 7.45 20.77 27.47 7.65 22.47 28.71 coo 0.03 12.24 67.96 -1.63 12.38 65.68 4.11 23.72 25.55 5.20 26.22 24.94 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 6 3 # 6 B 185 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 188 HIS C 148 HIS~? 13.04 O8 EPE C 377 B 190 TYR C 226 TYR.? 6.49 C7 EPE C 377 coo -2.40 8.56 71.48 -2.16 8.28 69.42 26.69 -40.96 16.23 26.39 -40.40 14.23 coo -0.71 6.39 65.98 -1.92 4.69 66.21 27.13 -47.60 14.36 28.94 -48.66 14.50 coo 0.03 12.24 67.96 -1.63 12.38 65.68 30.28 -40.41 12.42 29.70 -41.48 9.92 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 7 3 # 7 B 185 HIS C 316 HIS~? -20.42 O8 EPE C 376s B 188 HIS C 319 HIS~? 24.70 ZN ZN C 374 B 190 TYR C 315 TYR~? 21.59 O8 EPE C 376 coo -2.40 8.56 71.48 -2.16 8.28 69.42 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo -0.71 6.39 65.98 -1.92 4.69 66.21 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 0.03 12.24 67.96 -1.63 12.38 65.68 -10.50 -13.02 60.73 -13.04 -12.15 61.66 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 8 3 # 8 B 185 HIS C 319 HIS~? 24.70 ZN ZN C 374 B 188 HIS C 316 HIS~? -20.42 O8 EPE C 376s B 190 TYR C 315 TYR~? 21.59 O8 EPE C 376 coo -2.40 8.56 71.48 -2.16 8.28 69.42 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo -0.71 6.39 65.98 -1.92 4.69 66.21 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 0.03 12.24 67.96 -1.63 12.38 65.68 -10.50 -13.02 60.73 -13.04 -12.15 61.66 2hsa_c00 source 2hsa 12-OXOPHYTODIENOATE REDUCTASE 3 : 8 hits 2hsa_c00 naa= 3 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 1 3 # 1 A 185 HIS A 224 HIS~? 7.33 C7 EPE A 377 A 188 HIS A 148 HIS~? 11.43 C8 EPE A 377 A 190 TYR A 226 TYR.? 5.45 C8 EPE A 377 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 14.39 1.55 40.83 12.71 2.07 39.67 14.41 -28.00 -10.43 13.63 -27.83 -12.37 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 7.72 -24.64 -8.18 7.45 -27.31 -8.97 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 2 3 # 2 A 185 HIS A 316 HIS~? 20.33 O8 EPE A 376 A 188 HIS A 319 HIS~? 24.64 ZN ZN A 374 A 190 TYR A 315 TYR~? 21.30 O8 EPE A 376 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 36.36 -5.20 52.06 36.55 -4.24 53.92 coo 14.39 1.55 40.83 12.71 2.07 39.67 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 41.01 -3.77 51.66 42.24 -4.43 54.10 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 3 3 # 3 A 185 HIS A 319 HIS~? 24.64 ZN ZN A 374 A 188 HIS A 316 HIS~? 20.33 O8 EPE A 376 A 190 TYR A 315 TYR~? 21.30 O8 EPE A 376 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 14.39 1.55 40.83 12.71 2.07 39.67 36.36 -5.20 52.06 36.55 -4.24 53.92 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 41.01 -3.77 51.66 42.24 -4.43 54.10 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 4 3 # 4 A 185 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 188 HIS B 319 HIS~? 24.73 ZN ZN B 374 A 190 TYR B 315 TYR~? 21.53 O8 EPE B 376 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 7.45 20.77 27.47 7.65 22.47 28.71 coo 14.39 1.55 40.83 12.71 2.07 39.67 8.16 23.53 21.75 7.85 25.60 21.62 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 4.11 23.72 25.55 5.20 26.22 24.94 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 5 3 # 5 A 185 HIS B 319 HIS~? 24.73 ZN ZN B 374 A 188 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 190 TYR B 315 TYR~? 21.53 O8 EPE B 376 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 8.16 23.53 21.75 7.85 25.60 21.62 coo 14.39 1.55 40.83 12.71 2.07 39.67 7.45 20.77 27.47 7.65 22.47 28.71 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 4.11 23.72 25.55 5.20 26.22 24.94 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 6 3 # 6 A 185 HIS C 224 HIS~? 8.36 C3 EPE C 377 A 188 HIS C 148 HIS~? 13.04 O8 EPE C 377 A 190 TYR C 226 TYR.? 6.49 C7 EPE C 377 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 14.39 1.55 40.83 12.71 2.07 39.67 27.13 -47.60 14.36 28.94 -48.66 14.50 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 30.28 -40.41 12.42 29.70 -41.48 9.92 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 7 3 # 7 A 185 HIS C 316 HIS~? -20.42 O8 EPE C 376s A 188 HIS C 319 HIS~? 24.70 ZN ZN C 374 A 190 TYR C 315 TYR~? 21.59 O8 EPE C 376 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 14.39 1.55 40.83 12.71 2.07 39.67 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 -10.50 -13.02 60.73 -13.04 -12.15 61.66 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 8 3 # 8 A 185 HIS C 319 HIS~? 24.70 ZN ZN C 374 A 188 HIS C 316 HIS~? -20.42 O8 EPE C 376s A 190 TYR C 315 TYR~? 21.59 O8 EPE C 376 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 14.39 1.55 40.83 12.71 2.07 39.67 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 -10.50 -13.02 60.73 -13.04 -12.15 61.66 2hsa_c01 source 2hsa 12-OXOPHYTODIENOATE REDUCTASE 3 : 8 hits 2hsa_c01 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS A 148 HIS~? 11.43 C8 EPE A 377 A 341 GLU A 151 GLU~? 15.60 C7 EPE A 377 A 356 HIS A 224 HIS~? 7.33 C7 EPE A 377 coo 121.00 36.37 19.26 121.57 38.37 19.56 14.41 -28.00 -10.43 13.63 -27.83 -12.37 coo 125.72 32.70 19.75 124.44 34.16 18.84 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 124.34 41.73 25.55 123.79 42.60 23.72 12.08 -23.60 -5.02 10.59 -24.98 -4.54 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 341 GLU A 336 GLU~? 2.52 ZN ZN A 375s A 356 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 121.00 36.37 19.26 121.57 38.37 19.56 40.60 0.33 34.12 38.69 0.39 33.24 coo 125.72 32.70 19.75 124.44 34.16 18.84 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 124.34 41.73 25.55 123.79 42.60 23.72 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 A 311 HIS B 148 HIS~? 20.83 O3S EPE A 377 A 341 GLU B 151 GLU~? 19.22 O3S EPE A 377 A 356 HIS B 224 HIS.? 17.79 O2S EPE A 377 coo 121.00 36.37 19.26 121.57 38.37 19.56 -6.64 -44.75 10.12 -7.62 -46.49 10.77 coo 125.72 32.70 19.75 124.44 34.16 18.84 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 124.34 41.73 25.55 123.79 42.60 23.72 -4.29 -40.29 15.37 -2.45 -41.31 15.36 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 A 311 HIS B 224 HIS.? 17.79 O2S EPE A 377 A 341 GLU B 227 GLU.? 24.58 O3S EPE A 377 A 356 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 121.00 36.37 19.26 121.57 38.37 19.56 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 125.72 32.70 19.75 124.44 34.16 18.84 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 124.34 41.73 25.55 123.79 42.60 23.72 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 5 3 # 5 A 311 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 341 GLU B 336 GLU~? 2.48 ZN ZN B 375s A 356 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 121.00 36.37 19.26 121.57 38.37 19.56 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 125.72 32.70 19.75 124.44 34.16 18.84 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 124.34 41.73 25.55 123.79 42.60 23.72 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 6 3 # 6 A 311 HIS C 148 HIS~? 13.04 O8 EPE C 377 A 341 GLU C 151 GLU~? 17.15 O8 EPE C 377 A 356 HIS C 224 HIS~? 8.36 C3 EPE C 377 coo 121.00 36.37 19.26 121.57 38.37 19.56 27.13 -47.60 14.36 28.94 -48.66 14.50 coo 125.72 32.70 19.75 124.44 34.16 18.84 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 124.34 41.73 25.55 123.79 42.60 23.72 26.69 -40.96 16.23 26.39 -40.40 14.23 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 7 3 # 7 A 311 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 341 GLU C 336 GLU~? 2.53 ZN ZN C 375s A 356 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 121.00 36.37 19.26 121.57 38.37 19.56 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 125.72 32.70 19.75 124.44 34.16 18.84 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 124.34 41.73 25.55 123.79 42.60 23.72 10.51 -24.81 51.94 8.80 -23.79 52.62 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 7 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS A 148 HIS~? 11.43 C8 EPE A 377 B 341 GLU A 151 GLU~? 15.60 C7 EPE A 377 B 356 HIS A 224 HIS~? 7.33 C7 EPE A 377 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 14.41 -28.00 -10.43 13.63 -27.83 -12.37 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 19.56 -26.98 -10.07 18.53 -25.78 -11.47 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 12.08 -23.60 -5.02 10.59 -24.98 -4.54 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 B 311 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 341 GLU A 336 GLU~? 2.52 ZN ZN A 375s B 356 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 40.60 0.33 34.12 38.69 0.39 33.24 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 41.61 -2.34 29.43 39.56 -1.83 29.49 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 B 311 HIS B 148 HIS~? 20.83 O3S EPE A 377 B 341 GLU B 151 GLU~? 19.22 O3S EPE A 377 B 356 HIS B 224 HIS.? 17.79 O2S EPE A 377 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -6.64 -44.75 10.12 -7.62 -46.49 10.77 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -9.61 -39.78 7.97 -10.79 -41.15 9.06 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -4.29 -40.29 15.37 -2.45 -41.31 15.36 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 B 311 HIS B 224 HIS.? 17.79 O2S EPE A 377 B 341 GLU B 227 GLU.? 24.58 O3S EPE A 377 B 356 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -9.17 -41.16 20.05 -10.13 -42.87 19.25 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 5 3 # 5 B 311 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 341 GLU B 336 GLU~? 2.48 ZN ZN B 375s B 356 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -10.29 7.50 19.92 -9.48 6.56 21.59 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 6 3 # 6 B 311 HIS C 148 HIS~? 13.04 O8 EPE C 377 B 341 GLU C 151 GLU~? 17.15 O8 EPE C 377 B 356 HIS C 224 HIS~? 8.36 C3 EPE C 377 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 27.13 -47.60 14.36 28.94 -48.66 14.50 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 24.82 -49.12 19.40 26.74 -49.67 18.68 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 26.69 -40.96 16.23 26.39 -40.40 14.23 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 7 3 # 7 B 311 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 341 GLU C 336 GLU~? 2.53 ZN ZN C 375s B 356 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 3.38 -29.70 55.34 4.58 -28.10 54.66 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 10.51 -24.81 51.94 8.80 -23.79 52.62 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 7 hits 2isd_c01 naa= 3 ULMN 3 2lip_c00 LIPASE user 1 3 # 1 87 SER A 168 SER^? 10.80 O1S EPE C 377 264 ASP A 158 ASP~? 15.23 O1S EPE C 377 286 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo 10.47 25.91 18.67 10.67 27.13 20.84 30.58 -27.33 4.57 31.12 -25.87 2.65 coo 2.34 22.49 22.56 3.80 23.95 22.00 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo 7.10 24.11 23.40 8.18 25.09 21.87 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 2lip_c00 LIPASE user 2 3 # 2 87 SER B 168 SER^? 10.59 O3S EPE A 377 264 ASP B 158 ASP~? 14.93 O3S EPE A 377 286 HIS B 169 HIS^? 10.86 O3S EPE A 377 coo 10.47 25.91 18.67 10.67 27.13 20.84 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 2.34 22.49 22.56 3.80 23.95 22.00 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo 7.10 24.11 23.40 8.18 25.09 21.87 -6.90 -28.98 1.72 -8.94 -28.69 2.07 ULMN 3 2lip_c00 LIPASE user 3 3 # 3 87 SER C 168 SER^? 24.11 O1 TRS A 378 264 ASP C 158 ASP~? 22.01 O1 TRS A 378 286 HIS C 169 HIS^? 22.39 O1 TRS A 378 coo 10.47 25.91 18.67 10.67 27.13 20.84 9.08 -45.42 26.78 10.19 -47.47 27.43 coo 2.34 22.49 22.56 3.80 23.95 22.00 19.06 -47.14 27.83 18.62 -49.09 27.08 coo 7.10 24.11 23.40 8.18 25.09 21.87 13.13 -47.52 24.96 14.34 -48.17 26.54 2lip_c00 source 2lip LIPASE : 3 hits 2lip_c00 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 193 GLY A 342 GLY~? 12.90 ZN ZN A 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 37.80 0.44 25.56 37.02 -1.29 26.44 coo 19.64 30.69 22.61 18.18 29.94 21.25 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 14.54 28.99 9.76 15.06 29.59 10.02 44.89 -3.04 18.23 44.73 -2.27 17.91 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 37.42 3.90 29.26 38.47 2.36 30.22 coo 19.64 30.69 22.61 18.18 29.94 21.25 40.70 8.14 28.73 41.06 6.40 29.84 coo 14.54 28.99 9.76 15.06 29.59 10.02 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 102 ASP A 48 ASP.? 7.40 ZN ZN A 374 A 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo 14.96 29.22 19.55 15.62 29.93 17.67 37.42 3.90 29.26 38.47 2.36 30.22 coo 19.64 30.69 22.61 18.18 29.94 21.25 40.70 8.14 28.73 41.06 6.40 29.84 coo 14.54 28.99 9.76 15.06 29.59 10.02 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 193 GLY A 290 GLY^? 5.60 ZN ZN A 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.64 30.69 22.61 18.18 29.94 21.25 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 14.54 28.99 9.76 15.06 29.59 10.02 41.03 -5.77 31.09 40.29 -6.09 31.40 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 102 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 193 GLY A 291 GLY^? 4.06 ZN ZN A 374 coo 14.96 29.22 19.55 15.62 29.93 17.67 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.64 30.69 22.61 18.18 29.94 21.25 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 14.54 28.99 9.76 15.06 29.59 10.02 39.29 -3.03 33.06 39.67 -3.69 33.42 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 6 3 # 6 A 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 193 GLY A 26 GLY.? 13.89 ZN ZN A 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.64 30.69 22.61 18.18 29.94 21.25 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 14.54 28.99 9.76 15.06 29.59 10.02 23.61 -0.70 30.49 24.31 -1.07 30.25 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 7 3 # 7 A 57 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 102 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 193 GLY A 30 GLY^? 14.83 ZN ZN A 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 32.91 0.46 27.63 33.66 0.11 29.56 coo 19.64 30.69 22.61 18.18 29.94 21.25 35.27 -5.88 26.81 35.94 -4.18 27.85 coo 14.54 28.99 9.76 15.06 29.59 10.02 27.68 4.60 19.76 28.15 4.96 20.33 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 8 3 # 8 A 57 HIS A 319 HIS~? 24.64 ZN ZN A 374 A 102 ASP A 320 ASP~? -21.81 ZN ZN A 374s A 193 GLY A 277 GLY.? 24.28 ZN ZN A 374 coo 14.96 29.22 19.55 15.62 29.93 17.67 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 19.64 30.69 22.61 18.18 29.94 21.25 36.60 -12.13 48.17 35.17 -11.15 49.43 coo 14.54 28.99 9.76 15.06 29.59 10.02 49.23 -14.07 46.91 49.73 -13.44 47.06 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 9 3 # 9 A 57 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 193 GLY B 342 GLY~? 13.01 ZN ZN B 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 19.64 30.69 22.61 18.18 29.94 21.25 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 14.54 28.99 9.76 15.06 29.59 10.02 -18.10 1.14 13.74 -18.67 1.02 14.34 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 10 3 # 10 A 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 19.64 30.69 22.61 18.18 29.94 21.25 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 14.54 28.99 9.76 15.06 29.59 10.02 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 11 3 # 11 A 57 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 102 ASP B 48 ASP.? 7.36 ZN ZN B 374 A 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo 14.96 29.22 19.55 15.62 29.93 17.67 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 19.64 30.69 22.61 18.18 29.94 21.25 -17.03 8.88 27.62 -15.41 9.62 26.60 coo 14.54 28.99 9.76 15.06 29.59 10.02 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 12 3 # 12 A 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 193 GLY B 290 GLY^? 5.66 ZN ZN B 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.64 30.69 22.61 18.18 29.94 21.25 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 14.54 28.99 9.76 15.06 29.59 10.02 -6.82 7.95 18.08 -6.13 7.62 18.39 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 13 3 # 13 A 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 102 ASP B 27 ASP.? 8.17 ZN ZN B 375 A 193 GLY B 291 GLY^? 4.09 ZN ZN B 374 coo 14.96 29.22 19.55 15.62 29.93 17.67 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.64 30.69 22.61 18.18 29.94 21.25 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo 14.54 28.99 9.76 15.06 29.59 10.02 -6.52 8.91 21.71 -6.06 9.31 21.13 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 14 3 # 14 A 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 193 GLY B 26 GLY.? 14.28 ZN ZN B 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.64 30.69 22.61 18.18 29.94 21.25 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 14.54 28.99 9.76 15.06 29.59 10.02 -1.82 -2.93 32.32 -2.26 -3.11 31.69 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 15 3 # 15 A 57 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 102 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 193 GLY B 30 GLY^? 14.63 ZN ZN B 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 19.64 30.69 22.61 18.18 29.94 21.25 -6.47 1.09 20.08 -7.49 2.52 21.22 coo 14.54 28.99 9.76 15.06 29.59 10.02 -13.71 -6.55 30.41 -13.82 -5.76 30.60 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 16 3 # 16 A 57 HIS B 319 HIS~? 24.73 ZN ZN B 374 A 102 ASP B 320 ASP~? -21.78 ZN ZN B 374s A 193 GLY B 277 GLY.? 24.23 ZN ZN B 374 coo 14.96 29.22 19.55 15.62 29.93 17.67 8.16 23.53 21.75 7.85 25.60 21.62 coo 19.64 30.69 22.61 18.18 29.94 21.25 9.35 16.65 21.02 10.22 16.89 22.90 coo 14.54 28.99 9.76 15.06 29.59 10.02 3.65 23.16 11.55 3.12 23.75 11.78 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 17 3 # 17 A 57 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 193 GLY C 342 GLY~? 13.18 ZN ZN C 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 19.64 30.69 22.61 18.18 29.94 21.25 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 14.54 28.99 9.76 15.06 29.59 10.02 7.81 -40.56 53.34 8.53 -40.45 53.72 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 18 3 # 18 A 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 19.64 30.69 22.61 18.18 29.94 21.25 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 14.54 28.99 9.76 15.06 29.59 10.02 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 19 3 # 19 A 57 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 102 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo 14.96 29.22 19.55 15.62 29.93 17.67 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 19.64 30.69 22.61 18.18 29.94 21.25 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 14.54 28.99 9.76 15.06 29.59 10.02 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 20 3 # 20 A 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 193 GLY C 290 GLY^? 5.72 ZN ZN C 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.64 30.69 22.61 18.18 29.94 21.25 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 14.54 28.99 9.76 15.06 29.59 10.02 0.35 -28.86 53.11 0.38 -28.21 52.55 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 21 3 # 21 A 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 102 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 193 GLY C 291 GLY^? 4.07 ZN ZN C 374 coo 14.96 29.22 19.55 15.62 29.93 17.67 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.64 30.69 22.61 18.18 29.94 21.25 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 14.54 28.99 9.76 15.06 29.59 10.02 1.77 -25.71 54.72 0.95 -25.76 54.56 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 22 3 # 22 A 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 193 GLY C 26 GLY.? 14.31 ZN ZN C 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.64 30.69 22.61 18.18 29.94 21.25 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 14.54 28.99 9.76 15.06 29.59 10.02 12.94 -16.92 46.05 12.77 -17.67 45.98 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 23 3 # 23 A 57 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 102 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 193 GLY C 30 GLY^? 14.80 ZN ZN C 375 coo 14.96 29.22 19.55 15.62 29.93 17.67 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 19.64 30.69 22.61 18.18 29.94 21.25 5.80 -28.16 48.27 6.08 -27.64 50.28 coo 14.54 28.99 9.76 15.06 29.59 10.02 20.37 -26.80 49.54 20.07 -26.59 50.27 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 24 3 # 24 A 57 HIS C 319 HIS~? 24.70 ZN ZN C 374 A 102 ASP C 320 ASP~? -21.75 ZN ZN C 374s A 193 GLY C 277 GLY.? 24.27 ZN ZN C 374 coo 14.96 29.22 19.55 15.62 29.93 17.67 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 19.64 30.69 22.61 18.18 29.94 21.25 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo 14.54 28.99 9.76 15.06 29.59 10.02 -18.35 -23.56 56.48 -18.29 -23.66 57.31 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 24 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 260 PHE~? 19.27 ZN ZN A 375 A 263 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 292 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 51.51 50.32 16.39 52.13 49.68 13.75 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 54.43 44.82 23.74 55.21 45.06 21.80 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 63.95 45.30 16.71 59.11 49.15 16.05 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 260 PHE~? 19.27 ZN ZN A 375 A 263 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 292 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 51.51 50.32 16.39 52.13 49.68 13.75 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 54.43 44.82 23.74 55.21 45.06 21.80 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 63.95 45.30 16.71 59.11 49.15 16.05 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE A 370 PHE.? 12.81 O8 EPE A 376 A 263 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 292 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 51.51 50.32 16.39 52.13 49.68 13.75 46.70 4.90 39.59 44.12 4.72 40.65 coo 54.43 44.82 23.74 55.21 45.06 21.80 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 63.95 45.30 16.71 59.11 49.15 16.05 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE B 260 PHE~? 19.39 ZN ZN B 375 A 263 ASP B 306 ASP.? 24.86 ZN ZN B 375 A 292 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 51.51 50.32 16.39 52.13 49.68 13.75 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 54.43 44.82 23.74 55.21 45.06 21.80 3.99 14.73 5.36 5.18 14.04 3.76 coo 63.95 45.30 16.71 59.11 49.15 16.05 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE B 370 PHE.? 12.32 O8 EPE B 376 A 263 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 292 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 51.51 50.32 16.39 52.13 49.68 13.75 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 54.43 44.82 23.74 55.21 45.06 21.80 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 63.95 45.30 16.71 59.11 49.15 16.05 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE C 260 PHE~? 19.40 ZN ZN C 375 A 263 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 292 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 51.51 50.32 16.39 52.13 49.68 13.75 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 54.43 44.82 23.74 55.21 45.06 21.80 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 63.95 45.30 16.71 59.11 49.15 16.05 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE C 370 PHE.? 12.75 O8 EPE C 376 A 263 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 292 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 51.51 50.32 16.39 52.13 49.68 13.75 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 54.43 44.82 23.74 55.21 45.06 21.80 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 63.95 45.30 16.71 59.11 49.15 16.05 -8.06 -35.63 62.23 -11.30 -33.36 66.69 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 7 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 260 PHE~? 19.27 ZN ZN A 375 B 263 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 292 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 49.99 26.05 6.28 51.46 26.87 8.49 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 60.53 31.67 0.97 57.79 27.51 3.63 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 260 PHE~? 19.27 ZN ZN A 375 B 263 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 292 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 49.99 26.05 6.28 51.46 26.87 8.49 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 60.53 31.67 0.97 57.79 27.51 3.63 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE A 370 PHE.? 12.81 O8 EPE A 376 B 263 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 292 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 49.99 26.05 6.28 51.46 26.87 8.49 46.70 4.90 39.59 44.12 4.72 40.65 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 60.53 31.67 0.97 57.79 27.51 3.63 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE B 260 PHE~? 19.39 ZN ZN B 375 B 263 ASP B 306 ASP.? 24.86 ZN ZN B 375 B 292 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 49.99 26.05 6.28 51.46 26.87 8.49 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 3.99 14.73 5.36 5.18 14.04 3.76 coo 60.53 31.67 0.97 57.79 27.51 3.63 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE B 370 PHE.? 12.32 O8 EPE B 376 B 263 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 292 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 49.99 26.05 6.28 51.46 26.87 8.49 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 60.53 31.67 0.97 57.79 27.51 3.63 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE B 370 PHE.? 12.32 O8 EPE B 376 B 263 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 292 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo 49.99 26.05 6.28 51.46 26.87 8.49 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 60.53 31.67 0.97 57.79 27.51 3.63 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE C 260 PHE~? 19.40 ZN ZN C 375 B 263 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 292 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 49.99 26.05 6.28 51.46 26.87 8.49 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 60.53 31.67 0.97 57.79 27.51 3.63 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE C 370 PHE.? 12.75 O8 EPE C 376 B 263 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 292 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 49.99 26.05 6.28 51.46 26.87 8.49 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 60.53 31.67 0.97 57.79 27.51 3.63 -8.06 -35.63 62.23 -11.30 -33.36 66.69 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 177 PHE C 370 PHE.? 12.75 O8 EPE C 376 B 263 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 292 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo 49.99 26.05 6.28 51.46 26.87 8.49 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 60.53 31.67 0.97 57.79 27.51 3.63 -6.09 -33.65 68.04 -3.07 -37.10 68.37 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 9 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 260 PHE~? 19.27 ZN ZN A 375 C 263 ASP A 306 ASP.? 24.91 ZN ZN A 375 C 292 LYS A 247 LYS^? 14.25 ZN ZN A 375 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 19.84 12.02 9.33 18.68 11.23 7.75 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 12.82 3.49 4.98 17.80 5.59 1.90 40.34 -15.07 28.39 38.70 -15.53 23.22 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 260 PHE~? 19.27 ZN ZN A 375 C 263 ASP A 306 ASP.? 24.91 ZN ZN A 375 C 292 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 52.43 -14.27 35.94 50.19 -13.42 34.56 coo 19.84 12.02 9.33 18.68 11.23 7.75 47.82 -20.71 38.37 47.81 -22.84 38.27 coo 12.82 3.49 4.98 17.80 5.59 1.90 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE A 370 PHE.? 12.81 O8 EPE A 376 C 263 ASP A 330 ASP^? 12.08 ZN ZN A 374 C 292 LYS A 265 LYS~? 22.38 ZN ZN A 374 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 46.70 4.90 39.59 44.12 4.72 40.65 coo 19.84 12.02 9.33 18.68 11.23 7.75 45.96 -5.26 40.35 44.85 -3.42 39.89 coo 12.82 3.49 4.98 17.80 5.59 1.90 54.99 -5.46 33.76 58.41 -3.92 38.21 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE B 260 PHE~? 19.39 ZN ZN B 375 C 263 ASP B 306 ASP.? 24.86 ZN ZN B 375 C 292 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -4.07 16.87 6.20 -4.31 14.59 7.80 coo 19.84 12.02 9.33 18.68 11.23 7.75 3.99 14.73 5.36 5.18 14.04 3.76 coo 12.82 3.49 4.98 17.80 5.59 1.90 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE B 370 PHE.? 12.32 O8 EPE B 376 C 263 ASP B 330 ASP^? 11.92 ZN ZN B 374 C 292 LYS B 265 LYS~? 21.91 ZN ZN B 374 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -11.49 20.06 25.00 -9.59 19.04 26.81 coo 19.84 12.02 9.33 18.68 11.23 7.75 -4.33 18.16 18.13 -5.04 17.21 19.90 coo 12.82 3.49 4.98 17.80 5.59 1.90 -12.32 18.80 10.54 -12.89 23.62 10.63 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE C 260 PHE~? 19.40 ZN ZN C 375 C 263 ASP C 306 ASP.? 24.81 ZN ZN C 375 C 292 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 19.84 12.02 9.33 18.68 11.23 7.75 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 12.82 3.49 4.98 17.80 5.59 1.90 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE C 260 PHE~? 19.40 ZN ZN C 375 C 263 ASP C 306 ASP.? 24.81 ZN ZN C 375 C 292 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -13.65 -33.95 54.79 -11.16 -33.57 53.58 coo 19.84 12.02 9.33 18.68 11.23 7.75 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo 12.82 3.49 4.98 17.80 5.59 1.90 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 177 PHE C 370 PHE.? 12.75 O8 EPE C 376 C 263 ASP C 330 ASP^? 11.91 ZN ZN C 374 C 292 LYS C 265 LYS~? 21.95 ZN ZN C 374 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -0.57 -23.85 66.95 0.19 -21.55 65.54 coo 19.84 12.02 9.33 18.68 11.23 7.75 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo 12.82 3.49 4.98 17.80 5.59 1.90 -8.06 -35.63 62.23 -11.30 -33.36 66.69 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 8 hits 2oat_c05 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 151 LYS A 20 LYS~? 16.95 ZN ZN A 375 A 186 THR A 104 THR~? 6.76 ZN ZN A 375 coo 41.42 17.90 44.98 43.39 18.36 45.61 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 45.75 16.58 39.61 47.43 18.26 45.54 26.66 -3.22 19.04 24.73 2.41 18.30 coo 45.88 23.02 44.72 46.99 21.16 44.68 32.17 -3.62 26.15 30.67 -3.61 27.70 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 280 ASP.? 32.54 ZN ZN A 374 A 151 LYS A 278 LYS.? 33.16 ZN ZN A 374 A 186 THR A 256 THR^? 28.88 ZN ZN A 375 coo 41.42 17.90 44.98 43.39 18.36 45.61 57.62 -18.45 47.11 59.50 -17.52 47.44 coo 45.75 16.58 39.61 47.43 18.26 45.54 52.59 -15.70 47.74 53.19 -20.67 51.64 coo 45.88 23.02 44.72 46.99 21.16 44.68 56.69 -18.34 40.21 58.60 -17.57 40.86 ULMN 3 2phk_c02 MC-PEPTIDE user 3 3 # 3 A 149 ASP A 281 ASP.? 28.06 ZN ZN A 375 A 151 LYS A 278 LYS.? 33.16 ZN ZN A 374 A 186 THR A 256 THR^? 28.88 ZN ZN A 375 coo 41.42 17.90 44.98 43.39 18.36 45.61 52.87 -20.75 45.53 51.52 -19.24 45.99 coo 45.75 16.58 39.61 47.43 18.26 45.54 52.59 -15.70 47.74 53.19 -20.67 51.64 coo 45.88 23.02 44.72 46.99 21.16 44.68 56.69 -18.34 40.21 58.60 -17.57 40.86 ULMN 3 2phk_c02 MC-PEPTIDE user 4 3 # 4 A 149 ASP B 280 ASP.? 32.17 ZN ZN B 374 A 151 LYS B 278 LYS.? 31.34 ZN ZN B 374 A 186 THR B 256 THR^? 29.14 ZN ZN B 375 coo 41.42 17.90 44.98 43.39 18.36 45.61 2.63 27.37 3.18 1.41 29.12 3.45 coo 45.75 16.58 39.61 47.43 18.26 45.54 3.65 25.62 8.65 8.47 28.09 9.23 coo 45.88 23.02 44.72 46.99 21.16 44.68 -1.04 21.83 2.11 -1.77 23.76 1.44 ULMN 3 2phk_c02 MC-PEPTIDE user 5 3 # 5 A 149 ASP B 368 ASP.? 11.70 ZN ZN B 374 A 151 LYS B 337 LYS~? 13.35 ZN ZN B 374 A 186 THR B 367 THR.? 10.99 ZN ZN B 374 coo 41.42 17.90 44.98 43.39 18.36 45.61 -15.86 16.57 22.39 -13.84 17.32 22.21 coo 45.75 16.58 39.61 47.43 18.26 45.54 -16.19 8.44 18.66 -16.77 14.07 16.03 coo 45.88 23.02 44.72 46.99 21.16 44.68 -18.95 13.55 24.81 -19.03 11.36 25.00 ULMN 3 2phk_c02 MC-PEPTIDE user 6 3 # 6 A 149 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 151 LYS C 20 LYS~? 17.53 ZN ZN C 375 A 186 THR C 104 THR~? 6.99 ZN ZN C 375 coo 41.42 17.90 44.98 43.39 18.36 45.61 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 45.75 16.58 39.61 47.43 18.26 45.54 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 45.88 23.02 44.72 46.99 21.16 44.68 9.25 -26.14 47.92 9.13 -24.05 47.44 ULMN 3 2phk_c02 MC-PEPTIDE user 7 3 # 7 A 149 ASP C 48 ASP.? 7.30 ZN ZN C 374 A 151 LYS C 337 LYS~? 12.69 ZN ZN C 374 A 186 THR C 367 THR.? 11.10 ZN ZN C 374 coo 41.42 17.90 44.98 43.39 18.36 45.61 10.65 -27.85 62.57 8.78 -27.40 61.73 coo 45.75 16.58 39.61 47.43 18.26 45.54 5.23 -34.02 59.10 0.53 -34.86 62.24 coo 45.88 23.02 44.72 46.99 21.16 44.68 7.09 -30.04 66.37 8.69 -30.35 64.94 ULMN 3 2phk_c02 MC-PEPTIDE user 8 3 # 8 A 149 ASP C 280 ASP.? 31.92 ZN ZN C 374 A 151 LYS C 278 LYS.? 30.91 ZN ZN C 374 A 186 THR C 256 THR^? 29.06 ZN ZN C 375 coo 41.42 17.90 44.98 43.39 18.36 45.61 -25.13 -30.20 58.02 -25.85 -28.27 58.51 coo 45.75 16.58 39.61 47.43 18.26 45.54 -21.60 -25.17 57.51 -24.75 -21.09 54.19 coo 45.88 23.02 44.72 46.99 21.16 44.68 -20.65 -33.80 55.44 -22.00 -34.26 57.11 ULMN 3 2phk_c02 MC-PEPTIDE user 9 3 # 9 A 149 ASP C 281 ASP.? 29.07 ZN ZN C 374 A 151 LYS C 278 LYS.? 30.91 ZN ZN C 374 A 186 THR C 256 THR^? 29.06 ZN ZN C 375 coo 41.42 17.90 44.98 43.39 18.36 45.61 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo 45.75 16.58 39.61 47.43 18.26 45.54 -21.60 -25.17 57.51 -24.75 -21.09 54.19 coo 45.88 23.02 44.72 46.99 21.16 44.68 -20.65 -33.80 55.44 -22.00 -34.26 57.11 2phk_c02 source 2phk MC-PEPTIDE : 9 hits 2phk_c02 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 27 ASP.? 8.12 ZN ZN A 375 A 151 LYS A 20 LYS~? 16.95 ZN ZN A 375 A 154 ASN A 105 ASN~? 9.65 ZN ZN A 375 coo 41.42 17.90 44.98 43.39 18.36 45.61 27.49 -0.90 27.62 29.53 -0.28 27.44 coo 45.75 16.58 39.61 47.43 18.26 45.54 26.66 -3.22 19.04 24.73 2.41 18.30 coo 44.77 13.10 43.25 45.01 14.21 45.03 30.92 -4.10 21.33 31.10 -1.93 21.21 ULMN 3 2phk_c03 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 96 ASP.? 22.36 O2S EPE A 376 A 151 LYS A 94 LYS~? 16.25 O2S EPE A 376 A 154 ASN A 95 ASN~? 18.99 O2S EPE A 376 coo 41.42 17.90 44.98 43.39 18.36 45.61 33.23 19.97 13.69 32.21 21.81 13.47 coo 45.75 16.58 39.61 47.43 18.26 45.54 33.79 23.90 18.72 34.24 28.62 22.89 coo 44.77 13.10 43.25 45.01 14.21 45.03 37.50 21.37 17.07 38.56 22.79 18.19 ULMN 3 2phk_c03 MC-PEPTIDE user 3 3 # 3 A 149 ASP A 115 ASP~? 13.24 ZN ZN A 375 A 151 LYS A 247 LYS^? 14.25 ZN ZN A 375 A 154 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 41.42 17.90 44.98 43.39 18.36 45.61 41.88 -11.27 21.52 40.65 -12.98 21.39 coo 45.75 16.58 39.61 47.43 18.26 45.54 40.34 -15.07 28.39 38.70 -15.53 23.22 coo 44.77 13.10 43.25 45.01 14.21 45.03 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 3 2phk_c03 MC-PEPTIDE user 4 3 # 4 A 149 ASP A 237 ASP^? 6.80 N TRS A 378 A 151 LYS A 239 LYS^? -7.47 O3 TRS A 378s A 154 ASN A 238 ASN^? -4.13 C2 TRS A 378s coo 41.42 17.90 44.98 43.39 18.36 45.61 18.36 -25.38 21.90 16.49 -24.92 22.81 coo 45.75 16.58 39.61 47.43 18.26 45.54 24.38 -22.19 19.59 20.35 -19.68 21.34 coo 44.77 13.10 43.25 45.01 14.21 45.03 22.25 -25.65 17.52 21.37 -27.55 17.01 ULMN 3 2phk_c03 MC-PEPTIDE user 5 3 # 5 A 149 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 151 LYS A 295 LYS.? 12.61 ZN ZN A 374 A 154 ASN A 294 ASN.? 12.36 ZN ZN A 374 coo 41.42 17.90 44.98 43.39 18.36 45.61 36.33 -2.54 36.72 35.44 -2.95 38.63 coo 45.75 16.58 39.61 47.43 18.26 45.54 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 44.77 13.10 43.25 45.01 14.21 45.03 35.77 -6.31 41.36 37.34 -5.07 42.10 ULMN 3 2phk_c03 MC-PEPTIDE user 6 3 # 6 A 149 ASP B 96 ASP.? 22.64 O2S EPE B 376 A 151 LYS B 94 LYS~? 17.44 O2S EPE B 376 A 154 ASN B 95 ASN~? 19.50 O2S EPE B 376 coo 41.42 17.90 44.98 43.39 18.36 45.61 -29.98 -4.37 36.65 -30.49 -4.93 38.64 coo 45.75 16.58 39.61 47.43 18.26 45.54 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 44.77 13.10 43.25 45.01 14.21 45.03 -30.82 1.14 36.18 -31.61 2.89 37.07 ULMN 3 2phk_c03 MC-PEPTIDE user 7 3 # 7 A 149 ASP B 115 ASP~? 12.98 ZN ZN B 375 A 151 LYS B 247 LYS^? 11.69 ZN ZN B 375 A 154 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo 41.42 17.90 44.98 43.39 18.36 45.61 -9.21 0.02 10.54 -7.53 -1.35 10.38 coo 45.75 16.58 39.61 47.43 18.26 45.54 -2.25 3.53 11.00 -3.66 -0.30 12.47 coo 44.77 13.10 43.25 45.01 14.21 45.03 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 3 2phk_c03 MC-PEPTIDE user 8 3 # 8 A 149 ASP B 237 ASP^? 15.58 N TRS A 378 A 151 LYS B 239 LYS^? 16.51 O1S EPE A 377 A 154 ASN B 238 ASN^? 8.84 O1S EPE A 377 coo 41.42 17.90 44.98 43.39 18.36 45.61 11.84 -17.75 12.41 13.28 -17.47 14.02 coo 45.75 16.58 39.61 47.43 18.26 45.54 5.23 -14.71 11.35 7.06 -15.38 16.25 coo 44.77 13.10 43.25 45.01 14.21 45.03 7.11 -18.54 9.31 8.52 -20.00 8.45 ULMN 3 2phk_c03 MC-PEPTIDE user 9 3 # 9 A 149 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 151 LYS B 295 LYS.? 11.37 ZN ZN B 375 A 154 ASN B 294 ASN.? 12.27 ZN ZN B 374 coo 41.42 17.90 44.98 43.39 18.36 45.61 -3.14 9.99 24.96 -1.24 10.75 25.71 coo 45.75 16.58 39.61 47.43 18.26 45.54 4.57 8.76 22.84 2.39 5.01 24.93 coo 44.77 13.10 43.25 45.01 14.21 45.03 2.18 12.34 23.84 0.88 14.02 24.05 ULMN 3 2phk_c03 MC-PEPTIDE user 10 3 # 10 A 149 ASP C 27 ASP.? 8.23 ZN ZN C 375 A 151 LYS C 20 LYS~? 17.53 ZN ZN C 375 A 154 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo 41.42 17.90 44.98 43.39 18.36 45.61 12.27 -21.58 47.53 11.82 -22.95 49.16 coo 45.75 16.58 39.61 47.43 18.26 45.54 16.25 -27.94 42.71 21.97 -27.95 45.58 coo 44.77 13.10 43.25 45.01 14.21 45.03 12.40 -28.97 45.42 13.67 -29.13 47.17 ULMN 3 2phk_c03 MC-PEPTIDE user 11 3 # 11 A 149 ASP C 96 ASP.? 22.89 O3S EPE C 376 A 151 LYS C 94 LYS~? 16.71 O3S EPE C 376 A 154 ASN C 95 ASN~? 19.32 O3S EPE C 376 coo 41.42 17.90 44.98 43.39 18.36 45.61 31.06 -32.15 62.51 32.92 -31.34 63.13 coo 45.75 16.58 39.61 47.43 18.26 45.54 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 44.77 13.10 43.25 45.01 14.21 45.03 27.60 -31.58 66.97 27.57 -31.41 69.09 ULMN 3 2phk_c03 MC-PEPTIDE user 12 3 # 12 A 149 ASP C 115 ASP~? 12.87 ZN ZN C 375 A 151 LYS C 247 LYS^? 13.94 ZN ZN C 375 A 154 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 41.42 17.90 44.98 43.39 18.36 45.61 1.88 -37.38 46.52 1.77 -36.70 44.54 coo 45.75 16.58 39.61 47.43 18.26 45.54 -3.51 -32.04 45.03 0.24 -34.55 41.94 coo 44.77 13.10 43.25 45.01 14.21 45.03 0.77 -32.01 47.92 1.06 -30.12 48.87 ULMN 3 2phk_c03 MC-PEPTIDE user 13 3 # 13 A 149 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 151 LYS C 239 LYS^? 16.29 N TRS A 378 A 154 ASN C 238 ASN^? 16.63 O2S EPE A 377 coo 41.42 17.90 44.98 43.39 18.36 45.61 4.59 -25.19 21.63 5.07 -23.28 20.96 coo 45.75 16.58 39.61 47.43 18.26 45.54 5.15 -29.07 27.87 7.72 -24.69 27.36 coo 44.77 13.10 43.25 45.01 14.21 45.03 5.28 -30.50 23.50 4.52 -30.81 21.55 ULMN 3 2phk_c03 MC-PEPTIDE user 14 3 # 14 A 149 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 151 LYS C 295 LYS.? 14.49 ZN ZN C 374 A 154 ASN C 294 ASN.? 11.92 ZN ZN C 374 coo 41.42 17.90 44.98 43.39 18.36 45.61 1.43 -20.86 54.35 0.32 -19.00 54.12 coo 45.75 16.58 39.61 47.43 18.26 45.54 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 44.77 13.10 43.25 45.01 14.21 45.03 -3.30 -17.98 52.78 -3.53 -18.25 54.87 2phk_c03 source 2phk MC-PEPTIDE : 14 hits 2phk_c03 naa= 3 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 1 3 # 1 10 ASN A 334 ASN~? 9.69 ZN ZN A 374 20 HIS A 333 HIS~? -3.55 ZN ZN A 374s 93 ASP A 292 ASP^? 8.63 ZN ZN A 374 coo 45.21 45.27 48.24 46.79 44.92 46.88 45.98 2.64 32.26 46.53 3.77 30.56 coo 47.05 39.55 45.24 48.99 39.30 44.46 40.60 0.33 34.12 38.69 0.39 33.24 coo 46.96 34.22 47.29 47.91 35.95 46.52 36.33 -2.54 36.72 35.44 -2.95 38.63 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 2 3 # 2 10 ASN A 334 ASN~? 9.69 ZN ZN A 374 20 HIS A 333 HIS~? -3.55 ZN ZN A 374s 93 ASP A 312 ASP.? 7.50 ZN ZN A 374 coo 45.21 45.27 48.24 46.79 44.92 46.88 45.98 2.64 32.26 46.53 3.77 30.56 coo 47.05 39.55 45.24 48.99 39.30 44.46 40.60 0.33 34.12 38.69 0.39 33.24 coo 46.96 34.22 47.29 47.91 35.95 46.52 39.49 -1.24 39.18 39.76 0.49 37.96 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 3 3 # 3 10 ASN B 334 ASN~? 9.65 ZN ZN B 374 20 HIS B 333 HIS~? -3.37 ZN ZN B 374s 93 ASP B 292 ASP^? 8.88 ZN ZN B 374 coo 45.21 45.27 48.24 46.79 44.92 46.88 -13.83 13.67 21.41 -15.89 13.09 21.50 coo 47.05 39.55 45.24 48.99 39.30 44.46 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 46.96 34.22 47.29 47.91 35.95 46.52 -3.14 9.99 24.96 -1.24 10.75 25.71 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 4 3 # 4 10 ASN B 334 ASN~? 9.65 ZN ZN B 374 20 HIS B 333 HIS~? -3.37 ZN ZN B 374s 93 ASP B 312 ASP.? 7.53 ZN ZN B 374 coo 45.21 45.27 48.24 46.79 44.92 46.88 -13.83 13.67 21.41 -15.89 13.09 21.50 coo 47.05 39.55 45.24 48.99 39.30 44.46 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 46.96 34.22 47.29 47.91 35.95 46.52 -4.08 14.12 24.69 -6.01 13.62 25.36 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 5 3 # 5 10 ASN C 334 ASN~? 9.79 ZN ZN C 374 20 HIS C 333 HIS~? -3.37 ZN ZN C 374s 93 ASP C 292 ASP^? 8.69 ZN ZN C 374 coo 45.21 45.27 48.24 46.79 44.92 46.88 2.44 -29.45 62.54 3.79 -30.90 63.32 coo 47.05 39.55 45.24 48.99 39.30 44.46 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 46.96 34.22 47.29 47.91 35.95 46.52 1.43 -20.86 54.35 0.32 -19.00 54.12 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 6 3 # 6 10 ASN C 334 ASN~? 9.79 ZN ZN C 374 20 HIS C 333 HIS~? -3.37 ZN ZN C 374s 93 ASP C 312 ASP.? 7.48 ZN ZN C 374 coo 45.21 45.27 48.24 46.79 44.92 46.88 2.44 -29.45 62.54 3.79 -30.90 63.32 coo 47.05 39.55 45.24 48.99 39.30 44.46 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 46.96 34.22 47.29 47.91 35.95 46.52 -0.90 -20.80 57.97 0.71 -21.61 59.03 2pth_c00 source 2pth PEPTIDYL-TRNA HYDROLASE : 6 hits 2pth_c00 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS A 68 HIS.? -3.31 ZN ZN A 375s A 40 LYS A 28 LYS.? 12.48 C7 EPE A 376 A 116 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 12.34 -0.45 10.80 13.53 1.19 11.34 37.80 0.44 25.56 37.02 -1.29 26.44 coo 18.50 3.53 20.10 16.17 2.61 14.41 26.87 3.56 26.76 22.81 3.70 30.35 coo 14.70 6.01 5.61 14.27 7.69 6.78 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 2 3 # 2 A 12 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 40 LYS A 28 LYS.? 12.48 C7 EPE A 376 A 116 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 12.34 -0.45 10.80 13.53 1.19 11.34 37.42 3.90 29.26 38.47 2.36 30.22 coo 18.50 3.53 20.10 16.17 2.61 14.41 26.87 3.56 26.76 22.81 3.70 30.35 coo 14.70 6.01 5.61 14.27 7.69 6.78 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 3 3 # 3 A 12 HIS A 69 HIS.? -3.40 ZN ZN A 374s A 40 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 116 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 12.34 -0.45 10.80 13.53 1.19 11.34 37.42 3.90 29.26 38.47 2.36 30.22 coo 18.50 3.53 20.10 16.17 2.61 14.41 44.47 1.55 20.70 47.30 5.10 24.27 coo 14.70 6.01 5.61 14.27 7.69 6.78 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 4 3 # 4 A 12 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 40 LYS A 340 LYS~? 12.75 ZN ZN A 374 A 116 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 12.34 -0.45 10.80 13.53 1.19 11.34 32.91 0.46 27.63 33.66 0.11 29.56 coo 18.50 3.53 20.10 16.17 2.61 14.41 44.47 1.55 20.70 47.30 5.10 24.27 coo 14.70 6.01 5.61 14.27 7.69 6.78 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 5 3 # 5 A 12 HIS A 224 HIS~? 7.33 C7 EPE A 377 A 40 LYS A 218 LYS~? 21.49 C3 EPE A 377 A 116 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo 12.34 -0.45 10.80 13.53 1.19 11.34 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 18.50 3.53 20.10 16.17 2.61 14.41 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 14.70 6.01 5.61 14.27 7.69 6.78 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 6 3 # 6 A 12 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 40 LYS A 295 LYS.? 12.61 ZN ZN A 374 A 116 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 12.34 -0.45 10.80 13.53 1.19 11.34 40.60 0.33 34.12 38.69 0.39 33.24 coo 18.50 3.53 20.10 16.17 2.61 14.41 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 14.70 6.01 5.61 14.27 7.69 6.78 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 7 3 # 7 A 12 HIS B 68 HIS.? -3.38 ZN ZN B 375s A 40 LYS B 28 LYS.? 11.75 C7 EPE B 376 A 116 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 18.50 3.53 20.10 16.17 2.61 14.41 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 14.70 6.01 5.61 14.27 7.69 6.78 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 8 3 # 8 A 12 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 40 LYS B 28 LYS.? 11.75 C7 EPE B 376 A 116 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 18.50 3.53 20.10 16.17 2.61 14.41 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 14.70 6.01 5.61 14.27 7.69 6.78 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 9 3 # 9 A 12 HIS B 69 HIS.? -3.36 ZN ZN B 374s A 40 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 116 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 18.50 3.53 20.10 16.17 2.61 14.41 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 14.70 6.01 5.61 14.27 7.69 6.78 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 10 3 # 10 A 12 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 40 LYS B 340 LYS~? 12.84 ZN ZN B 374 A 116 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 18.50 3.53 20.10 16.17 2.61 14.41 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 14.70 6.01 5.61 14.27 7.69 6.78 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 11 3 # 11 A 12 HIS B 224 HIS.? 17.79 O2S EPE A 377 A 40 LYS B 218 LYS~? 23.26 O3S EPE A 377 A 116 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 18.50 3.53 20.10 16.17 2.61 14.41 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 14.70 6.01 5.61 14.27 7.69 6.78 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 12 3 # 12 A 12 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 40 LYS B 295 LYS.? 11.37 ZN ZN B 375 A 116 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 18.50 3.53 20.10 16.17 2.61 14.41 4.57 8.76 22.84 2.39 5.01 24.93 coo 14.70 6.01 5.61 14.27 7.69 6.78 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 13 3 # 13 A 12 HIS C 68 HIS.? -3.41 ZN ZN C 375s A 40 LYS C 28 LYS.? 13.32 C7 EPE C 376 A 116 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 12.34 -0.45 10.80 13.53 1.19 11.34 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 18.50 3.53 20.10 16.17 2.61 14.41 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 14.70 6.01 5.61 14.27 7.69 6.78 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 14 3 # 14 A 12 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 40 LYS C 28 LYS.? 13.32 C7 EPE C 376 A 116 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 12.34 -0.45 10.80 13.53 1.19 11.34 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 18.50 3.53 20.10 16.17 2.61 14.41 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 14.70 6.01 5.61 14.27 7.69 6.78 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 15 3 # 15 A 12 HIS C 69 HIS.? -3.39 ZN ZN C 374s A 40 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 116 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 12.34 -0.45 10.80 13.53 1.19 11.34 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 18.50 3.53 20.10 16.17 2.61 14.41 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 14.70 6.01 5.61 14.27 7.69 6.78 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 16 3 # 16 A 12 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 40 LYS C 340 LYS~? 12.92 ZN ZN C 374 A 116 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 12.34 -0.45 10.80 13.53 1.19 11.34 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 18.50 3.53 20.10 16.17 2.61 14.41 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 14.70 6.01 5.61 14.27 7.69 6.78 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 17 3 # 17 A 12 HIS C 224 HIS~? 8.36 C3 EPE C 377 A 40 LYS C 218 LYS~? 12.80 O1 TRS A 378 A 116 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo 12.34 -0.45 10.80 13.53 1.19 11.34 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 18.50 3.53 20.10 16.17 2.61 14.41 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 14.70 6.01 5.61 14.27 7.69 6.78 27.13 -47.60 14.36 28.94 -48.66 14.50 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 18 3 # 18 A 12 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 40 LYS C 295 LYS.? 14.49 ZN ZN C 374 A 116 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 12.34 -0.45 10.80 13.53 1.19 11.34 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 18.50 3.53 20.10 16.17 2.61 14.41 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 14.70 6.01 5.61 14.27 7.69 6.78 10.51 -24.81 51.94 8.80 -23.79 52.62 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 18 hits 2rnf_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 68 HIS.? -3.31 ZN ZN A 375s B 40 LYS A 28 LYS.? 12.48 C7 EPE A 376 B 116 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo -6.35 21.42 14.69 -6.06 23.46 15.04 37.80 0.44 25.56 37.02 -1.29 26.44 coo -10.61 31.45 9.72 -8.75 26.69 13.45 26.87 3.56 26.76 22.81 3.70 30.35 coo -0.95 25.22 19.68 -0.68 26.73 18.24 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 2 3 # 2 B 12 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 40 LYS A 28 LYS.? 12.48 C7 EPE A 376 B 116 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo -6.35 21.42 14.69 -6.06 23.46 15.04 37.42 3.90 29.26 38.47 2.36 30.22 coo -10.61 31.45 9.72 -8.75 26.69 13.45 26.87 3.56 26.76 22.81 3.70 30.35 coo -0.95 25.22 19.68 -0.68 26.73 18.24 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 3 3 # 3 B 12 HIS A 69 HIS.? -3.40 ZN ZN A 374s B 40 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 116 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo -6.35 21.42 14.69 -6.06 23.46 15.04 37.42 3.90 29.26 38.47 2.36 30.22 coo -10.61 31.45 9.72 -8.75 26.69 13.45 44.47 1.55 20.70 47.30 5.10 24.27 coo -0.95 25.22 19.68 -0.68 26.73 18.24 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 4 3 # 4 B 12 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 40 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 116 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo -6.35 21.42 14.69 -6.06 23.46 15.04 32.91 0.46 27.63 33.66 0.11 29.56 coo -10.61 31.45 9.72 -8.75 26.69 13.45 44.47 1.55 20.70 47.30 5.10 24.27 coo -0.95 25.22 19.68 -0.68 26.73 18.24 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 5 3 # 5 B 12 HIS A 163 HIS.? 11.18 O1S EPE C 377 B 40 LYS A 215 LYS~? 16.65 O1S EPE C 377 B 116 HIS A 169 HIS^? 11.22 O1S EPE C 377 coo -6.35 21.42 14.69 -6.06 23.46 15.04 30.88 -23.32 6.66 32.97 -23.36 6.49 coo -10.61 31.45 9.72 -8.75 26.69 13.45 21.25 -14.20 2.18 27.53 -14.97 1.13 coo -0.95 25.22 19.68 -0.68 26.73 18.24 28.51 -27.02 0.13 29.35 -25.45 -0.99 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 6 3 # 6 B 12 HIS A 224 HIS~? 7.33 C7 EPE A 377 B 40 LYS A 218 LYS~? 21.49 C3 EPE A 377 B 116 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo -6.35 21.42 14.69 -6.06 23.46 15.04 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo -10.61 31.45 9.72 -8.75 26.69 13.45 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo -0.95 25.22 19.68 -0.68 26.73 18.24 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 7 3 # 7 B 12 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 40 LYS A 295 LYS.? 12.61 ZN ZN A 374 B 116 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo -6.35 21.42 14.69 -6.06 23.46 15.04 40.60 0.33 34.12 38.69 0.39 33.24 coo -10.61 31.45 9.72 -8.75 26.69 13.45 32.96 -9.31 39.54 28.55 -6.00 37.21 coo -0.95 25.22 19.68 -0.68 26.73 18.24 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 8 3 # 8 B 12 HIS A 359 HIS^? 27.14 ZN ZN A 375 B 40 LYS A 350 LYS~? 21.83 ZN ZN A 375 B 116 HIS A 361 HIS^? 22.47 ZN ZN A 375 coo -6.35 21.42 14.69 -6.06 23.46 15.04 45.80 8.64 6.53 46.53 8.87 4.58 coo -10.61 31.45 9.72 -8.75 26.69 13.45 39.19 -2.77 6.68 35.27 -5.97 7.17 coo -0.95 25.22 19.68 -0.68 26.73 18.24 46.25 9.10 12.92 46.66 10.09 11.12 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 9 3 # 9 B 12 HIS A 359 HIS^? 27.14 ZN ZN A 375 B 40 LYS A 355 LYS.? 33.47 ZN ZN A 375 B 116 HIS A 361 HIS^? 22.47 ZN ZN A 375 coo -6.35 21.42 14.69 -6.06 23.46 15.04 45.80 8.64 6.53 46.53 8.87 4.58 coo -10.61 31.45 9.72 -8.75 26.69 13.45 39.94 1.41 -1.05 41.91 -2.04 -4.52 coo -0.95 25.22 19.68 -0.68 26.73 18.24 46.25 9.10 12.92 46.66 10.09 11.12 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 10 3 # 10 B 12 HIS A 361 HIS^? 22.47 ZN ZN A 375 B 40 LYS A 340 LYS~? 12.75 ZN ZN A 374 B 116 HIS A 359 HIS^? 27.14 ZN ZN A 375 coo -6.35 21.42 14.69 -6.06 23.46 15.04 46.25 9.10 12.92 46.66 10.09 11.12 coo -10.61 31.45 9.72 -8.75 26.69 13.45 44.47 1.55 20.70 47.30 5.10 24.27 coo -0.95 25.22 19.68 -0.68 26.73 18.24 45.80 8.64 6.53 46.53 8.87 4.58 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 11 3 # 11 B 12 HIS B 68 HIS.? -3.38 ZN ZN B 375s B 40 LYS B 28 LYS.? 11.75 C7 EPE B 376 B 116 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo -6.35 21.42 14.69 -6.06 23.46 15.04 -12.57 2.98 23.02 -10.64 2.83 22.25 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 12 3 # 12 B 12 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 40 LYS B 28 LYS.? 11.75 C7 EPE B 376 B 116 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo -6.35 21.42 14.69 -6.06 23.46 15.04 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 13 3 # 13 B 12 HIS B 69 HIS.? -3.36 ZN ZN B 374s B 40 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 116 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo -6.35 21.42 14.69 -6.06 23.46 15.04 -12.32 6.27 26.70 -11.45 7.45 25.21 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 14 3 # 14 B 12 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 40 LYS B 340 LYS~? 12.84 ZN ZN B 374 B 116 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo -6.35 21.42 14.69 -6.06 23.46 15.04 -8.91 1.52 26.66 -7.77 3.28 26.73 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -19.41 3.70 18.30 -21.14 8.87 20.36 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 15 3 # 15 B 12 HIS B 224 HIS.? 17.79 O2S EPE A 377 B 40 LYS B 218 LYS~? 23.26 O3S EPE A 377 B 116 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 16 3 # 16 B 12 HIS B 316 HIS~? 20.54 O8 EPE B 376 B 40 LYS B 295 LYS.? 11.37 ZN ZN B 375 B 116 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo -6.35 21.42 14.69 -6.06 23.46 15.04 7.45 20.77 27.47 7.65 22.47 28.71 coo -10.61 31.45 9.72 -8.75 26.69 13.45 4.57 8.76 22.84 2.39 5.01 24.93 coo -0.95 25.22 19.68 -0.68 26.73 18.24 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 17 3 # 17 B 12 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 40 LYS B 295 LYS.? 11.37 ZN ZN B 375 B 116 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -8.75 11.09 23.63 -8.33 9.23 24.53 coo -10.61 31.45 9.72 -8.75 26.69 13.45 4.57 8.76 22.84 2.39 5.01 24.93 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 18 3 # 18 B 12 HIS C 68 HIS.? -3.41 ZN ZN C 375s B 40 LYS C 28 LYS.? 13.32 C7 EPE C 376 B 116 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo -6.35 21.42 14.69 -6.06 23.46 15.04 9.33 -29.64 54.17 7.95 -29.11 52.67 coo -10.61 31.45 9.72 -8.75 26.69 13.45 15.95 -21.05 50.17 18.02 -16.90 49.10 coo -0.95 25.22 19.68 -0.68 26.73 18.24 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 19 3 # 19 B 12 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 40 LYS C 28 LYS.? 13.32 C7 EPE C 376 B 116 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo -6.35 21.42 14.69 -6.06 23.46 15.04 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -10.61 31.45 9.72 -8.75 26.69 13.45 15.95 -21.05 50.17 18.02 -16.90 49.10 coo -0.95 25.22 19.68 -0.68 26.73 18.24 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 20 3 # 20 B 12 HIS C 69 HIS.? -3.39 ZN ZN C 374s B 40 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 116 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo -6.35 21.42 14.69 -6.06 23.46 15.04 9.38 -25.93 57.43 7.35 -26.43 57.48 coo -10.61 31.45 9.72 -8.75 26.69 13.45 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -0.95 25.22 19.68 -0.68 26.73 18.24 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 21 3 # 21 B 12 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 40 LYS C 340 LYS~? 12.92 ZN ZN C 374 B 116 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo -6.35 21.42 14.69 -6.06 23.46 15.04 10.51 -24.81 51.94 8.80 -23.79 52.62 coo -10.61 31.45 9.72 -8.75 26.69 13.45 9.58 -37.42 57.24 8.41 -35.76 62.90 coo -0.95 25.22 19.68 -0.68 26.73 18.24 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 22 3 # 22 B 12 HIS C 224 HIS~? 8.36 C3 EPE C 377 B 40 LYS C 218 LYS~? 12.80 O1 TRS A 378 B 116 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo -6.35 21.42 14.69 -6.06 23.46 15.04 26.69 -40.96 16.23 26.39 -40.40 14.23 coo -10.61 31.45 9.72 -8.75 26.69 13.45 26.24 -37.78 26.13 29.59 -36.75 30.95 coo -0.95 25.22 19.68 -0.68 26.73 18.24 27.13 -47.60 14.36 28.94 -48.66 14.50 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 23 3 # 23 B 12 HIS C 316 HIS~? -20.42 O8 EPE C 376s B 40 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 116 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 24 3 # 24 B 12 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 40 LYS C 295 LYS.? 14.49 ZN ZN C 374 B 116 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo -6.35 21.42 14.69 -6.06 23.46 15.04 2.70 -25.03 58.20 4.12 -24.40 56.79 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo -0.95 25.22 19.68 -0.68 26.73 18.24 10.51 -24.81 51.94 8.80 -23.79 52.62 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 24 hits 2rnf_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 27 ASP.? 8.12 ZN ZN A 375 166 GLY A 342 GLY~? 12.90 ZN ZN A 375 169 GLU A 119 GLU~? 15.23 ZN ZN A 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -8.58 13.22 3.21 -8.90 13.15 4.05 44.89 -3.04 18.23 44.73 -2.27 17.91 coo -16.67 7.89 2.78 -17.65 6.56 1.49 47.50 -11.03 21.23 45.94 -11.22 19.71 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 27 ASP.? 8.12 ZN ZN A 375 166 GLY A 342 GLY~? 12.90 ZN ZN A 375 169 GLU A 349 GLU~? 21.94 ZN ZN A 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 27.49 -0.90 27.62 29.53 -0.28 27.44 coo -8.58 13.22 3.21 -8.90 13.15 4.05 44.89 -3.04 18.23 44.73 -2.27 17.91 coo -16.67 7.89 2.78 -17.65 6.56 1.49 44.64 -4.62 8.34 45.23 -6.64 8.63 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 158 ASP~? 15.23 O1S EPE C 377 166 GLY C 178 GLY^? 3.71 C6 EPE C 377 169 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 27.01 -21.53 -3.21 27.96 -22.95 -4.50 coo -8.58 13.22 3.21 -8.90 13.15 4.05 23.14 -36.24 3.79 23.36 -36.64 3.06 coo -16.67 7.89 2.78 -17.65 6.56 1.49 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 232 ASP^? 4.68 O1S EPE A 377 166 GLY B 157 GLY~? 9.55 O3S EPE A 377 169 GLU B 150 GLU~? 12.97 C6 EPE A 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -6.18 -40.46 2.00 -5.62 -38.68 0.95 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 232 ASP^? 4.68 O1S EPE A 377 166 GLY B 157 GLY~? 9.55 O3S EPE A 377 169 GLU B 151 GLU~? 19.22 O3S EPE A 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.61 -39.78 7.97 -10.79 -41.15 9.06 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 232 ASP^? 4.68 O1S EPE A 377 166 GLY C 178 GLY^? 3.71 C6 EPE C 377 169 GLU C 197 GLU^? 9.42 O8 EPE C 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -8.58 13.22 3.21 -8.90 13.15 4.05 23.14 -36.24 3.79 23.36 -36.64 3.06 coo -16.67 7.89 2.78 -17.65 6.56 1.49 32.51 -36.09 0.58 33.81 -36.84 -0.90 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP A 232 ASP^? 4.68 O1S EPE A 377 166 GLY C 178 GLY^? 3.71 C6 EPE C 377 169 GLU C 200 GLU^? 10.81 O8 EPE C 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 9.54 -24.20 7.87 7.70 -24.91 7.05 coo -8.58 13.22 3.21 -8.90 13.15 4.05 23.14 -36.24 3.79 23.36 -36.64 3.06 coo -16.67 7.89 2.78 -17.65 6.56 1.49 22.01 -43.83 0.76 21.98 -45.84 -0.06 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP A 237 ASP^? 6.80 N TRS A 378 166 GLY C 157 GLY~? 18.60 O1 TRS A 378 169 GLU C 150 GLU~? 19.96 C2 EPE C 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 18.36 -25.38 21.90 16.49 -24.92 22.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 15.82 -44.70 25.16 16.57 -44.60 25.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 18.79 -51.73 16.88 16.73 -51.34 17.24 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP A 237 ASP^? 6.80 N TRS A 378 166 GLY C 157 GLY~? 18.60 O1 TRS A 378 169 GLU C 151 GLU~? 17.15 O8 EPE C 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 18.36 -25.38 21.90 16.49 -24.92 22.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 15.82 -44.70 25.16 16.57 -44.60 25.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 24.82 -49.12 19.40 26.74 -49.67 18.68 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP A 269 ASP.? 18.90 ZN ZN A 374 166 GLY A 246 GLY^? 9.76 ZN ZN A 375 169 GLU A 127 GLU^? 14.05 O3 TRS A 378 coo 8.28 6.87 1.62 10.08 5.77 1.34 54.82 -1.21 28.36 56.43 0.27 28.67 coo -8.58 13.22 3.21 -8.90 13.15 4.05 38.31 -12.10 29.42 37.83 -12.45 28.86 coo -16.67 7.89 2.78 -17.65 6.56 1.49 39.39 -22.49 26.46 38.47 -23.38 24.73 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP A 269 ASP.? 18.90 ZN ZN A 374 166 GLY A 258 GLY~? 25.62 ZN ZN A 374 169 GLU A 254 GLU^? 30.93 ZN ZN A 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 54.82 -1.21 28.36 56.43 0.27 28.67 coo -8.58 13.22 3.21 -8.90 13.15 4.05 56.88 -13.16 41.55 56.67 -13.61 40.87 coo -16.67 7.89 2.78 -17.65 6.56 1.49 55.35 -23.67 37.01 55.67 -25.35 38.24 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP A 292 ASP^? 8.63 ZN ZN A 374 166 GLY A 272 GLY.? 18.36 ZN ZN A 374 169 GLU A 262 GLU~? 24.15 ZN ZN A 374 coo 8.28 6.87 1.62 10.08 5.77 1.34 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -8.58 13.22 3.21 -8.90 13.15 4.05 54.23 -1.17 38.61 53.76 -1.27 37.97 coo -16.67 7.89 2.78 -17.65 6.56 1.49 59.50 -9.24 37.85 59.47 -7.16 38.33 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP A 312 ASP.? 7.50 ZN ZN A 374 166 GLY A 244 GLY^? 11.92 ZN ZN A 375 169 GLU A 127 GLU^? 14.05 O3 TRS A 378 coo 8.28 6.87 1.62 10.08 5.77 1.34 39.49 -1.24 39.18 39.76 0.49 37.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 32.51 -13.15 26.46 33.13 -12.90 26.03 coo -16.67 7.89 2.78 -17.65 6.56 1.49 39.39 -22.49 26.46 38.47 -23.38 24.73 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP A 320 ASP~? -21.81 ZN ZN A 374s 166 GLY A 246 GLY^? 9.76 ZN ZN A 375 169 GLU A 127 GLU^? 14.05 O3 TRS A 378 coo 8.28 6.87 1.62 10.08 5.77 1.34 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 38.31 -12.10 29.42 37.83 -12.45 28.86 coo -16.67 7.89 2.78 -17.65 6.56 1.49 39.39 -22.49 26.46 38.47 -23.38 24.73 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP A 320 ASP~? -21.81 ZN ZN A 374s 166 GLY A 304 GLY.? 22.37 O3 TRS A 378 169 GLU A 127 GLU^? 14.05 O3 TRS A 378 coo 8.28 6.87 1.62 10.08 5.77 1.34 36.60 -12.13 48.17 35.17 -11.15 49.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 41.24 -23.22 37.09 41.16 -22.48 36.89 coo -16.67 7.89 2.78 -17.65 6.56 1.49 39.39 -22.49 26.46 38.47 -23.38 24.73 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP A 330 ASP^? 12.08 ZN ZN A 374 166 GLY A 304 GLY.? 22.37 O3 TRS A 378 169 GLU A 127 GLU^? 14.05 O3 TRS A 378 coo 8.28 6.87 1.62 10.08 5.77 1.34 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -8.58 13.22 3.21 -8.90 13.15 4.05 41.24 -23.22 37.09 41.16 -22.48 36.89 coo -16.67 7.89 2.78 -17.65 6.56 1.49 39.39 -22.49 26.46 38.47 -23.38 24.73 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP A 352 ASP~? 25.70 ZN ZN A 375 166 GLY A 112 GLY~? 9.06 ZN ZN A 375 169 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 8.28 6.87 1.62 10.08 5.77 1.34 43.66 -0.56 3.32 44.78 0.99 4.29 coo -8.58 13.22 3.21 -8.90 13.15 4.05 39.28 -7.29 21.25 39.96 -7.72 21.33 coo -16.67 7.89 2.78 -17.65 6.56 1.49 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP B 27 ASP.? 8.17 ZN ZN B 375 166 GLY B 111 GLY.? 12.91 ZN ZN B 375 169 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -5.26 -2.13 28.94 -6.77 -0.82 28.14 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -11.60 -2.92 11.75 -11.04 -2.69 12.33 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 19 3 # 19 141 ASP B 48 ASP.? 7.36 ZN ZN B 374 166 GLY B 112 GLY~? 9.09 ZN ZN B 375 169 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -17.03 8.88 27.62 -15.41 9.62 26.60 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -10.98 -0.97 15.01 -10.85 -0.63 14.30 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 20 3 # 20 141 ASP B 158 ASP~? 14.93 O3S EPE A 377 166 GLY A 178 GLY^? 3.80 C6 EPE A 377 169 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 3.25 -33.31 -0.46 2.85 -33.92 -0.95 coo -16.67 7.89 2.78 -17.65 6.56 1.49 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 21 3 # 21 141 ASP B 158 ASP~? 14.93 O3S EPE A 377 166 GLY A 178 GLY^? 3.80 C6 EPE A 377 169 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 3.25 -33.31 -0.46 2.85 -33.92 -0.95 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 22 3 # 22 141 ASP B 158 ASP~? 14.93 O3S EPE A 377 166 GLY B 165 GLY.? 10.94 O1S EPE A 377 169 GLU A 227 GLU.? 13.15 O8 EPE A 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 -11.33 -30.60 6.63 -11.83 -31.70 4.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -0.63 -18.46 -0.95 -1.10 -19.11 -0.69 coo -16.67 7.89 2.78 -17.65 6.56 1.49 5.87 -17.01 -8.12 5.06 -15.73 -9.55 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 23 3 # 23 141 ASP B 232 ASP^? 14.54 O2S EPE A 377 166 GLY A 178 GLY^? 3.80 C6 EPE A 377 169 GLU A 200 GLU^? 11.53 C6 EPE A 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 3.25 -33.31 -0.46 2.85 -33.92 -0.95 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.52 -39.28 -5.41 6.61 -40.27 -3.48 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 24 3 # 24 141 ASP B 232 ASP^? 14.54 O2S EPE A 377 166 GLY B 162 GLY.? 5.31 O3S EPE A 377 169 GLU A 228 GLU.? 8.71 C3 EPE A 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -1.71 -25.67 5.15 -2.30 -25.15 5.24 coo -16.67 7.89 2.78 -17.65 6.56 1.49 3.91 -21.00 -3.12 3.67 -19.15 -2.10 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 25 3 # 25 141 ASP B 232 ASP^? 14.54 O2S EPE A 377 166 GLY C 157 GLY~? 18.60 O1 TRS A 378 169 GLU C 150 GLU~? 19.96 C2 EPE C 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 15.82 -44.70 25.16 16.57 -44.60 25.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 18.79 -51.73 16.88 16.73 -51.34 17.24 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 26 3 # 26 141 ASP B 232 ASP^? 14.54 O2S EPE A 377 166 GLY C 157 GLY~? 18.60 O1 TRS A 378 169 GLU C 151 GLU~? 17.15 O8 EPE C 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 6.16 -32.41 17.86 6.89 -34.31 18.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 15.82 -44.70 25.16 16.57 -44.60 25.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 24.82 -49.12 19.40 26.74 -49.67 18.68 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 27 3 # 27 141 ASP B 237 ASP^? 15.58 N TRS A 378 166 GLY A 157 GLY~? 9.65 O1S EPE C 377 169 GLU A 150 GLU~? 12.50 C5 EPE C 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 11.84 -17.75 12.41 13.28 -17.47 14.02 coo -8.58 13.22 3.21 -8.90 13.15 4.05 25.68 -24.30 0.57 25.46 -23.69 0.10 coo -16.67 7.89 2.78 -17.65 6.56 1.49 22.60 -31.63 -7.22 23.33 -32.82 -5.63 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 28 3 # 28 141 ASP B 269 ASP.? 18.26 ZN ZN B 374 166 GLY B 246 GLY^? 9.61 ZN ZN B 375 169 GLU B 127 GLU^? 21.05 ZN ZN B 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -18.05 15.19 12.20 -19.75 16.35 12.84 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -2.31 3.58 14.78 -2.28 2.80 14.58 coo -16.67 7.89 2.78 -17.65 6.56 1.49 2.11 -0.28 5.62 1.83 -2.30 4.96 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 29 3 # 29 141 ASP B 269 ASP.? 18.26 ZN ZN B 374 166 GLY B 258 GLY~? 25.40 ZN ZN B 374 169 GLU B 254 GLU^? 30.73 ZN ZN B 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -18.05 15.19 12.20 -19.75 16.35 12.84 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -3.80 23.92 6.13 -3.78 23.26 5.65 coo -16.67 7.89 2.78 -17.65 6.56 1.49 1.12 17.35 -1.99 2.87 17.99 -2.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 30 3 # 30 141 ASP B 281 ASP.? 29.04 ZN ZN B 374 166 GLY B 249 GLY^? 18.76 ZN ZN B 375 169 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 4.51 22.24 5.26 6.45 23.04 5.71 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -1.04 5.72 4.91 -0.82 6.46 5.20 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 31 3 # 31 141 ASP B 281 ASP.? 29.04 ZN ZN B 374 166 GLY B 311 GLY^? 8.79 ZN ZN B 374 169 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 8.28 6.87 1.62 10.08 5.77 1.34 4.51 22.24 5.26 6.45 23.04 5.71 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -5.28 13.83 20.42 -4.55 13.48 20.52 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 32 3 # 32 141 ASP B 292 ASP^? 8.88 ZN ZN B 374 166 GLY B 272 GLY.? 18.77 ZN ZN B 374 169 GLU B 262 GLU~? 24.13 ZN ZN B 374 coo 8.28 6.87 1.62 10.08 5.77 1.34 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -11.90 23.22 15.48 -12.02 22.37 15.54 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.48 23.81 6.41 -10.83 24.55 7.88 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 33 3 # 33 141 ASP B 312 ASP.? 7.53 ZN ZN B 374 166 GLY B 112 GLY~? 9.09 ZN ZN B 375 169 GLU B 119 GLU~? 15.38 ZN ZN B 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -10.98 -0.97 15.01 -10.85 -0.63 14.30 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.67 2.61 5.82 -11.38 1.03 7.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 34 3 # 34 141 ASP B 312 ASP.? 7.53 ZN ZN B 374 166 GLY B 244 GLY^? 11.85 ZN ZN B 375 169 GLU B 127 GLU^? 21.05 ZN ZN B 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -0.61 -2.61 16.62 -1.32 -2.49 16.19 coo -16.67 7.89 2.78 -17.65 6.56 1.49 2.11 -0.28 5.62 1.83 -2.30 4.96 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 35 3 # 35 141 ASP B 320 ASP~? -21.78 ZN ZN B 374s 166 GLY B 246 GLY^? 9.61 ZN ZN B 375 169 GLU B 127 GLU^? 21.05 ZN ZN B 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 9.35 16.65 21.02 10.22 16.89 22.90 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -2.31 3.58 14.78 -2.28 2.80 14.58 coo -16.67 7.89 2.78 -17.65 6.56 1.49 2.11 -0.28 5.62 1.83 -2.30 4.96 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 36 3 # 36 141 ASP B 320 ASP~? -21.78 ZN ZN B 374s 166 GLY B 304 GLY.? 23.11 ZN ZN B 375 169 GLU B 127 GLU^? 21.05 ZN ZN B 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 9.35 16.65 21.02 10.22 16.89 22.90 coo -8.58 13.22 3.21 -8.90 13.15 4.05 8.09 9.00 6.73 7.56 8.93 7.27 coo -16.67 7.89 2.78 -17.65 6.56 1.49 2.11 -0.28 5.62 1.83 -2.30 4.96 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 37 3 # 37 141 ASP B 330 ASP^? 11.92 ZN ZN B 374 166 GLY B 122 GLY~? 19.62 ZN ZN B 375 169 GLU B 253 GLU^? 31.12 ZN ZN B 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -9.36 8.56 2.89 -8.77 8.49 3.46 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -5.44 14.03 -5.56 -4.22 13.73 -7.31 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 38 3 # 38 141 ASP B 330 ASP^? 11.92 ZN ZN B 374 166 GLY B 304 GLY.? 23.11 ZN ZN B 375 169 GLU B 127 GLU^? 21.05 ZN ZN B 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -8.58 13.22 3.21 -8.90 13.15 4.05 8.09 9.00 6.73 7.56 8.93 7.27 coo -16.67 7.89 2.78 -17.65 6.56 1.49 2.11 -0.28 5.62 1.83 -2.30 4.96 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 39 3 # 39 141 ASP B 352 ASP~? 25.82 ZN ZN B 375 166 GLY B 112 GLY~? 9.09 ZN ZN B 375 169 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 8.28 6.87 1.62 10.08 5.77 1.34 -28.14 -9.98 12.04 -29.16 -8.30 12.82 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -10.98 -0.97 15.01 -10.85 -0.63 14.30 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 40 3 # 40 141 ASP C 115 ASP~? 12.87 ZN ZN C 375 166 GLY C 240 GLY^? 19.25 N TRS A 378 169 GLU C 136 GLU^? 12.99 N TRS A 378 coo 8.28 6.87 1.62 10.08 5.77 1.34 1.88 -37.38 46.52 1.77 -36.70 44.54 coo -8.58 13.22 3.21 -8.90 13.15 4.05 6.12 -31.91 30.25 5.48 -31.34 30.35 coo -16.67 7.89 2.78 -17.65 6.56 1.49 10.97 -24.78 28.83 12.54 -23.35 28.52 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 41 3 # 41 141 ASP C 158 ASP~? 22.01 O1 TRS A 378 166 GLY B 178 GLY^? 19.88 O2S EPE A 377 169 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 19.06 -47.14 27.83 18.62 -49.09 27.08 coo -8.58 13.22 3.21 -8.90 13.15 4.05 8.41 -45.68 15.01 8.59 -46.49 14.79 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 42 3 # 42 141 ASP C 232 ASP^? 3.77 O2S EPE C 377 166 GLY B 178 GLY^? 19.88 O2S EPE A 377 169 GLU B 197 GLU^? 29.51 O2S EPE A 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -8.58 13.22 3.21 -8.90 13.15 4.05 8.41 -45.68 15.01 8.59 -46.49 14.79 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.54 -53.58 20.85 4.69 -53.18 21.76 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 43 3 # 43 141 ASP C 232 ASP^? 3.77 O2S EPE C 377 166 GLY B 178 GLY^? 19.88 O2S EPE A 377 169 GLU B 200 GLU^? 21.89 O2S EPE A 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 18.91 -30.34 15.16 19.98 -30.20 13.32 coo -8.58 13.22 3.21 -8.90 13.15 4.05 8.41 -45.68 15.01 8.59 -46.49 14.79 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.58 -49.91 8.32 6.28 -50.66 6.33 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 44 3 # 44 141 ASP C 237 ASP^? 16.80 O1S EPE A 377 166 GLY B 157 GLY~? 9.55 O3S EPE A 377 169 GLU B 151 GLU~? 19.22 O3S EPE A 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 4.59 -25.19 21.63 5.07 -23.28 20.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -6.61 -29.59 5.82 -7.19 -29.80 6.34 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.61 -39.78 7.97 -10.79 -41.15 9.06 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 45 3 # 45 141 ASP C 237 ASP^? 16.80 O1S EPE A 377 166 GLY B 162 GLY.? 5.31 O3S EPE A 377 169 GLU A 228 GLU.? 8.71 C3 EPE A 377 coo 8.28 6.87 1.62 10.08 5.77 1.34 4.59 -25.19 21.63 5.07 -23.28 20.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -1.71 -25.67 5.15 -2.30 -25.15 5.24 coo -16.67 7.89 2.78 -17.65 6.56 1.49 3.91 -21.00 -3.12 3.67 -19.15 -2.10 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 46 3 # 46 141 ASP C 269 ASP~? 18.04 ZN ZN C 374 166 GLY C 246 GLY^? 9.60 ZN ZN C 375 169 GLU C 127 GLU^? 21.05 ZN ZN C 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.79 -38.40 63.28 -1.15 -38.99 65.26 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -1.22 -29.27 46.37 -0.90 -29.41 45.67 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -6.33 -33.63 38.15 -7.56 -32.26 37.10 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 47 3 # 47 141 ASP C 281 ASP.? 29.07 ZN ZN C 374 166 GLY C 249 GLY^? 18.92 ZN ZN C 375 169 GLU C 119 GLU~? 15.59 ZN ZN C 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -9.08 -35.38 44.08 -9.51 -34.84 44.55 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -0.72 -41.44 48.78 1.35 -42.03 49.11 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 48 3 # 48 141 ASP C 281 ASP.? 29.07 ZN ZN C 374 166 GLY C 311 GLY^? 8.68 ZN ZN C 374 169 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 8.28 6.87 1.62 10.08 5.77 1.34 -22.02 -28.08 53.32 -23.19 -26.28 53.39 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -2.62 -24.75 57.19 -2.77 -24.31 56.55 coo -16.67 7.89 2.78 -17.65 6.56 1.49 3.38 -29.70 55.34 4.58 -28.10 54.66 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 49 3 # 49 141 ASP C 292 ASP^? 8.69 ZN ZN C 374 166 GLY C 111 GLY.? 12.85 ZN ZN C 375 169 GLU C 241 GLU^? 18.99 ZN ZN C 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -8.58 13.22 3.21 -8.90 13.15 4.05 5.64 -38.51 45.88 5.60 -37.66 45.90 coo -16.67 7.89 2.78 -17.65 6.56 1.49 4.84 -34.67 34.91 4.64 -36.58 35.93 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 50 3 # 50 141 ASP C 292 ASP^? 8.69 ZN ZN C 374 166 GLY C 272 GLY.? 18.55 ZN ZN C 374 169 GLU C 262 GLU~? 24.05 ZN ZN C 374 coo 8.28 6.87 1.62 10.08 5.77 1.34 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -7.94 -30.61 66.74 -7.33 -30.77 66.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -15.17 -35.96 63.25 -14.01 -35.31 64.90 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 51 3 # 51 141 ASP C 312 ASP.? 7.48 ZN ZN C 374 166 GLY C 244 GLY^? 11.70 ZN ZN C 375 169 GLU C 127 GLU^? 21.05 ZN ZN C 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -8.58 13.22 3.21 -8.90 13.15 4.05 2.79 -27.67 41.30 2.83 -28.37 41.63 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -6.33 -33.63 38.15 -7.56 -32.26 37.10 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 52 3 # 52 141 ASP C 320 ASP~? -21.75 ZN ZN C 374s 166 GLY C 246 GLY^? 9.60 ZN ZN C 375 169 GLU C 127 GLU^? 21.05 ZN ZN C 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -11.50 -14.47 50.76 -10.89 -12.44 50.87 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -1.22 -29.27 46.37 -0.90 -29.41 45.67 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -6.33 -33.63 38.15 -7.56 -32.26 37.10 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 53 3 # 53 141 ASP C 330 ASP^? 11.91 ZN ZN C 374 166 GLY C 122 GLY~? 19.71 ZN ZN C 375 169 GLU C 253 GLU^? 31.42 ZN ZN C 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -7.79 -41.59 50.69 -7.69 -40.80 50.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -18.88 -44.02 49.77 -19.94 -45.34 51.07 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 54 3 # 54 141 ASP C 352 ASP~? 25.48 ZN ZN C 375 166 GLY C 111 GLY.? 12.85 ZN ZN C 375 169 GLU C 241 GLU^? 18.99 ZN ZN C 375 coo 8.28 6.87 1.62 10.08 5.77 1.34 18.63 -50.25 49.90 18.47 -49.69 51.95 coo -8.58 13.22 3.21 -8.90 13.15 4.05 5.64 -38.51 45.88 5.60 -37.66 45.90 coo -16.67 7.89 2.78 -17.65 6.56 1.49 4.84 -34.67 34.91 4.64 -36.58 35.93 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 55 3 # 55 141 ASP C 352 ASP~? 25.48 ZN ZN C 375 166 GLY C 112 GLY~? 9.08 ZN ZN C 375 169 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 8.28 6.87 1.62 10.08 5.77 1.34 18.63 -50.25 49.90 18.47 -49.69 51.95 coo -8.58 13.22 3.21 -8.90 13.15 4.05 6.12 -35.35 47.97 5.41 -35.71 47.93 coo -16.67 7.89 2.78 -17.65 6.56 1.49 3.38 -29.70 55.34 4.58 -28.10 54.66 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 55 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 315 TYR~? 21.30 O8 EPE A 376 A 172 HIS A 319 HIS~? 24.64 ZN ZN A 374 A 267 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 26.78 20.44 0.03 28.51 18.26 0.09 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 315 TYR~? 21.53 O8 EPE B 376 A 172 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 267 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 26.78 20.44 0.03 28.51 18.26 0.09 4.11 23.72 25.55 5.20 26.22 24.94 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 7.45 20.77 27.47 7.65 22.47 28.71 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 A 169 TYR B 315 TYR~? 21.53 O8 EPE B 376 A 172 HIS B 319 HIS~? 24.73 ZN ZN B 374 A 267 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 26.78 20.44 0.03 28.51 18.26 0.09 4.11 23.72 25.55 5.20 26.22 24.94 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 8.16 23.53 21.75 7.85 25.60 21.62 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 A 169 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 172 HIS C 316 HIS~? -20.42 O8 EPE C 376s A 267 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 26.78 20.44 0.03 28.51 18.26 0.09 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 5 3 # 5 A 169 TYR C 315 TYR~? 21.59 O8 EPE C 376 A 172 HIS C 316 HIS~? -20.42 O8 EPE C 376s A 267 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 26.78 20.44 0.03 28.51 18.26 0.09 -10.50 -13.02 60.73 -13.04 -12.15 61.66 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -11.50 -14.47 50.76 -10.89 -12.44 50.87 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 6 3 # 6 A 169 TYR C 315 TYR~? 21.59 O8 EPE C 376 A 172 HIS C 319 HIS~? 24.70 ZN ZN C 374 A 267 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 26.78 20.44 0.03 28.51 18.26 0.09 -10.50 -13.02 60.73 -13.04 -12.15 61.66 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -11.50 -14.47 50.76 -10.89 -12.44 50.87 2tmd_c00 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 6 hits 2tmd_c00 naa= 3 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 85 TYR~? -4.05 C2 EPE A 376s B 172 HIS A 80 HIS.? 6.41 O2S EPE A 376 B 267 ASP A 82 ASP.? 8.88 O2S EPE A 376 coo 44.86 1.98 33.27 42.75 1.12 31.67 33.18 16.26 32.13 31.71 14.36 30.75 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 28.52 23.28 34.79 26.69 23.10 35.81 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 34.38 27.71 34.24 32.73 27.59 35.53 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR A 315 TYR~? 21.30 O8 EPE A 376 B 172 HIS A 319 HIS~? 24.64 ZN ZN A 374 B 267 ASP A 320 ASP~? -21.81 ZN ZN A 374s coo 44.86 1.98 33.27 42.75 1.12 31.67 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 41.01 -9.30 52.79 42.52 -8.54 54.04 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 36.60 -12.13 48.17 35.17 -11.15 49.43 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 B 169 TYR B 315 TYR~? 21.53 O8 EPE B 376 B 172 HIS B 319 HIS~? 24.73 ZN ZN B 374 B 267 ASP B 320 ASP~? -21.78 ZN ZN B 374s coo 44.86 1.98 33.27 42.75 1.12 31.67 4.11 23.72 25.55 5.20 26.22 24.94 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 8.16 23.53 21.75 7.85 25.60 21.62 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 9.35 16.65 21.02 10.22 16.89 22.90 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 B 169 TYR C 315 TYR~? 21.59 O8 EPE C 376 B 172 HIS C 319 HIS~? 24.70 ZN ZN C 374 B 267 ASP C 320 ASP~? -21.75 ZN ZN C 374s coo 44.86 1.98 33.27 42.75 1.12 31.67 -10.50 -13.02 60.73 -13.04 -12.15 61.66 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -14.81 -13.18 56.82 -15.91 -13.11 58.61 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -11.50 -14.47 50.76 -10.89 -12.44 50.87 2tmd_c01 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 4 hits 2tmd_c01 naa= 3 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 172 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 174 TYR B 315 TYR~? 21.53 O8 EPE B 376 coo 26.78 20.44 0.03 28.51 18.26 0.09 2.08 17.58 27.10 3.13 18.35 29.60 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 7.45 20.77 27.47 7.65 22.47 28.71 coo 24.73 15.69 1.93 26.72 14.32 3.31 4.11 23.72 25.55 5.20 26.22 24.94 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 315 TYR~? 21.53 O8 EPE B 376 A 172 HIS B 316 HIS~? 20.54 O8 EPE B 376 A 174 TYR B 314 TYR~? 14.73 O8 EPE B 376 coo 26.78 20.44 0.03 28.51 18.26 0.09 4.11 23.72 25.55 5.20 26.22 24.94 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 7.45 20.77 27.47 7.65 22.47 28.71 coo 24.73 15.69 1.93 26.72 14.32 3.31 2.08 17.58 27.10 3.13 18.35 29.60 2tmd_c02 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c02 naa= 3 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR B 314 TYR~? 14.73 O8 EPE B 376 B 172 HIS B 316 HIS~? 20.54 O8 EPE B 376 B 174 TYR B 315 TYR~? 21.53 O8 EPE B 376 coo 44.86 1.98 33.27 42.75 1.12 31.67 2.08 17.58 27.10 3.13 18.35 29.60 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 7.45 20.77 27.47 7.65 22.47 28.71 coo 45.95 0.11 28.25 43.87 0.82 26.55 4.11 23.72 25.55 5.20 26.22 24.94 2tmd_c03 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 1 hits 2tmd_c03 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 133 TYR^? 12.87 O3 TRS A 378 A 214 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 256 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 26.66 -12.84 21.54 25.55 -13.01 18.92 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 231 TYR^? 10.06 O1S EPE A 377 A 214 ASP B 237 ASP^? 15.58 N TRS A 378 A 256 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 11.27 -20.99 3.01 11.22 -18.21 3.38 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 11.84 -17.75 12.41 13.28 -17.47 14.02 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR A 250 TYR^? 23.04 O3 TRS A 378 A 214 ASP A 306 ASP.? 24.91 ZN ZN A 375 A 256 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 47.39 -23.45 29.84 45.28 -25.08 30.70 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 47.82 -20.71 38.37 47.81 -22.84 38.27 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR A 296 TYR~? 11.37 ZN ZN A 375 A 214 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 256 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 34.09 -11.35 35.81 31.97 -10.07 34.54 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR A 296 TYR~? 11.37 ZN ZN A 375 A 214 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 256 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 34.09 -11.35 35.81 31.97 -10.07 34.54 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR A 296 TYR~? 11.37 ZN ZN A 375 A 214 ASP A 107 ASP~? -2.33 ZN ZN A 375s A 256 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 34.09 -11.35 35.81 31.97 -10.07 34.54 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR A 296 TYR~? 11.37 ZN ZN A 375 A 214 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 256 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 34.09 -11.35 35.81 31.97 -10.07 34.54 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR A 296 TYR~? 11.37 ZN ZN A 375 A 214 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 256 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 34.09 -11.35 35.81 31.97 -10.07 34.54 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 9 3 # 9 A 122 TYR A 296 TYR~? 11.37 ZN ZN A 375 A 214 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 256 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 34.09 -11.35 35.81 31.97 -10.07 34.54 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 39.49 -1.24 39.18 39.76 0.49 37.96 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 10 3 # 10 A 122 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 214 ASP A 292 ASP^? 8.63 ZN ZN A 374 A 256 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 11 3 # 11 A 122 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 214 ASP A 312 ASP.? 7.50 ZN ZN A 374 A 256 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 39.49 -1.24 39.18 39.76 0.49 37.96 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 12 3 # 12 A 122 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 214 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 256 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 13 3 # 13 A 122 TYR A 314 TYR~? 12.17 O8 EPE A 376 A 214 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 256 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 14 3 # 14 A 122 TYR A 314 TYR~? 12.17 O8 EPE A 376 A 214 ASP A 330 ASP^? 12.08 ZN ZN A 374 A 256 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 15 3 # 15 A 122 TYR B 133 TYR^? 17.24 ZN ZN B 375 A 214 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 256 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 16 3 # 16 A 122 TYR B 231 TYR^? 16.39 O2S EPE A 377 A 214 ASP C 237 ASP^? 16.80 O1S EPE A 377 A 256 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 4.59 -25.19 21.63 5.07 -23.28 20.96 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 17 3 # 17 A 122 TYR B 296 TYR~? 11.48 ZN ZN B 375 A 214 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 256 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 3.06 5.94 19.61 2.50 3.84 21.38 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 18 3 # 18 A 122 TYR B 296 TYR~? 11.48 ZN ZN B 375 A 214 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 256 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 3.06 5.94 19.61 2.50 3.84 21.38 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 19 3 # 19 A 122 TYR B 296 TYR~? 11.48 ZN ZN B 375 A 214 ASP B 107 ASP~? -2.23 ZN ZN B 375s A 256 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 3.06 5.94 19.61 2.50 3.84 21.38 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 20 3 # 20 A 122 TYR B 296 TYR~? 11.48 ZN ZN B 375 A 214 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 256 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 3.06 5.94 19.61 2.50 3.84 21.38 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 21 3 # 21 A 122 TYR B 296 TYR~? 11.48 ZN ZN B 375 A 214 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 256 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 3.06 5.94 19.61 2.50 3.84 21.38 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 22 3 # 22 A 122 TYR B 296 TYR~? 11.48 ZN ZN B 375 A 214 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 256 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 3.06 5.94 19.61 2.50 3.84 21.38 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 23 3 # 23 A 122 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 214 ASP B 292 ASP^? 8.88 ZN ZN B 374 A 256 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 1.32 11.76 14.56 0.84 10.00 16.68 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 24 3 # 24 A 122 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 214 ASP B 312 ASP.? 7.53 ZN ZN B 374 A 256 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 1.32 11.76 14.56 0.84 10.00 16.68 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 25 3 # 25 A 122 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 214 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 256 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 1.32 11.76 14.56 0.84 10.00 16.68 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 26 3 # 26 A 122 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 214 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 256 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 1.32 11.76 14.56 0.84 10.00 16.68 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 27 3 # 27 A 122 TYR B 314 TYR~? 14.73 O8 EPE B 376 A 214 ASP B 330 ASP^? 11.92 ZN ZN B 374 A 256 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 2.08 17.58 27.10 3.13 18.35 29.60 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 28 3 # 28 A 122 TYR C 133 TYR^? 16.76 ZN ZN C 375 A 214 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 256 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 8.59 -26.93 36.99 10.82 -27.74 35.52 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 29 3 # 29 A 122 TYR C 231 TYR^? -4.25 C2 TRS A 378s A 214 ASP A 237 ASP^? 6.80 N TRS A 378 A 256 LYS C 239 LYS^? 16.29 N TRS A 378 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 23.23 -33.44 18.32 24.66 -32.16 20.35 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 18.36 -25.38 21.90 16.49 -24.92 22.81 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 30 3 # 30 A 122 TYR C 234 TYR^? 9.10 O2S EPE C 377 A 214 ASP B 237 ASP^? 15.58 N TRS A 378 A 256 LYS A 215 LYS~? 16.65 O1S EPE C 377 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 14.09 -28.86 16.23 14.98 -29.39 13.69 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 11.84 -17.75 12.41 13.28 -17.47 14.02 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 21.25 -14.20 2.18 27.53 -14.97 1.13 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 31 3 # 31 A 122 TYR C 250 TYR^? 23.68 ZN ZN C 375 A 214 ASP C 306 ASP.? 24.81 ZN ZN C 375 A 256 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 32 3 # 32 A 122 TYR C 296 TYR~? 11.54 ZN ZN C 375 A 214 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 256 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 33 3 # 33 A 122 TYR C 296 TYR~? 11.54 ZN ZN C 375 A 214 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 256 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 34 3 # 34 A 122 TYR C 296 TYR~? 11.54 ZN ZN C 375 A 214 ASP C 107 ASP~? -2.30 ZN ZN C 375s A 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 35 3 # 35 A 122 TYR C 296 TYR~? 11.54 ZN ZN C 375 A 214 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 256 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 36 3 # 36 A 122 TYR C 296 TYR~? 11.54 ZN ZN C 375 A 214 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 37 3 # 37 A 122 TYR C 296 TYR~? 11.54 ZN ZN C 375 A 214 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 38 3 # 38 A 122 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 214 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 39 3 # 39 A 122 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 214 ASP C 312 ASP.? 7.48 ZN ZN C 374 A 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 40 3 # 40 A 122 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 214 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 256 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 41 3 # 41 A 122 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 214 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 42 3 # 42 A 122 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 214 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 256 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 43 3 # 43 A 122 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 214 ASP C 292 ASP^? 8.69 ZN ZN C 374 A 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 44 3 # 44 A 122 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 214 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 256 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 45 3 # 45 A 122 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 214 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 256 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 46 3 # 46 A 122 TYR C 314 TYR~? 12.22 O8 EPE C 376 A 214 ASP C 330 ASP^? 11.91 ZN ZN C 374 A 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 5.23 -34.02 59.10 0.53 -34.86 62.24 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 46 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 133 TYR^? 12.87 O3 TRS A 378 B 214 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 256 LYS A 295 LYS.? 12.61 ZN ZN A 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 26.66 -12.84 21.54 25.55 -13.01 18.92 coo -26.88 17.61 16.89 -26.08 17.11 15.00 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -16.04 12.06 11.09 -17.97 10.54 5.71 32.96 -9.31 39.54 28.55 -6.00 37.21 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 231 TYR^? 10.06 O1S EPE A 377 B 214 ASP B 237 ASP^? 15.58 N TRS A 378 B 256 LYS A 239 LYS^? -7.47 O3 TRS A 378s coo -32.67 22.74 10.17 -32.85 23.98 7.70 11.27 -20.99 3.01 11.22 -18.21 3.38 coo -26.88 17.61 16.89 -26.08 17.11 15.00 11.84 -17.75 12.41 13.28 -17.47 14.02 coo -16.04 12.06 11.09 -17.97 10.54 5.71 24.38 -22.19 19.59 20.35 -19.68 21.34 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR A 234 TYR^? 9.43 O2S EPE A 377 B 214 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 256 LYS B 215 LYS~? 17.38 O3S EPE A 377 coo -32.67 22.74 10.17 -32.85 23.98 7.70 12.00 -25.53 12.31 10.15 -27.11 10.97 coo -26.88 17.61 16.89 -26.08 17.11 15.00 4.59 -25.19 21.63 5.07 -23.28 20.96 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -9.31 -26.31 16.29 -12.50 -24.00 11.24 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR A 250 TYR^? 23.04 O3 TRS A 378 B 214 ASP A 306 ASP.? 24.91 ZN ZN A 375 B 256 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 47.39 -23.45 29.84 45.28 -25.08 30.70 coo -26.88 17.61 16.89 -26.08 17.11 15.00 47.82 -20.71 38.37 47.81 -22.84 38.27 coo -16.04 12.06 11.09 -17.97 10.54 5.71 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR A 296 TYR~? 11.37 ZN ZN A 375 B 214 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 256 LYS A 20 LYS~? 16.95 ZN ZN A 375 coo -32.67 22.74 10.17 -32.85 23.98 7.70 34.09 -11.35 35.81 31.97 -10.07 34.54 coo -26.88 17.61 16.89 -26.08 17.11 15.00 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -16.04 12.06 11.09 -17.97 10.54 5.71 26.66 -3.22 19.04 24.73 2.41 18.30 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR A 296 TYR~? 11.37 ZN ZN A 375 B 214 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 256 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo -32.67 22.74 10.17 -32.85 23.98 7.70 34.09 -11.35 35.81 31.97 -10.07 34.54 coo -26.88 17.61 16.89 -26.08 17.11 15.00 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -16.04 12.06 11.09 -17.97 10.54 5.71 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR A 296 TYR~? 11.37 ZN ZN A 375 B 214 ASP A 107 ASP~? -2.33 ZN ZN A 375s B 256 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 34.09 -11.35 35.81 31.97 -10.07 34.54 coo -26.88 17.61 16.89 -26.08 17.11 15.00 35.27 -5.88 26.81 35.94 -4.18 27.85 coo -16.04 12.06 11.09 -17.97 10.54 5.71 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR A 296 TYR~? 11.37 ZN ZN A 375 B 214 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 256 LYS A 28 LYS.? 12.48 C7 EPE A 376 coo -32.67 22.74 10.17 -32.85 23.98 7.70 34.09 -11.35 35.81 31.97 -10.07 34.54 coo -26.88 17.61 16.89 -26.08 17.11 15.00 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -16.04 12.06 11.09 -17.97 10.54 5.71 26.87 3.56 26.76 22.81 3.70 30.35 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 9 3 # 9 B 122 TYR A 296 TYR~? 11.37 ZN ZN A 375 B 214 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 256 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 34.09 -11.35 35.81 31.97 -10.07 34.54 coo -26.88 17.61 16.89 -26.08 17.11 15.00 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -16.04 12.06 11.09 -17.97 10.54 5.71 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 10 3 # 10 B 122 TYR A 296 TYR~? 11.37 ZN ZN A 375 B 214 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 256 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 34.09 -11.35 35.81 31.97 -10.07 34.54 coo -26.88 17.61 16.89 -26.08 17.11 15.00 39.49 -1.24 39.18 39.76 0.49 37.96 coo -16.04 12.06 11.09 -17.97 10.54 5.71 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 11 3 # 11 B 122 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 214 ASP A 292 ASP^? 8.63 ZN ZN A 374 B 256 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -26.88 17.61 16.89 -26.08 17.11 15.00 36.33 -2.54 36.72 35.44 -2.95 38.63 coo -16.04 12.06 11.09 -17.97 10.54 5.71 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 12 3 # 12 B 122 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 214 ASP A 312 ASP.? 7.50 ZN ZN A 374 B 256 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -26.88 17.61 16.89 -26.08 17.11 15.00 39.49 -1.24 39.18 39.76 0.49 37.96 coo -16.04 12.06 11.09 -17.97 10.54 5.71 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 13 3 # 13 B 122 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 214 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 256 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -26.88 17.61 16.89 -26.08 17.11 15.00 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -16.04 12.06 11.09 -17.97 10.54 5.71 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 14 3 # 14 B 122 TYR A 308 TYR^? 13.26 ZN ZN A 375 B 214 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 256 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 41.62 -12.73 37.70 39.41 -11.19 36.83 coo -26.88 17.61 16.89 -26.08 17.11 15.00 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -16.04 12.06 11.09 -17.97 10.54 5.71 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 15 3 # 15 B 122 TYR A 314 TYR~? 12.17 O8 EPE A 376 B 214 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 256 LYS A 271 LYS.? 23.00 ZN ZN A 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -26.88 17.61 16.89 -26.08 17.11 15.00 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -16.04 12.06 11.09 -17.97 10.54 5.71 56.12 0.48 35.73 59.67 4.01 35.99 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 16 3 # 16 B 122 TYR A 314 TYR~? 12.17 O8 EPE A 376 B 214 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 256 LYS A 278 LYS.? 33.16 ZN ZN A 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -26.88 17.61 16.89 -26.08 17.11 15.00 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -16.04 12.06 11.09 -17.97 10.54 5.71 52.59 -15.70 47.74 53.19 -20.67 51.64 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 17 3 # 17 B 122 TYR A 314 TYR~? 12.17 O8 EPE A 376 B 214 ASP A 330 ASP^? 12.08 ZN ZN A 374 B 256 LYS A 337 LYS~? 14.02 ZN ZN A 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 36.88 -2.62 44.67 35.35 -1.67 42.53 coo -26.88 17.61 16.89 -26.08 17.11 15.00 45.96 -5.26 40.35 44.85 -3.42 39.89 coo -16.04 12.06 11.09 -17.97 10.54 5.71 45.66 0.76 26.15 51.53 0.58 28.90 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 18 3 # 18 B 122 TYR B 133 TYR^? 17.24 ZN ZN B 375 B 214 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 256 LYS B 295 LYS.? 11.37 ZN ZN B 375 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -16.04 12.06 11.09 -17.97 10.54 5.71 4.57 8.76 22.84 2.39 5.01 24.93 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 19 3 # 19 B 122 TYR B 231 TYR^? 16.39 O2S EPE A 377 B 214 ASP C 237 ASP^? 16.80 O1S EPE A 377 B 256 LYS B 239 LYS^? 16.51 O1S EPE A 377 coo -32.67 22.74 10.17 -32.85 23.98 7.70 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo -26.88 17.61 16.89 -26.08 17.11 15.00 4.59 -25.19 21.63 5.07 -23.28 20.96 coo -16.04 12.06 11.09 -17.97 10.54 5.71 5.23 -14.71 11.35 7.06 -15.38 16.25 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 20 3 # 20 B 122 TYR B 296 TYR~? 11.48 ZN ZN B 375 B 214 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 256 LYS B 20 LYS~? 17.56 ZN ZN B 375 coo -32.67 22.74 10.17 -32.85 23.98 7.70 3.06 5.94 19.61 2.50 3.84 21.38 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -8.72 -9.62 24.89 -11.95 -11.12 29.74 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 21 3 # 21 B 122 TYR B 296 TYR~? 11.48 ZN ZN B 375 B 214 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 256 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo -32.67 22.74 10.17 -32.85 23.98 7.70 3.06 5.94 19.61 2.50 3.84 21.38 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 22 3 # 22 B 122 TYR B 296 TYR~? 11.48 ZN ZN B 375 B 214 ASP B 107 ASP~? -2.23 ZN ZN B 375s B 256 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 3.06 5.94 19.61 2.50 3.84 21.38 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -6.47 1.09 20.08 -7.49 2.52 21.22 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 23 3 # 23 B 122 TYR B 296 TYR~? 11.48 ZN ZN B 375 B 214 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 256 LYS B 28 LYS.? 11.75 C7 EPE B 376 coo -32.67 22.74 10.17 -32.85 23.98 7.70 3.06 5.94 19.61 2.50 3.84 21.38 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -8.34 -2.26 32.25 -5.11 -1.56 35.94 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 24 3 # 24 B 122 TYR B 296 TYR~? 11.48 ZN ZN B 375 B 214 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 256 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 3.06 5.94 19.61 2.50 3.84 21.38 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 25 3 # 25 B 122 TYR B 296 TYR~? 11.48 ZN ZN B 375 B 214 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 256 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 3.06 5.94 19.61 2.50 3.84 21.38 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 26 3 # 26 B 122 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 214 ASP B 292 ASP^? 8.88 ZN ZN B 374 B 256 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 1.32 11.76 14.56 0.84 10.00 16.68 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -3.14 9.99 24.96 -1.24 10.75 25.71 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 27 3 # 27 B 122 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 214 ASP B 312 ASP.? 7.53 ZN ZN B 374 B 256 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 1.32 11.76 14.56 0.84 10.00 16.68 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -4.08 14.12 24.69 -6.01 13.62 25.36 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 28 3 # 28 B 122 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 214 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 256 LYS B 271 LYS.? 19.93 ZN ZN B 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 1.32 11.76 14.56 0.84 10.00 16.68 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -15.49 22.23 14.65 -19.95 19.84 13.72 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 29 3 # 29 B 122 TYR B 308 TYR^? 13.33 ZN ZN B 375 B 214 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 256 LYS B 337 LYS~? 13.35 ZN ZN B 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 1.32 11.76 14.56 0.84 10.00 16.68 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -16.19 8.44 18.66 -16.77 14.07 16.03 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 30 3 # 30 B 122 TYR B 314 TYR~? 14.73 O8 EPE B 376 B 214 ASP B 330 ASP^? 11.92 ZN ZN B 374 B 256 LYS B 278 LYS.? 31.34 ZN ZN B 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 2.08 17.58 27.10 3.13 18.35 29.60 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -4.33 18.16 18.13 -5.04 17.21 19.90 coo -16.04 12.06 11.09 -17.97 10.54 5.71 3.65 25.62 8.65 8.47 28.09 9.23 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 31 3 # 31 B 122 TYR C 133 TYR^? 16.76 ZN ZN C 375 B 214 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 256 LYS C 295 LYS.? 14.49 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 8.59 -26.93 36.99 10.82 -27.74 35.52 coo -26.88 17.61 16.89 -26.08 17.11 15.00 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -2.95 -18.00 48.43 1.84 -13.91 47.77 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 32 3 # 32 B 122 TYR C 231 TYR^? -4.25 C2 TRS A 378s B 214 ASP A 237 ASP^? 6.80 N TRS A 378 B 256 LYS C 239 LYS^? 16.29 N TRS A 378 coo -32.67 22.74 10.17 -32.85 23.98 7.70 23.23 -33.44 18.32 24.66 -32.16 20.35 coo -26.88 17.61 16.89 -26.08 17.11 15.00 18.36 -25.38 21.90 16.49 -24.92 22.81 coo -16.04 12.06 11.09 -17.97 10.54 5.71 5.15 -29.07 27.87 7.72 -24.69 27.36 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 33 3 # 33 B 122 TYR C 234 TYR^? 9.10 O2S EPE C 377 B 214 ASP B 237 ASP^? 15.58 N TRS A 378 B 256 LYS A 215 LYS~? 16.65 O1S EPE C 377 coo -32.67 22.74 10.17 -32.85 23.98 7.70 14.09 -28.86 16.23 14.98 -29.39 13.69 coo -26.88 17.61 16.89 -26.08 17.11 15.00 11.84 -17.75 12.41 13.28 -17.47 14.02 coo -16.04 12.06 11.09 -17.97 10.54 5.71 21.25 -14.20 2.18 27.53 -14.97 1.13 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 34 3 # 34 B 122 TYR C 250 TYR^? 23.68 ZN ZN C 375 B 214 ASP C 306 ASP.? 24.81 ZN ZN C 375 B 256 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -16.81 -30.01 48.18 -17.96 -30.59 46.51 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 35 3 # 35 B 122 TYR C 296 TYR~? 11.54 ZN ZN C 375 B 214 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 256 LYS C 20 LYS~? 17.53 ZN ZN C 375 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo -26.88 17.61 16.89 -26.08 17.11 15.00 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -16.04 12.06 11.09 -17.97 10.54 5.71 16.25 -27.94 42.71 21.97 -27.95 45.58 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 36 3 # 36 B 122 TYR C 296 TYR~? 11.54 ZN ZN C 375 B 214 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 256 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo -26.88 17.61 16.89 -26.08 17.11 15.00 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -16.04 12.06 11.09 -17.97 10.54 5.71 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 37 3 # 37 B 122 TYR C 296 TYR~? 11.54 ZN ZN C 375 B 214 ASP C 107 ASP~? -2.30 ZN ZN C 375s B 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo -26.88 17.61 16.89 -26.08 17.11 15.00 5.80 -28.16 48.27 6.08 -27.64 50.28 coo -16.04 12.06 11.09 -17.97 10.54 5.71 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 38 3 # 38 B 122 TYR C 296 TYR~? 11.54 ZN ZN C 375 B 214 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 256 LYS C 28 LYS.? 13.32 C7 EPE C 376 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo -26.88 17.61 16.89 -26.08 17.11 15.00 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -16.04 12.06 11.09 -17.97 10.54 5.71 15.95 -21.05 50.17 18.02 -16.90 49.10 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 39 3 # 39 B 122 TYR C 296 TYR~? 11.54 ZN ZN C 375 B 214 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo -26.88 17.61 16.89 -26.08 17.11 15.00 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -16.04 12.06 11.09 -17.97 10.54 5.71 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 40 3 # 40 B 122 TYR C 296 TYR~? 11.54 ZN ZN C 375 B 214 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -16.04 12.06 11.09 -17.97 10.54 5.71 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 41 3 # 41 B 122 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 214 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -26.88 17.61 16.89 -26.08 17.11 15.00 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -16.04 12.06 11.09 -17.97 10.54 5.71 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 42 3 # 42 B 122 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 214 ASP C 312 ASP.? 7.48 ZN ZN C 374 B 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -0.90 -20.80 57.97 0.71 -21.61 59.03 coo -16.04 12.06 11.09 -17.97 10.54 5.71 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 43 3 # 43 B 122 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 214 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 256 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 44 3 # 44 B 122 TYR C 308 TYR^? 13.34 ZN ZN C 375 B 214 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -16.04 12.06 11.09 -17.97 10.54 5.71 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 45 3 # 45 B 122 TYR C 314 TYR~? 12.22 O8 EPE C 376 B 214 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 256 LYS C 247 LYS^? 13.94 ZN ZN C 375 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo -26.88 17.61 16.89 -26.08 17.11 15.00 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -3.51 -32.04 45.03 0.24 -34.55 41.94 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 46 3 # 46 B 122 TYR C 314 TYR~? 12.22 O8 EPE C 376 B 214 ASP C 292 ASP^? 8.69 ZN ZN C 374 B 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo -26.88 17.61 16.89 -26.08 17.11 15.00 1.43 -20.86 54.35 0.32 -19.00 54.12 coo -16.04 12.06 11.09 -17.97 10.54 5.71 5.23 -34.02 59.10 0.53 -34.86 62.24 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 47 3 # 47 B 122 TYR C 314 TYR~? 12.22 O8 EPE C 376 B 214 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 256 LYS C 271 LYS.? 19.51 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -6.09 -33.65 68.04 -3.07 -37.10 68.37 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 48 3 # 48 B 122 TYR C 314 TYR~? 12.22 O8 EPE C 376 B 214 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 256 LYS C 278 LYS.? 30.91 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -21.60 -25.17 57.51 -24.75 -21.09 54.19 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 49 3 # 49 B 122 TYR C 314 TYR~? 12.22 O8 EPE C 376 B 214 ASP C 330 ASP^? 11.91 ZN ZN C 374 B 256 LYS C 337 LYS~? 12.69 ZN ZN C 374 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -3.69 -15.10 57.54 -1.00 -15.00 58.41 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -7.16 -24.94 59.28 -5.20 -24.20 59.64 coo -16.04 12.06 11.09 -17.97 10.54 5.71 5.23 -34.02 59.10 0.53 -34.86 62.24 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 49 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG B 153 ARG~? 10.73 C6 EPE A 377 A 130 SER B 168 SER^? 10.59 O3S EPE A 377 A 159 LYS B 154 LYS~? 18.23 O3S EPE A 377 coo 18.35 45.84 20.99 16.20 47.83 21.89 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo 15.14 43.67 10.77 15.61 44.43 13.04 -4.73 -25.07 0.35 -6.94 -24.95 1.40 coo 11.57 48.49 22.18 13.51 49.99 17.21 -7.89 -34.48 4.91 -13.85 -35.95 3.01 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 1 hits 2tps_c00 naa= 3 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 1 3 # 1 A 202 HIS A 333 HIS~? -3.55 ZN ZN A 374s A 295 HIS A 103 HIS~? -4.82 ZN ZN A 375s A 296 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 65.34 65.04 50.22 63.95 63.70 51.06 40.60 0.33 34.12 38.69 0.39 33.24 coo 63.46 53.34 50.98 63.08 55.39 51.17 32.91 0.46 27.63 33.66 0.11 29.56 coo 64.71 54.80 47.28 63.92 56.57 48.06 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 2 3 # 2 A 202 HIS B 333 HIS~? -3.37 ZN ZN B 374s A 295 HIS B 103 HIS~? 5.04 ZN ZN B 375 A 296 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 65.34 65.04 50.22 63.95 63.70 51.06 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 63.46 53.34 50.98 63.08 55.39 51.17 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 64.71 54.80 47.28 63.92 56.57 48.06 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 3 3 # 3 A 202 HIS C 333 HIS~? -3.37 ZN ZN C 374s A 295 HIS C 103 HIS~? 4.97 ZN ZN C 375 A 296 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 65.34 65.04 50.22 63.95 63.70 51.06 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 63.46 53.34 50.98 63.08 55.39 51.17 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 64.71 54.80 47.28 63.92 56.57 48.06 9.33 -29.64 54.17 7.95 -29.11 52.67 4kbp_c00 source 4kbp PURPLE ACID PHOSPHATASE : 3 hits 4kbp_c00 naa= 3 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 1 3 # 1 B 202 HIS A 333 HIS~? -3.55 ZN ZN A 374s B 295 HIS A 103 HIS~? -4.82 ZN ZN A 375s B 296 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 20.09 23.80 58.44 19.07 25.34 59.44 40.60 0.33 34.12 38.69 0.39 33.24 coo 19.00 35.58 58.05 18.83 33.61 58.74 32.91 0.46 27.63 33.66 0.11 29.56 coo 22.88 34.01 57.66 22.04 32.37 58.63 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 2 3 # 2 B 202 HIS B 333 HIS~? -3.37 ZN ZN B 374s B 295 HIS B 103 HIS~? 5.04 ZN ZN B 375 B 296 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 20.09 23.80 58.44 19.07 25.34 59.44 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 19.00 35.58 58.05 18.83 33.61 58.74 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 22.88 34.01 57.66 22.04 32.37 58.63 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 3 3 # 3 B 202 HIS C 333 HIS~? -3.37 ZN ZN C 374s B 295 HIS C 103 HIS~? 4.97 ZN ZN C 375 B 296 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 20.09 23.80 58.44 19.07 25.34 59.44 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 19.00 35.58 58.05 18.83 33.61 58.74 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 22.88 34.01 57.66 22.04 32.37 58.63 9.33 -29.64 54.17 7.95 -29.11 52.67 4kbp_c01 source 4kbp PURPLE ACID PHOSPHATASE : 3 hits 4kbp_c01 naa= 3 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 1 3 # 1 C 202 HIS A 333 HIS~? -3.55 ZN ZN A 374s C 295 HIS A 103 HIS~? -4.82 ZN ZN A 375s C 296 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 56.07 24.38 61.64 57.15 25.46 60.21 40.60 0.33 34.12 38.69 0.39 33.24 coo 57.19 35.56 57.82 57.34 33.47 57.88 32.91 0.46 27.63 33.66 0.11 29.56 coo 53.24 34.19 58.78 54.08 32.31 58.44 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 2 3 # 2 C 202 HIS B 333 HIS~? -3.37 ZN ZN B 374s C 295 HIS B 103 HIS~? 5.04 ZN ZN B 375 C 296 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 56.07 24.38 61.64 57.15 25.46 60.21 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 57.19 35.56 57.82 57.34 33.47 57.88 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 53.24 34.19 58.78 54.08 32.31 58.44 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 3 3 # 3 C 202 HIS C 333 HIS~? -3.37 ZN ZN C 374s C 295 HIS C 103 HIS~? 4.97 ZN ZN C 375 C 296 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 56.07 24.38 61.64 57.15 25.46 60.21 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 57.19 35.56 57.82 57.34 33.47 57.88 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 53.24 34.19 58.78 54.08 32.31 58.44 9.33 -29.64 54.17 7.95 -29.11 52.67 4kbp_c02 source 4kbp PURPLE ACID PHOSPHATASE : 3 hits 4kbp_c02 naa= 3 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 1 3 # 1 D 202 HIS A 333 HIS~? -3.55 ZN ZN A 374s D 295 HIS A 103 HIS~? -4.82 ZN ZN A 375s D 296 HIS A 68 HIS.? -3.31 ZN ZN A 375s coo 61.78 113.98 49.61 62.80 115.33 50.85 40.60 0.33 34.12 38.69 0.39 33.24 coo 63.27 125.61 50.94 63.59 123.54 51.16 32.91 0.46 27.63 33.66 0.11 29.56 coo 63.24 124.12 46.99 63.79 122.40 48.02 37.80 0.44 25.56 37.02 -1.29 26.44 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 2 3 # 2 D 202 HIS B 333 HIS~? -3.37 ZN ZN B 374s D 295 HIS B 103 HIS~? 5.04 ZN ZN B 375 D 296 HIS B 68 HIS.? -3.38 ZN ZN B 375s coo 61.78 113.98 49.61 62.80 115.33 50.85 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 63.27 125.61 50.94 63.59 123.54 51.16 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 63.24 124.12 46.99 63.79 122.40 48.02 -12.57 2.98 23.02 -10.64 2.83 22.25 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 3 3 # 3 D 202 HIS C 333 HIS~? -3.37 ZN ZN C 374s D 295 HIS C 103 HIS~? 4.97 ZN ZN C 375 D 296 HIS C 68 HIS.? -3.41 ZN ZN C 375s coo 61.78 113.98 49.61 62.80 115.33 50.85 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 63.27 125.61 50.94 63.59 123.54 51.16 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 63.24 124.12 46.99 63.79 122.40 48.02 9.33 -29.64 54.17 7.95 -29.11 52.67 4kbp_c03 source 4kbp PURPLE ACID PHOSPHATASE : 3 hits 4kbp_c03 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 203 ARG^? 8.58 O3S EPE C 377 127 ARG B 203 ARG^? 8.69 O2S EPE A 377 270 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo -1.14 25.72 1.64 0.76 28.10 1.50 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 203 ARG^? 8.58 O3S EPE C 377 127 ARG C 203 ARG^? 8.27 O3S EPE C 377 270 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo -1.14 25.72 1.64 0.76 28.10 1.50 10.96 -32.82 5.66 12.34 -31.74 8.19 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG B 198 ARG^? 21.95 C2 EPE C 377 127 ARG C 153 ARG~? 15.97 C2 EPE C 377 270 GLU B 201 GLU^? 17.83 O2S EPE A 377 coo -1.14 25.72 1.64 0.76 28.10 1.50 11.64 -52.94 14.57 14.19 -52.83 16.31 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 3.89 -44.87 12.99 4.21 -43.80 14.75 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG B 198 ARG^? 21.95 C2 EPE C 377 127 ARG C 153 ARG~? 15.97 C2 EPE C 377 270 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo -1.14 25.72 1.64 0.76 28.10 1.50 11.64 -52.94 14.57 14.19 -52.83 16.31 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 15.73 -46.74 16.59 16.35 -47.76 13.75 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 3 # 5 71 ARG B 203 ARG^? 8.69 O2S EPE A 377 127 ARG A 203 ARG^? 8.58 O3S EPE C 377 270 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo -1.14 25.72 1.64 0.76 28.10 1.50 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 6 3 # 6 71 ARG B 203 ARG^? 8.69 O2S EPE A 377 127 ARG C 203 ARG^? 8.27 O3S EPE C 377 270 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo -1.14 25.72 1.64 0.76 28.10 1.50 8.58 -36.69 10.51 9.21 -33.68 10.79 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 12.76 -38.43 -2.33 12.71 -39.82 -3.96 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 7 3 # 7 71 ARG C 153 ARG~? 15.97 C2 EPE C 377 127 ARG B 198 ARG^? 21.95 C2 EPE C 377 270 GLU B 201 GLU^? 17.83 O2S EPE A 377 coo -1.14 25.72 1.64 0.76 28.10 1.50 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 11.64 -52.94 14.57 14.19 -52.83 16.31 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 3.89 -44.87 12.99 4.21 -43.80 14.75 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 8 3 # 8 71 ARG C 153 ARG~? 15.97 C2 EPE C 377 127 ARG B 198 ARG^? 21.95 C2 EPE C 377 270 GLU C 175 GLU^? 13.76 O8 EPE C 377 coo -1.14 25.72 1.64 0.76 28.10 1.50 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 11.64 -52.94 14.57 14.19 -52.83 16.31 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 16.33 -45.08 6.01 16.53 -46.96 5.10 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 9 3 # 9 71 ARG C 203 ARG^? 8.27 O3S EPE C 377 127 ARG A 203 ARG^? 8.58 O3S EPE C 377 270 GLU B 175 GLU^? 16.09 C9 EPE A 377 coo -1.14 25.72 1.64 0.76 28.10 1.50 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 6.08 -43.60 3.61 5.68 -45.21 2.31 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 10 3 # 10 71 ARG C 203 ARG^? 8.27 O3S EPE C 377 127 ARG B 203 ARG^? 8.69 O2S EPE A 377 270 GLU A 175 GLU^? 13.72 C8 EPE A 377 coo -1.14 25.72 1.64 0.76 28.10 1.50 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 8.58 -36.69 10.51 9.21 -33.68 10.79 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 12.76 -38.43 -2.33 12.71 -39.82 -3.96 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 10 hits 5cpa_c01 naa= 3 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 1 3 # 1 83 GLN A 344 GLN~? 19.01 ZN ZN A 375 94 HIS A 42 HIS^? 26.23 ZN ZN A 375 96 HIS A 359 HIS^? 27.14 ZN ZN A 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 45.67 2.52 13.85 47.64 2.01 13.33 coo 15.69 26.32 19.80 17.39 27.17 20.68 43.48 12.60 9.22 44.86 13.19 7.76 coo 14.38 20.59 22.16 12.49 20.21 21.35 45.80 8.64 6.53 46.53 8.87 4.58 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 2 3 # 2 83 GLN A 344 GLN~? 19.01 ZN ZN A 375 94 HIS A 42 HIS^? 26.23 ZN ZN A 375 96 HIS A 361 HIS^? 22.47 ZN ZN A 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 45.67 2.52 13.85 47.64 2.01 13.33 coo 15.69 26.32 19.80 17.39 27.17 20.68 43.48 12.60 9.22 44.86 13.19 7.76 coo 14.38 20.59 22.16 12.49 20.21 21.35 46.25 9.10 12.92 46.66 10.09 11.12 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 3 3 # 3 83 GLN A 348 GLN~? 22.76 ZN ZN A 375 94 HIS A 42 HIS^? 26.23 ZN ZN A 375 96 HIS A 359 HIS^? 27.14 ZN ZN A 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 45.30 1.40 7.97 44.85 3.48 7.99 coo 15.69 26.32 19.80 17.39 27.17 20.68 43.48 12.60 9.22 44.86 13.19 7.76 coo 14.38 20.59 22.16 12.49 20.21 21.35 45.80 8.64 6.53 46.53 8.87 4.58 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 4 3 # 4 83 GLN A 348 GLN~? 22.76 ZN ZN A 375 94 HIS A 42 HIS^? 26.23 ZN ZN A 375 96 HIS A 361 HIS^? 22.47 ZN ZN A 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 45.30 1.40 7.97 44.85 3.48 7.99 coo 15.69 26.32 19.80 17.39 27.17 20.68 43.48 12.60 9.22 44.86 13.19 7.76 coo 14.38 20.59 22.16 12.49 20.21 21.35 46.25 9.10 12.92 46.66 10.09 11.12 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 5 3 # 5 83 GLN A 364 GLN.? 19.99 ZN ZN A 374 94 HIS A 42 HIS^? 26.23 ZN ZN A 375 96 HIS A 361 HIS^? 22.47 ZN ZN A 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 51.39 8.85 19.52 52.22 6.89 19.00 coo 15.69 26.32 19.80 17.39 27.17 20.68 43.48 12.60 9.22 44.86 13.19 7.76 coo 14.38 20.59 22.16 12.49 20.21 21.35 46.25 9.10 12.92 46.66 10.09 11.12 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 6 3 # 6 83 GLN A 364 GLN.? 19.99 ZN ZN A 374 94 HIS A 359 HIS^? 27.14 ZN ZN A 375 96 HIS A 361 HIS^? 22.47 ZN ZN A 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 51.39 8.85 19.52 52.22 6.89 19.00 coo 15.69 26.32 19.80 17.39 27.17 20.68 45.80 8.64 6.53 46.53 8.87 4.58 coo 14.38 20.59 22.16 12.49 20.21 21.35 46.25 9.10 12.92 46.66 10.09 11.12 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 7 3 # 7 83 GLN B 344 GLN~? 18.67 ZN ZN B 375 94 HIS B 42 HIS^? 26.13 ZN ZN B 375 96 HIS B 359 HIS^? 24.30 ZN ZN B 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 -24.61 -0.12 16.09 -25.84 1.53 15.46 coo 15.69 26.32 19.80 17.39 27.17 20.68 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 14.38 20.59 22.16 12.49 20.21 21.35 -31.70 -2.47 18.00 -31.61 -0.90 16.60 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 8 3 # 8 83 GLN B 344 GLN~? 18.67 ZN ZN B 375 94 HIS B 42 HIS^? 26.13 ZN ZN B 375 96 HIS B 361 HIS^? 22.30 ZN ZN B 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 -24.61 -0.12 16.09 -25.84 1.53 15.46 coo 15.69 26.32 19.80 17.39 27.17 20.68 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 14.38 20.59 22.16 12.49 20.21 21.35 -29.54 0.86 20.66 -31.47 0.05 20.77 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 9 3 # 9 83 GLN B 348 GLN~? 22.96 ZN ZN B 375 94 HIS B 42 HIS^? 26.13 ZN ZN B 375 96 HIS B 359 HIS^? 24.30 ZN ZN B 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 15.69 26.32 19.80 17.39 27.17 20.68 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 14.38 20.59 22.16 12.49 20.21 21.35 -31.70 -2.47 18.00 -31.61 -0.90 16.60 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 10 3 # 10 83 GLN B 348 GLN~? 22.96 ZN ZN B 375 94 HIS B 42 HIS^? 26.13 ZN ZN B 375 96 HIS B 361 HIS^? 22.30 ZN ZN B 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 -27.40 -4.91 13.95 -28.54 -5.15 15.71 coo 15.69 26.32 19.80 17.39 27.17 20.68 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 14.38 20.59 22.16 12.49 20.21 21.35 -29.54 0.86 20.66 -31.47 0.05 20.77 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 11 3 # 11 83 GLN B 364 GLN.? 19.30 ZN ZN B 374 94 HIS B 42 HIS^? 26.13 ZN ZN B 375 96 HIS B 361 HIS^? 22.30 ZN ZN B 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 -28.00 8.56 19.07 -26.98 8.34 17.19 coo 15.69 26.32 19.80 17.39 27.17 20.68 -32.72 -2.76 23.44 -34.69 -2.87 22.69 coo 14.38 20.59 22.16 12.49 20.21 21.35 -29.54 0.86 20.66 -31.47 0.05 20.77 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 12 3 # 12 83 GLN B 364 GLN.? 19.30 ZN ZN B 374 94 HIS B 359 HIS^? 24.30 ZN ZN B 375 96 HIS B 361 HIS^? 22.30 ZN ZN B 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 -28.00 8.56 19.07 -26.98 8.34 17.19 coo 15.69 26.32 19.80 17.39 27.17 20.68 -31.70 -2.47 18.00 -31.61 -0.90 16.60 coo 14.38 20.59 22.16 12.49 20.21 21.35 -29.54 0.86 20.66 -31.47 0.05 20.77 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 13 3 # 13 83 GLN C 344 GLN~? 18.56 ZN ZN C 375 94 HIS C 42 HIS^? 26.23 ZN ZN C 375 96 HIS C 359 HIS^? 24.82 ZN ZN C 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 13.15 -43.20 56.87 12.11 -43.96 58.60 coo 15.69 26.32 19.80 17.39 27.17 20.68 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 14.38 20.59 22.16 12.49 20.21 21.35 19.80 -46.87 59.86 18.04 -47.50 60.82 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 14 3 # 14 83 GLN C 344 GLN~? 18.56 ZN ZN C 375 94 HIS C 42 HIS^? 26.23 ZN ZN C 375 96 HIS C 361 HIS^? 22.27 ZN ZN C 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 13.15 -43.20 56.87 12.11 -43.96 58.60 coo 15.69 26.32 19.80 17.39 27.17 20.68 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 14.38 20.59 22.16 12.49 20.21 21.35 17.80 -42.63 61.65 19.35 -43.97 62.12 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 15 3 # 15 83 GLN C 348 GLN~? 22.89 ZN ZN C 375 94 HIS C 42 HIS^? 26.23 ZN ZN C 375 96 HIS C 359 HIS^? 24.82 ZN ZN C 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 15.69 26.32 19.80 17.39 27.17 20.68 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 14.38 20.59 22.16 12.49 20.21 21.35 19.80 -46.87 59.86 18.04 -47.50 60.82 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 16 3 # 16 83 GLN C 348 GLN~? 22.89 ZN ZN C 375 94 HIS C 42 HIS^? 26.23 ZN ZN C 375 96 HIS C 361 HIS^? 22.27 ZN ZN C 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 16.26 -47.44 53.87 17.87 -46.87 55.15 coo 15.69 26.32 19.80 17.39 27.17 20.68 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 14.38 20.59 22.16 12.49 20.21 21.35 17.80 -42.63 61.65 19.35 -43.97 62.12 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 17 3 # 17 83 GLN C 364 GLN.? 20.24 ZN ZN C 374 94 HIS C 42 HIS^? 26.23 ZN ZN C 375 96 HIS C 361 HIS^? 22.27 ZN ZN C 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 11.17 -41.20 66.53 9.78 -42.57 65.67 coo 15.69 26.32 19.80 17.39 27.17 20.68 23.45 -43.42 61.49 24.00 -45.25 62.37 coo 14.38 20.59 22.16 12.49 20.21 21.35 17.80 -42.63 61.65 19.35 -43.97 62.12 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 18 3 # 18 83 GLN C 364 GLN.? 20.24 ZN ZN C 374 94 HIS C 359 HIS^? 24.82 ZN ZN C 375 96 HIS C 361 HIS^? 22.27 ZN ZN C 375 coo 12.06 13.83 19.61 9.96 13.82 20.00 11.17 -41.20 66.53 9.78 -42.57 65.67 coo 15.69 26.32 19.80 17.39 27.17 20.68 19.80 -46.87 59.86 18.04 -47.50 60.82 coo 14.38 20.59 22.16 12.49 20.21 21.35 17.80 -42.63 61.65 19.35 -43.97 62.12 5fit_c00 source 5fit FRAGILE HISTIDINE TRIAD PROTEIN : 18 hits 5fit_c00 naa= 3 ULMN 3 5rsa_c01 RIBONUCLEASE A user 1 3 # 1 12 HIS A 68 HIS.? -3.31 ZN ZN A 375s 41 LYS A 28 LYS.? 12.48 C7 EPE A 376 119 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 28.18 18.67 11.43 28.83 17.39 9.89 37.80 0.44 25.56 37.02 -1.29 26.44 coo 25.33 8.32 6.30 27.86 13.90 7.82 26.87 3.56 26.76 22.81 3.70 30.35 coo 33.68 19.99 5.35 34.98 18.36 5.19 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 5rsa_c01 RIBONUCLEASE A user 2 3 # 2 12 HIS A 69 HIS.? -3.40 ZN ZN A 374s 41 LYS A 28 LYS.? 12.48 C7 EPE A 376 119 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 28.18 18.67 11.43 28.83 17.39 9.89 37.42 3.90 29.26 38.47 2.36 30.22 coo 25.33 8.32 6.30 27.86 13.90 7.82 26.87 3.56 26.76 22.81 3.70 30.35 coo 33.68 19.99 5.35 34.98 18.36 5.19 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 5rsa_c01 RIBONUCLEASE A user 3 3 # 3 12 HIS A 69 HIS.? -3.40 ZN ZN A 374s 41 LYS A 340 LYS~? 12.75 ZN ZN A 374 119 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 28.18 18.67 11.43 28.83 17.39 9.89 37.42 3.90 29.26 38.47 2.36 30.22 coo 25.33 8.32 6.30 27.86 13.90 7.82 44.47 1.55 20.70 47.30 5.10 24.27 coo 33.68 19.99 5.35 34.98 18.36 5.19 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 5rsa_c01 RIBONUCLEASE A user 4 3 # 4 12 HIS A 103 HIS~? -4.82 ZN ZN A 375s 41 LYS A 340 LYS~? 12.75 ZN ZN A 374 119 HIS A 333 HIS~? -3.55 ZN ZN A 374s coo 28.18 18.67 11.43 28.83 17.39 9.89 32.91 0.46 27.63 33.66 0.11 29.56 coo 25.33 8.32 6.30 27.86 13.90 7.82 44.47 1.55 20.70 47.30 5.10 24.27 coo 33.68 19.99 5.35 34.98 18.36 5.19 40.60 0.33 34.12 38.69 0.39 33.24 ULMN 3 5rsa_c01 RIBONUCLEASE A user 5 3 # 5 12 HIS A 224 HIS~? 7.33 C7 EPE A 377 41 LYS A 218 LYS~? 21.49 C3 EPE A 377 119 HIS A 148 HIS~? 11.43 C8 EPE A 377 coo 28.18 18.67 11.43 28.83 17.39 9.89 12.08 -23.60 -5.02 10.59 -24.98 -4.54 coo 25.33 8.32 6.30 27.86 13.90 7.82 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 33.68 19.99 5.35 34.98 18.36 5.19 14.41 -28.00 -10.43 13.63 -27.83 -12.37 ULMN 3 5rsa_c01 RIBONUCLEASE A user 6 3 # 6 12 HIS A 333 HIS~? -3.55 ZN ZN A 374s 41 LYS A 295 LYS.? 12.61 ZN ZN A 374 119 HIS A 103 HIS~? -4.82 ZN ZN A 375s coo 28.18 18.67 11.43 28.83 17.39 9.89 40.60 0.33 34.12 38.69 0.39 33.24 coo 25.33 8.32 6.30 27.86 13.90 7.82 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 33.68 19.99 5.35 34.98 18.36 5.19 32.91 0.46 27.63 33.66 0.11 29.56 ULMN 3 5rsa_c01 RIBONUCLEASE A user 7 3 # 7 12 HIS A 359 HIS^? 27.14 ZN ZN A 375 41 LYS A 350 LYS~? 21.83 ZN ZN A 375 119 HIS A 361 HIS^? 22.47 ZN ZN A 375 coo 28.18 18.67 11.43 28.83 17.39 9.89 45.80 8.64 6.53 46.53 8.87 4.58 coo 25.33 8.32 6.30 27.86 13.90 7.82 39.19 -2.77 6.68 35.27 -5.97 7.17 coo 33.68 19.99 5.35 34.98 18.36 5.19 46.25 9.10 12.92 46.66 10.09 11.12 ULMN 3 5rsa_c01 RIBONUCLEASE A user 8 3 # 8 12 HIS A 361 HIS^? 22.47 ZN ZN A 375 41 LYS A 340 LYS~? 12.75 ZN ZN A 374 119 HIS A 359 HIS^? 27.14 ZN ZN A 375 coo 28.18 18.67 11.43 28.83 17.39 9.89 46.25 9.10 12.92 46.66 10.09 11.12 coo 25.33 8.32 6.30 27.86 13.90 7.82 44.47 1.55 20.70 47.30 5.10 24.27 coo 33.68 19.99 5.35 34.98 18.36 5.19 45.80 8.64 6.53 46.53 8.87 4.58 ULMN 3 5rsa_c01 RIBONUCLEASE A user 9 3 # 9 12 HIS B 68 HIS.? -3.38 ZN ZN B 375s 41 LYS B 28 LYS.? 11.75 C7 EPE B 376 119 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 28.18 18.67 11.43 28.83 17.39 9.89 -12.57 2.98 23.02 -10.64 2.83 22.25 coo 25.33 8.32 6.30 27.86 13.90 7.82 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 33.68 19.99 5.35 34.98 18.36 5.19 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 5rsa_c01 RIBONUCLEASE A user 10 3 # 10 12 HIS B 69 HIS.? -3.36 ZN ZN B 374s 41 LYS B 28 LYS.? 11.75 C7 EPE B 376 119 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 28.18 18.67 11.43 28.83 17.39 9.89 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 25.33 8.32 6.30 27.86 13.90 7.82 -8.34 -2.26 32.25 -5.11 -1.56 35.94 coo 33.68 19.99 5.35 34.98 18.36 5.19 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 5rsa_c01 RIBONUCLEASE A user 11 3 # 11 12 HIS B 69 HIS.? -3.36 ZN ZN B 374s 41 LYS B 340 LYS~? 12.84 ZN ZN B 374 119 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 28.18 18.67 11.43 28.83 17.39 9.89 -12.32 6.27 26.70 -11.45 7.45 25.21 coo 25.33 8.32 6.30 27.86 13.90 7.82 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 33.68 19.99 5.35 34.98 18.36 5.19 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 5rsa_c01 RIBONUCLEASE A user 12 3 # 12 12 HIS B 103 HIS~? 5.04 ZN ZN B 375 41 LYS B 340 LYS~? 12.84 ZN ZN B 374 119 HIS B 333 HIS~? -3.37 ZN ZN B 374s coo 28.18 18.67 11.43 28.83 17.39 9.89 -8.91 1.52 26.66 -7.77 3.28 26.73 coo 25.33 8.32 6.30 27.86 13.90 7.82 -19.41 3.70 18.30 -21.14 8.87 20.36 coo 33.68 19.99 5.35 34.98 18.36 5.19 -8.75 11.09 23.63 -8.33 9.23 24.53 ULMN 3 5rsa_c01 RIBONUCLEASE A user 13 3 # 13 12 HIS B 148 HIS~? 20.83 O3S EPE A 377 41 LYS B 154 LYS~? 18.23 O3S EPE A 377 119 HIS B 224 HIS.? 17.79 O2S EPE A 377 coo 28.18 18.67 11.43 28.83 17.39 9.89 -6.64 -44.75 10.12 -7.62 -46.49 10.77 coo 25.33 8.32 6.30 27.86 13.90 7.82 -7.89 -34.48 4.91 -13.85 -35.95 3.01 coo 33.68 19.99 5.35 34.98 18.36 5.19 -4.29 -40.29 15.37 -2.45 -41.31 15.36 ULMN 3 5rsa_c01 RIBONUCLEASE A user 14 3 # 14 12 HIS B 224 HIS.? 17.79 O2S EPE A 377 41 LYS B 218 LYS~? 23.26 O3S EPE A 377 119 HIS B 148 HIS~? 20.83 O3S EPE A 377 coo 28.18 18.67 11.43 28.83 17.39 9.89 -4.29 -40.29 15.37 -2.45 -41.31 15.36 coo 25.33 8.32 6.30 27.86 13.90 7.82 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 33.68 19.99 5.35 34.98 18.36 5.19 -6.64 -44.75 10.12 -7.62 -46.49 10.77 ULMN 3 5rsa_c01 RIBONUCLEASE A user 15 3 # 15 12 HIS B 316 HIS~? 20.54 O8 EPE B 376 41 LYS B 295 LYS.? 11.37 ZN ZN B 375 119 HIS B 319 HIS~? 24.73 ZN ZN B 374 coo 28.18 18.67 11.43 28.83 17.39 9.89 7.45 20.77 27.47 7.65 22.47 28.71 coo 25.33 8.32 6.30 27.86 13.90 7.82 4.57 8.76 22.84 2.39 5.01 24.93 coo 33.68 19.99 5.35 34.98 18.36 5.19 8.16 23.53 21.75 7.85 25.60 21.62 ULMN 3 5rsa_c01 RIBONUCLEASE A user 16 3 # 16 12 HIS B 333 HIS~? -3.37 ZN ZN B 374s 41 LYS B 295 LYS.? 11.37 ZN ZN B 375 119 HIS B 103 HIS~? 5.04 ZN ZN B 375 coo 28.18 18.67 11.43 28.83 17.39 9.89 -8.75 11.09 23.63 -8.33 9.23 24.53 coo 25.33 8.32 6.30 27.86 13.90 7.82 4.57 8.76 22.84 2.39 5.01 24.93 coo 33.68 19.99 5.35 34.98 18.36 5.19 -8.91 1.52 26.66 -7.77 3.28 26.73 ULMN 3 5rsa_c01 RIBONUCLEASE A user 17 3 # 17 12 HIS C 68 HIS.? -3.41 ZN ZN C 375s 41 LYS C 28 LYS.? 13.32 C7 EPE C 376 119 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 28.18 18.67 11.43 28.83 17.39 9.89 9.33 -29.64 54.17 7.95 -29.11 52.67 coo 25.33 8.32 6.30 27.86 13.90 7.82 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 33.68 19.99 5.35 34.98 18.36 5.19 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 5rsa_c01 RIBONUCLEASE A user 18 3 # 18 12 HIS C 69 HIS.? -3.39 ZN ZN C 374s 41 LYS C 28 LYS.? 13.32 C7 EPE C 376 119 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 28.18 18.67 11.43 28.83 17.39 9.89 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 25.33 8.32 6.30 27.86 13.90 7.82 15.95 -21.05 50.17 18.02 -16.90 49.10 coo 33.68 19.99 5.35 34.98 18.36 5.19 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 5rsa_c01 RIBONUCLEASE A user 19 3 # 19 12 HIS C 69 HIS.? -3.39 ZN ZN C 374s 41 LYS C 340 LYS~? 12.92 ZN ZN C 374 119 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 28.18 18.67 11.43 28.83 17.39 9.89 9.38 -25.93 57.43 7.35 -26.43 57.48 coo 25.33 8.32 6.30 27.86 13.90 7.82 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 33.68 19.99 5.35 34.98 18.36 5.19 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 5rsa_c01 RIBONUCLEASE A user 20 3 # 20 12 HIS C 103 HIS~? 4.97 ZN ZN C 375 41 LYS C 340 LYS~? 12.92 ZN ZN C 374 119 HIS C 333 HIS~? -3.37 ZN ZN C 374s coo 28.18 18.67 11.43 28.83 17.39 9.89 10.51 -24.81 51.94 8.80 -23.79 52.62 coo 25.33 8.32 6.30 27.86 13.90 7.82 9.58 -37.42 57.24 8.41 -35.76 62.90 coo 33.68 19.99 5.35 34.98 18.36 5.19 2.70 -25.03 58.20 4.12 -24.40 56.79 ULMN 3 5rsa_c01 RIBONUCLEASE A user 21 3 # 21 12 HIS C 224 HIS~? 8.36 C3 EPE C 377 41 LYS C 218 LYS~? 12.80 O1 TRS A 378 119 HIS C 148 HIS~? 13.04 O8 EPE C 377 coo 28.18 18.67 11.43 28.83 17.39 9.89 26.69 -40.96 16.23 26.39 -40.40 14.23 coo 25.33 8.32 6.30 27.86 13.90 7.82 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 33.68 19.99 5.35 34.98 18.36 5.19 27.13 -47.60 14.36 28.94 -48.66 14.50 ULMN 3 5rsa_c01 RIBONUCLEASE A user 22 3 # 22 12 HIS C 316 HIS~? -20.42 O8 EPE C 376s 41 LYS C 295 LYS.? 14.49 ZN ZN C 374 119 HIS C 319 HIS~? 24.70 ZN ZN C 374 coo 28.18 18.67 11.43 28.83 17.39 9.89 -9.15 -10.09 56.84 -9.69 -8.65 58.28 coo 25.33 8.32 6.30 27.86 13.90 7.82 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 33.68 19.99 5.35 34.98 18.36 5.19 -14.81 -13.18 56.82 -15.91 -13.11 58.61 ULMN 3 5rsa_c01 RIBONUCLEASE A user 23 3 # 23 12 HIS C 333 HIS~? -3.37 ZN ZN C 374s 41 LYS C 295 LYS.? 14.49 ZN ZN C 374 119 HIS C 103 HIS~? 4.97 ZN ZN C 375 coo 28.18 18.67 11.43 28.83 17.39 9.89 2.70 -25.03 58.20 4.12 -24.40 56.79 coo 25.33 8.32 6.30 27.86 13.90 7.82 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 33.68 19.99 5.35 34.98 18.36 5.19 10.51 -24.81 51.94 8.80 -23.79 52.62 5rsa_c01 source 5rsa RIBONUCLEASE A : 23 hits 5rsa_c01 naa= 3 ULMN 3 7atj_c00 PEROXIDASE C1A user 1 3 # 1 A 38 ARG A 41 ARG.? 31.19 ZN ZN A 375 A 42 HIS A 42 HIS^? 26.23 ZN ZN A 375 A 70 ASN A 63 ASN.? 24.76 C2 EPE A 376 coo 1.39 6.34 11.43 0.09 6.19 8.61 42.11 12.31 4.12 44.66 13.27 2.71 coo 5.40 8.25 8.15 4.09 6.62 7.93 43.48 12.60 9.22 44.86 13.19 7.76 coo 1.54 10.80 4.23 3.44 10.57 5.15 36.61 15.52 12.09 36.23 14.54 10.24 7atj_c00 source 7atj PEROXIDASE C1A : 1 hits 7atj_c00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 6 ASN~? 28.48 ZN ZN A 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 30.24 8.98 5.52 28.99 10.31 4.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 37 ASN.? 27.11 C3 EPE A 376 coo 5.80 63.03 55.85 5.52 65.03 56.45 25.93 12.74 7.54 24.88 14.13 8.79 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 63 ASN.? 24.76 C2 EPE A 376 coo 5.80 63.03 55.85 5.52 65.03 56.45 36.61 15.52 12.09 36.23 14.54 10.24 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 74 ASN.? -4.28 C7 EPE A 376s coo 5.80 63.03 55.85 5.52 65.03 56.45 26.98 10.15 34.57 28.23 8.78 35.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 95 ASN~? 18.99 O2S EPE A 376 coo 5.80 63.03 55.85 5.52 65.03 56.45 37.50 21.37 17.07 38.56 22.79 18.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 105 ASN~? 9.65 ZN ZN A 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 30.92 -4.10 21.33 31.10 -1.93 21.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 114 ASN~? 6.65 ZN ZN A 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 39.96 -10.05 26.73 39.22 -8.78 28.27 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 125 ASN^? 21.73 O3 TRS A 378 coo 5.80 63.03 55.85 5.52 65.03 56.45 45.28 -23.75 24.72 46.53 -25.05 23.61 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN A 166 ASN.? 13.31 C3 EPE C 377 coo 5.80 63.03 55.85 5.52 65.03 56.45 36.29 -29.92 9.78 37.81 -29.21 11.04 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN A 238 ASN^? -4.13 C2 TRS A 378s coo 5.80 63.03 55.85 5.52 65.03 56.45 22.25 -25.65 17.52 21.37 -27.55 17.01 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN A 294 ASN.? 12.36 ZN ZN A 374 coo 5.80 63.03 55.85 5.52 65.03 56.45 35.77 -6.31 41.36 37.34 -5.07 42.10 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN A 298 ASN~? 20.81 ZN ZN A 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 33.43 -16.52 41.59 33.28 -16.25 43.67 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN A 327 ASN^? 23.94 ZN ZN A 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 47.65 -15.59 42.64 48.42 -17.07 43.94 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN A 334 ASN~? 9.69 ZN ZN A 374 coo 5.80 63.03 55.85 5.52 65.03 56.45 45.98 2.64 32.26 46.53 3.77 30.56 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN A 357 ASN.? 31.19 ZN ZN A 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 41.74 8.14 0.39 43.66 9.05 0.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN B 6 ASN~? 27.30 ZN ZN B 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 -27.54 -14.58 28.45 -25.88 -15.90 28.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN B 37 ASN.? 26.70 C3 EPE B 376 coo 5.80 63.03 55.85 5.52 65.03 56.45 -25.23 -15.05 33.87 -25.13 -14.38 35.90 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN B 63 ASN.? 24.52 C3 EPE B 376 coo 5.80 63.03 55.85 5.52 65.03 56.45 -29.72 -4.44 30.85 -30.01 -6.28 29.82 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN B 74 ASN.? -4.36 C8 EPE B 376s coo 5.80 63.03 55.85 5.52 65.03 56.45 -8.12 5.35 39.22 -7.06 6.68 37.98 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN B 95 ASN~? 19.50 O2S EPE B 376 coo 5.80 63.03 55.85 5.52 65.03 56.45 -30.82 1.14 36.18 -31.61 2.89 37.07 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN B 105 ASN~? 9.47 ZN ZN B 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 -8.71 -5.38 22.66 -10.29 -4.82 23.98 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN B 114 ASN~? 6.61 ZN ZN B 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 -6.09 3.05 14.26 -5.63 4.05 16.11 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN B 125 ASN^? 24.74 ZN ZN B 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 -0.95 2.05 0.48 -1.46 1.54 -1.51 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN B 166 ASN.? 12.55 O8 EPE A 377 coo 5.80 63.03 55.85 5.52 65.03 56.45 -2.65 -19.38 -5.26 -2.77 -17.28 -5.58 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 25 1 # 25 A 461 ASN B 238 ASN^? 8.84 O1S EPE A 377 coo 5.80 63.03 55.85 5.52 65.03 56.45 7.11 -18.54 9.31 8.52 -20.00 8.45 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 26 1 # 26 A 461 ASN B 294 ASN.? 12.27 ZN ZN B 374 coo 5.80 63.03 55.85 5.52 65.03 56.45 2.18 12.34 23.84 0.88 14.02 24.05 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 27 1 # 27 A 461 ASN B 298 ASN~? 20.72 ZN ZN B 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 10.01 8.80 17.91 11.11 10.10 19.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 28 1 # 28 A 461 ASN B 327 ASN^? 24.15 ZN ZN B 374 coo 5.80 63.03 55.85 5.52 65.03 56.45 3.03 18.84 10.12 4.53 19.91 9.07 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 29 1 # 29 A 461 ASN B 334 ASN~? 9.65 ZN ZN B 374 coo 5.80 63.03 55.85 5.52 65.03 56.45 -13.83 13.67 21.41 -15.89 13.09 21.50 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 30 1 # 30 A 461 ASN B 357 ASN.? 31.68 ZN ZN B 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 -34.36 -10.98 18.28 -35.73 -11.88 19.64 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 31 1 # 31 A 461 ASN C 6 ASN~? 27.23 ZN ZN C 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 31.13 -38.29 51.04 30.92 -37.68 49.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 32 1 # 32 A 461 ASN C 37 ASN.? 26.80 C3 EPE C 376 coo 5.80 63.03 55.85 5.52 65.03 56.45 33.59 -33.22 51.01 34.15 -31.40 51.99 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 33 1 # 33 A 461 ASN C 63 ASN.? 24.62 C3 EPE C 376 coo 5.80 63.03 55.85 5.52 65.03 56.45 27.42 -36.13 60.56 28.02 -37.46 59.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 34 1 # 34 A 461 ASN C 74 ASN.? -4.45 C8 EPE C 376s coo 5.80 63.03 55.85 5.52 65.03 56.45 15.47 -13.97 57.59 13.34 -13.80 57.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 35 1 # 35 A 461 ASN C 95 ASN~? 19.32 O3S EPE C 376 coo 5.80 63.03 55.85 5.52 65.03 56.45 27.60 -31.58 66.97 27.57 -31.41 69.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 36 1 # 36 A 461 ASN C 105 ASN~? 9.60 ZN ZN C 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.40 -28.97 45.42 13.67 -29.13 47.17 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 37 1 # 37 A 461 ASN C 114 ASN~? 6.62 ZN ZN C 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 0.77 -32.01 47.92 1.06 -30.12 48.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 38 1 # 38 A 461 ASN C 125 ASN^? 24.77 ZN ZN C 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 -9.33 -39.33 40.03 -9.99 -41.26 39.43 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 39 1 # 39 A 461 ASN C 166 ASN.? 27.69 ZN ZN C 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 1.70 -45.88 30.14 0.89 -45.44 32.06 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 40 1 # 40 A 461 ASN C 238 ASN^? 16.63 O2S EPE A 377 coo 5.80 63.03 55.85 5.52 65.03 56.45 5.28 -30.50 23.50 4.52 -30.81 21.55 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 41 1 # 41 A 461 ASN C 294 ASN.? 11.92 ZN ZN C 374 coo 5.80 63.03 55.85 5.52 65.03 56.45 -3.30 -17.98 52.78 -3.53 -18.25 54.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 42 1 # 42 A 461 ASN C 298 ASN~? 20.98 ZN ZN C 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 -8.94 -17.91 43.67 -9.93 -16.29 44.63 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 43 1 # 43 A 461 ASN C 327 ASN^? 24.03 ZN ZN C 374 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.01 -26.28 53.09 -18.10 -26.10 52.88 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 44 1 # 44 A 461 ASN C 334 ASN~? 9.79 ZN ZN C 374 coo 5.80 63.03 55.85 5.52 65.03 56.45 2.44 -29.45 62.54 3.79 -30.90 63.32 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 45 1 # 45 A 461 ASN C 357 ASN.? 31.03 ZN ZN C 375 coo 5.80 63.03 55.85 5.52 65.03 56.45 27.30 -48.88 54.43 27.23 -49.76 56.37 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 45 hits 1kbk_p00 naa= 1 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 1 4 # 1 A 25 ILE A 207 ILE^? -4.28 O1S EPE C 377s A 52 ASN A 63 ASN.? 24.76 C2 EPE A 376 A 53 VAL A 64 VAL^? 19.56 ZN ZN A 375 A 78 ASN A 238 ASN^? -4.13 C2 TRS A 378s coo 71.59 -7.22 17.04 71.86 -6.51 15.90 22.07 -26.01 10.74 23.10 -26.05 11.78 coo 81.20 29.47 37.49 79.47 28.44 38.24 36.61 15.52 12.09 36.23 14.54 10.24 coo 82.17 24.86 36.27 81.03 23.67 37.80 36.29 11.32 14.67 34.97 9.92 13.64 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 22.25 -25.65 17.52 21.37 -27.55 17.01 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 2 4 # 2 A 25 ILE B 207 ILE^? 4.82 O1S EPE A 377 A 52 ASN B 334 ASN~? 9.65 ZN ZN B 374 A 53 VAL B 335 VAL~? 9.42 ZN ZN B 374 A 78 ASN B 238 ASN^? 8.84 O1S EPE A 377 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 2.53 -24.15 8.19 2.79 -22.88 7.58 coo 81.20 29.47 37.49 79.47 28.44 38.24 -13.83 13.67 21.41 -15.89 13.09 21.50 coo 82.17 24.86 36.27 81.03 23.67 37.80 -12.57 11.63 17.36 -10.94 12.67 16.39 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 7.11 -18.54 9.31 8.52 -20.00 8.45 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 3 4 # 3 A 25 ILE C 207 ILE^? 15.87 N TRS A 378 A 52 ASN C 63 ASN.? 24.62 C3 EPE C 376 A 53 VAL C 64 VAL^? 19.64 ZN ZN C 375 A 78 ASN C 238 ASN^? 16.63 O2S EPE A 377 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 9.85 -35.84 22.59 8.56 -35.68 23.24 coo 81.20 29.47 37.49 79.47 28.44 38.24 27.42 -36.13 60.56 28.02 -37.46 59.02 coo 82.17 24.86 36.27 81.03 23.67 37.80 23.38 -34.73 58.03 23.80 -34.96 55.86 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 5.28 -30.50 23.50 4.52 -30.81 21.55 1qfw_p00 source 1qfw GONADOTROPIN ALPHA SUBUNIT : 3 hits 1qfw_p00 naa= 4 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 1 3 # 1 A 44 ASN B 6 ASN~? 27.30 ZN ZN B 375 A 213 PRO B 39 PRO.? 29.82 ZN ZN B 375 A 219 ASN B 357 ASN.? 31.68 ZN ZN B 375 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -27.54 -14.58 28.45 -25.88 -15.90 28.21 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -32.92 -12.87 30.34 -30.99 -11.94 29.73 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -34.36 -10.98 18.28 -35.73 -11.88 19.64 1wbf_p00 source 1wbf PROTEIN (AGGLUTININ) : 1 hits 1wbf_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 105 ASN~? 9.65 ZN ZN A 375 A 384 ASN A 125 ASN^? 21.73 O3 TRS A 378 A 385 GLU A 127 GLU^? 14.05 O3 TRS A 378 coo 22.28 63.17 110.61 22.47 65.06 111.53 30.92 -4.10 21.33 31.10 -1.93 21.21 coo 7.06 50.07 96.17 8.50 48.54 96.31 45.28 -23.75 24.72 46.53 -25.05 23.61 coo 11.59 49.83 99.41 10.92 47.97 100.16 39.39 -22.49 26.46 38.47 -23.38 24.73 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 238 ASN^? -4.13 C2 TRS A 378s A 384 ASN A 125 ASN^? 21.73 O3 TRS A 378 A 385 GLU A 127 GLU^? 14.05 O3 TRS A 378 coo 22.28 63.17 110.61 22.47 65.06 111.53 22.25 -25.65 17.52 21.37 -27.55 17.01 coo 7.06 50.07 96.17 8.50 48.54 96.31 45.28 -23.75 24.72 46.53 -25.05 23.61 coo 11.59 49.83 99.41 10.92 47.97 100.16 39.39 -22.49 26.46 38.47 -23.38 24.73 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 294 ASN.? 12.36 ZN ZN A 374 A 384 ASN A 125 ASN^? 21.73 O3 TRS A 378 A 385 GLU A 127 GLU^? 14.05 O3 TRS A 378 coo 22.28 63.17 110.61 22.47 65.06 111.53 35.77 -6.31 41.36 37.34 -5.07 42.10 coo 7.06 50.07 96.17 8.50 48.54 96.31 45.28 -23.75 24.72 46.53 -25.05 23.61 coo 11.59 49.83 99.41 10.92 47.97 100.16 39.39 -22.49 26.46 38.47 -23.38 24.73 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN A 298 ASN~? 20.81 ZN ZN A 375 A 384 ASN A 334 ASN~? 9.69 ZN ZN A 374 A 385 GLU A 336 GLU~? 2.52 ZN ZN A 375s coo 22.28 63.17 110.61 22.47 65.06 111.53 33.43 -16.52 41.59 33.28 -16.25 43.67 coo 7.06 50.07 96.17 8.50 48.54 96.31 45.98 2.64 32.26 46.53 3.77 30.56 coo 11.59 49.83 99.41 10.92 47.97 100.16 41.61 -2.34 29.43 39.56 -1.83 29.49 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN B 105 ASN~? 9.47 ZN ZN B 375 A 384 ASN B 125 ASN^? 24.74 ZN ZN B 375 A 385 GLU B 127 GLU^? 21.05 ZN ZN B 375 coo 22.28 63.17 110.61 22.47 65.06 111.53 -8.71 -5.38 22.66 -10.29 -4.82 23.98 coo 7.06 50.07 96.17 8.50 48.54 96.31 -0.95 2.05 0.48 -1.46 1.54 -1.51 coo 11.59 49.83 99.41 10.92 47.97 100.16 2.11 -0.28 5.62 1.83 -2.30 4.96 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN B 238 ASN^? 8.84 O1S EPE A 377 A 384 ASN B 125 ASN^? 24.74 ZN ZN B 375 A 385 GLU B 127 GLU^? 21.05 ZN ZN B 375 coo 22.28 63.17 110.61 22.47 65.06 111.53 7.11 -18.54 9.31 8.52 -20.00 8.45 coo 7.06 50.07 96.17 8.50 48.54 96.31 -0.95 2.05 0.48 -1.46 1.54 -1.51 coo 11.59 49.83 99.41 10.92 47.97 100.16 2.11 -0.28 5.62 1.83 -2.30 4.96 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN B 294 ASN.? 12.27 ZN ZN B 374 A 384 ASN B 125 ASN^? 24.74 ZN ZN B 375 A 385 GLU B 127 GLU^? 21.05 ZN ZN B 375 coo 22.28 63.17 110.61 22.47 65.06 111.53 2.18 12.34 23.84 0.88 14.02 24.05 coo 7.06 50.07 96.17 8.50 48.54 96.31 -0.95 2.05 0.48 -1.46 1.54 -1.51 coo 11.59 49.83 99.41 10.92 47.97 100.16 2.11 -0.28 5.62 1.83 -2.30 4.96 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN B 298 ASN~? 20.72 ZN ZN B 375 A 384 ASN B 334 ASN~? 9.65 ZN ZN B 374 A 385 GLU B 336 GLU~? 2.48 ZN ZN B 375s coo 22.28 63.17 110.61 22.47 65.06 111.53 10.01 8.80 17.91 11.11 10.10 19.21 coo 7.06 50.07 96.17 8.50 48.54 96.31 -13.83 13.67 21.41 -15.89 13.09 21.50 coo 11.59 49.83 99.41 10.92 47.97 100.16 -10.29 7.50 19.92 -9.48 6.56 21.59 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 9 3 # 9 A 270 ASN C 105 ASN~? 9.60 ZN ZN C 375 A 384 ASN C 125 ASN^? 24.77 ZN ZN C 375 A 385 GLU C 127 GLU^? 21.05 ZN ZN C 375 coo 22.28 63.17 110.61 22.47 65.06 111.53 12.40 -28.97 45.42 13.67 -29.13 47.17 coo 7.06 50.07 96.17 8.50 48.54 96.31 -9.33 -39.33 40.03 -9.99 -41.26 39.43 coo 11.59 49.83 99.41 10.92 47.97 100.16 -6.33 -33.63 38.15 -7.56 -32.26 37.10 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 10 3 # 10 A 270 ASN C 238 ASN^? 16.63 O2S EPE A 377 A 384 ASN C 125 ASN^? 24.77 ZN ZN C 375 A 385 GLU C 127 GLU^? 21.05 ZN ZN C 375 coo 22.28 63.17 110.61 22.47 65.06 111.53 5.28 -30.50 23.50 4.52 -30.81 21.55 coo 7.06 50.07 96.17 8.50 48.54 96.31 -9.33 -39.33 40.03 -9.99 -41.26 39.43 coo 11.59 49.83 99.41 10.92 47.97 100.16 -6.33 -33.63 38.15 -7.56 -32.26 37.10 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 11 3 # 11 A 270 ASN C 294 ASN.? 11.92 ZN ZN C 374 A 384 ASN C 125 ASN^? 24.77 ZN ZN C 375 A 385 GLU C 127 GLU^? 21.05 ZN ZN C 375 coo 22.28 63.17 110.61 22.47 65.06 111.53 -3.30 -17.98 52.78 -3.53 -18.25 54.87 coo 7.06 50.07 96.17 8.50 48.54 96.31 -9.33 -39.33 40.03 -9.99 -41.26 39.43 coo 11.59 49.83 99.41 10.92 47.97 100.16 -6.33 -33.63 38.15 -7.56 -32.26 37.10 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 12 3 # 12 A 270 ASN C 298 ASN~? 20.98 ZN ZN C 375 A 384 ASN C 334 ASN~? 9.79 ZN ZN C 374 A 385 GLU C 336 GLU~? 2.53 ZN ZN C 375s coo 22.28 63.17 110.61 22.47 65.06 111.53 -8.94 -17.91 43.67 -9.93 -16.29 44.63 coo 7.06 50.07 96.17 8.50 48.54 96.31 2.44 -29.45 62.54 3.79 -30.90 63.32 coo 11.59 49.83 99.41 10.92 47.97 100.16 3.38 -29.70 55.34 4.58 -28.10 54.66 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 12 hits 2v3r_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG C 203 ARG^? 8.27 O3S EPE C 377 B 6 THR C 177 THR^? 8.04 C8 EPE C 377 B 8 THR C 179 THR^? -6.46 C5 EPE C 377s coo 40.52 16.08 100.90 37.97 16.41 102.60 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 36.11 13.64 95.03 34.54 14.86 95.91 20.64 -38.60 2.16 21.28 -38.84 0.08 coo 32.72 8.05 92.39 31.25 9.11 91.35 25.65 -34.16 1.85 24.40 -33.04 0.40 1b01_d00 source 1b01 GENE REGULATION/DNA : 1 hits 1b01_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 18 TYR~? 11.08 ZN ZN A 375 I 306 VAL A 343 VAL~? 12.11 ZN ZN A 375 I 308 VAL A 338 VAL~? 10.31 ZN ZN A 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 34.99 -4.02 17.62 37.68 -4.71 17.89 coo 23.55 29.53 9.81 23.15 27.39 10.24 41.83 -1.38 16.72 39.88 -0.62 17.58 coo 16.43 30.18 9.35 15.05 30.67 11.01 46.51 -2.21 23.86 46.85 -4.02 25.09 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 100 TYR^? 14.62 ZN ZN A 375 I 306 VAL A 64 VAL^? 19.56 ZN ZN A 375 I 308 VAL A 40 VAL.? 24.93 ZN ZN A 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 31.64 5.60 17.48 30.43 3.13 17.07 coo 23.55 29.53 9.81 23.15 27.39 10.24 36.29 11.32 14.67 34.97 9.92 13.64 coo 16.43 30.18 9.35 15.05 30.67 11.01 36.27 12.20 7.20 35.72 11.24 9.08 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 133 TYR^? 12.87 O3 TRS A 378 I 306 VAL A 108 VAL~? 9.21 ZN ZN A 375 I 308 VAL A 106 VAL~? 7.00 ZN ZN A 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 26.66 -12.84 21.54 25.55 -13.01 18.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 34.04 -9.04 23.95 31.94 -9.50 24.38 coo 16.43 30.18 9.35 15.05 30.67 11.01 35.49 -4.13 22.21 36.61 -2.42 21.36 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 133 TYR^? 12.87 O3 TRS A 378 I 306 VAL A 108 VAL~? 9.21 ZN ZN A 375 I 308 VAL A 128 VAL^? 14.60 O3 TRS A 378 coo 26.18 35.24 6.87 24.33 35.18 8.97 26.66 -12.84 21.54 25.55 -13.01 18.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 34.04 -9.04 23.95 31.94 -9.50 24.38 coo 16.43 30.18 9.35 15.05 30.67 11.01 36.57 -17.31 27.04 34.80 -16.49 26.01 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 226 TYR.? 5.45 C8 EPE A 377 I 306 VAL A 144 VAL^? 7.55 C3 EPE A 377 I 308 VAL A 142 VAL^? 8.16 C2 EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 7.72 -24.64 -8.18 7.45 -27.31 -8.97 coo 23.55 29.53 9.81 23.15 27.39 10.24 11.59 -29.15 -3.80 13.61 -28.22 -3.98 coo 16.43 30.18 9.35 15.05 30.67 11.01 12.52 -26.27 1.96 13.69 -25.47 0.25 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 226 TYR.? 5.45 C8 EPE A 377 I 306 VAL A 144 VAL^? 7.55 C3 EPE A 377 I 308 VAL A 146 VAL~? 10.97 C8 EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 7.72 -24.64 -8.18 7.45 -27.31 -8.97 coo 23.55 29.53 9.81 23.15 27.39 10.24 11.59 -29.15 -3.80 13.61 -28.22 -3.98 coo 16.43 30.18 9.35 15.05 30.67 11.01 13.35 -34.07 -7.27 13.17 -36.24 -7.21 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR A 226 TYR.? 5.45 C8 EPE A 377 I 306 VAL A 144 VAL^? 7.55 C3 EPE A 377 I 308 VAL A 152 VAL~? 12.53 C3 EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 7.72 -24.64 -8.18 7.45 -27.31 -8.97 coo 23.55 29.53 9.81 23.15 27.39 10.24 11.59 -29.15 -3.80 13.61 -28.22 -3.98 coo 16.43 30.18 9.35 15.05 30.67 11.01 18.66 -25.92 -4.44 16.56 -25.68 -3.83 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR A 226 TYR.? 5.45 C8 EPE A 377 I 306 VAL A 229 VAL.? 7.51 C3 EPE A 377 I 308 VAL A 142 VAL^? 8.16 C2 EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 7.72 -24.64 -8.18 7.45 -27.31 -8.97 coo 23.55 29.53 9.81 23.15 27.39 10.24 8.44 -21.56 -2.47 10.58 -21.25 -2.78 coo 16.43 30.18 9.35 15.05 30.67 11.01 12.52 -26.27 1.96 13.69 -25.47 0.25 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR A 226 TYR.? 5.45 C8 EPE A 377 I 306 VAL A 229 VAL.? 7.51 C3 EPE A 377 I 308 VAL A 221 VAL~? 12.55 C3 EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 7.72 -24.64 -8.18 7.45 -27.31 -8.97 coo 23.55 29.53 9.81 23.15 27.39 10.24 8.44 -21.56 -2.47 10.58 -21.25 -2.78 coo 16.43 30.18 9.35 15.05 30.67 11.01 14.44 -18.94 -3.55 12.92 -17.63 -2.74 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR A 231 TYR^? 10.06 O1S EPE A 377 I 306 VAL A 140 VAL^? 8.90 O1S EPE C 377 I 308 VAL A 216 VAL~? 11.74 O1S EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 23.55 29.53 9.81 23.15 27.39 10.24 15.83 -24.08 7.28 16.34 -22.37 5.99 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.56 -17.95 2.37 21.08 -19.60 3.74 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR A 231 TYR^? 10.06 O1S EPE A 377 I 306 VAL A 142 VAL^? 8.16 C2 EPE A 377 I 308 VAL A 144 VAL^? 7.55 C3 EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.52 -26.27 1.96 13.69 -25.47 0.25 coo 16.43 30.18 9.35 15.05 30.67 11.01 11.59 -29.15 -3.80 13.61 -28.22 -3.98 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR A 231 TYR^? 10.06 O1S EPE A 377 I 306 VAL A 142 VAL^? 8.16 C2 EPE A 377 I 308 VAL A 152 VAL~? 12.53 C3 EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.52 -26.27 1.96 13.69 -25.47 0.25 coo 16.43 30.18 9.35 15.05 30.67 11.01 18.66 -25.92 -4.44 16.56 -25.68 -3.83 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR A 231 TYR^? 10.06 O1S EPE A 377 I 306 VAL A 221 VAL~? 12.55 C3 EPE A 377 I 308 VAL A 152 VAL~? 12.53 C3 EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.44 -18.94 -3.55 12.92 -17.63 -2.74 coo 16.43 30.18 9.35 15.05 30.67 11.01 18.66 -25.92 -4.44 16.56 -25.68 -3.83 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR A 231 TYR^? 10.06 O1S EPE A 377 I 306 VAL A 221 VAL~? 12.55 C3 EPE A 377 I 308 VAL A 216 VAL~? 11.74 O1S EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.44 -18.94 -3.55 12.92 -17.63 -2.74 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.56 -17.95 2.37 21.08 -19.60 3.74 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR A 231 TYR^? 10.06 O1S EPE A 377 I 306 VAL A 229 VAL.? 7.51 C3 EPE A 377 I 308 VAL A 144 VAL^? 7.55 C3 EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 23.55 29.53 9.81 23.15 27.39 10.24 8.44 -21.56 -2.47 10.58 -21.25 -2.78 coo 16.43 30.18 9.35 15.05 30.67 11.01 11.59 -29.15 -3.80 13.61 -28.22 -3.98 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR A 234 TYR^? 9.43 O2S EPE A 377 I 306 VAL A 140 VAL^? 8.90 O1S EPE C 377 I 308 VAL A 142 VAL^? 8.16 C2 EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 23.55 29.53 9.81 23.15 27.39 10.24 15.83 -24.08 7.28 16.34 -22.37 5.99 coo 16.43 30.18 9.35 15.05 30.67 11.01 12.52 -26.27 1.96 13.69 -25.47 0.25 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR A 234 TYR^? 9.43 O2S EPE A 377 I 306 VAL A 233 VAL^? 11.84 O1S EPE A 377 I 308 VAL A 142 VAL^? 8.16 C2 EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 12.00 -25.53 12.31 10.15 -27.11 10.97 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.65 -21.47 9.47 13.76 -19.72 8.97 coo 16.43 30.18 9.35 15.05 30.67 11.01 12.52 -26.27 1.96 13.69 -25.47 0.25 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR A 250 TYR^? 23.04 O3 TRS A 378 I 306 VAL A 286 VAL^? 18.04 ZN ZN A 375 I 308 VAL A 283 VAL^? 24.05 ZN ZN A 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 23.55 29.53 9.81 23.15 27.39 10.24 46.33 -17.37 33.74 47.98 -15.99 33.42 coo 16.43 30.18 9.35 15.05 30.67 11.01 51.81 -20.25 38.35 51.17 -18.13 38.40 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR A 250 TYR^? 23.04 O3 TRS A 378 I 306 VAL A 286 VAL^? 18.04 ZN ZN A 375 I 308 VAL A 288 VAL^? 11.42 ZN ZN A 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 23.55 29.53 9.81 23.15 27.39 10.24 46.33 -17.37 33.74 47.98 -15.99 33.42 coo 16.43 30.18 9.35 15.05 30.67 11.01 43.05 -11.94 32.21 44.10 -11.19 30.38 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR A 308 TYR^? 13.26 ZN ZN A 375 I 306 VAL A 286 VAL^? 18.04 ZN ZN A 375 I 308 VAL A 283 VAL^? 24.05 ZN ZN A 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 23.55 29.53 9.81 23.15 27.39 10.24 46.33 -17.37 33.74 47.98 -15.99 33.42 coo 16.43 30.18 9.35 15.05 30.67 11.01 51.81 -20.25 38.35 51.17 -18.13 38.40 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 21 3 # 21 I 303 TYR A 308 TYR^? 13.26 ZN ZN A 375 I 306 VAL A 307 VAL^? 19.34 ZN ZN A 375 I 308 VAL A 276 VAL^? 20.58 ZN ZN A 374 coo 26.18 35.24 6.87 24.33 35.18 8.97 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 23.55 29.53 9.81 23.15 27.39 10.24 46.44 -16.28 38.69 48.29 -15.22 38.04 coo 16.43 30.18 9.35 15.05 30.67 11.01 47.74 -10.69 45.84 45.65 -10.33 46.28 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 22 3 # 22 I 303 TYR A 308 TYR^? 13.26 ZN ZN A 375 I 306 VAL A 307 VAL^? 19.34 ZN ZN A 375 I 308 VAL A 283 VAL^? 24.05 ZN ZN A 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 23.55 29.53 9.81 23.15 27.39 10.24 46.44 -16.28 38.69 48.29 -15.22 38.04 coo 16.43 30.18 9.35 15.05 30.67 11.01 51.81 -20.25 38.35 51.17 -18.13 38.40 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 23 3 # 23 I 303 TYR A 308 TYR^? 13.26 ZN ZN A 375 I 306 VAL A 329 VAL^? 17.09 ZN ZN A 374 I 308 VAL A 264 VAL~? 17.06 ZN ZN A 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 23.55 29.53 9.81 23.15 27.39 10.24 48.33 -9.29 39.53 50.17 -9.83 38.53 coo 16.43 30.18 9.35 15.05 30.67 11.01 53.11 -8.79 33.29 51.21 -9.10 34.32 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 24 3 # 24 I 303 TYR A 308 TYR^? 13.26 ZN ZN A 375 I 306 VAL A 329 VAL^? 17.09 ZN ZN A 374 I 308 VAL A 276 VAL^? 20.58 ZN ZN A 374 coo 26.18 35.24 6.87 24.33 35.18 8.97 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 23.55 29.53 9.81 23.15 27.39 10.24 48.33 -9.29 39.53 50.17 -9.83 38.53 coo 16.43 30.18 9.35 15.05 30.67 11.01 47.74 -10.69 45.84 45.65 -10.33 46.28 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 25 3 # 25 I 303 TYR B 100 TYR^? 14.57 ZN ZN B 375 I 306 VAL B 64 VAL^? 19.63 ZN ZN B 375 I 308 VAL B 40 VAL.? 24.68 ZN ZN B 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 -17.63 -5.70 28.19 -15.74 -7.29 26.85 coo 23.55 29.53 9.81 23.15 27.39 10.24 -25.30 -3.75 28.70 -24.30 -5.66 28.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 -30.18 -8.81 26.90 -28.09 -8.07 27.08 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 26 3 # 26 I 303 TYR B 133 TYR^? 17.24 ZN ZN B 375 I 306 VAL B 108 VAL~? 9.11 ZN ZN B 375 I 308 VAL B 106 VAL~? 6.75 ZN ZN B 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo 23.55 29.53 9.81 23.15 27.39 10.24 -5.25 -2.64 18.06 -3.55 -3.49 19.20 coo 16.43 30.18 9.35 15.05 30.67 11.01 -10.40 -1.85 20.05 -12.49 -1.20 20.20 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 27 3 # 27 I 303 TYR B 133 TYR^? 17.24 ZN ZN B 375 I 306 VAL B 108 VAL~? 9.11 ZN ZN B 375 I 308 VAL B 128 VAL^? 14.57 ZN ZN B 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 -0.70 -9.54 18.25 -1.85 -12.04 17.66 coo 23.55 29.53 9.81 23.15 27.39 10.24 -5.25 -2.64 18.06 -3.55 -3.49 19.20 coo 16.43 30.18 9.35 15.05 30.67 11.01 0.39 -0.46 11.26 0.17 -2.24 12.58 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 28 3 # 28 I 303 TYR B 226 TYR.? 21.63 O2S EPE A 377 I 306 VAL B 144 VAL^? 15.20 O2S EPE A 377 I 308 VAL B 142 VAL^? 11.88 O2S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.18 -44.73 18.44 0.01 -45.92 17.08 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.31 -41.74 12.04 -1.99 -40.63 11.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.69 -35.93 13.75 -0.47 -36.17 13.24 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 29 3 # 29 I 303 TYR B 226 TYR.? 21.63 O2S EPE A 377 I 306 VAL B 144 VAL^? 15.20 O2S EPE A 377 I 308 VAL B 146 VAL.? 18.11 O2S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.18 -44.73 18.44 0.01 -45.92 17.08 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.31 -41.74 12.04 -1.99 -40.63 11.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 -0.12 -45.90 7.27 1.37 -46.90 6.00 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 30 3 # 30 I 303 TYR B 226 TYR.? 21.63 O2S EPE A 377 I 306 VAL B 144 VAL^? 15.20 O2S EPE A 377 I 308 VAL B 152 VAL~? 13.46 O3S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.18 -44.73 18.44 0.01 -45.92 17.08 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.31 -41.74 12.04 -1.99 -40.63 11.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.73 -37.45 8.95 -4.57 -37.92 10.75 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 31 3 # 31 I 303 TYR B 226 TYR.? 21.63 O2S EPE A 377 I 306 VAL B 144 VAL^? 15.20 O2S EPE A 377 I 308 VAL B 202 VAL^? 13.09 O2S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.18 -44.73 18.44 0.01 -45.92 17.08 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.31 -41.74 12.04 -1.99 -40.63 11.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 3.82 -41.64 8.59 2.58 -41.50 6.80 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 32 3 # 32 I 303 TYR B 226 TYR.? 21.63 O2S EPE A 377 I 306 VAL B 229 VAL.? 18.54 O2S EPE A 377 I 308 VAL B 142 VAL^? 11.88 O2S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.18 -44.73 18.44 0.01 -45.92 17.08 coo 23.55 29.53 9.81 23.15 27.39 10.24 -1.81 -39.25 19.78 -2.91 -38.22 18.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.69 -35.93 13.75 -0.47 -36.17 13.24 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 33 3 # 33 I 303 TYR B 226 TYR.? 21.63 O2S EPE A 377 I 306 VAL B 229 VAL.? 18.54 O2S EPE A 377 I 308 VAL B 221 VAL~? 18.74 O3S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.18 -44.73 18.44 0.01 -45.92 17.08 coo 23.55 29.53 9.81 23.15 27.39 10.24 -1.81 -39.25 19.78 -2.91 -38.22 18.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 -6.89 -36.18 17.46 -6.27 -35.67 19.54 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 34 3 # 34 I 303 TYR B 231 TYR^? 16.39 O2S EPE A 377 I 306 VAL B 142 VAL^? 11.88 O2S EPE A 377 I 308 VAL B 144 VAL^? 15.20 O2S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 23.55 29.53 9.81 23.15 27.39 10.24 1.69 -35.93 13.75 -0.47 -36.17 13.24 coo 16.43 30.18 9.35 15.05 30.67 11.01 -0.31 -41.74 12.04 -1.99 -40.63 11.18 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 35 3 # 35 I 303 TYR B 231 TYR^? 16.39 O2S EPE A 377 I 306 VAL B 142 VAL^? 11.88 O2S EPE A 377 I 308 VAL B 152 VAL~? 13.46 O3S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 23.55 29.53 9.81 23.15 27.39 10.24 1.69 -35.93 13.75 -0.47 -36.17 13.24 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.73 -37.45 8.95 -4.57 -37.92 10.75 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 36 3 # 36 I 303 TYR B 231 TYR^? 16.39 O2S EPE A 377 I 306 VAL B 221 VAL~? 18.74 O3S EPE A 377 I 308 VAL B 152 VAL~? 13.46 O3S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 23.55 29.53 9.81 23.15 27.39 10.24 -6.89 -36.18 17.46 -6.27 -35.67 19.54 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.73 -37.45 8.95 -4.57 -37.92 10.75 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 37 3 # 37 I 303 TYR B 231 TYR^? 16.39 O2S EPE A 377 I 306 VAL B 221 VAL~? 18.74 O3S EPE A 377 I 308 VAL B 216 VAL~? 12.75 O3S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 23.55 29.53 9.81 23.15 27.39 10.24 -6.89 -36.18 17.46 -6.27 -35.67 19.54 coo 16.43 30.18 9.35 15.05 30.67 11.01 -6.83 -28.22 14.05 -5.28 -27.59 12.58 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 38 3 # 38 I 303 TYR B 231 TYR^? 16.39 O2S EPE A 377 I 306 VAL B 229 VAL.? 18.54 O2S EPE A 377 I 308 VAL B 144 VAL^? 15.20 O2S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 0.21 -33.87 18.84 -0.97 -32.67 21.03 coo 23.55 29.53 9.81 23.15 27.39 10.24 -1.81 -39.25 19.78 -2.91 -38.22 18.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 -0.31 -41.74 12.04 -1.99 -40.63 11.18 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 39 3 # 39 I 303 TYR B 234 TYR^? 11.34 O2S EPE A 377 I 306 VAL B 140 VAL^? 9.56 O2S EPE A 377 I 308 VAL B 142 VAL^? 11.88 O2S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 23.55 29.53 9.81 23.15 27.39 10.24 2.40 -29.34 13.57 0.33 -29.29 14.30 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.69 -35.93 13.75 -0.47 -36.17 13.24 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 40 3 # 40 I 303 TYR B 234 TYR^? 11.34 O2S EPE A 377 I 306 VAL B 233 VAL^? 13.35 O2S EPE A 377 I 308 VAL B 142 VAL^? 11.88 O2S EPE A 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 8.50 -28.26 15.53 9.64 -30.80 15.55 coo 23.55 29.53 9.81 23.15 27.39 10.24 4.19 -28.47 18.01 2.32 -27.56 18.53 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.69 -35.93 13.75 -0.47 -36.17 13.24 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 41 3 # 41 I 303 TYR B 250 TYR^? 23.22 ZN ZN B 375 I 306 VAL B 286 VAL^? 18.11 ZN ZN B 375 I 308 VAL B 283 VAL^? 24.18 ZN ZN B 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 0.70 6.87 1.10 3.12 5.62 1.69 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.28 10.71 7.05 -2.27 11.65 6.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.54 16.78 3.04 0.28 17.56 4.75 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 42 3 # 42 I 303 TYR B 250 TYR^? 23.22 ZN ZN B 375 I 306 VAL B 286 VAL^? 18.11 ZN ZN B 375 I 308 VAL B 288 VAL^? 11.46 ZN ZN B 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 0.70 6.87 1.10 3.12 5.62 1.69 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.28 10.71 7.05 -2.27 11.65 6.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -3.11 8.72 12.69 -5.08 8.23 11.99 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 43 3 # 43 I 303 TYR B 308 TYR^? 13.33 ZN ZN B 375 I 306 VAL B 286 VAL^? 18.11 ZN ZN B 375 I 308 VAL B 283 VAL^? 24.18 ZN ZN B 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 1.32 11.76 14.56 0.84 10.00 16.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.28 10.71 7.05 -2.27 11.65 6.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.54 16.78 3.04 0.28 17.56 4.75 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 44 3 # 44 I 303 TYR B 308 TYR^? 13.33 ZN ZN B 375 I 306 VAL B 307 VAL^? 19.39 ZN ZN B 375 I 308 VAL B 283 VAL^? 24.18 ZN ZN B 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 1.32 11.76 14.56 0.84 10.00 16.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 1.76 14.81 9.29 -0.23 15.57 8.69 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.54 16.78 3.04 0.28 17.56 4.75 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 45 3 # 45 I 303 TYR B 308 TYR^? 13.33 ZN ZN B 375 I 306 VAL B 329 VAL^? 17.03 ZN ZN B 374 I 308 VAL B 264 VAL~? 17.12 ZN ZN B 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 1.32 11.76 14.56 0.84 10.00 16.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 -3.22 18.08 13.56 -4.48 18.53 11.85 coo 16.43 30.18 9.35 15.05 30.67 11.01 -9.61 16.51 9.16 -7.89 16.02 10.42 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 46 3 # 46 I 303 TYR B 308 TYR^? 13.33 ZN ZN B 375 I 306 VAL B 329 VAL^? 17.03 ZN ZN B 374 I 308 VAL B 276 VAL^? 20.62 ZN ZN B 374 coo 26.18 35.24 6.87 24.33 35.18 8.97 1.32 11.76 14.56 0.84 10.00 16.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 -3.22 18.08 13.56 -4.48 18.53 11.85 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.67 22.27 14.69 2.71 21.36 16.39 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 47 3 # 47 I 303 TYR C 100 TYR^? 14.49 ZN ZN C 375 I 306 VAL C 64 VAL^? 19.64 ZN ZN C 375 I 308 VAL C 40 VAL.? 24.73 ZN ZN C 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.27 -30.73 51.89 19.47 -30.85 49.23 coo 23.55 29.53 9.81 23.15 27.39 10.24 23.38 -34.73 58.03 23.80 -34.96 55.86 coo 16.43 30.18 9.35 15.05 30.67 11.01 27.94 -40.28 56.43 26.59 -38.66 55.75 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 48 3 # 48 I 303 TYR C 133 TYR^? 16.76 ZN ZN C 375 I 306 VAL C 108 VAL~? 9.16 ZN ZN C 375 I 308 VAL C 106 VAL~? 6.93 ZN ZN C 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 23.55 29.53 9.81 23.15 27.39 10.24 5.99 -29.69 44.17 6.72 -28.03 42.88 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.38 -31.44 48.18 10.35 -32.52 49.88 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 49 3 # 49 I 303 TYR C 133 TYR^? 16.76 ZN ZN C 375 I 306 VAL C 108 VAL~? 9.16 ZN ZN C 375 I 308 VAL C 128 VAL^? 14.35 ZN ZN C 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 8.59 -26.93 36.99 10.82 -27.74 35.52 coo 23.55 29.53 9.81 23.15 27.39 10.24 5.99 -29.69 44.17 6.72 -28.03 42.88 coo 16.43 30.18 9.35 15.05 30.67 11.01 -2.00 -30.83 40.65 0.02 -30.12 40.01 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 50 3 # 50 I 303 TYR C 226 TYR.? 6.49 C7 EPE C 377 I 306 VAL C 144 VAL^? 8.51 C2 EPE C 377 I 308 VAL C 142 VAL^? 8.28 C2 EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 30.28 -40.41 12.42 29.70 -41.48 9.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 23.32 -41.84 12.07 23.04 -42.73 14.12 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.31 -37.06 15.27 21.29 -38.59 16.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 51 3 # 51 I 303 TYR C 226 TYR.? 6.49 C7 EPE C 377 I 306 VAL C 144 VAL^? 8.51 C2 EPE C 377 I 308 VAL C 146 VAL~? 11.46 O8 EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 30.28 -40.41 12.42 29.70 -41.48 9.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 23.32 -41.84 12.07 23.04 -42.73 14.12 coo 16.43 30.18 9.35 15.05 30.67 11.01 22.05 -47.47 9.33 20.56 -48.11 7.77 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 52 3 # 52 I 303 TYR C 226 TYR.? 6.49 C7 EPE C 377 I 306 VAL C 144 VAL^? 8.51 C2 EPE C 377 I 308 VAL C 152 VAL~? 13.37 C2 EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 30.28 -40.41 12.42 29.70 -41.48 9.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 23.32 -41.84 12.07 23.04 -42.73 14.12 coo 16.43 30.18 9.35 15.05 30.67 11.01 21.74 -45.12 18.90 22.67 -43.42 17.85 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 53 3 # 53 I 303 TYR C 226 TYR.? 6.49 C7 EPE C 377 I 306 VAL C 144 VAL^? 8.51 C2 EPE C 377 I 308 VAL C 202 VAL^? 10.27 C2 EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 30.28 -40.41 12.42 29.70 -41.48 9.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 23.32 -41.84 12.07 23.04 -42.73 14.12 coo 16.43 30.18 9.35 15.05 30.67 11.01 18.93 -42.23 9.15 18.29 -44.18 9.93 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 54 3 # 54 I 303 TYR C 226 TYR.? 6.49 C7 EPE C 377 I 306 VAL C 229 VAL.? 7.56 C3 EPE C 377 I 308 VAL C 142 VAL^? 8.28 C2 EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 30.28 -40.41 12.42 29.70 -41.48 9.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 28.28 -35.77 15.53 27.47 -37.37 16.83 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.31 -37.06 15.27 21.29 -38.59 16.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 55 3 # 55 I 303 TYR C 226 TYR.? 6.49 C7 EPE C 377 I 306 VAL C 229 VAL.? 7.56 C3 EPE C 377 I 308 VAL C 221 VAL~? 10.31 O2 TRS A 378 coo 26.18 35.24 6.87 24.33 35.18 8.97 30.28 -40.41 12.42 29.70 -41.48 9.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 28.28 -35.77 15.53 27.47 -37.37 16.83 coo 16.43 30.18 9.35 15.05 30.67 11.01 27.39 -39.31 21.28 28.50 -37.43 21.42 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 56 3 # 56 I 303 TYR C 231 TYR^? -4.25 C2 TRS A 378s I 306 VAL C 142 VAL^? 8.28 C2 EPE C 377 I 308 VAL C 144 VAL^? 8.51 C2 EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.31 -37.06 15.27 21.29 -38.59 16.57 coo 16.43 30.18 9.35 15.05 30.67 11.01 23.32 -41.84 12.07 23.04 -42.73 14.12 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 57 3 # 57 I 303 TYR C 231 TYR^? -4.25 C2 TRS A 378s I 306 VAL C 142 VAL^? 8.28 C2 EPE C 377 I 308 VAL C 152 VAL~? 13.37 C2 EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.31 -37.06 15.27 21.29 -38.59 16.57 coo 16.43 30.18 9.35 15.05 30.67 11.01 21.74 -45.12 18.90 22.67 -43.42 17.85 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 58 3 # 58 I 303 TYR C 231 TYR^? -4.25 C2 TRS A 378s I 306 VAL C 221 VAL~? 10.31 O2 TRS A 378 I 308 VAL C 152 VAL~? 13.37 C2 EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 23.55 29.53 9.81 23.15 27.39 10.24 27.39 -39.31 21.28 28.50 -37.43 21.42 coo 16.43 30.18 9.35 15.05 30.67 11.01 21.74 -45.12 18.90 22.67 -43.42 17.85 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 59 3 # 59 I 303 TYR C 231 TYR^? -4.25 C2 TRS A 378s I 306 VAL C 221 VAL~? 10.31 O2 TRS A 378 I 308 VAL C 216 VAL~? 11.24 O1 TRS A 378 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 23.55 29.53 9.81 23.15 27.39 10.24 27.39 -39.31 21.28 28.50 -37.43 21.42 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.82 -37.99 26.73 18.68 -38.12 26.18 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 60 3 # 60 I 303 TYR C 231 TYR^? -4.25 C2 TRS A 378s I 306 VAL C 229 VAL.? 7.56 C3 EPE C 377 I 308 VAL C 144 VAL^? 8.51 C2 EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.23 -33.44 18.32 24.66 -32.16 20.35 coo 23.55 29.53 9.81 23.15 27.39 10.24 28.28 -35.77 15.53 27.47 -37.37 16.83 coo 16.43 30.18 9.35 15.05 30.67 11.01 23.32 -41.84 12.07 23.04 -42.73 14.12 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 61 3 # 61 I 303 TYR C 234 TYR^? 9.10 O2S EPE C 377 I 306 VAL C 140 VAL^? 8.97 N TRS A 378 I 308 VAL C 142 VAL^? 8.28 C2 EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 23.55 29.53 9.81 23.15 27.39 10.24 16.48 -34.14 19.50 17.98 -34.81 20.89 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.31 -37.06 15.27 21.29 -38.59 16.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 62 3 # 62 I 303 TYR C 234 TYR^? 9.10 O2S EPE C 377 I 306 VAL C 233 VAL^? 5.14 N TRS A 378 I 308 VAL C 142 VAL^? 8.28 C2 EPE C 377 coo 26.18 35.24 6.87 24.33 35.18 8.97 14.09 -28.86 16.23 14.98 -29.39 13.69 coo 23.55 29.53 9.81 23.15 27.39 10.24 17.83 -29.66 19.44 18.57 -29.94 21.47 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.31 -37.06 15.27 21.29 -38.59 16.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 63 3 # 63 I 303 TYR C 250 TYR^? 23.68 ZN ZN C 375 I 306 VAL C 286 VAL^? 18.11 ZN ZN C 375 I 308 VAL C 283 VAL^? 24.17 ZN ZN C 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 23.55 29.53 9.81 23.15 27.39 10.24 -11.20 -32.24 48.22 -10.98 -33.34 50.12 coo 16.43 30.18 9.35 15.05 30.67 11.01 -18.34 -32.67 50.40 -17.17 -32.05 52.16 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 64 3 # 64 I 303 TYR C 250 TYR^? 23.68 ZN ZN C 375 I 306 VAL C 286 VAL^? 18.11 ZN ZN C 375 I 308 VAL C 288 VAL^? 11.43 ZN ZN C 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 23.55 29.53 9.81 23.15 27.39 10.24 -11.20 -32.24 48.22 -10.98 -33.34 50.12 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.15 -30.28 49.94 -4.23 -32.15 50.68 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 65 3 # 65 I 303 TYR C 250 TYR^? 23.68 ZN ZN C 375 I 306 VAL C 286 VAL^? 18.11 ZN ZN C 375 I 308 VAL C 307 VAL^? 19.37 ZN ZN C 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 23.55 29.53 9.81 23.15 27.39 10.24 -11.20 -32.24 48.22 -10.98 -33.34 50.12 coo 16.43 30.18 9.35 15.05 30.67 11.01 -13.56 -28.36 50.80 -13.18 -29.95 52.27 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 66 3 # 66 I 303 TYR C 308 TYR^? 13.34 ZN ZN C 375 I 306 VAL C 286 VAL^? 18.11 ZN ZN C 375 I 308 VAL C 283 VAL^? 24.17 ZN ZN C 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 -11.20 -32.24 48.22 -10.98 -33.34 50.12 coo 16.43 30.18 9.35 15.05 30.67 11.01 -18.34 -32.67 50.40 -17.17 -32.05 52.16 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 67 3 # 67 I 303 TYR C 308 TYR^? 13.34 ZN ZN C 375 I 306 VAL C 307 VAL^? 19.37 ZN ZN C 375 I 308 VAL C 276 VAL^? 20.51 ZN ZN C 374 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 -13.56 -28.36 50.80 -13.18 -29.95 52.27 coo 16.43 30.18 9.35 15.05 30.67 11.01 -14.81 -22.90 57.79 -13.74 -21.16 57.03 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 68 3 # 68 I 303 TYR C 308 TYR^? 13.34 ZN ZN C 375 I 306 VAL C 307 VAL^? 19.37 ZN ZN C 375 I 308 VAL C 283 VAL^? 24.17 ZN ZN C 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 -13.56 -28.36 50.80 -13.18 -29.95 52.27 coo 16.43 30.18 9.35 15.05 30.67 11.01 -18.34 -32.67 50.40 -17.17 -32.05 52.16 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 69 3 # 69 I 303 TYR C 308 TYR^? 13.34 ZN ZN C 375 I 306 VAL C 329 VAL^? 17.04 ZN ZN C 374 I 308 VAL C 264 VAL~? 17.06 ZN ZN C 375 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 -10.48 -27.66 57.23 -11.17 -29.63 57.69 coo 16.43 30.18 9.35 15.05 30.67 11.01 -8.92 -35.27 58.51 -8.62 -33.33 57.61 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 70 3 # 70 I 303 TYR C 308 TYR^? 13.34 ZN ZN C 375 I 306 VAL C 329 VAL^? 17.04 ZN ZN C 374 I 308 VAL C 276 VAL^? 20.51 ZN ZN C 374 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 -10.48 -27.66 57.23 -11.17 -29.63 57.69 coo 16.43 30.18 9.35 15.05 30.67 11.01 -14.81 -22.90 57.79 -13.74 -21.16 57.03 1cqt_d00 source 1cqt GENE REGULATION/DNA : 70 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO B 209 PRO^? 11.43 O1S EPE A 377 A 272 LEU B 212 LEU~? 13.91 O3S EPE A 377 A 276 ARG B 214 ARG~? 23.93 O3S EPE A 377 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -2.80 -19.50 10.65 -1.44 -20.50 12.15 coo 10.97 0.43 16.73 11.31 2.11 18.06 -5.99 -22.60 13.08 -7.30 -21.84 11.49 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -7.68 -23.63 22.44 -8.04 -24.96 25.17 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO C 182 PRO^? 9.82 C7 EPE C 377 A 272 LEU C 196 LEU.? 10.42 C5 EPE C 377 A 276 ARG C 198 ARG^? 10.55 C8 EPE C 377 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 35.38 -33.62 2.53 34.53 -31.81 3.53 coo 10.97 0.43 16.73 11.31 2.11 18.06 29.88 -32.25 -3.31 27.71 -32.07 -2.89 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 24.16 -38.26 -3.08 24.91 -35.49 -4.23 1emh_d00 source 1emh HYDROLASE/DNA : 2 hits 1emh_d00 naa= 3 ULMN 4 1hbx_d00 GENE REGULATION user 1 4 # 1 D 140 THR C 179 THR^? -6.46 C5 EPE C 377s D 143 ARG C 203 ARG^? 8.27 O3S EPE C 377 D 158 TYR A 231 TYR^? 10.06 O1S EPE A 377 D 163 LYS A 139 LYS^? -2.64 O3S EPE C 377s coo 59.11 133.43 75.29 57.02 133.64 74.76 25.65 -34.16 1.85 24.40 -33.04 0.40 coo 52.93 123.10 78.03 50.59 121.17 78.38 15.41 -35.90 9.66 13.77 -33.95 11.43 coo 39.29 134.52 82.26 37.39 135.28 80.34 11.27 -20.99 3.01 11.22 -18.21 3.38 coo 42.67 127.66 76.73 46.82 129.80 74.10 17.05 -24.82 10.77 19.64 -29.66 10.35 1hbx_d00 source 1hbx GENE REGULATION : 1 hits 1hbx_d00 naa= 4 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 153 ARG~? 11.00 C6 EPE C 377 C 71 LYS A 154 LYS~? 18.09 O1S EPE C 377 C 72 VAL A 152 VAL~? 12.53 C3 EPE A 377 coo 23.89 33.54 29.21 26.59 34.86 28.68 20.83 -31.38 -1.20 19.50 -33.43 -3.04 coo 25.82 26.89 29.68 23.33 22.98 25.84 24.03 -26.17 -4.04 26.99 -24.22 -8.52 coo 28.86 29.08 30.37 28.04 31.02 29.93 18.66 -25.92 -4.44 16.56 -25.68 -3.83 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG A 284 ARG^? 28.58 ZN ZN A 375 C 71 LYS A 282 LYS^? 34.08 ZN ZN A 375 C 72 VAL A 283 VAL^? 24.05 ZN ZN A 375 coo 23.89 33.54 29.21 26.59 34.86 28.68 52.06 -24.03 32.92 53.49 -25.85 30.90 coo 25.82 26.89 29.68 23.33 22.98 25.84 53.78 -21.68 41.24 59.13 -25.09 41.65 coo 28.86 29.08 30.37 28.04 31.02 29.93 51.81 -20.25 38.35 51.17 -18.13 38.40 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG B 153 ARG~? 10.73 C6 EPE A 377 C 71 LYS B 154 LYS~? 18.23 O3S EPE A 377 C 72 VAL B 152 VAL~? 13.46 O3S EPE A 377 coo 23.89 33.54 29.21 26.59 34.86 28.68 -1.46 -36.52 4.12 -1.19 -38.78 2.09 coo 25.82 26.89 29.68 23.33 22.98 25.84 -7.89 -34.48 4.91 -13.85 -35.95 3.01 coo 28.86 29.08 30.37 28.04 31.02 29.93 -5.73 -37.45 8.95 -4.57 -37.92 10.75 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 4 3 # 4 C 70 ARG B 284 ARG^? 30.04 ZN ZN B 375 C 71 LYS B 282 LYS^? 32.80 ZN ZN B 375 C 72 VAL B 283 VAL^? 24.18 ZN ZN B 375 coo 23.89 33.54 29.21 26.59 34.86 28.68 1.85 12.86 -2.25 0.88 12.89 -5.16 coo 25.82 26.89 29.68 23.33 22.98 25.84 2.91 20.00 1.64 2.74 22.03 -3.14 coo 28.86 29.08 30.37 28.04 31.02 29.93 1.54 16.78 3.04 0.28 17.56 4.75 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 5 3 # 5 C 70 ARG C 153 ARG~? 15.97 C2 EPE C 377 C 71 LYS C 154 LYS~? 23.94 C1 TRS A 378 C 72 VAL C 152 VAL~? 13.37 C2 EPE C 377 coo 23.89 33.54 29.21 26.59 34.86 28.68 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 25.82 26.89 29.68 23.33 22.98 25.84 18.67 -47.92 22.36 20.33 -51.69 25.99 coo 28.86 29.08 30.37 28.04 31.02 29.93 21.74 -45.12 18.90 22.67 -43.42 17.85 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 6 3 # 6 C 70 ARG C 284 ARG^? 27.80 ZN ZN C 375 C 71 LYS C 282 LYS^? 31.82 ZN ZN C 375 C 72 VAL C 283 VAL^? 24.17 ZN ZN C 375 coo 23.89 33.54 29.21 26.59 34.86 28.68 -17.70 -37.64 45.94 -17.45 -40.51 44.86 coo 25.82 26.89 29.68 23.33 22.98 25.84 -21.96 -32.19 51.48 -24.68 -36.28 53.46 coo 28.86 29.08 30.37 28.04 31.02 29.93 -18.34 -32.67 50.40 -17.17 -32.05 52.16 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 7 3 # 7 C 70 ARG C 284 ARG^? 27.80 ZN ZN C 375 C 71 LYS C 285 LYS^? 22.29 ZN ZN C 375 C 72 VAL C 286 VAL^? 18.11 ZN ZN C 375 coo 23.89 33.54 29.21 26.59 34.86 28.68 -17.70 -37.64 45.94 -17.45 -40.51 44.86 coo 25.82 26.89 29.68 23.33 22.98 25.84 -14.01 -33.36 45.98 -12.46 -31.50 40.58 coo 28.86 29.08 30.37 28.04 31.02 29.93 -11.20 -32.24 48.22 -10.98 -33.34 50.12 1hwt_d00 source 1hwt GENE REGULATION/DNA : 7 hits 1hwt_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 284 ARG^? 28.58 ZN ZN A 375 E 41 TYR A 250 TYR^? 23.04 O3 TRS A 378 E 83 ARG B 198 ARG^? 21.95 C2 EPE C 377 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 52.06 -24.03 32.92 53.49 -25.85 30.90 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 47.39 -23.45 29.84 45.28 -25.08 30.70 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 11.64 -52.94 14.57 14.19 -52.83 16.31 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG C 284 ARG^? 27.80 ZN ZN C 375 E 41 TYR C 250 TYR^? 23.68 ZN ZN C 375 E 83 ARG A 198 ARG^? 11.16 C6 EPE A 377 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -17.70 -37.64 45.94 -17.45 -40.51 44.86 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -13.28 -36.84 42.94 -13.77 -34.96 40.91 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -1.05 -38.83 -3.85 -3.04 -38.62 -1.48 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 2 hits 1id3_d00 naa= 3 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 1 4 # 1 G 5 LYS A 337 LYS~? 14.02 ZN ZN A 374 G 13 LYS A 110 LYS.? 16.46 O3 TRS A 378 G 42 ARG A 284 ARG^? 28.58 ZN ZN A 375 G 77 ARG C 203 ARG^? 8.27 O3S EPE C 377 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 45.66 0.76 26.15 51.53 0.58 28.90 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 37.52 -11.39 18.62 36.00 -16.08 14.56 coo 39.46 58.80 1.48 39.21 55.92 0.43 52.06 -24.03 32.92 53.49 -25.85 30.90 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 15.41 -35.90 9.66 13.77 -33.95 11.43 1kx5_d03 source 1kx5 STRUCTURAL PROTEIN/DNA : 1 hits 1kx5_d03 naa= 4 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 1 3 # 1 A 40 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 41 LYS A 94 LYS~? 16.25 O2S EPE A 376 A 42 ILE A 93 ILE~? 15.37 O2S EPE A 376 coo 36.07 63.73 124.22 32.72 60.75 122.39 36.23 21.81 22.32 41.86 22.67 23.70 coo 38.49 66.12 125.64 35.69 66.71 131.25 33.79 23.90 18.72 34.24 28.62 22.89 coo 41.08 63.27 123.17 40.13 62.43 122.44 30.85 21.40 20.79 29.56 20.89 20.34 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 2 3 # 2 A 40 LYS A 94 LYS~? 16.25 O2S EPE A 376 A 41 LYS A 91 LYS~? 15.85 O2S EPE A 376 A 42 ILE A 93 ILE~? 15.37 O2S EPE A 376 coo 36.07 63.73 124.22 32.72 60.75 122.39 33.79 23.90 18.72 34.24 28.62 22.89 coo 38.49 66.12 125.64 35.69 66.71 131.25 36.23 21.81 22.32 41.86 22.67 23.70 coo 41.08 63.27 123.17 40.13 62.43 122.44 30.85 21.40 20.79 29.56 20.89 20.34 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 3 3 # 3 A 40 LYS A 138 LYS^? 13.11 N TRS A 378 A 41 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 42 ILE A 207 ILE^? -4.28 O1S EPE C 377s coo 36.07 63.73 124.22 32.72 60.75 122.39 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 38.49 66.12 125.64 35.69 66.71 131.25 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 41.08 63.27 123.17 40.13 62.43 122.44 22.07 -26.01 10.74 23.10 -26.05 11.78 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 4 3 # 4 A 40 LYS A 138 LYS^? 13.11 N TRS A 378 A 41 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 42 ILE A 208 ILE^? 8.75 O1S EPE C 377 coo 36.07 63.73 124.22 32.72 60.75 122.39 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 38.49 66.12 125.64 35.69 66.71 131.25 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 41.08 63.27 123.17 40.13 62.43 122.44 21.33 -20.76 8.47 20.15 -20.38 7.77 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 5 3 # 5 A 40 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 41 LYS A 138 LYS^? 13.11 N TRS A 378 A 42 ILE A 207 ILE^? -4.28 O1S EPE C 377s coo 36.07 63.73 124.22 32.72 60.75 122.39 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 38.49 66.12 125.64 35.69 66.71 131.25 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 41.08 63.27 123.17 40.13 62.43 122.44 22.07 -26.01 10.74 23.10 -26.05 11.78 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 6 3 # 6 A 40 LYS A 139 LYS^? -2.64 O3S EPE C 377s A 41 LYS A 138 LYS^? 13.11 N TRS A 378 A 42 ILE A 208 ILE^? 8.75 O1S EPE C 377 coo 36.07 63.73 124.22 32.72 60.75 122.39 17.05 -24.82 10.77 19.64 -29.66 10.35 coo 38.49 66.12 125.64 35.69 66.71 131.25 18.11 -21.79 12.78 16.12 -17.81 15.44 coo 41.08 63.27 123.17 40.13 62.43 122.44 21.33 -20.76 8.47 20.15 -20.38 7.77 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 7 3 # 7 A 40 LYS A 215 LYS~? 16.65 O1S EPE C 377 A 41 LYS A 218 LYS~? 21.49 C3 EPE A 377 A 42 ILE A 217 ILE~? 14.44 O1S EPE A 377 coo 36.07 63.73 124.22 32.72 60.75 122.39 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 38.49 66.12 125.64 35.69 66.71 131.25 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 41.08 63.27 123.17 40.13 62.43 122.44 15.72 -16.98 2.77 14.88 -18.16 3.10 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 8 3 # 8 A 40 LYS A 218 LYS~? 21.49 C3 EPE A 377 A 41 LYS A 215 LYS~? 16.65 O1S EPE C 377 A 42 ILE A 217 ILE~? 14.44 O1S EPE A 377 coo 36.07 63.73 124.22 32.72 60.75 122.39 17.38 -15.22 -1.06 17.49 -9.91 -3.23 coo 38.49 66.12 125.64 35.69 66.71 131.25 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 41.08 63.27 123.17 40.13 62.43 122.44 15.72 -16.98 2.77 14.88 -18.16 3.10 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 9 3 # 9 A 40 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 41 LYS B 94 LYS~? 17.44 O2S EPE B 376 A 42 ILE B 93 ILE~? 15.68 O2S EPE B 376 coo 36.07 63.73 124.22 32.72 60.75 122.39 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 38.49 66.12 125.64 35.69 66.71 131.25 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 41.08 63.27 123.17 40.13 62.43 122.44 -25.22 -0.49 41.32 -24.50 -1.78 41.64 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 10 3 # 10 A 40 LYS B 94 LYS~? 17.44 O2S EPE B 376 A 41 LYS B 91 LYS~? 15.73 O3S EPE B 376 A 42 ILE B 93 ILE~? 15.68 O2S EPE B 376 coo 36.07 63.73 124.22 32.72 60.75 122.39 -29.53 0.46 40.71 -30.43 3.58 45.55 coo 38.49 66.12 125.64 35.69 66.71 131.25 -26.96 4.56 38.63 -29.49 9.20 36.26 coo 41.08 63.27 123.17 40.13 62.43 122.44 -25.22 -0.49 41.32 -24.50 -1.78 41.64 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 11 3 # 11 A 40 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 41 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 42 ILE B 207 ILE^? 4.82 O1S EPE A 377 coo 36.07 63.73 124.22 32.72 60.75 122.39 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 38.49 66.12 125.64 35.69 66.71 131.25 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 41.08 63.27 123.17 40.13 62.43 122.44 2.53 -24.15 8.19 2.79 -22.88 7.58 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 12 3 # 12 A 40 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 41 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 42 ILE B 208 ILE^? 10.23 O1S EPE A 377 coo 36.07 63.73 124.22 32.72 60.75 122.39 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 38.49 66.12 125.64 35.69 66.71 131.25 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 41.08 63.27 123.17 40.13 62.43 122.44 -1.70 -24.29 12.20 -1.92 -25.33 13.04 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 13 3 # 13 A 40 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 41 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 42 ILE B 207 ILE^? 4.82 O1S EPE A 377 coo 36.07 63.73 124.22 32.72 60.75 122.39 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 38.49 66.12 125.64 35.69 66.71 131.25 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 41.08 63.27 123.17 40.13 62.43 122.44 2.53 -24.15 8.19 2.79 -22.88 7.58 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 14 3 # 14 A 40 LYS B 139 LYS^? -2.84 O2S EPE A 377s A 41 LYS B 138 LYS^? 15.17 O1S EPE A 377 A 42 ILE B 208 ILE^? 10.23 O1S EPE A 377 coo 36.07 63.73 124.22 32.72 60.75 122.39 4.48 -26.42 12.36 5.89 -27.34 7.19 coo 38.49 66.12 125.64 35.69 66.71 131.25 3.52 -23.27 14.19 3.97 -21.31 18.72 coo 41.08 63.27 123.17 40.13 62.43 122.44 -1.70 -24.29 12.20 -1.92 -25.33 13.04 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 15 3 # 15 A 40 LYS B 215 LYS~? 17.38 O3S EPE A 377 A 41 LYS B 218 LYS~? 23.26 O3S EPE A 377 A 42 ILE B 217 ILE~? 16.43 O3S EPE A 377 coo 36.07 63.73 124.22 32.72 60.75 122.39 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 38.49 66.12 125.64 35.69 66.71 131.25 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 41.08 63.27 123.17 40.13 62.43 122.44 -4.71 -29.77 18.11 -4.22 -29.62 19.49 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 16 3 # 16 A 40 LYS B 218 LYS~? 23.26 O3S EPE A 377 A 41 LYS B 215 LYS~? 17.38 O3S EPE A 377 A 42 ILE B 217 ILE~? 16.43 O3S EPE A 377 coo 36.07 63.73 124.22 32.72 60.75 122.39 -9.21 -31.38 17.78 -12.41 -28.97 21.74 coo 38.49 66.12 125.64 35.69 66.71 131.25 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 41.08 63.27 123.17 40.13 62.43 122.44 -4.71 -29.77 18.11 -4.22 -29.62 19.49 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 17 3 # 17 A 40 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 41 LYS C 94 LYS~? 16.71 O3S EPE C 376 A 42 ILE C 93 ILE~? 15.43 O3S EPE C 376 coo 36.07 63.73 124.22 32.72 60.75 122.39 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 38.49 66.12 125.64 35.69 66.71 131.25 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 41.08 63.27 123.17 40.13 62.43 122.44 28.76 -24.81 63.85 29.48 -23.73 63.05 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 18 3 # 18 A 40 LYS C 94 LYS~? 16.71 O3S EPE C 376 A 41 LYS C 91 LYS~? 15.57 O3S EPE C 376 A 42 ILE C 93 ILE~? 15.43 O3S EPE C 376 coo 36.07 63.73 124.22 32.72 60.75 122.39 30.11 -27.61 67.14 30.55 -24.06 72.29 coo 38.49 66.12 125.64 35.69 66.71 131.25 24.97 -26.94 68.30 21.78 -29.04 72.70 coo 41.08 63.27 123.17 40.13 62.43 122.44 28.76 -24.81 63.85 29.48 -23.73 63.05 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 19 3 # 19 A 40 LYS C 138 LYS^? 8.30 N TRS A 378 A 41 LYS C 139 LYS^? 16.11 N TRS A 378 A 42 ILE C 207 ILE^? 15.87 N TRS A 378 coo 36.07 63.73 124.22 32.72 60.75 122.39 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 38.49 66.12 125.64 35.69 66.71 131.25 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 41.08 63.27 123.17 40.13 62.43 122.44 9.85 -35.84 22.59 8.56 -35.68 23.24 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 20 3 # 20 A 40 LYS C 138 LYS^? 8.30 N TRS A 378 A 41 LYS C 139 LYS^? 16.11 N TRS A 378 A 42 ILE C 208 ILE^? 11.16 O1 TRS A 378 coo 36.07 63.73 124.22 32.72 60.75 122.39 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 38.49 66.12 125.64 35.69 66.71 131.25 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 41.08 63.27 123.17 40.13 62.43 122.44 14.70 -34.97 25.78 15.99 -34.85 25.27 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 21 3 # 21 A 40 LYS C 139 LYS^? 16.11 N TRS A 378 A 41 LYS C 138 LYS^? 8.30 N TRS A 378 A 42 ILE C 207 ILE^? 15.87 N TRS A 378 coo 36.07 63.73 124.22 32.72 60.75 122.39 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 38.49 66.12 125.64 35.69 66.71 131.25 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 41.08 63.27 123.17 40.13 62.43 122.44 9.85 -35.84 22.59 8.56 -35.68 23.24 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 22 3 # 22 A 40 LYS C 139 LYS^? 16.11 N TRS A 378 A 41 LYS C 138 LYS^? 8.30 N TRS A 378 A 42 ILE C 208 ILE^? 11.16 O1 TRS A 378 coo 36.07 63.73 124.22 32.72 60.75 122.39 13.08 -32.56 20.05 9.65 -36.55 18.68 coo 38.49 66.12 125.64 35.69 66.71 131.25 12.95 -30.51 23.19 15.44 -26.53 25.46 coo 41.08 63.27 123.17 40.13 62.43 122.44 14.70 -34.97 25.78 15.99 -34.85 25.27 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 23 3 # 23 A 40 LYS C 215 LYS~? 17.39 O1 TRS A 378 A 41 LYS C 218 LYS~? 12.80 O1 TRS A 378 A 42 ILE C 217 ILE~? 6.28 C1 TRS A 378 coo 36.07 63.73 124.22 32.72 60.75 122.39 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 38.49 66.12 125.64 35.69 66.71 131.25 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 41.08 63.27 123.17 40.13 62.43 122.44 23.52 -34.57 24.36 23.07 -34.24 23.11 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 24 3 # 24 A 40 LYS C 218 LYS~? 12.80 O1 TRS A 378 A 41 LYS C 215 LYS~? 17.39 O1 TRS A 378 A 42 ILE C 217 ILE~? 6.28 C1 TRS A 378 coo 36.07 63.73 124.22 32.72 60.75 122.39 26.24 -37.78 26.13 29.59 -36.75 30.95 coo 38.49 66.12 125.64 35.69 66.71 131.25 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 41.08 63.27 123.17 40.13 62.43 122.44 23.52 -34.57 24.36 23.07 -34.24 23.11 1pyi_d00 source 1pyi PROTEIN (PYRIMIDINE PATHWAY REGULATOR 1) : 24 hits 1pyi_d00 naa= 3 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS A 282 LYS^? 34.08 ZN ZN A 375 A 564 VAL A 283 VAL^? 24.05 ZN ZN A 375 A 568 ARG A 284 ARG^? 28.58 ZN ZN A 375 coo -6.60 80.79 55.64 -8.55 79.48 61.01 53.78 -21.68 41.24 59.13 -25.09 41.65 coo -9.25 78.14 55.31 -11.11 77.94 56.39 51.81 -20.25 38.35 51.17 -18.13 38.40 coo -12.31 74.86 52.32 -13.99 74.91 54.92 52.06 -24.03 32.92 53.49 -25.85 30.90 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 563 LYS B 282 LYS^? 32.80 ZN ZN B 375 A 564 VAL B 283 VAL^? 24.18 ZN ZN B 375 A 568 ARG B 284 ARG^? 30.04 ZN ZN B 375 coo -6.60 80.79 55.64 -8.55 79.48 61.01 2.91 20.00 1.64 2.74 22.03 -3.14 coo -9.25 78.14 55.31 -11.11 77.94 56.39 1.54 16.78 3.04 0.28 17.56 4.75 coo -12.31 74.86 52.32 -13.99 74.91 54.92 1.85 12.86 -2.25 0.88 12.89 -5.16 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 563 LYS C 282 LYS^? 31.82 ZN ZN C 375 A 564 VAL C 283 VAL^? 24.17 ZN ZN C 375 A 568 ARG C 284 ARG^? 27.80 ZN ZN C 375 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -21.96 -32.19 51.48 -24.68 -36.28 53.46 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -18.34 -32.67 50.40 -17.17 -32.05 52.16 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -17.70 -37.64 45.94 -17.45 -40.51 44.86 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 3 hits 1r4i_d00 naa= 3 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS B 38 LYS.? 21.80 C3 EPE B 376 A1294 ASN B 6 ASN~? 27.30 ZN ZN B 375 A1297 GLU B 9 GLU~? 28.41 ZN ZN B 375 coo 39.24 18.84-161.99 36.62 21.47-165.99 -28.97 -12.32 32.11 -27.27 -6.31 33.15 coo 33.53 17.37-161.81 34.31 17.81-163.76 -27.54 -14.58 28.45 -25.88 -15.90 28.21 coo 29.78 23.31-161.30 31.23 23.66-162.84 -25.03 -16.61 24.42 -27.11 -17.15 24.13 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 1 hits 1xpx_d00 naa= 3 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 1 4 # 1 D 41 HIS A 8 HIS~? 24.55 ZN ZN A 375 D 67 LYS B 301 LYS~? 25.03 ZN ZN B 375 D 69 ILE B 248 ILE^? 17.17 ZN ZN B 375 D 70 VAL B 286 VAL^? 18.11 ZN ZN B 375 coo 33.21 28.24 12.68 34.93 27.24 13.36 26.75 7.68 8.85 25.49 8.72 10.18 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 8.36 10.35 11.75 10.05 14.82 9.04 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 1.53 5.19 8.85 2.92 5.26 8.57 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 -0.28 10.71 7.05 -2.27 11.65 6.87 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 2 4 # 2 D 41 HIS A 8 HIS~? 24.55 ZN ZN A 375 D 67 LYS B 303 LYS~? 19.29 ZN ZN B 375 D 69 ILE B 248 ILE^? 17.17 ZN ZN B 375 D 70 VAL B 128 VAL^? 14.57 ZN ZN B 375 coo 33.21 28.24 12.68 34.93 27.24 13.36 26.75 7.68 8.85 25.49 8.72 10.18 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 7.99 5.97 9.05 6.92 1.04 11.01 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 1.53 5.19 8.85 2.92 5.26 8.57 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 0.39 -0.46 11.26 0.17 -2.24 12.58 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 3 4 # 3 D 41 HIS A 8 HIS~? 24.55 ZN ZN A 375 D 67 LYS B 303 LYS~? 19.29 ZN ZN B 375 D 69 ILE B 248 ILE^? 17.17 ZN ZN B 375 D 70 VAL B 286 VAL^? 18.11 ZN ZN B 375 coo 33.21 28.24 12.68 34.93 27.24 13.36 26.75 7.68 8.85 25.49 8.72 10.18 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 7.99 5.97 9.05 6.92 1.04 11.01 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 1.53 5.19 8.85 2.92 5.26 8.57 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 -0.28 10.71 7.05 -2.27 11.65 6.87 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 4 4 # 4 D 41 HIS A 316 HIS~? 20.33 O8 EPE A 376 D 67 LYS A 301 LYS~? 24.94 ZN ZN A 375 D 69 ILE A 248 ILE^? 17.37 ZN ZN A 375 D 70 VAL A 286 VAL^? 18.04 ZN ZN A 375 coo 33.21 28.24 12.68 34.93 27.24 13.36 36.36 -5.20 52.06 36.55 -4.24 53.92 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 40.92 -18.65 31.37 40.47 -19.69 32.14 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 46.33 -17.37 33.74 47.98 -15.99 33.42 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 5 4 # 5 D 41 HIS B 8 HIS~? 24.51 ZN ZN B 375 D 67 LYS C 301 LYS~? 24.63 ZN ZN C 375 D 69 ILE C 248 ILE^? 17.32 ZN ZN C 375 D 70 VAL C 286 VAL^? 18.11 ZN ZN C 375 coo 33.21 28.24 12.68 34.93 27.24 13.36 -21.73 -14.76 29.99 -21.14 -14.36 31.97 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 -7.82 -30.82 43.49 -8.77 -30.10 42.68 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 -11.20 -32.24 48.22 -10.98 -33.34 50.12 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 6 4 # 6 D 41 HIS B 8 HIS~? 24.51 ZN ZN B 375 D 67 LYS C 303 LYS~? 17.98 ZN ZN C 375 D 69 ILE C 248 ILE^? 17.32 ZN ZN C 375 D 70 VAL C 286 VAL^? 18.11 ZN ZN C 375 coo 33.21 28.24 12.68 34.93 27.24 13.36 -21.73 -14.76 29.99 -21.14 -14.36 31.97 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 -11.06 -26.43 40.09 -5.81 -27.52 38.93 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 -7.82 -30.82 43.49 -8.77 -30.10 42.68 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 -11.20 -32.24 48.22 -10.98 -33.34 50.12 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 7 4 # 7 D 41 HIS B 316 HIS~? 20.54 O8 EPE B 376 D 67 LYS B 301 LYS~? 25.03 ZN ZN B 375 D 69 ILE B 248 ILE^? 17.17 ZN ZN B 375 D 70 VAL B 286 VAL^? 18.11 ZN ZN B 375 coo 33.21 28.24 12.68 34.93 27.24 13.36 7.45 20.77 27.47 7.65 22.47 28.71 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 8.36 10.35 11.75 10.05 14.82 9.04 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 1.53 5.19 8.85 2.92 5.26 8.57 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 -0.28 10.71 7.05 -2.27 11.65 6.87 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 8 4 # 8 D 41 HIS C 8 HIS~? 24.89 ZN ZN C 375 D 67 LYS A 301 LYS~? 24.94 ZN ZN A 375 D 69 ILE A 248 ILE^? 17.37 ZN ZN A 375 D 70 VAL A 286 VAL^? 18.04 ZN ZN A 375 coo 33.21 28.24 12.68 34.93 27.24 13.36 29.42 -33.76 48.01 30.25 -31.91 48.55 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 40.92 -18.65 31.37 40.47 -19.69 32.14 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 46.33 -17.37 33.74 47.98 -15.99 33.42 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 9 4 # 9 D 41 HIS C 8 HIS~? 24.89 ZN ZN C 375 D 67 LYS A 303 LYS~? 13.81 O3 TRS A 378 D 69 ILE A 248 ILE^? 17.37 ZN ZN A 375 D 70 VAL A 128 VAL^? 14.60 O3 TRS A 378 coo 33.21 28.24 12.68 34.93 27.24 13.36 29.42 -33.76 48.01 30.25 -31.91 48.55 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 40.92 -18.65 31.37 40.47 -19.69 32.14 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 36.57 -17.31 27.04 34.80 -16.49 26.01 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 10 4 # 10 D 41 HIS C 8 HIS~? 24.89 ZN ZN C 375 D 67 LYS A 303 LYS~? 13.81 O3 TRS A 378 D 69 ILE A 248 ILE^? 17.37 ZN ZN A 375 D 70 VAL A 286 VAL^? 18.04 ZN ZN A 375 coo 33.21 28.24 12.68 34.93 27.24 13.36 29.42 -33.76 48.01 30.25 -31.91 48.55 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 37.93 -22.13 35.45 34.81 -22.43 31.07 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 40.92 -18.65 31.37 40.47 -19.69 32.14 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 46.33 -17.37 33.74 47.98 -15.99 33.42 1zme_d00 source 1zme TRANSCRIPTION/DNA : 10 hits 1zme_d00 naa= 4 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 1 3 # 1 C 43 GLN A 213 GLN~? 14.95 O1S EPE C 377 C 44 LYS A 215 LYS~? 16.65 O1S EPE C 377 C 75 ARG A 214 ARG~? 20.32 O1S EPE C 377 coo 34.33 34.01 1.06 32.24 34.35 1.22 16.78 -16.27 7.73 15.34 -16.06 9.27 coo 36.27 30.15 5.40 32.93 24.83 5.96 21.25 -14.20 2.18 27.53 -14.97 1.13 coo 30.88 29.31 6.12 29.39 29.02 3.47 17.59 -9.46 5.35 20.56 -9.02 6.23 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 2 3 # 2 C 43 GLN B 213 GLN~? 15.99 O1S EPE A 377 C 44 LYS B 215 LYS~? 17.38 O3S EPE A 377 C 75 ARG B 214 ARG~? 23.93 O3S EPE A 377 coo 34.33 34.01 1.06 32.24 34.35 1.22 -2.28 -25.33 18.62 -0.54 -24.65 19.67 coo 36.27 30.15 5.40 32.93 24.83 5.96 -9.31 -26.31 16.29 -12.50 -24.00 11.24 coo 30.88 29.31 6.12 29.39 29.02 3.47 -7.68 -23.63 22.44 -8.04 -24.96 25.17 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 3 3 # 3 C 43 GLN C 213 GLN~? -4.56 O1 TRS A 378s C 44 LYS C 215 LYS~? 17.39 O1 TRS A 378 C 75 ARG C 214 ARG~? 11.90 O1 TRS A 378 coo 34.33 34.01 1.06 32.24 34.35 1.22 20.02 -31.25 25.96 19.87 -29.21 25.35 coo 36.27 30.15 5.40 32.93 24.83 5.96 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 30.88 29.31 6.12 29.39 29.02 3.47 25.43 -31.91 31.60 26.96 -33.72 33.51 2er8_d00 source 2er8 TRANSCRIPTION ACTIVATOR/DNA : 3 hits 2er8_d00 naa= 3 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG A 274 ARG^? 15.42 ZN ZN A 374 A 50 LYS A 295 LYS.? 12.61 ZN ZN A 374 A 51 ASN A 294 ASN.? 12.36 ZN ZN A 374 coo 28.68 23.77 42.74 27.76 26.72 42.93 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 14.40 30.33 40.28 14.25 28.31 45.36 32.96 -9.31 39.54 28.55 -6.00 37.21 coo 19.09 30.55 41.51 19.09 28.89 42.82 35.77 -6.31 41.36 37.34 -5.07 42.10 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 5 ARG B 274 ARG^? 15.33 ZN ZN B 374 A 50 LYS B 295 LYS.? 11.37 ZN ZN B 375 A 51 ASN B 294 ASN.? 12.27 ZN ZN B 374 coo 28.68 23.77 42.74 27.76 26.72 42.93 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 14.40 30.33 40.28 14.25 28.31 45.36 4.57 8.76 22.84 2.39 5.01 24.93 coo 19.09 30.55 41.51 19.09 28.89 42.82 2.18 12.34 23.84 0.88 14.02 24.05 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 5 ARG C 274 ARG^? 15.09 ZN ZN C 374 A 50 LYS C 295 LYS.? 14.49 ZN ZN C 374 A 51 ASN C 294 ASN.? 11.92 ZN ZN C 374 coo 28.68 23.77 42.74 27.76 26.72 42.93 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 14.40 30.33 40.28 14.25 28.31 45.36 -2.95 -18.00 48.43 1.84 -13.91 47.77 coo 19.09 30.55 41.51 19.09 28.89 42.82 -3.30 -17.98 52.78 -3.53 -18.25 54.87 2hos_d00 source 2hos TRANSCRIPTION/DNA : 3 hits 2hos_d00 naa= 3 ULMN 5 2qby_d01 REPLICATION/DNA user 1 5 # 1 B 329 SER A 174 SER^? 9.43 O3S EPE C 377 B 331 ARG A 203 ARG^? 8.58 O3S EPE C 377 B 352 ASN C 238 ASN^? 16.63 O2S EPE A 377 B 355 ARG B 214 ARG~? 23.93 O3S EPE A 377 B 359 VAL B 233 VAL^? 13.35 O2S EPE A 377 coo -14.13 14.72 1.48 -15.52 15.15 3.40 14.12 -36.94 2.65 13.97 -36.44 5.09 coo -15.11 20.94 6.27 -14.66 21.23 9.31 10.96 -32.82 5.66 12.34 -31.74 8.19 coo -5.71 36.31 7.24 -7.65 37.04 6.84 5.28 -30.50 23.50 4.52 -30.81 21.55 coo -8.93 45.79 -2.11 -10.63 48.12 -3.14 -7.68 -23.63 22.44 -8.04 -24.96 25.17 coo -7.47 32.51 4.20 -9.52 33.27 4.03 4.19 -28.47 18.01 2.32 -27.56 18.53 ULMN 5 2qby_d01 REPLICATION/DNA user 2 5 # 2 B 329 SER C 174 SER^? 11.73 O3S EPE C 377 B 331 ARG C 203 ARG^? 8.27 O3S EPE C 377 B 352 ASN B 238 ASN^? 8.84 O1S EPE A 377 B 355 ARG A 214 ARG~? 20.32 O1S EPE C 377 B 359 VAL A 233 VAL^? 11.84 O1S EPE A 377 coo -14.13 14.72 1.48 -15.52 15.15 3.40 13.31 -42.10 8.38 13.05 -39.69 8.34 coo -15.11 20.94 6.27 -14.66 21.23 9.31 15.41 -35.90 9.66 13.77 -33.95 11.43 coo -5.71 36.31 7.24 -7.65 37.04 6.84 7.11 -18.54 9.31 8.52 -20.00 8.45 coo -8.93 45.79 -2.11 -10.63 48.12 -3.14 17.59 -9.46 5.35 20.56 -9.02 6.23 coo -7.47 32.51 4.20 -9.52 33.27 4.03 12.65 -21.47 9.47 13.76 -19.72 8.97 2qby_d01 source 2qby REPLICATION/DNA : 2 hits 2qby_d01 naa= 5 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER B 211 SER.? 16.40 O1S EPE A 377 A 20 HIS B 21 HIS~? 17.19 ZN ZN B 375 A 22 LEU B 243 LEU^? 14.34 ZN ZN B 375 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -5.21 -19.23 16.51 -5.80 -18.14 14.41 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -4.82 -12.30 22.40 -5.26 -12.74 20.40 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -2.34 -6.48 15.24 -4.14 -7.33 14.39 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER B 267 SER~? 18.54 ZN ZN B 375 A 20 HIS B 263 HIS~? 20.98 ZN ZN B 375 A 22 LEU B 251 LEU^? 22.61 ZN ZN B 375 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -13.83 13.99 7.82 -11.74 14.03 6.57 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -9.35 15.85 4.33 -10.07 14.01 3.63 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -3.28 12.31 0.94 -3.84 13.59 2.55 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 18 SER C 211 SER.? 14.21 O1 TRS A 378 A 20 HIS C 21 HIS~? 17.02 O1 TRS A 378 A 22 LEU C 243 LEU^? 14.43 ZN ZN C 375 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 16.63 -31.54 32.35 15.08 -33.00 33.51 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 14.59 -28.36 37.80 14.05 -30.33 37.30 coo -14.55 2.62 13.63 -14.94 2.66 11.50 5.40 -30.33 38.72 6.46 -32.27 38.57 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 3 hits 3gxq_d00 naa= 3 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 1 4 # 1 B 122 ARG A 274 ARG^? 15.42 ZN ZN A 374 B 148 LYS A 301 LYS~? 24.94 ZN ZN A 375 B 151 LEU A 324 LEU~? 22.85 ZN ZN A 375 B 154 ILE A 297 ILE~? 17.21 ZN ZN A 374 coo 13.00 32.05 60.31 16.02 31.73 59.80 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 11.05 44.13 44.68 12.77 44.45 49.56 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 11.72 38.91 44.77 13.11 39.67 46.23 38.83 -17.83 45.97 36.79 -17.52 45.31 coo 7.03 36.97 46.99 7.83 37.90 47.52 37.67 -13.06 42.03 37.68 -12.21 43.11 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 2 4 # 2 B 122 ARG A 274 ARG^? 15.42 ZN ZN A 374 B 148 LYS A 301 LYS~? 24.94 ZN ZN A 375 B 151 LEU A 326 LEU.? 19.87 ZN ZN A 375 B 154 ILE A 297 ILE~? 17.21 ZN ZN A 374 coo 13.00 32.05 60.31 16.02 31.73 59.80 47.87 -1.95 44.32 44.79 -1.96 44.32 coo 11.05 44.13 44.68 12.77 44.45 49.56 39.11 -19.59 40.11 42.80 -21.77 43.38 coo 11.72 38.91 44.77 13.11 39.67 46.23 41.91 -16.58 43.18 41.53 -16.00 41.11 coo 7.03 36.97 46.99 7.83 37.90 47.52 37.67 -13.06 42.03 37.68 -12.21 43.11 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 3 4 # 3 B 122 ARG B 274 ARG^? 15.33 ZN ZN B 374 B 148 LYS B 301 LYS~? 25.03 ZN ZN B 375 B 151 LEU B 324 LEU~? 22.99 ZN ZN B 375 B 154 ILE B 297 ILE~? 17.30 ZN ZN B 374 coo 13.00 32.05 60.31 16.02 31.73 59.80 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 11.05 44.13 44.68 12.77 44.45 49.56 8.36 10.35 11.75 10.05 14.82 9.04 coo 11.72 38.91 44.77 13.11 39.67 46.23 10.75 15.22 14.78 11.25 13.52 16.05 coo 7.03 36.97 46.99 7.83 37.90 47.52 5.95 12.58 17.93 6.10 13.55 18.88 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 4 4 # 4 B 122 ARG B 274 ARG^? 15.33 ZN ZN B 374 B 148 LYS B 301 LYS~? 25.03 ZN ZN B 375 B 151 LEU B 326 LEU.? 20.03 ZN ZN B 375 B 154 ILE B 297 ILE~? 17.30 ZN ZN B 374 coo 13.00 32.05 60.31 16.02 31.73 59.80 -4.90 23.06 20.40 -3.60 21.04 22.31 coo 11.05 44.13 44.68 12.77 44.45 49.56 8.36 10.35 11.75 10.05 14.82 9.04 coo 11.72 38.91 44.77 13.11 39.67 46.23 6.72 15.30 12.83 5.45 13.58 12.99 coo 7.03 36.97 46.99 7.83 37.90 47.52 5.95 12.58 17.93 6.10 13.55 18.88 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 5 4 # 5 B 122 ARG C 153 ARG~? 15.97 C2 EPE C 377 B 148 LYS C 215 LYS~? 17.39 O1 TRS A 378 B 151 LEU C 212 LEU~? 13.73 O1 TRS A 378 B 154 ILE C 208 ILE^? 11.16 O1 TRS A 378 coo 13.00 32.05 60.31 16.02 31.73 59.80 15.73 -46.74 16.59 16.35 -47.76 13.75 coo 11.05 44.13 44.68 12.77 44.45 49.56 22.70 -37.10 29.95 20.60 -41.87 33.53 coo 11.72 38.91 44.77 13.11 39.67 46.23 16.61 -35.95 30.24 15.92 -37.59 31.51 coo 7.03 36.97 46.99 7.83 37.90 47.52 14.70 -34.97 25.78 15.99 -34.85 25.27 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 6 4 # 6 B 122 ARG C 274 ARG^? 15.09 ZN ZN C 374 B 148 LYS C 301 LYS~? 24.63 ZN ZN C 375 B 151 LEU C 324 LEU~? 22.87 ZN ZN C 375 B 154 ILE C 297 ILE~? 17.14 ZN ZN C 374 coo 13.00 32.05 60.31 16.02 31.73 59.80 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 11.05 44.13 44.68 12.77 44.45 49.56 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 11.72 38.91 44.77 13.11 39.67 46.23 -14.93 -18.61 47.10 -13.23 -17.62 46.16 coo 7.03 36.97 46.99 7.83 37.90 47.52 -8.93 -19.74 48.91 -8.97 -18.72 49.85 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 7 4 # 7 B 122 ARG C 274 ARG^? 15.09 ZN ZN C 374 B 148 LYS C 301 LYS~? 24.63 ZN ZN C 375 B 151 LEU C 326 LEU.? 19.90 ZN ZN C 375 B 154 ILE C 297 ILE~? 17.14 ZN ZN C 374 coo 13.00 32.05 60.31 16.02 31.73 59.80 -8.42 -22.35 63.85 -6.68 -20.58 62.11 coo 11.05 44.13 44.68 12.77 44.45 49.56 -12.73 -23.25 44.05 -17.55 -23.96 45.92 coo 11.72 38.91 44.77 13.11 39.67 46.23 -14.03 -22.47 49.19 -12.29 -23.67 48.73 coo 7.03 36.97 46.99 7.83 37.90 47.52 -8.93 -19.74 48.91 -8.97 -18.72 49.85 3odc_d00 source 3odc DNA BINDING PROTEIN/DNA : 7 hits 3odc_d00 naa= 4 ULMN 3 3pta_d00 TRANSFERASE/DNA user 1 3 # 1 A 682 SER A 267 SER~? 18.73 ZN ZN A 375 A 683 LYS A 265 LYS~? 22.38 ZN ZN A 374 A 684 GLN A 266 GLN~? 23.95 ZN ZN A 374 coo -8.24 -20.23 36.50 -7.44 -18.27 37.68 54.41 -7.54 28.59 54.43 -9.91 28.92 coo -5.30 -22.52 37.30 -6.47 -26.26 32.30 54.99 -5.46 33.76 58.41 -3.92 38.21 coo -3.80 -18.22 38.13 -1.93 -17.88 37.17 59.53 -7.13 31.68 60.94 -5.69 30.89 ULMN 3 3pta_d00 TRANSFERASE/DNA user 2 3 # 2 A 682 SER B 267 SER~? 18.54 ZN ZN B 375 A 683 LYS B 265 LYS~? 21.91 ZN ZN B 374 A 684 GLN B 266 GLN~? 23.22 ZN ZN B 374 coo -8.24 -20.23 36.50 -7.44 -18.27 37.68 -13.83 13.99 7.82 -11.74 14.03 6.57 coo -5.30 -22.52 37.30 -6.47 -26.26 32.30 -12.32 18.80 10.54 -12.89 23.62 10.63 coo -3.80 -18.22 38.13 -1.93 -17.88 37.17 -14.31 19.60 6.00 -15.56 21.05 7.00 ULMN 3 3pta_d00 TRANSFERASE/DNA user 3 3 # 3 A 682 SER C 267 SER~? 17.79 ZN ZN C 375 A 683 LYS C 265 LYS~? 21.95 ZN ZN C 374 A 684 GLN C 266 GLN~? 22.05 ZN ZN C 375 coo -8.24 -20.23 36.50 -7.44 -18.27 37.68 -6.30 -39.53 58.90 -6.77 -39.38 56.53 coo -5.30 -22.52 37.30 -6.47 -26.26 32.30 -8.06 -35.63 62.23 -11.30 -33.36 66.69 coo -3.80 -18.22 38.13 -1.93 -17.88 37.17 -8.78 -41.84 62.14 -8.45 -42.48 60.10 3pta_d00 source 3pta TRANSFERASE/DNA : 3 hits 3pta_d00 naa= 3 ULMN 5 3sm4_d00 HYDROLASE/DNA user 1 5 # 1 B 53 MET A 313 MET.? 14.44 ZN ZN A 374 B 73 VAL A 286 VAL^? 18.04 ZN ZN A 375 B 75 ALA A 118 ALA~? 13.84 ZN ZN A 375 B 77 ALA A 120 ALA~? 14.58 ZN ZN A 375 B 78 LEU A 121 LEU~? 15.51 ZN ZN A 375 coo 6.68 -12.20 6.91 4.65 -8.54 6.72 41.01 -4.53 42.47 40.91 -7.82 42.53 coo 4.09 -11.16 -10.83 4.39 -11.22 -8.63 46.33 -17.37 33.74 47.98 -15.99 33.42 coo -0.13 -5.63 -11.43 -0.24 -5.75 -9.91 46.25 -12.61 26.18 45.07 -13.50 25.76 coo 0.92 -0.50 -9.34 0.65 -0.74 -7.86 50.64 -9.84 24.82 50.10 -8.49 25.27 coo 4.14 -4.02 -10.28 4.18 -5.28 -8.49 50.00 -12.35 28.89 49.39 -10.93 30.41 3sm4_d00 source 3sm4 HYDROLASE/DNA : 1 hits 3sm4_d00 naa= 5 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 21 GLN A 299 GLN~? 16.37 O3 TRS A 378 A 41 TYR A 296 TYR~? 11.37 ZN ZN A 375 A 43 ASN A 298 ASN~? 20.81 ZN ZN A 375 coo 22.03 6.35 12.16 20.71 6.08 10.54 33.95 -17.11 35.05 32.58 -18.75 34.74 coo 18.67 0.21 9.03 16.70 -1.66 8.55 34.09 -11.35 35.81 31.97 -10.07 34.54 coo 14.90 7.30 8.78 14.25 8.14 6.97 33.43 -16.52 41.59 33.28 -16.25 43.67 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 21 GLN A 299 GLN~? 16.37 O3 TRS A 378 A 41 TYR A 308 TYR^? 13.26 ZN ZN A 375 A 43 ASN A 298 ASN~? 20.81 ZN ZN A 375 coo 22.03 6.35 12.16 20.71 6.08 10.54 33.95 -17.11 35.05 32.58 -18.75 34.74 coo 18.67 0.21 9.03 16.70 -1.66 8.55 41.62 -12.73 37.70 39.41 -11.19 36.83 coo 14.90 7.30 8.78 14.25 8.14 6.97 33.43 -16.52 41.59 33.28 -16.25 43.67 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 21 GLN B 299 GLN~? 17.46 ZN ZN B 375 A 41 TYR B 296 TYR~? 11.48 ZN ZN B 375 A 43 ASN B 298 ASN~? 20.72 ZN ZN B 375 coo 22.03 6.35 12.16 20.71 6.08 10.54 6.31 4.03 15.31 7.61 2.36 15.77 coo 18.67 0.21 9.03 16.70 -1.66 8.55 3.06 5.94 19.61 2.50 3.84 21.38 coo 14.90 7.30 8.78 14.25 8.14 6.97 10.01 8.80 17.91 11.11 10.10 19.21 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 21 GLN B 299 GLN~? 17.46 ZN ZN B 375 A 41 TYR B 308 TYR^? 13.33 ZN ZN B 375 A 43 ASN B 298 ASN~? 20.72 ZN ZN B 375 coo 22.03 6.35 12.16 20.71 6.08 10.54 6.31 4.03 15.31 7.61 2.36 15.77 coo 18.67 0.21 9.03 16.70 -1.66 8.55 1.32 11.76 14.56 0.84 10.00 16.68 coo 14.90 7.30 8.78 14.25 8.14 6.97 10.01 8.80 17.91 11.11 10.10 19.21 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 21 GLN C 299 GLN~? 18.18 ZN ZN C 375 A 41 TYR C 296 TYR~? 11.54 ZN ZN C 375 A 43 ASN C 298 ASN~? 20.98 ZN ZN C 375 coo 22.03 6.35 12.16 20.71 6.08 10.54 -5.59 -23.33 41.58 -5.78 -22.85 39.46 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -2.51 -21.77 46.19 0.10 -20.95 45.58 coo 14.90 7.30 8.78 14.25 8.14 6.97 -8.94 -17.91 43.67 -9.93 -16.29 44.63 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 21 GLN C 299 GLN~? 18.18 ZN ZN C 375 A 41 TYR C 308 TYR^? 13.34 ZN ZN C 375 A 43 ASN C 298 ASN~? 20.98 ZN ZN C 375 coo 22.03 6.35 12.16 20.71 6.08 10.54 -5.59 -23.33 41.58 -5.78 -22.85 39.46 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -8.26 -25.36 50.23 -5.59 -24.48 49.71 coo 14.90 7.30 8.78 14.25 8.14 6.97 -8.94 -17.91 43.67 -9.93 -16.29 44.63 3ssc_d00 source 3ssc DNA BINDING PROTEIN/DNA : 6 hits 3ssc_d00 naa= 3 ULMN 3 3uby_d00 HYDROLASE/DNA user 1 3 # 1 A 162 TYR A 315 TYR~? 21.30 O8 EPE A 376 A 164 MET A 313 MET.? 14.44 ZN ZN A 374 A 165 TYR A 314 TYR~? 12.17 O8 EPE A 376 coo 9.07 -0.64 37.53 6.51 -1.49 38.21 41.01 -3.77 51.66 42.24 -4.43 54.10 coo 15.31 0.97 33.48 17.04 -1.81 36.11 41.01 -4.53 42.47 40.91 -7.82 42.53 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 36.88 -2.62 44.67 35.35 -1.67 42.53 ULMN 3 3uby_d00 HYDROLASE/DNA user 2 3 # 2 A 162 TYR B 315 TYR~? 21.53 O8 EPE B 376 A 164 MET B 313 MET.? 15.01 ZN ZN B 374 A 165 TYR B 314 TYR~? 14.73 O8 EPE B 376 coo 9.07 -0.64 37.53 6.51 -1.49 38.21 4.11 23.72 25.55 5.20 26.22 24.94 coo 15.31 0.97 33.48 17.04 -1.81 36.11 -1.01 16.88 22.10 1.78 16.47 20.27 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 2.08 17.58 27.10 3.13 18.35 29.60 ULMN 3 3uby_d00 HYDROLASE/DNA user 3 3 # 3 A 162 TYR C 315 TYR~? 21.59 O8 EPE C 376 A 164 MET C 313 MET.? 14.23 ZN ZN C 374 A 165 TYR C 314 TYR~? 12.22 O8 EPE C 376 coo 9.07 -0.64 37.53 6.51 -1.49 38.21 -10.50 -13.02 60.73 -13.04 -12.15 61.66 coo 15.31 0.97 33.48 17.04 -1.81 36.11 -5.68 -20.02 57.53 -7.42 -20.42 54.94 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 -3.69 -15.10 57.54 -1.00 -15.00 58.41 3uby_d00 source 3uby HYDROLASE/DNA : 3 hits 3uby_d00 naa= 3 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 1 3 # 1 B 442 LYS A 282 LYS^? 34.08 ZN ZN A 375 B 443 VAL A 283 VAL^? 24.05 ZN ZN A 375 B 447 ARG A 284 ARG^? 28.58 ZN ZN A 375 coo -11.49 8.72 29.13 -11.20 3.78 25.16 53.78 -21.68 41.24 59.13 -25.09 41.65 coo -11.96 6.22 31.96 -10.74 4.61 32.81 51.81 -20.25 38.35 51.17 -18.13 38.40 coo -14.58 4.58 36.41 -12.11 2.82 36.84 52.06 -24.03 32.92 53.49 -25.85 30.90 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 2 3 # 2 B 442 LYS B 282 LYS^? 32.80 ZN ZN B 375 B 443 VAL B 283 VAL^? 24.18 ZN ZN B 375 B 447 ARG B 284 ARG^? 30.04 ZN ZN B 375 coo -11.49 8.72 29.13 -11.20 3.78 25.16 2.91 20.00 1.64 2.74 22.03 -3.14 coo -11.96 6.22 31.96 -10.74 4.61 32.81 1.54 16.78 3.04 0.28 17.56 4.75 coo -14.58 4.58 36.41 -12.11 2.82 36.84 1.85 12.86 -2.25 0.88 12.89 -5.16 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 3 3 # 3 B 442 LYS C 282 LYS^? 31.82 ZN ZN C 375 B 443 VAL C 283 VAL^? 24.17 ZN ZN C 375 B 447 ARG C 284 ARG^? 27.80 ZN ZN C 375 coo -11.49 8.72 29.13 -11.20 3.78 25.16 -21.96 -32.19 51.48 -24.68 -36.28 53.46 coo -11.96 6.22 31.96 -10.74 4.61 32.81 -18.34 -32.67 50.40 -17.17 -32.05 52.16 coo -14.58 4.58 36.41 -12.11 2.82 36.84 -17.70 -37.64 45.94 -17.45 -40.51 44.86